FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Okafor, CC
   Haleem-Smith, H
   Laqueriere, P
   Manner, PA
   Tuan, RS
AF Okafor, CC
   Haleem-Smith, H
   Laqueriere, P
   Manner, PA
   Tuan, RS
TI Particulate endocytosis mediates biological responses of human
   mesenchymal stem cells to titanium wear debris
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE mesenchymal stem cells; wear debris; endocytosis; titanium; osteolysis;
   aseptic loosening; orthopedic prosthesis
ID TOTAL HIP-REPLACEMENT; IN-VITRO; PARTICLES; OSTEOBLASTS; OSTEOLYSIS;
   PROSTHESES; ARTHROPLASTY; IMPLANTS; REVISION; MARROW
AB Continual loading and articulation cycles undergone by metallic (e.g., titanium) alloy arthroplasty prostheses lead to liberation of a large number of metallic debris particulates, which have long been implicated as a primary cause of periprosthetic osteolysis and postarthroplasty aseptic implant loosening. Long-term stability of total joint replacement prostheses relies on proper integration between implant biomaterial and osseous tissue, and factors that interfere with this integration are likely to cause osteolysis. Because multipotent mesenchymal stem cells (MSCs) located adjacent to the implant have an osteoprogenitor function and are critical contributors to osseous tissue integrity, when their functions or activities are compromised, osteollysis will most likely occur. To date, it is not certain or sufficiently confirmed whether MSCs endocytose titanium particles, and if so, whether particulate endocytosis has any effect on cellular responses to wear debris. This study seeks to clarify the phenomenon of titanium endocytosis by human MSCs (hMSCs), and investigates the influence of endocytosis on their activities. hMSCs incubated with commercially pure titanium particles exhibited internalized particles, as observed by scanning electron microscopy and confocal laser scanning microscopy, with time-dependent reduction in the number of extracellular particles. Particulate endocytosis was associated with reduced rates of cellular proliferation and cell-substrate adhesion, suppressed osteogenic differentiation, and increased rate of apoptosis. These cellular effects of exposure to titanium particles were reduced when endocytosis was inhibited by treatment with cytochalasin D, and no significant effect was seen when hMSCs were treated only with conditioned medium obtained from particulate-treated cells. These findings strongly suggest that the biological responses of hMSCs to wear debris are triggered primarily by the direct endocytosis of titanium particulates, and not mediated by secreted soluble factors. In this manner, therapeutical approaches that suppress particle endocytosis could reduce the bioreactivity of hMSCs to particulates, and enhance long-term orthopedic implant prognosis by minimizing wear-debris periprosthethic osteolysis. (c) 2006 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.
C1 NIAMSD, Cartilage Biol & Orthopaed Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.
   NIH, Div Bioengn & Phys Sci, Off Res Serv, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.
   George Washington Univ, Dept Orthopaed Surg, Washington, DC 20037 USA.
RP Tuan, RS (reprint author), Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA.
EM tuanr@mail.nih.gov
RI Laquerriere, Patrice/P-1025-2016
OI Laquerriere, Patrice/0000-0001-7637-9094
FU NIAMS NIH HHS [Z01 AR41113]
CR *AM AC ORTH SURG P, PROJ TOT HIP TOT KNE
   Blaine TA, 1996, J BONE JOINT SURG AM, V78A, P1181, DOI 10.2106/00004623-199608000-00008
   Brown TD, 2002, J BIOMECH ENG-T ASME, V124, P691, DOI 10.1115/1.1517275
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   CALLAGHAN JJ, 1985, J BONE JOINT SURG AM, V67A, P1074, DOI 10.2106/00004623-198567070-00011
   Callaghan JJ, 2002, CLIN ORTHOP RELAT R, P144, DOI 10.1097/01.blo.0000038471.05771.a2
   Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245
   Engh CA, 1997, J BONE JOINT SURG AM, V79A, P1721, DOI 10.2106/00004623-199711000-00014
   Fisher J, 1998, J BONE JOINT SURG BR, V80B, P190
   FRIEDMAN RJ, 1994, INST COURSE LECT, V43, P33
   Fritz EA, 2002, J ORTHOPAED RES, V20, P490, DOI 10.1016/S0736-0266(01)00154-1
   GLANT TT, 1994, J ORTHOPAED RES, V12, P720, DOI 10.1002/jor.1100120515
   Goodman S, 2005, ORTHOP CLIN N AM, V36, P41, DOI 10.1016/j.ocl.2004.06.015
   Granchi D, 2005, BIOMATERIALS, V26, P2371, DOI 10.1016/j.biomaterials.2004.07.0145
   Grottkau BE, 2002, J BIOMED MATER RES, V59, P288, DOI 10.1002/jbm.1244
   HANSSEN AD, 1988, J BONE JOINT SURG AM, V70A, P491, DOI 10.2106/00004623-198870040-00003
   Hirakawa K, 1996, J BONE JOINT SURG AM, V78A, P1235, DOI 10.2106/00004623-199608000-00014
   Jacobs JJ, 2001, CLIN ORTHOP RELAT R, P71
   Jacobs JJ, 1994, J AM ACAD ORTHOP SUR, V2, P212
   JAZRAWI LM, 1999, ARTHROPLASTY ARTHROS, V10, P1
   Konttinen YT, 2005, CLIN ORTHOP RELAT R, P28, DOI 10.1097/01.blo.0000150451.50452.da
   Maloney WJ, 1996, CLIN ORTHOP RELAT R, P268
   MARGEVICIUS KJ, 1994, J BONE JOINT SURG AM, V76A, P1664, DOI 10.2106/00004623-199411000-00010
   Mjoberg B, 1997, ORTHOPEDICS, V20, P1169
   Okafor CC, 2006, J ORTHOP RES, V24, P461, DOI 10.1002/jor.20075
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603
   Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Wang JC, 1999, SPINE, V24, P899, DOI 10.1097/00007632-199905010-00011
   Wang ML, 2004, J ARTHROPLASTY, V19, P1028, DOI 10.1016/j.arth.2004.03.024
   Wang ML, 2003, J ORTHOPAED RES, V21, P697, DOI 10.1016/S0736-0266(02)00241-3
   Wang ML, 2002, J ORTHOPAED RES, V20, P1175, DOI 10.1016/S0736-0266(02)00076-1
   Wooley PH, 2004, GENE THER, V11, P402, DOI 10.1038/sj.gt.3302202
NR 34
TC 48
Z9 48
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0736-0266
J9 J ORTHOP RES
JI J. Orthop. Res.
PD MAR
PY 2006
VL 24
IS 3
BP 461
EP 473
DI 10.1002/jor.20075
PG 13
WC Orthopedics
SC Orthopedics
GA 020OT
UT WOS:000235919900021
PM 16450379
OA Bronze
DA 2018-10-20
ER

PT J
AU Mushipe, MT
   Chen, X
   Jennings, D
   Li, G
AF Mushipe, MT
   Chen, X
   Jennings, D
   Li, G
TI Cells seeded on MBG scaffold survive impaction grafting technique:
   Potential application of cell-seeded biomaterials for revision
   arthroplasty
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE revision arthroplasty; impaction grafting; cell survival; allograft bone
   substitute; tissue engineering
ID TOTAL HIP-ARTHROPLASTY; TRICALCIUM PHOSPHATE; BONE-MATRIX; ALLOGRAFT;
   HYDROXYAPATITE; RECONSTRUCTION; CEMENT
AB The objective of this study was to investigate the potential application of cell-seeded biomaterials for revision arthroplasty and the reconstruction of major joints using the impaction grafting technique. Using morselized cancellous bone graft as a porous scaffold, MG63 cells were seeded on the scaffold and impacted into an acetabulum cup model using a mechanical device constructed from data obtained during impaction grafting by an orthopedic surgeon. Immediately after impaction, cells were trypsinized from the scaffold and processed for cell survival rates using the double-stranded DNA PicoGreen((R)) assay. Significant reductions in viable cells were obsened between the fifth impact and both the first and second impacts (p < 0.01 and p < 0.05, respectively). Cell survival rate was 21.5% after five impacts. The biological performance of cell-seeded biomaterials may be enhanced by these surviving cells. Compared to allograft bone that is not osteogenic, a cell-seeded biomaterial might also be a suitable substitute for allograft bone for major joint reconstruction at revision arthroplasty. (c) 2006 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.
C1 Queens Univ Belfast, Musgrave Pk Hosp, Sch Med & Dent, Musculoskeletal Educ & Res Unit, Belfast BT9 7JB, Antrim, North Ireland.
   Royal Grp Hosp, Belfast BT12 6BA, Antrim, North Ireland.
RP Mushipe, MT (reprint author), Queens Univ Belfast, Musgrave Pk Hosp, Sch Med & Dent, Musculoskeletal Educ & Res Unit, Belfast BT9 7JB, Antrim, North Ireland.
EM m.mushipe@qub.ac.uk
CR Best S, 1997, J MATER SCI-MATER M, V8, P97, DOI 10.1023/A:1018558816871
   Blom AW, 2002, P I MECH ENG H, V216, P265, DOI 10.1243/09544110260138754
   Bolder SBT, 2002, BIOMATERIALS, V23, P659, DOI 10.1016/S0142-9612(01)00153-3
   COCKIN J, 1971, J BONE JOINT SURG BR, V53, P153
   Eldridge JDJ, 2003, BIOMATERIALS, V24, P499, DOI 10.1016/S0142-9612(02)00363-0
   FEITH R, 1975, ACTA ORTHOP SCAND S, V161, P1
   FINERMAN GAM, 1998, TOTAL HIP ARTHROPLAS
   Galea G, 1998, J BONE JOINT SURG BR, V80B, P595, DOI 10.1302/0301-620X.80B4.8240
   GIE GA, 1993, J BONE JOINT SURG BR, V75, P14
   GIE GA, 1993, ORTHOP CLIN N AM, V24, P717
   Gierse H, 1999, ARCH ORTHOP TRAUM SU, V119, P349, DOI 10.1007/s004020050426
   HEINER AD, 2004, COMMUNICATION
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V157, P257
   JEFFERISS CD, 1975, J BONE JOINT SURG BR, V57, P511
   Kasten P, 2003, BIOMATERIALS, V24, P2593, DOI 10.1016/S0142-9612(03)00062-0
   LAVERNIA C, 1991, AM CERAM SOC BULL, V70, P95
   LEGEROS RZ, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P3
   LINDER L, 1977, J BONE JOINT SURG AM, V59, P82, DOI 10.2106/00004623-197759010-00015
   MALCHAU H, 1993, ACTA ORTHOP SCAND, V64, P497, DOI 10.3109/17453679308993679
   Mushipe MT, 2006, J ORTHOP RES, V24, P501, DOI 10.1002/jor.20044
   Mushipe MT, 2002, BIOMATERIALS, V23, P365, DOI 10.1016/S0142-9612(01)00114-4
   NIXON JR, 2003, CONSULTANT ORTHOPAED
   Pratt JNJ, 2002, BIOMATERIALS, V23, P3309, DOI 10.1016/S0142-9612(02)00018-2
   Ramires PA, 2002, BIOMATERIALS, V23, P397, DOI 10.1016/S0142-9612(01)00118-1
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP
   RICHARDSON JB, 2001, MAKING MAJOR IMPACT
   Simon J-P, 1991, J BONE JOINT SURG BR, V73, P73
   SLOOFF TJJ, 1998, ADULT HIP
   Vacanti C, 2004, SCIENTIST, V18, P22
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
NR 30
TC 10
Z9 10
U1 1
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0736-0266
J9 J ORTHOP RES
JI J. Orthop. Res.
PD MAR
PY 2006
VL 24
IS 3
BP 501
EP 507
DI 10.1002/jor.20044
PG 7
WC Orthopedics
SC Orthopedics
GA 020OT
UT WOS:000235919900025
PM 16453344
OA Bronze
DA 2018-10-20
ER

PT J
AU Pennekamp, PH
   Gessmann, J
   Diedrich, O
   Burian, B
   Wimmer, MA
   Frauchiger, VM
   Kraft, CN
AF Pennekamp, PH
   Gessmann, J
   Diedrich, O
   Burian, B
   Wimmer, MA
   Frauchiger, VM
   Kraft, CN
TI Short-term microvascular response of striated muscle to cp-Ti,
   Ti-6Al-4V, and Ti-6Al-7Nb
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE titanium; Ti-6Al-4V; Ti-6AI-7Nb; microcirculation; biocompatibility
ID COMPARATIVE IN-VIVO; STAINLESS-STEEL; IMPLANT MATERIALS; TITANIUM-ALLOY;
   METAL; VITRO; CORROSION; MICROCIRCULATION; PROSTHESES; BIOMATERIAL
AB Due to excellent mechanical properties and good corrosion resistance, titanium-aluminium-vanadium (Ti-6Al-4V) and titanium-aluminium-niobium (Ti-6Al-7Nb) are extensively used for orthopedic surgery. Concern has been voiced concerning the implications of the constituent vanadium in Ti-6Al-4V on the surrounding environment. Particularly in osteosynthesis where the alloys stand in direct contact to skeletal muscle, undesirable biologic reactions may have severe consequences. In a comparative study, we assessed in vivo nutritive perfusion and leukocytic response of striated muscle to the metals Ti-6Al-4V, Ti-6Al-7Nb, and commercially pure titanium (ep-Ti), thereby drawing conclusions on their short-term inflammatory potential. In 28 banisters, utilizing the dorsal skinfold chamber preparation and intravital microscopy, we quantified primary and secondary leukocyte-endothelial cell interaction, leukocyte extravasation, microvascular diameter change, and capillary perfusion in collecting and postcapillary venules of skeletal muscle. A manifest discrepancy between the metals concerning impact on local microvascular parameters was not found. All metals induced an only transient and moderate inflammatory response. Only a slight increase in leukocyte recruitment and a more sluggish recuperation of inflammatory parameters in animals treated with Ti-6Al-4V compared to the other two metals suggested a minor, overall not significant discrepancy in biocompatibility. Gross toxicity of bulk Ti-6Al-4V on surrounding tissue could not be found. Conclusively, the commonly used biomaterials Ti-6Al-4V, Ti-6A1-7NTb, and cp-Ti induce an only transient inflammatory answer of the skeletal muscle microvascular system. Our results indicate that on the microvascular level the tested bulk Ti-alloys and cpTi do not cause adverse biologic reactions in striated muscle. (c) 2006 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.
C1 Univ Bonn, Dept Orthoped Surg, D-53105 Bonn, Germany.
   Univ Basel, Dept Surg, Basel, Switzerland.
   Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA.
   Robert Mathys Fdn, Bettlach, Switzerland.
RP Pennekamp, PH (reprint author), Univ Bonn, Dept Orthoped Surg, Sigmund Freud Str 25, D-53105 Bonn, Germany.
EM peter.pennekamp@uni-bonn.de
CR Brunner J, 2000, MICROCIRCULATION, V7, P103, DOI 10.1038/sj.mn.7300094
   Chen FS, 1999, J BIOMED MATER RES, V48, P904, DOI 10.1002/(SICI)1097-4636(1999)48:6<904::AID-JBM21>3.0.CO;2-5
   DISEGI JA, 2000, INJURY S, V4, P14
   DORR LD, 1990, CLIN ORTHOP RELAT R, P82
   ENDRICH B, 1980, RES EXP MED, V177, P125, DOI 10.1007/BF01851841
   FANTONE JC, 1982, AM J PATHOL, V107, P397
   GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662
   HALLAB NJ, IN PRESS J TEST EVAL
   JACOBS JJ, 1991, J BONE JOINT SURG AM, V73A, P1475, DOI 10.2106/00004623-199173100-00005
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   Kim HK, 2004, J MATER SCI-MATER M, V15, P825, DOI 10.1023/B:JMSM.0000032824.62866.a1
   KIM KJ, 1994, J BONE JOINT SURG AM, V76A, P172, DOI 10.2106/00004623-199402000-00002
   Kraft CN, 2003, J BONE JOINT SURG BR, V85B, P133, DOI 10.1302/0301-620X.85B1.12749
   Kraft CN, 2001, J BIOMED MATER RES, V57, P404, DOI 10.1002/1097-4636(20011205)57:3<404::AID-JBM1183>3.0.CO;2-W
   Kraft CN, 2000, J BIOMED MATER RES, V49, P192, DOI 10.1002/(SICI)1097-4636(200002)49:2<192::AID-JBM6>3.0.CO;2-C
   McKay GC, 1996, BIOMATERIALS, V17, P1339, DOI 10.1016/0142-9612(96)88681-9
   MENGER MD, 1993, IMMUNOL TODAY, V14, P519, DOI 10.1016/0167-5699(93)90179-O
   Menger MD, 1996, BRIT J SURG, V83, P588, DOI 10.1002/bjs.1800830506
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   Pennekamp PH, 2006, J ORTHOP RES, V24, P531, DOI 10.1002/jor.20066
   Perren S. M., 1986, BIOL BIOMECHANICAL P, P397
   PRIES AR, 1988, INT J MICROCIRC, V7, P327
   RAE T, 1981, J BONE JOINT SURG BR, V63, P435
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Rogers SD, 1997, J BONE JOINT SURG BR, V79B, P311, DOI 10.1302/0301-620X.79B2.7192
   Ryhanen J, 1998, J BIOMED MATER RES, V41, P481, DOI 10.1002/(SICI)1097-4636(19980905)41:3<481::AID-JBM19>3.0.CO;2-L
   SCALES JT, 1991, J BONE JOINT SURG BR, V73, P534
   SEMLITSCH M, 1987, CLIN MATER, V2, P1, DOI DOI 10.1016/0267-6605(87)90015-1
   SEMLITSCH MF, 1992, BIOMATERIALS, V13, P781, DOI 10.1016/0142-9612(92)90018-J
   Shettlemore MG, 1999, J BIOMED MATER RES, V45, P395
   Sittig C, 1999, J MATER SCI-MATER M, V10, P35, DOI 10.1023/A:1008840026907
   SOLAR RJ, 1979, J BIOMED MATER RES, V13, P217, DOI 10.1002/jbm.820130206
   Sun ZL, 1997, J BIOMED MATER RES, V34, P29, DOI 10.1002/(SICI)1097-4636(199701)34:1<29::AID-JBM5>3.0.CO;2-P
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   THOMPSON GJ, 1995, J APPL BIOMATER, V6, P249, DOI 10.1002/jab.770060406
   Velten D, 2002, J BIOMED MATER RES, V59, P18, DOI 10.1002/jbm.1212
   WOODMAN J L, 1984, Journal of Orthopaedic Research, V1, P421
   Wooley PH, 2002, BIOMATERIALS, V23, P517, DOI 10.1016/S0142-9612(01)00134-X
NR 39
TC 20
Z9 20
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0736-0266
J9 J ORTHOP RES
JI J. Orthop. Res.
PD MAR
PY 2006
VL 24
IS 3
BP 531
EP 540
DI 10.1002/jor.20066
PG 10
WC Orthopedics
SC Orthopedics
GA 020OT
UT WOS:000235919900029
PM 16463365
OA Bronze
DA 2018-10-20
ER

PT J
AU Bouafsoun, A
   Othmane, A
   Kerkeni, A
   Jafferzic, N
   Ponsonnet, L
AF Bouafsoun, A
   Othmane, A
   Kerkeni, A
   Jafferzic, N
   Ponsonnet, L
TI Evaluation of endothelial cell adherence onto collagen and fibronectin:
   A comparison between jet impingement and flow chamber techniques
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT 4th Maghreb/Europe Meeting on Material and Their Applications for
   Devices and Physical, Chemical and Biological Sensors (MADICA 2004)
CY NOV 29-DEC 01, 2004
CL Tunis, TUNISIA
DE biomaterial; endothelial cell; cell adhesion; fibronectin; collagen
ID SHEAR-STRESS; DETACHMENT; POLYSTYRENE; SUBSTRATA; ADHESION; DEVICE;
   STATE; SERUM; GLASS; DISC
AB The study of the cell-biomaterial interface has been revolutionized by the understanding of molecular mechanisms and signaling cascades between living cells and their environment. A successful biomaterial is a product of sound knowledge of the material surface and molecular cell biology sciences, which allow us to establish accurate control of the interfacial interactions needed for biospecificity. To improve the cell-biomaterial interactions, we have functionalized polystyrene, which is a biomaterial commonly used for vascular implants, by adhesion proteins such as fibronectin and collagen. Cell adhesion remains an important goal of this study. This critical phenomenon that controls cell behavior was evaluated by two different techniques. We used a parallel plate flow chamber and jet impingement, which are effective and complementary devices for evaluating the strength of cell adhesion to the surface. (c) 2005 Elsevier B.V. All rights reserved.
C1 Ecole Cent Lyon, CNRS, Lab Ingn & Fonctionnarisat Surfaces, UMR 5005, F-69134 Ecully, France.
   Fac Med Monastir, Biophys Lab, Monastir 5019, Tunisia.
RP Ponsonnet, L (reprint author), Ecole Cent Lyon, CNRS, Lab Ingn & Fonctionnarisat Surfaces, UMR 5005, F-69134 Ecully, France.
EM Laurence.Ponsonnet@univ-rouen.fr
CR BARBEE KA, 1995, AM J PHYSIOL-HEART C, V37, pH1765
   Bouaziz A, 1997, BIOMATERIALS, V18, P107, DOI 10.1016/S0142-9612(96)00114-7
   Bouaziz A, 1996, BIOMATERIALS, V17, P2281, DOI 10.1016/0142-9612(96)00057-9
   Braddock M, 1998, NEWS PHYSIOL SCI, V13, P241
   BUNDY KJ, 2001, CELL BIOL INT, V4, P289
   CHARARA J, 1993, RBM, V15, P435
   De Keulenaer GW, 1998, CIRC RES, V82, P1094, DOI 10.1161/01.RES.82.10.1094
   Decave E, 2002, BIOPHYS J, V82, P2383, DOI 10.1016/S0006-3495(02)75583-5
   DESHPANDE MD, 1982, J FLUID MECH, V114, P213, DOI 10.1017/S0022112082000111
   DESHPANDE MD, 1983, J ENG MECH-ASCE, V109, P479, DOI 10.1061/(ASCE)0733-9399(1983)109:2(479)
   Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P763, DOI 10.1002/jbm.820220903
   Noria S, 1999, CIRC RES, V85, P504, DOI 10.1161/01.RES.85.6.504
   REUTELINGSPERGER CPM, 1994, J MATER SCI-MATER M, V5, P361, DOI 10.1007/BF00058964
   SCHAKENRAAD JM, 1988, CELL BIOPHYS, V13, P75, DOI 10.1007/BF02797367
   VAISHNAV RW, 1983, BIOMECH ENG, V105, P77
   VANKOOTEN TG, 1992, J BIOMED MATER RES, V26, P725, DOI 10.1002/jbm.820260604
   VANKOOTEN TG, 1994, COLLOID SURFACE B, V3, P147
   Yamamoto A, 2000, J BIOMED MATER RES, V50, P114, DOI 10.1002/(SICI)1097-4636(200005)50:2<114::AID-JBM4>3.3.CO;2-Y
NR 19
TC 21
Z9 21
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAR
PY 2006
VL 26
IS 2-3
SI SI
BP 260
EP 266
DI 10.1016/j.msec.2005.10.051
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 021VQ
UT WOS:000236014400019
DA 2018-10-20
ER

PT J
AU Kim, HY
   Ohmatsu, Y
   Kim, JI
   Inamura, T
   Hosoda, H
   Miyazaki, S
AF Kim, Hee Young
   Ohmatsu, Yoshinori
   Kim, Jae Il
   Inamura, Tomonari
   Hosoda, Hideki
   Miyazaki, Shuichi
TI Effect of Nb addition on shape memory behavior of Ti-Mo-Ga alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE shape memory alloy; superelasticity; biomaterial; smart material;
   titanium based alloy
ID MECHANICAL-PROPERTIES; INDUCED MARTENSITE; BIOMEDICAL ALLOYS;
   TITANIUM-ALLOYS; SUPERELASTICITY; DEFORMATION
AB Effect of Nb addition on mechanical properties and shape memory behavior of Ti-Mo-Ga alloys was investigated by cyclic loading-unloading tensile tests, tensile tests at various temperatures and Vickers hardness tests. The martensitic transformation start temperature (Ms) decreased by 20 K with 1 at% increase of Nb content in the Ti-6Mo-3Ga(at%) alloy. The shape memory effect was observed in the Ti-6Mo3Ga(at%) alloy. The superelastic strain increased with increasing Nb content. The increase of the yield stress during the cyclic deformation decreased the strain recovery rate in the Ti-6Mo-3Ga(at%) alloy. Aging at intermediate temperatures resulted in increase in hardness of the Ti6Mo-3Ga-(0-4)Nb(at%) alloys. The increase in hardness decreased significantly with increasing Nb content because the addition of Nb was effective to suppress the omega phase hardening. The yield stress decreased and the strain recovery rate increased with increasing number of cycle in the Ti-6Mo-3Ga-4Nb(at%) alloy.
C1 Univ Tsukuba, Inst Sci Mat, Tsukuba, Ibaraki 3058573, Japan.
   Dong A Univ, Pusan 604714, South Korea.
   Tokyo Inst Technol, Precis & Intelligent Lab, Yokohama, Kanagawa 2268503, Japan.
RP Miyazaki, S (reprint author), Univ Tsukuba, Inst Sci Mat, Tsukuba, Ibaraki 3058573, Japan.
EM miyazaki@ims.tsukuba.ac.jp
RI Miyazaki, Shuichi/A-3113-2012; Kim, Hee Young/F-6065-2011; Inamura,
   Tomonari/E-5712-2014
OI Miyazaki, Shuichi/0000-0003-3849-4176; Kim, Hee
   Young/0000-0003-1981-6678; 
CR Baker C., 1971, Metal Science Journal, V5, P92
   DUERIG TW, 1982, ACTA METALL MATER, V30, P2161, DOI 10.1016/0001-6160(82)90137-7
   FROES FH, 1980, METALL TRANS A, V11, P21, DOI 10.1007/BF02700435
   Fukui Y, 2004, MATER TRANS, V45, P1077, DOI 10.2320/matertrans.45.1077
   Grosdidier T, 2000, MAT SCI ENG A-STRUCT, V291, P218, DOI 10.1016/S0921-5093(00)00921-7
   Kim HY, 2006, MAT SCI ENG A-STRUCT, V417, P120, DOI 10.1016/j.msea.2005.10.065
   Kim HY, 2006, ACTA MATER, V54, P423, DOI 10.1016/j.actamat.2005.09.014
   Kim HY, 2004, MATER TRANS, V45, P2443, DOI 10.2320/matertrans.45.2443
   Kim HY, 2004, MATER TRANS, V45, P1090, DOI 10.2320/matertrans.45.1090
   Kim JI, 2005, MAT SCI ENG A-STRUCT, V403, P334, DOI 10.1016/j.msea.2005.05.050
   Kim JI, 2005, MATER TRANS, V46, P852, DOI 10.2320/matertrans.46.852
   LANGMAYR F, 1994, PHYS REV B, V49, P11759, DOI 10.1103/PhysRevB.49.11759
   Maeshima T, 2004, MATER TRANS, V45, P1101, DOI 10.2320/matertrans.45.1101
   Maeshima T, 2004, MATER TRANS, V45, P1096, DOI 10.2320/matertrans.45.1096
   MIYAZAKI S, 1986, METALL TRANS A, V17, P115, DOI 10.1007/BF02644447
   MIYAZAKI S, 1990, ENG ASPECTS SHAPE ME, P452
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Ohmatsu Y, 2001, 4 PAC RIM INT C ADV, P1627
   OKAZAKI Y, 1993, MATER T JIM, V34, P1217, DOI 10.2320/matertrans1989.34.1217
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
NR 20
TC 13
Z9 14
U1 0
U2 20
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD MAR
PY 2006
VL 47
IS 3
BP 518
EP 522
DI 10.2320/matertrans.47.518
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 046CS
UT WOS:000237789600016
OA Bronze
DA 2018-10-20
ER

PT J
AU Hayashi, Y
   Weber, CN
   Emoto, T
   Fujiwara, H
   Sanzen, N
   Futaki, S
   Sekiguchi, K
AF Hayashi, Y
   Weber, CN
   Emoto, T
   Fujiwara, H
   Sanzen, N
   Futaki, S
   Sekiguchi, K
TI A novel large-scale production system for modified basement membrane
   matrices using gene-swapped parietal endoderm cells
SO MATRIX BIOLOGY
LA English
DT Article
DE laminin; cre-lox system; biomaterial; tissue engineering;
   Engelbreth-Holm-Swann tumor
ID HOLM-SWARM TUMOR; LAMININ; IDENTIFICATION; EXPRESSION; SITES
AB Parietal endoderm-like cells, including Engelbreth-Holm-Swarm tumor and differentiated F9 embryonal carcinoma cells, produce huge amounts of basement membrane components, including laminin-1 (alpha 1 beta 1 gamma l). We employed a double-lox system-based gene-swapping strategy in F9 cells to replace the laminin alpha 1 gene with a laminin alpha 5 minigene. The gene-swapped F9 cells secreted laminin-10 (alpha 5 beta 1 gamma 1) consisting of the exogenous alpha 5 subunit and endogenous beta 1 and gamma 1 subunits on differentiation. The laminin-10 concentration in the conditioned medium exceeded 10 mg/l, which is 10-fold higher than the concentrations achieved by conventional recombinant expression systems. The gene-swapped F9 cells deposited basement membrane-like matrices containing laminin-10 on culture dishes, offering a novel microenvironment for in vitro cell manipulation. (c) 2005 Elsevier B.V/International Society of Matrix Biology. All rights reserved.
C1 Aichi Med Univ, JST, ERATO, Sekiguchi Biomatrix Signaling Project, Nagakute, Aichi 4801195, Japan.
   Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan.
RP Hayashi, Y (reprint author), Aichi Med Univ, JST, ERATO, Sekiguchi Biomatrix Signaling Project, 21 Karimata, Nagakute, Aichi 4801195, Japan.
EM hayashiy@riem.nagoya-u.ac.jp; sekiguch@protein.osaka-u.ac.jp
RI hayashi, yoshitaka/I-6168-2014; Fujiwara, Hironobu/A-5971-2016
OI hayashi, yoshitaka/0000-0002-7557-4303; Fujiwara,
   Hironobu/0000-0003-0883-3384
CR Araki K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf102
   Bethke B, 1997, NUCLEIC ACIDS RES, V25, P2828, DOI 10.1093/nar/25.14.2828
   Futaki S, 2003, J BIOL CHEM, V278, P50691, DOI 10.1074/jbc.M304985200
   Hayashi Y, 2004, MATRIX BIOL, V23, P47, DOI 10.1016/j.matbio.2004.02.003
   Hayashi Y, 2002, BIOCHEM BIOPH RES CO, V299, P498, DOI 10.1016/S0006-291X(02)02642-6
   Ido H, 2004, J BIOL CHEM, V279, P10946, DOI 10.1074/jbc.M313626200
   KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685
   Niimi T, 2003, J BIOL CHEM, V278, P9332, DOI 10.1074/jbc.M212578200
   Sasaki T, 2004, J CELL BIOL, V164, P959, DOI 10.1083/jcb.200401058
NR 11
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0945-053X
J9 MATRIX BIOL
JI Matrix Biol.
PD MAR
PY 2006
VL 25
IS 2
BP 85
EP 88
DI 10.1016/j.matbio.2005.10.004
PG 4
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 023OF
UT WOS:000236135400003
PM 16314080
DA 2018-10-20
ER

PT J
AU Han, D
   Gouma, PI
AF Han, Dong
   Gouma, Pelagia-Irene
TI Electrospun bioscaffolds that mimic the topology of extracellular matrix
SO NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
LA English
DT Article
AB Extracellular matrix (ECM) is a natural scaffold for cell, tissue, and organ growth. Its topology plays an important role in cell differentiation. There is a design challenge to fabricate biomaterials that mimic ECM's three-dimensional (3D) structures with defined shapes and complex porous architecture. The urinary bladder matrix (UBM) is used in this work as the model system of the ECM architecture. Cellulose acetate (CA) is the biomaterial of choice for building the UBM-mimicking scaffolds. Electrospinning is the fabrication method used to form complex, porous, 3D structures with specific design, in a single-step process. (c) 2006 Elsevier Inc. All rights reserved.
C1 SUNY Stony Brook, Dept Mat Sci & Engn, Stony Brook, NY 11794 USA.
RP Gouma, PI (reprint author), SUNY Stony Brook, Dept Mat Sci & Engn, Stony Brook, NY 11794 USA.
EM pgouma@notes.cc.sunysb.edu
CR ANTUCCI RA, 2005, INT BRAZ J UROL, V31, P192
   Badylak S. F., 2004, Clinical Techniques in Equine Practice, V3, P173, DOI 10.1053/j.ctep.2004.08.002
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   Berthiaume F, 1996, FASEB J, V10, P1471
   Colvert JR, 2002, J UROLOGY, V168, P1872, DOI 10.1097/01.ju.0000027285.05828.e6
   Cooper GM, 1997, CELL MOL APPROACH, P1
   Demir MM, 2002, POLYMER, V43, P3303, DOI 10.1016/S0032-3861(02)00136-2
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Entcheva E, 2004, BIOMATERIALS, V25, P5753, DOI 10.1016/j.biomaterials.2004.01.024
   Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   HAN D, 2005, MATER RES SOC S P, V845, pAA548
   Hodde JP, 2002, TISSUE ENG, V8, P225, DOI 10.1089/107632702753724996
   Kennedy J. F., 1985, CELLULOSE ITS DERIVA
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   KNAPP PM, 1994, J ENDOUROL, V8, P125, DOI 10.1089/end.1994.8.125
   Martson M, 1999, BIOMATERIALS, V20, P1989, DOI 10.1016/S0142-9612(99)00094-0
   Shin YM, 2001, POLYMER, V42, P9955, DOI 10.1016/S0032-3861(01)00540-7
   Sipe JD, 2002, ANN NY ACAD SCI, V961, P1, DOI 10.1111/j.1749-6632.2002.tb03040.x
   SKALAK R, 1988, NEW SERIES UCLA S MO, V107
   Wang A, 2004, POLYMER, V45, P5505, DOI 10.1016/j.polymer.2004.06.013
NR 21
TC 116
Z9 121
U1 7
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1549-9634
EI 1549-9642
J9 NANOMED-NANOTECHNOL
JI Nanomed.-Nanotechnol. Biol. Med.
PD MAR
PY 2006
VL 2
IS 1
BP 37
EP 41
DI 10.1016/j.nano.2006.01.002
PG 5
WC Nanoscience & Nanotechnology; Medicine, Research & Experimental
SC Science & Technology - Other Topics; Research & Experimental Medicine
GA 067XZ
UT WOS:000239337200005
PM 17292114
DA 2018-10-20
ER

PT J
AU Pradel, W
   Eckelt, U
   Lauer, G
AF Pradel, W
   Eckelt, U
   Lauer, G
TI Bone regeneration after enucleation of mandibular cysts: Comparing
   autogenous grafts from tissue-engineered bone and iliac bone
SO ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
LA English
DT Article
ID MATRIX; OSTEOINDUCTIVITY; MARSUPIALIZATION; RECONSTRUCTION;
   BIOMATERIALS; OSTEOBLASTS; SURGERY; MODEL
AB Objective. The aim of this study was to compare bone regeneration after grafting enucleated mandibular cyst cavities using either autogenous osteoblasts cultured on a biomaterial or autogenous spongiose iliac bone.
   Study design. Twenty patients with 22 mandibular cysts were assessed. Eleven cysts were filled in with tissue-engineered bone (autogenous osteblasts cultured on demineralized bone matrix Osteovit) and I I with spongiose iliac bone as controls. Panoramic radiographs were taken preoperatively, immediately postoperatively, and 3, 6, and 12 months after surgery. Radiolucency was computer analyzed using gray-level histograms.
   Results. In both groups bone regeneration took place in a similar fashion. After 3 and 6 months there were few differences in bone density between the groups. However, in radiographic controls after 12 months ossification was considerably stronger in cysts grafted with tissue-engineered bone.
   Conclusion. These results advocate for the clinical application of tissue-engineered bone as an alternative viable filling material for cysts.
C1 Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Oral & Maxillofacial Surg, Dresden, Germany.
RP Pradel, W (reprint author), Univ Hosp Carl Gustav Carus, Dept Oral & Maxillofacial Surg, Fetscherstr 74, D-01307 Dresden, Germany.
EM winnie.pradel@uniklinikum-dresden.de
CR Bodner L, 1998, DENTOMAXILLOFAC RAD, V27, P166, DOI 10.1038/sj.dmfr.4600344
   Bodner L, 1996, J ORAL MAXIL SURG, V54, P1282, DOI 10.1016/S0278-2391(96)90482-6
   Chen FL, 2002, J ORAL MAXIL SURG, V60, P1155, DOI 10.1053/joms.2002.34991
   Chiapasco M, 2000, J ORAL MAXIL SURG, V58, P942, DOI 10.1053/joms.2000.8732
   CONCANNON MJ, 1995, PLAST RECONSTR SURG, V95, P608
   Damante JH, 2002, DENTOMAXILLOFAC RAD, V31, P182, DOI 10.1038/sj/dmfr/4600696
   Furuki Y, 1997, DENTOMAXILLOFAC RAD, V26, P214, DOI 10.1038/sj.dmfr.4600250
   HEMPRICH A, 1998, DTSCH ZAHNARZTL Z, V41, P1091
   Hubner U., 1999, OSTEOLOGIE, V8, P179
   Hutmacher D.W., 2002, IMPLANTOLOGIE, V10, P143
   KRENNMAIR G, 1995, INT J ORAL MAX SURG, V24, P48, DOI 10.1016/S0901-5027(05)80856-2
   Kubler N R, 1997, Mund Kiefer Gesichtschir, V1, P2
   Peterson B, 2004, J BONE JOINT SURG AM, V86A, P2243, DOI 10.2106/00004623-200410000-00016
   Ripamonti U, 2001, PLAST RECONSTR SURG, V107, P977, DOI 10.1097/00006534-200104010-00012
   Schmelzeisen R, 2003, J CRANIO MAXILL SURG, V31, P34, DOI 10.1016/S1010-5182
   Traianedes K, 2004, J BIOMED MATER RES B, V70B, P21, DOI 10.1002/jbm.b.30015
   Velich N, 2004, J CRANIOFAC SURG, V15, P11, DOI 10.1097/00001665-200401000-00006
   Weng YL, 2001, J ORAL MAXIL SURG, V59, P185, DOI 10.1053/joms.2001.20491
   Wiesmann HP, 2003, J ORAL MAXIL SURG, V61, P1455, DOI 10.1016/j.joms.2003.05.001
   WOLFE SA, 1982, CLIN PLAST SURG, V9, P539
   ZAMBONIN G, 1995, BIOMATERIALS, V16, P397, DOI 10.1016/0142-9612(95)98857-A
NR 21
TC 36
Z9 38
U1 1
U2 10
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 1079-2104
J9 ORAL SURG ORAL MED O
JI Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.
PD MAR
PY 2006
VL 101
IS 3
BP 285
EP 290
DI 10.1016/j.tripleo.2005.06.001
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 018EQ
UT WOS:000235747200003
PM 16504859
DA 2018-10-20
ER

PT J
AU Eriksson, M
   Andersson, M
   Adolfsson, E
   Carlstrom, E
AF Eriksson, M
   Andersson, M
   Adolfsson, E
   Carlstrom, E
TI Titanium-hydroxyapatite composite biomaterial for dental implants
SO POWDER METALLURGY
LA English
DT Article
DE titanium powder; hydroxyapatite; composite; dental implant; high
   velocity compaction; biomaterial
ID HIGH-VELOCITY COMPACTION; POWDER-METALLURGY METHOD;
   TRICALCIUM-PHOSPHATE; CALCIUM; BIODEGRADATION; SIMULATION; CERAMICS;
   COPINGS; BONE; TI
AB The objective of the present study was to investigate high velocity compaction of titanium powder and to prepare a dense composite biomaterial of titanium and hydroxyapatite with the purpose of forming dental components with improved early healing properties. A high purity titanium powder was compacted using high velocity compaction to study the density distribution. Then, a titanium hydroxyapatite composite was prepared by mixing titanium powders and hydroxyapatite grains. Dental implant components were formed from the high velocity compacted specimens, exposing the hydroxyapatite grains at the component surface. The green density reached more than 98.5% after more than one impact. The composite was heated to 500 degrees C, enough to bind the titanium grains, but to avoid observable reactions. Compacted pure titanium could be sintered to full density. The heated composite material reached 99% density, no reaction was observed between titanium and hydroxyapatite, and the composite material could be formed into dental implants.
C1 IVF Ind Res & Dev Corp, Swedish Ceram Inst, SE-43153 Molndal, Sweden.
   Nobel Biocare AB, SE-40226 Gothenburg, Sweden.
RP Eriksson, M (reprint author), IVF Ind Res & Dev Corp, Swedish Ceram Inst, Argongatan 30, SE-43153 Molndal, Sweden.
EM mikael.eriksson@ivf.se
OI Carlstrom, Elis/0000-0003-0849-0393
CR ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P233
   ANDERSSON M, 2003, Patent No. 03061511
   BARBER J, 2000, MPR, V55, P22
   BENSON DJ, 1995, WAVE MOTION, V21, P85, DOI 10.1016/0165-2125(94)00044-6
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   Branemark PI, 1985, TISSUE INTEGRATED PR
   Cambronero LEG, 1996, MAT SCI ENG A-STRUCT, V207, P36, DOI 10.1016/0921-5093(95)09978-6
   DEGROOT K, 1990, HDB BIOACTIVE CERAMI, V11, P133
   DENISSEN HW, 1991, BIOCERAMICS HUMAN BO, P130
   Eriksson M, 2005, POWDER METALL, V48, P103, DOI 10.1179/003258905X37611
   Eriksson M, 2004, POWDER METALL, V47, P335, DOI 10.1179/003258904225020828
   Eriksson M, 2004, POWDER METALL, V47, P273, DOI 10.1179/0032589042250207756
   Eriksson M, 2004, INT J PROSTHODONT, V17, P11
   Haggblad HA, 2005, POWDER TECHNOL, V154, P33, DOI 10.1016/j.powtec.2005.01.026
   Karlsen WL, 2004, INT J POWDER METALL, V40, P29
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   KLEIN CPAT, 1994, BIOMATERIALS, V15, P146, DOI 10.1016/0142-9612(94)90264-X
   Kumar DR, 2002, POWDER METALL, V45, P219, DOI 10.1179/003258902225007005
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   LILJENSTEN E, 1999, THESIS GOTEBORG U GO
   Lind M, 1999, BIOMATERIALS, V20, P803, DOI 10.1016/S0142-9612(98)00216-6
   MOLL JH, 1998, ASM HDB, V7, P160
   Ning CQ, 2002, BIOMATERIALS, V23, P2909, DOI 10.1016/S0142-9612(01)00419-7
   NONAMI T, 1997, J CERAM SOC JPN, V105, P763
   Nygren M, 2003, SOLID STATE SCI, V5, P125, DOI 10.1016/S1293-2558(02)00086-9
   Skoglund P, 2001, POWDER METALL, V44, P199
   TAYLOR N, 1993, ACTA METALL MATER, V41, P955, DOI 10.1016/0956-7151(93)90030-V
   TROMBE JC, 1978, J INORG NUCL CHEM, V40, P15, DOI 10.1016/0022-1902(78)80298-X
   Tsipas S, 2003, POWDER METALL, V46, P73, DOI 10.1179/003258903225010523
   WENG J, 1994, J MATER SCI LETT, V13, P159, DOI 10.1007/BF00278148
NR 30
TC 16
Z9 19
U1 1
U2 10
PU MANEY PUBLISHING
PI LEEDS
PA HUDSON RD, LEEDS LS9 7DL, ENGLAND
SN 0032-5899
J9 POWDER METALL
JI Powder Metall.
PD MAR
PY 2006
VL 49
IS 1
BP 70
EP 77
DI 10.1179/174329006X94591
PG 8
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 034OT
UT WOS:000236940000026
DA 2018-10-20
ER

PT J
AU Stelzner, M
   Chen, DC
AF Stelzner, M
   Chen, DC
TI To make a new intestinal mucosa
SO REJUVENATION RESEARCH
LA English
DT Article; Proceedings Paper
CT 2nd Conference on Strategies for Engineered Negligible Senescence (SENS)
CY SEP, 2005
CL Cambridge, ENGLAND
ID ENGINEERED SMALL-INTESTINE; EPITHELIAL ORGANOID UNITS; STEM-CELL
   TRANSPLANTATION; SMALL-BOWEL; TISSUE; NEOINTESTINE; NEOMUCOSA;
   SCAFFOLDS; MODEL
AB A number of clinical conditions are caused by disorders affecting the mucosal lining of the gastrointestinal tract. Some patients suffer from a loss of mucosal surface area due to congenital defects or due to surgical resections ("short bowel syndrome"). Other patients have inborn or acquired defects of certain mucosal functions (e.g., glucose-galactose malabsorption, bile acid malabsorption). Many patients with these mucosal disorders could be more effectively treated if healthy mucosa were available in larger quantities as a replacement or functional supplement. We therefore developed methods to transplant mucosal stem cells from one part of the intestine to another and to make bioengineered intestinal mucosa.
   We generated an animal model of bile acid malabsorption using rats that underwent resection of the distal 25% of their small intestine (ileum). This resulted in significant losses of bile acids with the fecal excretions in these animals. We subsequently harvested ileal stem cell clusters from neonatal donors, removed the mucosa from a segment of proximal intestine (jejunum), and implanted the stem cell clusters into the debrided segment of jejunum. After four weeks, the animals had developed a functional "neomucosa." We inserted the "neo-ileal" segment into continuity as a substitute ileum. Postoperative measurements of fecal bile acid excretion showed that we were able to reverse the malabsorption syndrome in this model. This was the first reported neo-mucosa-based treatment of a malabsorption syndrome in vivo. We subsequently studied different biodegradable PGA and PLLA scaffoldings to generate bioengineered intestinal mucosa. We implanted these materials into omentum of rats and were able to identify a PGA/PLLA hybrid material on which engraftment rates of 36% of the available surface area could be achieved. Most recently, we developed a novel technique that permits direct observation of cell-biomaterial interactions after implantation into omentum or intestine in vivo. This method will help to optimize engraftment conditions for stem cell clusters on biomaterials.
C1 Vet Adm Greater Los Angeles, Surg Serv 10H2, Los Angeles, CA 90073 USA.
RP Stelzner, M (reprint author), Vet Adm Greater Los Angeles, Surg Serv 10H2, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA.
EM Matthias.Stelzner@va.gov
CR Avansino JR, 2005, J AM COLL SURGEONS, V201, P710, DOI 10.1016/j.jamcollsurg.2005.06.270
   Choi RS, 1997, TRANSPLANT P, V29, P848, DOI 10.1016/S0041-1345(96)00164-9
   De Faria W, 2004, TRANSPLANT P, V36, P375, DOI 10.1016/j.transproceed.2004.01.085
   Duxbury MS, 2004, TRANSPLANTATION, V77, P1162, DOI 10.1097/01.TP.0000121506.34924.3C
   EVANS GS, 1992, J CELL SCI, V101, P219
   Gardner-Thorpe J, 2003, TISSUE ENG, V9, P1255, DOI 10.1089/10763270360728161
   Grikscheit TC, 2004, ANN SURG, V240, P748, DOI 10.1097/01.sla.0000143246.07277.73
   Kayahara T, 2003, FEBS LETT, V535, P131, DOI 10.1016/S0014-5793(02)03896-6
   Kim SS, 1999, TRANSPLANTATION, V67, P227, DOI 10.1097/00007890-199901270-00007
   Kim SS, 1999, J SURG RES, V87, P6, DOI 10.1006/jsre.1999.5743
   Pearson PY, 2002, J PEDIATR SURG, V37, P1076, DOI 10.1053/jpsu.2002.33876
   Perez A, 2002, TRANSPLANTATION, V74, P619, DOI 10.1097/01.TP.0000026662.89071.A8
   Rocha FG, 2004, J SURG RES, V120, P320, DOI 10.1016/j.jss.2004.02.009
   TAIT IS, 1994, DIFFERENTIATION, V56, P91, DOI 10.1046/j.1432-0436.1994.56120091.x
   TAIT IS, 1994, AM J SURG, V167, P67, DOI 10.1016/0002-9610(94)90055-8
   Tavakkolizadeh A, 2003, TRANSPLANTATION, V75, P181, DOI 10.1097/01.TP.0000044101.03656.9F
NR 16
TC 6
Z9 7
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1549-1684
J9 REJUV RES
JI Rejuv. Res.
PD SPR
PY 2006
VL 9
IS 1
BP 20
EP 25
DI 10.1089/rej.2006.9.20
PG 6
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA 035OJ
UT WOS:000237010600004
PM 16608391
DA 2018-10-20
ER

PT J
AU Johnson, JM
   Carbonell, AM
   Carmody, BJ
   Jamal, MK
   Maher, JW
   Kellum, JM
   DeMaria, EJ
AF Johnson, JM
   Carbonell, AM
   Carmody, BJ
   Jamal, MK
   Maher, JW
   Kellum, JM
   DeMaria, EJ
TI Laparoscopic mesh hiatoplasty for paraesophageal hernias and
   fundoplications
SO SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
LA English
DT Article
DE hiatoplasty mesh biomaterial hiatal fundoplication; laparoscopic
   paraesophageal hernia repair outcome review recurrence; mesh hiatoplasty
ID GASTROESOPHAGEAL-REFLUX DISEASE; VERTICAL BANDED GASTROPLASTY;
   PROSTHETIC HIATAL CLOSURE; TENSION-FREE HIATOPLASTY; QUALITY-OF-LIFE;
   NISSEN FUNDOPLICATION; ANTIREFLUX SURGERY; INTRATHORACIC STOMACH;
   ANGELCHIK PROSTHESIS; INCISIONAL HERNIA
AB Background: Little grade A medical evidence exists to support the use of prosthetic material for hiatal closure. Therefore, the authors compiled and analyzed all the available literature to determine whether the use of prosthetic mesh in hiatoplasty for routine laparoscopic fundoplications (LF) or for the repair of large (> 5 cm) paraesophageal hernias (PEH) would decrease recurrence.
   Methods: A literature search was performed using an inclusive list of relevant search terms via Medline/PubMed to identify papers (n = 19) describing the use of prosthetic material to repair the crura of patients undergoing laparoscopic PEH reduction, LF, or both.
   Results: Case series (n = 5), retrospective reviews (n = 6), and prospective randomized (n = 4) and nonrandomized (n = 4) trials were identified. Laparoscopic procedures (n = 1,368) were performed for PEH, gastroesophageal reflux disease (GERD), hiatal hernia, or a combination of the three. Group A (n = 729) had primary suture repair of the crura, and group B (n = 639) had repair with either interposition of mesh to close the hiatus or onlay of prosthetic material after hiatal or crural closure. The use of mesh was associated with fewer recurrences than primary suture repair in both the LF and PEH groups. The mean follow-up period did not differ between the groups (20.7 months for group A vs. 19.2 months for group B). None of the papers cited any instance of prosthetic erosion into the gastrointestinal tract.
   Conclusions: The current data tend to support the use of prosthetic materials for hiatal repair in both routine LF and the repair of large PEHs. Longer and more stringent follow-up evaluation is necessary to delineate better the safety profile of mesh hiatoplasty. Future randomized trials are needed to confirm that mesh repair is superior to simple crural closure.
C1 Virginia Commonwealth Univ, Dept Gen Surg, Richmond, VA 23298 USA.
RP Johnson, JM (reprint author), Virginia Commonwealth Univ, Dept Gen Surg, 1200 E Broad St,POB 980519, Richmond, VA 23298 USA.
CR Arendt T, 2000, GASTROINTEST ENDOSC, V51, P607, DOI 10.1016/S0016-5107(00)70303-8
   Arnaud JP, 2000, SURG ENDOSC, V14, P1024
   Athanasakis H, 2001, ENDOSCOPY, V33, P590, DOI 10.1055/s-2001-15306
   Baladas HG, 2000, DIS ESOPHAGUS, V13, P72, DOI 10.1046/j.1442-2050.2000.00083.x
   Basso N, 1999, SURG LAPARO ENDO PER, V9, P257, DOI 10.1097/00019509-199908000-00005
   Basso N, 2000, SURG ENDOSC-ULTRAS, V14, P164, DOI 10.1007/s004649900092
   Burger JWA, 2004, ANN SURG, V240, P578
   Carlson MA, 1998, J AM COLL SURGEONS, V187, P227, DOI 10.1016/S1072-7515(98)00162-8
   Carlson MA, 1999, DIGEST SURG, V16, P407, DOI 10.1159/000018756
   Catarci M, 2004, ANN SURG, V239, P325, DOI 10.1097/01.sla.0000114225.46280.fe
   Champion JK, 2003, SURG ENDOSC, V17, P551, DOI 10.1007/s00464-002-8817-7
   COZACOV C, 1991, OBES SURG, V1, P443
   Dally E, 2004, AM J SURG, V187, P226, DOI 10.1016/j.amjsurg.2003.11.028
   FERNANDEZ LR, 2001, HERNIA, V5, P107
   Frantzides CT, 1999, SURG ENDOSC-ULTRAS, V13, P906, DOI 10.1007/s004649901131
   Frantzides CT, 1997, SURG ENDOSC-ULTRAS, V11, P769, DOI 10.1007/s004649900447
   Frantzides CT, 2002, ARCH SURG-CHICAGO, V137, P649, DOI 10.1001/archsurg.137.6.649
   Granderath FA, 2005, ARCH SURG-CHICAGO, V140, P40, DOI 10.1001/archsurg.140.1.40
   Granderath FA, 2003, ARCH SURG-CHICAGO, V138, P902, DOI 10.1001/archsurg.138.8.902
   Granderath FA, 2002, J GASTROINTEST SURG, V6, P347, DOI 10.1016/S1091-255X(01)00025-7
   Hashemi M, 2000, J AM COLL SURGEONS, V190, P553, DOI 10.1016/S1072-7515(00)00260-X
   Hawasli A, 1998, AM SURGEON, V64, P703
   Horstmann R, 2004, LANGENBECK ARCH SURG, V389, P23, DOI 10.1007/s00423-003-0437-8
   Hui TT, 2001, AM SURGEON, V67, P1170
   Huntington TR, 1997, SURG ENDOSC-ULTRAS, V11, P894, DOI 10.1007/s004649900481
   JAKAITE D, 1991, J PEDIATR GASTR NUTR, V13, P186, DOI 10.1097/00005176-199108000-00012
   Kamoz T, 2002, SURG ENDOSC, V16, P572, DOI 10.1007/s00464-001-9136-0
   Keidar A, 2003, SURG LAPARO ENDO PER, V13, P149, DOI 10.1097/00129689-200306000-00002
   Leeder PC, 2003, SURG ENDOSC, V17, P1372, DOI 10.1007/s00464-002-9192-0
   LICHTENSTEIN IL, 1989, AM J SURG, V157, P188, DOI 10.1016/0002-9610(89)90526-6
   LICHTENSTEIN IL, 1987, AM J SURG, V153, P553, DOI 10.1016/0002-9610(87)90153-X
   Losanoff J E, 2002, Hernia, V6, P144
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603
   Miller K, 1997, SURG ENDOSC-ULTRAS, V11, P772, DOI 10.1007/s004649900448
   Moreno P, 1998, ARCH SURG-CHICAGO, V133, P189, DOI 10.1001/archsurg.133.2.189
   MORINO F, 1992, OBES SURG, V2, P69, DOI 10.1381/096089292765560574
   Oelschlager BK, 2003, AM J SURG, V186, P4, DOI 10.1016/S0002-9610(03)00114-4
   Paul MG, 1997, SURG ENDOSC-ULTRAS, V11, P303, DOI 10.1007/s004649900351
   PURKISS SF, 1992, EUR J CARDIO-THORAC, V6, P517, DOI 10.1016/1010-7940(92)90252-S
   Schauer PR, 1998, AM J SURG, V176, P659, DOI 10.1016/S0002-9610(98)00272-4
   Soper NJ, 1999, ANN SURG, V229, P669, DOI 10.1097/00000658-199905000-00009
   SUBRAMANYAM K, 1989, AM J GASTROENTEROL, V84, P1319
   Targarona EM, 2004, ARCH SURG-CHICAGO, V139, P1286, DOI 10.1001/archsurg.139.12.1286
   Vrijland WW, 2002, BRIT J SURG, V89, P293, DOI 10.1046/j.0007-1323.2001.02030.x
   WICHTERMAN K, 1979, SURGERY, V86, P497
   Wiechmann RJ, 2001, ANN THORAC SURG, V71, P1080, DOI 10.1016/S0003-4975(00)01229-7
NR 46
TC 91
Z9 96
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0930-2794
J9 SURG ENDOSC
JI Surg. Endosc.
PD MAR
PY 2006
VL 20
IS 3
BP 362
EP 366
DI 10.1007/s00464-005-0357-5
PG 5
WC Surgery
SC Surgery
GA 013WZ
UT WOS:000235442000003
PM 16437267
DA 2018-10-20
ER

PT J
AU Kotch, FW
   Raines, RT
AF Kotch, FW
   Raines, RT
TI Self-assembly of synthetic collagen triple helices
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biomaterial; coiled-coil; nanotechnology; cystine knot; peptide
ID SYMMETRIC TOP MACROMOLECULES; CONFORMATIONAL PROPERTIES;
   ROTATIONAL-DYNAMICS; CIRCULAR-CYLINDERS; SMART MATERIALS; VISCOUS FORCE;
   PEPTIDE; STABILITY; BIOMATERIALS; BINDING
AB Collagen is the most abundant protein in animals and the major component of connective tissues. Although collagen isolated from natural sources has long served as the basis for some biomaterials, natural collagen is difficult to modify and can engender pathogenic and immunological side effects. Collagen comprises a helix of three strands. Triple helices derived from synthetic peptides are much shorter (< 10 nm) than natural collagen (approximate to 300 mm), limiting their utility. Here, we describe the synthesis of short collagen fragments in which the three strands are held in a staggered array by disulficle bonds. Data from CD spectroscopy, dynamic light scattering, analytical ultracentrifugation, atomic force microscopy, and transmission electron microscopy indicate that these "sticky-ended" fragments self-assemble via intermolecular triple-helix formation. The resulting fibrils resemble natural collagen, and some are longer (> 400 nm) than any known collagen. We anticipate that our self-assembly strategy can provide synthetic collagen-mimetic materials for a variety of applications.
C1 Univ Wisconsin, Dept Chem & Biochem, Madison, WI 53706 USA.
RP Raines, RT (reprint author), Univ Wisconsin, Dept Chem & Biochem, Madison, WI 53706 USA.
EM raines@biochem.wisc.edu
RI Raines, Ronald/A-5009-2013
OI Raines, Ronald/0000-0001-7164-1719
FU NIAMS NIH HHS [AR44276, AR50881, F32 AR050881, R01 AR044276]; NCRR NIH
   HHS [1RR13790]
CR Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198
   BACHINGER HP, 1982, J BIOL CHEM, V257, P4590
   BACHINGER HP, 1978, EUR J BIOCHEM, V90, P605, DOI 10.1111/j.1432-1033.1978.tb12641.x
   Barth D, 2003, CHEM-EUR J, V9, P3703, DOI 10.1002/chem.200304918
   BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3
   Boudko S, 2002, J MOL BIOL, V317, P459, DOI 10.1006/jmbi.2002.5439
   Bretscher LE, 2001, J AM CHEM SOC, V123, P777, DOI 10.1021/ja005542v
   BROERSMA S, 1981, J CHEM PHYS, V74, P6989, DOI 10.1063/1.441071
   BROERSMA S, 1960, J CHEM PHYS, V32, P1626, DOI 10.1063/1.1730994
   BROERSMA S, 1960, J CHEM PHYS, V32, P1632, DOI 10.1063/1.1730995
   Claire K, 1997, J PHYS CHEM B, V101, P746, DOI 10.1021/jp961607y
   COOPERMAN L, 1984, J AM ACAD DERMATOL, V10, P638, DOI 10.1016/S0190-9622(84)80271-6
   Fairman R, 2005, CURR OPIN STRUC BIOL, V15, P453, DOI 10.1016/j.sbi.2005.07.005
   Fields GB, 1998, BIOPOLYMERS, V47, P143, DOI 10.1002/(SICI)1097-0282(1998)47:2<143::AID-BIP3>3.3.CO;2-P
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Henkel W, 1999, BIOCHEMISTRY-US, V38, P13610, DOI 10.1021/bi9905157
   Hodges JA, 2003, J AM CHEM SOC, V125, P9262, DOI 10.1021/ja035881z
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573
   Jenkins CL, 2002, NAT PROD REP, V19, P49, DOI 10.1039/a903001h
   Johnson G, 2000, J BIOMED MATER RES, V51, P612, DOI 10.1002/1097-4636(20000915)51:4<612::AID-JBM9>3.3.CO;2-Q
   Kramer RZ, 1998, J MOL BIOL, V280, P623, DOI 10.1006/jmbi.1998.1881
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   MacPhee CE, 2004, CURR OPIN SOLID ST M, V8, P141, DOI 10.1016/j.cossms.2004.01.010
   Maeda H, 1999, LANGMUIR, V15, P8505, DOI 10.1021/la981738l
   Myers JC, 2003, J BIOL CHEM, V278, P32047, DOI 10.1074/jbc.M304629200
   Ottl J, 1999, J AM CHEM SOC, V121, P653, DOI 10.1021/ja983456d
   Pandya MJ, 2000, BIOCHEMISTRY-US, V39, P8728, DOI 10.1021/bi000246g
   Paramonov SE, 2005, MACROMOLECULES, V38, P7555, DOI 10.1021/ma0514065
   PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6
   Qian JJ, 1996, J BIOMED MATER RES, V31, P545, DOI 10.1002/(SICI)1097-4636(199608)31:4<545::AID-JBM15>3.0.CO;2-F
   Rajagopal K, 2004, CURR OPIN STRUC BIOL, V14, P480, DOI 10.1016/j.sbi.2004.06.006
   Ramshaw JAM, 1998, J STRUCT BIOL, V122, P86, DOI 10.1006/jsbi.1998.3977
   Ramshaw JAM, 1996, BIOTECHNOL GENET ENG, V13, P335, DOI 10.1080/02648725.1996.10647934
   RUSZCZAK ZB, 1998, BIOL MATRICES TISSUE, P21
   Sakaguchi M, 1999, J ALLERGY CLIN IMMUN, V104, P695, DOI 10.1016/S0091-6749(99)70344-1
   SCHECHTER NM, 1976, BIOCHEMISTRY-US, V15, P1897, DOI 10.1021/bi00654a016
   Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100
   TIRADO MM, 1979, J CHEM PHYS, V71, P2581, DOI 10.1063/1.438613
   TIRADO MM, 1980, J CHEM PHYS, V73, P1986, DOI 10.1063/1.440288
   Wagner DE, 2005, P NATL ACAD SCI USA, V102, P12656, DOI 10.1073/pnas.0505871102
   Wang AY, 2005, J AM CHEM SOC, V127, P4130, DOI 10.1021/ja0431915
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   Wright ER, 2002, ADV DRUG DELIVER REV, V54, P1057, DOI 10.1016/S0169-409X(02)00059-5
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 48
TC 185
Z9 196
U1 4
U2 75
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 28
PY 2006
VL 103
IS 9
BP 3028
EP 3033
DI 10.1073/pnas.0508783103
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 018QU
UT WOS:000235780700007
PM 16488977
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Landa, N
   Feinberg, MS
   Holbova, R
   Miller, L
   Cohen, S
   Leor, J
AF Landa, N
   Feinberg, MS
   Holbova, R
   Miller, L
   Cohen, S
   Leor, J
TI Novel injectable alginate biomaterial attenuates progressive infarct
   expansion and preserves left ventricular systolic and diastolic function
   late after myocardial infarction
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Meeting Abstract
CT 55th Annual Scientific Session of the American-College-of-Cardiology
CY MAR 11-14, 2006
CL Atlanta, GA
SP Amer Coll Cardiol
C1 Tel Aviv Univ, Sheba Med Ctr, Neufeld Cardiac Res Inst, Tel Hashomer, Israel.
   Ben Gurion Univ Negev, Inst Appl Biosci, IL-84105 Beer Sheva, Israel.
RI Leor, Jonathan/O-2930-2017; COHEN, SMADAR/F-1901-2012
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD FEB 21
PY 2006
VL 47
IS 4
SU A
BP 73A
EP 74A
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 015CV
UT WOS:000235530400317
DA 2018-10-20
ER

PT J
AU Stecchini, ML
   Del Torre, M
   Venir, E
   Morettin, A
   Furlan, P
   Maltini, E
AF Stecchini, ML
   Del Torre, M
   Venir, E
   Morettin, A
   Furlan, P
   Maltini, E
TI Glassy state in Bacillus subtilis spores analyzed by differential
   scanning calorimetry
SO INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
LA English
DT Article
DE Bacillus subtilis; glass transition; DSC
ID BACTERIAL-SPORES; PROTOPLAST DEHYDRATION; STRUCTURAL-ANALYSIS;
   HEAT-RESISTANCE; PEPTIDOGLYCAN; GERMINATION; CORTEX; COAT; ENDOSPORES;
   MECHANISMS
AB Thermal properties of dried spores of Bacillus subtilis, investigated by differential scanning calorimetry (DSC), were studied. A reversible heat capacity shift ascribable to glass-rubber transition was observed at 90-115 degrees C. The transition was found to be a pressure-inhibited volume-activated event. The decoated spores and the extracted peptidoglycan material exhibited glass transition, suggesting that the cortex could be involved in the event. Furthermore, the glass transition was evident when spores were treated with strong acid, and when the isogenic strain PS578 was scanned, indicating that core integrity and core components are not involved in the occurrence of the event. These results suggest that in the dried B. subtilis spores an amorphous biomaterial, possibly the cortex peptidoglycan, is present as a glass. (c) 2005 Elsevier B.V All rights reserved.
C1 Univ Udine, Dept Food Sci, I-33100 Udine, Italy.
RP Stecchini, ML (reprint author), Univ Udine, Dept Food Sci, Via Marangoni 97, I-33100 Udine, Italy.
EM mara.stecchini@dsa.uniud.it
CR Ablett S, 1999, INT J FOOD SCI TECH, V34, P59, DOI 10.1046/j.1365-2621.1999.00240.x
   Atrih A, 2002, INT DAIRY J, V12, P217, DOI 10.1016/S0958-6946(01)00157-1
   Atrih A, 1999, MICROBIOL-UK, V145, P1033, DOI 10.1099/13500872-145-5-1033
   Atrih A, 1998, J BACTERIOL, V180, P4603
   Atrih A, 2001, J APPL MICROBIOL, V91, P364, DOI 10.1046/j.1365-2672.2001.01394.x
   Atrih A, 1996, J BACTERIOL, V178, P6173, DOI 10.1128/jb.178.21.6173-6183.1996
   ATRIH A, 1999, ANTON LEEUW INT J G, V75, P99
   BEAMAN TC, 1986, APPL ENVIRON MICROB, V52, P1242
   BELLIVEAU BH, 1992, J BACTERIOL, V174, P4463
   BLOOMFIELD SF, 1994, J APPL BACTERIOL, V76, pS91, DOI 10.1111/j.1365-2672.1994.tb04361.x
   BLOOMFIELD SF, 1994, J APPL BACTERIOL, V76, P492, DOI 10.1111/j.1365-2672.1994.tb01107.x
   Driks A, 1999, MICROBIOL MOL BIOL R, V63, P1
   ERRINGTON J, 1993, MICROBIOL REV, V57, P1
   Gould G.W., 1986, MEMBRANES METABOLISM, P143
   Horsburgh GJ, 2003, J BACTERIOL, V185, P3813, DOI 10.1128/JB.185.3813-3820.2003
   KOSHIKAWA T, 1984, J BACTERIOL, V159, P624
   Leuschner RGK, 2000, MICROBIOL-UK, V146, P49, DOI 10.1099/00221287-146-1-49
   Leuschner RGK, 2001, INT J FOOD MICROBIOL, V63, P35, DOI 10.1016/S0168-1605(00)00396-2
   LEUSCHNER RGK, 2002, INT J FOOD MICROBIOL, V80, P131
   MAEDA Y, 1975, J GEN APPL MICROBIOL, V21, P119, DOI 10.2323/jgam.21.119
   Moriyama R, 1999, J BACTERIOL, V181, P2373
   NAKASHIO S, 1985, J BACTERIOL, V162, P571
   Nicholson W.L., 1990, MOL BIOL METHODS BAC, P391
   Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000
   Paidhungat M, 2001, J BACTERIOL, V183, P3982, DOI 10.1128/JB.183.13.3982-3990.2001
   PANDEY NK, 1979, J BACTERIOL, V137, P1208
   POPHAM DL, 1995, J BACTERIOL, V177, P4721, DOI 10.1128/jb.177.16.4721-4729.1995
   SAPRU V, 1993, J FOOD SCI, V58, P445, DOI 10.1111/j.1365-2621.1993.tb04294.x
   Serrano M, 1999, J BACTERIOL, V181, P3632
   Setlow B, 2002, J APPL MICROBIOL, V92, P362, DOI 10.1046/j.1365-2672.2002.01540.x
   Setlow P, 2000, BACTERIAL STRESS RESPONSES, P217
   SLADE L, 1991, CRIT REV FOOD SCI, V30, P115, DOI 10.1080/10408399109527543
   STELMA GN, 1978, J BACTERIOL, V134, P1157
   Tennen R, 2000, J APPL MICROBIOL, V89, P330, DOI 10.1046/j.1365-2672.2000.01114.x
   THWAITES JJ, 1991, J BACTERIOL, V173, P197, DOI 10.1128/jb.173.1.197-203.1991
NR 35
TC 10
Z9 12
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1605
J9 INT J FOOD MICROBIOL
JI Int. J. Food Microbiol.
PD FEB 15
PY 2006
VL 106
IS 3
BP 286
EP 290
DI 10.1016/j.ijfoodmicro.2005.06.028
PG 5
WC Food Science & Technology; Microbiology
SC Food Science & Technology; Microbiology
GA 015SD
UT WOS:000235570300006
PM 16257078
DA 2018-10-20
ER

PT J
AU Yi, F
   Li, Q
   Guo, ZX
   Yu, J
AF Yi, F
   Li, Q
   Guo, ZX
   Yu, J
TI Immobilization of soluble eggshell membrane protein on polyethylene film
   surface: Effect on the culture of NIH3T3 in vitro
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biomaterial; biocompatibility; plasma modification; polyethylene (PE);
   soluble eggshell membrane protein
ID GROWTH
AB Polyethylene (PE) film surface is modified by combining plasma treatment and soluble eggshell membrane protein (SEP) immobilization. Contact angle measurements, attenuated total reflectance infrared spectroscopy, and X-ray photoelectron spectroscopy confirm that SEP adheres tightly to the PE film surface. Mouse 3T3 fibroblasts are used as model cells to evaluate the biocompatibility of PE film surfaces before and after modification. Plasma pretreatment can incorporate polar groups onto the surface, benefitting tight immobilization of SEP. The hydrophilicity of the PE film surface modified by combining plasma treatment and SEP immobilization is increased as evidenced by contact angle measurements, and the biocompatibility of the surface is greatly improved as shown by cell culture. The surface of the modified material can endure rinsing with 10% acetic acid (a good solvent of SEP), which would be an advantage for further application as a biomaterial. (c) 2005 Wiley Periodicals, Inc.
C1 Tsinghua Univ, Sch Mat Sci & Engn, Dept Chem Engn, Inst Sci & Technol Policy, Beijing 100084, Peoples R China.
RP Yu, J (reprint author), Tsinghua Univ, Sch Mat Sci & Engn, Dept Chem Engn, Inst Sci & Technol Policy, Beijing 100084, Peoples R China.
EM yujian03@mail.tsinghua.edu.cn
CR Carrino DA, 1996, CONNECT TISSUE RES, V35, P325, DOI 10.3109/03008209609029207
   CHATELIER RC, 1995, LANGMUIR, V11, P2585, DOI 10.1021/la00007a043
   GRIESSER HJ, 1994, J BIOMAT SCI-POLYM E, V5, P531, DOI 10.1163/156856294X00194
   Holysz L, 2000, J MATER SCI, V35, P6081, DOI 10.1023/A:1026779816279
   Kang ET, 1996, MACROMOLECULES, V29, P6872, DOI 10.1021/ma960161g
   Maeda K, 1981, BURNS, V8, P313
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nys Y, 2001, WORLD POULTRY SCI J, V57, P401, DOI 10.1079/WPS20010029
   TAVASSOLI M, 1983, EXPERIENTIA, V39, P411, DOI 10.1007/BF01963153
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
   Yi F, 2004, BIOMATERIALS, V25, P4591, DOI 10.1016/j.biomaterials.2003.11.052
   Yi F, 2003, MACROMOL BIOSCI, V3, P234, DOI 10.1002/mabi.200390030
NR 12
TC 13
Z9 13
U1 0
U2 8
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD FEB 15
PY 2006
VL 99
IS 4
BP 1340
EP 1345
DI 10.1002/app.22222
PG 6
WC Polymer Science
SC Polymer Science
GA 000DN
UT WOS:000234441200005
DA 2018-10-20
ER

PT J
AU Collier, JH
   Mrksich, M
AF Collier, JH
   Mrksich, M
TI Engineering a biospecific communication pathway between cells and
   electrodes
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biomaterial; extracellular matrix; signal transduction
ID SELF-ASSEMBLED MONOLAYERS; MASS-SPECTROMETRY; PROTEINS; SENSOR
AB Methods for transducing the cellular activities of mammalian cells into measurable electronic signals are important in many biotechnical applications, including biosensors, cell arrays, and other cell-based devices. This manuscript describes an approach for functionally integrating cellular activities and electrical processes in an underlying substrate. The cells are engineered with a cell-surface chimeric receptor that presents the nonmammalian enzyme cutinase. Action of this cell-surface cutinase on enzyme substrate self-assembled monolayers switches a nonelectroactive hydroxyphenyl ester to an electroactive hydroquinone, providing an electrical activity that can be identified with cyclic voltammetry. In this way, cell-surface enzymatic activity is transduced into electronic signals. The development of strategies to directly interface the activities of cells with materials will be important to enabling a broad class of hybrid microsystems that combine living and nonliving components.
C1 Univ Chicago, Dept Chem, Chicago, IL 60637 USA.
   Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA.
RP Mrksich, M (reprint author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.
EM mmrksich@uchicago.edu
RI Mrksich, Milan/G-2469-2011
OI Mrksich, Milan/0000-0002-4964-796X
CR Bonifazi P, 2002, ADV MATER, V14, P1190, DOI 10.1002/1521-4095(20020903)14:17<1190::AID-ADMA1190>3.0.CO;2-#
   Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200
   Fong AM, 2000, J BIOL CHEM, V275, P3781, DOI 10.1074/jbc.275.6.3781
   FROMHERZ P, 1991, SCIENCE, V252, P1290, DOI 10.1126/science.1925540
   Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734
   HICKMAN JJ, 1991, SCIENCE, V252, P688, DOI 10.1126/science.252.5006.688
   Hodneland CD, 2002, P NATL ACAD SCI USA, V99, P5048, DOI 10.1073/pnas.072685299
   Hong HG, 1999, J ELECTROANAL CHEM, V476, P177, DOI 10.1016/S0022-0728(99)00380-0
   Houseman BT, 2003, LANGMUIR, V19, P1522, DOI 10.1021/la0262304
   Kato M, 2004, J AM CHEM SOC, V126, P6504, DOI 10.1021/ja039058e
   KOLATTUKUDY PE, 1981, METHOD ENZYMOL, V71, P652, DOI DOI 10.1016/0076-6879(81)71078-4
   Kuang Y, 2004, ANAL CHEM, V76, P2902, DOI 10.1021/ac0354589
   Nivens DE, 2004, J APPL MICROBIOL, V96, P33, DOI 10.1046/j.1365-2672.2003.02114.x
   Rider TH, 2003, SCIENCE, V301, P213, DOI 10.1126/science.1084920
   Simpson ML, 2001, SENSOR ACTUAT B-CHEM, V72, P134, DOI 10.1016/S0925-4005(00)00641-9
   Su J, 2003, LANGMUIR, V19, P4867, DOI 10.1021/la034071y
   Su J, 2002, ANGEW CHEM INT EDIT, V41, P4715, DOI 10.1002/anie.200290026
   Tucker CL, 2001, NAT BIOTECHNOL, V19, P1042, DOI 10.1038/nbt1101-1042
   Voelker M, 2004, BIOPHYS J, V86, p271A
   Yeo WS, 2003, ANGEW CHEM INT EDIT, V42, P3121, DOI 10.1002/anie.200250862
   Yousaf MN, 2001, P NATL ACAD SCI USA, V98, P5992, DOI 10.1073/pnas.101112898
   Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976
NR 22
TC 35
Z9 35
U1 0
U2 6
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 14
PY 2006
VL 103
IS 7
BP 2021
EP 2025
DI 10.1073/pnas.0504349103
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 013LU
UT WOS:000235411600006
PM 16461913
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Goda, T
   Watanabe, J
   Takai, M
   Ishihara, K
AF Goda, T
   Watanabe, J
   Takai, M
   Ishihara, K
TI Water structure and improved mechanical properties of phospholipid
   polymer hydrogel with phosphorylcholine centered intermolecular
   cross-linker
SO POLYMER
LA English
DT Article
DE hydrogel; hydrophilic cross-linker; phospholipid polymer
ID PROTEIN ADSORPTION; BIOMATERIALS; MEMBRANES; DELIVERY; BEHAVIOR; GEL
AB We investigated the water structure and the mechanical properties of 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer hydrogels cross-linked with a novel hydrophilic 2-(methacryloyloxy)ethyl-[N-(2-methacryloyloxy)ethyl]phosphorylcholine (MMPC) for soft contact lenses (SCL) applications and commercial methacrylic cross-linkers were in addition used for comparison with MMPC. Water structure in hydrogels, which influences the protein adsorption by dehydration was determined by differential scanning calorimetry. MMPC increased the freezing water content of the MPC polymer hydrogel compared with hydrophilic NN'-methylenebisacrylamide (BIS) at the same water content. MMPC also improved fracture strength of the MPC polymer hydrogel to 120 kPa in tensile, which was considerably higher than that hydrogel cross-linked with BIS. It is suggested that MMPC shows higher cross-linking reactivity with MPC than BIS. We concluded that the MMPC increase both the free water content and the tensile properties. The MPC polymer hydrogel cross-linked with MMPC can be a useful SCL biomaterial. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Tokyo, Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan.
RP Ishihara, K (reprint author), Univ Tokyo, Sch Engn, Dept Mat Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM ishihara@mpc.t.u-tokyo.ac.jp
RI Goda, Tatsuro/B-6484-2011
OI Goda, Tatsuro/0000-0003-2688-8186
CR AHMAD MB, 1994, POLYM INT, V33, P273, DOI 10.1002/pi.1994.210330306
   CLUFF EF, 1960, J POLYM SCI, V45, P341, DOI 10.1002/pol.1960.1204514605
   Dusek K., 1969, ADV POLYM SCI, V6, P1
   EFRON N, 1987, CLAO Journal, V13, P152
   Fernandez-Garcia M, 2000, POLYMER, V41, P8001, DOI 10.1016/S0032-3861(00)00167-1
   Garcia DM, 2004, EUR POLYM J, V40, P1637, DOI 10.1016/j.eurpolymj.2004.03.011
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Haraguchi K, 2002, ADV MATER, V14, P1120, DOI 10.1002/1521-4095(20020816)14:16<1120::AID-ADMA1120>3.0.CO;2-9
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   Ishihara K, 1999, J BIOMAT SCI-POLYM E, V10, P1047, DOI 10.1163/156856299X00676
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Kiritoshi Y, 2004, POLYMER, V45, P7499, DOI 10.1016/j.polymer.2004.09.014
   Kiritoshi Y, 2002, J BIOMAT SCI-POLYM E, V13, P213, DOI 10.1163/156856202317414384
   Kitano H, 2003, LANGMUIR, V19, P10260, DOI 10.1021/la0349673
   Kopecek J, 2003, EUR J PHARM SCI, V20, P1, DOI 10.1016/S0928-0987(03)00164-7
   Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233
   Nicolson PC, 2001, BIOMATERIALS, V22, P3273, DOI 10.1016/S0142-9612(01)00165-X
   Okumura Y, 2001, ADV MATER, V13, P485, DOI 10.1002/1521-4095(200104)13:7<485::AID-ADMA485>3.0.CO;2-T
   PARK K, 1990, BIODEGRADABEL HYDROG, pCH3
   PEPPAS NA, 1987, HYDROGELS MED PHARM, V3, pCH3
   Sawada S, 2003, J BIOMED MATER RES A, V64A, P411, DOI 10.1002/jbm.a.10433
   SMETANA K, 1990, J BIOMED MATER RES, V24, P463, DOI 10.1002/jbm.820240405
   TANAKA T, 1978, PHYS REV LETT, V40, P820, DOI 10.1103/PhysRevLett.40.820
   TASAKA M, 1988, J MEMBRANE SCI, V38, P175, DOI 10.1016/S0376-7388(00)80878-9
   Uchiyama T, 2003, BIOMATERIALS, V24, P5183, DOI 10.1016/S0142-9612(03)00441-1
   YOSHIDA H, 1990, POLYMER, V31, P693, DOI 10.1016/0032-3861(90)90291-6
NR 28
TC 66
Z9 69
U1 3
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD FEB 8
PY 2006
VL 47
IS 4
BP 1390
EP 1396
DI 10.1016/j.polymer.2005.12.043
PG 7
WC Polymer Science
SC Polymer Science
GA 014ZY
UT WOS:000235522900051
DA 2018-10-20
ER

PT J
AU Vicente, J
   Ramirez-Camacho, R
   Trinidad, A
   Garcia-Berrocal, JR
   Lobo, D
   Pinilla, M
AF Vicente, J
   Ramirez-Camacho, R
   Trinidad, A
   Garcia-Berrocal, JR
   Lobo, D
   Pinilla, M
TI Anti-adhesive properties of polytetrafluoroethylene (Gore-Tex (R)) in
   middle ear surgery. An experimental study
SO ACTA OTO-LARYNGOLOGICA
LA English
DT Article
DE adhesions; biomaterial; Gore-Tex (R); otitis media with effusion; Wistar
   rat
ID ABDOMINAL-WALL; TYMPANOPLASTY; BIOMATERIALS; CERAMICS; RAT
AB Conclusions. Polytetrafluoroethylene ( PTFE) may represent a material that prevents adhesions when implanted in the middle ear. This characteristic can be used to improve the design of prostheses. Objective. Prostheses in the middle ear have a relatively high failure rate due to extrusion, deformation and adhesion. Adhesion of prostheses to the walls of the tympanic cavity is the commonest cause of long-term hearing loss. The anti-adhesive properties of PTFE have been previously studied in abdominal and vascular surgery. To the best of our knowledge, this is the first work in which the properties of PTFE have been studied in the context of middle ear pathology. Material and methods. In order to induce otitis media with effusion, 27 Wistar rats underwent a technique based on permanent cauterization of the pharyngeal Eustachian tube. PTFE was subsequently implanted in the middle ear. Rats that underwent cauterization without implantation and cauterization with implantation of hydroxyapatite and Plastipore were included as controls. Results. Histopathological study of the tympanic bullae at 15 and 90 days after implantation demonstrated good biocompatibility of the PTFE implant under the analyzed conditions, with formation of a capsule around the material and no adhesions between the ear tissues and the prosthesis.
C1 Univ Autonoma Madrid, Hosp Univ Puerta Hierra, Serv Otorrinolaringol, Grp Invest Otol, Madrid 28035, Spain.
RP Vicente, J (reprint author), Univ Autonoma Madrid, Hosp Univ Puerta Hierra, Serv Otorrinolaringol, Grp Invest Otol, Calle San Martin Portes 4, Madrid 28035, Spain.
EM jvicenteh@seorl.net
OI GARCIA-BERROCAL, JOSE RAMON/0000-0003-2747-2991
CR BELLON JM, 1994, EUR J VASCULAR SURG, V8, P694, DOI 10.1016/S0950-821X(05)80649-8
   BELLON JM, 1995, BIOMATERIALS, V16, P381, DOI 10.1016/0142-9612(95)98855-8
   Bernal Sprekelsen M, 1992, Acta Otorrinolaringol Esp, V43, P5
   BERROCAL JRG, 1997, REV BRAS OTORRINOLAR, V63, P453
   BLUESTONE CD, 1983, PEDIAT OTOLARYNGOLOG, V1
   BRACKMANN DE, 1979, LARYNGOSCOPE, V89, P108
   GROTE JJ, 1986, ANN OTO RHINOL LARYN, V95, P1
   KUIJPERS W, 1977, CLIN OTOLARYNGOL, V2, P5, DOI 10.1111/j.1365-2273.1977.tb01329.x
   Pinilla M, 1995, J MATER SCI-MATER M, V6, P745, DOI 10.1007/BF00134311
   Pinilla M, 2003, OTOLARYNG HEAD NECK, V128, P124, DOI 10.1067/mhn.2003.55
   Pinilla M, 2001, OTOLARYNG HEAD NECK, V124, P515, DOI 10.1067/mhn.2001.115370
   Ramirez Camacho R, 2001, An Otorrinolaringol Ibero Am, V28, P513
   RAMIREZCAMACHO R, 1995, REV PORT OTORRINOLAR, V33, P219
   RECK R, 1984, LARYNGOSCOPE, V94, P1, DOI 10.1288/00005537-198402001-00001
   SHEA J, 1976, LARYNGOSCOPE, V86, P239, DOI 10.1288/00005537-197602000-00015
   VANDERLEI B, 1989, BRIT J SURG, V76, P803, DOI 10.1002/bjs.1800760813
   WALDMAN SR, 1991, ANN PLAS SURG, V26, P520, DOI 10.1097/00000637-199106000-00005
   WOLFMAN DE, 1986, ANN OTO RHINOL LARYN, V95, P639, DOI 10.1177/000348948609500619
   WULLSTEIN SR, 1985, AM J OTOL, V6, P31
NR 19
TC 4
Z9 4
U1 0
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0001-6489
EI 1651-2251
J9 ACTA OTO-LARYNGOL
JI Acta Oto-Laryngol.
PD FEB
PY 2006
VL 126
IS 2
BP 144
EP 148
DI 10.1080/00016480500312570
PG 5
WC Otorhinolaryngology
SC Otorhinolaryngology
GA 004IH
UT WOS:000234745300005
PM 16428190
DA 2018-10-20
ER

PT J
AU Johansson, H
   Goto, M
   Siegbahn, A
   Elgue, G
   Korsgren, O
   Nilsson, B
AF Johansson, H
   Goto, M
   Siegbahn, A
   Elgue, G
   Korsgren, O
   Nilsson, B
TI Low molecular weight dextran sulfate: A strong candidate drug to block
   IBMIR in clinical islet transplantation
SO AMERICAN JOURNAL OF TRANSPLANTATION
LA English
DT Article
DE dextran sulfate; IBMIR
ID HEPATOCYTE GROWTH-FACTOR; IN-VITRO MODEL; COMPLEMENT ACTIVATION;
   ENDOTHELIAL-CELLS; AUTOMATED-METHOD; BLOOD; INHIBITION; BIOMATERIAL;
   INFECTION; REJECTION
AB The instant blood-mediated inflammatory reaction (IBMIR) is triggered in clinical islet transplantation when human pancreatic islets come in contact with blood and may explain the initial tissue loss associated with this procedure. Low molecular weight dextran sulfate (LMW-DS; MM 5000), today available for clinical use, inhibits both complement and coagulation activation. In a tubing loop model, LMW-DS at concentrations ranging from 0.01 to 1 g/L showed a dose-dependent inhibition of IBMIR with an inhibition of coagulation and complement activation and less consumption of platelets and other blood cells. In blood or plasma APTT was demonstrated to be an excellent method for monitoring the LMW-DS concentration both in vitro and in vivo in a nonhuman primate model. The toxicity was assessed using a glucose challenge test and the pharmacokinetics was tested in the nonhuman primate model. Here, we present a tentative protocol for using LMW-DS in clinical islet transplantation.
C1 Univ Uppsala Hosp, Dept Radiol Oncol & Clin Immunol, Div Clin Immunol, Rudbeck Lab, Uppsala, Sweden.
   Tohoku Univ, Biomed Engn Res Org, Sendai, Miyagi 980, Japan.
   Univ Uppsala Hosp, Dept Med Sci, Uppsala, Sweden.
RP Nilsson, B (reprint author), Univ Uppsala Hosp, Dept Radiol Oncol & Clin Immunol, Div Clin Immunol, Rudbeck Lab, Uppsala, Sweden.
EM Bo.Nilsson@klinimm.uu.se
RI Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730; Gianello, Pierre/0000-0002-5326-0864
CR Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907
   Brandhorst H, 1998, CELL TRANSPLANT, V7, P489, DOI 10.1016/S0963-6897(98)00028-1
   Davalli AM, 1996, DIABETES, V45, P1161, DOI 10.2337/diabetes.45.9.1161
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   Fiorante P, 2001, XENOTRANSPLANTATION, V8, P24, DOI 10.1046/j.0908-665X.2000.00088.x
   FLEXNER C, 1991, ANTIMICROB AGENTS CH, V35, P2544, DOI 10.1128/AAC.35.12.2544
   FUJISHIMA M, 1986, ANGIOLOGY, V37, P487, DOI 10.1177/000331978603700702
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   Goto M, 2004, TRANSPLANTATION, V78, P1367, DOI 10.1097/01.TP.0000140882.53773.DC
   Goto M, 2004, TRANSPLANTATION, V77, P741, DOI 10.1097/01.TP.0000114872.26990.4F
   HARTMAN NR, 1990, AIDS RES HUM RETROV, V6, P805, DOI 10.1089/aid.1990.6.805
   Hedner U, 2000, ANN MED, V32, P68
   Hering BJ, 2004, AM J TRANSPLANT, V4, P390, DOI 10.1046/j.1600-6143.2003.00351.x
   HIEBERT LM, 1994, HUM EXP TOXICOL, V13, P233, DOI 10.1177/096032719401300402
   Hiebert LM, 1999, J LAB CLIN MED, V133, P161, DOI 10.1016/S0022-2143(99)90009-4
   Hisazumi J, 2004, PHARM RES, V21, P1223, DOI 10.1023/B:PHAM.0000033009.17594.e5
   Jakab F, 1996, HPB Surg, V9, P239, DOI 10.1155/1996/15760
   Johansson H, 2005, DIABETES, V54, P1755, DOI 10.2337/diabetes.54.6.1755
   Larsson R, 1997, IMMUNOPHARMACOLOGY, V38, P119, DOI 10.1016/S0162-3109(97)00064-7
   Lasne D, 2000, THROMB HAEMOSTASIS, V84, P794
   MAHADOO J, 1978, THROMB RES, V12, P79, DOI 10.7326/0003-4819-111-7-561
   Matsumiya A, 1999, Life Sci, V64, pPL9
   Moberg L, 2002, LANCET, V360, P2039, DOI 10.1016/S0140-6736(02)12020-4
   Nakano M, 2000, TRANSPLANTATION, V69, P214, DOI 10.1097/00007890-200001270-00004
   Ozmen L, 2002, DIABETES, V51, P1779, DOI 10.2337/diabetes.51.6.1779
   RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413
   ROOS F, 1995, AM J PHYSIOL-GASTR L, V268, pG380
   Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710
   Sanchez J, 1998, THROMB RES, V89, P41, DOI 10.1016/S0049-3848(97)00310-1
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   Thomas H, 1996, MOL IMMUNOL, V33, P643, DOI 10.1016/0161-5890(96)00028-4
   Thompson GR, 2003, ATHEROSCLEROSIS, V167, P1, DOI 10.1016/S0021-9150(02)00251-4
   Wuillemin WA, 1997, J IMMUNOL, V159, P1953
   Zeerleder S, 2002, THROMB RES, V105, P441, DOI 10.1016/S0049-3848(02)00041-5
   ZIONCHECK TF, 1995, J BIOL CHEM, V270, P16871, DOI 10.1074/jbc.270.28.16871
NR 35
TC 76
Z9 81
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1600-6135
EI 1600-6143
J9 AM J TRANSPLANT
JI Am. J. Transplant.
PD FEB
PY 2006
VL 6
IS 2
BP 305
EP 312
DI 10.1111/j.1600-6143.2005.01186.x
PG 8
WC Surgery; Transplantation
SC Surgery; Transplantation
GA 004EQ
UT WOS:000234735200008
PM 16426314
OA Bronze
DA 2018-10-20
ER

PT J
AU Scheibel, T
AF Scheibel, T
TI Silk - a biomaterial with several facets
SO APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING
LA English
DT Editorial Material
RI Scheibel, Thomas/I-1170-2014
OI Scheibel, Thomas/0000-0002-0457-2423
NR 0
TC 9
Z9 9
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0947-8396
J9 APPL PHYS A-MATER
JI Appl. Phys. A-Mater. Sci. Process.
PD FEB
PY 2006
VL 82
IS 2
BP 191
EP 192
DI 10.1007/s00339-005-3434-7
PG 2
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 990BI
UT WOS:000233717800001
DA 2018-10-20
ER

PT J
AU Vollrath, F
   Porter, D
AF Vollrath, F
   Porter, D
TI Spider silk as a model biomaterial
SO APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING
LA English
DT Article
ID MECHANICAL-PROPERTIES
AB Spider silk combines strength and extensibility, and a wide range of mechanical properties can be achieved with only minute (if any) changes in chemical structure. It appears that the full range of thermo-mechanical properties of such silk fibres can be predicted by examining the energy imparted during stretching with the theoretical framework provided by Mean Field Theory for Polymers. This approach attempts to integrate strain and tensile stress with a range of relevant energetic and mechanical parameters such as the loss tangent and potential energy of atomic inter-chain bonding as well as the tensile and bulk elastic moduli. The model reveals that the underlying design principle of silks seems to share an inherent and surprising simplicity at the macromolecular level. We conclude that our modelling approach allows in-depth analysis of natural silks as well as a comparison with synthetic fibres.
C1 Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
RP Porter, D (reprint author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.
EM david.porter@zoology.oxford.ac.uk
CR Bicerano J., 1993, PREDICTION POLYM PRO
   GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0
   GOSLINE JM, 1994, ACS SYM SER, V544, P328
   Liu Y, 2005, CHEM COMMUN, P2489, DOI 10.1039/b500319a
   LIU Y, 2005, NAT MATER, P901
   McCrum N. G., 1967, ANELASTIC DIELECTRIC
   Perez-Rigueiro J, 2000, POLYMER, V41, P8433, DOI 10.1016/S0032-3861(00)00179-8
   Porter D, 2005, EUR PHYS J E, V16, P199, DOI 10.1140/epje/e2005-00021-2
   Porter D, 1995, GROUP INTERACTION MO
   SEITZ JT, 1993, J APPL POLYM SCI, V49, P1331, DOI 10.1002/app.1993.070490802
   TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018
   THIEL BL, 1995, MRS BULL, V20, P52
   van Krevelen D. W., 1993, PROPERTIES POLYM
   Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590
   WITT PN, 1977, ARACHNOL, V4, P115
   YANG Y, 2005, ADV MATER, V17, P83
NR 16
TC 77
Z9 78
U1 1
U2 42
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0947-8396
J9 APPL PHYS A-MATER
JI Appl. Phys. A-Mater. Sci. Process.
PD FEB
PY 2006
VL 82
IS 2
BP 205
EP 212
DI 10.1007/s00339-005-3437-4
PG 8
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 990BI
UT WOS:000233717800003
DA 2018-10-20
ER

PT J
AU Rammensee, S
   Huemmerich, D
   Hermanson, KD
   Scheibel, T
   Bausch, AR
AF Rammensee, S
   Huemmerich, D
   Hermanson, KD
   Scheibel, T
   Bausch, AR
TI Rheological characterization of hydrogels formed by recombinantly
   produced spider silk
SO APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING
LA English
DT Article
ID DRAGLINE SILK; CROSS-LINKING; FIBROIN; ELASTICITY; SCAFFOLD; GELATION;
   DESIGN; GEL
AB Many fibrous proteins such as spider silks exhibit impressive mechanical properties and are highly biocompatible leading to many potential biomaterial applications. For applications such as tissue engineering, polymer hydrogels have been proposed as an effective means of producing porous but stable scaffolds. Here, nanofiber-based hydrogels were produced from engineered and recombinantly produced spider silk proteins. The silk nanofibers are stable semi-flexible polymers which assemble into hydrogel networks. We studied the hydrogel rheology and determined the concentration dependence of the elastic modulus. AFM images indicate that the nanofibers might assemble into branch-like structures, which would also be consistent with the measured rheological behavior. Since the developed spider silk hydrogels are stable over weeks and show a high elastic modulus at low volume fractions, they are well suited for a broad variety of applications.
C1 Tech Univ Munich, Dept Phys, D-85747 Garching, Germany.
   Tech Univ Munich, Dept Organ Chem & Biochem, D-85747 Garching, Germany.
RP Scheibel, T (reprint author), Tech Univ Munich, Dept Phys, E22 Biophys, D-85747 Garching, Germany.
EM thomas.scheibel@fiberlab.de; abausch@ph.tum.de
RI Scheibel, Thomas/I-1170-2014
OI Scheibel, Thomas/0000-0002-0457-2423
CR AYUB ZH, 1993, BIOSCI BIOTECH BIOCH, V57, P1910, DOI 10.1271/bbb.57.1910
   Chen X, 2002, BIOMACROMOLECULES, V3, P644, DOI 10.1021/bm0156126
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020
   Gardel ML, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.158302
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112
   HANAWA T, 1995, CHEM PHARM BULL, V43, P284
   Hinner B, 1998, PHYS REV LETT, V81, P2614, DOI 10.1103/PhysRevLett.81.2614
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Kang GD, 2000, MACROMOL RAPID COMM, V21, P788, DOI 10.1002/1521-3927(20000701)21:11<788::AID-MARC788>3.0.CO;2-X
   Kenney JM, 2002, EUR J BIOCHEM, V269, P4159, DOI 10.1046/j.1432-1033.2002.03112.x
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Knight DP, 1998, J BIOMED MATER RES, V41, P185, DOI 10.1002/(SICI)1097-4636(199808)41:2<185::AID-JBM2>3.3.CO;2-L
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425
   McDermott MK, 2004, BIOMACROMOLECULES, V5, P1270, DOI 10.1021/bm034529a
   Oroudjev E, 2002, P NATL ACAD SCI USA, V99, P6460, DOI 10.1073/pnas.082526499
   Ozbas B, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268106
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
NR 25
TC 92
Z9 96
U1 9
U2 69
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0947-8396
J9 APPL PHYS A-MATER
JI Appl. Phys. A-Mater. Sci. Process.
PD FEB
PY 2006
VL 82
IS 2
BP 261
EP 264
DI 10.1007/s00339-005-3431-x
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 990BI
UT WOS:000233717800010
DA 2018-10-20
ER

PT J
AU Chevalier, J
AF Chevalier, J
TI What future for zirconia as a biomaterial?
SO BIOMATERIALS
LA English
DT Article
DE zirconia; ageing; explant analysis; orthopedics
ID YTTRIA-STABILIZED ZIRCONIA; TOUGHENED ALUMINA CERAMICS; Y-TZP CERAMICS;
   TRANSFORMATION; REPLACEMENTS; IMPLANTS; HEADS; PHASE
AB The failure events of Prozyr (R) femoral heads in 2001-2002 have opened a strong, controversial issue on the future of zirconia as a biomaterial. The aim of this paper is to review and analyze the current knowledge on ageing process and on its effect on the long term performance of implants in order to distinguish between scientific facts and speculation. Current state of the art shows the strong variability of zirconia to in vivo degradation, as a consequence of the strong influence of processing on ageing process. As different zirconia from different vendors have different process related microstructure, there is a need to assess their ageing sensitivity with advanced and accurate techniques, and ISO standards should be modified, especially to gain confidence from clinicians. There is a trend today to develop alumina-zirconia composites as an alternative to monolithic alumina and zirconia: the issue of ageing is also discussed for these composites. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Inst Natl Sci Appl, UMR 5510, CNRS, F-69621 Villeurbanne, France.
RP Chevalier, J (reprint author), Inst Natl Sci Appl, UMR 5510, CNRS, 20 Ave Albert Einstein, F-69621 Villeurbanne, France.
EM jerome.chevalier@insa-lyon.fr
CR Affatato S, 1999, BIOMATERIALS, V20, P1925, DOI 10.1016/S0142-9612(99)00093-9
   Allain J, 1999, J BONE JOINT SURG BR, V81B, P835, DOI 10.1302/0301-620X.81B5.9454
   [Anonymous], 1997, 13356 ISO
   Catledge SA, 2003, J MATER SCI-MATER M, V14, P863, DOI 10.1023/A:1025678525474
   CATON J, 2004, P 9 BIOLOX S PAR 26, P73
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Chevalier J, 2004, BIOMATERIALS, V25, P5539, DOI 10.1016/j.biomaterials.2004.01.002
   Christel P, 1988, Ann N Y Acad Sci, V523, P234, DOI 10.1111/j.1749-6632.1988.tb38516.x
   Clarke IC, 2003, J BONE JOINT SURG AM, V85A, P73, DOI 10.2106/00004623-200300004-00009
   De Aza AH, 2002, BIOMATERIALS, V23, P937, DOI 10.1016/S0142-9612(01)00206-X
   Deville S, 2005, J BIOMED MATER RES B, V72B, P239, DOI 10.1002/jbm.b.30123
   Deville S, 2004, ACTA MATER, V52, P5697, DOI 10.1016/j.actamat.2004.08.034
   Deville S, 2003, J EUR CERAM SOC, V23, P2975, DOI 10.1016/S0955-2219(03)00313-3
   DEVILLE S, 2005, J AM CERAM SOC, V88, P1272
   DEVILLE S, UNPUB BIOMATERIALS
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   Gremillard L, 2002, J AM CERAM SOC, V85, P401
   Haraguchi K, 2001, J BONE JOINT SURG BR, V83B, P996, DOI 10.1302/0301-620X.83B7.12122
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   LU Z, 1999, J BIOMED MATER RES, V48, P465
   Maccauro G, 2004, J BONE JOINT SURG BR, V86B, P1192, DOI 10.1302/0301-620X.86B8.15012
   Munoz-Saldana J, 2003, J MATER RES, V18, P2415, DOI 10.1557/JMR.2003.0337
   Pecharroman C, 2003, ADV MATER, V15, P507, DOI 10.1002/adma.200390117
   Piconi C, 1998, BIOMATERIALS, V19, P1489, DOI 10.1016/S0142-9612(98)00064-7
   Rack R., 2000, P 5 INT BIOL S MARCH, P141
NR 25
TC 541
Z9 552
U1 6
U2 133
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2006
VL 27
IS 4
BP 535
EP 543
DI 10.1016/j.biomaterials.2005.07.034
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 986LF
UT WOS:000233450400001
PM 16143387
DA 2018-10-20
ER

PT J
AU Badami, AS
   Kreke, MR
   Thompson, MS
   Riffle, JS
   Goldstein, AS
AF Badami, AS
   Kreke, MR
   Thompson, MS
   Riffle, JS
   Goldstein, AS
TI Effect of fiber diameter on spreading, proliferation, and
   differentiation of osteoblastic cells on electrospun poly(lactic acid)
   substrates
SO BIOMATERIALS
LA English
DT Review
DE polylactide; poly(ethylene glycol); electrospinning; cell proliferation;
   tissue engineering
ID SELF-ASSEMBLED MONOLAYERS; SURFACE-CHEMISTRY; FIBRONECTIN CONFORMATION;
   MICROGROOVED SURFACES; MODEL SURFACES; ADHESION; GROWTH; BONE;
   ORGANIZATION; FABRICATION
AB Electrospinning is a promising method to construct fused-fiber biomaterial scaffolds for tissue engineering applications, but the efficacy of this approach depends on how substrate topography affects cell function. Previously, it has been shown that linear, parallel raised features with length scales of 0.5-2 mu m direct cell orientation through the phenomenon of contact guidance, and enhance phenotypic markers of osteoblastic differentiation. To determine how the linear, random raised features produced by electrospinning affect proliferation and differentiation of osteoprogenitor cells, poly(lactic acid) and poly(ethylene glycol)poly(lactic acid) diblock copolymers were electrospun with mean fiber diameters of 0.14-2.1 mu m onto rigid supports. MC3T3-E1 osteoprogenitor cells cultured on fiber surfaces in the absence of osteogenic factors exhibited a lower cell density after 7 and 14 days of culture than cells cultured on spin-coated surfaces, but cell density increased with fiber diameter. However, in the presence of osteogenic factors (2 mm beta-glycerophosphate, 0.13 mm L-ascorbate-2-phosphate), cell density after 7 and 14 days of culture on fiber surfaces was comparable to or exceeded spin-coated controls, and alkaline phosphatase activity after 14 days was comparable. Examination of cell morphology revealed that cells grown on fibers had smaller projected areas than those on planar surfaces. However, cells attached to electrospun substrates of 2.1 mu m diameter fibers exhibited a higher cell aspect ratio than cells on smooth surfaces. These studies show that topographical factors designed into biomaterial scaffolds can regulate spreading, orientation, and proliferation of osteoblastic cells. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA.
   Virginia Polytech Inst & State Univ, Dept Chem, Blacksburg, VA 24061 USA.
   Virginia Polytech Inst & State Univ, Dept Macromol Sci, Blacksburg, VA 24061 USA.
   Virginia Polytech Inst & State Univ, Engn Program, Blacksburg, VA 24061 USA.
RP Goldstein, AS (reprint author), Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA.
EM goldst@vt.edu
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Cheng SL, 2000, J BONE MINER RES, V15, P2362, DOI 10.1359/jbmr.2000.15.12.2362
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8
   den Braber ET, 1998, J BIOMED MATER RES, V40, P425, DOI 10.1002/(SICI)1097-4636(19980605)40:3<425::AID-JBM13>3.0.CO;2-I
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Goldstein AS, 2001, TISSUE ENG, V7, P817, DOI 10.1089/107632701753337753
   Gopferich A, 1999, J BIOMED MATER RES, V46, P390
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Koegler WS, 2004, BIOMATERIALS, V25, P2819, DOI 10.1016/j.biomaterials.2003.09.064
   Koski A, 2004, MATER LETT, V58, P493, DOI 10.1016/S0167-577X(03)00532-9
   Lauffenburger DA, 2001, P NATL ACAD SCI USA, V98, P4282, DOI 10.1073/pnas.081083698
   Lee MH, 2005, BIOMATERIALS, V26, P1721, DOI 10.1016/j.biomaterials.2004.05.026
   Lieb E, 2003, TISSUE ENG, V9, P71, DOI 10.1089/107632703762687555
   Lim JY, 2005, J ROY SOC INTERFACE, V2, P97, DOI 10.1098/rsif.2004.0019
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Matsuzaka K, 2003, BIOMATERIALS, V24, P2711, DOI 10.1016/S0142-9612(03)00085-1
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Nair LS, 2004, BIOMACROMOLECULES, V5, P2212, DOI 10.1021/bm049759j
   Ohgo K, 2003, POLYMER, V44, P841, DOI 10.1016/S0032-3861(02)00819-4
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   Schiller PC, 2001, BONE, V28, P362, DOI 10.1016/S8756-3282(00)00458-0
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   Stankus JJ, 2004, J BIOMED MATER RES A, V70A, P603, DOI 10.1002/jbm.a.30122
   Stephansson SN, 2002, BIOMATERIALS, V23, P2527, DOI 10.1016/S0142-9612(01)00387-8
   ter Brugge PJ, 2002, TISSUE ENG, V8, P615, DOI 10.1089/107632702760240535
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   Webb K, 2000, J BIOMED MATER RES, V49, P362, DOI 10.1002/(SICI)1097-4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   WEST DC, 1985, ANAL BIOCHEM, V147, P289, DOI 10.1016/0003-2697(85)90274-X
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
NR 44
TC 396
Z9 405
U1 11
U2 189
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2006
VL 27
IS 4
BP 596
EP 606
DI 10.1016/j.biomaterials.2005.05.084
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 986LF
UT WOS:000233450400007
PM 16023716
DA 2018-10-20
ER

PT J
AU van den Beucken, JJJP
   Vos, MRJ
   Thune, PC
   Hayakawa, T
   Fukushima, T
   Okahata, Y
   Walboomers, XF
   Sommerdijk, NAJM
   Nolte, RJM
   Jansen, JA
AF van den Beucken, JJJP
   Vos, MRJ
   Thune, PC
   Hayakawa, T
   Fukushima, T
   Okahata, Y
   Walboomers, XF
   Sommerdijk, NAJM
   Nolte, RJM
   Jansen, JA
TI Fabrication, characterization, and biological assessment of multilayered
   DNA-coatings for biomaterial purposes
SO BIOMATERIALS
LA English
DT Article
DE AFM; cell culture; cell morphology; cell proliferation; cell viability;
   electrostatic self-assembly; fibroblast; FTIR; MIT assay; mutagenicity;
   nanotopography; SEM; surface modification; titanium
ID POLYELECTROLYTE MULTILAYERS; NUCLEIC-ACIDS; FILMS; COMPLEXES; SURFACES;
   FIBROBLASTS; ADSORPTION; DEPOSITION; ADHESION; BUILDUP
AB This study describes the fabrication of two types of multilayered coatings onto titanium by electrostatic self-assembly (ESA), using deoxyribosenucleic acid (DNA) as the anionic polyelectrolyte and poly-D-lysine (PDL) or poly(allylamine hydrochloride) (PAH) as the cationic polyelectrolyte. Both coatings were characterized using UV-vis spectrophotometry, atomic force microscopy (AFM), X-ray photospectroscopy (XPS), contact angle measurements, Fourier transform infrared spectroscopy (FTIR), and for the amount of DNA immobilized. The mutagenicity of the constituents of the coatings was assessed. Titanium substrates with or without multilayered DNA-coatings were used in cell culture experiments to study cell proliferation, viability, and morphology. Results of UV-vis spectrophotometry, AFM, and contact angle measurements clearly indicated the progressive build-up of the multilayered coatings. Furthermore, AFM and XPS data showed a more uniform build-up and morphology of [PDL/DNA]-coatings compared to [PAH/DNA]-coatings. DNA-immobilization into both coatings was linear, and approximated 3 mu g/cm(2) into each double-layer. The surface morphology of both types of multilayered DNA-coatings showed elevations in the nanoscale range. No mutagenic effects of DNA, PDL, or PAH were detected, and cell viability and morphology were not affected by the presence of either type of multilayered DNA-coating. Still, the results of the proliferation assay revealed an increased proliferation of primary rat dermal fibroblasts on both types of multilayered DNA-coatings compared to non-coated controls. The biocompatibility and functionalization of the coatings produced here, will be assessed in subsequent cell culture and animal-implantation studies. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Radboud Univ Nijmegen, Coll Dent Sci, Med Ctr, Dept Periodontol & Biomat, NL-6500 HB Nijmegen, Netherlands.
   Eindhoven Univ Technol, Lab Macromol & Organ Chem, NL-5600 MB Eindhoven, Netherlands.
   Eindhoven Univ Technol, Schuit Inst Catalysis, NL-5600 MB Eindhoven, Netherlands.
   Nihon Univ, Sch Dent, Res Inst Oral Sci, Dept Dent Mat, Matsudo, Chiba 2718587, Japan.
   Fukuoka Dent Coll, Dept Dent Engn, Bioengn Sect, Sawara Ku, Fukuoka 8140193, Japan.
   Tokyo Inst Technol, Dept Biomol Engn, Midori Ku, Yokohama, Kanagawa 2268501, Japan.
   Radboud Univ Nijmegen, Dept Organ Chem, NL-6525 ED Nijmegen, Netherlands.
RP Jansen, JA (reprint author), Radboud Univ Nijmegen, Coll Dent Sci, Med Ctr, Dept Periodontol & Biomat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM j.jansen@dent.umcn.nl
RI van den beucken, jeroen/N-2910-2013; van den beucken,
   Jeroen/B-8790-2013; Jansen, John/H-8055-2014; Nolte,
   Roeland/C-9930-2013; van den beucken, jeroen/G-9940-2013; Walboomers,
   X.Frank/B-3692-2013; Sommerdijk, Nico/B-7239-2013
OI van den beucken, jeroen/0000-0002-0301-1966; Nolte,
   Roeland/0000-0002-5612-7815; Sommerdijk, Nico/0000-0002-8956-195X
CR Banyay M, 2003, BIOPHYS CHEM, V104, P477, DOI 10.1016/S0301-4622(03)00035-8
   Boura C, 2003, BIOMATERIALS, V24, P3521, DOI 10.1016/S0142-9612(03)00214-X
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chen XD, 2002, THIN SOLID FILMS, V409, P227, DOI 10.1016/S0040-6090(02)00045-7
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Freshney R.I., 1987, CULTURE ANIMAL CELLS
   Fukushima T, 2001, J DENT RES, V80, P1772, DOI 10.1177/00220345010800081801
   Garza JM, 2004, LANGMUIR, V20, P7298, DOI 10.1021/la049106o
   Hill IRC, 2001, ANAL BIOCHEM, V291, P62, DOI 10.1006/abio.2001.5004
   Inoue Y, 2003, J BIOMED MATER RES A, V65A, P203, DOI 10.1002/jbm.a.10483
   Kamei S, 1997, J BIOMED MATER RES, V37, P384
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Kitamura H, 1997, INT J BIOL MACROMOL, V21, P337, DOI 10.1016/S0141-8130(97)00085-8
   KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0
   KRIEG AM, 2000, VACCINE, V19, P18
   LIU W, BIOMATERIALS
   Luo LQ, 2001, BIOPHYS CHEM, V94, P11, DOI 10.1016/S0301-4622(01)00204-6
   LVOV Y, 1993, MACROMOLECULES, V26, P5396, DOI 10.1021/ma00072a016
   MCMICHAEL AJ, 1992, OXFORD TXB PATHOLOGY
   Pei RJ, 2001, BIOMACROMOLECULES, V2, P463, DOI 10.1021/bm0001289
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Richert L, 2002, BIOMACROMOLECULES, V3, P1170, DOI 10.1021/bm.0255490
   Sastry M, 2002, ACCOUNTS CHEM RES, V35, P847, DOI 10.1021/ar010094x
   Schonhoff M, 2003, J PHYS-CONDENS MAT, V15, pR1781, DOI 10.1088/0953-8984/15/49/R01
   Serrano MC, 2004, BIOMATERIALS, V25, P5603, DOI 10.1016/j.biomaterials.2004.01.037
   Shi XY, 2002, J PHYS CHEM B, V106, P1173, DOI 10.1021/jp0132634
   Stryer L., 1995, BIOCHEMISTRY
   SUKHORUKOV G, 1996, THIN SOLID FILMS, V220, P284
   Sukhorukov GB, 1996, BIOSENS BIOELECTRON, V11, P913, DOI 10.1016/0956-5663(96)89440-1
   Tedeschi C, 2001, J AM CHEM SOC, V123, P954, DOI 10.1021/ja0031974
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   TRETINNIKOV ON, 1994, J BIOMED MATER RES, V28, P1365, DOI 10.1002/jbm.820281115
   Tryoen-Toth P, 2002, J BIOMED MATER RES, V60, P657, DOI 10.1002/jbm.10110
   Werner MH, 1996, SCIENCE, V271, P778, DOI 10.1126/science.271.5250.778
   WILSON WD, 1996, NUCL ACIDS CHEM BIOL
   Yamada M, 2002, CHEM-EUR J, V8, P1407, DOI 10.1002/1521-3765(20020315)8:6<1407::AID-CHEM1407>3.0.CO;2-L
   Zhang RY, 2000, J BIOMED MATER RES, V52, P430, DOI 10.1002/1097-4636(200011)52:2<430::AID-JBM25>3.0.CO;2-L
   Zhou YL, 2004, LANGMUIR, V20, P7208, DOI 10.1021/la049652h
   Zhou YL, 2004, BIOPHYS CHEM, V107, P273, DOI 10.1016/j.bpc.2003.09.009
   Zhu HG, 2004, BIOMATERIALS, V25, P109, DOI 10.1016/S0142-9612(03)00481-2
NR 45
TC 66
Z9 66
U1 4
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2006
VL 27
IS 5
BP 691
EP 701
DI 10.1016/j.biomaterials.2005.06.015
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 992BE
UT WOS:000233858000003
PM 16076484
DA 2018-10-20
ER

PT J
AU Wright, JEI
   Gittens, SA
   Bansal, G
   Kitov, PI
   Sindrey, D
   Kucharski, C
   Uludag, H
AF Wright, JEI
   Gittens, SA
   Bansal, G
   Kitov, PI
   Sindrey, D
   Kucharski, C
   Uludag, H
TI A comparison of mineral affinity of bisphosphonate-protein conjugates
   constructed with disulfide and thioether linkages
SO BIOMATERIALS
LA English
DT Article
DE bone tissue engineering; drug delivery; hydroxyapatite; protein
   adsorption; coupling agent
ID FIBROBLAST-GROWTH-FACTOR; RAT ECTOPIC MODEL; BIOMATERIAL CARRIERS;
   CONTROLLED-RELEASE; BONE AFFINITY; TETHER LENGTH; STABILITY;
   PHARMACOKINETICS; IMMUNOTOXINS; GLUTATHIONE
AB Chemical conjugation of bisphosphonates (Bps) to therapeutic proteins is an effective means to impart mineral affinity to proteins. Such conjugates can be implanted with mineral-based matrices to control the local delivery kinetics of the proteins. BPs linked to proteins with reversible (i.e., cleavable) linkages are desirable over conjugates with stable linkages to release the protein in free form. This study conducted a direct comparison of mineral affinity of BP-protein conjugates linked together with cleavable disulfide and non-cleavable thioether linkages. Bovine serum albumin (BSA) was used as a model protein and the desired conjugates were created with N-succinimidyl-3-(2-pyridyldithio)propionate (disulfide) and succinimidyl-4-(N-maleimido-methyl)cyclohexane-1-carboxylate (thioether) linkers. The disulfide-linked conjugates were cleaved in the presence of a major thiol constituent of serum, cysteine. The imparted mineral affinity, as assessed by hydroxyapatite binding in vitro, was lost upon the cleavage of the disulfide-linked aminoBP. The presence of the serum did not accelerate the cleavage of disulfide-linked conjugates. The aminoBP BSA conjugates formed with disulfide and thioether linkages were subcutaneously implanted in rats with two different mineral-based matrices to assess protein loss from the matrices. All conjugates exhibited a higher retention in mineral matrices as compared to unmodified BSA. However, no significant differences in in situ pharmacokinetics of the disulfide- and thioether-linked conjugates were observed. We conclude that disulfide- linked BP conjugates were readily cleavable by the amino acid cysteine in vitro, but in vivo cleavage of the disulfide-linked conjugates was not evident when the proteins were implanted adsorbed to mineral-based matrices. BP-protein conjugates with faster-cleaving tethers might be required to significantly influence the release of the BP conjugates from the mineral matrices. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Alberta, Fac Engn, Dept Chem & Mat Engn, Edmonton, AB T6G 2G6, Canada.
   Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada.
   Univ Alberta, Fac Med & Dent, Dept Biomed Engn, Edmonton, AB T6G 2N8, Canada.
   Univ Alberta, Fac Sci, Dept Chem, Edmonton, AB, Canada.
   Millenium Biologix Inc, Mississauga, ON, Canada.
RP Uludag, H (reprint author), Univ Alberta, Fac Engn, Dept Chem & Mat Engn, 526 Chem & Mat Engn Bldg, Edmonton, AB T6G 2G6, Canada.
EM hasan.uludag@ualberta.ca
RI Kitov, Pavel/J-3714-2014
CR AMES BN, 1966, METHOD ENZYMOL, V8, P115, DOI DOI 10.1016/0076-6879(66)08014-5
   Arpicco S, 1997, BIOCONJUGATE CHEM, V8, P327, DOI 10.1021/bc970025w
   Bai J, 2004, J POLYM SCI POL CHEM, V42, P6143, DOI 10.1002/pola.20472
   Bansal G, 2004, J PHARM SCI-US, V93, P2788, DOI 10.1002/jps.20186
   BANSAL G, 2005, IN PRESS J BIOMED MA
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Buxton TB, 2004, BRIT J SURG, V91, P1192, DOI 10.1002/bjs.4644
   Dosio F, 1998, BIOCONJUGATE CHEM, V9, P372, DOI 10.1021/bc970192w
   EBETINO FH, 1999, PHOSPHORUS SULFUR, V146, P9
   Edlund U, 2003, ADV DRUG DELIVER REV, V55, P585, DOI 10.1016/S0169-409X(03)00036-X
   FLAVELL DJ, 1994, INT J CANCER, V58, P407, DOI 10.1002/ijc.2910580317
   Fracasso G, 2004, MINI-REV MED CHEM, V4, P545, DOI 10.2174/1389557043403909
   Garnett MC, 2001, ADV DRUG DELIVER REV, V53, P171, DOI 10.1016/S0169-409X(01)00227-7
   Gil L, 1999, BIOORGAN MED CHEM, V7, P901, DOI 10.1016/S0968-0896(99)00045-0
   Gittens SA, 2004, PHARM RES, V21, P608, DOI 10.1023/B:PHAM.0000022407.05163.01
   Gittens SA, 2003, PHARMACEUT RES, V20, P978, DOI 10.1023/A:1024445903306
   HEALY AM, 1992, EXP EYE RES, V55, P663, DOI 10.1016/0014-4835(92)90171-N
   Hernanz A, 2000, LIFE SCI, V67, P1317, DOI 10.1016/S0024-3205(00)00722-0
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Kitov PI, 2003, J AM CHEM SOC, V125, P3284, DOI 10.1021/ja0258529
   KUAN CT, 1994, J BIOL CHEM, V269, P7610
   Larcher Y, 2002, J BONE MINER RES, V17, pS403
   LETVIN NL, 1986, J CLIN INVEST, V77, P977, DOI 10.1172/JCI112399
   Lewis GP, 1996, EXP EYE RES, V62, P309, DOI 10.1006/exer.1996.0037
   Maeda H, 2004, INT J PHARM, V275, P109, DOI 10.1016/j.ijpharm.2004.01.040
   Pastore A, 1998, CLIN CHEM, V44, P825
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49
   Russell RGG, 1999, BONE, V25, P97, DOI 10.1016/S8756-3282(99)00116-7
   Saito G, 2003, ADV DRUG DELIVER REV, V55, P199, DOI 10.1016/S0169-409X(02)00179-5
   Stayton PS, 2003, CRIT REV ORAL BIOL M, V14, P370, DOI 10.1177/154411130301400507
   SZAJEWSKI RP, 1980, J AM CHEM SOC, V102, P2011, DOI 10.1021/ja00526a042
   TRAIL, 1977, CAN RES, V57, P100
   Trail PA, 1997, CANCER RES, V57, P100
   Uludag H, 2000, BIOTECHNOL PROGR, V16, P258, DOI 10.1021/bp990154m
   Uludag H, 1999, BIOTECHNOL BIOENG, V65, P668, DOI 10.1002/(SICI)1097-0290(19991220)65:6<668::AID-BIT7>3.0.CO;2-8
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 2002, BIOTECHNOL PROGR, V18, P604, DOI 10.1021/bp0200447
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Whitaker MJ, 2001, J PHARM PHARMACOL, V53, P1427, DOI 10.1211/0022357011777963
   Wiemann M, 2002, J BIOMED MATER RES, V62, P119, DOI 10.1002/jbm.10251
   WILSON JM, 1980, J AM CHEM SOC, V102, P359, DOI 10.1021/ja00521a058
   Wu DF, 2002, J DRUG TARGET, V10, P239, DOI 10.1080/10611860290022679
NR 43
TC 31
Z9 31
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2006
VL 27
IS 5
BP 769
EP 784
DI 10.1016/j.biomaterials.2005.06.012
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 992BE
UT WOS:000233858000011
PM 16055182
DA 2018-10-20
ER

PT J
AU Park, JY
   Acar, MH
   Akthakul, A
   Kuhlman, W
   Mayes, AM
AF Park, JY
   Acar, MH
   Akthakul, A
   Kuhlman, W
   Mayes, AM
TI Polysulfone-graft-poly(ethylene glycol) graft copolymers for surface
   modification of polysulfone membranes
SO BIOMATERIALS
LA English
DT Article
DE polysulfone; polyethylene glycol; surface modification; protein
   resistance; membrane; dialysis
ID LOW-TEMPERATURE PLASMA; POLY(VINYLIDENE FLUORIDE) MEMBRANES;
   ULTRAFILTRATION MEMBRANES; PROTEIN-ADSORPTION; PLATELET-ADHESION;
   HYDROPHILIC MODIFICATION; POLY(ETHYLENE GLYCOL); POLYMER MEMBRANES;
   PHASE INVERSION; COMB POLYMERS
AB Amphiphilic graft copolymers having polysulfone (PSf) backbones and poly(ethylene glycol) (PEG) side chains were synthesized via reaction of an alkoxide formed from PEG and a base (sodium hydride) with chloromethylated polysulfone. The resulting polysulfone-graft-poly(ethylene glycol), PSf-g-PEG, materials were hydrophilic but water insoluble, rendering them potentially useful as biomaterial coatings. PSf-g-PEG films exhibited high resistance to protein adsorption and cell attachment. When used as an additive in PSf membranes prepared by immersion precipitation, the graft copolymer preferentially segregates to the membrane surface, delivering enhanced wettability, porosity and protein resistance compared to unmodified PSf membranes. The surface properties of PSf-g-PEG modified membranes render them desirable candidates for hemodialysis. (c) 2005 Elsevier Ltd. All rights reserved.
C1 MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
RP Mayes, AM (reprint author), MIT, Dept Mat Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM amayes@mit.edu
RI Acar, Metin/N-3246-2014
OI Acar, Metin/0000-0001-8953-1905
FU NIGMS NIH HHS [1R0GM59870-01]
CR Akthakul A, 2002, J MEMBRANE SCI, V208, P147, DOI 10.1016/S0376-7388(02)00227-2
   Anke N, 1997, J MEMBRANE SCI, V133, P57
   Avram E, 1997, J MACROMOL SCI PURE, VA34, P1701, DOI 10.1080/10601329708010036
   Blanco JF, 2001, J MEMBRANE SCI, V186, P267, DOI 10.1016/S0376-7388(01)00331-3
   Bowry SK, 2002, INT J ARTIF ORGANS, V25, P447
   BRINK LES, 1993, J MEMBRANE SCI, V76, P281, DOI 10.1016/0376-7388(93)85225-L
   Chen MH, 1996, J APPL POLYM SCI, V61, P1205, DOI 10.1002/(SICI)1097-4628(19960815)61:7<1205::AID-APP16>3.0.CO;2-W
   GUIVER MD, 1993, J APPL POLYM SCI, V48, P1597, DOI 10.1002/app.1993.070480912
   Hancock LF, 2000, BIOMATERIALS, V21, P725, DOI 10.1016/S0142-9612(99)00237-9
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   Hasegawa T, 2001, BIOMATERIALS, V22, P243, DOI 10.1016/S0142-9612(00)00180-0
   Hester JF, 2002, MACROMOLECULES, V35, P7652, DOI 10.1021/ma0122270
   Hester JF, 2002, J MEMBRANE SCI, V202, P119, DOI 10.1016/S0376-7388(01)00735-9
   Hester JF, 2002, J MEMBRANE SCI, V208, P375, DOI 10.1016/S0376-7388(02)00317-4
   Hester JF, 1999, MACROMOLECULES, V32, P1643, DOI 10.1021/ma980707u
   HIGUCHI A, 1991, J MEMBRANE SCI, V57, P175, DOI 10.1016/S0376-7388(00)80677-8
   Higuchi A, 2003, BIOMATERIALS, V24, P3235, DOI 10.1016/S0142-9612(03)00186-8
   HIGUCHI A, 1990, J APPL POLYM SCI, V41, P1973, DOI 10.1002/app.1990.070410904
   HIGUCHI A, 1993, DESALINATION, V90, P127, DOI 10.1016/0011-9164(93)80170-R
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P545, DOI 10.1021/bm015510f
   Ishida T, 2001, POLYHEDRON, V20, P1545, DOI 10.1016/S0277-5387(01)00652-0
   Ishihara K, 1999, BIOMATERIALS, V20, P1553, DOI 10.1016/S0142-9612(98)00206-3
   IWATA H, 1994, J APPL POLYM SCI, V54, P125, DOI 10.1002/app.1994.070540113
   Kilduff JE, 2000, DESALINATION, V132, P133, DOI 10.1016/S0011-9164(00)00142-9
   Kim JH, 1998, J MEMBRANE SCI, V138, P153, DOI 10.1016/S0376-7388(97)00224-X
   KIM KJ, 1988, DESALINATION, V70, P229, DOI 10.1016/0011-9164(88)85057-4
   Kim YW, 2005, BIOMATERIALS, V26, P2867, DOI 10.1016/j.biomaterials.2004.08.026
   KINZER KE, 1985, J MEMBRANE SCI, V22, P1, DOI 10.1016/S0376-7388(00)80528-1
   LAFRENIERE LY, 1987, IND ENG CHEM RES, V26, P2385, DOI 10.1021/ie00071a035
   Malchesky PS, 2004, BIOMATERIALS SCI INT, P514
   Mcmurry J., 2004, ORGANIC CHEM
   MOK S, 1994, J APPL POLYM SCI, V51, P193, DOI 10.1002/app.1994.070510120
   Ochoa NA, 2001, J MEMBRANE SCI, V187, P227, DOI 10.1016/S0376-7388(01)00348-9
   Pieracci J, 2002, J MEMBRANE SCI, V202, P1, DOI 10.1016/S0376-7388(01)00624-X
   Pospiech D, 1999, MACROMOL CHEM PHYSIC, V200, P1311, DOI 10.1002/(SICI)1521-3935(19990601)200:6<1311::AID-MACP1311>3.0.CO;2-W
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Singh NP, 2003, RENAL FAILURE, V25, P419, DOI 10.1081/JDI-120021154
   Song YQ, 2000, J APPL POLYM SCI, V78, P979, DOI 10.1002/1097-4628(20001031)78:5<979::AID-APP60>3.0.CO;2-U
   Ulbricht M, 1996, J MEMBRANE SCI, V111, P193, DOI 10.1016/0376-7388(95)00207-3
   Walton DG, 1996, PHYS REV E, V54, P2811, DOI 10.1103/PhysRevE.54.2811
   Wavhal DS, 2002, J MEMBRANE SCI, V209, P255, DOI 10.1016/S0376-7388(02)00352-6
   Yoshikawa M, 1999, J APPL POLYM SCI, V74, P407, DOI 10.1002/(SICI)1097-4628(19991010)74:2<407::AID-APP23>3.0.CO;2-3
   Zhao CS, 2003, BIOMATERIALS, V24, P3747, DOI 10.1016/S0142-9612(03)00250-3
NR 44
TC 226
Z9 236
U1 11
U2 143
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2006
VL 27
IS 6
BP 856
EP 865
DI 10.1016/j.biomaterials.2005.07.010
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 995JE
UT WOS:000234095800006
PM 16105681
DA 2018-10-20
ER

PT J
AU Hee, CK
   Jonikas, MA
   Nicoll, SB
AF Hee, CK
   Jonikas, MA
   Nicoll, SB
TI Influence of three-dimensional scaffold on the expression of osteogenic
   differentiation markers by human dermal fibroblasts
SO BIOMATERIALS
LA English
DT Article
DE bone tissue engineering; calcium phosphate; fibroblast; osteoblast;
   polylactic acid
ID MESENCHYMAL STEM-CELLS; CALCIUM-PHOSPHATE CERAMICS; MARROW STROMAL
   CELLS; EXTRACELLULAR-MATRIX MINERALIZATION; BONE MORPHOGENETIC PROTEIN;
   OSTEOBLAST GENE-EXPRESSION; HUMAN ADIPOSE-TISSUE; IN-VITRO;
   TRANSCRIPTION FACTOR; SEEDING DENSITY
AB Current research in the field of tissue engineering utilizes biomaterial scaffolds, cells, and growth factors for the creation of a functional, biologically active tissue. This study examined the effect of two commercially available, three-dimensional scaffolds, ultraporous beta-tricalcium phosphate ceramics (beta-TCP, Vitoss) and open-celled poly(lactic acid) foams (OPLA, Drilac), on the osteogenic differentiation potential of human dermal fibroblasts. Serum-free, chemically-defined medium containing the metabolic factor 1 alpha,25-dihydroxyvitamin D-3 was used to promote an osteogenic phenotype in these cells. Osteoblast differentiation was assessed using PCR and immunohistochemical methods to detect gene and protein expression for the osteoblast markers alkaline phosphatase, osteopontin, and osteocalcin. Dermal fibroblasts cultured on beta-TCP scaffolds in chemically-defined medium with vitamin D-3 exhibited up-regulated gene and protein expression compared to cells cultured on OPLA scaffolds. These results suggest that Vitoss (beta-TCP) scaffolds seeded with dermal fibroblasts and maintained in chemically-defined medium with vitamin D-3 are better suited for bone tissue engineering applications than Drilac (OPLA) foams. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
   Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA.
RP Nicoll, SB (reprint author), Univ Penn, Dept Bioengn, 3320 Smith Walk,111 Hayden Hall, Philadelphia, PA 19104 USA.
EM heeck@seas.upenn.edu; jonikas@stanford.edu; nicoll@seas.upenn.edu
CR Awad HA, 2003, TISSUE ENG, V9, P1301, DOI 10.1089/10763270360728215
   BACHVAROV DR, 1983, PREP BIOCHEM, V13, P161, DOI 10.1080/00327488308068745
   BELAND FA, 1979, J CHROMATOGR, V174, P177, DOI 10.1016/S0021-9673(00)87048-X
   BONEWALD LF, 1992, J BIOL CHEM, V267, P8943
   Boo JS, 2002, J CRANIOFAC SURG, V13, P231, DOI 10.1097/00001665-200203000-00009
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Boyce T, 1999, ORTHOP CLIN N AM, V30, P571, DOI 10.1016/S0030-5898(05)70110-3
   Byers BA, 2002, J BONE MINER RES, V17, P1931, DOI 10.1359/jbmr.2002.17.11.1931
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Chaudhry GR, 2004, J BIOMED BIOTECHNOL, P203, DOI 10.1155/S111072430431003X
   Dong JA, 2002, BIOMATERIALS, V23, P4493, DOI 10.1016/S0142-9612(02)00193-X
   Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.3.CO;2-Q
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Dvir-Ginzberg M, 2003, TISSUE ENG, V9, P757, DOI 10.1089/107632703768247430
   Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61
   Fitzsimmons JS, 2004, J ORTHOPAED RES, V22, P716, DOI 10.1016/j.orthres.2003.10.020
   Frank RN, 2003, INVEST OPHTH VIS SCI, V44, P1
   FRAYSSINET P, 1993, BIOMATERIALS, V14, P423, DOI 10.1016/0142-9612(93)90144-Q
   FREDERICKS DC, 2004, ORTHOPEDICS, V27, P167
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Halvorsen YDC, 2001, TISSUE ENG, V7, P729, DOI 10.1089/107632701753337681
   HEE CK, 2004, T ORTHOP RES SOC, V29, P380
   Hirata K, 2003, BONE, V32, P502, DOI 10.1016/S8756-3282(03)00054-1
   Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Kiernan J.A., 1999, HISTOLOGICAL HISTOCH
   Knabe C, 2000, J BIOMED MATER RES, V52, P498, DOI 10.1002/1097-4636(20001205)52:3<498::AID-JBM8>3.0.CO;2-P
   Krebsbach PH, 2000, HUM GENE THER, V11, P1201, DOI 10.1089/10430340050015248
   Kruyt MC, 2004, J BIOMED MATER RES B, V69B, P113, DOI 10.1002/jbm.b.10073
   Kuznetsov SA, 2000, TRANSPLANTATION, V70, P1780, DOI 10.1097/00007890-200012270-00018
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   LENNON DP, 1995, EXP CELL RES, V219, P211, DOI 10.1006/excr.1995.1221
   Lian J B, 1993, J Oral Implantol, V19, P95
   Ma PX, 2001, J BIOMED MATER RES, V54, P284, DOI 10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W
   Majors AK, 1997, J ORTHOPAED RES, V15, P546, DOI 10.1002/jor.1100150410
   Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006
   Mizuno S, 1996, EXP CELL RES, V227, P89, DOI 10.1006/excr.1996.0253
   Mizuno S, 1996, BIOMATERIALS, V17, P1819, DOI 10.1016/0142-9612(96)00041-5
   Nicoll SB, 2002, BIOCHEM BIOPH RES CO, V292, P819, DOI 10.1006/bbrc.2002.6697
   Nicoll SB, 2001, CONNECT TISSUE RES, V42, P59, DOI 10.3109/03008200109014249
   Nishikawa M, 2004, CELL TRANSPLANT, V13, P367, DOI 10.3727/000000004783983819
   Notingher I, 2004, J CELL BIOCHEM, V92, P1180, DOI 10.1002/jcb.20136
   OSYCZKA AM, 2003, T ORTHOP RES SOC, V28, P932
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   OWEN TA, 1991, ENDOCRINOLOGY, V128, P1496, DOI 10.1210/endo-128-3-1496
   PHILLIPS JE, 2004, T ORTHOP RES SOC, V29, P800
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prince M, 2001, J CELL BIOCHEM, V80, P424, DOI 10.1002/1097-4644(20010301)80:3<424::AID-JCB160>3.0.CO;2-6
   REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601
   Rutherford RB, 2002, TISSUE ENG, V8, P441, DOI 10.1089/107632702760184709
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Sandhu HS, 1995, SPINE, V20, P2669, DOI 10.1097/00007632-199512150-00008
   Shalhoub V, 1998, J CELL BIOCHEM, V69, P154, DOI 10.1002/(SICI)1097-4644(19980501)69:2<154::AID-JCB6>3.0.CO;2-R
   Shui CX, 2002, J CELL PHYSIOL, V193, P164, DOI 10.1002/jcp.10157
   Singer VL, 1997, ANAL BIOCHEM, V249, P228, DOI 10.1006/abio.1997.2177
   STEIN GS, 1990, FASEB J, V4, P3111
   Taira M, 2003, J ORAL REHABIL, V30, P697, DOI 10.1046/j.1365-2842.2003.01118.x
   TAKEDA K, 1992, J CELL PHYSIOL, V153, P450, DOI 10.1002/jcp.1041530303
   Uemura T, 2003, BIOMATERIALS, V24, P2277, DOI 10.1016/S0142-9612(03)00039-5
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   van Leeuwen JPTM, 2001, CRIT REV EUKAR GENE, V11, P199
   Vogelin E, 2005, J BONE JOINT SURG AM, V87A, P1323, DOI 10.2106/JBJS.C.00913
   Wang CY, 2004, BIOMATERIALS, V25, P2507, DOI 10.1016/j.biomaterials.2003.09.035
   Wang YC, 2003, TISSUE ENG, V9, P1205, DOI 10.1089/10763270360728116
   Wickham MQ, 2003, CLIN ORTHOP RELAT R, P196, DOI 10.1097/01.blo.0000072467.53786.ca
   Xiao ZS, 1998, GENE, V214, P187, DOI 10.1016/S0378-1119(98)00227-3
   Xiao ZS, 1999, J CELL BIOCHEM, V74, P596, DOI 10.1002/(SICI)1097-4644(19990915)74:4<596::AID-JCB9>3.3.CO;2-6
   Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705
   Young HE, 2001, ANAT REC, V264, P51, DOI 10.1002/ar.1128
   Yuan HP, 2001, BIOMATERIALS, V22, P2617, DOI 10.1016/S0142-9612(00)00450-6
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 73
TC 38
Z9 40
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2006
VL 27
IS 6
BP 875
EP 884
DI 10.1016/j.biomaterials.2005.07.004
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 995JE
UT WOS:000234095800008
PM 16102817
DA 2018-10-20
ER

PT J
AU Wu, YC
   Shaw, SY
   Lin, HR
   Lee, TM
   Yang, CY
AF Wu, YC
   Shaw, SY
   Lin, HR
   Lee, TM
   Yang, CY
TI Bone tissue engineering evaluation based on rat calvaria stromal cells
   cultured on modified PLGA scaffolds
SO BIOMATERIALS
LA English
DT Article
DE bone tissue engineering; poly(lactic-co-glycolic acid); chitosan;
   N-succinyl-chitosan; collagen; scaffold
ID BIODEGRADABLE POLYMER SCAFFOLDS; IN-VITRO; HUMAN OSTEOBLASTS; CHITOSAN;
   MATRIX; DEGRADATION; ATTACHMENT; CARTILAGE; COLLAGEN; DEFECTS
AB Using natural materials to coat the scaffolds used for tissue-engineered bone-repair techniques is expected to increase osteoblast adhesion to the scaffold and to express normal physiological function. To test this hypothesis, we therefore modified poly(DL-lactic-co-glycolic acid) (PLGA) substrate by coating it with natural biomaterial solutions of collagen, chitosan, or N-succinyl-chitosan, and then used these three combinations as scaffolds to evaluate their effects on osteoblast attachment, proliferation, and differentiation. The results demonstrated that the pore size of scaffolds ranging from 125-500 mu m did not affect the osteoblast phenotype; however, the surface modification of the scaffolds coated with these natural biomaterials did. Collagen increased cell attachment and proliferation, but chitosan and N-succinyl-chitosan decreased them. Chitosan and N-succinyl-chitosan increased differentiation, but collagen decreased it. These results provide us a new strategy for modifying microenvironments to increase osteoblast adhesion, proliferation, and differentiation on PLGA scaffolds, a strategy that might be useful for tissue regeneration. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Natl Cheng Kung Univ, Coll Med, Dept Orthoped, Tainan 70428, Taiwan.
   Natl Cheng Kung Univ, Inst Biotechnol, Tainan 70428, Taiwan.
   Natl Cheng Kung Univ, Dept Chem, Tainan 70428, Taiwan.
   So Taiwan Univ Technol, Dept Chem Engn, Tainan 710, Taiwan.
   Natl Cheng Kung Univ, Coll Med, Inst Oral Med, Tainan 70428, Taiwan.
RP Yang, CY (reprint author), Natl Cheng Kung Univ, Coll Med, Dept Orthoped, Tainan 70428, Taiwan.
EM cyyang@mail.ncku.edu.tw
RI Lee, Tzer-Min/G-3713-2011
CR BROWN KLB, 1982, J BONE JOINT SURG AM, V64, P270, DOI 10.2106/00004623-198264020-00020
   Chen GP, 2001, J BIOMED MATER RES, V57, P8, DOI 10.1002/1097-4636(200110)57:1<8::AID-JBM1135>3.0.CO;2-H
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   ENNEKING WF, 1980, J BONE JOINT SURG AM, V62, P1039, DOI 10.2106/00004623-198062070-00001
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Gao CY, 2003, J BIOMAT SCI-POLYM E, V14, P937, DOI 10.1163/156856203322381429
   Garcia AJ, 1998, J BIOMED MATER RES, V40, P48, DOI 10.1002/(SICI)1097-4636(199804)40:1<48::AID-JBM6>3.0.CO;2-R
   GEPSTEIN R, 1987, J BONE JOINT SURG AM, V69A, P984, DOI 10.2106/00004623-198769070-00005
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Ishihara M, 2003, J BIOMED MATER RES A, V64A, P551, DOI 10.1002/jbm.a.10427
   Klokkevold PR, 1996, J PERIODONTOL, V67, P1170, DOI 10.1902/jop.1996.67.11.1170
   KNOX P, 1979, J CELL SCI, V40, P77
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   Lee YM, 2000, J PERIODONTOL, V71, P410, DOI 10.1902/jop.2000.71.3.410
   Lin HR, 2002, J BIOMED MATER RES, V63, P271, DOI 10.1002/jbm.10183
   PARK TG, 1995, BIOMATERIALS, V16, P1123, DOI 10.1016/0142-9612(95)93575-X
   Partridge K, 2002, BIOCHEM BIOPH RES CO, V292, P144, DOI 10.1006/bbrc.2002.6623
   Pozzi Ambra, 1998, Journal of Cell Biology, V142, P587, DOI 10.1083/jcb.142.2.587
   Saadeh PB, 2001, J CRANIOFAC SURG, V12, P573, DOI 10.1097/00001665-200111000-00015
   Sashiwa H, 1999, CARBOHYD POLYM, V39, P127, DOI 10.1016/S0144-8617(98)00167-2
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   SUMMERS BN, 1989, J BONE JOINT SURG BR, V71, P677
   Tan W, 2001, TISSUE ENG, V7, P203, DOI 10.1089/107632701300062831
   Tiedeman JJ, 1995, ORTHOPEDICS, V18, P1153
   VACANTI CA, 1993, TRANSPLANT P, V25, P1019
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   Wing LYC, 1998, LIFE SCI, V62, P981, DOI 10.1016/S0024-3205(98)00018-6
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 33
TC 100
Z9 112
U1 2
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2006
VL 27
IS 6
BP 896
EP 904
DI 10.1016/j.biomaterials.2005.07.002
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 995JE
UT WOS:000234095800010
PM 16125224
DA 2018-10-20
ER

PT J
AU Mabbett, AN
   Sanyahumbi, D
   Yong, P
   Macaskie, LE
AF Mabbett, AN
   Sanyahumbi, D
   Yong, P
   Macaskie, LE
TI Biorecovered precious metals from industrial wastes: Single-step
   conversion of a mixed metal liquid waste to a bioinorganic catalyst with
   environmental application
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID CHLORINATED AROMATIC-COMPOUNDS; SULFATE-REDUCING BACTERIA;
   DESULFOVIBRIO-DESULFURICANS; CHROMATE REDUCTION; ESCHERICHIA-COLI;
   PALLADIUM; CELLS; CHROMIUM(VI); RECOVERY; CR(VI)
AB The complete and continuous reduction of 1 mM Cr(VI) to Cr(III) was achieved in a flow-through reactor using a novel bioinorganic catalyst ("MM-bio-Pd(0)"), which was produced by single-step reduction of platinum group metals (PGM) from industrial waste solution onto biomass of Desulfovibrio desulfuricans ATCC 29577. Two flow-through,reactor systems were compared using both "MM-bio-Pd(0)" and chemically reduced Pd(0). Reactors containing the latter removed Cr(VI) for 1 week only at the expense of formate as the electron donor, whereas the former gave complete Cr(VI) removal for 3 months of continuous operation. Mass balance analysis showed 100% reduction of Cr(VI) to soluble Cr(Ill) in the bioreactor exit solution. With the use of electron paramagnetic resonance (EPR) no intermediate Cr(V) species could be detected. Pd(0) was biodeposited similarly using Escherichia coli MC4100 and "bio-Pd(0)". The latter was used to recover Pd(II) from two acidic industrial waste leachates to generate two types of "MM-bio-Pd(0)": "Sl-bio-Pd(0)" and "Sll-bio-Pd(0)", respectively. The biomaterial composition was comparable in both cases, and the catalytic activity was related inversely to the amount of chloride in the waste leachate from which it was derived.
C1 Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.
RP Mabbett, AN (reprint author), Univ Queensland, Sch Mol & Microbial Sci, St Lucia, Qld 4072, Australia.
EM anmabbett@gmail.com
CR Basnakova G, 1998, ENVIRON SCI TECHNOL, V32, P760, DOI 10.1021/es9705553
   Baxter-Plant V, 2003, BIODEGRADATION, V14, P83, DOI 10.1023/A:1024084611555
   Baxter-Plant VS, 2004, BIOTECHNOL LETT, V26, P1885, DOI 10.1007/s10529-004-6039-x
   Bond G. C., 1987, HETEROGENEOUS CATALY
   BOSE RN, 1992, INORG CHEM, V31, P1987, DOI 10.1021/ic00037a004
   COTTON FA, 1980, CHEM TRANSITION ELEM
   DALRYMPLE I, 2004, GRD1200025156 EUR CO
   Fogler H. S., 1999, ELEMENTS CHEM REACTI
   Heck R. H., 1985, PALLADIUM REAGENTS O
   HUMPHRIES AC, 2005, THESIS U BIRMINGHAM
   Johannson S., 1988, PIXE NOVEL TECHNIQUE
   Kaim W, 1994, BIOINORGANIC CHEM
   KOMORI K, 1989, APPL MICROBIOL BIOT, V31, P567, DOI 10.1007/BF00270796
   Lippard S. J., 1994, PRINCIPLES BIOINORGA
   LIU KJ, 1995, BIOCHEM BIOPH RES CO, V206, P829, DOI 10.1006/bbrc.1995.1118
   LLOVERA S, 1993, APPL ENVIRON MICROB, V59, P3516
   Lloyd JR, 1998, APPL ENVIRON MICROB, V64, P4607
   Lloyd JR, 1997, J BACTERIOL, V179, P2014, DOI 10.1128/jb.179.6.2014-2021.1997
   Mabbett AN, 2004, BIOTECHNOL BIOENG, V87, P104, DOI 10.1002/bit.20105
   Mabbett AN, 2002, J CHEM TECHNOL BIOT, V77, P1169, DOI 10.1002/jctb.693
   MABBETT AN, 2002, BIOTECHNOL BIOENG, V79, P299
   MABBETT AN, 2001, BIOHYDROMETALLLURGY, VB, P355
   MATTHEY J, 2000, PLATINUM MET REV, V44, P119
   MIKHEENKO IP, 2004, THESIS U BIRMINGHAM
   Penfold DW, 2003, ENZYME MICROB TECH, V33, P185, DOI 10.1016/S0141-0229(03)00115-7
   POSTGATE JR, 1979, SUPLHATE REDUCING BA
   Redwood M.D., 2005, 16 INT BIOH S CAP TO, P335
   ROLLISON CL, 1973, COMPREHENSIVE INORGA, V3, P6242
   SUZUKI T, 1992, J BACTERIOL, V174, P5340
   Tsuji J., 1995, PALLADIUM REAGENTS C
   WANG YT, 1995, J IND MICROBIOL, V14, P159, DOI 10.1007/BF01569898
   Yong P, 2002, J CHEM TECHNOL BIOT, V77, P593, DOI 10.1002/jctb.606
   Yong P, 2002, BIOTECHNOL BIOENG, V80, P369, DOI 10.1002/bit.10369
   Yong P, 2003, ENVIRON TECHNOL, V24, P289, DOI 10.1080/09593330309385561
   Yong P, 2002, BIOTECHNOL LETT, V24, P205, DOI 10.1023/A:1014141610562
   YONG P, 2001, BIOHYDROMETALLURGY F, P327
   YONG P, 2000, Patent No. 00041558
NR 37
TC 71
Z9 72
U1 1
U2 37
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD FEB 1
PY 2006
VL 40
IS 3
BP 1015
EP 1021
DI 10.1021/es0509836
PG 7
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 010WC
UT WOS:000235227600064
PM 16509351
DA 2018-10-20
ER

PT J
AU Hagerman, EM
   Chao, SHH
   Dunn, JCY
   Wu, BM
AF Hagerman, EM
   Chao, SHH
   Dunn, JCY
   Wu, BM
TI Surface modification and initial adhesion events for intestinal
   epithelial cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cell adhesion; cell signaling; surface modification
ID EXTRACELLULAR-MATRIX; JET IMPINGEMENT; IEC-6 CELLS; SIGNAL-TRANSDUCTION;
   ACTIN CYTOSKELETON; KINASE; FIBRONECTIN; RHO; PHOSPHORYLATION;
   FIBROBLASTS
AB Rapid resealing of the mucosal epithelia is imperative following injuries to the small intestine because the mucosa is responsible for the adsorption of nutrients as well as providing a barrier to noxious agents present in the lumen. Tissue engineering may provide a possible solution for treating intestinal erosions, ulcerations, inflammatory bowel disease, and infection. Cell-biomaterial interaction is a critical component in tissue engineering that can determine the success of the tissue construct. Cell-biomaterial interactions can be enhanced by various types of surface modification, which promote integrin ligation leading to increased cell function. In order to relate the effect of surface adhesion molecules to signaling events and macroscopic cell response, an intestinal epithelial cell line, IEC-6, was plated on fibronectin (receptor-mediated) and poly-L-lysine (non-specific) surfaces. Focal adhesion kinase (FAK) phosphorylation, cell spreading, and cell adhesion strength were measured. Results showed increases in FAK phosphorylation generally corresponded to increases in cell spreading and adhesion strength for IEC-6 cells. Therefore, in a simplified system, initial adhesion and signaling mechanisms appeared to correspond to subsequent physical responses in IEC-6 cells relevant to tissue engineering applications. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90024 USA.
   Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA.
   Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90024 USA.
RP Wu, BM (reprint author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90024 USA.
EM benwu@ucla.edu
CR Bundy KJ, 2001, CELL BIOL INT, V25, P289, DOI 10.1006/cbir.2000.0648
   Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0
   CARROLL KM, 1988, AM J PHYSIOL, V254, pG355
   DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1
   DESHPANDE MD, 1983, J ENG MECH-ASCE, V109, P479, DOI 10.1061/(ASCE)0733-9399(1983)109:2(479)
   Giliberti DC, 2002, J BIOMED MATER RES, V62, P422, DOI 10.1002/jbm.10343
   Goke M, 1996, AM J PHYSIOL-GASTR L, V271, pG729
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   INGBER DE, 1990, J CELL BIOL, V110, P1803, DOI 10.1083/jcb.110.5.1803
   INGBER DE, 1990, P NATL ACAD SCI USA, V87, P3579, DOI 10.1073/pnas.87.9.3579
   JAKEN S, 1989, J CELL BIOL, V109, P697, DOI 10.1083/jcb.109.2.697
   JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577
   Kilarski WW, 2003, EXP CELL RES, V291, P70, DOI 10.1016/S0014-4827(03)00374-4
   MIKAMI H, 1994, BIOCHEM BIOPH RES CO, V202, P285, DOI 10.1006/bbrc.1994.1925
   QUARONI A, 1978, P NATL ACAD SCI USA, V75, P5548, DOI 10.1073/pnas.75.11.5548
   Ray RM, 2001, AM J PHYSIOL-CELL PH, V281, pC475
   RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x
   Santos MF, 1997, AM J PHYSIOL-GASTR L, V273, pG175
   Schaller MD, 1996, J ENDOCRINOL, V150, P1, DOI 10.1677/joe.0.1500001
   Wood SR, 2003, TISSUE CELL, V35, P47, DOI 10.1016/S0040-8166(02)00103-9
   Wu SS, 2005, CELL SIGNAL, V17, P93, DOI 10.1016/j.cellsig.2004.06.001
   Wu SS, 2002, AM J PHYSIOL-CELL PH, V282, pC1432, DOI 10.1152/ajpcell.00323.2001
NR 22
TC 9
Z9 9
U1 0
U2 0
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2006
VL 76A
IS 2
BP 272
EP 278
DI 10.1002/jbm.a.30562
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 001OG
UT WOS:000234545600006
PM 16265651
DA 2018-10-20
ER

PT J
AU Jager, M
   Fischer, J
   Schultheis, A
   Lensing-Hohn, S
   Krauspe, R
AF Jager, M
   Fischer, J
   Schultheis, A
   Lensing-Hohn, S
   Krauspe, R
TI Extensive H+ release by bone substitutes affects biocompatibility in
   vitro testing
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone substitutes; bone marrow; bioincompatibility; in vitro; pH
ID GRAFT SUBSTITUTES; SPINAL-FUSION; NATURAL BONE; MATRIX; CELLS;
   HYDROXYAPATITE; SOLUBILITY; BEHAVIOR; COLLAGEN; CEMENT
AB Bone substitutes are widespread in orthopedic and trauma surgery to restore critical bony defects and/or promote local bone healing. Cell culture systems have been used for many years to screen biomaterials for their toxicity and biocompatibility. This study applies a human bone marrow cell culture system to evaluate the toxic in vitro effects of soluble components of different bone substitutes, which are already in clinical use. Different specimens of tricalcium phosphates (TCP) (Vitoss (TM), Cerasorb (TM)), nondecalcified bovine bone (Lubboc (TM)), demineralized human bone matrices (DBM) (Grafton (TM) Flex/Putty), and collagen I/III matrix (ACI-Maix (TM)) were tested in Dulbecco's modified Eagle's medium (DMEM) and Mesencult (TM) culture solution and compared with a biomaterial-free cell culture. Biocompatibility parameters were cell viability evaluated by phasecontrast microscopy and laser flow cytometry, morphology, and the local H+ release by bone substitutes. There were significant differences (p < 0.05) between the tested biomaterials and culture solutions. Collagen I/III, nondemineralized bovine bone, and TCP materials showed advantages for cell survival over other tested biomaterials (average values of vital cells/mL MesenCult (TM)/DMEM: Collagen I/III: 1090/1083; Vitoss (TM): 893/483; Cerasorb (TM): 471/523; Lubboc (TM): 815/410; Grafton (TM) Putty: 61/44; Grafton (TM) Flex: 149/ 57). Especially the DBM materials lead to a significant decrease of pH, which is considered to be a major factor for cell death. DMEM culture solution supports cell survival for those bone substitutes that induce an alkaline reaction, whereas MesenCUut (TM) media promotes cell vitality in biomaterials, which leads to an acidification of culture solution. (c) 2005 Wiley Periodicals, Inc.
C1 Heinrich Heine Univ Hosp Duesseldorf, Dept Orthoped, D-40225 Dusseldorf, Germany.
   Heinrich Heine Univ Hosp Duesseldorf, Inst Transplantat Diagnost & Cell Therapy, D-40225 Dusseldorf, Germany.
RP Jager, M (reprint author), Heinrich Heine Univ Hosp Duesseldorf, Dept Orthoped, Moorenstr 5, D-40225 Dusseldorf, Germany.
EM Jaeger@med.uni-duesseldorf.de
CR Becerra J, 1996, J BONE MINER RES, V11, P1703
   Blum B, 2004, ORTHOPEDICS, V27, pS161
   BOSKEY AL, 1995, ANN NY ACAD SCI, V760, P249, DOI 10.1111/j.1749-6632.1995.tb44635.x
   Bostrom MPG, 2001, SPINE, V26, P1425, DOI 10.1097/00007632-200107010-00007
   Bucholz RW, 2002, CLIN ORTHOP RELAT R, P44
   Bushinsky DA, 2000, CURR OPIN NEPHROL HY, V9, P369, DOI 10.1097/00041552-200007000-00008
   Callan D P, 2000, Implant Dent, V9, P36, DOI 10.1097/00008505-200009010-00008
   Campoccia D, 2003, BIOMATERIALS, V24, P587, DOI 10.1016/S0142-9612(02)00373-3
   CHAKKALAKAL DA, 1994, J BIOMED MATER RES, V28, P1439, DOI 10.1002/jbm.820281209
   Chow LC, 2001, J RES NATL INST STAN, V106, P1029, DOI 10.6028/jres.106.053
   CHRISTOFFERSEN J, 1981, J CRYST GROWTH, V53, P31
   Ciapetti G, 1995, Chir Organi Mov, V80, P409
   Driessens F.C.M., 1983, BIOCERAMICS CALCIUM, P2
   Greish YE, 2003, J BIOMED MATER RES B, V67B, P632, DOI 10.1002/jbm.b.10056
   Henderson IJP, 2003, J BONE JOINT SURG BR, V85B, P1060, DOI 10.1302/0301-620X.85B7.13782
   Ito M, 1996, J BIOMED MATER RES, V32, P95, DOI 10.1002/(SICI)1097-4636(199609)32:1<95::AID-JBM11>3.3.CO;2-L
   Jager M, 2003, J BIOMAT SCI-POLYM E, V14, P1283, DOI 10.1163/156856203322553491
   Jager M, 2003, BIOMED TECH, V48, P241, DOI 10.1515/bmte.2003.48.9.241
   JAGER M, 2005, IN PRESS ANN BIOMED
   JAW R, 2003, PITTB BON S 20 22 AU, P523
   KLEIN CPAT, 1984, BIOMATERIALS, V5, P157, DOI 10.1016/0142-9612(84)90051-6
   KLEIN CPAT, 1990, BIOMATERIALS, V11, P509, DOI 10.1016/0142-9612(90)90067-Z
   Laquerriere P, 2001, J BIOMED MATER RES, V58, P238, DOI 10.1002/1097-4636(2001)58:3<238::AID-JBM1012>3.3.CO;2-9
   Linhart W, 2001, J BIOMED MATER RES, V54, P162, DOI 10.1002/1097-4636(200102)54:2<162::AID-JBM2>3.0.CO;2-3
   Lomas RJ, 2001, BIOMATERIALS, V22, P913, DOI 10.1016/S0142-9612(00)00255-6
   Louis-Ugbo J, 2004, SPINE, V29, P360, DOI 10.1097/01.BRS.0000090823.12652.F9
   Ludwig SC, 2000, EUR SPINE J, V9, pS119, DOI 10.1007/PL00008317
   Ludwig SC, 1999, ORTHOP CLIN N AM, V30, P635, DOI 10.1016/S0030-5898(05)70116-4
   Marinucci L, 2003, J BIOMED MATER RES A, V67A, P504, DOI 10.1002/jbm.a.10082
   Matic D, 2002, PLAST RECONSTR SURG, V110, P1, DOI 10.1097/00006534-200207000-00001
   MEGHJI S, 2001, J PHYSL ENDOCRINOL M, V280, pE112
   Meli M, 2003, J PROTEIN CHEM, V22, P521, DOI 10.1023/B:JOPC.0000005501.48719.84
   Nath KA, 1998, KIDNEY INT, V53, P100, DOI 10.1046/j.1523-1755.1998.00731.x
   Nomura Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1919, DOI 10.1271/bbb.61.1919
   Perry CR, 1999, CLIN ORTHOP RELAT R, P71
   Peterson B, 2004, J BONE JOINT SURG AM, V86A, P2243, DOI 10.2106/00004623-200410000-00016
   Robinson D, 1999, Ann Transplant, V4, P91
   Rowley S D, 1992, J Hematother, V1, P233, DOI 10.1089/scd.1.1992.1.233
   SAALFELD U, 1994, BIOMATERIALS, V15, P905, DOI 10.1016/0142-9612(94)90115-5
   Sandhu HS, 1999, ORTHOP CLIN N AM, V30, P685, DOI 10.1016/S0030-5898(05)70120-6
   Stemberg F, 2001, J BIOMAT SCI-POLYM E, V12, P171, DOI 10.1163/156856201750180906
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   TAKAHASHI T, 1985, CRYOBIOLOGY, V22, P336, DOI 10.1016/0011-2240(85)90181-6
   Takikawa S, 2003, J BIOMED MATER RES A, V65A, P37, DOI 10.1002/jbm.a.10345
   Walter Z, 1999, Przegl Lek, V56 Suppl 1, P34
   WANG H, 2003, J BIOMED MATER RES A, V76, P599
   Yadav KL, 2003, J BIOMED MATER RES A, V65A, P158, DOI 10.1002/jbm.a.10278
   Zheng Dong, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P147
NR 48
TC 22
Z9 22
U1 1
U2 5
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2006
VL 76A
IS 2
BP 310
EP 322
DI 10.1002/jbm.a.30515
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 001OG
UT WOS:000234545600010
PM 16270341
DA 2018-10-20
ER

PT J
AU Arciola, CR
   Campoccia, D
   Baldassarri, L
   Donati, ME
   Pirini, V
   Gamberini, S
   Montanaro, L
AF Arciola, CR
   Campoccia, D
   Baldassarri, L
   Donati, ME
   Pirini, V
   Gamberini, S
   Montanaro, L
TI Detection of biofilm formation in Staphylococcus epidermidis from
   implant infections. Comparison of a PCR-method that recognizes the
   presence of ica genes with two classic phenotypic methods
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial-associated infections; Staphylococcus epidermidis; biofilm
   detection; ica genes; Congo red agar
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; COAGULASE-NEGATIVE STAPHYLOCOCCI;
   SLIME-PRODUCING STRAINS; PHASE VARIATION; ADHERENCE; MECHANISMS;
   EXPRESSION; AUREUS; LOCUS
AB Biofilm-forming ability is increasingly being recognized as an important virulence factor in Staphylococcus epidermidis. This study compares three different techniques for the detection of biofilm-positive strains. The presence of icaA and icaD genes responsible for biofilm synthesis was investigated by a PCR method in a collection of 80 S. epidermidis strains isolated from orthopedic implant infections. The results from molecular analysis were compared with those obtained by two classic phenotypic methods, the Congo red agar (CRA) plate test and the microtiter plate test (MtP). Fifty-seven percent of all the examined strains were found icaA/icaD-positive, of which only three were not positive for CRA test. Differently, by the MtP method, 66% of the strains were found to be biofilm-producers but only a limited agreement with the PCR-method was noticeable be-cause of the observation of (icaA/icaD+)MtP- strains (8%) and of a surprising ambiguous result of (icaA/icaD-)MtP+ strains (16%). The category of the weak biofilm-producers provided the highest contribution to these mismatching results (10%). The better agreement between the CRA plate test with the molecular detection of ica genes indicates the former as a reliable test for the phenotypic characterization of virulence of clinical isolates. However, MtP method remains a precious tool for the in vitro screening of different biornaterials for the adhesive properties using a reference strain. (c) 2005 Wiley Periodicals, Inc.
C1 Rizzoli Orthoped Inst, Res Unit Implant Infect, Bologna, Italy.
   Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.
   Ist Super Sanita, Dept Infect Parasit & Immuno Mediated Dis, I-00161 Rome, Italy.
RP Arciola, CR (reprint author), Rizzoli Orthoped Inst, Res Unit Implant Infect, Bologna, Italy.
EM carlarenata.arciola@ior.it
RI Campoccia, Davide/K-5348-2018; Baldassarri, Lucilla/B-1042-2013
OI Campoccia, Davide/0000-0002-3336-0219; Donati, Maria
   Benedetta/0000-0003-1747-5443
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Arciola Carla Renata, 2002, Expert Rev Mol Diagn, V2, P478, DOI 10.1586/14737159.2.5.478
   Arciola CR, 2002, BIOMATERIALS, V23, P4233, DOI 10.1016/S0142-9612(02)00171-0
   Arciola CR, 2002, J BIOMED MATER RES, V59, P557, DOI 10.1002/jbm.10006
   Arciola CR, 2001, J CLIN MICROBIOL, V39, P2151, DOI 10.1128/JCM.39.6.2151-2156.2001
   Arciola CR, 2001, DIAGN MOL PATHOL, V10, P130, DOI 10.1097/00019606-200106000-00010
   ARCIOLA CR, IN PRESS J BIOMED MA
   Baldassarri L, 1997, INFECT IMMUN, V65, P1522
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   CHRISTENSEN GD, 2000, HDB BACTERIAL ADHESI, P213
   Fitzpatrick F, 2005, J CLIN MICROBIOL, V43, P1973, DOI 10.1128/JCM.43.4.1973-1976.2005
   Foster T. J., 1994, P31
   FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872
   Garcia-Saenz MC, 2000, J CATARACT REFR SURG, V26, P1673, DOI 10.1016/S0886-3350(00)00483-1
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   KNOBLOCH JK, 2001, J BACTERIOL, V183, P26224
   Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001
   Mack D, 1996, J INFECT DIS, V174, P881, DOI 10.1093/infdis/174.4.881
   MACK D, 1992, INFECT IMMUN, V60, P2048
   MACK D, 2000, HDB STUDYING BACTERI, P307
   Merritt K, 1998, J BIOMED MATER RES, V39, P415, DOI 10.1002/(SICI)1097-4636(19980305)39:3<415::AID-JBM10>3.0.CO;2-9
   Montanaro L., 2000, HDB BACTERIAL ADHESI, P331
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x
   Ziebuhr W, 1997, INFECT IMMUN, V65, P890
NR 26
TC 60
Z9 65
U1 1
U2 13
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2006
VL 76A
IS 2
BP 425
EP 430
DI 10.1002/jbm.a.30552
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 001OG
UT WOS:000234545600021
PM 16270350
DA 2018-10-20
ER

PT J
AU Ong, ES
   Helton, WS
   Jho, D
   Espat, NJ
AF Ong, ES
   Helton, WS
   Jho, D
   Espat, NJ
TI SURGISIS-assisted surgical site control in the delayed repair of a
   complex bile duct injury after laparoscopic cholecystectomy
SO JOURNAL OF GASTROINTESTINAL SURGERY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the American-Hepato-Pancreato-Biliary-Association
CY APR 14-17, 2005
CL Ft Lauderdale, FL
SP Amer Hepato Pancreato Biliary Assoc
DE biliary injury; biologic prosthetic; bile duct repair; laparoscopic
   cholecystectomy
AB Although laparoscopic cholecystectomy has revolutionized the surgical approach to patients with gallbladder disease, it has also brought a marked increase in the incidence of complex and serious bile duct injuries. Many of these major injuries represent a trial. or technical challenge for even the most seasoned hepatobiliary-trained surgeon. Herein, we present a case outlining the algorithmic treatment approach for delayed-presentation complex biliary injury and report on the novel use of small intestinal submucosal biomaterial for surgical site control in the staged repair of a complex biliary injury (Strasberg E-4) after laparoscopic cholecystectomy.
C1 Univ Illinois, Dept Surg, Chicago, IL 60612 USA.
RP Espat, NJ (reprint author), Univ Illinois, Dept Surg, M-C 958,840 S Wood St,Room 435E, Chicago, IL 60612 USA.
EM jespat@uic.edu
CR Mercado MA, 2003, SURG ENDOSC, V17, P1351, DOI 10.1007/s00464-002-8705-1
   Rosen M, 2002, SURGERY, V132, P480, DOI 10.1067/msy.2002.126505
   Strasberg SM, 2001, J GASTROINTEST SURG, V5, P266, DOI 10.1016/S1091-255X(01)80047-0
   STRASBERG SM, 1995, J AM COLL SURGEONS, V180, P101
NR 4
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1091-255X
J9 J GASTROINTEST SURG
JI J. Gastrointest. Surg.
PD FEB
PY 2006
VL 10
IS 2
BP 202
EP 206
DI 10.1016/j.gassur.2005.07.004
PG 5
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 013DB
UT WOS:000235388700012
PM 16455451
DA 2018-10-20
ER

PT J
AU Mamalis, AG
   Petrosyan, GL
   Manolakos, DE
   Petrosyan, HG
AF Mamalis, AG
   Petrosyan, GL
   Manolakos, DE
   Petrosyan, HG
TI Determination of initial compression stresses when extruding bimetallic
   tubes with porous internal layer
SO JOURNAL OF MATERIALS PROCESSING TECHNOLOGY
LA English
DT Article
DE bimetallics; extrusion; plasticity of porous materials
ID EXTRUSION; BILLETS
AB This paper presents an analytical approach of the extrusion process applied to biomaterial tubes made of two prebonded metallic materials. The outer component of the bimetallic is a pore-free layer, whilst the internal one is a porous sintered tube.
   A generalized "slab method" of analysis, properly modified to describe the plastic behaviour of a porous-sintered material, developed in combination with the theory of thin shells, in order to investigate the initial stage of plastic deformation in the cylindrical chamber of the extrusion die. Numerical solution of the formulation suggested is conducted for components made of sintered and pore-free steel, respectively, and the effect of porosity on the stress-strain state of the bimetal is examined, allowing, in this manner, application of the method in relevant practical problems in the field of bimetallics. (c) 2005 Elsevier B.V. All rights reserved.
C1 Natl Tech Univ Athens, Dept Mech Engn, Athens, Greece.
   State Engn Univ Armenia, Dept Mech & Machine Sci, Yerevan, Armenia.
RP Mamalis, AG (reprint author), Natl Tech Univ Athens, Dept Mech Engn, Athens, Greece.
EM mamalis@central.ntua.gr
CR Alcaraz JL, 1996, J MATER PROCESS TECH, V60, P133, DOI 10.1016/0924-0136(96)02318-7
   Alcaraz JL, 1996, INT J SOLIDS STRUCT, V33, P2075, DOI 10.1016/0020-7683(95)00144-1
   Alcaraz JL, 1996, J MATER PROCESS TECH, V61, P265, DOI 10.1016/0924-0136(95)02186-8
   Alcaraz JL, 1996, INT J MECH SCI, V38, P157, DOI 10.1016/0020-7403(95)00044-X
   Chitkara NR, 2001, INT J MECH SCI, V43, P2833, DOI 10.1016/S0020-7403(01)00067-4
   Chitkara NR, 2001, INT J MECH SCI, V43, P2857, DOI 10.1016/S0020-7403(01)00066-2
   Johnson W., 1973, ENG PLASTICITY
   Mamalis AG, 1999, J MATER PROCESS TECH, V96, P117, DOI 10.1016/S0924-0136(99)00265-4
   PETROSSIAN GL, 1988, PLASTIC DEFORMATION
   PETROSSIAN GL, 2001, COLLECT MAT ANN SCI, V1, P209
NR 10
TC 3
Z9 3
U1 0
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-0136
J9 J MATER PROCESS TECH
JI J. Mater. Process. Technol.
PD FEB
PY 2006
VL 172
IS 2
BP 277
EP 282
DI 10.1016/j.jmatprotec.2005.09.018
PG 6
WC Engineering, Industrial; Engineering, Manufacturing; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA 018DF
UT WOS:000235743300018
DA 2018-10-20
ER

PT J
AU Eglin, D
   Maalheem, S
   Livage, J
   Coradin, T
AF Eglin, D
   Maalheem, S
   Livage, J
   Coradin, T
TI In vitro apatite forming ability of type I collagen hydrogels containing
   bioactive glass and silica sol-gel particles
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SODIUM-SILICATE; BONE TISSUE; HYDROXYAPATITE; BIOMATERIALS; INTERFACE;
   COMPOSITE; MECHANISM; RESPONSES; GROWTH; ACID
AB Type I collagen hydrogel containing bioactive glass (CaO-P2O5-SiO2) and silica sol-gel micrometric particles were prepared and their in vitroapatite-forming ability in simulated body fluid assessed. X-ray diffraction and scanning electron microscopy analysis showed that bioactive glass particles entrapment in collagen matrix did not inhibit calcium phosphate formation and induced morphology variations on the crystalline phase precipitated on the hydrogel surface. The silica-collagen hydrogel composite precipitated calcium phosphate whereas silica particles and collagen hydrogel alone did not, indicating a possible synergetic effect between collagen and silica on the apatite-forming ability. Mechanisms of calcium phosphate precipitation and its relevance to biomaterial development are discussed. (c) 2006 Springer Science + Business Media, Inc.
C1 Univ Paris 06, CNRS, UMR 7574, Lab Chim Mat Condensee, F-75252 Paris 05, France.
RP Coradin, T (reprint author), Univ Paris 06, CNRS, UMR 7574, Lab Chim Mat Condensee, 4 Pl Jussieu, F-75252 Paris 05, France.
EM coradin@ccr.jussieu.fr
RI Coradin, Thibaud/L-8932-2013
OI Eglin, David/0000-0002-8500-6887
CR BERGER G, 1991, Patent No. 296065
   Brinker C. G., 1990, PHYS CHEM SOL GEL PR
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Combes C, 2002, BIOMATERIALS, V23, P2817, DOI 10.1016/S0142-9612(02)00073-X
   Coradin T, 2004, SPECTROSC-INT J, V18, P567, DOI 10.1155/2004/356207
   Coradin T, 2002, MATER RES SOC SYMP P, V726, P79
   Eglin D, 2005, BIO-MED MATER ENG, V15, P43
   GIRAUDGUILLE MM, 1994, J STRUCT BIOL, V113, P99, DOI 10.1006/jsbi.1994.1035
   Girija EK, 2004, J MATER SCI-MATER M, V15, P593, DOI 10.1023/B:JMSM.0000026101.53272.86
   HATA K, 1995, J AM CERAM SOC, V78, P1049, DOI 10.1111/j.1151-2916.1995.tb08435.x
   Hayakawa S, 1999, J AM CERAM SOC, V82, P2155
   Hench LL, 1997, CURR OPIN SOLID ST M, V2, P604, DOI 10.1016/S1359-0286(97)80053-8
   HENCH LL, 1974, J BIOMED MATER RES, V8, P49, DOI 10.1002/jbm.820080307
   IIJIMA M, 1995, CUR TOP CRY GRO RES, V2, P1
   Jaakkola T, 2004, BIOMATERIALS, V25, P575, DOI 10.1016/S0142-9612(03)00558-1
   JCPDS-Joint Committee on Powder Diffraction Standards/Internati onal Center for Diffraction Data Pennsylvania, 2003, POWD DIFFR FIL
   Kikuchi M, 2004, COMPOS SCI TECHNOL, V64, P819, DOI 10.1016/j.compscitech.2003.09.002
   Kobuko T, 1990, J BIOMED MATER RES, V24, P721
   LANDIS WJ, 1986, CALCIFIED TISSUE INT, V38, P52, DOI 10.1007/BF02556595
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103
   Murata M, 1999, INT J ORAL MAX SURG, V28, P232, DOI 10.1034/j.1399-0020.1999.283280316.x
   PEREIRA MM, 1995, J AM CERAM SOC, V78, P2463, DOI 10.1111/j.1151-2916.1995.tb08686.x
   POHUNKOVA H, 1995, BIOMATERIALS, V16, P67, DOI 10.1016/0142-9612(95)91098-J
   Porter AE, 2004, BIOMATERIALS, V25, P3303, DOI 10.1016/j.biomaterials.2003.10.006
   Scotchford CA, 1998, BIOMATERIALS, V19, P1, DOI 10.1016/S0142-9612(97)00236-6
   SERRE CM, 1993, BIOMATERIALS, V14, P97, DOI 10.1016/0142-9612(93)90217-P
   Wen HB, 1999, BIOMATERIALS, V20, P1717, DOI 10.1016/S0142-9612(99)00085-X
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
NR 29
TC 37
Z9 37
U1 3
U2 20
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2006
VL 17
IS 2
BP 161
EP 167
DI 10.1007/s10856-006-6820-6
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 017DH
UT WOS:000235673800008
PM 16502249
DA 2018-10-20
ER

PT J
AU Li, JP
   Li, SH
   Van Blitterswijk, CA
   De Groot, K
AF Li, JP
   Li, SH
   Van Blitterswijk, CA
   De Groot, K
TI Cancellous bone from porous Ti6Al4V by multiple coating technique
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MECHANICAL-PROPERTIES; TITANIUM-ALLOYS; IMPLANTS; FEMUR; REPLACEMENT;
   INTERFACE; FIXATION; BEHAVIOR; INGROWTH
AB A highly porous Ti6Al4V with interconnected porous structure has been developed in our previous study. By using a so-called "Multiple coating" technique, the porous Ti6Al4V can be tailored to resemble cancellous bone in terms of porous structure and mechanical properties. A thin layer of Ti6Al4V slurry was coated on the struts of base porous Ti6Al4V to improve the pore structure. After two additional coating, pore sizes ranged from 100 mu m to 700 mu m, and the porosity was decreased from similar to 90% to similar to 75%, while the compressive strength was increased from 10.3 +/- 3.3 MPa to 59.4 +/- 20.3 MPa and the Young's modulus increased from 0.8 +/- 0.3 GPa to 1.8 +/- 0.3 GPa. The pore size and porosity are similar to that of cancellous bone, meanwhile the compressive strength is higher than that of cancellous bone, and the Young's modulus is between that of cancellous bone and cortical bone. Porosity, pore size and mechanical properties can be controlled by the parameters in such multiple coating processes. Therefore the porous Ti6Al4V with the characteristics of cancellous bone is expected to be a promising biomaterial for biomedical applications. (c) 2006 Springer Science + Business Media, Inc.
C1 Univ Twente, iBME, NL-3723 MB Bilthoven, Netherlands.
   CAM Implants, NL-2333 CL Leiden, Netherlands.
   Beihang Univ, Sch Mech Engn & Automat, Beijing 100083, Peoples R China.
RP Li, JP (reprint author), Univ Twente, iBME, Prof Bronkhorstlaan 10D, NL-3723 MB Bilthoven, Netherlands.
EM jiaping.li@tnw.utwente.nl
OI van Blitterswijk, Clemens/0000-0003-2371-4615
CR AHMED T, 1995, 8 WORLD TIT C 1995 B
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P291
   BOBYN JD, 1999, P AAOS AN CA
   BREZNY R, 1989, J AM CERAM SOC, V72, P1145, DOI 10.1111/j.1151-2916.1989.tb09698.x
   CAMERON HU, 1976, J BIOMED MATER RES, V10, P295
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   CHEAL EJ, 1992, J ORTHOPAED RES, V10, P405, DOI 10.1002/jor.1100100314
   CLEMOW AJT, 1981, J BIOMED MATER RES, V15, P73, DOI 10.1002/jbm.820150111
   Crowninshield R D, 1986, Instr Course Lect, V35, P144
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
   Grimm MJ, 1997, J BIOMECH, V30, P743, DOI 10.1016/S0021-9290(97)00016-X
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Krygier JJ, 1999, P SIROT SYDN AUSTR
   Lange F. F., 1985, J AM CERAM SOC, V68, P225
   Lemons J E, 1986, J Arthroplasty, V1, P143, DOI 10.1016/S0883-5403(86)80053-5
   LEWIS JL, 1984, J BONE JOINT SURG AM, V66A, P280, DOI 10.2106/00004623-198466020-00016
   Li JP, 2005, J BIOMED MATER RES A, V73A, P223, DOI 10.1002/jbm.a.30278
   Li JP, 2004, J MATER SCI-MATER M, V15, P951, DOI 10.1023/B:JMSM.0000042680.10087.15
   LI JP, 2001, KEY ENG MATER, V218, P52
   Li SH, 2003, TISSUE ENG, V9, P535, DOI 10.1089/107632703322066714
   LIN JY, 2000, POWDER METALL TECHNO, V18, P12
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MATIN B, 2000, ADV ENG MATER, V2, P196
   MOYLE DD, 1973, J BIOMED MATER RES, V7, P363, DOI 10.1002/jbm.820070323
   OKAZAKI Y, 1993, MATER T JIM, V34, P1217, DOI 10.2320/matertrans1989.34.1217
   Pilliar RM, 1998, INT J POWDER METALL, V34, P33
   PRENDERGAST PJ, 1990, J BIOMED ENG, V12, P379, DOI 10.1016/0141-5425(90)90020-N
   WHITE EW, 1975, J BIOMED MATER RES, V9, P23, DOI 10.1002/jbm.820090406
NR 28
TC 19
Z9 21
U1 0
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2006
VL 17
IS 2
BP 179
EP 185
DI 10.1007/s10856-006-6822-4
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 017DH
UT WOS:000235673800010
PM 16502251
DA 2018-10-20
ER

PT J
AU Stokes, CW
   van Noort, R
   Hand, RJ
AF Stokes, CW
   van Noort, R
   Hand, RJ
TI Investigation of the chemical solubility of mixed-alkali fluorcanasite
   forming glasses
SO JOURNAL OF NON-CRYSTALLINE SOLIDS
LA English
DT Article
DE biomaterial; chemical durability; glass ceramics; optical microscopy;
   scanning electron microscopy; silicates; thermal properties
ID BIAXIAL FLEXURAL STRENGTH; CERAMICS
AB There is currently significant interest in all-ceramic dental restorations due to the demand in replace metals its the primary load-bearing tooth restorative material. A promising non-metallic material for Such restorations is fluorcanasite, it chain-silicate glass-ceramic that is castable using conventional dental metal-casting techniques and which exhibits enhanced fracture toughness and flexural strength compared with currently available resin-bonded ceramics. Unfortunately, because of its relatively lock silica content. it exhibits poor chemical durability, The aim of this study was to assess the influence of compositional changes on the formation and chemical solubility of the fluorcariasite forming glass, crystalline phase and residual glass. To this end, mixed-alkali compositions have been investigated and it has been shown that the solubility of the glass is a function of the alkali species present in the glass. By changing the alkali ratio of the fluorcanasite forming glass from 0.33 ([K][K + Na]) of the base composition derived from stoichiometry to 0,47, it was possible to reduce the chemical solubility of the fluorcanasite material significantly. The addition of extra CaF2 to refine the grain structure resulted in a decrease in the durability of the material, making it currently unacceptable for dental applications, The glass-ceramic exhibits it minimum chemical solubility at the composition K-7/Na-8. The residual glass may have it slightly elevated K content compared to the original glass. The addition of extra CaF, to refine the grain structure resulted in an unacceptable decrease in the durability of the material, (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Sheffield, Sch Clin Dent, Dept Adult Dent Care, Sheffield S10 2TA, S Yorkshire, England.
   Univ Sheffield, Dept Mat Engn, Sheffield S1 3JD, S Yorkshire, England.
RP Stokes, CW (reprint author), Univ Sheffield, Sch Clin Dent, Dept Adult Dent Care, Claremont Crescent, Sheffield S10 2TA, S Yorkshire, England.
EM c.w.stokes@sheffield.ac.uk
CR ANUSAVICE KJ, 1997, J DENT RES SISI, P1443
   BAKEL AJ, 2001, CORROSION MECH BIOCE
   Beall G. H., 1983, US Patent, Patent No. [4,386,162, 4386162]
   BEALL GH, 1991, J NON-CRYST SOLIDS, V129, P163, DOI 10.1016/0022-3093(91)90092-K
   BUNKER BC, 1983, J NON-CRYST SOLIDS, V58, P295, DOI 10.1016/0022-3093(83)90031-5
   DAY DE, 1976, J NON-CRYST SOLIDS, V21, P343, DOI 10.1016/0022-3093(76)90026-0
   DOUGLAS RW, 1967, J AM CERAM SOC, V50, P1, DOI 10.1111/j.1151-2916.1967.tb14960.x
   GELHOFF G, 1925, Z TECH PHYS, V6, P333
   HENCH LL, 1978, J NONCRYST SOLIDS, V28, P68
   HUBBARD D, 1951, J RES NAT BUR STAND, V46, P168, DOI 10.6028/jres.046.023
   Isard J. O., 1969, Journal of Non-Crystalline Solids, V1, P235, DOI 10.1016/0022-3093(69)90003-9
   IVANOV AO, 1964, SOV PHYS-SOL STATE, V5, P1933
   Johnson A, 1998, DENT MATER, V14, P412, DOI 10.1016/S0300-5712(99)00015-9
   Johnson A, 1999, J DENT RES, V78, P1074
   Johnson A, 2000, DENT MATER, V16, P280, DOI 10.1016/S0109-5641(00)00018-X
   PEDDLE CJ, 1921, J SOC GLASS TECHNOL, V5, P195
   STOKES CW, 2002, J GLASS TECHNOL, P229
   Wright BM, 2000, PHYS CHEM GLASSES, V41, P192
NR 18
TC 8
Z9 9
U1 2
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-3093
J9 J NON-CRYST SOLIDS
JI J. Non-Cryst. Solids
PD FEB 1
PY 2006
VL 352
IS 2
BP 142
EP 149
DI 10.1016/j.jnoncrysol.2005.11.030
PG 8
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA 007IT
UT WOS:000234963000007
DA 2018-10-20
ER

PT J
AU Linares, CF
   Palencia, A
   Goldwasser, MR
   Rodriguez, K
AF Linares, CF
   Palencia, A
   Goldwasser, MR
   Rodriguez, K
TI Study of activated carbon modified with sodium carbonate as a possible
   antacid drug
SO MATERIALS LETTERS
LA English
DT Article
DE microstructure; powder technology; impregnation; biomaterial; sodium
   carbonate; antacid
AB Activated carbon was modified with different sodium carbonate solutions (0.5 to 3.0 M) to produce a series of possible antacids. The modified carbon was characterized by means of XRD and BET surface area measurements. XRD confirmed the presence of bicarbonate species on the surface of the modified carbons, while the surface areas indicated that microporous of the solids were partially blocked. These solids were tested as antacids in a synthetic gastric juice. Results showed that these new antacids are effective to control the stomach hyperacidity. Furthermore, they are expected to be less expensive due to their low production costs. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Carabobo, Dept Quim, Lab Catalisis & Met Transic, Fac Ciencias & Tecnol, Valencia, Edo Carabobo, Venezuela.
   Cent Univ Venezuela, Fac Ciencia, Ctr Catalisis Petr & Petroquim, Escuela Quim, Caracas 1020A, Venezuela.
RP Linares, CF (reprint author), Univ Carabobo, Dept Quim, Lab Catalisis & Met Transic, Fac Ciencias & Tecnol, Apartado Postal 3336, Valencia, Edo Carabobo, Venezuela.
EM clinares@thor.uc.edu.ve
CR BEERS MH, 1991, MERK MANUAL, P221
   BOKROS JC, 1976, CARBON, V14, P291, DOI 10.1016/0008-6223(76)90137-8
   FORDTRAN JS, 1973, NEW ENGL J MED, V288, P923, DOI 10.1056/NEJM197305032881801
   Linares C. F., 2004, Journal of Applied Sciences, V4, P472
   Linares CF, 2005, MICROPOR MESOPOR MAT, V77, P215, DOI 10.1016/j.micromeso.2004.08.030
NR 5
TC 5
Z9 5
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD FEB
PY 2006
VL 60
IS 4
BP 439
EP 441
DI 10.1016/j.matlet.2005.09.020
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 992KC
UT WOS:000233881800002
DA 2018-10-20
ER

PT J
AU Lee, SH
   Takahashi, E
   Nomura, N
   Chiba, A
AF Lee, SH
   Takahashi, E
   Nomura, N
   Chiba, A
TI Effect of carbon addition on microstructure and mechanical properties of
   a wrought Co-Cr-Mo implant alloy
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE cobalt chromium molybdenum alloy; microstructure; mechanical properties;
   biomaterial; carbon; wrought
ID SURGICAL IMPLANTS; STAINLESS-STEEL; CAST; TRANSFORMATION
AB The wrought Co-Cr-Mo alloys with C contents of 0.02, 0.09 and 0.18% (mass%) were fabricated by hot-forging process to Study the influence of carbon contents on the microstructures and mechanical properties. The microstructures of Co-29Cr-6Mo-0.02C and Co-29Cr-6Mo-0.09C consist of equiaxed uniform grains which contain stacking faults. twins and epsilon martensite hands. No carbide found at inter- and intragranular region. Co-29Cr-Wo-0.18C consists of irregular grain sizes and carbide found at inter- and intra-granular region. The carbide in Co-29Cr-6Mo-0.18C was identified as M23C6 type carbide from the XRD pattern analysis. It is found that the amount of stacking fault and epsilon martensite are strongly dependent upon the C content. The density of stacking faults and epsilon martensites observed in Co-29Cr-6Mo-0.09C decrease as compared with those observed in Co-29Cr-6Mo-0.02C. Moreover. the volume fraction of the gamma phase slightly increased with C content. Within an extent of C addition that no carbide precipitation occurs, the carbon addition reduces the amounts of crystal defects such as stacking faults and twins. and epsilon martensites. In addition, tensile strength slightly increases with C content and ductility reaches a maximum at C content of 0.09%. though 0.2% proof strength shows no noticeable differences.
C1 Iwate Univ, Ctr Reg Collaborat Res & Educ, Morioka, Iwate 0208551, Japan.
   Iwate Univ, Fac Engn, Dept Welf Engn, Morioka, Iwate 0208551, Japan.
RP Lee, SH (reprint author), Iwate Univ, Ctr Reg Collaborat Res & Educ, Morioka, Iwate 0208551, Japan.
RI Chiba, Akihiko/D-1326-2011; NOMURA, Naoyuki/L-7149-2017
CR Chiba A, 2005, MATER SCI FORUM, V475-479, P2317, DOI 10.4028/www.scientific.net/MSF.475-479.2317
   CLEMOW AJT, 1979, J BIOMED MATER RES, V13, P265, DOI 10.1002/jbm.820130208
   Cong Dahn N., 1984, Acta Metallurgica, V32, P1317
   FUJITA H, 1972, ACTA METALL MATER, V20, P759, DOI 10.1016/0001-6160(72)90104-6
   Hsu HC, 2003, J MATER PROCESS TECH, V138, P231, DOI 10.1016/S0924-0136(03)00077-3
   Hsu RWW, 2005, MATER CHEM PHYS, V93, P531, DOI 10.1016/j.matchemphys.2005.04.007
   KILNER T, 1986, J MATER SCI, V21, P1349, DOI 10.1007/BF00553274
   MANGONON PL, 1970, METALL TRANS, V1, P1577, DOI 10.1007/BF02642003
   Montero-Ocampo C, 1999, METALL MATER TRANS A, V30, P611, DOI 10.1007/s11661-999-0052-6
   OLSON GB, 1976, METALL TRANS A, V7, P1897, DOI 10.1007/BF02659822
   RAJAN K, 1982, METALL TRANS A, V13, P1161, DOI 10.1007/BF02645497
   Sage M., 1950, REV MET, V47, P139
   SHI LQ, 1993, J MATER SCI, V28, P1312, DOI 10.1007/BF01191970
   VANDERSANDE JB, 1976, METALL TRANS A, V7, P389
   ZHUANG LZ, 1989, J MATER SCI, V24, P381, DOI 10.1007/BF01107415
NR 15
TC 47
Z9 47
U1 0
U2 17
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD FEB
PY 2006
VL 47
IS 2
BP 287
EP 290
DI 10.2320/matertrans.47.287
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 032OT
UT WOS:000236784700012
OA Bronze
DA 2018-10-20
ER

PT J
AU Yoshida, K
   Mishina, H
   Sasaki, S
   Morita, M
   Mabuchi, K
AF Yoshida, K
   Mishina, H
   Sasaki, S
   Morita, M
   Mabuchi, K
TI Mechanical properties of titanium cermets for joint prostheses
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE joint prostheses; biomaterial; cermet; toughness; bending strength;
   biocompatibility
ID TOTAL HIP-ARTHROPLASTY; PERCENT-MO ALLOY; CORROSION-RESISTANCE;
   OMEGA-PHASE; MEDICAL IMPLANTS; COMPOSITES; TI; TRANSFORMATION;
   FABRICATION; FRACTURES
AB TiC/Ti and TiC/Ti-15Mo cermets were fabricated for the bearings of joint prostheses and were then evaluated in terms of their mechanical properties, such as density. hardness, bending strength and fracture toughness, as well as biocompatibility. The cermets were fabricated by spark plasma sintering. When the volume fraction of the metal phase was increased, the fracture toughness and the bending strength of the TiC/Ti and TiC/Ti-15Mo increased. The TiC/Ti and the TiC/Ti-15Mo cermets show high biocompatibility and corrosion resistance. These results indicate that TiC/Ti-15Mo cermets are suitable for use in the bearings of joint prostheses.
C1 Chiba Univ, Grad Sch Sci & Technol, Dept Artificial Sci & Syst, Chiba 2638522, Japan.
   Chiba Univ, Fac Engn, Dept Elect & Mech Engn, Chiba 2638522, Japan.
   Natl Inst AIST, Tsukuba, Ibaraki 3058564, Japan.
   Saitama Univ, Fac Engn, Dept Mech Engn, Saitama 3388570, Japan.
   Kitasato Univ, Sch Allied Hlth Sci, Sagamihara, Kanagawa 2288555, Japan.
RP Yoshida, K (reprint author), Chiba Univ, Grad Sch Sci & Technol, Dept Artificial Sci & Syst, Chiba 2638522, Japan.
CR *ASTM, 1996, F39478 ASTM
   Blackwood DJ, 2000, CORROS SCI, V42, P481, DOI 10.1016/S0010-938X(99)00103-1
   CHARNLEY J, 1961, LANCET, V1, P1129
   Ding LX, 2002, J JPN I MET, V66, P597, DOI 10.2320/jinstmet1952.66.6_597
   FENG JC, 1995, J JPN I MET, V59, P978, DOI 10.2320/jinstmet1952.59.9_978
   Fritsch EW, 1996, CLIN ORTHOP RELAT R, P129
   Hannouche D, 2003, CLIN ORTHOP RELAT R, P19, DOI 10.1097/01.blo.0000096806.78689.50
   ISO 10993-5, 1999, 109935 ISO
   *JIS, 1998, R1634 JIS
   *JIS, 1996, R1625 JIS
   *JIS, 1995, R1607 JIS R
   *JIS, 1991, R1610 JIS
   Lee MH, 2000, J JPN I MET, V64, P578, DOI 10.2320/jinstmet1952.64.7_578
   Liu CH, 1996, MAT SCI ENG C-BIOMIM, V4, P139, DOI 10.1016/S0928-4931(96)00145-2
   Matsumoto H, 2001, J JPN I MET, V65, P374, DOI 10.2320/jinstmet1952.65.5_374
   MCGINNES K, 1986, J IMMUNOL METHODS, V86, P7, DOI 10.1016/0022-1759(86)90258-9
   McKee G K, 1966, J Bone Joint Surg Br, V48, P245
   Mitura E, 1996, DIAM RELAT MATER, V5, P998, DOI 10.1016/0925-9635(95)00469-6
   Niihara K., 1982, Journal of the American Ceramic Society, V65
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   OKAZAKI Y, 1993, J JPN I MET, V57, P338, DOI 10.2320/jinstmet1952.57.3_338
   Okazaki Y, 1997, J JPN I MET, V61, P656, DOI 10.2320/jinstmet1952.61.7_656
   OKAZAKI Y, 1995, J JPN I MET, V59, P229, DOI 10.2320/jinstmet1952.59.2_229
   OKAZAKI Y, 1993, J JPN I MET, V57, P347, DOI 10.2320/jinstmet1952.57.3_347
   Predel B., 2003, PHASE EQUILIBRIA BIN
   Shi W, 2001, J JPN I MET, V65, P183, DOI 10.2320/jinstmet1952.65.3_183
   Sukedai E, 1999, J JPN I MET, V63, P277, DOI 10.2320/jinstmet1952.63.2_277
   TAKEMOTO Y, 1995, J JPN I MET, V59, P780, DOI 10.2320/jinstmet1952.59.8_780
   Tong XH, 1996, J CERAM SOC JPN, V104, P594, DOI 10.2109/jcersj.104.594
   Weibull W, 1939, ING VETENSKAPS AKAD, V151, P1
   WILES P, 1958, BRIT J SURG, V45, P488, DOI 10.1002/bjs.18004519315
   Wirganowicz PZ, 1997, CLIN ORTHOP RELAT R, P100
   Yoshida K, 2004, MATER TRANS, V45, P3209, DOI 10.2320/matertrans.45.3209
NR 33
TC 11
Z9 11
U1 0
U2 1
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD FEB
PY 2006
VL 47
IS 2
BP 418
EP 425
DI 10.2320/matertrans.47.418
PG 8
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 032OT
UT WOS:000236784700035
OA Bronze
DA 2018-10-20
ER

PT J
AU Yu, ZT
   Zhou, L
   Niu, JL
   Cai, YR
   Luo, LJ
   Huang, FQ
AF Yu, ZT
   Zhou, L
   Niu, JL
   Cai, YR
   Luo, LJ
   Huang, FQ
TI beta type titanium alloys used in surgical implant materials
SO RARE METAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT Xi An International Titanium Conference (XITC05)
CY OCT 16-19, 2005
CL Xi an, PEOPLES R CHINA
SP NW Inst Nonferrous Metal Res, Nonferrous Metals Soc China, Asian Off Aerospace Res & Dev
DE biomaterial; beta type titanium alloys; surgical implant materials
ID MECHANICAL-PROPERTIES; DESIGN
AB Titanium and its titanium alloys are becoming more and more promising biomedical materials with their lower density and lower modulus, high ratio of strength vs. density, fine corrosion resistance and workability, especially its fine biocompatibility. The paper summarized the category, characteristic, R & D, and application of biomedical titanium and its titanium alloys, and the alloy designing, melting, processing, heat treatment and microstructure, surface modification etc. of beta type titanium alloys were introduced. Finally, the future developing direction on biomedical implant materials is also discussed.
C1 NW Inst Nonferrous Met Res, Xian 710016, Peoples R China.
RP Yu, ZT (reprint author), NW Inst Nonferrous Met Res, Xian 710016, Peoples R China.
CR Bothe R., 1940, SURG GYNECOL OBSTET, V71, P598
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   Chu Chenglin, 1998, MAT SCI TECHNOLOGY, V6, P40
   FENG YF, 2001, RARE METALS, V25, P349
   [葛建华 Ge Jianhua], 2003, [化工新型材料, New Chemical Materials], V31, P34
   HUANG YL, 2002, J MAT ENG, V11, P35
   JUDY RW, 1986, RARE METAL MAT ENG, V6, P50
   Jun Chen, 2002, ACTA METALLURGICA SI, V38, P108
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   LEVENTHAL GS, 1951, J BONE JOINT SURG AM, V33-A, P473, DOI 10.2106/00004623-195133020-00021
   LI ZC, 1998, RARE METAL MAT ENG, V27, P56
   Liang FH, 2003, RARE METAL MAT ENG, V32, P241
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   [宁聪琴 Ning Congqin], 2002, [材料科学与工艺, Material Science and Technology], V10, P100
   OKAZAKI Y, 1995, J JPN I MET, V59, P1078, DOI 10.2320/jinstmet1952.59.10_1078
   Ren Yibin, 2002, MAT REV, V16, P12
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
   WANG JY, 1987, P 6 CHIN TI C, P187
   YU ZT, Patent No. 031531393
   YU ZT, Patent No. 031531385
   YU ZT, 2005, MATER SCI FORUM, V475, P2349
   Zhang YP, 2000, CHINESE PHYS LETT, V17, P206, DOI 10.1088/0256-307X/17/3/018
NR 24
TC 2
Z9 3
U1 0
U2 0
PU NORTHWEST INST NONFERROUS METAL RESEARCH
PI SHAANXI
PA C/O RARE METAL MATERIAL ENGINEERING PRESS, PO BOX 51, XIAN, SHAANXI
   710016, PEOPLES R CHINA
SN 1002-185X
J9 RARE METAL MAT ENG
JI Rare Metal Mat. Eng.
PD FEB
PY 2006
VL 35
SU 1
BP 261
EP 265
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 041FY
UT WOS:000237440700064
DA 2018-10-20
ER

PT J
AU Kirkpatrick, CJ
   Peters, K
   Fuchs, S
   Unger, RE
AF Kirkpatrick, CJ
   Peters, K
   Fuchs, S
   Unger, RE
TI Titanium in the age of tissue engineering: Challenges and opportunities
SO RARE METAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT Xi An International Titanium Conference (XITC05)
CY OCT 16-19, 2005
CL Xi an, PEOPLES R CHINA
SP NW Inst Nonferrous Metal Res, Nonferrous Metals Soc China, Asian Off Aerospace Res & Dev
DE tissue engineering; intelligent biomaterials; drug delivery;
   nanostructuring; in vitro models
ID IN-VITRO; ENDOTHELIAL-CELLS; GENE-REGULATION; ELUTING STENTS; WEAR
   DEBRIS; BIOCOMPATIBILITY; ACTIVATION; GROWTH; VASCULARIZATION;
   MACROPHAGES
AB Clinical experience indicates that titanium can be considered as a biomaterial with good biocompatibility, although its success in conventional medical device application depends very largely on the site of implantation. The rapid development of the field of Tissue Engineering (TE) has initiated a paradigm change in the approach to treating diseased organs, so that the emphasis has moved from replacement to the promotion of inherent healing processes. One of the major areas of expansion in this so-called biomimetic approach in TE is the development of synthetic bioresorbable polymers with the ability to respond to microenvironmental change, making these materials suitable for drug and gene delivery. This paper will highlight how this development of "intelligent" biomaterials, as well as the fields of micro-and nanostructuring, can be applied to titanium for TE purposes. In addition, emphasis will be placed on the necessity in the life sciences to develop relevant in vitro models to test the efficacy of these novel developments in the material sciences.
C1 Univ Mainz, Inst Pathol, Repair Lab, D-55101 Mainz, Germany.
RP Kirkpatrick, CJ (reprint author), Univ Mainz, Inst Pathol, Repair Lab, D-55101 Mainz, Germany.
RI Peters, Kirsten/S-3484-2016
CR Beloti MM, 2005, BIOMATERIALS, V26, P4245, DOI 10.1016/j.biomaterials.2004.10.039
   Chen FS, 1999, J BIOMED MATER RES, V48, P904, DOI 10.1002/(SICI)1097-4636(1999)48:6<904::AID-JBM21>3.0.CO;2-5
   Duda SH, 2002, CIRCULATION, V106, P1505, DOI 10.1161/01.CIR.0000029746.10018.36
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   ELAGLI K, 1995, BIOMATERIALS, V16, P1345, DOI 10.1016/0142-9612(95)91051-Y
   EVANS EJ, 1994, BIOMATERIALS, V15, P713, DOI 10.1016/0142-9612(94)90170-8
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   Haynes DR, 1998, CLIN ORTHOP RELAT R, P223
   Hirakawa K, 1996, J BONE JOINT SURG AM, V78A, P1235, DOI 10.2106/00004623-199608000-00014
   Jansen JA, 2005, J CONTROL RELEASE, V101, P127, DOI 10.1016/j.jconrel.2004.07.005
   Kirkpatrick C. J., 2005, ITBM RBM, V26, P192
   Kirkpatrick CJ, 2003, J MATER SCI-MATER M, V14, P677, DOI 10.1023/A:1024903514335
   Kirkpatrick CJ, 2002, BIOMOL ENG, V19, P211, DOI 10.1016/S1389-0344(02)00019-9
   Lau Kean-Wah, 2004, J Invasive Cardiol, V16, P411
   Manlapaz M, 1996, J ORTHOP RES, V14, P465, DOI 10.1002/jor.1100140317
   Nakamura H, 2005, J DENT RES, V84, P515, DOI 10.1177/154405910508400606
   O'Connor DT, 2004, J ORTHOP RES, V22, P229, DOI 10.1016/S0736-0266(03)00167-0
   Peters K, 2002, BIOMATERIALS, V23, P3413, DOI 10.1016/S0142-9612(02)00042-X
   PETERS K, 2004, J MATER SCI-MATER M, V15, P319
   Porte-Durrieu MC, 2004, BIOMATERIALS, V25, P4837, DOI 10.1016/j.biomaterials.2003.11.037
   Schneider GB, 2004, J BIOMED MATER RES A, V69A, P462, DOI 10.1002/jbm.a.30016
   Stayton P S, 2005, Orthod Craniofac Res, V8, P219, DOI 10.1111/j.1601-6343.2005.00336.x
   Unger RE, 2005, BIOMATERIALS, V26, P3461, DOI 10.1016/j.biomaterials.2004.09.047
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   van der Hoeven BL, 2005, INT J CARDIOL, V99, P9, DOI 10.1061/j.ijcard.2004.01.021
   Wildemann B, 2005, BIOMATERIALS, V26, P4035, DOI 10.1016/j.biomaterials.2004.10.004
NR 26
TC 0
Z9 0
U1 0
U2 0
PU NORTHWEST INST NONFERROUS METAL RESEARCH
PI SHAANXI
PA C/O RARE METAL MATERIAL ENGINEERING PRESS, PO BOX 51, XIAN, SHAANXI
   710016, PEOPLES R CHINA
SN 1002-185X
J9 RARE METAL MAT ENG
JI Rare Metal Mat. Eng.
PD FEB
PY 2006
VL 35
SU 1
BP 273
EP 276
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 041FY
UT WOS:000237440700067
DA 2018-10-20
ER

PT J
AU Dong, Q
   Chen, CZ
   Wang, DG
   Ji, QM
AF Dong, Qing
   Chen, Chuanzhong
   Wang, Diangang
   Ji, Qianmao
TI Research status about surface modification of biomedical Ti and its
   alloys by micro-arc oxidation
SO SURFACE REVIEW AND LETTERS
LA English
DT Article
DE micro-arc oxidation; biomaterial; microstructure; property
ID TOTAL HIP-ARTHROPLASTY; TREATED TITANIUM; OXIDIZED TITANIUM; BONE
   RESPONSE; IN-VITRO; COATINGS; IMPLANTS; FILMS; MICROSTRUCTURE;
   HYDROXYAPATITE
AB Ti and its alloys are considered to be very promising in biological material field. But their biological activity and corrosion resistance in body fluid still need to be improved. As a novel technique for surface treatment, Micro-arc oxidation (MAO) is attracting interest from those who want to improve their implant properties through surface modification. This paper reviewed the application of MAO on biomedical Ti-alloys. The structure characteristic such as surface and cross-section micrographs, phase components, and element distribution were analyzed. The mechanical and biological properties of MAO films were further discussed on this basis. The effects of current density, voltage, and electrolyte on the structure and properties of the films were summarized.
C1 Shandong Univ, Sch Mat Sci & Engn, Jinan 250061, Peoples R China.
   Shandong Informat Technol Coll, Shandong 261041, Weifang, Peoples R China.
RP Chen, CZ (reprint author), Shandong Univ, Sch Mat Sci & Engn, Jinan 250061, Peoples R China.
EM czchen@sdu.edu.cn
OI Wang, Diangang/0000-0003-4980-116X
CR Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   Buly R L, 1992, J Arthroplasty, V7, P315, DOI 10.1016/0883-5403(92)90056-V
   CHEAL EJ, 1992, J ORTHOPAED RES, V10, P405, DOI 10.1002/jor.1100100314
   Fini M, 1999, BIOMATERIALS, V20, P1587, DOI 10.1016/S0142-9612(99)00060-5
   Han Y, 2004, J BIOMED MATER RES A, V71A, P608, DOI 10.1002/jbm.a.30177
   Han Y, 2003, SURF COAT TECH, V168, P249, DOI 10.1016/S0257-8972(03)00016-1
   Han Y, 2002, MATER LETT, V56, P744, DOI 10.1016/S0167-577X(02)00606-7
   Hsieh MF, 2002, MATER CHEM PHYS, V74, P245, DOI 10.1016/S0254-0584(01)00474-6
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   Ichikawa T, 2000, INT J ORAL MAX IMPL, V15, P231
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1459, DOI 10.1002/jbm.820291118
   Kim HM, 1999, J BIOMED MATER RES, V45, P100, DOI 10.1002/(SICI)1097-4636(199905)45:2<100::AID-JBM4>3.0.CO;2-0
   Kim HM, 2000, J BIOMED MATER RES, V52, P553, DOI 10.1002/1097-4636(20001205)52:3<553::AID-JBM14>3.0.CO;2-X
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MEACHIM G, 1973, J BIOMED MATER RES, V7, P555, DOI 10.1002/jbm.820070607
   Nie X, 2000, SURF COAT TECH, V133, P331, DOI 10.1016/S0257-8972(00)00953-1
   Nie X, 2000, SURF COAT TECH, V125, P407, DOI 10.1016/S0257-8972(99)00612-X
   Nishiguchi S, 1999, BIOMATERIALS, V20, P491, DOI 10.1016/S0142-9612(98)90203-4
   PAJUNEN M, 1992, Z METALLKD, V83, P17
   Piveteau LD, 1999, J MATER SCI-MATER M, V10, P161, DOI 10.1023/A:1008985423644
   SHIRKHANZADEH M, 1995, NANOSTRUCT MATER, V5, P33, DOI 10.1016/0965-9773(95)00006-Z
   Song WH, 2004, BIOMATERIALS, V25, P3341, DOI 10.1016/j.biomaterials.2003.09.103
   Sul YT, 2002, CLIN ORAL IMPLAN RES, V13, P252, DOI 10.1034/j.1600-0501.2002.130304.x
   Sul YT, 2003, BIOMATERIALS, V24, P3893, DOI 10.1016/S0142-9612(03)00261-8
   Sul YT, 2002, BIOMATERIALS, V23, P1809, DOI 10.1016/S0142-9612(01)00307-6
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
   Sundararajan G, 2003, SURF COAT TECH, V167, P269, DOI 10.1016/S0257-8972(02)00918-0
   TANG G, 2004, KUEI SUAN JEN HSUEH, V32, P127
   [唐光昕 Tang Guangxin], 2004, [材料研究学报, Chinese Journal of Materials Research], V18, P435
   Tang GX, 2004, MATER LETT, V58, P1857, DOI 10.1016/j.matlet.2003.11.016
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   Wang YM, 2004, RARE METAL MAT ENG, V33, P502
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Xue WB, 2002, MATER LETT, V56, P737, DOI 10.1016/S0167-577X(02)00605-5
   Xue WB, 2002, MATER LETT, V52, P435, DOI 10.1016/S0167-577X(01)00440-2
   Yan WQ, 1997, J BIOMED MATER RES, V37, P267, DOI 10.1002/(SICI)1097-4636(199711)37:2<267::AID-JBM17>3.0.CO;2-B
   Yang GL, 2002, J ALLOY COMPD, V345, P196
   ZHANG Y, 2004, KUEI SUAN JEN HSUEH, V32, P122
   Zhang YM, 2004, J BIOMED MATER RES A, V68A, P383, DOI 10.1002/jbm.a.20063
NR 42
TC 14
Z9 15
U1 1
U2 23
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0218-625X
J9 SURF REV LETT
JI Surf. Rev. Lett.
PD FEB
PY 2006
VL 13
IS 1
BP 35
EP 43
DI 10.1142/S0218625X06007792
PG 9
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 068YI
UT WOS:000239410500006
DA 2018-10-20
ER

PT J
AU Juncosa-Melvin, N
   Boivin, GP
   Gooch, C
   Galloway, MT
   West, JR
   Dunn, MG
   Butler, DL
AF Juncosa-Melvin, N
   Boivin, GP
   Gooch, C
   Galloway, MT
   West, JR
   Dunn, MG
   Butler, DL
TI The effect of autologous mesenchymal stem cells on the biomechanics and
   histology of gel-collagen sponge constructs used for rabbit patellar
   tendon repair
SO TISSUE ENGINEERING
LA English
DT Article
ID ROTATOR CUFF TEARS; ACHILLES-TENDON; SURGICAL REPAIR; TISSUE; AGE;
   BIOMATERIAL; PROSTHESIS; PARAMETERS; COMPOSITE; INJURIES
AB The objective of this study was to introduce mesenchymal stem cells (MSCs) into a gel-sponge composite and examine the effect the cells have on repair biomechanics and histology 12 weeks postsurgery. We tested two related hypotheses - adding MSCs would significantly improve repair biomechanics and cellular organization, and would result in higher failure forces than peak in vivo patellar tendon ( PT) forces recorded for an inclined hopping activity. Autogenous tissue-engineered constructs were created by seeding MSCs from 15 adult rabbits at 0.1 x 10(6) cells/mL in 2.6 mg/mL of collagen gel in collagen sponges. Acellular constructs were created using the same concentration of collagen gel in matching collagen sponges. These cellular and acellular constructs were implanted in bilateral full-thickness, full-length defects in the central third of patellar tendons. At 12 weeks after surgery, repair tissues were assigned for biomechanical ( n = 12 pairs) and histological ( n = 3 pairs) analyses. Maximum force and maximum stress for the cellular repairs were about 60 and 50% of corresponding values for the normal central third of the PT, respectively. Likewise, linear stiffness and linear modulus for these cellular repairs averaged 75 and 30% of normal PT values, respectively. By contrast, the acellular repairs exhibited lower percentages of normal PT values for maximum force (40%), maximum stress (25%), linear stiffness ( 30%), and linear modulus (20%). Histologically, both repairs showed strong staining for collagen types III and V, fibronectin, and decorin. The cellular repairs also showed cellular alignment comparable to that of normal tendon. This study shows that introducing autogenous mesenchymal stem cells into a gel-collagen sponge composite significantly improves tendon repair compared to the use of a gel-sponge composite alone in the range of in vivo loading.
C1 Univ Cincinnati, Noyes Tissue Engn & Biomech Labs, Engn Res Ctr 840, Dept Biomed Engn, Cincinnati, OH 45221 USA.
   Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA.
   Cincinnati Sportsmed & Orthopaed Ctr Inc, Cincinnati, OH USA.
   Wright State Univ, Sch Med, Cincinnati, OH USA.
   Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Orthopaed Surg, New Brunswick, NJ USA.
RP Butler, DL (reprint author), Univ Cincinnati, Noyes Tissue Engn & Biomech Labs, Engn Res Ctr 840, Dept Biomed Engn, 2901 Campus Dr, Cincinnati, OH 45221 USA.
EM david.butler@uc.edu
FU NIAMS NIH HHS [AR 46574]
CR Ahmad CS, 2000, AM J SPORT MED, V28, P804, DOI 10.1177/03635465000280060701
   AMIEL D, 1984, Journal of Orthopaedic Research, V1, P257
   Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267
   Awad HA, 2003, J ORTHOPAED RES, V21, P420, DOI 10.1016/S0736-0266(02)00163-8
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Butler DL, 2004, ANNU REV BIOMED ENG, V6, P303, DOI 10.1146/annurev.bioeng.6.040803.140240
   BUTLER DL, 1984, J BIOMECH, V17, P579, DOI 10.1016/0021-9290(84)90090-3
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   BUTLER DL, 2004, CLIN ORTHOP S, V427, pS190
   Cofield RH, 2001, J BONE JOINT SURG AM, V83A, P71, DOI 10.2106/00004623-200101000-00010
   Dressler MR, 2005, J ORTHOP RES, V23, P287, DOI 10.1016/j.orthres.2004.06.017
   Dressler MR, 2002, J ORTHOPAED RES, V20, P1315, DOI 10.1016/S0736-0266(02)00052-9
   DUNN MG, 1992, AM J SPORT MED, V20, P507, DOI 10.1177/036354659202000504
   GUILAK F, 2003, FUNCTIONAL TISSUE EN
   Huang HH, 2000, CURR OPIN RHEUMATOL, V12, P150, DOI 10.1097/00002281-200003000-00009
   Juncosa N, 2003, J BIOMECH, V36, P483, DOI 10.1016/S0021-9290(02)00459-1
   Juncosa-Melvin N, 2005, TISSUE ENG, V11, P448, DOI 10.1089/ten.2005.11.448
   Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x
   KATO YP, 1991, J BONE JOINT SURG AM, V73A, P561, DOI 10.2106/00004623-199173040-00013
   Kuwada G T, 1995, Clin Podiatr Med Surg, V12, P633
   LENNON DP, 1995, EXP CELL RES, V219, P211, DOI 10.1006/excr.1995.1221
   Liu Stephen H., 1999, Current Opinion in Rheumatology, V11, P132
   Louie LK, 1997, TISSUE ENG, V3, P187, DOI 10.1089/ten.1997.3.187
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X
   PRAEMER A, 1999, MUSCULOSKELETAL COND
   PRAEMER A, 1992, MUSCULOSKELETAL COND
   Romeo AA, 1999, CLIN ORTHOP RELAT R, P243
   Salehpour A, 1995, J ORTHOP RES, V13, P898, DOI 10.1002/jor.1100130614
   Soslowsky LJ, 2000, J SHOULDER ELB SURG, V9, P79, DOI 10.1067/mse.2000.101962
   Wong J, 2002, AM J SPORT MED, V30, P565, DOI 10.1177/03635465020300041701
   Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403
NR 32
TC 113
Z9 124
U1 2
U2 6
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4947
J9 TISSUE ENG
JI Tissue Eng.
PD FEB
PY 2006
VL 12
IS 2
BP 369
EP 379
DI 10.1089/ten.2006.12.369
PG 11
WC Cell & Tissue Engineering
SC Cell Biology
GA 027FZ
UT WOS:000236401100016
PM 16548695
DA 2018-10-20
ER

PT J
AU Tenke, P
   Kovacs, B
   Jackel, M
   Nagy, E
AF Tenke, P
   Kovacs, B
   Jackel, M
   Nagy, E
TI The role of biofilm infection in urology
SO WORLD JOURNAL OF UROLOGY
LA English
DT Article
DE biofilm infection; urology
ID URINARY-TRACT-INFECTION; PSEUDOMONAS-AERUGINOSA; BACTERIAL BIOFILMS;
   URETERAL STENTS; GROWTH-RATE; GENITOURINARY PROSTHESES; ANTIMICROBIAL
   AGENTS; MICROBIAL ADHESION; ANIMAL-MODEL; PATHOGENESIS
AB In the process of endourological development a great variety of foreign bodies have been invented besides urinary catheters on which biofilm can be formed. Bacteria in the biofilm are less sensible to antibiotics. An additional problem of medical biomaterials in the urinary tract environment is the development of encrustation and consecutive obstruction. In this review, we tried to sum up the conditions where biofilm formation has a great impact on the development or maintenance of urological infections and on treatment success. Modification of the biomaterial surface seems to be the most promising prevention strategy for bacterial biofilms. Easier methods for diagnosing and quantifying biofilm infection, to develop more specific antimicrobial agents and ideal device surfaces would surely help the fight against biofilm formation.
C1 Jahn Ferenc S Pest Hosp, Dept Urol, H-1204 Budapest, Hungary.
   Cent Hosp Def Forces, Budapest, Hungary.
   Univ Szeged, Fac Med, Inst Clin Microbiol, Szeged, Hungary.
RP Tenke, P (reprint author), Jahn Ferenc S Pest Hosp, Dept Urol, Koves Utca 2-4, H-1204 Budapest, Hungary.
EM tenkep@chello.hu
CR Biering-Sorensen Fin, 2002, Curr Opin Urol, V12, P45, DOI 10.1097/00042307-200201000-00009
   Bitschay J., 1956, HIST UROLOGY EGYPT, P76
   BROWN MRW, 1988, J ANTIMICROB CHEMOTH, V22, P777, DOI 10.1093/jac/22.6.777
   BROWN MRW, 1990, ANTIMICROB AGENTS CH, V34, P1623, DOI 10.1128/AAC.34.9.1623
   BUSSCHER HJ, 1995, FEMS MICROBIOL LETT, V128, P229, DOI 10.1016/0378-1097(95)00103-C
   BUSSCHER HJ, 1987, FEMS MICROBIOL LETT, V46, P165, DOI 10.1111/j.1574-6968.1987.tb02457.x
   BUSSCHER HJ, 1991, CELL MATER, V1, P49
   Caldwell D.E, 1995, MICROBIAL BIOFILMS, V1195, P64
   Carson CC, 1999, UROL CLIN N AM, V26, P829, DOI 10.1016/S0094-0143(05)70223-8
   CARSON CC, 1989, UROL CLIN N AM, V16, P139
   Choong S, 2001, INT J ANTIMICROB AG, V17, P305, DOI 10.1016/S0924-8579(00)00348-4
   Choong S, 2000, BJU INT, V86, P935, DOI 10.1046/j.1464-410x.2000.00949.x
   Costerton JW, 1999, INT J ANTIMICROB AG, V11, P217, DOI 10.1016/S0924-8579(99)00018-7
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Denstedt JD, 1998, J ENDOUROL, V12, P493, DOI 10.1089/end.1998.12.493
   Denstedt JD, 2000, WORLD J UROL, V18, P237, DOI 10.1007/PL00007074
   Farsi HMA, 1995, J ENDOUROL, V9, P469, DOI 10.1089/end.1995.9.469
   FISHMAN IJ, 1987, J UROLOGY, V137, pA202, DOI 10.1016/S0022-5347(17)75546-2
   FLETCHER M, 1996, BACTERIAL ADHESION M
   GANDERTON L, 1992, EUR J CLIN MICROBIOL, V11, P789, DOI 10.1007/BF01960877
   Goto T, 1999, INT J ANTIMICROB AG, V11, P227, DOI 10.1016/S0924-8579(99)00019-9
   Goto T, 1999, UROLOGY, V53, P1058, DOI 10.1016/S0090-4295(98)00649-9
   Habash M, 1999, J CLIN PHARMACOL, V39, P887, DOI 10.1177/00912709922008506
   Kumon H, 1996, J INFECT CHEMOTHER, V2, P18
   KUNIN CM, 1987, J UROLOGY, V138, P899, DOI 10.1016/S0022-5347(17)43412-4
   LAWRENCE JR, 1987, MICROBIAL ECOL, V14, P15, DOI 10.1007/BF02011567
   LICHT MR, 1995, J UROLOGY, V154, P387, DOI 10.1016/S0022-5347(01)67058-7
   Liedl B, 2001, Curr Opin Urol, V11, P75, DOI 10.1097/00042307-200101000-00011
   MARDIS HK, 1988, UROL CLIN N AM, V15, P471
   Nickel J, 1990, INT UROGYNECOL J PEL, V1, P218
   Nickel J C, 1991, Can J Infect Control, V6, P38
   NICKEL JC, 1994, J ANTIMICROB CHEMOTH, V33, P31, DOI 10.1093/jac/33.suppl_A.31
   NICKEL JC, 1990, BRIT J UROL, V66, P47, DOI 10.1111/j.1464-410X.1990.tb14864.x
   NICKEL JC, 1987, BRIT J UROL, V59, P21, DOI 10.1111/j.1464-410X.1987.tb04573.x
   NICKEL JC, 1992, UROLOGY, V39, P93
   NICKEL JC, 1985, EUR J CLIN MICROBIOL, V4, P213, DOI 10.1007/BF02013600
   NICKEL JC, 1993, PROSTATITIS
   Reid G, 1999, INT J ANTIMICROB AG, V11, P223, DOI 10.1016/S0924-8579(99)00020-5
   REID G, 1992, J UROLOGY, V148, P1592, DOI 10.1016/S0022-5347(17)36976-8
   Reid G, 2001, INT J ANTIMICROB AG, V17, P317, DOI 10.1016/S0924-8579(00)00353-8
   Reid G, 1998, MED IMPORTANCE NORMA, P423
   REID G, 2000, INT J ANTIMICROB AG, V4, P305
   Shigeta M, 1997, CHEMOTHERAPY, V43, P137, DOI 10.1159/000239548
   Sofer M, 2000, Curr Opin Urol, V10, P563, DOI 10.1097/00042307-200011000-00005
   Stickler DJ, 1995, LIFE DEATH BIOFILM, P119
   TENKE P, 2004, INT J ANTIMICROB AG, pS67
   Tsukamoto T, 1999, INT J ANTIMICROB AG, V11, P233, DOI 10.1016/S0924-8579(99)00021-7
   van Loosdrecht M. C. M., 1987, APPL ENVIRON MICROB, V53, P1989
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   Warren JW, 2001, INT J ANTIMICROB AG, V17, P299, DOI 10.1016/S0924-8579(00)00359-9
   Warren KW, 2000, BOUNDARY TWO, V27, P153, DOI 10.1215/01903659-27-3-153
NR 51
TC 61
Z9 74
U1 1
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0724-4983
J9 WORLD J UROL
JI World J. Urol.
PD FEB
PY 2006
VL 24
IS 1
BP 13
EP 20
DI 10.1007/s00345-005-0050-2
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA 015JM
UT WOS:000235547700003
PM 16402262
DA 2018-10-20
ER

PT J
AU Schneider, A
   Francius, G
   Obeid, R
   Schwinte, P
   Hemmerle, J
   Frisch, B
   Schaaf, P
   Voegel, JC
   Senger, B
   Picart, C
AF Schneider, A
   Francius, G
   Obeid, R
   Schwinte, P
   Hemmerle, J
   Frisch, B
   Schaaf, P
   Voegel, JC
   Senger, B
   Picart, C
TI Polyelectrolyte multilayers with a tunable Young's modulus: Influence of
   film stiffness on cell adhesion
SO LANGMUIR
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; SMOOTH-MUSCLE-CELLS; SUCCINIMIDE DERIVATIVES;
   QUANTITATIVE-ANALYSIS; SUBSTRATE MECHANICS; EXPONENTIAL-GROWTH; IR
   SPECTROMETRY; IN-VITRO; SURFACE; SOFT
AB Mechanical properties of model and natural gels have recently been demonstrated to play an important role in various cellular processes such as adhesion, proliferation, and differentiation, besides events triggered by chemical ligands. Understanding the biomaterial/cell interface is particularly important in many tissue engineering applications and in implant surgery. One of the final goals would be to control cellular processes precisely at the biomaterial surface and to guide tissue regeneration. In this work, we investigate the substrate mechanical effect on cell adhesion for thin polyelectrolyte multilayer (PEM) films, which can be easily deposited on any type of material. The films were cross linked by means of a water-soluble carbodiimide (EDC), and the film elastic modulus was determined using the AFM nanoindentation technique with a colloidal probe. The Young's modulus could be varied over 2 orders of magnitude (from 3 to 400 kPa) for wet poly((L)-lysine)/hyaluronan (PLL/HA) films by changing the EDC concentration. The chemical changes upon cross linking were characterized by means of Fourier transform infrared spectroscopy (FTIR). We demonstrated that the adhesion and spreading of human chondrosarcoma cells directly depend on the Young's modulus. These data indicate that, besides the chemical properties of the polyelectrolytes, the substrate mechanics of PEM films is an important parameter influencing cell adhesion and that PEM offer a new way to prepare thin films of tunable mechanical properties with large potential biomedical applications including drug release.
C1 Univ Strasbourg 1, INSERM, U595, Fac Chirurg Dentaire, F-67085 Strasbourg, France.
   Univ Freiburg, Inst Mol Med & Zellforsch, Sekt Biophys, D-79104 Freiburg, Germany.
   Univ Strasbourg 1, CNRS, UMR 7514, Chim Bioorgan Lab,Fac Pharm, F-67401 Illkirch Graffenstaden, France.
   Univ Strasbourg 1, Inst Charles Sadron, CNRS, F-67083 Strasbourg, France.
RP Picart, C (reprint author), Univ Strasbourg 1, INSERM, U595, Fac Chirurg Dentaire, 11 Rue Humann, F-67085 Strasbourg, France.
EM catherine.picart@univ-montp2.fr
RI SCHAAF, Pierre/J-2751-2016; Francius, Gregory/A-4246-2015
OI SCHAAF, Pierre/0000-0001-7423-5492; Francius,
   Gregory/0000-0001-8533-9449; PICART, Catherine/0000-0002-4854-6366;
   PICART, Catherine/0000-0003-0130-1000; Frisch,
   Benoit/0000-0002-8378-2508
CR Aylin F, 2003, ORG BIOMOL CHEM, V1, P2290, DOI 10.1039/b211936f
   Beningo KA, 2002, METHOD CELL BIOL, V69, P325, DOI 10.1016/S0091-679X(02)69021-1
   Berg MC, 2004, LANGMUIR, V20, P1362, DOI 10.1021/la0355489
   BHUSHAN B, 2001, WEAR 2, V250, P1105
   Bischofs IB, 2003, P NATL ACAD SCI USA, V100, P9274, DOI 10.1073/pnas.1233544100
   BOTT R, 2000, AUST J CHEM, P53
   Boura C, 2005, BIOMATERIALS, V26, P4568, DOI 10.1016/j.biomaterials.2004.11.036
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Deroanne CF, 2001, CARDIOVASC RES, V49, P647, DOI 10.1016/S0008-6363(00)00233-9
   Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8
   Dubreuil F, 2003, EUR PHYS J E, V12, P215, DOI 10.1140/epje/i2003-10056-0
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   ENGLER A, 2005, SURF SCI, V570, P253
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Etienne O, 2005, BIOMACROMOLECULES, V6, P726, DOI 10.1021/bm049425u
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   FRANCIUS G, 2005, IN PRESS MICROSC RES
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D
   Groth T, 2004, ANGEW CHEM INT EDIT, V43, P926, DOI 10.1002/anie.200301708
   Haxaire K, 2003, BIOPOLYMERS, V72, P149, DOI 10.1002/bip.10342
   Haxaire K, 2003, BIOPOLYMERS, V72, P10, DOI 10.1002/bip.10245
   Hemmerle J, 1999, P NATL ACAD SCI USA, V96, P6705, DOI 10.1073/pnas.96.12.6705
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ, P169
   Jessel N., 2004, ADV FUNCT MATER, V14, P174
   Koktysh DS, 2002, ADV FUNCT MATER, V12, P255, DOI 10.1002/1616-3028(20020418)12:4<255::AID-ADFM255>3.0.CO;2-1
   Konuklar FA, 2002, J PHYS CHEM A, V106, P11205, DOI 10.1021/jp0261531
   Lavalle P, 2002, MACROMOLECULES, V35, P4458, DOI 10.1021/ma0119833
   Levy R, 2002, NANOTECHNOLOGY, V13, P33, DOI 10.1088/0957-4484/13/1/307
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Mahaffy RE, 2004, BIOPHYS J, V86, P1777, DOI 10.1016/S0006-3495(04)74245-9
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Picart C, 2005, ADV FUNCT MATER, V15, P83, DOI 10.1002/adfm.200400106
   PICART C, 2005, ADV FUNCT MAT    NOV, P1771
   PISTORIUS AMA, 1993, INT J PEPT PROT RES, V42, P570
   Price RL, 2004, J BIOMED MATER RES A, V70A, P129, DOI 10.1002/jbm.a.30073
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Richert L, 2004, BIOMACROMOLECULES, V5, P1908, DOI 10.1021/bm0498023
   RICHERT L, 2005, IN PRESS CELL BIOCH
   Richert L., 2004, LANGMUIR, V1, P284
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Rutland MW, 2004, J ADHES SCI TECHNOL, V18, P1199, DOI 10.1163/1568561041581324
   Salloum DS, 2005, BIOMACROMOLECULES, V6, P161, DOI 10.1021/bm0497015
   Schreyeck G, 1999, LANGMUIR, V15, P8212, DOI 10.1021/la990229w
   Shen G, 2004, NUCLEIC ACIDS RES, V32, P5973, DOI 10.1093/nar/gkh932
   Thompson MT, 2005, BIOMATERIALS, V26, P6836, DOI 10.1016/j.biomaterials.2005.05.003
   TIMKOVICH R, 1977, ANAL BIOCHEM, V79, P135, DOI 10.1016/0003-2697(77)90387-6
   VOGLER EA, 1987, J BIOMED MATER RES, V21, P1197, DOI 10.1002/jbm.820211004
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Xiao SJ, 2004, J PHYS CHEM B, V108, P16508, DOI 10.1021/jp0477262s
   Yang SY, 2003, BIOMACROMOLECULES, V4, P987, DOI 10.1021/bm034035d
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
NR 60
TC 211
Z9 211
U1 6
U2 123
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JAN 31
PY 2006
VL 22
IS 3
BP 1193
EP 1200
DI 10.1021/la0521802
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 008VF
UT WOS:000235068100050
PM 16430283
DA 2018-10-20
ER

PT J
AU Ban, WP
   Song, JG
   Argyropoulos, DS
   Lucia, LA
AF Ban, WP
   Song, JG
   Argyropoulos, DS
   Lucia, LA
TI Influence of natural biomaterials on the elastic properties of
   starch-derived films: An optimization study
SO INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH
LA English
DT Article
ID MECHANICAL-PROPERTIES; DESIGN
AB A D-optimization design was applied to investigate the strength properties of biomaterial-doped starch films. The individual effect of each additive and associated interactive effects were investigated. Cellulosic fibers and chitosan were able to substantially enhance film strength. Lignin and gelatin also demonstrated significant interactive effects on strength, while different interactive effects were evident between the major biopolymers (fiber and chitosan) and minor biopolymers (lignin and gelatin). The film stretch depended on the material composition where diminishing returns were observed for stretch, while strength increased for increasing levels of each of the biopolymers. An increase in fiber and chitosan contents led to increases in film density that correlated well with strength. The latter data indicate that fiber and chitosan biopolymers act synergistically by providing increased film bonding that eventually generates a stronger film.
C1 N Carolina State Univ, Coll Nat Resources, Forest Biomat Lab, Raleigh, NC 27695 USA.
   Georgia Inst Technol, Inst Paper Sci & Technol, Atlanta, GA 30332 USA.
   Dalian Inst Light Ind, Dalian 116034, Peoples R China.
RP Lucia, LA (reprint author), N Carolina State Univ, Coll Nat Resources, Forest Biomat Lab, Campus Box 8005, Raleigh, NC 27695 USA.
CR BALTES M, 1994, BIOTECHNOL PROGR, V10, P480, DOI 10.1021/bp00029a005
   BAN W, 2005, IN PRESS J APPL POLY
   Baumberger S, 1998, POLYM DEGRAD STABIL, V59, P273, DOI 10.1016/S0141-3910(97)00193-6
   Chauvelon G, 2000, CARBOHYD POLYM, V42, P385, DOI 10.1016/S0144-8617(99)00187-3
   Chiellini E, 2001, POLYM DEGRAD STABIL, V73, P549, DOI 10.1016/S0141-3910(01)00132-X
   Dufresne A, 1998, MACROMOLECULES, V31, P2693, DOI 10.1021/ma971532b
   Emery AF, 1998, MEAS SCI TECHNOL, V9, P864, DOI 10.1088/0957-0233/9/6/003
   Hinkelmann K, 1994, DESIGN ANAL EXPT, V1
   Kim DH, 2003, J APPL POLYM SCI, V88, P2100, DOI 10.1002/app.11630
   Nerin C, 1996, J AGR FOOD CHEM, V44, P4009, DOI 10.1021/jf960326k
   OTEY FH, 1974, IND ENG CHEM PROD RD, V13, P90, DOI 10.1021/i360049a018
   Shamekh S, 2002, STARCH-STARKE, V54, P20, DOI 10.1002/1521-379X(200201)54:1<20::AID-STAR20>3.0.CO;2-M
   Zhai ML, 2004, CARBOHYD POLYM, V57, P83, DOI 10.1016/j.carbpol.2004.04.003
NR 13
TC 13
Z9 13
U1 1
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0888-5885
J9 IND ENG CHEM RES
JI Ind. Eng. Chem. Res.
PD JAN 18
PY 2006
VL 45
IS 2
BP 627
EP 633
DI 10.1021/ie050219s
PG 7
WC Engineering, Chemical
SC Engineering
GA 005OY
UT WOS:000234834900020
DA 2018-10-20
ER

PT J
AU Renaudin, A
   Tabourier, P
   Zhang, V
   Camart, JC
   Druon, C
AF Renaudin, A
   Tabourier, P
   Zhang, V
   Camart, JC
   Druon, C
TI SAW nanopump for handling droplets in view of biological applications
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article
DE SAW; microfluidics; droplet; hydrophilic microtrack; hydrophobic
   pre-treatment; radiofrequency pulsed excitation
ID ACOUSTIC-WAVES; MANIPULATION
AB This paper reports on the fabrication and development of a surface acoustic waves (SAW) platform dedicated to digital micro fluidics for biological applications. SAW at about 20 MHz are generated by InterDigital Transducers (IDT) laid on a LiNbO3 piezoelectric substrate. An electrical characterization of the IDT is reported and first results related to droplet handling with the SAW platform are given. We show that accurate droplet displacement is the result of both a radio frequency (RF) pulsed excitation and a chemical pre-treatment of the platform surface. For biological applications the droplet carrying the biomaterial is squeezed between the platform and a cover to increase the surface exchange between the droplet and hydrophilic functionalized areas. Out of such areas the free displacement is significantly improved by a surface hydrophobic pre-treatment. Moreover, the fabrication of additional hydrophilic micro tracks is shown to be a solution for crossing these areas without droplet splitting. This result is a key point to validate the structure of the novel micro fluidic platform proposed in this paper. (c) 2005 Elsevier B.V. All rights reserved.
C1 CNRS, UMR 8520, IEMN, F-59652 Villeneuve Dascq, France.
RP Renaudin, A (reprint author), CNRS, UMR 8520, IEMN, Ave Poincare,Cite Sci,BP60069, F-59652 Villeneuve Dascq, France.
EM alan.renaudin@iemn.univ-lille1.fr
CR BREHOVSKIKH L, 1960, WAVES LAYERED MEDIA
   de Gentles P.-G., 2002, GOUTTES BULLES PERLE
   Fan SK, 2003, PROC IEEE MICR ELECT, P694
   FELDMANN M, 1986, TRAITEMENT SIGNAL PA
   Helin P, 1998, SENSOR ACTUAT A-PHYS, V70, P67, DOI 10.1016/S0924-4247(98)00114-9
   Kino G. S., 1987, ACOUSTIC WAVES
   Kurosawa M, 1995, SENSOR ACTUAT A-PHYS, V50, P69, DOI 10.1016/0924-4247(96)80086-0
   Nyborg W., 1965, PHYS ACOUSTICS B, V2
   ROYRE D, 1996, ONDES ELASTIQUES SOL
   Scortesse J, 2002, J SOUND VIB, V254, P927, DOI 10.1006/jsvi.2001.4137
   SHIGEMATSU T, 2001, MICROELECTROMECHANIC, P252
   STROBL CJ, 2002, INT ULTR S MUN OCT
   Viktorov I. A., 1967, RAYLEIGH LAMB WAVES
   Wixforth A, 2004, ANAL BIOANAL CHEM, V379, P982, DOI 10.1007/s00216-004-2693-z
   WIXFORTH A, 2002, FLATLANDFLUIDIES MST, V5
   Young T, 1804, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005
   Zhang VY, 2001, IEEE T ULTRASON FERR, V48, P1449, DOI 10.1109/58.949756
NR 17
TC 94
Z9 102
U1 2
U2 21
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD JAN 17
PY 2006
VL 113
IS 1
BP 389
EP 397
DI 10.1016/j.snb.2005.03.100
PG 9
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA 002QS
UT WOS:000234626900054
DA 2018-10-20
ER

PT J
AU Zacco, E
   Pividori, MI
   Alegret, S
AF Zacco, E
   Pividori, MI
   Alegret, S
TI Electrochemical biosensing based on universal affinity biocomposite
   platforms
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE graphite-epoxy biocomposite; protein G; (strept)avidin; electrochemical
   biosensing
ID PROTEIN-G; GLUCOSE-OXIDASE; ELECTRODE; STREPTAVIDIN; BINDING; SYSTEM;
   ASSAY; IGG; ANTIBODIES; IMMOBILIZATION
AB Rigid conducting biocomposites are versatile and effective transducing materials for the construction of a wide range of amperometric biosensors such as immunosensors, genosensors and enzymosensors, particularly if the transducer is bulk-modified with universal affinity biomolecules.
   The strept(avidin)-graphite-epoxy biocomposite could be considered as an universal immobilization platform whereon biotinylated DNAs, oligonucleotides, enzymes or antibodies can be captured by means of the highly affinity (strept)avidin-biotin reaction. Universal affinity biocomposite-based biosensors offer many potential advantages compared to more traditional electrochemical biosensors commonly based on a biologically surface-modified transducer. The integration of many materials into one matrix is their main advantage. As biological bulk-modified materials, the conducting biocomposites act not only as transducers, but also as reservoir for the biomaterial. After its use, the electrode surface can be renewed by a simple polishing procedure, establishing a clear advantage of these approaches relative to classical biosensors and other common biological assays. Moreover, the same material is useful for the analysis of many molecules whose determinations are based on genetic, enzymatic or immunological reactions. The different strategies for electrochemical genosensing, immunosensing and enzymosensing, all of them being dependent on the presence of a redox enzyme marker for the generation of the electrochemical signal, based on this universal affinity biocomposite platform are all presented and discussed. (c) 2005 Published by Elsevier B.V.
C1 Univ Autonoma Barcelona, Grp Sensors & Biosensors, Dept Quim, Bellaterra 08193, Catalonia, Spain.
   Univ Barcelona, Dept Analyt Chem, E-08028 Barcelona, Catalonia, Spain.
RP Pividori, MI (reprint author), Univ Autonoma Barcelona, Grp Sensors & Biosensors, Dept Quim, Bellaterra 08193, Catalonia, Spain.
EM Isabel.Pividori@ub.edu
RI Pividori Gurgo, Maria Isabel/K-9602-2015
OI Pividori Gurgo, Maria Isabel/0000-0002-5266-7873
CR AKERSTROM B, 1985, J IMMUNOL, V135, P2589
   Amounas M, 2000, J MEMBRANE SCI, V176, P169, DOI 10.1016/S0376-7388(00)00441-5
   Bakker E, 2004, ANAL CHEM, V76, P3285, DOI 10.1021/ac049580z
   Cespedes F, 1996, TRAC-TREND ANAL CHEM, V15, P296, DOI 10.1016/0165-9936(96)00042-8
   COMPTON BJ, 1989, ANAL CHEM, V61, P1314, DOI 10.1021/ac00188a003
   Da Silva S, 2004, BIOELECTROCHEMISTRY, V63, P297, DOI 10.1016/j.bioelechem.2003.09.027
   Darain F, 2003, BIOSENS BIOELECTRON, V18, P773, DOI 10.1016/S0956-5663(03)00004-6
   HOSHI T, 1995, ANAL CHEM, V67, P770, DOI 10.1021/ac00100a013
   JANIS LJ, 1989, ANAL CHEM, V61, P1901, DOI 10.1021/ac00192a024
   JONES ML, 1995, BIOCHEMISTRY-US, V34, P11750, DOI 10.1021/bi00037a012
   Jurinke C, 1997, ANAL CHEM, V69, P904, DOI 10.1021/ac960879u
   Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000
   LARSSON A, 1990, J IMMUNOL METHODS, V135, P273, DOI 10.1016/0022-1759(90)90281-Y
   Limoges B, 2003, J AM CHEM SOC, V125, P9192, DOI 10.1021/ja0354263
   Lu B, 1996, ANAL CHIM ACTA, V331, P97, DOI 10.1016/0003-2670(96)00191-2
   Luppa PB, 2001, CLIN CHIM ACTA, V314, P1, DOI 10.1016/S0009-8981(01)00629-5
   Oh BK, 2004, MAT SCI ENG C-BIO S, V24, P65, DOI 10.1016/j.msec.2003.09.065
   Pividori MI, 2003, BIOSENS BIOELECTRON, V19, P473, DOI 10.1016/S0956-5663(03)00222-7
   Pividori MI, 2001, BIOSENS BIOELECTRON, V16, P1133, DOI 10.1016/S0956-5663(01)00242-1
   PIVIDORI MI, 2005, IMMOBILIZATION DNA C
   Reinecke M, 1997, J BIOTECHNOL, V59, P145, DOI 10.1016/S0168-1656(97)00177-6
   SNEJDARKOVA M, 1993, ANAL CHEM, V65, P665, DOI 10.1021/ac00054a002
   Song JM, 2004, ANAL CHIM ACTA, V507, P115, DOI 10.1016/j.aca.2003.11.072
   Valat C, 2000, ANAL CHIM ACTA, V404, P187, DOI 10.1016/S0003-2670(99)00718-7
   Williams E, 2003, BIOSENS BIOELECTRON, V19, P165, DOI 10.1016/S0956-5663(03)00171-4
   Yakovleva J, 2003, BIOSENS BIOELECTRON, V19, P21, DOI 10.1016/S0956-5663(03)00126-X
   Zacco E, 2004, J IMMUNOL METHODS, V286, P35, DOI 10.1016/j.jim.2003.11.014
   Zatta PF, 1996, J BIOCHEM BIOPH METH, V32, P7, DOI 10.1016/0165-022X(95)00042-P
NR 28
TC 33
Z9 34
U1 1
U2 10
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD JAN 15
PY 2006
VL 21
IS 7
BP 1291
EP 1301
DI 10.1016/j.bios.2005.05.016
PG 11
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA 002XC
UT WOS:000234644400037
PM 16098736
DA 2018-10-20
ER

PT J
AU Bonfield, W
AF Bonfield, W
TI Designing porous scaffolds for tissue engineering
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL
   AND ENGINEERING SCIENCES
LA English
DT Article; Proceedings Paper
CT Royal-Society Discussion Meeting on Engineered Foams and Porous
   Materials
CY NOV, 2005
CL London, ENGLAND
SP Royal Soc
DE scaffolds; tissue engineering; calcium phosphate
ID SILICON-SUBSTITUTED HYDROXYAPATITE
AB Biomaterials are either modified natural or synthetic materials, with an appropriate response in the host tissue, which find application in a wide spectrum of implants and prostheses used in reconstructive medicine. The subsequent integration and longevity of the implanted device depends on the effectiveness of the associated biological repair. Hence, there has been considerable interest in the development of novel, second generation, biomaterials, which are favourably bioactive in terms of promoting the desired cellular response in vivo. Such biomaterials in a porous form can also act as cellular scaffolds and allow in. vitro, as well as in vivo incorporation of the appropriate tissue cells, with potential control of the sequence of cell attachment, proliferation and the production of extra-cellular matrix. Such generic tissue engineering depends critically on the porous architecture of the biomaterial scaffold so as to allow both the cellular ingress and vascularization required to create a living tissue. The particular requirements of tissue-engineering scaffolds with respect to macro- and micro-porosity, as well as chemistry, are reviewed.
C1 Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
RP Bonfield, W (reprint author), Univ Cambridge, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 3QZ, England.
EM wb210@hermes.cam.ac.uk
CR BONFIELD W, 1967, J APPL PHYS, V38, P2450, DOI 10.1063/1.1709926
   CURREY J. D., 1964, BIORHEOLOGY, V2, P1
   de Groot K, 1983, BIOCERAMICS CALCIUM
   EVANS FG, 1973, MECH PROPERTIES BONE
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   HING KA, 2005, J MATER SCI-MATER M, V16, P469
   KATZ JL, 1971, J BIOMECH, V4, P455, DOI 10.1016/0021-9290(71)90064-9
   Lysaght MJ, 2004, TISSUE ENG, V10, P309, DOI 10.1089/107632704322791943
   Patel N, 2005, J MATER SCI-MATER M, V16, P429, DOI 10.1007/s10856-005-6983-6
   Porter AE, 2003, BIOMATERIALS, V24, P4609, DOI 10.1016/S0142-9612(03)00355-7
NR 10
TC 61
Z9 66
U1 0
U2 22
PU ROYAL SOCIETY
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1364-503X
J9 PHILOS T ROY SOC A
JI Philos. Trans. R. Soc. A-Math. Phys. Eng. Sci.
PD JAN 15
PY 2006
VL 364
IS 1838
BP 227
EP 232
DI 10.1098/rsta.2005.1692
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 002FN
UT WOS:000234597000015
PM 18272463
DA 2018-10-20
ER

PT J
AU Wang, F
   Li, MS
   Lu, YP
   Qi, YX
   Liu, YX
AF Wang, F
   Li, MS
   Lu, YP
   Qi, YX
   Liu, YX
TI Synthesis and microstructure of hydroxyapatite nanofibers synthesized at
   37 degrees C
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Review
DE biomaterial; chemical synthesis; crystal structure; defects
ID CRYSTALS; BONE; TEMPERATURE; WHISKERS; ROUTE
AB Using the stimulated body fluid (SBF) as solvent, nano-sized single-crystalline HAp fibers have been synthesized in SBF solution at 37 degrees C without adjusting the pH values during the whole reaction time. The synthesized HAp fibers have a length ranging from 60 nm to 100 nm, a uniform diameter of 3-5 nm. Characterization by high-resolution transmission electron microscopy (HRTEM) shows that the synthesized HAp fibers grow along [0 0 1] or [0 10], and there exist structural defects in the synthesized HAp nanofibers. the thermal gravity analysis (TG) and corresponding X-ray powder diffraction (XRD) analysis indicate that the heat treatment temperature for HAp fibers should not be above 700 degrees C. The HAp fibers with length and diameter in the range of nano-size could be an ideal structure as a specific reinforcement in the biomaterials for bone tissue implantation. (c) 2005 Elsevier B.V All rights reserved.
C1 Shandong Univ, Sch Mat Sci & Engn, Jinan 250061, Peoples R China.
   Shandong Univ Sci & Technol, Sch Chem & Environm Engn, Jinan 250031, Peoples R China.
RP Li, MS (reprint author), Shandong Univ, Sch Mat Sci & Engn, 73 Jingshi Rd, Jinan 250061, Peoples R China.
EM wf890916@163.com; msli@sdu.edu.cn
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
CR Cao MH, 2004, LANGMUIR, V20, P4784, DOI 10.1021/la0498197
   FRATZL P, 1992, J BONE MINER RES, V7, P329
   GLIMCHER MJ, 1992, DISORDERS BONE MINER
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   KIM HM, 1995, J BONE MINER RES, V10, P1589
   Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x
   LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003
   LI PJ, 1994, J AM CERAM SOC, V77, P1307, DOI 10.1111/j.1151-2916.1994.tb05407.x
   Ota Y, 1998, J AM CERAM SOC, V81, P1665
   Park HC, 2004, J MATER SCI, V39, P2531, DOI 10.1023/B:JMSC.0000020021.82216.6b
   PARTENFELDER U, 1993, J MATER SCI-MATER M, V4, P292, DOI 10.1007/BF00122283
   RAMSELAAR MMA, 1991, J MATER SCI-MATER M, V2, P63, DOI 10.1007/BF00703460
   Rodriguez-Lorenzo LM, 2000, CHEM MATER, V12, P2460, DOI 10.1021/cm001033g
   Shu C., 2005, CERAM INT, V31, P135
   Su X, 2003, BONE, V32, P150, DOI 10.1016/S8756-3282(02)00945-6
   Suvorova EI, 1998, J CRYST GROWTH, V186, P262, DOI 10.1016/S0022-0248(97)00445-4
   WEINER S, 1986, CALCIFIED TISSUE INT, V39, P365, DOI 10.1007/BF02555173
   Weng WJ, 1998, BIOMATERIALS, V19, P125, DOI 10.1016/S0142-9612(97)00177-4
   YOSHIMURA M, 1994, J MATER SCI, V29, P3399, DOI 10.1007/BF00352039
   ZHOU JM, 1993, J MATER SCI-MATER M, V4, P83, DOI 10.1007/BF00122983
NR 20
TC 33
Z9 33
U1 0
U2 26
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD JAN 10
PY 2006
VL 95
IS 1
BP 145
EP 149
DI 10.1016/j.matchemphys.2005.05.034
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 977OQ
UT WOS:000232813500026
DA 2018-10-20
ER

PT B
AU Hee, CK
   Nicoll, SB
AF Hee, Christopher K.
   Nicoll, Steven B.
GP IEEE
TI Induction of osteoblast differentiation markers in human dermal
   fibroblasts: Potential application to bone tissue engineering
SO 2006 28TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN
   MEDICINE AND BIOLOGY SOCIETY, VOLS 1-15
LA English
DT Proceedings Paper
CT 28th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 30-SEP 03, 2006
CL New York, NY
SP IEEE Engn Med & Biol Soc
ID STROMAL CELLS; IN-VITRO; EXPRESSION; VIVO
AB Tissue engineered constructs have the potential to be used as replacements for current bone graft technologies. One component necessary for bone tissue engineering is a readily available, osteogenic cell source. Human dermal fibroblasts may have the potential to differentiate along an osteoblastic lineage, making them a candidate for use in bone tissue engineering applications. The objective of this study was to validate the ability of dermal fibroblasts to express gene and protein markers of osteoblastic differentiation and to explore their potential, in combination with biomaterial scaffolds and signaling factors, for use in bone tissue engineering.
C1 [Hee, Christopher K.; Nicoll, Steven B.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
RP Hee, CK (reprint author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
FU Whitaker Foundation
FX Manuscript received May 15, 2006. This work was supported in part by the
   Whitaker Foundation.
CR Boyce T, 1999, ORTHOP CLIN N AM, V30, P571, DOI 10.1016/S0030-5898(05)70110-3
   Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174
   Halvorsen YDC, 2001, TISSUE ENG, V7, P729, DOI 10.1089/107632701753337681
   Hee CK, 2006, BIOMATERIALS, V27, P875, DOI 10.1016/j.biomaterials.2005.07.004
   Hirata K, 2003, BONE, V32, P502, DOI 10.1016/S8756-3282(03)00054-1
   Krebsbach PH, 2000, HUM GENE THER, V11, P1201, DOI 10.1089/10430340050015248
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Nicoll SB, 2001, CONNECT TISSUE RES, V42, P59, DOI 10.3109/03008200109014249
   Notingher I, 2004, J CELL BIOCHEM, V92, P1180, DOI 10.1002/jcb.20136
   REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601
   Rutherford RB, 2002, TISSUE ENG, V8, P441, DOI 10.1089/107632702760184709
   Shui CX, 2002, J CELL PHYSIOL, V193, P164, DOI 10.1002/jcp.10157
   Singer VL, 1997, ANAL BIOCHEM, V249, P228, DOI 10.1006/abio.1997.2177
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Weiss L, 2002, TISSUE ENG, V8, P167
NR 15
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-0032-4
PY 2006
BP 6130
EP +
PG 2
WC Engineering, Biomedical
SC Engineering
GA BGI19
UT WOS:000247284707030
DA 2018-10-20
ER

PT B
AU Ngan, OT
   McPhail, DS
   Chater, RJ
   Shollock, BA
AF Ngan, Ooi Thian
   McPhail, David S.
   Chater, Richard J.
   Shollock, Barbara A.
GP IEEE
TI Characterization of thin oxide using FIB-SIMS and FIB-TEM techniques
SO 2006 IEEE CONFERENCE ON EMERGING TECHNOLOGIES - NANOELECTRONICS
LA English
DT Proceedings Paper
CT IEEE Conference on Emerging Technologies - Nanoelectronics
CY JAN 10-13, 2006
CL Singapore, SINGAPORE
SP IEEE
DE FIB-SIMS; FIB-TEM; alumina scales; isotopic tracer experiments
ID COATINGS
AB The use of SIMS for the characterization and study of biomaterial surfaces is fast gaining popularity in the development of bio-functional and bioactive tissue compatible interfaces. The presence of TiO2 oxide in metallic Ti implants and its ability to promote bioactivity is still unclear. FIB-SIMS (Focused Ion Beam-Secondary Ion Mass Spectrometry) and FIB-TEM (FIB-Transmission Electron Microscopy) techniques represent powerful tools for characterizing the oxide layer. This paper investigates the oxygen transport mechanism of thermal barrier coating systems applied on nickel-base superalloy turbine blades. In this study, a two-stage oxidation experiment is used. O-18(2) is used as a tracer during the second stage oxidation on previously oxidized Ni-base superalloys with a layer of bond coat material. The aluminium oxide grown in O-16(2) during the first stage oxidation serves as a background oxide. Mass spectra collected by FIB-SIMS reveal the counter mass transportation by inward diffusion of oxygen and outward diffusion of aluminium. New oxide formation during the second stage oxidation under an O-18(2) enriched environment is observed at both the gas/oxide interface as well as oxide/superalloy interface. Transmission Electron Microscopy (TEM) can be used to identify the very fine phases developed in both the inter-diffusion zone as well as the thermally grown oxide layer. The use of Focused Ion Beam (FIB) technique allows for selective nano-machining of areas of interest for the production of TEM samples. FIB-SIMS and TEM are carried out to determine the specific phase transformations occurring in the TBC system. This is an approach with great potential for the future investigation of the abovementioned TiO2 layer that plays an important part in promoting the bioactivity of materials.
C1 [Ngan, Ooi Thian; McPhail, David S.; Chater, Richard J.; Shollock, Barbara A.] Univ London Imperial Coll Sci & Technol, Dept Mat, Exhibit Rd, London SW7 2AZ, England.
RP Ngan, OT (reprint author), Univ London Imperial Coll Sci & Technol, Dept Mat, Exhibit Rd, London SW7 2AZ, England.
CR Alibhai AA, 2003, APPL SURF SCI, V203, P630, DOI 10.1016/S0169-4332(02)00780-8
   GARRIGAMAJO D, 1999, J INORG MATER, V1, P325
   GRAHAM MJ, 1990, MICROSCOPY OXIDATION, V500, P10
   HAYNES JA, 1995, ELEVATED TEMPERATURE, V3
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   *MATHS WORKS INC, MATLAB
   Moritz N, 2005, BIOMATERIALS, V26, P4460, DOI 10.1016/j.biomaterials.2004.11.020
   Nakahara S, 2003, SURF COAT TECH, V169, P721, DOI 10.1016/S0257-8972(03)00206-8
   JCPDS
NR 9
TC 1
Z9 1
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-0-7803-9357-8
PY 2006
BP 206
EP +
PG 2
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Physics, Condensed Matter
SC Engineering; Science & Technology - Other Topics; Physics
GA BFW82
UT WOS:000245207000043
DA 2018-10-20
ER

PT S
AU Zhou, DB
   Claffee, MR
   Lee, KM
   McMurray, GV
AF Zhou, Debao
   Claffee, Mark R.
   Lee, Kok-Meng
   McMurray, Gary V.
GP IEEE
TI Cutting, 'by pressing and slicing', applied to robotic cutting
   bio-materials, part I: Modeling of stress distribution
SO 2006 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION (ICRA),
   VOLS 1-10
SE IEEE International Conference on Robotics and Automation ICRA
LA English
DT Proceedings Paper
CT IEEE International Conference on Robotics and Automation (ICRA)
CY MAY 15-19, 2006
CL Orlando, FL
SP IEEE
DE robot cutting; stress; modeling; biomaterial
ID CONSTANT
AB Bio-material cutting, such as meat deboning, is one the most common operations in food processing. Automating this process using robotic devices with closed-loop force control has shown some promise. The control of the force trajectory directly relates to the internal stress in the material being cut, and must provide enough force to initiate the cut. The ability to model the stress distribution in the bio-materials being cut would provide a better understanding of the influencing factors and help predict the required cutting force for the design of the cutting mechanism and for automating the cutting operations. This research is presented in two parts: part I models the stress distribution when a blade acts on the bio-material and part II discusses the principles of biomaterial cutting. Starting with modeling a point force in the normal and tangential direction on the boundary of a semi-infinite body, an analytical expression for the stress tensor has been obtained and simulated using direct integral method. This paper provides the theoretical basis for explaining the cutting phenomena and predicting the cutting forces, a topic to be presented in Part II.
C1 [Zhou, Debao; McMurray, Gary V.] Georgia Tech Res Inst, Food Proc Technol Div, HES Lab, Atlanta, GA 30332 USA.
   [Claffee, Mark R.; Lee, Kok-Meng] Georgia Tech Res Inst, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Zhou, DB (reprint author), Georgia Tech Res Inst, Food Proc Technol Div, HES Lab, Atlanta, GA 30332 USA.
EM debao.zhou@gtri.gatech.edu; m.claffee@gatech.edu;
   kokmeng.lee@me.gatech.edu; gary.mcmurray@gtri.gatech.edu
CR Boussinesq J., 1885, APPL POTENTIELS ETUD
   DYDO JR, 1995, J ELASTICITY, V38, P153, DOI 10.1007/BF00042496
   FISCHERCRIPPS AC, 2000, INTRO COTNACT MECH
   Hellan K., 1984, INTRO FRACTURE MECH
   Johnson K. L., 1985, CONTACT MECH
   Li JS, 2001, J ELASTICITY, V63, P137, DOI 10.1023/A:1014013425423
   LOVE AEH, 1927, TREATISE MATH THEORY
   LOVE AEH, PHIL T R SOC LOND A, V667, P377
   PORITSKY H, 1950, J APPL MECH, V17
   Sadd M. H., 2005, ELASTICITY THEORY AP
   Svec OJ, 1971, J ELASTICITY, V1, P167
   Timoshenko S. P., 1970, THEORY ELASTICITY
   Way S., 1940, J APPL MECH, V7, P147
   Xu Z., 1996, ELASTICITY MECH
   ZHOU D, 2006, P IEEE INT C ROB AUT
NR 15
TC 1
Z9 1
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1050-4729
BN 0-7803-9505-0
J9 IEEE INT CONF ROBOT
PY 2006
BP 2896
EP +
DI 10.1109/ROBOT.2006.1642141
PG 2
WC Automation & Control Systems; Computer Science, Artificial Intelligence;
   Engineering, Mechanical; Robotics
SC Automation & Control Systems; Computer Science; Engineering; Robotics
GA BFB71
UT WOS:000240886906030
DA 2018-10-20
ER

PT B
AU Gindre, M
   Le Guillou-Buffello, D
   Sewing, A
   Bareille, R
   Amedee, J
   Laugier, P
AF Gindre, Marcel
   Le Guillou-Buffello, Delphine
   Sewing, Andreas
   Bareille, Reine
   Amedee, Joelle
   Laugier, Pascal
GP IEEE
TI Adhesion of human osteoprogenitor cells on peptide immobilization onto
   titanium monitored a quartz crystal resonator technique
SO 2006 IEEE INTERNATIONAL WORKSHOP ON MEDICAL MEASUREMENT AND APPLICATIONS
SE IEEE International Workshop on Medical Measurements and Applications
LA English
DT Proceedings Paper
CT IEEE International Workshop on Medical Measurement and Applications
CY APR 20-21, 2006
CL Benevento, ITALY
DE quartz crystal resonator; cell adhesion; HOP cells; biosensor; titanium
ID MICROBALANCE; ATTACHMENT
AB The thickness Shear Mode (TSM) quartz crystal resonator has been extensively used as sensitive sensor in various electrochemical and biological applications. This technique is based on the transverse propagation of an acoustic shear wave generated by a sinusoidal electric field through a piezoelectric quartz resonator. Its provides a non destructive and powerful mean for probing changes at solid-solid or solid-liquid interfaces, and for characterizing specific cell-substrate interactions. In the present, work, we show the results obtained by using the thickness shear mode sensor based technique to characterize activation of Human OsteoProgenitor (HOP) cells on different peptide immobilization on titanium. We have measured the time evolution of a quartz electric characteristic: the motional resistance in the vicinity of the mechanical sensor resonant frequency. The quartz crystal resonator.ferent biomaterials to test the cell adhesion. was coated with dif hydroxyapatite, the Arg-Gly-Asp (RGD) adhesion sequence, type I collagen and untreated titanium as a reference. The effects of a progressive induced activation for HOP adhesion on peptide immobilization on titanium were analyzed and finally discussed in the frame of a possible application in the biomaterial field such as bone prostheses.
C1 [Gindre, Marcel; Le Guillou-Buffello, Delphine; Laugier, Pascal] Univ Paris 06, CNRS, UMR 7623, Lab Imagerie Parametr, 15 Rue Ecol Med, F-75006 Paris, France.
   [Bareille, Reine; Amedee, Joelle] INSERM, Lab Biomat & Reparat, U577, F-33076 Bordeaux, France.
   [Sewing, Andreas] BioMat GmbH, Biomet Merck, D-64293 Darmstadt, Germany.
RP Gindre, M (reprint author), Univ Paris 06, CNRS, UMR 7623, Lab Imagerie Parametr, 15 Rue Ecol Med, F-75006 Paris, France.
EM marcel.gindre@u-cergy.fr
RI VILAMITJANA AMEDEE, Joelle/F-3369-2013; Laugier, Pascal/P-1658-2017
OI Laugier, Pascal/0000-0002-7498-0262
FU French Department of Education [02 B 0112]
FX This study was granted by the French Department of Education (projet
   RNTS : os hybride no 02 B 0112).
CR Bandey HL, 1999, ANAL CHEM, V71, P2205, DOI 10.1021/ac981272b
   DARBEIDA H, 1999, CAHIERS RHEOLOGIE, V16, P73
   GRYTE DM, 1993, BIOTECHNOL PROGR, V9, P105, DOI 10.1021/bp00019a016
   Haider L, 2004, IEEE SENS J, V4, P535, DOI 10.1109/JSEN.2004.832856
   Le Guillou-Buffello D, 2005, BIOMATERIALS, V26, P4197, DOI 10.1016/j.biomaterials.2004.10.024
   Matsuda T., 1992, ASAIO J, V38, P171
   Murakami Y, 1997, DRUG DELIV, V4, P23, DOI 10.3109/10717549709033184
   Pallu S, 2003, PEPTIDES, V24, P1349, DOI 10.1016/j.peptides.2003.09.003
   REDEPENNING J, 1993, ANAL CHEM, V65, P3378, DOI 10.1021/ac00071a008
   VILLARS, 2002, AM J CELL PHYSL, V4, P775
   Wegener J, 2001, CELL BIOCHEM BIOPHYS, V34, P121, DOI 10.1385/CBB:34:1:121
NR 11
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-0252-6
J9 IEEE INT WORK MED ME
PY 2006
BP 108
EP +
DI 10.1109/MEMEA.2006.1644472
PG 2
WC Engineering, Biomedical
SC Engineering
GA BFW75
UT WOS:000245157600024
DA 2018-10-20
ER

PT B
AU Toy, WC
   Gan, YY
   Law, SK
   Yeo, JH
   Chiu, JJ
   Chen, LJ
   Hwang, HC
AF Toy, W. C.
   Gan, Y. Y.
   Law, S. K.
   Yeo, J. H.
   Chiu, J. J.
   Chen, L. J.
   Hwang, H. C.
GP IEEE
TI Porcine small intestinal submucosa is a suitable small diameter vascular
   substitute
SO 2006 INTERNATIONAL CONFERENCE ON BIOMEDICAL AND PHARMACEUTICAL
   ENGINEERING, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT International Conference on Biomedical and Pharmaceutical Engineering
CY DEC 11-14, 2006
CL Singapore, SINGAPORE
DE endothelial cells; small intestine submucosa; monocytes; growth factors;
   vascular graft
ID ENDOTHELIAL-CELL ADHERENCE; EXTRACELLULAR-MATRIX; SHEAR-STRESS; WALL
   REPAIR; ADHESION; FLOW; INFLAMMATION; EXPRESSION; SUBSTRATE; ARREST
AB Biomaterials have become the critical component in the development of small diameter vascular graft. In this project, the suitability of a biomaterial, rich in collagen and other growth factors, derived from the porcine small intestine submucosa (SIS) to be used as a small diameter vascular substitute was studied. Endothelial cells (ECs) are the innermost cell linings of the lumen of all blood vessels. The morphology of ECs cultured on SIS was examined in vitro using scanning electron microscopy. Results showed that endothelial cells became round shape, proliferated and attached to the surface of SIS to form a confluent monolayer. Organization of the cytoskeleton of the endothelial cells cultured on SIS and on glass slides coated with Type I collagen was also examined using fluorescent immunostaining. Actin bundles were relatively thin and disorganized in endothelial cells seeded on SIS. Thick actin filaments were found at the periphery of the cells seeded on glass slides coated with Type I collagen. This different organization could be due to the porosity, composition and hydrophilicity of the biomaterials used. During cell inflammation, monocytes were found adhering to ECs in the blood vessels causing ECs dysfunction. Activated leukocytes and macrophages release proinflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha) to enable ECs to increase their expression of adhesion molecules. In addition, TNF-alpha also causes ECs to produce vasodilators to increase blood flow to the affected area. Monocytes adhesion to endothelial cells was most likely the consequences of inflammation that might lead to the graft rejection. Human monocytes THP-1 cells were used to study the adhesion assay of monocytes to ECs seeded on SIS and glass slides coated with Type I collagen using fluorescent microscope. When activated with TNF-alpha, THP-1 cells showed more prominent adhesion to ECs cultured on glass slides coated with Type I collagen as compared to SIS. This result suggested that TNF-alpha induced higher number of endothelial cells-monocytes: interaction on glass slides coated with Type I collagen compared to SIS.
C1 [Toy, W. C.; Gan, Y. Y.] Nanyang Technol Univ, Natl Inst Educ, Nat Sci & Sci Educ, Singapore, Singapore.
   [Law, S. K.] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.
   [Yeo, J. H.] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore.
   [Chiu, J. J.; Chen, L. J.; Hwang, H. C.] Natl Hlth Res Inst, Med Div Engn Res, Miaoli, Taiwan.
RP Toy, WC (reprint author), Nanyang Technol Univ, Natl Inst Educ, Nat Sci & Sci Educ, Singapore, Singapore.
RI Chiu, Jeng-Jiann/E-3980-2010
CR Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   BRETSCHER A, 1994, J CELL BIOL, V126, P821, DOI 10.1083/jcb.126.4.821
   CAMPANERO MR, 1994, J CELL BIOL, V127, P867, DOI 10.1083/jcb.127.3.867
   Chiu JJ, 1998, J BIOMECH ENG-T ASME, V120, P2, DOI 10.1115/1.2834303
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Cobb MA, 1996, SURG NEUROL, V46, P389, DOI 10.1016/S0090-3019(96)00202-9
   Cobb MA, 1999, SURG NEUROL, V51, P99, DOI 10.1016/S0090-3019(97)00475-8
   CONTRAN R, 1987, J PATHOL, V129, P407
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   DAVIES PF, 1995, PHYSIOL REV, V75, P519
   DEJANA E, 1987, J CELL BIOL, V104, P1403, DOI 10.1083/jcb.104.5.1403
   Faveeuw C, 2000, INT IMMUNOL, V12, P241, DOI 10.1093/intimm/12.3.241
   Gimbrone M A Jr, 1976, Prog Hemost Thromb, V3, P1
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hodde JP, 2002, TISSUE ENG, V8, P225, DOI 10.1089/107632702753724996
   Jordan AT, 2005, J INSECT SCI, V5
   Kataoka N, 2002, P NATL ACAD SCI USA, V99, P15638, DOI 10.1073/pnas.242590799
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   KROPP JP, 1995, MUSCLE MATRIX BLADDE, V755, P229
   Kunkel EJ, 2000, J IMMUNOL, V164, P3301, DOI 10.4049/jimmunol.164.6.3301
   LEY K, SELECTIONS INITIATOR, P63
   MALEK AM, 1994, J HYPERTENS, V12, P989
   Marcia G. Honig, 1986, J CELL BIOL, V103, P171
   McPherson TB, 1998, TISSUE ENG, V4, P75, DOI 10.1089/ten.1998.4.75
   MORIGI M, 1995, BLOOD, V85, P1696
   OSBORN L, 1990, CELL, V62, P3, DOI 10.1016/0092-8674(90)90230-C
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   RAO JY, 1990, CANCER RES, V50, P2215
   Reape TJ, 1999, ATHEROSCLEROSIS, V147, P213, DOI 10.1016/S0021-9150(99)00346-9
   Robotin-Johnson MC, 1998, J THORAC CARDIOV SUR, V116, P805, DOI 10.1016/S0022-5223(98)00436-X
   SANDUSKY GE, 1995, J SURG RES, V58, P415, DOI 10.1006/jsre.1995.1064
   SEVERS NJ, 1995, RAPID FREEZING FREEZ
   Voytik-Harbin SL, 1998, TISSUE ENG, V4, P157, DOI 10.1089/ten.1998.4.157
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Weber KSC, 1999, BLOOD, V93, P3685
   Yang YY, 2004, ATHEROSCLEROSIS, V174, P207, DOI 10.1016/j.atherosclerosis.2004.01.024
NR 40
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-981-05-7943-2
PY 2006
BP 290
EP +
PG 3
WC Chemistry, Medicinal; Engineering, Biomedical
SC Pharmacology & Pharmacy; Engineering
GA BGT54
UT WOS:000250420600061
DA 2018-10-20
ER

PT B
AU Gras, SL
   Squires, AM
   Dobson, CM
   MacPhee, CE
AF Gras, Sally L.
   Squires, Adam M.
   Dobson, Christopher M.
   MacPhee, Cait E.
GP IEEE
TI Functionalised fibrils for bio-nanotechnology
SO 2006 INTERNATIONAL CONFERENCE ON NANOSCIENCE AND NANOTECHNOLOGY, VOLS 1
   AND 2
LA English
DT Proceedings Paper
CT International Conference on Nanoscience and Nanotechnology
CY JUL 03-07, 2006
CL Brisbane, AUSTRALIA
DE bio-nanotechnology; amyloid; fibrils; self-assembly; peptide; bioactive;
   biomaterial; bio-scaffold
ID AMYLOID FIBRIL; CELL-ADHESION; AGGREGATION RATES; IN-VITRO; PEPTIDE;
   PROTEIN; TRANSTHYRETIN; CONFORMATION; NANOWIRES; SURFACES
AB Amyloid fibrils offer great potential as nano-materials. Functionalised fibrils assembled from peptides coupled to bioactive ligands interact specifically with cells compared to non functionalized fibrils, suggesting that these fibrils are also promising bio-scaffolds.
C1 [Gras, Sally L.] Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3010, Australia.
   [Squires, Adam M.] Univ Reading, Dept Chem, Reading RG6 2AH, Berks, England.
   [Dobson, Christopher M.] Univ Cambridge, Dept Chem, Cambridge CB2 1TN, England.
   [MacPhee, Cait E.] Univ Edinburgh, Sch Phys, Edinburgh EH8 9YL, Midlothian, Scotland.
RP Gras, SL (reprint author), Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3010, Australia.
EM sgras@unimelb.edu.au
RI Gras, Sally/G-2025-2014
OI Gras, Sally/0000-0002-4660-1245
FU Gates Cambridge Scholarship; Wellcome and Leverhulme Trusts; C.E.M. is a
   Royal Society University Research Fellow
FX We thank Dr Anna Tickler for peptide synthesis and mass spectrometry,
   Darerca Owen for cell culture facilities and Dr Filip Meersman and
   Professor Mike Horton for discussions. S.L.G. is funded by a Gates
   Cambridge Scholarship, C.M.D is funded by the Wellcome and Leverhulme
   Trusts and C.E.M. is a Royal Society University Research Fellow.
CR Baldwin AJ, 2006, J AM CHEM SOC, V128, P2162, DOI 10.1021/ja0565673
   Banerjee P, 2000, J BIOMED MATER RES, V50, P331, DOI 10.1002/(SICI)1097-4636(20000605)50:3<331::AID-JBM6>3.3.CO;2-K
   Baxa U, 2002, P NATL ACAD SCI USA, V99, P5253, DOI 10.1073/pnas.082097899
   Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   de Oliveira PT, 2004, BIOMATERIALS, V25, P403, DOI 10.1016/S0142-9612(03)00539-8
   Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0
   Dubay KF, 2004, J MOL BIOL, V341, P1317, DOI 10.1016/j.jmb.2004.06.043
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   GRAS SL, UNPUB AMYLOID FIBRIL
   Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224
   GUSTAVSSON A, 1991, BIOCHEM BIOPH RES CO, V175, P1159, DOI 10.1016/0006-291X(91)91687-8
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Jaroniec CP, 2004, P NATL ACAD SCI USA, V101, P711, DOI 10.1073/pnas.0304849101
   Jaroniec CP, 2002, P NATL ACAD SCI USA, V99, P16748, DOI 10.1073/pnas.252625999
   Kammerer RA, 2004, P NATL ACAD SCI USA, V101, P4435, DOI 10.1073/pnas.0306786101
   Kodama H, 2004, CHEM COMMUN, P2876, DOI 10.1039/b409641j
   MacPhee CE, 2000, J AM CHEM SOC, V122, P12707, DOI 10.1021/ja0029580
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012
   PAULING L, 1951, P NATL ACAD SCI USA, V37, P251, DOI 10.1073/pnas.37.5.251
   Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100
   Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
NR 28
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-0452-0
PY 2006
BP 265
EP +
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic;
   Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BGO69
UT WOS:000249051500069
DA 2018-10-20
ER

PT B
AU Zhang, ZC
   Xiao, Y
   Dai, CM
   Dai, H
AF Zhang Zongcai
   Xiao Yao
   Dai Chunmei
   Dai Hong
GP Sichuan Univ
TI Study on the unhairing process with the low-temperature plasma
SO 7th Asian International Conference of Leather Science and Technology
   Sect 1 and 2
LA English
DT Proceedings Paper
CT 7th Asian International Conference of Leather Science and Technology
CY OCT 15-18, 2006
CL Chengdu, PEOPLES R CHINA
SP China Leather Ind Assoc, Japanese Assoc Leather Technol, Korea Inst Footwear & Leather Technol, Sichuan Leather Assoc, China Leather & Footwear Ind Res Inst, Shandong Coll Light Ind, Tanners Council Japan, Hokkaido Univ, Tokyo Univ Agr & Technol
DE LTP; modification; unhairing; leather processing
AB Dehairing is a serious pollutant process of leathermaking. The widely used sulphur-dehairing method will produce abundant COD, BOD and suspended solid materials, and also brings the pollutant of sulfide. Enzyme dehairing and Oxidation-dehairing are limited in batch-production because of some disadvantages that are not easy to overcome. The pioneering works were carried out by applying the Low-temperature plasma (UP) technology to the Leather processing, which based on the surface modification of biomaterial using LTR In the present work, we treated the degreasing skin with UP, and received dehairing, then compared with the untreated sample which went through the subsequent processes straightly. The results showed that the UP treatment made the dehairing more easily and effectively, but its effect is not very obvious when it was used in tanning process; while in the application of dying, it can increase surface dying and dyefastness. The results were different when the conditions of UP treatment changed.
C1 Sichuan Univ, Minist Educ, Key Lab Leather Chem & Engn, Chengdu 610065, Peoples R China.
RP Zhang, ZC (reprint author), Sichuan Univ, Minist Educ, Key Lab Leather Chem & Engn, Chengdu 610065, Peoples R China.
CR Choi JH, 2003, SURF COAT TECH, V171, P257, DOI 10.1016/S0257-8972(03)00282-2
   GU JW, 2001, HIGH TECHNOLOGY B, V11, P7
   HU JF, 1994, CHINESE J MAT RES, V8, P82
   Kan CW, 1998, J MATER PROCESS TECH, V83, P180, DOI 10.1016/S0924-0136(98)00060-0
   Yu N., 1998, VACUUM, V51, P221
   ZHANG QQ, 1994, CHINESE J MAT RES, V8, P551
   ZHANG ZC, 2004, LEATHER SCI ENG, V14, P20
NR 7
TC 0
Z9 0
U1 0
U2 2
PU CHINESE LEATHER INDUSTRY ASSOC
PI CHENGDU
PA C/O KEY LABORATORY OF LEATHER CHEM & ENG MINISTRY EDUCATION, SICHUAN
   UNIV, CHENGDU, 610065, PEOPLES R CHINA
PY 2006
BP 647
EP 652
PG 6
WC Engineering, Manufacturing; Materials Science, Textiles
SC Engineering; Materials Science
GA BFS71
UT WOS:000244383100087
DA 2018-10-20
ER

PT B
AU Lin, H
   Dan, WH
   Dan, NH
   Ye, YC
   Guan, LB
   Mi, ZJ
AF Lin Hai
   Dan Weihua
   Dan Nianhua
   Ye Yichun
   Guan Linbo
   Mi Zhenjian
GP Sichuan Univ
TI Preparation and characterization of collagen powder
SO 7th Asian International Conference of Leather Science and Technology
   Sect 1 and 2
LA English
DT Proceedings Paper
CT 7th Asian International Conference of Leather Science and Technology
CY OCT 15-18, 2006
CL Chengdu, PEOPLES R CHINA
SP China Leather Ind Assoc, Japanese Assoc Leather Technol, Korea Inst Footwear & Leather Technol, Sichuan Leather Assoc, China Leather & Footwear Ind Res Inst, Shandong Coll Light Ind, Tanners Council Japan, Hokkaido Univ, Tokyo Univ Agr & Technol
DE collagen powder; preparation; characterization; biomaterial; porcine
   skin
AB Possessed with particular structure, collagen has low antigencity associated with high biocompatibility and constitutes one of the major raw materials for biomaterial applications, which is being much more important in biomedical realm. Collagen powder was prepared from porcine skin with the optimized techniques acquired. The results of determination focused on collagen's components, structure and integrative performances, inculding Hydroxyproline Content Test, Amino Acid Analysis, Protein Content, Circular Dichroism (CD), FTIR, DSC, Isoelectric Point (PI) and SEM, indicated that collagen powder was pure, conformed to the characters of Type I Collagen and was preserved the natural triple helix in a great degree, which was indispensable as biomaterials.
C1 Sichuan Univ, Key Lab Leather Chem & Engn, Minist Educ, Chengdu 610065, Sichuan, Peoples R China.
RP Dan, NH (reprint author), Sichuan Univ, Key Lab Leather Chem & Engn, Minist Educ, Chengdu 610065, Sichuan, Peoples R China.
CR BAILEY AJ, 1992, J SOC LEATH TECH CH, V76, P111
   *CHINA PHARM COMM, 2000, CHIN PHARM
   DAN WH, 2004, BIOMEDICAL ENG CLIN, V8, P45
   DAN WH, LEATHER CHEM, V21, P24
   DAN WH, 2004, BIOMEDICAL ENG CLIN, V8, P52
   Hafemann B, 2001, J MATER SCI-MATER M, V12, P437, DOI 10.1023/A:1011205221972
   LEE CH, 2001, INT J PHARM, V222, P1
   LIN H, 2006, CHINESE LEATHER, V35, P26
   LIN H, 2006, CHINESE LEATHER, V35, P19
   LU ZX, 1987, CIRCULAR DICHROISM I
   Plepis AMD, 1996, POLYM ENG SCI, V36, P2932
   Sivakumar P, 2000, COMP BIOCHEM PHYS B, V125, P555, DOI 10.1016/S0305-0491(00)00167-X
   TAN W, 2000, P 22 ANN INT C IEEE, V2, P1509
   Usha R, 2005, COLLOID SURFACE B, V41, P21, DOI 10.1016/j.colsurfb.2004.11.001
   Uskokovic V, 2003, MATER SCI FORUM, V413, P269
   WANG Ji-hua, 2004, CHEMISTRY, V7, P482
   Xie MX, 2003, CHEM J CHINESE U, V24, P226
NR 17
TC 0
Z9 0
U1 0
U2 9
PU CHINESE LEATHER INDUSTRY ASSOC
PI CHENGDU
PA C/O KEY LABORATORY OF LEATHER CHEM & ENG MINISTRY EDUCATION, SICHUAN
   UNIV, CHENGDU, 610065, PEOPLES R CHINA
PY 2006
BP 1099
EP 1106
PG 8
WC Engineering, Manufacturing; Materials Science, Textiles
SC Engineering; Materials Science
GA BFS71
UT WOS:000244383100147
DA 2018-10-20
ER

PT S
AU Araujo, JV
   Lopes-Da-Silva, JA
   Almeida, MM
   Costa, MEV
AF Araujo, JV
   Lopes-Da-Silva, JA
   Almeida, MM
   Costa, MEV
BE Vilarinho, PM
TI Preparation and characterization of chitosan-based scaffolds for
   biomedical applications
SO ADVANCED MATERIALS FORUM III, PTS 1 AND 2
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 3rd International Materials Symposium/12th Meeting of the
   Sociedad-Portuguesa-da-Materials (Materials 2005/SPM)
CY MAR 20-23, 2005
CL Univ Aveiro, Aveiro, PORTUGAL
SP Portuguese Mat Soc, Mat Network Atlantic Arc, CiCECO, BPI, Bayer Mat Sci, DURIT, IZASA, GIC, Novagres, Rauschert, CRIOLAB CRYOGENICS Vacuum Syst Vacuum Chambers, FCT, NTI EUROPE, Fdn Calouste Gulbenkian, ScienTec, ThermoLab, Papelave, cienciapt net, Air Liquide
HO Univ Aveiro
DE biomaterial; chitosan; brushite; calcium phosphate; composite; scaffold
ID PHOSPHATE COMPOSITE SCAFFOLDS; CALCIUM PHOSPHATES; TISSUE
AB Porous chitosan/brushite composite scaffolds were prepared by a freeze-drying technique, starting from brushite suspensions in chitosan solutions. The obtained scaffolds showed a regular macroporous and interconnected structure with brushite particles uniformly distributed in the chitosan matrix. The variation of the brushite concentration affected the microstructure of the final freeze-dried scaffold, in particular, its porosity and its average pore size. The yield strengths of the composite scaffolds could also be improved by the increase of the brushite content.
C1 Univ Aveiro, CICECO, Dept Ceram & Glass Engn, P-3810193 Aveiro, Portugal.
   Univ Aveiro, Dept Chem, P-3810193 Aveiro, Portugal.
RP Araujo, JV (reprint author), Univ Aveiro, CICECO, Dept Ceram & Glass Engn, P-3810193 Aveiro, Portugal.
EM jjunior@cv.ua.pt; jsilva@dq.ua.pt; margarida@cv.ua.pt;
   elisabete@cv.ua.pt
RI Lopes da Silva, Jose/A-4240-2013; costa, maria elizabete/L-3541-2014
OI Lopes da Silva, Jose/0000-0002-2863-1790; costa, maria
   elizabete/0000-0001-7803-6212; ALMEIDA, MARGARIDA/0000-0002-7915-4090
CR BOHNER M, 2001, EUR SPINE J, V10, P114
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Guehennec LL, 2004, EUR CELLS MATER, V8, P1
   Hu QL, 2004, BIOMATERIALS, V25, P779, DOI 10.1016/S0142-9612(03)00582-9
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   SARASWATHY I, 2001, B MATER SCI, V24, P415
   Sato T, 2001, BIOMATERIALS, V22, P2075, DOI 10.1016/S0142-9612(00)00385-9
   TOVBORG JA, 1953, INORG SYNTH, V4, P19
   WANG K, 1995, POLYMER, V3, P837
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yin YJ, 2003, J BIOMED MATER RES A, V67A, P844, DOI 10.1002/jbm.a.10153
   Yoshida A, 2004, MATER TRANS, V45, P994, DOI 10.2320/matertrans.45.994
   Zhang Y, 2004, J MATER SCI-MATER M, V15, P255, DOI 10.1023/B:JMSM.0000015485.94665.25
   Zhang Y, 2001, J NON-CRYST SOLIDS, V282, P159, DOI 10.1016/S0022-3093(01)00345-3
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
   Zhao L, 2004, J MATER SCI-MATER M, V15, P625, DOI 10.1023/B:JMSM.0000026103.44687.d0
NR 16
TC 1
Z9 1
U1 0
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2006
VL 514-516
BP 1005
EP 1009
DI 10.4028/www.scientific.net/MSF.514-516.1005
PN 1-2
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA BEL93
UT WOS:000238056400200
DA 2018-10-20
ER

PT S
AU Weinard, WR
   Goncalves, FFR
   Lima, WM
AF Weinard, W. R.
   Goncalves, F. F. R.
   Lima, W. M.
BE Salgado, L
   Filho, FA
TI Effect of sintering temperature in physical-mechanical behaviour and in
   titanium-hydroxyapatite composite sinterability
SO ADVANCED POWDER TECHNOLOGY V
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 5th International Latin American Conference on Powder Technology
CY OCT 26-29, 2005
CL Salvador, BRAZIL
SP Abbott, Basf, Brats, Bruker, Citra, Cofap, Combustol Metalpo, Dorst, Durit, Eckagranules, Engefor, GIG, Hoganas Brasil, Inco, Mahle Miba, Magneti Marelli, Metaldyne `, Mextra, QMP, Qualisinter, SCM, Shimadzu, Zoz
DE composite; biomaterial; sinterability; physical-mechanical property
AB Mechanical alloying (MA) has been successfully used to produce alloys and composites with a high homogeneity degree. In current research, titanium (Ti) powder was mixed with 40, 50% volume of hydroxyapatite (HAp). MA was performed without atmosphere control, at room temperature, for 4.5 hours of milling time at rotation speed of 300 rpm. Samples of material were compacted in cylindrical form at 350 MPa and sintered in 2.0 flux air (l/min) at 1000, 1100 and 1200 degrees C during I hr. The material's morphological and microstructural characterization, in powder form and in sintered material, was performed by scanning electronic microscope and X-ray diffractometry. Thermal treatments revealed that sintering temperature affects the microstructure, microhardness and the composition of the composites evaluated by EDS.
C1 [Weinard, W. R.; Lima, W. M.] Univ Estadual Maringa, Dept Phys, Av Colombo 5970, BR-87020900 Maringa, Parana, Brazil.
   [Goncalves, F. F. R.] Univ Estadual Maringa, Dept Engn Mech, BR-87020900 Maringa, Parana, Brazil.
RP Weinard, WR (reprint author), Univ Estadual Maringa, Dept Phys, Av Colombo 5970, BR-87020900 Maringa, Parana, Brazil.
EM walter@dfi.uem.br; wilson@dfi.uem.br
CR ANDRADE MC, 2002, J EUR CERAM SOC, V22, P505
   Chu CL, 1999, MAT SCI ENG A-STRUCT, V271, P95, DOI 10.1016/S0921-5093(99)00152-5
   DeGroot K., 1981, SCI CERAM, V11, P433
   Fu L, 2001, MAT SCI ENG A-STRUCT, V316, P46, DOI 10.1016/S0921-5093(01)01253-9
   KASUGA T, 1993, J MATER SCI-MATER M, V4, P36, DOI 10.1007/BF00122975
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   KLEIN CPAT, 1991, J BIOMED MATER RES, V25, P53, DOI 10.1002/jbm.820250105
   Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x
   LIMA WM, 2003, 4 INT LAT AM C POWD, P1238
   Miao X, 2003, MATER LETT, V57, P1848, DOI 10.1016/S0167-577X(02)01080-7
   *MPIF, 1986, 42 MPIF
   Ning CQ, 2002, BIOMATERIALS, V23, P2909, DOI 10.1016/S0142-9612(01)00419-7
   Rao RR, 1997, J MATER SCI-MATER M, V8, P511, DOI 10.1023/A:1018586412270
   Sridhar TM, 2003, CORROS SCI, V45, P2337, DOI 10.1016/S0010-938X(03)00063-5
   TAKAGI M, 1992, J MATER SCI-MATER M, V3, P199, DOI 10.1007/BF00713450
   Tester M, 1999, TRENDS PLANT SCI, V4, P5, DOI 10.1016/S1360-1385(98)01352-1
   Wang J, 2004, BIOMATERIALS, V25, P583, DOI 10.1016/S0142-9612(03)00559-3
   XIONG L, 2003, IN PRESS BIOMATERIAL
   YANG Y, 2003, IN PRESS BIOMATERIAL
NR 19
TC 1
Z9 1
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2006
VL 530-531
BP 249
EP +
DI 10.4028/www.scientific.net/MSF.530-531.249
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BFT13
UT WOS:000244481100040
DA 2018-10-20
ER

PT S
AU Hanawa, T
AF Hanawa, T
BE Umakoshi, Y
   Fujimoto, S
TI Recent development of new alloys for biomedical use
SO ADVANCED STRUCTURAL AND FUNCTIONAL MATERIALS DESIGN, PROCEEDINGS
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT International Symposium on Advanced Structural and Functional Materials
   Design
CY NOV 10-12, 2004
CL Osaka, JAPAN
SP 21st Century COE Program, Osaka Univ
DE alloy; biomaterial; titanium; stainless steel; shape memory alloy;
   surface modification; surface morphology
ID NITROGEN ABSORPTION TREATMENT; AUSTENITIC STAINLESS-STEEL;
   MECHANICAL-PROPERTIES; CORROSION BEHAVIOR; AMORPHOUS-ALLOYS
AB Metallic materials are widely used in medicine not only for orthopedic implants but also for cardiovascular devices and other purposes. New alloys for biomedical use are developed all over the world continuously to decrease corrosion, toxicity and fracture during implantation and increase interfacial and dynamical tissue compatibility. Most of efforts are made to develop titanium alloys, especially in P-type alloys whose Young's modulus is as low as cortical bone. Nickel-free alloy is also necessary to prevent nickel allergy: nickel-free austenitic stainless steels and shape memory alloys are developed. To increase biocompatibility, the controls of surface morphology and surface treatment or modification are necessary.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Met, Chiyoda Ku, Tokyo 1010062, Japan.
RP Hanawa, T (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Met, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM hanawa.met@tmd.ac.jp
CR Baker C., 1971, Metal Science Journal, V5, P92
   DUERIG TW, 1982, ACTA METALL MATER, V30, P2161, DOI 10.1016/0001-6160(82)90137-7
   Endo K., 1998, ZAIRYO TO KANKYO, V47, P570
   Gebeau RC, 2001, ADV MATER PROCESS, V159, P46
   Hiromoto S, 2001, MATER TRANS, V42, P656, DOI 10.2320/matertrans.42.656
   Hiromoto S, 2001, CORROS SCI, V43, P1767, DOI 10.1016/S0010-938X(00)00168-2
   Hosoda H, 2001, T MRS J, V26, P243
   Hosoda H, 2001, T MRS J, V26, P235
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   *JAP STAINL STEEL, 1995, SUT BINR, P491
   KATADA Y, 2001, J MAT PROCESS TECHNO, V117
   KATADA Y, 2000, CUR ADV MAT P, V13, P116
   KOLLEROV MY, 1995, TITANIUM 95 SCI TECH, P2571
   Kuroda D, 2003, MATER TRANS, V44, P1363, DOI 10.2320/matertrans.44.1363
   Kuroda D, 2003, MATER TRANS, V44, P414, DOI 10.2320/matertrans.44.414
   Kuroda D, 2002, MATER TRANS, V43, P3100, DOI 10.2320/matertrans.43.3100
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   MATSUSHITA T, 1999, MAT JAPAN, V38, P239
   Menzel J, 1996, ISIJ INT, V36, P893, DOI 10.2355/isijinternational.36.893
   Nitta K, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P25
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   SASANO H, 1988, P 6 WORLD C TIT, P1667
   Uggowitzer PJ, 1996, ISIJ INT, V36, P901, DOI 10.2355/isijinternational.36.901
NR 23
TC 18
Z9 18
U1 2
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-996-2
J9 MATER SCI FORUM
PY 2006
VL 512
BP 243
EP 248
DI 10.4028/www.scientific.net/MSF.512.243
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BEH28
UT WOS:000237250000042
DA 2018-10-20
ER

PT J
AU Cook, JL
   Fox, DB
   Malaviya, P
   Tomlinson, JL
   Kuroki, K
   Cook, CR
   Kladakis, S
AF Cook, JL
   Fox, DB
   Malaviya, P
   Tomlinson, JL
   Kuroki, K
   Cook, CR
   Kladakis, S
TI Long-term outcome for large meniscal defects treated with small
   intestinal submucosa in a dog model
SO AMERICAN JOURNAL OF SPORTS MEDICINE
LA English
DT Article; Proceedings Paper
CT 50th Annual Meeting of the Orthopaedic-Research-Society
CY MAR 07-10, 2004
CL San Francisco, CA
SP Orthopaed Res Soc
DE meniscus; small intestinal submucosa; meniscectomy; tissue engineering;
   dog
ID 5-YEAR FOLLOW-UP; ALLOGRAFT TRANSPLANTATION; CARTILAGE DEGENERATION;
   KNEE; MENISCECTOMY; REGENERATION; RECONSTRUCTION; REPLACEMENT;
   BIOMATERIAL; STABILITY
AB Background: Large meniscal defects are a common problem for which current treatment options are limited.
   Hypothesis: Treatment of posterior medial meniscal defects in dogs with small intestinal submucosa is superior to partial meniscectomy in terms of clinical limb function, chondroprotection, and amount and type of new tissue in the defect.
   Study Design: Controlled laboratory study.
   Methods: A total of 51 mongrel dogs underwent medial arthrotomy with creation of standardized meniscal defects. The dogs were divided into groups based on defect treatment: small intestinal submucosa meniscal implant (n = 29) or meniscectomy (n = 22). The dogs were assessed for lameness by subjective scoring after surgery and sacrificed at 3, 6, or 12 months and assessed for articular cartilage damage, gross and histologic appearance of the operated meniscus, amount of new tissue in the defect, equilibrium compressive modulus of meniscal tissue, and relative compressive stiffness of articular cartilage.
   Results: Dogs in the meniscectomy groups were significantly (P < .001) more lame than dogs treated with small intestinal submucosa. Joints treated with small intestinal submucosa had significantly (P < .001) less articular cartilage damage, based on india ink staining, than did those treated with meniscectomy. Menisci receiving small intestinal submucosa had more tissue filling in the defects than did menisci receiving no implants, and this new tissue was more mature and meniscus-like and better integrated with remaining meniscus.
   Conclusion: Small intestinal submucosa scaffolds placed in large meniscal defects resulted in production of meniscus-like replacement tissue, which was consistently superior to meniscectomy in amount, type, and integration of new tissue; chondroprotection; and limb function in the long term.
   Clinical Relevance: Small intestinal submucosa implants might be useful for treatment of large posterior vascular meniscal defects in humans.
C1 Univ Missouri, Comparat Orthopaed Lab, Columbia, MO 65211 USA.
   DePuy Orthopaed Inc, Indiana, PA USA.
   DePuy Biol, Raynham, MA USA.
RP Cook, JL (reprint author), Univ Missouri, Comparat Orthopaed Lab, 379 E Campus Dr, Columbia, MO 65211 USA.
EM cookjl@missouri.edu
OI Cook, James/0000-0002-0862-995X
CR Alhalki MM, 2000, AM J SPORT MED, V28, P370, DOI 10.1177/03635465000280031501
   Andersson-Molina H, 2002, ARTHROSCOPY, V18, P183, DOI 10.1053/jars.2002.30435
   Arnoczky amd S. P., 2000, ORTHOPAEDIC BASIC SC, P531
   Bonneux I, 2002, Acta Orthop Belg, V68, P356
   Cameron JC, 1997, CLIN ORTHOP RELAT R, P164
   Chatain F, 2001, KNEE SURG SPORT TR A, V9, P15, DOI 10.1007/s001670000146
   CICUTTINI FM, 2002, J RHEUMATOL, V29, P1809
   Cook J.L., 2003, T ORTHOP RES SOC, V28, P967
   Cook J.L., 2001, T ORTHOP RES SOC, V26, P599
   Cook James L, 2004, J Knee Surg, V17, P99
   Cook JL, 2001, TISSUE ENG, V7, P321, DOI 10.1089/10763270152044189
   Cook JL, 1999, AM J SPORT MED, V27, P658, DOI 10.1177/03635465990270051901
   Englund M, 2001, RHEUMATOLOGY, V40, P631, DOI 10.1093/rheumatology/40.6.631
   Favenesi J.A., 1983, T ORTHOP RES SOC, V8, P57
   FITHIAN DC, 1990, CLIN ORTHOP RELAT R, P19
   Fox DB, 2004, TISSUE ENG, V10, P129, DOI 10.1089/107632704322791772
   FOX DB, 2003, T ORTHOP RES SOC, V28, P981
   GARRETT J C, 1991, Arthroscopy, V7, P57, DOI 10.1016/0749-8063(91)90079-D
   Garrett JC, 1993, SPORTS MED ARTHROSC, V2, P164
   Gastel JA, 2001, ARTHROSCOPY, V17, P151, DOI 10.1053/jars.2001.20959
   Laasanen MS, 2003, J BONE JOINT SURG AM, V85A, P78, DOI 10.2106/00004623-200300002-00010
   LEVY IM, 1989, J BONE JOINT SURG AM, V71A, P401, DOI 10.2106/00004623-198971030-00014
   Lyyra-Laitinen T, 1999, PHYS MED BIOL, V44, P2511, DOI 10.1088/0031-9155/44/10/310
   Noone TJ, 2002, AM J VET RES, V63, P419, DOI 10.2460/ajvr.2002.63.419
   Paletta GA, 1997, AM J SPORT MED, V25, P692, DOI 10.1177/036354659702500519
   Rath E, 2001, AM J SPORT MED, V29, P410, DOI 10.1177/03635465010290040401
   RODKEY WG, 1999, CLIN ORTHOP S, V367, P281
   Seedhom B. B., 1979, Engineering in Medicine, V8, P220
   Stollsteimer GT, 2000, ARTHROSCOPY, V16, P343, DOI 10.1016/S0749-8063(00)90077-X
   Stone KR, 1997, J BONE JOINT SURG AM, V79A, P1770, DOI 10.2106/00004623-199712000-00002
   Szomor ZL, 2000, J BONE JOINT SURG AM, V82A, P80, DOI 10.2106/00004623-200001000-00010
   van Tienen TG, 2003, OSTEOARTHR CARTILAGE, V11, P78, DOI 10.1053/joca.2002.0870
   VANARKEL ERA, 1995, J BONE JOINT SURG BR, V77B, P589
   WALKER PS, 1975, CLIN ORTHOP RELAT R, P184
   Wu WH, 2002, AM J SPORT MED, V30, P845, DOI 10.1177/03635465020300061501
   Wyland DJ, 2002, J ORTHOP RES, V20, P996, DOI 10.1016/S0736-0266(02)00022-0
   2003, MED DATA INT DATABAS
NR 37
TC 71
Z9 79
U1 1
U2 9
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0363-5465
J9 AM J SPORT MED
JI Am. J. Sports Med.
PD JAN
PY 2006
VL 34
IS 1
BP 32
EP 42
DI 10.1177/0363546505278702
PG 11
WC Orthopedics; Sport Sciences
SC Orthopedics; Sport Sciences
GA 999HQ
UT WOS:000234380800005
PM 16157845
DA 2018-10-20
ER

PT J
AU Chung, TW
   Wang, YZ
   Huang, YY
   Pan, CI
   Wang, SS
AF Chung, TW
   Wang, YZ
   Huang, YY
   Pan, CI
   Wang, SS
TI Poly (epsilon-caprolactone) grafted with nano-structured chitosan
   enhances growth of human dermal fibroblasts
SO ARTIFICIAL ORGANS
LA English
DT Article
DE nano-structured bioactive surface; chitosan; cell growth; tissue
   engineering
ID HUMAN ENDOTHELIAL-CELLS; SURFACE-ROUGHNESS; NANOMETER-SCALE; IN-VITRO;
   ADHESION; DIFFERENTIATION; PROLIFERATION; TOPOGRAPHY; FEATURES; SCAFFOLD
AB Polyester films are modified with their bioactivity for tissue engineering by grafting a nano-structured bioactive material, nano-structured chitosan (nano-CS), on a model polymer, poly (epsilon-caprolactone) (PCL). The nano-CS was duplicated using a solvent-etched PCL mold and then grafted onto PCL using a selected solvent. The structure of the nano-CS/PCL surface was characterized using an atomic force microscope to observe the topography and determine the roughness. The centerline average roughness, Ra, of the surface of the nano-CS/PCL film is 106.0 +/- 4.0 nm whereas that of the surface of the CS-grafted PCL film (CS/PCL) is 3.6 +/- 0.4 nm. The latter is therefore very smooth. CS is known to swell following hydration, so the Ra values were determined again after immersion for 12 h in phosphate buffered saline. Although the centerline average roughness of the nano-CS/PCL was lower, it still markedly exceeded that of the CS/PCL film. Cells grown on nano-CS/PCL, CS/PCL, nano-structured PCL (nano-PCL), and PCL films were observed by fluorescent staining and analyzed by MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) viability assay following 3 and 7 days of culture, to evaluate the effects of the design on the growth of fibroblasts. The viability assay of the cells reveals that the growth rate of cells on both CS/PCL and nano-CS/PCL films significantly exceeds (P < 0.001) those of PCL and nano-PCL films on both cultural days. Additionally, the growth rate and proliferation of fibroblasts on nano-CS/PCL films significantly exceed (P < 0.001) those on CS/PCL films after both periods of culturing, suggesting that the bioactive surface following a nano-structured treatment promotes the growth rate of cells. However, nano-PCL films do not have the same effects as nano-CS/PCL films do. In conclusion, a novel biomaterial, nano-CS/PCL, is developed by grafting a nano-structured bioactive surface, CS, onto the PCL surface to promote the the growth rate of fibroblasts. This work elucidates a new concept for designing films or scaffolds for tissue engineering-the grafting of nano-structured bioactive biomaterials to the films or scaffolds to promote the growth of cells.
C1 Natl Yunlin Univ Sci & Technol, Dept Chem Engn, Douliou, Yunlin, Taiwan.
   Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.
   Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan.
RP Chung, TW (reprint author), Natl Yunlin Univ Sci & Technol, Dept Chem Engn, Sect 3,123 Univ Rd, Douliou, Yunlin, Taiwan.
EM twchung@yuntech.edu.tw
CR Aiedeh K, 1997, J MICROENCAPSUL, V14, P567, DOI 10.3109/02652049709006810
   Breitbart AS, 1998, PLAST RECONSTR SURG, V101, P567, DOI 10.1097/00006534-199803000-00001
   Calvert JW, 2000, J BIOMED MATER RES, V52, P279, DOI 10.1002/1097-4636(200011)52:2<279::AID-JBM6>3.0.CO;2-8
   CHIOU SH, 2001, J MICROENCAPSUL, V18, P603
   Chuang WY, 1999, BIOMATERIALS, V20, P1479, DOI 10.1016/S0142-9612(99)00054-X
   Chung TW, 2003, BIOMATERIALS, V24, P4655, DOI 10.1016/S0142-9612(03)00361-1
   Chung TW, 2005, J BIOMED MATER RES A, V72A, P213, DOI 10.1002/jbm.a.30225
   CHUNG TW, 2003, ARTIF ORGANS, V27, P154
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E
   Han DK, 1996, MACROMOLECULES, V29, P5233, DOI 10.1021/ma9601070
   Hao JY, 2003, BIOMATERIALS, V24, P1531, DOI 10.1016/S0142-9612(02)00516-1
   HOCH HC, 1987, SCIENCE, V235, P1659, DOI 10.1126/science.235.4796.1659
   HOOGENBOOM LAP, 1997, TOXICOLOGY, V11, P385
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kratz G, 1997, SCAND J PLAST RECONS, V31, P119, DOI 10.3109/02844319709085478
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lanza R, 2000, PRINCIPLES TISSUE EN
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Sung HW, 1999, J BIOMED MATER RES, V46, P520
   Sung HW, 1998, J BIOMED MATER RES, V42, P560, DOI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
   Thapa A, 2003, J BIOMED MATER RES A, V67A, P1374, DOI 10.1002/jbm.a.20037
   Ural E, 2000, BIOMATERIALS, V21, P2147, DOI 10.1016/S0142-9612(00)00098-3
   Vance RJ, 2004, BIOMATERIALS, V25, P2095, DOI 10.1016/j.biomaterials.2003.08.064
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Yagi K, 1997, BIOL PHARM BULL, V20, P1290
   Yamazaki M, 2004, EUR J PHARMACOL, V488, P35, DOI 10.1016/j.ejphar.2004.02.009
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
NR 30
TC 31
Z9 34
U1 0
U2 12
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD JAN
PY 2006
VL 30
IS 1
BP 35
EP 41
DI 10.1111/j.1525-1594.2006.00178.x
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 995FJ
UT WOS:000234085900008
PM 16409396
DA 2018-10-20
ER

PT J
AU Martin, E
   Manceur, A
   Polizu, S
   Savadogo, O
   Wu, MH
   Yahia, L
AF Martin, E
   Manceur, A
   Polizu, S
   Savadogo, O
   Wu, MH
   Yahia, L
TI Corrosion behaviour of a beta-titanium alloy
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE beta-titanium; corrosion; cyclic polarization; surface characterization;
   biocompatibility
ID MECHANICAL-PROPERTIES; MICROSTRUCTURE; BIOMATERIALS; MARTENSITE;
   RESISTANCE
AB The beta-titanium alloy, a particular type of titanium, has been investigated as a biomaterial because of its good mechanical performances and its high corrosion resistance and biocompatibility. This work focuses on the corrosion performance of a beta-titanium alloy of composition Ti-11Mo-2V-4Nb-3Al in Hank's physiological solution. Potentiodynamic tests were performed from -0.25 V to 3.5 V; the breakdown potential was not reached. To observe the behaviour of the alloy while submitted to long-term aggressive conditions, 1, 4 and 8 cycles of cyclic polarization were carried out. Results show a high resistance of the alloy to corrosion and a stabilization of the surface after several corrosion cycles. Pitting was not observed and a fast ability of the surface to repassivate was noticed. The surface was characterized by different techniques before and after corrosion testing. Following the corrosion tests, X-ray Photoelectron Spectroscopy (XPS) showed the presence of calcium and phosphorus, an increase of the oxide layer was measured by Auger Electron Spectroscopy (AES), a relatively smooth surface was visualised by Scanning Electron Microscopy (SEM) and contact-angle measurements showed that the surface energy increased.
C1 Ecole Polytech, Dept Mech Engn, Biomech & Biomat Res Grp, Montreal, PQ H3C 3A7, Canada.
   Ecole Polytech, Lab Electrochim & Mat Energet, Montreal, PQ H3C 3A7, Canada.
   Memry Corp, Bethel, CT 06801 USA.
RP Yahia, L (reprint author), Ecole Polytech, Dept Mech Engn, Biomech & Biomat Res Grp, POB 6079,Stn Ctr Ville,Succ Cv, Montreal, PQ H3C 3A7, Canada.
EM yahia@grbb.polymtl.ca
CR Akahori T, 2000, METALL MATER TRANS A, V31, P1949, DOI 10.1007/s11661-000-0222-z
   *AM STAND TEST MAT, 1994, G5 ASTM
   *ASTM, 2001, F2129 ASTM
   Black J., 1998, HDB BIOMATERIAL PROP
   BUNDY KJ, 1994, CRIT REV BIOMED ENG, V22, P139
   EYLON D, 1994, JOM, P14
   FRIBERG L, 1986, HDB TOXICOLOGY METAL
   Gilbert JL, 1996, ASTM STP, V1272, P199
   GOLDBERG J, 1979, J DENT RES, V58, P593, DOI 10.1177/00220345790580020901
   Grosdidier T, 2000, MAT SCI ENG A-STRUCT, V291, P218, DOI 10.1016/S0921-5093(00)00921-7
   Hanawa T, 1998, J BIOMED MATER RES, V40, P530, DOI 10.1002/(SICI)1097-4636(19980615)40:4<530::AID-JBM3>3.0.CO;2-G
   HOAR TP, 1966, PROC R SOC LON SER-A, V294, P486, DOI 10.1098/rspa.1966.0220
   HUANG X, 1994, J MATER ENG PERFORM, V3, P560, DOI 10.1007/BF02645322
   Jha SK, 2000, JOM-J MIN MET MAT S, V52, P30, DOI 10.1007/s11837-000-0097-x
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   Kim TI, 1997, BIO-MED MATER ENG, V7, P253
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Lee HC, 2001, ELECTROCHEM SOLID ST, V4, pB31, DOI 10.1149/1.1399875
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Marcus P., 1995, CORROSION MECH THEOR
   NIINOMI GM, 2002, ISIJ INT, V42, P191
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   SCHUTZ RW, 1989, METALS HDB
   SCHUTZ W, 1994, JOM, P24
   Scully J. C, 1990, FUNDAMENTALS CORROSI
   Sun QY, 2002, J MATER SCI, V37, P2543, DOI 10.1023/A:1015456026919
   TENGVALL P, 2001, PROTEINS TITANIUM IN, P457
   West J. M., 1980, BASIC CORROSION OXID
   Zardiackas L. D., 1996, MED APPL TITANIUM IT, P60
NR 30
TC 4
Z9 4
U1 0
U2 3
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2006
VL 16
IS 3
BP 171
EP 182
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 016ZY
UT WOS:000235665100002
PM 16518016
DA 2018-10-20
ER

PT J
AU Leung, TK
   Chang, CP
   Lee, CM
   Shen, LK
AF Leung, TK
   Chang, CP
   Lee, CM
   Shen, LK
TI Retrospective study of the total insertion period of peripherally
   inserted central catheter: Discussion of anti-thrombogenic surface and
   other biomaterial requirements
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE PICC insertion; thrombocytopenia; anti-thrombogenic; clinical;
   silicone-rubber; biomaterials; intravenous cannulation; polyurethane;
   surface coating
ID IN-VITRO; COMPLICATION RATES
AB A retrospective study of patients' records on reviewing the purpose of venous catheter insertion (chemotherapy, blood transfusion, antibiotics or parenteral nutrition); total period of insertion; reason for catheter removal. 120 admitted patients who received fluoroscopic guide PICC (4-French single lumen silicone rubber catheter) insertions into distal SVC via antecubital region of forearm. We retrospectively review human factors including the patients' laboratory data of pre- and post-insertion, total insertion period and reasons for withdrawal. The important human factors that affect the clinical outcome of PICC were also evaluated. The results indicated that the most common complications were wound oozing, phlebitis, occlusion, infection and leaking. Persistent wound oozing for over 3-day-period is the higher incidence of complication. It also demonstrated a surprisingly high ratio (> 77%) in those patients with thrombocytopenia and leukemia. In this group, persistent low platelet counts could be noted, the ratio of failure (remove PICC within 3 days) is 10% and there is 40% decrease insertion period (< 30 days). Prospectively, it is worthwhile to choose new material or new technology of surface coating of PICC, to decrease consumption of platelet thrombogenic proteins and to maintain normal coagulate function of human bodies.
C1 Chinese Culture Univ, Fac Engn, Dept Text Engn, Taipei 11192, Taiwan.
   Taipei Med Univ, Taipei Med Univ Hosp, Dept Diagnost Radiol, Taipei, Taiwan.
RP Chang, CP (reprint author), Chinese Culture Univ, Fac Engn, Dept Text Engn, Shihlin Dist, Taipei 11192, Taiwan.
EM yyrubber2002@yahoo.com.tw
CR ANIL S, 2002, INDIAN PEDIATR, V39, P752
   Chu SY, 2004, CHIN J RADIOL, V29, P61
   Dadsetan M, 2001, J BIOMED MATER RES, V54, P540
   Duerksen DR, 1999, JPEN-PARENTER ENTER, V23, P85, DOI 10.1177/014860719902300285
   GRAHAM DR, 1991, AM J MED S3B, V91, P95
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P87, DOI 10.1002/jbm.820231309
   HECKER JF, 1985, J BIOMED MATER RES, V19, P381, DOI 10.1002/jbm.820190404
   Hietala EM, 2003, J BIOMED MATER RES A, V67A, P785, DOI 10.1002/jbm.a.10154
   Marosok R, 1996, J BIOMED MATER RES, V30, P245
   Meyer-Plath AA, 2003, VACUUM, V71, P391, DOI 10.1016/S0042-207X(02)00766-2
   Mirzadeh H, 2003, J BIOMED MATER RES A, V67A, P727, DOI 10.1002/jbm.a.10107
   Racadio JM, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.2.e28
   RANCHERE J Y, 1988, Annales Francaises d'Anesthesie et de Reanimation, V7, P517, DOI 10.1016/S0750-7658(88)80093-5
   Tessier PY, 2003, DIAM RELAT MATER, V12, P1066, DOI 10.1016/S0925-9635(02)00314-X
   Walshe LJ, 2002, J CLIN ONCOL, V20, P3276, DOI 10.1200/JCO.2002.11.135
   YEOW KM, 1999, CHIN J RADIOL, V24, P61
   YUAN C, 2004, POLYM INT, P62
   Zhu AL, 2004, WORLD J GASTROENTERO, V10, P1659, DOI 10.3748/wjg.v10.i11.1659
NR 18
TC 3
Z9 4
U1 0
U2 4
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2006
VL 16
IS 3
BP 183
EP 188
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 016ZY
UT WOS:000235665100003
PM 16518017
DA 2018-10-20
ER

PT J
AU Chu, CL
   Xue, XY
   Zhu, JC
   Yin, ZD
AF Chu, CL
   Xue, XY
   Zhu, JC
   Yin, ZD
TI In vivo study on biocompatibility and bonding strength of
   hydroxyapatite-20vol%Ti composite with bone tissues in the rabbit
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE hydroxyapatite composite; titanium; biocompatibility; osseointegration
ID SPRAYED HYDROXYAPATITE COATINGS; BIOLOGICAL-PROPERTIES;
   MECHANICAL-PROPERTIES; CONTROLLED POROSITY; REPLACEMENT; PARTICLES;
   BIOMATERIALS; BIOCERAMICS; FABRICATION; ADDITIVES
AB Biocompatibility and bonding strength of hydroxyapatite-20vol%Ti composite fabricated by hot-pressing technique with bone tissues in the rabbit were investigated by in vivo studies in comparison with those of Ti metal and dense HA ceramic. Although fibrous tissues formed at the interface between the composite and bone tissues at 3 weeks in vivo, bonding strength of the composite increases faster than that of dense HA after 4 weeks. At 3 months in vivo, bonding strength of the composite is higher than that of dense HA and exceeds 6.5 MPa. Moreover, as compared with the visible bonding interfaces between dense HA and new bones, the bonding interfaces for the composite cannot already be distinguished and the composite was osseointegrated fully with bone tissues into one bony body. The shear fracture of bonding strength test for the composite occurred in new bone zones near the interface, which indicates that bonding strength of the composite could even exceed the shear strength of new bones after 3 months in vivo. In conclusion, HA-Ti composite has better osteoconduction and osseointegration abilities than Ti metal and dense HA ceramic after 3 months in vivo and is a promising biomaterial for hard tissue replacement.
C1 SE Univ, Dept Mat Sci & Engn, Nanjing 210018, Peoples R China.
   SE Univ, Zhong Da Hosp, Gen Med Ctr, Nanjing 210009, Peoples R China.
   Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Peoples R China.
RP Chu, CL (reprint author), SE Univ, Dept Mat Sci & Engn, Si Pai Lou 2, Nanjing 210018, Peoples R China.
EM clchu@seu.edu.cn
RI Zhu, Jingchuan/B-3573-2018
OI Zhu, Jingchuan/0000-0002-6075-2373
CR AOKI H, 1991, SCI MED APPL HYDROXY
   ARITA IH, 1995, J MATER SCI-MATER M, V6, P19, DOI 10.1007/BF00121241
   BIRCHALL JD, 1988, J MATER SCI LETT, V7, P350, DOI 10.1007/BF01730738
   BONFIELD W, 1988, BIOCERAMICS MATERIAL, V523, P173
   CHAKI TK, 1994, J MATER SCI-MATER M, V5, P533, DOI 10.1007/BF00124886
   Chu C, 2002, J MATER SCI-MATER M, V13, P985, DOI 10.1023/A:1019873015772
   Chu CL, 2004, J MATER SCI-MATER M, V15, P665, DOI 10.1023/B:JMSM.0000030207.16887.f2
   DEWITH G, 1981, J MATER SCI, V16, P1592
   DEWITH G, 1989, J MATER SCI, V24, P3411, DOI 10.1007/BF01139073
   FRAYSSINET P, 1994, J MATER SCI-MATER M, V5, P11, DOI 10.1007/BF00121147
   Ha SW, 1998, J AM CERAM SOC, V81, P81
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   JI HX, 1993, J MATER SCI, V28, P1941, DOI 10.1007/BF00595767
   Liu DM, 1997, J MATER SCI-MATER M, V8, P227, DOI 10.1023/A:1018591724140
   MOSSMAN BT, 1990, SCIENCE, V247, P294, DOI 10.1126/science.2153315
   Raynaud S, 1998, J MATER SCI-MATER M, V9, P221, DOI 10.1023/A:1008840308094
   RUYS AJ, 1995, J MATER SCI-MATER M, V6, P297, DOI 10.1007/BF00120274
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Suchanek W, 1997, J AM CERAM SOC, V80, P2805, DOI 10.1111/j.1151-2916.1997.tb03197.x
   TAKAGI M, 1992, J MATER SCI-MATER M, V3, P199, DOI 10.1007/BF00713450
   Tampieri A, 1997, J MATER SCI-MATER M, V8, P29, DOI 10.1023/A:1018538212328
   Van N. R., 1987, J MATER RES, V22, P3801
   WANG BC, 1993, SURF COAT TECH, V58, P107, DOI 10.1016/0257-8972(93)90181-M
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   WILLIAMS DF, 1987, MATER SCI TECH-LOND, V3, P797, DOI 10.1179/mst.1987.3.10.797
   WU JM, 1988, J MATER SCI, V23, P3771, DOI 10.1007/BF00540526
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   Zhang X, 1997, J MATER SCI, V32, P235, DOI 10.1023/A:1018568308926
NR 28
TC 6
Z9 9
U1 0
U2 5
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2006
VL 16
IS 3
BP 203
EP 213
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 016ZY
UT WOS:000235665100005
PM 16518019
DA 2018-10-20
ER

PT J
AU Amedee, J
   Guillotin, B
   Pallu, S
   Bareille, R
   Guignandon, A
   Bourget, C
   Durrieu, MC
   Bordenave, L
AF Amedee, J
   Guillotin, B
   Pallu, S
   Bareille, R
   Guignandon, A
   Bourget, C
   Durrieu, MC
   Bordenave, L
TI Functionalization of biomaterials and cell to cell communication
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT Conference on Cell and Tissue Bioengineering and Teraphy
CY MAY 10-11, 2005
CL Nancy, FRANCE
ID HUMAN OSTEOPROGENITOR CELLS; TISSUE-ENGINEERED BONE; ENDOTHELIAL-CELLS;
   TITANIUM IMPLANTS; STEM-CELLS; DIFFERENTIATION; ADHESION; GROWTH;
   OSTEOBLASTS; EXPRESSION
AB In the field of osseous substitution, the possibilities being offered to the surgeons prove sometimes difficult to apply in particular in the case of great losses of osseous substance. For these reasons, it is necessary to develop innovative techniques to satisfy the request increasing for substitutes and to see appearing on the market solutions combining availability, perenniality and biosecurity of the implants. The implantation of stem cells in a biomaterial opens a way of development of therapeutic substitute. Moreover, in order to optimize the rehabitation of the biomaterials by the cells and the host tissues, the second approach consists in modifying the surface of materials by the coating or the grafting of adhesive factors in order to stimulate their colonization. At least, one cannot consider a tissue mechanism of repair without a better knowledge of the respective role of the various cell populations implied in the rebuilding of this tissue and their cell to cell communication processes.
C1 Univ Victor Segalen Bordeaux 2, INSERM, U577, F-33076 Bordeaux, France.
RP Amedee, J (reprint author), Univ Victor Segalen Bordeaux 2, INSERM, U577, F-33076 Bordeaux, France.
EM joelle.amedee@bordeaux.inserm.fr
RI VILAMITJANA AMEDEE, Joelle/F-3369-2013; DURRIEU,
   Marie-Christine/I-4358-2016
OI DURRIEU, Marie-Christine/0000-0003-0583-9289
CR Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Baquey C, 1988, ORGANES ARTIFICIELS
   Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6
   DECKER B, 1995, ANAT REC, V242, P310, DOI 10.1002/ar.1092420304
   Elisseeff JH, 2004, TRENDS BIOTECHNOL, V22, P155, DOI 10.1016/j.tibtech.2004.02.006
   FERNANDEZ P, 2005, IN PRESS TISSUE ENG
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Gauvreau V, 2005, BIOCONJUGATE CHEM, V16, P1088, DOI 10.1021/bc049717s
   Gramsch B, 2001, EXP CELL RES, V264, P397, DOI 10.1006/excr.2000.5145
   Guillotin B, 2004, CELL PHYSIOL BIOCHEM, V14, P325, DOI 10.1159/000080342
   Kilian O, 2005, GROWTH FACTORS, V23, P125, DOI 10.1080/08977190500126306
   Mauney JR, 2005, TISSUE ENG, V11, P787, DOI 10.1089/ten.2005.11.787
   Meinhart JG, 2005, TISSUE ENG, V11, P887, DOI 10.1089/ten.2005.11.887
   Orban JM, 2002, TISSUE ENG, V8, P529, DOI 10.1089/107632702760240454
   Pallu S, 2005, BIOMATERIALS, V26, P6932, DOI 10.1016/j.biomaterials.2005.04.054
   Pallu S, 2003, PEPTIDES, V24, P1349, DOI 10.1016/j.peptides.2003.09.003
   Pelissier P, 2003, PLAST RECONSTR SURG, V111, P1932, DOI 10.1097/01.PRS.0000055044.14093.EA
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Porte-Durrieu MC, 2004, BIOMATERIALS, V25, P4837, DOI 10.1016/j.biomaterials.2003.11.037
   POTHUAUD L, 2005, BIOMATERIALS
   Schliephake H, 2002, CLIN ORAL IMPLAN RES, V13, P312, DOI 10.1034/j.1600-0501.2002.130312.x
   Schliephake H, 2005, J BIOMED MATER RES B, V73B, P88, DOI 10.1002/jbm.b.30183
   Stahl A, 2004, BIOCHEM BIOPH RES CO, V322, P684, DOI 10.1016/j.bbrc.2004.07.175
   Suda T, 2001, Novartis Found Symp, V232, P235
   Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345
   Verrier S, 2002, BIOMATERIALS, V23, P585, DOI 10.1016/S0142-9612(01)00145-4
   VILAMITJANAAMEDEE J, 1993, IN VITRO CELL DEV-AN, V29, P699
   Villars F, 2000, J CELL BIOCHEM, V79, P672, DOI 10.1002/1097-4644(20001215)79:4<672::AID-JCB150>3.0.CO;2-2
   Villars F, 2002, AM J PHYSIOL-CELL PH, V282, pC775, DOI 10.1152/ajpcell.00310.2001
   Wang DS, 1997, ENDOCRINOLOGY, V138, P2953, DOI 10.1210/en.138.7.2953
NR 30
TC 0
Z9 0
U1 0
U2 3
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2006
VL 16
IS 4
SU S
BP S53
EP S60
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 057EZ
UT WOS:000238580400005
PM 16823113
DA 2018-10-20
ER

PT J
AU Vinatier, C
   Guicheux, J
   Daculsi, G
   Layrolle, P
   Weiss, P
AF Vinatier, C
   Guicheux, J
   Daculsi, G
   Layrolle, P
   Weiss, P
TI Cartilage and bone tissue engineering using hydrogels
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT Conference on Cell and Tissue Bioengineering and Teraphy
CY MAY 10-11, 2005
CL Nancy, FRANCE
ID CALCIUM-PHOSPHATE BIOMATERIAL; ARTICULAR-CARTILAGE; HYDROXYPROPYL
   METHYLCELLULOSE; 3-DIMENSIONAL CULTURE; GENERAL-PROPERTIES; CELL
   ATTACHMENT; REPAIR; CHONDROCYTES; ALGINATE; MATRIX
AB Tissue engineering is an emerging field of regenerative medicine which holds promise for the restoration of tissues and organs affected by chronic diseases, age-linked degeneration, congenital deformity and trauma. During the past decade, tissue engineering has evolved from the use of naked biomaterials, which may just replace small area of damaged tissue, to the use of controlled three-dimensional scaffolds in which cells can be seeded before implantation. These cellularized constructs aims at being functionally equal to the unaffected tissue and could make possible the regeneration of large tissue defects. Among the recently developed scaffolds for tissue engineering, polymeric hydrogels have proven satisfactory in cartilage and bone repair. Major technological progress and advances in basic knowledge (physiology and developmental biology) are today necessary to bring this proof of concept to clinical reality. The present review focuses on the recent advances in hydrogel-based tissue engineered constructs potentially utilizable in bone and cartilage regenerative medicine.
C1 INSERM 791, Nantes, France.
   Univ Nantes, Fac Chirurg Dentaire, F-44042 Nantes, France.
RP Guicheux, J (reprint author), INSERM 791, Nantes, France.
EM jerome.guicheux@nantes.inserm.fr
RI guicheux, Jerome/F-7767-2013; Daculsi, Guy/P-1320-2014; Layrolle,
   Pierre/K-9257-2015; Vinatier, Claire/P-1686-2014; Weiss,
   Pierre/P-1372-2014
OI guicheux, Jerome/0000-0003-2754-3024; Daculsi, Guy/0000-0003-1030-3446;
   Layrolle, Pierre/0000-0001-9800-5210; Vinatier,
   Claire/0000-0002-6063-9901; Weiss, Pierre/0000-0002-6159-8590
CR Bagnaninchi PO, 2003, BIOTECHNOL BIOENG, V84, P343, DOI 10.1002/bit.10770
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   Bourges X, 2002, BIOPOLYMERS, V63, P232, DOI 10.1002/bip.10053
   Bourges X, 2002, ADV COLLOID INTERFAC, V99, P215, DOI 10.1016/S0001-8686(02)00035-0
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buckwalter JA, 1998, J ORTHOP SPORT PHYS, V28, P192, DOI 10.2519/jospt.1998.28.4.192
   Chaipinyo K, 2002, J ORTHOPAED RES, V20, P1070, DOI 10.1016/S0736-0266(02)00025-6
   Cohen SB, 2003, BIOMATERIALS, V24, P2653, DOI 10.1016/S0142-9612(03)00058-9
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   de Groot K, 1983, BIOCERAMICS CALCIUM
   DELECRIN J, 1994, CELL MATER, V4, P51
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Galois L, 2004, BIORHEOLOGY, V41, P433
   Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   Hacker M, 2003, BIOMATERIALS, V24, P4459, DOI 10.1016/S0142-9612(03)00346-6
   Hou QP, 2004, J MATER CHEM, V14, P1915, DOI 10.1039/b401791a
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   KAEMMERLEN P, 1989, NEW ENGL J MED, V321, P121
   Kafienah W, 2002, TISSUE ENG, V8, P817, DOI 10.1089/10763270260424178
   LAPKOWSKI M, 1995, Patent No. 97059110
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   MAGNE D, 2005, IN PRESS TRENDS MOL
   MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P460, DOI 10.2106/00004623-198264030-00022
   Marijnissen WJCM, 2002, BIOMATERIALS, V23, P1511, DOI 10.1016/S0142-9612(01)00281-2
   Nguyen H, 2003, BIOCHEM BIOPH RES CO, V311, P179, DOI 10.1016/j.bbrc.2003.09.192
   Passaretti D, 2001, TISSUE ENG, V7, P805, DOI 10.1089/107632701753337744
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   Pavesio A., 2003, NOVART FDN SYMP, V249, P234
   Pavesio A., 2003, NOVART FDN SYMP, V249, P239
   Pavesio A., 2003, NOVART FDN SYMP, V249, P229
   Pavesio Alessandra, 2003, Novartis Found Symp, V249, P203
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Ren L, 2002, BIOMATERIALS, V23, P4765, DOI 10.1016/S0142-9612(02)00226-0
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Schneider GB, 2004, BIOMATERIALS, V25, P3023, DOI 10.1016/j.biomaterials.2003.09.084
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Toquet J, 1999, J BIOMED MATER RES, V44, P98, DOI 10.1002/(SICI)1097-4636(199901)44:1<98::AID-JBM11>3.0.CO;2-P
   Trojani C, 2005, BIOMATERIALS, V26, P5509, DOI 10.1016/j.biomaterials.2005.02.001
   Vangsness C Thomas Jr, 2004, Am J Orthop (Belle Mead NJ), V33, P29
   Verrier S, 2002, BIOMATERIALS, V23, P585, DOI 10.1016/S0142-9612(01)00145-4
   Vinatier C, 2005, BIOMATERIALS, V26, P6643, DOI 10.1016/j.biomaterials.2005.04.057
   VINATIER C, UNPUB OSTEOARTHRITIS
   Weiss P, 2004, KEY ENG MATER, V254-2, P1107, DOI 10.4028/www.scientific.net/KEM.254-256.1107
   Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1
   Williams JM, 2003, J ORTHOPAED RES, V21, P305, DOI 10.1016/S0736-0266(02)00156-0
NR 49
TC 55
Z9 57
U1 0
U2 16
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2006
VL 16
IS 4
SU S
BP S107
EP S113
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 057EZ
UT WOS:000238580400010
PM 16823101
DA 2018-10-20
ER

PT J
AU Ohdan, K
   Fujii, K
   Yanase, M
   Takaha, T
   Kuriki, T
AF Ohdan, Kohji
   Fujii, Kazutoshi
   Yanase, Michiyo
   Takaha, Takeshi
   Kuriki, Takashi
TI Enzymatic synthesis of amylose
SO BIOCATALYSIS AND BIOTRANSFORMATION
LA English
DT Article; Proceedings Paper
CT 6th Carbohydrate Bioengineering Meeting
CY APR 03-06, 2005
CL Barcelona, SPAIN
DE amylose; cellobiose phosphorylase; glucan phosphorylase; sucrose
   phosphorylase
ID BACILLUS-STEAROTHERMOPHILUS; PSEUDOMONAS ISOAMYLASE; PHOSPHORYLASE;
   AMYLOSUCRASE; HYDROLYSIS; GLYCOGEN
AB Amylose is a linear polymer of alpha-1,4-linked glucose and is expected to be used in various industries as a functional biomaterial. However, pure amylose is currently not available for industrial purposes, since the separation of natural amylose from amylopectin is difficult. It is known that amylose has been synthesized using various enzymes. Glucan phosphorylase, together with its substrate, glucose-1-phosphate, is the most suitable system for the production of amylose since the molecular size of amylose can be controlled precisely. However, the problem with this system is that glucose-1-phosphate is too expensive for industrial purposes. This review summarizes our work on the enzymatic synthesis of essentially linear amylose, together with recent progress in the production of synthetic amylose using sucrose or cellobiose through the combined actions of phosphorylases.
C1 Ezaki Glico Co Ltd, Biochem Res Lab, Osaka 5558502, Japan.
RP Ohdan, K (reprint author), Ezaki Glico Co Ltd, Biochem Res Lab, 4-6-5 Utajima, Osaka 5558502, Japan.
EM odan-kouji@glico.co.jp
CR AKAI H, 1971, BIOCHIM BIOPHYS ACTA, V237, P422, DOI 10.1016/0304-4165(71)90259-5
   Albenne C, 2004, J BIOL CHEM, V279, P726, DOI 10.1074/jbc.M309891200
   Becker M, 2002, BIOTECHNOL PROGR, V18, P964, DOI 10.1021/bp020013b
   FUJII K, 2006, J APPL GLYCOSCI, V21, P167
   GIDLEY MJ, 1989, MACROMOLECULES, V22, P341, DOI 10.1021/ma00191a062
   HARADA T, 1972, BIOCHIM BIOPHYS ACTA, V268, P497, DOI 10.1016/0005-2744(72)90345-2
   HEHRE EJ, 1949, J BIOL CHEM, V177, P289
   Kim YK, 2002, J BIOCHEM, V132, P197, DOI 10.1093/oxfordjournals.jbchem.a003210
   KITAMURA S, 1982, POLYM J, V14, P93, DOI 10.1295/polymj.14.93
   Kitamura S, 1996, POLYM MAT ENCY SYNTH, P7915
   KUBOTA M, 1988, J BIOCHEM-TOKYO, V104, P12, DOI 10.1093/oxfordjournals.jbchem.a122406
   Nagle N, 1999, APPL BIOCHEM BIOTECH, V77-9, P595, DOI 10.1385/ABAB:79:1-3:595
   Potocki-Veronese G, 2005, BIOMACROMOLECULES, V6, P1000, DOI 10.1021/bm049326g
   Shibuya T., 1993, Denpun Kagaku, V40, P375
   Takaha T., 2001, J APPL GLYCOSCI, V48, P71
   Takata H, 1998, J FERMENT BIOENG, V85, P156, DOI 10.1016/S0922-338X(97)86760-8
   WALDMANN H, 1986, CARBOHYD RES, V157, pC4, DOI 10.1016/0008-6215(86)85078-9
   WALKER GJ, 1959, NATURE, V183, P46, DOI 10.1038/183046a0
   YANASE M, 2005, APPL ENVIRON MICROB, V71, P5333
   YOKOBAYA, 1970, BIOCHIM BIOPHYS ACTA, V212, P458
NR 20
TC 62
Z9 64
U1 0
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1024-2422
EI 1029-2446
J9 BIOCATAL BIOTRANSFOR
JI Biocatal. Biotransform.
PD JAN-APR
PY 2006
VL 24
IS 1-2
BP 77
EP 81
DI 10.1080/10242420600598152
PG 5
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 064KZ
UT WOS:000239089700009
DA 2018-10-20
ER

PT S
AU Lewis, K
   Boonyang, U
   Evans, L
   Siripaisarnpipat, S
   Ben-Nissan, B
AF Lewis, K
   Boonyang, U
   Evans, L
   Siripaisarnpipat, S
   Ben-Nissan, B
BE Nakamura, T
   Yamashita, K
   Neo, M
TI A comparative study of Thai and Australian crocodile bone for use as a
   potential biomaterial
SO BIOCERAMICS 18, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 18th International Symposium on Ceramics in Medicine
CY DEC 05-08, 2005
CL Kyoto, JAPAN
SP Int Soc Ceram Med
DE hydroxyapatite; crocodile; biomaterial; bone; bonegraft; bioceramic
ID PHOSPHATE; APATITES; FTIR
AB This study aims to characterize the structure and properties of crocodile bone to assess the potential for use in biomedical applications. Crocodile bone samples obtained from Thailand (Crocodylus siamensis) and Australia (Crocodylus porosus), being the tail and the tibia respectively, were treated to remove organic material and the inner spongy (trabecular) material. The dense cortical bone was used for comparative instrumental analyses. Specific comparisons were made against bovine cortical bone and pure synthetic hydroxyapatite. The material was then analyzed using simultaneous differential thermal analysis/thermogravimetric analysis (DTA/TGA), Fourier-Transform infrared spectroscopy (FTIR), and X-ray diffraction analysis (XRD). Imaging of full bone samples was also conducted using an environmental scanning electron microscopy (ESEM). The SEM provided valuable information through the imaging of samples, showing a marked increase in bone porosity for crocodile material when compared to bovine samples. The crystallinity and/or crystallite size of carbonated hydroxyapatite has been found to be lower than synthetic apatite, with the tibia being the least crystalline of the bone types studied. The crystallinity index (CI) is used as a measure of crystallite size and internal strain. The strain is affected by substitutions in the structure and these results provide a starting point for comparison of the resulting mechanical properties. There is a need for any biomaterial chosen for bone replacement to allow adequate osteointegration. Thus the study this far shows that crocodile bone is a very promising source of carbonated apatite for biomedical applications.
C1 Univ Technol Sydney, Dept Chem Mat & Forens Sci, Broadway, NSW 2007, Australia.
   Kasetsart Univ, Dept Chem, Bangkok 10903, Thailand.
RP Lewis, K (reprint author), Univ Technol Sydney, Dept Chem Mat & Forens Sci, POB 123, Broadway, NSW 2007, Australia.
EM Kanthi.C.Lewis@its.edu.au; g4784020@ku.ac.th; Louise.Evans@uts.edu.au;
   fscits@ku.ac.th; Besim.Ben-Nissan@uts.edu.au
CR APFELBAUM F, 1992, J INORG BIOCHEM, V45, P277, DOI 10.1016/0162-0134(92)84016-G
   Ben-Nissan B, 1995, ENCY HDB BIOMATERIAL, V1, P191
   *DAT JOINT COMM PO, 1995, 90432 DAT JOINT COMM
   LEGEROS RZ, 1981, PROG CRYST GROWTH CH, V4, P1
   MUCALO MR, 2004, CROAT CHEM ACTA, V3, P509
   Overgaard S, 1999, J BONE JOINT SURG BR, V81B, P725, DOI 10.1302/0301-620X.81B4.9282
   Paschalis EP, 1996, CALCIFIED TISSUE INT, V59, P480, DOI 10.1007/s002239900161
   PERSON A, 1995, J ARCHAEOL SCI, V22, P211, DOI 10.1006/jasc.1995.0023
   Seebacher F, 2003, AUST J ZOOL, V51, P15, DOI 10.1071/ZO02036
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
NR 10
TC 3
Z9 3
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-992-X
J9 KEY ENG MAT
PY 2006
VL 309-311
BP 15
EP 18
DI 10.4028/www.scientific.net/KEM.309-311.15
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BED87
UT WOS:000236902500004
DA 2018-10-20
ER

PT S
AU Oktar, FN
   Sayrak, H
   Ozsoy, S
   Heybeli, N
AF Oktar, FN
   Sayrak, H
   Ozsoy, S
   Heybeli, N
BE Nakamura, T
   Yamashita, K
   Neo, M
TI A histological study of human derived tooth-hydroxyapatite (THA)
SO BIOCERAMICS 18, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 18th International Symposium on Ceramics in Medicine
CY DEC 05-08, 2005
CL Kyoto, JAPAN
SP Int Soc Ceram Med
DE hydroxyapatite; grafting; bone graft; osteoconduction
ID BOVINE CANCELLOUS BONE; BIOMEDICAL APPLICATIONS; YIELD MATERIALS
AB Different types of bone-graft substitutes have been developed and are in the market worldwide to eliminate the drawbacks of autogenous grafting. They vary in composition, strength, osteoinductive and osteoconductive properties, mechanism and rates by which they are resorbed and remodelled. Tooth derived hydroxyapatite (THA) is a novel biomaterial. This study was performed to determine the histological properties of THA on animals. A commercial coralline HA (CHA, Proosteon 200, Interpore Cross, USA) was used as control material. 20 sheeps were used and divided into 2 groups. Human THA (Group A) and CHA (Group B) materials were implanted to the tibiae of 10 sheeps for each group. The histological examinations of surrounding bone response were done 12 weeks after implantation. There was no significant difference histologically between group A and B. All materials were found to be surrounded by new bone tissue. THA was found to be as efficient as the standard CHA on histological basis. In addition, economical production of THA should be taken into consideration. Therefore, THA may be a viable alternative on bone grafting provided that clinical trials will be completed.
C1 Marmara Univ, Dept Ind Engn, Sch Engn, TR-34722 Istanbul, Turkey.
   Pasabahce State Hosp, Dept Pathol, Istanbul, Turkey.
   Istanbul Univ, Sch Vet Med, Dept Surg, Istanbul, Turkey.
   Baltalimani Bone Dis Educ & Res Hosp, Istanbul, Turkey.
RP Oktar, FN (reprint author), Marmara Univ, Dept Ind Engn, Sch Engn, TR-34722 Istanbul, Turkey.
EM foktar@eng.marmara.edu.tr; hsayrak@turknokta.net; serhatozsoy@yahoo.com;
   heybelin@yahoo.com
CR Anderson LA, 2000, J MATER SCI-MATER M, V11, P743
   Broz JJ, 1997, J MATER SCI-MATER M, V8, P395, DOI 10.1023/A:1018545303184
   Guizzardi S, 2000, J BIOMED MATER RES, V53, P227, DOI 10.1002/(SICI)1097-4636(2000)53:3<227::AID-JBM7>3.3.CO;2-5
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Johnson GS, 2000, J MATER SCI-MATER M, V11, P725, DOI 10.1023/A:1008979929632
   Lin FH, 1999, BIOMATERIALS, V20, P475, DOI 10.1016/S0142-9612(98)00193-8
   Ohbayashi Y, 2000, BIOMATERIALS, V21, P501, DOI 10.1016/S0142-9612(99)00208-2
   Oktar FN, 1999, ARTIF CELL BLOOD SUB, V27, P367, DOI 10.3109/10731199909117706
   OKTAR FN, 1997, P NAT BIOM ENG S BIY, P54
   PONGKAO D, 1999, P 12 INT S CER MED, V12, P357
   VARGAS G, 1997, P 10 INT S CER MED, V10, P565
   VEHOF WM, 2000, BIOMATER, V21, P2001
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Zhang M, 1997, J PERIODONTOL, V68, P1085, DOI 10.1902/jop.1997.68.11.1085
NR 14
TC 7
Z9 8
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-992-X
J9 KEY ENG MAT
PY 2006
VL 309-311
BP 27
EP 30
DI 10.4028/www.scientific.net/KEM.309-311.27
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BED87
UT WOS:000236902500007
DA 2018-10-20
ER

PT S
AU Teraoka, K
   Saito, T
   Yokogawa, Y
AF Teraoka, K
   Saito, T
   Yokogawa, Y
BE Nakamura, T
   Yamashita, K
   Neo, M
TI Effects of through-holes' diameter on initial cell attachment and cell
   proliferation
SO BIOCERAMICS 18, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 18th International Symposium on Ceramics in Medicine
CY DEC 05-08, 2005
CL Kyoto, JAPAN
SP Int Soc Ceram Med
DE hydroxyapatite; pore geometry; cell proliferation
ID BIOCERAMICS
AB Porous calcium phosphate ceramic biomaterials have become one of standard scaffolds to regenerate bone tissues and culture cells. The osteogenesis in scaffold is thought to be dependent on geometries of the pores in the scaffold. Ideally, pores in the scaffold are to be infiltrated by fluid elements and precursor cells. However, principle of the osteoconductive pore geometry is unclear. In this study, effects of through-holes' diameter on initial cell attachment and proliferation were evaluated by using HA beads with various through-holes. As a result, this study confirmed a functional through-hole's diameter that could be a principle for macropore design of the ceramic biomaterial for bone repair.
C1 Natl Inst AIST, Moriyama Ku, Aichi 4638560, Japan.
RP Teraoka, K (reprint author), Natl Inst AIST, Moriyama Ku, 2266-98 Anagahora, Aichi 4638560, Japan.
EM ok-teraoka@aist.go.jp; t-saito@aist.go.jp; y-yokogawa@aist.go.jp
CR Aubin JE, 1996, PRINCIPLES BONE BIOL
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   KLEIN CPAT, 1989, BIOMATERIALS, V10, P59
   Teraoka K, 2004, J CERAM SOC JPN, V112, P863
NR 4
TC 1
Z9 1
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-992-X
J9 KEY ENG MAT
PY 2006
VL 309-311
BP 89
EP 92
DI 10.4028/www.scientific.net/KEM.309-311.89
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BED87
UT WOS:000236902500022
DA 2018-10-20
ER

PT S
AU Teixeira, S
   Queiroz, AC
   Monteiro, FJ
   Ferraz, MP
   Vilar, R
   Eugenio, S
AF Teixeira, S
   Queiroz, AC
   Monteiro, FJ
   Ferraz, MP
   Vilar, R
   Eugenio, S
BE Nakamura, T
   Yamashita, K
   Neo, M
TI Osteoblast proliferation and morphology analysis on laser modified
   hydroxyapatite surfaces: Preliminary results
SO BIOCERAMICS 18, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 18th International Symposium on Ceramics in Medicine
CY DEC 05-08, 2005
CL Kyoto, JAPAN
SP Int Soc Ceram Med
DE surface modification; hydroxyapatite; cell adhesion; excimer laser
ID IMPLANT MATERIALS; MODEL
AB Biocompatibility has long been associated with surface microtopography, microtexture and microchemistry. The surface topography ultimately affects the nature and the strength of the interactions that occur at biomaterial-biological environment (cell adhesion, mobility, spreading and proliferation). Thus, it is necessary to produce and work with controlled microtopographical surfaces that present reproducible microdomains of a dimension similar to that of the biological elements of interest (for instance, cells). [1] There are a number of substrates that already have been studied (such as silicone, polystyrene, poly-L-lactic acid and titanium coated polystyrene) in terms of surface topography. [2].
   However, few studies are related to hydroxyapatite substrates. As it is well established, hydroxyapatite is a well known ceramic that is extremely used in medical applications, namely implants and coatings.
   In this work, the surface topography of dense hydroxyapatite substrates was altered by using KFr excimer laser. Excimer lasers produce high-intensity, pulsed ultraviolet radiation and are especially well suited for materials processing due to their large beam cross-section area, which permits using mask projection technologies to process relatively large areas in a single step.[3].
C1 INEB, Lab Biomat, P-4150180 Oporto, Portugal.
   Univ Porto, Fac Engn, Dept Met & Mat Engn, P-4200466 Oporto, Portugal.
   Escola Super Tecnol & Gestao, P-4901 Viana Do Castelo, Portugal.
   Univ Fernando Pessoa, Fac Ciencias Saude, P-4200150 Oporto, Portugal.
   IST, P-1049001 Lisbon, Portugal.
RP Teixeira, S (reprint author), INEB, Lab Biomat, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM smsilva@ineb.up.pt; aqueiroz@ineb.up.pt; fjmont@ineb.up.pt;
   mpferraz@upf.pt; rui.vilar@ist.utl.pt; s.eugenio@popsrv.ist.utl.pt
RI Vilar, Rui/C-1079-2011; Ferraz, Maria/M-6316-2013; Eugenio,
   Sonia/B-2254-2013
OI Ferraz, Maria/0000-0002-0274-106X; Eugenio, Sonia/0000-0002-1386-5236;
   Vilar, Rui/0000-0003-1167-6164; Monteiro, Fernando/0000-0002-1361-4605
CR Ahmad M, 1999, BIOMATERIALS, V20, P211, DOI 10.1016/S0142-9612(98)00152-5
   Duncan AC, 2002, BIOSENS BIOELECTRON, V17, P413, DOI 10.1016/S0956-5663(01)00281-0
   Queiroz AC, 2004, BIOMATERIALS, V25, P4607, DOI 10.1016/j.biomaterials.2003.11.054
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
NR 4
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-992-X
J9 KEY ENG MAT
PY 2006
VL 309-311
BP 105
EP 108
DI 10.4028/www.scientific.net/KEM.309-311.105
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BED87
UT WOS:000236902500026
DA 2018-10-20
ER

PT S
AU Guth, K
   Buckland, T
   Hing, KA
AF Guth, K
   Buckland, T
   Hing, KA
BE Nakamura, T
   Yamashita, K
   Neo, M
TI Silicon dissolution from microporous silicon substituted hydroxyapatite
   and its effect on osteoblast behaviour
SO BIOCERAMICS 18, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Article; Proceedings Paper
CT 18th International Symposium on Ceramics in Medicine
CY DEC 05-08, 2005
CL Kyoto, JAPAN
SP Int Soc Ceram Med
DE hydroxyapatite; silicon substituted hydroxyapatite; dissolution;
   osteoblast; bone; biomaterial
ID IN-VITRO; BONE; DIFFERENTIATION; CERAMICS; CELLS; VIVO
AB In this study silicon release from SiHA into tissue culture medium was investigated under static and semi-dynamic conditions. The effect of silicon release under semi-dynamic conditions on alkaline phosphatase activity (ALP) and collagen I (CICP) expression by osteoblast like cells (HOS TE85) was also examined.
   Under static conditions a low level of silicon was released within 24 hours, this initial level dropped over 3-7 days but subsequently increased again by 10-14 days. Under semi-dynamic conditions silicon was released within 24 hours and was subsequently reduced with each medium change until equilibrating at close to 0 after 10 days. ALP and CICP showed significant variation in expression between culture conditions. In direct contact with SiHA ALP peaked at day 10 and CICP was constantly elevated. Cells grown in the presence of but not on SiHA expressed progressively decreasing levels of ALP from 7-14 days, with CICP peaking at day 10. On thermanox (TMX) ALP constantly increased and CICP peaked at day 10. The results indicate that silicon leaches out of the lattice of the SiHA crystal structure but may also be reprecipitated onto the substrate. We have also demonstrated that Si influences osteoblast metabolism and differentiation whether it is available as free silicon or 'bound' in the apatite lattice.
C1 Queen Mary Univ London, IRC Biomed Mat, London E1 4NS, England.
   ApaTech Ltd, London E1 4NS, England.
RP Guth, K (reprint author), Queen Mary Univ London, IRC Biomed Mat, Mile End Rd, London E1 4NS, England.
EM k.guth@qmul.ac.uk; Tom.Buckland@apatech.com; k.a.hing@qmul.ac.uk
CR AOKI M, 1991, SCI MED APPL HYDROXY
   BETZ RR, 2003, ORTHOPEDICS S5, V25, pS561
   CARLISLE EM, 1972, SCIENCE, V178, P619, DOI 10.1126/science.178.4061.619
   Gough JE, 2004, J BIOMED MATER RES A, V69A, P621, DOI 10.1002/jbm.a.30024
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   HING KA, 2004, 50 ANN M ORTH RES SO
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   Ng KW, 2005, TISSUE ENG, V11, P182, DOI 10.1089/ten.2005.11.182
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   Porter AE, 2004, J BIOMED MATER RES A, V69A, P670, DOI 10.1002/jbm.a.30035
   Raggi MA, 1999, J PHARMACEUT BIOMED, V20, P335, DOI 10.1016/S0731-7085(99)00054-0
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Rosa AL, 2003, DENT MATER, V19, P768, DOI 10.1016/S0109-5641(03)00024-1
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
NR 15
TC 11
Z9 11
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-992-X
J9 KEY ENG MATER
PY 2006
VL 309-311
BP 117
EP 120
DI 10.4028/www.scientific.net/KEM.309-311.117
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BED87
UT WOS:000236902500029
DA 2018-10-20
ER

PT S
AU Kim, TG
   Jung, UW
   Kim, CS
   Lee, YK
   Choi, SH
   Cho, KS
   Kim, CK
   Chai, JK
AF Kim, TG
   Jung, UW
   Kim, CS
   Lee, YK
   Choi, SH
   Cho, KS
   Kim, CK
   Chai, JK
BE Nakamura, T
   Yamashita, K
   Neo, M
TI The effects of autograft and calcium carbonate on the periodontal
   healing of 3-wall intrabony defects in dogs
SO BIOCERAMICS 18, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 18th International Symposium on Ceramics in Medicine
CY DEC 05-08, 2005
CL Kyoto, JAPAN
SP Int Soc Ceram Med
DE ankylosis; autograft; beagle dog; calcium carbonate; regeneration of
   periodontal tissue; root resorption; 3-wall intrabony defect
ID BONE GRAFTS
AB This study evaluated periodontal repair and biomaterial reaction following implantation of a calcium carbonate and autogenous bone on the regeneration of 3-wall intrabony defects in the beagle dogs. The surgical control group received a flap operation only, while the experimental group I was treated with a calcium carbonate and the experimental group 11 was treated with autograft. The subjects were sacrificed 8 weeks after surgery and a comparative histometric analysis was done. No root resorption or ankylosis were observed in the experimental group. ANOVA post Hoc test showed that the experimental group II produced statistically significant higher gain in connective tissue adhesion, new cementum regeneration and new bone formation. These results suggest that the use of autograft in 3-wall intrabony defects has a significant effect on new cementum and new bone formation height.
C1 Yonsei Univ, Dept Periodontol, Res Inst Periodontol Regenerat, Coll Dent, Seoul 120752, South Korea.
   Yonsei Univ, Dept Res, Inst Dent Biomat & Bioengn, Coll Dent, Seoul 120752, South Korea.
   Yonsei Univ, Brain Korea Project Med Sci 21, Seoul 120752, South Korea.
RP Kim, TG (reprint author), Yonsei Univ, Dept Periodontol, Res Inst Periodontol Regenerat, Coll Dent, Seoul 120752, South Korea.
EM Kimtg99@freechal.com; shchoi726@yumc.yonsei.ac.kr;
   jkchai@yumc.yonsei.ac.kr
OI Jung, Ui-Won/0000-0001-6371-4172
CR DRAGOO MR, 1973, J PERIODONTOL, V44, P614, DOI 10.1902/jop.1973.44.10.614
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   KIM CK, 1996, J PERIODONTOL, V67, P1306
   RIVAULT AF, 1971, J PERIODONTOL, V42, P787, DOI 10.1902/jop.1971.42.12.787
   Wikesjo UME, 2003, J PERIODONTOL, V74, P635, DOI 10.1902/jop.2003.74.5.635
NR 5
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-992-X
J9 KEY ENG MAT
PY 2006
VL 309-311
BP 187
EP 190
DI 10.4028/www.scientific.net/KEM.309-311.187
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BED87
UT WOS:000236902500046
DA 2018-10-20
ER

PT S
AU Bernstein, A
   Gildenhaar, R
   Nobel, D
   Berger, G
AF Bernstein, A
   Gildenhaar, R
   Nobel, D
   Berger, G
BE Nakamura, T
   Yamashita, K
   Neo, M
TI Biodegradation of different calcium phosphate coatings
SO BIOCERAMICS 18, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 18th International Symposium on Ceramics in Medicine
CY DEC 05-08, 2005
CL Kyoto, JAPAN
SP Int Soc Ceram Med
DE ceramics; coating; biomaterial; bone; biodegradation
ID IMPLANTS
C1 Univ Halle, Dept Orthopaed, D-06097 Halle, Germany.
   Fed Inst Mat Res & Testing, D-12205 Berlin, Germany.
RP Bernstein, A (reprint author), Univ Halle, Dept Orthopaed, Magdeburger Str 22, D-06097 Halle, Germany.
EM anke.bernstein@medizin.uni-halle.de; renate.gildenhaar@bam.de;
   doreen.noebel@medizin.uni-halle.de; georg.berger@bam.de
CR Darimont GL, 2002, BIOMATERIALS, V23, P2569, DOI 10.1016/S0142-9612(01)00392-1
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   GILDENHAAR R, 2003, 1J S VERB WERKST, P732
   GILDENHAAR R, 2003, BIOCERAMICS, V16, P407
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Rueger JM, 1998, ORTHOPADE, V27, P89
   Schilling AF, 2004, BIOMATERIALS, V25, P3963, DOI 10.1016/j.biomaterials.2003.10.079
NR 7
TC 1
Z9 1
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-992-X
J9 KEY ENG MAT
PY 2006
VL 309-311
BP 623
EP 626
DI 10.4028/www.scientific.net/KEM.309-311.623
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BED87
UT WOS:000236902500152
DA 2018-10-20
ER

PT S
AU Gross, KA
   Muller, DM
AF Gross, KA
   Muller, DM
BE Nakamura, T
   Yamashita, K
   Neo, M
TI Topography control of hydroxyapatite coatings
SO BIOCERAMICS 18, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 18th International Symposium on Ceramics in Medicine
CY DEC 05-08, 2005
CL Kyoto, JAPAN
SP Int Soc Ceram Med
DE hydroxyapatite; coatings; microtopography; roughness; thermal spraying
AB The biomaterial surface represents the first contact point for proteins and cells and is thus critical to optimise the features to transmit the best signals for tissue and organ regeneration. Both chemistry and topography are surface characteristics that can be modified by the manufacturing process and provide signals to cells. While chemistry and crystallinity have received attention for thermally sprayed hydroxyapatite coatings, the control of the surface microtopography has not been addressed. This study collected a range of implants with a coating and assessed the topography on dental implants, orthopaedic screws and hip prostheses. The surface was found to be composed of large topographic features (angular particulate and smooth areas) and micron sized aspects (fine grains, cracks and ridges). Thermal spray experiments were designed to determine the influence of processing conditions on droplet spreading. This knowledge was then applied to see the effect of different parameters on the final coating topography. The parameters investigated for their influence on the surface topography included substrate roughness, substrate temperature, spray distance and particle size. The particle size showed the largest influence on altering the roughness, R. of the coating. A two-fold increase in particle size doubled the roughness from R-a of 4.8 mu m when the powder was sprayed under the same conditions.
C1 Univ Melbourne, Dept Mech & Mfg Engn, Melbourne, Vic 3010, Australia.
   Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
RP Gross, KA (reprint author), Univ Melbourne, Dept Mech & Mfg Engn, Melbourne, Vic 3010, Australia.
EM kgross@unimelb.edu.au
RI Gross, Karlis/G-2793-2010
NR 0
TC 1
Z9 1
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-992-X
J9 KEY ENG MAT
PY 2006
VL 309-311
BP 693
EP 696
DI 10.4028/www.scientific.net/KEM.309-311.693
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BED87
UT WOS:000236902500169
DA 2018-10-20
ER

PT S
AU Wang, XX
   Xie, L
   Luo, C
   Wang, RZ
AF Wang, XX
   Xie, L
   Luo, C
   Wang, RZ
BE Nakamura, T
   Yamashita, K
   Neo, M
TI Natural nacre coatings on titanium implant grown by fresh water bivalve
   shell
SO BIOCERAMICS 18, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 18th International Symposium on Ceramics in Medicine
CY DEC 05-08, 2005
CL Kyoto, JAPAN
SP Int Soc Ceram Med
DE dental implant; nacre; biomineralization; biomaterial coatings
ID BONE
AB Titanium dental implant screws were implanted into the pearl sacs of a fresh water bivalve (hyriopsis cunfingii Lea) by replacing the pearls. After 45 days of cultivation, the implant surfaces were deposited with a nacre coating with iridescent luster. The coating was about 200-600 mu m in thickness and composed of a laminated nacreous layer and a transitional non-laminated layer that consisted mainly of vaterite and calcite polymorphs of calcium carbonate. The transitional layer was around 2-10 mu m thick in the convex and flat region of the implant surface and could form close contact with titanium surface; while the transitional layer was much thicker in the steep concave regions and could not form close contact with the titanium surface. The improvement to the design of the dental implant with respect to this coating method was suggested in the paper. The results suggest that it is possible to fabricate a biologically active and degradable, and mechanically tough and strong nacre coating on titanium dental implant by this novel coating technology.
C1 Zhejiang Univ, Dept Mater Sci & Eng, Hangzhou 310027, Peoples R China.
   Univ British Columbia, Dept Mater Eng, Vancouver, BC V6T 1Z4, Canada.
RP Wang, XX (reprint author), Zhejiang Univ, Dept Mater Sci & Eng, Hangzhou 310027, Peoples R China.
EM mse_wangxx@dial.zju.edu.cn
CR Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5
   Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0
   FRITZ M, 1994, NATURE, V371, P49, DOI 10.1038/371049a0
   Jiang Xin-nong, 2001, Acta Hydrobiologica Sinica, V25, P123
   Liao HH, 2000, BIOMATERIALS, V21, P457, DOI 10.1016/S0142-9612(99)00184-2
   [马红艳 Ma Hongyan], 2003, [矿物学报, Acta Mineralogica Sinica], V23, P241
   Mouries LP, 2002, COMP BIOCHEM PHYS B, V132, P217
   Wang R, 2004, J MATER SCI, V39, P4961, DOI 10.1023/B:JMSC.0000035346.59232.49
   Wang RZ, 2001, J MATER RES, V16, P2485, DOI 10.1557/JMR.2001.0340
   WILBUR KM, 1963, ANN NY ACAD SCI, V109, P82, DOI 10.1111/j.1749-6632.1963.tb13463.x
   Zhang Gang-sheng, 2003, Journal of Tropical Oceanography, V22, P55
NR 11
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-992-X
J9 KEY ENG MAT
PY 2006
VL 309-311
BP 743
EP 746
DI 10.4028/www.scientific.net/KEM.309-311.743
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BED87
UT WOS:000236902500181
DA 2018-10-20
ER

PT S
AU Shinzato, S
   Nakamura, T
   Goto, K
   Kokubo, T
AF Shinzato, S
   Nakamura, T
   Goto, K
   Kokubo, T
BE Nakamura, T
   Yamashita, K
   Neo, M
TI Alumina powder containing delta , gamma crystal phases: Evaluation of
   osteoconductivity
SO BIOCERAMICS 18, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 18th International Symposium on Ceramics in Medicine
CY DEC 05-08, 2005
CL Kyoto, JAPAN
SP Int Soc Ceram Med
DE alumina; crystal phase; osteoconductivity; bioactive bone cement
ID BIOACTIVE BONE-CEMENT; GLASS BEAD FILLER; VIVO AGING TEST;
   MECHANICAL-PROPERTIES; BIOLOGICAL-PROPERTIES; POLY(METHYL METHACRYLATE);
   HISTOLOGICAL CHANGE; PMMA; COMPOSITES; TIME
AB Alumina powder containing delta, gamma crystal phases (designated delta AP) showed osteoconducfivity. delta AP was manufactured by fusing pulverized alumina powder and quenching it. The purpose of the present study was to evaluate osteoconductivity of delta AP using rat tibiae. Alumina powder containing a crystal phase (designated alpha AP) was used as a reference material. These two types of alumina powder were packed into the intramedullary canals of rat tibiae to evaluate osteoconductivity, as determined by an affinity index. Rats were sacrificed at 4 and 8 weeks after surgery. The affinity index, equal to the length of bone in direct contact with the powder surface expressed as a percentage of the total length of the powder surface, was calculated for each alumina powder at each interval. At 4 and 8 weeks, the affinity indices for delta AP were significantly higher than those for alpha AP. For both delta AP and alpha AP, there were no significant differences between the values for 4 and 8 weeks. This study revealed that the osteoconductivity of delta AP was due to the alumina's delta crystal phases. delta AP shows promise as a basis for developing a osteoconductive biomaterial.
C1 Moriyama Municipal Hosp, Dept Orthopaed Surg, Moriyama, Shiga 5240022, Japan.
   Kyoto Univ, Grad Sch Engn, Dept Orthopaed Surg, Sakyo Ku, Kyoto 6068507, Japan.
   Chubu Univ, Sci & Technol Res Inst, Kasugai, Aichi 4878501, Japan.
RP Shinzato, S (reprint author), Moriyama Municipal Hosp, Dept Orthopaed Surg, Moriyama 4-14-1, Moriyama, Shiga 5240022, Japan.
EM shinzato@mbox.kyoto-inet.or.jp; ntaka@kuhp.kyoto-u.ac.jp;
   k.g.bau@kuhp.kyoto-u.ac.jp; ntaka@kuhp.kyoto-u.ac.jp
CR Kamimura M, 2002, J BIOMED MATER RES, V61, P564, DOI 10.1002/jbm.10214
   KOKUBO T, 1985, J MATER SCI, V20, P2001, DOI 10.1007/BF01112282
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   NAKAMURA T, 2000, BIOCERAMICS, V13, P661
   Shinzato S, 2004, J BIOMED MATER RES B, V68B, P132, DOI 10.1002/jbm.b.20008
   Shinzato S, 2003, J BIOMED MATER RES B, V65B, P262, DOI 10.1002/jbm.b.10008
   Shinzato S, 2002, J BIOMED MATER RES, V60, P585, DOI 10.1002/jbm.10104
   Shinzato S, 2002, J BIOMED MATER RES, V60, P556, DOI 10.1002/jbm.10098
   Shinzato S, 2001, J BIOMED MATER RES, V56, P571, DOI 10.1002/1097-4636(20010915)56:4<571::AID-JBM1129>3.0.CO;2-H
   Shinzato S, 2001, J BIOMED MATER RES, V54, P491, DOI 10.1002/1097-4636(20010315)54:4<491::AID-JBM40>3.3.CO;2-F
   Shinzato S, 2002, J BIOMED MATER RES, V59, P225, DOI 10.1002/jbm.1236
   Shinzato S, 2001, J BIOMED MATER RES, V56, P452, DOI 10.1002/1097-4636(20010905)56:3<452::AID-JBM1115>3.0.CO;2-1
   Shinzato S, 2001, J BIOMED MATER RES, V55, P277, DOI 10.1002/1097-4636(20010605)55:3<277::AID-JBM1015>3.0.CO;2-5
   Shinzato S, 1999, J BIOMED MATER RES, V46, P287, DOI 10.1002/(SICI)1097-4636(199908)46:2<287::AID-JBM19>3.0.CO;2-I
   Shinzato S, 2000, J BIOMED MATER RES, V51, P258, DOI 10.1002/(SICI)1097-4636(200008)51:2<258::AID-JBM15>3.0.CO;2-S
   SHINZATO S, 2005, KEY ENG MATER, V17, P133
   SHINZATO S, 2000, BIOCERAMICS, V13, P665
NR 17
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-992-X
J9 KEY ENG MAT
PY 2006
VL 309-311
BP 789
EP 792
DI 10.4028/www.scientific.net/KEM.309-311.789
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BED87
UT WOS:000236902500192
DA 2018-10-20
ER

PT S
AU Tazaki, J
   Akazawa, T
   Murata, M
   Yamamoto, M
   Tabata, Y
   Yoshimoto, R
   Arisue, M
AF Tazaki, J
   Akazawa, T
   Murata, M
   Yamamoto, M
   Tabata, Y
   Yoshimoto, R
   Arisue, M
BE Nakamura, T
   Yamashita, K
   Neo, M
TI BMP-2 dose-response and release studies in functionally graded HAp
SO BIOCERAMICS 18, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 18th International Symposium on Ceramics in Medicine
CY DEC 05-08, 2005
CL Kyoto, JAPAN
SP Int Soc Ceram Med
DE BMP-2; dose-response; release; functionally graded HAp
ID BONE MORPHOGENETIC PROTEIN; OSTEOINDUCTION; BIOMATERIALS
AB Hydroxyapatite (HAp) has been used as a biomaterial for hard tissues. Critical characteristics of biomaterials will include surface geometry, hydrophobicity and hydrophilicity, crystallinity, biodegradation rates, and release pharmacokinetics (PK) of incorporated molecules such as BMP-2. Optimizing BMP-2 for clinical application may be dependent on localized sustained release from biomaterials. We forcused on in vivo local BMP-2 PK and bone induction in two ceramics systems, based on different surface structures. The functionally graded apatites (fg-HAp) was designed by the step-wise calcinations and partial dissolution-precipitation methods. We estimated the in vivo release profile of I-125-labeled BMP-2 from fg-HAp and the dose response of bone induction by BMP-2 in the back subcutis histologically. Bulk-HAp (b-HAp) by only the step-wise calcinations was prepared as a control. The amount of BMP-2 remaining in the fg-RAp at 1 day after implantation was 83.8%, while that was 34.6% in the b-HAp. Moreover, ectopic bone formation were found surely in the fg-HAp/BMP-2 (0.5 mu g) system at 3 weeks, not in the b-HAp/BMP-2 system. By using fg-HAp, it is likely that an extremely low dose of BMP-2 is enough to enhance bone induction if BMP-2 is appropriately delivered to the site of action.
C1 Hlth Sci Univ Hokkaido, Sch Dent, Tobetsucho 0610293, Japan.
   Hokkaido Ind Res Inst, Kita Ku, Sapporo, Hokkaido 0600819, Japan.
   Kyoto Univ, Biomed Engn Res Ctr, Sakyo Ku, Kyoto 606, Japan.
RP Tazaki, J (reprint author), Hlth Sci Univ Hokkaido, Sch Dent, Kanazawa 1757, Tobetsucho 0610293, Japan.
EM j-tazaki@hoku-iryo-u.ac.jp; akazawa@hokkaido-iri.go.jp;
   murata@hoku-iryo-u.ac.jp
CR Akazawa T, 1996, J CERAM SOC JPN, V104, P284, DOI 10.2109/jcersj.104.284
   BURCHARDT H, 1987, ORTHOP CLIN N AM, V18, P187
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Kubler N, 1995, J CRANIO MAXILL SURG, V23, P337, DOI 10.1016/S1010-5182(05)80128-3
   Ripamonti U, 1999, S AFR J SCI, V95, P335
   Taddei F, 2002, P I MECH ENG H, V216, P95, DOI 10.1243/0954411021536315
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   Yamamoto M, 1998, J BIOMAT SCI-POLYM E, V9, P439, DOI 10.1163/156856298X00550
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
NR 9
TC 7
Z9 7
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-992-X
J9 KEY ENG MAT
PY 2006
VL 309-311
BP 965
EP 968
DI 10.4028/www.scientific.net/KEM.309-311.965
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BED87
UT WOS:000236902500235
DA 2018-10-20
ER

PT S
AU Sotome, S
   Orii, H
   Kikuchi, M
   Ikoma, T
   Ishida, A
   Tanaka, J
   Shinomiya, K
AF Sotome, S
   Orii, H
   Kikuchi, M
   Ikoma, T
   Ishida, A
   Tanaka, J
   Shinomiya, K
BE Nakamura, T
   Yamashita, K
   Neo, M
TI In vivo evaluation of porous hydroxyapatite/collagen composite as a
   carrier of OP-1 in a rabbit PLF model.
SO BIOCERAMICS 18, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 18th International Symposium on Ceramics in Medicine
CY DEC 05-08, 2005
CL Kyoto, JAPAN
SP Int Soc Ceram Med
DE hydroxyapatite; collagen; OP-1; posterolateral lumbar fusion
ID BIOMATERIAL
AB Transplantation surgeries of autologous bone require a second surgery with inherent risks. To avoid these risks, we developed a multi porous implant of hydroxyapatite/collagen composite with desirable biophysical properties (flexibility, elasticity and compression resistance) for use with OP-1 as a graft implant. In this study, we tested the efficacy of this multi porous implant as OP-1 carrier using rabbit posterolateral lumbar fusion model (PLF). PLFs were performed in the following 4 groups of 8 New Zealand white rabbits each: autograft, HAp/Col alone, HAp/Col plus 0.3 mg OP-1, and HAp/Col plus 1.2 mg OP-1. At 5 weeks, fusion masses were analyzed by radiographic and biomechanical tests. Implants consisting of HAp/Col plus OP-1 were more effective than autologous bone in promoting spinal fusion. Low dose and high dose OP-1 were equally effective.
C1 Tokyo Med & Dent Univ, Grad Sch, Dept Orthoped & Spinal Surg, Bunkyo Ku, Tokyo, Japan.
   Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki, Japan.
   Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Bunkyo Ku, Tokyo, Japan.
   Tokyo Med & Dent Univ, Ctr Excellence Program Frontier Res Mol Destruct, Bunkyo Ku, Tokyo, Japan.
RP Sotome, S (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Orthoped & Spinal Surg, Bunkyo Ku, 1-4-45 Yushima, Tokyo, Japan.
EM sotome.orth@tmd.ac.jp; shinomiya.orth@tmd.ac.jp
RI Kikuchi, Masanori/B-5993-2008; Ikoma, Toshiyuki/E-4288-2012
OI Kikuchi, Masanori/0000-0002-9451-8147; Ikoma,
   Toshiyuki/0000-0003-3154-1777
CR Alam I, 2001, J Biomed Mater Res, V54, P129
   Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005
   Grauer JN, 2000, EUR SPINE J, V9, P250, DOI 10.1007/s005860000141
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.0.CO;2-9
   Itoh S, 2002, J BIOMED MATER RES, V63, P507, DOI 10.1002/jbm.10305
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715
   Sotome S, 2004, MAT SCI ENG C-BIO S, V24, P341, DOI 10.1016/j.msec.2003.12.003
   Winn SR, 1998, ADV DRUG DELIVER REV, V31, P303, DOI 10.1016/S0169-409X(97)00126-9
NR 10
TC 3
Z9 3
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-992-X
J9 KEY ENG MAT
PY 2006
VL 309-311
BP 977
EP 980
DI 10.4028/www.scientific.net/KEM.309-311.977
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BED87
UT WOS:000236902500238
DA 2018-10-20
ER

PT S
AU Okazaki, M
   Tieliewuhan, Y
   Hirata, I
AF Okazaki, M
   Tieliewuhan, Y
   Hirata, I
BE Nakamura, T
   Yamashita, K
   Neo, M
TI Osteoblast Behavior at the surface of CO(3)Ap-collagen sponges
SO BIOCERAMICS 18, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 18th International Symposium on Ceramics in Medicine
CY DEC 05-08, 2005
CL Kyoto, JAPAN
SP Int Soc Ceram Med
DE CO(3)apatite; collagen; sponge; osteoblast; HAp frame
ID COMPOSITES
AB Carbonate apatite (CO(3)Ap) was synthesized at 60 +/- 1 degrees C and pH 7.4 +/- 0.2, to develop a new biodegradable scaffold biomaterial. The synthetic CO(3)Ap was mixed with a neutralized collagen gel and the CO(3)Ap-collagen mixtures with different kinds Of CO(3)Ap contents and porosity were frozen and dried in lyophilized into the sponges. CO(3)Ap-collagen mixtures were also lyophilized into sponges in a HAp frame ring with 0.5 mm pores. To examine the degree of cell invasion, mouse MC3T3-E1 cells were grown in a MEM with 10% heat-inactivated FBS in 96-well plates containing the CO(3)Ap-collagen sponges at 37 degrees C in a 5% humidified atmosphere. Under pentobarbital anesthesia, samples of UV-irradiated CO(3)Ap-collagen sponges with frames were surgically implanted beneath the periosteum cranii of rats. SEM observation of CO(3)Ap-collagen sponges showed favorable pores for cell invasion. Approximately 50 similar to 300 mu m size pores seemed to continue into the deep bottom. X-ray high-resolution microtomography revealed a clear image of 3D structure of the sponges. 70 wt% CO(3)Ap-collagen sponge seemed to be most favorable biomaterial from the viewpoint of the natural bone properties. Then, to avoid the shrinkage of the sponges, we successfully made a hybridized CO(3)Ap-collagcn sponge with a frame. When these sponge-frame complexes were implanted beneath the periosteum cranii of rats, newly created bone was observed toward the inner core of the complex from the surface of the periosteum cranii.
C1 Hiroshima Univ, Grad Sch Biomed Sci, Minami Ku, Hiroshima 7348553, Japan.
RP Okazaki, M (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.
EM okazakix@hiroshima-u.ac.jp; elnure@hiroshima-u.ac.jp;
   isao@hiroshima-u.ac.jp
CR Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   Ignatius AA, 2001, J BIOMED MATER RES, V58, P564, DOI 10.1002/jbm.1055
   NERY EB, 1975, J PERIODONTOL, V46, P328, DOI 10.1902/jop.1975.46.6.328
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   OKAZAKI M, 1989, BIOMATERIALS, V10, P564, DOI 10.1016/0142-9612(89)90064-1
   OKAZAKI M, 1990, BIOMATERIALS, V11, P568, DOI 10.1016/0142-9612(90)90080-A
   ROTHSTEIN SS, 1984, J ORAL MAXIL SURG, V42, P224, DOI 10.1016/0278-2391(84)90453-1
   TENHUISEN KS, 1994, J BIOMED MATER RES, V28, P27, DOI 10.1002/jbm.820280105
   Yamasaki Y, 2003, BIOMATERIALS, V24, P4913, DOI 10.1016/S0142-9612(03)00414-9
   Yamasaki Y, 2002, J BIOMED MATER RES, V62, P99, DOI 10.1002/jbm.10220
NR 10
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-992-X
J9 KEY ENG MAT
PY 2006
VL 309-311
BP 989
EP 992
DI 10.4028/www.scientific.net/KEM.309-311.989
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BED87
UT WOS:000236902500241
DA 2018-10-20
ER

PT S
AU Kobayashi, S
   Ozeki, K
   Hirakuri, KK
   Aoki, H
AF Kobayashi, S
   Ozeki, K
   Hirakuri, KK
   Aoki, H
BE Nakamura, T
   Yamashita, K
   Neo, M
TI Improvements of wear properties DLC coated UHMWPE and PMMA for
   biomaterial
SO BIOCERAMICS 18, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 18th International Symposium on Ceramics in Medicine
CY DEC 05-08, 2005
CL Kyoto, JAPAN
SP Int Soc Ceram Med
DE diamond-like carbon; UHMWPE; PMMA; adhesion; wear debris
ID CARBON COATINGS; PERFORMANCE; ADHESION; PLASMA
AB Diamond-like carbon (DLC) films were deposited onto UHMWPE and PMMA substrates using plasma CVD process. To improve adhesion of DLC films, substrates were treated plasma before DLC deposition. Samples were analyzed by ball-on disk tester, atomic force microscopy (AFM), and scratch test. Wear and scratch resistance of DLC-coated each substrates were evaluated and showed good results.
C1 Tokyo Denki Univ, Fac Sci & Engn, Hiki, Saitama 3500394, Japan.
RP Kobayashi, S (reprint author), Tokyo Denki Univ, Fac Sci & Engn, Hiki, Saitama 3500394, Japan.
EM kobayasi@ff.f.dendai.ac.jp
CR Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   Guo YB, 2003, DIAM RELAT MATER, V12, P946, DOI 10.1016/S0925-9635(02)00320-5
   Huang GF, 2003, DIAM RELAT MATER, V12, P1406, DOI 10.1016/S0925-9635(03)00168-7
   PAUL S, 1999, MRS P, P558
   Schulz U, 2001, SURF COAT TECH, V142, P507, DOI 10.1016/S0257-8972(01)01202-6
   Sheeja D, 2001, SURF COAT TECH, V146, P410, DOI 10.1016/S0257-8972(01)01425-6
   Shi B, 2003, WEAR, V255, P1015, DOI 10.1016/S0043-1648(03)00276-X
NR 7
TC 1
Z9 1
U1 1
U2 11
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-992-X
J9 KEY ENG MAT
PY 2006
VL 309-311
BP 1289
EP 1292
DI 10.4028/www.scientific.net/KEM.309-311.1289
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BED87
UT WOS:000236902500314
DA 2018-10-20
ER

PT S
AU Oktar, FN
   Turoglu, HT
   Yenici, FU
   Altintas, S
AF Oktar, FN
   Turoglu, HT
   Yenici, FU
   Altintas, S
BE Nakamura, T
   Yamashita, K
   Neo, M
TI Nuclear bone scintigraphy (NBS): A valuable tool depicting
   osseointegration at the sites of dental grafts
SO BIOCERAMICS 18, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 18th International Symposium on Ceramics in Medicine
CY DEC 05-08, 2005
CL Kyoto, JAPAN
SP Int Soc Ceram Med
DE osseointegration; hydroxyapatite grafting; bone scintigraphy; root
   resection
ID TC-99M MDP; CORALLINE HYDROXYAPATITE; OCULAR IMPLANT; VASCULARIZATION
AB Hydroxyapatite (HA) implants were used as grafting materials to fill some of the root resections in three patients. Two of the patients had previous root resections without implant insertion. Being implanted to the resection sites, the porous structure of HA serves as a framework for vascular and soft tissue ingrowth. Previous reports on the utilization of three phase nuclear bone scintigraphy (NBS) to evaluate the degree of fibrovascular ingrowth into HA dental implants after surgery are scarce. Three cases are described in which bone scintigraphy was performed at 6 months after implant insertion. The images revealed technetium-99m methylenediphosphonate (Tc-99m-MDP) uptake at dental implant sites consistent with vascularization and osteoconduction. The current results strongly indicate that osseointegration is complete. This study demonstrates that NBS is a valuable test in the follow up of osseointegration rate at implantation sites and HA is found to be a good biomaterial for grafting purposes showing high osseointegration rates.
C1 Marmara Univ, Sch Engn, Dept Ind Engn, TR-34722 Istanbul, Turkey.
   Marmara Univ, Sch Med, Dept Nucl Med, Istanbul, Turkey.
   Sisli Etfal State Hosp, Dept Nucl Med, Istanbul, Turkey.
   Bogazici Univ, Sch Engn, Dept Mech Engn, Istanbul, Turkey.
RP Oktar, FN (reprint author), Marmara Univ, Sch Engn, Dept Ind Engn, TR-34722 Istanbul, Turkey.
EM foktar@eng.marmara.edu.tr; turgut.turoglu@caramail.com;
   corhanyenici@hotmail.com; altintas@boun.edu.tr
CR CHRISTENSEN SB, 1980, J BONE JOINT SURG AM, V62, P90, DOI 10.2106/00004623-198062010-00013
   CHRISTENSEN SB, 1981, J NUCL MED, V22, P237
   CIVELEK AC, 1995, CLIN NUCL MED, V20, P779, DOI 10.1097/00003072-199509000-00005
   DUTTON JJ, 1991, OPHTHALMOLOGY, V98, P370
   FERRONE PJ, 1992, OPHTHALMOLOGY, V99, P376
   LARSON FG, 1994, MED DEVICE DIAGN IND, V16, P34
   MEIDAN Z, 1994, J PERIODONTOL, V65, P330, DOI 10.1902/jop.1994.65.4.330
   NUMEROW LM, 1994, CLIN NUCL MED, V19, P9, DOI 10.1097/00003072-199401000-00003
   OONISHI H, 1997, CLIN ORTHOP RELAT R, V334, P316
   RASHMIRRAVEN AM, 1995, J APPL BIOMATER, V6, P237, DOI 10.1002/jab.770060404
   SAHA GB, 1992, FUNDAMENTALS NUCL PH, P227
   Zarb G, 1991, INT J PERIODONT REST, V11, P88
NR 12
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-992-X
J9 KEY ENG MAT
PY 2006
VL 309-311
BP 1393
EP 1396
DI 10.4028/www.scientific.net/KEM.309-311.1393
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BED87
UT WOS:000236902500338
DA 2018-10-20
ER

PT J
AU Chen, XG
   Liu, CS
   Liu, CG
   Meng, XH
   Lee, CM
   Park, HJ
AF Chen, XG
   Liu, CS
   Liu, CG
   Meng, XH
   Lee, CM
   Park, HJ
TI Preparation and biocompatibility of chitosan microcarriers as
   biomaterial
SO BIOCHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE affinity; microcarrier; tissue cell culture; adsorption
ID CHITIN; AFFINITY; PURIFICATION; MEMBRANES; PROTEINS; SKIN
AB Chitosan microcarriers (100-200 mu m) were prepared by the methods of emulsification and ethanol coagulant. It has smooth surface and was stable in phosphate buffer solution (PBS) of at pH 7.2 in the treatment of temperature 120 degrees C and pressure 150 kPa. The chitosan microcarriers showed molecular affinity to the bovine serum proteins at pH 7.2. The adsorptive capacity of the microcarriers to the serum albumin was 6.8 mg protein/g chitosan bead. The chitosan microcarriers were found to have good biocompatibility and no cytotoxicity to both human and mouse fibroblasts in tissue cell culture. The fibroblasts well adhered on the smooth surface of the chitosan microcarriers and grew in high cell density. The results suggest a good potential of the chitosan microcarriers as a wound-healing biomaterial. (c) 2005 Elsevier B.V. All rights reserved.
C1 Ocean Univ China, Coll Marine Life Sci, Qingdao 266003, Peoples R China.
   Univ Rhode Isl, Dept Nutr & Food Sci, FSN Res Ctr, Kingston, RI 02881 USA.
   Korea Univ, Grad Sch Biotechnol, Seoul 136701, South Korea.
RP Chen, XG (reprint author), Ocean Univ China, Coll Marine Life Sci, 5 Yushan Rd, Qingdao 266003, Peoples R China.
EM xgchen@ouc.edu.cn
RI Park, Hyun Jin/I-4942-2015; Park, Hyun Jin/F-4735-2013; Liu,
   Chengsheng/L-5296-2018
OI Liu, Chengsheng/0000-0002-1454-0193
CR Chen XG, 2002, J AGR FOOD CHEM, V50, P5915, DOI 10.1021/jf020151g
   Chen XG, 2002, BIOMATERIALS, V23, P4609, DOI 10.1016/S0142-9612(02)00207-7
   CHEN XG, 2000, J OCEAN U QINGDAO, V30, P221
   CHEN XG, 2002, Patent No. 961157143
   He P, 1999, INT J PHARM, V187, P53, DOI 10.1016/S0378-5173(99)00125-8
   Humphries HE, 2002, PROTEIN EXPRES PURIF, V26, P243, DOI 10.1016/S1046-5928(02)00534-X
   IIUM L, 2001, ADV DRUG DELIV RES, V51, P81
   KAMAMURA Y, 1985, Patent No. 62100534
   KERSTIN B, 2002, PROTEIN EXPRES PURIF, V24, P313
   MUHAMMAD YNL, 2001, J BIOMED MATER RES, V54, P59
   Nakade T, 2000, CARBOHYD POLYM, V41, P327, DOI 10.1016/S0144-8617(99)00118-6
   Ohshima Y, 1987, EUR J PLAST SURG, V10, P66
   Poirier M, 2002, CARBOHYD POLYM, V50, P363, DOI 10.1016/S0144-8617(02)00040-1
   Ravi Kumar Majeti N. V., 2000, REACTIVE FUNCTIONAL, V46, P1
   Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X
   ROBERTS GAF, 1989, 4 INT C LOND, P577
   SACHS L, 1993, STAT METHODEN PLANUN, P312
   Sanz Y, 1999, J AGR FOOD CHEM, V47, P3441, DOI 10.1021/jf981255n
   Shigemasa Y, 1996, INT J BIOL MACROMOL, V18, P237, DOI 10.1016/0141-8130(95)01079-3
   YOKOTA H, 1987, Patent No. 6317990U
   YOSHIKAWA M, 1997, Patent No. 794223
   Zeng XF, 1999, J MEMBRANE SCI, V156, P97, DOI 10.1016/S0376-7388(98)00338-X
NR 22
TC 60
Z9 64
U1 3
U2 26
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1369-703X
J9 BIOCHEM ENG J
JI Biochem. Eng. J.
PD JAN
PY 2006
VL 27
IS 3
BP 269
EP 274
DI 10.1016/j.bej.2005.08.021
PG 6
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA 985AO
UT WOS:000233348700010
DA 2018-10-20
ER

PT J
AU Ramachandran, S
   Yu, YB
AF Ramachandran, Sivakumar
   Yu, Yihua Bruce
TI Peptide-based viscoelastic matrices for drug delivery and tissue repair
SO BIODRUGS
LA English
DT Article
ID SELF-ASSEMBLING PEPTIDE; COMPLEMENTARY OLIGOPEPTIDE; REVERSIBLE
   HYDROGELS; DESIGNED PEPTIDE; SYSTEMATIC VARIATION; BIOLOGICAL-MATERIALS;
   NANOFIBERS; SCAFFOLDS; PROTEINS; DIFFERENTIATION
AB Molecular self-assembly has paved the way to create novel, supramolecular, functional biomaterials. Peptide-based biomaterials are gaining interest as a result of their programability, biodegradability, and bioresorbability. Further, unlike polymeric materials,. peptides can be made monodisperse with precise control over sequence, chain length, and stereochemistry. Peptide-based viscoelastic matrices have been designed and characterized for various biomedical applications, such as tissue engineering scaffolds or drug delivery vehicles. The 'holy grail' in designing an ideal tissue engineering scaffold lies in mimicking the cues of the tissue's natural extracellular matrix (ECM). Some of the key elements of ECM that are incorporated into these peptide scaffolds include cell-adhesive and protease-sensitive sequences for enhanced cell-cell and cell-biomaterial interactions. Peptide-based viscoelastic matrices can also be engineered with drug carrying protease-sensitive sequences for controlled and site-specific drug delivery. Molecular-level engineering of simple oligopeptide modules can be used to control the position and density of the bio-mimetic functionalities in the supramolecular structures, which demonstrates the power of the 'bottom-up' approach in self-assembly.
C1 Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
RP Yu, YB (reprint author), Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
EM bruce.yu@utah.edu
FU NIBIB NIH HHS [EB 004416]
CR Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198
   Aggeli A, 2003, J AM CHEM SOC, V125, P9619, DOI 10.1021/ja021047i
   BERG JM, 2002, BIOCHEMISTRY-US, P58
   Bokhari MA, 2005, BIOMATERIALS, V26, P5198, DOI 10.1016/j.biomaterials.2005.01.040
   Caplan MR, 2002, J BIOMAT SCI-POLYM E, V13, P225, DOI 10.1163/156856202320176493
   Caplan MR, 2000, BIOMACROMOLECULES, V1, P627, DOI 10.1021/bm005586w
   Caplan MR, 2002, BIOMATERIALS, V23, P219, DOI 10.1016/S0142-9612(01)00099-0
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dobson CM, 2001, PHILOS T ROY SOC B, V356, P133, DOI 10.1098/rstb.2000.0758
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Fairman R, 2005, CURR OPIN STRUC BIOL, V15, P453, DOI 10.1016/j.sbi.2005.07.005
   Fisher A. B., 2001, AM J PHYSIOL-LUNG C, V281, P529
   Ghandehari H, 1998, PHARMACEUT RES, V15, P813, DOI 10.1023/A:1011999810298
   Haider M, 2005, MOL PHARMACEUT, V2, P139, DOI 10.1021/mp049906s
   Haines LA, 2005, J AM CHEM SOC, V127, P17025, DOI 10.1021/ja054719o
   Hartgerink JD, 2004, CURR OPIN CHEM BIOL, V8, P604, DOI 10.1016/j.cbpa.2004.10.001
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Hwang WM, 2003, J CHEM PHYS, V118, P389, DOI 10.1063/1.1524618
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Keyes-Baig C, 2004, J AM CHEM SOC, V126, P7522, DOI 10.1021/ja0381297
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Koide T, 2005, BIOORG MED CHEM LETT, V15, P5230, DOI 10.1016/j.bmcl.2005.08.041
   Kopecek J, 2003, EUR J PHARM SCI, V20, P1, DOI 10.1016/S0928-0987(03)00164-7
   Kretsinger JK, 2005, BIOMATERIALS, V26, P5177, DOI 10.1016/j.biomaterials.2005.01.029
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Law B, 2006, BIOMACROMOLECULES, V7, P1261, DOI 10.1021/bm050920f
   Megeed Z, 2002, PHARMACEUT RES, V19, P954, DOI 10.1023/A:1016406120288
   Moss JA, 2006, BIOMACROMOLECULES, V7, P1011, DOI 10.1021/bm051001s
   Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005
   Niece KL, 2003, J AM CHEM SOC, V125, P7146, DOI 10.1021/ja028215r
   Ozbas B, 2004, MACROMOLECULES, V37, P7331, DOI 10.1021/ma0491762
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Philip D, 2005, STEM CELLS, V23, P288, DOI 10.1634/stemcells.2002.0109
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Rajagopal K, 2004, CURR OPIN STRUC BIOL, V14, P480, DOI 10.1016/j.sbi.2004.06.006
   Ramachandran S, 2005, BIOMACROMOLECULES, V6, P1316, DOI 10.1021/bm049284w
   Ryadnov MG, 2003, ANGEW CHEM INT EDIT, V42, P3021, DOI 10.1002/anie.200351418
   Ryadnov MG, 2003, NAT MATER, V2, P329, DOI 10.1038/nmat885
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Seliktar D, 2001, ANN BIOMED ENG, V29, P923, DOI 10.1114/1.1415522
   Tang AJ, 2000, BIOCONJUGATE CHEM, V11, P363, DOI 10.1021/bc990133d
   Tauro JR, 2005, MOL PHARMACEUT, V2, P435, DOI 10.1021/mp050028n
   Tovar JD, 2005, J AM CHEM SOC, V127, P7337, DOI 10.1021/ja043764d
   Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
   Yang JY, 2006, BIOMACROMOLECULES, V7, P1187, DOI 10.1021/bm051002k
   Yu B.Y, 2005, CHEM MATER, V17, P6583
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
   Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
NR 62
TC 21
Z9 21
U1 0
U2 12
PU ADIS INTERNATIONAL LTD
PI AUCKLAND
PA 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 1311, NEW
   ZEALAND
SN 1173-8804
J9 BIODRUGS
JI Biodrugs
PY 2006
VL 20
IS 5
BP 263
EP 269
DI 10.2165/00063030-200620050-00001
PG 7
WC Oncology; Immunology; Pharmacology & Pharmacy
SC Oncology; Immunology; Pharmacology & Pharmacy
GA 105CD
UT WOS:000242006000001
PM 17025372
DA 2018-10-20
ER

PT J
AU Morin, R
   Kaplan, D
   Perez-Ramirez, B
AF Morin, R
   Kaplan, D
   Perez-Ramirez, B
TI Bone morphogenetic protein-2 binds as multilayers to a collagen delivery
   matrix: An equilibrium thermodynamic analysis
SO BIOMACROMOLECULES
LA English
DT Article
ID MARROW STROMAL CELLS; RAT ECTOPIC MODEL; BIOMATERIAL CARRIERS; SPONGES;
   PHARMACOKINETICS; RHBMP-2; TISSUE; DIFFERENTIATION; REGENERATION; RANGE
AB Recombinant human bone morphogenetic protein-2 (rhBMP-2) promotes bone growth but must be retained at the delivery site for optimal efficacy in vivo. rhBMP-2 release from a collagen-based matrix has shown favorable pharmacokinetics. The present study assessed binding affinity and binding saturation of rhBMP-2 to a collagen matrix as a function of solution and rhBMP-2 isoform variables. Results indicate that rhBMP-2 binds to the collagen matrix with affinities on the order of 10(3) to 10(4) M-1. Maximum binding, v, was primarily a function of pH for heterogeneous rhBMP-2 and the extended (T-266/T-266) isoform. However, binding saturation of the < Q(283)/ < Q(283) isoform was unaffected by pH. Overall, binding saturation was higher than the calculated saturation of a rhBMP-2 monolayer, suggesting both hydrophobic and ionic interactions in a multilayer formation. The contributions of pH and ionic strength to the linkage free energy of interaction was on the order of 1.3 kcal mol(-1) and similar to 0.3 kcal mol(-1), respectively. This thermodynamic approach can serve to optimize interactions between therapeutic proteins and delivery systems.
C1 Wyeth BioPharma, Formulat & Proc Dev, Andover, MA 01810 USA.
   Tufts Univ, Dept Biomed Engn & Chem & Biol Engn, Medford, MA 02155 USA.
RP Perez-Ramirez, B (reprint author), Genzyme Corp, BioFormulat Dev, 1 Mt Rd, Framingham, MA 01701 USA.
EM bernardo.perez@genzyme.com
FU NIBIB NIH HHS [EB 003210, EB 002520]
CR Abbatiello S., 1997, PROTEIN SCI, V6, P99
   Boix T, 2005, J INORG BIOCHEM, V99, P1043, DOI 10.1016/j.jinorgbio.2005.01.011
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Friess W, 1996, BIOMATERIALS, V17, P2289, DOI 10.1016/0142-9612(96)00047-6
   Friess W, 1999, INT J PHARM, V185, P51, DOI 10.1016/S0378-5173(99)00128-3
   Friess W, 1999, PHARM DEV TECHNOL, V4, P387, DOI 10.1081/PDT-100101374
   FRIESS W, 2000, THESIS FRIEDRICH ALE
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   ISRAEL DI, 1996, GROWTH FACTORS, V13, P139
   Jones CM, 1996, CURR BIOL, V6, P1468, DOI 10.1016/S0960-9822(96)00751-8
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kirker-Head CA, 2000, ADV DRUG DELIVER REV, V43, P65, DOI 10.1016/S0169-409X(00)00078-8
   Lecanda F, 1997, J CELL BIOCHEM, V67, P386, DOI 10.1002/(SICI)1097-4644(19971201)67:3<386::AID-JCB10>3.0.CO;2-B
   Li RH, 2001, TRENDS BIOTECHNOL, V19, P255, DOI 10.1016/S0167-7799(01)01665-1
   MARKS MG, 1991, J BIOMED MATER RES, V25, P683, DOI 10.1002/jbm.820250510
   MEINEL L, 2004, BIOTECHNOL BIOENG, P379
   MORIN R, 2001, THESIS TUFTS U MEDFO
   Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4
   PEREZRAMIREZ B, 2005, THERAPEUTIC PROTEINS, V308, P301
   PORTER TJ, 2004, J ASTM INT, V1, P1
   RATHORE S, 1995, PROTEIN SCI S2, V4, P110
   RATNER BD, 1996, BIOMATERAILS SCI INT, P88
   Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590
   SINGH M, 2004, THESIS U MARYLAND
   SINGH MP, 1995, J CONTROL RELEASE, V35, P165, DOI 10.1016/0168-3659(95)00033-5
   TIMASHEFF SN, 1991, PHARMACOL THERAPEUT, V52, P191, DOI 10.1016/0163-7258(91)90008-A
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Uludag H, 1999, ANN NY ACAD SCI, V875, P369, DOI 10.1111/j.1749-6632.1999.tb08519.x
   URIST MR, 1996, BONE MORPHOGENETIC P, P7
   WALKER TA, 1989, J LIQ CHROMATOGR, V12, P1213, DOI 10.1080/01483918908049502
   WINN SR, 1999, CLIN ORTHOP S, V367, P95
   Zhu Y, 1999, J CELL BIOL, V144, P1069, DOI 10.1083/jcb.144.5.1069
NR 34
TC 12
Z9 12
U1 0
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN
PY 2006
VL 7
IS 1
BP 131
EP 138
DI 10.1021/bm050461i
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 001PP
UT WOS:000234549100020
PM 16398507
DA 2018-10-20
ER

PT J
AU Toth, JM
   Wang, M
   Estes, BT
   Scifert, JL
   Seim, HB
   Turner, AS
AF Toth, JM
   Wang, M
   Estes, BT
   Scifert, JL
   Seim, HB
   Turner, AS
TI Polyetheretherketone as a biomaterial for spinal applications
SO BIOMATERIALS
LA English
DT Article
DE polyetheretherketone; bone morphogenetic protein (BMP); PEEK; spinal
   surgery; spine fusion; spine fusion cages
ID LUMBAR INTERBODY FUSION; IN-VIVO MODEL; TITANIUM CAGES; ORTHOPEDIC
   IMPLANTS; BIOLOGICAL RESPONSE; ARTHRODESIS; RHBMP-2; BONE; PROTEIN;
   SYSTEM
AB Threaded lumbar interbody spinal fusion devices (TIBFD) made from titanium have been reported to be 90% effective for single-level lumbar interbody fusion, although radiographic determination of fusion has been intensely debated in the literature. Using blinded radiographic, biomechanic, histologic, and statistical measures, we evaluated a radiolucent polyetheretherketone (PEEK)threaded interbody fusion device packed with autograft or rhBMP-2 on an absorbable collagen sponge in 13 sheep at 6 months. Radiographic fusion, increased spinal level biomechanical stiffness, and histologic fusion were demonstrated for the PEEK cages filled with autograft or rhBMP-2 on a collagen sponge. No device degradation or wear debris was observed. Only mild chronic inflammation consisting of a few macrophages was observed in peri-implant tissues. Based on these results, the polymeric biomaterial PEEK may be a useful biomaterial for interbody fusion cages due to the polymer's increased radiolucency and decreased stiffness. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Med Coll Wisconsin, Dept Orthopaed Surg, Milwaukee, WI 53226 USA.
   Duke Univ, Dept Biomed Engn, Durham, NC 27710 USA.
   Duke Univ, Div Orthopaed Surg, Orthopaed Res Labs, Durham, NC 27710 USA.
   Medtron Sofamor Danek, Memphis, TN 38132 USA.
   Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA.
RP Toth, JM (reprint author), Med Coll Wisconsin, Dept Orthopaed Surg, 9200 W Wisconsein Ave,Box 26099, Milwaukee, WI 53226 USA.
EM jtoth@mcw.edu
CR Abu Bakar MS, 2003, BIOMATERIALS, V24, P2245, DOI 10.1016/S0142-9612(03)00028-0
   Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4
   BAGBY GW, 1988, ORTHOPEDICS, V11, P931
   Boden SD, 1998, J SPINAL DISORD, V11, P95
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   Cho DY, 2003, NEUROSURGERY, V52, P693
   Cizek GR, 2000, SPINE, V25, P2633, DOI 10.1097/00007632-200010150-00015
   Cunningham BW, 1999, SPINE, V24, P509, DOI 10.1097/00007632-199903150-00002
   Fujihara K, 2003, BIOMATERIALS, V24, P2661, DOI 10.1016/S0142-9612(03)00065-6
   JOCKISCH KA, 1992, J BIOMED MATER RES, V26, P133, DOI 10.1002/jbm.820260202
   Katzer A, 2002, BIOMATERIALS, V23, P1749, DOI 10.1016/S0142-9612(01)00300-3
   Kuslich SD, 1998, SPINE, V23, P1267, DOI 10.1097/00007632-199806010-00019
   Martz EO, 1997, J BIOMED MATER RES, V38, P267, DOI 10.1002/(SICI)1097-4636(199723)38:3<267::AID-JBM12>3.0.CO;2-8
   McAfee PC, 1998, SPINE, V23, P1476, DOI 10.1097/00007632-199807010-00009
   McAfee PC, 2001, SPINE, V26, P320, DOI 10.1097/00007632-200102010-00020
   MORRISON C, 1995, BIOMATERIALS, V16, P987, DOI 10.1016/0142-9612(95)94906-2
   PRAEMER A, 1999, MUSCULOSKELETAL COND
   Ray CD, 1997, SPINE, V22, P667, DOI 10.1097/00007632-199703150-00019
   Rivard CH, 2002, J BIOMED MATER RES, V62, P488, DOI 10.1002/jbm.10159
   Sandhu HS, 1998, ORTHOP CLIN N AM, V29, P621, DOI 10.1016/S0030-5898(05)70035-3
   Sandhu HS, 1996, SPINE, V21, P1201, DOI 10.1097/00007632-199605150-00013
   Sandhu HS, 2002, SPINE, V27, P567, DOI 10.1097/00007632-200203150-00003
   Sandhu HS, 1995, SPINE, V20, P2669, DOI 10.1097/00007632-199512150-00008
   Sandhu HS, 1999, ANIMAL MODELS ORTHOP
   Senegas J, 2002, EUR SPINE J, V11, pS164, DOI 10.1007/s00586-002-0423-9
   Smit TH, 2002, EUR SPINE J, V11, P137, DOI 10.1007/s005860100346
   Toth JM, 2000, SPINE, V25, P2580, DOI 10.1097/00007632-200010150-00007
   TOTH JM, 1999, SPINAL INSTRUMENTATI, P73
   TURNER JA, 1992, JAMA-J AM MED ASSOC, V268, P907, DOI 10.1001/jama.268.7.907
   van Dijk M, 2002, SPINE, V27, P682, DOI 10.1097/00007632-200204010-00003
   Weiner BK, 1998, SPINE, V23, P634, DOI 10.1097/00007632-199803010-00020
   WHITE AA, 1990, CLIN BIOMECHANICS SP
   Whitecloud TS, 1998, J SPINAL DISORD, V11, P479
   Wilke HJ, 1997, SPINE, V22, P2365, DOI 10.1097/00007632-199710150-00009
   Zdeblick TA, 1998, SPINE, V23, P758, DOI 10.1097/00007632-199804010-00002
NR 35
TC 256
Z9 267
U1 9
U2 94
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2006
VL 27
IS 3
BP 324
EP 334
DI 10.1016/j.biomaterials.2005.07.011
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 982UO
UT WOS:000233187300005
PM 16115677
OA Green Published
DA 2018-10-20
ER

PT J
AU Hamilton, DJ
   Seguin, CA
   Wang, J
   Pilliar, RM
   Kandel, RA
AF Hamilton, DJ
   Seguin, CA
   Wang, J
   Pilliar, RM
   Kandel, RA
CA BioEngineering Skeletal Tissues
TI Formation of a nucleus pulposus-cartilage endplate construct in vitro
SO BIOMATERIALS
LA English
DT Article
DE intervertebral disc; nucleus pulposus; cartilage endplate; interface
   shear strength; biomaterial
ID CALCIUM POLYPHOSPHATE SCAFFOLDS; BONE SUBSTITUTE APPLICATIONS; HUMAN
   INTERVERTEBRAL DISC; VERTEBRAL COLUMN; CELL-SHAPE; DEGENERATION; SPINE;
   EXPRESSION; CALCIFICATION; CHONDROCYTES
AB Intervertebral disc (IVD) degeneration is a common problem and treatment options for persistent symptomatic disease are limited. Tissue engineering is being explored for its ability to reconstitute the functional components of the IVD. The purpose of this study was to determine whether it was possible to form in vitro a triphasic construct consisting of nucleus pulposus (NP), cartilage endplate (CEP), and a porous calcium polyphosphate (CPP) bone substitute. Bovine articular chondrocytes were placed on the top surface of a porous CPP construct and allowed to form cartilage in vitro. Nucleus pulposus cells were then placed onto the in vitroformed hyaline cartilage. At 24h scanning electron microscopy demonstrated that the NP cells maintained their rounded morphology, similar to NP cells placed directly on porous CPP. At 8 weeks histological examination of the triphasic constructs by light microscopy showed that a continuous layer of NP tissue had formed and was fused to the underlying cartilage tissue, which itself was integrated with the porous CPP. The incorporation of the cartilage layer was beneficial to the construct by improving tissue attachment to the CPP, as demonstrated by increased peak load and increased energy required for failure during shear loading when compared to a biphasic construct composed of nucleus pulposus-bone substitute only. This study demonstrates that it is possible to generate a multi-component construct with the incorporation of a CEP-like layer resulting in improved bone substitute-to-IVD tissue interface characteristics. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Toronto, Dept Lab Med & Pathobiol, Mt Sinai Hosp, Toronto, ON M5X 1G5, Canada.
   Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3E3, Canada.
RP Kandel, RA (reprint author), Univ Toronto, Dept Lab Med & Pathobiol, Mt Sinai Hosp, 600 Univ Ave,Suite 600, Toronto, ON M5X 1G5, Canada.
EM rkandel@mtsinai.on.ca
RI Seguin, Cheryle/G-4511-2013; Kandel, Rita/E-2149-2017
OI Kandel, Rita/0000-0003-4047-3913
CR BERNICK S, 1982, SPINE, V7, P97, DOI 10.1097/00007632-198203000-00002
   BOGDUK N, 1997, CLIN ANATOMY LUMBAR, P13
   BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022
   Chanchairujira K, 2004, RADIOLOGY, V230, P499, DOI 10.1148/radiol.2302011842
   Ciolfi VJD, 2003, BIOMATERIALS, V24, P4761, DOI 10.1016/S0142-9612(03)00373-9
   CROCK HV, 1976, CLIN ORTHOP RELAT R, P6
   FRICK SL, 1994, SPINE, V19, P1826, DOI 10.1097/00007632-199408150-00006
   Ganey TM, 2002, EUR SPINE J, V11, pS206, DOI 10.1007/s00586-002-0494-7
   GLOWACKI J, 1983, P SOC EXP BIOL MED, V172, P93
   Gruber H E, 2000, BMC Musculoskelet Disord, V1, P1, DOI 10.1186/1471-2474-1-1
   Gruber HE, 2003, BIOTECH HISTOCHEM, V78, P109, DOI 10.1080/10520290310001593793
   Grynpas MD, 2002, BIOMATERIALS, V23, P2063, DOI 10.1016/S0142-9612(01)00336-2
   Horner HA, 2002, SPINE, V27, P1018, DOI 10.1097/00007632-200205150-00004
   HUMZAH MD, 1988, ANAT RECORD, V220, P337, DOI 10.1002/ar.1092200402
   Hunter CJ, 2004, TISSUE ENG, V10, P736, DOI 10.1089/1076327041348310
   Kokkonen SM, 2002, SPINE, V27, P2274, DOI 10.1097/01.BRS.0000029248.13169.51
   Kroeber MW, 2002, SPINE, V27, P2684, DOI 10.1097/00007632-200212010-00007
   Lee MC, 2000, CLIN ORTHOP RELAT R, P286
   Luk KDK, 1997, CLIN ORTHOP RELAT R, P13
   MOORE RJ, 1992, SPINE, V17, P874, DOI 10.1097/00007632-199208000-00003
   Moore RJ, 2000, EUR SPINE J, V9, P92, DOI 10.1007/s005860050217
   NACHEMSON A, 1970, ACTA ORTHOP SCAND, V41, P589, DOI 10.3109/17453677008991550
   Nishimura K, 1998, SPINE, V23, P1531, DOI 10.1097/00007632-199807150-00006
   Okuma M, 2000, J ORTHOPAED RES, V18, P988, DOI 10.1002/jor.1100180620
   OLSON EJ, 1991, SPINE, V16, P1081, DOI 10.1097/00007632-199109000-00013
   Peretti GM, 2003, J BIOMED MATER RES A, V64A, P517, DOI 10.1002/jbm.a.10367
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   ROBERTS S, 1989, SPINE, V14, P166, DOI 10.1097/00007632-198902000-00005
   Roberts S, 1996, SPINE, V21, P415, DOI 10.1097/00007632-199602150-00003
   Sahlman J, 2001, SPINE, V26, P2558, DOI 10.1097/00007632-200112010-00008
   Seguin CA, 2004, SPINE, V29, P1299, DOI 10.1097/01.BRS.0000127183.43765.AF
   URBAN JPG, 1977, CLIN ORTHOP RELAT R, P101
   Waddell G, 1996, SPINE, V21, P2820, DOI 10.1097/00007632-199612150-00002
   Waldman SD, 2002, J BIOMED MATER RES, V62, P323, DOI 10.1002/jbm.10235
NR 34
TC 44
Z9 58
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2006
VL 27
IS 3
BP 397
EP 405
DI 10.1016/j.biomaterials.2005.07.007
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 982UO
UT WOS:000233187300013
PM 16139883
DA 2018-10-20
ER

PT J
AU Dang, JM
   Sun, DDN
   Shin-Ya, Y
   Sieber, AN
   Kostuik, JP
   Leong, KW
AF Dang, JM
   Sun, DDN
   Shin-Ya, Y
   Sieber, AN
   Kostuik, JP
   Leong, KW
TI Temperature-responsive hydroxybutyl chitosan for the culture of
   mesenchymal stem cells and intervertebral disk cells
SO BIOMATERIALS
LA English
DT Article
DE chitin/chitosan; thermally responsive material; hydrogel; mesenchymal
   stem cells; intervertebral disk
ID IN-VIVO; STERILIZATION; REGENERATION; TRANSFECTION; EFFICIENCY;
   COPOLYMER; HYDROGELS; DELIVERY; THERAPY; DISEASE
AB Temperature-responsive polymers are attractive candidates for applications related to injectable delivery of biologically active therapeutics, such as stem cells. In this study, we evaluate the potential of thermosensitive hydroxybutyl chitosan (HBC) as a biomaterial for the culture of human mesenchymal stem cells (hMSC) and cells derived from the intervertebral disk, with the eventual goal of using the HBC polymer as an injectable matrix/cell therapeutic. Conjugation of hydroxybutyl groups to chitosan renders the polymer water soluble and thermally responsive. Below its lower critical solution temperature, a solution of HBC can be maintained indefinitely in its solvated state. Upon exposure to a 37 degrees C environment, within 60 s, a 3.8 wt% HBC solution rapidly forms a gel that can be maneuvered with forceps. Upon cooling, the gel once again is able to revert to its solvated state. The gel exhibits a dramatic increase in both G' and G" with increasing temperature, signifying a temperature-dependent enhancement of gel mechanical properties. Although a solid structure upon gelation, due to its physical nature of polymer interaction and gel formation, the gel exhibits a fluid-like viscoelastic behavior when exposed to shear stresses of up to 10% strain, with both G' and G" approaching zero with increasing shear stress. Formulations of HBC gels presented in this study have gelation temperatures ranging from 13.0 to 34.6 degrees C and water contents of 67-95%. Minimal cytotoxicity in MSC and disk cell cultures was observed with these polymers up to a concentration of 5 wt%. Detection of metabolic activity, genetic analysis of synthesized mRNA, and histological staining of MSC and disk cell cultures in these gels collectively indicate cell proliferation without a loss in metabolic activity and extracellular matrix production. This study suggests the potential of HBC gel as an injectable carrier for future applications of delivering therapeutics to encourage a biologically relevant reconstruction of the degenerated disk. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA.
   Johns Hopkins Univ Hosp, Dept Orthopaed Surg, Baltimore, MD 21287 USA.
RP Leong, KW (reprint author), Johns Hopkins Univ, Dept Biomed Engn, 720 Rutland Ave,Ross 729, Baltimore, MD 21205 USA.
EM kleong@bmc.jhu.edu
RI Leong, Kam/A-7270-2009
OI Leong, Kam/0000-0002-8133-4955
CR Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010
   Aklonis J. J., 1983, INTRO POLYM VISCOELA
   An HS, 2003, SPINE, V28, pS86, DOI 10.1097/00007632-200308011-00015
   Au A, 2004, J BIOMED MATER RES A, V69A, P367, DOI 10.1002/jbm.a.20132
   Blanchard J, 1999, PHARMACEUT RES, V16, P1796, DOI 10.1023/A:1011930821801
   Bono CM, 2004, SPINE, V29, P455, DOI 10.1097/01.BRS.0000090825.94611.28
   Chiba K, 1997, SPINE, V22, P2885, DOI 10.1097/00007632-199712150-00011
   Cho JH, 2004, BIOMATERIALS, V25, P5743, DOI 10.1016/j.biomaterials.2004.01.051
   Crevensten G, 2004, ANN BIOMED ENG, V32, P430, DOI 10.1023/B:ABME.0000017545.84833.7c
   Gupta R.K., 2000, POLYM COMPOSITE RHEO
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Guyer RD, 2003, SPINE, V28, pS15, DOI 10.1097/00007632-200308011-00004
   IMOTO T, 1971, AGR BIOL CHEM TOKYO, V35, P1154, DOI 10.1080/00021369.1971.10860050
   Itoh S, 2003, BRAIN RES, V993, P111, DOI 10.1016/j.brainres.2003.09.003
   Jarry C, 2002, CHEM PHARM BULL, V50, P1335, DOI 10.1248/cpb.50.1335
   Jarry C, 2001, J BIOMED MATER RES, V58, P127, DOI 10.1002/1097-4636(2001)58:1<127::AID-JBM190>3.0.CO;2-G
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kiang T, 2004, BIOMATERIALS, V25, P5293, DOI 10.1016/j.biomaterials.2003.12.036
   Kim KS, 2003, J NEUROSURG, V99, P291, DOI 10.3171/spi.2003.99.3.0291
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8
   Marreco PR, 2004, J BIOMED MATER RES B, V71B, P268, DOI 10.1002/jbm.b.30081
   Molinaro G, 2002, BIOMATERIALS, V23, P2717, DOI 10.1016/S0142-9612(02)00004-2
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Quick DJ, 2004, J CONTROL RELEASE, V97, P333, DOI 10.1016/j.jconrel.2004.03.001
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V58, P409, DOI 10.1016/j.ejpb.2004.03.019
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V57, P53, DOI 10.1016/S0939-6411(03)00095-X
   Satake K, 2004, SPINE, V29, P1971, DOI 10.1097/01.brs.0000138273.02820.0a
   Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45
   Smits P, 2003, DEVELOPMENT, V130, P1135, DOI 10.1242/dev.00331
   Sobajima S, 2004, GENE THER, V11, P390, DOI 10.1038/sj.gt.3302200
   Tsuda Y, 2004, J BIOMED MATER RES A, V69A, P70, DOI 10.1002/jbm.a.20114
   Weinstein James N, 2003, Spine (Phila Pa 1976), V28, pS1
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   Zdeblick TA, 2003, SPINE, V28, pS2, DOI 10.1097/00007632-200308011-00002
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 36
TC 146
Z9 163
U1 6
U2 76
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2006
VL 27
IS 3
BP 406
EP 418
DI 10.1016/j.biomaterials.2005.07.033
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 982UO
UT WOS:000233187300014
PM 16115680
DA 2018-10-20
ER

PT J
AU King, VR
   Phillips, JB
   Hunt-Grubbe, H
   Brown, R
   Priestley, JV
AF King, VR
   Phillips, JB
   Hunt-Grubbe, H
   Brown, R
   Priestley, JV
TI Characterization of non-neuronal elements within fibronectin mats
   implanted into the damaged adult rat spinal cord
SO BIOMATERIALS
LA English
DT Article
DE fibronectin; nerve tissue engineering; laminin; macrophage
ID PERIPHERAL-NERVE REGENERATION; CULTURED SCHWANN-CELLS; AXONAL
   REGENERATION; FUNCTIONAL RECOVERY; PLASMA FIBRONECTIN; SENSORY AXONS;
   GROWTH-FACTOR; BRAIN INJURY; LAMININ; REPAIR
AB Previous studies have shown that mats made from fibronectin (FN) integrate well into spinal cord lesion sites and support extensive axonal growth. Using immunohistochemistry, we have investigated the non-neuronal factors that contribute to these properties. Extensive vascularization was observed in FN mats by 1 week along with heavy inacrophage infiltration by 3 days post-implantation. By 1 week post-implantation, laminin tubules had formed and were associated with axons and p75 immunoreactive Schwann cells. By 4 weeks post-implantation, most axons were associated with Schwarm cell derived myelin. Few oligodendrocytes were present within the mat, even with an increase in the number of oligodendrocyte precursors around the implant site by 7 days post-implantation. Astrocyte proliferation also occurred in the intact tissue, with a prominent glial scar forming around the implant within 4 weeks. However, by 2 months post-implantation astrocytes were present in the FN implant site and were intermingled with the axons. Axonal ingrowth and integration of the FN mats is probably due to the ability of FN mats to support and organize infiltration of Schwarm cells and deposition of laminin. At later time points, myelinated axons remain in the implant site, even after other elements (e.g. macrophages and laminin) have disappeared. Both of these properties are likely to be important in the design of biomaterial bridges for CNS regeneration. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Queen Mary Univ London, St Bartholomews & Royal London Sch Med & Dent, Ctr Neurosci, Inst Cell & Mol Sci, London E1 2AT, England.
   UCL, Inst Orthopaed, Tissue Repair & Engn Ctr, Stanmore HA7 4LP, Middx, England.
RP King, VR (reprint author), Queen Mary Univ London, St Bartholomews & Royal London Sch Med & Dent, Ctr Neurosci, Inst Cell & Mol Sci, 4 Newark St, London E1 2AT, England.
EM Vonrking@yahoo.co.uk
RI Phillips, James/G-7926-2014
OI Phillips, James/0000-0001-8117-3074
FU Wellcome Trust
CR Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695
   Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0
   Bhat RV, 1996, GLIA, V17, P169
   Brook GA, 1998, J NEUROSCI RES, V53, P51, DOI 10.1002/(SICI)1097-4547(19980701)53:1<51::AID-JNR6>3.0.CO;2-I
   Casella GTB, 2002, EXP NEUROL, V173, P63, DOI 10.1006/exnr.2001.7827
   Chauhan NB, 1999, INT J DEV NEUROSCI, V17, P255, DOI 10.1016/S0736-5748(99)00003-9
   CHIU AY, 1991, GLIA, V4, P11, DOI 10.1002/glia.440040103
   DOUGHERTY KD, 2000, NEUROBIOL DIS, V7, P575
   EJIM OS, 1993, BIOMATERIALS, V14, P743, DOI 10.1016/0142-9612(93)90038-4
   ENG LF, 1992, PROG BRAIN RES, V94, P353
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Franzen R, 1998, J NEUROSCI RES, V51, P316, DOI 10.1002/(SICI)1097-4547(19980201)51:3<316::AID-JNR5>3.3.CO;2-6
   Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   Hobson MI, 1997, BRIT J PLAST SURG, V50, P125, DOI 10.1016/S0007-1226(97)91325-4
   Hoke A, 1996, PROG BRAIN RES, V108, P149, DOI 10.1016/S0079-6123(08)62538-8
   HOULE JD, 1994, J NEURAL TRANSP PLAS, V5, P115, DOI 10.1155/NP.1994.115
   Houweling DA, 1998, EXP NEUROL, V153, P49, DOI 10.1006/exnr.1998.6867
   King VR, 2003, EXP NEUROL, V182, P383, DOI 10.1016/S0014-4886(03)00033-5
   Li Y, 1997, EXP NEUROL, V145, P397, DOI 10.1006/exnr.1997.6502
   LI Y, 1994, J NEUROSCI, V14, P4050
   LuckenbillEdds L, 1997, BRAIN RES REV, V23, P1, DOI 10.1016/S0165-0173(96)00013-6
   Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1
   McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001
   Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Phillips JB, 2004, BIOMATERIALS, V25, P2769, DOI 10.1016/j.biomaterias.2003.09.052
   Plant GW, 1997, EXP NEUROL, V143, P287, DOI 10.1006/exnr.1997.6407
   Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S
   Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118
   Prewitt CMF, 1997, EXP NEUROL, V148, P433, DOI 10.1006/exnr.1997.6694
   Ramer LM, 2004, J COMP NEUROL, V473, P1, DOI 10.1002/cne.20049
   Rangappa N, 2000, J BIOMED MATER RES, V51, P625, DOI 10.1002/1097-4636(20000915)51:4<625::AID-JBM10>3.0.CO;2-U
   Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814
   Rappolee D A, 1992, Curr Top Microbiol Immunol, V181, P87
   Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471
   SCHWARTZ M, 2001, J NEUROIMMUNOL, V113, P120
   Shindler KS, 1996, J HISTOCHEM CYTOCHEM, V44, P1331, DOI 10.1177/44.11.8918908
   SOSALE A, 1988, EXP NEUROL, V102, P14, DOI 10.1016/0014-4886(88)90074-X
   Takami T, 2002, J NEUROSCI, V22, P6670
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Trigg DJ, 1998, AM J OTOLARYNG, V19, P29, DOI 10.1016/S0196-0709(98)90062-X
   VENSTROM KA, 1993, FASEB J, V7, P996
   Wang X, 1997, EXP NEUROL, V148, P568, DOI 10.1006/exnr.1997.6702
   Woerly S, 1998, J BIOMAT SCI-POLYM E, V9, P681, DOI 10.1163/156856298X00091
   Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x
   XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113
   Yanaka K, 1996, J NEUROSURG, V85, P125, DOI 10.3171/jns.1996.85.1.0125
   Zhang QL, 1996, J NEUROSCI RES, V43, P496, DOI 10.1002/(SICI)1097-4547(19960215)43:4<496::AID-JNR11>3.0.CO;2-0
NR 49
TC 43
Z9 48
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2006
VL 27
IS 3
BP 485
EP 496
DI 10.1016/j.biomaterials.2005.06.033
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 982UO
UT WOS:000233187300021
PM 16102813
DA 2018-10-20
ER

PT S
AU Park, MJ
   Choi, WM
   Park, OO
AF Park, MJ
   Choi, WM
   Park, OO
BE Nicolau, DV
TI Cell-micropatterning by micromolding in capillary technique based on UV
   polymerization
SO BIOMEMS AND NANOTECHNOLOGY II
SE Progress in Biomedical Optics and Imaging
LA English
DT Proceedings Paper
CT Conference on BioMEMS and Nanotechnology II
CY DEC 12-14, 2005
CL Brisbane, AUSTRALIA
SP SPIE, Queensland Univ Technol, USAF Off Sci Res Asian Off Aerosp Res & Dev, Def Sci & Technol Org, Bandwidth Foundry
DE cell-micropatterning; poly(ethylene glycol); fibronectin; micromolding
   in capillary; UV polymerization
ID PROTEIN SURFACE INTERACTIONS; SELF-ASSEMBLED MONOLAYERS; POLYETHYLENE
   OXIDE; LITHOGRAPHY; MICROARRAYS
AB Although optical lithography or photolithography is one of the most well-established techniques for micro, nanofabrication, its usage with proteins and cells is restricted by steps that must be carried out in harsh organic solvents. Here, we present simple methods for cell-micropatterning using poly(dimethylsiloxane) (PDMS) as a mold. Cell non-adhesive surface or nonfouling surface providing a physico-chemical barrier to cell attachment was introduced for biomaterial pattering, where cells fail to interact with the surface over desired periods of time determined by each application. Poly(ethylene glycol) (PEG) was selected as nonfouling material to inhibit protein adsorption from biological media. The fouling resistance of PEG polymer is often explained by a steric repulsion interaction, resulting from the compression of PEG chains as proteins approach the surface. We also chose fibronectin to direct cell attachment because it is an extracellular matrix protein that is involved in the adhesion and spreading of anchorage-dependent cells. In our experiment, we propose two methods by application of micromolding in capillary (MIMIC) method based on UV polymerization to obtain a surface of alternating PEG and fibronectin. First to fabricate PEG microstructure via MIMIC method, a pre-patterned PDMS mold is placed on a desired substrate, and then the relief structure in the mold forms a network of empty channels. A drop of ethylene glycol monomer solution containing initiator for UV polymerization is placed at the open ends of the network of channels, which is then polymerized by exposure to UV light at room temperature. Once PEG microstructure is fabricated, incubation of the patterned surface in a fibronectin-containing solution allows back-filling of only the bare regions with fibronectin via adsorption. In the alternative method, a substrate is first incubated in a fibronectin-containing solution, leading to the adsorption of fibronectin over the entire surface, and the fibronectin-adsorbed substrate is then micropatterned with the PEG by MIMIC based on UV polymerization. Both methods create reproducible alternating PEG and fibronectin patterns applicable to cell-surface interactions on the microscale.
C1 Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, 373-1 Guseong Dong, Taejon 305701, South Korea.
RP Park, MJ (reprint author), Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, 373-1 Guseong Dong, Taejon 305701, South Korea.
EM ookpark@kaist.ac.kr
FU KOSEF; Brain Korea 21 Project
FX The authors are grateful to the Center for Advanced Functional Polymers,
   which is supported by KOSEF. This work is also partially supported by
   the Brain Korea 21 Project.
CR Avseenko NV, 2001, ANAL CHEM, V73, P6047, DOI 10.1021/ac010460q
   BAILEY FE, 1984, POLYETHYLENE OXIDE
   Bernard A, 2000, ADV MATER, V12, P1067, DOI 10.1002/1521-4095(200007)12:14<1067::AID-ADMA1067>3.0.CO;2-M
   Bernard A, 1998, LANGMUIR, V14, P2225, DOI 10.1021/la980037l
   Bhatia SN, 1998, J BIOMAT SCI-POLYM E, V9, P1137, DOI 10.1163/156856298X00695
   DONG M, 1995, J COLLOID INTERF SCI, V172, P21, DOI 10.1006/jcis.1995.1221
   Garno JC, 2002, LANGMUIR, V18, P8186, DOI 10.1021/la020518b
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kung LA, 2000, LANGMUIR, V16, P6773, DOI 10.1021/la000653t
   Lahiri J, 1999, LANGMUIR, V15, P2055, DOI 10.1021/la9811970
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   Martin BD, 1998, LANGMUIR, V14, P3971, DOI 10.1021/la9713311
   Myers D., 1991, SURFACE INTERFACES C
   Nicolau DV, 1999, LANGMUIR, V15, P3845, DOI 10.1021/la980914n
   PALEGROSDEMANGE C, 1991, J AM CHEM SOC, V113, P12, DOI 10.1021/ja00001a002
   Patel N, 1998, FASEB J, V12, P1447
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Renault JP, 2002, ANGEW CHEM INT EDIT, V41, P2320, DOI 10.1002/1521-3773(20020703)41:13<2320::AID-ANIE2320>3.0.CO;2-Z
   Rowe CA, 1999, ANAL CHEM, V71, P433, DOI 10.1021/ac980798t
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
NR 24
TC 0
Z9 0
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 1605-7422
BN 0-8194-6067-2
J9 PRO BIOMED OPT IMAG
PY 2006
VL 6036
AR 60361I
DI 10.1117/12.638215
PG 8
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BEB08
UT WOS:000236540300037
DA 2018-10-20
ER

PT J
AU Facchini, A
   Lisignoli, G
   Cristino, S
   Roseti, L
   De Franceschi, L
   Marconi, E
   Grigolo, B
AF Facchini, Andrea
   Lisignoli, Gina
   Cristino, Sandra
   Roseti, Livia
   De Franceschi, Luciana
   Marconi, Emanuele
   Grigolo, Brunella
TI Human chondrocytes and mesenchymal stem cells grown onto engineered
   scaffold
SO BIORHEOLOGY
LA English
DT Article; Proceedings Paper
CT 4th International Symposium on Mechanobiology of Cartilage and
   Chondrocyte
CY MAY 20-22, 2006
CL Budapest, HUNGARY
DE human chondrocytes; mesenchymal stem cells; hyaluronan-based scaffold;
   chondrogenic differentiation
ID ARTICULAR-CARTILAGE REPAIR; IN-VITRO; DIFFERENTIATION; TRANSPLANTATION;
   CHONDROGENESIS; DEFECTS; OSTEOARTHRITIS; SCIENCE; MATRIX; KNEE
AB The development of improved methods for treatment of chondral defects using autologous cells in combination with biomaterials leads to a new generation of implantable devices. Their association gives rise to a hybrid construct combining biological and material components that can be specifically committed. The comprehension of cellular and molecular mechanisms of cartilage repair and the use of biomaterials in combination with chondrocytes or mesenchymal stem cells in the treatment of cartilage defects has opened a new era of therapeutical strategies. Recently, their applicability in the treatment of early lesions in osteoarthritis is under investigation. To obtain new information on the behaviour of chondrocytes and mesenchymal stem cells grown on a hyaluronan derivative scaffold (Hyaff((R))-11) already used in cartilage repair, we analysed a series of molecules expressed by these cells by Real-Time RT-PCR and immunohistochemical analyses. The data obtained with this work showed that this biomaterial is able to reduce the expression of some catabolic molecules by human chondrocytes and provide a good environment to support the differentiation of mesenchymal stem cells in chondrogenic sense. These observations confirm Hyaff((R))-11 as a suitable scaffold both for chondrocytes and mesenchymal stem cells for the treatment of articular cartilage defects.
C1 IOR, Ist Ric Codivilla Putti, Lab Immunol & Genet, I-40136 Bologna, Italy.
   Univ Bologna, Dipartimento Med Interna & Gastroenterol, I-40138 Bologna, Italy.
RP Grigolo, B (reprint author), IOR, Ist Ric Codivilla Putti, Lab Immunol & Genet, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM grigolob@alma.unibo.it
RI Grigolo, Brunella/J-5417-2016
OI Grigolo, Brunella/0000-0002-3990-6745
CR BLANCO FJ, 1995, J IMMUNOL, V154, P4018
   Bosnakovski D, 2004, EXP HEMATOL, V32, P502, DOI 10.1016/j.exphem.2004.02.009
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   BUCKWALTER JA, 1990, BRIS MYER Z, P19
   Chimal-Monroy J, 2003, DEV BIOL, V257, P292, DOI 10.1016/S0012-1606(03)00066-6
   Dickinson SC, 2005, TISSUE ENG, V11, P277, DOI 10.1089/ten.2005.11.277
   Frenkel SR, 2004, ANN BIOMED ENG, V32, P26, DOI 10.1023/B:ABME.0000007788.41804.0d
   Galois L, 2004, BIORHEOLOGY, V41, P433
   Grigolo B, 2002, BIOMATERIALS, V23, P1187, DOI 10.1016/S0142-9612(01)00236-8
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   Heng BC, 2004, STEM CELLS, V22, P1152, DOI 10.1634/stemcells.2004-0062
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Iannone F, 2003, AGING CLIN EXP RES, V15, P364, DOI 10.1007/BF03327357
   Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbre.2004.06.029
   KAISHO T, 1992, J IMMUNOL, V149, P4088
   Kavalkovich Karl W., 2002, In Vitro Cellular and Developmental Biology Animal, V38, P457, DOI 10.1290/1071-2690(2002)038<0457:CDOHMS>2.0.CO;2
   KUETTNER KE, 1998, RHEUMATOLOGY, V2, P6
   Landis WJ, 2005, ORTHOP CLIN N AM, V36, P97, DOI 10.1016/j.ocl.2004.06.006
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Majumdar MK, 2000, J CELL PHYSIOL, V185, P98
   Maleski MP, 1996, EXP CELL RES, V225, P55, DOI 10.1006/excr.1996.0156
   Martin JA, 2002, BIOGERONTOLOGY, V3, P257, DOI 10.1023/A:1020185404126
   Miura Y, 2002, J BONE JOINT SURG AM, V84A, P793, DOI 10.2106/00004623-200205000-00015
   Moskowitz Roland W, 2004, Am J Orthop (Belle Mead NJ), V33, P10
   Okazaki K, 2004, CLIN ORTHOP RELAT R, pS123, DOI 10.1097/01.blo.0000144478.51284.f3
   Pavesio Alessandra, 2003, Novartis Found Symp, V249, P203
   Peterson L, 2003, J BONE JOINT SURG AM, V85A, P17, DOI 10.2106/00004623-200300002-00003
   Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W
   Schmitt B, 2003, DIFFERENTIATION, V71, P567, DOI 10.1111/j.1432-0436.2003.07109003.x
   Solchaga LA, 2005, OSTEOARTHR CARTILAGE, V13, P297, DOI 10.1016/j.joca.2004.12.016
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   Vacanti CA, 2000, ORTHOP CLIN N AM, V31, P351, DOI 10.1016/S0030-5898(05)70155-3
   Wang XH, 2004, BIOMATERIALS, V25, P3681, DOI 10.1016/j.biomaterials.2003.10.102
NR 33
TC 29
Z9 30
U1 0
U2 7
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0006-355X
J9 BIORHEOLOGY
JI Biorheology
PY 2006
VL 43
IS 3-4
BP 471
EP 480
PG 10
WC Biophysics; Engineering, Biomedical; Hematology
SC Biophysics; Engineering; Hematology
GA 071YB
UT WOS:000239638700029
PM 16912418
DA 2018-10-20
ER

PT J
AU Knabe, C
   Kraska, B
   Koch, C
   Gross, U
   Zreiqat, H
   Stiller, M
AF Knabe, C.
   Kraska, B.
   Koch, C.
   Gross, U.
   Zreiqat, H.
   Stiller, M.
TI A method for immunohistochemical detection of osteogenic markers in
   undecalcified bone sections
SO BIOTECHNIC & HISTOCHEMISTRY
LA English
DT Article
DE bone-biomaterial interface; bone-matrix proteins; hard tissue histology;
   immunohistochemistry; osteogenic markers; PMMA resins; undecalcified
   sections
ID IN-SITU HYBRIDIZATION; BETA-TCP PARTICLES; BIOACTIVE GLASS;
   CELL-FUNCTION; EXPRESSION; INTERFACE; PHENOTYPE; IMPLANTS; MARROW;
   SYSTEM
AB To evaluate the osteogenic potential of novel implant materials, it is important to examine their effect on osteoblastic differentiation. Characterizing the tissue response at the bone-biomaterial interface in vivo at a molecular level would contribute significantly to enhancing our understanding of tissue integration of endosseous implant materials. We describe here a new technique that overcomes difficulties commonly associated with performing immunohistochemistry on undecalcified sawed sections of bone. Sheep mandible specimens were fixed in an ethanol based fixative to maintain adequate antigenicity of the tissue. As a result, it was possible to omit antigen retrieval at high temperature for recovery of antigenicity, and detachment of sections from the slides was avoided. Following dehydration and infiltration, the specimens were embedded in a resin composed of polymethylmethacrylate and polybutylmethacrylate. Polymerization was achieved by adding benzoylperoxide and N,N-dimethyl-toluidine. This resin was selected because it maintained the antigenicity of the tissue, provided adequate properties for cutting 50 mu m thick sections, and it facilitated deacrylizing the sawed sections. Acid-resistant acrylic slides were glued to the blocks using an epoxy resin based two-component adhesive to avoid detachment of the slides during the deacrylation procedure. Samples were stained for alkaline phosphatase, type I collagen, osteonectin, osteopontin, osteocalcin and bone sialoprotein. The EnVision + (TM) dextran polymer conjugate two-step visualization system was applied for immunohistochemical detection of these bone matrix proteins. This procedure yielded positive staining for the osteogenic markers in cells and matrix components. The protocol described here facilitates the use of immunohistochemistry on resin embedded sawed sections of bone and provides a convenient and reliable method that can be used routinely for immunohistochemical analysis of hard tissue specimens containing implant materials.
C1 Charite Univ, Med Ctr, Dept Expt Dent, D-14197 Berlin, Germany.
   Charite Univ, Med Ctr, Inst Pathol, D-14197 Berlin, Germany.
   Charite Univ, Med Ctr, Dept Plast & Maxillofacial Surg, Div Oral Surg, D-14197 Berlin, Germany.
   Univ New S Wales, Sch Med Sci, Dept Pathol, Kensington, NSW 2033, Australia.
RP Knabe, C (reprint author), Charite Univ, Med Ctr, Dept Expt Dent, Campus Benjamin Franklin,Assmannshauser Str 4-6, D-14197 Berlin, Germany.
EM christine.knabe@charite.de
CR Bolind P, 1999, CLIN IMPLANT DENT R, V1, P33
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   ElGhannam A, 1997, J BIOMED MATER RES, V36, P167, DOI 10.1002/(SICI)1097-4636(199708)36:2<167::AID-JBM5>3.0.CO;2-I
   ElGhannam A, 1997, BIOMATERIALS, V18, P295, DOI 10.1016/S0142-9612(96)00059-2
   GROSS UM, 1977, STAIN TECHNOL, V52, P217, DOI 10.3109/10520297709116778
   GROSS UM, 2002, P 17 EUR C BIOM BARC, P23
   Hantschick M, 1998, PATHOL RES PRACT, V194, P111, DOI 10.1016/S0344-0338(98)80078-2
   Kammerer U, 2001, J HISTOCHEM CYTOCHEM, V49, P623, DOI 10.1177/002215540104900509
   KAPLOW LS, 1955, BLOOD, V10, P1023
   Knabe C, 2004, J BIOMED MATER RES A, V69A, P145, DOI 10.1002/jbm.a.20131
   Neo M, 1996, J BIOMED MATER RES, V30, P485, DOI 10.1002/(SICI)1097-4636(199604)30:4<485::AID-JBM6>3.0.CO;2-L
   Neo M, 1998, J BIOMED MATER RES, V39, P1, DOI 10.1002/(SICI)1097-4636(199801)39:1<1::AID-JBM1>3.0.CO;2-U
   Neo M, 1998, J BIOMED MATER RES, V39, P71, DOI 10.1002/(SICI)1097-4636(199801)39:1<71::AID-JBM9>3.0.CO;2-F
   Ohsawa K, 2000, J BIOMED MATER RES, V52, P460, DOI 10.1002/1097-4636(20001205)52:3<460::AID-JBM3>3.3.CO;2-L
   Reis SA, 1996, CLIN ORAL IMPLAN RES, V7, P253, DOI 10.1034/j.1600-0501.1996.070307.x
   Roeser Kerstin, 2000, Journal of Biomedical Materials Research, V51, P280
   Sabattini E, 1998, J CLIN PATHOL, V51, P506, DOI 10.1136/jcp.51.7.506
   Vyberg M, 1998, APPL IMMUNOHISTOCHEM, V6, P3, DOI 10.1097/00022744-199803000-00002
   Werther K, 1999, J HISTOCHEM CYTOCHEM, V47, P959, DOI 10.1177/002215549904700713
   Yang R, 2003, Eur Cell Mater, V6, P57
   Zreiqat H, 1999, J BIOMED MATER RES, V44, P389, DOI 10.1002/(SICI)1097-4636(19990315)44:4<389::AID-JBM4>3.0.CO;2-O
   Zreiqat H, 1996, J BIOMED MATER RES, V33, P217, DOI 10.1002/(SICI)1097-4636(199624)33:4<217::AID-JBM2>3.0.CO;2-S
NR 23
TC 27
Z9 29
U1 0
U2 3
PU B I O S SCIENTIFIC PUBLISHERS LTD
PI OXFORD
PA 9 NEWTEC PLACE, MAGDALEN RD, OXFORD OX4 1RE, ENGLAND
SN 1052-0295
J9 BIOTECH HISTOCHEM
JI Biotech. Histochem.
PD JAN-FEB
PY 2006
VL 81
IS 1
BP 31
EP 39
DI 10.1080/10520290600725474
PG 9
WC Biotechnology & Applied Microbiology; Cell Biology
SC Biotechnology & Applied Microbiology; Cell Biology
GA 063VK
UT WOS:000239047800005
PM 16760125
DA 2018-10-20
ER

PT J
AU Bentolila, LA
   Weiss, S
AF Bentolila, LA
   Weiss, S
TI Single-step multicolor fluorescence in situ hybridization using
   semiconductor quantum dot-DNA conjugates
SO CELL BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE quantum dots; FISH; DNA; heterochromatin; centromere; fluorescence;
   imaging; microscopy; hybridization; biomaterial; nanotechnology
ID HIGH-RESOLUTION; INSITU HYBRIDIZATION; HUMAN-CHROMOSOMES; SATELLITE DNA;
   NANOCRYSTALS; PROBES; INTERMITTENCY; BLINKING; CELLS; FISH
AB We report a rapid method for the direct multicolor imaging of multiple subnuclear genetic sequences using novel quantum dot-based fluorescence in situ hybridization (FISH) probes (QD-FISH). Short DNA oligonucleotides were attached on QDs and used in a single hybridization/detection step of target sites in situ. QD-FISH probes penetrate both intact interphase nuclei and metaphase chromosomes and showed good targeting of dense chromatin domains with minimal steric hindrances. We further demonstrated that QD's broad absorption spectra allowed different colored probes specific for distinct subnuclear genetic sequences to be simultaneously excited with a single excitation wavelength and imaged free of chromatic aberrations in a single exposure. Thus, these results demonstrate that QD-FISH probes are very effective in multicolor FISH applications. This work also documents new possibilities of using QD-FISH probes detection down to the single molecule.
C1 Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.
RP Bentolila, LA (reprint author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.
EM lbento@chem.ucla.edu
RI weiss, shimon/B-4164-2009
OI weiss, shimon/0000-0002-0720-5426
FU NIBIB NIH HHS [R01 EB000312, R01 EB000312-04]
CR Banin U, 1999, J CHEM PHYS, V110, P1195, DOI 10.1063/1.478161
   Chan PM, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni162
   Crut A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni097
   DIRKS RW, 1993, J CELL SCI, V104, P1187
   Doose S, 2005, ANAL CHEM, V77, P2235, DOI 10.1021/ac050035n
   HENG HHQ, 1992, P NATL ACAD SCI USA, V89, P9509, DOI 10.1073/pnas.89.20.9509
   Hess BC, 2001, PHYS REV LETT, V86, P3132, DOI 10.1103/PhysRevLett.86.3132
   Hohng S, 2004, J AM CHEM SOC, V126, P1324, DOI 10.1021/ja039686w
   JOSEPH A, 1989, EXP CELL RES, V183, P494, DOI 10.1016/0014-4827(89)90408-4
   Kuno M, 2000, J CHEM PHYS, V112, P3117, DOI 10.1063/1.480896
   Lacoste TD, 2000, P NATL ACAD SCI USA, V97, P9461, DOI 10.1073/pnas.170286097
   Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518
   Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274
   NEDERLOF PM, 1990, CYTOMETRY, V11, P126, DOI 10.1002/cyto.990110115
   Nirmal M, 1996, NATURE, V383, P802, DOI 10.1038/383802a0
   PARRA I, 1993, NAT GENET, V5, P17, DOI 10.1038/ng0993-17
   Pathak S, 2001, J AM CHEM SOC, V123, P4103, DOI 10.1021/ja0058334
   Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494
   Silver J, 2005, NANO LETT, V5, P1445, DOI 10.1021/nl050808n
   Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368
   Trask BJ, 2002, NAT REV GENET, V3, P769, DOI 10.1038/nrg905
   VISSEL B, 1989, GENOMICS, V5, P407, DOI 10.1016/0888-7543(89)90003-7
   WIEGANT J, 1992, HUM MOL GENET, V1, P587, DOI 10.1093/hmg/1.8.587
   Xiao Y, 2005, NAT METHODS, V2, P723, DOI 10.1038/nmeth1005-723
   Xiao Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh024
NR 25
TC 45
Z9 51
U1 0
U2 15
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1085-9195
J9 CELL BIOCHEM BIOPHYS
JI Cell Biochem. Biophys.
PY 2006
VL 45
IS 1
BP 59
EP 70
DI 10.1385/CBB:45:1:59
PG 12
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 040TT
UT WOS:000237404000005
PM 16679564
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kannan, RY
   Salacinski, HJ
   Sales, KM
   Butler, PE
   Seifalian, AM
AF Kannan, Ruben Y.
   Salacinski, Henryk J.
   Sales, Kevin M.
   Butler, Peter E.
   Seifalian, Alexander M.
TI The endothelialization of polyhedral oligomeric silsesquioxane
   nanocomposites - An in vitro study
SO CELL BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE polyhedral oligomeric silsesquioxanes (POSS); endothelial cells; bypass
   graft; cytocompatibility; tissue engineering; nanocomposite
ID INFRAINGUINAL EPTFE GRAFTS; BYPASS GRAFTS; VASCULAR GRAFTS;
   SILICONE-RUBBER; CELL-ADHESION; GROWTH; POLYURETHANE; ELASTOMERS;
   MEMBRANES; POLYMERS
AB It has been recognized that seeding vascular bypass grafts with endothelial cells is the ideal method of improving their long-term patency rates. The aim of this study was to assess the in vitro cytocompatibility of a novel silica nanocomposite, polyhedral oligomeric silsesquioxane-poly(carbonate-urea)urethane (POSS-PCU) and hence elicit its feasibility at the vascular interface for potential use in cardiovascular devices such as vascular grafts. Using primary human umbilical vein endothelial cells (HUVEC), cell viability and adhesion were studied using AlamarBlue assays, whereas cell proliferation on the polymer was assessed using the PicoGreen dye assay Cellular confluence and morphology on the nanocomposite were analyzed using light and electron microscopy, respectively. Our results showed that there was no significant difference between cell viability in standard culture media and POSS-PCU. Endothelial cells were capable of adhering to the polymer within 30 min of contact (Student's t-test, p < 0.05) with no difference between POSS-PCU and control cell culture plates. POSS-PCU was also capable of sustaining good cell proliferation for up to 14 d even from low seeding densities (1.0 x 103 cells/cm(2)) and reaching saturation by 21 d. Microscopic analysis showed evidence of optimal endothelial cell adsorption morphology with the absence of impaired motility and morphogenesis. In conclusion, these results support the application of POSS-PCU as a suitable biomaterial scaffold in bio-hybrid vascular prostheses and biomedical devices.
C1 UCL, Biomat & Tissue Engn Ctr, Acad Div Surg & Intervent Sci, London NW3 2PF, England.
   Royal Free Hosp, Hampstead NHS Trust, Dept Plast & Reconstruct Surg, London NW3 2QG, England.
RP Seifalian, AM (reprint author), UCL, Biomat & Tissue Engn Ctr, Acad Div Surg & Intervent Sci, Mortimer St, London NW3 2PF, England.
EM A.Seifalian@MedSch.UCL.AC.UK
RI Seifalian, Alexander/I-6028-2013
OI Seifalian, Alexander/0000-0002-1180-3322
FU Engineering and Physical Sciences Research Council [EP/C519353/1]
CR Ai H, 2003, CELL BIOCHEM BIOPHYS, V38, P103, DOI 10.1385/CBB:38:2:103
   Ai H, 2002, IN VITRO CELL DEV-AN, V38, P487
   [Anonymous], 1992, 10260 ISO, P1
   Baguneid M, 2004, BIOTECHNOL APPL BIOC, V39, P151, DOI 10.1042/BA20030148
   Berrocal MJ, 2001, ANAL CHEM, V73, P5328, DOI 10.1021/ac010375i
   BROSSOLLET LJ, 1992, INT J ARTIF ORGANS, V15, P579
   Cenni E, 2001, J MATER SCI-MATER M, V12, P345, DOI 10.1023/A:1011203322367
   Deutsch M, 1999, SURGERY, V126, P847, DOI 10.1067/msy.2099.99852
   Hamm Christian W, 2003, J Invasive Cardiol, V15, P557
   Hesse Y, 2003, GRAEF ARCH CLIN EXP, V241, P823, DOI 10.1007/s00417-003-0718-5
   HOFFMAN D, 1993, CLIN MATER, V13, P95
   Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   Kidane AG, 2004, BIOMACROMOLECULES, V5, P798, DOI 10.1021/bm0344553
   Kidane AG, 2003, MED BIOL ENG COMPUT, V41, P740, DOI 10.1007/BF02349983
   Lateef SS, 2002, BIOMATERIALS, V23, P3159, DOI 10.1016/S0142-9612(02)00062-5
   Lau H, 2001, ANN VASC SURG, V15, P383, DOI 10.1007/s100160010085
   Lehle K, 2003, J BIOMED MATER RES A, V65A, P393, DOI 10.1002/jbm.a.10492
   LICHTENHAN JD, 1995, COMMENT INORG CHEM, V17, P115, DOI 10.1080/02603599508035785
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   NYILAS E, 1977, J BIOMED MATER RES, V11, P69, DOI 10.1002/jbm.820110108
   Park JC, 2002, YONSEI MED J, V43, P518, DOI 10.3349/ymj.2002.43.4.518
   Park JH, 2002, BIOMATERIALS, V23, P1797, DOI 10.1016/S0142-9612(01)00306-4
   Punshon G, 2005, BIOMATERIALS, V26, P6271, DOI 10.1016/j.biomaterials.2005.03.034
   Salacinski HJ, 2001, MED BIOL ENG COMPUT, V39, P609, DOI 10.1007/BF02345431
   Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04
   SALACINSKI HJ, 2005, Patent No. 2005000189
   Schubert MA, 1997, J BIOMED MATER RES, V34, P519, DOI 10.1002/(SICI)1097-4636(19970315)34:4<519::AID-JBM12>3.0.CO;2-7
   Seifalian AM, 2002, ARTIF ORGANS, V26, P307, DOI 10.1046/j.1525-1594.2002.06841.x
   Seifalian AM, 2001, J BIOMED MATER RES, V55, P637, DOI 10.1002/1097-4636(20010615)55:4<637::AID-JBM1058>3.0.CO;2-Z
   Singer VL, 1997, ANAL BIOCHEM, V249, P228, DOI 10.1006/abio.1997.2177
   Tai NR, 2000, BRIT J SURG, V87, P1516, DOI 10.1046/j.1365-2168.2000.01566.x
   Tiwari A, 2003, MICROVASC RES, V65, P61, DOI 10.1016/S0026-2862(02)00013-4
   Tiwari A, 2003, EUR J VASC ENDOVASC, V25, P325, DOI 10.1053/ejvs.2002.1854
   WILSNACK RE, 1976, BIOMATER ARTIF CELL, V4, P235, DOI 10.3109/10731197609118653
   ZILLA P, 1987, J VASC SURG, V6, P535, DOI 10.1067/mva.1987.avs0060535
NR 36
TC 58
Z9 59
U1 0
U2 39
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1085-9195
EI 1559-0283
J9 CELL BIOCHEM BIOPHYS
JI Cell Biochem. Biophys.
PY 2006
VL 45
IS 2
BP 129
EP 136
DI 10.1385/CBB:45:2:129
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 050JM
UT WOS:000238083600001
PM 16757813
DA 2018-10-20
ER

PT J
AU Wargo, SL
   Kumar, TR
   Russell, AJ
AF Wargo, Sara L.
   Kumar, Thangappan Ravi
   Russell, Alan J.
TI Tissue engineering and the challenges within
SO CELL TRANSPLANTATION
LA English
DT Article; Proceedings Paper
CT International Workshop on Regenerative Medicine
CY APR 21, 2005
CL Palermo, ITALY
SP ISMETT, Cell Transplant Soc, European Tissue Engn Soc, Assoc Res Transplantat, McGowan Inst Regenerat Med, Univ Pittsburgh
DE tissue engineering; biomaterials; cell source; gradient scaffolds
ID SCAFFOLDS; OPPORTUNITIES
AB Researchers face many challenges, both scientific and societal, in the field of tissue engineering. Herein we discuss the challenges in material design, selection of therapeutic cell source, the in vitro culturing of cells and materials, and finally the integration of the cultured construct into the body. We focus special attention on a new approach to the design of a biomaterial that would bridge synthetic and biologic materials seamlessly. The scaffolds we have developed serve as a transitional material between biotic and abiotic systems.
C1 Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
RP Russell, AJ (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, 100 Technool Dr,Suite 200, Pittsburgh, PA 15219 USA.
EM russellaj@upmc.edu
RI Thangappan, Ravikumar/A-7683-2008
CR Abu Bakar MS, 2003, BIOMATERIALS, V24, P2245, DOI 10.1016/S0142-9612(03)00028-0
   Bonassar LJ, 1998, J CELL BIOCHEM, P297, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<297::AID-JCB36>3.0.CO;2-6
   Chapekar MS, 2000, J BIOMED MATER RES, V53, P617, DOI 10.1002/1097-4636(2000)53:6<617::AID-JBM1>3.3.CO;2-3
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   Heath CA, 2000, TRENDS BIOTECHNOL, V18, P17, DOI 10.1016/S0167-7799(99)01396-7
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   Langer R, 1997, PHARMACEUT RES, V14, P840, DOI 10.1023/A:1012131329148
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194
   Sousa RA, 2000, J APPL POLYM SCI, V77, P1303, DOI 10.1002/1097-4628(20000808)77:6<1303::AID-APP15>3.0.CO;2-1
   Stankus JJ, 2004, J BIOMED MATER RES A, V70A, P603, DOI 10.1002/jbm.a.30122
   Stock UA, 2001, ANNU REV MED, V52, P443, DOI 10.1146/annurev.med.52.1.443
   Sundback C, 2003, BIOMATERIALS, V24, P819, DOI 10.1016/S0142-9612(02)00409-X
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zeng Jing, 2003, Journal of Controlled Release, V92, P227, DOI 10.1016/S0168-3659(03)00372-9
   Zhang N, 1999, Curr Opin Hematol, V6, P44, DOI 10.1097/00062752-199901000-00008
NR 19
TC 3
Z9 3
U1 0
U2 1
PU COGNIZANT COMMUNICATION CORP
PI ELMSFORD
PA 3 HARTSDALE ROAD, ELMSFORD, NY 10523-3701 USA
SN 0963-6897
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2006
VL 15
SU 1
BP S11
EP S15
PG 5
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA 057TJ
UT WOS:000238617800003
PM 16826791
DA 2018-10-20
ER

PT J
AU Leo, AJ
   Grande, DA
AF Leo, Andrew J.
   Grande, Daniel A.
TI Mesenchymal stem cells in tissue engineering
SO CELLS TISSUES ORGANS
LA English
DT Review
DE mesenchymal stem cells; engineering, tissue; repair, tissue
ID MARROW STROMAL CELLS; AUTOLOGOUS CHONDROCYTE TRANSPLANTATION;
   ARTICULAR-CARTILAGE REPAIR; FIBROBLAST-GROWTH-FACTOR; HUMAN
   ADIPOSE-TISSUE; IN-VITRO CHONDROGENESIS; MUSCLE SATELLITE CELLS;
   FULL-THICKNESS DEFECTS; EMBRYONIC CHICK TIBIA; HUMAN TRABECULAR BONE
AB The repair of diseased or damaged cartilage remains one of the most challenging problems of musculoskeletal medicine. Tissue engineering advances in cartilage repair have utilized autologous and allogenic chondrocyte and cartilage grafts, biomaterial scaffolds, growth factors, stem cells, and genetic engineering. The mesenchymal stem cell has specifically attracted much attention because of its accessibility, potential for differentiation, and manipulability to modern molecular, tissue and genetic engineering techniques. Mesenchymal stem cells provide invaluable tools for the study of tissue repair when combined with a carrier vehicle/matrix scaffold, and/or bioactive growth factors. However, an underappreciated source of knowledge lies in the relationship between fetal development and adult tissue repair. The multitude of events that take place during fetal development which lead from stem cell to functional tissue are poorly understood. A more thorough understanding of the events of development as they pertain to cartilage organogenesis may help elucidate some of the unknowns of adult tissue repair. Copyright (c) 2006 S. Karger AG, Basel.
C1 N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Dept Orthoped Surg, Manhasset, NY 11030 USA.
RP Grande, DA (reprint author), N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Dept Orthoped Surg, 350 Community Dr, Manhasset, NY 11030 USA.
EM dgrande@nshs.edu
CR Abe M, 2004, TISSUE ENG, V10, P585, DOI 10.1089/107632704323061942
   ADZICK NS, 1994, ANN SURG, V220, P10, DOI 10.1097/00000658-199407000-00003
   AKESON WH, 2001, CLIN ORTHOP S, V391, pS124
   ALAISH SM, 1994, J PEDIATR SURG, V29, P1040, DOI 10.1016/0022-3468(94)90275-5
   Alsalameh S, 2004, ARTHRITIS RHEUM, V50, P1522, DOI 10.1002/art.20269
   Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x
   Aslan H, 2006, STEM CELLS, V24, P1728, DOI 10.1634/stemcells.2005-0546
   Aubin JE, 1995, BONE, V17, P77
   Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267
   Ball SG, 2004, INT J BIOCHEM CELL B, V36, P714, DOI 10.1016/j.biocel.2003.10.015
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Bedada FB, 2006, CELL CYCLE, V5, P223, DOI 10.4161/cc.5.3.2364
   BENNETT JH, 1991, J CELL SCI, V99, P131
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BERESFORD JN, 1992, J CELL SCI, V102, P341
   Bosch P, 2000, J ORTHOP RES, V18, P933, DOI 10.1002/jor.1100180613
   BRUDER SP, 1990, DEV BIOL, V141, P319, DOI 10.1016/0012-1606(90)90388-Y
   BRUDER SP, 1990, BONE, V11, P189, DOI 10.1016/8756-3282(90)90213-I
   BRUDER SP, 1990, BONE, V11, P133, DOI 10.1016/8756-3282(90)90061-3
   BRUDER SP, 1989, BONE, V10, P359, DOI 10.1016/8756-3282(89)90133-6
   BURRINGTON JD, 1971, J PEDIATR SURG, V6, P523, DOI 10.1016/0022-3468(71)90373-3
   Cabrera RC, 1995, BIOCHEM MOL BIOL INT, V37, P151
   Cao T, 2003, TISSUE ENG, V9, pS103, DOI 10.1089/10763270360697012
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Caplan AI, 1997, CLIN ORTHOP RELAT R, P254
   Carlberg AL, 2001, DIFFERENTIATION, V67, P128, DOI 10.1046/j.1432-0436.2001.670405.x
   Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245
   Caterson EJ, 2001, J BIOMED MATER RES, V57, P394, DOI 10.1002/1097-4636(20011205)57:3<394::AID-JBM1182>3.0.CO;2-9
   *CDCP, 1999, PUBLIC HLTH REP, V114, P102
   *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P1124
   Cheng LZ, 2000, J CELL PHYSIOL, V184, P58, DOI 10.1002/(SICI)1097-4652(200007)184:1<58::AID-JCP6>3.0.CO;2-B
   Cherubino P, 2003, J Orthop Surg (Hong Kong), V11, P10
   CHU CR, 1995, J BIOMED MATER RES, V29, P1147, DOI 10.1002/jbm.820290915
   Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.3.CO;2-3
   D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115
   Dao MA, 1998, INT J MOL MED, V1, P257
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P
   Deng WM, 2005, TISSUE ENG, V11, P110, DOI 10.1089/ten.2005.11.110
   Deng YB, 2006, CYTOTHERAPY, V8, P210, DOI 10.1080/14653240600760808
   DEPALMA RL, 1989, MATRIX, V9, P224
   Dicker A, 2005, EXP CELL RES, V308, P283, DOI 10.1016/j.yexcr.2005.04.029
   DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x
   Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912
   Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x
   Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   FRENKEL SR, 1990, BIOMATERIALS, V11, P38
   Frenkel SR, 1997, J BONE JOINT SURG BR, V79B, P831, DOI 10.1302/0301-620X.79B5.7278
   FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x
   FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267
   Fukumoto T, 2003, OSTEOARTHR CARTILAGE, V11, P55, DOI 10.1053/joca.2002.0869
   Gelse K, 2003, ARTHRITIS RHEUM, V48, P430, DOI 10.1002/art.10759
   Giurea A, 2003, J ORTHOPAED RES, V21, P584, DOI 10.1016/S0736-0266(02)00263-2
   Gluhak J, 1996, DEV DYNAM, V205, P24
   Grande D A, 1995, Tissue Eng, V1, P345, DOI 10.1089/ten.1995.1.345
   Grande DA, 2003, J BONE JOINT SURG AM, V85A, P111, DOI 10.2106/00004623-200300002-00015
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   Grande DA, 1999, CLIN ORTHOP S, V367s, P176
   Guo X, 2001, J Tongji Med Univ, V21, P314
   Guo Xiaodong, 2002, J Huazhong Univ Sci Technolog Med Sci, V22, P112
   Halvorsen YDC, 2001, TISSUE ENG, V7, P729, DOI 10.1089/107632701753337681
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Haynesworth SE, 1996, J CELL PHYSIOL, V166, P585, DOI 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.3.CO;2-7
   Herzog EL, 2003, BLOOD, V102, P3483, DOI 10.1182/blood-2003-05-1664
   Hickey Derrick G, 2003, Am J Orthop (Belle Mead NJ), V32, P70
   Huang JI, 2006, J BONE JOINT SURG AM, V88A, P744, DOI 10.2106/JBJS.E.00669
   Huard Johnny, 2003, Birth Defects Research, V69, P230, DOI 10.1002/bdrc.10020
   Hunziker E. B., 2001, CLIN ORTHOP S, V391S, P171
   Im GI, 2001, J BONE JOINT SURG BR, V83B, P289, DOI 10.1302/0301-620X.83B2.10495
   Iocona JA, 1998, J PEDIATR SURG, V33, P564, DOI 10.1016/S0022-3468(98)90317-7
   Jackson D W, 2001, Clin Orthop Relat Res, pS14, DOI 10.1097/00003086-200110001-00003
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jiang YH, 2002, EXP HEMATOL, V30, P896, DOI 10.1016/S0301-472X(02)00869-X
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Jorgensen C, 2001, ANN RHEUM DIS, V60, P305, DOI 10.1136/ard.60.4.305
   Kadiyala S, 1997, TISSUE ENG, V3, P173, DOI 10.1089/ten.1997.3.173
   Karsenty G, 2000, MATRIX BIOL, V19, P85, DOI 10.1016/S0945-053X(00)00053-6
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Kim HD, 2002, J BIOMED MATER RES, V59, P573, DOI 10.1002/jbm.10011
   Koc ON, 2001, BONE MARROW TRANSPL, V27, P235, DOI 10.1038/sj.bmt.1702791
   Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711
   Kraut N, 1998, EMBO J, V17, P6276, DOI 10.1093/emboj/17.21.6276
   Kuznetsov SA, 1997, BRIT J HAEMATOL, V97, P561, DOI 10.1046/j.1365-2141.1997.902904.x
   LANE JM, 1977, J BONE JOINT SURG AM, V59, P218, DOI 10.2106/00004623-197759020-00015
   Liang LC, 2002, STEM CELLS, V20, P21, DOI 10.1634/stemcells.20-1-21
   Loeffler M, 2002, CELLS TISSUES ORGANS, V171, P8, DOI 10.1159/000057688
   Long MW, 2001, BLOOD CELL MOL DIS, V27, P677, DOI 10.1006/bcmd.2001.0431
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   MACKIE EJ, 1987, J CELL BIOL, V105, P2569, DOI 10.1083/jcb.105.6.2569
   MADRY H, 2002, HUM GENE THER, V1, P1621
   Majumdar MK, 1998, J CELL PHYSIOL, V176, P57, DOI 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7
   Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456
   Martin I, 1998, J ORTHOPAED RES, V16, P181, DOI 10.1002/jor.1100160205
   Mason JM, 1998, GENE THER, V5, P1098, DOI 10.1038/sj.gt.3300703
   Mason JM, 2000, CLIN ORTHOP RELAT R, pS171
   McMahon JM, 2006, STEM CELLS DEV, V15, P87, DOI 10.1089/scd.2006.15.87
   Miller JB, 1999, CURR TOP DEV BIOL, V43, P191
   Minas T, 1999, CLIN SPORT MED, V18, P13, DOI 10.1016/S0278-5919(05)70128-9
   Minguell JJ, 2001, EXP BIOL MED, V226, P507
   Mizuno Hiroshi, 2003, Journal of Nippon Medical School, V70, P428, DOI 10.1272/jnms.70.428
   Moran JM, 2003, TISSUE ENG, V9, P63, DOI 10.1089/107632703762687546
   MOSCA JD, 2000, CLIN ORTHOP S, V379, pS71
   MOYNIHAN DP, 2002, SEMIN ARTHROPLASTY, V13, P229
   Murphy JM, 2002, ARTHRITIS RHEUM, V46, P704, DOI 10.1002/art.10118
   NAKAHARA H, 1991, J ORTHOP RES, V9, P465, DOI 10.1002/jor.1100090402
   NISWANDER L, 1992, DEVELOPMENT, V114, P755
   Nixon AJ, 1999, J ORTHOPAED RES, V17, P475, DOI 10.1002/jor.1100170404
   Noel D, 2003, STEM CELLS, V22, P74, DOI 10.1634/stemcells.22-1-74
   Noth U, 2002, J ORTHOPAED RES, V20, P1060, DOI 10.1016/S0736-0266(02)00018-9
   O'Connor WJ, 2000, ORTHOP CLIN N AM, V31, P399, DOI 10.1016/S0030-5898(05)70159-0
   ODRISCOLL SW, 2001, CLIN ORTHOP S, V391, P190
   Oreffo ROC, 1998, CLIN SCI, V94, P549, DOI 10.1042/cs0940549
   Oshima Y, 2005, J HISTOCHEM CYTOCHEM, V53, P207, DOI 10.1369/jhc.4A6280.2005
   Osyczka AM, 2002, ANN NY ACAD SCI, V961, P73, DOI 10.1111/j.1749-6632.2002.tb03054.x
   Palmer GD, 2005, MOL THER, V12, P219, DOI 10.1016/j.ymthe.2005.03.024
   PATE DW, 1993, CLIN RES, V41, pA374
   PECHAK DG, 1986, BONE, V7, P441, DOI 10.1016/8756-3282(86)90004-9
   PECHAK DG, 1986, BONE, V7, P459, DOI 10.1016/8756-3282(86)90005-0
   Pereira RF, 1998, P NATL ACAD SCI USA, V95, P1142, DOI 10.1073/pnas.95.3.1142
   PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857
   Peterson L, 2002, AM J SPORT MED, V30, P2, DOI 10.1177/03635465020300011601
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prockop DJ, 2003, P NATL ACAD SCI USA, V100, P11917, DOI 10.1073/pnas.1834138100
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   REDINI F, 1988, FEBS LETT, V234, P172, DOI 10.1016/0014-5793(88)81327-9
   Reyes M, 1999, BLOOD, V94, p377A
   REYES M, 1999, BLOOD S, V94, pA568
   Ringe J, 2002, NATURWISSENSCHAFTEN, V89, P338, DOI 10.1007/s00114-002-0344-9
   ROGERS JJ, 1995, AM SURGEON, V61, P231
   Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105
   SAAHEH PB, 1999, ANN PLAST SURG, V42, P509
   Saito T, 1995, Tissue Eng, V1, P327, DOI 10.1089/ten.1995.1.327
   SALDANHA V, 2001, BIOMATERIALS, V21, P2427
   Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565
   Sellers RS, 1997, J BONE JOINT SURG AM, V79A, P1452, DOI 10.2106/00004623-199710000-00002
   SHAH M, 1995, J CELL SCI, V108, P985
   Shao XX, 2006, TISSUE ENG, V12, P1539, DOI 10.1089/ten.2006.12.1539
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Steinert A, 2003, J ORTHOPAED RES, V21, P1090, DOI 10.1016/S0736-0266(03)00100-1
   Tanaka H, 2004, TISSUE ENG, V10, P633, DOI 10.1089/107632704323061988
   Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730
   VACANTI CA, 1994, AM J SPORT MED, V22, P485, DOI 10.1177/036354659402200408
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   WAKITANI S, 1995, MUSCLE NERVE, V18, P1471
   Watanabe N, 2003, J BONE MINER METAB, V21, P344, DOI 10.1007/s00774-003-0428-4
   Weng YL, 2001, J ORAL MAXIL SURG, V59, P185, DOI 10.1053/joms.2001.20491
   West DC, 1997, INT J BIOCHEM CELL B, V29, P201, DOI 10.1016/S1357-2725(96)00133-1
   WHITBY DJ, 1991, DEV BIOL, V147, P207, DOI 10.1016/S0012-1606(05)80018-1
   WHITBY DJ, 1991, DEVELOPMENT, V112, P651
   Wickham MQ, 2003, CLIN ORTHOP RELAT R, P196, DOI 10.1097/01.blo.0000072467.53786.ca
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   Williams JT, 1999, AM SURGEON, V65, P22
   Winter A, 2003, ARTHRITIS RHEUM, V48, P418, DOI 10.1002/art.10767
   Worster AA, 2001, J ORTHOPAED RES, V19, P738, DOI 10.1016/S0736-0266(00)00054-1
   Worster AA, 2000, AM J VET RES, V61, P1003, DOI 10.2460/ajvr.2000.61.1003
   Yajima Y, 2003, ENDOCRINOLOGY, V144, P2559, DOI 10.1210/en.2002-220894
   Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729
   YOUNG HE, 1993, IN VITRO CELL DEV-AN, V29, P723, DOI 10.1007/BF02631429
   Young HE, 1999, P SOC EXP BIOL MED, V221, P63, DOI 10.1046/j.1525-1373.1999.d01-55.x
   Young HE, 2001, ANAT REC, V264, P51, DOI 10.1002/ar.1128
   Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403
   ZHAO GQ, 1993, P NATL ACAD SCI USA, V90, P8633, DOI 10.1073/pnas.90.18.8633
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
   Zvaifler NJ, 2000, ARTHRITIS RES, V2, P477, DOI 10.1186/ar130
NR 170
TC 40
Z9 55
U1 1
U2 18
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2006
VL 183
IS 3
BP 112
EP 122
DI 10.1159/000095985
PG 11
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA 107JG
UT WOS:000242166400003
PM 17108682
DA 2018-10-20
ER

PT J
AU Schagemann, JC
   Mrosek, EH
   Landers, R
   Kurz, H
   Erggelet, C
AF Schagemann, Jan C.
   Mrosek, Eike H.
   Landers, Ruediger
   Kurz, Haymo
   Erggelet, Christoph
TI Morphology and function of ovine articular cartilage chondrocytes in 3-D
   hydrogel culture
SO CELLS TISSUES ORGANS
LA English
DT Article
DE cartilage tissue engineering; chondrocyte proliferation; alginate;
   hyaline matrix; 3-D cell culture
ID ALGINATE BEADS; IN-VITRO; INJECTABLE CARTILAGE; CALCIUM ALGINATE;
   GROWTH-FACTORS; ANIMAL-MODELS; REPAIR; TRANSPLANTATION; CELLS; MATRIX
AB Different cell- and biomaterial-based tissue engineering techniques are under investigation to restore damaged tissue. Strategies that use chondrogenic cells or tissues in combination with bioresorbable delivery materials are considered to be suitable to regenerate bio-artificial cartilage. Three-dimensional (3-D) cell embedding techniques can provide anchorage-independent cell growth and homogenous spatial cell arrangement, which play a key role in the maintenance of the characteristic phenotype and thus the formation of differentiated tissue. We developed a new injectable high water content (90%) hydrogel formulation with 5% sodium alginic acid and 5% gelatin as a temporary supportive intercellular matrix for 3-D cell culture. The objective was to determine whether the in vitro hydrogel culture of chondrocytes could preserve hyaline characteristics and thus could provide cartilage regeneration in vitro. Chondrocytes harvested from knee joints of skeletally mature sheep were cultured 3-D in hydrogel (7 x 10(6) cells/ml, 2.8-mu l beads) for up to 10 weeks. Cell morphology and viability were evaluated with light microscopy, and proliferative activity was assessed with antibromodeoxyuridine immunofluorescence. Expression of collagens type I (COL1) and II (COL2), cartilage proteoglycans (PG) and hyaluronan synthases (HAS) were studied immunohistochemically. We observed that up to 36% of chondrocytes proliferated, while almost 100% presented a differentiated spheroidal phenotype. After an initial decrease at 2 weeks, cell density recovered to 85% of the initial absolute value at 10 weeks. Expression of hyaline matrix molecules resembled the in vivo pattern with increasing spatial deposition of PG and COL2. The proportion of PG-positive cells increased from initially 13 to 53% after 10 weeks, in contrast to consistently 100% COL2-positive cells. We conclude that 3-D hydrogel culture, even without mechanical stimulation or growth factor application, can keep chondrocytes in a differentiated state and provides a chondrogenic cell environment for in vitro cartilage regeneration for at least 10 weeks. Moreover, this hydrogel appears to be a suitable cell delivery material for subsequent in vivo implantation. Copyright (c) 2006 S. Karger AG, Basel.
C1 Univ Freiburg, Dept Mol Embryol, Inst Anat & Cell Biol, DE-79104 Freiburg, Germany.
   Univ Freiburg, Dept Mol Embryol, Inst Macromol Chem, DE-79104 Freiburg, Germany.
   Univ Hosp Freiburg, Dept Orthopaed Surg & Traumatol, Freiburg, Germany.
   Mayo Clin, Coll Med, Dept Orthopaed Surg, Cartilage & Connect Tissue Res Lab, Rochester, MN USA.
RP Kurz, H (reprint author), Univ Freiburg, Dept Mol Embryol, Inst Anat & Cell Biol, Albertstr 17, DE-79104 Freiburg, Germany.
EM haymo.kurz@anat.uni-freiburg.de
RI Kurz, Haymo/E-1587-2011
CR Alford JW, 2005, AM J SPORT MED, V33, P443, DOI 10.1177/0363546505274578
   Almqvist KF, 2001, ANN RHEUM DIS, V60, P781, DOI 10.1136/ard.60.8.781
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P109, DOI 10.2106/00004623-200300003-00017
   Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P477
   Buckwalter JA, 2004, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000131638.81519.de
   Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P487
   Chubinskaya S, 2001, J HISTOCHEM CYTOCHEM, V49, P1211, DOI 10.1177/002215540104901003
   Cohen SB, 2003, BIOMATERIALS, V24, P2653, DOI 10.1016/S0142-9612(03)00058-9
   De Ceuninck F, 2004, METH MOLEC MED, V100, P15
   Draget KI, 1997, INT J BIOL MACROMOL, V21, P47, DOI 10.1016/S0141-8130(97)00040-8
   Ehlers EM, 1999, ANN ANAT, V181, P513, DOI 10.1016/S0940-9602(99)80055-7
   Elisseeff J, 2004, EXPERT OPIN BIOL TH, V4, P1849, DOI 10.1517/14712598.4.12.1849
   Gagne TA, 2000, J ORTHOPAED RES, V18, P882, DOI 10.1002/jor.1100180606
   Giannoni P, 2005, TISSUE ENG, V11, P237, DOI 10.1089/ten.2005.11.237
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   Hauselmann HJ, 1996, AM J PHYSIOL-CELL PH, V271, pC742
   HEDBOM E, 2001, OSTEOARTHR CARTILAGE, pS123
   Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   HUNZIKER EB, 1982, J ULTRA MOL STRUCT R, V81, P1, DOI 10.1016/S0022-5320(82)90036-3
   KURZ H, 1995, DEV DYNAM, V203, P174, DOI 10.1002/aja.1002030206
   Marijnissen WJCM, 2002, BIOMATERIALS, V23, P1511, DOI 10.1016/S0142-9612(01)00281-2
   Mierisch CM, 2003, J BONE JOINT SURG AM, V85A, P1757, DOI 10.2106/00004623-200309000-00015
   Mouw JK, 2005, OSTEOARTHR CARTILAGE, V13, P828, DOI 10.1016/j.joca.2005.04.020
   Mrosek E, 2003, CELLS TISSUES ORGANS, V173, P93, DOI 10.1159/000068944
   Ochi M, 2001, ARTIF ORGANS, V25, P172, DOI 10.1046/j.1525-1594.2001.025003172.x
   Paige KT, 1996, PLAST RECONSTR SURG, V97, P168, DOI 10.1097/00006534-199601000-00027
   PAIGE KT, 1995, PLAST RECONSTR SURG, V96, P1390, DOI 10.1097/00006534-199511000-00024
   Panasyuk A, 2004, CELLS TISSUES ORGANS, V177, P201, DOI 10.1159/000080133
   Perka C, 2001, TISSUE ENG, V7, P359, DOI 10.1089/10763270152044215
   Qi WN, 2003, J ORTHOPAED RES, V21, P282, DOI 10.1016/S0736-0266(02)00136-5
   Reinholz GG, 2004, BIOMATERIALS, V25, P1511, DOI 10.1016/S0142-9612(03)00498-8
   Risbud MV, 2002, TRENDS BIOTECHNOL, V20, P351, DOI 10.1016/S0167-7799(02)02016-4
   Schulze M, 2000, ORTHOPADE, V29, P100
   Schulze-Tanzil G, 2002, CELL TISSUE RES, V308, P371, DOI 10.1007/s00441-002-0562-7
   Sittinger M, 2004, CURR OPIN BIOTECH, V15, P411, DOI 10.1016/j.copbio.2004.08.010
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Smith GD, 2005, J BONE JOINT SURG BR, V87B, P445, DOI 10.1302/0301-620X.87B4
   Stevens MM, 2004, J ORTHOPAED RES, V22, P1114, DOI 10.1016/j.orthres.2003.12.021
   Thornton AJ, 2004, TRANSPLANTATION, V77, P1798, DOI 10.1097/01.tp.0000131152.71117.0e
   VACANTI CA, 1994, AM J SPORT MED, V22, P485, DOI 10.1177/036354659402200408
   van Osch GJVM, 2002, BIORHEOLOGY, V39, P215
   vanSusante JLC, 1995, ACTA ORTHOP SCAND, V66, P549, DOI 10.3109/17453679509002314
NR 44
TC 18
Z9 26
U1 2
U2 9
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
EI 1422-6421
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2006
VL 182
IS 2
BP 89
EP 97
DI 10.1159/000093063
PG 9
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA 058ES
UT WOS:000238648900003
PM 16804299
DA 2018-10-20
ER

PT J
AU Balamurugan, A
   Michel, J
   Faure, J
   Benhayoune, H
   Wortham, L
   Sockalingum, G
   Banchet, V
   Bouthors, S
   Laurent-Maquin, D
   Balossier, G
AF Balamurugan, A
   Michel, J
   Faure, J
   Benhayoune, H
   Wortham, L
   Sockalingum, G
   Banchet, V
   Bouthors, S
   Laurent-Maquin, D
   Balossier, G
TI Synthesis and structural analysis of sol gel derived stoichiometric
   monophasic hydroxyapatite
SO CERAMICS-SILIKATY
LA English
DT Article
DE sol-gel; monophasic; hydroxyapatite (HAP); biocompatible; biomaterial
AB This paper reports on a novel sol-gel technique for synthesis phase pure hydroxyapatite Ca(10)(PO(4))(6)(OH)(2) powder Triethyl phosphite and calcium nitrate were used as phosphorus and calcium precursors, when the stoichiometric Ca/P ratio 1.67 was maintained. The powders obtained were dried and calcined at different temperatures zip to 900 degrees C X-ray diffraction analysis and Raman spectra showed the presence of phase pure HAP The powders exhibited the FT-IR signature peaks of HAP. In addition, morphological characterizations of the HAP powder was carried out using STEM, EDXS and EELS. The STEM micrographs indicated mill-fractured surface of a HAP particles. The elemental composition analyzed by EDXS and EELS showed the powder calcined at 900 degrees C contains monophasic stoichiometric HAP.
C1 Univ Reims, INSERM, ERM 0203, Lab Microscopie Elect Analyt, F-51685 Reims 2, France.
   Univ Reims, UFR Pharm, Unite MeDIAN, CNRS,UMR 6142, F-51096 Reims, France.
   Ecole Cent Lyon, Dept STMS, LTDS, CNRS,UMR 5513, F-69134 Ecully, France.
RP Balamurugan, A (reprint author), Univ Reims, INSERM, ERM 0203, Lab Microscopie Elect Analyt, 21 Rue Clement Ader, F-51685 Reims 2, France.
EM gerard.balossier@univ-reims.fr
CR BALAMURUGAN A, 2004, CAN MET Q, V43, P3
   Banchet V, 2003, J PHYS D APPL PHYS, V36, P1599, DOI 10.1088/0022-3727/36/13/326
   CHENG K, 2003, J MATER CHEM PHYS, V78, P159
   CLIFF G, 1975, J MICROSC-OXFORD, V103, P203, DOI 10.1111/j.1365-2818.1975.tb03895.x
   Gross KA, 1998, J MATER SCI-MATER M, V9, P797, DOI 10.1023/A:1008983809316
   JILLAVENKATESA A, 1998, J MATER SCI, V33, P411
   LIU DM, 1994, J MATER SCI-MATER M, V5, P1721
   LIVAGE J, 1992, J NONCRYST SOLIDS, V147, P211
   Rapacz-Kmita A., 2004, J MOL STRUCT, V704, P65, DOI 10.1016/j.molstruc.2004.02.047
   RIMAN RE, 2002, SOLID STATE IONICS, V151, P89
   SMEULDERS DE, 2001, IND ENG CHEM RES, V40, P10
   SUN L, 2003, MAT SCI ENG A-STRUCT, V360, P135
   TOTH JM, 1991, J APPL BIOMAT, V2, P169
   VANDERHOUWEN JAM, 2003, J CRYST GROWTH, V249, P96
   WENG W, 2003, SURF COAT TECH, V167, P54
NR 15
TC 19
Z9 19
U1 1
U2 5
PU INST CHEMICAL TECHNOLOGY, DEPT GLASS CERAMICS
PI PRAGUE
PA TECHNICKA 5, PRAGUE 166 28, CZECH REPUBLIC
SN 0862-5468
J9 CERAM-SILIKATY
JI Ceram.-Silik.
PY 2006
VL 50
IS 1
BP 27
EP 31
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA 037GD
UT WOS:000237134200005
OA DOAJ Gold
DA 2018-10-20
ER

PT S
AU Roosjen, A
   Norde, W
   van der Mei, HC
   Busscher, HJ
AF Roosjen, Astrid
   Norde, Willem
   van der Mei, Henny C.
   Busscher, Henk J.
BE Grundke, K
   Stamm, M
   Adler, HJ
TI The use of positively charged or low surface free energy coatings versus
   polymer brushes in controlling biofilm formation
SO Characterization of Polymer Surfaces and Thin FIlms
SE PROGRESS IN COLLOID AND POLYMER SCIENCE
LA English
DT Proceedings Paper
CT 10th Dresden Polymer Meeting
CY APR 10-13, 2005
CL Dresden, GERMANY
DE biofilm; biomaterial centered infection; microbial adhesion; polymer
   brushes; surface free energy
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; POLY(ETHYLENE OXIDE) BRUSHES;
   SELF-ASSEMBLED MONOLAYERS; BACTERIAL ADHESION; POLYETHYLENE-GLYCOL;
   PROTEIN ADSORPTION; POLYSTYRENE SURFACES; BIOMEDICAL POLYMERS; MICROBIAL
   ADHESION; PARALLEL-PLATE
AB Biofilm formation on biomaterials implant surfaces and subsequent infectious complications are a frequent reason for failure of many biomedical devices, such as total hip arthroplasties, vascular catheters and urinary catheters. The development of a biofilm is initiated by the formation of a conditioning film of adsorbed macromolecules, such as proteins, followed by adhesion of microorganisms, where after they grow and anchor through secretion of extracellular polymeric substances. Adhesion of microorganisms is influenced by the physico-chemical properties of the biomaterial surface. Positively charged materials stimulate bacterial adhesion, but prevent growth of adhering bacteria. The use of low surface free energy materials did not always reduce in vitro adhesion of bacteria, but has been found beneficial in in vivo applications where fluctuating shear forces prevail, like on intra-oral devices and urine catheters. Polymer brushes have shown a very high reduction in in vitro adhesion of a great variety of microorganisms. However, for clinical application, the long term stability of polymer brushes is still a limiting factor. Further effort is therefore required to enhance the stability of polymer brushes on biomaterial implant surfaces to facilitate clinical use of these promising coatings.
C1 Univ Groningen, Med Ctr, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   Univ Wageningen & Res Ctr, Lab Phys Chem & Colloid Sci, NL-67036 HB Wageningen, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Med Ctr, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   Azeredo J, 1999, COLLOID SURFACE B, V14, P141, DOI 10.1016/S0927-7765(99)00031-4
   Bakker DP, 2003, COLLOID SURFACE B, V32, P179, DOI 10.1016/S0927-7765(03)00159-0
   BHATT MV, 1983, SYNTHESIS-STUTTGART, P249, DOI 10.1055/s-1983-30301
   Branch DW, 2001, BIOMATERIALS, V22, P1035, DOI 10.1016/S0142-9612(00)00343-4
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   BUSSCHER HJ, 1987, FEMS MICROBIOL LETT, V46, P165, DOI 10.1111/j.1574-6968.1987.tb02457.x
   BUSSCHER HJ, 1990, MICROBIAL CELL SURFA, P335
   CHRISTENSEN GD, 1989, INFECT ASS INDWELLIN, P27
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Currie EPK, 2003, ADV COLLOID INTERFAC, V100, P205, DOI 10.1016/S0001-8686(02)00061-1
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DEXTER SC, 1975, APPL MICROBIOL, V30, P298
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Dufrene YF, 1996, MICROBIOL-SGM, V142, P855, DOI 10.1099/00221287-142-4-855
   ESCHER A, 1990, BIOFILMS, P445
   Everaert EPJM, 1999, ARCH OTOLARYNGOL, V125, P1329, DOI 10.1001/archotol.125.12.1329
   Everaert EPJM, 1998, COLLOID SURFACE B, V10, P179, DOI 10.1016/S0927-7765(98)00003-4
   Gilbert P, 1997, Adv Dent Res, V11, P160
   Golander C. G., 1992, POLYETHYLENE GLYCOL, P221, DOI DOI 10.1007/978-1-4899-0703-5_15.
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Gomez-Suarez C, 2001, APPL ENVIRON MICROB, V67, P2531, DOI 10.1128/AEM.67.6.2531-2537.2001
   Gottenbos B, 2003, BIOMATERIALS, V24, P2707, DOI 10.1016/S0142-9612(03)00083-8
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Halperin A, 1999, LANGMUIR, V15, P2525, DOI 10.1021/la981356f
   Han S, 1997, POLYMER, V38, P317, DOI 10.1016/S0032-3861(97)88175-X
   HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K
   HARRIS J, 1992, PROCEEDINGS OF THE SIXTH NORTH AMERICAN CRANE WORKSHOP, P1
   Harris J. M., 1992, POLYETHYLENE GLYCOL, P283
   HARRIS JM, 1992, POLYETHYLENEGLYCOL
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   Holland NB, 1998, NATURE, V392, P799
   HONG HG, 1994, LANGMUIR, V10, P153, DOI 10.1021/la00013a023
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   Ista LK, 1996, FEMS MICROBIOL LETT, V142, P59
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jucker BA, 1996, J BACTERIOL, V178, P5472, DOI 10.1128/jb.178.18.5472-5479.1996
   Kawai F, 2002, APPL MICROBIOL BIOT, V58, P30, DOI 10.1007/s00253-001-0850-2
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   KI DP, 1998, BIOMATERIALS, V19, P851
   Kingshott P, 2003, LANGMUIR, V19, P6912, DOI 10.1021/la034032m
   Leckband D, 1999, J BIOMAT SCI-POLYM E, V10, P1125, DOI 10.1163/156856299X00720
   LEE J, 1989, J COLLOID INTERF SCI, V131, P252, DOI 10.1016/0021-9797(89)90166-5
   Lee- Smith J, 2001, J ORTHOPAEDIC NURSIN, V5, P37
   LYKLEMA J, 1989, COLLOID SURFACE, V39, P175, DOI 10.1016/0166-6622(89)80186-6
   Maas JH, 2003, THIN SOLID FILMS, V426, P135, DOI 10.1016/S0040-6090(03)00033-6
   MAHAN J, 1991, ORTHOPEDICS, V14, P305
   Marsh LH, 2002, J BIOMED MATER RES, V61, P641, DOI 10.1002/jbm.10174
   Morra M, 1999, J BIOMAT SCI-POLYM E, V10, P1107, DOI 10.1163/156856299X00711
   Nomura S, 1997, J BIOMED MATER RES, V38, P35
   NORDE W, 2003, COLLOID INTERFACES L, P47
   OLSSON J, 1992, CARIES RES, V26, P428, DOI 10.1159/000261482
   OLSSON J, 1990, J DENT RES, V69, P1586, DOI 10.1177/00220345900690091001
   PAULSSON M, 1994, J BIOMED MATER RES, V28, P311, DOI 10.1002/jbm.820280305
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   QUIRYNEN M, 1989, J DENT RES, V68, P796, DOI 10.1177/00220345890680050801
   QUIRYNEN M, 1994, J PERIODONTOL, V65, P162, DOI 10.1902/jop.1994.65.2.162
   Razatos A, 2000, LANGMUIR, V16, P9155, DOI 10.1021/la000818y
   RIEKERINK MBO, 2001, THESIS STRUCTURAL CH, P65
   Rolla G., 1991, BIOFOULING, V3, P175
   Roosjen A, 2005, J BIOMED MATER RES B, V73B, P347, DOI 10.1002/jbm.b.30227
   Roosjen A, 2004, LANGMUIR, V20, P10949, DOI 10.1021/la0484691
   Roosjen A, 2003, MICROBIOL-SGM, V149, P3239, DOI 10.1099/mic.0.26519-0
   RYLE AP, 1965, NATURE, V206, P1256, DOI 10.1038/2061256a0
   SHARMA PK, 2002, COLLOID INTERFACE SC, V98, P341
   Szleifer I, 1997, BIOPHYS J, V72, P595, DOI 10.1016/S0006-3495(97)78698-3
   Thomas R.R., 1999, FLUOROPOLYMERS, P47
   Tsibouklis J, 1999, BIOMATERIALS, V20, P1229, DOI 10.1016/S0142-9612(99)00023-X
   Tsibouklis J, 2003, ADV MATER, V15, P647, DOI 10.1002/adma.200301638
   Van Oss C. J., 1991, BIOFOULING, V4, P25
   Vrolijk N.H., 1990, Biofouling, V2, P39
   WEERKAMP AH, 1989, MICROBIAL ECOLOGY HL, V2, P11
   Young T, 1804, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005
   Zhu B, 2001, J BIOMED MATER RES, V56, P406, DOI 10.1002/1097-4636(20010905)56:3<406::AID-JBM1110>3.0.CO;2-R
NR 77
TC 46
Z9 46
U1 0
U2 19
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0340-255X
BN 3-540-31241-2
J9 PROG COLL POL SCI S
PY 2006
VL 132
BP 138
EP 144
DI 10.1007/2882_026
PG 7
WC Materials Science, Characterization & Testing; Polymer Science
SC Materials Science; Polymer Science
GA BEL71
UT WOS:000238029200018
OA Green Published
DA 2018-10-20
ER

PT S
AU Guicheteau, J
   Christesen, SD
AF Guicheteau, Jason
   Christesen, Steven D.
BE Gardner, PJ
   Fountain, AW
TI Principal component analysis of bacteria using surface-enhanced Raman
   spectroscopy
SO CHEMICAL AND BIOLOGICAL SENSING VII
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Chemical and Biological Sensing VII
CY APR 19-21, 2006
CL Kissimmee, FL
SP SPIE
DE SERS; bacteria; PCA
ID DIPICOLINIC ACID; BACILLUS SPORES; SILVER; DISCRIMINATION; CELLS; SERS
AB Surface-enhanced Raman scattering (SERS) provides rapid fingerprinting of biomaterial in a non-destructive manner. The problem of tissue fluorescence, which can overwhelm a normal Raman signal from biological samples, is largely overcome by treatment of biomaterials with colloidal silver. This work presents a study into the applicability of qualitative SER spectroscopy with principal component analysis (PCA) for the discrimination of four biological threat simulants; Bacillus globigii, Pantoea agglomerans, Brucella noetomae, and Yersinia rohdei. We also demonstrate differentiation of gram-negative and gram-positive species and as well as spores and vegetative cells of Bacillus globigii.
C1 [Guicheteau, Jason; Christesen, Steven D.] US Army Edgewood Chem Biol Ctr, Aberdeen Proving Ground, MD 21010 USA.
RP Guicheteau, J (reprint author), US Army Edgewood Chem Biol Ctr, Aberdeen Proving Ground, MD 21010 USA.
CR Alexander TA, 2003, APPL SPECTROSC, V57, P1340, DOI 10.1366/000370203322554482
   Bell SEJ, 2005, ANALYST, V130, P545, DOI 10.1039/b415290e
   CARRON K, 1999, J RAMAN, V30, P853
   CARRON KT, 1992, SPECTROSCOPY, V7, P24
   Clarke SJ, 2005, ANALYST, V130, P1019, DOI 10.1039/b502540k
   Edwards H. G. M., 2002, HDB VIBRATIONAL SPEC
   Farquharson S, 2004, APPL SPECTROSC, V58, P351, DOI 10.1366/000370204322886735
   Farquharson S, 2004, J RAMAN SPECTROSC, V35, P82, DOI 10.1002/jrs.1111
   Fell NF, 2002, P SOC PHOTO-OPT INS, V4577, P174, DOI 10.1117/12.455735
   GHIAMATI E, 1992, APPL SPECTROSC, V46, P357, DOI 10.1366/0003702924125609
   Gonster KR, 2004, P SOC PHOTO-OPT INS, V5585, P136, DOI 10.1117/12.577591
   Goodacre R, 1998, MICROBIOL-UK, V144, P1157, DOI 10.1099/00221287-144-5-1157
   Guicheteau JA, 2004, P SOC PHOTO-OPT INS, V5585, P113, DOI 10.1117/12.580466
   Guzelian AA, 2002, P SOC PHOTO-OPT INS, V4577, P182, DOI 10.1117/12.455736
   Huang WE, 2004, ANAL CHEM, V76, P4452, DOI 10.1021/ac049753k
   Hughes JM, 2002, EMERG INFECT DIS, V8, P1013, DOI 10.3201/eid0810.020466
   Inscore FE, 2004, P SOC PHOTO-OPT INS, V5585, P53, DOI 10.1117/12.580460
   Jarvis RM, 2004, ANAL CHEM, V76, P5198, DOI 10.1021/ac049663f
   Jarvis RM, 2004, ANAL CHEM, V76, P40, DOI 10.1021/ac034689c
   KITAGAWA T, 2002, HDB VIBRATIONAL SPEC, P3426
   Kneipp K, 2002, J PHYS-CONDENS MAT, V14, pR597, DOI 10.1088/0953-8984/14/18/202
   LEE PC, 1982, J PHYS CHEM-US, V86, P3391, DOI 10.1021/j100214a025
   Lopez-Diez EC, 2004, ANAL CHEM, V76, P585, DOI 10.1021/ac035110d
   Magee J.T., 1993, HDB NEW BACTERIAL SY, P383
   Maquelin K, 2000, ANAL CHEM, V72, P12, DOI 10.1021/ac991011h
   MCCREERY RL, 2000, RAMAN SPECTROSCOPY C, V157, P420
   NELSON WH, 1991, MODERN TECHNIQUES RA, P97
   Premasiri WR, 2005, J PHYS CHEM B, V109, P312, DOI 10.1021/jp040442n
   Schuster KC, 2000, ANAL CHEM, V72, P5529, DOI 10.1021/ac000718x
   Sengupta A, 2005, APPL SPECTROSC, V59, P1016, DOI 10.1366/0003702054615124
   Strachan CJ, 2004, J RAMAN SPECTROSC, V35, P347, DOI 10.1002/jrs.1140
   SUH JS, 1986, J AM CHEM SOC, V108, P4711, DOI 10.1021/ja00276a005
   Torok TJ, 1997, JAMA-J AM MED ASSOC, V278, P389, DOI 10.1001/jama.278.5.389
   Zeiri L, 2004, APPL SPECTROSC, V58, P33, DOI 10.1366/000370204322729441
   Zeiri L, 2002, COLLOID SURFACE A, V208, P357, DOI 10.1016/S0927-7757(02)00162-0
   Zhang XY, 2005, J AM CHEM SOC, V127, P4484, DOI 10.1021/ja0436623b0b
NR 36
TC 4
Z9 4
U1 0
U2 7
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 0-8194-6274-8
J9 PROC SPIE
PY 2006
VL 6218
AR 62180G
DI 10.1117/12.664502
PG 8
WC Instruments & Instrumentation
SC Instruments & Instrumentation
GA BES56
UT WOS:000239300700015
DA 2018-10-20
ER

PT J
AU Ohmori, H
   Katahira, K
   Akinou, Y
   Komotori, J
   Mizutani, M
AF Ohmori, H.
   Katahira, K.
   Akinou, Y.
   Komotori, J.
   Mizutani, M.
TI Investigation on grinding characteristics and surface-modifying effects
   of Biocompatible Co-Cr alloy
SO CIRP ANNALS-MANUFACTURING TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 56th General Assembly of CIRP
CY AUG 20-26, 2006
CL Kobe, JAPAN
DE biomedical; grinding; finishing process
ID FILMS
AB Co-Cr alloy used as a biomaterial is required to possess excellent resistance to corrosion, wear, and biocompatibility. In the present work, we performed Electrolytic In-Process Dressing grinding on Co-Cr alloy, and evaluated the processing characteristics and resulting surface properties. Final finishing using a #8000 wheel produced an extremely smooth ground surface with a roughness Ra of 7 nm. In addition, as compared with the conventionally polished samples, the ground samples demonstrated superior surface hardness and biocompatibility. These advantages can be attributed to the diffusion of several kinds of elements during the grinding process and the effect of grinding fluid compositions.
C1 RIKEN, Inst Phys & Chem Res, Wako, Saitama, Japan.
   Keio Univ, Kanagawa, Japan.
RP Ohmori, H (reprint author), RIKEN, Inst Phys & Chem Res, Wako, Saitama, Japan.
RI Komotori, Jun/G-9232-2014; Ohmori, Hitoshi/A-7562-2015
CR Brinksmeier E., 2004, ANN CIRP, V53, P685
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Katahira K, 2002, INT J MACH TOOL MANU, V42, P1307, DOI 10.1016/S0890-6955(02)00076-7
   Klocke F, 2002, CIRP ANN-MANUF TECHN, V51, P245, DOI 10.1016/S0007-8506(07)61509-1
   Ohmori H, 2005, CIRP ANN-MANUF TECHN, V54, P511, DOI 10.1016/S0007-8506(07)60157-7
   OHMORI H, 2002, ANN CIRP, V51, P491
   Ohmori H, 1995, ANN CIRP, V44, P287
   Serrano MC, 2004, BIOMATERIALS, V25, P5603, DOI 10.1016/j.biomaterials.2004.01.037
   WINTER GD, 1980, EVALUATION BIOMATERI
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
NR 10
TC 17
Z9 17
U1 1
U2 6
PU TECHNISCHE RUNDSCHAU EDITION COLIBRI LTD
PI BERN
PA NORDRING 4, CH-3001 BERN, SWITZERLAND
SN 0007-8506
J9 CIRP ANN-MANUF TECHN
JI CIRP Ann-Manuf. Technol.
PY 2006
VL 55
IS 1
BP 597
EP 600
DI 10.1016/S0007-8506(07)60491-0
PG 4
WC Engineering, Industrial; Engineering, Manufacturing
SC Engineering
GA 078AS
UT WOS:000240073900139
DA 2018-10-20
ER

PT J
AU Lee, WK
AF Lee, WK
TI Synthesis of polyester/poly(dimethylsiloxane)/polyester triblock
   copolymers and their rearrangement under water: rearrangement of
   PDMS-containing copolymers
SO COMPOSITE INTERFACES
LA English
DT Article
DE poly(dimethylsiloxane); polyester; surface; water; rearrangement
ID ELECTRON-SPECTROSCOPY; SURFACE-COMPOSITION; CHEMICAL-ANALYSIS;
   BLOCK-COPOLYMERS; DIMETHYLSILOXANE; STYRENE; BLENDS
AB Triblock copolymers consisting of a poly(dimethylsiloxane) (PDMS, Mn = 1000) middle block coupled to hydrolytically degradable polyester end blocks having different glass transition temperatures (T-g) as a newly developed biomaterial were synthesized by ring open polymerization initiated by both alcohol end groups of PDMS.H-1-NMR and X-ray photoelectron spectroscopy (XPS) were used to determine the bulk and surface compositions of the copolymers.
   Quantitative angle-dependent XPS data from cast thin films of the copolymers showed significantly high mole fractions of PDMS (0.7-0.92) at low takeoff angles as opposed to low mole fractions of PDMS (0.009-0.065) in the bulk. XPS data also showed that exposing the film to water significantly effect the surface composition of which PDMS concentration was decreased. This suggests that the copolymer chains undergo a structure rearrangement at the polymer water interface, depending on both T(g)s of polyester blocks in the copolymers and immersing time.
C1 Pukyong Natl Univ, Div Chem Engn, Pusan 608739, South Korea.
RP Lee, WK (reprint author), Pukyong Natl Univ, Div Chem Engn, Pusan 608739, South Korea.
EM wonki@pknu.ac.kr
CR CHAPMAN TM, 1995, MACROMOLECULES, V28, P2081, DOI 10.1021/ma00110a047
   CHEN J, 1998, THESIS STATE U NY BU
   Chen JX, 1998, MACROMOLECULES, V31, P9328, DOI 10.1021/ma980639b
   CHEN X, 1994, MACROMOLECULES, V27, P3363, DOI 10.1021/ma00090a034
   CHEN X, 1992, MACROMOLECULES, V25, P6621, DOI 10.1021/ma00050a035
   CHEN X, 1995, MACROMOLECULES, V28, P1635, DOI 10.1021/ma00109a041
   Chen X., 1993, MACROMOLECULES, V26, P4601
   Erbil HY, 1997, LANGMUIR, V13, P5484, DOI 10.1021/la9620521
   GAINES GL, 1972, MACROMOLECULES, V5, P82, DOI 10.1021/ma60025a019
   Hawkridge AM, 2000, J VAC SCI TECHNOL A, V18, P567, DOI 10.1116/1.582227
   Jannasch P, 1998, MACROMOLECULES, V31, P1341, DOI 10.1021/ma971351+
   Lee WK, 2000, LANGMUIR, V16, P3401, DOI 10.1021/la990800r
   MAYES AM, 1994, MACROMOLECULES, V27, P3114, DOI 10.1021/ma00089a033
   SCOTT G, 1995, DEGRADABLE POLYM
   SMITH SD, 1992, MACROMOLECULES, V25, P2575, DOI 10.1021/ma00036a002
   Van Krevelen D.W., 1990, PROPERTIES POLYM
   Wen JM, 1997, MACROMOLECULES, V30, P7206, DOI 10.1021/ma961442r
   YILGOR I, 1989, J POLYM SCI POL CHEM, V27, P3673, DOI 10.1002/pola.1989.080271110
NR 18
TC 2
Z9 2
U1 3
U2 8
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0927-6440
J9 COMPOS INTERFACE
JI Compos. Interfaces
PY 2006
VL 13
IS 2-3
BP 159
EP 171
DI 10.1163/156855406775997088
PG 13
WC Materials Science, Composites
SC Materials Science
GA 043GQ
UT WOS:000237588700005
DA 2018-10-20
ER

PT J
AU Mollica, F
   Ventre, M
   Sarracino, F
   Ambrosio, L
   Nicolais, L
AF Mollica, F
   Ventre, M
   Sarracino, F
   Ambrosio, L
   Nicolais, L
TI Mechanical properties and modelling of a hydrophilic composite used as a
   biomaterial
SO COMPOSITES SCIENCE AND TECHNOLOGY
LA English
DT Article
DE biomaterials; mathematical modelling; fibre/matrix bond; plasma
   treatment
ID ANTERIOR CRUCIATE LIGAMENT; FIBER-REINFORCED POLYPROPYLENE;
   OXYGEN-PLASMA TREATMENT; FIBER/VINYLESTER COMPOSITES; KNEE STABILITY;
   ACL; RECONSTRUCTION; BEHAVIOR; TENDONS; SATISFACTION
AB Artificial ligaments were fabricated by reinforcing a hydrophilic thermoplastic polyurethane matrix with poly-ethyleneterephtalate (PET) fibres, using the filament winding technology. The specimens were then tested in simple tension to measure the mechanical properties of the artificial ligaments. In order to investigate on the effect of technological parameters, three types of windings were manufactured, each type being identified by the winding angle and the fibre volume fraction that were used. Moreover, a certain amount of the PET fibres was plasma-treated before winding, so composite ligaments reinforced with plasma-treated fibres were obtained. All of the artificial ligaments displayed the typical J-shaped stress-strain curve of natural ligaments, the plasma-treated ones mainly exhibiting a smaller toe region. A mathematical model is proposed to predict the mechanical behaviour of the artificial ligaments. The model is able to reproduce the behaviour of the artificial ligaments, especially the ones reinforced with plasma-treated fibres, and can be further used to simulate the behaviour of artificial ligaments subject to a more physiological deformation history, such as the combination of tension and torsion. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Ferrara, Dept Engn, I-44100 Ferrara, Italy.
   CNR, Inst Composite & Biomed Mat, I-80125 Naples, Italy.
RP Mollica, F (reprint author), Univ Ferrara, Dept Engn, Via Saragat 1, I-44100 Ferrara, Italy.
EM fmollica@ing.unife.it
RI Mollica, Francesco/I-8826-2012
OI AMBROSIO, LUIGI/0000-0002-8367-2405; Ventre,
   Maurizio/0000-0003-3375-9112
CR Ambrosio L., 1994, Clinical Materials, V15, P29, DOI 10.1016/0267-6605(94)90006-X
   Ambrosio L, 1998, J BIOMED MATER RES, V42, P6, DOI 10.1002/(SICI)1097-4636(199810)42:1<6::AID-JBM2>3.0.CO;2-U
   Atkinson KE, 1998, COMPOS SCI TECHNOL, V58, P1917, DOI 10.1016/S0266-3538(98)00012-8
   Cioffi MOH, 2003, MATER CHARACT, V50, P209, DOI 10.1016/S1044-5803(03)00094-9
   DAVIS PA, 1992, J MATER SCI-MATER M, V3, P359, DOI 10.1007/BF00705368
   De Santis R, 2004, COMPOS SCI TECHNOL, V64, P861, DOI 10.1016/j.compscitech.2003.09.008
   Devaux E, 1999, COMPOS SCI TECHNOL, V59, P459, DOI 10.1016/S0266-3538(98)00090-6
   DUVAL N, 1987, LIGAMENTS LIGAMENT 2, pCH2
   Gamstedt EK, 1999, COMPOS SCI TECHNOL, V59, P759, DOI 10.1016/S0266-3538(98)00119-5
   GERSHON B, 1990, BIOMATERIALS, V11, P548, DOI 10.1016/0142-9612(90)90076-3
   Guidoin MF, 2000, BIOMATERIALS, V21, P2461, DOI 10.1016/S0142-9612(00)00114-9
   Hirokawa S, 1997, MED ENG PHYS, V19, P637, DOI 10.1016/S1350-4533(96)00077-X
   Hirokawa S, 2000, J BIOMECH, V33, P1069, DOI 10.1016/S0021-9290(00)00073-7
   Holzapfel GA, 2000, NONLINEAR SOLID MECH
   IANNACE S, 1995, BIOMATERIALS, V16, P675, DOI 10.1016/0142-9612(95)99693-G
   Kazanci M, 2002, J MATER SCI-MATER M, V13, P465, DOI 10.1023/A:1014789815441
   KOLARIK J, 1981, J BIOMED MATER RES, V15, P147, DOI 10.1002/jbm.820150204
   Lavoie P, 2001, KNEE, V8, P19, DOI 10.1016/S0968-0160(00)00076-4
   Lavoie P, 2000, KNEE, V7, P157, DOI 10.1016/S0968-0160(00)00039-9
   MCCARTHY DM, 1993, ANTERIOR CRUCIATE LI
   MIGLIARESI C, 1984, P 2 WORLD C BIOM WAS
   Moon SI, 1999, COMPOS SCI TECHNOL, V59, P487, DOI 10.1016/S0266-3538(98)00093-1
   Moon SI, 1997, COMPOS SCI TECHNOL, V57, P197, DOI 10.1016/S0266-3538(96)00130-3
   Mooney M, 1940, J APPL PHYS, V11, P582, DOI 10.1063/1.1712836
   Murray AW, 2004, KNEE, V11, P9, DOI 10.1016/S0968-0160(03)00076-0
   Netti P, 1996, J MATER SCI-MATER M, V7, P525, DOI 10.1007/BF00122175
   Park JM, 2004, COMPOS SCI TECHNOL, V64, P847, DOI 10.1016/j.composcitech.2003.09.009
   RIVILIN RS, 1948, PHILOS T R SOC A, V241, P379
   Tang LG, 1997, POLYM COMPOSITE, V18, P100, DOI 10.1002/pc.10265
   van den Oever M, 1998, COMPOS PART A-APPL S, V29, P227, DOI 10.1016/S1359-835X(97)00089-4
   VENA P, 1998, SYNTHESIS BIO SOLID, P67
   Wu GM, 2004, MATER CHEM PHYS, V85, P81, DOI 10.1016/j.matchemphys.2003.12.004
   Yang QS, 2003, MAT SCI ENG A-STRUCT, V344, P140, DOI 10.1016/S0921-5093(02)00399-4
NR 33
TC 6
Z9 6
U1 1
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0266-3538
J9 COMPOS SCI TECHNOL
JI Compos. Sci. Technol.
PD JAN
PY 2006
VL 66
IS 1
BP 92
EP 101
DI 10.1016/j.compscitech.2005.05.022
PG 10
WC Materials Science, Composites
SC Materials Science
GA 985RT
UT WOS:000233396700008
DA 2018-10-20
ER

PT B
AU Kato, E
   Yoshida, H
   Hayashi, S
   Ogawa, Y
   Kawase, K
AF Kato, Eiji
   Yoshida, Hisa
   Hayashi, Shin'ichiro
   Ogawa, Yuichi
   Kawase, Kodo
BE Shen, XC
   Lu, W
   Zhang, J
   Dou, WB
TI THz sensing method based on thin metallic mesh and an application for
   bimolecular sensing
SO CONFERENCE DIGEST OF THE 2006 JOINT 31ST INTERNATIONAL CONFERENCE ON
   INFRARED AND MILLIMETER WAVES AND 14TH INTERNATIONAL CONFERENCE ON
   TERAHERTZ ELECTRONICS
LA English
DT Proceedings Paper
CT Joint 31st International Conference on Infrared and Millimeter
   Waves/14th International Conference on Terahertz Electronics
CY SEP 18-22, 2006
CL Shanghai, PEOPLES R CHINA
SP Chinese Acad Sci, Shanghai Inst Tech Phys, SE Univ, Chinese Acad Sci, Natl Nat Sci Fdn China, IEEE MTT S, IEEE Nanjing Joint Chapter, IEEE Shanghai Sub Sect, Shanghai Int Culture Assoc, Chinese Phys Soc, Chinese Opt Soc, Chinese Inst Elect
ID TECHNOLOGY
AB We report on a novel sensing method in the terahertz (THz) range using thin metallic mesh (TMM). Conventionally, the filter property of a TMM can be changed by the geometrical parameters of the TMM. Considering that it is also change when the medium in the vicinity of the mesh openings has a different refractive index, we inspected this principle. For the biomaterial measurements, we deposited the avidin solution uniformly on the TMM. We observed the change of the transmission characteristics.
C1 [Kato, Eiji] Advantest Labs Ltd, Aoba Ku, 48-2 Matsubara,Kamiayashi, Sendai, Miyagi 9893124, Japan.
   [Kato, Eiji; Kawase, Kodo] Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648603, Japan.
   [Yoshida, Hisa; Hayashi, Shin'ichiro; Ogawa, Yuichi; Kawase, Kodo] Tohoku Univ, Aoba Ku, Sendai, Miyagi 9818555, Japan.
   [Hayashi, Shin'ichiro; Kawase, Kodo] SENDAI, RIKEN, Aoba Ku, Sendai, Miyagi 9800845, Japan.
RP Kato, E (reprint author), Advantest Labs Ltd, Aoba Ku, 48-2 Matsubara,Kamiayashi, Sendai, Miyagi 9893124, Japan.
EM eiji.kato@atl.advantest.co.jp
FU Fuence Co., Ltd for electrospray deposition system
FX The authors would like to acknowledge for the support Fuence Co., Ltd.
   for electrospray deposition system.
CR Menikh A, 2004, BIOSENS BIOELECTRON, V20, P658, DOI 10.1016/j.bios.2004.03.006
   Mickan SP, 2002, PHYS MED BIOL, V47, P3789, DOI 10.1088/0031-9155/47/21/317
   Morozov VN, 1999, ANAL CHEM, V71, P3110, DOI 10.1021/ac981412h
   Sakai K., 1983, REV INFRARED MILLIME, V1, P155
   Tanaka M, 2005, OPT LETT, V30, P1210, DOI 10.1364/OL.30.001210
NR 5
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-0399-8
PY 2006
BP 185
EP 185
PG 1
WC Engineering, Electrical & Electronic
SC Engineering
GA BGH25
UT WOS:000246942200183
DA 2018-10-20
ER

PT B
AU Tsibouklis, J
   Nevell, TG
   Baru, E
AF Tsibouklis, John
   Nevell, Thomas G.
   Baru, Eugen
BE Mittal, KL
TI Biofouling-resistant coatings from low-surface-energy polymers
SO CONTACT ANGLE, WETTABILITY AND ADHESION, VOL 4
LA English
DT Proceedings Paper
CT 4th International Symposium on Contact Angle, Wettability and Adhesion
CY JUN 14-16, 2004
CL Philadelphia, PA
SP MST
DE low surface energy; antifouling; fluoropolymer
ID MOLECULAR DESIGN REQUIREMENTS; BACTERIAL ADHESION; PROTEIN ADSORPTION;
   BIOMATERIAL SURFACES; SETTLEMENT; MECHANISMS; MICROSCOPY; MONOLAYERS;
   DEXTRAN; ABILITY
AB For protecting surfaces against microbial contamination, an alternative to chemical attack (bleaches, detergents) on established colonies of fouling organisms and to the use of toxic surfaces (antibiotics, copper, organotin additives to paints) is to utilise surfaces of environmentally friendly, non-toxic polymeric materials onto which microbial colonisers will not adhere. In this paper, the deployment of low-surface-energy coatings that inhibit settlement by removing the ability of the surface to form a permanent bond with the microorganism is described.
C1 [Tsibouklis, John; Nevell, Thomas G.; Baru, Eugen] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England.
RP Tsibouklis, J (reprint author), Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England.
EM john.tsibouklis@port.ac.uk
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   Brady RF, 1997, CHEM IND-LONDON, P219
   Brady RF, 1999, PROG ORG COAT, V35, P31, DOI 10.1016/S0300-9440(99)00005-3
   Callow ME, 1997, J PHYCOL, V33, P938, DOI 10.1111/j.0022-3646.1997.00938.x
   CLARE AS, 1992, INVERTEBR REPROD DEV, V22, P67, DOI 10.1080/07924259.1992.9672258
   Clare AS, 1996, BIOFOULING, V10, P141, DOI 10.1080/08927019609386276
   Cunliffe D, 2000, BIOTECHNOL LETT, V22, P141, DOI 10.1023/A:1005622424821
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   EVANS LV, 1993, J APPL BACTERIOL, V74, pS119, DOI 10.1111/j.1365-2672.1993.tb04348.x
   Frazier RA, 2000, BIOMATERIALS, V21, P957, DOI 10.1016/S0142-9612(99)00270-7
   Graham PD, 2000, BIOFOULING, V16, P289, DOI 10.1080/08927010009378452
   Green RJ, 2000, BIOMATERIALS, V21, P1823, DOI 10.1016/S0142-9612(00)00077-6
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   Holland NB, 1998, NATURE, V392, P799
   HOLMBERG K, 1993, J ADHES SCI TECHNOL, V7, P503, DOI 10.1163/156856193X00826
   Ista LK, 1996, FEMS MICROBIOL LETT, V142, P59
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jeong JH, 2000, COLLOID SURFACE B, V18, P371, DOI 10.1016/S0927-7765(99)00162-9
   LEE JH, 1988, POLYM SURFACE DYNAMI, P119
   Lindner E, 1992, BIOFOULING, V6, P193, DOI 10.1080/08927019209386222
   Merrill EW, 1983, AM SOC ARTIF INTERN, V6, P60
   MORTON LHG, 1994, INT BIODETER BIODEGR, V34, P203, DOI 10.1016/0964-8305(94)90083-3
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   Razatos A, 1998, P NATL ACAD SCI USA, V95, P11059, DOI 10.1073/pnas.95.19.11059
   Schrader M. E., 1988, Marine biodeterioration., P261
   Tsibouklis J, 1999, LANGMUIR, V15, P7076, DOI 10.1021/la990411x
   Tsibouklis J, 1999, BIOMATERIALS, V20, P1229, DOI 10.1016/S0142-9612(99)00023-X
   Tsibouklis J, 2003, ADV MATER, V15, P647, DOI 10.1002/adma.200301638
   Vacheethasanee K, 2000, J BIOMED MATER RES, V50, P302, DOI 10.1002/(SICI)1097-4636(20000605)50:3<302::AID-JBM3>3.0.CO;2-1
   Vrolijk N.H., 1990, Biofouling, V2, P39
NR 33
TC 0
Z9 0
U1 2
U2 6
PU VSP BV-C/O BRILL ACAD PUBL
PI LEIDEN
PA PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
BN 90-6764-436-6
PY 2006
BP 461
EP +
PG 3
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing
SC Materials Science
GA BFK30
UT WOS:000242465600027
DA 2018-10-20
ER

PT J
AU Meyer, A
   Auemheimer, J
   Modlinger, A
   Kessler, H
AF Meyer, A.
   Auemheimer, J.
   Modlinger, A.
   Kessler, H.
TI Targeting RGD recognizing integrins: Drug development, biomaterial
   research, tumor imaging and targeting
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Review
DE biomaterial; drug targeting; integrin ligands; radiolabeling; RGD
   peptides; structure based drug design; tumor imaging
ID ARG-GLY-ASP; NONPEPTIDE ALPHA(V)BETA(3) ANTAGONISTS; VITRONECTIN
   RECEPTOR ANTAGONISTS; MONOCLONAL-ANTIBODY BINDING; TITANIUM IMPLANT
   MATERIALS; CELL-ADHESION PEPTIDES; GLYCOPROTEIN-IIB-IIIA; SOLID-PHASE
   SYNTHESIS; DEEP-VEIN THROMBOSIS; IN-VIVO EVALUATION
AB Integrins constitute an important class of cell adhesion receptors responsible not only for cell-matrix adhesion but also for signaling bidirectionally across the membrane. Integrins are involved in many biological processes such as angiogenesis, thrombosis, inflammation, osteoporosis and cancer. Integrins thus play a key role in many severe human diseases. In this review we will describe recent research and development of RGD-containing integrin ligands for medical applications including drug design, radiolabeling, drug targeting, as well as biomaterial research.
   Many ligands have been developed for targeting the alpha v beta 3 integrin in order to block angiogenesis or osteoporosis, but there are also other integrins like alpha v beta 5 and alpha 5 beta 1 which become more and more interesting for similar purposes. alpha IIb beta 3 constitutes a potent target in thrombosis therapy; but the search for suitable ligands is still ongoing. We will reconstruct the drug development process for these integrin subtypes considering selected examples with focus on structure based design. Different structural requirements are pointed out concerning integrin activity and particularly the selectivity towards the distinct integrin types. Furthermore, we will show recent progress in tumor and thrombosis imaging based on radiolabeled RGD-containing ligands binding alpha v beta 3 or alpha IIb beta 3, respectively. Additionally further advances in biornaterial research are presented. We describe the coating of different implant materials with various alpha v beta 3 recognizing ligands for the purpose of increasing cell attachment and biocompatibility.
C1 Univ Munich, Lehrstuhl Organ Chem 2, Dept Chem, D-85747 Garching, Germany.
RP Kessler, H (reprint author), Univ Munich, Lehrstuhl Organ Chem 2, Dept Chem, Lichtenbergstr 4, D-85747 Garching, Germany.
EM horst.kessler@ch.tum.de
RI Kessler, Horst/C-1178-2010
CR Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199
   ADLER M, 1991, SCIENCE, V253, P445, DOI 10.1126/science.1862345
   AGREZ M, 1994, J CELL BIOL, V127, P547, DOI 10.1083/jcb.127.2.547
   Akhtar N, 2004, NEOPLASIA, V6, P106, DOI 10.1593/neo.03334
   Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   Anderluh M, 2005, EUR J MED CHEM, V40, P25, DOI 10.1016/j.ejmech.2004.09.004
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377
   Arnaout MA, 2002, IMMUNOL REV, V186, P125, DOI 10.1034/j.1600-065X.2002.18612.x
   ARNAOUT MA, 1990, BLOOD, V75, P1037
   Arnaout MA, 2002, CURR OPIN CELL BIOL, V14, P641, DOI 10.1016/S095506740200371X
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   ARONOW MA, 1990, J CELL PHYSIOL, V143, P213, DOI 10.1002/jcp.1041430203
   Aubin JE, 1998, J CELL BIOCHEM, P73, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<73::AID-JCB11>3.0.CO;2-L
   Auernheimer J, 2006, BIOORG MED CHEM LETT, V16, P271, DOI 10.1016/j.bmcl.2005.10.018
   Auernheimer J, 2005, CHEMBIOCHEM, V6, P2034, DOI 10.1002/cbic.200500031
   AUMAILLEY M, 1991, FEBS LETT, V291, P50, DOI 10.1016/0014-5793(91)81101-D
   Bach AC, 1996, J AM CHEM SOC, V118, P293, DOI 10.1021/ja953163+
   Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9
   Banerjee P, 2000, J BIOMED MATER RES, V50, P331, DOI 10.1002/(SICI)1097-4636(20000605)50:3<331::AID-JBM6>3.3.CO;2-K
   Barrett JA, 1997, BIOCONJUGATE CHEM, V8, P155, DOI 10.1021/bc970001p
   Barrett JA, 1996, BIOCONJUGATE CHEM, V7, P203, DOI 10.1021/bc9500960
   BAUER TW, 2000, CLIN ORTHOP RELAT R, V371, P10, DOI DOI 10.1097/00003086-200002000-00003
   BAUTOVICH G, 1994, J NUCL MED, V35, P195
   Bernard B, 2004, CANCER BIOTHER RADIO, V19, P173, DOI 10.1089/108497804323071940
   Biltresse S, 2004, BIOORGAN MED CHEM, V12, P5379, DOI 10.1016/j.bmc.2004.07.055
   Blum JE, 2002, CURR PHARM DESIGN, V8, P1815, DOI 10.2174/1381612023393891
   Bork P, 1999, TRENDS BIOCHEM SCI, V24, P261, DOI 10.1016/S0968-0004(99)01416-4
   BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751
   BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227
   BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8
   Brouwers FM, 2003, CLIN NUCL MED, V28, P480, DOI 10.1097/00003072-200306000-00006
   Bubenik M, 2003, BIOORG MED CHEM LETT, V13, P503, DOI 10.1016/S0960-894X(02)00942-3
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Burkhart DJ, 2004, MOL CANCER THER, V3, P1593
   Calzada MJ, 2002, J BIOL CHEM, V277, P39899, DOI 10.1074/jbc.M205886200
   Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003
   Chen XY, 2004, EUR J NUCL MED MOL I, V31, P1081, DOI 10.1007/s00259-003-1452-2
   Chew D P, 2001, Curr Cardiol Rep, V3, P63, DOI 10.1007/s11886-001-0012-2
   Chinn JA, 1998, J BIOMED MATER RES, V39, P130, DOI 10.1002/(SICI)1097-4636(19980101)39:1<130::AID-JBM15>3.0.CO;2-J
   Claasen B, 2005, J AM CHEM SOC, V127, P916, DOI 10.1021/ja044434w
   Clark RAF, 1996, BRIT J DERMATOL, V135, P46
   Coleman PJ, 2004, J MED CHEM, V47, P4829, DOI 10.1021/jm049874c
   Coleman PJ, 2002, BIOORG MED CHEM LETT, V12, P2463, DOI 10.1016/S0960-894X(02)00396-7
   Coller BS, 1997, J CLIN INVEST, V100, pS57
   Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Cowles EA, 1998, CALCIFIED TISSUE INT, V62, P74, DOI 10.1007/s002239900397
   Cowles EA, 2000, J BIOMED MATER RES, V52, P725, DOI 10.1002/1097-4636(20001215)52:4<725::AID-JBM18>3.3.CO;2-F
   Cox D, 2000, J AM COLL CARDIOL, V36, P1514, DOI 10.1016/S0735-1097(00)00919-0
   Craig D, 2004, STRUCTURE, V12, P2049, DOI 10.1016/j.str.2004.09.009
   Cue D, 2000, P NATL ACAD SCI USA, V97, P2858, DOI 10.1073/pnas.050587897
   Dahmen C, 2004, ANGEW CHEM INT EDIT, V43, P6649, DOI 10.1002/anie.200460770
   De Corte BL, 2004, BIOORG MED CHEM LETT, V14, P5227, DOI 10.1016/j.bmcl.2004.06.061
   Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g
   Delforge D, 1996, ANAL BIOCHEM, V242, P180, DOI 10.1006/abio.1996.0451
   DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1
   DRUMHELLER PD, 1994, ANAL BIOCHEM, V222, P380, DOI 10.1006/abio.1994.1506
   DUCHEYNE P, 1988, Journal of Oral Implantology, V14, P325
   Duggan ME, 2000, J MED CHEM, V43, P3736, DOI 10.1021/jm000133v
   Egbertson MS, 1999, J MED CHEM, V42, P2409, DOI 10.1021/jm980722p
   Eid K, 2001, J BIOMED MATER RES, V57, P224, DOI 10.1002/1097-4636(200111)57:2<224::AID-JBM1162>3.0.CO;2-F
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Elicieri B, 1997, FASEB J, V11, pA1290
   Elmengaard B, 2005, BIOMATERIALS, V26, P3521, DOI 10.1016/j.biomaterials.2004.09.039
   EZEKOWITZ MD, 1986, CIRCULATION, V73, P668, DOI 10.1161/01.CIR.73.4.668
   Feng YZ, 2004, BIOCHEMISTRY-US, V43, P15811, DOI 10.1021/bi049174+
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Feuston BP, 2003, J MED CHEM, V46, P5316, DOI 10.1021/jm030146j
   Feuston BP, 2002, J MED CHEM, V45, P5640, DOI 10.1021/JM0203130
   Fichna J, 2003, BIOCONJUGATE CHEM, V14, P3, DOI 10.1021/bc025542f
   Fields GB, 1998, BIOPOLYMERS, V47, P143, DOI 10.1002/(SICI)1097-0282(1998)47:2<143::AID-BIP3>3.3.CO;2-P
   Francesconi LC, 2004, INORG CHEM, V43, P2867, DOI 10.1021/ic035473w
   FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500
   Friedlander M, 1996, P NATL ACAD SCI USA, V93, P9764, DOI 10.1073/pnas.93.18.9764
   Fullard JF, 2004, CURR PHARM DESIGN, V10, P1567, DOI 10.2174/1381612043384682
   Ganta DR, 1997, ENDOCRINOLOGY, V138, P3606, DOI 10.1210/en.138.9.3606
   Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6
   GEORGE EL, 1993, DEVELOPMENT, V119, P1079
   GERSTENFELD LC, 1987, DEV BIOL, V122, P49, DOI 10.1016/0012-1606(87)90331-9
   Ghosh S, 2004, BIOORG MED CHEM LETT, V14, P5937, DOI 10.1016/j.bmcl.2004.08.067
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gibson C, 2001, ANGEW CHEM INT EDIT, V40, P165, DOI 10.1002/1521-3773(20010105)40:1<165::AID-ANIE165>3.0.CO;2-8
   GLOWACKI J, 1985, CLIN PLAST SURG, V12, P233
   Goodman SL, 2002, J MED CHEM, V45, P1045, DOI 10.1021/jm0102598
   Gottschalk KE, 2004, STRUCTURE, V12, P1109, DOI 10.1016/j.str.2004.02.039
   Gottschalk KE, 2002, CHEMBIOCHEM, V3, P470, DOI 10.1002/1439-7633(20020503)3:5<470::AID-CBIC470>3.0.CO;2-X
   Gottschalk KE, 2002, ANGEW CHEM INT EDIT, V41, P3767, DOI 10.1002/1521-3773(20021018)41:20<3767::AID-ANIE3767>3.0.CO;2-T
   GOULD RJ, 1990, P SOC EXP BIOL MED, V195, P168
   Grashoff C, 2004, CURR OPIN CELL BIOL, V16, P565, DOI 10.1016/j.ceb.2004.07.004
   Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490
   GURRATH M, 1992, EUR J BIOCHEM, V210, P911, DOI 10.1111/j.1432-1033.1992.tb17495.x
   Hammes HP, 1996, NAT MED, V2, P529, DOI 10.1038/nm0596-529
   Hartman George D., 1995, Drugs of the Future, V20, P897
   Haubner R, 1997, ANGEW CHEM INT EDIT, V36, P1375
   Haubner R, 2005, PLOS MED, V2, P244, DOI 10.1371/journal.pmed.0020070
   Haubner R, 2004, BIOCONJUGATE CHEM, V15, P61, DOI 10.1021/bc034170n
   Haubner R, 2001, EUR J NUCL MED, V28, P1175
   Haubner R, 1999, J NUCL MED, V40, P1061
   Haubner R, 1996, J AM CHEM SOC, V118, P7461, DOI 10.1021/ja9603721
   Haubner R, 1996, J AM CHEM SOC, V118, P7881, DOI 10.1021/ja9608757
   Haubner R, 2004, CURR PHARM DESIGN, V10, P1439, DOI 10.2174/1381612043384745
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hlady V, 1996, CURR OPIN BIOTECH, V7, P72, DOI 10.1016/S0958-1669(96)80098-X
   Ho MH, 2005, BIOMATERIALS, V26, P3197, DOI 10.1016/j.biomaterials.2004.08.032
   Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487
   Holland J, 1996, BIOMATERIALS, V17, P2147, DOI 10.1016/0142-9612(96)00028-2
   HORBETT TA, 1994, J BIOMAT SCI-POLYM E, V6, P15, DOI 10.1163/156856295X00724
   HORTON MA, 1991, EXP CELL RES, V195, P368, DOI 10.1016/0014-4827(91)90386-9
   Houseman BT, 2001, BIOMATERIALS, V22, P943, DOI 10.1016/S0142-9612(00)00259-3
   Huang XZ, 1996, J CELL BIOL, V133, P921, DOI 10.1083/jcb.133.4.921
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Huebsch JB, 1996, J BIOMED MATER RES, V31, P555, DOI 10.1002/(SICI)1097-4636(199608)31:4<555::AID-JBM16>3.0.CO;2-F
   Hulshoff JEG, 1998, J BIOMED MATER RES, V40, P464, DOI 10.1002/(SICI)1097-4636(19980605)40:3<464::AID-JBM18>3.0.CO;2-J
   Hulshoff JEG, 1997, CLIN ORAL IMPLAN RES, V8, P393, DOI 10.1034/j.1600-0501.1997.080506.x
   Humphries MJ, 2003, TRENDS BIOCHEM SCI, V28, P313, DOI 10.1016/S0968-0004(03)00112-9
   Hutchinson JH, 2003, J MED CHEM, V46, P4790, DOI 10.1021/jm030306r
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   Hynes RO, 2003, SCIENCE, V300, P755, DOI 10.1126/science.1084854
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P545, DOI 10.1021/bm015510f
   ITO Y, 1991, J BIOMED MATER RES, V25, P1325, DOI 10.1002/jbm.820251102
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   Jo S, 2001, BIOMACROMOLECULES, V2, P255, DOI 10.1021/bm000107e
   Johnson R, 1997, Biomed Sci Instrum, V34, P47
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   KANTLEHNER M, 1999, ANGEW CHEM, V111, P587
   Kao WJ, 1999, J MATER SCI-MATER M, V10, P601, DOI 10.1023/A:1008971222932
   Kao WYJ, 1998, BIOTECHNOL BIOENG, V59, P2, DOI 10.1002/(SICI)1097-0290(19980705)59:1<2::AID-BIT2>3.0.CO;2-G
   Kao WYJ, 2001, BIOMATERIALS, V22, P2901, DOI 10.1016/S0142-9612(01)00037-0
   Kasono K, 1999, CLIN CANCER RES, V5, P2571
   Keenan RM, 1998, BIOORG MED CHEM LETT, V8, P3165, DOI 10.1016/S0960-894X(98)00555-1
   Keenan RM, 1997, J MED CHEM, V40, P2289, DOI 10.1021/jm970205r
   Keenan RM, 1999, BIOORG MED CHEM LETT, V9, P1801, DOI 10.1016/S0960-894X(99)00282-6
   Kessler H, 1996, PURE APPL CHEM, V68, P1201, DOI 10.1351/pac199668061201
   Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174
   Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5
   Kling A, 2002, BIOORG MED CHEM LETT, V12, P441, DOI 10.1016/S0960-894X(01)00773-9
   KNIGHT LC, 1989, RADIOLOGY, V173, P163, DOI 10.1148/radiology.173.1.2781002
   KNIGHT LC, 1978, J NUCL MED, V19, P891
   KOBAYASHI H, 1991, CURR EYE RES, V10, P899, DOI 10.3109/02713689109020325
   KOIVUNEN E, 1994, J CELL BIOL, V124, P373, DOI 10.1083/jcb.124.3.373
   KOPPLE KD, 1992, J AM CHEM SOC, V114, P9615, DOI 10.1021/ja00050a049
   Krause A, 2000, J BIOMED MATER RES, V52, P738, DOI 10.1002/1097-4636(20001215)52:4<738::AID-JBM19>3.0.CO;2-F
   Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385
   Kumar CC, 2001, CANCER RES, V61, P2232
   Lacefield W R, 1999, Adv Dent Res, V13, P21
   Lange UEW, 2002, BIOORG MED CHEM LETT, V12, P1379, DOI 10.1016/S0960-894X(02)00161-0
   Langer A, 2000, J AM COLL CARDIOL, V35, p308A
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0
   Lestini BJ, 2002, J CONTROL RELEASE, V78, P235, DOI 10.1016/S0168-3659(01)00505-3
   LEWANDOWSKA K, 1992, J BIOMED MATER RES, V26, P1343, DOI 10.1002/jbm.820261007
   Lhoest JB, 1998, J BIOMED MATER RES, V41, P95, DOI 10.1002/(SICI)1097-4636(199807)41:1<95::AID-JBM12>3.0.CO;2-G
   Li R, 2004, BIOCHEM SOC T, V32, P412, DOI 10.1042/BST0320412
   Li RH, 2004, J BIOL CHEM, V279, P26666, DOI 10.1074/jbc.M314168200
   Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441
   Liddington RC, 2002, J CELL BIOL, V158, P833, DOI 10.1083/jcb.200206011
   Lieb E, 2005, BIOMATERIALS, V26, P2333, DOI 10.1016/j.biomaterials.2004.07.010
   Lin YS, 2001, ARTIF ORGANS, V25, P617, DOI 10.1046/j.1525-1594.2001.025008617.x
   Lohof E, 2000, ANGEW CHEM INT EDIT, V39, P2761, DOI 10.1002/1521-3773(20000804)39:15<2761::AID-ANIE2761>3.0.CO;2-9
   Marcinkiewicz C, 2005, CURR PHARM DESIGN, V11, P815, DOI 10.2174/1381612053381765
   Marinelli L, 2005, J MED CHEM, V48, P4204, DOI 10.1021/jm040224i
   Marinelli L, 2004, J MED CHEM, V47, P4166, DOI 10.1021/jm030635j
   Marinelli L, 2003, J MED CHEM, V46, P4393, DOI 10.1021/jm020577m
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   MATSUDA T, 1989, T AM SOC ART INT ORG, V35, P677
   McQuade P, 2004, BIOCONJUGATE CHEM, V15, P988, DOI 10.1021/bc049961j
   Meissner RS, 2002, BIOORG MED CHEM LETT, V12, P25, DOI 10.1016/S0960-894X(01)00687-4
   MEYER J, 2000, Patent No. 10040105
   Miller WH, 2000, J MED CHEM, V43, P22, DOI 10.1021/jm990446u
   Mitra A, 2005, J CONTROL RELEASE, V102, P191, DOI 10.1016/j.jconrel.2004.09.023
   MOGHADDAM MJ, 1993, J POLYM SCI POL CHEM, V31, P1589, DOI 10.1002/pola.1993.080310629
   Moitessier N, 2004, J MED CHEM, V47, P4178, DOI 10.1021/jm0311386
   MONTGOMERY AMP, 1994, P NATL ACAD SCI USA, V91, P8856, DOI 10.1073/pnas.91.19.8856
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200
   Mould AP, 2004, CURR OPIN CELL BIOL, V16, P544, DOI 10.1016/j.ceb.2004.07.003
   Mousa SA, 2002, CURR OPIN CHEM BIOL, V6, P534, DOI 10.1016/S1367-5931(02)00350-2
   MULLER G, 1994, J COMPUT AID MOL DES, V8, P709, DOI 10.1007/BF00124017
   Nakamura I, 1999, J CELL SCI, V112, P3985
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   Nisato Riccardo E., 2003, Angiogenesis, V6, P105, DOI 10.1023/B:AGEN.0000011801.98187.f2
   Pande G, 2000, CURR OPIN CELL BIOL, V12, P569, DOI 10.1016/S0955-0674(00)00133-2
   PEISHOFF CE, 1992, J MED CHEM, V35, P3962, DOI 10.1021/jm00099a026
   Penning TD, 2004, BIOORG MED CHEM LETT, V14, P1471, DOI 10.1016/j.bmcl.2004.01.015
   Peter K, 1998, BLOOD, V92, P3240
   Peters K, 2002, BIOMATERIALS, V23, P3413, DOI 10.1016/S0142-9612(02)00042-X
   Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1
   PETTIT DK, 1994, J BIOMED MATER RES, V28, P685, DOI 10.1002/jbm.820280605
   Peyman A, 2001, BIOORG MED CHEM LETT, V11, P2011, DOI 10.1016/S0960-894X(01)00357-2
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Plant GW, 1997, EXP NEUROL, V143, P287, DOI 10.1006/exnr.1997.6407
   PLOW EF, 1989, PROG HEMOST THROMB, V9, P117
   Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200
   PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Rajagopalan P, 2004, BIOPHYS J, V87, P2818, DOI 10.1529/biophysj.103.037218
   Rapuano BE, 2004, J ORTHOP RES, V22, P353, DOI 10.1016/S0736-0266(03)00180-3
   Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27
   Richman GP, 2005, J CONTROL RELEASE, V101, P3, DOI 10.1016/j.jconrel.2004.07.034
   Robinson A, 2004, CURR PHARM DESIGN, V10, P1603, DOI 10.2174/1381612043384628
   Rouhi AM, 1999, CHEM ENG NEWS, V77, P51, DOI 10.1021/cen-v077n003.p051
   Ruegg C, 2002, ENDOTHELIUM-NEW YORK, V9, P151, DOI 10.1080/10623320290016591
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sakuma T, 2004, J NUCL MED, V45, P1194
   SAUDEK V, 1991, BIOCHEMISTRY-US, V30, P7369, DOI 10.1021/bi00244a003
   SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1066
   Scarborough RM, 2000, J MED CHEM, V43, P3453, DOI 10.1021/jm000022w
   Schaffner P, 1999, J MATER SCI-MATER M, V10, P837, DOI 10.1023/A:1008904513304
   Schiffelers RM, 2003, J CONTROL RELEASE, V91, P115, DOI 10.1016/S0168-3659(03)00240-2
   Schliephake H, 2002, CLIN ORAL IMPLAN RES, V13, P312, DOI 10.1034/j.1600-0501.2002.130312.x
   Schneider D, 2004, J BIOL CHEM, V279, P9840, DOI 10.1074/jbc.M312749200
   SCHNEIDER G, 1994, EXP CELL RES, V214, P264, DOI 10.1006/excr.1994.1257
   Seemayer CA, 2001, Z RHEUMATOL, V60, P309, DOI 10.1007/s003930170030
   SENN H, 1993, J MOL BIOL, V232, P907, DOI 10.1006/jmbi.1993.1439
   Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257
   Shattil SJ, 1997, J CLIN INVEST, V100, pS91
   SHEMYAKIN MM, 1969, ANGEW CHEM INT EDIT, V8, P492, DOI 10.1002/anie.196904921
   Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Smallheer JM, 2004, BIOORG MED CHEM LETT, V14, P383, DOI 10.1016/j.bmcl.2003.10.057
   SMITH JW, 1990, J BIOL CHEM, V265, P11008
   SMITH JW, 1994, J BIOL CHEM, V269, P960
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0
   Srivatsa SS, 1997, CARDIOVASC RES, V36, P408, DOI 10.1016/S0008-6363(97)00184-3
   STEIN GS, 1989, CONNECT TISSUE RES, V20, P3, DOI 10.3109/03008208909049996
   STOCKMANN A, 1993, J BIOL CHEM, V268, P22874
   Sulyok GAG, 2001, J MED CHEM, V44, P1938, DOI 10.1021/jm0004953
   Sykaras N, 2000, INT J ORAL MAX IMPL, V15, P675
   Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2
   Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445
   Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x
   Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3
   Tepmongkol S, 2002, NEURORADIOLOGY, V44, P819, DOI 10.1007/s00234-002-0857-0
   Thumshirn G, 2003, CHEM-EUR J, V9, P2717, DOI 10.1002/chem.200204304
   Topol EJ, 1999, LANCET, V353, P227, DOI 10.1016/S0140-6736(98)11086-3
   Travis MA, 2003, TRENDS PHARMACOL SCI, V24, P192, DOI 10.1016/S0165-6147(03)00069-5
   UNDERWOOD PA, 1993, J CELL SCI, V104, P793
   Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434
   Unger RE, 2005, BIOMATERIALS, V26, P3461, DOI 10.1016/j.biomaterials.2004.09.047
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Vaidyanathan G, 2004, CURR PHARM DESIGN, V10, P2965, DOI 10.2174/1381612043383449
   Verrier S, 2002, BIOMATERIALS, V23, P585, DOI 10.1016/S0142-9612(01)00145-4
   Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6
   Walluscheck KP, 1996, EUR J VASC ENDOVASC, V12, P321, DOI 10.1016/S1078-5884(96)80251-6
   Wataha JC, 1996, J ORAL REHABIL, V23, P79, DOI 10.1111/j.1365-2842.1996.tb01214.x
   Wermuth J, 1997, J AM CHEM SOC, V119, P1328, DOI 10.1021/ja961908l
   Wester HJ, 2005, J NUCL MED, V46, P1940
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   WLODARSKI KH, 1990, CLIN ORTHOP RELAT R, P276
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976
   Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535
   Xiong JP, 2003, J THROMB HAEMOST, V1, P1642, DOI 10.1046/j.1538-7836.2003.00277.x
   Xiong JP, 2003, BLOOD, V102, P1155, DOI 10.1182/blood-2003-01-0334
   Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040
   Yang C, 2001, ORAL SURG ORAL MED O, V92, P606, DOI 10.1067/moe.2001.118477
   YANG JT, 1993, DEVELOPMENT, V119, P1093
   YU YM, 1991, BIOCHEM BIOPH RES CO, V177, P427, DOI 10.1016/0006-291X(91)92001-Z
   Zamir E, 2001, J CELL SCI, V114, P3583
   Zarovni N, 2004, HUM GENE THER, V15, P373, DOI 10.1089/104303404322959524
   Zhang L, 2002, J AM CHEM SOC, V124, P2862, DOI 10.1021/ja016773k
   Zimmermann D, 2005, CHEMBIOCHEM, V6, P272, DOI 10.1002/cbic.200400279
NR 275
TC 212
Z9 227
U1 2
U2 77
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2006
VL 12
IS 22
BP 2723
EP 2747
DI 10.2174/138161206777947740
PG 25
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 069XH
UT WOS:000239482000002
PM 16918408
DA 2018-10-20
ER

PT J
AU Campos, A
   Sanchez-Quevedo, MC
   Fernandez-Segura, E
   Moreu, G
   Rodriguez, IA
   Alaminos, M
AF Campos, A.
   Sanchez-Quevedo, M. C.
   Fernandez-Segura, E.
   Moreu, G.
   Rodriguez, I. A.
   Alaminos, M.
TI Evaluation of the cytotoxicity of 2-hydroxymethylmethacrylate (HEMA)
   used as a biomaterial in tissue engineering
SO CYTOTHERAPY
LA English
DT Meeting Abstract
C1 Univ Granada, Dept Histol, Granada, Spain.
   Univ Granada, Dept Stomatol, Granada, Spain.
   Univ Cordoba, Dept Stomatol, Cordoba, Argentina.
   Fundac Hosp Clin, Granada, Spain.
RI ALAMINOS, MIGUEL/N-9960-2016; Fernandezsegura, Eduardo/F-3756-2016
OI ALAMINOS, MIGUEL/0000-0003-4876-2672; 
NR 0
TC 1
Z9 1
U1 1
U2 3
PU TAYLOR & FRANCIS AS
PI OSLO
PA PO BOX 12 POSTHUSET, NO-0051 OSLO, NORWAY
SN 1465-3249
J9 CYTOTHERAPY
JI Cytotherapy
PY 2006
VL 8
SU 2
MA P-42
BP 46
EP 46
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Hematology; Medicine, Research & Experimental
SC Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research
   & Experimental Medicine
GA 067YD
UT WOS:000239337800167
DA 2018-10-20
ER

PT J
AU Kirchhof, K
   Altankov, G
   Groth, T
AF Kirchhof, K.
   Altankov, G.
   Groth, T.
TI Layer-by-layer technique for the formation of extracellular matrix-like
   biomaterial coatings
SO CYTOTHERAPY
LA English
DT Meeting Abstract
C1 Univ Halle Wittenberg, Dept Pharm, Halle, Germany.
   Bulgarian Acad Sci, Inst Biophys, Sofia, Bulgaria.
OI Groth, Thomas/0000-0001-6647-9657
NR 0
TC 0
Z9 0
U1 0
U2 2
PU TAYLOR & FRANCIS AS
PI OSLO
PA PO BOX 12 POSTHUSET, NO-0051 OSLO, NORWAY
SN 1465-3249
J9 CYTOTHERAPY
JI Cytotherapy
PY 2006
VL 8
SU 2
MA P-41
BP 46
EP 46
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Hematology; Medicine, Research & Experimental
SC Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research
   & Experimental Medicine
GA 067YD
UT WOS:000239337800166
DA 2018-10-20
ER

PT J
AU Schopka, S
   Schmid, FX
   Birnbaum, DE
   Lehle, K
AF Schopka, S.
   Schmid, F. X.
   Birnbaum, D. E.
   Lehle, K.
TI Evaluation of endothelial cell properties after adhesion to
   decellularized biomaterial
SO CYTOTHERAPY
LA English
DT Meeting Abstract
C1 Univ Regensburg, Dept Cardiothorac Surg, Regensburg, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU TAYLOR & FRANCIS AS
PI OSLO
PA PO BOX 12 POSTHUSET, NO-0051 OSLO, NORWAY
SN 1465-3249
J9 CYTOTHERAPY
JI Cytotherapy
PY 2006
VL 8
SU 2
MA P-51
BP 48
EP 49
PG 2
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Hematology; Medicine, Research & Experimental
SC Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research
   & Experimental Medicine
GA 067YD
UT WOS:000239337800176
DA 2018-10-20
ER

PT J
AU Reppenhagen, S
   Raab, P
   Eulert, J
   Noth, U
AF Reppenhagen, S.
   Raab, P.
   Eulert, J.
   Noeth, U.
TI TricOs (R) bone substitute: One-year experience with fibrin sealant
   biomaterial composite in the repair of benign bone defects
SO CYTOTHERAPY
LA English
DT Meeting Abstract
C1 Univ Wurzburg, Orthoped Clin, Wurzburg, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS AS
PI OSLO
PA PO BOX 12 POSTHUSET, NO-0051 OSLO, NORWAY
SN 1465-3249
J9 CYTOTHERAPY
JI Cytotherapy
PY 2006
VL 8
SU 2
MA P-103
BP 62
EP 63
PG 2
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Hematology; Medicine, Research & Experimental
SC Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research
   & Experimental Medicine
GA 067YD
UT WOS:000239337800227
DA 2018-10-20
ER

PT S
AU Liu, Y
   Ren, LQ
   Han, ZW
   Yu, SR
AF Liu, Y.
   Ren, L. Q.
   Han, Z. W.
   Yu, S. R.
BE Brebbia, CA
TI The preparation of biomimetic nano-Al2O3 surface modification materials
   on gray cast iron surface
SO DESIGN AND NATURE III: COMPARING DESIGN IN NATURE WITH SCIENCE AND
   ENGINEERING
SE WIT Transactions on Ecology and the Environment
LA English
DT Proceedings Paper
CT 3rd International Conference on Design and Nature
CY MAY 24-26, 2006
CL New Forest, ENGLAND
SP Wessex Inst Technol, Int Journal Design & Nat
DE nano-Al2O3; biomimetic; surface modification; gray cast iron;
   microstructure
AB Through evolution over hundreds of millions of years, the natural biomaterials generally have superior microstructure and function to normal material. The surface layer of teeth is enamel, which is the hardest structure in the human body. Enamel as a kind of nanoceramic biomaterial; most of its physical and chemical characteristics are similar to normal ceramics. It is of high hardness and is particularly wear resistance. However, the gray cast iron is one of widely used materials. In the process of casting, surface blowholes and micro-pores, which can't be seen by the naked eye, are formed in castings because of the solidification shrinkage of alloy and separation of gas dissolving in liquid alloy, which results in the poor property of materials. Therefore, the gray cast iron and nano-Al2O3 were chosen as the substrate and reinforcement in this paper, respectively. A laser cladding method was used to prepare biomimetic nanoceramic surface modification composite materials. The surface property of gray cast iron was largely improved. The process and the factors influencing laser cladding were analysed. The microstructure of the surface modification layer can be divided into a cladding layer, bonding layer and substrate layer, and the formation mechanism of each different layer was researched.
C1 [Liu, Y.; Ren, L. Q.; Han, Z. W.] Jilin Univ, Key Lab Terrain Machine Bion Engn, Minist Educ, Jilin, Peoples R China.
   [Yu, S. R.] Jilin Univ, Coll Mat Sci & Engn, Jilin 130122, Peoples R China.
RP Liu, Y (reprint author), Jilin Univ, Key Lab Terrain Machine Bion Engn, Minist Educ, Jilin, Peoples R China.
FU Trans-Century Training Program Foundation for the Talents by Chinese
   Ministry of Education and the Foundation for Distinguished Young
   Scholars of Jilin Province [20040104]
FX The authors are grateful for the financial support provided by
   Trans-Century Training Program Foundation for the Talents by Chinese
   Ministry of Education (2003) and the Foundation for Distinguished Young
   Scholars of Jilin Province (Grant No. 20040104)
CR CUI FZ, 2004, BIONIC MAT
   HE ZY, 1983, HISTOLOGY EMBRYOLOGY
   LUGSCHEIDER E, 1991, SURF ENG, V7, P341
   Nicolas G, 1999, APPL SURF SCI, V138, P169, DOI 10.1016/S0169-4332(98)00396-1
   WANG XL, 2001, APPL LASER, V21, P164
   ZHENG S, 1996, J IRON STEEL RES, V8, P46
NR 6
TC 0
Z9 0
U1 0
U2 8
PU WIT PRESS
PI SOUTHAMPTON
PA ASHURST LODGE, SOUTHAMPTON SO40 7AA, ASHURST, ENGLAND
SN 1743-3541
BN 1-84564-166-3
J9 WIT TRANS ECOL ENVIR
JI WIT Trans. Ecol. Environ.
PY 2006
VL 87
BP 137
EP +
DI 10.2495/DN060131
PG 2
WC Biology; Engineering, Multidisciplinary
SC Life Sciences & Biomedicine - Other Topics; Engineering
GA BEQ27
UT WOS:000238900300013
OA Bronze
DA 2018-10-20
ER

PT B
AU Boland, T
   Cui, XF
   Aho, M
   Baicu, C
   Zile, M
AF Boland, Thomas
   Cui Xiaofeng
   Aho, Michael
   Baicu, Catallin
   Zile, Michael
GP IS&T
TI Image based printing of structured biomaterials for realizing complex 3D
   cardiovascular constructs
SO Digital Fabrication 2006, Final Program and Proceedings
LA English
DT Proceedings Paper
CT 2nd International Conference on Digital Fabrication Technologies
CY SEP 17-22, 2006
CL Denver, CO
SP Soc Imaging Sci & Technol, Imaging Soc Japan
ID TISSUE; FABRICATION; DESIGN; CELLS
AB Considerable effort has been focused on printing synthetic biodegradable scaffolds for hard tissue applications. The requirements for soft tissues, in particular cardiac tissue are somewhat unique since the cellular arrangement is more essential for achieving function. The goal of this study was to develop a technique that allows aligning of cardiomyocytes in printed channels.
   A fabrication chamber was filled with a 2% alginic acid solution, a liquid that is known to crosslink under mild conditions to form a biodegradable hydrogel scaffold. An ink cartridge was filled with calcium chloride cross-linker. By printing a variety of concentrations of cross-linker, the fabrication process could be optimized by comparing the fidelity of the printed pattern to the designs.
   Adult feline cardiomyocytes were added to the biomaterial and the resulting cardiac constructs were electrically stimulated. In response, the cardiac constructs contracted rhythmically and synchronously. The shortening extent of the edge was up to 7.0% of the total length of the constructs compared to 3.5% in constructs without channels. In this study printed alginate gels demonstrated that by engineering the microstructures of the printed alginate scaffolds improved function can be achieved.
C1 Clemson Univ, Dept Bioengn, Clemson, SC USA.
RP Boland, T (reprint author), Clemson Univ, Dept Bioengn, Clemson, SC USA.
RI Cui, Xiaofeng/A-7208-2012
OI Cui, Xiaofeng/0000-0003-2761-3934
CR BOLAND T, 2006, IN PRESS BIOTECHNOLO
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Mironov V, 2003, EXPERT OPIN BIOL TH, V3, P701, DOI 10.1517/14712598.3.5.701
   Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7
   Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Tsang VL, 2004, ADV DRUG DELIVER REV, V56, P1635, DOI 10.1016/j.addr.2004.05.001
   Wilson WC, 2003, ANAT REC PART A, V272A, P491, DOI 10.1002/ar.a.10057
   Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
   Zile MR, 1998, AM J PHYSIOL-HEART C, V274, pH2188, DOI 10.1152/ajpheart.1998.274.6.H2188
NR 13
TC 0
Z9 0
U1 0
U2 6
PU SOC IMAGING SCIENCE & TECHNOLOGY
PI SPRINGFIELD
PA 7003 KILWORTH LANE, SPRINGFIELD, VA 22151 USA
BN 0-89208-264-X
PY 2006
BP 86
EP 88
PG 3
WC Engineering, Electrical & Electronic; Imaging Science & Photographic
   Technology
SC Engineering; Imaging Science & Photographic Technology
GA BFN45
UT WOS:000243319100028
DA 2018-10-20
ER

PT B
AU Sumerel, J
   Doraiswamy, A
   Narayan, R
AF Sumerel, Jan
   Doraiswamy, Arand
   Narayan, Roger
GP IS&T
TI Digital printing of bioinks
SO Digital Fabrication 2006, Final Program and Proceedings
LA English
DT Proceedings Paper
CT 2nd International Conference on Digital Fabrication Technologies
CY SEP 17-22, 2006
CL Denver, CO
SP Soc Imaging Sci & Technol, Imaging Soc Japan
ID ELECTRODE
AB Recently piezo-based ink jet printers have proven to be reliable, productive manufacturing tools particularly where expensive materials are involved. As bioengineers, we are capitalizing on the ability of piezoelectric-based drop-on-demand ink jets printers to precisely deposit a wide variety of biologically active materials to create custom arrayed libraries and patterns. These applications and many others take advantage of ink jet strengths as an additive, non-contact process. We have developed disposable ink jet cartridges and a laboratory bench-top printing system. We have printed many biological materials, and optimization of ink compositions has been the focus of our research. At this conference, we will discuss both solvent-based and aqueous bioinks. We will show the spatial deposition of both nanoinks and microinks and show the resulting biomaterial designs and arrays including DNA, bacteria, proteins and carbon nanotubes. We have printed gold nanoparticles and protein-bound nanospheres to allow patterning of fluorescent proteins. We will discuss ink composition and printing characteristics of these materials. Finally we will discuss wave form parameters for printing a broad range of aqueous materials used in the biosciences and performance characteristics during printing.
C1 Dimatix Inc, Mat Deposit Div, Santa Clara, CA USA.
RP Sumerel, J (reprint author), Dimatix Inc, Mat Deposit Div, Santa Clara, CA USA.
CR Anzai Misaki, 2002, J Oral Sci, V44, P147
   Coe S, 2002, NATURE, V420, P800, DOI 10.1038/nature01217
   Lee SJ, 2006, BIOMATERIALS, V27, P3466, DOI 10.1016/j.biomaterials.2006.01.059
   Li YL, 2004, SCIENCE, V304, P276, DOI 10.1126/science.1094982
   Luesebrink H, 2005, J NANOSCI NANOTECHNO, V5, P864, DOI 10.1166/jnn.2005.129
   Marquette CA, 2006, ANAL CHEM, V78, P959, DOI 10.1021/ac051585o
   Stamm C, 2004, ANN THORAC SURG, V78, P2084, DOI 10.1016/j.athoracsur.2004.03.106
   Ye YK, 2005, BIOSENS BIOELECTRON, V21, P735, DOI 10.1016/j.bios.2005.01.004
NR 8
TC 1
Z9 1
U1 0
U2 4
PU SOC IMAGING SCIENCE & TECHNOLOGY
PI SPRINGFIELD
PA 7003 KILWORTH LANE, SPRINGFIELD, VA 22151 USA
BN 0-89208-264-X
PY 2006
BP 93
EP 95
PG 3
WC Engineering, Electrical & Electronic; Imaging Science & Photographic
   Technology
SC Engineering; Imaging Science & Photographic Technology
GA BFN45
UT WOS:000243319100030
DA 2018-10-20
ER

PT S
AU Guo, DG
   Han, Y
   Xu, KW
AF Guo, DG
   Han, Y
   Xu, KW
BE Kim, HS
   Li, YB
   Lee, SW
TI Preparation and characterization of a new type of Sr-contained
   hydroxyapatite bone cement
SO ECO-MATERIALS PROCESSING & DESIGN VII
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 7th International Symposium on Eco-Materials Processing and Design
CY JAN 08-11, 2006
CL Chengdu, PEOPLES R CHINA
SP Res Ctr Nano-Biomat, Sichuan Univ, Analyt & Testing Ctr, Natl Incubat Base Nano-Biomat Industrializat, Dept Sci & Technol, Sichuan Univ, S West Jiaotong Univ, Soc Nano-Technol, Korean Sci & Engn Fdn, Japan Soc Promot Sci, Hanyang Univ, Core Univ Program, Osaka Univ, Core Univ Program, Sichuan Guona Sci & Tech Co Ltd
DE calcium phosphate cement; strontium; hydroxyapatite; biomaterial
ID STRONTIUM KINETICS; SR-89 THERAPY
AB A novel route is developed to prepare a new type of Sr-contained hydroxyapatite bone cement. Tetracalcium phosphate, strontium hydrogen phosphate or anhydrous strontium chlorite, dicalcium phosphate, phosphoric and water are used as precursors. XRD, FTIR and EDXS are used to characterize the incorporation of 5% or 10% Sr2+ into the crystal lattice of hydroxyapatite. Results indicate that the Sr-contained CPC system of TTCP/DCPA/DSPA can set in 0.5M diluted phosphate acid with a final product of non-stoichiometric Sr-contained hydroxyapatite.
C1 Xian Jiaotong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China.
RP Guo, DG (reprint author), Xian Jiaotong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China.
EM dgguo@mailst.xjtu.edu.cn; yonghan@mail.xjtu.edu.cn;
   kxwu@mail.xjtu.edu.cn
CR BLAKE GM, 1986, J NUCL MED, V27, P1030
   BLAKE GM, 1986, EUR J NUCL MED, V12, P447
   Brown WE, 1986, United States patent, Patent No. [4612053, EP 4612053]
   BROWN WE, 1986, AM CERAM SOC BULL, P351
   Chen D, 2001, CHIN J BIOMED ENG, V20, P278
   CHEN DM, 2001, J STOMAT MAT APPAR, V19, P178
   Christoffersen J, 1997, BONE, V20, P47, DOI 10.1016/S8756-3282(96)00316-X
   Constantino PD, 1992, PLAST RECONSTR SURG, V90, P174
   DAGANG G, 2005, RARE METAL MAT ENG, V34, P799
   FRIEDMAN CD, 1991, ARCH OTOLARYNGOL, V117, P385
   Grynpas MD, 1996, BONE, V18, P253, DOI 10.1016/8756-3282(95)00484-X
   Leroux L, 2001, J MATER RES, V16, P171, DOI 10.1557/JMR.2001.0028
   MEFFERT RM, 1985, J PERIODONTOL, V56, P63, DOI 10.1902/jop.1985.56.2.63
   SHINDO ML, 1993, ARCH OTOLARYNGOL, V119, P185
   SHORR E, 1952, Bull Hosp Joint Dis, V13, P59
NR 15
TC 1
Z9 1
U1 0
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-995-4
J9 MATER SCI FORUM
PY 2006
VL 510-511
BP 846
EP 849
DI 10.4028/www.scientific.net/MSF.510-511.846
PG 4
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BEF98
UT WOS:000237176000212
DA 2018-10-20
ER

PT S
AU Kim, WY
   Kim, HS
   Yeo, ID
AF Kim, WY
   Kim, HS
   Yeo, ID
BE Kim, HS
   Li, YB
   Lee, SW
TI Low elastic modulus beta Ti-Nb-Si alloys for biomedical applications
SO ECO-MATERIALS PROCESSING & DESIGN VII
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 7th International Symposium on Eco-Materials Processing and Design
CY JAN 08-11, 2006
CL Chengdu, PEOPLES R CHINA
SP Res Ctr Nano-Biomat, Sichuan Univ, Analyt & Testing Ctr, Natl Incubat Base Nano-Biomat Industrializat, Dept Sci & Technol, Sichuan Univ, S West Jiaotong Univ, Soc Nano-Technol, Korean Sci & Engn Fdn, Japan Soc Promot Sci, Hanyang Univ, Core Univ Program, Osaka Univ, Core Univ Program, Sichuan Guona Sci & Tech Co Ltd
DE biomaterial; Ti based alloy; elastic modulus; phase stability
AB We report on advanced beta-titanium alloys having excellent biocompatibility without containing V or Al that has been known as a toxic element for human body, and on a low elastic modulus to be used in the fields of artificial joint and dental implant in the replacement of natural human bone. Martensite structure with alpha' (hcp) or alpha" (orthorhombic) was observed in Ti-xNb-1.5at.%Si, where x=10-20at.%. The crystal structure of martensite formed from water quenching process was largely dependent upon Nb content but does not on Si content. On the basis of experimental results obtained, it is suggested that Si has an effective role to suppress the precipitation of omega phase leading to reduction in elastic modulus in the metastable beta phase region. Metastable beta phase region was superior to reduce the elastic modulus than stable beta phase region in the present alloy system. The minimum value of elastic modulus was measured to 48GPa.
C1 Korea Inst Ind Technol, Adv Mat R&D Ctr, Inchon 406130, South Korea.
RP Kim, WY (reprint author), Korea Inst Ind Technol, Adv Mat R&D Ctr, 994-32 Dongchun Dong, Inchon 406130, South Korea.
EM wykim@kitech.re.kr
CR Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   SUMMER DR, 1992, CLIN ORTHOP RELAT R, V274, P202
NR 2
TC 4
Z9 4
U1 1
U2 8
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-995-4
J9 MATER SCI FORUM
PY 2006
VL 510-511
BP 858
EP 861
DI 10.4028/www.scientific.net/MSF.510-511.858
PG 4
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BEF98
UT WOS:000237176000215
DA 2018-10-20
ER

PT S
AU Wu, L
   Li, YB
   Zu, Y
   Zhang, L
   Yang, WH
   Mu, YH
AF Wu, Lan
   Li, YuBao
   Zu, Yi
   Zhang, Li
   Yang, Weihu
   Mu, Yuanhua
BE Kim, HS
   Li, YB
   Lee, SW
TI Study on the biomimetic properties of bone substitute material:
   Nano-hydroxyapatite/polyamide 66 composite
SO ECO-MATERIALS PROCESSING & DESIGN VII
SE Materials Science Forum
LA English
DT Article; Proceedings Paper
CT 7th International Symposium on Eco-Materials Processing and Design
CY JAN 08-11, 2006
CL Chengdu, PEOPLES R CHINA
SP Res Ctr Nano-Biomat, Sichuan Univ, Analyt & Testing Ctr, Natl Incubat Base Nano-Biomat Industrializat, Dept Sci & Technol, Sichuan Univ, S West Jiaotong Univ, Soc Nano-Technol, Korean Sci & Engn Fdn, Japan Soc Promot Sci, Hanyang Univ, Core Univ Program, Osaka Univ, Core Univ Program, Sichuan Guona Sci & Tech Co Ltd
DE biomimetic; nano-hydroxyapatite; polyamide 66; human cortical bone;
   crystal structure
ID SPECTROSCOPY
AB To compare with the human cortical bone, the biomimetic properties of nano-hydroxyapatite/polyamide 66 composite (n-HA/PA66) were preliminarily studied qualitatively and quantitatively with TEM, XRD in crystal morphology, phase composition and crystal structure. A series of structure parameters such as cell lattice parameters (a and c), mean crystallite size and micro-strain were calculated to characterize quantitatively the microstructure of n-HA/PA66 and human cortical bone at the atomic level. The results show that n-HA/PA66 is a good biomimetic biomaterial. But there still are some differences between n-HA/PA66 and human cortical bone. Compared to human cortical bone, the crystal microstructure of n-HA/PA66 is denser, the crystal lattice of n-HA is more perfect and the distortion of crystal lattice decreases.
C1 Sichuan Univ, Analyt & Testing Ctr, Res Ctr Nano Biomat, Chengdu 610064, Peoples R China.
RP Li, YB (reprint author), Sichuan Univ, Analyt & Testing Ctr, Res Ctr Nano Biomat, Chengdu 610064, Peoples R China.
EM wlmiss@163.com; nic7504@scu.edu.cn; zoae@vip.sina.com;
   zhangli9111@126.com; godsail@126.com; myh25@163.com
CR Camacho NP, 1999, BONE, V25, P287, DOI 10.1016/S8756-3282(99)00165-9
   JIE W, 2001, HIGH TECHNOLOGY LETT, V7, P8
   MEI H, 2003, J MATER SCI-MATER M, V14, P1
   Miller LM, 2001, BBA-GEN SUBJECTS, V1527, P11, DOI 10.1016/S0304-4165(01)00093-9
   Peters F, 2000, THERMOCHIM ACTA, V361, P131, DOI 10.1016/S0040-6031(00)00554-2
   Rubin MA, 2003, BONE, V33, P270, DOI 10.1016/S8756-3282(03)00194-7
   Wei J, 2003, J MATER SCI, V38, P3303, DOI 10.1023/A:1025194122977
   WEI J, 2004, EUR POLYM J, V40, P509, DOI DOI 10.1016/J.EURP0LYMJ.2003.10.028
   XUEJIANG W, 2002, BIOMATERIALS, V23, P4787
   Zhang LJ, 2004, MATER LETT, V58, P719, DOI 10.1016/j.matlet.2003.07.009
NR 10
TC 10
Z9 13
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 0-87849-995-4
J9 MATER SCI FORUM
PY 2006
VL 510-511
BP 938
EP 941
DI 10.4028/www.scientific.net/MSF.510-511.938
PG 4
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BEF98
UT WOS:000237176000235
DA 2018-10-20
ER

PT S
AU Zuo, Y
   Li, YB
   Zhang, X
   Yang, WH
   Li, JD
   Mo, LR
   Wang, HN
AF Zuo, Y
   Li, YB
   Zhang, X
   Yang, WH
   Li, JD
   Mo, LR
   Wang, HN
BE Kim, HS
   Li, YB
   Lee, SW
TI Effect of compatibilizers on the properties of nano-hydroxyapatite
   reinforced polyamide 66 and high density polyethylene blends
SO ECO-MATERIALS PROCESSING & DESIGN VII
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 7th International Symposium on Eco-Materials Processing and Design
CY JAN 08-11, 2006
CL Chengdu, PEOPLES R CHINA
SP Res Ctr Nano-Biomat, Sichuan Univ, Analyt & Testing Ctr, Natl Incubat Base Nano-Biomat Industrializat, Dept Sci & Technol, Sichuan Univ, S West Jiaotong Univ, Soc Nano-Technol, Korean Sci & Engn Fdn, Japan Soc Promot Sci, Hanyang Univ, Core Univ Program, Osaka Univ, Core Univ Program, Sichuan Guona Sci & Tech Co Ltd
DE functionalized biomaterial; blends; compatibilizer; interphase
AB The compatibility efficiency on different compatibilizer for nano-hydroxyapatite (n-HA) reinforced polyamide 66 (PA66) and high density polyethylene (HDPE) blends at a composition of 40/42/18 as functionalized biomaterial was investigated by mechanical properties testing and scanning electron microscopy (SEM). The results showed that mechanical properties of compatibilized blends were much improved by the compatibilizers of maleic anhydride grafted polyethylene (PE-g-MAH) and ethylene/methacrylic acid ionomer-sodium ion (ION) compared with the uncompatibilized blends. Blends had peak mechanical values of different compatibilizer. Both PE-g and ION formed adhesion during melt mixing and stabilized the morphology and significantly reduced the size of dispersed PE phase. PE-g gave the blends with PE spheres ranging from 1 to 4 mu m and ION with well-dispersed spheres with an average diameter of l mu m. The more enlarged interphase of the blends containing ION reduced the lower interfacial energy to increase the miscibiliy of the blends. Consequently, ION had better contribution to rigidity properties than PE-g for n-HA/PA/PE blends.
C1 Sichuan Univ, Natl Incubat Base Nano Biomat Ind, Chengdu 610064, Peoples R China.
RP Li, YB (reprint author), Sichuan Univ, Natl Incubat Base Nano Biomat Ind, Chengdu 610064, Peoples R China.
EM zoae@vip.sina.com; lyb890130@263.net; zzxl-1@163.com; godsailor@163.com;
   blueljd@163.com; more311@126.com; whn732@hotmail.com; lyb890130@263.net
RI Wang, Huanan/N-1971-2013
CR GAYLORD NG, 1992, REACTIVE EXTRUSION P
   Hallden A, 2000, J APPL POLYM SCI, V78, P2416, DOI 10.1002/1097-4628(20001220)78:13<2416::AID-APP190>3.0.CO;2-T
   Harrats C, 2002, POLYMER, V43, P5347, DOI 10.1016/S0032-3861(02)00363-4
   JAKEDA Y, 1992, J POLYM SCI POL LETT, V30, P1273
   Koulouri EG, 1996, POLYMER, V37, P2555, DOI 10.1016/0032-3861(96)85372-9
   Pan LH, 2002, POLYMER, V43, P337, DOI 10.1016/S0032-3861(01)00616-4
   Rea SM, 2004, BIOMATERIALS, V25, P4503, DOI 10.1016/j.biomaterials.2003.11.016
   WEI J, 2005, J MATER SCI LETT, V40, P793
   YI Z, 2005, IN PRESS POLYM MAT S, V21
   Yu ZZ, 2000, J APPL POLYM SCI, V76, P1285, DOI 10.1002/(SICI)1097-4628(20000523)76:8<1285::AID-APP9>3.3.CO;2-L
NR 10
TC 1
Z9 1
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-995-4
J9 MATER SCI FORUM
PY 2006
VL 510-511
BP 978
EP 981
DI 10.4028/www.scientific.net/MSF.510-511.978
PG 4
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BEF98
UT WOS:000237176000245
DA 2018-10-20
ER

PT J
AU Oh, JH
   Kim, EH
   Kang, DH
   Ryu, JH
   Jang, J
AF Oh, Jae Hwan
   Kim, Eun Hyun
   Kang, Dong Han
   Ryu, Je Hwang
   Jang, Jin
TI A method of forming a polycrystalline Si with the biomolecule ferritin
SO ELECTROCHEMICAL AND SOLID STATE LETTERS
LA English
DT Article
ID METAL-INDUCED CRYSTALLIZATION; AMORPHOUS-SILICON; MEDIATED
   CRYSTALLIZATION; POLYSILICON
AB We studied the metal-induced crystallization of a-Si using a Ni-ferritin molecule of 7 nm diameter. The Ni-ferritin molecules were coated onto the SiNx/amorphous silicon (a-Si)/buffer/glass and it was heated at 580 degrees C for 20 h for crystallization after UV burning of the biomaterial. It was found that the grain size of poly-Si increases with decreasing the ferritin density. A grain size of similar to 220 mu m was achieved, and its surface roughness was 2.1 nm. (c) 2006 The Electrochemical Society.
C1 Kyung Hee Univ, Adv Display Res Ctr, Seoul 130701, South Korea.
   Kyung Hee Univ, Dept Informat Display, Seoul 130701, South Korea.
RP Oh, JH (reprint author), Kyung Hee Univ, Adv Display Res Ctr, Seoul 130701, South Korea.
EM jjang@khu.ac.kr
CR CALLISTER DW, 1991, MAT SCI ENG INT, pCH7
   Choi JH, 2003, ELECTROCHEM SOLID ST, V6, pG16, DOI 10.1149/1.1527411
   CHOI JH, 2003, THIN SOLID FILMS, V440, P34
   DEAL BE, 1978, J ELECTROCHEM SOC, V125, P576, DOI 10.1149/1.2131502
   Hikono T, 2003, JPN J APPL PHYS 2, V42, pL398, DOI 10.1143/JJAP.42.L398
   Jagar S, 2001, SOLID STATE ELECTRON, V45, P743, DOI 10.1016/S0038-1101(01)00031-4
   Jang J, 2000, J APPL PHYS, V88, P3099, DOI 10.1063/1.1286064
   KIRIMURA H, 2005, APPL PHYS LETT, V86
   Mariucci L, 1999, THIN SOLID FILMS, V337, P137, DOI 10.1016/S0040-6090(98)01174-2
   Nogita K, 2001, MATER CHARACT, V46, P305, DOI 10.1016/S1044-5803(00)00109-1
   Oh JH, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2140585
   Oh JH, 2004, ELECTROCHEM SOLID ST, V7, pH52, DOI 10.1149/1.1807533
   PORTER DA, 1992, PHASE TRANSFORMATION, P118
   RANDLE V, 2000, INTRO TEXTURE ANAL, P264
   SHON WS, 2003, J APPL PHYS, V94, P4326
   Yoon SY, 2001, THIN SOLID FILMS, V383, P34, DOI 10.1016/S0040-6090(00)01790-9
   Yoon SY, 1997, J APPL PHYS, V82, P5865, DOI 10.1063/1.366455
NR 17
TC 2
Z9 2
U1 0
U2 3
PU ELECTROCHEMICAL SOC INC
PI PENNINGTON
PA 65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA
SN 1099-0062
EI 1944-8775
J9 ELECTROCHEM SOLID ST
JI Electrochem. Solid State Lett.
PY 2006
VL 9
IS 10
BP H96
EP H99
DI 10.1149/1.2256689
PG 4
WC Electrochemistry; Materials Science, Multidisciplinary
SC Electrochemistry; Materials Science
GA 076DG
UT WOS:000239936600025
DA 2018-10-20
ER

PT S
AU Abrams, KJ
   Donnelly, SE
AF Abrams, K. J.
   Donnelly, S. E.
BE Brown, PD
   Baker, R
   Hamilton, B
TI A transmission electron microscopy study of porous silicon
SO EMAG-NANO 2005: IMAGING, ANALYSIS AND FABRICATION ON THE NANOSCALE
SE Journal of Physics Conference Series
LA English
DT Proceedings Paper
CT EMAG/NANO Conference on Imaging, Analysis and Fabrication on the
   Nanoscale
CY AUG 31-SEP 02, 2005
CL Univ Leeds, Leeds, ENGLAND
SP Elect Microscopy & Anal Grp, Nanoscale Phys & Technol Grp
HO Univ Leeds
AB Porous silicon (PoSi) has been investigated for more than a decade because of its room-temperature photoluminescence resulting from quantum confinement effects. PoSi is, however, also biodegradable, biocompatible and often bioactive, rendering it of considerable research interest for a number of possible applications as a biomaterial. This paper presents details of work which forms part of a PhD study of the use of PoSi in drug delivery systems. In the current work, a method of utilising electron energy-loss spectroscopy (EELS) to obtain a porosity value is being developed.
C1 [Abrams, K. J.; Donnelly, S. E.] Univ Salford, Inst Mat Res, Manchester M5 4WT, Lancs, England.
RP Abrams, KJ (reprint author), Univ Salford, Inst Mat Res, Manchester M5 4WT, Lancs, England.
EM K.J.Abrams@pgr.salford.ac.uk
OI Donnelly, Stephen/0000-0002-9749-5550; Abrams, Kerry/0000-0002-2789-7204
CR BELLET D, 1994, PHYS REV B, V50, P17162, DOI 10.1103/PhysRevB.50.17162
   Bisi O, 2000, SURF SCI REP, V38, P1, DOI 10.1016/S0167-5729(99)00012-6
   Canham LT, 1997, THIN SOLID FILMS, V297, P304, DOI 10.1016/S0040-6090(96)09534-X
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   CANHAM LT, 2001, PHYS WORLD       JUL, P27
   EGERTON RF, 1986, ELECTRON ENERGY LOSS, P291
   Halimaoui A., 1997, PROPERTIES POROUS SI, P1222
   KARKSSON LM, 2003, THESIS U LINKOPING
   Martin-Palma RJ, 2004, APPL PHYS LETT, V85, P2517, DOI 10.1063/1.1797558
   MCCAFFREY JP, 1991, ULTRAMICROSCOPY, V38, P149, DOI 10.1016/0304-3991(91)90116-N
NR 10
TC 1
Z9 1
U1 0
U2 2
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1742-6588
J9 J PHYS CONF SER
PY 2006
VL 26
BP 272
EP +
DI 10.1088/1742-6596/26/1/065
PG 2
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA BEM04
UT WOS:000238090200065
OA Bronze
DA 2018-10-20
ER

PT J
AU Lodeiro, P
   Herrero, R
   de Vicente, MES
AF Lodeiro, Pablo
   Herrero, Roberto
   Sastre de Vicente, Manuel E.
TI Thermodynamic and kinetic aspects on the biosorption of cadmium by low
   cost materials: A review
SO ENVIRONMENTAL CHEMISTRY
LA English
DT Review
DE acid-base properties; biosorption; cadmium; isotherms; kinetics
ID HEAVY-METAL BIOSORPTION; NATURAL ORGANIC-MATTER; ACID-BASE PROPERTIES;
   ION-EXCHANGE PROCESS; AQUEOUS-SOLUTIONS; WASTE-WATER; BONE CHAR;
   MARINE-ALGAE; HUMIC SUBSTANCES; PROTON BINDING
AB Cadmium is internationally recognized as an important pollutant in the environment, and different methods for its removal from wastewaters (chemical precipitation being the most commonly used) have been reported in the literature. Those methods are in most cases oriented to situations with high concentrations of the pollutant. Thus, alternative removal and recovery methods are being considered for removing very low concentrations of cadmium. These methods are all based on biosorption, the passive adsorption and sequestration of metals by several natural materials of biological origin. In this review we have considered the biosorption of cadmium onto biomaterials from a physicochemical, thermodynamic, and kinetic perspective. The thermodynamic perspective is based on the characterization of the interactions of the binding sites of the biosorbents with cadmium species in aqueous solution. Traditionally, this approach has been quantified using different kinds of isotherms. In addition, the description is completed by taking into account electrostatic effects, and the influence of pH and ionic strength, which are associated with the negative charge developed, in most cases, by the biomaterial. The other point of view in this review is the kinetic one, which is necessary for a full physicochemical description of the sorbate - biosorbent system. Consequently, an updated description of the various approaches commonly employed in kinetic studies in biosorption has been carried out.
C1 Univ A Coruna, Dept Quim Fis & Enxeneria Quim, La Coruna 15008, Spain.
RP de Vicente, MES (reprint author), Univ A Coruna, Dept Quim Fis & Enxeneria Quim, Alejandro de la Sota 1, La Coruna 15008, Spain.
EM eman@udc.es
RI Lodeiro, Pablo/L-2409-2015; Herrero, Roberto/E-2266-2016; Lodeiro
   Fernandez, Pablo/B-7925-2011; de Vicente, Sastre/I-4604-2015
OI Lodeiro, Pablo/0000-0002-2557-5391; Herrero,
   Roberto/0000-0002-8709-9247; de Vicente, Sastre/0000-0002-1657-2930
CR Abia AA, 2003, BIORESOURCE TECHNOL, V90, P345, DOI 10.1016/S0960-8524(03)00145-7
   Abollino O, 2003, WATER RES, V37, P1619, DOI 10.1016/S0043-1354(02)00524-9
   AHARONI C, 1991, SSSA SPEC PUBL, V27, P1
   Aksu Z, 2001, SEP PURIF TECHNOL, V21, P285, DOI 10.1016/S1383-5866(00)00212-4
   ALLEN SJ, 1995, J CHEM TECHNOL BIOT, V62, P17, DOI 10.1002/jctb.280620103
   An HK, 2001, WATER RES, V35, P3551, DOI 10.1016/S0043-1354(01)00099-9
   Arica MY, 2001, BIORESOURCE TECHNOL, V80, P121, DOI 10.1016/S0960-8524(01)00084-0
   Avena MJ, 1999, J COLLOID INTERF SCI, V217, P37, DOI 10.1006/jcis.1999.6317
   Azizian S, 2004, J COLLOID INTERF SCI, V276, P47, DOI 10.1016/j.jcis.2004.03.048
   Babel S, 2003, J HAZARD MATER, V97, P219, DOI 10.1016/S0304-3894(02)00263-7
   Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8
   BARTSCHAT BM, 1992, ENVIRON SCI TECHNOL, V26, P284, DOI 10.1021/es00026a007
   Basso MC, 2002, IND ENG CHEM RES, V41, P3580, DOI 10.1021/ie020023h
   Benaissa H, 2006, J HAZARD MATER, V132, P189, DOI 10.1016/j.jhazmat.2005.07.085
   Benguella B, 2002, WATER RES, V36, P2463, DOI 10.1016/S0043-1354(01)00459-6
   Benguella B, 2002, COLLOID SURFACE A, V201, P143, DOI 10.1016/S0927-7757(01)00899-8
   Benhammou A, 2005, J COLLOID INTERF SCI, V282, P320, DOI 10.1016/j.jcis.2004.08.168
   BLANCHARD G, 1984, WATER RES, V18, P1501, DOI 10.1016/0043-1354(84)90124-6
   Borkovec M, 2001, SURF COLLOID SCI, V16, P99
   Borrok DM, 2005, J COLLOID INTERF SCI, V286, P110, DOI 10.1016/j.jcis.2005.01.015
   Brassard P, 1996, ENVIRON SCI TECHNOL, V30, P3216, DOI 10.1021/es950920v
   Buffle J, 1998, ENVIRON SCI TECHNOL, V32, P2887, DOI 10.1021/es980217h
   Chamarthy S, 2001, J CHEM TECHNOL BIOT, V76, P593, DOI 10.1002/jctb.418
   Chang JS, 1997, WATER RES, V31, P1651, DOI 10.1016/S0043-1354(97)00008-0
   CHEN D, 1993, BIOTECHNOL BIOENG, V41, P755, DOI 10.1002/bit.260410710
   Cheung CW, 2000, J CHEM TECHNOL BIOT, V75, P963, DOI 10.1002/1097-4660(200011)75:11<963::AID-JCTB302>3.0.CO;2-Z
   Cheung CW, 2001, ENVIRON SCI TECHNOL, V35, P1511, DOI 10.1021/es0012725
   Cheung CW, 2001, WATER RES, V35, P605, DOI 10.1016/S0043-1354(00)00306-7
   Chojnacka K, 2005, CHEMOSPHERE, V59, P75, DOI 10.1016/j.chemosphere.2004.10.005
   CHONG KH, 1995, BIOTECHNOL BIOENG, V47, P451, DOI 10.1002/bit.260470406
   Choy KKH, 2005, CHEMOSPHERE, V60, P1141, DOI 10.1016/j.chemosphere.2004.12.041
   Choy KKH, 2004, J COLLOID INTERF SCI, V271, P284, DOI 10.1016/j.jcis.2003.12.015
   Chu KH, 2002, J CHEM TECHNOL BIOT, V77, P685, DOI 10.1002/jctb.621
   Cordero B, 2004, ENVIRON CHEM, V1, P180, DOI 10.1071/EN04039
   Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001
   Crini G, 2005, PROG POLYM SCI, V30, P38, DOI 10.1016/j.progpolymsci.2004.11.002
   CRIST DR, 1994, FEMS MICROBIOL REV, V14, P309, DOI 10.1111/j.1574-6976.1994.tb00104.x
   CRIST RH, 1992, ENVIRON SCI TECHNOL, V26, P496, DOI 10.1021/es00027a007
   CRIST RH, 1990, ENVIRON SCI TECHNOL, V24, P337, DOI 10.1021/es00073a008
   CRIST RH, 1994, ENVIRON SCI TECHNOL, V28, P1859, DOI 10.1021/es00060a016
   Crist RH, 2002, ENVIRON SCI TECHNOL, V36, P1485, DOI 10.1021/es011136f
   Crist RH, 1999, ENVIRON SCI TECHNOL, V33, P2252, DOI 10.1021/es981278i
   Crist RH, 1996, ENVIRON SCI TECHNOL, V30, P2456, DOI 10.1021/es950569d
   Cruz CCV, 2004, BIORESOURCE TECHNOL, V91, P249, DOI 10.1016/S0960-8524(03)00194-9
   Dal Bosco SM, 2005, J COLLOID INTERF SCI, V281, P424, DOI 10.1016/j.jcis.2004.08.060
   Davis TA, 2000, WATER RES, V34, P4270, DOI 10.1016/S0043-1354(00)00177-9
   Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8
   De Stefano C, 2005, ANAL BIOANAL CHEM, V383, P587, DOI 10.1007/s00216-005-0025-6
   Demirbas A, 2005, J COLLOID INTERF SCI, V282, P20, DOI 10.1016/j.jcis.2004.08.147
   DEWIT JCM, 1990, ANAL CHIM ACTA, V232, P189, DOI 10.1016/S0003-2670(00)81235-0
   DEWIT JCM, 1993, ENVIRON SCI TECHNOL, V27, P2005, DOI 10.1021/es00047a004
   Dhakal RP, 2005, HYDROMETALLURGY, V79, P182, DOI 10.1016/j.hydromet.2005.06.007
   DZULEROSA MS, 2001, HYDROMETALLURGY, V61, P157, DOI DOI 10.1016/S0304-386X(01)00166-9
   Esposito A, 2001, HYDROMETALLURGY, V60, P129, DOI 10.1016/S0304-386X(00)00195-X
   *EUR PARL COUNC, 2006, OFFICIAL J EUROPEA L, V33, P1
   Evans A, 2002, SCI COMPUT PROGRAM, V44, P1, DOI 10.1016/S0167-6423(02)00028-X
   Feng D, 2004, HYDROMETALLURGY, V73, P1, DOI 10.1016/S0304-386X(03)00138-5
   FOUREST E, 1994, FEMS MICROBIOL REV, V14, P325
   FOUREST E, 1992, APPL MICROBIOL BIOT, V37, P399, DOI 10.1007/BF00211001
   Ghoul M, 2003, WATER RES, V37, P729, DOI 10.1016/S0043-1354(02)00410-4
   Gin KYH, 2002, WATER RES, V36, P1313, DOI 10.1016/S0043-1354(01)00332-3
   Goksungur Y, 2005, BIORESOURCE TECHNOL, V96, P103, DOI 10.1016/j.biortech.2003.04.002
   Gotoh T, 2004, CHEMOSPHERE, V55, P135, DOI 10.1016/j.chemosphere.2003.11.016
   Gupta VK, 2003, WATER RES, V37, P4038, DOI 10.1016/S0043-1354(03)00292-6
   Gupta VK, 2002, ENVIRON SCI TECHNOL, V36, P3612, DOI 10.1021/es020010v
   Hashim MA, 2004, CHEM ENG J, V97, P249, DOI 10.1016/S1385-8947(03)00216-X
   Hawari AH, 2006, BIORESOURCE TECHNOL, V97, P692, DOI 10.1016/j.biortech.2005.03.033
   Herrero R, 2006, MAR CHEM, V99, P106, DOI 10.1016/j.marchem.2005.05.009
   Heyrovsky J., 1966, PRINCIPLES POLAROGRA
   Ho YS, 2004, PROCESS BIOCHEM, V39, P759, DOI 10.1016/S0032-9592(03)00184-5
   Ho YS, 1998, PROCESS SAF ENVIRON, V76, P332, DOI 10.1205/095758298529696
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Ho YS, 1996, ENVIRON TECHNOL, V17, P71, DOI 10.1080/09593331708616362
   HO YS, 1999, T I CHEM E, V77, P165, DOI DOI 10.1205/095758299529983
   HOLAN ZR, 1993, BIOTECHNOL BIOENG, V41, P819, DOI 10.1002/bit.260410808
   HOLAN ZR, 1995, APPL BIOCHEM BIOTECH, V53, P133, DOI 10.1007/BF02788603
   Horsfall M, 2006, BIORESOURCE TECHNOL, V97, P283, DOI 10.1016/j.biortech.2005.02.016
   Hsien TY, 1997, IND ENG CHEM RES, V36, P3631, DOI 10.1021/ie9701579
   Iqbal M, 2005, CHEMOSPHERE, V61, P510, DOI 10.1016/j.chemosphere.2005.02.060
   Iqbal M, 2004, BIOTECHNOL LETT, V26, P165, DOI 10.1023/B:BILE.0000012899.76157.19
   Justi KC, 2005, J COLLOID INTERF SCI, V291, P369, DOI 10.1016/j.jcis.2005.05.017
   KATCHALSKY A, 1947, J POLYM SCI, V2, P432, DOI 10.1002/pol.1947.120020409
   Khosravi M, 2005, J HAZARD MATER, V127, P228, DOI 10.1016/j.jhazmat.2005.07.023
   Kinniburgh DG, 1999, COLLOID SURFACE A, V151, P147, DOI 10.1016/S0927-7757(98)00637-2
   Klimmek S, 2001, ENVIRON SCI TECHNOL, V35, P4283, DOI 10.1021/es010063x
   Ko DCK, 2004, CHEMOSPHERE, V54, P273, DOI 10.1016/j.chemosphere.2003.08.004
   Koopal LK, 2005, COLLOID SURFACE A, V265, P40, DOI 10.1016/j.colsurfa.2004.11.050
   Kumar U, 2006, BIORESOURCE TECHNOL, V97, P104, DOI 10.1016/j.biortech.2005.02.027
   Lamelas C, 2005, BIOMACROMOLECULES, V6, P2756, DOI 10.1021/bm050252y
   Lazaro N, 2003, WATER RES, V37, P2118, DOI 10.1016/S0043-1354(02)00575-4
   Lee HS, 2004, MINER ENG, V17, P487, DOI 10.1016/j.mineng.2004.01.002
   LEUSCH A, 1995, J CHEM TECHNOL BIOT, V62, P279, DOI 10.1002/jctb.280620311
   Leusch A, 1996, APPL BIOCHEM BIOTECH, V61, P231
   Leyva-Ramos R, 2005, SEP PURIF TECHNOL, V45, P41, DOI 10.1016/j.seppur.2005.02.005
   LeyvaRamos R, 1997, WATER SCI TECHNOL, V35, P205, DOI 10.1016/S0273-1223(97)00132-7
   Li XS, 2005, J COLLOID INTERF SCI, V281, P267, DOI 10.1016/j.jcis.2004.08.141
   Liu Y, 2003, PROCESS BIOCHEM, V38, P997, DOI 10.1016/S0032-9592(02)00225-X
   Lodeiro P, 2006, ENVIRON POLLUT, V142, P264, DOI 10.1016/j.envpol.2005.10.001
   Lodeiro P, 2005, J COLLOID INTERF SCI, V289, P352, DOI 10.1016/j.jcis.2005.04.002
   Lodeiro P, 2005, BIORESOURCE TECHNOL, V96, P1796, DOI 10.1016/j.biortech.2005.01.002
   Lodeiro P, 2004, BIOTECHNOL BIOENG, V88, P237, DOI 10.1002/bit.20229
   Loukidou MX, 2004, J CHEM TECHNOL BIOT, V79, P711, DOI 10.1002/jctb.1043
   Low KS, 2000, PROCESS BIOCHEM, V36, P59, DOI 10.1016/S0032-9592(00)00177-1
   Martin MI, 2005, J CHEM TECHNOL BIOT, V80, P1223, DOI 10.1002/jctb.1305
   Martinez JL, 2003, RE ADV MAR BIOTECHNO, V10, P13
   Martinez M, 2006, J HAZARD MATER, V133, P203, DOI 10.1016/j.jhazmat.2005.10.030
   Matheickal JT, 1999, WATER RES, V33, P335, DOI 10.1016/S0043-1354(98)00237-1
   Matos GD, 2003, PROCESS BIOCHEM, V39, P81, DOI 10.1016/S0032-9592(02)00315-1
   McKay G, 1997, J CHEM TECHNOL BIOT, V69, P309, DOI 10.1002/(SICI)1097-4660(199707)69:3<309::AID-JCTB724>3.0.CO;2-W
   Miretzky P, 2006, CHEMOSPHERE, V62, P247, DOI 10.1016/j.chemosphere.2005.05.010
   Mohan D, 2002, WATER RES, V36, P2304, DOI 10.1016/S0043-1354(01)00447-X
   Mohan D, 2006, J COLLOID INTERF SCI, V297, P489, DOI 10.1016/j.jcis.2005.11.023
   MOREL FMM, 1993, PRINCIPLES APPL AQUA
   Ozdemir G, 2004, CHEM ENG J, V102, P249, DOI 10.1016/j.cej.2004.01.032
   Ozer A, 1999, PROCESS BIOCHEM, V34, P919, DOI 10.1016/S0032-9592(99)00011-4
   Pagnanelli F, 2005, HYDROMETALLURGY, V80, P107, DOI 10.1016/j.hydromet.2005.07.008
   Pagnanelli F, 2005, WATER RES, V39, P1639, DOI 10.1016/j.watres.2005.01.019
   Pagnanelli F, 2004, CHEMOSPHERE, V54, P905, DOI 10.1016/j.chemosphere.2003.09.003
   Pagnanelli F, 2003, CHEM ENG SCI, V58, P4709, DOI 10.1016/j.ces.2003.08.001
   Pagnanelli F, 2002, WATER RES, V36, P4095, DOI 10.1016/S0043-1354(02)00112-4
   Pagnanelli F, 2000, ENVIRON SCI TECHNOL, V34, P2773, DOI 10.1021/es99127g
   Pardo R, 2003, ANAL BIOANAL CHEM, V376, P26, DOI 10.1007/s00216-003-1843-z
   Percival E., 1967, CHEM ENZYMOLOGY MARI
   Peternele WS, 1999, BIORESOURCE TECHNOL, V68, P95, DOI 10.1016/S0960-8524(98)00083-2
   Poon C. P. C., 1986, CADMIUM ENV, P46
   Rao MM, 2006, J HAZARD MATER, V129, P123, DOI 10.1016/j.jhazmat.2005.08.018
   Reddad Z, 2002, ENVIRON SCI TECHNOL, V36, P2242, DOI 10.1021/es010237a
   Reddad Z, 2002, ENVIRON SCI TECHNOL, V36, P2067, DOI 10.1021/es0102989
   Rey-Castro C, 2004, CHEM SPEC BIOAVAILAB, V16, P61, DOI 10.3184/095422904782775117
   Rey-Castro C, 2004, J ELECTROANAL CHEM, V564, P223, DOI 10.1016/j.jelechem.2003.10.023
   Rey-Castro C, 2003, ENVIRON SCI TECHNOL, V37, P5159, DOI 10.1021/es0343353
   Rincon J, 2005, J CHEM TECHNOL BIOT, V80, P1403, DOI 10.1002/jctb.1342
   RITCHIE AG, 1977, J CHEM SOC FARAD T 1, V73, P1650, DOI 10.1039/f19777301650
   Saeed A, 2005, SEP PURIF TECHNOL, V45, P25, DOI 10.1016/j.seppur.2005.02.004
   Sag Y, 2001, SEPAR PURIF METHOD, V30, P1, DOI 10.1081/SPM-100102984
   Saiano F, 2005, WATER RES, V39, P2273, DOI 10.1016/j.watres.2005.04.022
   Saito T, 2005, COLLOID SURFACE A, V265, P104, DOI 10.1016/j.colsurfa.2004.10.139
   Sastre de Vicente M. E., 1997, CURR TOP SOLUTION CH, V2, P157
   Schiewer S, 1997, ENVIRON SCI TECHNOL, V31, P1863, DOI 10.1021/es960434n
   Schiewer S, 1997, ENVIRON SCI TECHNOL, V31, P2478, DOI 10.1021/es960751u
   Schiewer S, 1999, J APPL PHYCOL, V11, P79, DOI 10.1023/A:1008025411634
   SCHIEWER S, 1995, ENVIRON SCI TECHNOL, V29, P3049, DOI 10.1021/es00012a024
   Schiewer S, 1999, ENVIRON SCI TECHNOL, V33, P3821, DOI 10.1021/es981288j
   Schiewer S, 2000, CHEMOSPHERE, V41, P271, DOI 10.1016/S0045-6535(99)00421-X
   Schiewer S, 1996, ENVIRON SCI TECHNOL, V30, P2921, DOI 10.1021/es950800n
   Schneider IAH, 1999, ENVIRON SCI TECHNOL, V33, P2213, DOI 10.1021/es981090z
   Schneider IAH, 2001, INT J MINER PROCESS, V62, P111, DOI 10.1016/S0301-7516(00)00047-8
   Seki H, 2002, J COLLOID INTERF SCI, V246, P259, DOI 10.1006/jcis.2001.8090
   Selatnia A, 2004, HYDROMETALLURGY, V75, P11, DOI 10.1016/j.hydromet.2004.06.005
   Sen Gupta S, 2006, J HAZARD MATER, V128, P247, DOI 10.1016/j.jhazmat.2005.08.008
   Sharma A, 2005, J HAZARD MATER, V125, P102, DOI 10.1016/j.jhazmat.2005.05.012
   Shen JC, 2005, PROCESS BIOCHEM, V40, P3446, DOI 10.1016/j.procbio.2005.02.016
   Sheng PX, 2004, J COLLOID INTERF SCI, V275, P131, DOI 10.1016/j.jcis.2004.01.036
   Singh KK, 2006, BIORESOURCE TECHNOL, V97, P994, DOI 10.1016/j.biortech.2005.04.043
   Srikrajib S, 1999, PROCESS MET, V9, P419, DOI 10.1016/S1572-4409(99)80132-1
   Suzuki Y, 2005, WATER RES, V39, P1803, DOI 10.1016/j.watres.2005.02.020
   Tanford C., 1961, PHYS CHEM MACROMOLEC
   Taty-Costodes VC, 2003, J HAZARD MATER, V105, P121, DOI 10.1016/j.jhazmat.2003.07.009
   Teng H, 1999, IND ENG CHEM RES, V38, P292, DOI 10.1021/ie980107j
   Vasudevan P, 2003, BIORESOURCE TECHNOL, V89, P281, DOI 10.1016/S0960-8524(03)00067-1
   Veglio F, 1997, HYDROMETALLURGY, V44, P301, DOI 10.1016/S0304-386X(96)00059-X
   Vilar VJP, 2006, WATER RES, V40, P291, DOI 10.1016/j.watres.2005.11.008
   VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001
   WEBER WJ, 1991, WATER RES, V25, P499, DOI 10.1016/0043-1354(91)90125-A
   Yalcinkaya Y, 2002, HYDROMETALLURGY, V63, P31, DOI 10.1016/S0304-386X(01)00200-6
   Yan GY, 2003, WATER RES, V37, P4486, DOI 10.1016/S0043-1354(03)00409-3
   Yang JB, 1999, ENVIRON SCI TECHNOL, V33, P751, DOI 10.1021/es980412w
   Yang JB, 1996, J CHEM TECHNOL BIOT, V66, P355, DOI 10.1002/(SICI)1097-4660(199608)66:4<355::AID-JCTB519>3.0.CO;2-F
   Yee N, 2001, GEOCHIM COSMOCHIM AC, V65, P2037, DOI 10.1016/S0016-7037(01)00587-7
   Yin P, 2001, ENVIRON TECHNOL, V22, P509, DOI 10.1080/09593332208618254
   Yin PH, 1999, WATER RES, V33, P1960, DOI 10.1016/S0043-1354(98)00400-X
   Yu QM, 1999, WATER RES, V33, P1534, DOI 10.1016/S0043-1354(98)00363-7
   Yun YS, 2003, ENVIRON SCI TECHNOL, V37, P3601, DOI 10.1021/es011454e
   Zhou D, 2004, WATER RES, V38, P2643, DOI 10.1016/j.watres.2004.03.026
   Zouboulis AI, 2004, PROCESS BIOCHEM, V39, P909, DOI 10.1016/S0032-9592(03)00200-0
NR 175
TC 52
Z9 53
U1 5
U2 53
PU CSIRO PUBLISHING
PI CLAYTON
PA UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC
   3168, AUSTRALIA
SN 1448-2517
EI 1449-8979
J9 ENVIRON CHEM
JI Environ. Chem.
PY 2006
VL 3
IS 6
BP 400
EP 418
DI 10.1071/EN06043
PG 19
WC Chemistry, Analytical; Environmental Sciences
SC Chemistry; Environmental Sciences & Ecology
GA 116HA
UT WOS:000242791900004
DA 2018-10-20
ER

PT S
AU Toh, SL
   Teh, TKH
   Vallaya, S
   Goh, JCH
AF Toh, S. L.
   Teh, T. K. H.
   Vallaya, S.
   Goh, J. C. H.
BE Lee, SB
   Kim, YJ
TI Novel silk scaffolds for ligament tissue engineering applications
SO EXPERIMENTAL MECHANICS IN NANO AND BIOTECHNOLOGY, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT International Conference on Experimental Mechanics (ICEM 2006)/5th Asian
   Conference on Experimental Mechanics (ACEM5)
CY SEP 26-26, 2006
CL Cheju Isl, SOUTH KOREA
SP Korea Adv Inst Sci & Technol, Asian Comm Expt Mech
DE ligament reconstruction; tissue engineering; knitted silk scaffold;
   nanofibers
ID MARROW STROMAL CELLS; BIOMATERIALS; SUTURES
AB Scaffold technology is integral in advancing tissue engineering and one of the tissues of interest here is the tendon/ligament. Advancement in the tissue engineering of tendon/ligament has become very much a materials engineering problem than ever, with the selection of appropriate biomaterial and scaffold architecture. Such is the key to successful tendon/ligament tissue regeneration construct. Popular materials used in recent years include various poly (1-lactic) biomaterials and collagen. However, shortcomings of these materials, in terms of poor mechanical strength or short degradation period, are yet overcome. Bombyx mori silk, though used in biomedical sutures for decades due to its excellent mechanical properties, has been overlooked for applications in ligament tissue engineering, only until recently. This is largely due to previous misconceptions in its biocompatibility and biodegradability characteristics. This paper describes the use of a silk-based scaffold with knitted architecture and investigates its strengths as compared to previous PLGA-based knitted scaffolds. An electrospun nanofiber surface on knitted microfiber architecture is adopted and it is found to have better composite-material integrity, in vitro degradation resistance, and encourages cell adhesion and proliferation.
C1 [Toh, S. L.; Teh, T. K. H.; Goh, J. C. H.] Natl Univ Singapore, Div Bioengn, Singapore 117548, Singapore.
   [Goh, J. C. H.] Natl Univ Singapore, Dept Orthopaed Surg, Singapore 117548, Singapore.
   [Toh, S. L.] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore.
   [Vallaya, S.] Mahasarakaham Univ, Bangkok, Thailand.
RP Toh, SL (reprint author), Natl Univ Singapore, Div Bioengn, Singapore 117548, Singapore.
EM bietohsl@nus.edu.sg; khteh@nus.edu.sg; svallaya@gmail.com;
   dosgohj@nus.edu.sg
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   BELL E, 1995, TISSUE ENG, P63
   Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014
   LAURENCIN CT, 2005, LIGAMENT TISSUE ENG
   Miyasaka KC, 1991, AM J KNEE SURG, V4, P3
   Ouyang HW, 2003, TISSUE ENG, V9, P431, DOI 10.1089/107632703322066615
   ROSSITCH E, 1987, CHILD NERV SYST, V3, P375, DOI 10.1007/BF00270712
   Sahoo S, 2006, TISSUE ENG, V12, P91, DOI 10.1089/ten.2006.12.91
   SILVER FH, 1991, J LONG-TERM EFF MED, P35
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Van Eijk F, 2004, TISSUE ENG, V10, P893, DOI 10.1089/1076327041348428
NR 12
TC 7
Z9 7
U1 1
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-415-4
J9 KEY ENG MATER
PY 2006
VL 326-328
BP 727
EP +
DI 10.4028/www.scientific.net/KEM.326-328.727
PN 1-2
PG 2
WC Biotechnology & Applied Microbiology; Engineering, Mechanical;
   Nanoscience & Nanotechnology; Materials Science, Ceramics; Materials
   Science, Multidisciplinary; Materials Science, Characterization &
   Testing; Materials Science, Composites
SC Biotechnology & Applied Microbiology; Engineering; Science & Technology
   - Other Topics; Materials Science
GA BFO49
UT WOS:000243448200178
DA 2018-10-20
ER

PT S
AU Ramdan, RD
   Jauhari, I
   Hasan, R
   Masdek, NRN
   Zakaria, FA
   Jamuna, K
AF Ramdan, Raden Dadan
   Jauhari, Iswadi
   Hasan, Rafidah
   Masdek, Nik Roslin Nik
   Zakaria, Fadzil Ayad
   Jamuna, K.
BE Lee, SB
   Kim, YJ
TI The effect of carbonated apatite powder size on its embedment into
   titanium alloy by superplastic deformation process
SO Experimental Mechanics in Nano and Biotechnology, Pts 1 and 2
SE KEY ENGINEERING MATERIALS
LA English
DT Proceedings Paper
CT International Conference on Experimental Mechanics (ICEM 2006)/5th Asian
   Conference on Experimental Mechanics (ACEM5)
CY SEP   26, 2006
CL Cheju Isl, SOUTH KOREA
SP Korea Adv Inst Sci & Technol, Asian Comm Expt Mech
DE biomaterial; superplastic deformation; powder size; carbonated apatite
AB The effect of carbonated apatite powder size on the carbonated apatite embedded on titanium alloy was studied. The process was conducted using superplastic deformation method at 750 degrees C and initial pressure of 34MPa. In order to evaluate the characteristics of the resulting embedded layer, X-ray diffraction method was conducted followed with microstructure characterization. From X-ray diffraction characterization, it can be concluded that small stress layers of carbonated apatite were resulted for all samples with different initial powder size. In addition, initial powder size of carbonated apatite only significantly influences the intensity of diffraction peak for certain plane of crystal structure. From the experimental results, it can also be concluded that superplastic deformation can be used as an alternative method for the coating process of bio apatite material on titanium alloy substrate.
C1 Univ Malaya, Dept Mech Engn, Ctr Nanotechnol Precis & Advance Mat, Kuala Lumpur, Malaysia.
RP Ramdan, RD (reprint author), Univ Malaya, Dept Mech Engn, Ctr Nanotechnol Precis & Advance Mat, Kuala Lumpur, Malaysia.
RI JAUHARI, ISWADI/B-8675-2010
CR Danilchenko SN, 2004, CRYST RES TECHNOL, V39, P71, DOI 10.1002/crat.200310151
   Holliday S, 2004, SURF COAT TECH, V188, P741, DOI 10.1016/j.surfcoat.2004.07.044
   KRAJEWSKI A, 2004, J MOL STRUCT, P1
   Nonami T, 1998, MAT SCI ENG C-BIO S, V6, P281, DOI 10.1016/S0928-4931(98)00063-0
   Suping H, 2004, MATER LETT, V58, P3582
   Thian ES, 2005, BIOMATERIALS, V26, P2947, DOI 10.1016/j.biomaterials.2004.07.058
NR 6
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-415-4
J9 KEY ENG MAT
PY 2006
VL 326-328
BP 785
EP 788
DI 10.4028/www.scientific.net/KEM.326-328.785
PN 1-2
PG 4
WC Biotechnology & Applied Microbiology; Engineering, Mechanical;
   Nanoscience & Nanotechnology; Materials Science, Ceramics; Materials
   Science, Multidisciplinary; Materials Science, Characterization &
   Testing; Materials Science, Composites
SC Biotechnology & Applied Microbiology; Engineering; Science & Technology
   - Other Topics; Materials Science
GA BFO49
UT WOS:000243448200192
DA 2018-10-20
ER

PT S
AU Kang, MS
   Yoon, SH
   Jin, HJ
AF Kang, Minsung
   Yoon, Seok Ho
   Jin, Hyoung-Joon
BE Lee, SB
   Kim, YJ
TI Preparation of electrospun protein nanofibers with multiwalled carbon
   nanotubes
SO EXPERIMENTAL MECHANICS IN NANO AND BIOTECHNOLOGY, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT International Conference on Experimental Mechanics (ICEM 2006)/5th Asian
   Conference on Experimental Mechanics (ACEM5)
CY SEP 26-26, 2006
CL Cheju Isl, SOUTH KOREA
SP Korea Adv Inst Sci & Technol, Asian Comm Expt Mech
DE silk fibroin; electrospinning; nanofibers; multiwalled carbon nanotubes;
   membranes
ID BOMBYX-MORI SILK; NORMAL HUMAN KERATINOCYTES; REGENERATION
AB A simple and mass producible method was developed to incorporate multiwalled carbon nanotubes (MWCNTs) into electrospun silk fibroin (Bombyx mori) nanofibers. The process consists of dispersing the acid-treated MWCNTs in an aqueous silk fibroin solution, and blending this solution with a water-soluble polymer, poly(ethylene oxide) (PEO), followed by electrospinning of the composite solution. The morphology and microstructure of the electrospun nanofibers were characterized using field emission scanning electron microscopy (FESEM) and transmission electron microscopy (TEM). The FESEM and TEM images show that the MWCNTs are embedded along the nanofibers. Aqueous-based electrospinning of silk/PEO/MWCNTs composites provides potentially useful options for the fabrication of biomaterial scaffolds, e.g. wound dressings, based on this unique fibrous protein.
C1 Inha Univ, Dept Polymer Sci & Engn, Inchon 402751, South Korea.
RP Kang, MS (reprint author), Inha Univ, Dept Polymer Sci & Engn, Inchon 402751, South Korea.
EM mskang@inhaian.net; shyoon@inhaian.net; hjjin@inha.ac.kr
CR IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Jin HJ, 2005, CHEM MATER, V17, P4034, DOI 10.1021/cm050500x
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   KIM HS, 2006, CHIN MACROMOL RAPID, V27, P146
   Min BM, 2004, INT J BIOL MACROMOL, V34, P281, DOI 10.1016/j.ijbiomac.2004.08.004
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Stephens JS, 2005, BIOMACROMOLECULES, V6, P1405, DOI 10.1021/bm049296h
   Sukigara S, 2004, POLYMER, V45, P3701, DOI 10.1016/j.polymer.2004.03.059
   Sukigara S, 2003, POLYMER, V44, P5721, DOI 10.1016/S0032-3861(03)00532-9
   Sung JH, 2004, MACROMOLECULES, V37, P9899, DOI 10.1021/ma048355g
   Wang M, 2004, MACROMOLECULES, V37, P6856, DOI 10.1021/ma048988v
NR 12
TC 1
Z9 1
U1 1
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-415-4
J9 KEY ENG MATER
PY 2006
VL 326-328
BP 1737
EP 1740
DI 10.4028/www.scientific.net/KEM.326-328.1737
PN 1-2
PG 4
WC Biotechnology & Applied Microbiology; Engineering, Mechanical;
   Nanoscience & Nanotechnology; Materials Science, Ceramics; Materials
   Science, Multidisciplinary; Materials Science, Characterization &
   Testing; Materials Science, Composites
SC Biotechnology & Applied Microbiology; Engineering; Science & Technology
   - Other Topics; Materials Science
GA BFO49
UT WOS:000243448201203
DA 2018-10-20
ER

PT J
AU Lin, YK
   Liu, DC
AF Lin, YK
   Liu, DC
TI Comparison of physical-chemical properties of type I collagen from
   different species
SO FOOD CHEMISTRY
LA English
DT Article
DE physical-chemical properties; species; collagen
ID PROTEINS; FEET
AB Type I collagen is an important biopolymer and has been widely used in biomaterials due to its excellent biocompatibility and biodegradable properties. However, only a few studies have been reported on its comparison in different species. The amino acid composition, SDS-PAGE, UV-Vis spectrum, thermal transition temperatures, extractable uronic acid/protein ratio and enzymatic sensitivity of type I collagen from bird feet (BF), bovine skin (BS), frog skin (FS), porcine skin (PS) and shark skin (SS) were evaluated. The amino acid composition of type I collagens were different from different species, BF collagen contained higher glutamic acid (Glu) and aspartic acid (Asp), SS collagen contained lower aspartic acid and hydroxyproline (Hyp). Similar SDS-PAGE profiles were found from different animal's collagen, all samples were composed of two alpha 1-chain and one alpha 2-chain. All UV-Vis spectrums exhibited a typical absorption peak at 218 nm. The UV absorption spectrum of BF collagen ranged from 190 to 340 nm, FS collagen ranged from 190 to 270 nm; the other species collagen ranged from 190 to 240 nm. Thermal transition temperatures of type I collagen from different animals decreased in the order of BF > BS > PS > FS > SS. PS collagen had higher extractable uronic acid/protein ratio and the lowest enzymatic sensitivity. Summarizing these results, the BF collagen had higher hyproxyproline (Hyp) + proline (Pro) value and exhibited higher thermal stability; the PS collagen contained larger amount of glycosaminoglycan and resulted in a high enzymes resistance. However, the BF and PS collagen should be used as a suitable material in biomaterial utilitys because of its better biostability. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Natl Chung Hsing Univ, Dept Anim Sci, Taichung 40227, Taiwan.
RP Liu, DC (reprint author), Natl Chung Hsing Univ, Dept Anim Sci, 250 Kao Kuang Rd, Taichung 40227, Taiwan.
EM dcliu@dragon.nchu.edu.tw
CR Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   DOYLE RJ, 1968, BIOCHEM BIOPH RES CO, V31, P869, DOI 10.1016/0006-291X(68)90532-9
   HUANGLEE LLH, 1993, BIOMED ENG ABC, V5, P60
   ITZHAKI RF, 1964, ANAL BIOCHEM, V9, P401, DOI 10.1016/0003-2697(64)90200-3
   JOSE J, 1964, J MOL BIOL, V9, P269
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Li H, 2004, FOOD CHEM, V84, P65, DOI 10.1016/S0308-8146(03)00167-5
   Lin YK, 2006, FOOD CHEM, V94, P621, DOI 10.1016/j.foodchem.2004.12.007
   Liu DC, 2001, ASIAN AUSTRAL J ANIM, V14, P1638, DOI 10.5713/ajas.2001.1638
   NA GC, 1988, COLLAGEN REL RES, V8, P315
   Nagai T, 2000, FOOD CHEM, V70, P205, DOI 10.1016/S0308-8146(00)00081-9
   Nomura Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1919, DOI 10.1271/bbb.61.1919
   Nomura Y, 1996, BIOSCI BIOTECH BIOCH, V60, P2092, DOI 10.1271/bbb.60.2092
   Nomura Y, 2000, J AGR FOOD CHEM, V48, P6332, DOI 10.1021/jf000584o
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   PURNA K, 2001, COMP BIOCH PHYSL B, V128, P81
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6
   Robinson JJ, 1997, COMP BIOCHEM PHYS B, V117, P307, DOI 10.1016/S0305-0491(97)00092-8
   SATHYA KV, 2002, J BIOMEDICAL MAT RES, V61, P197
   Shingleton WD, 1996, BIOCHEM CELL BIOL, V74, P759, DOI 10.1139/o96-083
   Sivakumar P, 1998, BBA-GEN SUBJECTS, V1381, P161, DOI 10.1016/S0304-4165(98)00023-3
   Weadock KS, 1996, J BIOMED MATER RES, V32, P221, DOI 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M
   WU AB, 1999, J AGR ASSOC CHINA, V187, P93
   Yoshimura Keiji, 1996, Animal Science and Technology, V67, P445
NR 27
TC 71
Z9 88
U1 4
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
J9 FOOD CHEM
JI Food Chem.
PY 2006
VL 99
IS 2
BP 244
EP 251
DI 10.1016/j.foodchem.2005.06.053
PG 8
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA 050GV
UT WOS:000238076400004
DA 2018-10-20
ER

PT S
AU Li, W
   Li, Q
   Loughran, J
   Swain, M
   Ichim, I
   Fujisawa, N
AF Li, Wei
   Li, Qing
   Loughran, Jeffery
   Swain, Michael
   Ichim, Ionut
   Fujisawa, Naoki
BE Aliabadi, MH
   Li, Q
   Li, L
   Buchholz, FG
TI Contact-driven crack formation in dental ceramic materials
SO FRACTURE AND DAMAGE MECHANICS V, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 5th International Conference on Fracture and Damage Mechanics
CY SEP 13-15, 2006
CL Harbin, PEOPLES R CHINA
SP Harbin Engn Univ
DE dental ceramics; contact damage; finite and discrete element; fracture
   mechanics
ID DAMAGE
AB Natural human tooth consists of multiple layered quasi-brittle biomaterials, which make dental restorations experience a complex stress state under masticatory contact loading. As such, many restorations are prone to failure and a constant effort is made to improve the mechanical characteristics of the restorative materials. Clinical observations have shown that improved strengths and fracture toughness in ceramic materials do not necessarily lead to an anticipated higher functional longevity of the restoration. While substantial experimental investigations have been carried out to identify the contact induced fracture in such multi-layer material systems, numerical modelling of this event was largely unexplored. This paper presents a new numerical method to account for micro-damage driven fracture in various multi-layered biomaterial structures. In this study, a Rankine constitutive model is adopted and the crack initiation and propagation are automatically implemented in an explicit finite element (FE) framework. The effects of indenter radius, surface curvature and thickness of layered biomaterials on the cracking patterns are investigated. The results show good agreement with the experimental studies in literature.
C1 [Li, Wei; Li, Qing] Univ Sydney, Sch Aerosp & Mech Engn, Sydney, NSW 2006, Australia.
   [Li, Qing; Loughran, Jeffery] James Cook Univ, Sch Engn, Townsville, Qld 4811, Australia.
   [Swain, Michael; Fujisawa, Naoki] Univ Sydney, Fac Dent, Sydney, NSW 2006, Australia.
   [Swain, Michael; Ichim, Ionut] Univ Otago, Fac Dent, Dept Oral Sci, Dunedin, New Zealand.
RP Li, W (reprint author), Univ Sydney, Sch Aerosp & Mech Engn, Sydney, NSW 2006, Australia.
EM wei@aeromech.usyd.edu.au; Qing.Li@aeromech.usyd.edu.au;
   jeffrey.loughran@jcu.edu.au; mswain@mail.usyd.edu.au;
   ionut.ichim@stonebow.otago.ac.nz; n.fujisawa@usyd.edu.au
RI Li, Qing/B-3422-2009; Swain, Michael/J-7266-2017
OI Li, Qing/0000-0002-7930-2145; 
FU Australian Research Council [DP0666446]
FX This study was supported by Australian Research Council (DP0666446) and
   2006 James Cook Universitys new staff Grant.
CR Ford C, 2004, MAT SCI ENG A-STRUCT, V380, P137, DOI 10.1016/j.msea.2004.03.071
   Jung YG, 1999, J DENT RES, V78, P887, DOI 10.1177/00220345990780040901
   Klerck PA, 2004, COMPUT METHOD APPL M, V193, P3035, DOI 10.1016/j.cma.2003.10.015
   O'Brien W.J, 1997, DENT MAT THEIR SELEC
   Peterson IM, 1998, J DENT RES, V77, P589, DOI 10.1177/00220345980770041201
   Qasim T, 2005, J BIOMED MATER RES B, V73B, P179, DOI 10.1002/jbm.b.30188
   Qasim T, 2006, INT J MECH SCI, V48, P244, DOI 10.1016/j.ijmecsci.2005.10.004
   Shrotriya P, 2003, J MATER SCI-MATER M, V14, P17, DOI 10.1023/A:1021541101823
NR 8
TC 2
Z9 2
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2006
VL 324-325
BP 1257
EP +
DI 10.4028/www.scientific.net/KEM.324-325.1257
PN 1-2
PG 2
WC Materials Science, Ceramics; Mechanics; Materials Science, Composites
SC Materials Science; Mechanics
GA BFN88
UT WOS:000243377000307
DA 2018-10-20
ER

PT B
AU Wang, BQ
   Deng, CJ
   Li, YD
   Wu, MF
AF Wang, Baoqiang
   Deng, Changjian
   Li, Yiding
   Wu, Maofang
GP IEEE
TI The design optimization of ultrasonic equipment for Chinese Traditional
   Medicine Extraction
SO IEEE ICMA 2006: PROCEEDING OF THE 2006 IEEE INTERNATIONAL CONFERENCE ON
   MECHATRONICS AND AUTOMATION, VOLS 1-3, PROCEEDINGS
LA English
DT Proceedings Paper
CT IEEE International Conference on Mechatronics and Automation
CY JUN 25-28, 2006
CL Henan Univ Sci & Technol, Luoyang, PEOPLES R CHINA
SP IEEE Robot & Automat Soc, Shandong Univ, Harbin Engn Univ, Univ Elect Sci & Technol China, IEEE Hong Kong Sect Joint RACS Chapter, Robot Soc Japan, Japan Soc Mech Engineers, Japan Soc Precis Engn, Chinese Univ Hong Kong, Chiba Inst Technol, Kagawa Univ
HO Henan Univ Sci & Technol
DE biomaterial technology; ultrasound-assisted process; Chinese Tradition
   Medicine Extraction
AB Traditional Chinese Medicine (TCM) has made great contributions to the prosperity of China. Today both of TCM and western medicine are being used in providing medical and health services in China. TCM is accepted for its unique and abundant medical function. It is well known that the sonication is one of effective and economical techniques for material processing. Chinese traditional medicine extraction assisted by power ultrasound is a very important subject nowadays. To overcome some shortages of existing ultrasonic processors used for medicine extraction, the characteristics of ultrasonic propagation in the mixture of biomaterials and liquors are farther researched, and a new design method of ultrasonic biomaterial processor called self-circumrotated ultrasound cylinder is introduced in the paper. The design method has been used in the medicine manufactory. Three techniques are used in the design of the self-circumrotated cylinder: (1) The ultrasonic field of multi-direction radiation is set up in the processor. (2) The multi-frequency ultrasound is used in the structure. (3) The auto-circumrotation is realized in the ultrasonic processor. Comparing with some same-type of ultrasonic processors, there are three advantages of the design at least: (1) Ultrasonic intensity is stronger and the medicine extraction efficiency is 1.3-2.8 times as high as the efficiency of others. (2) The ultrasonic intensity is symmetrical in all over the processor. (3) The mechanical beater is replaced by the auto-circumrotation in the processor. It was proved that design of the ultrasonic equipment is optimized and the self-circumrotated ultrasound cylinder is more effective for Chinese traditional medicine extraction.
C1 [Wang, Baoqiang; Deng, Changjian; Li, Yiding; Wu, Maofang] Cehngdu Univ Informat & Technol, Inst Biomat Engn, Cehngdu, Sichuan, Peoples R China.
RP Wang, BQ (reprint author), Cehngdu Univ Informat & Technol, Inst Biomat Engn, Cehngdu, Sichuan, Peoples R China.
EM bqwang@cuit.edu.cn; jywmfang@126.com
FU NSFC [30470420]
FX The work is supported by the NSFC Research Project (30470420)
CR Doche ML, 2003, ULTRASON SONOCHEM, V10, P357, DOI 10.1016/S1350-4177(03)00099-3
   Feng R, 2002, ULTRASON SONOCHEM, V9, P231, DOI 10.1016/S1350-4177(02)00083-4
   SEONGNAM SK, 2003, ULTRASON SONOCHEM, V10, P139
   SUSLICK KS, 1998, ULTRASOUND ITS CHEM, P265
   WANB BQ, 2004, IEEE P ICIMAI, P763
   WANG BQ, 2003, J CHENGDU U INFORM T, V18, P25
   Wang J, 2004, ADV ATMOS SCI, V21, P662, DOI 10.1007/BF02915733
   YOKIO R, 2002, IEEE T ULTRASONICS, V49, P1260
NR 8
TC 2
Z9 2
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 1-4244-0465-7
PY 2006
BP 463
EP +
PG 3
WC Automation & Control Systems; Robotics
SC Automation & Control Systems; Robotics
GA BFE23
UT WOS:000241434600082
DA 2018-10-20
ER

PT B
AU Choi, YS
   Moon, JD
   Kwon, YS
   Lee, KS
AF Choi, Yong-Sung
   Moon, Jong-Dae
   Kwon, Young-Soo
   Lee, Kyung-Sup
GP IEEE
TI Three-dimensional bochip microarray using magnetic force interaction and
   self-asswmbly
SO IEEE NMDC 2006: IEEE NANOTECHNOLOGY MATERIALS AND DEVICES CONFERENCE
   2006, PROCEEDINGS
LA English
DT Proceedings Paper
CT IEEE Nanotechnology Materials and Devices Conference
CY OCT 22-25, 2006
CL Gyeongju, SOUTH KOREA
SP IEEE
DE hydrophili; biochip; magnetic force; self-assembly; DNA; hybridization
AB This paper describes a new constructing method of multifunctional biosensor using many kinds of biomaterials. A metal particle and an array were fabricated by photolithographic. The metal particles were in a multilayer structure (Au, Ti, and Ni). Biomaterials were immobilized on the metal particle. Sidewalls of patterned Ni dots on the array were covered by thick negative photoresist (SU-8), and the array was magnetized. The array and the particles were mixed in a buffer solution, and were arranged by magnetic force interaction and random fluidic self-assembly. Binding direction of the metal particle onto Ni dots was controlled by multilayer structure and direction of magnetization. A quarter of total Ni dots were covered by the particles. The binding direction of the particles was controllable, and condition of particles was almost with An surface on top. The particles were successfully arranged on the array. The biomaterial activities were detected by chemiluminescence and electrochemical methods.
C1 [Choi, Yong-Sung; Moon, Jong-Dae; Lee, Kyung-Sup] Dongshin Univ, Dept Elect Engn, Naju 520714, South Korea.
   [Kwon, Young-Soo] Dong A Univ, Dept Elect Engn, Busan 604714, South Korea.
RP Choi, YS (reprint author), Dongshin Univ, Dept Elect Engn, Naju 520714, South Korea.
EM yschoi67@dsu.ac.kr; jdmoon@dsu.ac.kr; yskwon@dau.ack.r; kslee@dsu.ac.kr
CR ANDREAS T, 1997, NATURE, V386, P162
   Antony S. D., 1996, LANGMUIR, V12, P1303
   JOHN JL, 1998, J AM CHEM SOC, V120, P6429
   KARRI LM, 1998, ANAL CHEM, V70, P1242
   WILHELM TS, 1998, J AM CHEM SOC, V120, P8267
NR 5
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-0540-4
PY 2006
BP 346
EP +
PG 2
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BHM97
UT WOS:000254409500101
DA 2018-10-20
ER

PT J
AU Vasita, R
   Katti, DS
AF Vasita, Rajesh
   Katti, Dhirendra S.
TI Nanofibers and their applications in tissue engineering
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Review
DE electrospinning; phase separation; self-assembly; nanofiber;
   biomaterial; tissue engineering; scaffold; drug delivery
ID MESENCHYMAL STEM-CELLS; PEPTIDE-AMPHIPHILE NANOFIBERS;
   CHEMICAL-VAPOR-DEPOSITION; MOLECULAR ARCHITECTURE; EXTRACELLULAR-MATRIX;
   BIOMEDICAL APPLICATIONS; ELECTROSPINNING PROCESS; POLYMERIC NANOFIBERS;
   OSTEOBLAST ADHESION; P(LLA-CL) NANOFIBER
AB Developing scaffolds that mimic the architecture of tissue at the nanoscale is one of the major challenges in the field of tissue engineering. The development of nanofibers has greatly enhanced the scope for fabricating scaffolds that can potentially meet this challenge. Currently, there are three techniques available for the synthesis of nanofibers: electrospinning, self-assembly, and phase separation. Of these techniques, electrospinning is the most widely studied technique and has also demonstrated the most promising results in terms of tissue engineering applications. The availability of a wide range of natural and synthetic biomaterials has broadened the scope for development of nanofibrous scaffolds, especially using the electrospinning technique. The three dimensional synthetic biodegradable scaffolds designed using nanofibers serve as an excellent framework for cell adhesion, proliferation, and differentiation. Therefore, nanofibers, irrespective of their method of synthesis, have been used as scaffolds for musculoskeletal tissue engineering (including bone, cartilage, ligament, and skeletal muscle), skin tissue engineering, vascular tissue engineering, neural tissue engineering, and as carriers for the controlled delivery of drugs, proteins, and DNA. This review summarizes the currently available techniques for nanofiber synthesis and discusses the use of nanofibers in tissue engineering and drug delivery applications.
C1 [Vasita, Rajesh; Katti, Dhirendra S.] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.
RP Katti, DS (reprint author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.
EM dsk@iitk.ac.in
CR ATALA A, 2002, METHODS TISSUE ENG
   BERNDT P, 1995, J AM CHEM SOC, V117, P9515, DOI 10.1021/ja00142a019
   BHATTARAI N, 2005, BIOMATERIALS
   Bhattarai SR, 2004, BIOMATERIALS, V25, P2595, DOI 10.1016/j.biomaterials.2003.09.043
   Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313
   Bruder SP, 2000, PRINCIPLES TISSUE EN, P683
   Che G, 1998, CHEM MATER, V10, P260, DOI 10.1021/cm970412f
   Clark R. A. F., 2000, PRINCIPLES TISSUE EN, P855
   COLWELL CW, 2001, CLIN ORTHOPAEDICS S, V391
   Cooper S. L., 2004, BIOMATERIALS SCI, P67
   Cui H, 2000, J APPL PHYS, V88, P6072, DOI 10.1063/1.1320024
   DiEdwardo CA, 1999, CLIN PLAST SURG, V26, P647
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Dzenis Y, 2004, SCIENCE, V304, P1917, DOI 10.1126/science.1099074
   Elias KL, 2002, BIOMATERIALS, V23, P3279, DOI 10.1016/S0142-9612(02)00087-X
   Fang X, 1997, J MACROMOL SCI PHYS, VB36, P169, DOI 10.1080/00222349708220422
   Fields GB, 1998, BIOPOLYMERS, V47, P143, DOI 10.1002/(SICI)1097-0282(1998)47:2<143::AID-BIP3>3.3.CO;2-P
   Fine EG, 2000, PRINCIPLES TISSUE EN, P785, DOI DOI 10.1016/B978-012436630-5/50060-X
   Fradkin L. G., 2000, PRINCIPLES TISSUE EN, P383
   Frenot A, 2003, CURR OPIN COLLOID IN, V8, P64, DOI 10.1016/S1359-0294(03)00004-9
   Fridrikh SV, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.144502
   Funhoff AM, 2005, J CONTROL RELEASE, V102, P711, DOI 10.1016/j.jconrel.2004.11.005
   Geng XY, 2005, BIOMATERIALS, V26, P5427, DOI 10.1016/j.biomaterials.2005.01.066
   Gersbach CA, 2004, BIOTECHNOL BIOENG, V88, P369, DOI 10.1002/bit.20251
   Goulet F, 2000, PRINCIPLES TISSUE EN, P711
   Hammel E, 2004, CARBON, V42, P1153, DOI 10.1016/j.carbon.2003.12.043
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Heller J., 2004, BIOMATERIALS SCI, P629
   HOERSTRUP SP, 2004, BIOMATERIAL SCI INTR, P712
   Hohman MM, 2001, PHYS FLUIDS, V13, P2201, DOI 10.1063/1.1383791
   HOHMAN MM, 2001, PHYS FLUIDS, V13, P1
   Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hwang J.J., 2002, METHODS TISSUE ENG, P741
   Jayaraman K, 2004, J NANOSCI NANOTECHNO, V4, P52, DOI 10.1166/jnn.2004.078
   Jia HF, 2002, BIOTECHNOL PROGR, V18, P1027, DOI 10.1021/bp020042m
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kameoka J, 2003, APPL PHYS LETT, V83, P371, DOI 10.1063/1.1592638
   Katti DS, 2004, J BIOMED MATER RES B, V70B, P286, DOI 10.1002/jbm.b.30041
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Khil MS, 2003, J BIOMED MATER RES B, V67B, P675, DOI 10.1002/jbm.b.10058
   Khil MS, 2005, J BIOMED MATER RES B, V72B, P117, DOI 10.1002/jbm.b.30122
   Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009
   Kim K, 2003, BIOMATERIALS, V24, P4977, DOI 10.1016/S0142-9612(03)00407-1
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Li D, 2005, NANO LETT, V5, P913, DOI 10.1021/nl0504235
   LI M, 2005, IN PRESS BIOMATERIAL
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Lin VS, 1999, TISSUE ENG, V5, P443, DOI 10.1089/ten.1999.5.443
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269
   Ma PX, 1999, J BIOMED MATER RES, V46, P60, DOI 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
   Ma ZW, 2005, BIOMATERIALS, V26, P2527, DOI 10.1016/j.biomaterials.2004.07.026
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Malkar NB, 2003, BIOMACROMOLECULES, V4, P518, DOI 10.1021/bm0256597
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   McKenzie JL, 2004, BIOMATERIALS, V25, P1309, DOI 10.1016/j.biomaterials.2003.08.006
   McPherson JM, 2000, PRINCIPLES TISSUE EN, P697
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Mo XM, 2004, MACROMOL SYMP, V217, P413, DOI 10.1002/masy.200451337
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Nair LS, 2004, BIOMACROMOLECULES, V5, P2212, DOI 10.1021/bm049759j
   PARENTEAU NL, 2000, PRINCIPLES TISSUE EN, P879
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Price RL, 2004, J BIOMED MATER RES A, V70A, P129, DOI 10.1002/jbm.a.30073
   Price RL, 2003, J BIOMED MATER RES A, V67A, P1284, DOI 10.1002/jbm.a.20011
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   RAMAY HR, 2003, BIOMATERIALS, V24, P3292
   Ramay HRR, 2004, BIOMATERIALS, V25, P5171, DOI 10.1016/j.biomaterials.2003.12.023
   RAYLEIGH JWG, 1882, LONDON EDINBURGH DUB, V44, P184
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Reneker DH, 2002, POLYMER, V43, P6785, DOI 10.1016/S0032-3861(02)00595-5
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Shields KJ, 2004, TISSUE ENG, V10, P1510, DOI 10.1089/1076327042500373
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   Shin YM, 2001, POLYMER, V42, P9955, DOI 10.1016/S0032-3861(01)00540-7
   SHIN YM, 2001, APPL PHYS LETT, V78, P1
   Skalak R, 1988, TISSUE ENG
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Stupp SI, 1997, SCIENCE, V276, P384, DOI 10.1126/science.276.5311.384
   Sundaray B, 2004, APPL PHYS LETT, V84, P1222, DOI 10.1063/1.1647685
   Teo KBK, 2003, ENCY NANOSCIENCE NAN
   Theron A, 2001, NANOTECHNOLOGY, V12, P384, DOI 10.1088/0957-4484/12/3/329
   Tu CF, 2003, POLYM ADVAN TECHNOL, V14, P565, DOI 10.1002/pat.370
   Tuli R, 2003, ARTHRITIS RES THER, V5, P235, DOI 10.1186/ar991
   Uematsu K, 2005, BIOMATERIALS, V26, P4273, DOI 10.1016/j.biomaterials.2004.10.037
   Um IC, 2004, BIOMACROMOLECULES, V5, P1428, DOI 10.1021/bm034539b
   Verreck G, 2003, PHARMACEUT RES, V20, P810, DOI 10.1023/A:1023450006281
   Verreck G, 2003, J CONTROL RELEASE, V92, P349, DOI 10.1016/S0168-3659(03)00342-0
   Wal R. L. V., 2002, APPL OPTICS, V41, P5678
   WANG X, 2002, MACROMOLECULAR SCI A, V39, P1251
   Wang XY, 2002, NANO LETT, V2, P1273, DOI 10.1021/nl020216u
   Webster TJ, 2005, BIOMATERIALS, V26, P953, DOI 10.1016/j.biomaterials.0204.03.040
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Woerdeman DL, 2005, BIOMACROMOLECULES, V6, P707, DOI 10.1021/bm0494545
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Xu CY, 2004, TISSUE ENG, V10, P1160, DOI 10.1089/ten.2004.10.1160
   Yang F, 2004, J BIOMAT SCI-POLYM E, V15, P1483, DOI 10.1163/1568562042459733
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yannas I., 2004, BIOMATERIALS SCI INT, P127
   Yarin AL, 2001, J APPL PHYS, V90, P4836, DOI 10.1063/1.1408260
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Yu YC, 1998, J AM CHEM SOC, V120, P9979, DOI 10.1021/ja981654z
   Yu YC, 1999, BIOCHEMISTRY-US, V38, P1659, DOI 10.1021/bi982315l
   Yu YC, 1996, J AM CHEM SOC, V118, P12515, DOI 10.1021/ja9627656
   Zeleny J, 1914, PHYS REV, V3, P69, DOI 10.1103/PhysRev.3.69
   Zeng J, 2005, BIOMACROMOLECULES, V6, P1484, DOI 10.1021/bm0492576
   ZHANG R, 2002, METHODS TISSUE ENG, P715
   Zhang RY, 2000, J BIOMED MATER RES, V52, P430, DOI 10.1002/1097-4636(200011)52:2<430::AID-JBM25>3.0.CO;2-L
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 120
TC 382
Z9 390
U1 6
U2 224
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1176-9114
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2006
VL 1
IS 1
BP 15
EP 30
DI 10.2147/nano.2006.1.1.15
PG 16
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 246ZR
UT WOS:000252047400003
PM 17722259
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Forti, FL
   Goissis, G
   Plepis, AMG
AF Forti, FL
   Goissis, G
   Plepis, AMG
TI Modifications on collagen structures promoted by 1,4-dioxane improve
   thermal and biological properties of bovine pericardium as a biomaterial
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE 1,4-dioxane; collagen; bovine pericardium; biomaterials; glutaraldehyde
ID CROSS-LINKING; SOLVENT ENVIRONMENT; SKIN COLLAGEN; TISSUE;
   GLUTARALDEHYDE; CALCIFICATION; BIOPROSTHESES; XENOGRAFT; GRAFTS
AB Collagen is a widely used raw material for biomaterial manufacture, which generally depends on chemical modifications of this fibrillar protein with cross-linking agents to improve biocompatibility and mechanical properties. However, cross-linking reduces the natural properties of collagen, such as low immune response, low toxicity as well as the ability to promote cellular growth and attachment. In this work, the modifications promoted by 1,4-dioxane solvent on the collagen present in native bovine pericardium (NBP) matrix routinely used in bioprosthesis manufacture, with or without subsequent cross-linking by glutaraldehyde, has been studied. The structural changes of NBP evaluated by scanning electron microscopy show that 1,4-dioxane induces a more homogeneous material by increasing aggregation of collagen fibers, while transmission scanning electron microscopy shows that natural collagen fibril arrangement, integrity, and the D-periodicity pattern are maintained by solvent treatments. Measurements of thermal stability and resistance to collagenase enzymatic digestion of NBP matrices treated with 1,4-dioxane show an increase in melting temperature and decrease in biodegradability, as compared to native pericardium. Cross-linking with glutaraldehyde improves all the analyzed NBP properties, which are not impaired by previous treatment with 1,4-dioxane. Histological evaluation of NBP submitted to 1,4-dioxane treatment shows lower lipid and cell contents and improvement in other morphologic characteristics compared to native pericardium. Altogether, these results suggest the use of 1,4-dioxane organic solvent as an alternative non-cross-linking treatment for direct utilization on rich collagen matrices, resulting in materials with improved biocompatibility and physicochemical properties suitable for tissue engineering.
C1 Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Quim Sao Carlos, Dept Quim & Fis Mol, BR-13560970 Sao Paulo, Brazil.
RP Forti, FL (reprint author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil.
EM flforti@quim.iq.usp.br
RI Forti, Fabio/F-8085-2012; Plepis, Ana/J-2559-2012
OI Forti, Fabio/0000-0002-2278-6396; Plepis, Ana/0000-0002-4360-8433
CR ANFINSEN CB, 1962, ADVANCES PROTEIN CHE, V17, P1
   BERNACCA GM, 1992, BIOMATERIALS, V13, P345
   Bet MR, 2001, BIOMACROMOLECULES, V2, P1074, DOI 10.1021/bm0001188
   BRAILE DM, 1990, THESIS ESCOLA PAULIS, P14
   CROFTS CE, 1988, J BIOMED MATER RES, V22, P89, DOI 10.1002/jbm.820220202
   CROFTS CE, 1988, J MATER SCI, V2, P1510
   DELUSTRO F, 1990, CLIN ORTHOP RELAT R, P263
   Duncan AC, 1996, BIOMATERIALS, V17, P1849, DOI 10.1016/0142-9612(96)00006-3
   FLANDIN F, 1984, BIOCHIM BIOPHYS ACTA, V791, P205, DOI 10.1016/0167-4838(84)90010-4
   Goissis G, 1998, ARTIF ORGANS, V22, P210, DOI 10.1046/j.1525-1594.1998.06006.x
   Goissis G, 2000, ARTIF ORGANS, V24, P217, DOI 10.1046/j.1525-1594.2000.06537.x
   GOISSIS G, 2001, ARTIF ORGANS, V25, P822
   Goissis G, 1994, Patent No., Patent No. [BR PI 9.405.043-0, 94050430]
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   Gratzer PF, 1996, J BIOMED MATER RES, V31, P533, DOI 10.1002/(SICI)1097-4636(199608)31:4<533::AID-JBM14>3.0.CO;2-H
   HAYASHI T, 1972, J BIOCHEM-TOKYO, V72, P749, DOI 10.1093/oxfordjournals.jbchem.a129953
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   Imamura E, 1989, J Card Surg, V4, P50, DOI 10.1111/j.1540-8191.1989.tb00256.x
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Martins VCA, 1998, ARTIF ORGANS, V22, P215, DOI 10.1046/j.1525-1594.1998.06004.x
   NA GC, 1986, BIOCHEMISTRY-US, V25, P967, DOI 10.1021/bi00353a004
   NAIMARK WA, 1995, J MATER SCI-MATER M, V6, P235, DOI 10.1007/BF00146862
   Park KD, 1997, BIOMATERIALS, V18, P47, DOI 10.1016/S0142-9612(96)00096-8
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   PINERI MH, 1978, BIOPOLYMERS, V17, P2799, DOI 10.1002/bip.1978.360171205
   Probst M, 1997, BRIT J UROL, V79, P505, DOI 10.1046/j.1464-410X.1997.00103.x
   RAMACHANDRAN GN, 1967, TREATISE COLLAGEN, V1, P367
   SCHOEN FJ, 1986, AM J PATHOL, V123, P134
   STAGEMAN H, 1967, CLIN CHIM ACTA, V18, P267
   Stark GB, 1998, BIOL MATRICES TISSUE, P197
   Valente M, 1998, J HEART VALVE DIS, V7, P180
   WOODROOF EA, 1978, J BIOENG, V2, P1
   YOSHIOCA SA, 1994, THESIS U SAO PAULO S, P23
NR 34
TC 6
Z9 7
U1 2
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JAN
PY 2006
VL 20
IS 3
BP 267
EP 285
DI 10.1177/0885328206054048
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 002ZY
UT WOS:000234652600006
PM 16364966
DA 2018-10-20
ER

PT J
AU Yang, XH
   Zhu, WL
   Yan, JF
AF Yang, XH
   Zhu, WL
   Yan, JF
TI A time-temperature rheological study of konjac glucomannan hydrocolloid
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE biomaterial; konjac glucomannan; hydrocolloid; time-temperature
   superposition
ID BLEND MEMBRANES
AB Konjac glucomannan (KGM) is one of the most versatile soluble biomaterials having wide-ranging applications. The shear storage, G', and loss, G", moduli of this hydrocolloid were recorded as functions of angular frequency varying from 0.1 to 100.0 rad/s and temperature from 5 to 50 degrees C. It was found that both G' and G" mainly increase with angular frequency in the range from 0.1 to 100 rad/s. As the temperature increases from 5 to 95 degrees C, the values of G' and G" decrease. A novel criterion for the thermorheologically simple material, and a procedure to calculate the shift factor from the angular frequency sweep and temperature ramp data were presented. By these methods, the KGM hydrocolloid is found to obey the TTS principle as log G" and log G' are less than 1.529 and 1.436, respectively. The Williams-Landel-Ferry equation can describe the shift factor of the KGM hydrocolloid.
C1 Wuhan Polytech Univ, Dept Biotechnol & Chem Engn, Wuhan 430023, Peoples R China.
RP Yang, XH (reprint author), Wuhan Polytech Univ, Dept Biotechnol & Chem Engn, Wuhan 430023, Peoples R China.
EM yangxh88@yahoo.com.cn
CR ARVILL A, 1995, AM J CLIN NUTR, V61, P585
   DOI K, 1979, LANCET, V1, P987
   Du J, 2005, J BIOMED MATER RES B, V72B, P299, DOI 10.1002/jbm.b.30156
   FERRY JD, 1980, VISCOELASTIC PROPERT
   Fritz G, 2003, J RHEOL, V47, P303, DOI 10.1122/1.1538608
   Haley JC, 2004, COLLOID POLYM SCI, V282, P793, DOI 10.1007/s00396-004-1092-5
   Kim SO, 1999, POLYMER, V40, P6443, DOI 10.1016/S0032-3861(98)00852-0
   Madbouly SA, 2004, J MACROMOL SCI PHYS, VB43, P471, DOI 10.1081/MB-120029782
   Nishinari K, 2003, CURR OPIN COLLOID IN, V8, P396, DOI 10.1016/S1359-0294(03)00099-2
   OHYA Y, 1994, CARBOHYD POLYM, V25, P123, DOI 10.1016/0144-8617(94)90148-1
   WALSH DE, 1984, INT J OBESITY, V8, P289
   WILLIAMS ML, 1955, J AM CHEM SOC, V77, P3701, DOI 10.1021/ja01619a008
   WU WX, 1998, ACTA BOT BOREAL OCCI, V18, P300
   Yang G, 2002, J MEMBRANE SCI, V201, P161, DOI 10.1016/S0376-7388(01)00727-X
   Yang GA, 1998, J MEMBRANE SCI, V139, P47
   ZHOU X, 1995, MODERN CHEM IND, V15, P15
NR 16
TC 7
Z9 7
U1 1
U2 6
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2006
VL 17
IS 1-2
BP 53
EP 59
DI 10.1163/156856206774879063
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 000UL
UT WOS:000234487800004
PM 16411598
DA 2018-10-20
ER

PT J
AU Mikhail, A
   Sharifpoor, S
   Amsden, B
AF Mikhail, A
   Sharifpoor, S
   Amsden, B
TI Initiator structure influence on thermal and rheological properties of
   oligo(epsilon-caprolactone)
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE thermoplastics; biodegradable oligomers; melt viscosity; crystallinity
ID EPSILON-CAPROLACTONE; POLYMERIZATION; BLENDS; TAXOL
AB Biodegradable thermoplastic oligomers have potential as biomaterials for tissue augmentation and drug-delivery applications. One means of obtaining such a biomaterial is through the ring-opening polymerization of E-caprolactone using an alcohol initiator. In this paper we continue to examine the influence of the structure of the initiator used on the thermal and rheological properties of oligo(epsilon-caprolactone). Specifically, primary and secondary pentanol, and cis- and trans-pentenol were studied as initiators in the preparation of oligomers of constant molecular weight. In agreement with previous work. the secondary conformer yielded higher inch viscosities, lower degrees of crystallinity and lower glass transition temperatures. The cis conformer produced the lowest melt viscosity: however. the activation energy for flow was hi-her than obtained previously with oleyl alcohol. This result was attributed to the alkane chain lengths on either side of the cis double bond in the initiator. The order of melt viscosity increased with initiator conformer as follows: cis, trans, primary and secondary. The results were explained in terms of oligomer chain flexibility in the melt.
C1 Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
RP Amsden, B (reprint author), Queens Univ, Dept Chem Engn, Dupuis Hall, Kingston, ON K7L 3N6, Canada.
EM Amsden@chee.queensu.ca
OI Mikhail, Andrew/0000-0001-9206-5765
CR Amsden B, 2004, BIOMACROMOLECULES, V5, P637, DOI 10.1021/bm034457n
   Bezwada RS, 1997, United States Patent US, Patent No. [5653992, 5,653,992]
   BEZWADA RS, 1995, Patent No. 5442033
   BRODE GL, 1972, J MACROMOL SCI CHEM, VA  6, P1109, DOI 10.1080/10601327208056888
   Carreau P. J., 1997, RHEOLOGY POLYM SYSTE
   CRESCENZI V, 1972, EUR POLYM J, V8, P449, DOI 10.1016/0014-3057(72)90109-7
   DAVIS PA, 1995, Patent No. 5384333
   Guo Q, 2001, POLYMER, V42, P6031, DOI 10.1016/S0032-3861(01)00093-3
   Hatefi A, 2004, J PHARM SCI-US, V93, P1195, DOI 10.1002/jps.20045
   SCHINDLER A, 1982, J POLYM SCI POL CHEM, V20, P319, DOI 10.1002/pol.1982.170200206
   SCOPELIANOS AG, 1998, Patent No. 5728752
   SCOPELIANOS AG, 1998, Patent No. 5824333
   Storey RF, 2002, MACROMOLECULES, V35, P1504, DOI 10.1021/ma010986c
   Tomkins A, 2005, J BIOMAT SCI-POLYM E, V16, P1009, DOI 10.1163/1568562054414694
   Winternitz CI, 1996, PHARMACEUT RES, V13, P368, DOI 10.1023/A:1016032207246
   Zhang XC, 1996, INT J PHARM, V137, P199, DOI 10.1016/0378-5173(96)04521-8
NR 16
TC 2
Z9 2
U1 0
U2 2
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2006
VL 17
IS 3
BP 291
EP 301
DI 10.1163/156856206775997278
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 041XT
UT WOS:000237491000002
PM 16689016
DA 2018-10-20
ER

PT J
AU Porjazoska, A
   Yilmaz, OK
   Baysal, K
   Cvetkovska, M
   Sirvanci, S
   Ercan, F
   Baysal, BM
AF Porjazoska, A
   Yilmaz, OK
   Baysal, K
   Cvetkovska, M
   Sirvanci, S
   Ercan, F
   Baysal, BM
TI Synthesis and characterization of poly(ethylene
   glycol)-poly(D,L-lactide-co-glycolide) poly(ethylene glycol) tri-block
   co-polymers modified with collagen: a model surface suitable for cell
   interaction
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE poly(D,L-lactide-co-glycolide); poly(ethylene glycol); collagen; cell
   viability; fibroblast; cell culture; biomaterial
ID ACRYLIC-ACID; ADHESION; BIOMATERIALS; HYDROGELS; PEPTIDE; FILMS
AB This study focused oil the synthesis and characterization of poly(ethylene glycol)-poly(D,L-lactide-co-glycolide)-poly(ethylene glycol) tri-block co-polymer (PEG-PDI-LG-PEG), and its modification with type-I collagen. To this aim, a PEG-PDLLG-PEG tri-block co-polymer was synthesized in two steps by reacting poly(ethylene glycol)bis(carboxymethyl)ether with thionyl chloride to obtain all acyl-halide-terminated poly(ethylene glycol) and Subsequently Coupling this compound to hydroxyl-terminated poly(D,L-lactide-co-glycolide) (PDLLG). The new carboxyl end-groups of PEG-PDLLG-PEG were subsequently reacted with N-hydroxysuccinimide (NHS) in the presence of the hetero-bifunctional cross-linking agent dicyclohexylcarbodiimide (DCC) in order to activate the co-polymer for coupling with collagen. PEG-PDLLG-PEG and its activated form PEG-PDLLG-NHS were characterized by Fourier transform infrared (FT-IR) and H-1-NMR spectroscopy. Molecular weights of the polymeric products were determined by SEC. Type-I collagen in phosphate buffer was reacted with PEG-PDLLG-NHS. The resultant product. PEG-PDLLG-Col, was characterized by FT-IR. This biopolymer was used for preparation of a suitable Surface for cell growth experiment. To measure the degree of cell proliferation, the films prepared with PDLLG. PEG-PDLLG-NHS and PEG-PDLLG-Col were seeded with L929 mouse fibroblasts. Cell growth was followed by SEM photography and quantitated by the neutral red uptake assay. It was shown that the attachment of collagen significantly increased the number of cells oil the co-polymers.
C1 Bogazici Univ, Dept Chem Engn, TR-81815 Bebek, Turkey.
   Marmara Univ, Fac Med, Dept Histol & Embryol, TR-34668 Istanbul, Turkey.
   Res Inst Genet Engn & Biotechnol, TUBITAK, TR-41470 Gebze, Turkey.
   Univ St Cyril & Methudius, Fac Technol & Met, Skopje 91000, Macedonia.
RP Baysal, BM (reprint author), Bogazici Univ, Dept Chem Engn, TR-81815 Bebek, Turkey.
EM bmbaysal@hotmail.com
CR Cai Q, 2002, POLYMER, V43, P3585, DOI 10.1016/S0032-3861(02)00197-0
   Caillol S, 2003, MACROMOLECULES, V36, P1118, DOI 10.1021/ma021187c
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Csucs G, 2003, BIOMATERIALS, V24, P1713, DOI 10.1016/S0142-9612(02)00568-9
   DRUMHELLER PD, 1995, J BIOMED MATER RES, V29, P207, DOI 10.1002/jbm.820290211
   Fu BX, 2002, POLYMER, V43, P5527, DOI 10.1016/S0032-3861(02)00389-0
   Guo YL, 1998, J BIOL CHEM, V273, P4027, DOI 10.1074/jbc.273.7.4027
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Jeong JH, 2000, COLLOID SURFACE B, V18, P371, DOI 10.1016/S0927-7765(99)00162-9
   Jo S, 2000, POLYMER, V41, P7595, DOI 10.1016/S0032-3861(00)00117-8
   Lanza R. P., 1997, PRINCIPLES TISSUE EN
   Lee SD, 1996, BIOMATERIALS, V17, P1599, DOI 10.1016/0142-9612(95)00316-9
   Li S., 1999, ENCY CONTROLLED DRUG, V1, P71
   PENCO M, 2001, J APPL POLYM SCI, V78, P1721
   Seretoudi G, 2002, POLYMER, V43, P5405, DOI 10.1016/S0032-3861(02)00433-0
   Suggs LJ, 1999, J BIOMED MATER RES, V46, P22, DOI 10.1002/(SICI)1097-4636(199907)46:1<22::AID-JBM3>3.0.CO;2-R
   Suggs LJ, 1999, BIOMATERIALS, V20, P683, DOI 10.1016/S0142-9612(98)00226-9
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Wan YQ, 2003, BIOMATERIALS, V24, P2195, DOI 10.1016/S0142-9612(03)00107-8
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
NR 22
TC 17
Z9 18
U1 0
U2 27
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2006
VL 17
IS 3
BP 323
EP 340
DI 10.1163/156856206775997296
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 041XT
UT WOS:000237491000004
PM 16689018
DA 2018-10-20
ER

PT J
AU Abbasi, F
   Mirzadeh, H
   Simjoo, M
AF Abbasi, F
   Mirzadeh, H
   Simjoo, M
TI Hydrophilic interpenetrating polymer networks of poly(dimethyl siloxane)
   (PDMS) as biomaterial for cochlear implants
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article; Proceedings Paper
CT IUPAC Macro 2004 Meeting
CY JUL, 2004
CL Paris, FRANCE
SP IUPAC
DE cochlear implant; poly(dimethyl siloxane); poly(acrylic acid);
   interpenetrating polymer network; cell behavior
ID VISCOELASTIC PROPERTIES; METHACRYLATE); FIBRONECTIN; ELECTRODES;
   MODIOLUS
AB Poly(dimethyl siloxane) (PDMS) was bulk-modified to develop a new intra-cochlear electrode that can closely hug the inner wall of scala tympani (ST). The hydrophilicity of bulk and surface of PDMS was changed using a structural method for preparation of interpenetrating polymer networks (IPNs). A series of IPNs, based on PDMS and poly(acrylic acid) (PAAc), was synthesized and characterized by means of attenuated total reflectance Fourier transform infrared spectroscopy, water contact-an,de measurement, dynamic mechanical thermal analysis and peel strength tests. The performances of actual-sized fabricated electrodes were assessed inside a transparent model of ST, which was filled with saline. The cell behavior of L929 fibroblasts on materials was studied in vitro.
C1 Sahand Univ Technol, Res Ctr Polymer Mat, Tabriz, Iran.
   Iran Polymer & Petrochem Inst, Tehran, Iran.
RP Abbasi, F (reprint author), Sahand Univ Technol, Res Ctr Polymer Mat, POB 51335-1996, Tabriz, Iran.
EM f.abbasi@sut.ac.ir
OI Abbasi, Farhang/0000-0001-9770-4255
CR Abbasi F, 2004, INT J ADHES ADHES, V24, P247, DOI 10.1016/j.ijadhadh.2003.10.006
   Abbasi F, 2003, J POLYM SCI POL PHYS, V41, P2145, DOI 10.1002/polb.10559
   Abbasi F, 2002, J APPL POLYM SCI, V86, P3480, DOI 10.1002/app.10774
   Abbasi F, 2002, J APPL POLYM SCI, V85, P1825, DOI 10.1002/app.10609
   ABBASI F, 2004, Patent No. 1425940
   *ASTM, 1993, 90393 ASTM
   Cords SM, 2000, AM J OTOL, V21, P212, DOI 10.1016/S0196-0709(00)80011-3
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   Hansen C., 1981, US Patent, Patent No. [4,284,085, 4284085]
   HOCHMAIR IJ, 1982, Patent No. 4357497
   JOLLY C, 1999, Patent No. 5999859
   Kuzma J., 1996, US Patent, Patent No. [5,578,084, 5578084]
   KUZMA JA, 2000, Patent No. 6078841
   KUZMA JA, 1997, Patent No. 5645585
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Mirzadeh H, 2004, J BIOMED MATER RES B, V68B, P191, DOI 10.1002/jbm.b.20011
   NISHI S, 1985, MACROMOLECULES, V18, P1519, DOI 10.1021/ma00150a001
   PARKER JL, 1997, Patent No. 5653742
   PETTIT DK, 1994, J BIOMED MATER RES, V28, P685, DOI 10.1002/jbm.820280605
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   ROY RK, 2001, DESIGN EXPT USING TA, P14
   SELDON HL, 1994, BIOMATERIALS, V15, P1161, DOI 10.1016/0142-9612(94)90237-2
   SPERLING LH, 1997, POLYM MULTICOMPONENT, P335
NR 23
TC 23
Z9 23
U1 2
U2 17
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2006
VL 17
IS 3
BP 341
EP 355
DI 10.1163/156856206775997287
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 041XT
UT WOS:000237491000005
PM 16689019
DA 2018-10-20
ER

PT J
AU Zhao, X
AF Zhao, X.
TI Synthesis and characterization of a novel hyaluronic acid hydrogel
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article; Proceedings Paper
CT Hyaluronan 2003 Conference
CY OCT, 2003
CL Cleveland, OH
DE hyaluronic acid (hyaluronan); cross-linking; rheology; biostability;
   degradation; viscoelasticity
ID DRUG-DELIVERY; CROSS-LINKING
AB Hyaluronic acid (hyaluronan, HA) has many medical applications as a biomaterial. To enhance its biostability, a novel hydrogel of cross-linked hyaluronic acid was prepared using a double cross-linking process, which involves building cross-linkages between hydroxyl group pairs and carboxyl group pairs. The present study explored a number of cross-linking processes in order to obtain different degrees of cross-linking, which were evaluated by the measurement of water absorption capacity as an index of the gel network density. To gain a better understanding of the stability of the gel, the chemical structure and particularly the rheological behaviour of the crosslinked HA. which included the influences of factors, such as degree of cross-linking, HA concentration and gel particle size, were investigated. The in vitro biostability against hyaluronidase and free radical degradation was tested to show that the cross-linked hydrogel had improved resistance to in vitro hyaluronidase and free radical degradation.
C1 Mentor Biopolymers Ltd, Edinburgh EH14 4AP, Midlothian, Scotland.
RP Zhao, X (reprint author), Mentor Biopolymers Ltd, Heriot Watt Res Pk, Edinburgh EH14 4AP, Midlothian, Scotland.
EM xzhao@mentorcorp.com
CR Ambrosio L, 1999, J MACROMOL SCI PURE, VA36, P991, DOI 10.1080/10601329908951195
   BALAZS EA, 1986, Patent No. 4713448
   BALAZS EA, 1986, Patent No. 46056691
   Barbucci R, 2000, J BIOMAT SCI-POLYM E, V11, P383, DOI 10.1163/156856200743779
   Bellini D., 2000, [No title captured], Patent No. [W00001733 (Al), 0001733, WO0001733A1]
   CALLEGARO L, 2000, Patent No. 0001394
   COMPER WD, 1978, PHYSIOL REV, V58, P255
   DELBELDER AN, 1989, Patent No. 0190215
   DELINGER JL, 1998, CHEM BIOL MED APPL H, P235
   DELLA VF, 1989, Patent No. 0216453
   DROBNIK J, 1991, ADV DRUG DELIVER REV, V7, P295, DOI 10.1016/0169-409X(91)90008-Z
   Hutmacher DW, 2001, ANN ACAD MED SINGAP, V30, P183
   MALSON T, 1987, GIOMATERIALS CLIN AP, P345
   MORRIS ER, 1980, J MOL BIOL, V138, P383, DOI 10.1016/0022-2836(80)90294-6
   PAPE LG, 1980, OPHTHALMOLOGY, V87, P699
   Phillips GO, 1998, WENN GR INT, V72, P93
   STRACHAN RK, 1990, ANN RHEUM DIS, V49, P949, DOI 10.1136/ard.49.11.949
   Tomihata K, 1997, BIOMATERIALS, V18, P189, DOI 10.1016/S0142-9612(96)00116-0
   Tomihata K, 1997, J BIOMED MATER RES, V37, P243
   Tomihata K, 1997, J POLYM SCI POL CHEM, V35, P3553, DOI 10.1002/(SICI)1099-0518(19971130)35:16<3553::AID-POLA22>3.0.CO;2-D
   Vercruysse KP, 1998, CRIT REV THER DRUG, V15, P513
   WELSH EJ, 1980, J MOL BIOL, V138, P375, DOI 10.1016/0022-2836(80)90293-4
   YUI N, 1992, J CONTROL RELEASE, V22, P105
   ZHAO X, 2000, Patent No. 0046253
   Zhao XB, 2002, J MATER SCI-MATER M, V13, P11, DOI 10.1023/A:1013618115163
NR 25
TC 24
Z9 24
U1 2
U2 34
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2006
VL 17
IS 4
BP 419
EP 433
DI 10.1163/156856206776374115
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 049QE
UT WOS:000238030600003
PM 16768293
DA 2018-10-20
ER

PT J
AU Bahadur, KCR
   Aryal, S
   Bhattarai, SR
   Bhattarai, N
   Kim, CH
   Kim, HY
AF Bahadur, KCR
   Aryal, S
   Bhattarai, SR
   Bhattarai, N
   Kim, CH
   Kim, HY
TI Stabilization of gold nanoparticles by hydrophobically-modified
   polycations
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE polycation; gold nanoparticles; chitosan; self-assembly; biomaterial
ID CHITOSAN NANOCOMPOSITES; CHITIN; ACETYLATION; DERIVATIVES; MATRICES;
   SYSTEM; WATER; ACID
AB Surface-modified gold nanoparticles have pronounced benefits in the biomedical field due to their significant interaction with delivery materials. In the present study we used hydrophobically-modified polycations (i.e., N-acylated chitosan) to stabilize gold nanoparticles. Aliphatic hydrophobic groups, having carbon chains of different lengths, were first grafted onto the backbone of chitosan by N-acylation with fatty-acid chlorides in order to increase its hydrophobicity. Gold nanoparticles stabilized with native chitosan and N-acylated chitosan were prepared by the graft-onto approach. Chemical modification and its quantification were studied by Fourier-transform infrared (FT-IR) spectroscopy. Further, the stabilized gold nanoparticles were characterized by different physico-chemical techniques such as UV-Vis, FT-IR, TEM, TGA and DLS. Spectral studies of gold nanoparticles show the backbone and the side chain functional groups of chitosan were not cleaved during the conjugation process. TEM observations revealed that the modified chitosan gold nanoparticles were well dispersed and spherical in shape with average size around 10-12 nm in triply-distilled water at pH 7.4, whereas the native chitosan gold nanoparticles appeared as clusters with 9.9 nm as average diameter and were dispersed only in dilute HCl. The size of modified chitosan gold nanoparticles varied depending on the length of grafting molecules.
C1 Chonbuk Natl Univ, Dept Bio Nanosyst Engn, Chonju 561756, South Korea.
   Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA.
   Chonbuk Natl Univ, Dept Text Engn, Chonju 561756, South Korea.
RP Kim, HY (reprint author), Chonbuk Natl Univ, Dept Bio Nanosyst Engn, Chonju 561756, South Korea.
EM khy@moak.chonbuk.ac.kr
RI Kim, Hak Yong/G-3826-2013; Aryal, Santosh/E-7310-2013
OI Kim, Hak Yong/0000-0002-4133-124X; KC, Remant/0000-0002-3554-7247;
   Aryal, Santosh/0000-0002-7807-6342
CR ARYAL S, 2006, IN PRESS SPECTROCH A
   ARYAL S, 2006, IN PRESS MAT CHEM PH
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Brewer SH, 2002, LANGMUIR, V18, P4460, DOI 10.1021/la025613z
   Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801
   Chakrabarti R, 2003, J AM CHEM SOC, V125, P12531, DOI 10.1021/ja035399g
   Coche-Guerente L, 2005, ELECTROCHIM ACTA, V50, P2865, DOI 10.1016/j.electacta.2004.11.040
   Corbierre MK, 2001, J AM CHEM SOC, V123, P10411, DOI 10.1021/ja0166287
   Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078
   Esumi K, 2003, COLLOID SURFACE B, V32, P117, DOI 10.1016/S0927-7765(03)00151-6
   GRABAR KC, 1995, ANAL CHEM, V67, P735, DOI 10.1021/ac00100a008
   HARRIS JM, 1984, J POLYM SCI POL CHEM, V22, P341, DOI 10.1002/pol.1984.170220207
   HOFFMAN AJ, 1992, J PHYS CHEM-US, V96, P5546, DOI 10.1021/j100192a067
   Huang HZ, 2005, J COLLOID INTERF SCI, V282, P26, DOI 10.1016/j.jcis.2004.08.063
   Huang HZ, 2003, COLLOID SURFACE A, V226, P77, DOI 10.1016/S0927-7757(03)00382-0
   Kolhe P, 2003, BIOMACROMOLECULES, V4, P173, DOI 10.1021/bm025689+
   Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7
   Kwon S, 2003, LANGMUIR, V19, P10188, DOI 10.1021/la0350608
   Le Tien C, 2003, J CONTROL RELEASE, V93, P1, DOI 10.1016/S0168-3659(03)00327-4
   Lee KY, 1998, J CONTROL RELEASE, V51, P213, DOI 10.1016/S0168-3659(97)00173-9
   Mao JS, 2003, BIOMATERIALS, V24, P1621, DOI 10.1016/S0142-9612(02)00549-5
   MOORE GK, 1980, INT J BIOL MACROMOL, V2, P115, DOI 10.1016/0141-8130(80)90040-9
   OKAMOTO Y, 1993, J VET MED SCI, V55, P739, DOI 10.1292/jvms.55.739
   Qu X, 2000, POLYMER, V41, P4589, DOI 10.1016/S0032-3861(99)00685-0
   Sashiwa H, 2002, BIOMACROMOLECULES, V3, P1126, DOI 10.1021/bm0200480
   SASHIWA H, 1990, INT J BIOL MACROMOL, V12, P295, DOI 10.1016/0141-8130(90)90016-4
   Teranishi T, 1998, ADV MATER, V10, P596, DOI 10.1002/(SICI)1521-4095(199805)10:8<596::AID-ADMA596>3.0.CO;2-Y
   Tokura S, 1997, MACROMOL SYMP, V120, P1, DOI 10.1002/masy.19971200103
   Wyrwa D, 2002, NANO LETT, V2, P419, DOI 10.1021/nl0157086
   Yamamoto H, 2000, MACROMOL CHEM PHYSIC, V201, P84, DOI 10.1002/(SICI)1521-3935(20000101)201:1<84::AID-MACP84>3.0.CO;2-Y
NR 32
TC 15
Z9 16
U1 2
U2 7
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2006
VL 17
IS 5
BP 579
EP 589
DI 10.1163/156856206776986279
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 053UH
UT WOS:000238330600006
PM 16800156
DA 2018-10-20
ER

PT J
AU Nederberg, F
   Watanabe, J
   Ishihara, K
   Hilborn, J
   Bowden, T
AF Nederberg, Fredrik
   Watanabe, Junji
   Ishihara, Kazuhiko
   Hilborn, Jons
   Bowden, Tim
TI Biocompatible and biodegradable phosphorylcholine ionomers with reduced
   protein adsorption and cell adhesion
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE biodegradable polymers; biomimetic; protein adsorption; cell adhesion;
   amphiphilic; ionomer; phosphorylcholine
ID HYDROPHOBIC SURFACES; PHOSPHOLIPID POLYMER; PLASMA-PROTEINS; FIBRINOGEN;
   BLOOD; PLATELETS; BINDING; BIOMATERIAL; ACTIVATION; COPOLYMERS
AB In this paper a recently developed biodegradable phosphorylcholine ionomer (PC ionomer) was evaluated in different biological environments with a focus on the adsorption of proteins (fibrinogen) and the adhesion of cells. Out results have shown that the polar phosphoryl choline (PC) group may be enriched at the surface of cast films with an added hydrophilic environment. X-ray photoelectron spectroscopy confirmed the surface depletion of PC groups in dry conditions, as nitrogen and phosphorous atoms were found in the bulk of the material but not at the outermost surface layer. The surface enrichment leads to a strongly hydrophilic surface that prevents the adsorption of proteins and reduces the adhesion of cells. The non-functional and hydrophobic reference poly(trimethylene carbonate) (PTMC) adsorbs both proteins and cells, thus the wetting and low adhesion behavior of the PC ionomer can be attributed to the introduced PC functionality. Since the in vivo acceptance of biomaterials is determined by their ability to withstand protein adsorption the PC ionomer described in this paper is highly interesting for a number of in vivo applications in which the adsorption of proteins may be critical, for example, blood contact events.
C1 Uppsala Univ, Dept Chem Mat, S-75121 Uppsala, Sweden.
   Univ Tokyo, Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan.
RP Bowden, T (reprint author), Uppsala Univ, Dept Chem Mat, Box 358, S-75121 Uppsala, Sweden.
EM tim.bowden@polymer.uu.se
OI Hilborn, Jons/0000-0001-6947-9601; Melander Bowden,
   Tim/0000-0003-0851-4316
CR Andersson J, 2003, J BIOMED MATER RES A, V67A, P458, DOI 10.1002/jbm.a.10104
   BAGNALL RD, 1978, J BIOMED MATER RES, V12, P203, DOI 10.1002/jbm.820120206
   BAGNALL RD, 1978, J BIOMED MATER RES, V12, P707, DOI 10.1002/jbm.820120511
   Brunius CF, 2001, MACROMOL RAPID COMM, V22, P1474, DOI 10.1002/1521-3927(20011201)22:18<1474::AID-MARC1474>3.0.CO;2-7
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   DIMINNO G, 1983, BLOOD, V61, P140
   DURRANI AA, 1986, BIOMATERIALS, V7, P121, DOI 10.1016/0142-9612(86)90068-2
   Eberhart RC, 2003, J BIOMAT SCI-POLYM E, V14, P299, DOI 10.1163/156856203321478838
   ENGBERS GH, 1991, INT J ARTIF ORGANS, V14, P199
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Hunt BJ, 1997, BLOOD COAGUL FIBRIN, V8, P223, DOI 10.1097/00001721-199706000-00003
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Iwasaki Y, 1998, J BIOMAT SCI-POLYM E, V9, P801, DOI 10.1163/156856298X00163
   KADOMA Y, 1978, KOBUNSHI RONBUNSHU, V35, P423, DOI 10.1295/koron.35.423
   KORNECKI E, 1981, J BIOL CHEM, V256, P5696
   KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6
   MCLEAN J, 1914, AM J PHYSIOL, V41, P250
   MORRA M, 2001, WATER BIOMATERIALS S, V12, P307
   Nederberg F, 2005, POLYM ADVAN TECHNOL, V16, P108, DOI 10.1002/pat.556
   Nederberg F, 2004, J AM CHEM SOC, V126, P15350, DOI 10.1021/ja0457314
   Nederberg F, 2004, MACROMOLECULES, V37, P954, DOI 10.1021/ma035433b
   PAYNE MS, 1987, J BIOMED MATER RES, V21, P843, DOI 10.1002/jbm.820210703
   Pego AP, 2003, J MATER SCI-MATER M, V14, P767, DOI 10.1023/A:1025084304766
   PLOW EF, 1980, BLOOD, V56, P553
   Salzman E W, 1969, J Biomed Mater Res, V3, P69
   Smith G., 1985, Parasitology Today, V1, P76, DOI 10.1016/0169-4758(85)90047-X
   Watanabe J, 2005, BIOMACROMOLECULES, V6, P1797, DOI 10.1021/bm050138f
NR 27
TC 14
Z9 14
U1 2
U2 15
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2006
VL 17
IS 6
BP 605
EP 614
DI 10.1163/156856206777346304
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 067VX
UT WOS:000239331800001
PM 16892723
DA 2018-10-20
ER

PT J
AU Yoshida, M
   Babensee, JE
AF Yoshida, Mutsumi
   Babensee, Julia E.
TI Molecular aspects of microparticle phagocytosis by dendritic cells
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE biomaterial; dendritic cells; microparticle; phagocytosis
ID MACROPHAGES IN-VITRO; WEAR DEBRIS; HUMAN BLOOD;
   POLY(LACTIDE-CO-GLYCOLIDE) MICROSPHERES; PROTEIN ADSORPTION; PARTICLE
   UPTAKE; MONOCYTE; MATURATION; ANTIGEN; OSTEOBLASTS
AB The ability of immature dendritic cells (iDCs) derived from human peripheral blood mononuclear cells to phagocytose poly(lactic-co-glycolic acid) (PLGA) microparticles (MPs) as compared to polystyrene MPs and the molecular aspects of this phagocytosis were investigated. Treating iDCs with PLGA or polystyrene fluorospheres of approximately 3 gm in diameter resulted in the internalization of the particles as evidenced by confocal laser scanning micrographs. This uptake of fluorospheres by DCs was decreased by pretreatment of cells with cytochalasin D or by incubation with the fluorospheres at 4 C, and was sensitive to EDTA and trypsin pretreatments in a dose-dependent manner. In agreement with our previous studies, treatment of iDCs with PLGA MPs, but not with polystyrene MPs, led to DC maturation, as measured by increase in release of the autocrine maturation cytokine, tumor necrosis factor-a, which was dependent on ratio of PLGA MPs to DCs. Taken together, this work begins to address the role of phagocytosis on PLGA MP-induced DC maturation and the molecular mechanisms involved.
C1 Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   Emory Univ, Atlanta, GA 30332 USA.
RP Babensee, JE (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM julia.babensee@bme.gatech.edu
FU NIBIB NIH HHS [1R01EB004633-01A1]
CR ARTURSSON P, 1998, BIOMATERIALS, V9, P241
   Audran R, 2003, VACCINE, V21, P1250, DOI 10.1016/S0264-410X(02)00521-2
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Bainbridge JA, 2001, J BIOMED MATER RES, V54, P328
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Bender A, 1996, J IMMUNOL METHODS, V196, P121, DOI 10.1016/0022-1759(96)00079-8
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   Collier TO, 2002, J BIOMED MATER RES, V60, P487, DOI 10.1002/jbm.10043
   COLLIER TO, 1990, J BIOMED MATER RES, V60, P487
   de Saint-Vis B, 1998, J IMMUNOL, V160, P1666
   EZEKOWITZ RAB, 1985, J CLIN INVEST, V76, P2368, DOI 10.1172/JCI112249
   Faulkner L, 2000, IMMUNOLOGY, V99, P523, DOI 10.1046/j.1365-2567.2000.00018.x
   Foged C, 2005, INT J PHARM, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035
   Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200
   Gessner A, 2002, EUR J PHARM BIOPHARM, V54, P165, DOI 10.1016/S0939-6411(02)00081-4
   Gessner A, 2000, INT J PHARM, V196, P245, DOI 10.1016/S0378-5173(99)00432-9
   GODDETTE DW, 1986, J BIOL CHEM, V261, P5974
   Harshyne LA, 2003, J IMMUNOL, V170, P2302, DOI 10.4049/jimmunol.170.5.2302
   Hedley ML, 2003, EXPERT OPIN BIOL TH, V3, P903, DOI 10.1517/eobt.3.6.903.21268
   Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209
   Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758
   Lohmann CH, 2000, BIOMATERIALS, V21, P551, DOI 10.1016/S0142-9612(99)00211-2
   Loudovaris M, 2001, J HEMATOTH STEM CELL, V10, P569, DOI 10.1089/15258160152509172
   Lutsiak MEC, 2002, PHARM RES-DORDR, V19, P1480, DOI 10.1023/A:1020452531828
   Matsuno K, 1996, J EXP MED, V183, P1865, DOI 10.1084/jem.183.4.1865
   Matzelle MM, 2004, BIOMATERIALS, V25, P295, DOI 10.1016/S0142-9612(03)00531-3
   MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015
   Newman KD, 2002, J BIOMED MATER RES, V60, P480, DOI 10.1002/jbm.10019
   Otto M, 2003, J MATER SCI-MATER M, V14, P263, DOI 10.1023/A:1022840909038
   Prior S, 2002, EUR J PHARM SCI, V15, P197, DOI 10.1016/S0928-0987(01)00218-4
   Reece JC, 2001, IMMUNOL CELL BIOL, V79, P255, DOI 10.1046/j.1440-1711.2001.01011.x
   Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6
   SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389
   SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109
   Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058
   TABATA Y, 1991, HIGH PERFORMANCE BIO, P621
   Thiele L, 2003, PHARM RES-DORDR, V20, P221, DOI 10.1023/A:1022271020390
   Thiele L, 2003, BIOMATERIALS, V24, P1409, DOI 10.1016/S0142-9612(02)00525-2
   Thiele L, 2001, J CONTROL RELEASE, V76, P59, DOI 10.1016/S0168-3659(01)00412-6
   Vermes C, 2000, J BONE MINER RES, V15, P1756, DOI 10.1359/jbmr.2000.15.9.1756
   Waeckerle-Men Y, 2004, J IMMUNOL METHODS, V287, P109, DOI 10.1016/j.jim.2004.01.010
   Wake MC, 1998, BIOMATERIALS, V19, P1255
   Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   YOSHIDA M, 2006, IN PRESS J BIOMED MA
NR 46
TC 28
Z9 28
U1 0
U2 12
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2006
VL 17
IS 8
BP 893
EP 907
DI 10.1163/156856206777996844
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 090OA
UT WOS:000240959400004
PM 17024879
DA 2018-10-20
ER

PT J
AU Hoffmann, J
   Groll, J
   Heuts, J
   Rong, HT
   Klee, D
   Ziemer, G
   Moeller, M
   Wendel, HP
AF Hoffmann, Jan
   Groll, Juergen
   Heuts, Jean
   Rong, Haitao
   Klee, Doris
   Ziemer, Gerhard
   Moeller, Martin
   Wendel, Hans P.
TI Blood cell and plasma protein repellent properties of Star-PEG-modified
   surfaces
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE haemocompatibility; polyethylene glycol; platelets; plasma proteins
ID CONFIGURED POLYETHYLENE-GLYCOLS; ULTRATHIN COATINGS; FIELD ANALYSIS;
   CHAIN DENSITY; ADSORPTION; LAYERS; COMPLEMENT; ACTIVATION; PLATELET;
   POLYMERS
AB The implantation of biomaterials, medical devices or prostheses can instigate a rejection response or initiate an undesirable adsorption of plasma proteins, as well as blood cells on the implant surface, thus triggering diverse defense mechanisms against the supposed pathologic invader. The extent of this inflammatory reaction depends in part on the biocompatibility of the used materials or coatings. Although adsorption and coagulation responses can appear during the total in vivo lifetime of the implant, they are initially and crucially formed within the first 2-4 weeks of implantation. This early phase is of decisive importance for the consecutive in-growth and healing process. The present study was intended to elucidate the effects of blood contact to surfaces modified with reactive six-arm star-shaped poly(ethylene glycol-stat-propylene glycol) pre-polymers (Star PEG). Taken together, for Star-PEG-covered substrates we could demonstrate a profound reduction of various blood-biomaterial interactions compared to non-coated substrates, indicating the promising potential of this material as future coating for biomaterials with blood contact.
C1 Univ Tubingen, Dept Thorac Cardiac & Vasc Surg, D-72076 Tubingen, Germany.
   SusTech GmbH & Co KG, D-64287 Darmstadt, Germany.
   Univ Technol Aachen, Dept Text & Macromol Chem, Aachen, Germany.
RP Wendel, HP (reprint author), Univ Tubingen, Dept Thorac Cardiac & Vasc Surg, Calwerstr 7-1, D-72076 Tubingen, Germany.
EM hp.wendel@uni-tuebingen.de
RI Groll, Jurgen/F-4202-2012; Moller, Martin/F-7860-2015; Wendel,
   Hans/C-5687-2009
OI Groll, Jurgen/0000-0003-3167-8466; Moller, Martin/0000-0002-5955-4185; 
CR Gemmell CH, 2000, J BIOMAT SCI-POLYM E, V11, P1197, DOI 10.1163/156856200744273
   Groll J, 2005, J BIOMED MATER RES A, V74A, P607, DOI 10.1002/jbm.a.30335
   Groll J, 2005, LANGMUIR, V21, P3076, DOI 10.1021/la047438n
   Groll J, 2004, J AM CHEM SOC, V126, P4234, DOI 10.1021/ja0318028
   GROLL J, 2006, BIOMACROMOLECULES, V6, P956
   Halperin A, 1999, LANGMUIR, V15, P2525, DOI 10.1021/la981356f
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   Irvine DJ, 1996, MACROMOLECULES, V29, P6037, DOI 10.1021/ma951903t
   KAPLAN KL, 1981, BLOOD, V57, P199
   Malmsten M, 1998, J COLLOID INTERF SCI, V202, P507, DOI 10.1006/jcis.1998.5513
   McPherson T, 1998, LANGMUIR, V14, P176, DOI 10.1021/la9706781
   Mollnes TE, 1998, VOX SANG, V74, P303, DOI 10.1111/j.1423-0410.1998.tb05435.x
   PELZER H, 1988, THROMB HAEMOSTASIS, V59, P101
   Ross EA, 2000, J BIOMED MATER RES, V51, P29
   Ross EA, 2001, J BIOMED MATER RES, V55, P114, DOI 10.1002/1097-4636(200104)55:1<114::AID-JBM150>3.0.CO;2-Z
   Sandor J., 2002, Smarandache Notions Journal, V13, P16
   Szleifer I, 1997, CURR OPIN SOLID ST M, V2, P337, DOI 10.1016/S1359-0286(97)80125-8
   Szleifer I, 2000, MACROMOL RAPID COMM, V21, P423, DOI 10.1002/(SICI)1521-3927(20000501)21:8<423::AID-MARC423>3.0.CO;2-J
   Unsworth LD, 2006, J COLLOID INTERF SCI, V296, P520, DOI 10.1016/j.jcis.2005.09.056
NR 19
TC 45
Z9 45
U1 1
U2 18
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2006
VL 17
IS 9
BP 985
EP 996
DI 10.1163/156856206778366059
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 100ZS
UT WOS:000241709300003
PM 17094637
DA 2018-10-20
ER

PT J
AU Godek, ML
   Sampson, JA
   Duchsherer, NL
   McElwee, Q
   Grainger, DW
AF Godek, M. L.
   Sampson, J. A.
   Duchsherer, N. L.
   McElwee, Q.
   Grainger, D. W.
TI Rho GTPase protein expression and activation in murine
   monocytes/macrophages are not modulated by model biomaterial surfaces in
   serum-containing in vitro cultures
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE macrophage; GTPase; Rho; Cdc; Rac; biomaterial; signaling cascade;
   foreign body reaction
ID GIANT-CELL FORMATION; ACTIN STRESS FIBERS; EXTRACELLULAR-MATRIX;
   MACROPHAGE FUSION; ADHESION; INTEGRINS; PHAGOCYTOSIS; CDC42; RAC;
   MOTILITY
AB The Rho GTPase cellular signaling cascade was investigated in pro-monocyte and (monocyte-)macrophage cells by examining GTPase expression and activation in serum-containing cultures on model biomaterials. Abundance of Rho GDI and the Rho GTPase proteins RhoA, Cdc42 and Rac1 was determined in cells grown on tissue-culture polystyrene, polystyrene, poly-L-lactide and Teflon (R) AF surfaces. Protein expression was compared based on cell maturity (promonocyte to monocyte to macrophage lineages) and by model surface chemistry: Rho proteins were present in the majority of macrophage cells tested on model surfaces suggesting that a pool of Rho proteins is readily available for signaling events in response to numerous activating cues, including biomaterials surface encounter. Rho GTPase activation profiles in these cell lines indicate active Cdc42 and Rho proteins in RAW 264.7, Rac1 and Rho in J774A.1, and Cdc42 and Rac1 in IC-21 cell lines, respectively. Collectively, these proteins are known to play critical roles in all actin-based cytoskeletal rearrangement necessary for cell adhesion, spreading and motility, and remain important to establishing cellular responses required for foreign body reactions in vivo. Differences in Rho GTPase protein expression levels based on cell sourcing (primary versus secondary-derived cell source), or as a function of surface chemistry were insignificant. Rho GTPase expression profiles varied between pro-monocytic non-adherent precursor cells and mature adherent monocyte/macrophage cells. The active GTP-bound forms of the Rho GTPase proteins were detected from monocyte-macrophage cell lines RAW 264.7 and J774A.1 on all polymer surfaces, suggesting that while these proteins are central to cell adhesive behavior, differences in surface chemistry are insufficient to differentially regulate GTPase activation in these cell types. Active Cdc42 was detected from cells cultured on the more-polar tissue-culture polystyrene and poly-L-lactide surfaces after several days, but absent from those grown on apolar polystyrene and Teflon (R) AF, indicating some surface influence on this GTPase in serum-containing cultures.
C1 Colorado State Univ, Cell & Mol Biol Program, Ft Collins, CO 80523 USA.
   Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.
RP Grainger, DW (reprint author), Colorado State Univ, Cell & Mol Biol Program, Ft Collins, CO 80523 USA.
EM grainger@lamar.colostate.edu
FU NIBIB NIH HHS [R01 EB000894, R01 EB000894-08]
CR ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6
   Berrier AL, 2002, J CELL SCI, V115, P4285, DOI 10.1242/jcs.00109
   Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717
   Danen EHJ, 2000, J CELL BIOL, V151, P1413, DOI 10.1083/jcb.151.7.1413
   del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008
   DESAI NP, 1992, BIOMATERIALS, V13, P505, DOI 10.1016/0142-9612(92)90101-S
   Dumontier M, 2000, J CELL SCI, V113, P2253
   Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8
   Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3
   Godek Marisha L, 2004, Biomed Sci Instrum, V40, P7
   Guruvenket S, 2003, J APPL POLYM SCI, V90, P1618, DOI 10.1002/app.12816
   HORBETT TA, 1994, COLLOID SURFACE B, V2, P225, DOI 10.1016/0927-7765(94)80037-5
   Hotchin NA, 1995, J CELL BIOL, V131, P1857, DOI 10.1083/jcb.131.6.1857
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Kaibuchi K, 1999, CURR OPIN CELL BIOL, V11, P591, DOI 10.1016/S0955-0674(99)00014-9
   Karnoub AE, 2004, BREAST CANCER RES TR, V84, P61, DOI 10.1023/B:BREA.0000018427.84929.5c
   Koenig AL, 2003, J BIOMED MATER RES A, V64A, P20, DOI 10.1002/jbm.a.10316
   KOSSOVSKY N, 1991, J BIOMED MATER RES, V25, P1287, DOI 10.1002/jbm.820251009
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   LARSON RS, 1990, IMMUNOL REV, V114, P181, DOI 10.1111/j.1600-065X.1990.tb00565.x
   Lee DJ, 2000, J BIOL CHEM, V275, P141, DOI 10.1074/jbc.275.1.141
   Leverrier Y, 2001, CURR BIOL, V11, P195, DOI 10.1016/S0960-9822(01)00047-1
   MALKOV G, 2006, UNPUB CHEM MAT
   McClary KB, 1999, BIOMATERIALS, V20, P2435, DOI 10.1016/S0142-9612(99)00171-4
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   Miao H, 2002, J CELL SCI, V115, P2199
   NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4
   Patel JC, 2000, METHOD ENZYMOL, V325, P462
   Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863
   Putnam AJ, 2003, AM J PHYSIOL-CELL PH, V284, pC627, DOI 10.1152/ajpcell.00137.2002
   Puto LA, 2003, J BIOL CHEM, V278, P9388, DOI 10.1074/jbc.M208414200
   Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578
   Rhoades ER, 1998, MECH AGEING DEV, V106, P145, DOI 10.1016/S0047-6374(98)00113-4
   Ridley AJ, 1999, BIOCHEM SOC SYMP, V65, P111
   RIDLEY AJ, 1992, COLD SPRING HARB SYM, V57, P661, DOI 10.1101/SQB.1992.057.01.072
   RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7
   Ridley AJ, 2001, FEBS LETT, V498, P168, DOI 10.1016/S0014-5793(01)02481-4
   Ruoslahti E, 1996, EXP CELL RES, V227, P1, DOI 10.1006/excr.1996.0243
   Salsmann A, 2006, EUR J CELL BIOL, V85, P249, DOI 10.1016/j.ejcb.2005.08.003
   Steen ML, 2001, CHEM MATER, V13, P2749, DOI 10.1021/cm010452q
   Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124
   VAN AL, 1997, GENE DEV, V11, P2295
   Wittmann T, 2001, J CELL SCI, V114, P3795
   Zalcman G, 1996, J BIOL CHEM, V271, P30366, DOI 10.1074/jbc.271.48.30366
NR 46
TC 16
Z9 16
U1 0
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2006
VL 17
IS 10
BP 1141
EP 1158
DI 10.1163/156856206778530731
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 113XS
UT WOS:000242631900005
PM 17235380
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Matheson, LA
   Maksym, GN
   Santerre, JP
   Labow, RS
AF Matheson, LA
   Maksym, GN
   Santerre, JP
   Labow, RS
TI Cyclic biaxial strain affects U937 macrophage-like morphology and
   enzymatic activities
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE macrophages; U937 cells; esterases; biaxial strain; siloxane
ID SMOOTH-MUSCLE-CELLS; POLYCARBONATE-BASED POLYURETHANES; IN-VITRO;
   MEDIATED BIODEGRADATION; ENDOTHELIAL-CELLS; FOCAL ADHESIONS; STRESS;
   DEPENDENCE; SUBSTRATE; RESPONSES
AB As monocytes migrate to the site of a foreign body and differentiate into mature monocyte-derived macrophages (MDMs), the cells undergo a morphological transformation that involves mechanical stimulation via membrane stretch. Because the site of many cardiovascular implant devices includes substrates that are also undergoing mechanical change, it is of interest to assess the effect of such dynamic conditions on cellular-biomaterial responses. This study investigated the influence of cyclic (0.25 Hz) biaxial strain (maximum 10% amplitude) on human U937 macrophage-like cells cultured on a flexible siloxane membrane. Cell attachment was unaffected by the strain but total protein levels were significantly higher in stimulated cells. Intracellular esterase and released acid phosphatase activities were elevated by dynamic loading in addition to a strain-induced increase of monocyte-specific esterase protein as demonstrated by immunoblotting analysis. The morphology of static cells changed with cyclic strain from a round cell shape to an irregular, spread phenotype with a progressive reorganization of filamentous actin. The focal adhesion protein vinculin showed distinct reorganization in structure going from a well-defined arrangement in static cells to a diffuse staining pattern in mechano-stimulated cells. This study has demonstrated that U937 cells respond to cyclic deformation with an augmentation of select enzymatic activities that have been identified as being important in polymer biodegradation processes, as well as morphological changes, which may be characteristic of mechanical stressinduced cell activation. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.
   Dalhousie Univ, Sch Biomed Engn, Halifax, NS, Canada.
   Univ Toronto, Dept Biol & Diagnost Sci, Toronto, ON, Canada.
   Univ Ottawa, Heart Inst, Dept Surg, Ottawa, ON, Canada.
RP Labow, RS (reprint author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.
EM rlabow@ottawaheart.ca
CR AMIEVA MR, 1995, EXP CELL RES, V219, P180, DOI 10.1006/excr.1995.1218
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Bune AJ, 2001, IMMUNOLOGY, V102, P103, DOI 10.1046/j.1365-2567.2001.01145.x
   Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8
   Dos Santos CC, 2000, J APPL PHYSIOL, V89, P1645
   GILBERT JA, 1994, J BIOMECH, V27, P1169, DOI 10.1016/0021-9290(94)90057-4
   Greenwood JA, 1998, MICROSC RES TECHNIQ, V43, P420, DOI 10.1002/(SICI)1097-0029(19981201)43:5<420::AID-JEMT8>3.0.CO;2-B
   Hayman AR, 2000, J HISTOCHEM CYTOCHEM, V48, P219, DOI 10.1177/002215540004800207
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Kumar A, 2003, J BIOL CHEM, V278, P18868, DOI 10.1074/jbc.M212777200
   Labow RS, 2005, J BIOMAT SCI-POLYM E, V16, P1167, DOI 10.1163/1568562054798563
   Labow RS, 2002, BIOMATERIALS, V23, P3969, DOI 10.1016/S0142-9612(02)00137-0
   Labow RS, 2005, BIOMATERIALS, V26, P7357, DOI 10.1016/j.biomaterials.2005.05.048
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   Labow RS, 1999, J BIOMAT SCI-POLYM E, V10, P699, DOI 10.1163/156856299X00595
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   Lee AA, 1999, J MOL CELL CARDIOL, V31, P1833, DOI 10.1006/jmcc.1999.1017
   Li F, 1997, J BIOL CHEM, V272, P28666, DOI 10.1074/jbc.272.45.28666
   Lotters JC, 1996, J MICROMECH MICROENG, V6, P52, DOI 10.1088/0960-1317/6/1/010
   Ludwig MS, 2004, CLIN EXP ALLERGY, V34, P926, DOI 10.1111/j.1365-2222.2004.01980.x
   MARTIN DK, 1995, J MEMBRANE BIOL, V147, P305
   Matheson LA, 2002, J BIOMED MATER RES, V61, P505, DOI 10.1002/jbm.10286
   Matheson LA, 2004, J CELL PHYSIOL, V199, P8, DOI 10.1002/jcp.10412
   Matsumoto T, 1996, J BIOMECH ENG-T ASME, V118, P420, DOI 10.1115/1.2796026
   Meazzini MC, 1998, J ORTHOP RES, V16, P170, DOI 10.1002/jor.1100160204
   Miyazaki H, 2001, BIO-MED MATER ENG, V11, P301
   Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb901
   NEREM RM, 1992, J BIOMECH ENG-T ASME, V114, P274, DOI 10.1115/1.2891384
   Ohki R, 2002, J HYPERTENS, V20, P685, DOI 10.1097/00004872-200204000-00026
   Pugin J, 1998, AM J PHYSIOL-LUNG C, V275, pL1040, DOI 10.1152/ajplung.1998.275.6.L1040
   Santavirta S, 1999, J LONG-TERM EFF MED, V9, P67
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Satoh T, 1998, ANNU REV PHARMACOL, V38, P257, DOI 10.1146/annurev.pharmtox.38.1.257
   Shafrir Y, 2002, AM J PHYSIOL-CELL PH, V282, pC479, DOI 10.1152/ajpcell.00394.2001
   Smith PG, 2003, AM J RESP CELL MOL, V28, P436, DOI 10.1165/rcmb.4754
   Smith PG, 2003, AM J PHYSIOL-LUNG C, V285, pL456, DOI 10.1152/ajplung.00329.2002
   Smith PG, 1997, EXP CELL RES, V232, P127, DOI 10.1006/excr.1997.3492
   Tang YW, 2003, BIOMATERIALS, V24, P2805, DOI 10.1016/S0142-9612(03)00081-4
   Tang YW, 2001, J BIOMED MATER RES, V57, P597, DOI 10.1002/1097-4636(20011215)57:4<597::AID-JBM1207>3.0.CO;2-T
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   Uphoff CC, 2000, LEUKEMIA LYMPHOMA, V39, P257, DOI 10.3109/10428190009065825
   Wang CCB, 2001, J BIOMECH, V34, P75, DOI 10.1016/S0021-9290(00)00137-8
   Wang JHC, 2000, CELL MOTIL CYTOSKEL, V46, P137, DOI 10.1002/1097-0169(200006)46:2<137::AID-CM6>3.0.CO;2-8
   WECHEZAK AR, 1985, LAB INVEST, V53, P639
   Yamamoto K, 2001, CIRCULATION, V103, P1459, DOI 10.1161/01.CIR.103.10.1459
   Yang JH, 2000, AM J PATHOL, V156, P1797, DOI 10.1016/S0002-9440(10)65051-1
NR 46
TC 20
Z9 20
U1 0
U2 3
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2006
VL 76A
IS 1
BP 52
EP 62
DI 10.1002/jbm.a.30448
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 995MW
UT WOS:000234105400006
PM 16224781
DA 2018-10-20
ER

PT J
AU Hsu, SH
   Huang, TB
   Chuang, SC
   Tsai, IJ
   Chen, DC
AF Hsu, SH
   Huang, TB
   Chuang, SC
   Tsai, IJ
   Chen, DC
TI Ultrasound preexposure improves endothelial cell binding and retention
   on biomaterial surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE endothelial cells; cell adhesion; vascular graft
ID LOW-INTENSITY ULTRASOUND; POLYURETHANE VASCULAR GRAFT; AGGRECAN
   GENE-EXPRESSION; IN-VITRO; THERAPEUTIC ULTRASOUND; HUMAN-FIBROBLASTS;
   RAT CHONDROCYTES; NITRIC-OXIDE; ADHESION; OSTEOBLASTS
AB In spite of the extensive studies regarding the effects of ultrasound on biological systems, the influence of low-intensity ultrasound on endothelial cells has rarely been investigated. In this work, the effect of ultrasound in improving the binding between endothelial cells and biomaterial substrates was evaluated. Based on the results, low-intensity ultrasound could change the morphology and matrix secretion of endothelial cells, and such effects persisted when preexposed cells were seeded to another substrate. The cells preexposed to ultrasound were spread further on the substrate. The actin stress fibers of ultrasound-preexposed cells on RGD-modified surfaces were especially intense and well oriented. Ultrasound could probably activate cellular integrins and subsequently allow RGD to bind them. A much firmer adhesion of ultrasound-preexposed endothelial cells to the biomaterial surface coated with the RGD-containing protein was demonstrated. Finally, polyurethane small-diameter vascular grafts seeded with ultrasound-preexposed endothelial cells showed enhanced cell retention on graft surfaces upon Hushing. (c) 2005 Wiley Periodicals, Inc.
C1 Natl Chung Hsing Univ, Dept Chem Engn, Taichung, Taiwan.
   Natl Chung Hsing Univ, Inst Vet Microbiol, Taichung, Taiwan.
RP Hsu, SH (reprint author), Natl Chung Hsing Univ, Dept Chem Engn, Taichung, Taiwan.
EM shhsu@nchu.edu.tw
OI Hsu, Shan-hui/0000-0003-3399-055X
CR Bowlin GL, 2001, J BIOMATER APPL, V16, P157, DOI 10.1106/NCQT-JFV9-2EQ1-EBGU
   CHEN DC, 2002, Patent No. 6407208
   Cheresh D., 1993, ADV MOL CELL BIOL, V6, P225
   COOK SD, 2001, CLIN ORTHOP RELAT R, V391, P231
   DEJUN L, 1994, APPL SURF SCI, V78, P195
   Doan N, 1999, J ORAL MAXIL SURG, V57, P409, DOI 10.1016/S0278-2391(99)90281-1
   DOREEN L, 1981, RADIOLOGY, V138, P419
   Dyson M, 1983, Ultrasound Med Biol, VSuppl 2, P61
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Fields C, 2002, J BIOMATER APPL, V17, P135, DOI 10.1106/088532802030556
   Fields C, 2002, J BIOMATER APPL, V17, P45, DOI 10.1106/088532802027861
   HAGIWARA H, 1984, THROMB RES, V33, P363, DOI 10.1016/0049-3848(84)90075-6
   Harle J, 2001, ULTRASOUND MED BIOL, V27, P579, DOI 10.1016/S0301-5629(00)00326-4
   HARRIS M, 1992, BRIT J ORAL MAX SURG, V30, P313, DOI 10.1016/0266-4356(92)90181-H
   HECKMAN JD, 1994, J BONE JOINT SURG AM, V76A, P26, DOI 10.2106/00004623-199401000-00004
   HSU S, 2003, ARTIF ORGANS, V27, P1090
   Hsu SH, 2004, BIOMOL ENG, V21, P99, DOI 10.1016/j.bioeng.2004.06.001
   Hsu SH, 2004, J BIOTECHNOL, V111, P143, DOI 10.1016/j.jbiotec.2004.03.014
   Ito M, 2000, ULTRASOUND MED BIOL, V26, P161, DOI 10.1016/S0301-5629(99)00110-6
   Kent K C, 1988, ASAIO Trans, V34, P578
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Ko KS, 2001, J CELL SCI, V114, P1155
   Li JGR, 2002, ULTRASOUND MED BIOL, V28, P683, DOI 10.1016/S0301-5629(02)00485-4
   MAXWELL L, 1994, ULTRASOUND MED BIOL, V20, P383, DOI 10.1016/0301-5629(94)90007-8
   Myrdycz A, 2002, BIOMOL ENG, V19, P219, DOI 10.1016/S1389-0344(02)00035-7
   NATHAN C, 1992, FASEB J, V6, P3051
   Parvizi J, 2002, J ORTHOPAED RES, V20, P51, DOI 10.1016/S0736-0266(01)00069-9
   Parvizi J, 1999, J ORTHOPAED RES, V17, P488, DOI 10.1002/jor.1100170405
   Pignataro B, 1997, BIOMATERIALS, V18, P1461, DOI 10.1016/S0142-9612(97)00090-2
   Reher P, 1997, ULTRASOUND MED BIOL, V23, P1251, DOI 10.1016/S0301-5629(97)00031-8
   Reher P, 1998, EUR J CANCER, V34, P1962, DOI 10.1016/S0959-8049(98)00238-X
   Reher P, 2002, BONE, V31, P236, DOI 10.1016/S8756-3282(02)00789-5
   Reher P, 1999, CYTOKINE, V11, P416, DOI 10.1006/cyto.1998.0444
   RUBANYI GM, 1993, J CARDIOVASC PHARM, V22, pS1, DOI 10.1097/00005344-199322004-00002
   Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04
   Sato H, 1999, J BIOMATER APPL, V14, P169, DOI 10.1177/088532829901400203
   Sheehan D., 1980, THEORY PRACTICE HIST, P226
   Spadaro JA, 1998, ULTRASOUND MED BIOL, V24, P567, DOI 10.1016/S0301-5629(98)00006-4
   STANSBY G, 1994, BRIT J SURG, V81, P1286, DOI 10.1002/bjs.1800810908
   Sun JS, 2001, J BIOMED MATER RES, V57, P449, DOI 10.1002/1097-4636(20011205)57:3<449::AID-JBM1188>3.0.CO;2-0
   UCHIDA N, 1993, J BIOMED MATER RES, V27, P1269, DOI 10.1002/jbm.820271007
   Walluscheck KP, 1996, EUR J VASC ENDOVASC, V12, P321, DOI 10.1016/S1078-5884(96)80251-6
   WEBSTER DF, 1980, ULTRASONICS, V18, P33, DOI 10.1016/0041-624X(80)90050-5
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   WU CC, 1996, T ORTHOP RES SOC, V21, P622
   Yang KH, 1996, J ORTHOP RES, V14, P802, DOI 10.1002/jor.1100140518
   ZHANG ZJ, 2002, ULTRASOUND MED BIOL, V14, P499
NR 47
TC 4
Z9 4
U1 0
U2 1
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2006
VL 76B
IS 1
BP 85
EP 92
DI 10.1002/jbm.b.30345
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 998FO
UT WOS:000234304200011
PM 16206256
DA 2018-10-20
ER

PT J
AU Bartels, P
   Kotze, A
AF Bartels, Paul
   Kotze, Antoinette
TI Wildlife biomaterial banking in Africa for now and the future
SO JOURNAL OF ENVIRONMENTAL MONITORING
LA English
DT News Item
AB The Wildlife Biological Resource Centre (wBRC) together with its partners in BioBank SA, have created a Biological Resource Bank (BRB) that is dedicated to the acquisition, processing, banking, using and provision of biomaterials to the scientific and conservation industry that are viable, diverse and representative of southern Africa's wildlife populations. Banked biomaterials include tissue such as muscle, kidney, fat, liver, embryos, fibroblast cultures, blood, sperm, hair, egg shells and other tissue, fluids and cells. Biomaterials are made available for research, biodiversity conservation and biotechnology development. Biomaterials are used in many disciplines, including genetics, reproduction, nutrition, and disease studies. Biomaterials from selected species are also useful for the detection and monitoring of Persistent Organic Pollutants and other potentially harmful substances found in the environment. Biomaterials are made available to third parties with prior consent from the biomaterials "owner" and only after the signing of a customised Material Transfer Agreement (MTA) or Cooperative Research and Development Agreement (CRADA). The training of staff from National and Provincial Game Reserves, Zoological Gardens, Animal Breeders and laboratories is carried out on a regular basis with the aim of securing good quality biomaterials. Sampling kits are made available to persons tasked with the collection of wildlife biomaterials. The Biobank SA consortium acts as an integrated resource centre linking partner collections. The consortium's operational arm, namely wBRC, is active in the development of relevant policy, regulations and legislation pertaining to biomaterials, including Access and Benefit Sharing systems. The main sponsor of the project is the Department of Science and Technology, National Government of South Africa.
EM paulb@wbrc.org.za
CR GLAZEWSKY J, 2000, ENV LAW S AFRICA
   *UN, 1992, CONV BIOL DIV
NR 2
TC 14
Z9 15
U1 0
U2 7
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1464-0325
J9 J ENVIRON MONITOR
JI J. Environ. Monit.
PY 2006
VL 8
IS 8
BP 779
EP 781
DI 10.1039/b602809h
PG 3
WC Chemistry, Analytical; Environmental Sciences
SC Chemistry; Environmental Sciences & Ecology
GA 071YO
UT WOS:000239640000002
PM 16896459
DA 2018-10-20
ER

PT J
AU Xu, H
   Luo, MH
   Yu, MH
   Teng, CQ
   Xie, S
AF Xu, H
   Luo, MH
   Yu, MH
   Teng, CQ
   Xie, S
TI The effect of crystallization on the solid state polycondensation of
   poly(L-lactic acid)
SO JOURNAL OF MACROMOLECULAR SCIENCE PART B-PHYSICS
LA English
DT Article; Proceedings Paper
CT International Conference on Advanced Fibers and Polymer Materials
   (ICAFPM 2005)
CY OCT 19-21, 2005
CL Shanghai, PEOPLES R CHINA
SP State Key Lab Modificat Chem Fibers & Polymer Mat
DE poly(L-lactic acid); crystallization; solid-state polycondensation
ID HIGH-MOLECULAR-WEIGHT; LACTIC-ACID; POLYMERIZATION;
   POLY(ETHYLENE-TEREPHTHALATE); BIODEGRADABILITY; COPOLYMERS
AB Melt solid polycondensation is an approach to increase the molecular weight of poly (L-lactic acid) (PLLA). For this report, the effect of crystallization time of PLLA prepolymer on the molecular weight of the biomaterial was studied. In this process, PLLA prepolymer with a molecular weight of 18,000 was first prepared by the ordinary melt-polycondensation process. The prepolymer was crystallized at 105 degrees C for various times, and then heated at 135 degrees C for 15-50 h for further solid state polycondensation (SSP). The differential scanning calorimetry (DSC) and viscosity measurements were used to characterize the crystalline properties and molecular weight of the resulting PLLA polymers, respectively. The results showed that the molecular weight of PLLA reached a maximum value under the condition of a crystallization time of 30 min and SSP of 35 h.
C1 Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai 200051, Peoples R China.
RP Yu, MH (reprint author), Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai 200051, Peoples R China.
EM yumuhuo@dhu.edu.cn
CR Duh B, 2002, POLYMER, V43, P3147, DOI 10.1016/S0032-3861(02)00138-6
   Hiltunen K, 1997, J APPL POLYM SCI, V63, P1091
   Kohler WH, 2005, J MACROMOL SCI PHYS, VB44, P185, DOI 10.1081/MB-200049786
   Kricheldorf HR, 1996, MACROMOLECULES, V29, P1375, DOI 10.1021/ma9509826
   Miyata T, 1998, POLYMER, V39, P5515, DOI 10.1016/S0032-3861(97)10203-8
   Moon S.-II, 2001, HIGH PERFORM POLYM, V13, P189, DOI DOI 10.1088/0954-0083/13/2/317
   Moon SI, 2001, POLYMER, V42, P5059, DOI 10.1016/S0032-3861(00)00889-2
   Ouchi T, 2003, J POLYM SCI POL CHEM, V41, P2462, DOI 10.1002/pola.10783
   Shirahama H, 2005, J POLYM SCI POL CHEM, V43, P438, DOI 10.1002/pola.20516
   Stridsberg K, 2000, MACROMOLECULES, V33, P2862, DOI 10.1021/ma991811u
   Teng CQ, 2004, J POLYM SCI POL CHEM, V42, P5045, DOI 10.1002/pola.20412
   WOO SI, 1995, POLYM BULL, V35, P415, DOI 10.1007/BF00297606
   Yao KZ, 2001, CHEM ENG SCI, V56, P4801, DOI 10.1016/S0009-2509(01)00133-6
   Yu HM, 2004, J APPL POLYM SCI, V94, P971, DOI 10.1002/app.20888
   Zhao JX, 2005, POLYMER, V46, P7309, DOI 10.1016/j.polymer.2005.05.090
NR 15
TC 21
Z9 23
U1 2
U2 13
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0022-2348
J9 J MACROMOL SCI B
JI J. Macromol. Sci. Part B-Phys.
PY 2006
VL 45
IS 4
BP 681
EP 687
DI 10.1080/00222340600770400
PG 7
WC Polymer Science
SC Polymer Science
GA 057SS
UT WOS:000238616100028
DA 2018-10-20
ER

PT J
AU Lee, KW
   Ban, JS
   Kim, SJ
   Cho, KZ
AF Lee, KW
   Ban, JS
   Kim, SJ
   Cho, KZ
TI Deformation behaviour of Ti-8Ta-3Nb during hot forging
SO JOURNAL OF MECHANICAL SCIENCE AND TECHNOLOGY
LA English
DT Article
DE deformation; forging; stress; strain rate
ID PLASTIC-FLOW; TITANIUM; WORKABILITY; TI-6AL-4V; ALLOY
AB Ti-8Ta-3Nb, as a new biomaterial, was prepared by cast and swaging process. Their deformation behavior of Ti-8Ta-3Nb alloy has been characterized on the basis of its flow stress variation obtained from the true strain rate compression testing in the temperature of 700-900 degrees C and strain rate of 0.001-10 s(-1). At the strain rates lower than 0.1 s(-1) and the all temperature ranges which consist of two phase alpha+beta as well as beta single phase Fields, the flow curves show a small degree of now softening behavior. In contrast, the shapes of the now Curves at other strain rates indicate unstable behavior. The shapes of the flow curves were similar in both as-cast and swaged specimen Lis well as in both alpha+beta phase and beta phase. The flow stress data did not obey the kinetic rate equation over the entire regime of testing but a good fit has been obtained in the intermediate range of temperatures (750-850 degrees C). In this range, a stress exponent value of about 7.7 in as-cast specimens and about 6.2 in swaged specimens with an apparent activation energy of about 300 kJ/mol and about 206 kJ/mol respectively have been evaluated.
C1 Chonnam Natl Univ, Dept Mech Engn, Kwangju 500757, South Korea.
   Seokang Coll, Kwangju 500742, South Korea.
RP Lee, KW (reprint author), Chonnam Natl Univ, Dept Mech Engn, Kwangju 500757, South Korea.
EM leekw3@hanmail.net
CR BRYANT WA, 1975, J MATER SCI, V10, P1793, DOI 10.1007/BF00554942
   DERECA NEW, 1968, ACTA METALL MATER, V16, P1297, DOI 10.1016/0001-6160(68)90010-2
   Dyment F, 1968, J MATER SCI, V3, P349, DOI 10.1007/BF00550978
   Huang C, 1996, MAT SCI ENG A-STRUCT, V208, P166, DOI 10.1016/0921-5093(95)10053-9
   Jonas JJ, 1969, MET REV, V130, P1, DOI [10.1179/095066069790138056, DOI 10.1179/095066069790138056]
   LEE KW, 2004, IN PRESS KSME INT J
   LIU Y, 1995, MAT SCI ENG A-STRUCT, V197, P125, DOI 10.1016/0921-5093(95)09691-4
   MCQUEEN HJ, 1987, JOM-J MIN MET MAT S, V39, P28, DOI 10.1007/BF03257647
   Park NK, 2002, J MATER PROCESS TECH, V130, P540, DOI 10.1016/S0924-0136(02)00801-4
   SEMIATIN SL, 1992, METALL TRANS A, V23, P295, DOI 10.1007/BF02660872
   Sundar RS, 2003, MAT SCI ENG A-STRUCT, V347, P86, DOI 10.1016/S0921-5093(02)00585-3
   Zener C, 1944, J APPL PHYS, V15, P22, DOI 10.1063/1.1707363
NR 12
TC 5
Z9 5
U1 1
U2 6
PU KOREAN SOC MECHANICAL ENGINEERS
PI SEOUL
PA KSTC NEW BLD. 7TH FLOOR, 635-4 YEOKSAM-DONG KANGNAM-KU, SEOUL 135-703,
   SOUTH KOREA
SN 1738-494X
J9 J MECH SCI TECHNOL
JI J. Mech. Sci. Technol.
PD JAN
PY 2006
VL 20
IS 1
BP 13
EP 18
DI 10.1007/BF02916195
PG 6
WC Engineering, Mechanical
SC Engineering
GA 005OU
UT WOS:000234834500002
DA 2018-10-20
ER

PT J
AU Carr, A
   Kemp, A
   Tibbetts, I
   Truss, R
   Drennan, J
AF Carr, A
   Kemp, A
   Tibbetts, I
   Truss, R
   Drennan, J
TI Microstructure of pharyngeal tooth enameloid in the parrotfish Scarus
   rivulatus (Pisces : Scaridae)
SO JOURNAL OF MICROSCOPY-OXFORD
LA English
DT Article
DE biological apatite; biomaterial; enameloid; microstructure; parrotfish
   dentition
ID FAMILY SCARIDAE; JAW APPARATUS; MICROWEAR; FISHES; REEF
AB The microstructure of parrotfish pharyngeal teeth was examined using scanning electron microscopy to infer possible mechanical properties of the dentition with respect to their function. Parrotfish tooth enameloid is formed from fluorapatite crystals grouped into bundles. In the upper and lower pharyngeal jaw, the majority of the crystal bundles are orientated either perpendicularly or vertically to the enameloid surface. The only exception is in the trailing apical enameloid in which the majority of bundles are orientated perpendicularly or horizontally to the trailing surface. A distinct transition occurs through the middle of the apex between the leading and trailing enameloid in teeth of the lower pharyngeal jaw. This transition appears less distinct in the teeth of the upper pharyngeal jaw. Enameloid microstructure indicates that shear forces predominate at the apex of the teeth. In the remainder of the enameloid, the microstructure indicates that wear is predominant, and the shear forces are of less importance.
C1 Univ Queensland, Ctr Microscopy & Microanal, Sch Engn, St Lucia, Qld 4072, Australia.
   Univ Queensland, Ctr Marine Studies, Sch Engn, St Lucia, Qld 4072, Australia.
   Univ Queensland, Div Mat, Sch Engn, St Lucia, Qld 4072, Australia.
RP Kemp, A (reprint author), Univ Queensland, Ctr Microscopy & Microanal, Sch Engn, St Lucia, Qld 4072, Australia.
EM a.kemp@mailbox.uq.edu.au
RI Tibbetts, Ian/K-6191-2013; Drennan, John/C-8824-2013
OI Tibbetts, Ian/0000-0002-1481-238X; 
CR Bellwood David R., 1994, Records of the Australian Museum Supplement, V20, P1
   BELLWOOD DR, 1990, ENVIRON BIOL FISH, V28, P189, DOI 10.1007/BF00751035
   Bellwood DR, 1996, MAR BIOL, V125, P795, DOI 10.1007/BF00349262
   BOARD P. A., 1956, PROC ZOOL SOC LONDON, V127, P59
   BOYDE A, 1986, ZOOL J LINN SOC-LOND, V87, P181, DOI 10.1111/j.1096-3642.1986.tb01336.x
   BOYDE A, 1984, ANAT EMBRYOL, V170, P57, DOI 10.1007/BF00319458
   BRUGGEMANN JH, 1994, MAR ECOL PROG SER, V112, P51, DOI 10.3354/meps112051
   Ferreira CEL, 1998, J FISH BIOL, V53, P222, DOI 10.1006/jfbi.1998.0824
   Fortelius M., 1985, ACTA ZOOL FENN, V180, P1
   GOBALET KW, 1989, AM ZOOL, V29, P319
   Gregory WK, 1959, FISH SKULLS STUDY EV
   GRUBICH J, 2003, BIOL J LINN SOC, V8, P147
   HOJO T, 1992, SCANNING MICROSCOPY, V6, P785
   Horn M.H., 1989, Oceanography and Marine Biology an Annual Review, V27, P167
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, P270
   KOENIGSWALD W, 1991, CONSTRUCTION MORPHOL
   LIEM KF, 1986, J MORPHOL, V187, P143, DOI 10.1002/jmor.1051870203
   LIEM KF, 1981, AM ZOOL, V21, P83
   Lowrison G. C., 1974, CRUSHING GRINDING SI
   Lucas P.W., 1984, P283
   Lucas P. W., 1991, FEEDING TEXTURE FOOD, P93
   LUCAS PW, 1982, TEETH FORM FUNCTION
   MAAS MC, 1991, AM J PHYS ANTHROPOL, V85, P31, DOI 10.1002/ajpa.1330850106
   OGDEN J C, 1978, Environmental Biology of Fishes, V3, P49, DOI 10.1007/BF00006308
   OWENS R, ODONTOGRAPHY TREATIS
   POLUNIN NVC, 1995, J FISH BIOL, V47, P455, DOI 10.1111/j.1095-8649.1995.tb01914.x
   RENSBERGER JM, 1992, SCANNING MICROSCOPY, V6, P495
   RENSBERGER JM, 1980, PALEOBIOLOGY, V6, P477
   RENSBERGER JM, 1995, DETERMINATION STRESS
   SHELLIS RP, 1976, J ZOOL, V180, P69
   SMITH RL, 1974, COPEIA, P796
   Stefen C, 1999, ALCHERINGA, V23, P111, DOI 10.1080/03115519908619325
   STERN D, 1989, ZOOL J LINN SOC-LOND, V95, P311, DOI 10.1111/j.1096-3642.1989.tb02314.x
   SUGA S, 1992, J DENT RES, V71, P1316, DOI 10.1177/00220345920710060901
   Teaford MF, 1996, AM J PHYS ANTHROPOL, V101, P527
   WAINWRIGHT PC, 1987, J ZOOL, V213, P283, DOI 10.1111/j.1469-7998.1987.tb03704.x
   Young W.G., 1990, P145
NR 37
TC 12
Z9 12
U1 0
U2 12
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0022-2720
J9 J MICROSC-OXFORD
JI J. Microsc.-Oxf.
PD JAN
PY 2006
VL 221
BP 8
EP 16
DI 10.1111/j.1365-2818.2006.01526.x
PN 1
PG 9
WC Microscopy
SC Microscopy
GA 007MZ
UT WOS:000234975100002
PM 16438685
DA 2018-10-20
ER

PT J
AU Liyanage, SH
   Purohit, GS
   Frye, JNR
   Giordano, P
AF Liyanage, SH
   Purohit, GS
   Frye, JNR
   Giordano, P
TI Anterior abdominal wall reconstruction with a Permacol implant
SO JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY
LA English
DT Article
DE abdominal wall reconstruction; porcine dermal collagen implant
ID CLINICAL-EXPERIENCE; POLYPROPYLENE MESH; NONABSORBABLE MESH; INCISIONAL
   HERNIA; SUTURE REPAIR
AB Laparostomy wound management is a difficult problem especially with a stoma and the potential risk of infection. A case describing the use of a permanent porcine dermal collagen implant in the repair of a massive ventral hernia, in a patient with a large post-laparostomy defect and colostomy is outlined. The implant was not rejected, and after 12 months, there was no evidence of residual or recurrent hernia. The search for the ultimate biomaterial for reconstructing abdominal wall defects is ongoing. Collagen based implants appear to have many of the requirements that an ideal material should possess. (C) 2005 The British Association of Plastic Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 Whipps Cross Univ Hosp, Dept Surg, London E11 1NR, England.
   Royal London Hosp, Ctr Acad Surg, London E1 1BB, England.
RP Giordano, P (reprint author), Whipps Cross Univ Hosp, Dept Surg, Whipps Cross Rd, London E11 1NR, England.
EM pasquale.giordano@whippsx.nhs.uk
CR Adedeji OA, 2002, BRIT J PLAST SURG, V55, P85, DOI 10.1054/bjps.2001.3711
   CAUFMAN Z, 1981, DIS COLON RECTUM, V24, P543
   Geisler DJ, 2003, DIS COLON RECTUM, V46, P1118, DOI 10.1097/01.DCR.0000081172.03955-34
   Harper C, 2001, HOSP MED, V62, P90, DOI 10.12968/hosp.2001.62.2.2379
   Holl-Allen R T, 1984, J R Coll Surg Edinb, V29, P154
   Korenkov M, 2002, BRIT J SURG, V89, P50, DOI 10.1046/j.0007-1323.2001.01974.x
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603
   Mathes SJ, 2000, ANN SURG, V232, P586, DOI 10.1097/00000658-200010000-00014
   Miller K, 1997, SURG ENDOSC-ULTRAS, V11, P772, DOI 10.1007/s004649900448
   Morris-Stiff GJ, 1998, J AM COLL SURGEONS, V186, P352, DOI 10.1016/S1072-7515(98)00002-7
   SARMAH BD, 1984, BRIT J SURG, V71, P524, DOI 10.1002/bjs.1800710717
   SIMMERMACHER RKJ, 1994, J AM COLL SURGEONS, V178, P613
   White TJ, 1998, AM SURGEON, V64, P276
   Williams NS, 2005, DIS COLON RECTUM, V48, P307, DOI 10.1007/s10350-004-0806-6
NR 14
TC 58
Z9 59
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1748-6815
J9 J PLAST RECONSTR AES
JI J. Plast. Reconstr. Aesthet. Surg.
PY 2006
VL 59
IS 5
BP 553
EP 555
DI 10.1016/j.bjps.2005.06.008
PG 3
WC Surgery
SC Surgery
GA 040SQ
UT WOS:000237401100023
PM 16749204
DA 2018-10-20
ER

PT J
AU Shinohara, H
   Takei, H
   Saito, D
   Kotani, M
   Ueno, S
   Nakahira, A
AF Shinohara, H
   Takei, H
   Saito, D
   Kotani, M
   Ueno, S
   Nakahira, A
TI Fundamental study on bone formation using collagen orientation induced
   by magnetic fields
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article; Proceedings Paper
CT 18th Fall Meeting of the Ceramic-Society-of-Japan
CY 2005
CL Kawasaki, JAPAN
SP Ceram Soc Japan
DE biomaterial; collagen; magnetic vector; orientation; hybrid
AB In this study, highly oriented collagen structures were successfully synthesized using a conventional superconducting magnet with magnetic field intensities of 2.5 to 8 T. The relationship between the orientation order parameters f(2D) of osteoblasts cells (that is, the orientation of collagens) and the magnetic field intensity was mainly investigated. As a result, it was clarified that collagens highly oriented perpendicular to the magnetic field direction were obtained by exposure to a magnetic field intensity of 3.0 T.
C1 Tokyo Denki Univ, Res Ctr Adv Technol, Inzai, Chiba 2701325, Japan.
   Tokyo Denki Univ, Grad Sch Engn, Inzai, Chiba 2701325, Japan.
   Univ Tokyo, Grad Sch Med, Dept Biomed Engn, Bunkyo Ku, Tokyo 1130033, Japan.
   Osaka Prefecture Univ, Dept Mat Sci, Sakai, Osaka 5998531, Japan.
RP Shinohara, H (reprint author), Tokyo Denki Univ, Res Ctr Adv Technol, 2-1200 Muzai Gakuendai, Inzai, Chiba 2701325, Japan.
CR Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Kotani H, 2002, J BONE MINER RES, V17, P1814, DOI 10.1359/jbmr.2002.17.10.1814
   Kotani H, 2000, J APPL PHYS, V87, P6191, DOI 10.1063/1.372652
   Nakahira A., 2003, Journal of the Magnetics Society of Japan, V27, P670, DOI 10.3379/jmsjmag.27.670
   NAKAHIRA A, 2003, BIOMATERIALS, P44
   TORBET J, 1984, BIOCHEM J, V219, P1057, DOI 10.1042/bj2191057
NR 6
TC 1
Z9 1
U1 0
U2 1
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD JAN
PY 2006
VL 114
IS 1325
BP 131
EP 134
DI 10.2109/jcersj.114.131
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA 018LI
UT WOS:000235765400026
OA Bronze
DA 2018-10-20
ER

PT J
AU Norlin, A
   Pan, J
   Leygraf, C
AF Norlin, A
   Pan, J
   Leygraf, C
TI Fabrication of porous Nb2O5 by plasma electrolysis anodization and
   electrochemical characterization of the oxide
SO JOURNAL OF THE ELECTROCHEMICAL SOCIETY
LA English
DT Article
ID MICRO-ARC OXIDATION; ANODIC BEHAVIOR; TITANIUM-ALLOYS; IMPEDANCE
   SPECTROSCOPY; TANTALUM ELECTRODES; NIOBIUM ELECTRODES; PASSIVATED
   NIOBIUM; INITIAL-STAGES; FILMS; IMPLANTS
AB Porous Nb2O5 electrodes were fabricated by applying anodic pulses of 700 V and 10 ms duration to pure Nb in phosphate buffered saline solution (PBS), aiming at biomaterial applications. The porosity of the oxide could be controlled by the number of pulses. X-ray photoelectron spectroscopy analysis confirmed the oxide to be Nb2O5. The electrochemical behavior and interfacial properties of the porous Nb2O5 were characterized in PBS by using electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV). EIS measurements indicate that the oxide film has a two-layer structure with a compact inner layer and a porous outer layer, and the pores were sealed by precipitates during long-time aging in PBS. The two-layer structure of the oxide film was observed by examination of the cross section using scanning electron microscopy in backscatter mode. The CV measurements reveal that the oxide exhibits an electrochemical "rectifying" property. It is stable over a wide potential range but shows hydrogen uptake upon cathodic polarization below -1 V vs Ag/AgCl. (c) 2006 The Electrochemical Society.
C1 Royal Inst Technol, Dept Mat Sci & Engn, SE-10044 Stockholm, Sweden.
   St Jude Med AB, SE-17584 Jarfalla, Sweden.
RP Norlin, A (reprint author), Royal Inst Technol, Dept Mat Sci & Engn, SE-10044 Stockholm, Sweden.
EM jinshanp@kth.se
CR ALKHARAFI FM, 1995, ELECTROCHIM ACTA, V40, P2623, DOI 10.1016/0013-4686(95)00123-V
   BADAWY WA, 1990, J APPL ELECTROCHEM, V20, P139, DOI 10.1007/BF01012483
   Cavigliasso GE, 1998, J APPL ELECTROCHEM, V28, P1213, DOI 10.1023/A:1003449917148
   Chang YS, 1996, BIOMATERIALS, V17, P1141, DOI 10.1016/0142-9612(96)85917-5
   DALKAINE CV, 1993, CORROS SCI, V34, P117, DOI 10.1016/0010-938X(93)90263-G
   DALKAINE CV, 1993, CORROS SCI, V34, P109, DOI 10.1016/0010-938X(93)90262-F
   DALKAINE CV, 1993, CORROS SCI, V34, P129, DOI 10.1016/0010-938X(93)90264-H
   Dasquet JP, 2000, THIN SOLID FILMS, V371, P183, DOI 10.1016/S0040-6090(00)01016-6
   de Levie R., 1967, ADV ELECTROCHEMISTRY, P329
   DIQUARTO F, 1989, ELECTROCHIM ACTA, V34, P321
   DIQUARTO F, 1984, J ELECTROCHEM SOC, V131, P2901, DOI 10.1149/1.2115439
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Fischer V, 2003, P 7 INT C PROP APPL, V3, P1134
   Fu ZW, 1999, J ELECTROCHEM SOC, V146, P3914, DOI 10.1149/1.1392572
   Gonzalez JA, 1999, J APPL ELECTROCHEM, V29, P229, DOI 10.1023/A:1003481418291
   Han Y, 2003, SURF COAT TECH, V168, P249, DOI 10.1016/S0257-8972(03)00016-1
   Hayashi Y, 1995, J ALLOY COMPD, V231, P702, DOI 10.1016/0925-8388(95)01756-9
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   KERREC O, 1995, ELECTROCHIM ACTA, V40, P719, DOI 10.1016/0013-4686(94)00330-4
   KOLSKI TL, 1965, J ELECTROCHEM SOC, V112, P272, DOI 10.1149/1.2423522
   Kovacs K, 2003, J ELECTROCHEM SOC, V150, pB361, DOI 10.1149/1.1585052
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Li YM, 2000, J ELECTROCHEM SOC, V147, P1344, DOI 10.1149/1.1393360
   LIU SH, 1985, PHYS REV LETT, V55, P529, DOI 10.1103/PhysRevLett.55.529
   MACAGNO V, 1984, J ELECTROANAL CHEM, V180, P157, DOI 10.1016/0368-1874(84)83577-7
   Maehara K, 2002, MATER TRANS, V43, P2936, DOI 10.2320/matertrans.43.2936
   Mansfeld F, 1999, ANAL INTERPRETATION
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Modestov AD, 1999, J ELECTROANAL CHEM, V460, P214, DOI 10.1016/S0022-0728(98)00378-7
   Norlin A, 2004, ELECTROCHIM ACTA, V49, P4011, DOI 10.1016/j.electacta.2003.11.040
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   PIAZZA S, 1990, J ELECTROANAL CHEM, V293, P69, DOI 10.1016/0022-0728(90)80053-9
   Rosenfeld D, 1996, SENSOR ACTUAT B-CHEM, V37, P83, DOI 10.1016/S0925-4005(96)01991-0
   SAPOVAL B, 1988, PHYS REV A, V38, P5867, DOI 10.1103/PhysRevA.38.5867
   SCHIDER S, 1986, INT J POWDER METALL, V22, P47
   SCHULTZE JW, 1986, ELECTROCHIM ACTA, V31, P355, DOI 10.1016/0013-4686(86)80090-1
   Silva RA, 2002, J MATER SCI-MATER M, V13, P495, DOI 10.1023/A:1014779008598
   Sittig C, 1999, J MATER SCI-MATER M, V10, P191, DOI 10.1023/A:1008997726370
   Song WH, 2004, BIOMATERIALS, V25, P3341, DOI 10.1016/j.biomaterials.2003.09.103
   Suay JJ, 2003, CORROS SCI, V45, P611, DOI 10.1016/S0010-938X(02)00137-3
   Sul YT, 2002, BIOMATERIALS, V23, P491, DOI 10.1016/S0142-9612(01)00131-4
   Sul YT, 2003, BIOMATERIALS, V24, P3893, DOI 10.1016/S0142-9612(03)00261-8
   Tanabe K, 2003, CATAL TODAY, V78, P65, DOI 10.1016/S0920-5861(02)00343-7
   Teh TH, 2003, CORROS SCI, V45, P2757, DOI 10.1016/S0010-938X(03)00101-X
   Thomsen P, 1997, J MATER SCI-MATER M, V8, P653, DOI 10.1023/A:1018579605426
   VASKEVICH A, 1995, J ELECTROCHEM SOC, V142, P1501, DOI 10.1149/1.2048604
   Velten D, 2004, J MATER SCI-MATER M, V15, P457, DOI 10.1023/B:JMSM.0000021120.86985.f7
   Verne E, 2002, J EUR CERAM SOC, V22, P2315, DOI 10.1016/S0955-2219(02)00030-4
   WONG JY, 2004, SURF SCI, V570, P199
   Xu X, 2004, ANAL CHIM ACTA, V519, P31, DOI 10.1016/j.aca.2004.05.061
   Xue WB, 2002, J MATER SCI TECHNOL, V18, P37
   Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7
   Young L., 1961, ANODIC OXIDE FILMS
   Zhang YM, 2004, J BIOMED MATER RES A, V68A, P383, DOI 10.1002/jbm.a.20063
NR 54
TC 18
Z9 18
U1 0
U2 26
PU ELECTROCHEMICAL SOC INC
PI PENNINGTON
PA 65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA
SN 0013-4651
J9 J ELECTROCHEM SOC
JI J. Electrochem. Soc.
PY 2006
VL 153
IS 7
BP B225
EP B230
DI 10.1149/1.2196788
PG 6
WC Electrochemistry; Materials Science, Coatings & Films
SC Electrochemistry; Materials Science
GA 048KF
UT WOS:000237945300027
DA 2018-10-20
ER

PT J
AU Ollivon, M
   Keller, G
   Bourgaux, C
   Kalnin, D
   Villeneuve, P
   Lesieur, P
AF Ollivon, M.
   Keller, G.
   Bourgaux, C.
   Kalnin, D.
   Villeneuve, P.
   Lesieur, P.
TI DSC and high resolution X-ray diffraction coupling
SO JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY
LA English
DT Article; Proceedings Paper
CT 33rd Annual Meeting of the North-American-Thermal-Analysis-Society
CY SEP 19-21, 2005
CL Univ City, CA
SP N Amer Thermal Anal Soc
DE lipid structures; mesophase and biomaterial studies; polymorphism; small
   angle X-ray scattering; triacylglycerol
ID BEHAVIOR; PHASE; CRYSTALLIZATION; CALORIMETRY; FAT
AB Coupling of time-resolved synchrotron X-ray diffraction at both small and wide angles with differential scanning calorimetry is a new technique that allows simultaneous characterization of thermal and structural properties of a sample. The apparatus, called Microcalix, works between -30 and +230 degrees C at scanning rates comprised between 0.01 and 20 degrees C min(-1) with a high sensitivity in both measurements using a single sample of small volume (from about I to 20 mu L). The last version of the instrument is designed for laboratory bench and conventional source but preferably with rotating anode or multilayered mirrors. Measurements under low pressure or under shear as well as recordings of isothermal evolution are also possible. The example of the study of polymorphism of a monounsaturated triglyceride (PPO) will be presented as an application.
C1 Univ Paris Sud, Pharm Galen & Biopharm Lab, CNRS, UMR 8612, F-92296 Chatenay Malabry, France.
   Univ Paris 11, LURE, F-91405 Orsay, France.
   CIRAD, F-34398 Montpellier, France.
   Univ Henri Poincare, UMR 7565, F-54506 Vandoeuvre Les Nancy, France.
RP Ollivon, M (reprint author), Univ Paris Sud, Pharm Galen & Biopharm Lab, CNRS, UMR 8612, F-92296 Chatenay Malabry, France.
EM miche1.ollivon@cep.u-psud.fr
RI Kalnin, Daniel/A-8384-2008; Villeneuve, Pierre/C-1264-2008
OI Villeneuve, Pierre/0000-0003-1685-1494
CR Angelov B, 2003, J AM CHEM SOC, V125, P7188, DOI 10.1021/ja034578v
   Angelova A, 2005, LANGMUIR, V21, P4138, DOI 10.1021/la047745t
   Blanton TN, 2000, J APPL CRYSTALLOGR, V33, P172, DOI 10.1107/S0021889899012388
   Brubach JB, 2004, J PHYS CHEM B, V108, P17721, DOI 10.1021/jp047989m
   Carion-Taravella B, 2002, LANGMUIR, V18, P325, DOI 10.1021/la001638r
   GRABIELLEMADELMONT C, 1983, J COLLOID INTERF SCI, V95, P483, DOI 10.1016/0021-9797(83)90208-4
   GUINIER A, 1964, THEORIE TECHNIQUE RA, P1
   Kalnin D, 2004, CRYST GROWTH DES, V4, P1283, DOI 10.1021/cg030071k
   KALNIN D, UNPUB
   KELLENS M, 1990, CHEM PHYS LIPIDS, V52, P79, DOI 10.1016/0009-3084(90)90153-I
   Keller G, 1998, J THERM ANAL CALORIM, V51, P783, DOI 10.1007/BF03341455
   LARSSON K, 1972, FETTE SEIFEN ANSTR V, V74, P136, DOI 10.1002/lipi.19720740302
   Larsson K, 1994, LIPIDS MOL ORG PHYSI, P7
   Lopez C, 2002, J COLLOID INTERF SCI, V254, P64, DOI 10.1006/jcis.2002.8548
   LOPEZ C, 2002, J AM OIL CHEM SOC, V78, P1233
   Rysanek N, 2002, J PHYS CHEM B, V106, P11870, DOI 10.1021/jp015607w
NR 16
TC 49
Z9 50
U1 1
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-6150
J9 J THERM ANAL CALORIM
JI J. Therm. Anal. Calorim.
PY 2006
VL 85
IS 1
BP 219
EP 224
DI 10.1007/s10973-005-7351-y
PG 6
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA 076MA
UT WOS:000239961200038
DA 2018-10-20
ER

PT S
AU Diggs, DE
   Grote, JG
   Hopkins, FK
   Hagen, J
AF Diggs, Darnell E.
   Grote, James G.
   Hopkins, Frank K.
   Hagen, Josh
BE Norwood, RA
   Eich, M
   Nunzi, JM
TI Characterization of DNA-based materials for optical device applications
SO LINEAR AND NONLINEAR OPTICS OF ORGANIC MATERIALS VI
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Linear and Nonlinear Optics of Organic Materials VI
CY AUG 15-17, 2006
CL San Diego, CA
SP SPIE
DE DNA; deoxyribonucleic acid; PMMA; Bromocresol Purple (BCP); optical
   planar waveguide; chemical sensor; and poled polymer
ID COMPLEX; SENSOR
AB The use of DNA as a functional biomaterial for optical device applications is becoming a fast-expanding technology. Various researchers are investigating salmon DNA as the primary ingredient in the design of optical waveguide devices. The interaction of the indicator dye molecule, Bromocresol Purple (BCP) with the unique homogeneous double helical structure of DNA for potential electro-optic and chemical sensing applications is reported.
C1 [Diggs, Darnell E.; Grote, James G.; Hopkins, Frank K.] USAF, Res Lab, Mat & Mfg Directorate, Wright Patterson AFB, OH 45433 USA.
   [Hagen, Josh] Univ Cincinnati, Nanoelect Lab, Cincinnati, OH 45221 USA.
RP Diggs, DE (reprint author), USAF, Res Lab, Mat & Mfg Directorate, Wright Patterson AFB, OH 45433 USA.
CR Diggs DE, 2000, P SOC PHOTO-OPT INS, V4106, P31, DOI 10.1117/12.408527
   Heckman EM, 2004, P SOC PHOTO-OPT INS, V5516, P47, DOI 10.1117/12.563071
   KIEL JL, 2003 JOINT SERV SCI
   KLEIN R, 1993, P SOC PHOTO-OPT INS, V1885, P81, DOI 10.1117/12.144699
   Sarkisov SS, 2004, P SOC PHOTO-OPT INS, V5586, P33, DOI 10.1117/12.572426
   Wang L, 2002, P SOC PHOTO-OPT INS, V4905, P143, DOI 10.1117/12.480996
   Wang LL, 2001, CHEM MATER, V13, P1273, DOI 10.1021/cm000869g
   Zhang GJ, 2002, P SOC PHOTO-OPT INS, V4905, P375, DOI 10.1117/12.481027
NR 8
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6410-4
J9 PROC SPIE
PY 2006
VL 6331
AR 63310O
DI 10.1117/12.683467
PG 7
WC Materials Science, Multidisciplinary; Optics
SC Materials Science; Optics
GA BFI59
UT WOS:000242040400020
DA 2018-10-20
ER

PT J
AU Zhou, T
   Itoh, G
   Motohashi, Y
   Niinomi, M
AF Zhou, T
   Itoh, G
   Motohashi, Y
   Niinomi, M
TI Microstructural modification in a beta titanium alloy for implant
   applications
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE beta titanium alloy; biomaterial; segregation; deformation; high
   temperature
AB A recently developed beta titanium alloy, Ti-29-13, for biomedical applications has been subjected to microstructure examination and tensile test. Band structure is observed both in the as-received and cold-rolled specimens. By EDX in SEM, the band structure is confirmed to originate From the segregation of beta stabilizer. Thermomechanical processings consisting of repeated Solution treatment. water quenching and cold-rolling are performed to reduce the segregation. The considerable reduction of the band Structure is found in the processed specimen. The elongation at high temperature of the processed specimen is larger than that of the cold-rolled specimen although no difference in the strain rate sensitivity is confirmed between them.
C1 Ibaraki Univ, Coll Engn, Dept Engn Mech, Hitachi, Ibaraki 3168511, Japan.
   Ibaraki Univ, Satellite Venture Business Lab, Hitachi, Ibaraki 3168511, Japan.
   Ibaraki Univ, Res Ctr Superplastic, Hitachi, Ibaraki 3168511, Japan.
   Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
RP Itoh, G (reprint author), Ibaraki Univ, Coll Engn, Dept Engn Mech, Hitachi, Ibaraki 3168511, Japan.
EM gitoh@mech.ibaraki.ac.jp
RI Niinomi, Mitsuo/B-5965-2011
CR Argon AS, 1996, PHYSICAL METALLURGY, P1958
   BANIA PJ, 1994, J MET, V41, P16
   EYLON D, 1994, METALLURGY AND TECHNOLOGY OF PRACTICAL TITANIUM ALLOYS, P29
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Niinomi M., 2002, MAT JPN, V41, P221
   SEMLITSCH M, 1985, BIOMED TECH, V30, P334, DOI 10.1515/bmte.1985.30.12.334
   Zhou Q, 2005, MATER SCI FORUM, V475-479, P2299, DOI 10.4028/www.scientific.net/MSF.475-479.2299
   ZWICKER R, 1980, TITANIUM 80 SCI TECH, P505
NR 8
TC 9
Z9 9
U1 1
U2 6
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JAN
PY 2006
VL 47
IS 1
BP 90
EP 95
DI 10.2320/matertrans.47.90
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 015RL
UT WOS:000235568400017
OA Bronze
DA 2018-10-20
ER

PT B
AU Zeugolis, D
   Paul, G
   Attenburrow, GE
AF Zeugolis, D
   Paul, G
   Attenburrow, GE
BE Anand, SC
   Kennedy, JF
   Miraftab, M
   Rajendran, S
TI Reformed collagen fibres
SO Medical Textiles and Biomaterials for Healthcare
SE WOODHEAD PUBLISHING IN TEXTILES
LA English
DT Proceedings Paper
CT International Conference and Exhibition on Healthcare and Medical
   Textiles (MedTex 03)
CY JUL 08-09, 2003
CL Univ Bolton, Ctr Mat Res & Innovat, Bolton, ENGLAND
SP SSL Int plc, Shilo, Vernoncarus, Lantor, nw texnet, TechniTex, Textile Ind, dti, CRC Press
HO Univ Bolton, Ctr Mat Res & Innovat
ID FRACTURE-BEHAVIOR; BIOMATERIALS; SKIN
AB Collagen is the primary structural component of connective tissue and because of its inherent biocompatibility is an ideal candidate for biomedical applications such as scaffolds for tissue regeneration. One route to create a collagenous biomaterial which can be produced in a variety of forms is to render the collagen soluble and then reconstitute it. The research reported here is concerned with reconstituted collagen fibres and specifically compares different solubilisation processes (acid soluble collagen, ASC vs pepsin soluble collagen, PSC), and the influence of polyethylene glycol (PEG) solution on fibre formation. The structure and mechanical properties of reformed fibres were examined. It was found that PEG was essential for the formation of fibres from PSC but its use caused a decrease in the strength of the fibres from ASC. The yield of fibres from PSC was much greater than that from ASC. Some dried reformed fibres produced from both acid soluble and pepsin soluble collagen had a tensile strength equal to that of dried native collagen fibres.
C1 Univ Coll Northampton, Sch Appl Sci, Northampton NN2 7AL, England.
RP Zeugolis, D (reprint author), Univ Coll Northampton, Sch Appl Sci, Boughton Green Rd, Northampton NN2 7AL, England.
CR ARUMUGAM V, 1992, J MATER SCI, V27, P2649, DOI 10.1007/BF00540684
   Bienkiewicz K., 1983, PHYS CHEM LEATHER MA
   Bonassar L J, 1998, J Cell Biochem Suppl, V30-31, P297
   BYROM D, 1991, BIOMATERIALS NOVEL M, pCH2
   CAVALLARO JF, 1994, BIOTECHNOL BIOENG, V43, P781, DOI 10.1002/bit.260430813
   CHARULATHA V, 2000, J BIOM MAT RES, V54, P122
   COLLINS RLL, 1991, J BIOMED MATER RES, V25, P267, DOI 10.1002/jbm.820250212
   COTE MF, 1992, BIOMATERIALS, V13, P612, DOI 10.1016/0142-9612(92)90029-N
   DELORENZI NJ, 1993, MATRIX, V13, P407, DOI 10.1016/S0934-8832(11)80046-6
   DUNN MG, 1993, J BIOMED MATER RES, V27, P1545, DOI 10.1002/jbm.820271211
   Friess W, 1996, BIOMATERIALS, V17, P2289, DOI 10.1016/0142-9612(96)00047-6
   Holmes DF, 1998, J MOL BIOL, V283, P1049, DOI 10.1006/jmbi.1998.2153
   HSU S, 1994, BIORHEOLOGY, V31, P21
   Matsumoto K, 1999, ASAIO J, V45, P288, DOI 10.1097/00002480-199907000-00007
   MONTERO P, 1995, J FOOD SCI, V60, P1, DOI 10.1111/j.1365-2621.1995.tb05593.x
   MORGAN FR, 1960, J SOC LEATHER TRADES, V44, P170
   Parenteau N, 1999, SCI AM, V280, P83
   PIKKARAINEN J, 1968, ACTA PHYSL SCAND
   Rajini KH, 2001, J MATER SCI, V36, P5589, DOI 10.1023/A:1012509514714
   Raspanti M, 1997, J STRUCT BIOL, V119, P118, DOI 10.1006/jsbi.1997.3865
NR 20
TC 0
Z9 0
U1 0
U2 2
PU WOODHEAD PUBL LTD
PI CAMBRIDGE
PA ABINGTON HALL ABINGTON, CAMBRIDGE CB1 6AH, CAMBS, ENGLAND
BN 1-85573-683-7
J9 WOODH PUBL TEXT
PY 2006
BP 29
EP 36
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials; Materials
   Science, Textiles
SC Engineering; Materials Science
GA BDS54
UT WOS:000235184900003
DA 2018-10-20
ER

PT B
AU Bide, MJ
   Choi, HM
   Phaneuf, MD
   Quist, WC
   LoGerfo, FW
AF Bide, MJ
   Choi, HM
   Phaneuf, MD
   Quist, WC
   LoGerfo, FW
BE Anand, SC
   Kennedy, JF
   Miraftab, M
   Rajendran, S
TI The use of dye-like interactions for developing novel
   infection-resistant materials
SO Medical Textiles and Biomaterials for Healthcare
SE WOODHEAD PUBLISHING IN TEXTILES
LA English
DT Proceedings Paper
CT International Conference and Exhibition on Healthcare and Medical
   Textiles (MedTex 03)
CY JUL 08-09, 2003
CL Univ Bolton, Ctr Mat Res & Innovat, Bolton, ENGLAND
SP SSL Int plc, Shilo, Vernoncarus, Lantor, nw texnet, TechniTex, Textile Ind, dti, CRC Press
HO Univ Bolton, Ctr Mat Res & Innovat
AB Textile and other polymeric materials are ubiquitous in medical devices, whether used in implanted (e.g. prosthetic arterial grafts, prosthetic valve sewing cuffs), percutaneous (e.g. catheters, sutures) or extra-corporeal (e.g. wound dressings, cardiac bypass pump tubing) devices.
   Depending on the use (in or out of the body, short or long term), these materials can suffer a variety of problems. One of the most significant is that of infection. Infection affects both the biomaterial and the patient. Infection in the biomaterial leads to failure, and the need for replacement with associated cost and risks. For the patient, limb loss and mortality are potential outcomes. The treatment for an infected biomaterial is typically a systemic dosage of antibiotic that represents a potential source of resistant strains of bacteria. For urinary and indwelling catheters the infection rate is as high as 40%. This series of projects began originally to look specifically at prosthetic arterial grafts, and problems of infection associated with them. It has led to a series of projects in which dye-like interactions of several different biomedical materials with bioactive materials have produced potentially useful products.
C1 Univ Rhode Isl, Dept Text, Kingston, RI 02881 USA.
RP Bide, MJ (reprint author), Univ Rhode Isl, Dept Text, Kingston, RI 02881 USA.
CR BIDE M, 1993, TEXT CHEM COLOR, V25, P15
   Bide M. J., 2001, AATCC REV, V1, P35
   BIDE MJ, 2001, ACS S SERIES, V792
   CHOI HM, UNPUB J APPL POLYM S
   Golan J F, 1989, Infect Dis Clin North Am, V3, P247
   GROHE K, 1992, CHEM BRIT, V28, P34
   HUANG HX, 2002, THESIS U RHODE ISLAN
   JOKLEK W, 1984, ZINSSER MICROBIOLOGY, pCH9
   MOORE W, 1991, VASCULAR SURG COMPRE, pCH16
   OZAKI CK, 1993, J SURG RES, V55, P543, DOI 10.1006/jsre.1993.1181
   PHANEUF MD, 1999, MERGING BIOMEDICAL T
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   SUMNER HH, 1989, THEORY COLORATION TE, pCH4
   WOOD MJ, 1988, BRIT J CLIN PRACT, V42, P469
NR 14
TC 2
Z9 2
U1 0
U2 0
PU WOODHEAD PUBL LTD
PI CAMBRIDGE
PA ABINGTON HALL ABINGTON, CAMBRIDGE CB1 6AH, CAMBS, ENGLAND
BN 1-85573-683-7
J9 WOODH PUBL TEXT
PY 2006
BP 136
EP 143
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials; Materials
   Science, Textiles
SC Engineering; Materials Science
GA BDS54
UT WOS:000235184900016
DA 2018-10-20
ER

PT B
AU Gellynck, K
   Verdonk, P
   Almqvist, F
   Van Nimmen, E
   De Bakker, D
   Van Langenhove, L
   Mertens, J
   Verbruggen, G
   Kiekens, P
AF Gellynck, K
   Verdonk, P
   Almqvist, F
   Van Nimmen, E
   De Bakker, D
   Van Langenhove, L
   Mertens, J
   Verbruggen, G
   Kiekens, P
BE Anand, SC
   Kennedy, JF
   Miraftab, M
   Rajendran, S
TI A spider silk supportive matrix used for cartilage regeneration
SO Medical Textiles and Biomaterials for Healthcare
SE WOODHEAD PUBLISHING IN TEXTILES
LA English
DT Proceedings Paper
CT International Conference and Exhibition on Healthcare and Medical
   Textiles (MedTex 03)
CY JUL 08-09, 2003
CL Univ Bolton, Ctr Mat Res & Innovat, Bolton, ENGLAND
SP SSL Int plc, Shilo, Vernoncarus, Lantor, nw texnet, TechniTex, Textile Ind, dti, CRC Press
HO Univ Bolton, Ctr Mat Res & Innovat
ID PROTEINS; REPAIR; FIBERS; CELLS
AB Injured cartilage, not accreting by itself, often decreases the quality of life. The chondrocytes need an implanted support to bridge and recover the wound with extracellular matrix products forming fresh cartilage. Advances in cell biology and biomaterial research have lead to new possibilities in tissue engineering. Transplanted scaffolds, holding a 3D cell culture, should copy the cartilage characteristics. Strength and flexibility are important, but even more an adequate porosity, so the chondrocytes can migrate through the matrix, but are not able to float around.
   Looking for regeneration and not a repair, we want the scaffold material to disappear while real cartilage is healing the wound. In this way the material and its hydrolysis products have to be biocompatible and harmless. In the case of synthetic polymers, the hydrolysis products are frequently toxic, Spider silk is a promising fibre for many applications. Completely made out of protein a suspected biocompatibility is already proven. The harmless amino acid hydrolysis products make the silk a good candidate for creating a bioresorbable textile scaffold.
   The chondrocytes cells adhere quite well on the spider cocoon silk threads. Cocoons can be obtained each autumn in large numbers from the Araneus diadematus garden spider. The mechanical properties of the silk are more appropriate than polymeric gels, like hyaluronic acid, collagen and alginate, which have proved to be successful in 3D immobilisation and maintaining the differentiated phenotype of chondrocytes. The phenotypical products collagen II and aggrecan were also detected around the cells growing on the spider cocoon silk. A silk 3D textile could possibly be applied in combination with a polymer gel, probably alginate, in order to achieve some biomechanical stability. While biodegradation is occurring, the silk textile is overgrown with real cartilage and eventually the wound will be recovered without any definitive synthetic implants.
C1 Univ Ghent, Dept Text, B-9000 Ghent, Belgium.
RP Gellynck, K (reprint author), Univ Ghent, Dept Text, B-9000 Ghent, Belgium.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Coutts RD, 2001, CLIN ORTHOP RELAT R, pS271, DOI 10.1097/00003086-200110001-00025
   DOSER M, 2000, NONWOVENS IND TEXTIL, P10
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Kubik S, 2002, ANGEW CHEM INT EDIT, V41, P2721, DOI 10.1002/1521-3773(20020802)41:15<2721::AID-ANIE2721>3.0.CO;2-3
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Solchaga LA, 2001, CLIN ORTHOP S, V391, P161
   TAKAHASHI Y, 1991, J POLYM SCI POL PHYS, V29, P889, DOI 10.1002/polb.1991.090290714
   WATZL A, 2000, TECHNICAL TEXTILES, V43, P295
NR 16
TC 2
Z9 2
U1 0
U2 6
PU WOODHEAD PUBL LTD
PI CAMBRIDGE
PA ABINGTON HALL ABINGTON, CAMBRIDGE CB1 6AH, CAMBS, ENGLAND
BN 1-85573-683-7
J9 WOODH PUBL TEXT
PY 2006
BP 350
EP 354
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials; Materials
   Science, Textiles
SC Engineering; Materials Science
GA BDS54
UT WOS:000235184900042
DA 2018-10-20
ER

PT B
AU Patel, P
   Jalal, A
   Ohkoshi, Y
AF Patel, P
   Jalal, A
   Ohkoshi, Y
BE Anand, SC
   Kennedy, JF
   Miraftab, M
   Rajendran, S
TI Enhancing physio-chemical behaviour of P(LLA/CL) suture by solvent
   treatment
SO Medical Textiles and Biomaterials for Healthcare
SE WOODHEAD PUBLISHING IN TEXTILES
LA English
DT Proceedings Paper
CT International Conference and Exhibition on Healthcare and Medical
   Textiles (MedTex 03)
CY JUL 08-09, 2003
CL Univ Bolton, Ctr Mat Res & Innovat, Bolton, ENGLAND
SP SSL Int plc, Shilo, Vernoncarus, Lantor, nw texnet, TechniTex, Textile Ind, dti, CRC Press
HO Univ Bolton, Ctr Mat Res & Innovat
ID FIBERS; SPUN
AB Suture is polimeric biomaterial either in monofilament or multifilament form used in surgical application in medical and healthcare sector. The monofilament suture is very easy in handling and knot throw-down and also less risky in picking up infection. The paper described the experimental study on a recently developed resorbable monofilament copolymer of L-lactic acid and e-caprolactone [P(LLA/CL)] suture. For security of suturing, "knot-pull strength" is more important than tensile strength. The monofilament having higher denier makes it stiffer and difficult for easy knot throw-down. Using laboratory fabricated set-up, solvent treatment is given by immerging the fibre in the acetone: water mixture for different time periods. Birefringence measurement was made to study the change in the orientation of the fibre across its section. The tensile strength and knot-pull strength results of the treated fibres are compared to show enhancement in physio-chemical behaviour of the suture.
C1 Maharaja Sayajirao Univ Baroda, Baroda, Gujarat, India.
RP Patel, P (reprint author), Maharaja Sayajirao Univ Baroda, Baroda, Gujarat, India.
CR BEZWADA RS, 1995, BIOMATERIALS, V16, P1141, DOI 10.1016/0142-9612(95)93577-Z
   ELING B, 1982, POLYMER, V23, P1587, DOI 10.1016/0032-3861(82)90176-8
   GOGOLEWSKI S, 1983, J APPL POLYM SCI, V28, P1045, DOI 10.1002/app.1983.070280312
   JALAL A, 1999, THESIS U BARODA INDI
   KARACA E, 2001, TEXT RES J, V5, P435
   KRONENTHAL RL, 1975, POLYM SCI TECHNOLOGY
   OHKOSHI Y, SENI GAKKAISHI, P21
   PEREGO G, 1994, BIOMATERIALS, V15, P189, DOI 10.1016/0142-9612(94)90066-3
   Tomihata K, 1998, POLYM DEGRAD STABIL, V59, P13, DOI 10.1016/S0141-3910(97)00183-3
NR 9
TC 0
Z9 0
U1 0
U2 2
PU WOODHEAD PUBL LTD
PI CAMBRIDGE
PA ABINGTON HALL ABINGTON, CAMBRIDGE CB1 6AH, CAMBS, ENGLAND
BN 1-85573-683-7
J9 WOODH PUBL TEXT
PY 2006
BP 386
EP 394
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials; Materials
   Science, Textiles
SC Engineering; Materials Science
GA BDS54
UT WOS:000235184900047
DA 2018-10-20
ER

PT B
AU Yildiz, N
AF Yildiz, N
BE Anand, SC
   Kennedy, JF
   Miraftab, M
   Rajendran, S
TI Nerve implants
SO Medical Textiles and Biomaterials for Healthcare
SE WOODHEAD PUBLISHING IN TEXTILES
LA English
DT Proceedings Paper
CT International Conference and Exhibition on Healthcare and Medical
   Textiles (MedTex 03)
CY JUL 08-09, 2003
CL Univ Bolton, Ctr Mat Res & Innovat, Bolton, ENGLAND
SP SSL Int plc, Shilo, Vernoncarus, Lantor, nw texnet, TechniTex, Textile Ind, dti, CRC Press
HO Univ Bolton, Ctr Mat Res & Innovat
DE graft; nerve implant; biomaterials; nerve regeneration
ID BIOMATERIALS; REGENERATION; TISSUE
AB Synthetic materials have been used in the medical field for surgical grafts due to lack of insufficient organic graft prosthesis. In the first years of their development, properties of an ideal graft were defined. "An ideal graft must be durable on implantation, must be produced at the required dimension, must be biocompatible, must be inert, must be nontoxic and non-allergic." It must also be elastic, comfortable, biostable and biomechanic. In this study nonresorbable and resorbable artificial nerve grafts are being searched as implantable textile materials based on various biomaterial in nerve tissue defects which occur in peripheral neurons in hands and arms and spinal cord neurons in the central nervous system. Evaluation of nerve implants are also being carried out according to their implantable biomaterial properties in medical textiles including electrophysiological studies and nerve regeneration of implants in nervous systems.
C1 Pamukkale Univ, Camlik, Denizli, Turkey.
RP Yildiz, N (reprint author), Pamukkale Univ, Camlik, Denizli, Turkey.
CR Adanur S, 1995, WELLINGTON SEARS HDB
   Anand S. C., 2000, HDB TECHNICAL TEXTIL
   Decherchi P, 1996, EXP NEUROL, V137, P1, DOI 10.1006/exnr.1996.0001
   FRANCEL P, 1996, AM ASS NEUROLOGICAL
   Iwai M, 2001, MICROSURG, V21, P43, DOI 10.1002/micr.1007
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   *SCI TECHN POL I I, 2000, BIOM AV POT EFF MED
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   *SWED I FIBR POLYM, 2000, MED TEXT
   YILDIZ N, 2002, 1 INT C TECHN TEXT I
NR 10
TC 0
Z9 0
U1 0
U2 1
PU WOODHEAD PUBL LTD
PI CAMBRIDGE
PA ABINGTON HALL ABINGTON, CAMBRIDGE CB1 6AH, CAMBS, ENGLAND
BN 1-85573-683-7
J9 WOODH PUBL TEXT
PY 2006
BP 441
EP 447
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials; Materials
   Science, Textiles
SC Engineering; Materials Science
GA BDS54
UT WOS:000235184900054
DA 2018-10-20
ER

PT B
AU Ekevall, E
   Wilson, JIB
   Mather, RR
AF Ekevall, E
   Wilson, JIB
   Mather, RR
BE Anand, SC
   Kennedy, JF
   Miraftab, M
   Rajendran, S
TI The effect of ammonia and sulphur dioxide gas plasma treatments on
   polymer surfaces
SO Medical Textiles and Biomaterials for Healthcare
SE WOODHEAD PUBLISHING IN TEXTILES
LA English
DT Proceedings Paper
CT International Conference and Exhibition on Healthcare and Medical
   Textiles (MedTex 03)
CY JUL 08-09, 2003
CL Univ Bolton, Ctr Mat Res & Innovat, Bolton, ENGLAND
SP SSL Int plc, Shilo, Vernoncarus, Lantor, nw texnet, TechniTex, Textile Ind, dti, CRC Press
HO Univ Bolton, Ctr Mat Res & Innovat
ID CELLS; ATTACHMENT
AB Gas discharge plasma treatment can be used to modify the surface properties of biomaterials for a variety of biomedical applications. An established application is the use of oxygen and nitrogen plasmas to improve the hydrophilicity of surfaces, encouraging cell attachment and subsequent growth. The physical properties and surface chemistry of the biomaterial influences cell attachment and subsequent culture. In-situ cells are surrounded by a complex extracellular matrix (ECM) containing fibronectin, laminin, collagen types I-V, and proteoglycans. In this study, ammonia and sulphur dioxide gases have been chosen with the objective of incorporating carboxylic. acid, sulphur and nitrogen containing groups on the surface.
   Aim: To investigate the effect of gas plasma treatments on untreated polystyrene Petri dishes and apply the technology to tissue engineering scaffolds.
   Methods: Untreated tissue culture Petri dishes (TCPD) (35 mm 0) were gas plasma treated with either ammonia, sulphur dioxide or ammonia followed by sulphur dioxide gases in a low temperature radio-frequency gas plasma chamber. An orthogonal design was used to optimise the treatments, which looked at the effect of varying the power, distance between the (upper and lower) plates and treatment time. To determine changes in hydrophilicity, the static contact angle was measured using image analysis equipment. Samples were kept in the laboratory and the contact angle of the surface measured one, three and six months after gas plasma treatment. To investigate the surface changes some samples were analysed using the X-ray Photoelectron Spectrometer (XPS) at the RUSTI, CLRC Daresbury Laboratory, UK.
   Results: The untreated TCPD (controls) had a static contact angle of 53.5 +/- 0.8 degrees. Gas plasma treatment with ammonia lowered the contact angle to approximately 25 - 30 degrees after 1 month, which remained relatively constant at 3 and 6 months depending on the treatment parameters. Treatment with sulphur dioxide produced more variable results. Overall treatment with ammonia followed by sulphur dioxide produced the greatest change in hydrophilicity lowering the contact angle to between 18.3 +/- 4.2 degrees and 29.7 +/- 2.0 degrees for all four sets of parameters. The XPS spectra show changes in the O1s and C1s groups and the introduction of N1s, S2p and S2s groups in the treated samples
   Conclusions: Ammonia and sulphur dioxide plasma treatments do alter the surface functional groups in the biomaterial, increasing the hydrophilicity of the surface. In this study the greatest increase in hydrophilicity was observed after treatment with ammonia followed by sulphur dioxide. However, to successfully apply the results to tissue engineering scaffolds, the effect on cell attachment, coverage and morphology must be evaluated on the optimised surfaces.
   Treatment 1 appears to produce the most stable results but further investigation into the correlations between the individual parameters (power, distance and time) is required. In this study the minimum treatment time is one minute, which may be too long for the sulphur dioxide treatments and treatment times below one minute should be investigated. Although, when the samples are examined under the electron microscope no changes in the surface, such as etching, are observed. The XPS results confirm that the surface has indeed changed, with gas plasma discharge treatment introducing new functional groups on the surface. The next step is to quantify these changes.
C1 Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland.
RP Ekevall, E (reprint author), Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland.
CR Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Daw R, 1998, J MATER CHEM, V8, P2583, DOI 10.1039/a806612d
   France RM, 1998, J MATER CHEM, V8, P37, DOI 10.1039/a705098d
   Gumusderelioglu M, 2002, BIOMATERIALS, V23, P3927, DOI 10.1016/S0142-9612(02)00128-X
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   Lu A, 2001, BIOMATERIALS, V22, P1439, DOI 10.1016/S0142-9612(00)00302-1
   Thull R, 2002, BIOMOL ENG, V19, P43, DOI 10.1016/S1389-0344(02)00009-6
   TRISANOV S, 2002, CONTACT ANGLE MATH S
   YIN GZ, 1987, SOLID STATE TECHNOL, P127
   1999, BECTON DICKINSON LAB, P66
NR 10
TC 0
Z9 0
U1 0
U2 3
PU WOODHEAD PUBL LTD
PI CAMBRIDGE
PA ABINGTON HALL ABINGTON, CAMBRIDGE CB1 6AH, CAMBS, ENGLAND
BN 1-85573-683-7
J9 WOODH PUBL TEXT
PY 2006
BP 491
EP 498
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials; Materials
   Science, Textiles
SC Engineering; Materials Science
GA BDS54
UT WOS:000235184900058
DA 2018-10-20
ER

PT S
AU Bai, J
   Saheb-Djawaher, R
   Ma, T
   Chu, W
   Wang, R
   Silva, L
   Michal, C
   Chiao, JC
   Chiao, M
AF Bai, J
   Saheb-Djawaher, R
   Ma, T
   Chu, W
   Wang, R
   Silva, L
   Michal, C
   Chiao, JC
   Chiao, M
GP IEEE
TI Spider silk as a new biomaterial for MEMS
SO MEMS 2006: 19TH IEEE INTERNATIONAL CONFERENCE ON MICRO ELECTRO
   MECHANICAL SYSTEMS, TECHNICAL DIGEST
SE Proceedings IEEE Micro Electro Mechanical Systems
LA English
DT Proceedings Paper
CT 19th IEEE International Conference on Micro Electro Mechanical Systems
   (MEMS 2006)
CY JAN 22-26, 2006
CL Istanbul, TURKEY
SP IEEE, Robot & Automat Soc
ID C-13; NMR
AB In this work, spider drag-line silk is introduced for the first time as a new biomaterial for Micro-electro-mechanical Systems (MEMS). The tasks accomplished were focused on material characterization of regenerated spider silk under two conditions: (1) spin-coated thin film formed onto a silicon substrate; (2) formation of a free-standing microbridge (800 X 800 X 150 pm 3) obtained by a surface micromachining process with sacrificial etching. Preliminary micro mechanical testing showed the spider silk microstructure having an elastic modulus of 7.251 GPa, an ultimate tensile strength of 21.15 MPa and a loss tangent of 0.044.
C1 Univ British Columbia, Dept Mech Engn, Vancouver, BC V5Z 1M9, Canada.
   Univ British Columbia, Sch Occupat & Envinornm Hygiene, Vancouver, BC V5Z 1M9, Canada.
   Univ British Columbia, Dept Mat, Vancouver, BC V5Z 1M9, Canada.
   Univ British Columbia, Dept Phys, Vancouver, BC V5Z 1M9, Canada.
   Univ Texas Arlington, Dept Elect Engn, Arlington, TX USA.
RP Bai, J (reprint author), Univ British Columbia, Dept Mech Engn, Vancouver, BC V5Z 1M9, Canada.
EM muchiao@mech.ubc.ca
RI Michal, Carl/G-5288-2012
OI Michal, Carl/0000-0002-5764-3221
FU Canada Research Chairs Program; Canada Foundation for Innovation;
   Natural Sciences and Engineering Research Council of Canada (NSERC)
   Discovery Program
FX This project is supported in part by the Canada Research Chairs Program,
   Canada Foundation for Innovation and the Natural Sciences and
   Engineering Research Council of Canada (NSERC) Discovery Program.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907
   HIBBELER RC, 1999, MECH MAT
   Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5
   KUBIK S, 2002, ANGEW CHEM INT, V41
   Li XD, 2002, MATER CHARACT, V48, P11
   *MIT OP COURS, 2003, DES MED DEV IMPL, pCH8
   *MTS SYST CORP, 2001, NAN IND XP US MAN
   Seidel A, 1998, MACROMOLECULES, V31, P6733, DOI 10.1021/ma9808880
   Seidel A, 2000, MACROMOLECULES, V33, P775, DOI 10.1021/ma990893j
   Shao ZZ, 1999, POLYMER, V40, P1799, DOI 10.1016/S0032-3861(98)00266-3
   Shao ZZ, 2003, MACROMOLECULES, V36, P1157, DOI 10.1021/ma0214660
   SILVAL, MRS P 05 SPR M
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Stephens JS, 2005, BIOMACROMOLECULES, V6, P1405, DOI 10.1021/bm049296h
   Yang ZT, 2000, J AM CHEM SOC, V122, P9019, DOI 10.1021/ja0017099
NR 16
TC 0
Z9 0
U1 1
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1084-6999
BN 0-7803-9475-5
J9 PROC IEEE MICR ELECT
PY 2006
BP 226
EP 229
PG 4
WC Engineering, Electrical & Electronic; Engineering, Mechanical;
   Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BEE74
UT WOS:000236994500057
DA 2018-10-20
ER

PT J
AU Gast, FU
   Dittrich, PS
   Schwille, P
   Weigel, M
   Mertig, M
   Opitz, J
   Queitsch, U
   Diez, S
   Lincoln, B
   Wottawah, F
   Schinkinger, S
   Guck, J
   Kas, J
   Smolinski, J
   Salchert, K
   Werner, C
   Duschl, C
   Jager, MS
   Uhlig, K
   Geggier, P
   Howitz, S
AF Gast, FU
   Dittrich, PS
   Schwille, P
   Weigel, M
   Mertig, M
   Opitz, J
   Queitsch, U
   Diez, S
   Lincoln, B
   Wottawah, F
   Schinkinger, S
   Guck, J
   Kas, J
   Smolinski, J
   Salchert, K
   Werner, C
   Duschl, C
   Jager, MS
   Uhlig, K
   Geggier, P
   Howitz, S
TI The microscopy cell (MicCell), a versatile modular flowthrough system
   for cell biology, biomaterial research, and nanotechnology
SO MICROFLUIDICS AND NANOFLUIDICS
LA English
DT Article
DE lab-on-chip; PDMS microchannel; microscopy; hydrogel valve;
   microelectrodes
ID HIGHLY CONDUCTIVE NANOWIRES; CHEMICAL-ANALYSIS SYSTEMS; OPTICAL
   DEFORMABILITY; MICROFLUIDIC SYSTEMS; MOTOR PROTEINS; FLOW-CYTOMETRY; DNA
   MOLECULE; GRADIENTS; GENERATION; SURFACES
AB We describe a novel microfluldic perfusion system for high-resolution microscopes. Its modular design allows pre-coating of the coverslip surface with reagents, biomolecules, or cells. A poly(dimethylsiloxane) (PDMS) layer is cast in a special molding station, using masters made by photolithography and dry etching of silicon or by photoresist patterning on glass or silicon. This channel system can be reused while the coverslip is exchanged between experiments. As normal fluidic connectors are used, the link to external, computer-programmable syringe pumps is standardized and various fluidic channel networks can be used in the same setup. The system can house hydrogel microvalves and microelectrodes close to the imaging area to control the influx of reaction partners. We present a range of applications, including single-molecule analysis by fluorescence correlation spectroscopy (FCS), manipulation of single molecules for nanostructuring by hydrodynamic flow fields or the action of motor proteins, generation of concentration gradients, trapping and stretching of live cells using optical fibers precisely mounted in the PDMS layer, and the integration of microelectrodes for actuation and sensing.
C1 GeSiM mbH, D-01454 Grosserkmannsdorf, Germany.
   Inst Analyt Sci, Dept Miniaturizat, D-44139 Dortmund, Germany.
   Tech Univ Dresden, Inst Biophys Biotec, D-01307 Dresden, Germany.
   TU Dresden, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
   TU Dresden, Inst Mat Sci, D-01069 Dresden, Germany.
   Max Planck Inst Mol Cell Biol & Genet, Grp Opt Technol Dev & Bioanotechnol, D-01307 Dresden, Germany.
   Univ Leipzig, Dept Phys & Geosci, Inst Soft Matter Phys, D-04103 Leipzig, Germany.
   Leibniz Inst Polymer Res, Dept Ciocompatible Mat, D-01069 Dresden, Germany.
   Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
   Fraunhofer Inst Biomed Engn, FhIBMT, D-10115 Berlin, Germany.
RP Gast, FU (reprint author), GeSiM mbH, D-01454 Grosserkmannsdorf, Germany.
EM gast@gesim.de
RI Guck, Jochen/B-4412-2014; Werner, Carsten/F-8127-2010; Diez,
   Stefan/E-8172-2010; Duschl, Claus/G-6106-2016; Schwille,
   Petra/A-4983-2010; Dittrich, Petra/C-6717-2008; Umlauf,
   Ursula/D-3356-2014
OI Guck, Jochen/0000-0002-1453-6119; Werner, Carsten/0000-0003-0189-3448;
   Diez, Stefan/0000-0002-0750-8515; Dittrich, Petra/0000-0001-5359-8403;
   Opitz, Joerg/0000-0003-3142-2479
CR Allemand JF, 1997, BIOPHYS J, V73, P2064, DOI 10.1016/S0006-3495(97)78236-5
   Alon R, 2002, SEMIN IMMUNOL, V14, P93, DOI 10.1006/smim.2001.0346
   Andersson H, 2003, SENSOR ACTUAT B-CHEM, V92, P315, DOI 10.1016/S0925-4005(03)00266-1
   Bohm KJ, 2000, FEBS LETT, V466, P59, DOI 10.1016/S0014-5793(99)01757-3
   Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826
   Brunner C, 2004, NANOTECHNOLOGY, V15, pS540, DOI 10.1088/0957-4484/15/10/008
   Cesaro-Tadic S, 2004, LAB CHIP, V4, P563, DOI 10.1039/b408964b
   Dertinger SKW, 2001, ANAL CHEM, V73, P1240, DOI 10.1021/ac001132d
   Dertinger SKW, 2002, P NATL ACAD SCI USA, V99, P12542, DOI 10.1073/pnas.192457199
   Diez S, 2003, NANO LETT, V3, P1251, DOI 10.1021/nl034504h
   Dittrich PS, 2005, CHEMBIOCHEM, V6, P811, DOI 10.1002/cbic.200400321
   Dittrich PS, 2004, PHYS CHEM CHEM PHYS, V6, P4416, DOI 10.1039/b406899h
   Dittrich PS, 2003, ANAL CHEM, V75, P5767, DOI 10.1021/ac034568c
   DUSCHL C, 2004, LAB ON CHIPS CELLOMI
   EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740
   ELSON EL, 1988, ANNU REV BIOPHYS BIO, V17, P397
   FIEDLER S, 1995, ANAL CHEM, V67, P820, DOI 10.1021/ac00101a006
   Fu AY, 1999, NAT BIOTECHNOL, V17, P1109
   Georgiou G, 2001, ADV PROTEIN CHEM, V55, P293, DOI 10.1016/S0065-3233(01)55007-X
   Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935
   Guck J, 2000, PHYS REV LETT, V84, P5451, DOI 10.1103/PhysRevLett.84.5451
   Guck J, 2001, BIOPHYS J, V81, P767, DOI 10.1016/S0006-3495(01)75740-2
   Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476
   Hess H, 2001, NANO LETT, V1, P235, DOI 10.1021/nl015521e
   Hess H, 2002, NANO LETT, V2, P1113, DOI 10.1021/nl025724i
   Hess H, 2002, NANO LETT, V2, P113, DOI 10.1021/nl015647b
   Howard J., 2001, MECH MOTOR PROTEINS
   Huang HD, 2004, AM J PHYSIOL-CELL PH, V287, pC1, DOI 10.1152/ajpcell.00559.2003
   Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b
   Knoblauch M, 2004, CELL MOTIL CYTOSKEL, V58, P137, DOI 10.1002/cb.20006
   Knoblauch M, 2003, NAT MATER, V2, P600, DOI 10.1038/nmat960
   Kobayashi J, 2004, SCIENCE, V304, P1305, DOI 10.1126/science.1096956
   Laemer F., 1994, US Patent, Patent No. [5,501,893, 5501893]
   Laermer F., German Patent, Patent No. [DE4241045, 4241045]
   Larson RG, 1997, PHYS REV E, V55, P1794, DOI 10.1103/PhysRevE.55.1794
   Lincoln B, 2004, CYTOM PART A, V59A, P203, DOI 10.1002/cyto.a.20050
   Lipman EA, 2003, SCIENCE, V301, P1233, DOI 10.1126/science.1085399
   MADGE D, 1972, PHYS REV LETT, V29, P6706
   MANZ A, 1990, SENSOR ACTUAT B-CHEM, V1, P244, DOI 10.1016/0925-4005(90)80209-I
   MANZ A, 1991, TRAC-TREND ANAL CHEM, V10, P144, DOI 10.1016/0165-9936(91)85116-9
   Maubach G, 2003, NANOTECHNOLOGY, V14, P1055
   Mertig M, 2002, NANO LETT, V2, P841, DOI 10.1021/nl025612r
   MERTIG M, 2004, NANOBIOTECHNOLOGY CO, P256
   Muller T, 1999, BIOSENS BIOELECTRON, V14, P247, DOI 10.1016/S0956-5663(99)00006-8
   Pompe T, 2003, BIOMACROMOLECULES, V4, P1072, DOI 10.1021/bm034071c
   Prots I, 2003, CELL BIOL INT, V27, P251, DOI 10.1016/S1065-6995(02)00313-X
   Richter A, 2004, SENSOR ACTUAT B-CHEM, V99, P451, DOI 10.1016/j.snb.2003.12.014
   Richter A, 2003, J MICROELECTROMECH S, V12, P748, DOI 10.1109/JMEMS.2003.817898
   Richter J, 2001, APPL PHYS LETT, V78, P536, DOI 10.1063/1.1338967
   Ruardy TG, 1997, SURF SCI REP, V29, P3, DOI 10.1016/S0167-5729(97)00008-3
   Schinkinger S, 2004, P SOC PHOTO-OPT INS, V5514, P170, DOI 10.1117/12.556795
   SCHNAPP BJ, 1990, P NATL ACAD SCI USA, V87, P10053, DOI 10.1073/pnas.87.24.10053
   Scholey J.M., 1993, METHODS CELL BIOL, V39
   Seeman NC, 1996, CURR OPIN STRUC BIOL, V6, P519, DOI 10.1016/S0959-440X(96)80118-7
   Stracke R, 2000, NANOTECHNOLOGY, V11, P52, DOI 10.1088/0957-4484/11/2/302
   Van Vliet KJ, 2003, ACTA MATER, V51, P5881, DOI 10.1016/j.actamat.2003.09.001
   WIRTZ D, 1995, PHYS REV LETT, V75, P2436, DOI 10.1103/PhysRevLett.75.2436
   Wottawah F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.098103
   Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389
   ZIMMERMANN RM, 1994, NUCLEIC ACIDS RES, V22, P492, DOI 10.1093/nar/22.3.492
NR 60
TC 42
Z9 43
U1 1
U2 24
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1613-4982
J9 MICROFLUID NANOFLUID
JI Microfluid. Nanofluid.
PD JAN
PY 2006
VL 2
IS 1
BP 21
EP 36
DI 10.1007/s10404-005-0047-6
PG 16
WC Nanoscience & Nanotechnology; Instruments & Instrumentation; Physics,
   Fluids & Plasmas
SC Science & Technology - Other Topics; Instruments & Instrumentation;
   Physics
GA 011XW
UT WOS:000235303100003
DA 2018-10-20
ER

PT S
AU Kogan, BY
   Titov, AA
   Rakitin, VY
   Larisa, D
   Kuzmin, SG
   Vorozhtsov, GN
AF Kogan, Boris Ya.
   Titov, Andrey A.
   Rakitin, Viktor Yu.
   Kvacheva, Larisa D.
   Kuzmin, Sergey G.
   Vorozhtsov, Georgy N.
BE Cartwright, AN
   Nicolau, DV
TI Cytotoxical products formation on the nanoparticles heated by the pulsed
   laser radiation
SO NANOBIOPHOTONICS AND BIOMEDICAL APPLICATIONS III
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Nanobiophotonics and Biomedical Applications III
CY JAN 23-24, 2006
CL San Jose, CA
SP SPIE
DE nanoparticles; pulsed irradiation; cytotoxical products
ID DAMAGE; MICROPARTICLES; MECHANISM
AB Cytotoxical effect of a pulsed laser irradiation in presence of nanoparticles of carbon black, sulphuretted carbon and fullerene-60 on death of human uterus nick cancer HeLa and mice lymphoma P 388 cells was studied in vitro. Bubbles formation as result of "microexplosions" of nanoparticles is one of possible mechanisms of this effect. Other possible mechanism is cytotoxical products formation in result of pyrolysis of nanoparticles and biomaterial which is adjoining. The cytotoxical effect of addition of a supernatant from the carbon nanoparticles suspensions irradiated by the pulsed laser was studied to test this assumption. Analysis using gas chromatograph determined that carbon monoxide is principal gaseous product of such laser pyrolysis. This is known as cytotoxical product. Efficiency of its formation is estimated.
C1 [Kogan, Boris Ya.; Kuzmin, Sergey G.; Vorozhtsov, Georgy N.] Organ Intermediates & Dyes Inst, 1-4 B Sadovaya St, Moscow 123995, Russia.
   [Titov, Andrey A.] ICP, Moscow 127276, Russia.
   [Rakitin, Viktor Yu.] Inst Plant Physiol, Moscow 127276, Russia.
   [Kvacheva, Larisa D.] AN Nesmeyanov Inst Organoelement Compounds, Moscow 119991, Russia.
RP Kogan, BY (reprint author), Organ Intermediates & Dyes Inst, 1-4 B Sadovaya St, Moscow 123995, Russia.
EM bkogan@mail.mipt.ru
FU Mayor of Moscow and Moscow government
FX Financial support of cancer researches from the Mayor of Moscow and
   Moscow government is gratefully acknowledged.
CR BUTENIN AV, 1976, KVANTOVAYA ELEKTRON+, V3, P1136
   BUTENIN AV, 1990, KVANTOVAYA ELEKTRON+, V17, P237
   BUTENIN AV, 1986, KVANTOVAYA ELEKTRON+, V13, P2149
   BUTENIN AV, 1974, OPT SPEKTROSK+, V37, P1000
   BUTENIN AV, 1979, ZH TEKH FIZ+, V49, P870
   BUTENIN AV, 1974, PRIB TEKH EKSP, P175
   BUTENIN AV, 1977, JETP LETT, V3, P433
   BUTENIN AV, 1971, KVANTOVAYA ELEKTRON, V5, P143
   Huttmann G, 1999, IEEE J SEL TOP QUANT, V5, P954, DOI 10.1109/2944.796317
   KOGAN BY, 2004, P 15 INT C LAS SCI T
   KOGAN BY, 2005, 22 ANN M HYP ONC ECH, P104
   KOGAN BY, 1991, IZV AN SSSR FIZ, V55, P1391
   KOGAN BY, 1969, OPT SPEKTROSK, V27, P530
   KOGAN BY, 2003, BIOS EUR 2003 MUN GE, V5142
   Kurita H, 1998, APPL PHYS LETT, V72, P789, DOI 10.1063/1.120894
   Lin CP, 1999, IEEE J SEL TOP QUANT, V5, P963, DOI 10.1109/2944.796318
   Lin CP, 1998, APPL PHYS LETT, V72, P2800, DOI 10.1063/1.121462
   McGrath TE, 2002, J PHYS CHEM A, V106, P10072, DOI 10.1021/jp0208135
   NEUMANN J, 2005, P SPIE THERAPEUTIC 2, V5863
   NEUMANN J, 2005, THESIS LUEBECK
   Pitsillides CM, 2003, BIOPHYS J, V84, P4023, DOI 10.1016/S0006-3495(03)75128-5
   Zharov VP, 2005, LASER SURG MED, V37, P219, DOI 10.1002/lsm.20223
   ZHAROV VP, 2005, J PHYS D, V38, P1
   ZHAROV VP, 2006, BIOPHYS J, V90, P1
NR 24
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6137-7
J9 PROC SPIE
PY 2006
VL 6095
AR 60950S
DI 10.1117/12.658131
PG 5
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Optics
SC Engineering; Science & Technology - Other Topics; Optics
GA BEL17
UT WOS:000237699500018
DA 2018-10-20
ER

PT J
AU Salvadori, MC
   Teixeira, FS
   Brown, IG
AF Salvadori, MC
   Teixeira, FS
   Brown, IG
TI On the origin of microcraters on the surface of ion beam bombarded plant
   cell walls
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article
DE electron microscopy; ion implantation; biological material; cell damage;
   biological cells; DNA transfer; microcraters
AB Ion bombardment of plant and bacterial cellular material has recently been used as a tool for the transfer of exogenous DNA macromolecules into the cell interior region. The precise mechanism that leads to the transfer of macromolecules through the cell envelope is not yet clear, however it has been observed that the ion bombardment is accompanied by the formation of "microcraters" on the cell wall, and it is possible that these features provide channels for the macromolecule transfer. Thus the nature and origin of the microcraters is of importance to understanding the DNA transfer phenomenon as well as being of fundamental interest. We report here on some scanning electron microscope observations we have made of onion skin cells that have been subjected to electron beam bombardment of sufficiently high power density to damage the cell wall. The damage seen is much less than and different from the microcraters formed subsequent to ion bombardment. We speculate that the microcraters may originate from the explosive release of gas generated in the biomaterial by ion bombardment. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Sao Paulo, Inst Phys, BR-05315970 Sao Paulo, Brazil.
   Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.
RP Salvadori, MC (reprint author), Univ Sao Paulo, Inst Phys, CP 66318, BR-05315970 Sao Paulo, Brazil.
EM mcsalvadori@if.usp.br
RI Institute of Physics, USP/H-5191-2017; Teixeira, Fernanda/A-9395-2013;
   Salvadori, Maria Cecilia/A-9379-2013
CR Anuntalabhochai S, 2001, APPL PHYS LETT, V78, P2393, DOI 10.1063/1.1362338
   Goldstein J., 1981, SCANNING ELECT MICRO
   HASE Y, 1998, 98016 JAERI, P81
   Markwitz A, 2003, NUCL INSTRUM METH B, V206, P179, DOI 10.1016/S0168-583X(03)00719-5
   Phanchaisri B, 2002, SURF COAT TECH, V158, P624, DOI 10.1016/S0257-8972(02)00320-1
   Sangyuenyongpipat S, 2005, NUCL INSTRUM METH B, V227, P289, DOI 10.1016/j.nimb.2004.09.004
   Vilaithong T, 2000, SURF COAT TECH, V128, P133, DOI 10.1016/S0257-8972(00)00650-2
   Yu LD, 2003, NUCL INSTRUM METH B, V206, P586, DOI 10.1016/S0168-583X(03)00840-1
   Yu LD, 2002, SURF COAT TECH, V158, P146, DOI 10.1016/S0257-8972(02)00243-8
   YU ZL, 1993, NUCL INSTRUM METH B, V80-1, P1328
   YU ZL, IN PRESS INTRO ION B
NR 11
TC 6
Z9 6
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD JAN
PY 2006
VL 243
IS 1
BP 250
EP 252
DI 10.1016/j.nimb.2005.07.221
PG 3
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 003CI
UT WOS:000234658800042
DA 2018-10-20
ER

PT S
AU Orozco, M
   Acosta, AC
   Espana, EM
   Pinchuk, L
   Weber, B
   Davis, S
   Arrieta, E
   Dubovy, S
   Fantes, F
   Aly, M
   Zhou, YH
   Parel, JM
AF Orozco, Marcia
   Acosta, Ana C.
   Espana, Edgar M.
   Pinchuk, Leonard
   Weber, Bruce
   Davis, Stewart
   Arrieta, Esdras
   Dubovy, Sander
   Fantes, Francisco
   Aly, Mohamed
   Zhou, Yonghua
   Parel, Jean-Marie
BE Manns, F
   Soderberg, PG
   Ho, A
TI New styrene-b-isobutylene-b-styrene (SIBS) glaucoma drainage implant
SO OPHTHALMIC TECHNOLOGIES XVI
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT 16th Conference on Ophthalmic Technologies
CY JAN 21-24, 2006
CL San Jose, CA
SP Pascal Rol Fdn, Carl Zeiss Medtec Inc, SPIE
DE biocompatibility; wound healing; intraocular pressure; aqueous
AB Purpose: To design and test the Miami-InnFocus Drainage Implant (MiDi) as a glaucoma shunt that is biocompatible, flexible, and significantly smaller than existing commercial implants in order to prevent postoperative hypotony, inflammation, scarring, erosion, and extrusion.
   Methods: A new biomaterial composed of styrene-b-isobutylene-b-styrene (SIBS) was used in a novel design for a glaucoma drainage implant. The implant consists of a tube 11mm long with an inner diameter of 70, 100, and 150 mu m and outer diameter of 250 mu m with a 1mm(2) tab located 4.5mm from the proximal tip to prevent migration. The device was implanted in 15 New Zealand White rabbits for biocompatibility and efficacy testing. A similarly designed implant made of polydimethylsiloxane was implanted in 6 other animals as a pseudo-control. Typical GDI implantation technique was modified for this device. The proximal end of the new SIBS implant was inserted 2mm into the anterior chamber and the distal end placed in a subconjunctival space created by the surgeon. Biocompatibility of the device was studied by slit-lamp follow-up and intraocular pressure (IOP) measurements recorded periodically. Results: Biocompatibility of the MiDi was excellent. A low and diffuse bleb was observed with these devices. All SIBS tubes were patent 9 months after insertion. Immunostaining demonstrated non-continuous deposition of collagen with virtually no encapsulation. No macrophages or myofibroblast were visible around the SIBS polymer which was found more bioinert than the control PDMS.
   Conclusion: This newly designed glaucoma implant is clinically biocompatible in the rabbit model and maintained 100% patency at 9 months.
C1 [Orozco, Marcia; Acosta, Ana C.; Espana, Edgar M.; Pinchuk, Leonard; Arrieta, Esdras; Dubovy, Sander; Fantes, Francisco; Aly, Mohamed; Parel, Jean-Marie] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Ophthalm Biophys Ctr, Miami, FL 33152 USA.
   [Orozco, Marcia; Pinchuk, Leonard; Parel, Jean-Marie] Univ Miami, Coll Engn, Dept Biomed Engn, Miami, FL USA.
   [Pinchuk, Leonard; Weber, Bruce; Zhou, Yonghua] InnFocus LLC, Miami, FL USA.
   [Parel, Jean-Marie] Univ Liege, CHU Sart Tilman, Liege, Belgium.
RP Orozco, M (reprint author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Ophthalm Biophys Ctr, Miami, FL 33152 USA.
FU InnFocus LLC, Miami FL; NIH center [P30-EY014801]; Florida Lions Eye
   Bank; Research to Prevent Blindness; Henri and Flore Lesieur Foundation
FX This project is supported in part by InnFocus LLC, Miami FL; NIH center
   grant P30-EY014801; Florida Lions Eye Bank; Research to Prevent
   Blindness; the Henri and Flore Lesieur Foundation.
CR ACOSTA AC, 2004, INVESTIGATIVE OPHTHA, V45
   Britt MT, 1999, OPHTHALMOLOGY, V106, P2312, DOI 10.1016/S0161-6420(99)90532-8
   Lim KS, 2001, BRIT J OPHTHALMOL, V85, P1231
   MOSELEY H, 1983, CLIN PHYS PHYSIOL M, V4, P47, DOI 10.1088/0143-0815/4/1/005
   Pinchuk N.S., 2003, US Patent, Patent No. [6,545,097, 6545097]
   RANADE S, 2004, PHYS CHARACTERIZATIO, P625
   SIEGNER SW, 1995, OPHTHALMOLOGY, V102, P1298, DOI 10.1016/S0161-6420(95)30871-8
   Sipos L, 2005, BIOMACROMOLECULES, V6, P2570, DOI 10.1021/bm050299j
   Wilcox MJ, 2000, J GLAUCOMA, V9, P74
NR 9
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6181-4
J9 PROC SPIE
PY 2006
VL 6138
AR 61380U
DI 10.1117/12.652297
PG 8
WC Ophthalmology; Optics; Physics, Applied
SC Ophthalmology; Optics; Physics
GA BEL28
UT WOS:000237708800022
DA 2018-10-20
ER

PT S
AU Ishii, K
   Ninomiya, Y
   Takegoshi, M
   Kushibiki, T
   Yoshihashi-Suzuki, S
   Yamamoto, M
   Tabata, Y
   Awazu, K
AF Ishii, Katsunori
   Ninomiya, Yoshihisa
   Takegoshi, Minori
   Kushibiki, Toshihiro
   Yoshihashi-Suzuki, Sachiko
   Yamamoto, Masaya
   Tabata, Yasuhiko
   Awazu, Kunio
BE Jacques, SL
   Roach, WP
TI Laser-depho sphorylation of phosphogelatin and its indirect quantitative
   analysis using FT-IR
SO OPTICAL INTERACTIONS WITH TISSUE AND CELLS XVII
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Optical Interactions with Tissue and Cells XVII
CY JAN 23-25, 2006
CL San Jose, CA
DE FT-IR; molybdenum blue method; laser-dephosphorylation; phosphate group;
   phosphate ester; phosphogelatin; Free Electron Laser; regenerative
   medicine
ID DEPOSITION; POLYMER
AB Phosphorylation and dephosphorylation are considered to be important reactions that control the active and inactive factors of proteins. In regenerative medicine of the osteoconnective tissue (a tendon, a ligament), it has been reported that the biomaterial possessing phosphate groups promote formation of HAP, the main component of hard tissues. The noncontact measurement of phosphate groups and low-destructive controlling of phosphate groups allow for the accurate regeneration of the osteoconnective tissue, and the validation. Our objective is to propose the nondestructive controlling and measuring method of phosphorylation for regenerative medicine. In this study, as the indirect quantitative analysis of phosphate groups, we examine the correlation between the mid-infrared absorbance ratio and the ratio of phosphate groups introduction theoretically calculated from a colorimetric determination method. And the noncontact controlling method of the quantities of phosphate groups, we examine the selective and low-destructive bond cutting of phosphate groups in the phosphogelatin using a mid-infrared laser.
C1 [Ishii, Katsunori; Ninomiya, Yoshihisa; Kushibiki, Toshihiro; Awazu, Kunio] Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka, Japan.
   [Takegoshi, Minori; Yamamoto, Masaya; Tabata, Yasuhiko] Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan.
RP Ishii, K (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka, Japan.
CR HERMANSON GT, BIOCONJUGATE TECHNIQ, P170
   HERMANSON GT, BIOCONJUGATE TECHNIQ, P139
   HORIGUCHI H, 1973, BOOK INFRARED ABSORP
   Kato K, 1996, J BIOMED MATER RES, V32, P687, DOI 10.1002/(SICI)1097-4636(199612)32:4<687::AID-JBM23>3.0.CO;2-9
   TRETINNIKOV ON, 1994, J BIOMED MATER RES, V28, P1365, DOI 10.1002/jbm.820281115
NR 5
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6126-1
J9 PROC SPIE
PY 2006
VL 6084
AR 608412
DI 10.1117/12.642598
PG 8
WC Cell Biology; Engineering, Biomedical; Instruments & Instrumentation;
   Optics
SC Cell Biology; Engineering; Instruments & Instrumentation; Optics
GA BEF89
UT WOS:000237158300030
DA 2018-10-20
ER

PT S
AU Hampp, N
   Neebe, M
AF Hampp, N
   Neebe, M
BE Renesse, RLV
TI Bacteriorhodopsin-based multi-level optical security features
SO OPTICAL SECURITY AND COUNTERFEIT DETERRENCE TECHNIQUES VI
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT 6th Conference on Optical Security and Counterfeit Deterrence Techniques
CY JAN 17-19, 2006
CL San Jose, CA
DE bacteriorhodopsin; data storage; photochromic pigment; optically
   variable ink; traceability
AB Bacteriorhodopsin (BR) is a crystalline photochromic protein which shows an astonishing stability towards chemical and thermal degradation. This material is used in a variety of applications which have been developed, among them photochromic color-changes, optical data storage and molecular traceability of the material. Integration of all three security levels in a document will be shown. One year lasting field tests have proven the stability of the system in daily use. First applications of polarization encoded data storage and data encryption have been realized successfully. The development of BR-based security features will be reviewed and newer developments will be presented, among them individualized computer generated holograms and the development of ink-jet inks. The data-storage capabilities of the biomaterial BR have been further developed and now visual detectable as well as visual non-detectable storage processes are available. The molecular mechanisms of the data storage process will be presented.
C1 Univ Marburg, Fac Chem, D-35032 Marburg, Germany.
   Univ Marburg, Ctr Mat Sci, D-35032 Marburg, Germany.
RP Hampp, N (reprint author), Univ Marburg, Fac Chem, D-35032 Marburg, Germany.
EM hampp@staff.uni-marburg.de
FU German Ministry for Education and Research (BMBF) [FKZ 13N8196]
FX This work was supported by the German Ministry for Education and
   Research (BMBF, FKZ 13N8196). The cooperation with MIB - Munich
   Innovative Biomaterials, Leonhard Kurz GmbH and Agfa Gevaert AG is
   gratefully acknowledged.
CR Balashov SP, 1995, ISR J CHEM, V35, P415
   Fischer T, 2005, BIOPHYS J, V89, P1175, DOI 10.1529/biophysj.104.055806
   Fischer T, 2003, IEEE T NANOBIOSCI, V2, P1, DOI 10.1109/TNB.2003.810163
   Hampp N, 2000, P SOC PHOTO-OPT INS, V3973, P118, DOI 10.1117/12.382181
NR 4
TC 1
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 0-8194-6115-6
J9 PROC SPIE
PY 2006
VL 6075
AR 60750M
DI 10.1117/12.642627
PG 9
WC Imaging Science & Photographic Technology
SC Imaging Science & Photographic Technology
GA BEE60
UT WOS:000236971500022
DA 2018-10-20
ER

PT J
AU Asberg, AE
   Videm, V
AF Asberg, Ann E.
   Videm, Vibeke
TI Concentration-dependent effect of abciximab on platelets and neutrophils
   in a model of cardiopulmonary bypass
SO PERFUSION-UK
LA English
DT Article
ID GLYCOPROTEIN IIB/IIIA INHIBITORS; ACTIVATION; GRANULOCYTES; ANGIOPLASTY;
   ANTAGONISTS; HEPARIN; RELEASE
AB Abciximab is a GPIIb/IIIa antagonist used in percutaneous coronary interventions to avoid platelet activation, thrombosis and inflammation. We investigated whether abciximab influenced platelet activation and platelet interaction with neutrophils and polyvinyl chloride (PVC) in a cardiopulmonary bypass (CPB) model. Isolated platelets, preincubated with and without 0.1-20 mu g/mL of abciximab, were resuspended with neutrophils in plasma and recirculated by a roller pump. Platelet, but not neutrophil adhesion to PVC was inhibited by abciximab. Only high doses of abciximab reduced platelet aggregation size, but simultaneously increased platelet-neutrophil aggregation. Abciximab had no effect on platelet CD62P expression or degranulation, but platelet activation on platelet-neutrophil aggregates increased with high doses. Only low doses inhibited neutrophil degranulation. The concentration-dependent effect of abciximab on platelet-neutrophil interaction reduces its usefulness and stresses the dependency on experimental design in the evaluation of abciximab. Our study does not support the use of abciximab alone in CPB. However, incorporation of surface-coating the biomaterial with abciximab may be an interesting option.
C1 Norwegian Univ Sci & Technol, Dept Lab Med, Trondheim, Norway.
   Univ Trondheim Hosp, Dept Immunol & Transfus Med, N-7006 Trondheim, Norway.
RP Asberg, AE (reprint author), Univ Trondheim Hosp, St Olavs Hosp, Dept Immunol & Transfus Med, N-7006 Trondheim, Norway.
EM ann.asberg@ntnu.no
CR Abernethy DR, 2002, CLIN PHARMACOL THER, V71, P186, DOI 10.1067/mcp.2002.121775
   Asberg AE, 2005, ARTIF ORGANS, V29, P927, DOI 10.1111/j.1525-1594.2005.00162.x
   Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P9
   Cohen Sidney A., 2000, Pathology and Oncolgy Research, V6, P163
   Coller BS, 1999, AM HEART J, V138, pS1, DOI 10.1053/hj.1999.v138.99078
   Coller BS, 1999, THROMB HAEMOSTASIS, V82, P326
   Conover W., 1999, PRACTICAL NONPARAMET
   Dickfeld T, 2001, THROMB RES, V101, P53, DOI 10.1016/S0049-3848(00)00385-6
   Furman MI, 2004, J AM COLL CARDIOL, V43, P2319, DOI 10.1016/j.jacc.2003.12.055
   HEGNHOJ J, 1985, SCAND J CLIN LAB INV, V45, P489, DOI 10.3109/00365518509155248
   Hobbach HP, 2003, Z KARDIOL, V92, P213, DOI 10.1007/s00392-003-0895-6
   Kanemitsu S, 2003, J THORAC CARDIOV SUR, V126, P428, DOI 10.1016/S0022-5223(02)73288-1
   Kereiakes DJ, 2003, AM HEART J, V146, DOI 10.1016/j.ahj.2003.09.003
   Marciniak SJ, 2002, THROMB HAEMOSTASIS, V87, P1020
   Mickelson JK, 1999, J AM COLL CARDIOL, V33, P97, DOI 10.1016/S0735-1097(98)00532-4
   MOLLNES TE, 1995, ARTIF ORGANS, V19, P909, DOI 10.1111/j.1525-1594.1995.tb02450.x
   Moser M, 2003, J CARDIOVASC PHARM, V41, P586, DOI 10.1097/00005344-200304000-00011
   Rosove MH, 2004, BEST PRACT RES CL HA, V17, P65, DOI 10.1016/j.berh.2004.02.013
   Seiffert D, 2002, THROMB RES, V108, P181, DOI 10.1016/S0049-3848(02)00395-X
   Straub A, 2005, EUR J CARDIO-THORAC, V27, P617, DOI 10.1016/j.ejcts.2004.12.005
   Videm V, 1996, SCAND J IMMUNOL, V43, P385, DOI 10.1046/j.1365-3083.1996.d01-57.x
NR 21
TC 2
Z9 2
U1 0
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0267-6591
J9 PERFUSION-UK
JI Perfusion-UK
PY 2006
VL 21
IS 6
BP 343
EP 352
DI 10.1177/0267659106070509
PG 10
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 135ON
UT WOS:000244163000005
PM 17312858
DA 2018-10-20
ER

PT S
AU Lauto, A
   Stoodley, M
   Avolio, A
   Foster, LJR
AF Lauto, A.
   Stoodley, M.
   Avolio, A.
   Foster, L. J. R.
BE Kollias, N
   Zeng, H
   Choi, B
   Malek, RS
   Wong, BJF
   Ilgner, JFR
   Trowers, EA
   DeRiese, WTW
   Gregory, KW
   Tearney, GJ
   Marcu, L
   Hirschberg, H
   Madsen, SJ
   Lucroy, MD
   Tate, LP
TI Chitosan adhesive for laser tissue repair
SO PHOTONIC THERAPEUTICS AND DIAGNOSTICS II
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Photonic Therapeutics and Diagnostics II
CY JAN 21-24, 2006
CL San Jose, CA
SP SPIE
DE biomaterials; solder; tissue welding
ID PHYSICOCHEMICAL CHARACTERISTICS; PROTEIN SOLDER; COLLAGEN; TEMPERATURE;
   SURGERY; CLOSURE; SKIN
AB Background. Laser tissue repair usually relics on haemoderivate solders, based on serum albumin. These solders have intrinsic limitations that impair their widespread use, such as limited repair strength, high solubility, brittleness and viral transmission. Furthermore, the solder activation temperature (65-70 degrees C) can induce significant damage to tissue. In this study, a new laser-activated biomaterial for tissue repair was developed and tested its vitro and in vivo to overcome some of the shortcomings of traditional solders.
   Materials and Methods. Flexible and insoluble strips of chitosan adhesive (surface area similar to 34 mm(2), thickness similar to 20 mu m) were developed and bonded on sheep intestine with a laser fluence and irradiance of 52 +/- 2 J/cm(2) and similar to 15 W/cm(2) respectively. The temperature between tissue and adhesive was measured using small thermocouples. The strength of repaired tissue was tested by a calibrated tensiometer. The adhesive was also bonded in vivo to the sciatic nerve of rats to assess the thermal damage induced by the laser (fluence = 65 +/- 11 J/cm(2), irradiance 15 W/cm(2)) four days post-operatively.
   Results. Chitosan adhesives successfully repaired intestine tissue, achieving a repair strength of 0.50 +/- 0.15 N (shear stress = 14.7 +/- 4.7 KPa, n=30) at a temperature of 60-65 degrees C. The laser caused demyelination of axons at the operated site; nevertheless, the myelinated axons retained their normal morphology proximally and distally.
C1 Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
RP Lauto, A (reprint author), Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
OI Stoodley, Marcus/0000-0002-4207-8493
CR Barrieras D, 2000, J UROLOGY, V164, P1106, DOI 10.1016/S0022-5347(05)67263-1
   Fung LC, 1999, LASER SURG MED, V25, P285, DOI 10.1002/(SICI)1096-9101(1999)25:4<285::AID-LSM3>3.0.CO;2-S
   Hino M, 2000, BRIT J HAEMATOL, V108, P194, DOI 10.1046/j.1365-2141.2000.01818.x
   Kasper CK, 2002, HAEMOPHILIA, V8, P161, DOI 10.1046/j.1365-2516.2002.00601.x
   Kirsch AJ, 2001, J UROLOGY, V165, P574, DOI 10.1097/00005392-200102000-00073
   Lauto A, 1998, MICROSURG, V18, P60, DOI 10.1002/(SICI)1098-2752(1998)18:1<60::AID-MICR13>3.0.CO;2-Q
   Lauto A, 2005, LASER SURG MED, V36, P193, DOI 10.1002/lsm.20145
   Lauto A, 2001, LASER SURG MED, V28, P44, DOI 10.1002/1096-9101(2001)28:1<44::AID-LSM1015>3.0.CO;2-W
   Maitz PKM, 1999, PLAST RECONSTR SURG, V104, P1726, DOI 10.1097/00006534-199911000-00017
   MCCLAIN PE, 1972, J BIOL CHEM, V247, P692
   Menovsky T, 2000, MICROSURG, V20, P150, DOI 10.1002/(SICI)1098-2752(2000)20:3<150::AID-MICR10>3.0.CO;2-H
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   POLSVEN B, 1994, J HAND SURG-BRIT, V19, P250
   POPPAS DP, 1988, J UROLOGY, V139, P415, DOI 10.1016/S0022-5347(17)42446-3
   Simhon D, 2004, LASER SURG MED, V35, P1, DOI 10.1002/lsm.20074
   Simhon D, 2001, LASER SURG MED, V29, P265, DOI 10.1002/lsm.1118
   TARAVEL MN, 1995, BIOMATERIALS, V16, P865, DOI 10.1016/0142-9612(95)94149-F
   TARAVEL MN, 1993, BIOMATERIALS, V14, P930, DOI 10.1016/0142-9612(93)90135-O
NR 18
TC 0
Z9 0
U1 0
U2 5
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 0-8194-6120-2
J9 PROC SPIE
PY 2006
VL 6078
AR 60780X
DI 10.1117/12.645155
PG 13
WC Engineering, Biomedical; Optics
SC Engineering; Optics
GA BEF69
UT WOS:000237107600021
DA 2018-10-20
ER

PT J
AU Nagahama, K
   Ohya, Y
   Ouchi, T
AF Nagahama, Koji
   Ohya, Yuichi
   Ouchi, Tatsuro
TI Synthesis of star-shaped 8 arms poly(ethylene glycol)-poly(L-lactide)
   block copolymer and physicochemical properties of its solution cast film
   as soft biomaterial
SO POLYMER JOURNAL
LA English
DT Article
DE 8 arms poly(ethylene glycol); poly(L-lactide); star-shaped block
   copolymer; biodegradable; soft biomaterial
ID POLYLACTIDE-GRAFTED DEXTRAN; L-LACTIDE; PHYSICAL-PROPERTIES; IN-VITRO;
   DEGRADATION; BIODEGRADABILITY; POLY(L-LACTIDE); INVITRO; INVIVO; BLENDS
AB Biodegradable star-shaped 8 arms PEG-b-PLLA block copolymer was synthesized to create a novel implantable soft material. The differences in physicochemical properties between star-shaped 8 arms PEG10K-b-PLLA35K film and linear 2 arms PEG10K-b-PLLA33K film having same compositions of PEG and PLLA units was investigated to reveal the architecture effects on their physicochemical properties. Thermal analysis of these copolymer films revealed that the crystallinity of PLLA in the 8 arms PEG10K-b-PLLA35K films (1.8%) was drastically low compared with that in the 2 arms PEG 10K-b-PLLA33K film (37.5%). Additionally, TEM observation of the copolymer films revealed that the larger PLLA domains (greater than 200 nm) with miscellaneous structure were formed in the 2 arms PEG10K-b-PLLA33K film while the smaller PLLA domains (80 nm) with lamellar structure were formed in the 8 arms PEG10K-b-PLLA35K film. Consequently, the 8 arms PEG10K-b-PLLA35K film showed higher swelling ability, lower tensile strength and higher elongation at break than the 2 arms PEG10K-b-PLLA33K film. Moreover, the 8 arms PEG35K-b-PLLA37K film showed higher elongation at break than the 8 arms PEG10K-b-PLLA35K film because of the fine PLLA domains with highly ordered structure. The 8 arms PEG35K-b-PLLA37K film which having the high swelling ability and desirable mechanical properties such as softness as well as tenacity was available as a novel implantable soft material.
C1 Kansai Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5648680, Japan.
   Kansai Univ, High Technol Res Ctr, Suita, Osaka 5648680, Japan.
RP Ohya, Y (reprint author), Kansai Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5648680, Japan.
EM yohya@ipcku.kansai-u.ac.jp; touchi@ipcku.kansai-u.ac.jp
CR CHABOT F, 1983, POLYMER, V24, P53, DOI 10.1016/0032-3861(83)90080-0
   Choi YK, 1996, P INT S CONTR REL BI, V23, P349
   Choi YR, 1998, MACROMOLECULES, V31, P8766, DOI 10.1021/ma981069i
   COHN D, 1988, J BIOMED MATER RES, V22, P993, DOI 10.1002/jbm.820221104
   Finne A, 2002, BIOMACROMOLECULES, V3, P684, DOI 10.1021/bm020009o
   KIMURA Y, 1989, POLYMER, V30, P1342, DOI 10.1016/0032-3861(89)90058-X
   Li YX, 1998, POLYMER, V39, P4421, DOI 10.1016/S0032-3861(97)10362-7
   Malin M, 1996, J APPL POLYM SCI, V59, P1289, DOI 10.1002/(SICI)1097-4628(19960222)59:8<1289::AID-APP12>3.0.CO;2-1
   Martin O, 2001, POLYMER, V42, P6209, DOI 10.1016/S0032-3861(01)00086-6
   MATSUSUE Y, 1992, J BIOMED MATER RES, V26, P1553, DOI 10.1002/jbm.820261203
   Ohya Y, 1998, MACROMOLECULES, V31, P4662, DOI 10.1021/ma980377d
   Ouchi T, 2003, J POLYM SCI POL CHEM, V41, P2462, DOI 10.1002/pola.10783
   Ouchi T, 2003, POLYMER, V44, P3927, DOI 10.1016/S0032-3861(03)000308-2
   Tasaka F, 2001, MACROMOLECULES, V34, P5494, DOI 10.1021/ma010067m
   Tasaka F, 1999, MACROMOLECULES, V32, P6386, DOI 10.1021/ma990766n
   TSUJI H, 1992, MACROMOLECULES, V25, P5719, DOI 10.1021/ma00047a024
   Yamaoka T, 2001, J BIOMED MATER RES, V54, P470, DOI 10.1002/1097-4636(20010315)54:4<470::AID-JBM20>3.3.CO;2-O
   YAMAOKA T, 2003, BIOMATERIARU, V21, P37
   Youxin L., 1994, J CONTROL RELEASE, V32, P121
NR 19
TC 23
Z9 25
U1 0
U2 8
PU SOC POLYMER SCIENCE JAPAN
PI TOKYO
PA TSUKIJI DAISAN NAGAOKA BLDG, 2-4-2 TSUKIJI, CHUO-KU, TOKYO, 104, JAPAN
SN 0032-3896
J9 POLYM J
JI Polym. J.
PY 2006
VL 38
IS 8
BP 852
EP 860
DI 10.1295/polymj.PJ2005240
PG 9
WC Polymer Science
SC Polymer Science
GA 078QY
UT WOS:000240119500013
OA Bronze
DA 2018-10-20
ER

PT S
AU Kabanov, AV
   Batrakoval, EV
   Sherman, S
   Alakhov, VY
AF Kabanov, AV
   Batrakoval, EV
   Sherman, S
   Alakhov, VY
BE SatchiFainaro, R
   Duncan, R
TI Polymer genomics
SO POLYMER THERAPEUTICS II: POLYMERS AS DRUGS, CONJUGATES AND GENE DELIVERY
   SYSTEMS
SE Advances in Polymer Science
LA English
DT Review; Book Chapter
DE artificial vaccines; DNA microarray; drug resistance; phenotype; signal
   transduction
ID PLURONIC BLOCK-COPOLYMERS; RESISTANCE-ASSOCIATED PROTEIN; BIOMATERIAL
   SURFACE-CHEMISTRY; OVARIAN-CARCINOMA CELLS; MDR CANCER-CELLS; IN-VIVO;
   MULTIDRUG-RESISTANCE; GENE-EXPRESSION; DRUG-DELIVERY; PLASMID DNA
AB Biological activities of biocompatible synthetic polymers used in drug delivery, gene delivery, vaccine development or biomaterial surface modification are discussed. Synthetic polymers display selective phenotypic effects in cells and in the body, affecting signal transduction mechanisms involving inflammation, differentiation, proliferation, and apoptosis. These effects are realized as a result of interactions of water-soluble polymers with plasma cell membranes, delivery of polymers to intracellular organelles, and at the sites of cell contacts with polymer-coated surfaces. The ability of the cells and organisms to respond to the effects of these polymers can be dependent on phenotype or genotype. In selected cases, polymer agents can bypass limitations on biological response imposed by the genotype; for example, achievement of phenotypic correction of immune response by polyelectrolytes. Overall, these effects are relatively weak as they do not result in cytotoxicity or major toxicities in the body. However, when combined with specific biological agents, such as cytotoxic agents, bacterial DNA or antigens, either by mixing or by covalent conjugation, the polymers can drastically alter specific genetically controlled responses to these agents. Collectively these studies propose the need for thorough assessment of pharmacogenomic effects of polymer materials in order to maximize the clinical outcomes and understand the pharmacological and toxicological effects of polymer formulations of biological agents - polymer genomics.
C1 Univ Nebraska, Med Ctr, Ctr Drug Delivery & Nanomed, Omaha, NE 68182 USA.
   Univ Nebraska, Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68182 USA.
   Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68182 USA.
   Supartek Pharma Inc, Laval, PQ H9S 1A9, Canada.
RP Kabanov, AV (reprint author), Univ Nebraska, Med Ctr, Ctr Drug Delivery & Nanomed, 985830 Nebraska Med Ctr, Omaha, NE 68182 USA.
EM akabanov@unmc.edu
CR Alakhov V, 2001, EXPERT OPIN BIOL TH, V1, P583, DOI 10.1517/14712598.1.4.583
   Alakhov VY, 1996, BIOCONJUGATE CHEM, V7, P209, DOI 10.1021/bc950093n
   Alila H, 1997, HUM GENE THER, V8, P1785, DOI 10.1089/hum.1997.8.15-1785
   Altan N, 1998, J EXP MED, V187, P1583, DOI 10.1084/jem.187.10.1583
   ATAULLAKHANOV RI, 1984, DOKL AKAD NAUK SSSR+, V274, P479
   ATKINSON TP, 1988, J IMMUNOL, V141, P1307
   ATKINSON TP, 1988, J IMMUNOL, V141, P1302
   Batrakova E, 1999, PHARM RES-DORDR, V16, P1373, DOI 10.1023/A:1018942823676
   Batrakova EV, 2001, J PHARMACOL EXP THER, V299, P483
   Batrakova EV, 2003, J PHARMACOL EXP THER, V304, P845, DOI 10.1124/jpet.102.043307
   Batrakova EV, 1996, BRIT J CANCER, V74, P1545, DOI 10.1038/bjc.1996.587
   Batrakova EV, 2003, PHARMACEUT RES, V20, P1581, DOI 10.1023/A:1026179132599
   Batrakova EV, 2001, BRIT J CANCER, V85, P1987, DOI 10.1054/bjoc.2001.2165
   Benderra Z, 1998, INT J ONCOL, V12, P711
   Benderra Z, 1999, ADV EXP MED BIOL, V457, P151
   Blezinger P, 1999, NAT BIOTECHNOL, V17, P343, DOI 10.1038/7895
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Chin KV, 2002, PHARM RES-DORDR, V19, P1773, DOI 10.1023/A:1021425004264
   Cristiano RJ, 1998, ANTICANCER RES, V18, P3241
   Dharap SS, 2003, J CONTROL RELEASE, V91, P61, DOI 10.1016/S0168-3659(03)00209-8
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   GEBHART CL, 2003, P CONTR REL SOC 30 A
   Gilmore TD, 1999, ONCOGENE, V18, P6842, DOI 10.1038/sj.onc.1203237
   GONG YK, 2004, J BIOMED MAT RES
   Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706
   Hartikka J, 2001, MOL THER, V4, P407, DOI 10.1006/mthe.2001.0483
   Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491
   Hofmann CS, 2003, FASEB J, V17, P702, DOI 10.1096/fj.02-0665fje
   HOWERTON DA, 1990, J IMMUNOL, V144, P1578
   Hubbell JA, 2003, SCIENCE, V300, P595, DOI 10.1126/science.1083625
   HUNTER R, 1991, VACCINE, V9, P250, DOI 10.1016/0264-410X(91)90108-I
   HUNTER R, 1981, J IMMUNOL, V127, P1244
   HUNTER RL, 1994, AIDS RES HUM RETROV, V10, pS95
   HUNTER RL, 1984, J IMMUNOL, V133, P3167
   HUNTER RL, 1986, SCAND J IMMUNOL, V23, P287, DOI 10.1111/j.1365-3083.1986.tb01970.x
   KABANOV AV, 1992, BIOCHEM INT, V26, P1035
   Kabanov AV, 2002, ADV DRUG DELIVER REV, V54, P759, DOI 10.1016/S0169-409X(02)00047-9
   Kabanov AV, 2005, J CONTROL RELEASE, V101, P259, DOI 10.1016/j.jconrel.2004.07.009
   Kabanov AV, 2002, CRIT REV THER DRUG, V19, P1, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i1.10
   Kabanov AV, 2003, J CONTROL RELEASE, V91, P75, DOI 10.1016/S0168-3659(03)00211-6
   KABANOV AV, 1992, J CONTROL RELEASE, V22, P141, DOI 10.1016/0168-3659(92)90199-2
   KABANOV AV, 1989, FEBS LETT, V258, P343, DOI 10.1016/0014-5793(89)81689-8
   KABANOV AV, 1998, SELF ASSEMBLING COMP, P442
   KABANOV AV, 2004, POLYM PREPR, V45, P392
   KABANOV AV, 2004, POLYM PREPR, V45, P442
   KABANOV V, 1984, SOV SCI REV D, V5
   Kabanov V. A., 1975, POLYM IONIZING MONOM
   Kabanov VA, 2004, PURE APPL CHEM, V76, P1659, DOI 10.1351/pac200476091659
   KABANOV VA, 1986, MAKROMOL CHEM-M SYMP, V1, P101, DOI 10.1002/masy.19860010110
   Khaitov R. M., 2003, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P83
   KRISHAN A, 1997, CYTOMETRY, V29, P297
   Langer R, 1998, NATURE, V392, P5
   Lemieux P, 2000, GENE THER, V7, P986, DOI 10.1038/sj.gt.3301189
   Liaw J, 2001, GENE THER, V8, P999, DOI 10.1038/sj.gt.3301485
   Lu QL, 2003, GENE THER, V10, P131, DOI 10.1038/sj.gt.3301874
   MANTHORPE M, 1993, HUM GENE THER, V4, P419, DOI 10.1089/hum.1993.4.4-419
   Minko T, 2005, J CONTROL RELEASE, V105, P269, DOI 10.1016/j.jconrel.2005.03.019
   Minko T, 2001, J CONTROL RELEASE, V71, P227, DOI 10.1016/S0168-3659(01)00220-6
   Mumper RJ, 1996, PHARMACEUT RES, V13, P701, DOI 10.1023/A:1016039330870
   Nishiyama N, 2003, ADV EXP MED BIOL, V519, P155
   Nishiyama N, 2003, BIOCONJUGATE CHEM, V14, P449, DOI 10.1021/bc025555t
   Omidi Y, 2003, J DRUG TARGET, V11, P311, DOI 10.1080/10611860310001636908
   Parker Alan L., 2003, Expert Reviews in Molecular Medicine, V5, P1
   PETROV RV, 1983, DOKL AKAD NAUK SSSR+, V270, P1257
   PETROV RV, 1979, DOKL AKAD NAUK SSSR+, V249, P249
   PETROV RV, 1977, DOKL AKAD NAUK SSSR+, V236, P1260
   PETROV RV, 1986, AM J REPROD IMMUNOL, V10, P105
   PETROV RV, 1985, VACCINE, V3, P392, DOI 10.1016/0264-410X(85)90130-6
   PETROV RV, 1986, IMMUNOL LETT, V12, P237, DOI 10.1016/0165-2478(86)90010-6
   PETROV RV, 1984, CELL INTERACTIONS VA
   Pitard B, 2002, HUM GENE THER, V13, P1767, DOI 10.1089/104303402760293592
   RAGOT T, 1993, NATURE, V361, P647, DOI 10.1038/361647a0
   RAPOPORT N, 2000, ARCH BIOCHEM BIOPHYS, V384, P1000
   Riera M, 2004, J GENE MED, V6, P111, DOI 10.1002/jbm.463
   ROLLAND AP, 1998, ADV DRUG DELIV REV, V30, P151
   Roses AD, 2004, NAT REV GENET, V5, P645, DOI 10.1038/nrg1432
   Russell-Jones GJ, 1998, CRIT REV THER DRUG, V15, P557
   Savic R, 2003, SCIENCE, V300, P615, DOI 10.1126/science.1078192
   Schwartz B, 1996, GENE THER, V3, P405
   Tokui M, 1997, BIOCHEM BIOPH RES CO, V233, P527, DOI 10.1006/bbrc.1997.6485
   Tripathy SK, 1996, P NATL ACAD SCI USA, V93, P10876, DOI 10.1073/pnas.93.20.10876
   Valle JW, 2004, J CLIN ONCOL, V22, p362S
   van Veen HW, 1997, SEMIN CANCER BIOL, V8, P183, DOI 10.1006/scbi.1997.0064
   Venne A, 1996, CANCER RES, V56, P3626
   Vergani L, 2004, INT J BIOCHEM CELL B, V36, P1447, DOI 10.1016/j.biocel.2003.11.015
   Watts GS, 2001, J PHARMACOL EXP THER, V299, P434
   WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918
   Xiao L, 2003, FEBS LETT, V538, P117, DOI 10.1016/S0014-5793(03)00156-X
   YANG Z, 2005, J CONTROL RELEA 0905
   ZAMAN GJR, 1995, P NATL ACAD SCI USA, V92, P7690, DOI 10.1073/pnas.92.17.7690
NR 94
TC 5
Z9 5
U1 0
U2 5
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 3-540-29211-X
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 2006
VL 193
BP 173
EP 198
DI 10.1007/12_028
D2 10.1007/11547785
PG 26
WC Polymer Science
SC Polymer Science
GA BEE41
UT WOS:000236938400005
DA 2018-10-20
ER

PT S
AU Zhao, XJ
   Zhang, SG
AF Zhao, Xiaojun
   Zhang, Shuguang
BE Werner, C
   Eisseeff, JH
   Fischbach, C
   Freier, T
   Garcia, AJ
   Mooney, DJ
   Pompe, T
   Salchert, K
   Varghese, S
   Werner, C
   Zhang, S
   Zhao, X
TI Self-assembling nanopeptides become a new type of biomaterial
SO POLYMERS FOR REGENERATIVE MEDICINE
SE Advances in Polymer Science
LA English
DT Review; Book Chapter
DE regenerative medicine; polymers; nanobiotechnology; self-assembly
   peptide; designer nanomaterials
ID SURFACTANT-LIKE PEPTIDES; AMYLOID-FIBRIL FORMATION; DIP-PEN
   NANOLITHOGRAPHY; COILED-COIL PEPTIDES; DE-NOVO PROTEINS; DESIGNED
   PEPTIDE; ALPHA-HELIX; BETA-SHEET; COMPLEMENTARY OLIGOPEPTIDE; AMPHIPHILE
   NANOFIBERS
AB Combining physics, engineering, chemistry and biology, we can now design, synthesize and fabricate biological nano-materials at the molecular scale using self-assembling peptide systems. These peptides have been used for fabrication of nanomaterials including nanofibers, nanotubes and vesicles, nanometer-thick surface coating and nanowires. Some of these peptides are used for stabilizing membrane proteins, and others provide a more permissive environment for cell growth, repair of tissues in regenerative medicine, and delivering genes and drugs. Self-assembling peptides are also useful for fabricating a wide spectrum of exquisitely fine architectures, new materials and nanodevices for nanobiotechnology and a variety of engineering. These systems lie at the interface between molecular biology, chemistry, materials science and engineering. Molecular self-assembly will harness nature's enormous power to benefit other disciplines and society.
C1 Sichuan Univ, W China Hosp, Inst Nanobiomed Technol & Membrane Biol, Chengdu 610041, Peoples R China.
   MIT, Ctr Bits & Atoms, Ctr Biomed Engn, Cambridge, MA 02139 USA.
RP Zhao, XJ (reprint author), Sichuan Univ, W China Hosp, Inst Nanobiomed Technol & Membrane Biol, Res Bldg 1 Sci Pk 4 Gao Peng Rd, Chengdu 610041, Peoples R China.
EM xiaojunz@mit.edu
CR Aizenberg J, 2003, SCIENCE, V299, P1205, DOI 10.1126/science.1079204
   Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573
   Altman M, 2000, PROTEIN SCI, V9, P1095, DOI 10.1110/ps.9.6.1095
   Anderson WF, 1998, NATURE, V392, P25
   Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129
   Blondelle SE, 1996, TRENDS BIOTECHNOL, V14, P60, DOI 10.1016/0167-7799(96)80922-X
   Branden C., 1999, INTRO PROTEIN STRUCT
   Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826
   Bull SR, 2005, NANO LETT, V5, P1, DOI 10.1021/nl0484898
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen YC, 2002, J MED CHEM, V45, P1624, DOI 10.1021/jm010479l
   CHRISTOPHER J, 2002, NUCLEIC ACIDS RES, V30, P2782
   Ciani B, 2002, J BIOL CHEM, V277, P10150, DOI 10.1074/jbc.M107663200
   Das R, 2004, NANO LETT, V4, P1079, DOI 10.1021/nl049579f
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199
   DEMERS LM, 2002, SCIENCE, V296, P5574
   Dillow AK, 2001, BIOMATERIALS, V22, P1493, DOI 10.1016/S0142-9612(00)00304-5
   Djalali R, 2002, J AM CHEM SOC, V124, P13660, DOI 10.1021/ja028261r
   Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514
   GAJDUSEK DC, 1977, SCIENCE, V197, P943, DOI 10.1126/science.142303
   GORAMAN J, 2000, SCI NEWS, V158, P23
   Gorecki Dariusz C., 1997, Archivum Immunologiae et Therapiae Experimentalis, V45, P375
   Gorman J., 2003, SCI NEWS, V163, P43
   Guler MO, 2005, NANO LETT, V5, P249, DOI 10.1021/nl048238z
   Hammarstrom P, 2001, SCIENCE, V293, P2459, DOI 10.1126/science.1062245
   Harnack O, 2002, NANO LETT, V2, P919, DOI 10.1021/nl020259a
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Heuser J, 1981, Methods Cell Biol, V22, P97
   HOL WGJ, 1981, NATURE, V294, P532, DOI 10.1038/294532a0
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Hone E, 2005, J ALZHEIMERS DIS, V7, P303
   Israelachvili J. N., 1991, INTERMOLECULAR SURFA
   Jimenez JL, 2001, J MOL BIOL, V311, P241, DOI 10.1006/jmbi.2001.4863
   Kammerer RA, 2004, P NATL ACAD SCI USA, V101, P4435, DOI 10.1073/pnas.0306786101
   Kiley P, 2005, PLOS BIOL, V3, P1180, DOI 10.1371/journal.pbio.0030230
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054
   Lehn J.-M, 1995, SUPRAMOLECULAR CHEM
   Leon EJ, 1998, J BIOMAT SCI-POLYM E, V9, P297, DOI 10.1163/156856298X00668
   Leufgen K, 2003, J AM CHEM SOC, V125, P8911, DOI 10.1021/ja0210749
   Lindquist SL, 2002, P NATL ACAD SCI USA, V99, P16377, DOI 10.1073/pnas.212504699
   Loll PJ, 2003, J STRUCT BIOL, V142, P144, DOI 10.1016/S1047-8477(03)00045-5
   Luna-Munoz J, 2005, J ALZHEIMERS DIS, V8, P29
   Lvov YM, 2000, LANGMUIR, V16, P5932, DOI 10.1021/la000069k
   Lynn DG, 2000, J STRUCT BIOL, V130, P153, DOI 10.1006/jsbi.2000.4287
   Mao CB, 2003, P NATL ACAD SCI USA, V100, P6946, DOI 10.1073/pnas.0832310100
   Marini DM, 2002, NANO LETT, V2, P295, DOI 10.1021/nl015697g
   Melnik TN, 2003, PROTEIN ENG, V16, P1125, DOI 10.1093/protein/gzg138
   Mertig M, 2002, NANO LETT, V2, P841, DOI 10.1021/nl025612r
   Minor DL, 1996, NATURE, V380, P730, DOI 10.1038/380730a0
   Moffet DA, 2001, CHEM REV, V101, P3191, DOI 10.1021/cr000051e
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005
   Norman TC, 1999, SCIENCE, V285, P591, DOI 10.1126/science.285.5427.591
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Pandya MJ, 2000, BIOCHEMISTRY-US, V39, P8728, DOI 10.1021/bi000246g
   Patolsky F, 2002, ANGEW CHEM INT EDIT, V41, P2323, DOI 10.1002/1521-3773(20020703)41:13<2323::AID-ANIE2323>3.0.CO;2-H
   Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   PETSKO GA, 2003, PROTEIN STRUCTURE FU
   Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661
   Potekhin SA, 2001, CHEM BIOL, V8, P1025, DOI 10.1016/S1074-5521(01)00073-4
   Rajagopal K, 2004, CURR OPIN STRUC BIOL, V14, P480, DOI 10.1016/j.sbi.2004.06.006
   Ratner M., 2003, NANOTECHNOLOGY GENTL
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   Reches M, 2002, J BIOL CHEM, V277, P35475, DOI 10.1074/jbc.M206039200
   Richter J, 2001, APPL PHYS LETT, V78, P536, DOI 10.1063/1.1338967
   Richter J, 2002, APPL PHYS A-MATER, V74, P725, DOI 10.1007/s003390201289
   Roher AE, 2000, BBA-MOL BASIS DIS, V1502, P31, DOI 10.1016/S0925-4439(00)00030-2
   Ryadnov MG, 2003, ANGEW CHEM INT EDIT, V42, P3021, DOI 10.1002/anie.200351418
   Ryadnov MG, 2003, NAT MATER, V2, P329, DOI 10.1038/nmat885
   Santoso S, 2002, NANO LETT, V2, P687, DOI [10.1021/nl025563i, 10.1021/n1025563i]
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100
   Scheibel T, 2001, CURR BIOL, V11, P366, DOI 10.1016/S0960-9822(01)00099-9
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Schwartz JJ, 2000, CURR OPIN MOL THER, V2, P162
   Seeman NC, 2004, SCI AM, V290, P64, DOI 10.1038/scientificamerican0604-64
   Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406
   SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.ne.17.030194.002421
   Service RF, 2005, SCIENCE, V308, P44
   Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Sundar VC, 2003, NATURE, V424, P899, DOI 10.1038/424899a
   Takahashi Y, 1999, BIOORGAN MED CHEM, V7, P177, DOI 10.1016/S0968-0896(98)00236-3
   Tan S, 1998, NATURE, V391, P660
   Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599
   von Maltzahn G, 2003, LANGMUIR, V19, P4332, DOI 10.1021/la026526+
   Wagner DE, 2005, P NATL ACAD SCI USA, V102, P12656, DOI 10.1073/pnas.0505871102
   Wallin E, 1998, PROTEIN SCI, V7, P1029
   Wanker EE, 2000, MOL MED TODAY, V6, P387, DOI 10.1016/S1357-4310(00)01761-5
   Wei YN, 2003, PROTEIN SCI, V12, P92, DOI 10.1110/ps.0228003
   West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211
   Whaley SR, 2000, NATURE, V405, P665
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   Zerovnik E, 2002, EUR J BIOCHEM, V269, P3362, DOI 10.1046/j.1432-1033.2002.03024.x
   Zhang S., 2001, ENCY MAT SCI TECHNOL, P5822
   ZHANG S, 2001, DIS CONFORMATION COM, P63
   ZHANG S, 2002, CURR OPIN CHEM BIOL, P6865
   Zhang SG, 1999, REACT FUNCT POLYM, V41, P91, DOI 10.1016/S1381-5148(99)00031-0
   ZHANG SG, 1992, EMBO J, V11, P3787, DOI 10.1002/j.1460-2075.1992.tb05464.x
   Zhang SG, 1997, P NATL ACAD SCI USA, V94, P23, DOI 10.1073/pnas.94.1.23
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SG, 2004, J MATER CHEM, V14, P2082, DOI 10.1039/b406136e
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
   Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
   Zhao XJ, 2004, TRENDS BIOTECHNOL, V22, P470, DOI 10.1016/j.tibech.2004.07.011
   Zimenkov Y, 2004, TETRAHEDRON, V60, P7237, DOI 10.1016/j.tet.2004.06.068
NR 116
TC 24
Z9 25
U1 0
U2 29
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 3-540-33353-3
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 2006
BP 145
EP 170
DI 10.1007/12_088
D2 10.1007/11604228
PG 26
WC Polymer Science
SC Polymer Science
GA BFJ92
UT WOS:000242423000004
DA 2018-10-20
ER

PT S
AU Garcia, AJ
AF Garcia, Andres J.
BE Werner, C
   Eisseeff, JH
   Fischbach, C
   Freier, T
   Garcia, AJ
   Mooney, DJ
   Pompe, T
   Salchert, K
   Varghese, S
   Werner, C
   Zhang, S
   Zhao, X
TI Interfaces to control cell-biomaterial adhesive interactions
SO POLYMERS FOR REGENERATIVE MEDICINE
SE Advances in Polymer Science
LA English
DT Review; Book Chapter
DE cell adhesion; collagen; fibronectin; focal adhesions; integrins
ID SELF-ASSEMBLED MONOLAYERS; CALVARIAL OSTEOBLAST DIFFERENTIATION; ACUTE
   INFLAMMATORY RESPONSES; INTEGRINS MEDIATE ADHESION;
   EXTRACELLULAR-MATRIX; SURFACE-CHEMISTRY; PROTEIN ADSORPTION; FIBRONECTIN
   CONFORMATION; MOLECULAR SIMULATION; SIGNALING PATHWAYS
AB Cell adhesion to adsorbed proteins and adhesive sequences engineered on surfaces is crucial to cellular and host responses to implanted devices, biological integration of biomaterials and tissue-engineered constructs, and the performance of biosensors, cell-based arrays, and biotechnological cell-culture supports. This review focuses on interfaces controlling cell-adhesive interactions, with particular emphasis on surfaces controlling protein adsorption, biomimetic substrates presenting bioadhesive motifs, and micropatterned surfaces to engineer adhesive areas. These approaches represent promising strategies to engineer cell-material biomolecular interactions in order to elicit specific cellular responses and enhance the biological performance of materials in biomedical and biotechnological applications.
C1 Georgia Inst Technol, Petit Inst Bioengn & Biosci, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Petit Inst Bioengn & Biosci, Woodruff Sch Mech Engn, 315 Ferst Dr, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu; andres.garcia@me.gatech.edu
CR Agashe M, 2005, LANGMUIR, V21, P1103, DOI 10.1021/la0478364
   AKIYAMA SK, 1995, CELL ADHES COMMUN, V3, P13, DOI 10.3109/15419069509081275
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Broberg M, 2002, J LAB CLIN MED, V139, P163, DOI 10.1067/mlc.2002.121604
   Capadona JR, 2005, ADV MATER, V17, P2604, DOI 10.1002/adma.200500959
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   Danen EHJ, 2003, J PATHOL, V201, P632, DOI 10.1002/path.1472
   De Arcangelis A, 2000, TRENDS GENET, V16, P389, DOI 10.1016/S0168-9525(00)02074-6
   Dillow AK, 2001, BIOMATERIALS, V22, P1493, DOI 10.1016/S0142-9612(00)00304-5
   Eid K, 2001, J BIOMED MATER RES, V57, P224, DOI 10.1002/1097-4636(200111)57:2<224::AID-JBM1162>3.0.CO;2-F
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   FAULL RJ, 1993, J CELL BIOL, V121, P155, DOI 10.1083/jcb.121.1.155
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741
   Gallant ND, 2002, LANGMUIR, V18, P5579, DOI 10.1021/la025554p
   Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170
   Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gorbet MB, 2003, J BIOMED MATER RES A, V67A, P792, DOI 10.1002/jbm.a.10155
   Grant RP, 1997, J BIOL CHEM, V272, P6159, DOI 10.1074/jbc.272.10.6159
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hoffman AS, 1999, J BIOMAT SCI-POLYM E, V10, P1011, DOI 10.1163/156856299X00658
   Holland NB, 1998, NATURE, V392, P799
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   HUHTALA P, 1995, J CELL BIOL, V129, P867, DOI 10.1083/jcb.129.3.867
   Humphries JD, 2000, J BIOL CHEM, V275, P20337, DOI 10.1074/jbc.M000568200
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Jin H, 2004, BRIT J CANCER, V90, P561, DOI 10.1038/sj.bjc.6601576
   Kane RS, 2003, LANGMUIR, V19, P2388, DOI 10.1021/la020737x
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kim JH, 2002, BIOMATERIALS, V23, P2015, DOI 10.1016/S0142-9612(01)00330-1
   Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287
   KOIVUNEN E, 1994, J CELL BIOL, V124, P373, DOI 10.1083/jcb.124.3.373
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836
   Li FF, 2003, P NATL ACAD SCI USA, V100, P15346, DOI 10.1073/pnas.2536767100
   Liu JC, 2004, BIOMACROMOLECULES, V5, P497, DOI 10.1021/bm034340z
   LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795
   Luk YY, 2000, LANGMUIR, V16, P9604, DOI 10.1021/la0004653
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   Merrill E.W., 1992, GLYCOL CHEM BIOTECHN, P199
   Mostafavi-Pour Z, 2003, J CELL BIOL, V161, P155, DOI 10.1083/jcb.200210176
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Moursi AM, 1996, J CELL SCI, V109, P1369
   Norde W, 2004, LANGMUIR, V20, P4162, DOI 10.1021/la030417t
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Reyes CD, 2004, J BIOMED MATER RES A, V69A, P591, DOI 10.1002/jbm.a.30034
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Sastry SK, 1996, J CELL BIOL, V133, P169, DOI 10.1083/jcb.133.1.169
   SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1066
   Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schwartz MA, 2001, J CELL SCI, V114, P2553
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Tate MC, 2004, MOL CELL NEUROSCI, V27, P22, DOI 10.1016/j.men.2004.05.001
   Vreeland WN, 2002, CURR OPIN BIOTECH, V13, P87, DOI 10.1016/S0958-1669(02)00292-6
   Wehrle-Haller B, 2003, J PATHOL, V200, P481, DOI 10.1002/path.1399
   White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Wilson K, 2004, J BIOMED MATER RES A, V69A, P686, DOI 10.1002/jbm.a.30042
   Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988
   Yu XJ, 2003, TISSUE ENG, V9, P421, DOI 10.1089/107632703322066606
   Zheng J, 2005, BIOPHYS J, V89, P158, DOI 10.1529/biophysj.105.059428
NR 101
TC 38
Z9 38
U1 3
U2 51
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 3-540-33353-3
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 2006
BP 171
EP 190
DI 10.1007/12_071
D2 10.1007/11604228
PG 20
WC Polymer Science
SC Polymer Science
GA BFJ92
UT WOS:000242423000005
DA 2018-10-20
ER

PT J
AU Cao, SS
   Deng, XB
   Liu, BL
   Luo, R
   Chen, HL
AF Cao, Shunsheng
   Deng, Xiaobo
   Liu, Bailing
   Luo, Rong
   Chen, Hualing
TI The preparation and characterisation of a novel siloxane biomaterial
SO POLYMERS & POLYMER COMPOSITES
LA English
DT Article
ID PROTEIN ADSORPTION; POLYMERIC BIOMATERIALS; SURFACE MODIFICATION;
   IMMOBILIZATION; COPOLYMERS; INTERFACES; SUPPORTS; FORCES; SHELL
AB It is well known that polysiloxane interacts strongly with proteins and has been shown to adsorb significant quantities of protein due to its strong hydrophobicity, which often promotes conformational and orientational changes in the adsorbed proteins so as to decrease their biocompatibility. Therefore, the control of protein adsorption to biomaterials and the preparation of suitable siloxane biomaterials become necessary and significant for the actual application. In this paper, a novel siloxane biomaterial (siloxane microspheres) was prepared by dispersion polymerization under kinetically controlled conditions. And then, the siloxane biomaterial was characterized by particle size analyser, X-ray Photoelectron Spectroscopy (XPS) and static contact angle.
   The siloxane microspheres were used as the matrix, and bovine serum albumin (BSA) as the template protein, the adsorption has been investigated. The study shows that the amount of protein adsorption (BSA) is higher in the prescence of siloxane monomer than than in its absence, and the effects become more evident with the increase in the contents of siloxane monomer. This indicates that its hydrophobicity of siloxane microspheres can be shepherded through the amount of siloxane monomer added.
C1 Jiangsu Univ, Sch Mat Sci & Engn, Zhenjiang 212013, Peoples R China.
   CAS, Grad Sch, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
RP Cao, SS (reprint author), Jiangsu Univ, Sch Mat Sci & Engn, Zhenjiang 212013, Peoples R China.
EM sscaochem@hotmail.com
CR ALDENHOFF YBJ, 1995, J BIOMED MATER RES, V29, P917, DOI 10.1002/jbm.820290803
   ALMOG Y, 1982, BRIT POLYM J, V14, P131, DOI 10.1002/pi.4980140402
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   Bartzoka V, 2000, LANGMUIR, V16, P4589, DOI 10.1021/la991136h
   Bartzoka V, 1999, ADV MATER, V11, P257, DOI 10.1002/(SICI)1521-4095(199903)11:3<257::AID-ADMA257>3.0.CO;2-S
   Beyer D, 1996, LANGMUIR, V12, P2514, DOI 10.1021/la950459k
   BILJANA AC, 2000, ANAL CHEM, V72, P1523
   Chen H, 2004, BIOMATERIALS, V25, P2273, DOI 10.1016/j.biomaterials.2003.09.023
   CHILDS MA, 2001, BIOMACROMOLECULES, V2, P256
   Erbil HY, 2003, SCIENCE, V299, P1377, DOI 10.1126/science.1078365
   Feng L, 2002, ADV MATER, V14, P1857, DOI 10.1002/adma.200290020
   Ha JW, 2002, MACROMOLECULES, V35, P6811, DOI 10.1021/ma011692u
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   Hines MA, 2003, ADV MATER, V15, P1844, DOI 10.1002/adma.200305395
   HOGT AH, 1985, J COLLOID INTERF SCI, V106, P289, DOI 10.1016/S0021-9797(85)80002-3
   JAE HP, 2002, BIOMATERIALS, V23, P1797
   KOSSOVSKY N, 1987, J BIOMED MATER RES, V21, P1125, DOI 10.1002/jbm.820210906
   Koutsopoulos S, 2004, LANGMUIR, V20, P6401, DOI 10.1021/la049821y
   Lim KT, 1999, MACROMOLECULES, V32, P2811, DOI 10.1021/ma981658o
   Liu XQ, 2004, COLLOID SURFACE A, V238, P127, DOI 10.1016/j.colsurfa.2004.03.004
   Ma ML, 2005, LANGMUIR, V21, P5549, DOI 10.1021/la047064y
   Malpass CA, 2002, J BIOMED MATER RES, V63, P822, DOI 10.1002/jbm.10410
   Merrett K, 2003, J BIOMED MATER RES A, V67A, P981, DOI 10.1002/jbm.a.10165
   Norde W, 1998, SURF SCI SERIES, V75, P27
   Ostuni E, 2003, LANGMUIR, V19, P1861, DOI 10.1021/la020649c
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Schmalenberg KE, 2004, BIOMATERIALS, V25, P1851, DOI 10.1016/j.biomaterials.2003.08.048
   Tunc I, 2005, J PHYS CHEM B, V109, P7597, DOI 10.1021/jp050767j
   WEETALL HH, 1993, APPL BIOCHEM BIOTECH, V41, P157, DOI 10.1007/BF02916421
   Yoon JY, 1999, COLLOID SURFACE A, V153, P413, DOI 10.1016/S0927-7757(98)00533-0
   YOUNG BR, 1988, J COLLOID INTERF SCI, V124, P28, DOI 10.1016/0021-9797(88)90321-9
   Zelisko PM, 2002, LANGMUIR, V18, P8982, DOI 10.1021/la025867k
NR 32
TC 1
Z9 1
U1 0
U2 3
PU RAPRA TECHNOLOGY LTD
PI SHREWSBURY
PA SHAWBURY, SHREWSBURY SY4 4NR, SHROPS, ENGLAND
SN 0967-3911
J9 POLYM POLYM COMPOS
JI Polym. Polym. Compos.
PY 2006
VL 14
IS 8
BP 833
EP 840
DI 10.1177/096739110601400808
PG 8
WC Materials Science, Characterization & Testing; Materials Science,
   Composites; Polymer Science
SC Materials Science; Polymer Science
GA 117XX
UT WOS:000242907700008
DA 2018-10-20
ER

PT S
AU Falcone, SJ
   Palmeri, D
   Berg, RA
AF Falcone, Samuel J.
   Palmeri, David
   Berg, Richard A.
BE Marchessault, RH
   Ravenelle, F
   Zhu, XX
TI Biomedical applications of hyaluronic acid
SO POLYSACCHARIDES FOR DRUG DELIVERY AND PHARMACEUTICAL APPLICATIONS
SE ACS Symposium Series
LA English
DT Review
CT Symposium on Polysaccharides for Drug Delivery and Pharmaceutical
   Applications held at the 228th ACS National Meeting
CY AUG 22-26, 2004
CL Philadelphia, PA
SP Amer Chem Soc, Div Cellulose & Renewable Mat
ID POSTSURGICAL ADHESIONS; MOUSE MACROPHAGES; FRAGMENTS; RECEPTOR;
   MULTICENTER; EXPRESSION; PREVENTION; EFFICACY; BEHAVIOR; CLONING
AB Hyaluronic acid (HA), also named hyaluronan, is a high molecular weight polysaccharide found in the body in pericellular matrices, various bodily fluids, and in specialized tissues such as the vitreous humor of the eye and cartilage. Hyaluronic acid possesses both biological activities and physical properties that add to the uniqueness of this ubiquitous polysaccharide. The uniqueness of HA and its importance both biologically and physically apparently accounts for its identical structure when synthesized in bacteria, birds, and mammals. Because of this property, HA has been purified from chickens or bacteria for use as a biomaterial in medical devices in humans or other mammals. Hyaluronic acid is unique because of its viscoelastic and hydrodynamic properties, its assembly into extracellular and pericellular matrices, and its effects on cell signaling. Its use as a biomaterial has been driven largely by its physical properties and viscoelastic behavior. The biological properties of HA and its fragments have largely been ignored in its use as a biomaterial. As HA is more widely used and studied, these properties are becoming increasingly apparent and important in its use in medical devices. (c) 2006 American Chemical Society
C1 FzioMed Inc, San Luis Obispo, CA 93401 USA.
RP Falcone, SJ (reprint author), FzioMed Inc, 231 Bonetti Dr, San Luis Obispo, CA 93401 USA.
CR ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A
   BALAZS EA, 1989, CIBA F SYMP, V143, P265
   Balazs EA, 2003, CELLS TISSUES ORGANS, V174, P49, DOI 10.1159/000070574
   Balazs EA, 1989, CIBA F SYMP, V143, P281
   Balazs Endre A, 2004, Surg Technol Int, V12, P278
   Belluco C, 2001, J SURG RES, V100, P217, DOI 10.1006/jsre.2001.6248
   BOTHNER H, 1987, ACTA OTO-LARYNGOL, P25
   Cowman MK, 2005, CARBOHYD RES, V340, P791, DOI 10.1016/j.carres.2005.01.022
   Csoka TB, 1997, INVAS METAST, V17, P297
   FALCONE S, 2005, UNPUB RHEOMETRIC COH
   Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x
   Frost GI, 1997, BIOCHEM BIOPH RES CO, V236, P10, DOI 10.1006/bbrc.1997.6773
   Gatej L, 2005, BIOMACROMOLECULES, V6, P61, DOI 10.1021/bm040050m
   GIBBS DA, 1968, BIOPOLYMERS, V6, P777, DOI 10.1002/bip.1968.360060603
   GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009
   Gomis A, 2004, ARTHRITIS RHEUM-US, V50, P314, DOI 10.1002/art.11421
   HARDWICK C, 1992, J CELL BIOL, V117, P1343, DOI 10.1083/jcb.117.6.1343
   HASCALL VC, 1974, J BIOL CHEM, V249, P4232
   Himeda Y, 2003, J INT MED RES, V31, P509, DOI 10.1177/147323000303100607
   Horton MR, 1999, J IMMUNOL, V162, P4171
   Horton MR, 1998, J BIOL CHEM, V273, P35088, DOI 10.1074/jbc.273.52.35088
   Johns DB, 2001, FERTIL STERIL, V76, P595, DOI 10.1016/S0015-0282(01)01954-9
   Kelly Michael A, 2004, Am J Orthop (Belle Mead NJ), V33, P15
   Lapcik L, 1998, CHEM REV, V98, P2663, DOI 10.1021/cr941199z
   LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lowe NJ, 2001, J AM ACAD DERMATOL, V45, P930, DOI 10.1067/mjd.2001.117381
   Manna F, 1999, J EUR ACAD DERMATOL, V13, P183
   McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054
   Micheels P, 2001, DERMATOL SURG, V27, P185, DOI 10.1046/j.1524-4725.2001.00248.x
   Milas M, 2001, BIOPOLYMERS, V59, P191, DOI 10.1002/1097-0282(20011005)59:4<191::AID-BIP1018>3.0.CO;2-M
   Narins RS, 2003, DERMATOL SURG, V29, P588, DOI 10.1046/j.1524-4725.2003.29150.x
   PECK LS, 2000, PERITONEAL SURG, P499
   Poyer JF, 1998, J CATARACT REFR SURG, V24, P1130, DOI 10.1016/S0886-3350(98)80109-0
   Prevo R, 2001, J BIOL CHEM, V276, P19420, DOI 10.1074/jbc.M011004200
   Sasaki M, 2003, TOXICOL PATHOL, V31, P321, DOI 10.1080/01926230390204360
   Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200
   Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863
   Toole BP, 1990, CURR OPIN CELL BIOL, V2, P839, DOI 10.1016/0955-0674(90)90081-O
   TURLEY EA, 1991, J CELL BIOL, V112, P1041, DOI 10.1083/jcb.112.5.1041
   Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200
   UCHIYAMA H, 1990, J BIOL CHEM, V265, P7753
   Verheye S, 2000, ARTERIOSCL THROM VAS, V20, P1168, DOI 10.1161/01.ATV.20.4.1168
   WEST DC, 1989, CIBA F SYMP, V143, P187
NR 44
TC 14
Z9 14
U1 1
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
EI 1947-5918
BN 0-8412-3960-6
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 2006
VL 934
BP 155
EP 174
PG 20
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA BEW10
UT WOS:000239744300008
DA 2018-10-20
ER

PT S
AU Grant, J
   Allen, C
AF Grant, J.
   Allen, C.
BE Marchessault, RH
   Ravenelle, F
   Zhu, XX
TI Chitosan as a biomaterial for preparation of depot-based delivery
   systems
SO POLYSACCHARIDES FOR DRUG DELIVERY AND PHARMACEUTICAL APPLICATIONS
SE ACS SYMPOSIUM SERIES
LA English
DT Article; Proceedings Paper
CT Symposium on Polysaccharides for Drug Delivery and Pharmaceutical
   Applications held at the 228th ACS National Meeting
CY AUG 22-26, 2004
CL Philadelphia, PA
SP Amer Chem Soc, Div Cellulose & Renewable Mat
ID MUCOSAL DRUG-DELIVERY; IN-VIVO BIOCOMPATIBILITY; PHYSICAL-PROPERTIES;
   CONTROLLED-RELEASE; DEGRADATION RATES; POLYMER BLENDS; PH SENSITIVITY;
   FILMS; CHITIN; VITRO
AB Chitosan is a natural polysaccharide that has become established as a material with great potential for use in biomedical applications. In addition, the recent success of many polymeric depot delivery systems has encouraged further research to identify new materials and develop new systems for use in regional therapy. Several strategies have been developed for preparation of stable chitosan-based depot systems for drug delivery. Chitosan can be physically or chemically crosslinked to prepare microspheres, films and gels. Chitosan has also been blended with a wide range of polymers to produce mostly two-phase systems, which have unique properties that are required for specific applications. These stable chitosan-based depot systems have been investigated for treatment of various diseases including cancer and bacterial infection. This review includes a summary of the favorable chemical, physical and biological properties of chitosan. In addition, the properties of an ideal depot system for use in drug delivery are outlined. Overall, it is hoped that the reader gains an appreciation for the use of chitosan-based systems for the regional or localized delivery of drugs. (c) 2006 American Chemical Society
C1 Univ Toronto, Dept Pharmaceut Sci, Toronto, ON M5S 2S2, Canada.
RP Grant, J (reprint author), Univ Toronto, Dept Pharmaceut Sci, 100 Coll St, Toronto, ON M5S 2S2, Canada.
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Aimin C, 1999, Clin Orthop Relat Res, P239, DOI 10.1097/00003086-199909000-00031
   ALLEN LV, 2005, ANSELS PHARM DOSAGE, P738
   Arvanitoyannis IS, 1998, CARBOHYD POLYM, V37, P371, DOI 10.1016/S0144-8617(98)00083-6
   BLAIR HS, 1987, J APPL POLYM SCI, V33, P641, DOI 10.1002/app.1987.070330226
   Brem H, 2001, J CONTROL RELEASE, V74, P63, DOI 10.1016/S0168-3659(01)00311-X
   Brown CD, 2001, J CONTROL RELEASE, V72, P35, DOI 10.1016/S0168-3659(01)00260-7
   Buranapanitkit B, 2004, CLIN ORTHOP RELAT R, P244, DOI 10.1097/01.blo.0000130268.27024.c1
   Cao SG, 1998, POLYM BULL, V41, P553, DOI 10.1007/s002890050401
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chaubal M., 2002, DRUG DELIV TECHNOL, V2, P34
   Chen LY, 2004, BIOMATERIALS, V25, P3725, DOI 10.1016/j.biomaterials.2003.09.100
   Chen X, 1997, J APPL POLYM SCI, V65, P2257, DOI 10.1002/(SICI)1097-4628(19970912)65:11<2257::AID-APP23>3.0.CO;2-Z
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Cheung MK, 2002, J APPL POLYM SCI, V86, P1253, DOI 10.1002/app.11091
   Chuang WY, 1999, BIOMATERIALS, V20, P1479, DOI 10.1016/S0142-9612(99)00054-X
   Dhanikula Anand Babu, 2004, AAPS J, V6, pe27
   Dufresne A, 1999, POLYMER, V40, P1657, DOI 10.1016/S0032-3861(98)00335-8
   ERRINGTON N, 1993, INT J BIOL MACROMOL, V15, P113, DOI 10.1016/0141-8130(93)90008-A
   Fang L, 2000, J APPL POLYM SCI, V76, P1785, DOI 10.1002/(SICI)1097-4628(20000620)76:12<1785::AID-APP8>3.0.CO;2-B
   Felt O, 1998, DRUG DEV IND PHARM, V24, P979, DOI 10.3109/03639049809089942
   FRIEDLAND D, 1993, J NATL CANCER I, V85, P2036, DOI 10.1093/jnci/85.24.2036
   Fulzele SV, 2003, EUR J PHARM SCI, V20, P53, DOI 10.1016/S0928-0987(03)00168-4
   Genta I, 1999, EXS, V87, P305
   GRANT J, 2005, IN PRESS J PHARM SCI
   GRANT J, 2005, UNPUB J APPL POLYM S
   Grayson ACR, 2004, J BIOMAT SCI-POLYM E, V15, P1281, DOI 10.1163/1568562041959991
   Hedley ML, 2003, EXPERT OPIN BIOL TH, V3, P903, DOI 10.1517/eobt.3.6.903.21268
   Hickey T, 2002, J BIOMED MATER RES, V61, P180, DOI 10.1002/jbm.10016
   HIRANO S, 1989, BIOMATERIALS, V10, P574, DOI 10.1016/0142-9612(89)90066-5
   HO E, 2005, IN PRESS J CONTROL R
   Honma T, 2003, POLYM INT, V52, P1839, DOI 10.1002/pi.1380
   Hui A, 1997, ARTHRITIS RHEUM, V40, P1073, DOI 10.1002/art.1780400612
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   Jackson JK, 2000, CANCER RES, V60, P4146
   Jaworska M, 2003, POLYM INT, V52, P198, DOI 10.1002/pi.1159
   Jin J, 2004, BIOMACROMOLECULES, V5, P162, DOI 10.1021/bm034286m
   Jones DS, 1999, INT J PHARM, V179, P167, DOI 10.1016/S0378-5173(98)00337-8
   Jones DS, 1997, INT J PHARM, V151, P223, DOI 10.1016/S0378-5173(97)04904-1
   Jones DS, 1997, PHARMACEUT RES, V14, P450, DOI 10.1023/A:1012091231023
   Katti DS, 2002, ADV DRUG DELIVER REV, V54, P933, DOI 10.1016/S0169-409X(02)00052-2
   Khan TA, 2000, J PHARM PHARM SCI, V3, P303
   Khoo CGL, 2003, EUR J PHARM BIOPHARM, V55, P47, DOI 10.1016/S0939-6411(02)00155-8
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kumbar SG, 2003, J APPL POLYM SCI, V87, P1525, DOI 10.1002/app.11552
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Lacevic Amela, 2004, Bosn J Basic Med Sci, V4, P73
   LANGER R, 1983, PHARMACOL THERAPEUT, V21, P35, DOI 10.1016/0163-7258(83)90066-9
   LI Q, 1992, J BIOACT COMPAT POL, V7, P370, DOI 10.1177/088391159200700406
   Lim LY, 1999, J BIOMED MATER RES, V48, P111
   Liu CH, 2004, J APPL POLYM SCI, V92, P559, DOI 10.1002/app.20040
   Liu YH, 2003, J APPL POLYM SCI, V89, P2283, DOI 10.1002/app.12102
   Macleod GS, 1999, J CONTROL RELEASE, V58, P303, DOI 10.1016/S0168-3659(98)00168-0
   Messer T, 2002, PSYCHOPHARMAKOTHERAP, V9, P133
   Mi FL, 2000, J POLYM SCI POL CHEM, V38, P2804, DOI 10.1002/1099-0518(20000801)38:15<2804::AID-POLA210>3.3.CO;2-P
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Miller ML, 2001, CHEM REC, V1, P195, DOI 10.1002/tcr.1008
   Molinaro G, 2002, BIOMATERIALS, V23, P2717, DOI 10.1016/S0142-9612(02)00004-2
   Muzzarelli R. A. A., 1995, ADV CHITIN SCI, P448
   Muzzarelli R.A.A., 2000, CHITOSAN PER OS DIET
   Mwale F, 2005, TISSUE ENG, V11, P130, DOI 10.1089/ten.2005.11.130
   Needleman IG, 1997, J CLIN PERIODONTOL, V24, P394, DOI 10.1111/j.1600-051X.1997.tb00203.x
   Needleman IG, 1998, J CLIN PERIODONTOL, V25, P74, DOI 10.1111/j.1600-051X.1998.tb02366.x
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   Nsereko S, 2002, BIOMATERIALS, V23, P2723, DOI 10.1016/S0142-9612(02)00005-4
   Nunthanid J, 2001, DRUG DEV IND PHARM, V27, P143, DOI 10.1081/DDC-100000481
   Oztop HN, 2002, APPL BIOCHEM BIOTECH, V101, P239, DOI 10.1385/ABAB:101:3:239
   Peppas L. B, 1997, POLYM CONTROLLED DRU, V4, P34
   PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110
   Perugini P, 2003, INT J PHARM, V252, P1, DOI 10.1016/S0378-5173(02)00602-6
   Qu X, 1999, J APPL POLYM SCI, V74, P3193, DOI 10.1002/(SICI)1097-4628(19991220)74:13<3193::AID-APP23>3.0.CO;2-V
   Rao SB, 1995, J BIOMATER APPL, V10, P136, DOI 10.1177/088532829501000204
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Ratto JA, 1996, J APPL POLYM SCI, V59, P1451, DOI 10.1002/(SICI)1097-4628(19960228)59:9<1451::AID-APP13>3.0.CO;2-1
   Risbud M, 2000, J BIOSCIENCES, V25, P25, DOI 10.1007/BF02985178
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V57, P53, DOI 10.1016/S0939-6411(03)00095-X
   Sampath, 1998, Cancer Control, V5, P130
   Sanford P.A., 1990, AM CHEM SOC DIV POLY, V31, P628
   Sato M, 2004, J APPL POLYM SCI, V93, P1616, DOI 10.1002/app.20610
   SCREENIVASAN K, 1996, POLYM DEGRAD STABIL, V52, P85
   Shu X, 2000, INT J PHARM, V201, P51, DOI 10.1016/S0378-5173(00)00403-8
   Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441
   Sionkowska A, 2004, BIOMATERIALS, V25, P795, DOI 10.1016/S0142-9612(03)00595-7
   Skaugrud O., 1991, DRUG COSMET IND, V148, P24
   SKJKBRK G, 1989, CHITIN CHITOSAN SOUR, P835
   SPENCER CM, 1994, DRUGS, V48, P794, DOI 10.2165/00003495-199448050-00009
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Sung HW, 2000, BIOMATERIALS, V21, P1353, DOI 10.1016/S0142-9612(00)00017-X
   Suyatma NE, 2004, J POLYM ENVIRON, V12, P1, DOI 10.1023/B:JOOE.0000003121.12800.4e
   Tirkistani FAA, 1998, POLYM DEGRAD STABIL, V61, P161, DOI 10.1016/S0141-3910(97)00145-6
   Toffey A, 1996, J APPL POLYM SCI, V60, P75, DOI 10.1002/(SICI)1097-4628(19960404)60:1<75::AID-APP9>3.0.CO;2-S
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1
   Wu YB, 2004, CARBOHYD POLYM, V57, P435, DOI 10.1016/j.carbpol.2004.05.013
   Yusof NLBM, 2003, J BIOMED MATER RES A, V66A, P224, DOI 10.1002/jbm.a.10545
   Zhang H, 2004, BIOMACROMOLECULES, V5, P2461, DOI 10.1021/bm0496211
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
   ZHAO WW, 1995, J MACROMOL SCI PHYS, VB34, P231, DOI 10.1080/00222349508215531
NR 100
TC 7
Z9 7
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 0-8412-3960-6
J9 ACS SYM SER
PY 2006
VL 934
BP 201
EP 225
PG 25
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA BEW10
UT WOS:000239744300010
DA 2018-10-20
ER

PT S
AU Rabanel, JM
   Bertrand, N
   Sant, S
   Louati, S
   Hildgen, P
AF Rabanel, Jean-Michel
   Bertrand, Nicolas
   Sant, Shilpa
   Louati, Salma
   Hildgen, Patrice
BE Marchessault, RH
   Ravenelle, F
   Zhu, XX
TI Polysaccharide hydrogels for the preparation of immunoisolated cell
   delivery systems
SO POLYSACCHARIDES FOR DRUG DELIVERY AND PHARMACEUTICAL APPLICATIONS
SE ACS Symposium Series
LA English
DT Review
CT Symposium on Polysaccharides for Drug Delivery and Pharmaceutical
   Applications held at the 228th ACS National Meeting
CY AUG 22-26, 2004
CL Philadelphia, PA
SP Amer Chem Soc, Div Cellulose & Renewable Mat
ID L-LYSINE MICROCAPSULES; MOLECULAR-WEIGHT DISTRIBUTION; ALGINATE
   MICROCAPSULES; PANCREATIC-ISLETS; BIOARTIFICIAL PANCREAS;
   MICROENCAPSULATED ISLETS; IN-VITRO; BIOMEDICAL APPLICATIONS;
   ENCAPSULATED ISLETS; CELLULOSE SULFATE
AB In the last decades, the rapid advances in the understanding of the role of proteins and peptides in several diseases have propelled them as therapeutic entities. Protein delivery is a challenge and one of the new approaches to their administration is to implant cells producing the therapeutic protein of interest. However, the grafted cells or tissues have to overcome inummological defences of the organism. Cell microencapsulation is one of the most promising avenues to protect cells from immune rejection, while permitting their survival alongwith the protein secretion activity without deleterious effects of immunosuppressant drugs. Polysaccharides (PS) have been retained as biomaterial to prepare such devices, in a variety of applications because of their ability to form non-toxic and biocompatible hydrogels which can show desired properties for cell immunoisolation such as selective permeability and soft surfaces identical to, or mimicking natural biological extracellular matrices. This chapter will address the main classes of natural and modified PS used in this field and will discuss different issues in regard to particular applications. The performances of the encapsulation systems are largely dictated by the physicochemical properties of the PS, such as sugar monomer composition, primary and secondary structure, degree and nature of substitutions, type of gel crosslinking, as well as microbead preparation techniques. However, all the current microencapsulation technologies display limitations particularly on long-term performances. A new approach is thus portrayed based on amylopectin hydrogel microencapsulation. With this new technique, the gel forming and encapsulation steps are dissociated, allowing use of a wider range of gel forming methods and biomaterials as well as complete capsule characterization before cell encapsulation.
C1 Univ Montreal, Fac Pharm, Montreal, PQ H3T 2M4, Canada.
RP Hildgen, P (reprint author), Univ Montreal, Fac Pharm, 2900,Edouard Montpetit, Montreal, PQ H3T 2M4, Canada.
EM patrice.hildgen@umontreal.ca
RI Bertrand, Nicolas/B-1269-2012
OI Bertrand, Nicolas/0000-0002-2568-3771; Sant, Shilpa/0000-0002-2017-9584
CR Aebischer P, 2001, TRENDS NEUROSCI, V24, P533, DOI 10.1016/S0166-2236(00)01899-3
   Awrey DE, 1996, BIOTECHNOL BIOENG, V52, P472, DOI 10.1002/(SICI)1097-0290(19961120)52:4<472::AID-BIT3>3.0.CO;2-M
   Bartkowiak A, 2001, ANN NY ACAD SCI, V944, P120
   Bartkowiak A, 2001, COLLOID SURFACE B, V21, P285, DOI 10.1016/S0927-7765(00)00211-3
   Becker A, 1998, APPL MICROBIOL BIOT, V50, P145, DOI 10.1007/s002530051269
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   Bienaime C, 2003, J BIOMED MATER RES A, V67A, P376, DOI 10.1002/jbm.a.10487
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   Brissova M, 1998, J BIOMED MATER RES, V39, P61, DOI 10.1002/(SICI)1097-4636(199801)39:1<61::AID-JBM8>3.0.CO;2-G
   Brissova M, 1996, ANAL BIOCHEM, V242, P104, DOI 10.1006/abio.1996.0435
   Bryant SJ, 2004, MACROMOLECULES, V37, P6726, DOI 10.1021/ma0499324
   CALAFIORE R, 1992, TRANSPLANT P, V24, P935
   Calafiore R, 1996, ACTA DIABETOL, V33, P150
   Chandy T, 1999, ARTIF ORGANS, V23, P894, DOI 10.1046/j.1525-1594.1999.06244.x
   CHIBATA I, 1987, METHOD ENZYMOL, V135, P189
   Cirone P, 2002, HUM GENE THER, V13, P1157, DOI 10.1089/104303402320138943
   Colton CK, 1996, TRENDS BIOTECHNOL, V14, P158, DOI 10.1016/0167-7799(96)10021-4
   Coradin T, 2003, APPL MICROBIOL BIOT, V61, P429, DOI 10.1007/s00253-003-1308-5
   Dautzenberg H, 1999, ANN NY ACAD SCI, V875, P46, DOI 10.1111/j.1749-6632.1999.tb08493.x
   David B, 2004, BIOTECHNOL PROGR, V20, P1204, DOI 10.1021/bp034031z
   de Groot M, 2004, J SURG RES, V121, P141, DOI 10.1016/j.jss.2004.02.018
   de Haan BJ, 2003, CELL TRANSPLANT, V12, P617, DOI 10.3727/000000003108747226
   de Vos P, 2003, BIOMATERIALS, V24, P305, DOI 10.1016/S0142-9612(02)00319-8
   Desai NP, 2000, J MICROENCAPSUL, V17, P677
   DeVos P, 1997, DIABETOLOGIA, V40, P262
   Dornish M, 2001, ANN NY ACAD SCI, V944, P388
   Dusseault J, 2005, BIOMATERIALS, V26, P1515, DOI 10.1016/j.biomaterials.2004.05.013
   Elcin YM, 1999, ARTIF ORGANS, V23, P146, DOI 10.1046/j.1525-1594.1999.06222.x
   Esposito E, 2001, ANN NY ACAD SCI, V944, P160
   Gaserod O, 1998, BIOMATERIALS, V19, P1815, DOI 10.1016/S0142-9612(98)00073-8
   Gaserod O, 1999, BIOMATERIALS, V20, P773, DOI 10.1016/S0142-9612(98)00230-0
   Gehrke SH, 1997, ANN NY ACAD SCI, V831, P179
   GIN H, 1987, J MICROENCAPSUL, V4, P239, DOI 10.3109/02652048709021817
   GOOSEN MFA, 1985, BIOTECHNOL BIOENG, V27, P146, DOI 10.1002/bit.260270207
   HALLE JP, 1993, TRANSPLANTATION, V55, P350, DOI 10.1097/00007890-199302000-00023
   Hamdi G, 2001, J MICROENCAPSUL, V18, P373, DOI 10.1080/02652040010019505
   Haque T, 2005, MOL PHARMACEUT, V2, P29, DOI 10.1021/mp049901v
   Hardikar AA, 1999, J BIOSCIENCE, V24, P371, DOI 10.1007/BF02941251
   Hasse C, 1998, WORLD J SURG, V22, P659, DOI 10.1007/s002689900449
   Hasse C, 2000, WORLD J SURG, V24, P1361, DOI 10.1007/s002680010225
   HEALD KA, 1994, CELL TRANSPLANT, V3, P333, DOI 10.1177/096368979400300410
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   HILDGEN P, 2003, Patent No. 6047347052803
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hunkeler D, 2001, ANN NY ACAD SCI, V944, P456
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   Itoh Y, 2004, CHEM LETT, V33, P1552, DOI 10.1246/cl.2004.1552
   IWATA H, 1989, DIABETES, V38, P224, DOI 10.2337/diab.38.1.S224
   IWATA H, 1992, J BIOMED MATER RES, V26, P967, DOI 10.1002/jbm.820260711
   IWATA H, 1994, J BIOMED MATER RES, V28, P1003, DOI 10.1002/jbm.820280905
   IWATA H, 1992, TRANSPLANT P, V24, P952
   IWATA H, 1992, TRANSPLANT P, V24, P997
   IWATA H, 1994, J BIOMED MATER RES, V28, P1201, DOI 10.1002/jbm.820281010
   Iwata H, 1999, ANN NY ACAD SCI, V875, P7, DOI 10.1111/j.1749-6632.1999.tb08490.x
   JAIN K, 1995, TRANSPLANTATION, V59, P319, DOI 10.1097/00007890-199502150-00002
   Jen AC, 1996, BIOTECHNOL BIOENG, V50, P357, DOI 10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K
   Joki T, 2001, NAT BIOTECHNOL, V19, P35
   Joly A, 1997, TRANSPLANTATION, V63, P795, DOI 10.1097/00007890-199703270-00002
   KARTHA KPR, 1985, STARKE, V37, P297, DOI 10.1002/star.19850370905
   KIERSTAN M, 1977, BIOTECHNOL BIOENG, V19, P387, DOI 10.1002/bit.260190309
   Kim YM, 2004, ARTIF ORGANS, V28, P1059, DOI 10.1111/j.1525-1594.2004.00024.x
   Kin T, 2002, PANCREAS, V25, P94, DOI 10.1097/01.MPA.0000015216.27722.72
   King A, 2003, J BIOMED MATER RES A, V64A, P533, DOI 10.1002/jbm.a.10276
   Kino Y, 1998, J SURG RES, V79, P71, DOI 10.1006/jsre.1998.5389
   KLOCK G, 1994, APPL MICROBIOL BIOT, V40, P638
   Klock G, 1997, BIOMATERIALS, V18, P707, DOI 10.1016/S0142-9612(96)00204-9
   Kobayashi N, 2003, TRANSPLANT P, V35, P443, DOI 10.1016/S0041-1345(02)03783-1
   Kong HJ, 2003, CELL TRANSPLANT, V12, P779, DOI 10.3727/000000003108747253
   Kong HJ, 2004, BIOMACROMOLECULES, V5, P1720, DOI 10.1021/bm049879r
   Krasaekoopt W, 2003, INT DAIRY J, V13, P3, DOI 10.1016/S0958-6946(02)00155-3
   Kulseng B, 1999, TRANSPLANTATION, V67, P978, DOI 10.1097/00007890-199904150-00008
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   KUNG IM, 1995, BIOMATERIALS, V16, P649, DOI 10.1016/0142-9612(95)93863-9
   Kurillova L, 2000, J MICROENCAPSUL, V17, P279
   Kwon YJ, 2002, BIOTECHNIQUES, V33, P212, DOI 10.2144/02331dd05
   Leblond FA, 1996, BIOMATERIALS, V17, P2097, DOI 10.1016/0142-9612(96)00027-0
   Leblond FA, 1999, CELL TRANSPLANT, V8, P327, DOI 10.1177/096368979900800303
   Lee BH, 1997, EXP TECHNIQUES, V21, P9, DOI 10.1111/j.1747-1567.1997.tb00501.x
   Legallais C, 2001, J MEMBRANE SCI, V181, P81, DOI 10.1016/S0376-7388(00)00539-1
   Levy MC, 1996, J MICROENCAPSUL, V13, P169, DOI 10.3109/02652049609052905
   Li Q, 2004, J BIOMED MATER RES A, V68A, P28, DOI 10.1002/jbm.a.20007
   Li RH, 1998, ADV DRUG DELIVER REV, V33, P87, DOI 10.1016/S0169-409X(98)00022-2
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Lindner MD, 1998, CELL TRANSPLANT, V7, P165, DOI 10.1016/S0963-6897(97)00169-3
   MARTINSEN A, 1992, BIOTECHNOL BIOENG, V39, P186, DOI 10.1002/bit.260390210
   MATTHEW HW, 1993, BIOTECHNOL PROGR, V9, P510, DOI 10.1021/bp00023a010
   Meier W, 2000, CHEM SOC REV, V29, P295, DOI 10.1039/a809106d
   Mercier P, 2001, J MICROENCAPSUL, V18, P323
   MERCIER P, Patent No. 0205943
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   Miyoshi Y, 1996, EXP NEUROL, V138, P169, DOI 10.1006/exnr.1996.0055
   Mori K, 2005, CHEM REC, V5, P1, DOI 10.1002/tcr.20030
   Morris PJ, 1996, TRENDS BIOTECHNOL, V14, P163, DOI 10.1016/0167-7799(96)10020-2
   Moslemy P, 2002, BIOTECHNOL BIOENG, V80, P175, DOI 10.1002/bit.10358
   Murakami Y, 2003, J BIOMAT SCI-POLYM E, V14, P875, DOI 10.1163/156856203322381384
   NIJENHUIS KT, 1987, ADV POLYM SCI, V136, P194
   Omer A, 2005, TRANSPLANTATION, V79, P52, DOI 10.1097/01.TP.0000149340.37865.46
   Orive G, 2004, TRENDS BIOTECHNOL, V22, P87, DOI 10.1016/j.tibtech.2003.11.004
   Orive G, 2003, EUR J PHARM SCI, V18, P23, DOI 10.1016/S0928-0987(02)00220-8
   OSHEA GM, 1984, BIOCHIM BIOPHYS ACTA, V804, P133, DOI 10.1016/0167-4889(84)90107-1
   Pappas GD, 1997, NEUROL RES, V19, P71
   Pelegrin M, 1998, GENE THER, V5, P828, DOI 10.1038/sj.gt.3300632
   POLK A, 1994, J PHARM SCI, V83, P178, DOI 10.1002/jps.2600830213
   Poncelet D, 2001, ANN NY ACAD SCI, V944, P74
   Powers AC, 1997, ANN NY ACAD SCI, V831, P208
   Prokop A, 1998, ADV POLYM SCI, V136, P1
   PROKOP A, 1998, ADV POLYM SCI, V136, P52
   Rabanel JM, 2004, J MICROENCAPSUL, V21, P413, DOI 10.1080/02652040410001729223
   Raymond MC, 2004, ARTIF CELL BLOOD SUB, V32, P275, DOI 10.1081/BIO-120037832
   Read TA, 2001, NAT BIOTECHNOL, V19, P29, DOI 10.1038/83471
   Rehor A, 2001, J BIOMAT SCI-POLYM E, V12, P157, DOI 10.1163/156856201750180898
   Rihova B, 2000, ADV DRUG DELIVER REV, V42, P65
   Risbud M, 2001, CELL TRANSPLANT, V10, P195
   Risbud MV, 2003, J BIOMED MATER RES A, V66A, P86, DOI 10.1002/jbm.a.10522
   Risbud MV, 2001, J BIOMED MATER RES, V54, P436, DOI 10.1002/1097-4636(20010305)54:3<436::AID-JBM180>3.3.CO;2-#
   Robitaille R, 1999, J BIOMED MATER RES, V44, P116, DOI 10.1002/(SICI)1097-4636(199901)44:1<116::AID-JBM13>3.3.CO;2-0
   Robitaille R, 2005, BIOMATERIALS, V26, P4119, DOI 10.1016/j.biomaterials.2004.10.028
   Rokstad AM, 2003, CELL TRANSPLANT, V12, P351, DOI 10.3727/000000003108746902
   Rose T, 2000, CHEM ENG TECHNOL, V23, P769, DOI 10.1002/1521-4125(200009)23:9<769::AID-CEAT769>3.0.CO;2-M
   Rosinski S, 2002, J MICROENCAPSUL, V19, P641, DOI 10.1080/02652040210142533
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   SAGEN J, 1993, J NEUROSCI, V13, P2415
   Sakai S, 2005, BIOMATERIALS, V26, P4786, DOI 10.1016/j.biomaterials.2004.11.043
   Sakai S, 2000, J MICROENCAPSUL, V17, P691
   SAWHNEY AS, 1993, BIOMATERIALS, V14, P1008, DOI 10.1016/0142-9612(93)90194-7
   SAWHNEY AS, 1992, BIOMATERIALS, V13, P863, DOI 10.1016/0142-9612(92)90180-V
   Schaffellner S, 2005, TRANSPL P, V37, P248, DOI 10.1016/j.transproceed.2005.01.042
   Schneider S, 2001, BIOMATERIALS, V22, P1961, DOI 10.1016/S0142-9612(00)00380-X
   Serp D, 2000, BIOTECHNOL BIOENG, V70, P41, DOI 10.1002/1097-0290(20001005)70:1<41::AID-BIT6>3.0.CO;2-U
   Shoichet MS, 2000, ADV DRUG DELIVER REV, V42, P81, DOI 10.1016/S0169-409X(00)00055-7
   Soon-Shiong P, 1999, ADV DRUG DELIVER REV, V35, P259, DOI 10.1016/S0169-409X(98)00076-3
   SOONSHIONG P, 1991, TRANSPLANT P, V23, P758
   SOONSHIONG P, 1994, LANCET, V343, P950, DOI 10.1016/S0140-6736(94)90067-1
   Strand BL, 2001, CELL TRANSPLANT, V10, P263, DOI 10.3727/000000001783986800
   Strand BL, 2003, J BIOMED MATER RES A, V64A, P540, DOI 10.1002/jbm.a.10337
   Strand BL, 2000, MINERVA BIOTECNOL, V12, P223
   Sugiura S, 2005, BIOMATERIALS, V26, P3327, DOI 10.1016/j.biomaterials.2004.08.029
   Suzuki R, 2002, CELL TRANSPLANT, V11, P787, DOI 10.3727/000000002783985305
   Thu B, 1996, BIOMATERIALS, V17, P1031, DOI 10.1016/0142-9612(96)84680-1
   Thu B, 1996, BIOMATERIALS, V17, P1069, DOI 10.1016/0142-9612(96)85907-2
   Toso C, 2003, TRANSPLANT INT, V16, P405, DOI 10.1007/s00147-003-0555-9
   Tsang VL, 2004, ADV DRUG DELIVER REV, V56, P1635, DOI 10.1016/j.addr.2004.05.001
   Tun T, 1996, CELL TRANSPLANT, V5, pS59, DOI 10.1016/0963-6897(96)00042-5
   Uludag H, 2000, ADV DRUG DELIVER REV, V42, P29, DOI 10.1016/S0169-409X(00)00053-3
   Van Raamsdonk JM, 2001, J BIOMED MATER RES, V54, P264, DOI 10.1002/1097-4636(200102)54:2<264::AID-JBM14>3.0.CO;2-7
   van Schilfgaarde R, 1999, J MOL MED-JMM, V77, P199, DOI 10.1007/s001090050336
   Visted T, 2003, HUM GENE THER, V14, P1429, DOI 10.1089/104303403769211646
   Wandrey C, 2001, ANN NY ACAD SCI, V944, P187
   Wang T, 1997, NAT BIOTECHNOL, V15, P358, DOI 10.1038/nbt0497-358
   Weber W, 2004, J BIOTECHNOL, V114, P315, DOI 10.1016/j.jbiotec.2004.07.014
   Wei OY, 2004, J PHARM PHARM SCI, V7, P315
   WINN SR, 1991, EXP NEUROL, V113, P322, DOI 10.1016/0014-4886(91)90022-5
   Xu BY, 2001, CELL TRANSPLANT, V10, P403
   Xue YL, 2001, ARTIF ORGANS, V25, P131, DOI 10.1046/j.1525-1594.2001.025002131.x
   YI Y, 2005, POLYSACCHARIDES STRU, P867
   Yin C, 2003, BIOMATERIALS, V24, P1771, DOI 10.1016/S0142-9612(02)00580-X
   Yu SH, 1999, BIOTECHNOL TECH, V13, P609, DOI 10.1023/A:1008922607119
   ZEKORN T, 1992, TRANSPLANT P, V24, P937
   ZIELINSKI BA, 1994, BIOMATERIALS, V15, P1049
   Zimmermann H, 2003, BIOMATERIALS, V24, P2083, DOI 10.1016/S0142-9612(02)00639-7
   Zimmermann U, 2001, ANN NY ACAD SCI, V944, P199, DOI 10.1111/j.1749-6632.2001.tb03833.x
NR 162
TC 10
Z9 11
U1 1
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
EI 1947-5918
BN 0-8412-3960-6
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 2006
VL 934
BP 305
EP 339
PG 35
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA BEW10
UT WOS:000239744300016
DA 2018-10-20
ER

PT B
AU Jun, X
   Tao, KS
   Liang, CJ
AF Jun, Xu
   Tao Kaishan
   Liang Chengjun
BE Yao, M
TI Design and evaluation of wound bandage with mixed chitosan fabric
SO Proceedings of 2006 China International Wool Textile Conference & IWTO
   Wool Forum
LA English
DT Proceedings Paper
CT China International Wool Textile Conference/IWTO Wool Forum
CY NOV 19-21, 2006
CL Xian, PEOPLES R CHINA
DE chitosan; wound bandage; structure; mechanical property; antibacterial
   activity
AB There exists a contradiction between good medicine performance of biomaterial and its high cost. In this paper wound bandages with mixed chitosan fabric were designed which adopted woven double-faced structure and knitted jacquard-rid weave separately. And the feature of low chitosan content and high performance was achieved for the designed wound bandages which content of chitosan were 42.92% and 60.23%. Through analyzing their fabric structures and mechanical properties, the results show that the designed wound bandages were more superior to the non-woven dressings with pure chitosan in tensile strength, moisture absorption and capillary flow, which ensure the elastic property of wound bandages and enhance guiding flow of liquid at wound. And the structure characters can fully exert biological accommodation of the chitosan that fibers were mostly distributed in outer layer of blending fiber and closely attached on skin. The experimental results of antibacterial activity expressed that the designed wound bandages were effect on wound infection-proof. They have relative much higher microbial repellence to Escherichia coli, and staphylococcus aureus(>50%). Thus, good trend of market application is foreseen from the designed wound bandages.
C1 Xian Polytech Univ, Sch Fash & Art Design, Xian 710048, Peoples R China.
RP Jun, X (reprint author), Xian Polytech Univ, Sch Fash & Art Design, Xian 710048, Peoples R China.
CR DILIP R, 2001, TEXT RES J, V71, P813
   DOMARD A, 1998, P 3 AS PAC CHIR CHIT, P24
   JIANG TD, 1996, ENV SCI, P99
   Kim SH, 2003, TEXT RES J, V73, P455
   MU Y, 1997, TEXTILE MAT, P326
   QIAN C, 2004, TECHNOLOGY TEXTILES, V22, P22
   YONEDA M, 2003, P 32 TEXT RES S
   YOU L, 2002, CHINA FIBER TEST, P12
NR 8
TC 0
Z9 0
U1 0
U2 1
PU CHINA TEXTILE & APPAREL PRESS
PI BEIJING
PA NO. 6, DONG ZHI MEN NAN DA JIE,, BEIJING, 100027, PEOPLES R CHINA
BN 978-7-5064-4382-1
PY 2006
BP 294
EP 299
PG 6
WC Materials Science, Textiles
SC Materials Science
GA BGR46
UT WOS:000250107100052
DA 2018-10-20
ER

PT B
AU Toom, A
   Suutre, S
   Arend, A
   Martson, A
AF Toom, A.
   Suutre, S.
   Arend, A.
   Martson, A.
BE Liepsch, D
TI Cellular dynamics in bone formation. A biomaterial based model
SO PROCEEDINGS OF THE 5TH WORLD CONGRESS OF BIOMECHANICS
LA English
DT Proceedings Paper
CT 5th World Congress of Biomechanics/World Council of Biomechanics
CY JUL 29-AUG 04, 2006
CL Munich, GERMANY
ID CARRIERS
AB In order to study behavior of the cells contributing in ectopic bone formation an artificial biomaterial based model was developed in rats. Stereologic techniques including application of isotropic scale to locate any polarity in cellular penetration were used. rhBMP-2 treated implants showed significantly higher rate of mesenchymal-like cell penetration at three days and tremendously higher rate of bone formation at 21 days as compared to control implants. No polarity of tissue reactions was detected in either group or at any time-point. This study provides us with an animal model of ectopic bone formation at the site of most common clinical occurrence of this phenomenon. This model is suitable for standardization due to its artificial entity and for assessment due to its spherical isotropicity.
C1 [Toom, A.; Martson, A.] Univ Tartu, Clin Traumatol & Orthopaed, Tartu, Estonia.
   [Suutre, S.; Arend, A.] Univ Tartu, Dept Anat, Tartu, Estonia.
RP Toom, A (reprint author), Univ Tartu, Clin Traumatol & Orthopaed, Tartu, Estonia.
FU Estonian Science Foundation [5210, 5445, 6218]
FX Supported by Estonian Science Foundation, grants no 5210, 5445, 6218.
CR Ahn SH, 2003, J PERIODONTOL, V74, P787, DOI 10.1902/jop.2003.74.6.787
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x
   Kim CS, 2005, BIOMATERIALS, V26, P2501, DOI 10.1016/j.biomaterials.2004.07.015
   Neal BC, 2000, ACTA ORTHOP SCAND, V71, P122, DOI 10.1080/000164700317413076
   Okubo Y, 2000, INT J ORAL MAX SURG, V29, P62, DOI 10.1016/S0901-5027(00)80127-7
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
NR 8
TC 0
Z9 0
U1 0
U2 0
PU MEDIMOND S R L
PI 40128 BOLOGNA
PA VIA MASERATI 5, 40128 BOLOGNA, 00000, ITALY
BN 978-88-7587-270-0
PY 2006
BP 261
EP +
PG 2
WC Engineering, Biomedical
SC Engineering
GA BFY74
UT WOS:000245468100046
DA 2018-10-20
ER

PT B
AU Wang, BQ
   Deng, CJ
   Li, YD
   Sun, YS
AF Wang Baoqiang
   Deng Changjian
   Li Yiding
   Sun Yuansheng
BE Qi, J
   Cui, JP
TI Acoustic parameter measurement for low-frequency ultrasound
SO PROCEEDINGS OF THE FIRST INTERNATIONAL SYMPOSIUM ON TEST AUTOMATION &
   INSTRUMENTATION, VOLS 1 - 3
LA English
DT Proceedings Paper
CT 1st International Symposium on Test Automation and Instrumentation
CY SEP 13-16, 2006
CL Beijing, PEOPLES R CHINA
SP China Instrument & Control Soc, Chinese Measurement Soc, Foreign Instrument Technol Comm
DE acoustic intensity measurement; DSP; hydrophone; MSP430F149
AB Ultrasonic cavitation in the mixture of liquid and solid is one of the most important actions in biomaterial processing with low-frequency (20 similar to 100kHZ) ultrasound. Because the degree of cavitation is related to some acoustic parameters (such as intensity and frequency), the relative Parameter detection and control are needed. It is regrettable that an ideal instrument is difficult to get. The aim of the work is to study the principle of detecting acoustic parameters and to design an intelligent device for low-frequency ultrasonic intensity or other parameters. In the design method, the CS-3 hydrophone, signal buffer, programmable amplifier, band-pass filter, amplitude demodulation, frequency detection. temperature compensation circuits and the ultra-low consumption MSP430F-149 are integrated in the hardware. The software for system management, control and digital signal processing is designed in assembly and C++ language. Based on the hardware and software mentioned above. an intelligent system is Set LIP. The test results of the work explained that, the advantage. stability and reliability of the system are excellent. The measurement precision of acoustic intensity is better than +/- 5% in 10-100kHz and in the range of 0-100 degrees C. The performance is better than what of expected.
C1 Chengdu Univ Informat Technol, Chengdu 610225, Peoples R China.
RP Wang, BQ (reprint author), Chengdu Univ Informat Technol, Chengdu 610225, Peoples R China.
CR BAO GL, 2005, ACOUSTICS TECHNOLOGY, P25
   Feng R, 2002, ULTRASON SONOCHEM, V9, P231, DOI 10.1016/S1350-4177(02)00083-4
   FENG R, 1999, ULTRASONIC HDB
   WANG BQ, IEEE P ICIMA, P763
   Wang J, 2004, ADV ATMOS SCI, V21, P662, DOI 10.1007/BF02915733
NR 5
TC 1
Z9 1
U1 0
U2 1
PU WORLD PUBLISHING CORPORATION
PI BEIJING
PA 137 CHAONEI DAJIE, BEIJING 100010, PEOPLES R CHINA
BN 978-7-5062-8230-7
PY 2006
BP 1338
EP 1343
PG 6
WC Automation & Control Systems; Instruments & Instrumentation
SC Automation & Control Systems; Instruments & Instrumentation
GA BFQ11
UT WOS:000243723702030
DA 2018-10-20
ER

PT J
AU Hao, L
   Lawrence, J
AF Hao, L
   Lawrence, J
TI Albumin and fibronectin protein adsorption on CO2-laser-modified
   biograde stainless steel
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE CO2 laser; stainless steel; human serum albumin; human plasma
   fibronectin; wettability characteristics; surface roughness
ID PARTIALLY-STABILIZED ZIRCONIA; BOVINE SERUM-ALBUMIN; FIBROBLAST CELL
   RESPONSE; POWER DIODE-LASERS; MGO-PSZ; WETTABILITY CHARACTERISTICS;
   SURFACE ENERGIES; EFFECTS THEREOF; SOLID-SURFACES; TITANIUM
AB The surface properties of a biomaterial play an essential role in protein adsorption, which in turn determines the cellular response to the adsorbed surface. In order to obtain a surface that would yield favourable protein adsorption for successful cellular response, the surface properties of a biograde stainless steel were modified by CO, laser treatment. An investigation of the CO2-laser-modified surface properties and the effects thereof on the adsorption of human serum albumin (no-cell adhesive) and human plasma fibronectin (cell adhesive) was conducted. It was found that the thickness of the adsorbed fibronectin layer increased with increasing CO2 laser power density, while the thickness of the adsorbed albumin layer decreased with increasing CO2 laser power density. The surface roughness and wettability characteristics contributed to the observed changes in protein adsorption. The wettability characteristics of the biograde stainless steel were found to be the predominant mechanism governing the observed change in protein adsorption. Since the wettability characteristics of the biograde stainless steel can be modified in an efficient and controllable way with the CO2 laser, it is believed that this work presents a demonstrable alternative to the techniques currently available for enhancing the biocompatibility of biograde stainless steels.
C1 Univ Loughborough, Rapid Mfg Res Grp, Wolfson Sch Mech & Mfg Engn, Loughborough LE11 3TU, Leics, England.
RP Hao, L (reprint author), Univ Loughborough, Rapid Mfg Res Grp, Wolfson Sch Mech & Mfg Engn, Loughborough LE11 3TU, Leics, England.
EM l.hao@lboro.ac.uk
OI Lawrence, Jonathan/0000-0002-1649-9948; Hao, Liang/0000-0003-2071-7044
CR ADAM NK, 1958, J CHEM SOC, V18, P2206
   Amaral M, 2002, BIOMATERIALS, V23, P4123, DOI 10.1016/S0142-9612(02)00155-2
   Cacciafesta P, 2001, SURF SCI, V491, P405, DOI 10.1016/S0039-6028(01)01303-6
   Dadsetan M, 2001, J BIOMED MATER RES, V57, P183, DOI 10.1002/1097-4636(200111)57:2<183::AID-JBM1157>3.0.CO;2-M
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   Feng B, 2002, MATER CHARACT, V49, P129, DOI 10.1016/S1044-5803(02)00341-8
   FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008
   Galli C, 2002, COLLOID SURFACE B, V26, P255, DOI 10.1016/S0927-7765(02)00015-2
   GOOD RJ, 1960, J PHYS CHEM-US, V64, P561, DOI 10.1021/j100834a012
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Hao L, 2004, J BIOMATER APPL, V19, P81, DOI 10.1177/0885328204043546
   Hao L, 2004, J MATER SCI-MATER M, V15, P967, DOI 10.1023/B:JMSM.0000042682.20595.74
   Hao L, 2004, J BIOMED MATER RES A, V69A, P748, DOI 10.1002/jbm.a.30055
   Hao L, 2004, COLLOID SURFACE B, V34, P87, DOI 10.1016/j.colsurfb.2003.12.008
   Hao L, 2003, MAT SCI ENG C-BIO S, V23, P627, DOI 10.1016/S0928-4931(03)00056-0
   Horbett T. A., 1996, CELL CULTURING SURFA
   Janocha B, 2001, SURF COAT TECH, V142, P1051, DOI 10.1016/S0257-8972(01)01279-8
   Kinloch A. J, 1987, ADHESION ADHESIVES S
   Lawrence J, 2005, LASER ENG, V15, P75
   Lawrence J, 1999, APPL SURF SCI, V138, P388, DOI 10.1016/S0169-4332(98)00431-0
   Lawrence J, 1999, J PHYS D APPL PHYS, V32, P2311, DOI 10.1088/0022-3727/32/18/301
   Lawrence J, 1999, J PHYS D APPL PHYS, V32, P1075, DOI 10.1088/0022-3727/32/10/301
   Lawrence J., 2001, LASER MODIFICATION W
   Lawrence J., 2000, OPT LASER ENG, V32, P353
   NEUMANN AW, 1972, J COLLOID INTERF SCI, V38, P341, DOI 10.1016/0021-9797(72)90251-2
   OLSSON J, 1995, COLLOID SURFACE B, V5, P161, DOI 10.1016/0927-7765(95)01212-2
   Schmidt C, 2001, J BIOMED MATER RES, V54, P209, DOI 10.1002/1097-4636(200102)54:2<209::AID-JBM7>3.0.CO;2-7
   Song Q, 1998, J ADHES SCI TECHNOL, V12, P957
   TABORELLI M, 1995, J BIOMED MATER RES, V29, P707, DOI 10.1002/jbm.820290606
   WALTON AG, 1982, BIOMATERIALS INTERFA, P245
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
   Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7
NR 34
TC 12
Z9 12
U1 0
U2 2
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI WESTMINISTER
PA 1 BIRDCAGE WALK, WESTMINISTER SW1H 9JJ, ENGLAND
SN 0954-4119
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PD JAN
PY 2006
VL 220
IS H1
BP 47
EP 55
DI 10.1243/095441105X68999
PG 9
WC Engineering, Biomedical
SC Engineering
GA 006ZR
UT WOS:000234937100005
PM 16459445
DA 2018-10-20
ER

PT B
AU Koller, M
   Kroll, V
   Schildhauer, TA
   Muhr, G
AF Koeller, M.
   Kroll, V.
   Schildhauer, T. A.
   Muhr, G.
BE Vollmar, B
TI Activated leukocytes promote osteogenic differentiation of human
   mesenchymal stem cells
SO PROCEEDINGS OF THE XLI CONGRESS OF THE EUROPEAN SOCIETY FOR SURGICAL
   RESEARCH
LA English
DT Proceedings Paper
CT 41st Congress of the European-Society-for-Surgical-Research
CY MAY 17-20, 2006
CL Rostock, GERMANY
SP European Soc Surg Res
AB Autologous transplantation of expanded mesenchymal stem cells (MSCs) from bone marrow may offer a new approach for the therapy of critical bone defects. It is known that polymorphonuclear neutrophil granulocytes (PMN) were activated after tissue trauma or at biomaterial surfaces. Thus, it was the purpose of this study to analyze the influence of PMN-conditioned cell culture media on the differentiation of human mesenchymal stem cells (hMSC). Isolated PMN were stimulated with lipopolysaccharide (LPS) and cell-free culture supernatants (conditioned media) were transferred to human mesenchymal stem cells. After an additional cell culture period up to 35 days it was observed that conditioned media decreased hMSC proliferation and induced osteogenic cell differentiation indicated by Alizarin-positive bone nodule formation. These data demonstrate a potential role of activated leukocytes in the osteogenic differentiation of progenitor cells.
C1 [Koeller, M.; Kroll, V.; Schildhauer, T. A.; Muhr, G.] BG Kliniken Bergmannsheil Univ Klin, Dept Surg Surg Res, D-44789 Bochum, Germany.
RP Koller, M (reprint author), BG Kliniken Bergmannsheil Univ Klin, Dept Surg Surg Res, D-44789 Bochum, Germany.
FU Alma and Heinrich-Vogelsang-Foundation of the Ruhr-Universitat Bochum,
   Germany
FX This work is part of the thesis of VK. The authors greatfully appreciate
   the support of VK by the Alma and Heinrich-Vogelsang-Foundation of the
   Ruhr-Universitat Bochum, Germany.
CR ENGLISH D, 1974, J IMMUNOL METHODS, V5, P249, DOI 10.1016/0022-1759(74)90109-4
   Horowitz MC, 1998, J CLIN DENSITOM, V1, P187, DOI 10.1385/JCD:1:2:187
   Timlin M, 2005, J TRAUMA, V58, P1223, DOI 10.1097/01.TA.0000169866.88781.F1
   Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0
   Wang T, 2005, TISSUE ENG, V11, P1159, DOI 10.1089/ten.2005.11.1159
NR 5
TC 0
Z9 0
U1 0
U2 0
PU MEDIMOND S R L
PI 40128 BOLOGNA
PA VIA MASERATI 5, 40128 BOLOGNA, 00000, ITALY
BN 88-7587-243-0
PY 2006
BP 49
EP +
PG 3
WC Medicine, General & Internal; Surgery
SC General & Internal Medicine; Surgery
GA BFO67
UT WOS:000243471700009
DA 2018-10-20
ER

PT J
AU Onuma, K
AF Onuma, Kazuo
TI Recent research on pseudobiological hydroxyapatite crystal growth and
   phase transition mechanisms
SO PROGRESS IN CRYSTAL GROWTH AND CHARACTERIZATION OF MATERIALS
LA English
DT Review
DE hydroxyapatite; growth mechanism; cluster; phase transition;
   third-generation biomaterial
ID ATOMIC-FORCE MICROSCOPY; LASER-LIGHT-SCATTERING; CALCIUM-PHOSPHATE;
   AQUEOUS-SOLUTION; SHIFT INTERFEROMETRY; IN-SITU; DILUTE-SOLUTIONS;
   SINGLE-CRYSTALS; POSNERS CLUSTER; KINETICS
AB We have studied the growth and phase transition mechanisms of hydroxyapatite (HAP) and its interaction with a growth factor protein in a simulated physiological environment. Using atomic force microscopy (AFM) and real-time phase shift interferometry, we performed in situ observations of growth in simulated human body fluid solutions seeded with millimeter-sized HAP single crystals produced by bydrothenrial synthesis, and we measured the normal growth rate. The step kinetic coefficient (derived from the velocity of growth steps) and the edge free energy (calculated from the variation in the non-nal growth rate with the degree of supersaturation) both deviated greatly from the standard values for typical inorganic salt crystals and were found to be close to those of protein crystals. This suggests that the growth units of HAP crystals are clusters rather than simple ions and that growth proceeds through the accumulation of these clusters. Observations using dynamic light scattering confirmed the presence of clusters with a diameter of about I nm in simulated body fluids. Ab initio analysis of the cluster energy stability indicated that calcium phosphate clusters based on Ca-3(PO4)(2) units achieve an energy minimum for clusters of the form [Ca-3(PO4)(2)](3). These clusters have S6 symmetry, and, when they are used to build a HAP crystal structure, their structure is likely to become slightly modified, resulting in the formation Of C-3 structures.
   Since these clusters would also be the building blocks of amorphous'calciuM phosphate (ACP), they provide vital clues to the phase transition from ACP to HAP. Using time-resolved static light scattering, we tracked the ACP-HAP phase transition process and found that the degree of coarseness inside a cluster aggregate changes abruptly within a specific time interval and HAP is formed and deposited in the final stages. This suggests that an ACP aggregate changes into HAP as its internal structure becomes regularized. Using this phase transition process, we produced a complex of HAP and the FGF-2 growth factor protein. This complex releases the FGF-2 into a physiological saline solution over a period of at least a week, meaning that it can be used as a pharmacologically active third-generation biornaterial. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Natl Inst Adv Ind Sci & Technol, Inst Human Sci & Biomed Engn, Tsukuba, Ibaraki 3058566, Japan.
RP Onuma, K (reprint author), Natl Inst Adv Ind Sci & Technol, Inst Human Sci & Biomed Engn, Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.
EM k.onuma@aist.go.jp
CR Abrams L, 1994, Biomed Sci Instrum, V30, P169
   ARENDS J, 1987, J CRYST GROWTH, V84, P515, DOI 10.1016/0022-0248(87)90284-3
   ARENDS J, 1979, J CRYST GROWTH, V46, P213, DOI 10.1016/0022-0248(79)90060-5
   BLAKESLEE KC, 1971, J AM CERAM SOC, V54, P559, DOI 10.1111/j.1151-2916.1971.tb12207.x
   Chernov A. A., 1986, Soviet Physics - Crystallography, V31, P705
   Chernov A.A., 1980, MODERN CRYSTALLOGRAP
   CHERNOV AA, 1987, J CRYST GROWTH, V84, P389, DOI 10.1016/0022-0248(87)90265-X
   CHRISTOFFERSEN J, 1992, J CRYST GROWTH, V121, P608, DOI 10.1016/0022-0248(92)90568-4
   CHRISTOFFERSEN MR, 1992, J CRYST GROWTH, V121, P617, DOI 10.1016/0022-0248(92)90569-5
   Chu B, 1974, LASER LIGHT SCATTERI
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   DOHERTY TM, 1994, CALCIFIED TISSUE INT, V54, P224, DOI 10.1007/BF00301683
   DURBIN SD, 1986, J CRYST GROWTH, V76, P583, DOI 10.1016/0022-0248(86)90175-2
   Elliott JC, 1994, STRUCTURE CHEM APATI
   ENNEVER J, 1973, BACTERIAL CALCIFICAT
   GLIMCHER M, 1960, SPECIFICITY MOL STRU
   HAYEK E, 1955, ANGEW CHEM INT EDIT, V67, P326, DOI 10.1002/ange.19550671203
   HAYEK E, 1958, Z ANORG ALLG CHEM, V295, P241, DOI 10.1002/zaac.19582950311
   HENCH L, 1993, INTRO BIOCERAMICS
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HEUGHEBAERT JC, 1990, J COLLOID INTERF SCI, V135, P20, DOI 10.1016/0021-9797(90)90285-V
   Ito A, 1996, J CRYST GROWTH, V163, P311, DOI 10.1016/0022-0248(95)00955-8
   ITO A, 1999, PHOSPHORUS LETT, V35, P25
   JULLMANN H, 1966, Z NATURFORSCH PT B, VB 21, P493
   Kanzaki N, 1998, J PHYS CHEM B, V102, P6471, DOI 10.1021/jp981512r
   Kanzaki N, 2001, BIOMATERIALS, V22, P2921, DOI 10.1016/S0142-9612(01)00039-4
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KOUTSOUKOS P, 1980, J AM CHEM SOC, V102, P1553, DOI 10.1021/ja00525a015
   Kuznetsov YG, 1996, J CRYST GROWTH, V168, P63, DOI 10.1016/0022-0248(96)00363-6
   LAND TA, 1995, PHYS REV LETT, V75, P2774, DOI 10.1103/PhysRevLett.75.2774
   LAPRAZ D, 1979, PHYS STATUS SOLIDI A, V54, P605, DOI 10.1002/pssa.2210540223
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   MAIWA K, 1990, J CRYST GROWTH, V102, P43, DOI 10.1016/0022-0248(90)90887-Q
   MALKIN AI, 1989, J CRYST GROWTH, V97, P765, DOI 10.1016/0022-0248(89)90580-0
   MALKIN AJ, 1995, PHYS REV LETT, V75, P2778, DOI 10.1103/PhysRevLett.75.2778
   Malkin AJ, 1996, J PHYS CHEM-US, V100, P11736, DOI 10.1021/jp960745k
   MANN S, 1989, BIOMINERALIZATION
   Markov I.V., 1995, CRYSTAL GROWTH BEGIN
   MCLEAN FC, 1968, EVOLUTION BONE
   Midy V, 1998, J BIOMED MATER RES, V41, P405, DOI 10.1002/(SICI)1097-4636(19980905)41:3<405::AID-JBM10>3.0.CO;2-H
   MORENO EC, 1977, CALC TISS RES, V24, P47, DOI 10.1007/BF02223296
   MORENO EC, 1981, J CRYST GROWTH, V53, P20, DOI 10.1016/0022-0248(81)90052-X
   MURPHY B T, 1962, Br J Urol, V34, P129, DOI 10.1111/j.1464-410X.1962.tb06505.x
   NANCOLLAS GH, 1980, PROG CRYST GROWTH CH, V3, P77, DOI 10.1016/0146-3535(80)90013-1
   Onuma K, 2000, J PHYS CHEM B, V104, P10563, DOI 10.1021/jp002697g
   Onuma K, 1998, CHEM MATER, V10, P3346, DOI 10.1021/cm980062c
   Onuma K, 2004, MACROMOL BIOSCI, V4, P39, DOI 10.1002/mabi.200350037
   Onuma K, 1996, J CRYST GROWTH, V167, P773, DOI 10.1016/0022-0248(96)00421-6
   ONUMA K, 1995, J CRYST GROWTH, V154, P118, DOI 10.1016/0022-0248(95)00201-4
   ONUMA K, 1993, J CRYST GROWTH, V129, P706, DOI 10.1016/0022-0248(93)90507-S
   ONUMA K, 1990, J CRYST GROWTH, V100, P125, DOI 10.1016/0022-0248(90)90615-R
   ONUMA K, 1994, J CRYST GROWTH, V137, P610, DOI 10.1016/0022-0248(94)91006-5
   Onuma K, 1998, J PHYS CHEM B, V102, P7833, DOI 10.1021/jp981617u
   ONUMA K, 1995, J CRYST GROWTH, V148, P201, DOI 10.1016/0022-0248(94)00879-5
   Oyane A, 1999, J PHYS CHEM B, V103, P8230, DOI 10.1021/jp9910340
   PAK CYC, 1982, J UROLOGY, V128, P1157, DOI 10.1016/S0022-5347(17)53403-5
   PARFITT AM, 1982, METABOLIC BONE DIS A
   PERLOFF A, 1956, SCIENCE, V124, P583, DOI 10.1126/science.124.3222.583-a
   POSNER AS, 1975, ACCOUNTS CHEM RES, V8, P273, DOI 10.1021/ar50092a003
   REY C, 1989, CONNECT TISSUE RES, V21, P597, DOI 10.3109/03008208909050016
   REY C, 1990, Biomaterials, V11, P13
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SHAPIRO F, 1980, J BONE JOINT SURG AM, V62, P384, DOI 10.2106/00004623-198062030-00008
   SILLENCE D, 1981, CLIN ORTHOP RELAT R, P11
   SIMPSON DR, 1965, SCIENCE, V147, P501, DOI 10.1126/science.147.3657.501
   Takayasu H, 1978, Nihon Hinyokika Gakkai Zasshi, V69, P436
   TARLO LBH, 1964, ORIGIN BONE
   Treboux G, 2000, J AM CHEM SOC, V122, P8323, DOI 10.1021/ja994286n
   Treboux G, 2000, J PHYS CHEM A, V104, P5111, DOI 10.1021/jp994399t
   Tsutsui K, 1999, INT J POLYM ANAL CH, V5, P257, DOI 10.1080/10236669908009741
   Tsutsui K, 1998, REV SCI INSTRUM, V69, P3482, DOI 10.1063/1.1149124
   Wang JS, 1996, ACTA ORTHOP SCAND, V67, P1
   ZAWACKI SJ, 1986, ACS SYM SER, V323, P650
NR 74
TC 37
Z9 40
U1 2
U2 31
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8974
J9 PROG CRYST GROWTH CH
JI Prog. Cryst. Growth Charact. Mater.
PY 2006
VL 52
IS 3
BP 223
EP 245
DI 10.1016/j.pcrysgrow.2006.06.003
PG 23
WC Crystallography; Materials Science, Characterization & Testing
SC Crystallography; Materials Science
GA 090AI
UT WOS:000240922600003
DA 2018-10-20
ER

PT B
AU Zhao, XW
   Cao, Y
   Gu, ZZ
AF Zhao, Xiangwei
   Cao, Yun
   Gu, Zhongze
BE Zhou, G
   Lu, Z
   Takeyama, H
TI Morpho butterfly wing as label-free detector for microfluidic chip
SO Progress on Post-Genome Technologies
LA English
DT Proceedings Paper
CT 4th International Forum on Post-Genome Technologies
CY SEP 25-26, 2006
CL Hangzhou, PEOPLES R CHINA
SP Shanxi Chaoying Biotech Co Ltd, Eastwin Life Sci Inc, Roche Diagnost Ltd, Gene Co Ltd, Waters China Ltd, Cold Spring Biotech Corp, Nanjing Univ, SE Univ, Zhejiang Univ, Jiangsu Sci & Technol Assoc, Life-Surveyor Project Japan, Hitachi Ltd, Huadong Res Inst Med & Biotech, Biomed Elect Soc Chinese Inst Elect, Ebiotrade Web
DE natural biomaterial; label-free biosensor; micro-fluidic chip
AB Natural blomaterials have been extensively studied not only from the view point of biology but also from the point of material. And microfluidic chip is a recent-developed technique for the integrated and miniaturized assays. In this paper, we will show that the wing of one kind of morpho butterfly, the nature material can be used as a label-free biosensor in microfluidic chip.
C1 SE Univ, State Key Lab Bioelect, Nanjing 210096, Peoples R China.
RP Zhao, XW (reprint author), SE Univ, State Key Lab Bioelect, Nanjing 210096, Peoples R China.
RI Zhao, Xiangwei/H-4095-2014
OI Zhao, Xiangwei/0000-0003-0678-5219
CR BECHGER L, J PHYS CHEM B, V109, P9980
   FLEISCHHAKER F, CHEM MAT, V17, P1346
   PARKER AR, PHIL T R COC LOND A, V362, P2709
   QIAN WP, LANGMUIR, V18, P4526
   XIA YN, ANGEW CHEM INT ED, V37, P550
NR 5
TC 0
Z9 0
U1 0
U2 4
PU SOUTHEAST UNIV PRESS
PI NANJING
PA 2 SIPAILOU, NANJING 210096, PEOPLES R CHINA
BN 978-7-5641-0565-5
PY 2006
BP 261
EP 263
PG 3
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA BFQ08
UT WOS:000243719500082
DA 2018-10-20
ER

PT J
AU Hassan, GM
   Sharaf, MA
AF Hassan, GM
   Sharaf, MA
TI Uncertainties in low gamma-dose determinations by means of ESR using the
   biomaterial modem coral reef
SO RADIATION MEASUREMENTS
LA English
DT Article
DE electron spin resonance; modem coral reef; biomineral; low dose range
ID ALANINE DOSIMETRY; RADICAL FORMATION; TOOTH ENAMEL; LITHIUM; EPR
AB The ESR spectrum of unirradiated modem aragonite coral (CaCO3) material from the Red Sea (Hurgada area) is characterized by four signals with spectroscopic splitting factors of g = 2.0056, 2.0030, 2.0006 and 1.997. The most intensive and stable line in this spectrum is attributed to CO2- radicals at g = 2.0006 +/- 0.0005. The dose response from 50 mGy to 20 Gy, energy dependence and effective atomic number are calculated so as to investigate coral as a dosimeter material in the clinical dose range. The lower experimental gamma-dose limit was found to be 50mGy with signal-to-noise (SIN) ratio of 15. The combined and expanded uncertainties accompanying these measurements are 1.72% and 3.44%, respectively. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Natl Inst Stand, Dept Ionizing Radiat Metrol, El Giza, Egypt.
RP Hassan, GM (reprint author), Natl Inst Stand, Dept Ionizing Radiat Metrol, Tersa St El Haram El Giza,POB 136, El Giza, Egypt.
EM gamalhassan65@hotmail.com
CR ALEXANDRE AC, 1992, APPL RADIAT ISOTOPES, V43, P1407
   Andreo P, 2000, TRS398 IAEA
   Azorin J, 1996, APPL RADIAT ISOTOPES, V47, P1539, DOI 10.1016/S0969-8043(96)00248-5
   BARTOLOTTA A, 1993, APPL RADIAT ISOTOPES, V44, P13, DOI 10.1016/0969-8043(93)90189-H
   Bergstrand ES, 1998, APPL RADIAT ISOTOPES, V49, P845, DOI 10.1016/S0969-8043(97)10011-2
   BURLIN TE, 1966, BRIT J RADIOL, V39, P727, DOI 10.1259/0007-1285-39-466-727
   BURLIN TE, 1969, INT J APPL RADIAT IS, V20, P767, DOI 10.1016/0020-708X(69)90040-4
   CONINCKX F, 1989, APPL RADIAT ISOTOPES, V40, P977
   Hassan GM, 1999, APPL MAGN RESON, V17, P93, DOI 10.1007/BF03162072
   Hassan GM, 1999, RADIAT MEAS, V30, P189, DOI 10.1016/S1350-4487(99)00034-7
   Hassan GM, 1999, JPN J APPL PHYS 1, V38, P6703, DOI 10.1143/JJAP.38.6703
   HASSAN GM, 2004, APPL RADIAT ISOTOPES, V62, P375
   *ICRU, 1976, 24 INT COMM RAD UN M
   *ICRU, 1984, 37 ICRU
   Ignatiev EA, 1996, APPL RADIAT ISOTOPES, V47, P333, DOI 10.1016/0969-8043(95)00293-6
   *ISO, 1995, GUIDE EXPR UNC MEAS
   KOJIMA T, 1989, APPL RADIAT ISOTOPES, V40, P851
   LOEVINGER R, 1956, RADIOLOGY, V66, P55, DOI 10.1148/66.1.55
   MCLAUGHLIN WL, 1993, RADIAT PROT DOSIM, V47, P255
   MCLAUGHLIN WL, 1990, RADIAT PHYS CHEM, V35, P693
   Olsson SK, 2000, APPL RADIAT ISOTOPES, V52, P1235, DOI 10.1016/S0969-8043(00)00077-4
   Pass B, 2000, RADIAT MEAS, V32, P163, DOI 10.1016/S1350-4487(99)00283-8
   REGULLA D, 1993, APPL RADIAT ISOTOPES, V44, P23, DOI 10.1016/0969-8043(93)90191-C
   Schaeken B, 1996, APPL RADIAT ISOTOPES, V47, P1177, DOI 10.1016/S0969-8043(96)00040-1
   Scherbina OI, 2000, APPL RADIAT ISOTOPES, V52, P1071, DOI 10.1016/S0969-8043(00)00048-8
   SELTZER SM, 1985, NUCL INSTRUM METH B, V12, P95, DOI 10.1016/0168-583X(85)90707-4
   SELTZER SM, 1993, RADIAT RES, V136, P147, DOI 10.2307/3578607
   Sharaf MA, 2004, NUCL INSTRUM METH B, V217, P603, DOI 10.1016/j.nimb.2003.11.088
NR 28
TC 1
Z9 1
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1350-4487
J9 RADIAT MEAS
JI Radiat. Meas.
PD JAN
PY 2006
VL 41
IS 1
BP 48
EP 54
DI 10.1016/j.radmeas.2005.06.005
PG 7
WC Nuclear Science & Technology
SC Nuclear Science & Technology
GA 993NW
UT WOS:000233961800008
DA 2018-10-20
ER

PT J
AU Yeong, WY
   Chua, CK
   Leong, KF
   Chandrasekaran, M
   Lee, MW
AF Yeong, Wai-Yee
   Chua, Chee-Kai
   Leong, Kah-Fai
   Chandrasekaran, Margam
   Lee, Mun-Wai
TI Indirect fabrication of collagen scaffold based on inkjet printing
   technique
SO RAPID PROTOTYPING JOURNAL
LA English
DT Article
DE print media; rapid prototypes; design
ID HYDROXYAPATITE IMPLANTS; DEGRADATION; MORPHOLOGY
AB Purpose - This paper presents a new indirect scaffold fabrication method for soft tissue based on rapid prototyping (RP) technique and preliminary characterization for collagen scaffolds.
   Design/methodology/approach - This paper introduces the processing steps for indirect scaffold fabrication based on the inkjet printing technology. The scaffold morphology was characterized by scanning electron microscopy. The designs of the scaffolds are presented and discussed.
   Findings - Theoretical studies on the inkjet printing process are presented. Previous research showed that the availability of biomaterial that can be processed on a commercial RP system is very limited. This is due mainly to the unfavorable machine processing parameters such as high working temperature and restrictions on the form of raw material input. The process described in this paper overcomes these problems while retaining the strength of RP techniques. Technical challenges of the process are presented as well.
   Research limitations/implications - Harnessing the ability of RP techniques to control the internal morphology of the scaffold, it is possible to couple the design of the scaffold with controlled cell-culture condition to modulate the behavior of the cells. However, this is just initial work, further development will be needed.
   Practical implications - This method enables the designer to manipulate the scaffold at three different length scales, namely the macroscopic scale, intermediate scale and the cellular scale.
   Originality/value - The work presented in this paper focuses on important processing steps for indirect scaffold fabrication using thermal-sensitive natural biomaterial. A mathematical model is proposed to estimate the height of a printed line.
C1 Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore.
   Singapore Inst Mfg Technol, Forming Technol Grp, Singapore, Singapore.
RP Yeong, WY (reprint author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore.
RI Chua, Chee Kai/B-6171-2009; Yeong, Wai Yee/G-2655-2013; Leong,
   Kah-Fai/B-6183-2009
OI Yeong, Wai Yee/0000-0003-3640-0877; 
CR Bellare A, 1996, BIOMATERIALS, V17, P2325, DOI 10.1016/S0142-9612(96)00086-5
   Bhola R, 1999, J MATER SCI, V34, P4883, DOI 10.1023/A:1004680315199
   BOGY DB, 1984, IBM J RES DEV, V28, P314, DOI 10.1147/rd.283.0314
   BOSE S, 2003, MAT SCI ENG C-BIOMIM, V4, P479
   CAKMAK M, 2005, POLYMER, V10, P3425
   CAMP J, 2002, THESIS MIT
   CHEN ZZ, 2004, RAPID PROTOTYPING J, V5, P327
   Chita C. K, 2003, RAPID PROTOTYPING PR
   Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5
   Chu TMG, 2001, J MATER SCI-MATER M, V12, P471, DOI 10.1023/A:1011203226053
   Cihlar J, 1996, BIOMATERIALS, V17, P1905, DOI 10.1016/0142-9612(95)00243-X
   Fox RW, 1998, INTRO FLUID MECH
   GAO F, 1994, P MATH PHYS SCI, P533
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Hou Q, 2003, BIOMATERIALS, V11, P1937
   JIANG G, 2005, BIOMATERIALS, V15, P2281
   KATOH K, 2004, BIOMATERIALS, V12, P2265
   LEE M, 2005, BIOMATERIALS, V20, P4281
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   LIU XH, 2004, ANN BIOMED ENG, V3, P477
   Marler JJ, 1998, ADV DRUG DELIVER REV, V33, P165, DOI 10.1016/S0169-409X(98)00025-8
   MIKOS AG, 2000, ELECT J BIOTECHNOLOG
   OH SH, 2003, BIOMATERIALS, V22, P4011
   PISHKO WGK, 2003, LANGMUIR, V24, P10310
   SACHLOS E, 2003, BIOMATERIALS, V8, P1487
   SOUSA R, 2000, J APPL POLYM SCI, V6, P1303
   SUNDBACK C, 2003, BIOMATERIALS, V5, P819
   TIMMER MD, 2003, BIOMATERIALS, V25, P4707
   Witt C, 2000, BIOMATERIALS, V21, P931, DOI 10.1016/S0142-9612(99)00262-8
   WU JJ, 2002, BIOMATERIALS, V17, P3773
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
NR 32
TC 62
Z9 64
U1 1
U2 44
PU EMERALD GROUP PUBLISHING LIMITED
PI BRADFORD
PA 60/62 TOLLER LANE, BRADFORD BD8 9BY, W YORKSHIRE, ENGLAND
SN 1355-2546
J9 RAPID PROTOTYPING J
JI Rapid Prototyping J.
PY 2006
VL 12
IS 4
BP 229
EP 237
DI 10.1108/13552540610682741
PG 9
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 080OQ
UT WOS:000240257800008
DA 2018-10-20
ER

PT S
AU Kandic, L
   Mitric, M
   Ignjatovic, N
AF Kandic, Lj.
   Mitric, M.
   Ignjatovic, N.
BE Uskokovic, DP
   Milonjic, SK
   Rakovic, DI
TI XRD analysis of calcium phosphate and biocomposite calcium
   phosphate/bioresorbable polymer
SO RECENT DEVELOPMENTS IN ADVANCED MATERIALS AND PROCESSES
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 7th Conference of the Yugoslav-Materials-Research-Society (Yu-MRS)
CY SEP 12-16, 2005
CL Herceg Novi, SERBIA MONTENEG
SP Yugoslav Mat Res Soc
DE calcium phosphate; composite; hydroxyapatite;
   poly-(DL-lacticle-co-glycolide); rietveld analysis; X-ray powder
   diffraction
ID CA-DEFICIENT APATITE; ATOMIC RATIO; BONE TISSUE; HYDROXYAPATITE;
   REFINEMENT; COMPOSITES; FILLER
AB Composite biomaterials based on calcium phosphate ceramic due to their high bioactivity are of interest for biological application and bone tissue repair. Structural and microstructural parameters of inorganic constituent of these materials are very important for the synthesis and characterization of composites. Quantitative and qualitative content, crystallite size of phases, as well as the degree of crystallinity have a great influence on the quality of composites, their application and bone tissue repair. X-ray diffractometry was employed to investigate the components of biocomposite materials, calcium phosphate (CaP) ceramic and poly-DL-lactide-coglycolide (DLPLG) polymer, as well as the biocomposite obtained from the mentioned components. Composite biomaterial was obtained by modified emulsion process. Using the Rietveld refinement, we analyzed CaP as an inorganic component of the composite, whence we have determined structural and microstructural properties of ceramic component of the investigated composite. The results obtained by structure refinement show that calcium phosphate ceramic materials synthesized at room temperature contain hydroxyapatite HAp as a predominant phase. The calculated Ca/P ratio is 1.667. The Rietveld analysis revealed lattice parameters a(angstrom)=9.4324(7) and c(angstrom)=6.8785(6) that are in agreement with the theoretical values.
C1 Serbian Acad Arts & Sci, Inst Tech Sci, Belgrade 11000, Serbia.
   Vinca Inst Nucl Sci, Belgrade 11001, Serbia.
RP Kandic, L (reprint author), Serbian Acad Arts & Sci, Inst Tech Sci, Knez Mihajlova 35-4, Belgrade 11000, Serbia.
EM ljiljanakandic@yahoo.com; mmitric@vin.bg.ac.yu; advamat@itn.sanu.ac.yu
RI Mitric, Miodrag/D-5056-2011; Veselinovic, Ljiljana/A-7420-2011;
   Ignjatovic, Nenad/C-4489-2008
OI Veselinovic, Ljiljana/0000-0002-6100-9178; Ignjatovic,
   Nenad/0000-0002-5749-094X; Mitric, Miodrag/0000-0002-1709-9890
CR BALZAR D, 1997, ADV XRAY ANAL, V39
   Durucan C, 2000, J BIOMED MATER RES, V51, P726, DOI 10.1002/1097-4636(20000915)51:4<726::AID-JBM22>3.3.CO;2-C
   El-Amin SF, 2003, BIOMATERIALS, V24, P1213, DOI 10.1016/S0142-9612(02)00451-9
   Gomez-Morales J, 2001, CRYST RES TECHNOL, V36, P15, DOI 10.1002/1521-4079(200101)36:1<15::AID-CRAT15>3.3.CO;2-5
   HUGHES JM, 1989, AM MINERAL, V74, P870
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 2005, MATER SCI FORUM, V494, P519, DOI 10.4028/www.scientific.net/MSF.494.519
   Ignjatovic N, 2005, J MATER SCI-MATER M, V16, P621, DOI 10.1007/s10856-005-2532-6
   Ignjatovic N, 2004, MATER SCI FORUM, V453-454, P537, DOI 10.4028/www.scientific.net/MSF.453-454.537
   IGNJATOVIC N, 2001, THESIS U BELGRADE
   *INT CTR DIFFR DAT, JCPDS FIL NO 34 0010
   KARANOVIC L, 1995, PRIMENJENA KRISTALOG
   KARANOVIC L, 2003, RENDGENSKA STRUKTURN
   POSNER AS, 1958, ACTA CRYSTALLOGR, V11, P308, DOI 10.1107/S0365110X58000815
   Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6
   Raynaud S, 2001, J AM CERAM SOC, V84, P359
   RODRIGUEZCARVAJ.J, 2005, FULLPROF COMPUTER PR
   Rusu VM, 2005, BIOMATERIALS, V26, P5414, DOI 10.1016/j.biomaterials.2005.01.051
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Wilson RM, 2005, BIOMATERIALS, V26, P1317, DOI 10.1016/j.biomaterials.2004.04.038
   Wilson RM, 2003, J SOLID STATE CHEM, V174, P132, DOI 10.1016/S0022-4596(03)00188-9
   Wilson RM, 1999, AM MINERAL, V84, P1406
   Young R.A., 1993, RIETVELD METHOD
NR 23
TC 4
Z9 4
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2006
VL 518
BP 507
EP 512
DI 10.4028/www.scientific.net/MSF.518.507
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BES77
UT WOS:000239351800083
DA 2018-10-20
ER

PT J
AU Kang, S
   Hoek, EMV
   Choi, H
   Shin, H
AF Kang, S
   Hoek, EMV
   Choi, H
   Shin, H
TI Effect of membrane surface properties during the fast evaluation of cell
   attachment
SO SEPARATION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE membranes; biofouling; surface potentials; surface roughness;
   hydrophobicity; membrane selection
ID REVERSE-OSMOSIS MEMBRANES; WASTE-WATER TREATMENT; BACTERIAL ADHESION;
   BIOMATERIAL SURFACES; MICROFILTRATION; RO; MECHANISMS; OPERATION;
   SYSTEMS
AB The biofouling potential is one of the important factors to design and to select membranes for water and wastewater treatment. In this investigation, the effect of membrane surface properties during the attachment of S. cerevisiae cells was examined using a laboratory-scale membrane filtration cell enabling direct microscopic observation of microbial cell deposition. The experimental results from 6 commercially available membranes showed that the initial adhesion rate, k(d) , was affected by the zeta potentials, hydrophobicity, and roughness of membrane surfaces. The k(d) value was significantly lower at the membrane which had more negative, hydrophilic, and smooth surfaces. The results will be helpful to minimize the time for selecting membranes in different situations, and for testing the performance of newly designed membranes.
C1 Korea Adv Inst Sci & Technol, Dept Civil & Environm Engn, Taejon 305701, South Korea.
   Univ Calif Los Angeles, Dept Civil & Environm Engn, Los Angeles, CA 90024 USA.
   Yale Univ, Dept Chem Engn, New Haven, CT 06520 USA.
RP Shin, H (reprint author), Korea Adv Inst Sci & Technol, Dept Civil & Environm Engn, Taejon 305701, South Korea.
EM hangshin@kaist.ac.kr
RI Kang, Seoktae/J-2165-2015; Shin, Hang Sik/C-1879-2011
CR Al-Ahmad M, 2000, DESALINATION, V132, P173, DOI 10.1016/S0011-9164(00)00146-6
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Baker JS, 1998, DESALINATION, V118, P81, DOI 10.1016/S0011-9164(98)00091-5
   BellonFontaine MN, 1996, COLLOID SURFACE B, V7, P47, DOI 10.1016/0927-7765(96)01272-6
   Bowen WR, 2001, J MATER SCI, V36, P623, DOI 10.1023/A:1004864219379
   Brant JA, 2004, J MEMBRANE SCI, V241, P235, DOI 10.1016/j.memsci.2004.04.036
   Brant JA, 2002, J MEMBRANE SCI, V203, P257, DOI 10.1016/S0376-7388(02)00014-5
   Campbell P, 1999, BIOTECHNOL BIOENG, V64, P527, DOI 10.1002/(SICI)1097-0290(19990905)64:5<527::AID-BIT3>3.3.CO;2-O
   Chen JC, 2004, ADV COLLOID INTERFAC, V107, P83, DOI 10.1016/j.cis.2003.10.018
   Defrance L, 2000, BIORESOURCE TECHNOL, V73, P105, DOI 10.1016/S0960-8524(99)00163-7
   FLEMMING HC, 1988, DESALINATION, V70, P95, DOI 10.1016/0011-9164(88)85047-1
   Ghayeni SBS, 1998, DESALINATION, V116, P65
   Ghayeni SBS, 1998, J MEMBRANE SCI, V138, P29
   Goosen MFA, 2004, SEPAR SCI TECHNOL, V39, P2261, DOI 10.1081/SS-120039343
   Hilal N, 2003, DESALINATION, V158, P65, DOI 10.1016/S0011-9164(03)00434-X
   Kabsch-Korbutowicz M, 1999, DESALINATION, V126, P179, DOI 10.1016/S0011-9164(99)00172-1
   Kang ST, 2004, J MEMBRANE SCI, V244, P151, DOI 10.1016/j.memsci.2004.07.011
   Knoell T, 1999, J MEMBRANE SCI, V157, P117, DOI 10.1016/S0376-7388(98)00365-2
   LESLIE GL, 1993, COLLOID SURFACE A, V73, P165, DOI 10.1016/0927-7757(93)80014-6
   Lipke PN, 1998, J BACTERIOL, V180, P3735
   Lopez LAG, 2003, WATER SCI TECHNOL, V47, P61
   Ma HM, 2001, SEPAR SCI TECHNOL, V36, P1557, DOI 10.1081/SS-100103888
   Mercier-Bonin M, 2004, J COLLOID INTERF SCI, V271, P342, DOI 10.1016/j.jcis.2003.11.045
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   Pang CM, 2005, ENVIRON SCI TECHNOL, V39, P7541, DOI 10.1021/es050170h
   Pankhania M, 1999, CHEM ENG J, V73, P131, DOI 10.1016/S1385-8947(99)00026-1
   Pasmore M, 2001, J MEMBRANE SCI, V194, P15, DOI 10.1016/S0376-7388(01)00468-9
   Redman JA, 2004, ENVIRON SCI TECHNOL, V38, P1777, DOI 10.1021/es0348871
   Ridgway H, 1999, METHOD ENZYMOL, V310, P463
   Terada A, 2005, COLLOID SURFACE B, V43, P99, DOI 10.1016/j.colsurfb.2005.03.016
   VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7
   Vrijenhoek EM, 2001, J MEMBRANE SCI, V188, P115, DOI 10.1016/S0376-7388(01)00376-3
   Vrouwenvelder HS, 1998, DESALINATION, V118, P157, DOI 10.1016/S0011-9164(98)00116-7
   Vrouwenvelder JS, 2001, DESALINATION, V139, P65, DOI 10.1016/S0011-9164(01)00295-8
   Zhan J, 2004, SEPAR SCI TECHNOL, V39, P2977, DOI 10.1081/SS-200035950
NR 35
TC 45
Z9 47
U1 0
U2 14
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0149-6395
J9 SEPAR SCI TECHNOL
JI Sep. Sci. Technol.
PY 2006
VL 41
IS 7
BP 1475
EP 1487
DI 10.1080/01496390600634673
PG 13
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 049ZT
UT WOS:000238057600017
DA 2018-10-20
ER

PT J
AU Gunja, NJ
   Athanasiou, KA
AF Gunja, Najmuddin J.
   Athanasiou, Kyriacos A.
TI Biodegradable materials in arthroscopy
SO SPORTS MEDICINE AND ARTHROSCOPY REVIEW
LA English
DT Review
DE biodegradable implant; biomaterial; polymer; arthroscopy; knee; shoulder
ID SELF-REINFORCED POLYGLYCOLIDE; CRUCIATE LIGAMENT RECONSTRUCTION;
   BIOABSORBABLE INTERFERENCE SCREW; MENISCAL REPAIR DEVICES; SHAPE-MEMORY
   POLYMERS; ROTATOR CUFF TEARS; IN-VITRO; OSTEOCHONDRITIS-DISSECANS;
   MECHANICAL-PROPERTIES; STRENGTH RETENTION
AB The use of biodegradable materials as implants has revolutionized the way medicine is practiced today. This review provides a general description of salient biodegradable polymeric materials currently used in arthroscopy. These materials include polyglycolic acid, self-reinforced polyglycolic acid, poly-L-lactic acid, self-reinforced polylactic-L-acid, poly-D-L-lactic acid, copolymer of poly-D-L-lactic acid polyglycolic acid, and polyglyconate. The mechanical strength, degradation properties, and widespread use of these materials, especially in the knee and shoulder, are discussed individually. Also discussed are the relatively few complications that are related to these materials' arthroscopic use. Future directions in biodegradable materials, including smart polymers, are also considered. In the future, novel techniques to identify the ideal polymer for a particular application will need to be developed to minimize the risk for implant complications.
C1 Rice Univ, Dept Bioengn, Houston, TX 77005 USA.
RP Athanasiou, KA (reprint author), Rice Univ, Dept Bioengn, MS-142,POB 1892, Houston, TX 77251 USA.
EM athanasiou@rice.edu
CR Agrawal C. M., 1995, P1055
   Agrawal C M, 1995, Tissue Eng, V1, P241, DOI 10.1089/ten.1995.1.241
   Agrawal CM, 1997, MATER SCI FORUM, V250, P115, DOI 10.4028/www.scientific.net/MSF.250.115
   Al-Othman AA, 2002, INT ORTHOP, V26, P247, DOI 10.1007/s00264-002-0359-z
   Albrecht-Olsen P, 1999, KNEE SURG SPORT TR A, V7, P268, DOI 10.1007/s001670050162
   AlbrechtOlsen P, 1997, ARTHROSCOPY, V13, P183, DOI 10.1016/S0749-8063(97)90153-5
   Andriano KP, 1999, J BIOMED MATER RES, V48, P528, DOI 10.1002/(SICI)1097-4636(1999)48:4<528::AID-JBM19>3.0.CO;2-F
   ARCIERO RA, 1995, ARTHROSCOPY, V11, P410, DOI 10.1016/0749-8063(95)90192-2
   Asik M, 2002, KNEE SURG SPORT TR A, V10, P300, DOI 10.1007/s00167-002-0304-0
   Assad M, 1999, BIO-MED MATER ENG, V9, P1
   ATHANASIOU KA, 1995, CLIN ORTHOP RELAT R, P272
   Athanasiou KA, 1998, ARTHROSCOPY, V14, P726, DOI 10.1016/S0749-8063(98)70099-4
   Barber FA, 2003, J SHOULDER ELB SURG, V12, P535, DOI 10.1016/S1058-2746(03)00175-7
   Barber FA, 2000, ARTHROSCOPY, V16, P613, DOI 10.1053/jars.2000.4819
   Becker R, 2001, ARTHROSCOPY, V17, P439, DOI 10.1053/jars.2001.19975
   Benedetto KP, 2000, ARTHROSCOPY, V16, P41, DOI 10.1016/S0749-8063(00)90126-9
   Bohnsack M, 2003, KNEE SURG SPORT TR A, V11, P379, DOI 10.1007/s00167-003-0411-6
   BOS RRM, 1987, J ORAL MAXIL SURG, V45, P751, DOI 10.1016/0278-2391(87)90194-7
   Burkart A, 2000, ARTHROSCOPY, V16, P91, DOI 10.1016/S0749-8063(00)90134-8
   Burkhart SS, 2000, BIOMATERIALS, V21, P2631, DOI 10.1016/S0142-9612(00)00131-9
   Burkhart SS, 1996, CLIN SPORT MED, V15, P635
   BURKHART SS, 1991, CLIN ORTHOP RELAT R, V267, P45
   Calder SJ, 1999, ARTHROSCOPY, V15, P651, DOI 10.1053/ar.1999.v15.015065
   CASPER RA, 1985, POLYM MATER SCI ENG, V53, P497
   CHRISTEL P, 1982, BIOMATERIALS 1980, P271
   CLAES L E, 1992, Clinical Materials, V10, P41, DOI 10.1016/0267-6605(92)90083-6
   COHN D, 1988, J BIOMED MATER RES, V22, P993, DOI 10.1002/jbm.820221104
   DANIELS AU, 1990, J APPL BIOMATER, V1, P57, DOI 10.1002/jab.770010109
   DeJong LES, 2004, ARTHROSCOPY, V20, P511, DOI 10.1016/j.arthro.2004.03.008
   Demirhan M, 2000, ARTHROSCOPY, V16, P383, DOI 10.1016/S0749-8063(00)90083-5
   Dervin GF, 1997, ARTHROSCOPY, V13, P296, DOI 10.1016/S0749-8063(97)90024-4
   Diduch DR, 1999, J LONG-TERM EFF MED, V9, P367
   Dora C, 2000, J SHOULDER ELB SURG, V9, P294, DOI 10.1067/mse.2000.106745
   ELING B, 1982, POLYMER, V23, P1587, DOI 10.1016/0032-3861(82)90176-8
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Farrar DF, 2002, BIOMATERIALS, V23, P3905, DOI 10.1016/S0142-9612(02)00140-0
   Fealy S, 2001, CLIN ORTHOP RELAT R, P31
   Fink C, 2000, ARTHROSCOPY, V16, P491, DOI 10.1053/jars.2000.4633
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   GERBER C, 1994, J BONE JOINT SURG BR, V76B, P371
   Gerlach K L, 1987, Dtsch Z Mund Kiefer Gesichtschir, V11, P211
   GERLACH KL, 1988, DEUT ZAHNAERZTL Z, V43, P41
   Gibbons D. F., 1992, DEGRADATION PHENOMEN, P97
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Haltia AM, 2002, J MATER SCI-MATER M, V13, P903, DOI 10.1023/A:1019803022615
   Hofmann G O, 1992, Clin Mater, V10, P1, DOI 10.1016/0267-6605(92)90076-6
   HOFMANN GO, 1995, ARCH ORTHOP TRAUM SU, V114, P123, DOI 10.1007/BF00443385
   HOLLINGER JO, 1986, CLIN ORTHOP RELAT R, V207, P290
   Johnson LL, 1996, ARTHROSCOPY, V12, P452, DOI 10.1016/S0749-8063(96)90039-0
   Jones HP, 2002, ARTHROSCOPY, V18, P64, DOI 10.1053/jars.2002.25343
   Jukkala-Partio K, 2001, ANN CHIR GYNAECOL, V90, P219
   Karlsson J, 2001, AM J SPORT MED, V29, P538, DOI 10.1177/03635465010290050201
   KELLEY BS, 1987, ADV BIOMEDICAL POLYM
   KOHN J, 2004, BIOMATERIALS SCI INT, P115
   Lajtai G, 1999, ARTHROSCOPY, V15, P481, DOI 10.1053/ar.1999.v15.015048
   Lajtai G, 2001, ARTHROSCOPY, V17, P597, DOI 10.1053/jars.2001.21535
   LAURENCIN CT, 1996, CLIN ORTHOP RELAT R, V332, P132
   Learmonth ID, 2003, SURG-J R COLL SURG E, V1, P1, DOI 10.1016/S1479-666X(03)80002-1
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P70, DOI 10.1016/0142-9612(87)90034-2
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P311, DOI 10.1016/0142-9612(87)90121-9
   Lembeck B, 2005, KNEE SURG SPORT TR A, V13, P283, DOI 10.1007/s00167-004-0545-1
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2005, CLIN HEMORHEOL MICRO, V32, P105
   Macdonald Peter, 2003, Arthroscopy, V19, pE22, DOI 10.1016/S0749-8063(03)00382-7
   Maitra RS, 1998, SPORTS MED ARTHROSC, V6, P103
   MANNINEN MJ, 1992, ACTA ORTHOP SCAND, V63, P437, DOI 10.3109/17453679209154763
   McBirnie JM, 2005, ARTHROSCOPY, V21, P1421, DOI 10.1016/j.arthro.2005.09.017
   McFarland EG, 2005, AM J SPORT MED, V33, P1918, DOI 10.1177/0363546505282621
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   Miller MD, 2004, AM J SPORT MED, V32, P858, DOI 10.1177/0363546503260068
   MILLER RA, 1977, J BIOMED MATER RES, V11, P711, DOI 10.1002/jbm.820110507
   Muller M, 2002, Injury, V33 Suppl 2, pB30
   Nakafuku C, 2004, J APPL POLYM SCI, V93, P2164, DOI 10.1002/app.20687
   Obedian RS, 1997, CLIN SPORT MED, V16, P157, DOI 10.1016/S0278-5919(05)70012-0
   Peltoniemi HH, 1999, J CRANIO MAXILL SURG, V27, P42, DOI 10.1016/S1010-5182(99)80009-2
   PIHLAJAMAKI H, 2002, J MATER SCI-MATER M, V13, P289
   RESCH H, 1992, UNFALLCHIRURG, V95, P91
   ROZEMA FR, 1990, INT J ORAL MAX SURG, V19, P374, DOI 10.1016/S0901-5027(05)80086-4
   Scioscia T N, 2001, Arthroscopy, V17, pE7, DOI 10.1053/jars.2001.17995
   Shafer Brian L, 2002, Arthroscopy, V18, pE35
   SNOW ET, 1992, PHARMACOL THERAPEUT, V53, P31, DOI 10.1016/0163-7258(92)90043-Y
   Song EK, 1999, ARTHROSCOPY, V15, P726, DOI 10.1016/S0749-8063(99)70004-6
   SPEER KP, 1993, CLIN ORTHOP RELAT R, P67
   Speer KP, 1996, J BONE JOINT SURG AM, V78A, P1801, DOI 10.2106/00004623-199612000-00002
   Sperber A, 2001, J SHOULDER ELB SURG, V10, P105, DOI 10.1067/mse.2001.112019
   Stahelin AC, 1997, ARTHROSCOPY, V13, P238, DOI 10.1016/S0749-8063(97)90162-6
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   TORMALA P, 1991, J BIOMED MATER RES, V25, P1, DOI 10.1002/jbm.820250102
   Tormala P, 1998, P I MECH ENG H, V212, P101, DOI 10.1243/0954411981533872
   TORMALA P, 1992, Clinical Materials, V10, P29, DOI 10.1016/0267-6605(92)90081-4
   TORMALA P, 1987, BIOMATERIALS, V8, P42, DOI 10.1016/0142-9612(87)90027-5
   Tsai AM, 2004, ARTHROSCOPY, V20, P586, DOI 10.1016/j.arthro.2004.04.064
   Tuompo P, 1997, INT ORTHOP, V21, P355
   Tuompo P, 2001, ARCH ORTHOP TRAUM SU, V121, P261, DOI 10.1007/s004020000221
   VAINIONPAA S, 1987, BIOMATERIALS, V8, P46, DOI 10.1016/0142-9612(87)90028-7
   VASENIUS J, 1994, CLIN MATER, V17, P119, DOI 10.1016/0267-6605(94)90134-1
   VERT M, 1992, Clinical Materials, V10, P3, DOI 10.1016/0267-6605(92)90077-7
   Warme WJ, 1999, AM J SPORT MED, V27, P742, DOI 10.1177/03635465990270061001
   Weiler A, 1998, AM J SPORT MED, V26, P119, DOI 10.1177/03635465980260010401
   Weiler A, 2002, ARTHROSCOPY, V18, P113, DOI 10.1053/jars.2002.30656
   Weiler A, 2000, ARTHROSCOPY, V16, P305, DOI 10.1016/S0749-8063(00)90055-0
   Willcox N, 2004, ARTHROSCOPY, V20, P20, DOI 10.1016/j.arthro.2004.04.018
   Wouters DB, 2004, KNEE SURG SPORT TR A, V12, P52, DOI 10.1007/s00167-003-0435-y
   YASUNAGA T, 2001, CLIN OTHOP, V287, P232
   Zantop T, 2004, KNEE SURG SPORT TR A, V12, P317, DOI 10.1007/s00167-003-0439-7
NR 106
TC 16
Z9 17
U1 1
U2 17
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1062-8592
EI 1538-1951
J9 SPORTS MED ARTHROSC
JI Sports Med. Arthrosc. Rev.
PY 2006
VL 14
IS 3
BP 112
EP 119
DI 10.1097/00132585-200609000-00002
PG 8
WC Sport Sciences
SC Sport Sciences
GA 175OD
UT WOS:000247022000002
PM 17135957
DA 2018-10-20
ER

PT J
AU Coons, DA
   Barber, FA
AF Coons, David A.
   Barber, F. Alan
TI Tendon graft substitutes-rotator cuff patches
SO SPORTS MEDICINE AND ARTHROSCOPY REVIEW
LA English
DT Review
DE rotator cuff tendon; GraftJacket; CuffPatch; restore; TissueMend; graft
   substitutes
ID SMALL-INTESTINAL SUBMUCOSA; SUTURE ANCHORS; INTERVAL SLIDE; MASSIVE
   TEARS; REPAIR; COLLAGEN; SCAFFOLD; MATRIX; INTERPOSITION; BIOMATERIAL
AB Over the past few years, many biologic patches have been developed to augment repairs of large or complex tendon tears. These patches include both allograft and xenografts. Regardless of their origins, these products are primarily composed of purified type I collagen. Many factors should be considered when choosing an augmentation patch including tissue origin, graft processing, cross-linking, clinical experience, and physical properties. The purpose of this article is to familiarize the sports medicine community with several tendon augmentation grafts: GraftJacket (Wright Medical Technology, Arlington, TN), CuffPatch (Organogenesis, Canton, MA, licensed to Arthrotek, Warsaw, IN), Restore (Depuy, Warsaw, IN), Zimmer Collagen Repair (Permacol) patch (Tissue Science Laboratories Covington, GA, licensed to Zimmer, Warsaw, IN), TissueMend (TEI Biosciences, Boston, MA, licensed to Stryker Howmedica Osteonics, Kalamazoo, MI), OrthoADAPT (Pegasus Biologics, Irvine, CA), and BioBlanket (Kensey Nash, Exton, PA).
C1 Pacific Sports Med Multicare, Tacoma, WA USA.
   Plano Orthoped & Sports Med Ctr, Plano, TX USA.
RP Coons, DA (reprint author), 3315 S 23rd St,Suite 200, Tacoma, WA 98405 USA.
EM cnsdav@yahoo.com
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   AIKEN SW, 1994, VET COMP ORTHOPAED, V7, P124
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Bakos D, 2000, Polim Med, V30, P57
   Barber FA, 2003, ARTHROSCOPY, V19, P985, DOI 10.1016/S0749-8063(03)00833-8
   Barber FA, 2006, ARTHROSCOPY, V22, P534, DOI 10.1016/j.arthro.2005.12.021
   Belcher HJCR, 2001, J HAND SURG-BRIT EUR, V26, P159, DOI 10.1054/jhsb.2001.0554
   Beniker D, 2003, ORTHOPEDICS, V26, pS591
   BUCKWALTER JA, 2000, ORTHOPAEDIC BASIC SC, V582, pCH24
   Calero P, 2002, BIOMATERIALS, V23, P3473, DOI 10.1016/S0142-9612(02)00054-6
   Cobb MA, 1996, SURG NEUROL, V46, P389, DOI 10.1016/S0090-3019(96)00202-9
   Cummins CA, 2003, J SHOULDER ELB SURG, V12, P128, DOI 10.1067/mse.2003.21
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   GAZIELLY DF, 1994, CLIN ORTHOP RELAT R, P43
   HARRYMAN DT, 1991, J BONE JOINT SURG AM, V73A, P982, DOI 10.2106/00004623-199173070-00004
   IONNOTTI JP, 2006, J BONE JOINT SURG AM, V88, P1238
   Jorge-Herrero E, 1999, BIOMATERIALS, V20, P539, DOI 10.1016/S0142-9612(98)90205-8
   Koh JL, 2002, AM J SPORT MED, V30, P410, DOI 10.1177/03635465020300031701
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Lam F, 2004, J SHOULDER ELB SURG, V13, P517, DOI 10.1016/j.jse.2004.02.016
   Lo IKY, 2004, ARTHROSCOPY, V20, P435, DOI 10.1016/j.arthro.2004.01.016
   Ma CB, 2004, J BONE JOINT SURG AM, V86A, P1211
   MacGillivray JD, 2004, ARTHROSCOPY, V20, P669, DOI 10.1016/j.atthro.2004.04.065
   Malcarney HL, 2005, AM J SPORT MED, V33, P907, DOI 10.1177/0363546504271500
   Mura N, 2003, CLIN ORTHOP RELAT R, P131, DOI 10.1097/01/blo.0000092967.12414.4c
   PORTER SE, 2004, CLIN ORTJOP RELAT RE, V423, P287
   Richards CF, 2004, CRIT CARE CLIN, V20, P1, DOI 10.1016/S0749-0704(03)00097-6
   Rokito AS, 1999, J BONE JOINT SURG AM, V81A, P991, DOI 10.2106/00004623-199907000-00012
   RUBINO LJ, 2005, INCIDENCE IMMUNOLOGI
   Scheibel MT, 2003, ARTHROSCOPY, V19, P330, DOI 10.1053/jars.2003.50079
   Sclamberg SG, 2004, J SHOULDER ELB SURG, V13, P538, DOI 10.1016/j.jse.2004.03.005
   SHEA KP, 1992, ARTHROSCOPY, V8, P179, DOI 10.1016/0749-8063(92)90033-8
   Sugihara T, 2003, J SHOULDER ELB SURG, V12, P222, DOI 10.1016/S1058-2746(02)86888-4
   Sundine MJ, 2002, PLAST RECONSTR SURG, V110, P1266, DOI 10.1097/01.PRS.0000025288.90099.85
   Tauro JC, 1999, ARTHROSCOPY, V15, P527, DOI 10.1053/ar.1999.v15.0150521
   Vandenbussche E, 2004, INT ORTHOP, V28, P226, DOI 10.1007/s00264-004-0565-y
   Woods AM, 2004, BIOMATERIALS, V25, P515, DOI 10.1016/S0142-9612(03)00552-0
   Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170
NR 39
TC 58
Z9 58
U1 2
U2 16
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1062-8592
J9 SPORTS MED ARTHROSC
JI Sports Med. Arthrosc. Rev.
PY 2006
VL 14
IS 3
BP 185
EP 190
DI 10.1097/00132585-200609000-00011
PG 6
WC Sport Sciences
SC Sport Sciences
GA 175OD
UT WOS:000247022000011
PM 17135966
DA 2018-10-20
ER

PT S
AU Marion, NW
   Mao, JJ
AF Marion, Nicholas W.
   Mao, Jeremy J.
BE Klimanskaya, I
   Lanza, R
TI Mesenchymal stem cells and tissue engineering
SO STEM CELL TOOLS AND OTHER EXPERIMENTAL PROTOCOLS
SE Methods in Enzymology
LA English
DT Review; Book Chapter
ID HUMAN BONE-MARROW; ARTICULAR-CARTILAGE REPAIR; DIFFERENTIATION IN-VITRO;
   STROMAL CELLS; PROGENITOR CELLS; OSTEOGENIC DIFFERENTIATION;
   ADIPOSE-TISSUE; MULTILINEAGE DIFFERENTIATION; OSTEOBLAST
   DIFFERENTIATION; OSTEOCHONDRAL CONSTRUCTS
AB Mesenchymal stem cells (MSCs) have become one of the most studied stem cells, especially toward the healing of diseased and damaged tissues and organs. MSCs can be readily isolated from a number of adult tissues by means of minimally invasive approaches. MSCs are capable of self-replication to many passages and, therefore, can potentially be expanded to sufficient numbers for tissue and organ regeneration. MSCs are able to differentiate into multiple cell lineages that resemble osteoblasts, chondrocytes, myoblasts, adipocytes, and fibroblasts and express some of the key markers typical of endothelial cells, neuron-like cells, and cardiomyocytes. MSCs have been used alone for cell delivery or seeded in biomaterial scaffolds toward the healing of tissue and organ defects. After an increasing number of the "proof of concept" studies, the remaining tasks are many, such as to determine MSC interactions with host cells and signaling molecules, to investigate the interplay between MSCs and biological scaffold materials, and to apply MSC-based therapies toward clinically relevant defect models. The ultimate goal of MSC-based therapies has valid biological rationale in that clusters of MSCs differentiate to form virtually all connective tissue during development. MSC-based therapies can only be realized our improved understanding of not only their fundamental properties such as population doubling and differentiation pathways but also translational studies that use MSCs in the de novo formation and/or regeneration of diseased or damaged tissues and organs.
C1 Columbia Univ, Sch Engn & Appl Sci, Fu Fdn Sch Engn & Appl Sci, Coll Dent Med, New York, NY USA.
RP Marion, NW (reprint author), Columbia Univ, Sch Engn & Appl Sci, Fu Fdn Sch Engn & Appl Sci, Coll Dent Med, New York, NY USA.
FU NIBIB NIH HHS [R01 EB002332, EB02332]; NIDCR NIH HHS [RC2 DE020767-02,
   R01 DE015391, DE15391, RC2 DE020767]
CR Alberts B, 2002, MOL BIOL CELL
   Alhadlaq A, 2005, TISSUE ENG, V11, P556, DOI 10.1089/ten.2005.11.556
   Alhadlaq A, 2005, J BONE JOINT SURG AM, V87A, P936, DOI 10.2106/JBJS.D.02104
   Alhadlaq A, 2004, STEM CELLS DEV, V13, P436, DOI 10.1089/1547328041797552
   Alhadlaq A, 2004, ANN BIOMED ENG, V32, P911, DOI 10.1023/B:ABME.0000032454.53116.ee
   Alhadlaq A, 2003, J DENT RES, V82, P951, DOI 10.1177/154405910308201203
   Allen DM, 2004, J STRUCT BIOL, V145, P196, DOI 10.1016/j.jsb.2003.10.003
   Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   Archer Charles W., 2003, Birth Defects Research, V69, P144, DOI 10.1002/bdrc.10015
   Aubin J E, 1998, J Cell Biochem Suppl, V30-31, P73
   Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0
   Barry Frank P., 2003, Birth Defects Research, V69, P250, DOI 10.1002/bdrc.10021
   Beahm EK, 2003, CLIN PLAST SURG, V30, P547, DOI 10.1016/S0094-1298(03)00072-5
   Bhagavati S, 2004, BIOCHEM BIOPH RES CO, V318, P119, DOI 10.1016/j.bbrc.2004.03.192
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0
   Caplan AI, 2006, J CELL BIOCH
   Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200
   Cohen NP, 1998, J ORTHOP SPORT PHYS, V28, P203, DOI 10.2519/jospt.1998.28.4.203
   Dayoub H, 2003, TISSUE ENG, V9, P347, DOI 10.1089/107632703764664819
   Derubeis AR, 2004, ANN BIOMED ENG, V32, P160, DOI 10.1023/B:ABME.0000007800.89194.95
   Dowthwaite GP, 2003, MATRIX BIOL, V22, P311, DOI 10.1016/S0945-053X(03)00037-4
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174
   FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x
   FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267
   FRIEDENSTEIN AJ, 1995, CALCIFIED TISSUE INT, V56, pS17, DOI 10.1007/BF03354643
   Friedman MS, 2006, J CELL BIOCHEM, V98, P538, DOI 10.1002/jcb.20719
   Gang EJ, 2004, STEM CELLS, V22, P617, DOI 10.1634/stemcells.22-4-617
   GAO J, 2003, CHIR ORG MOVIMENTO, V3, P305
   Gilbert S., 2000, DEV BIOL
   Graves S, 1994, BONE, V15, P132
   GRAVES SE, 1994, BONE, V15, P133
   Gregory CA, 2005, EXP CELL RES, V306, P330, DOI 10.1016/j.yexcr.2005.03.018
   Gregory CA, 2005, ANN NY ACAD SCI, V1049, P97, DOI 10.1196/annals.1334.010
   Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691
   Guilak F, 2000, BIORHEOLOGY, V37, P27
   Guilak F, 2000, J BIOMECH, V33, P1663, DOI 10.1016/S0021-9290(00)00105-6
   Haudenschild DR, 2001, ANAT RECORD, V263, P91, DOI 10.1002/ar.1079
   Hung CT, 2004, ANN BIOMED ENG, V32, P35, DOI 10.1023/B:ABME.0000007789.99565.42
   Hung CT, 2003, J BIOMECH, V36, P1853, DOI 10.1016/S0021-9290(03)00213-6
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbre.2004.06.029
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J
   Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   Kerin A, 2002, CELL MOL LIFE SCI, V59, P27, DOI 10.1007/s00018-002-8402-1
   Khan E, 2003, J LAB CLIN MED, V142, P29, DOI 10.1016/S0022-2143(03)00058-1
   Kim TK, 2003, OSTEOARTHR CARTILAGE, V11, P653, DOI 10.1016/S1063-4584(03)00120-1
   Klein TJ, 2003, OSTEOARTHR CARTILAGE, V11, P595, DOI 10.1016/S1063-4584(03)00090-6
   Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165, DOI 10.1177/10454411990100020401
   Kuo CK, 2003, IEEE ENG MED BIOL, V22, P51, DOI 10.1109/MEMB.2003.1256272
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341
   Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Lin CY, 2004, J BIOMECH, V37, P623, DOI 10.1016/j.jbiomech.2003.09.029
   LONG MW, 1995, J CLIN INVEST, V95, P881, DOI 10.1172/JCI117738
   Malaval L, 1999, J CELL BIOCHEM, V74, P616
   Mao JJ, 2005, BIOL CELL, V97, P289, DOI 10.1042/BC20040100
   MAO JJ, 2006, IN PRESS J DENT RES
   MARION NW, 2005, MECH ADV MATER STRUC, V3, P239
   Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456
   Masuda K, 2003, J ORTHOPAED RES, V21, P139, DOI 10.1016/S0736-0266(02)00109-2
   Mauney JR, 2005, TISSUE ENG, V11, P787, DOI 10.1089/ten.2005.11.787
   McKnight AL, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781411
   Mistry AS, 2005, ADV BIOCHEM ENG BIOT, V94, P1, DOI 10.1007/b99997
   Mow VC, 1999, OSTEOARTHR CARTILAGE, V7, P41, DOI 10.1053/joca.1998.0161
   MOW VC, 1984, J BIOMECH, V17, P377, DOI 10.1016/0021-9290(84)90031-9
   Nakamura T, 2003, BIOCHEM BIOPH RES CO, V303, P306, DOI 10.1016/S0006-291X(03)00325-5
   Nesic D, 2006, ADV DRUG DELIVER REV, V58, P300, DOI 10.1016/j.addr.2006.01.012
   Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487
   Osyczka AM, 2002, CALCIFIED TISSUE INT, V71, P447, DOI 10.1007/s00223-001-1090-2
   PAIRAULT J, 1979, P NATL ACAD SCI USA, V76, P5138, DOI 10.1073/pnas.76.10.5138
   Patel PN, 2005, TISSUE ENG, V11, P1498, DOI 10.1089/ten.2005.11.1498
   Patrick CW, 2004, ANNU REV BIOMED ENG, V6, P109, DOI 10.1146/annurev.bioeng.6.040803.140032
   Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   POOLE CA, 1988, J ORTHOPAED RES, V6, P408, DOI 10.1002/jor.1100060312
   POOLE CA, 1991, J HISTOCHEM CYTOCHEM, V39, P1175, DOI 10.1177/39.9.1717545
   Rahaman MN, 2005, BIOTECHNOL BIOENG, V91, P261, DOI 10.1002/bit.20292
   RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022
   RODAN G A, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P85
   Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145
   Saito T, 2003, J THORAC CARDIOV SUR, V126, P114, DOI 10.1016/S0022-5223(03)00118-1
   Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199
   Sekiya I, 2001, BIOCHEM BIOPH RES CO, V284, P411, DOI 10.1006/bbrc.2001.4898
   Shake JG, 2002, ANN THORAC SURG, V73, P1919, DOI 10.1016/S0003-4975(02)03517-8
   Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.y,the.2004.02.012
   STOSICH MS, 2006, IN PRESS PLAST RECON
   STOSICH MS, 2005, SEMIN PLAST SURG, V19, P251
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   TROKEN AJ, 2005, WILEY ENCY MED DEVIC
   Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777
   Tuli R, 2003, MOL BIOTECHNOL, V23, P37, DOI 10.1385/MB:23:1:37
   WAN N, 2006, DENT CLIN N AM, V50, P175
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   Woodfield TBF, 2002, CRIT REV EUKAR GENE, V12, P209, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i3.40
   WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212
   Xu WR, 2004, EXP BIOL MED, V229, P623
   YLOSTALO J, 2006, STEM CELLS
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
NR 107
TC 93
Z9 109
U1 0
U2 27
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0076-6879
BN 0-12-373651-X
J9 METHOD ENZYMOL
JI Methods Enzymol.
PY 2006
VL 420
BP 339
EP 361
DI 10.1016/S0079-6879(06)20016-8
PG 23
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BFO40
UT WOS:000243420300016
PM 17161705
DA 2018-10-20
ER

PT B
AU Kim, YS
   Kesavadas, T
AF Kim, Young-Seok
   Kesavadas, Thenkurussi
BE Hannaford, B
   Weisenberger, J
   Gillespie, B
TI Material property recognition by active tapping for fingertip digitizing
SO SYMPOSIUM ON HAPTICS INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR
   SYSTEMS 2006, PROCEEDINGS
LA English
DT Proceedings Paper
CT 14th Symposium on Haptics Interfaces for Virtual Environment and
   Teleoperator Systems
CY MAR 25-26, 2006
CL Alexandria, VA
SP IEEE Comp Soc, Visualizat & Graph Tech Comm
DE digitizing; finger; material property; optimization; tapping; tissue;
   touch
ID FORCE RESPONSE; IMPEDANCE; PULP
AB This paper presents a methodology of material property determination by a human subject's active finger tapping. Object digitization by direct finger touch is a prerequisite for good quality intuitive haptic input interface. Previous attempts were limited to scanning the surface geometry, and were not capable of describing the material characteristics of the object being touched. In this research, a compound mechanical model was developed to characterize the non-linear, viscoelastic behavior of the fingertip and the test object. Using a new active touch digitizer, subject's tapping input and response were analyzed for material recognition Parameters to describe material properties were obtained by successive, optimized model fit. In an experiment, our methodology was successful in recognizing the elastic properties of five common materials, including a biomaterial.
C1 [Kim, Young-Seok; Kesavadas, Thenkurussi] SUNY Buffalo, Dept Mech & Aerosp Engn, Virual Real Lab, 1006 Furnas Hall, Buffalo, NY 14260 USA.
RP Kim, YS (reprint author), SUNY Buffalo, Dept Mech & Aerosp Engn, Virual Real Lab, 1006 Furnas Hall, Buffalo, NY 14260 USA.
EM ykim5@eng.buffalo.edu; kesh@eng.buffalo.edu
CR ASADA HH, MIT HOM AUT HEALTHC
   Dennerlein JT, 1998, EXP BRAIN RES, V121, P1, DOI 10.1007/s002210050430
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   GHISTA DN, 1980, HUMAN BODY DYNAMICS
   GIBSON JJ, 1963, UNPUB PURPLE PERILS
   Griffin M. J, 1990, HDB HUMAN VIBRATION
   GULATI RJ, 1995, DETERMINATION MECH P
   Hajian AZ, 1997, J BIOMECH ENG-T ASME, V119, P109, DOI 10.1115/1.2796052
   Jindrich DL, 2004, J BIOMECH, V37, P1589, DOI 10.1016/j.jbiomech.2004.01.001
   Jindrich DL, 2003, J BIOMECH, V36, P497, DOI 10.1016/S0021-9290(02)00438-4
   Lederman SJ, 2004, PERCEPT PSYCHOPHYS, V66, P618, DOI 10.3758/BF03194906
   LEDERMAN SJ, 1992, ADV TACTILE SENSING
   LYNCH CT, 1989, PRACTICAL HDB MAT SC
   MAYROSE J, 2000, MECH AEROSPACE ENG
   Pawluk DTV, 1999, J BIOMECH ENG-T ASME, V121, P178, DOI 10.1115/1.2835100
   Pawluk DTV, 1999, J BIOMECH ENG-T ASME, V121, P605, DOI 10.1115/1.2800860
   Pugliese PT, 2002, BIOENGINEERING SKIN, P147
   REMPEL D, 1994, J BIOMECH, V27, P1101, DOI 10.1016/0021-9290(94)90227-5
   Serina ER, 1997, J BIOMECH, V30, P1035, DOI 10.1016/S0021-9290(97)00065-1
   SMALLEY KR, 2004, MECH AEROSPACE ENG
   Wu JZ, 2003, J BIOMECH, V36, P383, DOI 10.1016/S0021-9290(02)00427-X
NR 21
TC 1
Z9 1
U1 0
U2 0
PU IEEE COMPUTER SOC
PI LOS ALAMITOS
PA 10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1264 USA
BN 1-4244-0226-3
PY 2006
BP 133
EP 139
PG 7
WC Computer Science, Cybernetics; Computer Science, Hardware &
   Architecture; Engineering, Biomedical
SC Computer Science; Engineering
GA BEG57
UT WOS:000237225000022
DA 2018-10-20
ER

PT S
AU Feng, Z
   Cai, N
   Chan, V
   Mhaisalka, PS
   Chian, KS
   Ratner, BD
   Liao, K
AF Feng, Z.
   Cai, N.
   Chan, V.
   Mhaisalka, P. S.
   Chian, K. S.
   Ratner, B. D.
   Liao, K.
BE Fisher, JP
TI Novel biophysical techniques for investigating long-term cell adhesion
   dynamics on biomaterial surfaces
SO TISSUE ENGINEERING
SE ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY
LA English
DT Article; Proceedings Paper
CT 2nd International Tissue Engineering Conference
CY MAY 22-27, 2005
CL Crete, GREECE
ID MICROSCOPY
AB Cell adhesion on biomaterial surface is crucial for the regeneration and function of clinically viable cell and tissues. In turn, the cellular phenotypes, following the mechanochemical transduction of adherent cells on biomaterials, are directly correlated to the biophysical responses of cells. However, the lack of an integrated bio-analytical system for probing the cell-substrate interface poses significant obstacles to understanding the behavior of cells on biomaterial surface. We have developed a novel method, based on the principle of confocal reflectance interference contrast microscopy (C-RICM) that has enabled us to study the biomechanical deformation of cells on biomaterial surfaces. In this article, we would like to describe our recent development of the C-RICM system that integrates a confocal fluorescence microscope, phase contrast microscope and GFP expression system. We shall demonstrate the system by determining the adhesion contact kinetics, initial deformation rate, cytoskeleton structures of adherent cells on extracellular matrices (e.g., collagen and fibronectin) and biodegradable polymer (e.g., poly(lactic acid)) during long-term culture. We shall demonstrate that this unique approach could provide valuable biophysical information necessary for designing optimized biomaterial surfaces for cell/tissue regeneration applications.
C1 Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.
   Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore.
   Nanyang Technol Univ, BioMed Engn Res Ctr, Singapore 639798, Singapore.
   Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RP Feng, Z (reprint author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
RI Chan, Vincent/G-6197-2010; Liao, Kin/A-7915-2014; Chian, Kerm
   Sin/B-4771-2008
OI Chan, Vincent/0000-0003-2149-4479; Liao, Kin/0000-0001-6352-2349; 
CR Dong C, 2000, J BIOMECH, V33, P35, DOI 10.1016/S0021-9290(99)00174-8
   FEDER TJ, 1995, PHYS REV E, V51, P3427, DOI 10.1103/PhysRevE.51.3427
   Inanlou MR, 2005, DEV DYNAM, V232, P43, DOI 10.1002/dvdy.20202
   Iqbal J, 2005, BIOCHEM BIOPH RES CO, V328, P751, DOI 10.1016/j.bbrc.2004.12.087
   Kusano Y, 2000, EXP CELL RES, V256, P434, DOI 10.1006/excr.2000.4802
   Li F, 2005, BIOMATERIALS, V26, P3093, DOI 10.1016/j.biomaterials.2004.07.063
   Mathur AB, 2001, J BIOMECH, V34, P1545, DOI 10.1016/S0021-9290(01)00149-X
   Prasad NK, 2005, J BIOL CHEM, V280, P13129, DOI 10.1074/jbc.M410289200
   Wan KT, 2001, MED BIOL ENG COMPUT, V39, P605, DOI 10.1007/BF02345154
   Wang YQ, 2004, BIOMATERIALS, V25, P4777, DOI 10.1016/j.biomaterials.2003.11.051
   Yin C, 2003, BIOMATERIALS, V24, P837, DOI 10.1016/S0142-9612(02)00416-7
NR 11
TC 0
Z9 0
U1 0
U2 7
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
BN 0-387-32664-2
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2006
VL 585
BP 151
EP 165
PG 15
WC Cell Biology; Engineering, Biomedical; Medicine, Research & Experimental
SC Cell Biology; Engineering; Research & Experimental Medicine
GA BFG57
UT WOS:000241729000011
PM 17120783
DA 2018-10-20
ER

PT J
AU Wang, XH
   Yan, YN
   Pan, YQ
   Xiong, Z
   Liu, HX
   Cheng, B
   Liu, F
   Lin, F
   Wu, RD
   Zhang, RJ
   Lu, QP
AF Wang, XH
   Yan, YN
   Pan, YQ
   Xiong, Z
   Liu, HX
   Cheng, B
   Liu, F
   Lin, F
   Wu, RD
   Zhang, RJ
   Lu, QP
TI Generation of three-dimensional hepatocyte/gelatin structures with rapid
   prototyping system
SO TISSUE ENGINEERING
LA English
DT Article
ID DEPOSITION; SCAFFOLDS
AB Using rapid prototyping technology, three-dimensional (3D) structures composed of hepatocytes and gelatin hydrogel have been formed. This technique employs a highly accurate 3D micropositioning system with a pressure-controlled syringe to deposit cell/biomaterial structures with a lateral resolution of 10 mu m. The pressure-activated micro-syringe is equipped with a fine-bore exit needle for which a wide variety of 3D patterns with different arrays of channels (through-holes) were created. More than 30 layers of a hepatocyte/gelatin mixture were laminated into a high spacial structure using this method. The laminated hepatocytes remained viable and performed biological functions in the construct for more than 2 months. The rapid prototyping technology offers potential for eventual high-throughout production of artificial human tissues or organs.
C1 Tsing Hua Univ, Ctr Organism Mfg, Dept Engn Mech, Beijing 100084, Peoples R China.
   Tsing Hua Univ, Key Lab Adv Mfg Mat Proc Technol, Beijing 100084, Peoples R China.
   Tsing Hua Univ, Inst Life Sci & Med, Beijing 100084, Peoples R China.
RP Wang, XH (reprint author), Tsing Hua Univ, Ctr Organism Mfg, Dept Engn Mech, Beijing 100084, Peoples R China.
EM wangxiaohong@tsinghua.edu.cn
RI Lin, Feng/K-7906-2012
OI Lin, Feng/0000-0003-1855-504X
CR BRUCE C, 2004, TRENDS BIOTECHNOL, V22, P157
   DOWEIKO JP, 1991, JPEN-PARENTER ENTER, V15, P207, DOI 10.1177/0148607191015002207
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Kim SS, 2000, TISSUE ENG, V6, P39, DOI 10.1089/107632700320874
   LISA RB, 2003, TISSUE ENG, V9, P401
   Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7
   Mooney DJ, 1997, J BIOMED MATER RES, V37, P413, DOI 10.1002/(SICI)1097-4636(19971205)37:3<413::AID-JBM12>3.0.CO;2-C
   PRINCEN HMG, 1982, BIOCHIM BIOPHYS ACTA, V699, P12
   REICHLING JJ, 1988, DIGEST DIS SCI, V33, P1601, DOI 10.1007/BF01535953
   SACHS E, 1992, J ENG IND-T ASME, V114, P481
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Vozzi G, 2002, TISSUE ENG, V8, P1089, DOI 10.1089/107632702320934182
   Xiong Z, 2002, SCRIPTA MATER, V46, P771, DOI 10.1016/S1359-6462(02)00071-4
NR 13
TC 177
Z9 186
U1 4
U2 38
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JAN
PY 2006
VL 12
IS 1
BP 83
EP 90
DI 10.1089/ten.2006.12.83
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA 019NV
UT WOS:000235844900009
PM 16499445
DA 2018-10-20
ER

PT S
AU Jablokov, VR
   Murray, NGD
   Rack, HJ
   Freese, HL
AF Jablokov, Victor R.
   Murray, Naomi G. D.
   Rack, Henry J.
   Freese, Howard L.
BE Zardiackas, LD
   Kraay, MJ
   Freese, HL
TI Influence of oxygen content on the mechanical properties of
   Titanium-35Niobium-7Zirconium-5Tantalum beta titanium alloy
SO TITANIUM, NIOBIUM, ZIRCONIUM, AND TANTALUM FOR MEDICAL AND SURGICAL
   APPLICATIONS
SE American Society for Testing and Materials Selected Technical Papers
LA English
DT Proceedings Paper
CT Symposium on Titanium, Niobium, Zirconium, and Tantalum for Medical and
   Surgical Applications
CY NOV, 2004
CL Washington, DC
DE metals (for surgical implants); orthopedic medical devices; titanium
   alloys; beta titanium alloys; alpha-beta titanium alloys
AB Titanium-35Niobium-7Zirconium-5 Tantalum beta titanium alloy (also known as TiOsteum (R) beta titanium alloy) is a new metallic biomaterial that was designed to have outstanding osseointegratabilty, good mechanical strength, improved ductility, very low elastic modulus, and good hot and cold workability [1]. In this study, mechanical property data are presented from several TiOsteum alloy production lots with ingot oxygen contents ranging from 0.05 to 0.68 %. Additionally, mill annealed mechanical property data collected over the last 10 to 15 years for the more common alpha, alpha-beta, and beta titanium alloys are presented as a function of oxygen content and compared to TiOsteum alloy. The influence of oxygen as an interstitial strengthening element is well established in titanium alloys. This study examines this effect over a broad range of oxygen values, and has significance for the application of the new TiOsteum alloy and other beta titanium alloys being considered for use in medical and surgical devices.
C1 [Jablokov, Victor R.; Freese, Howard L.] Allegheny Technol Co, Monroe, NC 28110 USA.
   [Murray, Naomi G. D.] Stryker Orthopaed, Mahwah, NJ 07430 USA.
   [Rack, Henry J.] Clemson Univ, Mat Sci & Engn, Clemson, SC 29634 USA.
RP Jablokov, VR (reprint author), Allegheny Technol Co, Monroe, NC 28110 USA.
CR AHMED T, 1999, Patent No. 0707085
   AHMED T., 1999, U. S. Patent, Patent No. [5,871,595, 5871595]
   [Anonymous], ANN BOOK ASTM STAND
   *ASM, 4894 ASM SAE
   *ASM, 4957 ASM SAE
   *ASTM, 1295 ASTM F
   *ASTM, 563 ASTM F
   *ASTM, 2001, STAND SPEC WROUGHT T
   *ASTM INT, ANN BOOK ASTM STAN
   *ASTM INT, MET ALL UN NUMB SYST
   *BS I, 1990, 7252 BS BRIT STAND 9
   DAVIS RM, 1996, MED APPL TITANIUM IT, P17
   HAWKINS MJ, 2000, 6 WORLD BIOM C SOC B
   Imam MA, 1996, ADVANCES IN THE SCIENCE AND TECHNOLOGY OF TITANIUM ALLOY PROCESSING, P435
   Lemons J. E., 2002, BONEZONE, P5
   Qazi J.I., 2004, TITANIUM 2003 SCI TE, P1651
   QAZI JI, IN PRESS TITANIUM NI
   RADLEY D, 2003, ASM INT M PMD C AN C
   SHORTKROFF S, 2002, 341 SOC BIOM BRIGH W
   SHORTKROFF S, Patent No. 5871595
   3936297
   6773520
   3820980
   4687290
   3907551
   6187045
   421137
   4714468
   4217150
   3847599
   6539607
   0047140
NR 32
TC 0
Z9 0
U1 0
U2 5
PU AMER SOCIETY TESTING AND MATERIALS
PI W CONSHOHOCKEN
PA 100 BARR HARBOR DRIVE, W CONSHOHOCKEN, PA 19428-2959 USA
SN 0066-0558
BN 0-8031-3497-5
J9 AM SOC TEST MATER
PY 2006
VL 1471
BP 40
EP +
DI 10.1520/STP37546S
PG 3
WC Engineering, Biomedical; Metallurgy & Metallurgical Engineering;
   Materials Science, Biomaterials
SC Engineering; Metallurgy & Metallurgical Engineering; Materials Science
GA BEK08
UT WOS:000237508300004
DA 2018-10-20
ER

PT B
AU Nam, K
   Kimura, T
   Kishida, A
AF Nam, Kwangwoo
   Kimura, Tsuyoshi
   Kishida, Akio
BE Somiya, S
   Doyama, M
TI Influence of cross-linking on physicochemical and biological properties
   of collagen-phospholipid polymer hybrid gel
SO TRANSACTIONS OF THE MATERIALS RESEARCH SOCIETY OF JAPAN, VOL 31, NO 3
SE Transactions of the Materials Research Society of Japan
LA English
DT Proceedings Paper
CT Joint Symposia of the Materials-Research-Society-of-Japan
CY DEC 09-11, 2005
CL Nihon Univ, Tokyo, JAPAN
SP Mat Res Soc Japan
HO Nihon Univ
DE collagen; phospholipids polymer; cross-link; gel; cell adhesion
AB To adopt collagen as a biomaterial, collagen should be modified due to disadvantages such as poor mechanical strength and high thrombogenicity. Preparation of collagen-polymer hybrid gel for application as an artificial vascular graft was executed by immobilizing 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer, poly(MPC-co-methacrylic acid) (PMA), using N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide and N-hydroxysuccinimide as cross-linkers. In order to alter the density of interchain cross-links (intermolecular bonding) between collagen fibrils and the MPC polymer chains, collagen-polymer hybrid gel was prepared by changing the mole ratio of MPC moiety of PMA. The intra- and interhelical cross-links made the gel thermodynamically stable. The interchain cross-links made the gel mechanically and dimensionally stable by supporting the network structure of the hybrid gel, which is thought to be achieved by connecting collagen fibrils. Enzymatic stability was depending on the density of interchain cross-links, because the adsorption of collagenase was prohibited. Increase in the MPC moiety made the gel cell adhesion property decrease. This implies that the interaction between cells and surface of the hybrid gel is being regulated by the MPC groups, making the hybrid gel much efficient for artificial vascular graft use.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
RP Nam, K (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Kanda Surugadai 2-3-10, Tokyo 1010062, Japan.
EM bloodnam.fm@tmd.ac.jp
CR Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   FRIESS W, 1998, EUR J PHARM BIOPHARM, V45, P112
   Fujioka K, 1998, ADV DRUG DELIVER REV, V31, P247, DOI 10.1016/S0169-409X(97)00119-1
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Watanabe J, 2003, ARTIF ORGANS, V27, P242, DOI 10.1046/j.1525-1594.2003.07015.x
   Wissink MJB, 2001, BIOMATERIALS, V22, P151, DOI 10.1016/S0142-9612(00)00164-2
   Zeeman R, 1999, BIOMATERIALS, V20, P921, DOI 10.1016/S0142-9612(98)00242-7
NR 8
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
J9 T MRS JAP
PY 2006
VL 31
IS 3
BP 735
EP 738
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA BFK71
UT WOS:000242517100042
DA 2018-10-20
ER

PT B
AU Tadokoro, Y
   Nagase, Y
   Iwasaki, Y
   Ishihara, K
AF Tadokoro, Yoshinori
   Nagase, Yu
   Iwasaki, Yasuhiko
   Ishihara, Kazuhiko
BE Somiya, S
   Doyama, M
TI Synthesis of aromatic carboxylic acid compound containing
   phosphorylcholine moiety and the polymer reaction with ethyl cellulose
SO Transactions of the Materials Research Society of Japan, Vol 31, No 4
SE TRANSACTIONS OF THE MATERIALS RESEARCH SOCIETY OF JAPAN
LA English
DT Proceedings Paper
CT Joint Symposia of the Materials-Research-Society-of-Japan
CY DEC 09-11, 2005
CL Nihon Univ, Tokyo, JAPAN
SP Mat Res Soc Japan
HO Nihon Univ
DE biomaterial; phosphorylcholine; aromatic carboxylic acid compound;
   biocompatibility; polymeric reaction
ID BLOOD COMPATIBILITY; HEMODIALYSIS MEMBRANE; PHOSPHOLIPID POLYMER
AB An introduction of phosphorylcholine (PC) group to ethyl cellulose through oxyphenylenecarboxylate linkage was investigated, in order to obtain the improved biocompatible material. For this purpose, a novel aromatic carboxylic acid compound containing PC group, 2-(4-carboxylphenyloxy)ethyl phosphorylcholine (CPC), was synthesized, which could be used for the reagent to introduce the PC group into the polymers containing hydroxyl or amino group via polymer reactions. Thus, polymer reaction between CPC and ethyl cellulose using dicyclohexylcarbodiimide gave ethyl cellulose partially substituted with PC group. The chemical structure of the obtained cellulose with PC moiety was confirmed by H-1-NMR and FT-IR and the elements of PC g;roup were observed on the film surface by XPS analysis. Furthermore, it was revealed that the obtained polymers containing PC moiety exhibited the higher biocompatibility than the starting ethyl cellulose.
C1 Tokai Univ, Grad Sch Engn, Dept Appl Chem, Hiratsuka, Kanagawa 2591292, Japan.
RP Tadokoro, Y (reprint author), Tokai Univ, Grad Sch Engn, Dept Appl Chem, 1117 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan.
RI Iwasaki, Yasuhiko/D-6870-2011
OI Iwasaki, Yasuhiko/0000-0003-1603-6174
CR Ishihara K, 1999, J BIOMAT SCI-POLYM E, V10, P271, DOI 10.1163/156856299X00342
   Ishihara K, 1998, MAT SCI ENG C-BIO S, V6, P253, DOI 10.1016/S0928-4931(98)00059-9
   Kawano H, 1998, KOBUNSHI RONBUNSHU, V55, P334, DOI 10.1295/koron.55.334
   Nakajima S., 2004, Proceedings of the School of Engineering of Tokai University (English Edition), V44, P1
   OKU M, 2005, T MAT RES SOC, V30, P1035
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
   Ye SH, 2005, J MEMBRANE SCI, V249, P133, DOI 10.1016/j.memsci.2004.10.006
NR 7
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
J9 T MRS JAP
PY 2006
VL 31
IS 4
BP 1053
EP 1056
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA BFX21
UT WOS:000245241300051
DA 2018-10-20
ER

PT J
AU Murphy, MR
   Faucher, KM
   Sun, XL
   Chaikof, EL
   Dluhy, RA
AF Murphy, MR
   Faucher, KM
   Sun, XL
   Chaikof, EL
   Dluhy, RA
TI Analysis of photoinitiated polymerization in a membrane mimetic film
   using infrared spectroscopy and near-IR Raman microscopy
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE infrared; Raman; biomaterials surfaces
ID IN-SITU POLYMERIZATION; CYTOMIMETIC BIOMATERIALS; PHOTOPOLYMERIZATION
   ACTIVITY; PERESTER DERIVATIVES; ALKYLATED SURFACE; PHOSPHOLIPIDS;
   MONOLAYERS; HEMOCOMPATIBILITY; BENZOPHENONE; SIMULATION
AB A method has been developed to investigate the extent of polymer cross-linking that results following in situ photopolymerization of an acrylate-functionalized phospholipid assembly adsorbed onto a stabilized, membrane-mimetic film produced from a polyelectrolyte multilayer (PEM) on polytetrafluoroethylene (PTFE) grafts. The acrylate phospholipid monomer was synthesized, prepared as a unilamellar vesicle, and fused onto closed-packed acyl chains that make up the PEM membrane-mimetic barrier on the PTFE graft. Both broad band white light and 514.5 nm laser radiation were used as excitation sources for photoinitiation; eosin Y was used as the photoinitiator. The use of 514.5 nm excitation reduced the time for maximum polymerization of the acrylate lipid from 60 min to 240 s. Infrared spectroscopy was successfully used to analyze the extent of photopolymerization in simplified model acrylate lipid systems; however, this method could not be used to analyze acrylate polymerization in heterogeneous, multicomponent PEM membrane-mimetic barriers on PTFE grafts. A near-infrared Raman microscopy method based on the ratio of the integrated areas of the C=C and C-N vibrations was shown to provide equivalent information to the IR method for analysis of the extent of polymerization efficiency in acrylate lipids. In addition, it proved feasible to extend this near-IR Raman method to the in situ analysis of the extent of polymerization in a stabilized acrylate lipid membrane on a PEM film in a PTFE vascular graft. This work describes a new approach for generating and analyzing the robustness of a membrane-mimetic coating on biomaterial surfaces, and may improve our ability to predict the long-term stability of polymeric membrane-mimetic films on implantable medical devices. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Georgia, Dept Chem, Athens, GA 30602 USA.
   Emory Univ, Dept Surg, Atlanta, GA 30322 USA.
   Emory Univ, Dept Biomed Engn, Atlanta, GA 30322 USA.
   Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30322 USA.
RP Dluhy, RA (reprint author), Univ Georgia, Dept Chem, Athens, GA 30602 USA.
EM dluhy@chem.uga.edu
FU NIBIB NIH HHS [EB001956]; NHLBI NIH HHS [HL56819]
CR ALLEN NS, 1991, J APPL POLYM SCI, V42, P1169, DOI 10.1002/app.1991.070420501
   ALLEN NS, 1990, EUR POLYM J, V26, P1041, DOI 10.1016/0014-3057(90)90120-S
   CAREY PR, 1982, BIOCHN APPL RAMAN RE
   CEVC G, 1987, PHOSPHOLIPID BILAYER, P57
   Chon JH, 1999, J BIOMAT SCI-POLYM E, V10, P95, DOI 10.1163/156856299X00306
   CHONG CK, 1992, VIB SPECTROSC, V3, P35
   Cruise GM, 1998, BIOTECHNOL BIOENG, V57, P655, DOI 10.1002/(SICI)1097-0290(19980320)57:6<655::AID-BIT3>3.0.CO;2-K
   Feng J, 2002, LANGMUIR, V18, P9907, DOI 10.1021/la025931y
   Georgieva R, 2004, LANGMUIR, V20, P1895, DOI 10.1021/la035779f
   HALL B, 1989, BIOMATERIALS, V10, P219, DOI 10.1016/0142-9612(89)90096-3
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   HENDRA PJ, 1988, J RAMAN SPECTROSC, V19, P413, DOI 10.1002/jrs.1250190607
   ISHIHARA K, 1994, J BIOMED MATER RES, V28, P225, DOI 10.1002/jbm.820280213
   Katagiri K, 2004, MACROMOLECULES, V37, P9947, DOI 10.1021/ma048706r
   Katagiri K, 2005, ADV MATER, V17, P738, DOI 10.1002/adma.200401441
   Kunitake T, 2000, PHYSICAL CHEMISTRY OF BIOLOGICAL INTERFACES, P283
   Liu H, 2002, LANGMUIR, V18, P1332, DOI 10.1021/la011254g
   Long D. A., 2002, RAMAN EFFECT
   Marra KG, 1997, LANGMUIR, V13, P5697, DOI 10.1021/la970473s
   Marra KG, 1997, MACROMOLECULES, V30, P6483, DOI 10.1021/ma970481f
   Mauk AW, 1998, LANGMUIR, V14, P5255, DOI 10.1021/la970987r
   Moya S, 2003, BIOMACROMOLECULES, V4, P808, DOI 10.1021/bm034013r
   Orban JM, 2000, MACROMOLECULES, V33, P4205, DOI 10.1021/ma9915780
   PATHAK CP, 1992, J AM CHEM SOC, V114, P8311, DOI 10.1021/ja00047a065
   PLAZA P, 1986, APPL OPTICS, V25, P3448, DOI 10.1364/AO.25.003448
   Ringsdorf H, 2000, PHYSICAL CHEMISTRY OF BIOLOGICAL INTERFACES, P243
   Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43
   Sanderson CT, 2002, MACROMOLECULES, V35, P9648, DOI 10.1021/ma0212238
   Steel D, 2002, HDB VIBRATIONAL SPEC, P44
   VALDESAGUILERA O, 1992, MACROMOLECULES, V25, P541, DOI 10.1021/ma00028a008
   Wang UY, 2004, J PHYS CHEM B, V108, P4767, DOI 10.1021/jp036413e
   Winger TM, 1999, LANGMUIR, V15, P3866, DOI 10.1021/la980990q
   Winger TM, 1998, LANGMUIR, V14, P4148, DOI 10.1021/la980077p
   YANG DB, 1993, J POLYM SCI POL CHEM, V31, P199, DOI 10.1002/pola.1993.080310124
NR 34
TC 5
Z9 5
U1 1
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD DEC 30
PY 2005
VL 46
IS 4
BP 226
EP 232
DI 10.1016/j.colfurfb.2005.11.011
PG 7
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 007LJ
UT WOS:000234970200004
PM 16343863
DA 2018-10-20
ER

PT J
AU Barbetta, A
   Dentini, M
   Zannoni, EM
   De Stefano, ME
AF Barbetta, A
   Dentini, M
   Zannoni, EM
   De Stefano, ME
TI Tailoring the porosity and morphology of gelatin-methacrylate polyHIPE
   scaffolds for tissue engineering applications
SO LANGMUIR
LA English
DT Article
ID SOLUBLE POROGENIC SOLVENTS; CONTAINING ARTIFICIAL SKIN; IN-OIL
   EMULSIONS; CLOUD-POINT; NONIONIC SURFACTANTS; CHONDROITIN SULFATE;
   GEL-EMULSIONS; FOAMS; PHASE; SPONGE
AB Gelatin is a natural protein with many desirable properties for application as a biomaterial, including scaffolding for tissue engineering. In this work gelatin A with a molecular weight in the range 50-100 kg mol(-1) was modified with methacrylic anhydride and processed into a concentrated oil-in-water emulsion. Polymerization of the continuous phase gave rise to a polyHIPE, a porous material possessing a highly interconnected, trabecular morphology. In the paper, we focused on the goal of obtaining matrixes characterized by suitable sizes of both voids and interconnects, to allow an in depth colonization from transplanted cells. In this respect, we investigated the role of the volume percentage of the dispersed phase and the effect of additives. It was established that high pore volumes (>= 90%) are to be preferred, because they allow the production of solid foams characterized by average void and interconnect diameters of approximately 20 and 10 mu m, respectively. These values are still inadequate for the intended application of these scaffolds but represent a good starting point for further improvements. These were achieved through the use of additives, namely sodium chloride and dimethyl sulfoxide, which partially destabilized the precursor emulsion and allowed a solid foam to be obtained with void and interconnect diameters in the range of 30-150 mu m and 10-50 mu m, respectively.
C1 Univ Roma La Sapienza, Dept Chem, Rome, Italy.
   Univ Roma La Sapienza, Dipartimento Biol Cellulare & Sviluppo, Rome, Italy.
RP Barbetta, A (reprint author), Univ Roma La Sapienza, Dept Chem, Rome, Italy.
EM andrea.barbetta@uniroma1.it; mariella.dentini@uniroma1.it
RI Dentini, Mariella/N-2653-2013
OI Dentini, Mariella/0000-0003-0783-0982; Barbetta,
   Andrea/0000-0001-9292-4734
CR Akay G, 2004, BIOMATERIALS, V25, P3991, DOI 10.1016/j.biomaterials.2003.10.086
   Akay G, 1995, POLYM POWDER TECHNOL, P541
   AlGhamdi AM, 1997, COLLOID SURFACE A, V125, P5, DOI 10.1016/S0927-7757(96)03860-5
   ANDERSON D, 1989, J PHYS CHEM-US, V93, P4243, DOI 10.1021/j100347a067
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ARONSON MP, 1993, J COLLOID INTERF SCI, V159, P134, DOI 10.1006/jcis.1993.1305
   AUVRAY L, 1984, J PHYS-PARIS, V45, P913, DOI 10.1051/jphys:01984004505091300
   Barbetta A, 2000, CHEM COMMUN, P221, DOI 10.1039/a909060f
   Barbetta A, 2005, ADV FUNCT MATER, V15, P118, DOI 10.1002/adfm.200400072
   Barbetta A, 2004, MACROMOLECULES, V37, P3188, DOI 10.1021/ma0359436
   Barbetta A, 2004, MACROMOLECULES, V37, P3202, DOI 10.1021/ma035944y
   BARBETTA A, 2003, Patent No. A000307
   BARNES HA, 1994, COLLOID SURFACE A, V91, P89, DOI 10.1016/0927-7757(93)02719-U
   Benson JR, 2003, AM LAB, V35, P44
   Busby W, 2001, BIOMACROMOLECULES, V2, P154, DOI 10.1021/bm0000889
   Cameron NR, 2000, J MATER CHEM, V10, P2466, DOI 10.1039/b003596n
   Cameron NR, 1996, COLLOID POLYM SCI, V274, P592, DOI 10.1007/BF00655236
   Choi YS, 1999, BIOMATERIALS, V20, P409, DOI 10.1016/S0142-9612(98)00180-X
   Choi YS, 2001, J MATER SCI-MATER M, V12, P67, DOI 10.1023/A:1026765321117
   Choi YS, 1999, J BIOMED MATER RES, V48, P631, DOI 10.1002/(SICI)1097-4636(1999)48:5<631::AID-JBM6>3.0.CO;2-Y
   CHVAPIL M, 1977, J BIOMED MATER RES, V11, P721, DOI 10.1002/jbm.820110508
   CHVAPIL M, 1982, J BIOMED MATER RES, V16, P245, DOI 10.1002/jbm.820160306
   CORTI M, 1984, J PHYS CHEM-US, V88, P309, DOI 10.1021/j150646a029
   Crescenzi V, 2002, BIOMACROMOLECULES, V3, P1384, DOI 10.1021/bm025657m
   DEGUCHI K, 1975, J COLLOID INTERF SCI, V50, P233
   DOSCHER TM, 1951, J COLL SCI IMP U TOK, V6, P223, DOI 10.1016/0095-8522(51)90041-4
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FRIBERG S, 1975, ADV LIQ CRYST, V2, P173
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
   HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2
   Hayman MW, 2004, BIOCHEM BIOPH RES CO, V314, P483, DOI 10.1016/j.bbrc.2003.12.135
   HINZE WL, 1993, CRIT REV ANAL CHEM, V24, P133, DOI 10.1080/10408349308048821
   JONES RT, 1971, PROCESS BIOCHEM, V6, P19
   KITAGAWA, 2000, Patent No. 6048908
   KITAGAWA N, 1999, Patent No. 9900187
   KUNIEDA H, 1990, COLLOID SURFACE, V47, P35, DOI 10.1016/0166-6622(90)80060-H
   Lee JM, 1996, J MATER SCI-MATER M, V7, P531, DOI 10.1007/BF00122176
   LI NH, Patent No. 5863957
   LI NH, 1998, Patent No. 5760097
   Lissant K., 1974, EMULSION EMULSION TE, V6
   LIVSHITS VA, 1993, COLLOID SURFACE A, V72, P313, DOI 10.1016/0927-7757(93)80481-S
   MULLER HJ, 1994, COLLOID POLYM SCI, V272, P433, DOI 10.1007/BF00659456
   Olijve J, 2001, J COLLOID INTERF SCI, V243, P476, DOI 10.1006/jcis.2001.7816
   OSTWALD W, 1910, KOLLOID W, V7, P63
   Ostwald W., 1910, KOLLOID Z, V6, P103
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   PONS R, 1992, PROG COLL POL SCI S, V89, P110
   PONS R, 1993, COLLOID SURFACE A, V76, P171, DOI 10.1016/0927-7757(93)80076-Q
   Rich D. H., 1979, PEPTIDES, P241
   SADAGHIANIA AS, 1991, J COLLOID INTERF SCI, V144, P191, DOI 10.1016/0021-9797(91)90250-C
   SCHOTT H, 1984, J COLLOID INTERF SCI, V98, P196, DOI 10.1016/S0021-9797(84)80026-0
   SCHOTT H, 1973, J COLLOID INTERF SCI, V43, P150, DOI 10.1016/0021-9797(73)90358-5
   Sherman P., 1983, ENCY EMULSION TECHNO, V1
   Shinoda K, 1986, EMULSIONS SOLUBILIZA
   Tai H, 2001, POLYM ENG SCI, V41, P1540, DOI 10.1002/pen.10853
   Taylor P, 1998, ADV COLLOID INTERFAC, V75, P107, DOI 10.1016/S0001-8686(98)00035-9
   WALD HL, 1993, BIOMATERIALS, V14, P270, DOI 10.1016/0142-9612(93)90117-K
   Wang LF, 2003, CARBOHYD POLYM, V52, P389, DOI 10.1016/S0144-8617(02)00328-4
   WILLIAMS JM, 1990, LANGMUIR, V6, P437, DOI 10.1021/la00092a026
   Zhang H, 2002, CHEM MATER, V14, P4017, DOI 10.1021/cm0206643
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 61
TC 99
Z9 99
U1 4
U2 54
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD DEC 20
PY 2005
VL 21
IS 26
BP 12333
EP 12341
DI 10.1021/la0520233
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 994WX
UT WOS:000234063000043
PM 16343011
DA 2018-10-20
ER

PT J
AU Garza, JM
   Jessel, N
   Ladam, G
   Dupray, V
   Muller, S
   Stoltz, JF
   Schaaf, P
   Voegel, JC
   Lavalle, P
AF Garza, JM
   Jessel, N
   Ladam, G
   Dupray, V
   Muller, S
   Stoltz, JF
   Schaaf, P
   Voegel, JC
   Lavalle, P
TI Polyelectrolyte multilayers and degradable polymer layers as
   multicompartment films
SO LANGMUIR
LA English
DT Article
ID BIOLOGICAL-ACTIVITY; BUILDUP; MEMBRANES; MICROCAPSULES; GROWTH
AB Polyelectrolyte multilayers are now a well established concept with numerous potential applications in particular as biomaterial coatings. To timely control the biological activity of cells in contact with a substrate, multicompartment films made of different polyelectrolyte multilayers deposited sequentially on the solid substrate constitute a promising new approach. In a first paper (Langmuir 2004,20, 7298) we showed that such multicompartment films can be designed by alternating exponentially growing polyelectrolyte multilayers acting as reservoirs and linearly growing ones acting as barriers. In the present study, we first demonstrate however that these barriers composed of synthetic polyelectrolytes are not degraded despite the presence of phagocytic cells. We propose an alternative approach where exponentially growing poly(L-lysine)/hyaluronic acid (PLL/HA) multilayers, used as reservoirs, are alternated with biodegradable polymer layers consisting in poly(lactic-co-glycolic acid) (PLGA) and acting as barriers for PLL chains that diffuse within the PLL/HA reservoirs. We first show that these PLGA layers can be deposited alternatively with PLL/HA multilayers leading to polyelectrolyte multilayer/hydrolyzable polymeric layer films and acting as a reservoirs/barriers system. Bone marrow cells seeded on these films ending by a PLL/HA reservoir rapidly degrade it and internalize the PLL chains confined in this reservoir. Then the cells degraded locally the PLGA barrier and internalize the PLL localized in a lower (PLL/HA) compartment after 5 days of seeding. By changing the thickness of the PLGA layer, we hope to be able to tune the time delay of degradation. Such mixed architectures made of polyelectrolyte multilayers and hydrolyzable polymeric layers could act as coatings allowing us to induce a time scheduled cascade of biological activities. We are currently working on the use of comparable films with compartments filled by proteins or peptides and in which the degradation of the barriers results from a hydrolysis over tunable time scales.
C1 INSERM, U595, F-67085 Strasbourg, France.
   Univ Louis Pasteur Strasbourg 1, Fac Chirurg Dent, F-67085 Strasbourg, France.
   CNRS, UMR 7563, LEMTA, F-54500 Vandoeuvre Les Nancy, France.
   Univ Henri Pointcare, Fac Med, F-54500 Vandoeuvre Les Nancy, France.
   CNRS, UPR22, Inst Charles Sadron, F-67083 Strasbourg, France.
RP Lavalle, P (reprint author), INSERM, U595, F-67085 Strasbourg, France.
EM philippe.lavalle@odonto-ulp.u-strasbg.fr
RI DUPRAY, Valerie/C-6659-2012; Lavalle, Philippe/E-6328-2016; Ladam,
   Guy/C-4362-2011; SCHAAF, Pierre/J-2751-2016
OI Lavalle, Philippe/0000-0001-8798-912X; SCHAAF,
   Pierre/0000-0001-7423-5492; Benkirane-Jessel, Nadia/0000-0003-3059-3559
CR Benkirane-Jessel N, 2005, ADV FUNCT MATER, V15, P648, DOI 10.1002/adfm.200400129
   Benkirane-Jessel N, 2004, ADV FUNCT MATER, V14, P174, DOI 10.1002/adfm.200304413
   Boulmedais F, 2004, BIOMATERIALS, V25, P2003, DOI 10.1016/j.biomaterials.2003.08.039
   Caruso F, 1997, LANGMUIR, V13, P3427, DOI 10.1021/la9608223
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DECHER G, 1991, BER BUNSEN PHYS CHEM, V95, P1430, DOI 10.1002/bbpc.19910951122
   Garza JM, 2004, LANGMUIR, V20, P7298, DOI 10.1021/la049106o
   Glinel K, 2004, LANGMUIR, V20, P4898, DOI 10.1021/la036078l
   Grayson ACR, 2003, NAT MATER, V2, P767, DOI 10.1038/nmat998
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ, P169
   JESSEL N, 2002, ADV MATER, V15, P692
   JESSEL N, 2004, ADV MATER, V16, P1507
   Krasemann L, 2001, J MEMBRANE SCI, V181, P221, DOI 10.1016/S0376-7388(00)00535-4
   LAVALLE P, 2004, J PHYS CHEM B, V108, P636
   Miller MD, 2004, LANGMUIR, V20, P11545, DOI 10.1021/la0479859
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Radt B, 2004, ADV MATER, V16, P2184, DOI 10.1002/adma.200400920
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Rmaile HH, 2003, J AM CHEM SOC, V125, P6602, DOI 10.1021/ja035251x
   Schuster KC, 2000, J MICROBIOL METH, V42, P29, DOI 10.1016/S0167-7012(00)00169-X
   Shchukin DG, 2004, J AM CHEM SOC, V126, P3374, DOI 10.1021/ja036952x
   van Apeldoorn AA, 2004, J AM CHEM SOC, V126, P13226, DOI 10.1021/ja0459936
   Volodkin DV, 2004, LANGMUIR, V20, P3398, DOI 10.1021/la036177z
   Wood KC, 2005, LANGMUIR, V21, P1603, DOI 10.1021/la0476480
NR 26
TC 55
Z9 55
U1 0
U2 14
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD DEC 20
PY 2005
VL 21
IS 26
BP 12372
EP 12377
DI 10.1021/la051465b
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 994WX
UT WOS:000234063000048
PM 16343016
DA 2018-10-20
ER

PT J
AU Hahn, MS
   Miller, JS
   West, JL
AF Hahn, MS
   Miller, JS
   West, JL
TI Laser scanning lithography for surface micropatterning on hydrogels
SO ADVANCED MATERIALS
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; GRADIENTS; PROTEIN; CELLS; MICROSTRUCTURES;
   IMMOBILIZATION; NETWORKS; DELIVERY
AB A versatile confocal-based laser scanning lithographic method for controlled, high-fidelity two-dimensional and three-dimensional surface patterning of deformable, solvated, photoactive substrates is presented (see Figure; scale bars represent 200 mu m). Patterned substrates functionalized with gradients of different cell-adhesive ligands can be fabricated, providing a tool for investigating cell-biomaterial interactions and the structure-function relationships of tissues.
C1 Rice Univ, Dept Bioengn, Houston, TX 77005 USA.
RP West, JL (reprint author), Rice Univ, Dept Bioengn, MS 144,6100 Main St, Houston, TX 77005 USA.
EM jwest@rice.edu
RI West, Jennifer/A-4582-2008; Miller, Jordan/P-8755-2014
OI West, Jennifer/0000-0001-8550-2875; Miller, Jordan/0000-0002-7931-551X
CR Brock A, 2003, LANGMUIR, V19, P1611, DOI 10.1021/la026394k
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Chen GP, 2001, BIOMATERIALS, V22, P2453, DOI 10.1016/S0142-9612(00)00432-4
   Chovan T, 2002, TRENDS BIOTECHNOL, V20, P116, DOI 10.1016/S0167-7799(02)01905-4
   Delamarche E, 1997, SCIENCE, V276, P779, DOI 10.1126/science.276.5313.779
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Dertinger SKW, 2002, P NATL ACAD SCI USA, V99, P12542, DOI 10.1073/pnas.192457199
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Ghislain LP, 1999, APPL PHYS LETT, V74, P501, DOI 10.1063/1.123168
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Herbert CB, 1997, CHEM BIOL, V4, P731, DOI 10.1016/S1074-5521(97)90311-2
   HILLWEST JL, 1994, P NATL ACAD SCI USA, V91, P5967, DOI 10.1073/pnas.91.13.5967
   Ito Y, 2001, J BIOMAT SCI-POLYM E, V12, P367, DOI 10.1163/156856201750195270
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Khademhosseini A, 2003, ADV MATER, V15, P1995, DOI 10.1002/adma.200305433
   RENSCH C, 1989, APPL OPTICS, V28, P3754, DOI 10.1364/AO.28.003754
   Ryan D, 2004, LANGMUIR, V20, P9080, DOI 10.1021/la048443u
   Sarkar S, 2005, ACTA BIOMATER, V1, P93, DOI 10.1016/j.actbio.2004.08.003
   Suh KY, 2004, BIOMATERIALS, V25, P557, DOI 10.1016/S0142-9612(03)00543-X
   Takayama S, 1999, P NATL ACAD SCI USA, V96, P5545, DOI 10.1073/pnas.96.10.5545
   WEST JL, 1995, REACT POLYM, V25, P139, DOI 10.1016/0923-1137(94)00096-N
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
NR 22
TC 59
Z9 62
U1 1
U2 32
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD DEC 16
PY 2005
VL 17
IS 24
BP 2939
EP +
DI 10.1002/adma.200500184
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 000OT
UT WOS:000234472400003
DA 2018-10-20
ER

PT J
AU Lovino, M
   Cardinal, MF
   Zubiri, DB
   Bernik, DL
AF Lovino, M
   Cardinal, MF
   Zubiri, DB
   Bernik, DL
TI Electronic nose screening of ethanol release during sol-gel
   encapsulation - A novel non-invasive method to test silica
   polymerisation
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE e-nose technology; TEOS polymerisation; silica materials; encapsulation
   matrices; controlled release matrices
ID PECTIN GELS; PROTEINS
AB Porous silica matrices prepared by sol-gel process yield biocompatible materials adequate for encapsulation of biomolecules or drugs. The procedure is simple and fast, but when alkoxyde precursors like tetraethoxysilane (TEOS) are used the polymerisation reaction leads to the formation of alcohol as a by-product, which can produce undesirable effects on the activity of entrapped enzymes or modify a drug release kinetic. Therefore, it is critical to determine that no remnant ethanol is left prior using or storing the obtained biomaterial. In this regard, the technique used in the alcohol determination should be non-invasive and non-destructive to preserve the encapsulation device intact and ready to use. In this work we have successfully used a portable electronic nose (e-nose) for the screening of silica polymerisation process during theophylline encapsulation. TEOS reaction was "smelt" since precursor pre-hydrolysis until the end of ethanol release, sensed directly at the headspace of matrices slabs. Measurements showed that ethanol was negligible since 10th day in polymeric slabs of 10 mm width and 2 cm diameter. This first use of e-nose following a polymerisation reaction opens a wide number of putative applications in pharmaceutical and biochemical fields. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Inorgan Analit & Quim Fis, Inst Quim Fis Mat Ambiente & Energia, Buenos Aires, DF, Argentina.
RP Bernik, DL (reprint author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Inorgan Analit & Quim Fis, Inst Quim Fis Mat Ambiente & Energia, Pabellon 11,Ciudad Univ,C1428HA, Buenos Aires, DF, Argentina.
EM dbernik@qi.fcen.uba.ar
CR Besanger TR, 2003, ANAL CHEM, V75, P2382, DOI 10.1021/ac026370i
   CASTELVETRO V, 2004, ADV COLLOID INTERFAC, V167, P108
   Di Natale C, 2003, BIOSENS BIOELECTRON, V18, P1209, DOI 10.1016/S0956-5663(03)00086-1
   ECHEVERRIA G, 2004, J AGR FOOD CHEM, V19, P3069
   Ferrer ML, 2002, CHEM MATER, V14, P3619, DOI 10.1021/cm025562r
   Gardner J. W., 1999, ELECT NOSES PRINCIPL
   Jin W, 2002, ANAL CHIM ACTA, V461, P1, DOI 10.1016/S0003-2670(02)00229-5
   Machatha SG, 2004, INT J PHARM, V283, P83, DOI 10.1016/j.ijpharm.2004.06.020
   Martinez-Perez D, 2003, ANAL BIOCHEM, V322, P238, DOI 10.1016/j.ab.2003.08.018
   Monge ME, 2004, SENSOR ACTUAT B-CHEM, V101, P28, DOI 10.1016/j.snb.2004.02.019
   Monge ME, 2004, COMB CHEM HIGH T SCR, V7, P337
   Radin S, 2005, BIOMATERIALS, V26, P1043, DOI 10.1016/j.biomaterials.2004.04.004
   Reetz MT, 1997, ADV MATER, V9, P943, DOI 10.1002/adma.19970091203
   Shchipunov YA, 2003, J COLLOID INTERF SCI, V268, P68, DOI 10.1016/S0021-9797(03)00457-0
   Unger B, 1994, J SOL-GEL SCI TECHN, V2, P51, DOI 10.1007/BF00486212
   Zhu LM, 2004, J PHARMACEUT BIOMED, V34, P453, DOI 10.1016/S0731-7085(03)00651-4
NR 16
TC 11
Z9 11
U1 0
U2 5
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD DEC 15
PY 2005
VL 21
IS 6
BP 857
EP 862
DI 10.1016/j.bios.2005.02.003
PG 6
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA 984ZQ
UT WOS:000233346300004
PM 16257653
DA 2018-10-20
ER

PT J
AU Yevdokimov, YM
   Salyanov, VI
   Kondrashina, OV
   Borshevsky, VI
   Semenov, SV
   Gasanov, AA
   Reshetov, IV
   Kuznetsov, VD
   Nikiforov, VN
   Akulinichev, SV
   Mordovskoi, MV
   Potashev, SI
   Skorkin, VM
AF Yevdokimov, YM
   Salyanov, VI
   Kondrashina, OV
   Borshevsky, VI
   Semenov, SV
   Gasanov, AA
   Reshetov, IV
   Kuznetsov, VD
   Nikiforov, VN
   Akulinichev, SV
   Mordovskoi, MV
   Potashev, SI
   Skorkin, VM
TI Particles of liquid-crystalline dispersions formed by (nucleic acid-rare
   earth element) complexes as a potential platform for neutron capture
   therapy
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE nucleic acids; liquid-crystalline dispersions; neutron capture therapy;
   rare earth elements; magnetometric and neutron activation analysis
ID DNA; GD-157; NANOPARTICLES; DESIGN; CANCER; STATES; CD
AB Microscopic size particles of the cholesteric double-stranded DNA (RNA) liquid-crystalline dispersions, containing the ions of the rare earth elements in their content, have been obtained for the first time. The properties of these particles differ from those of classical DNA cholesterics noticeably. The local concentration of the rare earth elements in a particle reaches 200 mg/ml. The particles of the liquid-crystalline dispersion of the (DNA-gadolinium) complex maintain the properties for a long time. The combination of the microscopic size of particles, high concentration of gadolinium in particles and their stability opens a way to practical application of this new biomaterial. (c) 2005 Elsevier B.V. All rights reserved.
C1 Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 119991, Russia.
   PA Hertzen Canc Res Inst, Moscow, Russia.
   Moscow MV Lomonosov State Univ, Dept Phys, Moscow, Russia.
   Russian Acad Sci, Inst Nucl Res, Moscow, Russia.
RP Yevdokimov, YM (reprint author), Russian Acad Sci, VA Engelhardt Mol Biol Inst, Vavilova Str 32, Moscow 119991, Russia.
EM yevdokim@eimb.ru
RI Nikiforov, Vladimir/G-5649-2010; Yevdokimov, Yuri/Q-3349-2016;
   Borshchevskiy, Valentin/F-2287-2014
OI Nikiforov, Vladimir/0000-0002-6153-2188; Borshchevskiy,
   Valentin/0000-0003-4398-9712
CR ALLEN BJ, 1989, STRAHLENTHER ONKOL, V165, P156
   Andreev AV, 1999, CZECH J PHYS, V49, P377, DOI 10.1007/s10582-999-0049-9
   ANDREEV AV, 1989, ATOM ENERG, V66, P133
   BARTOLINI ME, 2004, MAGN RESON, V21, P541
   Belyakov VA, 1996, LIQ CRYST, V20, P777, DOI 10.1080/02678299608033172
   Brugel TA, 2003, J ORG CHEM, V68, P8409, DOI 10.1021/jo030183i
   BRUGGER RM, 1989, STRAHLENTHER ONKOL, V165, P153
   CARAVAN P, 2003, CHEM COMMUN, V20, P2574
   De Stasio Gelsomina, 2001, Cancer Research, V61, P4272
   DESOETE D, 1972, NEUTRON ACTIVATION A
   Goorley T, 2004, INT J RADIAT BIOL, V80, P933, DOI 10.1080/09553000400017564
   GRASSO D, 1993, LIQ CRYST, V15, P701, DOI 10.1080/02678299308036488
   GRASSO D, 1991, LIQ CRYST, V9, P299, DOI 10.1080/02678299108035507
   GREENWOOD RC, 1978, NUCL PHYS A, V304, P327, DOI 10.1016/0375-9474(78)90242-7
   Greisberg JK, 2001, J ORTHOP RES, V19, P797, DOI 10.1016/S0736-0266(01)00025-0
   GRUENWEDEL DW, 1991, J INORG BIOCHEM, V43, P29, DOI 10.1016/0162-0134(91)84066-I
   HAERTLE T, 1981, NUCLEIC ACIDS RES, V9, P6191, DOI 10.1093/nar/9.22.6191
   Kuznetsov V. D., 1985, PRIB TEKH EKSP, V4, P196
   Leclercq F, 2003, BIOCONJUGATE CHEM, V14, P112, DOI 10.1021/bc025567e
   Li L, 2003, J LUMIN, V101, P141, DOI 10.1016/S0022-2313(02)00406-4
   MARTIN RF, 1988, INT J RADIAT BIOL, V54, P205, DOI 10.1080/09553008814551641
   Mizgerd JP, 1996, J LEUKOCYTE BIOL, V59, P189
   Nikiforov VN, 2005, JETP LETT+, V81, P264, DOI 10.1134/1.1931012
   RADFORD IR, 1985, INT J RADIAT BIOL, V48, P45, DOI 10.1080/09553008514551051
   Rosetto F. E., 1994, J INORG BIOCHEM, V54, P167
   Saha TK, 1998, CHEM PHARM BULL, V46, P537
   Shin J.L.A., 1992, MED PHYS, V19, P733
   Tokumitsu H, 2000, CANCER LETT, V150, P177, DOI 10.1016/S0304-3835(99)00388-2
   Tokumitsu H, 1999, PHARMACEUT RES, V16, P1830, DOI 10.1023/A:1018995124527
   Tokumitsu H, 2000, STP PHARMA SCI, V10, P39
   TOKUMITSU H, 1999, CHEM PHARM BULL, V47, P1830
   Yevdokimov Yu. M., 2003, LIQUID CRYSTALS THEI, V3, P10
NR 32
TC 10
Z9 14
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD DEC 15
PY 2005
VL 37
IS 4
BP 165
EP 173
DI 10.1016/j.ijbiomac.2005.10.001
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 001YH
UT WOS:000234578100001
PM 16293300
DA 2018-10-20
ER

PT J
AU Bloch, K
   Lozinsky, VI
   Galaev, IY
   Yavriyanz, K
   Vorobeychik, M
   Azarov, D
   Damshkaln, LG
   Mattiasson, B
   Vardi, P
AF Bloch, K
   Lozinsky, VI
   Galaev, IY
   Yavriyanz, K
   Vorobeychik, M
   Azarov, D
   Damshkaln, LG
   Mattiasson, B
   Vardi, P
TI Functional activity of insulinoma cells (INS-1E) and pancreatic islets
   cultured in agarose cryogel sponges
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cryogel sponge; pancreatic islets; insulinoma cells; viability; insulin
   secretion
ID POROUS ALGINATE SCAFFOLDS; FIBROBLAST-GROWTH-FACTOR; IN-VITRO;
   TRANSPLANTATION; MICROSPHERES; COLLAGEN; RELEASE; RAT
AB Here, we describe the preparation, structure, and properties of cryogel sponges, which represent a new type of macroporous biomaterial for tissue engineering. Cryogels were produced through freeze-thawing techniques, either from agarose alone or from agarose with grafted gelatin. The aim of this study was to evaluate agarose cryogel sponges as scaffolds for Culturing both isolated pancreatic islets and insulinoma cells (INS-IE). In order to evaluate the effect of cell entrapment in artificial scaffolds, cell function reflected by insulin secretion and content was studied in cells cultivated for a 2-week period either in Culture plastic plates or in cryogel sponge disks. Our results show that tumor-derived INS-1E cells grown either on plastic or on cryogels do not differ in their proliferation, morphology, insulin release, and intracellular insulin content. However, isolated pancreatic islets cultivated on cryogels sponge show 15-fold higher basal insulin secretion at 3.0 mM glucose than islets cultivated on plastic plates and fail to respond to stimulation with 16.7 mM glucose. In addition, these islets have about 2-fold lower insulin content compared to those grown in plastic plates. It is possible that the cell dysfunction noted in these in vitro experiments is due to the effect of the limited oxygen supply to the islets cultivated in cryogel sponge. Further in vivo Studies are needed to clarify the nature of such an observation since according to previous reports, agarose and gelatin induce new vessel formation supporting enhanced oxygen supply. (c) 2005 Wiley Periodicals, Inc.
C1 Sackler Fac Med, Felsenstein Med Res Ctr, Diabet & Obes Res Lab, Sackler Fac Med, Petah Tiqwa, Israel.
   Russian Acad Sci, AN Nesmeyanov Organoelement Cpds Inst, Lab Cryochem Biopolymers, Moscow, Russia.
   Lund Univ, Ctr Chem & Chem Engn, Dept Biotechnol, Lund, Sweden.
   Lin Med Ctr, Childhood Diabet Unit, Clalit Hlth Serv, Haifa, Israel.
RP Bloch, K (reprint author), Sackler Fac Med, Felsenstein Med Res Ctr, Diabet & Obes Res Lab, Sackler Fac Med, Petah Tiqwa, Israel.
EM kbloch@post.tau.ac.il
CR Aung T, 2002, J BIOMED MATER RES, V61, P75, DOI 10.1002/jbm.10144
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   Cui WX, 2001, CELL TRANSPLANT, V10, P499
   DIONNE KE, 1993, DIABETES, V42, P12, DOI 10.2337/diabetes.42.1.12
   GERMANSON GT, 1992, IMMOBILLIZED AFFINIT
   Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2
   Janjic D, 1999, BIOCHEM PHARMACOL, V57, P639, DOI 10.1016/S0006-2952(98)00346-3
   Juang JH, 1996, TRANSPLANTATION, V61, P1557, DOI 10.1097/00007890-199606150-00001
   Langer R, 2000, MOL THER, V1, P12, DOI 10.1006/mthe.1999.0003
   Lee SB, 2004, BIOMATERIALS, V25, P2309, DOI 10.1016/j.biomaterials.2003.09.016
   Lozinsky VI, 2003, TRENDS BIOTECHNOL, V21, P445, DOI 10.1016/j.tibtech.2003.08.002
   Lozinsky VI, 2002, RUSS CHEM REV, V71, P489, DOI DOI 10.1070/RC2002V071N06ABEH000720
   LOZINSKY VJ, 2001, Patent No. 2001134882
   Mao JS, 2003, J BIOMED MATER RES A, V64A, P301, DOI 10.1002/jbm.a.10223
   MUKUNDAN NE, 1995, BIOCHEM BIOPH RES CO, V210, P113, DOI 10.1006/bbrc.1995.1634
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Prokop A, 2001, Diabetes Technol Ther, V3, P431, DOI 10.1089/15209150152607213
   Ricordi C, 2003, DIABETES, V52, P1595, DOI 10.2337/diabetes.52.7.1595
   Shapiro AMJ, 2003, IMMUNOL REV, V196, P219, DOI 10.1046/j.1600-065X.2003.00085.x
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Sweet Ian R, 2002, Diabetes Technol Ther, V4, P661, DOI 10.1089/152091502320798303
   Tabata Y, 1999, J BIOMAT SCI-POLYM E, V10, P79, DOI 10.1163/156856299X00298
   von Heimburg D, 2001, BIOMATERIALS, V22, P429, DOI 10.1016/S0142-9612(00)00186-1
   Wang WJ, 2002, TRANSPLANTATION, V73, P122, DOI 10.1097/00007890-200201150-00023
   Weir GC, 1997, DIABETES, V46, P1247, DOI 10.2337/diabetes.46.8.1247
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
NR 26
TC 40
Z9 43
U1 2
U2 22
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 15
PY 2005
VL 75A
IS 4
BP 802
EP 809
DI 10.1002/jbm.a.30466
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 989RD
UT WOS:000233690500006
PM 16138321
DA 2018-10-20
ER

PT J
AU Cimini, M
   Boughner, DR
   Ronald, JA
   Johnston, DE
   Rogers, KA
AF Cimini, M
   Boughner, DR
   Ronald, JA
   Johnston, DE
   Rogers, KA
TI Dermal fibroblasts cultured on small intestinal submucosa: Conditions
   for the formation of a neotissue
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE SIS (small intestinal submucosa); scaffold; fibroblast; ECM
   (extracellular matrix); collagenl; cell culture
ID ENDOTHELIAL-CELL ADHERENCE; CALCIFIC AORTIC-STENOSIS; HUMAN
   HEART-VALVES; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX;
   ASCORBIC-ACID; GELATINASE-A; IN-VITRO; INTERSTITIAL-CELLS;
   COLLAGEN-SYNTHESIS
AB Small intestinal submucosa (SIS) is a naturally occuring, acellular biomaterial that has been used extensively as a soft tissue replacement, as a scaffold for tissue engineering, and as a Substrate for the study of cells in 3D Culture. The aim Of this Study is to define Culture parameters that promote neotissue formation With the use of dermal fibroblasts and SIS. SIS sheets were seeded with dermal fibroblasts and Cultured for 4 weeks. The resultant cell-scaffold composites (CSCs) Were Cultured with media alone, media Supplemented with ascorbic acid, or fibronectin-pre-treated SIS and ascorbic acid. CSCs Were analyzed for cellular invasion into the scaffold, the rate of type I collagen production, MMP gelatinolytic activity, thickness, and ultrastructural morphology. CSCs treated with fibronectin and ascorbate showed an increase in Type I collagen production, no change in the MMP gelatinolytic activity, an increase in CSC thickness, and an organized neotissue on the surface of the SIS. Minimal cellular invasion was noted, suggesting that fibroblasts use the SIS as a template for neotissue growth rather than as a scaffold. These results indicate that fibronectin-treated SIS Cultured with dermal fibroblasts in the presence of ascorbic acid will promote true neotissue formation for future cardiovascular tissue engineering efforts. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada.
   John P Robarts Res Inst, London, ON N6A 5K8, Canada.
RP Rogers, KA (reprint author), Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada.
EM krogers@uwo.ca
RI Ronald, John/B-7123-2008; Boughner, Derek/G-3282-2011
OI Ronald, John/0000-0003-3665-173X; 
CR AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872
   AZZAM HS, 1992, CANCER RES, V52, P4540
   Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   Balcells M, 2002, J CELL PHYSIOL, V191, P155, DOI 10.1002/jcp.10087
   Chepda T, 2001, IN VITRO CELL DEV-AN, V37, P26
   Cuy JL, 2003, J BIOMED MATER RES A, V67A, P538, DOI 10.1002/jbm.a.10095
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dreger SA, 2002, J HEART VALVE DIS, V11, P875
   Ellerbroek SM, 2001, ARCH BIOCHEM BIOPHYS, V390, P51, DOI 10.1006/abbi.2001.2345
   Flanagan Thomas C., 2003, European Cells & Materials, V6, P28
   GEESIN JC, 1993, EXP CELL RES, V206, P283, DOI 10.1006/excr.1993.1148
   Haas TL, 1998, J BIOL CHEM, V273, P3604, DOI 10.1074/jbc.273.6.3604
   HATA RI, 1989, J CELL PHYSIOL, V138, P8, DOI 10.1002/jcp.1041380103
   Hodde J, 2002, BIOMATERIALS, V23, P1841, DOI 10.1016/S0142-9612(01)00310-6
   Hodde JP, 2002, TISSUE ENG, V8, P225, DOI 10.1089/107632702753724996
   HURST RE, 2001, J BIOMAT SCI-POLYM E, V12, P267
   Ishikawa Y, 1997, POTENTIAL ANAL, V6, P11, DOI 10.1023/A:1017943607502
   Jian B, 2001, AM J PATHOL, V159, P321, DOI 10.1016/S0002-9440(10)61698-7
   Kaden JJ, 2004, Z KARDIOL, V93, P124, DOI 10.1007/s00392-004-1021-0
   Koumas L, 2003, AM J PATHOL, V163, P1291, DOI 10.1016/S0002-9440(10)63488-8
   Lai JY, 2003, J PEDIATR SURG, V38, P1752, DOI 10.1016/S0022-3468(03)00617-1
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   Lee AY, 1997, P NATL ACAD SCI USA, V94, P4424, DOI 10.1073/pnas.94.9.4424
   Legakis JE, 2002, MOL BIOL CELL, V13, P4243, DOI 10.1091/mbc.E02-06-0322
   Libby P, 2000, CIRCULATION, V102, P1874, DOI 10.1161/01.CIR.102.16.1874
   Lindberg K, 2001, BURNS, V27, P254, DOI 10.1016/S0305-4179(00)00113-3
   Matheny RG, 2000, J HEART VALVE DIS, V9, P769
   McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144
   McPherson TB, 1998, TISSUE ENG, V4, P75, DOI 10.1089/ten.1998.4.75
   MICHIELS C, 1990, J CELL PHYSIOL, V144, P295, DOI 10.1002/jcp.1041440216
   Mol A, 2004, J HEART VALVE DIS, V13, P272
   Novotna J, 2002, PHYSIOL RES, V51, P323
   Nuininga JE, 2004, BIOMATERIALS, V25, P1657, DOI 10.1016/S0142-9612(03)00519-2
   Ohgoda O, 1998, J DERMATOL SCI, V17, P123, DOI 10.1016/S0923-1811(98)00003-6
   PHILLIPS CL, 1994, J INVEST DERMATOL, V103, P228, DOI 10.1111/1523-1747.ep12393187
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   Rabkin E, 2002, CARDIOVASC PATHOL, V11, P305, DOI 10.1016/S1054-8807(02)00130-8
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   Robotin-Johnson MC, 1998, J THORAC CARDIOV SUR, V116, P805, DOI 10.1016/S0022-5223(98)00436-X
   Roeder R, 1999, J BIOMED MATER RES, V47, P65, DOI 10.1002/(SICI)1097-4636(199910)47:1<65::AID-JBM9>3.0.CO;2-F
   Ruangpanit N, 2001, MATRIX BIOL, V20, P193, DOI 10.1016/S0945-053X(01)00135-4
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   SELTZER JL, 1994, EXP CELL RES, V213, P365, DOI 10.1006/excr.1994.1211
   SHINOKA T, 1997, CIRCULATION, V96, P7
   Spina M, 2003, J BIOMED MATER RES A, V67A, P1338, DOI 10.1002/jbm.a.20025
   Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400
   Stanton H, 1998, J CELL SCI, V111, P2789
   Taylor PM, 2002, J HEART VALVE DIS, V11, P298
   Taylor PM, 2000, J HEART VALVE DIS, V9, P150
   Tomasek JJ, 1997, J BIOL CHEM, V272, P7482, DOI 10.1074/jbc.272.11.7482
   Tyagi, 2000, Pathophysiology, V7, P177, DOI 10.1016/S0928-4680(00)00046-8
   Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D
   Voytik-Harbin SL, 1998, TISSUE ENG, V4, P157, DOI 10.1089/ten.1998.4.157
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Woods AM, 2004, BIOMATERIALS, V25, P515, DOI 10.1016/S0142-9612(03)00552-0
   Zajaczkowski MB, 2003, TISSUE ENG, V9, P525, DOI 10.1089/107632703322066705
   Zeltinger J, 2001, TISSUE ENG, V7, P9, DOI 10.1089/107632701300003250
   Zhang YY, 2000, J UROLOGY, V164, P928, DOI 10.1016/S0022-5347(05)67220-5
   Zigrino P, 2001, EUR J CELL BIOL, V80, P68, DOI 10.1078/0171-9335-00134
   Zund G, 1997, EUR J CARDIO-THORAC, V11, P493, DOI 10.1016/S1010-7940(96)01005-6
NR 63
TC 14
Z9 16
U1 0
U2 3
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 15
PY 2005
VL 75A
IS 4
BP 895
EP 906
DI 10.1002/jbm.a.30493
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 989RD
UT WOS:000233690500015
PM 16118790
DA 2018-10-20
ER

PT J
AU Servoli, E
   Maniglio, D
   Motta, A
   Predazzer, R
   Migliaresi, C
AF Servoli, E
   Maniglio, D
   Motta, A
   Predazzer, R
   Migliaresi, C
TI Surface properties of silk fibroin films and their interaction with
   fibroblasts
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE atomic force microscopy (AFM); biopolymers; cell adhesion; morphology;
   silk fibroin
ID ATOMIC-FORCE MICROSCOPY; IN-VITRO; BIOMATERIALS; MORPHOLOGY; INTERFACE;
   ADHESION; FIBERS; AFM
AB There is a growing interest in the use of silk as a biomaterial for tissue engineering. Silk threads from Bombyx mori have a fibrous core of fibroin, the protein responsible for biocompatibility and bioactivity, which is surrounded by a family of "gummy" proteins, called sericins, which are almost completely removed during silk degumming. Three different methanol treatments on regenerated fibroin films were used to convert viscous solutions of Silk I to an insoluble crystalline form (Silk II), in an attempt to devise new processing protocols for the creation of a cell guiding fibroin surface. Human fibroblasts (MCR5 line) were used as probes of the cell-biomaterial interaction in the early stages of the process (1 h, 3 h. 6 h and 4 d after seeding). The effect of each treatment on cell adhesion, spreading and distribution was monitored by scanning electron microscopy (SEM) and was correlated to superficial properties (like roughness and crystallinity) and fibroin conformation by means of atomic force microscopy (AFM), used in both topographical and acoustic mode, and attenuated total internal reflection infrared spectroscopy (FTIR-ATR). It was found that traditional methanol treatments where fibroin films were soaked in methanol solution produced roughness patterns that affected only the very early stages of fibroblast adhesion (until 3 h from seeding), while the new treatment proposed could really dialogue with the cells. Its non-homogenous surface can explain the existence of cells spreading in specific directions and the presence of cell repellent areas even 4 d after seeding.
C1 Univ Trent, Fac Engn, DIMTI, I-38050 Trento, Italy.
   Univ Trent, Fac Engn, INSTM Res Unit, I-38050 Trento, Italy.
   INSTM, Natl Consortium Mat Sci & Technol, I-50132 Florence, Italy.
RP Servoli, E (reprint author), Univ Trent, Fac Engn, DIMTI, Via Mesiano 77, I-38050 Trento, Italy.
EM eva.servoli@ing.unitn.it
RI Maniglio, Devid/C-4187-2014
OI Maniglio, Devid/0000-0002-1653-861X; Motta,
   Antonella/0000-0003-4893-6863
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bacakova L, 2004, PHYSIOL RES, V53, pS35
   Cacciafesta P, 2001, SURF SCI, V491, P405, DOI 10.1016/S0039-6028(01)01303-6
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Holland NB, 2000, J BIOMED MATER RES, V51, P307, DOI 10.1002/1097-4636(20000905)51:3<307::AID-JBM3>3.0.CO;2-H
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kester E, 2000, J PHYS CHEM SOLIDS, V61, P1275, DOI 10.1016/S0022-3697(99)00412-6
   Lee K, 2003, INT J BIOL MACROMOL, V33, P75, DOI 10.1016/S0141-8130(03)00069-2
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Magonov SN, 1997, SURF SCI, V375, P385
   MAGOSHI J, 1985, J APPL POLYM SCI APP, V41, P187
   Miller LD, 1999, INT J BIOL MACROMOL, V24, P159, DOI 10.1016/S0141-8130(99)00024-0
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Ortega-Vinuesa JL, 1998, THIN SOLID FILMS, V324, P257, DOI 10.1016/S0040-6090(98)00363-0
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   SHAW JTB, 1951, NATURE, V168, P745, DOI 10.1038/168745a0
   Shen Y, 1998, MACROMOLECULES, V31, P8857, DOI 10.1021/ma980281j
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   TSUKADA M, 1983, NIPPON SANSHIGAKU, V52, P157
   Valluzzi R, 1999, INT J BIOL MACROMOL, V24, P237, DOI 10.1016/S0141-8130(99)00002-1
   VINEY C, 1997, SUPRAMOL SCI, V4, P475
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   XING C, 2001, BIOPHYSICAL CHEM, V89, P25
   YAMADA K, 2003, THIN SOLID FILMS, V440, P203
NR 25
TC 57
Z9 64
U1 3
U2 36
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD DEC 15
PY 2005
VL 5
IS 12
BP 1175
EP 1183
DI 10.1002/mabi.200500137
PG 9
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 000MD
UT WOS:000234465200003
PM 16315185
DA 2018-10-20
ER

PT J
AU Kim, HI
   Park, SJ
   Kim, SI
   Kim, NG
   Kim, SJ
AF Kim, HI
   Park, SJ
   Kim, SI
   Kim, NG
   Kim, SJ
TI Electroactive polymer hydrogels composed of polyacrylic acid and
   poly(vinyl sulfonic acid) copolymer for application of biomaterial
SO SYNTHETIC METALS
LA English
DT Article; Proceedings Paper
CT International Conference on Science and Technology of Synthetic Metals
CY JUN 28-JUL 02, 2004
CL Wollongong, AUSTRALIA
DE hydrogel; electric field; biomaterial
ID POLY(ACRYLIC ACID); NETWORK HYDROGEL
AB The volume change of hydrogels has potential for application of biomaterials that quickly can reduce by an applied electric field. This volume change of the hydrogel was similar to natural muscle, can be utilized as biosensors and as artificial muscle when employing an electrical stimulus. (C) 2005 Elsevier B.V. All rights reserved.
C1 Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea.
   Chonbuk Natl Univ, Dept Bion & Biomed Engn, Chonju, South Korea.
RP Kim, SJ (reprint author), Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea.
EM sjk@hanyang.ac.kr
CR Bar-Cohen Y., 2001, ELECTROACTIVE POLYM, P3
   GONG JP, 1994, J PHYS CHEM-US, V98, P9583, DOI 10.1021/j100089a036
   Kim SJ, 2004, SMART MATER STRUCT, V13, P317, DOI 10.1088/0964-1726/13/2/010
   Kim SJ, 2002, J APPL POLYM SCI, V86, P2290, DOI 10.1002/app.11217
   Lee JH, 2002, J BIOMED MATER RES, V60, P44, DOI 10.1002/jbm.10013
   Lee JW, 1999, J APPL POLYM SCI, V73, P113
   Mun GA, 2002, MACROMOL RAPID COMM, V23, P965, DOI 10.1002/1521-3927(200211)23:16<965::AID-MARC965>3.0.CO;2-#
   Shin HS, 1998, J APPL POLYM SCI, V69, P479, DOI 10.1002/(SICI)1097-4628(19980718)69:3<479::AID-APP7>3.0.CO;2-D
   Sun S, 2000, J APPL POLYM SCI, V76, P542, DOI 10.1002/(SICI)1097-4628(20000425)76:4<542::AID-APP12>3.0.CO;2-U
   YUK SH, 1993, J POLYM SCI POL PHYS, V31, P487, DOI 10.1002/polb.1993.090310415
NR 10
TC 20
Z9 20
U1 0
U2 9
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0379-6779
J9 SYNTHETIC MET
JI Synth. Met.
PD DEC 15
PY 2005
VL 155
IS 3
BP 674
EP 676
DI 10.1016/j.synthmet.2005.08.027
PG 3
WC Materials Science, Multidisciplinary; Physics, Condensed Matter; Polymer
   Science
SC Materials Science; Physics; Polymer Science
GA 996PE
UT WOS:000234185700043
DA 2018-10-20
ER

PT J
AU Heller, J
AF Heller, J
TI Ocular delivery using poly(ortho esters)
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE poly(ortho ester); 5-fluorouracil delivery; bioerodible polymer;
   glaucoma; biocompatibility; ophthalmology; injectable polymer
ID GLAUCOMA FILTERING SURGERY; CONTROLLED DRUG-RELEASE; 5-FLUOROURACIL;
   BIOCOMPATIBILITY; BIOMATERIAL; DEGRADATION; POLYMERS
AB Three families of poly(ortho esters) were investigated as a means of delivering 5-fluorouracil (5-FU), an anti proliferative agent used as an adjunct to glaucoma filtering surgery. Release of 5-FU from a crosslinked POE II occurred predominantly by diffusion with little weight loss, while release of 5-FU from a linear polymer occurred by an erosion-controlled process confined predominantly to the surface layers. No ocular biocompatibility studies were carried out. Rate of release of 5-FU from POE III, a viscous, injectable material, could be controlled by polymer molecular weight and polymer hydrophobicity. Excellent biocompatibility was demonstrated in subconjunctival, intravitreal and suprachoroidal injections. Polymer lifetime in the various sites investigated was between I and 3 weeks. The effect of sustained 5-FU release was investigated in rabbits that underwent a trabeculectomy and the effectiveness of maintaining low intraocular pressure for I month demonstrated. Release of 5-FU from POE IV was investigated using both solid and viscous, injectable materials. Good control over rate of 5-FU release by an erosion-controlled process was achieved from both types of formulations. Excellent biocompatibility was demonstrated in subconjunctival, intracameral, intravitreal and suprachoroidal injections. Lifetimes in the various sites ranged from 5 weeks for subconjunctival injections to 3 months for intravitreal injections to more than 6 months for intracameral and suprachoroidal injections. (c) 2005 Elsevier B.V. All rights reserved.
RP Heller, J (reprint author), POB 3519, Ashland, OR 97520 USA.
EM jorgeheller2@aol.com
CR BERNATCHEZ SF, 1994, J BIOMED MATER RES, V28, P1037, DOI 10.1002/jbm.820280908
   BERNATCHEZ SF, 1993, J BIOMED MATER RES, V27, P677, DOI 10.1002/jbm.820270515
   Deshpande AA, 1998, CRIT REV THER DRUG, V15, P381
   Einmahl S, 2002, INVEST OPHTH VIS SCI, V43, P1533
   Einmahl S, 2001, ADV DRUG DELIVER REV, V53, P45, DOI 10.1016/S0169-409X(01)00220-4
   Einmahl S, 2000, J BIOMED MATER RES, V50, P566, DOI 10.1002/(SICI)1097-4636(20000615)50:4<566::AID-JBM12>3.0.CO;2-M
   Einmahl S, 2003, J BIOMED MATER RES A, V67A, P44, DOI 10.1002/jbm.a.10597
   EINMAHL S, 2001, OPHTHALMOL VISUAL SC, V42, P251
   HELLER J, 1985, Journal of Controlled Release, V2, P167, DOI 10.1016/0168-3659(85)90042-2
   HELLER J, 1987, Journal of Controlled Release, V6, P217, DOI 10.1016/0168-3659(87)90078-2
   Heller J, 2000, EUR J PHARM BIOPHARM, V50, P121, DOI 10.1016/S0939-6411(00)00085-0
   HELLER J, 1983, CONTRACEPT DELIV SYS, V4, P43
   Heller J, 2002, ADV DRUG DELIVER REV, V54, P1015, DOI 10.1016/S0169-409X(02)00055-8
   HELLER J, 1981, POLYM ENG SCI, V21, P727, DOI 10.1002/pen.760211117
   HELLER J, 1990, BIOMATERIALS, V11, P235, DOI 10.1016/0142-9612(90)90003-9
   HELLER J, 1993, ADV POLYM SCI, V107, P451
   HELLER J, 1985, J CONTROL RELEASE, V1, P233
   HEUER DK, 1984, OPHTHALMOLOGY, V91, P384
   LEE DA, 1987, OPHTHALMIC SURG LAS, V18, P187
   MAA YF, 1990, J CONTROL RELEASE, V13, P11, DOI 10.1016/0168-3659(90)90070-A
   MERKLI A, 1994, J CONTROL RELEASE, V29, P105, DOI 10.1016/0168-3659(94)90126-0
   Merkli A, 1998, PROG POLYM SCI, V23, P563, DOI 10.1016/S0079-6700(97)00048-8
   Ng SY, 1997, MACROMOLECULES, V30, P770, DOI 10.1021/ma9610626
   Ng SY, 1997, ANN NY ACAD SCI, V831, P168
   Ng SY, 2000, J CONTROL RELEASE, V65, P367, DOI 10.1016/S0168-3659(99)00218-7
   Schwach-Abdellaoui K, 1999, J BIOMAT SCI-POLYM E, V10, P375, DOI 10.1163/156856299X00432
   Sintzel MB, 1997, INT J PHARM, V155, P263, DOI 10.1016/S0378-5173(97)00169-5
   Zignani M, 1997, J CONTROL RELEASE, V48, P115, DOI 10.1016/S0168-3659(97)00050-3
   Zignani M, 2000, BIOMATERIALS, V21, P1773, DOI 10.1016/S0142-9612(00)00065-X
   Zignani M, 2000, EUR J PHARM BIOPHARM, V50, P251, DOI 10.1016/S0939-6411(00)00107-7
NR 30
TC 37
Z9 42
U1 1
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD DEC 13
PY 2005
VL 57
IS 14
BP 2053
EP 2062
DI 10.1016/j.addr.2005.09.007
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 996QD
UT WOS:000234188300006
PM 16289431
DA 2018-10-20
ER

PT J
AU Asberg, AE
   Videm, V
AF Asberg, AE
   Videm, V
TI Activation of neutrophil granulocytes in an in vitro model of a
   cardiopulmonary bypass
SO ARTIFICIAL ORGANS
LA English
DT Article
DE neutrophil; platelet; neutrophil adhesion; polyvinylchloride; plasma
   proteins; complement
ID EXTRACORPOREAL-CIRCULATION; INFLAMMATORY RESPONSE; ADHERENT PLATELETS;
   WHOLE-BLOOD; P-SELECTIN; ADHESION; LACTOFERRIN; COMPLEMENT;
   MYELOPEROXIDASE; EXPRESSION
AB Activated neutrophils play a central role in the pathogenesis of postoperative organ dysfunction after surgery with cardiopulmonary bypass. The researchers used an in vitro roller pump model to investigate the relative importance of the biomaterial, platelets, plasma proteins including activated complement, and flow mode on neutrophil activation as shown by the adhesion, degranulation, and increased the surface expression of CD11b. Neutrophil adhesion to the biomaterial increased with platelet addition, but not with plasma. Biomaterial contact activated neutrophils in a serum-free buffer, but was significantly increased by activated complement. Platelets increased neutrophil degranulation in a serum-free buffer but tended to reduce it in plasma. CD11b expression increased in both media. Complement activation was higher with neutrophils alone than with neutrophils and platelets combined. The roller pump reduced neutrophil adhesion and increased degranulation compared to passive rotation. Neutrophil interaction with platelets and complement were more important for activation than biomaterial contact and use of the roller pump. Improvement of biocompatibility is dependent on modifying complement activation and platelet interaction with neutrophils.
C1 Univ Trondheim Hosp, Dept Immunol & Transfus Med, Trondheim, Norway.
   Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, Trondheim, Norway.
RP Asberg, AE (reprint author), Univ Trondheim Hosp, St Olavs Hosp, Dept Immunol & Transfus Med, N-7006 Trondheim, Norway.
EM ann.asberg@ntnu.no
CR Abbitt KB, 2003, AM J PHYSIOL-HEART C, V285, pH229, DOI 10.1152/ajpheart.00408.2002
   Afeltra A, 1997, CLIN EXP IMMUNOL, V109, P279, DOI 10.1046/j.1365-2249.1997.4351333.x
   Bengtsson T, 1996, BLOOD, V87, P4411
   Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77
   Brandt E, 2000, J LEUKOCYTE BIOL, V67, P471
   Broberg M, 2003, J BIOMED MATER RES A, V66A, P403, DOI 10.1002/jbm.a.10554
   Conover W., 1999, PRACTICAL NONPARAMET
   Deriy LV, 2000, BIOCHEM BIOPH RES CO, V275, P241, DOI 10.1006/bbrc.2000.3284
   Ehlert JE, 2000, BLOOD, V96, P2965
   Gorbet MB, 1999, J BIOMED MATER RES, V44, P289, DOI 10.1002/(SICI)1097-4636(19990305)44:3<289::AID-JBM7>3.0.CO;2-O
   Gorbet MB, 2003, J BIOMED MATER RES A, V67A, P792, DOI 10.1002/jbm.a.10155
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gourlay T, 2001, PERFUSION-UK, V16, P381, DOI 10.1177/026765910101600508
   Grunkemeier JM, 2000, BIOMATERIALS, V21, P2243, DOI 10.1016/S0142-9612(00)00150-2
   Harmand MF, 1999, BIOMATERIALS, V20, P1561, DOI 10.1016/S0142-9612(99)00051-4
   HEGNHOJ J, 1985, SCAND J CLIN LAB INV, V45, P489, DOI 10.3109/00365518509155248
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Laffey JG, 2002, ANESTHESIOLOGY, V97, P215
   Lappegard KT, 2004, ANN THORAC SURG, V77, P932, DOI 10.1016/S0003-4975(03)01519-4
   Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102
   Levy JH, 2003, ANN THORAC SURG, V75, pS715, DOI 10.1016/S0003-4975(02)04701-X
   Ma YQ, 2004, BLOOD, V104, P2549, DOI 10.1182/blood-2004-03-1108
   MAZURIER J, 1994, ADV EXP MED BIOL, V357, P111
   MOLLNES TE, 1995, ARTIF ORGANS, V19, P909, DOI 10.1111/j.1525-1594.1995.tb02450.x
   Mollnes TE, 2002, BLOOD, V100, P1869
   Moreira PD, 2004, J BIOMED MATER RES B, V69B, P38, DOI 10.1002/jbm.b.20028
   Nilsson B, 1998, BLOOD, V92, P1661
   Nygren H, 1997, J LAB CLIN MED, V129, P35, DOI 10.1016/S0022-2143(97)90159-1
   Ortega-Vinuesa JL, 1998, BIOMATERIALS, V19, P251, DOI 10.1016/S0142-9612(97)00206-8
   Rhodes NP, 1996, BIOMATERIALS, V17, P1995, DOI 10.1016/0142-9612(96)00018-X
   SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2
   Tuluc F, 2004, AM J PHYSIOL-CELL PH, V287, pC1264, DOI 10.1152/ajpcell.00177.2004
   Videm V, 1996, SCAND J IMMUNOL, V43, P385, DOI 10.1046/j.1365-3083.1996.d01-57.x
   Wettero J, 2003, BIOMATERIALS, V24, P1559, DOI 10.1016/S0142-9612(02)00543-4
   YEO EL, 1994, BLOOD, V83, P2498
NR 35
TC 11
Z9 12
U1 0
U2 1
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD DEC
PY 2005
VL 29
IS 12
BP 927
EP 936
DI 10.1111/j.1525-1594.2005.00162.x
PG 10
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 985WU
UT WOS:000233410200002
PM 16305648
DA 2018-10-20
ER

PT J
AU Gorbet, MB
   Sefton, MV
AF Gorbet, MB
   Sefton, MV
TI Endotoxin: The uninvited guest
SO BIOMATERIALS
LA English
DT Article
DE endotoxin; biomaterials; cytokines; LPS
ID TUMOR-NECROSIS-FACTOR; CARDIOPULMONARY BYPASS; ADHERENT ENDOTOXIN;
   IN-VITRO; INFLAMMATORY RESPONSE; CYTOKINE PRODUCTION; TITANIUM
   PARTICLES; PROTEIN SOLUTIONS; LIPOPOLYSACCHARIDE; ACTIVATION
AB In the laboratory environment where biomaterials are synthesized and their biocompatibility assessed, we find that endotoxin contamination is hard to avoid and must not be ignored. In those relatively few cases where endotoxin was known to be present, it has been clearly shown that endotoxin call significantly affect the biological response observed and hence confound any effect of the material. This short review explains what endotoxin is, how to test for it and remove it and what its effect on the biological response to biomaterials is. We advocate routine testing of endotoxin on biomaterials and of reagents used in experimental evaluation of biomaterials and this should be the responsibility of every scientist to ensure the validity of any biomaterial study. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
   Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.
   McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
RP Sefton, MV (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, 100 Coll St, Toronto, ON, Canada.
EM sefton@chem-eng.utoronto.ca
CR AKISUE T, 2001, J BIOMED MATER RES, V59, P507
   [Anonymous], 1987, GUID VAL LIM AM LYS, P1
   Bi YM, 2001, J BONE MINER RES, V16, P2082, DOI 10.1359/jbmr.2001.16.11.2082
   Bi YM, 2002, J ORTHOPAED RES, V20, P696, DOI 10.1016/S0736-0266(01)00176-0
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BUTLER J, 1993, ANN THORAC SURG, V55, P552, DOI 10.1016/0003-4975(93)91048-R
   CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001
   CASKO G, 1988, THROMB HAEMOSTASIS, V59, P375
   Cho DR, 2002, J ORTHOPAED RES, V20, P704, DOI 10.1016/S0736-0266(01)00179-6
   Daniels AU, 2000, J BIOMED MATER RES, V49, P469, DOI 10.1002/(SICI)1097-4636(20000315)49:4<469::AID-JBM5>3.3.CO;2-1
   DINARELLO CA, 1993, ANN INTERN MED, V119, P853, DOI 10.7326/0003-4819-119-8-199310150-00013
   Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200
   Gorbet MB, 1999, J BIOMED MATER RES, V44, P289, DOI 10.1002/(SICI)1097-4636(19990305)44:3<289::AID-JBM7>3.0.CO;2-O
   Gorbet MB, 2001, J LAB CLIN MED, V137, P345, DOI 10.1067/mlc.2001.114677
   GORBET MB, 2001, IMPORTANCE PLATELETS, P66
   Greenfield EM, 2005, J BIOMED MATER RES B, V72B, P179, DOI 10.1002/jbm.b.30150
   Hermann C, 2003, J IMMUNOL METHODS, V275, P69, DOI 10.1016/S0022-1759(03)00003-6
   Hirayama C, 2002, J CHROMATOGR B, V781, P419, DOI 10.1016/S1570-0232(02)00430-0
   HIRTHLER M, 1992, J PEDIATR SURG, V27, P1199, DOI 10.1016/0022-3468(92)90787-8
   Hitchins VM, 1999, J BIOMED MATER RES, V46, P434
   Khabar KSA, 1997, CLIN IMMUNOL IMMUNOP, V85, P97, DOI 10.1006/clin.1997.4413
   KHAZAZMI A, 1989, J THORAC CARDIOVASC, V98, P381
   LAUDESHARP M, 1990, KIDNEY INT, V38, P1089, DOI 10.1038/ki.1990.317
   LEMKE HD, 1994, NEPHROL DIAL TRANSPL, V9, P90
   LYNN WA, 1992, IMMUNOL TODAY, V13, P271, DOI 10.1016/0167-5699(92)90009-V
   Nakagawa Y, 2003, J BIOMED MATER RES B, V66B, P347, DOI 10.1002/jbm.b.10020
   NILSSON L, 1990, J THORAC CARDIOV SUR, V100, P777
   OHNO N, 1989, J BIOL CHEM, V264, P4434
   ORRIVE G, 2002, BIOMATERIALS, V23, P3825
   Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x
   PEARSON FC, 1985, BACTERIAL ENDOTOXINS, P251
   Petsch D, 2000, J BIOTECHNOL, V76, P97, DOI 10.1016/S0168-1656(99)00185-6
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   Prins JM, 1998, CLIN EXP IMMUNOL, V114, P215
   Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603
   ROCKE DA, 1987, J THORAC CARDIOV SUR, V93, P832
   ROSS VC, 1985, ENDOTOXINS MED DEVIC, P267
   Ryan J., 2004, CORNING LIFE SCI TEC, P1
   SKOGLUND B, 2000, J BONE JOINT SURG BR, V84, P767
   SONG PI, 2001, INVEST OPHTH VIS SCI, V42, P2687
   Suri RM, 1998, J IMMUNOL METHODS, V214, P149, DOI 10.1016/S0022-1759(98)00048-9
   Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0
   Ung DY, 1999, J BIOMED MATER RES, V46, P324, DOI 10.1002/(SICI)1097-4636(19990905)46:3<324::AID-JBM3>3.0.CO;2-5
   van Schilfgaarde R, 1999, J MOL MED-JMM, V77, P199, DOI 10.1007/s001090050336
   WRIGHT SD, 1991, J EXP MED, V173, P1281, DOI 10.1084/jem.173.5.1281
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
NR 46
TC 150
Z9 153
U1 2
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2005
VL 26
IS 34
BP 6811
EP 6817
DI 10.1016/j.biomaterials.2005.04.063
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 957CW
UT WOS:000231348000001
PM 16019062
DA 2018-10-20
ER

PT J
AU Darrabie, MD
   Kendall, WF
   Opara, EC
AF Darrabie, MD
   Kendall, WF
   Opara, EC
TI Characteristics of poly-L-ornithine-coated alginate microcapsules
SO BIOMATERIALS
LA English
DT Article
DE alginate; microencapsulation; poly-amino acid membrane; physical
   properties
ID MOLECULAR-WEIGHT CUTOFF; MAMMALIAN-CELL CULTURE; MICROENCAPSULATED
   ISLETS; POLYLYSINE MICROCAPSULES; QUANTITATIVE METHOD; TRANSPLANTATION;
   IMMUNOPROTECTION; BIOCOMPATIBILITY; MEMBRANES; RATS
AB Poly-L-Lysine (PLL) is the most widely used biomaterial for providing perm-selectivity in alginate ,microcapsules for islet transplantation. We had previously reported that Poly-L-Ornithine (PLO) is less immunogenic than PLL, and in the present study, we have compared the physical characteristics of PLO- and PLL-coated hollow alginate microcapsules. Microspheres made with 1.5% alginate were divided into 2 groups that were first coated with either 0.1% PLO or PLL, followed by a second coating with 0.25% alginate. After liquefaction of the inner alginate core with sodium citrate, the microcapsules were washed with saline and used for experiments. Pore size exclusion studies were performed with FITC-labeled lectins incubated with encapsulated pig islets followed by examination for fluorescence activity. Mechanical strength was assessed by an osmotic pressure test and by 36h of mechanical agitation of microcapsules with inert soda lime beads. The pore size exclusion limit of microcapsules after 20 min of coating was significantly smaller with PLO. While the mean +/- SEM diameter of PLL-coated microcapsules increased from 718 +/- 17 to 821 +/- 17 mu m(p < 0.05) during 14 days incubation at 37 degrees C, the PLO group did not change in size. Also, PILL group had a higher percentage of broken capsules (52.7 +/- 4.9%) compared to 3.1 +/- 2.05% for PLO capsules (p < 0.0001, n = 6). We conclude that PLO-coated alginate microcapsules are mechanically stronger and provide better perm-selectivity than PLL-coated microcapsules. (c) 2005 Elsevier Ltd. All rights reserved.
C1 IIT, Pritzker Inst Biomed Sci & Engn, Chicago, IL 60616 USA.
   VA Med Ctr, Durham, NC USA.
   Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.
RP Opara, EC (reprint author), IIT, Pritzker Inst Biomed Sci & Engn, Chicago, IL 60616 USA.
EM opara@iit.edu
CR Basta G, 2004, TRANSPL IMMUNOL, V13, P289, DOI 10.1016/j.trim.2004.10.003
   Brissova M, 1996, ANAL BIOCHEM, V242, P104, DOI 10.1006/abio.1996.0435
   BRUNETTI P, 1991, INT J ARTIF ORGANS, V14, P789
   Calafiore R, 1997, TRANSPLANT P, V29, P2126, DOI 10.1016/S0041-1345(97)00260-1
   Ching CD, 2001, ARCH SURG-CHICAGO, V136, P276, DOI 10.1001/archsurg.136.3.276
   Darrabie M, 2001, J BIOMED MATER RES, V54, P396, DOI 10.1002/1097-4636(20010305)54:3<396::AID-JBM120>3.3.CO;2-2
   DeVos P, 1997, DIABETOLOGIA, V40, P262
   DeVos P, 1997, BIOMATERIALS, V18, P273, DOI 10.1016/S0142-9612(96)00135-4
   Dusseault J, 2005, BIOMATERIALS, V26, P1515, DOI 10.1016/j.biomaterials.2004.05.013
   Hobbs HA, 2000, DIABETES, V49, pA111
   Hobbs HA, 2001, J INVEST MED, V49, P572, DOI 10.2310/6650.2001.33722
   HORCHER A, 1994, TRANSPLANT P, V26, P784
   Inaki Y, 1997, NUCL ACIDS S SER, V37, P25
   IWATA H, 1989, DIABETES, V38, P224, DOI 10.2337/diab.38.1.S224
   KENDALL WF, 2001, EXPERT OPIN BIOL TH, V2, P503
   King A, 2001, J BIOMED MATER RES, V57, P374, DOI 10.1002/1097-4636(20011205)57:3<374::AID-JBM1180>3.0.CO;2-L
   KING GA, 1987, BIOTECHNOL PROGR, V3, P231, DOI 10.1002/btpr.5420030407
   Krickhahn M, 2001, Ann Transplant, V6, P48
   LANZA RP, 1992, ENDOCRINOLOGY, V131, P637, DOI 10.1210/en.131.2.637
   LANZA RP, 1995, TRANSPLANTATION, V59, P1486
   Leblond FA, 1996, BIOMATERIALS, V17, P2097, DOI 10.1016/0142-9612(96)00027-0
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   MATTHEW HW, 1993, BIOTECHNOL PROGR, V9, P510, DOI 10.1021/bp00023a010
   Powers AC, 1997, ANN NY ACAD SCI, V831, P208
   Prevost P, 1997, ANN NY ACAD SCI, V831, P344
   RICKER A, 1986, DIABETES, V35, pA61
   SAWHNEY AS, 1992, BIOMATERIALS, V13, P863, DOI 10.1016/0142-9612(92)90180-V
   SCHREZENMEIER J, 1989, TRANSPLANT P, V21, P2730
   Strand BL, 2001, CELL TRANSPLANT, V10, P263, DOI 10.3727/000000001783986800
   Strand BL, 2002, J MICROENCAPSUL, V19, P615, DOI 10.1080/02652040210144243
   Thu B, 1996, BIOMATERIALS, V17, P1031, DOI 10.1016/0142-9612(96)84680-1
   Thu B, 1996, BIOMATERIALS, V17, P1069, DOI 10.1016/0142-9612(96)85907-2
   Van Raamsdonk JM, 2001, J BIOMED MATER RES, V54, P264, DOI 10.1002/1097-4636(200102)54:2<264::AID-JBM14>3.0.CO;2-7
   VANDENBOSSCHE GMR, 1993, BIOTECHNOL BIOENG, V42, P381, DOI 10.1002/bit.260420316
   Yang H, 1997, TRANSPLANTATION, V64, P28, DOI 10.1097/00007890-199707150-00006
NR 35
TC 91
Z9 96
U1 2
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2005
VL 26
IS 34
BP 6846
EP 6852
DI 10.1016/j.biomaterials.2005.05.009
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 957CW
UT WOS:000231348000005
PM 15955558
DA 2018-10-20
ER

PT J
AU Barber, TA
   Harbers, GM
   Park, S
   Gilbert, M
   Healy, KE
AF Barber, TA
   Harbers, GM
   Park, S
   Gilbert, M
   Healy, KE
TI Ligand density characterization of peptide-modified biomaterials
SO BIOMATERIALS
LA English
DT Article
DE peptide; surface analysis; surface modification; IPN; silane
ID SCANNING FORCE MICROSCOPY; SURFACE CHARACTERIZATION; TITANIUM SURFACES;
   CELL-ADHESIVE; IMMOBILIZATION; FLUORESCENCE; ATTACHMENT; SUPPORTS
AB A simple fluorescence based characterization method was developed to assess ligand density on peptide-modified biomaterials. The method exploits the exquisite sensitivity of proteolysis for the purpose of liberating a fluorescently labeled probe fragment from an immobilized peptide. The released fragment can then be detected in solution using high-throughput fluorometry. In silico screening tools identified the enzyme chymotrypsin as a promising candidate for releasing a detectable probe fragment from the fluorescently labeled peptide, Ac-CGGNGEPRGDTYRAYK(FITC)GG-NH2. After chymotrypsin digestion of the peptide in solution was first characterized using mass spectrometry and HPLC, a basic enzyme mediated release protocol was developed and implemented to generate peptide-binding isotherms on various peptide-modified biomaterials. The new method is sensitive, has good signal-to-noise ratio (S/N), and is easily standardized. Furthermore, the technique can be applied independent of material chemistry and geometry, making it a suitable alternative to radiolabeling for a wide range of biomaterial applications. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.
   Northwestern Univ, Dept Biomed Engn, Robert R McCormick Sch Engn & Appl Sci, Evanston, IL 60208 USA.
   Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
RP Healy, KE (reprint author), Univ Calif Berkeley, Dept Mat Sci & Engn, 370 Hearst Mem Min Bldg,MC 1760, Berkeley, CA 94720 USA.
EM kehealy@socrates.berkeley.edu
CR Barber TA, 2003, J BIOMED MATER RES A, V64A, P38, DOI 10.1002/jbm.a.10321
   Bearinger JP, 1998, J BIOMAT SCI-POLYM E, V9, P629, DOI 10.1163/156856298X00064
   Gestwicki JE, 2002, ANAL BIOCHEM, V305, P149, DOI 10.1006/abio.2002.5652
   HARBERS GM, 2005, IN PRESS LANGMUIR
   HEALY KE, 1992, J BIOMED MATER RES, V26, P319, DOI 10.1002/jbm.820260305
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ
   HIEMENZ PC, 1997, PRINCPLES COLLOID ST
   Ho CH, 1996, J MOL RECOGNIT, V9, P444, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<444::AID-JMR281>3.0.CO;2-I
   Keil B, 1987, Protein Seq Data Anal, V1, P13
   Keil B., 1992, SPECIFICITY PROTEOLY
   Kress J, 2002, CHEM-EUR J, V8, P3769, DOI 10.1002/1521-3765(20020816)8:16<3769::AID-CHEM3769>3.0.CO;2-V
   Lakowicz JR., 1999, PRINCIPLES FLUORESCE, P237, DOI DOI 10.1007/978-1-4757-3061-6
   Lehninger AL, 2000, LEHNINGER PRINCIPLES
   Model MA, 2000, J BIOMED MATER RES, V50, P90, DOI 10.1002/(SICI)1097-4636(200004)50:1<90::AID-JBM13>3.0.CO;2-3
   Perrin A, 1998, ANAL BIOCHEM, V256, P200, DOI 10.1006/abio.1997.2493
   Rezania A, 1999, LANGMUIR, V15, P6931, DOI 10.1021/la990024n
   Sittig C, 1999, J MATER SCI-MATER M, V10, P35, DOI 10.1023/A:1008840026907
   VANDERSTRAETEN K, 1999, CUTTER TOOL GENERATE
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   1999, INSTRUCTIONS REACTI, P2
NR 21
TC 30
Z9 31
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2005
VL 26
IS 34
BP 6897
EP 6905
DI 10.1016/j.biomaterials.2005.04.043
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 957CW
UT WOS:000231348000011
PM 16045984
DA 2018-10-20
ER

PT J
AU Nablo, BJ
   Prichard, HL
   Butler, RD
   Klitzman, B
   Schoenfisch, MH
AF Nablo, BJ
   Prichard, HL
   Butler, RD
   Klitzman, B
   Schoenfisch, MH
TI Inhibition of implant-associated infections via nitric oxide
SO BIOMATERIALS
LA English
DT Article
DE Staphylococcus aureus; implant infection; sol-gel; nitric oxide; in vivo
ID SOL-GELS; PREVENTION
AB The in vivo antibacterial activity of nitric oxide (NO)-releasing xerogel coatings was evaluated against an aggressive subcutaneous Staphylococcus aureus infection in a rat model. The NO-releasing implants were created by coating a medical-grade silicone elastomer with a sol-gel-derived (xerogel) film capable of storing NO. Four of the bare or xerogel-coated silicone materials were subcutaneously implanted into male rats. Ten rats were administered 10 mu l of a 10(8) cfu ml(-1) S. aureus colony directly into the subcutaneous pocket with the implant prior to wound closure. Infection was quantitatively and qualitatively evaluated after 8d of implantation with microbiological and histological methods, respectively. A 82% reduction in the number of infected implants was achieved with the NO-releasing coating. Histology revealed that the capsule formation around infected bare silicone rubber controls was immunoactive and that a biofilm may have formed. Capsule formation in response to NO-releasing implants had greater vascularity in comparison with uninoculated or untreated controls. These results suggest that NO-releasing coatings may dramatically reduce the incidence of biomaterial-associated infection. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.
   Duke Univ, Med Ctr, Kenan Plast Surg Res Labs, Durham, NC 27710 USA.
   Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27710 USA.
RP Schoenfisch, MH (reprint author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.
EM schoenfi@email.unc.edu
FU NIBIB NIH HHS [EB000708]
CR An YH, 1996, J HOSP INFECT, V33, P93, DOI 10.1016/S0195-6701(96)90094-8
   Baker DG, 1998, CLIN MICROBIOL REV, V11, P231
   HRABIE JA, 1993, J ORG CHEM, V58, P1472, DOI 10.1021/jo00058a030
   ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W
   Jarvis WR, 1996, INFECT CONT HOSP EP, V17, P552
   Marxer SM, 2003, CHEM MATER, V15, P4193, DOI 10.1021/cm034347n
   Nablo BJ, 2005, BIOMATERIALS, V26, P917, DOI 10.1016/j.biomaterials.2004.03.031
   Nablo BJ, 2004, BIOMACROMOLECULES, V5, P2034, DOI 10.1021/bm049727w
   Nablo BJ, 2003, J BIOMED MATER RES A, V67A, P1276, DOI 10.1002/jbm.a.20030
   Nablo BJ, 2001, J AM CHEM SOC, V123, P9712, DOI 10.1021/ja0165077
   O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49
   Potera C, 1999, SCIENCE, V283, P1837, DOI 10.1126/science.283.5409.1837
   STAMM WE, 1978, ANN INTERN MED, V89, P764, DOI 10.7326/0003-4819-89-5-764
   Williams I, 1999, MICROBIOL-UK, V145, P1325, DOI 10.1099/13500872-145-6-1325
   XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522
NR 15
TC 97
Z9 99
U1 1
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2005
VL 26
IS 34
BP 6984
EP 6990
DI 10.1016/j.biomaterials.2005.05.017
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 957CW
UT WOS:000231348000020
PM 15978663
DA 2018-10-20
ER

PT J
AU Zavan, B
   Brun, P
   Vindigni, V
   Amadori, A
   Habeler, W
   Pontisso, P
   Montemurro, D
   Abatangelo, G
   Cortivo, R
AF Zavan, B
   Brun, P
   Vindigni, V
   Amadori, A
   Habeler, W
   Pontisso, P
   Montemurro, D
   Abatangelo, G
   Cortivo, R
TI Extracellular matrix-enriched polymeric scaffolds as a substrate for
   hepatocyte cultures: in vitro and in vivo studies
SO BIOMATERIALS
LA English
DT Article
DE scaffold; cell morphology; hyaluronic acid; biomaterial; cell culture;
   fibroblast; hepatocyte
ID ALGINATE SCAFFOLDS; TISSUE; CELL; MORPHOLOGY; TRANSPLANTATION;
   METABOLISM; EXPRESSION; VIABILITY; GROWTH
AB Tissue engineering is a promising approach to developing hepatic tissue suitable for the functional replacement of a failing liver. The aim of the present study was to investigate whether an extracellular cell matrix obtained from fibroblasts-cultured within scaffolds of hyaluronic acid (HYAFF (TM)) could influence the proliferation rate and survival of rat hepatocytes both during long-term culture and after in vivo transplantation. Cultures were evaluated by histological and morphological analysis, a proliferation assay and metabolic activity (albumin secretion). Hepatocytes cultured in extracellular matrix-enriched scaffolds exhibited a round cellular morphology and re-established cell-cell contacts, growing into aggregates of several cells along and/or among fibers in the fabric. Hepatocytes were able to secrete albumin up to 14 days in culture. In vivo results demonstrated the biocompatibility of HYAFF-11 (TM) implanted in nude mice, in which hepatocytes maintained small well-organised aggregates until the 35th day. In conclusion, the presence of a fibroblast-secreted extracellular matrix improved the biological properties of the hyaluronan scaffold, favoring the survival and morphological integrity of hepatocytes in vitro and in vivo. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Padua, Dept Histol Microbiol & Med Biotecnol, I-35121 Padua, Italy.
   Univ Padua, Clin Plast Surg, I-35100 Padua, Italy.
   Univ Padua, Dept Oncol & Surg Sci, I-35100 Padua, Italy.
   Univ Padua, Clin Med 5, I-35100 Padua, Italy.
   Univ Padua, Univ Hosp, Dept Clin & Expt Med, I-35100 Padua, Italy.
RP Zavan, B (reprint author), Univ Padua, Dept Histol Microbiol & Med Biotecnol, Viale G Colombo 3, I-35121 Padua, Italy.
EM barbara.zavan@unipd.it
OI Vindigni, Vincenzo/0000-0001-6638-9010
CR Allen JW, 2002, TISSUE ENG, V8, P725, DOI 10.1089/10763270260424097
   BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   BENZEEV A, 1988, P NATL ACAD SCI USA, V85, P2161, DOI 10.1073/pnas.85.7.2161
   Bhandari RNB, 2001, TISSUE ENG, V7, P345, DOI 10.1089/10763270152044206
   Catapano G, 2001, BIOMATERIALS, V22, P659, DOI 10.1016/S0142-9612(00)00228-3
   Chang TMS, 2001, J HEPATOL, V34, P148, DOI 10.1016/S0168-8278(00)00061-1
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   DIPERSIO CM, 1991, MOL CELL BIOL, V11, P4405, DOI 10.1128/MCB.11.9.4405
   Dvir-Ginzberg M, 2003, TISSUE ENG, V9, P757, DOI 10.1089/107632703768247430
   Galassi G, 2000, BIOMATERIALS, V21, P2183, DOI 10.1016/S0142-9612(00)00147-2
   Girotto D, 2003, BIOMATERIALS, V24, P3265, DOI 10.1016/S0142-9612(03)00160-1
   Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2
   Gupta S, 2002, SEMIN CELL DEV BIOL, V13, P439, DOI 10.1016/S1084-9521(02)00132-5
   Gupta S, 1996, Prog Liver Dis, V14, P199
   Gupta Sanjeev, 2002, J Gastroenterol Hepatol, V17 Suppl 3, pS287, DOI 10.1046/j.1440-1746.17.s3.15.x
   Gwak SJ, 2004, BIOTECHNOL LETT, V26, P505, DOI 10.1023/B:BILE.0000019558.99209.84
   Karamuk E, 1999, ARTIF ORGANS, V23, P881, DOI 10.1046/j.1525-1594.1999.06308.x
   KRAMER K, 1993, Z ERNAHRUNGSWISS, V32, P176
   Kulig KM, 2004, TRANSPL IMMUNOL, V12, P303, DOI 10.1016/j.trim.2003.12.005
   Lee Sung-W, 2004, Ann Hepatol, V3, P48
   Li JL, 2003, BIOMATERIALS, V24, P2317, DOI 10.1016/S0142-9612(03)00048-6
   MOONEY D, 1992, J CELL PHYSIOL, V151, P497, DOI 10.1002/jcp.1041510308
   Pavesio Alessandra, 2003, Novartis Found Symp, V249, P203
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   SUN AM, 1987, BIOMATER ARTIF CELL, V15, P483, DOI 10.3109/10731198709118540
   Tonello C, 2003, BIOMATERIALS, V24, P1205, DOI 10.1016/S0142-9612(02)00450-7
   Weiss TS, 2002, CELL PROLIFERAT, V35, P257, DOI 10.1046/j.1365-2184.2002.00248.x
   Zacchi V, 1998, J BIOMED MATER RES, V40, P187, DOI 10.1002/(SICI)1097-4636(199805)40:2<187::AID-JBM3>3.0.CO;2-H
NR 28
TC 53
Z9 63
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2005
VL 26
IS 34
BP 7038
EP 7045
DI 10.1016/j.biomaterials.2005.04.067
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 957CW
UT WOS:000231348000025
PM 15993941
DA 2018-10-20
ER

PT J
AU Smith, E
   Yang, J
   McGann, L
   Sebald, W
   Uludag, H
AF Smith, E
   Yang, J
   McGann, L
   Sebald, W
   Uludag, H
TI RGD-grafted thermoreversible polymers to facilitate attachment of BMP-2
   responsive C2C12 cells
SO BIOMATERIALS
LA English
DT Article
DE thermoreversible polymers; NiPAM; RGD; cell attachment; BMP-2
ID BONE MORPHOGENETIC PROTEIN-2; OSTEOBLASTIC DIFFERENTIATION; ADHESION;
   CULTURE; BIOMATERIAL; EXPRESSION; DETACHMENT; HYDROGELS; PEPTIDES;
   BEHAVIOR
AB The purpose of this study was to design thermoreversible biomaterials for enhanced adhesion of bone morphogenctic protein-2 (BMP-2)-responsive cells. Peptides containing the arginine-glycine-aspartic acid (RGD) sequence were conjugated to N-isopropylacrylamide (NiPAM) polymers via amine-reactive N-acryloxysuccinimide (NASI) groups. In monolayer cultures, the adhesion of BMP-2-responsive C2C12 cells to RGD-grafted NiPAM/NASI surfaces was significantly higher than adhesion on ungrafted NiPAM/NASI surfaces. Although the morphology of cells adhered to RGD-grafted NiPAM/NASI surfaces was comparable to cells adhered on tissue culture polystyrene (TCPS), long-term cell growth was limited on the NiPAM/NASI surfaces, even for RGD-grafted surfaces. Treatment of C2C12 cells with recombinant BMP-2 induced dose-dependent osteoblastic differentiation as assessed by alkaline phosphatase (ALP) activity. In the absence of BMP-2, cells cultured on NiPAM/NASI polymers (either grafted with RGD peptide or not) expressed significantly higher levels of ALP activity than the cells cultured on TCPS, indicating that the polymer surfaces induced some osteoblastic activity in C2C12 cells without the need for BMP-2. We conclude that NiPAM-based thermoreversible biomaterials, despite their limited ability to support cell growth, allowed an enhanced expression of the chosen osteogenic marker (ALP) by C2C12 cells in vitro. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB T6G 2G6, Canada.
   Univ Alberta, Dept Biomed Engn, Edmonton, AB T6G 2G6, Canada.
   Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB T6G 2G6, Canada.
   Univ Wurzburg, Theodor Boveri Inst Biowissensch, Biozentrum, Wurzburg, Germany.
RP Uludag, H (reprint author), Univ Alberta, Dept Chem & Mat Engn, 526 Chem & Mat Engn Bldg, Edmonton, AB T6G 2G6, Canada.
EM hasan.uludag@ualberta.ca
CR Chalaux E, 1998, J BIOL CHEM, V273, P537, DOI 10.1074/jbc.273.1.537
   Chen GP, 1998, J BIOMED MATER RES, V42, P38, DOI 10.1002/(SICI)1097-4636(199810)42:1<38::AID-JBM6>3.0.CO;2-P
   Collier TO, 2002, J BIOMED MATER RES, V59, P136, DOI 10.1002/jbm.1225
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Gao TJ, 2002, TISSUE ENG, V8, P429, DOI 10.1089/107632702760184691
   Gao TJ, 2001, J BIOMED MATER RES, V57, P92, DOI 10.1002/1097-4636(200110)57:1<92::AID-JBM1146>3.0.CO;2-1
   Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314
   Kwon OH, 2000, J BIOMED MATER RES, V50, P82, DOI 10.1002/(SICI)1097-4636(200004)50:1<82::AID-JBM12>3.3.CO;2-Z
   Lai CF, 2000, J BIOL CHEM, V275, P36400, DOI 10.1074/jbc.M002131200
   Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000
   Lian J, 1999, PRIMER METABOLIC BON, P14
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   Nishimura R, 1998, J BIOL CHEM, V273, P1872, DOI 10.1074/jbc.273.4.1872
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   ROLLASON G, 1993, BIOMATERIALS, V14, P153, DOI 10.1016/0142-9612(93)90230-Y
   ROSEN V, 1994, J BONE MINER RES, V9, P1759
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Shin CS, 2000, J CELL BIOCHEM, V78, P566, DOI 10.1002/1097-4644(20000915)78:4<566::AID-JCB6>3.0.CO;2-K
   Smith E, 2003, J POLYM SCI POL CHEM, V41, P3989, DOI 10.1002/pola.10965
   Stile RA, 2001, BIOMACROMOLECULES, V2, P185, DOI 10.1021/bm0000945
   Suzawa M, 2002, J BONE MINER RES, V17, P240, DOI 10.1359/jbmr.2002.17.2.240
   Trippel SB, 1996, J BONE JOINT SURG AM, V78A, P1272, DOI 10.2106/00004623-199608000-00020
   ULUDAG H, 1990, BIOMATERIALS, V11, P708, DOI 10.1016/0142-9612(90)90032-L
   Uludag H, 2003, MATERIALWISS WERKST, V34, P1076, DOI 10.1002/mawe.200300713
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 2000, J APPL POLYM SCI, V75, P583, DOI 10.1002/(SICI)1097-4628(20000124)75:4<583::AID-APP15>3.0.CO;2-L
   ULUDAG H, 2000, DRUG DELIVERY 21 CEN, V752, P253
   von Recum HA, 1998, J BIOMED MATER RES, V40, P631
NR 33
TC 44
Z9 45
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2005
VL 26
IS 35
BP 7329
EP 7338
DI 10.1016/j.biomaterials.2005.05.060
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 962RP
UT WOS:000231750200014
PM 16019067
DA 2018-10-20
ER

PT J
AU Gilbert, V
   Rouabhia, M
   Wang, HX
   Arnould, AL
   Remondetto, G
   Subirade, M
AF Gilbert, V
   Rouabhia, M
   Wang, HX
   Arnould, AL
   Remondetto, G
   Subirade, M
TI Characterization and evaluation of whey protein-based biofilms as
   substrates for in vitro cell cultures
SO BIOMATERIALS
LA English
DT Article
DE whey proteins; biofilms; cell culture
ID WATER-VAPOR PERMEABILITY; BETA-LACTOGLOBULIN GELS; ENGINEERED HUMAN
   SKIN; EUDRAGIT-E FILMS; MECHANICAL-PROPERTIES; ADHESION STRENGTH;
   N-ETHYLMALEIMIDE; GELATIN FILMS; EDIBLE FILMS; DNA-DAMAGE
AB Whey proteins-based biofilms were prepared using different plasticizers in order to obtain a biomaterial for the human keratinocytes and fibroblasts in vitro culture. The film properties were evaluated by Fourier Transform Infrared Spectroscopy (FTIR) technique and mechanical tests. A relationship was found between the decrease of intermolecular hydrogen bond strength and film mechanical behavior changes, expressed by a breaking stress and Young modulus values diminishing. These results allow stating that the film molecular configuration could induce dissimilarities in its mechanical properties. The films toxicity was assessed by evaluating the cutaneous cells adherence, growth, proliferation and structural stratification. Microscopic observation demonstrated that both keratinocytes and fibroblasts adhered to the biofilms. The trypan blue exclusion test showed that keratinocytes grew at a significantly high rate on all the biofilms. Structural analysis demonstrated that keratinocytes stratified when cultured on the whey protein-based biofilms and gave rise to multi-layered epidermal structures. The most organized epidermis was obtained with whey protein isolate/DEG biofilm. This structure had a well-organized basal layer under supra-basal and corneous layers. This study demonstrated that whey proteins, an inexpensive renewable resource which can be obtained readily, were nontoxic to cutaneous cells and thus they could be useful substrates for a variety of biomedical applications, including tissue engineering. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Laval, Ctr Rech, INAF, STELA,Chaire Rech Canada Prot Biosyst & Aliments, Ste Foy, PQ G1K 7P4, Canada.
   CHUQ, Hop St Francois Assise, Inst Biomat, Unite Biotechnol, Quebec City, PQ G1L 3L5, Canada.
   Univ Laval, GREB, Fac Med Dent, Ste Foy, PQ G1K 7P4, Canada.
RP Subirade, M (reprint author), Univ Laval, Ctr Rech, INAF, STELA,Chaire Rech Canada Prot Biosyst & Aliments, Ste Foy, PQ G1K 7P4, Canada.
EM muriel.subirade@aln.ulaval.ca
CR Amiot J, 2004, INT DAIRY J, V14, P619, DOI 10.1016/j.idairyj.2003.11.007
   Balcells M, 2002, J CELL PHYSIOL, V191, P155, DOI 10.1002/jcp.10087
   Beaulieu L, 2002, BIOMACROMOLECULES, V3, P239, DOI 10.1021/bm010082z
   Bigi A, 1998, BIOMATERIALS, V19, P739, DOI 10.1016/S0142-9612(97)00194-4
   Bigi A, 1998, BIOMATERIALS, V19, P2335, DOI 10.1016/S0142-9612(98)00149-5
   Bissonauth V, 2000, CLIN CANCER RES, V6, P4128
   BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307
   Choi YS, 1999, BIOMATERIALS, V20, P409, DOI 10.1016/S0142-9612(98)00180-X
   DUFOUR E, 1990, PROTEIN ENG, V4, P185, DOI 10.1093/protein/4.2.185
   Elisseeff JH, 2002, ANN NY ACAD SCI, V961, P118, DOI 10.1111/j.1749-6632.2002.tb03062.x
   Fairley P, 1996, J AGR FOOD CHEM, V44, P3789, DOI 10.1021/jf9601731
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Fujisato T, 1996, BIOMATERIALS, V17, P155, DOI 10.1016/0142-9612(96)85760-7
   Gaussier H, 2003, APPL ENVIRON MICROB, V69, P6777, DOI 10.1128/AEM.69.11.6777-6784.2003
   JACKSON M, 1992, BIOCHIM BIOPHYS ACTA, V1118, P139, DOI 10.1016/0167-4838(92)90141-Y
   Kilara A, 2003, CRIT REV FOOD SCI, V43, P607, DOI 10.1080/10408690390251138
   KITSIOU PV, 2003, AM J PHYSIOL-RENAL, V284, P671
   Korhonen H, 2003, AUST J DAIRY TECHNOL, V58, P129
   Lefevre T, 2003, J COLLOID INTERF SCI, V263, P59, DOI 10.1016/S0021-9797(03)00252-2
   Lefevre T, 2000, BIOPOLYMERS, V54, P578, DOI 10.1002/1097-0282(200012)54:7<578::AID-BIP100>3.0.CO;2-2
   LEFEVRE T, 2001, BIOCHIM BIOPHYS ACTA, V15, P37
   LIN SY, 1995, J CONTROL RELEASE, V33, P375, DOI 10.1016/0168-3659(94)00109-8
   LIN SY, 1991, PHARMACEUT RES, V8, P1137, DOI 10.1023/A:1015850301214
   MCHUGH TH, 1994, J FOOD SCI, V59, P416, DOI 10.1111/j.1365-2621.1994.tb06980.x
   MCHUGH TH, 1994, J AGR FOOD CHEM, V42, P839
   Mostefaoui Y, 2002, J CLIN PERIODONTOL, V29, P1035, DOI 10.1034/j.1600-051X.2002.291109.x
   MULVIHILL DM, 1991, J FOOD SCI, V56, P1338, DOI 10.1111/j.1365-2621.1991.tb04767.x
   NELSON JW, 1989, BIOCHEMISTRY-US, V28, P5256, DOI 10.1021/bi00438a050
   Ochoa ER, 2002, ANN NY ACAD SCI, V979, P10, DOI 10.1111/j.1749-6632.2002.tb04863.x
   Paquet I, 1996, J CELL PHYSIOL, V166, P296, DOI 10.1002/(SICI)1097-4652(199602)166:2<296::AID-JCP7>3.0.CO;2-K
   Ragona L, 1999, BIOPOLYMERS, V49, P441, DOI 10.1002/(SICI)1097-0282(199905)49:6<441::AID-BIP2>3.0.CO;2-A
   REMONDETTO G, 2003, BIOPOLYMERS, V69, P469
   ROUABHIA M, 1989, THYMUS, V14, P205
   Rouabhia M, 2002, PHOTOCH PHOTOBIO SCI, V1, P471, DOI 10.1039/b107894c
   Subirade M, 1998, INT J BIOL MACROMOL, V23, P241, DOI 10.1016/S0141-8130(98)00052-X
   SUBIRADE M, 1995, BIOPHYS J, V69, P974, DOI 10.1016/S0006-3495(95)79971-4
   SUBIRADE M, 2001, P INT S CONTR REL BI, P591
   Wilson SH, 2003, INVEST OPHTH VIS SCI, V44, P1704, DOI 10.1167/iovs.02-0773
NR 38
TC 26
Z9 28
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2005
VL 26
IS 35
BP 7471
EP 7480
DI 10.1016/j.biomaterials.2005.05.085
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 962RP
UT WOS:000231750200028
PM 16023713
DA 2018-10-20
ER

PT J
AU Garcia, AJ
AF Garcia, AJ
TI Get a grip: integrins in cell-biomaterial interactions
SO BIOMATERIALS
LA English
DT Article
DE integrins; cell adhesion; extracellular matrix; signaling; inflammation;
   biomimetic materials; RGD
ID IN-VIVO; SURFACE-CHEMISTRY; EXTRACELLULAR-MATRIX; MEDIATE ADHESION;
   DIFFERENTIATION; FIBRONECTIN; RGD; BINDING; PROLIFERATION; MODULATION
AB Integrin adhesion receptors have emerged as central regulators of cell-biomaterial interactions. This opinion paper discusses how integrins control cellular and host responses to biornaterials and new strategies to manipulate these adhesive interactions in order to elicit specific cellular responses. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Georgia Inst Technol, Petit Inst Bioengn & Biosci, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Petit Inst Bioengn & Biosci, Woodruff Sch Mech Engn, 315 Ferst Dr, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
CR Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Broberg M, 2002, J LAB CLIN MED, V139, P163, DOI 10.1067/mlc.2002.121604
   Chavakis T, 2005, BLOOD, V105, P1036, DOI 10.1182/blood-2004-01-0166
   Collier TO, 2002, J BIOMED MATER RES, V60, P487, DOI 10.1002/jbm.10043
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   Danen EHJ, 2003, J PATHOL, V201, P632, DOI 10.1002/path.1472
   Eid K, 2001, J BIOMED MATER RES, V57, P224, DOI 10.1002/1097-4636(200111)57:2<224::AID-JBM1162>3.0.CO;2-F
   Elmengaard B, 2005, BIOMATERIALS, V26, P3521, DOI 10.1016/j.biomaterials.2004.09.039
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Gorbet MB, 2003, J BIOMED MATER RES A, V67A, P792, DOI 10.1002/jbm.a.10155
   Hong YJ, 2004, AM J CARDIOL, V94, P1050, DOI 10.1016/j.amjcard.2004.06.066
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   HUHTALA P, 1995, J CELL BIOL, V129, P867, DOI 10.1083/jcb.129.3.867
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Kao WYJ, 2001, BIOMATERIALS, V22, P2901, DOI 10.1016/S0142-9612(01)00037-0
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Li FF, 2003, P NATL ACAD SCI USA, V100, P15346, DOI 10.1073/pnas.2536767100
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   Mostafavi-Pour Z, 2003, J CELL BIOL, V161, P155, DOI 10.1083/jcb.200210176
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Reyes CD, 2004, J BIOMED MATER RES A, V69A, P591, DOI 10.1002/jbm.a.30034
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Shen MC, 2004, J BIOMED MATER RES A, V70A, P533, DOI 10.1002/jbm.a.30069
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Tate MC, 2004, MOL CELL NEUROSCI, V27, P22, DOI 10.1016/j.men.2004.05.001
   Vreeland WN, 2002, CURR OPIN BIOTECH, V13, P87, DOI 10.1016/S0958-1669(02)00292-6
   Wehrle-Haller B, 2003, J PATHOL, V200, P481, DOI 10.1002/path.1399
   Yu XJ, 2003, TISSUE ENG, V9, P421, DOI 10.1089/107632703322066606
NR 35
TC 195
Z9 199
U1 3
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2005
VL 26
IS 36
BP 7525
EP 7529
DI 10.1016/j.biomaterials.2005.05.029
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 966AK
UT WOS:000231991800001
PM 16002137
DA 2018-10-20
ER

PT J
AU Bosetti, M
   Lloyd, AW
   Santin, M
   Denyer, SP
   Cannas, M
AF Bosetti, M
   Lloyd, AW
   Santin, M
   Denyer, SP
   Cannas, M
TI Effects of phosphatidylserine coatings on titanium on inflammatory cells
   and cell-induced mineralisation in vitro
SO BIOMATERIALS
LA English
DT Article
DE mineralisation; phosphatidylserine; titanium; inflammation
ID OSTEOBLAST RESPONSE; CALCIFICATION; SURFACES; BIOMINERALIZATION
AB Ideally an active bone biomaterial should increase the mineralisation rate at the bone healing sites, keeping at the same time the inflammation process to levels required for tissue regeneration. Our studies suggest that in addition to improving the nucleation process for new bone formation, coating titanium with phospholipids may reduce the inflammatory response, which was shown to vary depending on the formulation employed. As phosphatidylserine reduced the inflammatory response to the greatest extent, in the second part of this study we examined its effect on osteoblast mineralisation. These studies demonstrated that phosphatidylserine improves the nucleation process for bone formation, by promoting the formation of bone-like tissue, so the high mineralisation potential of phosphatidylserine-coated titanium, together with the lower level of inflammatory response, supports the further development of this technology for coating osteointegrative devices. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Eastern Piedmont, Dept Med Sci, Novara, Italy.
   Univ Eastern Piedmont, Dept Chem Alimentar & Pharmacol Sci, Novara, Italy.
   Brighton Univ, Sch Pharm & Biomol Sci, Biomed Mat Res Grp, Brighton, E Sussex, England.
RP Cannas, M (reprint author), Univ Eastern Piedmont, Dept Med Sci, Novara, Italy.
EM cannas@med.unipmn.it
RI Lloyd, Andrew/D-1369-2011
OI Lloyd, Andrew/0000-0003-2778-8195; Bosetti, Michela/0000-0002-3682-8702
CR Bosetti M, 2001, BIOMATERIALS, V22, P987, DOI 10.1016/S0142-9612(00)00264-7
   Boskey AL, 1996, CALCIFIED TISSUE INT, V58, P45, DOI 10.1007/BF02509545
   BRAUN G, 1995, CLIN ORAL IMPLAN RES, V6, P1, DOI 10.1034/j.1600-0501.1995.060101.x
   Camolezi FL, 2002, INT J BIOCHEM CELL B, V34, P1091, DOI 10.1016/S1357-2725(02)00029-8
   EANES ED, 1992, BONE MINER, V17, P269, DOI 10.1016/0169-6009(92)90749-4
   EANES ED, 1987, CALCIFIED TISSUE INT, V40, P43, DOI 10.1007/BF02555727
   Hale LV, 2000, CALCIFIED TISSUE INT, V67, P80, DOI 10.1007/s00223001101
   Hoshi K, 2000, CALCIFIED TISSUE INT, V66, P430, DOI 10.1007/s002230010087
   Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI11638
   Letellier SR, 1998, BBA-GEN SUBJECTS, V1380, P31, DOI 10.1016/S0304-4165(97)00121-9
   Murphy WL, 2000, POLYHEDRON, V19, P357, DOI 10.1016/S0277-5387(99)00366-6
   Porter RM, 2003, J CELL BIOCHEM, V90, P13, DOI 10.1002/jcb.10592
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   RHYSWILLIAMS W, 1999, Patent No. 0020547
   Satsangi A, 2003, BIOMATERIALS, V24, P4585, DOI 10.1016/S0142-9612(03)00330-2
   Satsangi N, 2004, J MATER SCI-MATER M, V15, P693, DOI 10.1023/B:JMSM.0000030211.32655.80
   Sela J, 2000, CRIT REV ORAL BIOL M, V11, P423, DOI 10.1177/10454411000110040301
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420
   VOGEL JJ, 1976, CLIN ORTHOP RELAT R, P230
NR 20
TC 18
Z9 20
U1 2
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2005
VL 26
IS 36
BP 7572
EP 7578
DI 10.1016/j.biomaterials.2005.05.033
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 966AK
UT WOS:000231991800007
PM 16005956
DA 2018-10-20
ER

PT J
AU Singanan, M
   Abebaw, A
   Vinodhini, S
AF Singanan, M
   Abebaw, A
   Vinodhini, S
TI Removal of lead tons from industrial waste water by using biomaterials -
   A novel method
SO BULLETIN OF THE CHEMICAL SOCIETY OF ETHIOPIA
LA English
DT Article
DE removal of lead ions; industrial wastewater; biomaterial; Tridax
   procumbens (Asteraceae)
ID IONS; ADSORPTION
AB A simple cost effective and eco-friendly method for the remediation of lead from industrial wastewater has been investigated. A novel biomaterial, Tridax procumbens (Asteraceae) a medicinal plant, was used for the removal of lead ions from synthetic wastewater and the method was also applied for real sample analysis. The operational pH of the experimental solution was fixed as 4.5. The optimum amount of bioadsorbent was 3.5 g. The Pb(II) ions removal efficiency of the raw bioadsorbent was also determined. The removal efficiency of the activated carbon of the bioadsorbent was excellent. 98 % removal of Pb(II) ions was achieved at the dose rate of 3.5 g. The optimum contact time was estimated to be 160 minutes.
C1 Jimma Univ, Dept Appl Chem, Ambo Coll, Ambo Town, Western Shoa, Ethiopia.
RP Singanan, M (reprint author), Jimma Univ, Dept Appl Chem, Ambo Coll, POB 19, Ambo Town, Western Shoa, Ethiopia.
EM mssinganan@yahoo.co.in
CR Akhtar S, 1997, ADSORPT SCI TECHNOL, V15, P815, DOI 10.1177/026361749701501007
   Amritphale SS, 1999, MAIN GROUP MET CHEM, V22, P557
   BHATIA A, 2003, P INT C WAT ENV WE 2, P299
   CHANDRA N, 2003, P INT C WAT ENV WE 2, P125
   Ho YS, 1999, WATER RES, V33, P578, DOI 10.1016/S0043-1354(98)00207-3
   KEITH LH, 1979, ENVIRON SCI TECHNOL, V13, P416, DOI 10.1021/es60152a601
   MACKAY G, 1982, J APPL POLYM SCI, V27, P3043
   MAITY S, 2003, P INT C WAT ENV WE 2, P324
   Mier MV, 2001, WATER RES, V35, P373
   Prasad M, 2000, SEPAR SCI TECHNOL, V35, P2431, DOI 10.1081/SS-100102347
   Reddad Z, 2002, ENVIRON SCI TECHNOL, V36, P2067, DOI 10.1021/es0102989
   Renner Rebecca, 1995, Environmental Science and Technology, V29, P256
   SHIBI IG, 2003, P INT C WAT ENV WE 2, P169
   SINGANAN M, 2003, P INT C WAT ENV WE 2, P45
   STEPHEN IB, 2003, P INT C WAT ENV WE 2, P22
   *WHO, 1984, RECOMMENDATIONS, V1, P81
   ZHONGMING L, 1998, ENVIRON SCI TECHNOL, V32, P394
NR 17
TC 4
Z9 4
U1 0
U2 3
PU CHEM SOC ETHIOPIA
PI ADDIS ABABA
PA PO BOX 32934, ADDIS ABABA, ETHIOPIA
SN 1011-3924
J9 B CHEM SOC ETHIOPIA
JI Bull. Chem. Soc. Ethiop.
PD DEC
PY 2005
VL 19
IS 2
BP 289
EP 294
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 988GD
UT WOS:000233579500014
DA 2018-10-20
ER

PT J
AU Lin, Y
   Li, HB
   Huang, JT
   Zeng, S
AF Lin, Y
   Li, HB
   Huang, JT
   Zeng, S
TI Following the fate of murine epidermal stem cells in a syngeneic dermal
   equivalent in vivo
SO BURNS
LA English
DT Article
DE biomaterial; cell surface marker; dermal appendage; dermal equivalent;
   stem cell
ID SKIN-EQUIVALENT; GROWTH-FACTOR; EXPRESSION; TISSUE; MECHANISMS;
   PLACENTA; SCAFFOLD; VITRO
AB Background: Stem cells in healthy epidermis have the capacity to produce structures, such as interfollicular epidermis, hair follicle, and sebaceous glands. Embryonic stem (ES) cells can be induced to differentiate into epidermal stem cells in vitro. These ESCs (epidermal or epidermoid stem cells derived from ES cells) have the potential to be an ideal replacement of those stem cells destroyed in severe injury, such as in deep and extensive burn. The aim of this study was to follow the fate of murine ESCs which were seeded in a syngeneic dermal equivalent and implanted into syngeneic recipient mice subcutaneously.
   Methods: ES cells were induced in vitro to differentiate into ESCs. Stained with a fluorescent dye Hoechst 33342, these ESCs were seeded into a fibroblast-collagen-gelatin sponge complex, functioning as a dermal equivalent model, and then implanted subcutaneously into 129/J mice, which were syngeneic to these stem cells.
   Results: These ESCs were clearly visible in the implant by fluorescent microscopy 3 weeks or longer after implantation. These cells remained viable, differentiating into hair follicle-like structures, glandular structures, and gave rise to additional structures resembling native dermis. A number of markers were expressed in the differentiated structures, including CD29 (integrin beta 1 subunit) and cytokeratin 18 (CK18). No apparent rejection or severe side effects were observed at least during the 10 weeks following implantation. Conclusions: Now that ESCs can survive in vivo in this dermal equivalent model and differentiate into hair follicle-like structures as well as glandular structures, it is feasible to use these cells as seed cells in studies to fabricate dermal equivalents that have the potential to develop dermal appendages.
   Conclusions: Now that ESCs can survive in vivo in this dermal equivalent model and differentiate into hair follicle-like structures as well as glandular structures, it is feasible to use these cells as seed cells in studies to fabricate dermal equivalents that have the potential to develop dermal appendages. (c) 2005 Elsevier Ltd and ISBI. All rights reserved.
C1 Zhongshan Univ, Coll Med, Dept Histol & Embryol, Guangzhou 510080, Peoples R China.
   Jinan Univ, Inst Tissue Transplantat & Immunol, Guangzhou 510632, Peoples R China.
RP Lin, Y (reprint author), Zhongshan Univ, Coll Med, Dept Histol & Embryol, Guangzhou 510080, Peoples R China.
EM yilinonline@21cn.com
CR BELL E, 1981, SCIENCE, V211, P1052, DOI 10.1126/science.7008197
   BRY K, 1995, J SOC GYNECOL INVEST, V2, P167
   Cheung CY, 1999, J SOC GYNECOL INVEST, V6, P179, DOI 10.1016/S1071-5576(99)00016-7
   Coraux C, 2003, CURR BIOL, V13, P849, DOI 10.1016/S0960-9822(03)00296-3
   Dalcik H, 2001, ACTA HISTOCHEM, V103, P195, DOI 10.1078/0065-1281-00580
   Dunnwald M, 2001, EXP DERMATOL, V10, P45, DOI 10.1034/j.1600-0625.2001.100106.x
   Duplan-Perrat F, 2000, J INVEST DERMATOL, V114, P365, DOI 10.1046/j.1523-1747.2000.00885.x
   Huttmann A, 2001, EXP HEMATOL, V29, P1109, DOI 10.1016/S0301-472X(01)00684-1
   JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K
   Knoeller S, 2003, AM J REPROD IMMUNOL, V50, P41, DOI 10.1034/j.1600-0897.2003.00046.x
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634
   Michel M, 1996, J CELL SCI, V109, P1017
   Niemann C, 2002, TRENDS CELL BIOL, V12, P185, DOI 10.1016/S0962-8924(02)02263-8
   O'Shaughnessy RFL, 2001, SKIN PHARMACOL APPL, V14, P350, DOI 10.1159/000056368
   Ojeh NO, 2001, TISSUE ENG, V7, P457, DOI 10.1089/10763270152436508
   PRENTO P, 1993, HISTOCHEMISTRY, V99, P163, DOI 10.1007/BF00571877
   Socie G, 2003, BLOOD, V101, P3373, DOI 10.1182/blood-2002-07-2231
   Spector M, 2002, TISSUE ENG, V8, P351, DOI 10.1089/107632702760184628
   Svensjo T, 2002, TRANSPLANTATION, V73, P1033, DOI 10.1097/00007890-200204150-00004
   Tanaka R, 2001, J APPL PHYSIOL, V91, P2314
   YANG Y, 2001, DIFFERENTIATION, V68, P270
   Zakar T, 1998, BBA-LIPID LIPID MET, V1391, P37, DOI 10.1016/S0005-2760(97)00195-1
NR 23
TC 4
Z9 8
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0305-4179
J9 BURNS
JI Burns
PD DEC
PY 2005
VL 31
IS 8
BP 1007
EP 1012
DI 10.1016/j.burns.2005.06.020
PG 6
WC Critical Care Medicine; Dermatology; Surgery
SC General & Internal Medicine; Dermatology; Surgery
GA 993HO
UT WOS:000233945400012
PM 16288965
DA 2018-10-20
ER

PT J
AU Delong, L
   Sheng, M
   Wei, Z
   Du, QG
   Li, G
   Liu, JF
   Bakos, D
AF Delong, L
   Sheng, M
   Wei, Z
   Du, QG
   Li, G
   Liu, JF
   Bakos, D
TI Immobilization of biomacromolecules on poly-L-lactide surface via a
   layer-by-layer method for the improving of its cytocompatibility to bone
   marrow stromal cells
SO CHINESE SCIENCE BULLETIN
LA English
DT Article
DE poly-L-lactide; hyaluronic acid; chitosan; surface modification;
   biomaterial
ID COVALENT IMMOBILIZATION; TISSUE; DIFFERENTIATION; DEPOSITION; CHITOSAN;
   POLYELECTROLYTES; BIOMATERIALS; CULTURES; MATRIX; TOOL
AB Hyaluronic acid (HA) and chitosan (CS) were immobilized on the surface of poly-L-lactide (PLLA) by the following procedure: Firstly, PLLA was aminolyzed with 1, 6-hexanediamine, and part of the PLLA surface ester groups were converted to free amino groups. Then negatively charged hyaluronic acid and positively charged chitosan were deposited onto the surface of aminolyzed PLLA film in a layer-by-layer assembly manner. The effect of the layer-by-layer deposition was evaluated by ATR-FTIR spectroscopy, Raman spectroscopy and static contact angle measurements. The cytocompatibility of PLLA sample to bone marrow stromal cells (BMSCs) was improved after modification with chitosan and HA. The cell attachment, activity, and proliferation on CS/RA modified PLLA films were enhanced comparing with the control. The cells cultured on the modified PLLA samples excreted abundant cytoplasm and can differentiate to vascular smooth muscle (SM)-like (SM-like) cells. A macroporous three-dimensional PLLA scaffold was prepared by integrating both the technique of freeze-drying and particle leaching. Layer-by-layer modification by HA/CS and cell culture was also applied on this scaffold. The scaffold cultured with BMSCs for 2 weeks has been teste successfully in vivo as a patch for repairing the artificial incision on canine pulmonary artery.
C1 Fudan Univ, Dept Macromol Sci, Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
   Shanghai Med Ctr Children, Shanghai 200127, Peoples R China.
   Slovak Univ Technol Bratislava, Fac Chem & Food Technol, Bratislava, Slovakia.
RP Wei, Z (reprint author), Fudan Univ, Dept Macromol Sci, Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
EM weizhong@fudan.edu.cn
RI Meng, Sheng/E-1126-2012
OI Meng, Sheng/0000-0001-9191-9175
CR Chen W, 1997, MACROMOLECULES, V30, P78, DOI 10.1021/ma961096d
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   DECHER G, 1997, SCIENCE, V277, P5330
   GALMICHE MC, 1993, BLOOD, V82, P66
   Groth T, 2004, ANGEW CHEM INT EDIT, V43, P926, DOI 10.1002/anie.200301708
   Hou Q, 2003, J CONTROL RELEASE, V87, P304
   Hsieh MC, 1997, MACROMOLECULES, V30, P8453, DOI 10.1021/ma971196z
   Huang L, 2003, J BIOMED MATER RES A, V66A, P880, DOI 10.1002/jbm.a.10535
   Kashiwakura Y, 2003, CIRCULATION, V107, P2078, DOI 10.1161/01.CIR.0000070082.64414.B5
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Laurencin CT, 1996, J BIOMED MATER RES, V30, P133, DOI 10.1002/(SICI)1097-4636(199602)30:2<133::AID-JBM1>3.0.CO;2-S
   Margarett D.M.E., 1998, J BIOMED MATER RES, V40, P621
   MILOS AG, 1994, POLYMER, V35, P1068
   MUZZARELLI RAA, 1993, BIOMATERIALS, V14, P925, DOI 10.1016/0142-9612(93)90134-N
   Nerem RM, 2001, ANNU REV BIOMED ENG, V3, P225, DOI 10.1146/annurev.bioeng.3.1.225
   RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
   WILLIAMS RA, 1994, BIOSENS BIOELECTRON, V9, P159, DOI 10.1016/0956-5663(94)80108-8
   Yang Y, 2002, BIOMATERIALS, V23, P2119, DOI 10.1016/S0142-9612(01)00342-8
   Yaylaoglu MB, 1999, BIOMATERIALS, V20, P711, DOI 10.1016/S0142-9612(98)00199-9
   Yoo D, 1998, MACROMOLECULES, V31, P4309, DOI 10.1021/ma9800360
   ZHANG XC, 1992, POLYM BULL, V27, P623, DOI 10.1007/BF00297431
   Zhu AP, 2002, BIOMATERIALS, V23, P4657, DOI 10.1016/S0142-9612(02)00215-6
   Zhu YB, 2003, BIOMACROMOLECULES, V4, P446, DOI 10.1021/bm025723k
NR 26
TC 3
Z9 3
U1 0
U2 8
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1001-6538
J9 CHINESE SCI BULL
JI Chin. Sci. Bull.
PD DEC
PY 2005
VL 50
IS 24
BP 2809
EP 2816
DI 10.1360/982005-707
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 014CX
UT WOS:000235457500004
DA 2018-10-20
ER

PT J
AU Sader, MS
   Balduino, A
   Soares, GD
   Borojevic, R
AF Sader, MS
   Balduino, A
   Soares, GD
   Borojevic, R
TI Effect of three distinct treatments of titanium surface on osteoblast
   attachment, proliferation, and differentiation
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE cell-biomaterial interaction; osteoblasts; surface roughness; titanium
ID BONE-MARROW-CELLS; IN-VITRO; IMPLANT MATERIALS; SPECIAL EMPHASIS;
   GROWTH-BEHAVIOR; ROUGHNESS; TOPOGRAPHY; ACID; OSTEOGENESIS; INTERFACE
AB Cell-titanium interactions are crucial to the clinical success of bone and dental implants. The physico-chemical characteristics of the substrates surface influence osteoblast proliferation, differentiation, and activity as well. The osteoblast behavior was analyzed on three different titanium surfaces: ground with an abrasive 600 grit SiC paper, blasted with alumina particles (65 mu m diameter) and alumina blasted followed by a double chemical etch (4% HF+4% HF/8% H2O2). Scanning electron microscopy (SEM) and profilometry showed distinct microtopographies. Ground samples showed parallel-groove orientation. The Al2O3-blasted surface presented the roughest microtopography with aluminum-rich particles incrusted in the titanium surface. Osteoblasts cells from femora of Balb/c mice were seeded onto the substrates tested. Cell morphology and initial attachment were evaluated by SEM. Osteoblasts adhered to and spread on all samples tested. However, on rough surfaces, osteoblasts did not spread completely and acquired a polygonal morphology. Besides, the cell proliferation rate was diminished at the beginning of incubation on rough surfaces. Our results suggest a delay, rather than an impairment, in osteoblast viability and alkaline phosphatase activity when cells are cultured on rough surfaces, inducing a distinct osteoblast phenotype, rather than blocking its activity. At least in the culture conditions used in this work, alumina particles did not affect osteoblast behavior.
C1 UFRJ, COPPE, PEMM, Rio De Janeiro, Brazil.
   UFRJ, ICB, Dept Histol & Embriol, Rio De Janeiro, Brazil.
   UFRJ, HUCFF, PABCAM, Rio De Janeiro, Brazil.
RP Soares, GD (reprint author), UFRJ, COPPE, PEMM, POB 68505, Rio De Janeiro, Brazil.
EM gloria@ufrj.br
OI Borojevic, Radovan/0000-0002-2393-7280
CR Ahmad M, 1999, BIOMATERIALS, V20, P211, DOI 10.1016/S0142-9612(98)00152-5
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Barewal RM, 2003, INT J ORAL MAX IMPL, V18, P641
   Barrere F, 2002, BIOMATERIALS, V23, P2211, DOI 10.1016/S0142-9612(01)00354-4
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Buser D, 1998, INT J ORAL MAX IMPL, V13, P611
   Castellani R, 1999, CLIN ORAL IMPLAN RES, V10, P369, DOI 10.1034/j.1600-0501.1999.100504.x
   Chow JWM, 1998, J BONE MINER RES, V13, P1760, DOI 10.1359/jbmr.1998.13.11.1760
   de Groot K, 1998, P I MECH ENG H, V212, P137, DOI 10.1243/0954411981533917
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Diniz MG, 2002, J MATER SCI-MATER M, V13, P421, DOI 10.1023/A:1014357122284
   Eisenbarth E, 2002, BIOMOL ENG, V19, P243, DOI 10.1016/S1389-0344(02)00032-1
   FH Jones, 2001, SURF SCI REP, V42, P75, DOI DOI 10.1016/S0167-5729(00)00011-X
   Fisher L W, 1995, Acta Orthop Scand Suppl, V266, P61
   GRIGORIADIS AE, 1985, BONE, V6, P249, DOI 10.1016/8756-3282(85)90008-0
   Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   Lohmann CH, 2000, J BONE MINER RES, V15, P1169, DOI 10.1359/jbmr.2000.15.6.1169
   MALAVAL L, 1994, J CELL PHYSIOL, V158, P555, DOI 10.1002/jcp.1041580322
   MARIE PJ, 1989, IN VITRO CELL DEV B, V25, P373
   Matsuzaka K, 2003, BIOMATERIALS, V24, P2711, DOI 10.1016/S0142-9612(03)00085-1
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   MUELLER WD, 2002, CLIN ORAL IMPLAN RES, V14, P349
   Mustafa K, 2001, CLIN ORAL IMPLAN RES, V12, P515, DOI 10.1034/j.1600-0501.2001.120513.x
   Oreffo ROC, 1999, BONE, V25, p5S, DOI 10.1016/S8756-3282(99)00124-6
   ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Sena L. A., 2003, SURF COAT TECH, V166, P254
   SENA LA, 2002, J BIOMED MATER RES, V60, P1
   Sul YT, 2003, BIOMATERIALS, V24, P3893, DOI 10.1016/S0142-9612(03)00261-8
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   Ungersbock A, 1996, BIOMATERIALS, V17, P797, DOI 10.1016/0142-9612(96)81417-7
   Velten D, 2002, J BIOMED MATER RES, V59, P18, DOI 10.1002/jbm.1212
   Vidigal G M Jr, 1999, Implant Dent, V8, P295, DOI 10.1097/00008505-199903000-00015
   Wennerberg A, 1996, BIOMATERIALS, V17, P15, DOI 10.1016/0142-9612(96)80750-2
   Wennerberg A, 1998, INT J MACH TOOL MANU, V38, P657, DOI 10.1016/S0890-6955(97)00114-4
   Wennerberg A, 1996, MED ENG PHYS, V18, P548, DOI 10.1016/1350-4533(95)00005-4
   Xavier SP, 2003, J DENT, V31, P173, DOI 10.1016/S0300-5712(03)00027-7
   Yang YZ, 2002, BIOMATERIALS, V23, P1383, DOI 10.1016/S0142-9612(01)00259-9
   YEE JA, 1983, CALCIFIED TISSUE INT, V35, P571, DOI 10.1007/BF02405096
   Yerokhin AL, 2000, SURF COAT TECH, V130, P195, DOI 10.1016/S0257-8972(00)00719-2
NR 44
TC 63
Z9 65
U1 0
U2 10
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD DEC
PY 2005
VL 16
IS 6
BP 667
EP 675
DI 10.1111/j.1600-0501.2005.01135.x
PG 9
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 984GI
UT WOS:000233290200006
PM 16307573
DA 2018-10-20
ER

PT J
AU Gupta, G
   Zbib, A
   El-Ghannam, A
   Khraisheh, M
   Zbib, H
AF Gupta, G
   Zbib, A
   El-Ghannam, A
   Khraisheh, M
   Zbib, H
TI Characterization of a novel bioactive composite using advanced X-ray
   computed tomography
SO COMPOSITE STRUCTURES
LA English
DT Article; Proceedings Paper
CT 5th International Conference on Composite Science and Technology
   (ICCST-5)
CY FEB 01-03, 2005
CL Amer Univ Sharjah, Sharjah, U ARAB EMIRATES
SP Sch Engn, Univ KwaZulu-Natal, UAE Soc Engineers, Amer Soc Composites, Amer Soc Nondestruct Testing, European Soc Composite Mat
HO Amer Univ Sharjah
DE X-ray computed tomography; porosity; bioceramics; bone-graft
ID CEMENT-BASED MATERIALS; PORE-SIZE; POROSIMETRY; SCAFFOLDS
AB A novel bioactive, porous silica-calcium phosphate nanocomposite (SCPC) that can be used to treat large bone defects in load-bearing positions has been tested and has shown great potential for applications in tissue engineering. Porosity is essential to the performance of the composite material as a tissue engineering scaffold, as porous scaffolds provide a physical, 3-D template to support new tissue formation. However, porosity characterization using conventional techniques such as porosimetry or scanning electron microscopy requires extensive preparation of samples and may destroy important features during preparation and analysis stage. In this work, the new composite is characterized using an advanced high resolution X-ray computed tomography, which is a non-destructive testing technique that allows construction of the 3-D topology of the microstructure. The results clearly show the effectiveness and versatility of this technique in characterizing the porous architecture of the novel composite biomaterial. The pore distribution, morphology and interconnectivity in the composite scaffolds were found to be ideal for use in tissue engineering applications. (C) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Kentucky, Ctr Mfg, Lexington, KY 40506 USA.
   Univ Kentucky, Dept Mech Engn, Lexington, KY 40506 USA.
   Univ Kentucky, Ctr Biomed Engn, Lexington, KY 40506 USA.
   Washington State Univ, Sch Mech & Mat Engn, Washington State High Resolut Xray Computed Tomog, Pullman, WA 99164 USA.
RP Khraisheh, M (reprint author), Univ Kentucky, Ctr Mfg, Lexington, KY 40506 USA.
EM Khraisheh@engr.uky.edu
CR Abell AB, 1999, J COLLOID INTERF SCI, V211, P39, DOI 10.1006/jcis.1998.5986
   Diamond S, 2000, CEMENT CONCRETE RES, V30, P1517, DOI 10.1016/S0008-8846(00)00370-7
   El-Ghannam A, 2004, J BIOMED MATER RES A, V71A, P377, DOI 10.1002/jbm.a.30128
   El-Ghannam AR, 2004, J BIOMED MATER RES A, V69A, P490, DOI 10.1002/jbm.a.30022
   GUPTA G, UNPUB J BIOMED MATER
   Holzer L, 2004, J MICROSC-OXFORD, V216, P84, DOI 10.1111/j.0022-2720.2004.01397.x
   Jones AC, 2004, BIOMATERIALS, V25, P4947, DOI 10.1016/j.biomatcrials.2004.01.047
   Mawatari T, 1999, J Orthop Sci, V4, P431, DOI 10.1007/s007760050126
   Moore MJ, 2004, J BIOMED MATER RES A, V71A, P258, DOI 10.1002/jbm.a.30138
   Ritman E L, 1998, Technol Health Care, V6, P403
   WESTERMARCK S, 2000, THESIS U HELSINKI FI
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
NR 12
TC 12
Z9 12
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0263-8223
J9 COMPOS STRUCT
JI Compos. Struct.
PD DEC
PY 2005
VL 71
IS 3-4
BP 423
EP 428
DI 10.1016/j.compstruct.2005.09.023
PG 6
WC Materials Science, Composites
SC Materials Science
GA 998SO
UT WOS:000234339900025
DA 2018-10-20
ER

PT J
AU Pelletier, J
   Anders, A
AF Pelletier, J
   Anders, A
TI Plasma-blased ion implantation and deposition: A review of physics,
   technology, and applications
SO IEEE TRANSACTIONS ON PLASMA SCIENCE
LA English
DT Review
DE ion-assisted thin film deposition; plasma-based ion implantation; pulsed
   bias
ID AUSTENITIC STAINLESS-STEEL; CYCLOTRON-RESONANCE PLASMA; ULTRA-SHALLOW
   JUNCTIONS; DISCHARGE CATHODE MATERIALS; INNER SURFACE MODIFICATION;
   VOLTAGE PULSE-GENERATOR; SMALL CYLINDRICAL BORE; THIN-FILM DEPOSITION;
   AISI M2 STEEL; VACUUM-ARC
AB After pioneering work in the 1980s, plasma-based ion implantation (PBII) and plasma-based ion implantation and deposition (PBIID) can now be considered mature technologies for surface modification and thin film deposition. This review starts by looking at the historical development and recalling the basic ideas of PBII. Advantages and disadvantages are compared to conventional ion beam implantation and physical vapor deposition for PBII and PBIID, respectively, followed by a summary of the physics of sheath dynamics, plasma and pulse specifications, plasma diagnostics, and process modeling. The review moves on to technology considerations for plasma sources and process reactors. PBII surface modification and PBIID coatings are applied in a wide range of situations. They include the by-now traditional tribological applications of reducing wear and corrosion through the formation of hard, tough, smooth, low-friction, and chemically inert phases and coatings, e.g., for engine components. PBII has become viable for the formation of shallow junctions and other applications in microelectronics. More recently, the rapidly growing field of biomaterial synthesis makes use of PBII and PBIID to alter surfaces of or produce coatings on surgical implants and other biomedical devices. With limitations, also nonconducting materials such as plastic sheets can be treated. The major interest in PBII processing originates from its flexibility in ion energy (from a few electron volts up to about 100 keV), and the capability to efficiently treat, or deposit on, large areas, and (within limits) to process nonflat, three-dimensional workpieces, including forming and modifying metastable phases and nanostructures.
C1 CNRS, Ctr Rech Plasmas Mat Nanostruct, LPSC, F-38026 St Martin Dheres, France.
   Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.
RP Pelletier, J (reprint author), CNRS, Ctr Rech Plasmas Mat Nanostruct, LPSC, F-38026 St Martin Dheres, France.
EM jacques.pelletier@ujf-grenoble.fr; aanders@lbl.gov
RI Anders, Andre/B-8580-2009
OI Anders, Andre/0000-0002-5313-6505
CR ADLER RJ, 1985, NUCL INSTRUM METH B, V6, P123, DOI 10.1016/0168-583X(85)90621-4
   Alonso F, 1997, SURF COAT TECH, V93, P305, DOI 10.1016/S0257-8972(97)00065-0
   ANDERS A, 1994, J VAC SCI TECHNOL B, V12, P815, DOI 10.1116/1.587351
   Anders A, 1997, SURF COAT TECH, V93, P158, DOI 10.1016/S0257-8972(97)00037-6
   ANDERS A, 1995, NUCL INSTRUM METH B, V102, P132, DOI 10.1016/0168-583X(94)00797-7
   Anders A, 2002, SURF COAT TECH, V156, P3, DOI 10.1016/S0257-8972(02)00066-X
   Anders A, 2002, J APPL PHYS, V91, P4824, DOI 10.1063/1.1459619
   Anders A, 2001, SURF COAT TECH, V136, P111, DOI 10.1016/S0257-8972(00)01038-0
   Anders A, 2001, SURF COAT TECH, V136, P85, DOI 10.1016/S0257-8972(00)01017-3
   Anders A, 2000, APPL PHYS LETT, V76, P28, DOI 10.1063/1.125645
   Anders A, 2000, HDB PLASMA IMMERSION, P2
   Anders S, 1997, SURF COAT TECH, V94-5, P189, DOI 10.1016/S0257-8972(97)00346-0
   Bechu S, 2004, SURF COAT TECH, V186, P170, DOI 10.1016/j.surfcoat.2004.04.036
   BIERSACK JP, 1991, NUCL INSTRUM METH B, V59, P21, DOI 10.1016/0168-583X(91)95167-C
   Bilek MMM, 2004, SURF COAT TECH, V186, P21, DOI 10.1016/j.surfcoat.2004.04.051
   Bilek MMM, 2000, J APPL PHYS, V87, P4198, DOI 10.1063/1.373052
   Bilek MMM, 2003, IEEE T PLASMA SCI, V31, P939, DOI 10.1109/TPS.2003.818409
   Blawert C, 1996, SURF COAT TECH, V85, P15, DOI 10.1016/0257-8972(96)02880-0
   Blawert C, 1996, SURF COAT TECH, V83, P228, DOI 10.1016/0257-8972(95)02794-7
   Blawert C, 1997, NUCL INSTRUM METH B, V127, P873, DOI 10.1016/S0168-583X(97)00065-7
   Blawert C, 1997, SURF COAT TECH, V93, P274, DOI 10.1016/S0257-8972(97)00060-1
   BOHM G, 1994, J VAC SCI TECHNOL B, V12, P821, DOI 10.1116/1.587352
   Booske JH, 1997, J MATER RES, V12, P1356, DOI 10.1557/JMR.1997.0185
   Boxman R. L., 1995, HDB VACUUM ARC SCI T
   Brown I G, 1989, PHYS TECHNOLOGY ION
   BROWN IG, 1991, IEEE T PLASMA SCI, V19, P713, DOI 10.1109/27.108403
   BROWN IG, 1993, NUCL INSTRUM METH B, V80-1, P1281, DOI 10.1016/0168-583X(93)90782-2
   Brown IG, 1995, NUCL INSTRUM METH B, V106, P646, DOI 10.1016/0168-583X(95)00781-4
   BROWN IG, 1991, APPL PHYS LETT, V58, P1392, DOI 10.1063/1.104318
   Brundle C. Richard, 1992, ENCY MAT CHARACTERIZ
   Brutscher J, 1996, PLASMA SOURCES SCI T, V5, P54, DOI 10.1088/0963-0252/5/1/007
   Brutscher J, 1996, REV SCI INSTRUM, V67, P2621, DOI 10.1063/1.1147225
   CHEN J, 1992, SURF COAT TECH, V53, P267, DOI 10.1016/0257-8972(92)90385-N
   Cheung NW, 2002, SURF COAT TECH, V156, P24, DOI 10.1016/S0257-8972(02)00068-3
   CHEUNG NW, 1991, NUCL INSTRUM METH B, V55, P811, DOI 10.1016/0168-583X(91)96285-S
   Chhowalla M, 1997, J APPL PHYS, V81, P139, DOI 10.1063/1.364000
   Chu PK, 2002, SURF COAT TECH, V156, P244, DOI 10.1016/S0257-8972(02)00100-7
   Chung P.M., 1975, ELECT PROBES STATION
   Collins GA, 1994, PLASMA SOURCES SCI T, V3, P10, DOI 10.1088/0963-0252/3/1/002
   COLLINS GA, 1995, SURF COAT TECH, V74-5, P417, DOI 10.1016/0257-8972(95)08370-7
   Collins GA, 1997, SURF COAT TECH, V93, P181, DOI 10.1016/S0257-8972(97)00041-8
   Collins GA, 1996, SURF COAT TECH, V84, P537, DOI 10.1016/S0257-8972(95)02792-0
   COLLINS GA, 1994, J VAC SCI TECHNOL B, V12, P875, DOI 10.1116/1.587363
   COLLINS GA, 1991, MAT SCI ENG A-STRUCT, V139, P171, DOI 10.1016/0921-5093(91)90613-R
   CONRAD JR, 1990, J VAC SCI TECHNOL A, V8, P3146, DOI 10.1116/1.576598
   CONRAD JR, 1989, MAT SCI ENG A-STRUCT, V116, P197, DOI 10.1016/0921-5093(89)90146-9
   CONRAD JR, 1988, SURF COAT TECH, V36, P927, DOI 10.1016/0257-8972(88)90033-3
   CONRAD JR, 1987, J APPL PHYS, V62, P777, DOI 10.1063/1.339858
   CONRAD JR, 1987, J APPL PHYS, V62, P4591, DOI 10.1063/1.339055
   Current MI, 2001, SURF COAT TECH, V136, P138, DOI 10.1016/S0257-8972(00)01043-4
   DAVIS WD, 1969, J APPL PHYS, V40, P2212, DOI 10.1063/1.1657960
   Dong H, 2000, J MATER SCI LETT, V19, P1147, DOI 10.1023/A:1006755008958
   Dong H, 1999, SURF COAT TECH, V111, P29, DOI 10.1016/S0257-8972(98)00698-7
   ELMOURSI AA, 1991, NUCL INSTRUM METH B, V62, P293, DOI 10.1016/0168-583X(91)95914-Y
   EMMERT GA, 1994, J VAC SCI TECHNOL B, V12, P880, DOI 10.1116/1.587364
   Ensinger W, 2001, SURF COAT TECH, V136, P202, DOI 10.1016/S0257-8972(00)01056-2
   Felch SB, 2002, SURF COAT TECH, V156, P229, DOI 10.1016/S0257-8972(02)00097-X
   Forrester A. T., 1988, LARGE ION BEAMS
   FRANKLYN CB, 1994, J VAC SCI TECHNOL B, V12, P923, DOI 10.1116/1.587328
   Gan BK, 2004, J PHYS-CONDENS MAT, V16, P1751, DOI 10.1088/0953-8984/16/10/007
   Gaudreau MPJ, 1999, J VAC SCI TECHNOL B, V17, P888, DOI 10.1116/1.590657
   Goebel D. M, 2000, HDB PLASMA IMMERSION, P467
   GOEBEL DM, 1994, J VAC SCI TECHNOL B, V12, P838, DOI 10.1116/1.587356
   Goeckner MJ, 1999, J VAC SCI TECHNOL B, V17, P2290, DOI 10.1116/1.590906
   Gunzel R, 2002, SURF COAT TECH, V156, P54, DOI 10.1016/S0257-8972(02)00112-3
   GUNZEL R, 1994, J VAC SCI TECHNOL B, V12, P927, DOI 10.1116/1.587329
   Gunzel R, 1999, SURF COAT TECH, V112, P307, DOI 10.1016/S0257-8972(98)00776-2
   Ha JM, 2001, SURF COAT TECH, V136, P157, DOI 10.1016/S0257-8972(00)01047-1
   Han S, 1997, SURF COAT TECH, V93, P261, DOI 10.1016/S0257-8972(97)00057-1
   He XM, 1999, J VAC SCI TECHNOL B, V17, P822, DOI 10.1116/1.590662
   He XM, 1999, J VAC SCI TECHNOL A, V17, P2525, DOI 10.1116/1.581991
   Hirvonen JP, 1997, NUCL INSTRUM METH B, V127, P922, DOI 10.1016/S0168-583X(97)00032-3
   Hopwood J.A., 2000, IONIZED PHYS VAPOR D
   Horling A, 2005, SURF COAT TECH, V191, P384, DOI 10.1016/j.surfcoat.2004.04.056
   Horling A, 2002, J VAC SCI TECHNOL A, V20, P1815, DOI 10.1116/1.1503784
   HUTCHINGS R, 1992, SURF COAT TECH, V51, P489, DOI 10.1016/0257-8972(92)90287-K
   Iskanderova Z, 2000, SURF COAT TECH, V127, P18, DOI 10.1016/S0257-8972(99)00673-8
   Iskanderova Z, 1997, NUCL INSTRUM METH B, V127, P702, DOI 10.1016/S0168-583X(96)01161-5
   Iskanderova ZA, 1999, NUCL INSTRUM METH B, V148, P1090, DOI 10.1016/S0168-583X(98)00797-6
   Johns SM, 1996, SURF COAT TECH, V85, P7, DOI 10.1016/0257-8972(96)02884-8
   Keller G, 2001, SURF COAT TECH, V136, P117, DOI 10.1016/S0257-8972(00)01039-2
   KIM SH, 2000, FIBER POLYM, V1, P83
   KLEIN J, 1995, MEAS SCI TECHNOL, V6, P550, DOI 10.1088/0957-0233/6/5/015
   Kondyurin A, 2001, VACUUM, V64, P105, DOI 10.1016/S0042-207X(01)00381-5
   Kwok DTK, 2001, SURF COAT TECH, V136, P146, DOI 10.1016/S0257-8972(00)01045-8
   Lacoste A, 2002, SURF COAT TECH, V156, P225, DOI 10.1016/S0257-8972(02)00093-2
   Lacoste A, 2002, SURF COAT TECH, V156, P125, DOI 10.1016/S0257-8972(02)00076-2
   Lacoste A, 2001, SURF COAT TECH, V135, P268, DOI 10.1016/S0257-8972(00)00993-2
   Lallement F, 2004, SURF COAT TECH, V186, P17, DOI 10.1016/j.surfcoat.2004.04.004
   Le Coeur F, 1998, REV SCI INSTRUM, V69, P831, DOI 10.1063/1.1148530
   Le Coeur F, 2000, SURF COAT TECH, V125, P71, DOI 10.1016/S0257-8972(99)00554-X
   LeCoeur F, 1997, SURF COAT TECH, V93, P265, DOI 10.1016/S0257-8972(97)00058-3
   Lee DH, 1998, APPL PHYS LETT, V73, P2423, DOI 10.1063/1.122469
   Lee Y, 2001, J ADHES SCI TECHNOL, V15, P1079, DOI 10.1163/156856101317035495
   Lee Y, 1998, J VAC SCI TECHNOL A, V16, P1710, DOI 10.1116/1.581289
   Lenoble D, 2002, SURF COAT TECH, V156, P262, DOI 10.1016/S0257-8972(02)00105-6
   Li MS, 2003, SURF COAT TECH, V167, P197, DOI 10.1016/S0257-8972(02)00895-2
   Liao J, 2005, SURF COAT TECH, V191, P90, DOI 10.1016/j.surfcoat.2004.06.039
   Liao JX, 2004, SURF COAT TECH, V183, P157, DOI 10.1016/j.surfcoat.2003.10.003
   LIEBERMAN MA, 1989, J APPL PHYS, V66, P2926, DOI 10.1063/1.344172
   Lim H, 2001, J VAC SCI TECHNOL A, V19, P1490, DOI 10.1116/1.1382650
   Lim SHN, 2005, J PHYS-CONDENS MAT, V17, P2791, DOI 10.1088/0953-8984/17/17/029
   Lim SHN, 2003, J APPL PHYS, V93, P4283, DOI 10.1063/1.1558995
   LOSSY R, 1992, APPL PHYS LETT, V61, P171, DOI 10.1063/1.108208
   Lu X, 1997, APPL PHYS LETT, V71, P2767, DOI 10.1063/1.120127
   Ma XX, 2004, SURF COAT TECH, V186, P88, DOI 10.1016/j.surfcoat.2004.04.018
   Macak K, 2000, J VAC SCI TECHNOL A, V18, P1533, DOI 10.1116/1.582380
   Malaczynski GW, 1997, J MATER ENG PERFORM, V6, P223, DOI 10.1007/s11665-997-0019-y
   MALIK SM, 1994, J VAC SCI TECHNOL B, V12, P843, DOI 10.1116/1.587357
   Mandl S, 2002, BIOMOL ENG, V19, P129, DOI 10.1016/S1389-0344(02)00025-4
   Mandl S, 2004, SURF COAT TECH, V186, P82, DOI 10.1016/j.surfcoat.2004.04.017
   Mandl S, 2001, SURF COAT TECH, V136, P176, DOI 10.1016/S0257-8972(00)01053-7
   Mandl S, 1998, SURF COAT TECH, V100, P372, DOI 10.1016/S0257-8972(97)00651-8
   Mandl S, 1997, SURF COAT TECH, V93, P229, DOI 10.1016/S0257-8972(97)00050-9
   MATOSSIAN J, 2000, HDB PLASMA IMMERSION, P343
   MATOSSIAN JN, 1994, J VAC SCI TECHNOL B, V12, P850, DOI 10.1116/1.587358
   Matossian JN, 1996, SURF COAT TECH, V85, P111, DOI 10.1016/0257-8972(96)02873-3
   MATOSSIAN JN, 1993, SURF COAT TECH, V62, P595, DOI 10.1016/0257-8972(93)90305-8
   MATOSSIAN JN, 1994, SURFACE POTENTIAL CO
   Maulat O, 1999, J VAC SCI TECHNOL B, V17, P879, DOI 10.1116/1.590655
   McKenzie DR, 2004, SURF COAT TECH, V186, P239, DOI 10.1016/j.surfcoat.2004.04.093
   McKenzie DR, 2001, THIN SOLID FILMS, V382, P280, DOI 10.1016/S0040-6090(00)01702-8
   Miyagawa Y, 2004, SURF COAT TECH, V186, P2, DOI 10.1016/j.surfcoat.2004.04.043
   MIZUNO B, 1988, APPL PHYS LETT, V53, P2059, DOI 10.1063/1.100318
   Moller W, 1999, SURF COAT TECH, V116, P1, DOI 10.1016/S0257-8972(99)00144-9
   Moller W, 1999, NATO ASI 3 HIGH TECH, V67, P191
   MOLLER W, 1984, NUCL INSTRUM METH B, V2, P814, DOI 10.1016/0168-583X(84)90321-5
   Mukherjee S, 2002, SURF COAT TECH, V157, P111, DOI 10.1016/S0257-8972(02)00149-4
   Mukherjee S, 1997, SURF COAT TECH, V93, P188, DOI 10.1016/S0257-8972(97)00042-X
   Murakami N, 2001, SURF COAT TECH, V136, P265, DOI 10.1016/S0257-8972(00)01028-8
   Oates TWH, 2002, SURF COAT TECH, V156, P332, DOI 10.1016/S0257-8972(02)00107-X
   QIAN XY, 1991, APPL PHYS LETT, V59, P348, DOI 10.1063/1.106392
   QIAN XY, 1991, NUCL INSTRUM METH B, V55, P821, DOI 10.1016/0168-583X(91)96286-T
   QIN S, 1994, J VAC SCI TECHNOL B, V12, P962, DOI 10.1116/1.587336
   Qin S, 1992, PLASMA SOURCES SCI T, V1, P1, DOI 10.1088/0963-0252/1/1/001
   QIU X, 1991, NUCL INSTRUM METH B, V59, P951, DOI 10.1016/0168-583X(91)95740-5
   REASS WA, 1994, J VAC SCI TECHNOL B, V12, P854, DOI 10.1116/1.587359
   Redondo LM, 2002, SURF COAT TECH, V156, P61, DOI 10.1016/S0257-8972(02)00113-5
   Redondo LM, 2001, SURF COAT TECH, V136, P51, DOI 10.1016/S0257-8972(00)01010-0
   REDSTEN AM, 1992, J MATER PROCESS TECH, V30, P253, DOI 10.1016/0924-0136(92)90218-H
   REJ DJ, 1994, J VAC SCI TECHNOL B, V12, P861, DOI 10.1116/1.587360
   Rossi JO, 2001, SURF COAT TECH, V136, P43, DOI 10.1016/S0257-8972(00)01008-2
   ROSSNAGEL SM, 1994, J VAC SCI TECHNOL B, V12, P449, DOI 10.1116/1.587142
   SAMANDI M, 1992, SURF COAT TECH, V55, P447
   SAMANDI M, 1993, SURF COAT TECH, V59, P261, DOI 10.1016/0257-8972(93)90094-5
   SCHEUER JT, 1990, J APPL PHYS, V67, P1241, DOI 10.1063/1.345722
   Schoser S, 1997, SURF COAT TECH, V93, P339, DOI 10.1016/S0257-8972(97)00072-8
   SHAMIM M, 1991, J APPL PHYS, V69, P2904, DOI 10.1063/1.348600
   SHAMIM MM, 1991, J APPL PHYS, V70, P4756, DOI 10.1063/1.349067
   Shang ZK, 1996, SURF COAT TECH, V85, P105, DOI 10.1016/0257-8972(96)02861-7
   Sheridan TE, 1996, PHYS PLASMAS, V3, P3507, DOI 10.1063/1.871501
   SHERIDAN TE, 1993, J APPL PHYS, V74, P4903, DOI 10.1063/1.354323
   Sheridan TE, 1996, J APPL PHYS, V80, P66, DOI 10.1063/1.362771
   Shi W, 2001, WEAR, V250, P544, DOI 10.1016/S0043-1648(01)00636-6
   SMITH PP, 1994, J VAC SCI TECHNOL B, V12, P940, DOI 10.1116/1.587332
   SRIDHARAN K, 1990, MAT SCI ENG A-STRUCT, V128, P259, DOI 10.1016/0921-5093(90)90234-T
   SRIDHARAN K, 2000, HDB PLASMA IMMERSION, pCH10
   Sun M, 1998, J MATER RES, V13, P1823, DOI 10.1557/JMR.1998.0258
   Sun M, 1998, J VAC SCI TECHNOL A, V16, P2718, DOI 10.1116/1.581406
   Sun M, 1996, J VAC SCI TECHNOL A, V14, P367, DOI 10.1116/1.579902
   SZAPIRO B, 1988, APPL PHYS LETT, V53, P358, DOI 10.1063/1.100401
   SZAPIRO B, 1989, J APPL PHYS, V65, P3713, DOI 10.1063/1.342600
   Tan IH, 2004, SURF COAT TECH, V186, P234, DOI 10.1016/j.surfcoat.2004.04.029
   TANG BY, 1994, J VAC SCI TECHNOL B, V12, P867, DOI 10.1116/1.587361
   TENDYS J, 1988, APPL PHYS LETT, V53, P2143, DOI 10.1063/1.100299
   THOMAE RW, 1995, NUCL INSTRUM METH B, V99, P569, DOI 10.1016/0168-583X(95)00228-6
   Tian XB, 2004, SURF COAT TECH, V186, P47, DOI 10.1016/j.surfcoat.2004.04.008
   Tonosaki M, 2002, SURF COAT TECH, V156, P338, DOI 10.1016/S0257-8972(02)00108-1
   Tonosaki M, 2001, SURF COAT TECH, V136, P249, DOI 10.1016/S0257-8972(00)01024-0
   Torregrosa F, 2004, SURF COAT TECH, V186, P93, DOI 10.1016/j.surfcoat.2004.04.046
   Uglov VV, 1999, J VAC SCI TECHNOL B, V17, P836, DOI 10.1116/1.590665
   Uglov VV, 2001, SURF COAT TECH, V136, P226, DOI 10.1016/S0257-8972(00)01019-7
   VAHEDI V, 1991, J APPL PHYS, V69, P2008, DOI 10.1063/1.348774
   Vempaire D, 2005, PLASMA PHYS CONTR F, V47, pA153, DOI 10.1088/0741-3335/47/5A/011
   Vempaire D, 2004, SURF COAT TECH, V186, P245, DOI 10.1016/j.surfcoat.2004.04.030
   Vetter J, 1999, SURF COAT TECH, V120, P709, DOI 10.1016/S0257-8972(99)00363-1
   Volz K, 2002, SURF COAT TECH, V156, P237, DOI 10.1016/S0257-8972(02)00098-1
   Volz K, 2001, SURF COAT TECH, V136, P80, DOI 10.1016/S0257-8972(00)01016-1
   Walter KC, 1995, NUCL INSTRUM METH B, V106, P522, DOI 10.1016/0168-583X(95)00763-6
   Walter KC, 1997, SURF COAT TECH, V93, P287, DOI 10.1016/S0257-8972(97)00062-5
   Walter KC, 1996, SURF COAT TECH, V85, P1, DOI 10.1016/0257-8972(96)02886-1
   WALTER KC, 1994, J VAC SCI TECHNOL B, V12, P945, DOI 10.1116/1.587333
   Walther SR, 2004, SURF COAT TECH, V186, P68, DOI 10.1016/j.surfcoat.2004.04.014
   Wang J, 2004, SURF COAT TECH, V186, P299, DOI 10.1016/j.surfcoat.2004.02.046
   Wang SY, 1997, SURF COAT TECH, V93, P309, DOI 10.1016/S0257-8972(97)00066-2
   WANG YF, 1979, THIN SOLID FILMS, V63, P11, DOI 10.1016/0040-6090(79)90092-0
   Wei R, 1996, SURF COAT TECH, V83, P235, DOI 10.1016/0257-8972(95)02825-0
   Weldon MK, 1997, J VAC SCI TECHNOL B, V15, P1065, DOI 10.1116/1.589416
   WIDNER M, 1970, PHYS FLUIDS, V13, P2532, DOI 10.1063/1.1692823
   Wolf B. H., 1995, HDB ION SOURCES
   WOOD BP, 1995, NUCL INSTRUM METH B, V96, P429, DOI 10.1016/0168-583X(94)00534-6
   WOOD BP, 1994, J VAC SCI TECHNOL B, V12, P870, DOI 10.1116/1.587362
   WOOD BP, 2000, HDB PLASMA IMMERSION, pCH4
   Woods RH, 1997, NUCL INSTRUM METH B, V127, P1004, DOI 10.1016/S0168-583X(97)00048-7
   Wu Z., 1995, Surface Engineering, V11, P53
   Yang P, 2004, SURF COAT TECH, V186, P125, DOI 10.1016/j.surfcoat.2004.04.039
   Yankov RA, 2001, ANN PHYS-BERLIN, V10, P279, DOI 10.1002/1521-3889(200104)10:4<279::AID-ANDP279>3.0.CO;2-R
   YU C, 1994, IEEE ELECTR DEVICE L, V15, P196, DOI 10.1109/55.286690
   Yukimura K, 2004, SURF COAT TECH, V186, P73, DOI 10.1016/j.surfcoat.2004.04.015
   Yukimura K, 2002, SURF COAT TECH, V156, P66, DOI 10.1016/S0257-8972(02)00114-7
   Zeng XC, 1997, PHYS PLASMAS, V4, P4431, DOI 10.1063/1.872607
   Zeng XC, 1997, APPL PHYS LETT, V71, P1035, DOI 10.1063/1.119719
   Zeng XC, 2001, THIN SOLID FILMS, V390, P145, DOI 10.1016/S0040-6090(01)00950-6
   Zeng ZM, 1999, J APPL PHYS, V86, P120, DOI 10.1063/1.370708
   Ziegler J F, 1985, STOPPING RANGE IONS
NR 205
TC 89
Z9 94
U1 3
U2 76
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0093-3813
EI 1939-9375
J9 IEEE T PLASMA SCI
JI IEEE Trans. Plasma Sci.
PD DEC
PY 2005
VL 33
IS 6
BP 1944
EP 1959
DI 10.1109/TPS.2005.860079
PN 1
PG 16
WC Physics, Fluids & Plasmas
SC Physics
GA 994XO
UT WOS:000234064700014
DA 2018-10-20
ER

PT J
AU Lin, CC
   Cheng, HC
   Huang, CF
   Lin, CT
   Lee, SY
   Chen, CS
   Ou, KL
AF Lin, CC
   Cheng, HC
   Huang, CF
   Lin, CT
   Lee, SY
   Chen, CS
   Ou, KL
TI Enhancement of biocompatibility on bioactive titanium surface by
   low-temperature plasma treatment
SO JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS BRIEF
   COMMUNICATIONS & REVIEW PAPERS
LA English
DT Article
DE titanium; biocompatibility; allyamine; albumin; plasma polymerization;
   tissue healing
ID BARRIER CAPABILITY; IMPLANT MATERIALS; JUNCTION DIODES; CU DIFFUSION;
   BONE; STERILIZATION; BIOMATERIAL; FILMS; METALLIZATION; LAYER
AB The surface of implantable biomaterials directly contacts the host tissue and is critical in determining biocompatibility. To improve implant integration, interfacial reactions must be controlled to minimize nonspecific adsorption of proteins, and tissue-healing phenomena can be controlled. The purpose of this study was to develop a new method of functionalizing titanium surfaces by plasma treatment. The covalent immobilization of bioactive organic molecules and the bioactivities in vitro were assessed by transmission electron microscopy (TEM), atomic force spectroscopy (AFM), X-ray photoelectron spectroscopy (XPS), scanning electron microscopy (SEM), and 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as indices of cellular cytotoxicity. Argon plasma removed all of the adsorbed contaminants and impurities. Plasma-cleaned titanium surfaces showed better bioactive performances than untreated titanium surfaces. The analytical results reveal that plasma-cleaned titanium surfaces provide a clean and reproducible starting condition for further plasma treatments to create well-controlled surface layers. Allylamine was ionized by plasma treatment, and acted as a medium to link albumin. Cells demonstrated a good spread, and a wide attachment was attained on the Albu-Ti plate. Cell attachment and growth were shown to be influenced by the surface properties. The plasma treatment process plays an important role in facilitating tissue healing. This process not only provides a clean titanium surface, but also leads to surface amination on plasma-treated titanium surfaces. Surface cleaning by ion bombardment and surface modification by plasma polymerization are believed to remove contamination on titanium surfaces and thus promote tissue healing.
C1 Taipei Med Univ, Coll Oral Med, Grad Inst Oral Sci, Taipei 110, Taiwan.
   Shin Kong Wu Ho Su Mem Hosp, Taipei 110, Taiwan.
   Taipei Med Univ Hosp, Dept Dent, Taipei 110, Taiwan.
   Taipei Med Univ, Coll Oral Med, Sch Dent, Taipei 110, Taiwan.
   Taipei Med Univ, Dept Dent, Wan Fang Hosp, Taipei 110, Taiwan.
   Cathay Gen Hosp, Dept Dent, Taipei 110, Taiwan.
RP Lin, CC (reprint author), Taipei Med Univ, Coll Oral Med, Grad Inst Oral Sci, Taipei 110, Taiwan.
EM klou@tmu.edu.tw
CR ANCARZ IG, 2002, EUR POLYM J, V38, P1937
   ARMSTRONG NR, 1977, SURF SCI, V67, P451, DOI 10.1016/0039-6028(77)90007-3
   Aronsson BO, 1997, J BIOMED MATER RES, V35, P49
   BAIER RE, 1982, BIOMATERIALS, V3, P241, DOI 10.1016/0142-9612(82)90027-8
   BAIER RE, 1983, PHYSICOCHEMICAL ASPE, V2, P895
   CARLSSON L V, 1989, International Journal of Oral and Maxillofacial Implants, V4, P199
   Chang KM, 1997, J APPL PHYS, V82, P1469, DOI 10.1063/1.365925
   DIKS A, 1981, ELECT SPECTROSCOPY T, V4, pCH5
   DOUNDOULAKIS JH, 1987, J PROSTHET DENT, V58, P471, DOI 10.1016/0022-3913(87)90279-4
   GOMBOTZ WR, 1987, CRIT REV BIOCOMPAT, V4, P1
   GOPEL W, 1984, SURF SCI, V139, P333, DOI 10.1016/0039-6028(84)90054-2
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KELLER J C, 1990, International Journal of Oral and Maxillofacial Implants, V5, P360
   KUMMER FJ, 1992, J APPL BIOMATER, V3, P39, DOI 10.1002/jab.770030107
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   LAUSMAA J, 1990, APPL SURF SCI, V45, P189, DOI 10.1016/0169-4332(90)90002-H
   LAUSMAA J, 1988, SURFACE CHARACTERIZA, P161
   Maitz MF, 2003, J BIOMATER APPL, V17, P303, DOI 10.1177/088532803033178
   MOULDER JF, 1995, HDB XRAY PHOTOELECTR, P170
   Mustafa K, 2000, CLIN ORAL IMPLAN RES, V11, P116, DOI 10.1034/j.1600-0501.2000.011002116.x
   Ou KL, 2005, MICROELECTRON ENG, V81, P44, DOI 10.1016/j.mee.2005.03.001
   Ou KL, 2005, J ELECTROCHEM SOC, V152, pG138, DOI 10.1149/1.1850367
   Ou KL, 2002, J VAC SCI TECHNOL B, V20, P2154, DOI 10.1116/1.1511214
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Puleo DA, 2002, BIOMATERIALS, V23, P2079, DOI 10.1016/S0142-9612(01)00339-8
   QOMBOTZ WR, 1988, J APPL POLYM SCI APP, V42, P285
   RATNER BD, 1995, SURF INTERFACE ANAL, V23, P521, DOI 10.1002/sia.740230712
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   RICCI JL, 1991, BONE-BIOMATERIAL INTERFACE, P334
   ROWLAND TW, 1995, PEDIATR EXERC SCI, V7, P1
   Serro AP, 1997, BIOMATERIALS, V18, P963, DOI 10.1016/S0142-9612(97)00031-8
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1069, DOI 10.1002/jbm.820250903
   STANFORD CM, 1994, J DENT RES, V73, P1061, DOI 10.1177/00220345940730050801
   Sunny M C, 1991, J Biomater Appl, V6, P89, DOI 10.1177/088532829100600107
   Swart K M, 1992, J Oral Implantol, V18, P130
   THOMAS KA, 1987, J BIOMED MATER RES, V21, P1395, DOI 10.1002/jbm.820211205
   Yang WL, 2001, SOLID STATE ELECTRON, V45, P149, DOI 10.1016/S0038-1101(00)00228-8
NR 38
TC 20
Z9 21
U1 0
U2 9
PU JAPAN SOC APPLIED PHYSICS
PI TOKYO
PA KUDAN-KITA BUILDING 5TH FLOOR, 1-12-3 KUDAN-KITA, CHIYODA-KU, TOKYO,
   102-0073, JAPAN
SN 0021-4922
J9 JPN J APPL PHYS 1
JI Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Brief Commun. Rev. Pap.
PD DEC
PY 2005
VL 44
IS 12
BP 8590
EP 8598
DI 10.1143/JJAP.44.8590
PG 9
WC Physics, Applied
SC Physics
GA 997CY
UT WOS:000234223800063
DA 2018-10-20
ER

PT J
AU Mathur, T
   Singhal, S
   Khan, S
   Upadhyay, D
   Fatma, T
   Rattan, A
AF Mathur, T
   Singhal, S
   Khan, S
   Upadhyay, D
   Fatma, T
   Rattan, A
TI Adverse effect of staphylococci slime on in vitro activity of
   glycopeptides
SO JAPANESE JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; DEVICE-ASSOCIATED INFECTIONS;
   BACTERIAL BIOFILMS; VANCOMYCIN; AUREUS; ANTIBIOTICS; RESISTANCE;
   RIFAMPICIN; AGENTS
AB Adhesion to biomaterial is assumed to be a crucial step in the development of staphylococcal foreign body infections. Production of extracellular slime has major implications for the development and implementation of therapeutic strategies. The effect of extracted slime was investigated on the activity of vancomycin, teicoplanin, linezolid, quinupristin/dalfopristin, rifampicin and ranbezolid against 10 clinical and 4 ATCC staphylococcal isolates. The slime extract caused a 2- to 16-fold increase in the MICs of vancomycin and teicoplanin, with a shift in the MIC90 from 2 to 32 (vancomycin) and 2 to 16 (teicoplanin), whereas the MICs of linezolid and quinupristin/dalfopristin were only moderately affected. In time-kill studies, a significant decrease in bacterial killing (>3 log(10) cfu/ml) was observed with vancomycin and teicoplanin (4 X MIC) after addition of slime (5 and 20 mg/ml), whereas the effect of killing by linezolid and quinupristin/dalfopristin was very modest. The rifampicin and ranbezolid MICs and kill curves were not influenced by the addition of slime. The present study thus indicated that slime interferes with the antimicrobial effect of glycopeptide drugs (vancomycin, teicoplanin), and that for effective prevention and treatment of prosthetic device-related infections, appropriate and newer antibiotics such as ranbezolid should be considered.
C1 Ranbaxy Res Labs, New Drug Discovery Res, Dept Infect Dis,R&D 3, Gurgaon 122001, Haryana, India.
   Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India.
RP Rattan, A (reprint author), Ranbaxy Res Labs, New Drug Discovery Res, Dept Infect Dis,R&D 3, Plot 20,Sector 18,Udyog Vihar Ind Area, Gurgaon 122001, Haryana, India.
EM tarun.mathur@ranbaxy.com
CR Amorena B, 1999, J ANTIMICROB CHEMOTH, V44, P43, DOI 10.1093/jac/44.1.43
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   CRISTHENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   Delialioglu N, 2005, JPN J INFECT DIS, V58, P104
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Drago L, 2002, ANTIMICROB AGENTS CH, V46, P598, DOI 10.1128/AAC.46.2.598-599.2002
   DUNNE WM, 1993, ANTIMICROB AGENTS CH, V37, P2522, DOI 10.1128/AAC.37.12.2522
   FARBER BF, 1990, J INFECT DIS, V161, P37, DOI 10.1093/infdis/161.1.37
   Hoellman DB, 2003, ANTIMICROB AGENTS CH, V47, P1148, DOI 10.1128/AAC.47.3.1148-1150.2003
   HUSSAIN M, 1991, J INFECT DIS, V163, P534, DOI 10.1093/infdis/163.3.534
   Jones SM, 2001, LANCET, V357, P40, DOI 10.1016/S0140-6736(00)03572-8
   KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117
   Mathur T, 2004, INT J ANTIMICROB AG, V24, P369, DOI 10.1016/j.ijantimicag.2004.04.012
   National Committee for Clinical Laboratory Standards, 2003, M7A6 NCCLS
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Pagano PJ, 2004, INT J ANTIMICROB AG, V23, P226, DOI 10.1016/j.ijantimicag.2003.07.012
   Raad I, 1998, LANCET, V351, P893, DOI 10.1016/S0140-6736(97)10006-X
   RAAD I, 1995, ANTIMICROB AGENTS CH, V39, P741
   Schwank S, 1998, ANTIMICROB AGENTS CH, V42, P895, DOI 10.1128/AAC.42.4.895
   Souli M, 1998, ANTIMICROB AGENTS CH, V42, P939, DOI 10.1128/AAC.42.4.939
   Stone G, 2002, ANTIMICROB AGENTS CH, V46, P2458, DOI 10.1128/AAC.46.8.2458.2461.2002
   Tosun I, 2005, MICROB DRUG RESIST, V11, P48, DOI 10.1089/mdr.2005.11.48
NR 24
TC 14
Z9 16
U1 0
U2 5
PU NATL INST INFECTIOUS DISEASES
PI TOKYO
PA JPN J INFECT DIS ED OFF NATL INST INFECTIOUS DISEASES TOYAMA 1-23-1,
   SHINJUKU-KU, TOKYO, 162-8640, JAPAN
SN 1344-6304
EI 1884-2836
J9 JPN J INFECT DIS
JI Jpn. J. Infect. Dis.
PD DEC
PY 2005
VL 58
IS 6
BP 353
EP 357
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA 000CS
UT WOS:000234439100005
PM 16377866
DA 2018-10-20
ER

PT J
AU Bigerelle, M
   Anselme, K
AF Bigerelle, M
   Anselme, K
TI A kinetic approach to osteoblast adhesion on biomaterial surface
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cell proliferation; modeling; cell adhesion
ID CELL-ADHESION; EXTRACELLULAR-MATRIX; MEMBRANE ADHESION; MECHANICS;
   PROTEINS; STICK; MODEL; GRIP
AB An incompletely understood question in the field of biomaterials is how eucaryotic cells adhere on material surfaces. The adhesion of cells on materials is generally studied after some hours. Because this evaluation after some hours cannot let us presume about the future of the cells on the material, we have developed a culture model that does allow study in the long term of an elaborate cell/material interface closer to the in vivo situation. For that, we used a progressive trypsin-based detachment method. Here we report on the mathematical modeling of long-term human primary osteoblastic cell adhesion on metallic substrates, which allows us to quantify the real adhesion simultaneously by taking into account the effect of cell proliferation. A time-dependent adhesion index t(d) is proposed, which varies with culture time t according to the power law: t(d)(t) = at(b), a being independent of b. The exponent b is equal to 0.5 +/- 0.03 and is independent of the substrate's characteristics, meaning that the long-term adhesion increases proportionally to the square root of culture time. On the contrary, the parameter a significantly depends on the material's nature, the surface's topography, and the surface chemistry of the substrate and is sufficient to characterize cell adhesion. From this relationship, we suggest that a diffusion-based process related to the kinetic of formation of extracellular matrix should be involved in long-term adhesion on materials. (c) 2005 Wiley Periodicals, Inc.
C1 Ctr Rech Royallieu, CNRS, UTC, Lab Roberval,FRE 2833, F-60205 Compiegne, France.
   CNRS, Lab Met Phys & Genie Mat, ENSAM Lille, Equipe Surfaces & Interfaces,UMR 8517, F-59046 Lille, France.
   CNRS, ICSI, UPR 9069, F-68057 Mulhouse, France.
RP Anselme, K (reprint author), Ctr Rech Royallieu, CNRS, UTC, Lab Roberval,FRE 2833, BP 20529, F-60205 Compiegne, France.
EM Karine.Anselme@uha.fr
OI Anselme, Karine/0000-0002-6669-205X; Maxence,
   Bigerelle/0000-0002-4144-245X
CR Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Anselme K, 2002, J BIOMED MATER RES, V60, P529, DOI 10.1002/jbm.10101
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   BELL GI, 1984, BIOPHYS J, V45, P1051, DOI 10.1016/S0006-3495(84)84252-6
   Bigerelle M, 2005, J BIOMED MATER RES A, V72A, P36, DOI 10.1002/jbm.a.30212
   Bigerelle M, 2003, J MATER SCI, V38, P2525, DOI 10.1023/A:1023929807546
   Bigerelle M, 2002, BIOMATERIALS, V23, P1563, DOI 10.1016/S0142-9612(01)00271-X
   Boulbitch A, 2001, BIOPHYS J, V81, P2743, DOI 10.1016/S0006-3495(01)75917-6
   Brochard-Wyart F, 2002, P NATL ACAD SCI USA, V99, P7854, DOI 10.1073/pnas.112221299
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   EVANS EA, 1985, BIOPHYS J, V48, P175, DOI 10.1016/S0006-3495(85)83770-X
   Garcia AJ, 2003, CELL BIOCHEM BIOPHYS, V39, P61, DOI 10.1385/CBB:39:1:61
   Geiger B, 2001, SCIENCE, V294, P1661, DOI 10.1126/science.1066919
   GERSTENFELD LC, 1993, J BONE MINER RES, V8, P1031
   Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485
   MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531
   Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609
   Pierres A., 2002, European Cells & Materials, V3, P31
   REES DA, 1977, NATURE, V267, P124, DOI 10.1038/267124a0
   Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002
   Schmoranzer J, 2000, J CELL BIOL, V149, P23, DOI 10.1083/jcb.149.1.23
   SHULL KR, 1995, J POLYM SCI POL PHYS, V33, P1417, DOI 10.1002/polb.1995.090330911
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   SLATER M, 1995, EXPERIENTIA, V51, P235, DOI 10.1007/BF01931104
   Vereb G, 2003, P NATL ACAD SCI USA, V100, P8053, DOI 10.1073/pnas.1332550100
   Zhu C, 2000, J BIOMECH, V33, P23, DOI 10.1016/S0021-9290(99)00163-3
NR 28
TC 17
Z9 21
U1 2
U2 5
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2005
VL 75A
IS 3
BP 530
EP 540
DI 10.1002/jbm.a.30473
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 982HW
UT WOS:000233149700004
PM 16116602
DA 2018-10-20
ER

PT J
AU De Franceschi, L
   Grigolo, B
   Roseti, L
   Facchini, A
   Fini, M
   Giavaresi, G
   Tschon, M
   Giardino, R
AF De Franceschi, L
   Grigolo, B
   Roseti, L
   Facchini, A
   Fini, M
   Giavaresi, G
   Tschon, M
   Giardino, R
TI Transplantation of chondrocytes seeded on collagen-based scaffold in
   cartilage defects in rabbits
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE autologous chondrocytes; biomaterial-seeded cells; cartilage defects;
   rabbit
ID ARTICULAR-CARTILAGE; REPAIR; ALGINATE; GRAFTS; MODEL
AB Recent success in tissue engineering by restoring cartilage defects by transplanting autologous chondrocyte cells on a three-dimensional scaffold has prompted the improvement of this therapeutic strategy. Here we describe a new approach investigating the healing of rabbit cartilage by means of autologous chondrocytes seeded on a biomaterial made of an equine collagen type I-based scaffold. Full-thickness defects were created bilaterally in the weight-bearing surface of the medial femoral condyle of both femora of New Zealand male rabbits. The wounds were then repaired by using both chondrocytes seeded on the biomaterial and biomaterial alone. Controls were similarly treated but received either no treatment or implants of the delivery substance. Histological examination of the reconstructed tissues at 1, 3, 6, and 12 months after transplantation showed that at 1 and 3 months there was no formation of reconstructed tissue in any of the groups evaluated; after 6 months there was evidence of a newly regenerated tissue with some fibrocartilaginous features only in the group treated with biomaterial-seeded cells, and at 12 months a more organized tissue was evident in the same group. With regards to the group transplanted with biomaterial alone and the untreated control group, there was no evidence of new tissue production. These results advocate the use of this collagen-based scaffold for further in vivo studies on large size animals and, finally, in human clinical trials for the treatment of knee cartilage defects. (c) 2005 Wiley Periodicals, Inc.
C1 Ist Ric Codivilla Putti, Lab Immunol & Genet, Ist Ortoped Rizzoli, I-40136 Bologna, Italy.
   Univ Bologna, Dipartimento Med Interna & Gastroenterol, I-40138 Bologna, Italy.
   Ist Ric Codivilla Putti, Serv Chirurg Sperimentale, Ist Ortoped Rizzoli, I-40136 Bologna, Italy.
   Univ Bologna, Dipartimento Med Clin & Biotecnol Applicate D Cam, I-40138 Bologna, Italy.
RP Grigolo, B (reprint author), Ist Ric Codivilla Putti, Lab Immunol & Genet, Ist Ortoped Rizzoli, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM grigolob@alma.unibo.it
RI Grigolo, Brunella/J-5417-2016; Fini, Milena/J-4808-2016
OI Grigolo, Brunella/0000-0002-3990-6745; Fini, Milena/0000-0002-3732-3570;
   Giavaresi, Gianluca/0000-0001-7843-5969
CR Breinan HA, 1997, J BONE JOINT SURG AM, V79A, P1439, DOI 10.2106/00004623-199710000-00001
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buckwalter JA, 2002, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000026073.30435.dc
   Chaipinyo K, 2004, J ORTHOPAED RES, V22, P446, DOI 10.1016/j.orthres.2003.07.001
   Cohen SB, 2003, BIOMATERIALS, V24, P2653, DOI 10.1016/S0142-9612(03)00058-9
   DANDY DJ, 1991, J BONE JOINT SURG BR, V73, P877
   Frenkel SR, 1997, J BONE JOINT SURG BR, V79B, P831, DOI 10.1302/0301-620X.79B5.7278
   Grigolo B, 2002, BIOMATERIALS, V23, P1187, DOI 10.1016/S0142-9612(01)00236-8
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   Grunder T, 2004, OSTEOARTHR CARTILAGE, V12, P559, DOI 10.1016/j.joca.2004.04.001
   Hangody L, 1998, ORTHOPEDICS, V21, P751
   HENDRICKSON DA, 1994, J ORTHOP RES, V12, P484
   Honorati MC, 2004, OSTEOARTHR CARTILAGE, V12, P683, DOI 10.1016/j.joca.2004.05.009
   Kawamura S, 1998, ACTA ORTHOP SCAND, V69, P56, DOI 10.3109/17453679809002358
   MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P460, DOI 10.2106/00004623-198264030-00022
   Marcacci M, 2002, KNEE SURG SPORT TR A, V10, P154, DOI 10.1007/s00167-001-0275-6
   Minas T, 1997, ORTHOPEDICS, V20, P525
   NEHER S, 1998, BIOMATERIALS, V19, P2313
   ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017
   Pavesio Alessandra, 2003, Novartis Found Symp, V249, P203
   Reinholz GG, 2004, BIOMATERIALS, V25, P1511, DOI 10.1016/S0142-9612(03)00498-8
   Rodrigo J.J., 1994, AM J KNEE SURG, V7, P109
   Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0
   SHINTARO Y, 2005, BIOMATERIALS, V26, P611
   Siebert CH, 2003, ARTHROSCOPY, V19, P182, DOI 10.1053/jars.2003.50000
   SPEER DP, 1979, CLIN ORTHOP RELAT R, P326
   Stanton JS, 1995, J MATER SCI-MATER M, V6, P739
NR 27
TC 35
Z9 35
U1 0
U2 3
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2005
VL 75A
IS 3
BP 612
EP 622
DI 10.1002/jbm.a.30471
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 982HW
UT WOS:000233149700012
PM 16108031
DA 2018-10-20
ER

PT J
AU Uttayarat, P
   Toworfe, GK
   Dietrich, F
   Lelkes, PI
   Composto, RJ
AF Uttayarat, P
   Toworfe, GK
   Dietrich, F
   Lelkes, PI
   Composto, RJ
TI Topographic guidance of endothelial cells on silicone surfaces with
   micro- to nanogrooves: Orientation of actin filaments and focal
   adhesions
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cell alignment; substrate topography; endothelial cells; focal
   adhesions; poly(dimethylsiloxane)
ID CONTACT GUIDANCE; QUANTITATIVE-ANALYSIS; MORPHOLOGY; SUBSTRATA;
   POLY(DIMETHYLSILOXANE); PROLIFERATION; FIBROBLASTS; BIOMATERIAL;
   POLYMERS; BEHAVIOR
AB To mimic the uniformly elongated endothelium in natural linear vessels, bovine aortic endothelial cells (BAECs) are cultured on micro- to nanogrooved, model poly(dimethylsiloxane) (PDMS) substrates preadsorbed with about 300 ng/cm(2) of fibronectin. BAEC alignment, elongation, and projected area were investigated for channel depths of 200 nm, 500 nm, 1 mu m, and 5 mu m, as well as smooth surfaces. Except for the 5 mu m case, the ridge and channel widths were held nearly constant about 3.5 mu m. With increasing channel depth, the percentage of aligned BAECs increased by factors of 2, 2, 1.8, and 1.7 for 1, 4, 24, and 48 h. Maximum alignment, about 90%, was observed for 1 mu m deep channels at 1 h. The alignment of BAECs on grooved PDMS was maintained at least until cells reached near confluence. F-actin and vinculin at focal adhesions also aligned with channel direction. Analysis of confocal microscopy images showed that focal adhesions localized at corners and along the sidewalls of 1-mu m deep channels. In contrast, focal adhesions could not form on the bottom of the 5-mu m deep channels. Cell proliferation was similar on grooved and smooth substrates. In summary, PDMS substrates engraved with micro- and nanochannels provide a powerful method for investigating the interplay between topography and cell/cytoskeletal alignment. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.
   Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.
RP Composto, RJ (reprint author), Univ Penn, Dept Mat Sci & Engn, 3451 Walnut St, Philadelphia, PA 19104 USA.
EM composto@seas.upenn.edu
CR Alberts B, 2002, MOL BIOL CELL
   Boal D., 2002, MECH CELL
   Britland S, 1996, EXP CELL RES, V228, P313, DOI 10.1006/excr.1996.0331
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   DEBRABER ET, 1998, J BIOMED MATER RES, V40, P291
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   denBraber ET, 1996, BIOMATERIALS, V17, P2037, DOI 10.1016/0142-9612(96)00032-4
   DUNN GA, 1976, EXP CELL RES, V101, P1, DOI 10.1016/0014-4827(76)90405-5
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   HEUSER JE, 1980, J CELL BIOL, V86, P212, DOI 10.1083/jcb.86.1.212
   HONG HL, 1987, J CELL SCI, V87, P259
   IZZARD CS, 1976, J CELL SCI, V21, P129
   Jiang XY, 2002, LANGMUIR, V18, P3273, DOI 10.1021/la011668+
   LIN HB, 1994, J BIOMED MATER RES, V28, P329, DOI 10.1002/jbm.820280307
   MANOLOPOULOS VG, 1995, J CELL BIOCHEM, V57, P590, DOI 10.1002/jcb.240570403
   Mathur AB, 2003, J BIOMED MATER RES A, V66A, P729, DOI 10.1002/jbm.a.10581
   Mathur AB, 2003, J BIOMED MATER RES A, V64A, P155, DOI 10.1002/jbm.a.10403
   MEYLE J, 1995, J BIOMED MATER RES, V29, P81, DOI 10.1002/jbm.820290112
   Murugesan G, 2002, CELL COMMUN ADHES, V9, P59, DOI 10.1080/15419060290116339
   Nerem R M, 1991, ASGSB Bull, V4, P87
   NEREM RM, 1981, J BIOMECH ENG-T ASME, V103, P172, DOI 10.1115/1.3138275
   OAKLEY C, 1993, J CELL SCI, V106, P343
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   SATO M, 1987, ARTERIOSCLEROSIS, V7, P276, DOI 10.1161/01.ATV.7.3.276
   Sidouni FZ, 2001, SURF SCI, V491, P355, DOI 10.1016/S0039-6028(01)01299-7
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   Tan J, 2002, BIOMATERIALS, V23, P3215, DOI 10.1016/S0142-9612(02)00074-1
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Teixeira AI, 2003, J VAC SCI TECHNOL B, V21, P683, DOI 10.1116/1.1545753
   Toworfe GK, 2004, J BIOMED MATER RES A, V71A, P449, DOI 10.1002/jbm.a.30164
   van Kooten TG, 1999, TISSUE ENG, V5, P223
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   WEISS P, 1945, J EXP ZOOL, V100, P353, DOI 10.1002/jez.1401000305
   Weiss P, 1934, J EXP ZOOL, V68, P393, DOI 10.1002/jez.1400680304
   Weiss P., 1941, GROWTH             S, V5, P163
   Wilson DJ, 2000, INTERFACE SCI, V8, P389, DOI 10.1023/A:1008735929894
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
NR 40
TC 126
Z9 129
U1 3
U2 48
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2005
VL 75A
IS 3
BP 668
EP 680
DI 10.1002/jbm.a.30478
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 982HW
UT WOS:000233149700018
PM 16110489
DA 2018-10-20
ER

PT J
AU Chan, BP
   So, KF
AF Chan, BP
   So, KF
TI Photochemical crosslinking improves the physicochemical properties of
   collagen scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE collagen; crosslinking; photosensitization; physicochemical properties
ID PHYSICAL-PROPERTIES; MATRICES; STABILIZATION; PRINCIPLES; MEMBRANES;
   PROTEINS; TISSUES
AB Collagen is a natural biomaterial with excellent biocompatibility. However, unprocessed collagen has low stability and weak mechanical strength, which limits its application in tissue engineering. The current study aimed to improve the physicochemical properties of collagen scaffolds by using photochemical crosslinking. Collagen gel was reconstituted and photochemically crosslinked by using laser irradiation in the presence of a photosensitizer. Scanning electron microscope was used to characterize the surface and cross-sectional morphology. Stress-strain relationship and other mechanical properties were determined by uniaxial tensile tests. Thermostability and water-binding capacities also were analyzed by using differential scanning calorimetry and swelling ratio measurements, respectively. Photochemically crosslinked porous structures showed fine microstructure with interconnected micron-sized pores, whereas uncrosslinked controls only showed macrosheet-like structures. The stabilizing effect of photochemical crosslinking also was revealed by retaining the three-dimensional lamellae-like structures after thermal analysis in crosslinked membranes but not in the controls. Photochemical crosslinking also significantly reduced the swelling ratio, improved the stress-strain relationship, peak load, ultimate stress, rupture strain, and tangent modulus of collagen membranes. The current study showed that an innovative photochemical crosslinking process was able to produce collagen scaffolds with fine microstructures; to strengthen, stiffen, and stabilize collagen membranes; and to modify their swelling ratio. This may broaden the use of collagen-based scaffolds in tissue engineering, particularly for weight-bearing tissues. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Hong Kong, Dept Mech Engn, Med Engn Program, Hong Kong, Hong Kong, Peoples R China.
   Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China.
RP Chan, BP (reprint author), Univ Hong Kong, Dept Mech Engn, Med Engn Program, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.
EM bpchan@hkucc.hku.hk
RI Chan, BP/C-1886-2009; So, Kwok Fai/C-4399-2009
CR Adams AK, 2001, J BIOMED MATER RES, V57, P582, DOI 10.1002/1097-4636(20011215)57:4<582::AID-JBM1205>3.0.CO;2-6
   Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066
   BALASUBRAMANIAN D, 1990, PHOTOCHEM PHOTOBIOL, V52, P761, DOI 10.1111/j.1751-1097.1990.tb08679.x
   Berman B, 1998, EUR J DERMATOL, V8, P591
   Bigi A, 2002, BIOMATERIALS, V23, P4827, DOI 10.1016/S0142-9612(02)00235-1
   Billiar K, 2001, J BIOMED MATER RES, V56, P101, DOI 10.1002/1097-4636(200107)56:1<101::AID-JBM1074>3.0.CO;2-6
   Chan BP, 2002, J SURG RES, V108, P77, DOI 10.1006/jsre.2002.6516
   CHAN BP, 2005, IN PRESS J SURG RES
   CHAN BP, 2005, P PHOT W SPIE
   Charulatha V, 2003, BIOMATERIALS, V24, P759, DOI 10.1016/S0142-9612(02)00412-X
   CHEUNG DT, 1985, CONNECT TISSUE RES, V13, P109, DOI 10.3109/03008208509152389
   FEENSTRA RPG, 1992, ARCH OPHTHALMOL-CHIC, V110, P984, DOI 10.1001/archopht.1992.01080190090035
   Friess W, 1996, BIOMATERIALS, V17, P2289, DOI 10.1016/0142-9612(96)00047-6
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   HOTT JL, 1992, PHOTOCHEM PHOTOBIOL, V56, P257, DOI 10.1111/j.1751-1097.1992.tb02155.x
   Itoh S, 2002, BIOMATERIALS, V23, P4475, DOI 10.1016/S0142-9612(02)00166-7
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   LANSCHE RK, 1965, AM J OPHTHALMOL, V60, P520, DOI 10.1016/0002-9394(65)90721-X
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee JE, 2001, YONSEI MED J, V42, P172, DOI 10.3349/ymj.2001.42.2.172
   LI ST, 2000, BIOMEDICAL ENG HDB, V42
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   PEPPAS NA, 1996, BIOMATERIALS SCI INT, P60
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   SIMMONS DM, 1993, BIOTECHNOL APPL BIOC, V17, P23
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   WEBSTER A, 1989, ANAL BIOCHEM, V179, P154, DOI 10.1016/0003-2697(89)90216-9
   Yannas I. V., 1996, BIOMATERIALS SCI INT, V1, P84
   Yova D, 2001, J BIOMED OPT, V6, P52, DOI 10.1117/1.1331559
NR 29
TC 56
Z9 56
U1 0
U2 21
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2005
VL 75A
IS 3
BP 689
EP 701
DI 10.1002/jbm.a.30469
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 982HW
UT WOS:000233149700020
PM 16106436
DA 2018-10-20
ER

PT J
AU Subramanian, A
   Lin, HY
AF Subramanian, A
   Lin, HY
TI Crosslinked chitosan: Its physical properties and the effects of matrix
   stiffness on chondrocyte cell morphology and proliferation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cartilage tissue engineering; chitosan scaffold; chondrocytes;
   crosslinking; biomaterial mechanical testing
ID COLLAGEN-GLYCOSAMINOGLYCAN MATRICES; MORPHOGENETIC PROTEIN-2 RHBMP-2;
   IN-VITRO; ARTICULAR-CARTILAGE; MEDIATED CONTRACTION; CANINE
   CHONDROCYTES; SCAFFOLDS; TISSUE; EXPRESSION; PHENOTYPE
AB Chitosan [beta(1-4)-2 amino-2-deOXy-D-glucose], the natural polyaminosaccharide derived from N-deacetylation of chitin [beta(1-4)-2 acetamide-2-deoxy-D-glucose], has been shown to possess attractive biological and cell interactive properties. Recently chitosan and chitosan analogs have also been shown to support the growth and continued function of chondrocytes. In the present study, chitosan substrates are crosslinked with a functional diepoxide (1,4 butanediol diglycidyl ether) to alter its mechanical property, and the viability and proliferation of the canine articular chondrocytes seeded on the crosslinked surface are further assayed. Of interest is the impact of substrate stiffness on the growth and proliferation of articular canine chondrocytes. Crosslinked scaffolds were also subjected to degradation by chitosanase to examine the impact of crosslinking on enzyme-assisted degradation. The hydrophilicity and compression modulus of the crosslinked surfaces were measured via contact-angle measurements and compression tests, respectively. Scanning electron microscopy (SEM) and fluorescent staining were used to observe the proliferation and morphology of chondrocyte cells on noncrosslinked and crosslinked surfaces. The crosslinked chitosan was found to be nontoxic to chondrocytes and more hydrophilic. Its compression modulus and stiffness increased, which may improve the scaffold resistance to wear and in vivo shrinkage once implanted. The increased stiffness also seemed to serve as an additional mechanical stimulus to promote chondrocyte growth and proliferation. The cell morphology on crosslinked scaffolds seen by SEM and fluorescent stain was the typical chondrocytic rounded shape. The method proposed provides a nontoxic way to increase the mechanical strength of the chitosan scaffolds. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Nebraska, Dept Chem Engn, Lincoln, NE 68588 USA.
RP Subramanian, A (reprint author), Univ Nebraska, Dept Chem Engn, 207 Othmer Hall, Lincoln, NE 68588 USA.
EM asubramanian2@unl.edu
OI Lin, Hsin-Yi/0000-0002-1401-1603
CR Akiyama S K, 1996, Hum Cell, V9, P181
   ARCANGELI A, 1993, J CELL BIOL, V122, P1131, DOI 10.1083/jcb.122.5.1131
   AULTHOUSE AL, 1989, IN VITRO CELL DEV B, V25, P659
   Benjamin M., 2003, European Journal of Morphology, V41, P3, DOI 10.1076/ejom.41.1.3.28102
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Chowdhury TT, 2004, BIOCHEM BIOPH RES CO, V318, P873, DOI 10.1016/j.bbrc.2004.04.107
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   Hirano S, 1996, Biotechnol Annu Rev, V2, P237, DOI 10.1016/S1387-2656(08)70012-7
   HORNBY JE, 1973, J EMBRYOL EXP MORPH, V30, P511
   Hsu SH, 2004, ARTIF ORGANS, V28, P693, DOI 10.1111/j.1525-1594.2004.00046.x
   Hung CT, 2004, ANN BIOMED ENG, V32, P35, DOI 10.1023/B:ABME.0000007789.99565.42
   Hunter CJ, 2004, OSTEOARTHR CARTILAGE, V12, P117, DOI 10.1016/j.joca.2003.08.009
   KIMURA T, 1984, CLIN ORTHOP RELAT R, P231
   Klokkevold PR, 1996, J PERIODONTOL, V67, P1170, DOI 10.1902/jop.1996.67.11.1170
   LeBaron RG, 2000, BIOMATERIALS, V21, P2575, DOI 10.1016/S0142-9612(00)00125-3
   Lee CR, 2003, J BIOMED MATER RES A, V64A, P560, DOI 10.1002/jbm.a.10443
   Lee CR, 2001, BIOMATERIALS, V22, P3145, DOI 10.1016/S0142-9612(01)00067-9
   Lee JE, 2004, ARTIF ORGANS, V28, P829, DOI 10.1111/j.1525-1594.2004.00020.x
   Ma L, 2004, J BIOMED MATER RES A, V71A, P334, DOI 10.1002/jbm.a.30170
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Mauck RL, 2002, ANN BIOMED ENG, V30, P1046, DOI 10.1114/1.1512676
   MUZZARELLI RAA, 1994, BIOMATERIALS, V15, P1075, DOI 10.1016/0142-9612(94)90093-0
   MUZZARELLI RAA, 1994, J BIOMAT SCI-POLYM E, V6, P541
   Nehrer S, 1998, BIOMATERIALS, V19, P2313, DOI 10.1016/S0142-9612(98)00143-4
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   OHTAKARA A, 1988, AGR BIOL CHEM TOKYO, V52, P3181, DOI 10.1080/00021369.1988.10869204
   Risbud M, 2001, CELL TRANSPLANT, V10, P755, DOI 10.3727/000000001783986224
   Rowin ME, 1998, J CELL PHYSIOL, V175, P193, DOI 10.1002/(SICI)1097-4652(199805)175:2<193::AID-JCP9>3.3.CO;2-9
   Roy S. K., 1998, US Patent, Patent No. 5770712
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Sellers RS, 1997, J BONE JOINT SURG AM, V79A, P1452, DOI 10.2106/00004623-199710000-00002
   Sellers RS, 2000, J BONE JOINT SURG AM, V82A, P151, DOI 10.2106/00004623-200002000-00001
   Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9
   Shelton JC, 2003, CELLS TISSUES ORGANS, V175, P140, DOI 10.1159/000074630
   Subramanian A, 2005, J BIOMAT SCI-POLYM E, V16, P861, DOI 10.1163/1568562054255682
   Toolan BC, 1996, J BIOMED MATER RES, V31, P273, DOI 10.1002/(SICI)1097-4636(199606)31:2<273::AID-JBM15>3.0.CO;2-M
   Torres DS, 2000, BIOMATERIALS, V21, P1607
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Veilleux NH, 2004, TISSUE ENG, V10, P119, DOI 10.1089/107632704322791763
   Wang Q, 2000, WOUND REPAIR REGEN, V8, P145, DOI 10.1046/j.1524-475x.2000.00145.x
   Wong M, 2003, BONE, V33, P685, DOI 10.1016/S8756-3282(03)00242-4
   Yokota H, 2003, J BIOL CHEM, V278, P47275, DOI 10.1074/jbc.M304652200
   Zaleskas JM, 2004, BIOMATERIALS, V25, P1299, DOI 10.1016/j.biomaterials.2003.08.005
NR 46
TC 90
Z9 95
U1 2
U2 34
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2005
VL 75A
IS 3
BP 742
EP 753
DI 10.1002/jbm.a.30489
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 982HW
UT WOS:000233149700025
PM 16110496
DA 2018-10-20
ER

PT J
AU Sousa, SR
   Moradas-Ferreira, P
   Barbosa, MA
AF Sousa, SR
   Moradas-Ferreira, P
   Barbosa, MA
TI TiO2 type influences fibronectin adsorption
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 19th Conference of the European-Society-for-Biomaterials
CY SEP 11-15, 2005
CL Sorrento, ITALY
SP European Soc Biomat
ID SERUM-ALBUMIN ADSORPTION; SELF-ASSEMBLED MONOLAYERS; CELL-ADHESION;
   TITANIUM SURFACES; SOLID-SURFACES; PROTEINS; PLASMA; DEPOSITION;
   MEMBRANES
AB Human fibronectin (FN) plays a key role in the biointegration of implants as the success depends on adsorption of proteins like FN [1]. Indeed FN can be an intermediary between the biomaterial surface and cells.
   The adsorption of human fibronectin (FN) on commercially pure titanium with a titanium oxide layer formed in a H2O2 solution (TiO2 cp) and TiO2 sputtered on Si (TiO2 sp) was studied. Adsorption isotherms and the work of adhesion were assessed by wettability studies, X-ray photoelectron spectroscopy (XPS), and by radiolabelling of FN with I-125, I-125-FN. Exchangeability of bound FN by free FN, was also evaluated by the radiolabelling technique.
   Contact angle determinations have shown that FN displays higher affinity for the TiO2 cp surface than for the TiO2 sp. As expected from the surface free energy values, the work of adhesion of FN is higher for the TiO2 cp substrate, the more hydrophilic one, and lower for the TiO2 sp substrate, the more hydrophobic one.
   The adsorption isotherms were evaluated by two different techniques: radiolabelling of FN (I-125-FN) and XPS. TiO2 cp adsorbs more FN than the TiO2 sp surfaces as shown by the radiolabelling data. FN molecules are also more strongly attached to the former surface as indicated by the work of adhesion and by the exchangeability studies. Results using I-125-FN also suggests that FN adsorbs as a multilayer for FN concentrations in solution higher than 100 mu g/mL. (C) 2005 Springer Science + Business Media, Inc.
C1 INEB, Inst Biomed Engn, Lab Biomat, P-4150180 Oporto, Portugal.
   Univ Porto, Fac Engn, Dept Met & Mat Engn, P-4200465 Oporto, Portugal.
   ISEP, Inst Super Engn Porto, Dept Engn Quim, P-4200072 Oporto, Portugal.
   ICBAS, IBMC, Inst Biol Mol & Celular, P-4150180 Oporto, Portugal.
RP Sousa, SR (reprint author), INEB, Inst Biomed Engn, Lab Biomat, R Campo Alegre 823, P-4150180 Oporto, Portugal.
EM ssousa@ibmc.up.pt
RI MORADAS-FERREIRA, PEDRO/E-6357-2012; Sousa, Susana/D-5356-2013; Barbosa,
   Mario/F-5964-2011
OI MORADAS-FERREIRA, PEDRO/0000-0003-2994-0314; Sousa,
   Susana/0000-0001-8018-4310; Barbosa, Mario/0000-0003-3568-7482
CR *AM INT PLC, 2003, IOD 125 GUID RAD TEC, V199, P64
   Amaral IF, 2005, J BIOMED MATER RES A, V75A, P387, DOI 10.1002/jbm.a.30436
   Auditore A, 2002, BIOMOL ENG, V19, P85, DOI 10.1016/S1389-0344(02)00042-4
   Bergkvist M, 2003, J BIOMED MATER RES A, V64A, P349, DOI 10.1002/jbm.a.10423
   do Serro APVA, 1999, J BIOMED MATER RES, V46, P376, DOI 10.1002/(SICI)1097-4636(19990905)46:3<376::AID-JBM10>3.0.CO;2-T
   Ferraz MP, 2001, BIOMATERIALS, V22, P3105, DOI 10.1016/S0142-9612(01)00059-X
   Gehanno V, 1999, IEEE T MAGN, V35, P4361, DOI 10.1109/20.799086
   HORBETT TA, 1994, COLLOID SURFACE B, V2, P225, DOI 10.1016/0927-7765(94)80037-5
   Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473
   Lima J, 2001, J BIOMED MATER RES, V55, P45, DOI 10.1002/1097-4636(200104)55:1<45::AID-JBM70>3.0.CO;2-0
   LINDBERG B, 1983, J COLLOID INTERF SCI, V95, P308, DOI 10.1016/0021-9797(83)90190-X
   Matsuura T, 2000, BIOMATERIALS, V21, P1121, DOI 10.1016/S0142-9612(99)00264-1
   MILLER R, 1993, COLLOID SURFACE, V69, P203, DOI 10.1016/0166-6622(93)80001-V
   NORDE W, 1992, COLLOID SURFACE, V66, P73, DOI 10.1016/0166-6622(92)80122-I
   NORDE W, 1986, ADV COLLOID INTERFAC, V25, P267, DOI 10.1016/0001-8686(86)80012-4
   Rouxhet L, 1998, J BIOMAT SCI-POLYM E, V9, P1279, DOI 10.1163/156856298X00398
   Serro APV, 1997, COLLOID SURFACE A, V125, P209, DOI 10.1016/S0927-7757(97)00017-4
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Sousa SR, 2004, LANGMUIR, V20, P9745, DOI 10.1021/la049158d
   SUKENIK CN, 1990, J BIOMED MATER RES, V24, P1307, DOI 10.1002/jbm.820241004
   TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039
   YU XJ, 1993, TEST PROCEDURES BLOO, P287
NR 24
TC 43
Z9 43
U1 1
U2 17
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2005
VL 16
IS 12
BP 1173
EP 1178
DI 10.1007/s10856-005-4725-4
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 994IE
UT WOS:000234024000017
PM 16362218
DA 2018-10-20
ER

PT J
AU Melnig, V
   Ciobanu, C
AF Melnig, V
   Ciobanu, C
TI Characterization of water-soluble polyamidhydroxyurethane for biological
   applications
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article; Proceedings Paper
CT 8th Romanian Biophysics Conference
CY MAY 26-28, 2005
CL Iasi, ROMANIA
DE water-soluble polymer; polyamidhydroxyurethane; water characterization
ID POLYURETHANE-UREA ELASTOMERS; CROSSLINKING; DICHROISM; POLYMER
AB Polyamidhydroxyurethane becomes in the presence of water, a non-biodegradable hydrogel with a high capability of water sorption, exhibiting rubbery behaviour and good biocompatibility. When prepared with less content of water and suitable mixing hydrogel components, this becomes a promising biomaterial for artificial hard/soft tissue in biomedical applications. In this paper, the less-water films of polyamidhydroxyurethane are discussed, and are analysed the nature of inter- and intra- molecular interactions. Using X-ray diffraction, optical microscopy with polarized light, steady-state linear dichroism, infrared and UV-ellipsometry, the network structure of water in film of polyamidhydroxyurethane was determined. Water exhibits a high degree of homogeneity and consists of three phases: a water phase of low polyamidhydroxyurethane concentration, an amorphous phase, and a crystalline phase that restricts the motion of the amorphous domains.
C1 Al I Cuza Univ, Fac Phys, Iasi 700506, Romania.
   Petru Poni Inst Macromol Chem, Iasi 700487, Romania.
RP Melnig, V (reprint author), Al I Cuza Univ, Fac Phys, Bd Carol 1,Nr 11A, Iasi 700506, Romania.
EM vmelnig@uaic.ro
RI Cuza, UAIC/D-2604-2009
CR BONART R, 1974, J MACROMOL SCI PHYS, VB  9, P447, DOI 10.1080/00222347408204548
   BORN L, 1985, COLLOID POLYM SCI, V263, P335, DOI 10.1007/BF01412250
   Chen YC, 2004, MATER RES SOC SYMP P, V787, P35
   CIOBANU C, 1985, Patent No. 935721412
   DIPERRERA, 1995, POLYM INT, V36, P1985
   ESTES GM, 1971, MACROMOLECULES, V4, P452, DOI 10.1021/ma60022a018
   ISHIHARA H, 1974, J MACROMOL SCI PHYS, VB 10, P591, DOI 10.1080/00222347408219408
   ISHIMASA T, 1983, JPN J APPL PHYS 1, V22, P6, DOI 10.1143/JJAP.22.6
   KOENIG JL, 1992, SPECTROSCOPY POLYM
   Melnig V, 2005, J OPTOELECTRON ADV M, V7, P2521
   MELNIG V, 2005, J MEMBRANE SCI  0707
   Onu A, 1998, REV ROUM CHIM, V43, P565
   ONU A, 2000, ANN STIINTIFICE U C, V8, P297
   ONU A, 2001, AI I CUZALASI S C, V9, P81
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Schoonover JR, 2001, POLYM DEGRAD STABIL, V74, P87, DOI 10.1016/S0141-3910(01)00105-7
   SUNG CSP, 1977, MACROMOLECULES, V10, P452, DOI 10.1021/ma60056a041
   Tang ZG, 2000, COLLOID SURFACE B, V19, P19, DOI 10.1016/S0927-7765(00)00134-X
   Wu PY, 2003, CHEM PHYS LETT, V374, P74, DOI 10.1016/S0009-2614(03)00691-2
NR 19
TC 14
Z9 14
U1 0
U2 1
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD DEC
PY 2005
VL 7
IS 6
BP 2809
EP 2814
PG 6
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA 994JG
UT WOS:000234027300003
DA 2018-10-20
ER

PT J
AU Kangwantrakool, S
   Takenaka, A
   Suwanprateeb, J
   Shinohara, K
AF Kangwantrakool, S
   Takenaka, A
   Suwanprateeb, J
   Shinohara, K
TI Preparation of biomaterials composite with mechanically coated particles
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article
DE coated particle; rotational impact blending; elliptical-rotor-type
   mixer; composite biomaterials
ID HYDROXYAPATITE-REINFORCED POLYETHYLENE; CREEP
AB New preparation routes have been investigated for enhancing mechanical properties of a biomaterial composite consisting of with high-density polyethylene (HDPE) reinforced with hydroxyapatite (HA). HA was used as fine particles to coat each coarse particle of HDPE with an elliptical-rotor-type mixer and with a high-speed rotational impact blending machine. The effect of particle size of HDPE and mixing conditions were studied on mechanical properties of the composite material, such as rotor speed, total treatment time, number of preparation steps and total volume fraction of HA. In comparison, it was found that the embedment besides uniform coating and dispersion of HA fine particles onto the surface of HDPE core particle was easily achieved by rotational impact blending, due to high impact energy. This yielded relatively high properties. However, multi-coating steps or layers were required due to a high percentage of powder loss during operation. In contrast, uniform and tight coating of core particles was performed without particle loss by elliptical-rotor-type mixing. Nevertheless, due to a slight embedment of fine particles by gentle shear and compressive stress, HA could not disperse uniformly due to aggregates generated by the molten HDPE of core particles escaped through the thick and loose coating layer during material formation. This resulted in a weak bonding among coated particles to yield lower mechanical properties.
C1 Suranaree Univ Technol, Sch Ceram Engn, Inst Engn, Nakhon Ratchasima 30000, Thailand.
   Hokkaido Univ, Grad Sch Engn, Div Engn & Mat Sci, Kita Ku, Sapporo, Hokkaido 0608628, Japan.
   Minist Sci Technol & Environm, Natl Met & Mat Technol Ctr, Pathum Thani 12120, Thailand.
RP Kangwantrakool, S (reprint author), Suranaree Univ Technol, Sch Ceram Engn, Inst Engn, Nakhon Ratchasima 30000, Thailand.
RI Suwanprateeb, Jintamai/A-9008-2011
OI Suwanprateeb, Jintamai/0000-0002-5555-3927
CR Bonfield W, 1988, Ann N Y Acad Sci, V523, P173, DOI 10.1111/j.1749-6632.1988.tb38510.x
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   Kangwantrakool S, 2001, J CHEM ENG JPN, V34, P1486, DOI 10.1252/jcej.34.1486
   Pfeffer R, 2001, POWDER TECHNOL, V117, P40, DOI 10.1016/S0032-5910(01)00314-X
   Suwanprateeb J, 1997, J MATER SCI-MATER M, V8, P469, DOI 10.1023/A:1018522025474
   Suwanprateeb J, 1998, J BIOMED MATER RES, V39, P16, DOI 10.1002/(SICI)1097-4636(199801)39:1<16::AID-JBM3>3.0.CO;2-L
   TANNER KE, 1994, BRIT CERAM T, V93, P104
   Wang M, 1998, BIOMATERIALS, V19, P2357, DOI 10.1016/S0142-9612(98)00154-9
   WANG M, 1994, BRIT CERAM T, V93, P91
   WANG M, 1997, P 11 INT C COMP MAT, V1, P488
NR 10
TC 0
Z9 0
U1 0
U2 2
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD DEC
PY 2005
VL 113
IS 1324
BP 768
EP 773
DI 10.2109/jcersj.113.768
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 991WC
UT WOS:000233844100002
OA Bronze
DA 2018-10-20
ER

PT J
AU Kuroda, D
   Tanaka, Y
   Kawasaki, H
   Asami, K
   Hanawa, T
AF Kuroda, D
   Tanaka, Y
   Kawasaki, H
   Asami, K
   Hanawa, T
TI Characterization of surface oxide film formed on Ti-8Fe-8Ta-4Zr
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE beta-type titanium alloy; corrosion resistance; surface composition;
   simulated body environment; biomaterial
ID RAY PHOTOELECTRON-SPECTROSCOPY; TITANIUM-ALLOYS; MECHANICAL-PROPERTIES;
   XPS; CHROMIUM; BEHAVIOR; IRON
AB We have already developed a novel beta-type titanium alloy, Ti-8Fe-8Ta-4Zr, for biomedical applications. Ti-8Fe-8Ta-4Zr showed higher strength than conventional biomedical titanium alloys, such as Ti-6Al-4V ELI. Ti-6Al-7Nb, and Ti-13Nb-13Zr. In addition. the alloy also showed higher corrosion resistance than cp-Ti and Ti-6Al-4V ELI in Hanks' solution. In particular, the breakdown potential of the alloy (the pitting potential) was over 3.5 V vs. SCE (saturated calomel electrode) and much higher than those of cp-Ti and Ti-6Al-4V ELI. A slightly active region was observed at about 1.7 V vs. SCE that may be related to the high breakdown potential.
   In this study, the surface oxide films on Ti-8Fe-8Ta-4Zr after anodic polarization at I and 3 V in Hanks' solution were characterized using X-ray photoelectron spectroscopy and Auger electron spectroscopy to elucidate the high corrosion resistance mechanism of the alloy in Hanks' solution. In addition, the surface oxide film on the alloy before anodic polarization was also characterized for comparison.
   The surface oxide film on Ti-8Fe-8Ta-4Zr is grown with anodic polarization. Calcium phosphate is formed on the alloy after polarization. The corrosion resistance of the alloy after polarization at a potential above 1.7 V is improved by the concentration of iron and titanium in the surface oxide film. A titanium hyper-oxidized layer with a low iron concentration is observed within the surface oxide film. This layer is generated with polarization and worked as a corrosion-protective layer. The slight active region on the polarization curve may be caused by the dissolution of iron and titanium.
C1 Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 3050044, Japan.
   Shibaura Inst Technol, Minato Ku, Tokyo 1088548, Japan.
   Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
   Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
RP Hanawa, T (reprint author), Japan Lifeline Co Ltd, Tokyo 1740041, Japan.
EM hanawa.met@tmd.ac.jp
CR Ahmed T., 1996, TITANIUM 95 SCI TECH, P1760
   ASAMI K, 1984, CORROS SCI, V24, P83, DOI 10.1016/0010-938X(84)90039-8
   ASAMI K, 1990, CORROS SCI, V31, P727, DOI 10.1016/0010-938X(90)90188-B
   ASAMI K, 1993, CORROS SCI, V35, P43, DOI 10.1016/0010-938X(93)90131-Y
   ASAMI K, 1976, J ELECTRON SPECTROSC, V9, P469, DOI 10.1016/0368-2048(76)80065-5
   ASAMI K, 1977, CORROS SCI, V17, P559, DOI 10.1016/S0010-938X(77)80002-4
   ASAMI K, 1977, CORROS SCI, V17, P713, DOI 10.1016/0010-938X(77)90067-1
   Asami K., 1985, P 6 EUR S CORR BEH A, P769
   BHATTACHARJEE A, 2000, TITANIUM 99, P537
   DAVIDSON JA, Patent No. 5169597
   FUJII H, 1996, TITANIUM 95, P2309
   HAMMOND JS, 1981, CORROS SCI, V21, P239, DOI 10.1016/0010-938X(81)90033-0
   Hanawa T, 2002, MATER TRANS, V43, P3000, DOI 10.2320/matertrans.43.3000
   HANAWA T, 1992, J JPN I MET, V56, P1168, DOI 10.2320/jinstmet1952.56.10_1168
   HANAWA T, 1992, APPL SURF SCI, V55, P269, DOI 10.1016/0169-4332(92)90178-Z
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   HASHIMOTO K, 1977, BOSHOKU GIJUTSU, V26, P445
   Hiromoto S, 2004, BIOMATERIALS, V25, P979, DOI 10.1016/S0142-9612(03)00620-3
   Inoue K, 1998, TETSU TO HAGANE, V84, P206, DOI 10.2355/tetsutohagane1955.84.3_206
   Inoue K, 1998, TETSU TO HAGANE, V84, P790, DOI 10.2355/tetsutohagane1955.84.11_790
   KIM JH, 1992, CORROS SCI, V33, P1507, DOI 10.1016/0010-938X(92)90029-3
   Kuroda D, 2005, MAT SCI ENG C-BIO S, V25, P312, DOI 10.1016/j.msec.2005.04.004
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Li PJ, 1998, J BIOMED MATER RES, V41, P341, DOI 10.1002/(SICI)1097-4636(19980905)41:3<341::AID-JBM1>3.0.CO;2-C
   ONG JL, 1995, J MATER SCI-MATER M, V6, P113, DOI 10.1007/BF00120418
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
   SHIMIZU R, 1989, JITSUYO OHJE DENSHIB, P222
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Wagner C.D., 1990, PRACTICAL SURFACE AN, V1, P595
   Wagner CD, 1979, HDB XRAY PHOTOELECTR, P74
NR 30
TC 2
Z9 2
U1 1
U2 9
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD DEC
PY 2005
VL 46
IS 12
BP 3015
EP 3019
DI 10.2320/matertrans.46.3015
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 005TK
UT WOS:000234846500081
OA Bronze
DA 2018-10-20
ER

PT J
AU Vogt, S
   Kuhn, KD
   Gopp, U
   Schnabelrauch, M
AF Vogt, S
   Kuhn, KD
   Gopp, U
   Schnabelrauch, M
TI Resorbable antibiotic coatings for bone substitutes and implantable
   devices
SO MATERIALWISSENSCHAFT UND WERKSTOFFTECHNIK
LA English
DT Article
DE antibiotic coatings; gentamicin; local antibiotic therapy; bone
   substitutes; metallic implants
ID INFECTIONS; RELEASE; GENTAMICIN; DELIVERY; SYSTEMS
AB Antibiotic delivery systems based on biodegradable coatings have found considerable interest for the prophylaxis and local therapy of biomaterial-related infections. In this study sparingly water-soluble gentamicin salts have been prepared and tested as biodegradable antibiotic-releasing coating systems. Using the coating systems, homogeneous, well adhering films can be produced on various implant materials, like ceramics, glasses or metals surfaces, with different surface morphologies. The in vitro release profiles of the antibiotic coating systems were characterized by an initial burst release followed by a sustained release of small antibiotic amounts up to several weeks. It was found that the in vitro release, especially in the initial phase, can be modulated by the ratio between highly water-soluble gentamicin salts and sparingly soluble ones in the coating. Coating systems of the same type as described for gentamicin are available from a wide range of antibiotics differing in structure and mechanism of antibacterial action. Based on these results, the developed antibiotic coatings offer new perspectives to prevent and treat biomaterial-related infections.
C1 Innovent Technol eV, Bereich Biomat, D-07745 Jena, Germany.
   Heraeus Kulzet GmbH & Co KG, Wehrheim, Germany.
RP Schnabelrauch, M (reprint author), Innovent Technol eV, Bereich Biomat, Pruessingstr 27B, D-07745 Jena, Germany.
EM ms@innovent-jena.de
CR ANDERSON AB, 2003, MED DEVICE TECHNOL, P16
   Armarego W. L. F., 1996, PURIFICATION LAB CHE
   Blaker JJ, 2004, BIOMATERIALS, V25, P1319, DOI 10.1016/j.biomaterials.2003.08.007
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   Gollwitzer H, 2003, J ANTIMICROB CHEMOTH, V51, P585, DOI 10.1093/jac/dkg105
   Holtom Paul D, 2003, Instr Course Lect, V52, P745
   Hume EBH, 2004, BIOMATERIALS, V25, P5023, DOI 10.1016/j.biomaterials.2004.01.048
   Jeon HJ, 2003, BIOMATERIALS, V24, P4921, DOI 10.1016/S0142-9612(03)00415-0
   Kanellakopoulou K, 2000, DRUGS, V59, P1223, DOI 10.2165/00003495-200059060-00003
   KUHN KD, 2000, BONE CEMENTS, P149
   Lucke M, 2003, BONE, V32, P521, DOI 10.1016/S8756-3282(03)00050-4
   NIES B, 1998, BIOMATERIALS SURG, P52
   Price JS, 1996, J BIOMED MATER RES, V30, P281, DOI 10.1002/(SICI)1097-4636(199603)30:3<281::AID-JBM2>3.0.CO;2-M
   RUSHTON N, 1997, EUR J SURG S, V578, P27
   SAFDAR N, 2002, ANN INTERN MED, V11, P834
   Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052
   Sivakumar M, 2003, J BIOMED MATER RES A, V65A, P222, DOI 10.1002/jbm.a.10495
   SOLER AJ, 1975, Patent No. 2517600
   VOGEL J, 1997, BIOCERAMICS, V10, P57
   Vogt S, 2003, MATERIALWISS WERKST, V34, P1041, DOI 10.1002/mawe.200300701
   VOGT S, 2002, Patent No. 10227935
NR 21
TC 8
Z9 8
U1 0
U2 0
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0933-5137
J9 MATERIALWISS WERKST
JI Materialwiss. Werkstofftech.
PD DEC
PY 2005
VL 36
IS 12
BP 814
EP 819
DI 10.1002/mawe.200500963
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 001GF
UT WOS:000234520900009
DA 2018-10-20
ER

PT J
AU Chen, MT
   Weiss, R
AF Chen, MT
   Weiss, R
TI Artificial cell-cell communication in yeast Saccharomyces cerevisiae
   using signaling elements from Arabidopsis thaliana
SO NATURE BIOTECHNOLOGY
LA English
DT Article
ID MAMMALIAN-CELLS; GENE-EXPRESSION; TRANSCRIPTION CONTROL; FLUORESCENT
   PROTEIN; HISTIDINE; SYSTEM; KINASE; BIOSYNTHESIS; NETWORKS; SKN7P
AB The construction of synthetic cell-cell communication networks can improve our quantitative understanding of naturally occurring signaling pathways and enhance our capabilities to engineer coordinated cellular behavior in cell populations. Towards accomplishing these goals in eukaryotes, we developed and analyzed two artificial cell-cell communication systems in yeast. We integrated Arabidopsis thaliana signal synthesis and receptor components with yeast endogenous protein phosphorylation elements and new response promoters. In the first system, engineered yeast 'sender' cells synthesize the plant hormone cytokinin, which diffuses into the environment and activates a hybrid exogenous/endogenous phosphorylation signaling pathway in nearby engineered yeast 'receiver' cells. For the second system, the sender network was integrated into the receivers under positive-feedback regulation, resulting in population density-dependent gene expression (that is, quorum sensing). The combined experimental work and mathematical modeling of the systems presented here can benefit various biotechnology applications for yeast and higher level eukaryotes, including fermentation processes, biomaterial fabrication and tissue engineering.
C1 Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA.
   Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.
RP Weiss, R (reprint author), Princeton Univ, Dept Elect Engn, J319,Engn Quadrangle,Olden St, Princeton, NJ 08544 USA.
EM rweiss@princeton.edu
CR Bardwell L, 2004, PEPTIDES, V25, P1465, DOI 10.1016/j.peptides.2003.10.022
   Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461
   Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101
   Bulter T, 2004, P NATL ACAD SCI USA, V101, P2299, DOI 10.1073/pnas.0306484101
   Chen H, 2004, P NATL ACAD SCI USA, V101, P5048, DOI 10.1073/pnas.0401416101
   Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398
   Ferber D, 2004, SCIENCE, V303, P158, DOI 10.1126/science.303.5655.158
   Guelman R, 2002, BONE, V30, P943
   Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002
   Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117
   Janiak-Spens F, 2000, MOL MICROBIOL, V37, P136, DOI 10.1046/j.1365-2958.2000.01973.x
   Janiak-Spens F, 2000, J BACTERIOL, V182, P6673, DOI 10.1128/JB.182.23.6673-6678.2000
   Kakimoto T, 2003, J PLANT RES, V116, P233, DOI 10.1007/s10265-003-0095-5
   Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101
   Kramer BP, 2004, BIOTECHNOL BIOENG, V87, P478, DOI 10.1002/bit.20142
   Li S, 1998, EMBO J, V17, P6952, DOI 10.1093/emboj/17.23.6952
   Li S, 2002, MOL BIOL CELL, V13, P412, DOI 10.1091/mbc.01-09-0434
   Lu JMY, 2003, EUKARYOT CELL, V2, P1304, DOI 10.1128/EC.2.6.1304-1314.2003
   MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0
   Mateus C, 2000, YEAST, V16, P1313, DOI 10.1002/1097-0061(200010)16:14<1313::AID-YEA626>3.0.CO;2-O
   Melcher K, 2000, GENE, V247, P53, DOI 10.1016/S0378-1119(00)00124-4
   Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165
   Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89
   MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767
   MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7
   Neddermann P, 2003, EMBO REP, V4, P159, DOI 10.1038/sj.embor.embor734
   Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130
   Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037
   Takei K, 2004, J BIOL CHEM, V279, P41866, DOI 10.1074/jbc.M406337200
   Takei K, 2001, J BIOL CHEM, V276, P26405, DOI 10.1074/jbc.M102130200
   Toman PD, 2000, J BIOL CHEM, V275, P23303, DOI 10.1074/jbc.M002284200
   Weber W, 2005, J GENE MED, V7, P518, DOI 10.1002/jgm.682
   Weiss R., 2003, Natural Computing, V2, P47, DOI 10.1023/A:1023307812034
   WEISS R, 2001, LECT NOTES COMPUTER, P2054
   Wildt S, 2005, NAT REV MICROBIOL, V3, P119, DOI 10.1038/nrmicro1087
   Williams SC, 2004, J BACTERIOL, V186, P2281, DOI 10.1128/JB.186.8.2281-2287.2004
   You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491
NR 37
TC 126
Z9 127
U1 2
U2 38
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1087-0156
EI 1546-1696
J9 NAT BIOTECHNOL
JI Nat. Biotechnol.
PD DEC
PY 2005
VL 23
IS 12
BP 1551
EP 1555
DI 10.1038/nbt1162
PG 5
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 992ED
UT WOS:000233866300032
PM 16299520
DA 2018-10-20
ER

PT J
AU Robinson, TN
   Clarke, JH
   Schoen, J
   Walsh, MD
AF Robinson, TN
   Clarke, JH
   Schoen, J
   Walsh, MD
TI Major mesh-related complications following hernia repair - Events
   reported to the Food and Drug Administration
SO SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
LA English
DT Article
DE mesh; complications; hernia repair; FDA database review
ID POLYPROPYLENE MESH; ABDOMINAL-WALL; IN-VIVO; POLYTETRAFLUOROETHYLENE
   MESH; INCISIONAL HERNIAS; ADHESION FORMATION; SUTURE; MODEL
AB Mesh material affects complications following hernia repair. Medical device reports on the use of surgical mesh for hernia repair were reviewed from the Food and Drug Administration's (FDA) Manufacturer User Facility Device Experience Database from January 1996 to September 2004. We analyzed 252 adverse event reports related to the use of surgical mesh for hernia repair. Adverse events included infection (42%, 107 reports), mechanical failure (18%, 46), pain (9%, 23). reaction (8%, 20), intestinal complications (7%, 18), adhesions (6%, 14), seroma (4%, 9), erosion (2%, 6), and other (4%, 9). Compared to all other mesh types, Sepra/ polypropylene mesh had more mechanical failures (80 vs 14%, p < 0.05), biomaterial mesh had more reactions (57 vs 7%, p < 0.05), polytetrafluoroethylene (PTFE)/ polypropylene mesh had more intestinal complications (14 vs 7%, p < 0.05), and PTFE mesh tended to have more infections (75 vs 41% all other, p = 0.07). Death occurred in 2% (5). We conclude that specific mesh materials are related to specific complications.
C1 Univ Colorado, Hlth Sci Ctr, Dept Surg, Denver, CO 80262 USA.
RP Robinson, TN (reprint author), Univ Colorado, Hlth Sci Ctr, Dept Surg, 4200 E 9th Ave,Box C311, Denver, CO 80262 USA.
RI Walsh, Mark/F-2054-2010
CR Baptista ML, 2000, SURGERY, V128, P86, DOI 10.1067/msy.2000.106810
   Burger JWA, 2004, ANN SURG, V240, P578
   Diaz JJ, 2004, AM SURGEON, V70, P396
   Fitzgibbons RJ, 2002, NYHUS CONDONS HERNIA
   Klinge U, 1998, EUR J SURG, V164, P965
   Klinge U, 2002, J BIOMED MATER RES, V63, P765, DOI 10.1002/jbm.10449
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603
   Matthews BD, 2005, J SURG RES, V123, P227, DOI 10.1016/j.jss.2004.08.012
   Matthews BD, 2003, J SURG RES, V114, P126, DOI 10.1016/S0022-4804(03)00158-6
   Menon NG, 2003, ANN PLAS SURG, V50, P523, DOI 10.1097/01.SAP.0000044252.76804.6B
   Pans A, 1998, WORLD J SURG, V22, P479, DOI 10.1007/s002689900420
   Riepe G, 1997, EUR J VASC ENDOVASC, V13, P540, DOI 10.1016/S1078-5884(97)80062-7
   Schmedt CG, 2005, SURG ENDOSC, V19, P188, DOI 10.1007/s00464-004-9126-0
   Schumpelick V, 2003, BRIT J SURG, V90, P1457, DOI 10.1002/bjs.4385
   SIMMERMACHER RKJ, 1994, J AM COLL SURGEONS, V178, P613
   USHER FC, 1962, JAMA-J AM MED ASSOC, V179, P780, DOI 10.1001/jama.1962.03050100034006b
   WOLSTENHOLME JT, 1956, ARCH SURG-CHICAGO, V73, P1004
NR 18
TC 104
Z9 108
U1 1
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0930-2794
J9 SURG ENDOSC
JI Surg. Endosc.
PD DEC
PY 2005
VL 19
IS 12
BP 1556
EP 1560
DI 10.1007/s00464-005-0120-y
PG 5
WC Surgery
SC Surgery
GA 993DV
UT WOS:000233933800007
PM 16211441
DA 2018-10-20
ER

PT J
AU Landa, N
   Feinberg, MS
   Holbova, R
   Miller, L
   Cohen, S
   Leor, J
AF Landa, N
   Feinberg, MS
   Holbova, R
   Miller, L
   Cohen, S
   Leor, J
TI Novel injectable alginate biomaterial attenuates progressive infarct
   expansion and preserves left ventricular systolic and diastolic function
   late after myocardial infarction
SO CIRCULATION RESEARCH
LA English
DT Meeting Abstract
CT Scientific Meeting of the American-Heart-Association
CY NOV 13-16, 2005
CL Dallas, TX
SP Amer Heart Assoc
C1 Tel Aviv Univ, Tel Hashomer, Israel.
   Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel.
RI Leor, Jonathan/O-2930-2017; COHEN, SMADAR/F-1901-2012
NR 0
TC 0
Z9 0
U1 1
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA
SN 0009-7330
J9 CIRC RES
JI Circ.Res.
PD NOV 25
PY 2005
VL 97
IS 11
MA 5013
BP 1202
EP 1203
PG 2
WC Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular
   Disease
SC Cardiovascular System & Cardiology; Hematology
GA 986OZ
UT WOS:000233460900033
DA 2018-10-20
ER

PT J
AU Wang, XY
   Kim, HJ
   Xu, P
   Matsumoto, A
   Kaplan, DL
AF Wang, XY
   Kim, HJ
   Xu, P
   Matsumoto, A
   Kaplan, DL
TI Biomaterial coatings by stepwise deposition of silk fibroin
SO LANGMUIR
LA English
DT Article
ID BOMBYX-MORI SILK; BY-LAYER ASSEMBLIES; MARROW STEM-CELLS; IN-VITRO;
   ALTERNATING BIOACTIVITY; MULTILAYER FILMS; HUMAN BLOOD; SCAFFOLDS;
   POLYELECTROLYTES; PROCOAGULATION
AB A completely aqueous, stepwise deposition process with Bombyx mori silk fibroin for the assembly of nanoscale thin film coatings is reported the first time. The focus of this work was to develop an understanding of the control of this deposition process and to characterize the films formed from a physicochemical perspective. The deposition process was monitored by UV spectrophotometry and research quartz crystal microbalance. Both absorbance and film thickness correlated linearly with the number of silk fibroin layers deposited, analogous to multilayered materials fabricated from conventional polyelectrolytes. The polymer adsorption process was stable and reproducible, with control of a single layer thickness ranging from a few to tens of nanometers, determined by the concentrations of silk fibroin, salt concentration in the dipping solution, and method of rinsing. The driving force for the assembly of silk fibroin onto the substrate was primarily hydrophobic interactions, while some electrostatic interactions were also involved. The difference with this approach from traditional polyelectrolyte layer-by-layer techniques is that an intervening drying step is used to control the structure and stability of the self-assembled silk fibroin. The assembled films were stable under physiological conditions and supported human bone marrow stem cell adhesion, growth, and differentiation. This approach offers new options to engineer biomaterial coatings as well as bulk materials with control of both interfacial properties conducive to specific cellular or tissue responses and the potential to entrap and deliver labile molecules or other components due to the all-aqueous process described.
C1 Tufts Univ, Dept Biomed Engn, Bioengn & Biotechnol Ctr, Medford, MA 02115 USA.
   Tufts Univ, Dept Biol & Chem Engn, Bioengn & Biotechnol Ctr, Medford, MA 02115 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Bioengn & Biotechnol Ctr, Medford, MA 02115 USA.
EM david.kplan@tufts.edu
RI Matsumoto, Akira/B-6935-2011
FU NIBIB NIH HHS [EB003210, EB002520]
CR ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   FISHER P, 2000, MACROMOLECULES, V33, P1100
   GRANT GGS, 2001, BIOMED MICRODEVICES, V4, P301
   HAMMOND PT, 2000, CURR OPIN COLLOID IN, V4, P430
   He SJ, 1999, INT J BIOL MACROMOL, V24, P187, DOI 10.1016/S0141-8130(99)00004-5
   Hossain KS, 2003, J PHYS CHEM B, V107, P8066, DOI 10.1021/jp0224490i
   ILER RK, 1966, J COLLOID INTERF SCI, V21, P569, DOI 10.1016/0095-8522(66)90018-3
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   JIN HJ, 2005, ADV FUNCT MATER, V15, P1
   Jin W, 2001, J AM CHEM SOC, V123, P8121, DOI 10.1021/ja015807l
   Johnston APR, 2005, NANO LETT, V5, P953, DOI 10.1021/nl050608b
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kotov NA, 1999, NANOSTRUCT MATER, V12, P789, DOI 10.1016/S0965-9773(99)00237-8
   Ladam G, 2001, LANGMUIR, V17, P878, DOI 10.1021/la0013087
   LOJOU E, 2003, LANGMUIR, V20, P748
   Lvov Y, 2001, NANO LETT, V1, P125, DOI 10.1021/nl0100015
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Nam J, 2001, J APPL POLYM SCI, V81, P3008, DOI 10.1002/app.1751
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   PARK WH, 2001, FIBER POLYM, V2, P58, DOI DOI 10.1007/BF02875259
   ROBINSON DR, 1965, J AM CHEM SOC, V87, P2470, DOI 10.1021/ja01089a029
   Sakabe H., 1989, SEN-I GAKKAISHI, V45, P487
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Serizawa T, 2002, BIOMACROMOLECULES, V3, P724, DOI 10.1021/bm0200027
   Serizawa T, 2000, BIOMACROMOLECULES, V1, P306, DOI 10.1021/bm000006g
   Shimazaki Y, 1998, LANGMUIR, V14, P2768, DOI 10.1021/la9713457
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Stockton WB, 1997, MACROMOLECULES, V30, P2717, DOI 10.1021/ma9700486
   Tiourina OP, 2001, MACROMOL BIOSCI, V1, P209, DOI 10.1002/1616-5195(20010701)1:5<209::AID-MABI209>3.0.CO;2-Y
   Zhang JT, 2004, LANGMUIR, V20, P8015, DOI 10.1021/la048888i
NR 40
TC 106
Z9 116
U1 4
U2 72
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD NOV 22
PY 2005
VL 21
IS 24
BP 11335
EP 11341
DI 10.1021/la051862m
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 985IQ
UT WOS:000233371200060
PM 16285808
DA 2018-10-20
ER

PT J
AU Stine, R
   Pishko, MV
   Hampton, JR
   Dameron, AA
   Weiss, PS
AF Stine, R
   Pishko, MV
   Hampton, JR
   Dameron, AA
   Weiss, PS
TI Heat-stabilized phospholipid films: Film characterization and the
   production of protein-resistant surfaces
SO LANGMUIR
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; BOVINE SERUM-ALBUMIN; SOLID SUPPORTS;
   ADSORPTION; ADHESION; BILAYERS; BIOMEMBRANES; MECHANISMS; MICROSCOPY;
   INTERFACE
AB Phospholipid films have been shown in a number of studies to exhibit potential as nonfouling surfaces for biomaterial applications. However, the practical application of such films has been hindered by instability in aqueous solutions and significant detachment under mild shear stresses. Methods for stabilizing lipid films have been investigated, but to date require the presence of specific functional groups or chemical modification of the lipid molecule. In contrast to these methods, we present a process for heat-stabilization of lipid films. These heat-stabilized films have been shown to be able to withstand repeated rinsing without significant detachment. Phosphatidylcholine monolayers were formed on hydrophobic self-assembled monolayers using the liposome fusion method and stabilized at 80 degrees C. The films were characterized using Fourier transform infrared spectroscopy, ellipsometry, and atomic force microscopy and were shown to be defect free after repeated rinsing. Further experiments using a quartz crystal microbalance showed that the heat-stabilized lipid films were highly resistant to nonspecific protein adhesion and compared very favorably with poly(ethylene glycol)-coated surfaces under identical exposure conditions.
C1 Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.
   Penn State Univ, Dept Chem, University Pk, PA 16802 USA.
   Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.
RP Pishko, MV (reprint author), Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.
EM mpishko@engr.psu.edu
RI Stine, Rory/C-6709-2013; Hampton, Jennifer/A-7836-2008; Weiss,
   Paul/A-2575-2011
OI Hampton, Jennifer/0000-0003-3953-5435; Weiss, Paul/0000-0001-5527-6248
FU NIBIB NIH HHS [EB000684-01]
CR BOUGHTON BJ, 1984, BIOCHEM BIOPH RES CO, V119, P1174, DOI 10.1016/0006-291X(84)90899-4
   Brechling A, 2003, THIN SOLID FILMS, V433, P281, DOI 10.1016/S0040-6090(03)00351-1
   CHAPMAN D, 1993, LANGMUIR, V9, P39, DOI 10.1021/la00025a012
   CHEN YL, 1991, J PHYS CHEM-US, V95, P10736, DOI 10.1021/j100179a041
   Cho D, 1997, LANGMUIR, V13, P4710, DOI 10.1021/la970348g
   Cremer PS, 1999, J PHYS CHEM B, V103, P2554, DOI 10.1021/jp983996x
   Elbert DL, 1998, CHEM BIOL, V5, P177, DOI 10.1016/S1074-5521(98)90062-X
   Glasmastar K, 2002, J COLLOID INTERF SCI, V246, P40, DOI 10.1006/jcis.2001.8060
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   Kim K, 2004, BIOMATERIALS, V25, P33, DOI 10.1016/S0142-9612(03)00469-1
   Lee DH, 2004, LANGMUIR, V20, P8124, DOI 10.1021/la049448u
   Liu YH, 1996, LANGMUIR, V12, P1235, DOI 10.1021/la950504o
   Lu JR, 1999, LANGMUIR, V15, P6975, DOI 10.1021/la990131h
   MALMSTEN M, 1995, J COLLOID INTERF SCI, V172, P106, DOI 10.1006/jcis.1995.1231
   Mitev DJ, 2002, COLLOID SURFACE B, V24, P185, DOI 10.1016/S0927-7765(01)00245-4
   Murphy EF, 2000, MACROMOLECULES, V33, P4545, DOI 10.1021/ma991642d
   Nakamura T, 2002, ELECTROCHIM ACTA, V47, P2407, DOI 10.1016/S0013-4686(02)00045-2
   Nakamura T, 2002, ELECTROCHEM COMMUN, V4, P521, DOI 10.1016/S1388-2481(02)00365-X
   PALEGROSDEMANGE C, 1991, J AM CHEM SOC, V113, P12, DOI 10.1021/ja00001a002
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Qian YL, 2003, LANGMUIR, V19, P6056, DOI 10.1021/la0267701
   Rodgers K, 1998, FERTIL STERIL, V69, P403, DOI 10.1016/S0015-0282(97)00574-8
   Ross EE, 2003, LANGMUIR, V19, P1766, DOI 10.1021/la026198d
   Ross EE, 2001, LANGMUIR, V17, P2305, DOI 10.1021/la010752
   Rowe-Taitt CA, 2000, ANAL BIOCHEM, V281, P123, DOI 10.1006/abio.2000.4571
   Stine R, 2005, ANAL CHEM, V77, P2882, DOI 10.1021/ac048126s
   Stine R, 2004, LANGMUIR, V20, P6501, DOI 10.1021/la049554w
   Tang ZY, 2000, LANGMUIR, V16, P1696, DOI 10.1021/la981491s
   van der Vegte EW, 2000, LANGMUIR, V16, P3249, DOI 10.1021/la990911q
   Winger TM, 1999, LANGMUIR, V15, P3866, DOI 10.1021/la980990q
   Wisniewski N, 2000, FRESEN J ANAL CHEM, V366, P611, DOI 10.1007/s002160051556
   YOSHIZAWA H, 1993, J PHYS CHEM-US, V97, P4128, DOI 10.1021/j100118a033
NR 33
TC 11
Z9 11
U1 1
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD NOV 22
PY 2005
VL 21
IS 24
BP 11352
EP 11356
DI 10.1021/la051150w
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 985IQ
UT WOS:000233371200062
PM 16285810
DA 2018-10-20
ER

PT J
AU Li, YL
   Neoh, KG
   Cen, L
   Kang, ET
AF Li, YL
   Neoh, KG
   Cen, L
   Kang, ET
TI Porous and electrically conductive polypyrrole-poly(vinyl alcohol)
   composite and its applications as a biomaterial
SO LANGMUIR
LA English
DT Article
ID GLUCOSE-OXIDASE; POLY(VINYL ALCOHOL); NEURITE OUTGROWTH; SURFACE
   FUNCTIONALIZATION; PROTEIN ADSORPTION; STATIONARY PHASES; EVAL
   MEMBRANES; DYE BINDING; THIN-FILMS; IN-VITRO
AB Bulk modification of polypyrrole (PPY) with poly(vinyl alcohol) (PVA) was carried out by the electropolymerization of pyrrole in the presence of PVA in the reaction solution, with tetraethylammonium perchlorate (TEAP) as the electrolyte. The surface morphology of the as-synthesized PPY-TEAP-PVA film was investigated using scanning electron microscopy, and the film was further characterized using X-ray photoelectron spectroscopy, electrical conductivity, the water contact angle, and BET surface area measurements. The PPY-TEAP-PVA composite is electrically conductive, hydrophilic, and microporous with a high surface area. Its potential as a biomaterial was investigated with respect to its blood compatibility and function as a substrate for biosensor fabrication and cell culture. The presence of PVA in the film attenuates blood protein adsorption, and the porous nature of the PPY-TEAP-PVA film results in a 10-fold increase in the amount of glucose oxidase covalently immobilized on the film over that on a nonporous PPY film. PC 12 cell attachment and growth on the PPY-TEAP-PVA film was also shown to be enhanced compared with that on tissue culture polystyrene. The attached cells proliferated and formed a monolayer on the film surface after 48 h of seeding.
C1 Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 119260, Singapore.
RP Neoh, KG (reprint author), Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 119260, Singapore.
EM chenkg@nus.edu.sg
RI Kang, En-Tang/G-8522-2012
OI Kang, En-Tang/0000-0003-0599-7834; Neoh, Koon Gee/0000-0002-2700-1914
CR ADAMS JC, 1990, CELL, V63, P425, DOI 10.1016/0092-8674(90)90175-E
   AKESON R, 1986, EXP CELL RES, V162, P347, DOI 10.1016/0014-4827(86)90340-X
   ASHWELL GJ, 1992, MOL ELECT, P65
   Azioune A, 2002, LANGMUIR, V18, P1150, DOI 10.1021/la010444o
   Barrett DA, 2001, ANAL CHEM, V73, P5232, DOI 10.1021/ac010368u
   Baumgartner JN, 1998, J BIOMED MATER RES, V40, P660, DOI 10.1002/(SICI)1097-4636(19980615)40:4<660::AID-JBM18>3.0.CO;2-J
   BIDAN G, 1992, SENSOR ACTUAT B-CHEM, V6, P45, DOI 10.1016/0925-4005(92)80029-W
   BLACKMAN CF, 1993, FASEB J, V7, P801
   BONDE M, 1992, ANAL BIOCHEM, V200, P195, DOI 10.1016/0003-2697(92)90298-L
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   CALICETI P, 1993, J BIOACT COMPAT POL, V8, P41, DOI 10.1177/088391159300800103
   Cen L, 2003, BIOSENS BIOELECTRON, V18, P363, DOI 10.1016/S0956-5663(02)00149-5
   Cosnier S, 1999, BIOSENS BIOELECTRON, V14, P443, DOI 10.1016/S0956-5663(99)00024-X
   Coupe B, 2001, MACROMOLECULES, V34, P1533, DOI 10.1021/ma001685q
   DAMON DH, 1988, J CELL PHYSIOL, V135, P293, DOI 10.1002/jcp.1041350217
   DEBENEDETTO GE, 1994, J CHEM SOC FARADAY T, V90, P1495, DOI 10.1039/ft9949001495
   ELGHANNAM A, 1995, J BIOMED MATER RES, V29, P359, DOI 10.1002/jbm.820290311
   GILGES M, 1994, ANAL CHEM, V66, P2038, DOI 10.1021/ac00085a019
   Goodman S L, 1991, J Biomater Sci Polym Ed, V2, P147, DOI 10.1163/156856291X00133
   Guiomar AJ, 1999, LANGMUIR, V15, P1198, DOI 10.1021/la980974t
   GUISEPPIELIE A, 1995, LANGMUIR, V11, P1768, DOI 10.1021/la00005a055
   HAILIN G, 1989, ANAL CHEM, V61, P198, DOI 10.1021/ac00178a002
   JANDA P, 1991, J ELECTROANAL CHEM, V300, P119, DOI 10.1016/0022-0728(91)85388-6
   KANG IK, 1993, BIOMATERIALS, V14, P787, DOI 10.1016/0142-9612(93)90045-4
   KIANI MS, 1992, POLYMER, V33, P4113, DOI 10.1016/0032-3861(92)90614-3
   KO JM, 1990, J ELECTROCHEM SOC, V137, P905, DOI 10.1149/1.2086576
   KULIK EA, 1993, BIOMATERIALS, V14, P763, DOI 10.1016/0142-9612(93)90041-Y
   LEONARD M, 1995, J CHROMATOGR B, V664, P39, DOI 10.1016/0378-4347(94)00347-8
   Li YL, 2003, BIOTECHNOL BIOENG, V84, P305, DOI 10.1002/bit.10757
   Liu HC, 2004, BIOMATERIALS, V25, P4047, DOI 10.1016/j.biomaterials.2003.10.098
   MENKO AS, 1987, CELL, V51, P51, DOI 10.1016/0092-8674(87)90009-2
   Nash DC, 1997, J CHROMATOGR A, V758, P53, DOI 10.1016/S0021-9673(96)00710-8
   RUCKENSTEIN E, 1991, J APPL POLYM SCI, V42, P925, DOI 10.1002/app.1991.070420406
   SALMON M, 1982, MOL CRYST LIQ CRYST, V83, P1297
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Schuhmann W, 1995, MIKROCHIM ACTA, V121, P1, DOI 10.1007/BF01248237
   *SIGM CHEM CO, SIGM QUAL CONTR TEST
   Small CJ, 1997, POLYM GELS NETW, V5, P251, DOI 10.1016/S0966-7822(96)00044-5
   SMITH AB, 1991, J APPL POLYM SCI, V43, P399, DOI 10.1002/app.1991.070430219
   Street G.B., 1982, MOL CRYST LIQ CRYST, V83, P253
   SUZUKI M, 1986, MACROMOLECULES, V19, P1804, DOI 10.1021/ma00161a005
   USMANI AM, 1994, ACS SYM SER, V556, P2
   Van der Pauw L.J., 1958, Philips Research Reports, V13, P1
   Verghese MM, 1998, J APPL POLYM SCI, V70, P1447, DOI 10.1002/(SICI)1097-4628(19981121)70:8<1447::AID-APP3>3.0.CO;2-4
   Wallace G. G., 2003, CONDUCTIVE ELECTROAC, P51
   Wallace GG, 2002, ADV MATER, V14, P953, DOI 10.1002/1521-4095(20020705)14:13/14<953::AID-ADMA953>3.0.CO;2-T
   WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   Yang JM, 2001, J MEMBRANE SCI, V187, P159, DOI 10.1016/S0376-7388(01)00340-4
   Young TH, 1998, BIOMATERIALS, V19, P717, DOI 10.1016/S0142-9612(98)00187-2
   Young TH, 2001, BIOMATERIALS, V22, P1771, DOI 10.1016/S0142-9612(00)00337-9
   Zhang X, 1996, J APPL POLYM SCI, V60, P625
NR 52
TC 56
Z9 57
U1 2
U2 44
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD NOV 8
PY 2005
VL 21
IS 23
BP 10702
EP 10709
DI 10.1021/la0514314
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 982AQ
UT WOS:000233129500072
PM 16262340
DA 2018-10-20
ER

PT J
AU Ganazzoli, F
   Raffaini, G
AF Ganazzoli, F
   Raffaini, G
TI Computer simulation of polypeptide adsorption on model biomaterials
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID STRETCHED-EXPONENTIAL APPROXIMATION; NONENTANGLED POLYMER MELTS;
   SELF-ASSEMBLED MONOLAYERS; DYNAMIC STRUCTURE FACTOR; ATOMIC-FORCE
   MICROSCOPY; DER-WAALS CONTRIBUTIONS; X-RAY REFLECTIVITY; PROTEIN
   ADSORPTION; MOLECULAR-DYNAMICS; CONFORMATIONAL-CHANGES
AB When biomaterials are inserted in a biological environment, for instance in a body implant, proteins do quickly adsorb on the exposed surface. Such process is of fundamental importance, since it directs the subsequent cell adhesion. Here we review recent advances in this field obtained with molecular simulations. While coarse-grained models can provide important general results, as it has long been recognized in polymer science, the hierarchical structure of a very complex copolymer such as a protein, together with the nature of the biomaterial surface suggest that atomistic models are better suited to investigate these phenomena. Thus, after briefly mentioning some common features of coarse-grained and atomistic force fields, we first discuss early theoretical and coarse-grained simulation results about protein adsorption, and then we highlight the main results recently obtained by us with atomistic models. In particular, we discuss some conformational and energetic aspects of the adsorption of protein fragments with different secondary structure on surfaces of different wettability, including hydrophobic graphite and hydrophilic poly(vinylalcohol). We also consider other features, such as the simulation of the materials wettability, the hydration of the adsorbed fragments, their kinetics of spreading, and the sequential adsorption of two protein fragments on top of each other, highlighting the results of general interest.
C1 Politecn Milan, Dipartimento Chim Mat & Ingn Chim G Natta, I-20131 Milan, Italy.
RP Ganazzoli, F (reprint author), Politecn Milan, Dipartimento Chim Mat & Ingn Chim G Natta, Via L Mancinelli 7, I-20131 Milan, Italy.
EM Fabio.Ganazzoli@polimi.it
RI Raffaini, Giuseppina/N-1578-2014; Ganazzoli, Fabio/F-9543-2013
OI Raffaini, Giuseppina/0000-0003-3462-6514; Ganazzoli,
   Fabio/0000-0002-9762-4535
CR *ACC INC, 2000, INSIGHTII 2000 CERIU
   Agashe M, 2005, LANGMUIR, V21, P1103, DOI 10.1021/la0478364
   ALLEN MP, 1987, COMPUTER SIMULATION
   ARRIGHI V, 2003, PHYS REV LETT, V90, P58301
   Asthagiri D, 1997, LANGMUIR, V13, P6761, DOI 10.1021/la970608u
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   BINDER K, 1995, MONTE CARLO MOL DYNA, P433
   BRASH JL, 1995, ACS S SERIES, V602
   Buijs J, 1996, LANGMUIR, V12, P1605, DOI 10.1021/la950665s
   CATELLS V, 2002, PHYS REV E, V65, P31912
   Cormack AN, 2004, J PHYS CHEM B, V108, P20408, DOI 10.1021/jp0463417
   DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106
   Debenedetti PG, 2001, NATURE, V410, P259, DOI 10.1038/35065704
   deGennes PG, 1979, SCALING CONCEPTS POL
   DILL KA, 1995, PROTEIN SCI, V4, P561
   Euston SR, 2004, CURR OPIN COLLOID IN, V9, P321, DOI 10.1016/j.cocis.2004.09.005
   Frenkel D., 2001, UNDERSTANDING MOL SI
   Ganazzoli F, 2003, CHEM PHYS, V287, P391, DOI 10.1016/S0301-0104(02)01027-3
   Ganazzoli F, 2002, PHYS CHEM CHEM PHYS, V4, P3734, DOI 10.1039/b203338k
   Ganazzoli F, 1998, J CHEM PHYS, V108, P9924, DOI 10.1063/1.476431
   Ganazzoli F, 2000, J CHEM PHYS, V112, P1547, DOI 10.1063/1.480701
   GANAZZOLI F, 1995, MACROMOLECULES, V28, P5285, DOI 10.1021/ma00119a018
   ISRAELACHVILI JN, 1992, INTERMOLECULAR SURFA
   Jurlewicz A, 2000, ACTA PHYS POL B, V31, P1077
   Kim DT, 2002, LANGMUIR, V18, P5841, DOI 10.1021/la0256331
   Kroes GJ, 2002, ACCOUNTS CHEM RES, V35, P193, DOI 10.1021/ar010104u
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Leonhard K, 2003, PHYS CHEM CHEM PHYS, V5, P5291, DOI 10.1039/b305414d
   Liu SM, 2004, J COLLOID INTERF SCI, V275, P458, DOI 10.1016/j.jcis.2004.02.075
   Lundqvist M, 2004, LANGMUIR, V20, P10639, DOI 10.1021/la0484725
   MAPLE JR, 1988, P NATL ACAD SCI USA, V85, P5350, DOI 10.1073/pnas.85.15.5350
   MAZUR S, 1991, J NON-CRYST SOLIDS, V131, P348, DOI 10.1016/0022-3093(91)90327-3
   METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114
   MONTROLL EW, 1984, J STAT PHYS, V34, P129, DOI 10.1007/BF01770352
   Morra M, 2001, WATER BIOMATERIAL SU
   Moulin AM, 1999, LANGMUIR, V15, P8776, DOI 10.1021/la990416u
   Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4
   NOINVILLE V, 1995, J PHYS CHEM-US, V99, P1516, DOI 10.1021/j100005a023
   NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334
   Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545
   Pande VS, 2000, REV MOD PHYS, V72, P259, DOI 10.1103/RevModPhys.72.259
   Petrash S, 1997, BIOTECHNOL PROGR, V13, P635, DOI 10.1021/bp970068r
   PRESS WH, 1992, NUMERICAL RECIPES FO
   Rabani E, 1999, PHYS REV LETT, V82, P3649, DOI 10.1103/PhysRevLett.82.3649
   Raffaini G, 2004, J PHYS CHEM B, V108, P13850, DOI 10.1021/jp0477452
   Raffaini G, 2004, LANGMUIR, V20, P3371, DOI 10.1021/la0357716
   Raffaini G, 2003, LANGMUIR, V19, P3403, DOI 10.1021/la026853h
   RAFFAINI G, IN PRESS J BIOMED A
   RAFFAINI G, UNPUB
   RAFFAINI G, 2004, NATO SCI SERIES 2, V177, P203
   Ravichandran S, 2001, J PHYS CHEM B, V105, P3610, DOI 10.1021/jp010223r
   Richmond GL, 2002, CHEM REV, V102, P2693, DOI 10.1021/cr0006876
   ROTH CM, 1993, LANGMUIR, V9, P962, DOI 10.1021/la00028a015
   ROTH CM, 1995, LANGMUIR, V11, P3500, DOI 10.1021/la00009a036
   Sheller NB, 1998, LANGMUIR, V14, P4535, DOI 10.1021/la970916s
   STAHLBERG J, 1991, ANAL CHEM, V63, P1867, DOI 10.1021/ac00017a036
   STAHLBERG J, 1992, ANAL CHEM, V64, P3118, DOI 10.1021/ac00048a009
   SUN H, 1994, J AM CHEM SOC, V116, P2978, DOI 10.1021/ja00086a030
   THEODOROU DN, 1986, MACROMOLECULES, V19, P139, DOI 10.1021/ma00155a022
   VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98
   WARNER HR, 1972, IND ENG CHEM FUND, V11, P379, DOI 10.1021/i160043a017
   WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216
   WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051
   Wertz CF, 1999, LANGMUIR, V15, P8884, DOI 10.1021/la990089q
   Wertz CF, 2001, LANGMUIR, V17, P3006, DOI 10.1021/la0017781
   WILLIAMS G, 1970, T FARADAY SOC, V66, P80, DOI 10.1039/tf9706600080
   YAMAKAWA H, 1971, MODERN THEORY POLYM
   YOON DY, 1995, MONTE CARLO MOL DYNA, P433
   Young TH, 2000, J BIOMED MATER RES, V50, P490, DOI 10.1002/(SICI)1097-4636(20000615)50:4<490::AID-JBM4>3.0.CO;2-N
   Yu CH, 2000, J MOL STRUCT, V556, P95, DOI 10.1016/S0022-2860(00)00655-4
   Zhdanov VP, 1998, PROTEINS, V30, P168, DOI 10.1002/(SICI)1097-0134(19980201)30:2<168::AID-PROT6>3.0.CO;2-J
   Zhdanov VP, 2001, PROTEINS, V42, P481, DOI 10.1002/1097-0134(20010301)42:4<481::AID-PROT70>3.0.CO;2-N
NR 73
TC 52
Z9 52
U1 0
U2 29
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PD NOV 7
PY 2005
VL 7
IS 21
BP 3651
EP 3663
DI 10.1039/b506813d
PG 13
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 986ED
UT WOS:000233432000014
PM 16358011
DA 2018-10-20
ER

PT J
AU Simicevic, N
AF Simicevic, N
TI Three-dimensional FDTD simulation of biomaterial exposure to
   electromagnetic nanopulses
SO PHYSICS IN MEDICINE AND BIOLOGY
LA English
DT Article
ID TIME-DOMAIN FORMULATION; DIELECTRIC RESONATOR; MAXWELLS EQUATIONS;
   NUMERICAL-SOLUTION; HIGH PERMITTIVITY; PROPAGATION; SCATTERING; PULSES;
   MEDIA; MODEL
AB Ultra-wideband (UWB) electromagnetic pulses of nanosecond duration, or nanopulses, have recently been approved by the Federal Communications Commission for a number of different applications. They are also being explored for applications in biotechnology and medicine. The simulation of the propagation of a nanopulse through biological matter, previously performed using a two-dimensional finite-difference time-domain (FDTD) method, has been extended here into a full three-dimensional computation. To account for the UWB frequency range, the geometrical resolution of the exposed sample was 0.25 mm and the dielectric properties of biological matter were accurately described in terms of the Debye model. The results obtained from the three-dimensional computation support the previously obtained results: the electromagnetic field inside a biological tissue depends on the incident pulse rise time and width, with increased importance of the rise time as the conductivity increases; no thermal effects are possible for the low pulse repetition rates, supported by recent experiments. New results show that the dielectric sample exposed to nanopulses behaves as a dielectric resonator. For a sample in a cuvette, we obtained the dominant resonant frequency and the Q-factor of the resonator.
C1 Louisiana Tech Univ, Ctr Appl Phys Studies, Ruston, LA 71272 USA.
RP Simicevic, N (reprint author), Louisiana Tech Univ, Ctr Appl Phys Studies, POB 10348, Ruston, LA 71272 USA.
EM neven@phys.latech.edu
CR Antar YMM, 1998, MICROW OPT TECHN LET, V19, P158, DOI 10.1002/(SICI)1098-2760(19981005)19:2<158::AID-MOP17>3.0.CO;2-1
   Balanis C. A., 1989, ADV ENG ELECTROMAGNE
   DVORAK SL, 1995, IEEE T ELECTROMAGN C, V37, P192, DOI 10.1109/15.385883
   Faulkner E.A., 1969, INTRO THEORY LINEAR
   Findlay RP, 2005, PHYS MED BIOL, V50, P3825, DOI 10.1088/0031-9155/50/16/011
   GABRIEL C, 1996, ALOETR19960037
   Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002
   HARMS PH, 1992, IEEE T MICROW THEORY, V40, P741, DOI 10.1109/22.127524
   Harrington R. F., 1961, TIME HARMONIC ELECTR
   Hu Q, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.031914
   Jackson J D, 1999, CLASSICAL ELECTRODYN
   Kajfez D., 1986, DIELECTRIC RESONATOR
   KO WL, 1991, IEEE T MICROW THEORY, V39, P2176, DOI 10.1109/22.106561
   Kunz K.S., 1993, FINITE DIFFERENCE TI
   LUEBBERS R, 1990, IEEE T ELECTROMAGN C, V32, P222, DOI 10.1109/15.57116
   LUEBBERS RJ, 1991, IEEE T ANTENN PROPAG, V39, P29, DOI 10.1109/8.64431
   LUEBBERS RJ, 1992, IEEE T ANTENN PROPAG, V40, P12
   MILLER RL, 2002, P 2 INT WORKSH BIOL
   Mongia RK, 1997, IEEE T ANTENN PROPAG, V45, P1348, DOI 10.1109/8.623123
   NAVARRO A, 1991, IEEE T MICROW THEORY, V39, P14, DOI 10.1109/22.64599
   Pereda J. A., 1992, IEEE Microwave and Guided Wave Letters, V2, P431, DOI 10.1109/75.165633
   POLK C, 1995, HDB BIOL EFFECTS ELE
   Sadiku M.N.O., 1992, NUMERICAL TECHNIQUES
   SAMN S, 1999, AFRLHEBRTR19990291
   Schoenbach KH, 2004, P IEEE, V92, P1122, DOI 10.1109/JPROC.2004.829009
   Simicevic N, 2005, PHYS MED BIOL, V50, P347, DOI 10.1088/0031-9155/50/2/012
   Sullivan D. M., 2000, ELECTROMAGNETIC SIMU
   TAFLOVE A, 1975, IEEE T MICROW THEORY, V23, P623, DOI 10.1109/TMTT.1975.1128640
   Taflove A, 2000, COMPUTATIONAL ELECTR
   Taylor J. D., 1995, INTRO ULTRA WIDEBAND
   van de Kamer JB, 2001, INT J HYPERTHER, V17, P123
   VANBLADEL J, 1975, IEEE T MICROW THEORY, VMT23, P208, DOI 10.1109/TMTT.1975.1128529
   VANBLADEL J, 1975, IEEE T MICROW THEORY, VMT23, P199, DOI 10.1109/TMTT.1975.1128528
   Vernier PT, 2004, BIOPHYS J, V86, P4040, DOI 10.1529/biophysj.103.037945
   Yang P, 2004, APPL OPTICS, V43, P4611, DOI 10.1364/AO.43.004611
   YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302
NR 36
TC 8
Z9 8
U1 0
U2 0
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0031-9155
J9 PHYS MED BIOL
JI Phys. Med. Biol.
PD NOV 7
PY 2005
VL 50
IS 21
BP 5041
EP 5053
DI 10.1088/0031-9155/50/21/007
PG 13
WC Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Radiology, Nuclear Medicine & Medical Imaging
GA 991EJ
UT WOS:000233794800007
PM 16237240
DA 2018-10-20
ER

PT J
AU Li, J
   Gong, YD
   Zhao, NM
   Zhang, XF
AF Li, J
   Gong, YD
   Zhao, NM
   Zhang, XF
TI Preparation of N-butyl chitosan and study of its physical and biological
   properties
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE chitosan; alkylation; mechanical property; biocompatibility; osteoblast
ID NERVE-CELL AFFINITY; ALKYLATED CHITOSAN; SYNTHETIC HYDROGELS; PH;
   DELIVERY; BEHAVIOR; ALBUMIN; BINDING; DRUG
AB N-Butyl chitosans with different substitution degrees were prepared by solid-liquid heterogeneous reaction, varying the ratio of chitosan to butyl bromide. FTIR and free amino percentage analysis confirmed that the substitution reaction occurred primarily on NH2 moieties. X-ray diffraction results of the chitosan derivatives showed that the hydrogen bonds were weakened by the incorporation of pendant alkyl. N-Butyl chitosan films exhibited a higher elastic modulus, a lower percentage of elongation at break, decreased equilibrium swelling ratios, and slightly increased surface hydrophobicity compared to chitosan film. The results of ELISA indicated that the adsorption amount of fibronectin on butyl chitosan films was much higher than on chitosan film, which was maybe due to the rearrangement of hydrophilicity/hydrophobicity after modification. The MTT assay suggested that the viability and proliferation of osteoblast cells on N-butyl chitosan films were higher than that on chitosan film. These results suggest that N-butyl chitosan is a promising candidate biomaterial for bone regeneration. (c) 2005 Wiley Periodicals, Inc.
C1 Tsing Hua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.
RP Zhang, XF (reprint author), Tsing Hua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.
EM zxf-dbs@mail.tsinghua.edu.cn
CR BARNES A, 1988, POLYMER, V29, P2191, DOI 10.1016/0032-3861(88)90111-5
   Cai KY, 2002, J BIOMAT SCI-POLYM E, V13, P53, DOI 10.1163/156856202753525936
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   CORKHILL PH, 1990, POLYMER, V31, P1526, DOI 10.1016/0032-3861(90)90161-Q
   DONG YM, 2001, J CELLULOSE SCI TECH, V9, P42
   Georgiou HM, 2001, PROTEOMICS, V1, P1503, DOI 10.1002/1615-9861(200111)1:12<1503::AID-PROT1503>3.0.CO;2-M
   Gong HP, 2000, J BIOMED MATER RES, V52, P285
   Itoh S, 2003, SCI TECHNOL ADV MAT, V4, P261, DOI 10.1016/S1468-6996(03)00049-4
   JIANG TD, 1996, MANUFACTURE TECHNOLO, P91
   JUDITH GH, 1981, DEV BIOL, V87, P256
   KWUNCHIT O, 1997, INT J PHARM, V156, P229
   Li F, 2002, BIOMATERIALS, V23, P343, DOI 10.1016/S0142-9612(01)00111-9
   Liu WG, 2003, J BIOMAT SCI-POLYM E, V14, P851, DOI 10.1163/156856203768366567
   Liu WG, 2002, POLYM INT, V51, P1459, DOI 10.1002/pi.1085
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Stephansson SN, 2002, BIOMATERIALS, V23, P2527, DOI 10.1016/S0142-9612(01)00387-8
   Sundararajan V. M., 1999, BIOMATERIALS, V20, P1133
   Tokura S, 1996, MACROMOL SYMP, V101, P389, DOI 10.1002/masy.19961010144
   VANOSS CJ, 1995, MOL IMMUNOL, V32, P199, DOI 10.1016/0161-5890(94)00124-J
   WANG AQ, 1998, FUNCT POLYM, V11, P83
   WAYNE RG, 1991, J BIOMED MATER RES, V25, P1547
   Xu J, 1996, MACROMOLECULES, V29, P3436, DOI 10.1021/ma951638b
   Yao KD, 1999, J APPL POLYM SCI, V71, P449, DOI 10.1002/(SICI)1097-4628(19990118)71:3<449::AID-APP11>3.3.CO;2-0
   Yao KD, 1996, POLYM INT, V39, P333
NR 24
TC 12
Z9 12
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD NOV 5
PY 2005
VL 98
IS 3
BP 1016
EP 1024
DI 10.1002/app.22212
PG 9
WC Polymer Science
SC Polymer Science
GA 963UC
UT WOS:000231830500011
DA 2018-10-20
ER

PT J
AU Rana, S
   Rawat, J
   Misra, RDK
AF Rana, S
   Rawat, J
   Misra, RDK
TI Anti-microbial active composite nanoparticles with magnetic core and
   photocatalytic shell: TiO2-NiFe2O4 biomaterial system
SO ACTA BIOMATERIALIA
LA English
DT Article
DE photocatalyst composite nanoparticles; anti-microbial activity; titania
ID REVERSE MICELLE TECHNIQUE; TITANIUM-DIOXIDE; ANATASE TIO2; SEMICONDUCTOR
   PHOTOCATALYSIS; SEPARATED PHOTOCATALYST; WATER; INACTIVATION; BROOKITE;
   BACTERIA; DYES
C1 Univ SW Louisiana, Dept Chem Engn, Lafayette, LA 70504 USA.
   Univ SW Louisiana, Ctr Struct & Funct Mat, Lafayette, LA 70504 USA.
RP Misra, RDK (reprint author), Univ SW Louisiana, Dept Chem Engn, POB 44130, Lafayette, LA 70504 USA.
EM dmisra@louisiana.edu
RI Dom, Rekha/B-7113-2012
CR Adachi M, 2003, J ELECTROCHEM SOC, V150, pG488, DOI 10.1149/1.1589763
   Beydoun D, 2002, MAT SCI ENG B-SOLID, V94, P71, DOI 10.1016/S0921-5107(02)00085-5
   Beydoun D, 2000, J PHYS CHEM B, V104, P4387, DOI 10.1021/jp992088c
   BISCHOFF BL, 1995, CHEM MATER, V7, P1772, DOI 10.1021/cm00058a004
   Chen F, 2001, CHEMOSPHERE, V44, P1159, DOI 10.1016/S0045-6535(00)00277-0
   CHOI WY, 1994, J PHYS CHEM-US, V98, P13669, DOI 10.1021/j100102a038
   FOX MA, 1993, CHEM REV, V93, P341, DOI 10.1021/cr00017a016
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0
   Gao Y, 2003, MATER CHEM PHYS, V80, P348, DOI 10.1016/S0254-0584(02)00515-1
   Gonzalez RJ, 1997, PHYS REV B, V55, P7014, DOI 10.1103/PhysRevB.55.7014
   GRATZEL M, 1990, J PHYS CHEM-US, V94, P2566
   Gubbala S, 2004, PHYSICA B, V348, P317, DOI 10.1016/j.physb.2003.12.017
   Halmann M.M., 1996, PHOTODEGRADATION WAT
   HARRIS GD, 1987, WATER RES, V21, P687, DOI 10.1016/0043-1354(87)90080-7
   HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004
   HUANG Z, 2000, J PHOTOCH PHOTOBIO A, V130, P163, DOI DOI 10.1016/S1010-6030(99)00205-1
   KAISER R, 1970, J APPL PHYS, V41, P1064, DOI 10.1063/1.1658812
   Kay A, 1996, SOL ENERG MAT SOL C, V44, P99, DOI 10.1016/0927-0248(96)00063-3
   Kodama RH, 1997, J APPL PHYS, V81, P5552, DOI 10.1063/1.364659
   Kominami H, 2003, CATAL LETT, V91, P41, DOI 10.1023/B:CATL.0000006316.45620.30
   Lachheb H, 2002, APPL CATAL B-ENVIRON, V39, P75, DOI 10.1016/S0926-3373(02)00078-4
   Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094
   Marci G, 2003, ANN CHIM-ROME, V93, P639
   Martinez B, 1998, PHYS REV LETT, V80, P181, DOI 10.1103/PhysRevLett.80.181
   MATSUNAGA T, 1985, FEMS MICROBIOL LETT, V29, P211
   MATSUNAGA T, 1988, APPL ENVIRON MICROB, V54, P1330
   MATSUNAGA T, 1995, ENVIRON SCI TECHNOL, V29, P501, DOI 10.1021/es00002a028
   Mills A, 1997, J PHOTOCH PHOTOBIO A, V108, P1, DOI 10.1016/S1010-6030(97)00118-4
   Misra RDK, 2004, MAT SCI ENG B-SOLID, V111, P164, DOI 10.1016/j.mseb.2004.04.014
   Nelson Cox, 2000, LEHNINGER PRINCIPLES
   Ollis D.F., 1993, PHOTOCATALYTIC PURIF
   Pottier A, 2001, J MATER CHEM, V11, P1116, DOI 10.1039/b100435m
   RILEY DP, 1984, J AM CHEM SOC, V106, P3179, DOI 10.1021/ja00323a020
   Rincon AG, 2001, J PHOTOCH PHOTOBIO A, V139, P233, DOI 10.1016/S1010-6030(01)00374-4
   SAITO T, 1992, J PHOTOCH PHOTOBIO B, V14, P369, DOI 10.1016/1011-1344(92)85115-B
   Shchukin DG, 2002, PHOTOCH PHOTOBIO SCI, V1, P742, DOI 10.1039/b207477j
   Shibata T, 2004, PHYS CHEM CHEM PHYS, V6, P1359, DOI 10.1039/b315777f
   Sunada K, 2003, J PHOTOCH PHOTOBIO A, V156, P227, DOI 10.1016/S1010-6030(02)00434-3
   Wang CY, 2003, J MATER CHEM, V13, P2322, DOI 10.1039/b303716a
   WATTS RJ, 1995, WATER RES, V29, P95, DOI 10.1016/0043-1354(94)E0122-M
   Yun CY, 2004, WATER SCI TECHNOL, V49, P177
NR 41
TC 130
Z9 136
U1 2
U2 81
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2005
VL 1
IS 6
BP 691
EP 703
DI 10.1016/j.actbio.2005.07.007
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 008RC
UT WOS:000235057400011
PM 16701850
DA 2018-10-20
ER

PT J
AU Greiner, C
   Oppenheimer, SM
   Dunand, DC
AF Greiner, C
   Oppenheimer, SM
   Dunand, DC
TI High strength, low stiffness, porous NiTi with superelastic properties
SO ACTA BIOMATERIALIA
LA English
DT Article
DE nickel; titanium; nitinol; foams; superelasticity; bone replacement
ID SHAPE-MEMORY ALLOY; HIGH-TEMPERATURE SYNTHESIS; ARGON-FILLED PORES;
   COMBUSTION SYNTHESIS; SUPERPLASTIC EXPANSION; NEUTRON-DIFFRACTION; BONE
   INGROWTH; MECHANICAL-PROPERTIES; TINI BIOMATERIAL; THERMAL HISTORY
C1 Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
RP Dunand, DC (reprint author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
EM dunand@northwestern.edu
RI Dunand, David/B-7515-2009; Greiner, Christian/B-6490-2009
OI Greiner, Christian/0000-0001-8079-336X; Dunand,
   David/0000-0001-5476-7379
CR Biswas A, 2005, ACTA MATER, V53, P1415, DOI 10.1016/j.actamat.2004.11.036
   BOBYN JD, 1992, CLIN ORTHOP RELAT R, P79
   Bourke MAM, 1996, APPL PHYS LETT, V69, P2477, DOI 10.1063/1.117503
   Chu CL, 2004, J MATER SCI, V39, P4949, DOI 10.1023/B:JMSC.0000035343.00893.f3
   Chu CL, 2004, MAT SCI ENG A-STRUCT, V366, P114, DOI 10.1016/j.msea.2003.08.118
   Chung CY, 2004, MATER LETT, V58, P1683, DOI 10.1016/j.matlet.2003.10.045
   Davis NG, 2001, J MATER RES, V16, P1508, DOI 10.1557/JMR.2001.0210
   Duering T.W., 1994, MAT PROPERTIES HDB T
   Dunand D. C., 2004, TMS LETT, V1, P93
   DUNAND DC, 1995, MATER MANUF PROCESS, V10, P373, DOI 10.1080/10426919508935033
   Entchev PB, 2004, MECH MATER, V36, P893
   Gibson L. J., 1997, CELLULAR SOLIDS
   Kang SB, 2002, MATER TRANS, V43, P1045, DOI 10.2320/matertrans.43.1045
   KEARNS MW, 1988, INT J POWDER METALL, V24, P59
   Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3
   Kim JS, 2004, MATER SCI FORUM, V449-4, P1097, DOI 10.4028/www.scientific.net/MSF.449-452.1097
   Kim JS, 2004, ADV ENG MATER, V6, P403, DOI 10.1002/adem.200405151
   Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4
   Lagoudas DC, 2002, J INTEL MAT SYST STR, V13, P837, DOI 10.1177/104538902032790
   Li BY, 2000, ACTA MATER, V48, P3895, DOI 10.1016/S1359-6454(00)00184-1
   Li BY, 2000, INTERMETALLICS, V8, P881, DOI 10.1016/S0966-9795(00)00024-8
   Li BY, 2000, METALL MATER TRANS A, V31, P1867, DOI 10.1007/s11661-006-0242-4
   Li BY, 1998, J MATER RES, V13, P2847, DOI 10.1557/JMR.1998.0389
   Li BY, 2000, Z METALLKD, V91, P291
   Li BY, 2000, J MATER RES, V15, P10, DOI 10.1557/JMR.2000.0004
   Li BY, 1999, SCI CHINA SER E, V42, P94, DOI 10.1007/BF02917064
   Li BY, 2000, INTERMETALLICS, V8, P643, DOI 10.1016/S0966-9795(99)00140-5
   Li HL, 2004, MATER TRANS, V45, P1124, DOI 10.2320/matertrans.45.1124
   Li YH, 2002, J MATER SCI TECHNOL, V18, P248
   Murray NGD, 2003, COMPOS SCI TECHNOL, V63, P2311, DOI 10.1016/S0266-3538(03)00264-1
   Murray NGD, 2004, ACTA MATER, V52, P2279, DOI 10.1016/j.actamat.2004.01.019
   Murray NGD, 2004, ACTA MATER, V52, P2269, DOI 10.1016/j.actamat.2004.01.039
   Murray NGD, 2003, SCRIPTA MATER, V49, P879, DOI 10.1016/S1359-6462(03)00438-X
   Otsuka K., 1998, SHAPE MEMORY MAT
   Queheillalt DT, 2000, METALL MATER TRANS A, V31, P261, DOI 10.1007/s11661-000-0070-x
   RAUSCH G, 2002, HDB CELLULAR METALS, P18
   Simske SJ, 1997, MATER SCI FORUM, V250, P151, DOI 10.4028/www.scientific.net/MSF.250.151
   Soballe K, 1991, J Arthroplasty, V6, P307, DOI 10.1016/S0883-5403(06)80181-6
   Stoeckel D, 2004, EUR RADIOL, V14, P292, DOI 10.1007/s00330-003-2022-5
   Stoeckel D, 2000, MINIM INVASIV THER, V9, P81, DOI 10.3109/13645700009063054
   Urban RM, 1996, J BONE JOINT SURG AM, V78A, P1068, DOI 10.2106/00004623-199607000-00012
   Vaidyanathan R, 1999, ACTA MATER, V47, P3353, DOI 10.1016/S1359-6454(99)00214-1
   Vaidyanathan R, 1999, J APPL PHYS, V86, P3020, DOI 10.1063/1.371163
   Vaidyanathan R, 2001, METALL MATER TRANS A, V32, P777
   Yuan B, 2004, MAT SCI ENG A-STRUCT, V382, P181, DOI 10.1016/j.msea.2004.04.068
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   Zhao Y, 2005, ACTA MATER, V53, P337, DOI 10.1016/j.actamat.2004.09.029
   Zhu SL, 2004, MATER LETT, V58, P2369, DOI 10.1016/j.matlet.2004.02.017
NR 48
TC 146
Z9 148
U1 1
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2005
VL 1
IS 6
BP 705
EP 716
DI 10.1016/j.actbio.2005.07.005
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 008RC
UT WOS:000235057400012
PM 16701851
DA 2018-10-20
ER

PT J
AU Senyah, N
   Hildebrand, G
   Liefeith, K
AF Senyah, N
   Hildebrand, G
   Liefeith, K
TI Comparison between RGD-peptide-modified titanium and borosilicate
   surfaces
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 12th Heiligenstadt Conference on Technical Systems for Biotechnology and
   Environment
CY SEP 27-29, 2004
CL Bad Heiligenstadt, GERMANY
DE RGD-peptides; surface distribution; cell adhesion; osteoblasts; titanium
ID MEDIATED ADHESION; CELL ATTACHMENT; FIBRONECTIN; OSTEOBLASTS; SEQUENCE
AB The use of synthetic peptides containing adhesive sequences, such as the Arg-Gly-Asp (RGD) motif, represents a promising strategy to control biological interactions at the cell-material interface. These peptides are known to improve the tissue-material contact owing to highly specific binding to cellular membrane receptors known as integrins, thereby promoting the adhesion, migration and proliferation of cells. The peptides were coupled to borosilicate glass and titanium surfaces using silanisation chemistry. A tryptophan residue was incorporated into the amino acid sequences of selected peptides to facilitate the detection of the covalently bound peptides. Successful peptide immobilisation was proven by fluorimetric measurements. The confocal imaging analysis suggests a homogeneous distribution of the immobilised peptide across the biomaterial surface. In vitro cell proliferation assays were employed to compare the adhesion potentials of the well-known RGD-containing peptides GRGDSP, GRADSP and RGDS to the three peptides designed by our group. The results demonstrate that the RGD sequence is not necessarily required to enhance the adhesion of cells to non-biological surfaces. Moreover, it is shown that the number of adhering cells can be increased by changes in the peptide hydrophobicity. Changes in the cytoskeleton are observed depending on the type of RGD-peptide modification.
C1 Inst Bioproc & Analyt Measurement Tech EV IBA, Dept Biomat, D-37308 Heilbad Heiligenstadt, Germany.
RP Liefeith, K (reprint author), Inst Bioproc & Analyt Measurement Tech EV IBA, Dept Biomat, D-37308 Heilbad Heiligenstadt, Germany.
EM klaus.liefeith@iba-heiligenstadt.de
CR DAVIS JR, 2003, HDB MAT MED DEVICES, P75
   DEDHAR S, 1987, J CELL BIOL, V104, P585, DOI 10.1083/jcb.104.3.585
   Duong LT, 1998, FRONT BIOSCI, V3, P757
   FLORES ME, 1992, EXP CELL RES, V201, P526, DOI 10.1016/0014-4827(92)90305-R
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   GRAF J, 1987, CELL, V48, P989, DOI 10.1016/0092-8674(87)90707-0
   Kantlehner M, 1999, ANGEW CHEM INT EDIT, V38, P560, DOI 10.1002/(SICI)1521-3773(19990215)38:4<560::AID-ANIE560>3.0.CO;2-F
   Olbrich KC, 1996, BIOMATERIALS, V17, P759, DOI 10.1016/0142-9612(96)81412-8
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PULEO DA, 1991, BONE, V12, P271, DOI 10.1016/8756-3282(91)90075-T
   Schliephake H, 2005, J BIOMED MATER RES B, V73B, P88, DOI 10.1002/jbm.b.30183
   Verrier S, 2002, BIOMATERIALS, V23, P585, DOI 10.1016/S0142-9612(01)00145-4
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   Yeo WS, 2003, J AM CHEM SOC, V125, P14994, DOI 10.1021/ja038265b
NR 15
TC 14
Z9 14
U1 0
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD NOV
PY 2005
VL 383
IS 5
BP 758
EP 762
DI 10.1007/s00216-005-3274-5
PG 5
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 992HL
UT WOS:000233874900009
PM 16151591
DA 2018-10-20
ER

PT J
AU Caplan, MR
   Rosca, EV
AF Caplan, MR
   Rosca, EV
TI Targeting drugs to combinations of receptors: A modeling analysis of
   potential specificity
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article; Proceedings Paper
CT 2nd Annual Biomedical Imaging Research Opportunities Workshop
CY FEB 25-26, 2004
CL Bethesda, MD
SP Biomed Engn Soc
DE mathematical model; multivalent; biomaterial; drug delivery
ID CANCER-CELLS; IN-VIVO; LIGAND; BINDING; DELIVERY; DESIGN; SITES
AB Targeting drugs to specific cells by conjugating the drug to an antibody or ligand for a cell surface receptor currently requires that the receptor be uniquely over-expressed by the target cell (the target cell over-expresses a particular receptor in comparison with untargeted cells, which do display this receptor type but a lesser number of them). Here we develop a mathematical model to predict the behavior of multivalent ligand-drug constructs containing two different ligands for two different receptors, which would allow targeting cells that do not uniquely over-express any receptor. In this model, target cells express both receptors at a high level; whereas, untargeted cells express one receptor type at the high level but the other at a lower level. The model predicts that these heterovalent conjugates (containing two different types of ligands) can achieve specificity even when the target cell does not uniquely over-express any one receptor type. Using the current approach, constructs in which only one ligand type is used will bind as much to untargeted cells as to the target cells. Therefore, this combination strategy can enormously expand the number of applications for which cell surface receptor targeting of drugs is an appropriate option.
C1 Arizona State Univ, Harrington Dept Bioengn, Tempe, AZ 85287 USA.
RP Caplan, MR (reprint author), Arizona State Univ, Harrington Dept Bioengn, POB 879709, Tempe, AZ 85287 USA.
EM michael.caplan@asu.edu
FU NIDCR NIH HHS [K22-DE014846]
CR Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945
   David A, 2004, EUR J CANCER, V40, P148, DOI 10.1016/j.ejca.2003.07.001
   Gillies RJ, 2003, EXPERT OPIN THER TAR, V7, P137, DOI 10.1517/14728222.7.2.137
   Goldstein B, 1988, THEORETICAL IMMUNO 1, P3
   HANDL HL, EXPERT OPIN THERAP T, V8, P565
   Hlavacek WS, 1999, BIOPHYS J, V76, P3031, DOI 10.1016/S0006-3495(99)77456-4
   Kiessling LL, 2000, ANNU REP MED CHEM, V35, P321, DOI 10.1016/S0065-7743(00)35030-8
   Kramer RH, 1998, NATURE, V395, P710, DOI 10.1038/27227
   Lauffenburger DA, 1993, RECEPTORS MODELS BIN
   MACKEN CA, 1985, BRANCHING PROCESSES
   Mammen Mathai, 1998, Angew Chem Int Ed Engl, V37, P2754, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3
   Mariani L, 2001, J NEURO-ONCOL, V53, P161, DOI 10.1023/A:1012253317934
   Maynard HD, 2000, MACROMOLECULES, V33, P6239, DOI 10.1021/ma000460c
   Maynard HD, 2001, J AM CHEM SOC, V123, P1275, DOI 10.1021/ja003305m
   Molema G., 2001, DRUG TARGETING ORGAN, P1
   Olivier V, 2003, BIOCONJUGATE CHEM, V14, P1203, DOI 10.1021/bc034077z
   Perelson A. S., 1984, CELL SURFACE DYNAMIC, P223
   Ramanathan M, 2001, J NEUROIMMUNOL, V116, P213, DOI 10.1016/S0165-5728(01)00308-3
   Sakhalkar HS, 2003, P NATL ACAD SCI USA, V100, P15895, DOI 10.1073/pnas.2631433100
   SAWYER TK, 1980, P NATL ACAD SCI-BIOL, V77, P5754, DOI 10.1073/pnas.77.10.5754
   Shadidi M, 2003, DRUG RESIST UPDATE, V6, P363, DOI 10.1016/j.drup.2003.11.002
   Vagner J, 2004, BIOORG MED CHEM LETT, V14, P211, DOI 10.1016/j.bmcl.2003.09.079
   Wang XZ, 2003, WORLD J GASTROENTERO, V9, P2671
NR 23
TC 43
Z9 43
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD NOV
PY 2005
VL 33
IS 8
BP 1113
EP 1124
DI 10.1007/s10439-005-5779-1
PG 12
WC Engineering, Biomedical
SC Engineering
GA 955RS
UT WOS:000231245600014
PM 16133919
DA 2018-10-20
ER

PT J
AU Bull, SR
   Guler, MO
   Bras, RE
   Venkatasubramanian, PN
   Stupp, SI
   Meade, TJ
AF Bull, SR
   Guler, MO
   Bras, RE
   Venkatasubramanian, PN
   Stupp, SI
   Meade, TJ
TI Magnetic resonance imaging of self-assembled biomaterial scaffolds
SO BIOCONJUGATE CHEMISTRY
LA English
DT Article
ID MRI-CONTRAST AGENTS; PEPTIDE-AMPHIPHILE NANOFIBERS; DRUG-RELEASE;
   POLYMER EROSION; SPECTROSCOPY; IMPLANTS
AB Current interest in biomaterials for tissue engineering and drug delivery applications have spurred research into self-assembling peptide amphiphiles (PAs). Nanofiber networks formed from self-assembling PAs can be used as biomaterial scaffolds with the advantage of specificity by the incorporation of peptide-epitopes. Imaging the materials noninvasively will give information as to their fate in vivo. We report here the synthesis and in vitro MR images of self-assembling peptide amphiphile contrast agents (PACAs) that form nanofibers. At 400 MHz using a 0.1 mM Gd(III) conjugate of the PA we observed a T-1 three times that of a control gel. The PA derivative was doped into various epitope bearing PA solutions and upon gelling resulted in a homogeneous biomaterial as imaged by MRI.
C1 Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.
   Northwestern Univ, Dept Biochem & Mol & Cell Biol, Evanston, IL 60208 USA.
   Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA.
   Northwestern Univ, Ctr Basic MR Res, Evanston, IL 60208 USA.
   Northwestern Univ, Dept Radiol, Evanston, IL 60208 USA.
   Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA.
RP Meade, TJ (reprint author), Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.
EM tmeade@northwestern.edu
RI Stupp, Samuel/B-6737-2009; Guler, Mustafa O./C-9453-2011
OI Guler, Mustafa O./0000-0003-1168-202X
FU NIGMS NIH HHS [T32 GM008449]; NIBIB NIH HHS [R01 EB003806-01, R01
   EB005866]; NIAID NIH HHS [7R01 AI47003-4]
CR Aime S, 2000, CHEM-EUR J, V6, P2609, DOI 10.1002/1521-3765(20000717)6:14<2609::AID-CHEM2609>3.0.CO;2-S
   ALETRAS A, 1995, INT J PEPT PROT RES, V45, P488
   Behanna HA, 2005, J AM CHEM SOC, V127, P1193, DOI 10.1021/ja044863u
   Bull SR, 2005, NANO LETT, V5, P1, DOI 10.1021/nl0484898
   Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x
   GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031
   Guidoin R, 2004, ARTIF CELL BLOOD SUB, V32, P105, DOI 10.1081/BIO-120028672
   Guler MO, 2005, NANO LETT, V5, P249, DOI 10.1021/nl048238z
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kohn J, 2004, NAT MATER, V3, P745, DOI 10.1038/nmat1249
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Mader K, 1997, PHARM RES-DORDR, V14, P820, DOI 10.1023/A:1012123127330
   Mader K, 1997, J PHARM SCI-US, V86, P126, DOI 10.1021/js9505105
   Meade TJ, 2003, CURR OPIN NEUROBIOL, V13, P597, DOI 10.1016/j.conb.2003.09.009
   Melia CD, 1998, PHARM SCI TECHNOL TO, V1, P32, DOI 10.1016/S1461-5347(98)00008-X
   Niece KL, 2003, J AM CHEM SOC, V125, P7146, DOI 10.1021/ja028215r
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Pihlajamaki H, 1997, BIOMATERIALS, V18, P1311, DOI 10.1016/S0142-9612(97)00068-9
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Stroman PW, 1999, MAGNET RESON MED, V42, P210, DOI 10.1002/(SICI)1522-2594(199907)42:1<210::AID-MRM29>3.0.CO;2-Q
   Toth E, 2002, TOP CURR CHEM, V221, P61
   Traore AS, 2000, TISSUE ENG, V6, P265, DOI 10.1089/10763270050044443
   WEISSLEDER R, 1995, ANTIMICROB AGENTS CH, V39, P839, DOI 10.1128/AAC.39.4.839
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 28
TC 68
Z9 68
U1 0
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD NOV-DEC
PY 2005
VL 16
IS 6
BP 1343
EP 1348
DI 10.1021/bc050153h
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA 985QS
UT WOS:000233393800003
PM 16287227
DA 2018-10-20
ER

PT J
AU Lim, JY
   Hansen, JC
   Siedlecki, CA
   Hengstebeck, RW
   Cheng, J
   Winograd, N
   Donahue, HJ
AF Lim, JY
   Hansen, JC
   Siedlecki, CA
   Hengstebeck, RW
   Cheng, J
   Winograd, N
   Donahue, HJ
TI Osteoblast adhesion on poly(L-lactic acid)/polystyrene demixed thin film
   blends: Effect of nanotopography, surface chemistry, and wettability
SO BIOMACROMOLECULES
LA English
DT Article
ID ION MASS-SPECTROMETRY; SPIN-CAST FILMS; CELL BEHAVIOR;
   QUANTITATIVE-ANALYSIS; TOPOGRAPHIC GUIDANCE; FIBROBLAST RESPONSE;
   POLY(LACTIC ACID); MOLECULAR-WEIGHT; IN-VITRO; POLYMER
AB Biomaterial surface characteristics are critical cues that regulate cell function. We produced a novel series Of poly(L-lactic acid) (PLLA) and polystyrene demixed nanotopographic films to provide nonbiological cell-stimulating cues. The increase in PLLA weight fraction (phi) in blend solutions resulted in topography changes in spin-cast films from pit-dominant to island-dominant morphologies having nanoscale depth or height (3-29 nm). Lower molecular weight PLLA segregated to the top surface of demixed films, as observed by X-ray photoelectron spectroscopy and secondary ion mass spectroscopy (SIMS). For phi >= 0.5, the topmost film layer was predominantly filled with PLLA (> 96% by SIMS at 20-angstrom depth). Nanotextured substrata stimulated osteoblastic cell adhesion to a greater degree than did flat PLLA (phi = 1), and this effect was more pronounced for nanoisland (phi = 0.7 and 0.9) relative to nanopit topographies (phi = 0.5). Demixed films having relatively lower water contact angles generally enhanced cell adhesion and spreading. Our results reveal that cell adhesion is affected by surface chemistry, topography, and wettability simultaneously and that nanotextured surfaces may be utilized in regulating cell adhesion.
C1 Penn State Univ, Coll Med, Dept Orthopaed & Rehabil, Div Musculoskeletal Sci,Ctr Biomed Devices & Func, Hershey, PA 17033 USA.
   Penn State Univ, Coll Med, Dept Bioengn, Hershey, PA 17033 USA.
   Penn State Univ, Coll Med, Dept Surg, Hershey, PA 17033 USA.
   Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA.
   Penn State Univ, Dept Chem, University Pk, PA 16802 USA.
RP Donahue, HJ (reprint author), Penn State Univ, Coll Med, Dept Orthopaed & Rehabil, Div Musculoskeletal Sci,Ctr Biomed Devices & Func, 500 Univ Dr, Hershey, PA 17033 USA.
EM hdonahue@psu.edu
FU NIBIB NIH HHS [EB002016-12]; NIA NIH HHS [AG-13087]
CR Affrossman S, 2000, COLLOID POLYM SCI, V278, P888, DOI 10.1007/s003960000359
   Affrossman S, 1998, MACROMOLECULES, V31, P6280, DOI 10.1021/ma971676q
   Affrossman S, 2000, COLLOID POLYM SCI, V278, P993, DOI 10.1007/s003960000358
   Affrossman S, 1996, MACROMOLECULES, V29, P5010, DOI 10.1021/ma9516910
   ALBERTS B, 1994, MOL BIOL CELL
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BEAMSON G, 1992, HIGH RESOLUTION XPS, P11
   Berlinger A, 2001, SURF INTERFACE ANAL, V32, P144, DOI 10.1002/sia.1025
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Braun RM, 1998, RAPID COMMUN MASS SP, V12, P1246, DOI 10.1002/(SICI)1097-0231(19980930)12:18<1246::AID-RCM316>3.0.CO;2-C
   Britland S, 1996, EXP CELL RES, V228, P313, DOI 10.1006/excr.1996.0331
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dalby MJ, 2004, INT J BIOCHEM CELL B, V36, P2005, DOI 10.1016/j.biocel.2004.03.001
   Dalby MJ, 2003, J BIOMED MATER RES A, V67A, P1025, DOI 10.1002/jbm.a.10139
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Heilshorn SC, 2005, BIOMACROMOLECULES, V6, P318, DOI 10.1021/bm049627q
   Hsu SH, 2004, BIOMATERIALS, V25, P5593, DOI 10.1016/j.biomaterials.2004.01.061
   Iwata R, 2004, BIOMACROMOLECULES, V5, P2308, DOI 10.1021/bm049613k
   Kim YS, 2005, TISSUE ENG, V11, P30, DOI 10.1089/ten.2005.11.30
   Lim JY, 2005, J ROY SOC INTERFACE, V2, P97, DOI 10.1098/rsif.2004.0019
   Lim JY, 2005, TISSUE ENG, V11, P19, DOI 10.1089/ten.2005.11.19
   Lim JY, 2004, J BIOMED MATER RES A, V68A, P504, DOI 10.1002/jbm.a.20087
   LIM JY, 2004, MUSCULOSKELET NEURON, V4, P396
   Liu SY, 2004, ANAL CHEM, V76, P5165, DOI 10.1021/ac049573a
   Mahoney CM, 2004, ANAL CHEM, V76, P3199, DOI 10.1021/ac035532n
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   NORDFORS D, 1988, J CHEM PHYS, V88, P2630, DOI 10.1063/1.454043
   Oakley C, 1997, EXP CELL RES, V234, P413, DOI 10.1006/excr.1997.3625
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Raczkowska J, 2004, MACROMOLECULES, V37, P7308, DOI 10.1021/ma035815h
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Riehle MO, 2003, MAT SCI ENG C-BIO S, V23, P337, DOI 10.1016/S0928-4931(02)00282-5
   Shard AG, 1996, MACROMOLECULES, V29, P748, DOI 10.1021/ma950622i
   SHIRATO I, 1991, CELL TISSUE RES, V266, P1, DOI 10.1007/BF00678705
   TANAKA K, 1995, MACROMOLECULES, V28, P934, DOI 10.1021/ma00108a021
   Tanaka K, 1998, MACROMOLECULES, V31, P863, DOI 10.1021/ma9709866
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   Walheim S, 1997, MACROMOLECULES, V30, P4995, DOI 10.1021/ma9619288
   Wang MT, 1999, POLYMER, V40, P7387, DOI 10.1016/S0032-3861(99)00008-7
   ZHAO X, 1991, MACROMOLECULES, V24, P5991, DOI 10.1021/ma00022a014
NR 48
TC 100
Z9 102
U1 0
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV-DEC
PY 2005
VL 6
IS 6
BP 3319
EP 3327
DI 10.1021/bm0503423
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 985QD
UT WOS:000233392100058
PM 16283761
DA 2018-10-20
ER

PT J
AU Pelsoczi, I
   Turzo, K
   Gergely, C
   Fazekas, A
   Dekany, I
   Cuisinier, F
AF Pelsoczi, I
   Turzo, K
   Gergely, C
   Fazekas, A
   Dekany, I
   Cuisinier, F
TI Structural characterization of self-assembled polypeptide films on
   titanium and glass surfaces by atomic force microscopy
SO BIOMACROMOLECULES
LA English
DT Article
ID POLYELECTROLYTE MULTILAYER FILMS; GUIDE LIGHTMODE SPECTROSCOPY;
   IN-VITRO; BIOMATERIALS; ADSORPTION; THICKNESS; ADHESION; LAYERS; CELLS
AB Chemically modified biomaterial surfaces (titanium and glass) covered with polyelectro,lyte self-assembled films formed by the alternating adsorption of cationic poly-L-lysine (PLL) and anionic poly-L-glutamic acid (PGA) were structurally characterized by atomic force microscopy. Complementary information concerning the thickness and layer-by-layer growth of the films was provided by optical waveguide light-mode spectroscopy. The frequently used ex situ and the rarely used in situ build-up methods were compared. Important aspects of the industrial applicability of these films, their stability in time, and possible differences in their morphology were investigated. The films revealed a granular pattern, with grain diameters of 270 +/- 87 nm for glass (up to 8 bilayers) and 303 +/- 89 nm for titanium (up to 10 bilayers), independently of the build-up procedure. Both surfaces displayed a rehydration capability, the titanium surface exhibiting a better stability in time. The high roughness values observed at acidic or basic pH are related to the degree of ionization of PGA and PLL.
C1 Univ Szeged, Dept Dent & Oral Surg, H-6720 Szeged, Hungary.
   Univ Montpellier 2, Etud Semicond Grp, F-34095 Montpellier, France.
   Univ Szeged, Dept Colloid Chem, H-6720 Szeged, Hungary.
   Univ Strasbourg, INSERM U595, F-67085 Strasbourg, France.
RP Turzo, K (reprint author), Univ Szeged, Dept Dent & Oral Surg, Tisza Lajos Krt 64, H-6720 Szeged, Hungary.
EM turzo@stoma.szote.u-szeged.hu
RI Dekany, Imre/C-7596-2018
OI Dekany, Imre/0000-0001-5472-5355
CR ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   Angelova N, 1999, TRENDS BIOTECHNOL, V17, P409, DOI 10.1016/S0167-7799(99)01356-6
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Boura C, 2003, BIOMATERIALS, V24, P3521, DOI 10.1016/S0142-9612(03)00214-X
   CANTOR R, 1980, BIOPHYSICAL CHEM, pB2
   Cheng YF, 1999, J PHYS CHEM B, V103, P8726, DOI 10.1021/jp9920693
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   Davies JE, 1998, INT J PROSTHODONT, V11, P391
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   El-Ghannam A, 1998, J BIOMED MATER RES, V41, P30, DOI 10.1002/(SICI)1097-4636(199807)41:1<30::AID-JBM4>3.0.CO;2-R
   Gergely C, 2004, LANGMUIR, V20, P5575, DOI 10.1021/la049932x
   Lavalle P, 2002, MACROMOLECULES, V35, P4458, DOI 10.1021/ma0119833
   Lobo RFM, 2003, NANOTECHNOLOGY, V14, P101, DOI 10.1088/0957-4484/14/1/322
   Menchaca JL, 2003, COLLOID SURFACE A, V222, P185, DOI 10.1016/S0927-7757(03)00223-1
   Morra M, 2003, BIOMATERIALS, V24, P4639, DOI 10.1016/S0142-9612(03)00360-0
   Morra M, 1997, J BIOMED MATER RES, V37, P198, DOI 10.1002/(SICI)1097-4636(199711)37:2<198::AID-JBM8>3.0.CO;2-M
   Picart C, 2001, J CHEM PHYS, V115, P1086, DOI 10.1063/1.1375156
   Picart C, 2004, BIOSENS BIOELECTRON, V20, P553, DOI 10.1016/j.bios.2004.03.005
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Ram MK, 2001, BIOSENS BIOELECTRON, V16, P849, DOI 10.1016/S0956-5663(01)00208-1
   Sano M, 1996, ANNU REV MATER SCI, V26, P153
   Shiratori SS, 2000, MACROMOLECULES, V33, P4213, DOI 10.1021/ma991645q
   Tryoen-Toth P, 2002, J BIOMED MATER RES, V60, P657, DOI 10.1002/jbm.10110
NR 24
TC 9
Z9 9
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV-DEC
PY 2005
VL 6
IS 6
BP 3345
EP 3350
DI 10.1021/bm050360k
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 985QD
UT WOS:000233392100061
PM 16283764
DA 2018-10-20
ER

PT J
AU Meinel, L
   Fajardo, R
   Hofmann, S
   Langer, R
   Chen, J
   Snyder, B
   Vunjak-Novakovic, G
   Kaplan, D
AF Meinel, L
   Fajardo, R
   Hofmann, S
   Langer, R
   Chen, J
   Snyder, B
   Vunjak-Novakovic, G
   Kaplan, D
TI Silk implants for the healing of critical size bone defects
SO BONE
LA English
DT Article
DE silk; stem cells; bone; fibroin; cranium; calvarial
ID GROWTH-FACTOR-I; TISSUE-ENGINEERED CARTILAGE; ITERATIVE SELECTION
   METHOD; MESENCHYMAL STEM-CELLS; THRESHOLDING ALGORITHMS; 3-DIMENSIONAL
   STRUCTURE; TRABECULAR BONE; DIFFERENTIATION; SCAFFOLDS; SUTURES
AB Bone (re)-generation and bone fixation strategies utilize biomaterial implants, which are gradually replaced by autologous tissues. Ideally, these biomaterials should be biodegradable, osteoconductive, and provide mechanical strength and integrity until newly formed host tissues can maintain function. Some protein-based biomaterials such as collagens are promising because of their biological similarities to natural proteins on bone surfaces. However, their use as bone implant materials is largely hampered by poor mechanical properties. In contrast, silks offer distinguishing mechanical properties that are tailorable, along with slow degradability to permit adequate time for remodeling. To assess the suitability of silk-based biomaterials as implants for bone healing, we explored the use of novel porous silk fibroin scaffolds as templates for the engineering of bone tissues starting from human bone marrow derived stem cells cultured under osteogenic conditions for up to 5 weeks. The slowly degrading protein matrix permitted adequate temporal control of hydroxyapatite deposition and resulted in the formation of a trabecular-like bone matrix in bioreactor studies. The organic and inorganic components of the engineered bone tissues resembled those of bone, as shown by gene expression analysis, biochemical assays, and X-ray diffractometry. Implantation of the tissue-engineered bone implants (grown in bioreactors for 5 weeks prior to implantation) into calvarial critical size defects in mice demonstrated the capacity of these systems to induce advanced bone formation within 5 weeks, whereas the implantation of stem cell loaded silk scaffolds, and scaffolds alone resulted in less bone formation. These results demonstrate the feasibility of silk-based implants with engineered bone for the (re-)generation of bone tissues and expand the class of protein-based bone-implant materials with a mechanically stable and durable option. (c) 2005 Elsevier Inc. All rights reserved.
C1 Tufts Univ, Dept Biomed Engn, Medford, MA 02115 USA.
   ETH, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland.
   MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Orthopaed Biomech Lab, Boston, MA 02215 USA.
   Tufts Univ, Div Oral Biol, Boston, MA 02111 USA.
RP Kaplan, D (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02115 USA.
EM david.kaplan@tufts.edu
RI Hofmann, Sandra/F-2832-2010; Meinel, Lorenz/D-9997-2015
OI Hofmann, Sandra/0000-0002-2568-8388; Meinel, Lorenz/0000-0002-7549-7627;
   Vunjak-Novakovic, Gordana/0000-0002-9382-1574
FU NIBIB NIH HHS [EB002520]; NIDCR NIH HHS [DE13405]
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Alsberg E, 2001, CRIT REV ORAL BIOL M, V12, P64, DOI 10.1177/10454411010120010501
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   BONAR LC, 1984, J ULTRA MOL STRUCT R, V86, P93, DOI 10.1016/S0022-5320(84)90099-6
   Caplan AI, 2000, TISSUE ENG, V6, P1, DOI 10.1089/107632700320838
   CHOONG PFM, 1993, J ORTHOPAED RES, V11, P638, DOI 10.1002/jor.1100110505
   CLINE HE, 1993, J COMPUT ASSIST TOMO, V17, P173, DOI 10.1097/00004728-199303000-00003
   Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C
   FAJARDO RJ, 2004, THESIS STONY BROOK U
   Fedarko Neal S., 2000, P17
   GLASBEY CA, 1993, CVGIP-GRAPH MODEL IM, V55, P532, DOI 10.1006/cgip.1993.1040
   Guilak F, 2002, ANN NY ACAD SCI, V961, P207, DOI 10.1111/j.1749-6632.2002.tb03086.x
   Hopper RA, 1996, J CRANIOFAC SURG, V7, P32, DOI 10.1097/00001665-199601000-00009
   Inoue S, 2004, EUR J BIOCHEM, V271, P356, DOI 10.1046/j.1432-1033.2003.03934.x
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   KOMORI TH, 1997, CELL, V89, P757
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Latour R A Jr, 1995, Clin Podiatr Med Surg, V12, P519
   Leung CK, 1996, PATTERN RECOGN, V29, P1523, DOI 10.1016/0031-3203(96)00009-X
   Luginbuehl V, 2005, PHARM RES, V22, P940, DOI 10.1007/s11095-005-4589-9
   Martin I, 2001, J BIOMED MATER RES, V55, P229, DOI 10.1002/1097-4636(200105)55:2<229::AID-JBM1009>3.3.CO;2-H
   MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2003, BONE, V33, P660, DOI 10.1016/S8756-3282(03)00207-2
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Meinel L, 2001, J CONTROL RELEASE, V70, P193, DOI 10.1016/S0168-3659(00)00352-7
   MEINEL L, 2004, J BIOMED MATER RES, V25, pA71
   MULLER R, 1994, PHYS MED BIOL, V39, P145, DOI 10.1088/0031-9155/39/1/009
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   OPPERMAN LA, 1995, J BONE MINER RES, V10, P1978
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   Reddi AH, 2000, BIOCHEM SOC T, V28, P345, DOI 10.1042/0300-5127:0280345
   RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630
   Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C
   RIMINUCCI M, 1995, CALCIFIED TISSUE INT, V57, P277, DOI 10.1007/BF00298883
   ROSSITCH E, 1987, CHILD NERV SYST, V3, P375, DOI 10.1007/BF00270712
   Rossitch E Jr, 1987, N C Med J, V48, P669
   Ryan TM, 2002, J HUM EVOL, V43, P1, DOI 10.1006/jhev.2002.0552
   Sharma B, 2004, ANN BIOMED ENG, V32, P148, DOI 10.1023/B:ABME.0000007799.60142.78
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   TRUSSELL HJ, 1979, IEEE T SYST MAN CYB, V9, P311, DOI 10.1109/TSMC.1979.4310204
   VANLUYN MJA, 1992, J BIOMED MATER RES, V26, P1091, DOI 10.1002/jbm.820260810
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
NR 53
TC 275
Z9 304
U1 6
U2 87
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD NOV
PY 2005
VL 37
IS 5
BP 688
EP 698
DI 10.1016/j.bone.2005.06.010
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 981FU
UT WOS:000233073700011
PM 16140599
DA 2018-10-20
ER

PT J
AU Balkin, SW
AF Balkin, SW
TI Injectable silicone and the foot: A 41-year clinical and histologic
   history
SO DERMATOLOGIC SURGERY
LA English
DT Article
ID LIQUID SILICONE; INJECTION; ULCERATION; ULCERS
AB BACKGROUND. Since 1964, the author has investigated injectable liquid silicone as a soft tissue substitute for the loss of plantar fat. This form of fatty tissue depletion over the sole is closely linked to a common painful weight-bearing foot disorder, metatarsalgia, and to painless diabetic foot ulcers.
   OBJECTIVES. To present the history of injectable silicone, corporate interest, individuals who helped pursue approval, its misuses, and events that have delayed its availability.
   MATERIALS AND METHODS. Dow Corning Corporation's 360 Medical Fluid of 350 centistoke was injected beneath corns and calluses in 1,585 patients. Diabetic neuropathic foot ulcers were injected after healing in an effort to prevent their recurrence. Surgical and postmortem specimens were gathered for histologic analysis.
   RESULTS. There was no evidence of significant adverse response in long-term clinical follow-up. Silicone specimens studied by two departments of pathology found no inflammation, infection, allergy, or granulomas.
   CONCLUSIONS. Medical Fluid silicone appears to be safe, effective, and stable biomaterial for treating weight-bearing loss of plantar fat. Trademarked PodiSil (Richard-James Inc., Peabody, MA, USA), a 350-centistoke injectable silicone has been approved for marketing in Europe for the prevention of diabetic foot ulcers.
C1 Univ So Calif, Med Ctr, Dept Orthopaed, Podiatry Sect, Los Angeles, CA 90089 USA.
RP Balkin, SW (reprint author), 229 N Cent Ave,Suite 610, Glendale, CA 91203 USA.
EM swbalkin@sbcglobal.net
CR ACHAUER BM, 1983, PLAST RECONSTR SURG, V71, P251, DOI 10.1097/00006534-198302000-00020
   Angell M., 1996, SCI TRIAL CLASH MED
   Balkin S W, 1991, Decubitus, V4, P38
   BALKIN SW, 1972, CLIN ORTHOP RELAT R, P235
   Balkin SW, 1991, FOOT, V2, P83
   Fox LP, 2004, J AM ACAD DERMATOL, V50, P450, DOI 10.1016/j.jaad.2003.09.008
   KAGAN HD, 1963, ARCHIV OTOLARYNGOL, V78, P663
   Mastruserio DN, 1996, J AM ACAD DERMATOL, V34, P849, DOI 10.1016/S0190-9622(96)90043-2
   RAE V, 1989, ARCH DERMATOL, V125, P670, DOI 10.1001/archderm.125.5.670
   SPANBAUER JM, 1997, YALE JL FEMINISM, V9, P157
   SPERBER PA, 1965, TREATMENT AGING SKIN
   Swaim SF, 1997, DECUBITUS ULCER CLIN, P217
   van Schie CHM, 2000, DIABETES CARE, V23, P634, DOI 10.2337/diacare.23.5.634
   Wallace WD, 2004, J AM PODIAT MED ASSN, V94, P550, DOI 10.7547/0940550
NR 14
TC 13
Z9 14
U1 0
U2 1
PU B C DECKER INC
PI HAMILTON
PA 20 HUGHSON ST SOUTH, PO BOX 620, L C D 1, HAMILTON, ONTARIO L8N 3K7,
   CANADA
SN 1076-0512
J9 DERMATOL SURG
JI Dermatol. Surg.
PD NOV
PY 2005
VL 31
IS 11
BP 1555
EP 1560
DI 10.2310/6350.2005.31241
PN 2
PG 6
WC Dermatology; Surgery
SC Dermatology; Surgery
GA 995BE
UT WOS:000234074100011
PM 16416638
DA 2018-10-20
ER

PT J
AU Lepidi, S
   Abatangelo, G
   Vindigni, V
   Deriu, GP
   Zavan, B
   Tonello, C
   Cortivo, R
AF Lepidi, S
   Abatangelo, G
   Vindigni, V
   Deriu, GP
   Zavan, B
   Tonello, C
   Cortivo, R
TI In vivo regeneration of small-diameter (2 mm) arteries using a polymer
   scaffold
SO FASEB JOURNAL
LA English
DT Article
DE vascular prosthesis; tissue engineering; remodeling; surgery
ID ENDOTHELIAL PROGENITOR CELLS; ENGINEERED VASCULAR GRAFTS; BLOOD-VESSELS;
   INTIMAL HYPERPLASIA; SAPHENOUS-VEIN; TISSUE; MUSCLE; BYPASS; VITRO;
   RECONSTRUCTION
AB The difficulty of obtaining significant long-term patency and good wall mechanical strength in vivo has been a significant obstacle in achieving small-diameter vascular prostheses. The aim of the present study was to develop a prosthetic graft that could perform as a small-diameter vascular conduit. Tubular structures of hyaluronan (HYAFF-11 tubules, 2 mm diameter, 1 cm length) were grafted in the abdominal aorta of 30 rats as temporary absorbable guides to promote regeneration of vascular structures. Performance was assessed by histology, immunohistochemistry, and ultra-structural analysis. These experiments resulted in three novel findings: 1) complete endothelialization of the tube's luminal surface occurred; 2) sequential regeneration of vascular components led to complete vascular wall regeneration 15 days after surgery; and 3) the biomaterial used created the ideal environment for the delicate regeneration process during the critical initial phases, yet its biodegradability allowed for complete degradation of the construct four months after implantation, at which time, a new artery remained to connect the artery stumps. This study assesses the feasibility to create a completely biodegradable vascular regeneration guide in vivo, able to sequentially orchestrate vascular regeneration events needed for very small artery reconstruction.
C1 Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35100 Padua, Italy.
   Univ Padua, Clin Vasc Surg, I-35100 Padua, Italy.
   Univ Padua, Clin Plast Surg, I-35100 Padua, Italy.
RP Abatangelo, G (reprint author), Univ Padua, Dept Histol Microbiol & Med Biotechnol, Via G Colombo 3, I-35100 Padua, Italy.
EM g.abatangelo@unipd.it
OI Vindigni, Vincenzo/0000-0001-6638-9010
CR Arts CHP, 2002, EUR J VASC ENDOVASC, V23, P404, DOI 10.1053/ejvs.2002.1604
   Bujan J, 2004, BIOTECHNOL APPL BIOC, V39, P17, DOI 10.1042/BA20030111
   Campbell JH, 1999, CIRC RES, V85, P1173
   Cho SW, 2005, ANN SURG, V241, P506, DOI 10.1097/01.sla.0000154268.12239.ed
   Chue WL, 2004, J VASC SURG, V39, P859, DOI 10.1016/j.jvs.2003.03.003
   DallaLibera L, 1997, J MUSCLE RES CELL M, V18, P295
   Daly CD, 2004, FRONT BIOSCI, V9, P1915, DOI 10.2741/1384
   De Lorenzi F, 2002, PLAST RECONSTR SURG, V109, P2023, DOI 10.1097/00006534-200205000-00037
   Gleason RL, 2004, FRONT BIOSCI, V9, P2045, DOI 10.2741/1387
   Hsu SH, 2003, ARTIF ORGANS, V27, P1068, DOI 10.1111/j.1525-1594.2003.07141.x
   Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Khot UN, 2004, CIRCULATION, V109, P2086, DOI 10.1161/01.CIR.0000127570.20508.5C
   Kidane AG, 2004, BIOMACROMOLECULES, V5, P798, DOI 10.1021/bm0344553
   Klinkert P, 2004, EUR J VASC ENDOVASC, V27, P357, DOI 10.1016/j.ejvs.2003.12.027
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   Kurotobi K, 2003, ARTIF ORGANS, V27, P582, DOI 10.1046/j.1525-1594.2003.07016.x
   L'Heureux N, 1998, FASEB J, V12, P47
   Leon Luis, 2003, Expert Rev Cardiovasc Ther, V1, P581, DOI 10.1586/14779072.1.4.581
   Matsuda T, 2004, ARTIF ORGANS, V28, P64, DOI 10.1111/j.1525-1594.2004.07324.x
   McFetridge PS, 2004, ASAIO J, V50, P591, DOI 10.1097/01.MAT.0000144365.22025.9B
   Mitchell SL, 2003, CARDIOVASC PATHOL, V12, P59, DOI 10.1016/S1054-8807(02)00183-7
   Nanobashvili J, 2004, EUR SURG RES, V36, P74, DOI 10.1159/000076646
   Nerem RM, 2003, BIORHEOLOGY, V40, P281
   Pawlowski KJ, 2004, FRONT BIOSCI-LANDMRK, V9, P1412, DOI 10.2741/1302
   Rashid ST, 2004, CELL PROLIFERAT, V37, P351, DOI 10.1111/j.1365-2184.2004.00318.x
   Remuzzi A, 2004, TISSUE ENG, V10, P699, DOI 10.1089/1076327041348347
   Remy-Zolghadri M, 2004, J VASC SURG, V39, P613, DOI 10.1016/j.jvs.2003.08.007
   Schaner PJ, 2004, J VASC SURG, V40, P146, DOI 10.1016/j.jvs.2004.03.033
   Schmidt D, 2004, ANN THORAC SURG, V78, P2094, DOI 10.1016/j.athoracsur.2004.06.052
   Thomas AC, 2003, CARDIOVASC PATHOL, V12, P271, DOI 10.1016/S1054-8807(03)00086-3
   Tiwari A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0826com
   Tonello C, 2003, BIOMATERIALS, V24, P1205, DOI 10.1016/S0142-9612(02)00450-7
   Turner NJ, 2004, BIOMATERIALS, V25, P5955, DOI 10.1016/j.biomaterials.2004.02.002
   VESCOVO G, 1996, BASIC APPL MYOL, V6, P183
   Vorp DA, 2005, FRONT BIOSCI, V10, P768, DOI 10.2741/1571
   Wang H, 2005, ARTERIOSCL THROM VAS, V25, P1817, DOI 10.1161/01.ATV.0000175840.90510.a8
   Williams C, 2004, TISSUE ENG, V10, P930, DOI 10.1089/1076327041348536
   Wu X, 2004, AM J PHYSIOL-HEART C, V287, pH480, DOI 10.1152/ajpheart.01232.2003
   Zhang Z, 2004, BIOMATERIALS, V25, P177, DOI 10.1016/S0142-9612(03)00478-2
NR 40
TC 16
Z9 16
U1 0
U2 11
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD NOV
PY 2005
VL 19
IS 13
BP 103
EP +
DI 10.1096/fj.05-4802fje
PG 16
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 994TC
UT WOS:000234053100010
PM 16291641
DA 2018-10-20
ER

PT J
AU Arciola, CR
   Alvi, FI
   An, YH
   Campoccia, D
   Montanaro, L
AF Arciola, CR
   Alvi, FI
   An, YH
   Campoccia, D
   Montanaro, L
TI Implant infection and infection resistant materials: A mini review
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Review
DE prosthetic infections; biofilm; MSCRAMM; biomaterials
ID TOTAL JOINT ARTHROPLASTY; ADHESION ICA LOCUS; HIGH-WATER-CONTENT;
   STAPHYLOCOCCUS-EPIDERMIDIS; IN-VITRO; BACTERIAL ADHESION;
   PSEUDOMONAS-AERUGINOSA; TOTAL HIP; ADHERENCE; SURFACES
AB Implant infection is an aggressive, often irreducible post-surgical infection. It remains the primary cause of implant failure. Bacterial contamination during surgery and subsequent adhesion onto biomaterial surface of opportunistic microorganisms, such as staphylococcal species, exopolysaccharidic slimes or specific adhesins, initiates the implant infection. Pathogenesis of periprosthestic infection is the focus of studies aimed at developing infection resistant materials.
C1 Ist Ortoped Rizzoli, Res Unit Implant Infect, I-40136 Bologna, Italy.
   Univ Bologna, Dept Expt Pathol, Bologna, Italy.
   Med Univ S Carolina, Orthoped Res Lab, Charleston, SC 29425 USA.
RP Arciola, CR (reprint author), Ist Ortoped Rizzoli, Res Unit Implant Infect, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM carlarenata.arciola@ior.it
RI Campoccia, Davide/K-5348-2018
OI Campoccia, Davide/0000-0002-3336-0219
CR An YH, 1996, J HOSP INFECT, V33, P93, DOI 10.1016/S0195-6701(96)90094-8
   An YH, 1996, J ORTHOPAED RES, V14, P846, DOI 10.1002/jor.1100140526
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   An YH, 2000, HDB BACTERIAL ADHESI, P609
   Arciola CR, 2004, BIOMATERIALS, V25, P4825, DOI 10.1016/j.biomaterials.2003.11.056
   Arciola CR, 2005, J BIOMED MATER RES A, V75A, P408, DOI 10.1002/jbm.a.30445
   Arciola CR, 2005, BIOMATERIALS, V26, P6530, DOI 10.1016/j.biomaterials.2005.04.031
   Arciola CR, 2005, FEMS MICROBIOL LETT, V246, P81, DOI 10.1016/j.femsle.2005.03.035
   Arciola CR, 2004, BIOMATERIALS, V25, P4117, DOI 10.1016/j.biomaterials.2003.11.027
   Arciola CR, 2003, ACTA ORTHOP SCAND, V74, P617, DOI 10.1080/00016470310018054
   Arciola CR, 2003, BIOMATERIALS, V24, P3013, DOI 10.1016/S0142-9612(03)00133-9
   Arciola CR, 2002, J BIOMED MATER RES, V59, P557, DOI 10.1002/jbm.10006
   ARCIOLA CR, 1995, BIOMATERIALS, V16, P685, DOI 10.1016/0142-9612(95)99695-I
   Arciola CR, 2001, J CLIN MICROBIOL, V39, P2151, DOI 10.1128/JCM.39.6.2151-2156.2001
   Arciola CR, 1998, J BIOMED MATER RES, V42, P1
   Arciola CR, 1999, BIOMATERIALS, V20, P323, DOI 10.1016/S0142-9612(98)00168-9
   ARCIOLA CR, 1993, BIOMATERIALS, V14, P1161, DOI 10.1016/0142-9612(93)90161-T
   ARCIOLA CR, 1994, J CATARACT REFR SURG, V20, P158, DOI 10.1016/S0886-3350(13)80157-5
   Baker C, 2005, J NANOSCI NANOTECHNO, V5, P244, DOI 10.1166/jnn.2005.034
   Barbucci R, 2002, J MATER CHEM, V12, P3084, DOI 10.1039/b205320a
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Borkow G, 2004, FASEB J, V18, P1728, DOI 10.1096/fj.04-2029fje
   Bustanji Y, 2003, P NATL ACAD SCI USA, V100, P13292, DOI 10.1073/pnas.1735343100
   CHANG CC, 1991, J ORTHOPAED RES, V9, P284, DOI 10.1002/jor.1100090217
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   COSTERTON JW, 1993, INT J ARTIF ORGANS, V16, P765
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   Deacon JM, 1996, J BONE JOINT SURG AM, V78A, P1755, DOI 10.2106/00004623-199611000-00020
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   Giulieri SG, 2004, INFECTION, V32, P222, DOI 10.1007/s15010-004-4020-1
   GRISTINA AG, 1993, INT J ARTIF ORGANS, V16, P755
   Gursel I, 2002, J MICROENCAPSUL, V19, P153, DOI 10.1080/02652040110065413
   Hebert CK, 1996, CLIN ORTHOP RELAT R, P140
   JENNINGS BR, 1983, BIOPHYS STRUCT MECH, V10, P71, DOI 10.1007/BF00535543
   Leung D, 2005, BIOMATERIALS, V26, P7145, DOI 10.1016/j.biomaterials.2005.05.014
   Levy ML, 2004, NEUROSURGERY, V54, P488, DOI 10.1227/01.NEU.0000103674.13196.7F
   Lewis K, 2005, TRENDS BIOTECHNOL, V23, P343, DOI 10.1016/j.tibtech.2005.05.004
   Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004
   Milovic NM, 2005, BIOTECHNOL BIOENG, V90, P715, DOI 10.1002/bit.20454
   MOLIN G, 1985, APPL ENVIRON MICROB, V50, P946
   Montanaro L, 2001, BIOMATERIALS, V22, P59, DOI 10.1016/S0142-9612(00)00163-0
   Nablo BJ, 2005, BIOMATERIALS, V26, P917, DOI 10.1016/j.biomaterials.2004.03.031
   Ohko Y, 2001, J BIOMED MATER RES, V58, P97, DOI 10.1002/1097-4636(2001)58:1<97::AID-JBM140>3.0.CO;2-8
   OLSON ME, 1988, J BIOMED MATER RES, V22, P485, DOI 10.1002/jbm.820220605
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   POSS R, 1984, CLIN ORTHOP RELAT R, P117
   SALVATI EA, 1982, J BONE JOINT SURG AM, V64, P525, DOI 10.2106/00004623-198264040-00007
   Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052
   SCHIERHOLZ JM, 2001, J CHEMOTHER, V1, P239
   Schneeberger PM, 2002, J HOSP INFECT, V51, P179, DOI 10.1053/jhin.2002.1256
   Sculco T P, 1993, Instr Course Lect, V42, P349
   Shirtliff ME, 2002, CLIN ORTHOP RELAT R, P239
   Singh P, 2004, TRENDS BIOTECHNOL, V22, P142, DOI 10.1016/j.tibtech.2004.01.010
   Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Trampuz A, 2005, SWISS MED WKLY, V135, P243
   von Eiff C, 2005, DRUGS, V65, P179, DOI 10.2165/00003495-200565020-00003
   Vote BJT, 2000, CLIN EXP OPHTHALMOL, V28, P437, DOI 10.1046/j.1442-9071.2000.00351.x
NR 60
TC 54
Z9 55
U1 0
U2 12
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD NOV
PY 2005
VL 28
IS 11
BP 1119
EP 1125
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 991LF
UT WOS:000233814800009
PM 16353118
DA 2018-10-20
ER

PT J
AU Thatte, S
   Datar, K
   Ottenbrite, RM
AF Thatte, S
   Datar, K
   Ottenbrite, RM
TI Perspectives on: Polymeric drugs and drug delivery systems
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE drug-conjugates; systemic drug administration; gene delivery; drug
   delivery implants
ID IN-VIVO EVALUATION; GENE DELIVERY; COMPLEXES; RELEASE; ACID;
   POLYPEPTIDES; DERIVATIVES; CONJUGATE; CONTRAST; VECTORS
AB Therapeutic uses of a variety of drug carrier systems have significant impact on the treatment and potential cure of many chronic diseases, including cancer, diabetes, mellitus, rheumatoid arthritis, HIV infection, and drug addiction. Drug delivery technology is a multidisciplinary science involving the physical, biological, medicinal, pharmaceutical, biomedical engineering and biomaterial fields. Polymeric systems can deliver drugs directly to the intended site of action and can also improve efficacy while minimizing unwanted side effects elsewhere in the body, which often limit the long-term use of many drugs. In this article, some recent publications on several polymeric drug conjugates, gene delivery systems and polymer implants are addressed.
C1 Virginia Commonwealth Univ, Dept Chem, Richmond, VA 23284 USA.
RP Ottenbrite, RM (reprint author), Virginia Commonwealth Univ, Dept Chem, Box 2006, Richmond, VA 23284 USA.
EM ottenbrite@vcu.edu
CR Borzacchiello A, 2004, J BIOACT COMPAT POL, V19, P331, DOI 10.1177/0883911504045229
   Bregazzi VS, 2000, J BIOACT COMPAT POL, V15, P85, DOI 10.1106/BLCC-E8VH-EKAN-GWGK
   Casali M, 2001, J BIOACT COMPAT POL, V16, P479, DOI 10.1106/470Q-MBQN-RN2Y-LB5L
   Chiellini E., 2001, BIOMEDICAL POLYM POL
   Chytry V, 2001, J BIOACT COMPAT POL, V16, P427, DOI 10.1106/FDUM-1LXE-WGJ9-BYVW
   De Winne K, 2004, J BIOACT COMPAT POL, V19, P439, DOI 10.1177/0883911504048327
   Demirkilic U, 2004, J BIOACT COMPAT POL, V19, P395, DOI 10.1177/0883911504046690
   Dernell WS, 2001, J BIOACT COMPAT POL, V16, P119, DOI 10.1106/LR91-0E0F-K1V0-3M89
   Dernell WS, 2001, J BIOACT COMPAT POL, V16, P235, DOI 10.1106/J42P-F4CF-H60Y-2P9K
   Dubruel P, 2000, J BIOACT COMPAT POL, V15, P191, DOI 10.1106/UCCK-VJ9J-V3DD-EP1D
   El-Sayed M, 2003, J BIOACT COMPAT POL, V18, P7, DOI 10.1177/088391103032794
   Gebhart CL, 2003, J BIOACT COMPAT POL, V18, P147, DOI 10.1177/088391103033853
   Haider M, 2003, J BIOACT COMPAT POL, V18, P93, DOI 10.1177/088391103033854
   Hoste K, 2002, J BIOACT COMPAT POL, V17, P123, DOI 10.1106/088391102024443
   Hreczuk-Hirst D, 2001, J BIOACT COMPAT POL, V16, P353, DOI 10.1106/QBKY-E3VM-19K4-3GA5
   Ito Y, 2000, J BIOACT COMPAT POL, V15, P376, DOI 10.1106/Q11W-F3ED-U05C-4GUR
   KISHIDA A, 2005, J BIOACT COMPAT POL, V15, P478
   Kondyurin A, 2005, J BIOACT COMPAT POL, V20, P77, DOI 10.1177/0883911505049896
   Lehn P, 1998, ADV DRUG DELIVER REV, V30, P5, DOI 10.1016/S0169-409X(97)00102-6
   Mahkam M, 2000, J BIOACT COMPAT POL, V15, P396, DOI 10.1106/M3WA-3MEW-XYYN-V3J4
   MARCONI W, 2004, J BIOACT COMPAT POL, V16, P393
   Massoumi B, 2002, J BIOACT COMPAT POL, V17, P51, DOI 10.1106/088391102023813
   Mihai D, 2000, J BIOACT COMPAT POL, V15, P245, DOI 10.1106/PEU7-TAWV-4G90-EGFJ
   Miller AD, 1998, ANGEW CHEM INT EDIT, V37, P1769
   Mustafaev M, 2002, J BIOACT COMPAT POL, V17, P251, DOI 10.1106/088391102027122
   Nagy IB, 2000, J BIOACT COMPAT POL, V15, P139, DOI 10.1106/9K92-9YDJ-PT40-YQGC
   Novakova K, 2002, J BIOACT COMPAT POL, V17, P285, DOI 10.1106/088391102027534
   Ottenbrite R. M., 1998, FRONTIERS BIOMEDICAL
   OTTENBRITE RM, 2001, POLYM DRUGS DRUG DEL
   Panaitescu L, 2002, J BIOACT COMPAT POL, V17, P357, DOI 10.1106/088391102029710
   Parker AL, 2002, J BIOACT COMPAT POL, V17, P229, DOI 10.1106/088391102027977
   Pasut G, 2005, J BIOACT COMPAT POL, V20, P213, DOI 10.1177/0883911505053377
   Poujol S, 2000, J BIOACT COMPAT POL, V15, P99, DOI 10.1106/Y060-8LFN-PAJT-KJAB
   Ramirez HL, 2002, J BIOACT COMPAT POL, V17, P161, DOI 10.1106/088391102024643
   Sakuma S, 2002, J BIOACT COMPAT POL, V17, P305, DOI 10.1106/088391102029557
   Sato H, 2004, J BIOACT COMPAT POL, V19, P65, DOI 10.1177/0883911504042640
   SUBUR V, 2002, J BIOACT COMPAT POL, V17, P105
   Szabo R, 2002, J BIOACT COMPAT POL, V17, P399, DOI 10.1177/088391102031640
   VANDEMAN MJ, 2000, EARTH ISL J, V15, P2
   Wang YP, 2004, J BIOACT COMPAT POL, V19, P481, DOI 10.1177/0883911504048326
   Yan GP, 2004, J BIOACT COMPAT POL, V19, P453, DOI 10.1177/0883911504048375
NR 41
TC 27
Z9 28
U1 2
U2 12
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD NOV
PY 2005
VL 20
IS 6
BP 585
EP 601
DI 10.1177/0883911505059549
PG 17
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 979KK
UT WOS:000232940700006
DA 2018-10-20
ER

PT J
AU Holmbom, J
   Sodergard, A
   Ekholm, E
   Martson, M
   Kuusilehto, A
   Saukko, P
   Penttinen, R
AF Holmbom, J
   Sodergard, A
   Ekholm, E
   Martson, M
   Kuusilehto, A
   Saukko, P
   Penttinen, R
TI Long-term evaluation of porous poly(epsilon-caprolactone-co-L-lactide)
   as a bone-filling material
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polylactide-polycaprolactone-co-polymer; biodegradable; biomimetic;
   apatite; bone-filling material; tissue engineering
ID BIOACTIVE GLASS S53P4; IN-VITRO; CELLULOSE SPONGE; POLY(L-LACTIC ACID);
   TISSUE REGENERATION; POLYMER FOAMS; SOFT-TISSUES; PORE-SIZE; SCAFFOLDS;
   HYDROXYAPATITE
AB Porous poly (F-caprolactone-CO-L-lactide) (P(CL-co-LA, wt % ca. 5/95) sponges were prepared, coated biomimetically with CaP/apatite, and implanted with noncoated control sponges into rat femur cortical defects and dorsal subcutaneous space. The implants were inspected histologically at 2, 4, and 33 weeks after the operation. All implants were filled with fibrovascular tissue within 4 weeks. The femur implants were partially ossified with compact bone, which in the CaP-coated sponges was less mature and more fragmented. Approximately equal amounts of bone were observed in both types of implants. The polymer induced a mild inflammatory reaction with foreign body giant cells but no accumulation of fluid. Degradation of the polymer was slow; most of it was found intact at 33 weeks in histological samples. Nondegraded polymer seems to prevent complete ossification. Cultured osteoblasts proliferated well on apatite-coated material, whereas only a few cells were seen on noncoated material. Thus CaP/apatite coating helped the attachment of osteoblasts in cell cultures but did not offer any advantage in bone formation over noncoated material in vivo. We conclude that a shorter degradation time of P(CL-co-LA) is needed to create an optimal implant. Furthermore, in vivo experiments seem to be necessary for the estimation of osteopromotive properties of a biomaterial. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Turku, Inst Biomed, Dept Med Biochem & Mol Biol, FIN-20520 Turku, Finland.
   Turku Univ, Turku Ctr Biomat, Turku, Finland.
   Turku Univ, Dept Pediat Surg, Turku, Finland.
   Turku Univ, Inst Dent, Turku, Finland.
   Univ Turku, Dept Forens Med, Turku, Finland.
RP Penttinen, R (reprint author), Univ Turku, Inst Biomed, Dept Med Biochem & Mol Biol, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.
EM risto.penttinen@utu.fi
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
CR Aitasalo K, 2001, J ORAL MAXIL SURG, V59, P1390, DOI 10.1053/joms.2001.27524
   Ambrose CG, 2004, ANN BIOMED ENG, V32, P171, DOI 10.1023/B:ABME.0000007802.59936.fc
   ANDERSSON OH, 1991, J NON-CRYST SOLIDS, V129, P145, DOI 10.1016/0022-3093(91)90090-S
   Antonov EN, 2003, J MATER SCI-MATER M, V14, P151, DOI 10.1023/A:1022071829917
   Chen GP, 2001, BIOMATERIALS, V22, P2563, DOI 10.1016/S0142-9612(00)00447-6
   Ciapetti G, 2003, BIOMATERIALS, V24, P3815, DOI 10.1016/S0142-9612(03)00263-1
   deGroot JH, 1997, BIOMATERIALS, V18, P613, DOI 10.1016/S0142-9612(96)00169-X
   DENDUNNEN WFA, 1993, MICROSURG, V14, P508, DOI 10.1002/micr.1920140808
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Ekholm EC, 1995, CONNECT TISSUE RES, V31, P211, DOI 10.3109/03008209509010812
   Ekholm M, 1999, BIOMATERIALS, V20, P1257, DOI 10.1016/S0142-9612(97)00080-X
   Forsback AP, 2004, ACTA ODONTOL SCAND, V62, P14, DOI 10.1080/00016350310008012
   Gan ZH, 1999, POLYMER, V40, P2859, DOI 10.1016/S0032-3861(98)00549-7
   Hench LL, 2004, J BIOMAT SCI-POLYM E, V15, P543, DOI 10.1163/156856204323005352
   HOLMES RE, 1979, PLAST RECONSTR SURG, V63, P626, DOI 10.1097/00006534-197905000-00004
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Lu LC, 2000, BIOMATERIALS, V21, P1595, DOI 10.1016/S0142-9612(00)00048-X
   Martson M, 1998, EUR SURG RES, V30, P419, DOI 10.1159/000008608
   Martson M, 1999, BIOMATERIALS, V20, P1989, DOI 10.1016/S0142-9612(99)00094-0
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   Oliveira AL, 2004, J MATER SCI-MATER M, V15, P533, DOI 10.1023/B:JMSM.0000021134.34651.d3
   Oliveira AL, 2002, J MATER SCI-MATER M, V13, P1181, DOI 10.1023/A:1021106525097
   Oyane A, 2003, BIOMATERIALS, V24, P1729, DOI 10.1016/S0142-9612(02)00581-1
   Pajulo O, 1996, J BIOMED MATER RES, V32, P439, DOI 10.1002/(SICI)1097-4636(199611)32:3<439::AID-JBM18>3.0.CO;2-B
   Peltola MJ, 2001, J BIOMED MATER RES, V58, P54, DOI 10.1002/1097-4636(2001)58:1<54::AID-JBM80>3.3.CO;2-K
   Pineda LM, 1996, J BIOMED MATER RES, V31, P385
   pitt C.G., 1990, BIODEGRADABLE POLYM
   Rich J, 2002, BIOMATERIALS, V23, P2143, DOI 10.1016/S0142-9612(01)00345-3
   Serrano MC, 2004, BIOMATERIALS, V25, P5603, DOI 10.1016/j.biomaterials.2004.01.037
   Shastri VP, 2000, P NATL ACAD SCI USA, V97, P1970, DOI 10.1073/pnas.97.5.1970
   Spaans CJ, 2000, BIOMATERIALS, V21, P2453, DOI 10.1016/S0142-9612(00)00113-7
   Suuronen R, 2004, BIO-MED MATER ENG, V14, P517
   Tsuji H, 2000, J APPL POLYM SCI, V75, P629, DOI 10.1002/(SICI)1097-4628(20000131)75:5<629::AID-APP5>3.0.CO;2-A
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
   Waris E, 2003, CLIN ORTHOP RELAT R, P310, DOI 10.1097/01.blo.0000063789.32430.c6
NR 40
TC 23
Z9 24
U1 0
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV 1
PY 2005
VL 75A
IS 2
BP 308
EP 315
DI 10.1002/jbm.a.30418
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 974GE
UT WOS:000232578500008
PM 16059893
DA 2018-10-20
ER

PT J
AU Perla, V
   Webster, TJ
AF Perla, V
   Webster, TJ
TI Better osteoblast adhesion on nanoparticulate selenium - A promising
   orthopedic implant material
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE orthopedic; anticancer; nanotechnology; selenium; osteoblast
ID NANOPHASE CERAMICS; BONE; INTERFACE; ALUMINA
AB Apart from problems such as poor osseointegration, stress shielding, and wear debris-associated bone cell death, a major concern of metallic orthopedic implants is that they slowly corrode under in vivo environments. It is possible that continuous tissue exposure to metallic corrosion products limits orthopedic implant efficacy; this is especially true for patients receiving implants due to bone cancer. To date, there is no metallic orthopedic implant available in the market that specifically deals with the prevention and/or recurring cancer that may happen in these patients. The objective of this study was to deal with these problems in an integrated way by introducing a new biomaterial to the orthopedic community with anticancer chemistry: selenium (Se). In this study, six types of Se compacts were tested for bone cell (osteoblast) adhesion under in vitro conditions. Two types of cylindrical compacts were made with conventional Se metal particles in the micron (6.539 +/- 1.364-mu m diameter) and submicron (0.963 +/- 0.139-mu m diameter) range. These two types of compacts were chemically etched with different concentrations of NaOH to create two additional types of Se particles in each category: conventional size particles with nanosurface roughness and nanometer particles (0.204- to 0.264-mu m diameter). Results showed for the first time, enhanced osteoblast adhesion on particulate surfaces of the compacts made from conventional Se compared with reference nonparticulate wrought titanium sheets. More importantly, this study provided the first evidence that osteoblast density was further increased on the surfaces of the Se compacts with nanometer particles. These initial findings indicate that there may be a promising future for nanoparticulate Se as an anticancer biocompatible orthopedic material. (c) 2005 Wiley Periodicats, Inc.
C1 Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
   Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA.
RP Webster, TJ (reprint author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
EM twebster@purdue.edu
CR AYAD L, 1994, EXTRACELLULAR MATRIX
   Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P145, DOI 10.1081/CLT-100102417
   Birringer M, 2002, NAT PROD REP, V19, P693, DOI 10.1039/b205802m
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   Chariot P, 2003, MUSCLE NERVE, V27, P662, DOI 10.1002/mus.10304
   CROMPTON K, 2004, J BUSINESS SPOKANE, V19
   de Oliveira PT, 2004, BIOMATERIALS, V25, P403, DOI 10.1016/S0142-9612(03)00539-8
   DORFMAN HD, 1998, PRECANCEROUS CONDITI, P1195
   ELIAS KE, 2000, BIOMATERIALS, V23, P3279
   Kaplan F. S., 1994, ORTHOPEDIC BASIC SCI, P460
   KAWAGUCHI H, 1993, CELL MATER, V3, P337
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   McDowell LR, 2003, MINERALS ANIMAL HUMA, P1
   Navarro-Alarcon M, 2000, SCI TOTAL ENVIRON, V249, P347, DOI 10.1016/S0048-9697(99)00526-4
   Oremland RS, 2004, APPL ENVIRON MICROB, V70, P52, DOI 10.1128/AEM.70.1.52-60.2004
   Park JB, 1992, BIOMATERIALS INTRO, P169
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   REILLY C, 1996, INTRO SELENIUM FOOD, P1
   SHAHGALDI BF, 1995, J BONE JOINT SURG BR, V77B, P962
   SILVER FH, 1994, SCOPE MARKETS MED IM, P1
   Simon SP, 1994, ORTHOPAEDIC BASIC SC, P127
   Supronowicz PR, 2002, J BIOMED MATER RES, V59, P499, DOI 10.1002/jbm.10015
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, NANOSTRUCT MATER, V12, P983, DOI 10.1016/S0965-9773(99)00283-4
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Webster TJ, 2001, NANOSTRUCT MATER, P125
NR 29
TC 42
Z9 43
U1 2
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV 1
PY 2005
VL 75A
IS 2
BP 356
EP 364
DI 10.1002/jbm.a.30423
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 974GE
UT WOS:000232578500014
PM 16059879
DA 2018-10-20
ER

PT J
AU Yeung, HY
   Qin, L
   Lee, KM
   Zhang, M
   Leung, KS
   Cheng, JCY
AF Yeung, HY
   Qin, L
   Lee, KM
   Zhang, M
   Leung, KS
   Cheng, JCY
TI Novel approach for quantification of porosity for biomaterial implants
   using microcomputed tomography (mu CT)
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bioceramics; porosity; pore connectivity; microcomputed tomography;
   evaluation method
AB Porous bioceramics have been widely investigated in orthopaedic tissue engineering. Attention has been given to manufacturing of a porous bioceramic that mimics the trabecular bone structure for proper bone regeneration. With the advance of biomedical imaging through microcomputed tomography (mu CT), this study attempted to quantify the pore structure of different bioceramics. Two bioceramic blocks (BSC and ChronOS) were synthesized by two methods. The specification claimed the porosity of the bioceramic ranged from 40% to 70%. Six blocks of each bioceramic were evaluated by conventional water immersion method and mu CT. The pore size and connectivity were evaluated with standardized protocols. By the water immersion method, the porosity of BSC and ChronOS was 60.4% and 74.7%, respectively. The three-dimensional results of mu CT showed that BSC porosity was 26.2% and ChronOS was 60.0%. The pore connectivity was evaluated to be 2.6 for BSC and 39.7 for ChronOS. ChronOS had functional pores with 200 gm to 400 mu m in diameter (87.8% +/- 0.5%), which is significantly more than 52.8% +/- 11.5% of pores in BSC (p < 0.05). Providing information on the functional pores objectively, the mu CT evaluation serves as a good standard for specification of the bioceramic-related implants. (c) 2005 Wiley Periodicals. Inc.
C1 Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.
   Chinese Univ Hong Kong, Lee Hysan Clin Res Lab, Hong Kong, Hong Kong, Peoples R China.
   Hong Kong Polytech Univ, Rehabil Engn Ctr, Hong Kong, Hong Kong, Peoples R China.
RP Qin, L (reprint author), Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.
EM lingqin@cuhk.edu.hk
RI Cheng, Jack/J-3878-2018; Zhang, Ming/F-8331-2011
OI Cheng, Jack/0000-0001-8153-364X; Zhang, Ming/0000-0002-6027-4594
CR Alam MI, 2001, BIOMATERIALS, V22, P1643
   ANGEL M F, 1985, Microsurgery, V6, P175, DOI 10.1002/micr.1920060309
   Bignon A, 2003, J MATER SCI-MATER M, V14, P1089, DOI 10.1023/B:JMSM.0000004006.90399.b4
   BODEN SD, 1995, SPINE, V20, P412, DOI 10.1097/00007632-199502001-00003
   Braye F, 1996, BIOMATERIALS, V17, P1345, DOI 10.1016/0142-9612(96)88682-0
   Cheng JCY, 2002, SPINE, V27, P467, DOI 10.1097/00007632-200203010-00006
   ENGELKE K, 1993, INVEST RADIOL, V28, P341, DOI 10.1097/00004424-199304000-00016
   Erbe EM, 2001, EUR SPINE J, V10, pS141, DOI 10.1007/s005860100287
   GRENGA TE, 1989, PLAST RECONSTR SURG, V84, P245, DOI 10.1097/00006534-198908000-00009
   Guo X, 2002, J ORTHOPAED RES, V20, P740, DOI 10.1016/S0736-0266(01)00167-X
   GUO X, 1993, THESIS MED SCH U ESS
   Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x
   Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   KLAWITTER JJ, 1979, THESIS CLEMSON U CLE
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Kurioka Kazuhito, 1999, Kobe Journal of Medical Sciences, V45, P149
   LeGeros R Z, 1988, Ann N Y Acad Sci, V523, P268, DOI 10.1111/j.1749-6632.1988.tb38519.x
   Liu DM, 1997, MATER SCI FORUM, V250, P183, DOI 10.4028/www.scientific.net/MSF.250.183
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   MULLER R, 1994, PHYS MED BIOL, V39, P145, DOI 10.1088/0031-9155/39/1/009
   Muller R, 1998, BONE, V23, P59, DOI 10.1016/S8756-3282(98)00068-4
   ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6
   Oya M, 2002, AM CERAM SOC BULL, V81, P52
   PREDECKI P, 1972, J BIOMED MATER RES, V6, P375, DOI 10.1002/jbm.820060506
   QU SX, 1994, GERMAN CERAM SOC, V7, P91
   Ruegsegger P, 1996, CALCIFIED TISSUE INT, V58, P24, DOI 10.1007/s002239900006
   Schmidt C, 2003, J BONE MINER RES, V18, P1486, DOI 10.1359/jbmr.2003.18.8.1486
   Shors EC, 1999, ORTHOP CLIN N AM, V30, P599, DOI 10.1016/S0030-5898(05)70113-9
   Spivak JM, 2001, EUR SPINE J, V10, pS197, DOI 10.1007/s005860100286
   Tancred DC, 1998, BIOMATERIALS, V19, P2303, DOI 10.1016/S0142-9612(98)00141-0
   Tay BKB, 1999, ORTHOP CLIN N AM, V30, P615, DOI 10.1016/S0030-5898(05)70114-0
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   URIST MR, 1987, CLIN ORTHOP RELAT R, P295
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   Washburn EW, 1921, P NATL ACAD SCI USA, V7, P115, DOI 10.1073/pnas.7.4.115
   Wilke A, 1998, J BIOMED MATER RES, V40, P301, DOI 10.1002/(SICI)1097-4636(199805)40:2<301::AID-JBM15>3.0.CO;2-O
NR 38
TC 6
Z9 6
U1 0
U2 0
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV
PY 2005
VL 75B
IS 2
BP 234
EP 242
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 981AO
UT WOS:000233059600002
DA 2018-10-20
ER

PT J
AU Marchisio, M
   Di Carmine, M
   Pagone, R
   Piattelli, A
   Miscia, S
AF Marchisio, M
   Di Carmine, M
   Pagone, R
   Piattelli, A
   Miscia, S
TI Implant surface roughness influences osteoclast proliferation and
   differentiation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE implant surface; multinucleated giant cells; monocyte-macrophages;
   osteoclast; osteoclast proliferation; osteoclast differentiation; RAW
   cells
AB The osteoclast is a hematopoietic cell derived from CFU-GM and branches from the monocyte-macrophage lineage during the differentiation process. Biological environment appears to be crucial for osteoclast formation and activity. It has been reported that bone remodeling following implant placement requires a coordinated activity by osteoclasts and osteoblasts. The response of such cells at the bone-implant interface has been suggested to be affected by the structural and morphological features of the biomaterial surface. To shed more light on this topic we performed a multiparametric analysis of murine monocytes response to different titanium surfaces. These cells, RAW 264.7 type TIB-71, represent a very useful system because they differentiate into osteoclasts following treatment of definite doses of the osteoclast-differentiation factor RANKL and macrophage colony-stimulating factor (M-CSF). Cells, cultured on glass (control), on grade 3 machined and on titanium pull-spray superficial-TPSS surfaces disclosed profound different responses in terms of morphological rearrangements, adhesion, and differentiation abilities. Indeed, after 14 days, cells cultured on glass and machined surfaces were uniformly distributed, while, on the TPSS surface cells strictly aggregated into small isolated clusters were observed. In addition, cells cultured on the machined surface displayed a higher adhesion ability, while cells cultured on the rougher surface disclosed a more evident capability to differentiate. These results could explain the higher bone-implant contact percentage found around implants with rougher surfaces and suggest that osteoclasts may play an important role in the initial period after implant placement to prime or prepare the implant surface for the osteoblast activity. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Chieti Pescara, Sch Dent, I-66100 Chieti, Italy.
   Univ Chieti Pescara, Sch Med, I-66100 Chieti, Italy.
   Univ G Annunzio, I-66100 Chieti, Italy.
RP Piattelli, A (reprint author), Univ Chieti Pescara, Sch Dent, I-66100 Chieti, Italy.
EM apiattelli@unich.it
OI Marchisio, Marco/0000-0003-3058-3422
CR ALSAFFAR N, 2000, BONE ENG, P152
   Assenza Bartolomeo, 2003, J Oral Implantol, V29, P1, DOI 10.1563/1548-1336(2003)029<0001:OAALAU>2.3.CO;2
   Bi YM, 2001, J BONE MINER RES, V16, P2082, DOI 10.1359/jbmr.2001.16.11.2082
   Burr DB, 2002, BONE, V30, P2, DOI 10.1016/S8756-3282(01)00619-6
   Carinci Francesco, 2003, J Oral Implantol, V29, P215, DOI 10.1563/1548-1336(2003)029<0215:AOOMCR>2.3.CO;2
   Cochran DL, 1996, CLIN ORAL IMPLAN RES, V7, P240, DOI 10.1034/j.1600-0501.1996.070306.x
   Crotti TN, 2004, BIOMATERIALS, V25, P565, DOI 10.1016/S0142-9612(03)00556-8
   Di Carmine M, 2003, J PERIODONTOL, V74, P289
   Futami T, 2000, J PERIODONTOL, V71, P287, DOI 10.1902/jop.2000.71.2.287
   Kawamoto S, 2002, ARCH ORAL BIOL, V47, P67, DOI 10.1016/S0003-9969(01)00086-3
   Martin RB, 2002, BONE, V30, P8, DOI 10.1016/S8756-3282(01)00620-2
   Masuda T, 1997, INT J ORAL MAX IMPL, V12, P472
   Minkin C, 1999, Adv Dent Res, V13, P49
   Mundy PR, 1999, FISHERIES, V24, P35
   Norman TL, 1997, BONE, V20, P375, DOI 10.1016/S8756-3282(97)00004-5
   Parfitt AM, 2002, BONE, V30, P5, DOI 10.1016/S8756-3282(01)00642-1
   Piattelli A, 1998, INT J ORAL MAX IMPL, V13, P805
   Piattelli Maurizio, 2002, J Oral Implantol, V28, P2, DOI 10.1563/1548-1336(2002)028<0002:BRTMAR>2.3.CO;2
   Roodman D, 1996, ENDOCR REV, V17, P308
   Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2
   Schulten AJM, 2003, MICROSC RES TECHNIQ, V61, P533, DOI 10.1002/jemt.10376
   SENNERBY L, 1993, J MATER SCI-MATER M, V4, P240, DOI 10.1007/BF00122275
   Srivastava S, 2001, J BIOL CHEM, V276, P8836, DOI 10.1074/jbc.M010764200
   Wennerberg A, 1996, Int J Oral Maxillofac Implants, V11, P38
   Wennerberg A, 1996, J BIOMED MATER RES, V30, P251, DOI 10.1002/(SICI)1097-4636(199602)30:2<251::AID-JBM16>3.0.CO;2-P
   Zreiqat H, 2003, J BIOMED MATER RES A, V64A, P105, DOI 10.1002/jbm.a.10376
NR 26
TC 33
Z9 36
U1 4
U2 13
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV
PY 2005
VL 75B
IS 2
BP 251
EP 256
DI 10.1002/jbm.b.30287
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 981AO
UT WOS:000233059600004
PM 16078239
DA 2018-10-20
ER

PT J
AU Adams, JE
   Zobitz, ME
   Reach, JS
   An, KN
   Lewallen, DG
   Steinmann, SP
AF Adams, JE
   Zobitz, ME
   Reach, JS
   An, KN
   Lewallen, DG
   Steinmann, SP
TI Canine carpal joint fusion: A model for four-corner arthrodesis using a
   porous tantalum implant
SO JOURNAL OF HAND SURGERY-AMERICAN VOLUME
LA English
DT Article
DE four-corner fusion; limited wrist arthrodesis; porous metal; tantalum;
   trabecular metal
ID VASCULARIZED BONE-GRAFTS; WRIST ARTHRODESIS; DEGENERATIVE ARTHRITIS;
   INTERFACE MECHANICS; SCAPHOID EXCISION; INTERCARPAL; BIOMATERIAL;
   ALLOGRAFTS; SURFACES; TITANIUM
AB Purpose: Interest has focused on porous materials that promote bony ingrowth. In this study a porous tantalum implant was used as an adjunct to intercarpal stabilization in a canine model of wrist arthrodesis.
   Methods: A defect was created at the junction of the radiocarpal, ulnocarpal, and fourth carpil bones, analogous to a four-corner fusion site in humans. A tantalum cylinder was press'-fit and stabilized with K-wires. Controls were represented by creating the defect without implant placement. Animals were killed at 4, 8, and 12 weeks.
   Results: Histology showed bony ingrowth as early as 4 weeks and mechanical testing showed a statistically significant increase in strength of the construct over time. Controls failed to achieve union at any time point.
   Conclusions: The implant served as an adjunct to stabilization of the carpus in this model of four-corner fusion, suggesting a novel application of this material in conditions in which bone graft has been required previously. This study represents a preliminary investigation of the use of a tantalum device for intercarpal stabilization; it does not compare this technique with conventional methods.
C1 Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA.
   Mayo Clin, Biomech Lab, Rochester, MN 55905 USA.
RP Steinmann, SP (reprint author), Mayo Clin, Dept Orthoped Surg, 200 1st St SW, Rochester, MN 55905 USA.
EM Steinmann.Scott@Mayo.edu
CR ARO HT, 1993, ANN MED, V25, P403, DOI 10.3109/07853899309147303
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   CANALE ST, 2003, CAMPBELLS OPERATIVE, P3543
   Cohen MS, 2001, J HAND SURG-AM, V26A, P94, DOI 10.1053/jhsu.2001.20160
   COOK SD, 1985, CLIN ORTHOP RELAT R, P271
   Frenkel SR, 2002, J BIOMED MATER RES, V63, P706, DOI 10.1002/jbm.10408
   Garcia-Lopez A, 2001, J HAND SURG-BRIT EUR, V26, P352, DOI 10.1054/jhsb.2001.0598
   Gruen TA, 2005, J ARTHROPLASTY, V20, P369, DOI 10.1016/j.arth.2004.12.049
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   Houshian S, 2001, J HAND SURG-BRIT EUR, V26, P355, DOI 10.1054/jhsb.2001.0600
   Kiuru M, 2003, J BIOMED MATER RES B, V66B, P425, DOI 10.1002/jbm.b.10029
   Luboshitz S, 2002, J HAND SURG-BRIT EUR, V27B, P568, DOI 10.1054/jhsb.2001.0720
   Meads BM, 2003, J HAND SURG-BRIT EUR, V28B, P571, DOI 10.1016/S0266-7681(03)00146-3
   Melican MC, 2001, J BIOMED MATER RES, V55, P194, DOI 10.1002/1097-4636(200105)55:2<194::AID-JBM1006>3.0.CO;2-K
   MIKIC ZD, 1992, ANAT REC, V233, P329
   Nehme A, 2004, CLIN ORTHOP RELAT R, P201, DOI 10.1097/01.blo.0000150133.88271
   NEWTON CD, 1985, TXB SMALL ANIMAL ORT, P267
   PIERMATTEI DL, 1997, PIERMATTEI FLO HDB S, P344
   Prigent H, 1998, J BIOMED MATER RES, V39, P200, DOI 10.1002/(SICI)1097-4636(199802)39:2<200::AID-JBM5>3.0.CO;2-T
   SANDOW MJ, 1992, J HAND SURG-BRIT EUR, V17B, P463, DOI 10.1016/S0266-7681(05)80275-X
   Sauerbier M, 2000, J HAND SURG-BRIT EUR, V25B, P341, DOI 10.1054/jhsb.2000.0434
   Shigetomi M, 1996, J RECONSTR MICROSURG, V12, P113, DOI 10.1055/s-2007-1006463
   Sunagawa T, 2000, J HAND SURG-AM, V25A, P849, DOI 10.1053/jhsu.2000.8639
   Tu YK, 2000, J HAND SURG-AM, V25A, P34
   Tu YK, 2000, J HAND SURG-AM, V25A, P46
   WATSON HK, 1981, J HAND SURG-AM, V6, P223, DOI 10.1016/S0363-5023(81)80074-3
   WATSON HK, 1984, J HAND SURG-AM, V9A, P358, DOI 10.1016/S0363-5023(84)80223-3
   Watson HK, 1999, J HAND SURG-BRIT EUR, V24B, P307, DOI 10.1054/jhsb.1999.0066
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
NR 31
TC 10
Z9 12
U1 0
U2 3
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0363-5023
J9 J HAND SURG-AM
JI J. Hand Surg.-Am. Vol.
PD NOV
PY 2005
VL 30A
IS 6
BP 1128
EP 1135
DI 10.1016/j.jhsa.2005.08.008
PG 8
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 998QX
UT WOS:000234335300004
PM 16344167
DA 2018-10-20
ER

PT J
AU Herath, HMTU
   Di Silvio, L
   Evans, JRG
AF Herath, HMTU
   Di Silvio, L
   Evans, JRG
TI Scandia - A potential biomaterial?
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IN-VITRO; BIOCOMPATIBILITY; OSTEOBLASTS; ASSAYS
AB Biocompatibility is a pre-requisite for all biomaterials used for medical application. During the last two decades significant advances have been made in the development of novel materials and selection and use of these materials has been directly dependent upon their biocompatibility.
   Several materials containing calcium or titanium cations demonstrate biocompatibility and are routinely used in various forms within the human body. Due to its position in the periodic table, scandium in the form of its oxide scandia (Sc2O3) was studied as the first stage of a wider exploration of the biocompatibility of ceramics. A commercial human osteoblast-like cell line (HOS TE 85) was used to study the biocompatibility of both sintered and abraded scandia surfaces. Scanning electron microscopy was used to examine cell adhesion, the MTT assay was used to measure cell metabolic function and the alamarBlue(TM) for the assessment of proliferation.
   Although the results are only preliminary findings, qualitative observations showed that both sintered and abraded surfaces favoured cell adhesion to the same extent. Quantitatively, a significant increase in cell proliferation was observed on Sc2O3 compared to Thermanox(TM), tissue culture control. Furthermore, Sc2O3 has been shown to be non-toxic, able to be maintain cell viability and support cell growth and proliferation. (C) 2005 Springer Science + Business Media, Inc.
C1 Univ London, Queen Mary, Dept Mat, London E1 4NS, England.
   Univ London Kings Coll, Guys Hosp, Guys Kings & St Thomas Med & Dent Inst, Biomat & Biomimet Dent Biomat Sci Dept, London SE1 9RT, England.
RP Herath, HMTU (reprint author), Univ London, Queen Mary, Dept Mat, Mile End Rd, London E1 4NS, England.
OI Di Silvio, Lucy/0000-0003-2554-2052
CR [Anonymous], 109935 ISO
   ARCHO MJ, 1981, CLIN ORTHOP RELAT R, V157, P259
   CHRISTEL PS, 1992, CLIN ORTHOP RELAT R, P10
   Clifford CJ, 1996, J MATER SCI-MATER M, V7, P637, DOI 10.1007/BF00058204
   CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0
   Di Silvio L, 1998, J MATER SCI-MATER M, V9, P845, DOI 10.1023/A:1008900312950
   GOODWIN CJ, 1995, J IMMUNOL METHODS, V179, P95, DOI 10.1016/0022-1759(94)00277-4
   GUNDLE R, 1995, BONE, V16, P597, DOI 10.1016/8756-3282(95)00112-Q
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hulbert SF, 1993, INTRO BIOCERAMICS, P25
   IBARAKI K, 1992, J BONE MINER RES, V7, P743
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   KIRKPATRICK CJ, 1992, ADV BIOMAT, V10, P31
   KIRKPATRICK CJ, 1992, REGULATORY AFFAIRS, V4, P13
   MOSSMANN T, 1983, J IMMUNOL METHODS, V65, P55
   Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4
   RODAN GA, 1984, BONE MINERAL RES ANN, V2, P244
   Rosse C, 1997, HOLLINSHEADS TXB ANA
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   SCHLAGER SI, 1983, METHOD ENZYMOL, V93, P233
   SUCHANEK W, 1998, PRO J MAT RES, V1, P94
   Williams DF, 1987, PROGR BIOMEDICAL ENG, V4, P54
NR 23
TC 1
Z9 1
U1 1
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2005
VL 16
IS 11
BP 1061
EP 1065
DI 10.1007/s10856-005-4760-1
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 981JN
UT WOS:000233085000009
PM 16388387
DA 2018-10-20
ER

PT J
AU Tsai, SW
   Cheng, YH
   Tsai, WB
AF Tsai, SW
   Cheng, YH
   Tsai, WB
TI Heparin modulates human osteosarcoma (MG-63) activities on
   collagen-coated substrata
SO JOURNAL OF THE CHINESE INSTITUTE OF CHEMICAL ENGINEERS
LA English
DT Article; Proceedings Paper
CT 10th Annual Conference on Biochemical Engineering
CY JUN 24-25, 2005
CL Taipei, TAIWAN
DE collagen; heparin; osteoblast; cell adhesion
ID MOLECULAR-WEIGHT HEPARINS; BINDING GROWTH-FACTORS; UNFRACTIONATED
   HEPARIN; CARRYING POLYSTYRENE; OSTEOBLAST GROWTH; IN-VITRO; SURFACE;
   PROTEOGLYCANS; FIBROBLASTS; INHIBITION
AB Collagen, the major extracellular matrix component, is a popular biomaterial due to its excellent biocompatibility. Collagen is widely used in sutures, corneal bandages, drug delivery gels, and as wound dressings, as well as in a newly emerging interdisciplinary biomedical field, tissue engineering. A better understanding of the interaction between cells and collagen substrata combining other ECM components should allow for a more rational scaffold design for tissue engineering. In this study, we explored the effects of heparin on the behavior of osteoblast-like cell lines (MG-63) on collagen-based substrates. Collagen mixture (0.1 mg/mL) with heparin at different concentrations (0.02 mg/mL, 0.1 mg/mL, and 0.5 mg/mL) was coated onto tissue culture polystyrene plates. We found that low concentration of heparin (0.02 mg/mL) enhanced cell adhesion and spreading on collagen-coated plates, but did not influence cell growth and alkaline phosphatase activity. On the other hand, high doses of heparin (0.1 and 0.5 mg/mL) decreased cell adhesion and spreading, as well as cell proliferation. Our results suggest that a small amount of heparin might support osteoblast attachment and spreading although high heparin concentration is not suitable for cell culture.
C1 Chung Gang Univ, Grad Inst Biochem & Biomed Engn, Taoyuan 333, Taiwan.
   Natl Taiwan Univ, Dept Chem Engn, Taipei 106, Taiwan.
RP Tsai, WB (reprint author), Chung Gang Univ, Grad Inst Biochem & Biomed Engn, Taoyuan 333, Taiwan.
RI Tsai, Wei-Bor/B-7953-2011
OI Tsai, Wei-Bor/0000-0002-2316-5751; Tsai, Shiao-Wen/0000-0002-6225-6613
CR Bell E., 2000, PRINCIPLES TISSUE EN, pxxxv
   BRETAUDIERE JP, 1984, METHOD ENZYMAT AN, V4, P75
   BURGESON RE, 1992, CLIN ORTHOP RELAT R, P250
   Douketis JD, 1996, THROMB HAEMOSTASIS, V75, P254
   ELSDALE T, 1972, NATURE, V236, P152, DOI 10.1038/236152a0
   ERHMANN RL, 1956, J NATL CANCER I, V16, P1375
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Ishihara M, 2001, J BIOMED MATER RES, V56, P536, DOI 10.1002/1097-4636(20010915)56:4<536::AID-JBM1125>3.3.CO;2-R
   Ishihara M, 2000, J BIOMED MATER RES, V50, P144, DOI 10.1002/(SICI)1097-4636(200005)50:2<144::AID-JBM8>3.0.CO;2-S
   Johnson G, 2000, J BIOMED MATER RES, V51, P612, DOI 10.1002/1097-4636(20000915)51:4<612::AID-JBM9>3.3.CO;2-Q
   KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303
   KLEBE RJ, 1974, NATURE, V250, P248, DOI 10.1038/250248a0
   Kock HJ, 2002, THROMB HAEMOSTASIS, V88, P361
   Kock HJ, 2002, CLIN APPL THROMB-HEM, V8, P251, DOI 10.1177/107602960200800309
   KONIGSBERG IR, 1970, CHEM MOL BIOL INTRAC, V3, P1799
   LINDAHL U, 1994, THROMB RES, V75, P1, DOI 10.1016/0049-3848(94)90136-8
   MURRAY JC, 1979, J CELL BIOL, V80, P197, DOI 10.1083/jcb.80.1.197
   NelsonPiercy C, 1997, BAILLIERE CLIN OB GY, V11, P489, DOI 10.1016/S0950-3552(97)80024-7
   OLSEN BR, 2000, PRINCIPLES TISSUE EN, P57
   Patino Maria G, 2002, Implant Dent, V11, P280, DOI 10.1097/00008505-200207000-00014
   POUYSSEGUR J, 1977, P NATL ACAD SCI USA, V74, P243, DOI 10.1073/pnas.74.1.243
   RAMALEY PB, 1973, FEBS LETT, V33, P187, DOI 10.1016/0014-5793(73)80189-9
   RUOSLAHTI E, 1988, ANNU REV CELL BIOL, V4, P229, DOI 10.1146/annurev.cellbio.4.1.229
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   SHIBATA Y, 1992, BIOCHEM INT, V28, P335
   Yu JL, 1997, BIOMATERIALS, V18, P421, DOI 10.1016/S0142-9612(96)00154-8
   Zhu AP, 2002, BIOMATERIALS, V23, P4657, DOI 10.1016/S0142-9612(02)00215-6
NR 27
TC 4
Z9 4
U1 0
U2 2
PU CHINESE INST CHEMICAL ENGINEER
PI TAIPEI
PA NATL TSING HUA UNIV, HSINCHU, DEPT CHEMICAL ENGINEERING, TAIPEI 300,
   TAIWAN
SN 0368-1653
J9 J CHIN INST CHEM ENG
JI J. Chin. Inst. Chem. Eng.
PD NOV
PY 2005
VL 36
IS 6
BP 661
EP 668
PG 8
WC Engineering, Chemical
SC Engineering
GA 008LO
UT WOS:000235042400013
DA 2018-10-20
ER

PT J
AU Miara, B
   Rohan, E
   Zidi, M
   Labat, B
AF Miara, B
   Rohan, E
   Zidi, M
   Labat, B
TI Piezomaterials for bone regeneration design - homogenization approach
SO JOURNAL OF THE MECHANICS AND PHYSICS OF SOLIDS
LA English
DT Article
DE piezoelectricity; microstructure; homogenization; bone regeneration;
   biomaterial
ID BIOMATERIALS; TISSUE
AB Relying on the piezoelectric properties of natural bone we propose a new biomaterial made of an inert perforated piezoelectric matrix filled with living ostcoblast cells. We expect that this device will help the process of bone regeneration. In this paper we give some conceptual and numerical tools based on homogenization theory as a starting point in the design of such a "smart system". (c) 2005 Elsevier Ltd. All rights reserved.
C1 ESIEE, Lab Modelisat & Simulat Numer, F-93160 Noisy Le Grand, France.
   Univ W Bohemia, Dept Mech, Fac Sci Appl, Plzen 30614, Czech Republic.
   Univ W Bohemia, New Technol Res Ctr, Plzen 30614, Czech Republic.
   Univ Paris 12, Fac Med, INSERM, Unite U651, F-94010 Creteil, France.
RP Miara, B (reprint author), ESIEE, Lab Modelisat & Simulat Numer, 2, Blvd Blaise Pascal, F-93160 Noisy Le Grand, France.
EM b.miara@esiee.fr; rohan@kme.zcu.cz
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Baiotto S, 2004, BIOMECH MODEL MECHAN, V3, P6, DOI 10.1007/s10237-004-0042-y
   BASSETT CAL, 1962, SCIENCE, V137, P1063, DOI 10.1126/science.137.3535.1063
   BENVENISTE Y, 1995, J MECH PHYS SOLIDS, V43, P553, DOI 10.1016/0022-5096(94)00079-K
   Breuls RGM, 2003, J BIOMECH ENG-T ASME, V125, P902, DOI 10.1115/1.1634287
   Breuls RGM, 2002, J BIOMECH ENG-T ASME, V124, P198, DOI 10.1115/1.1449492
   Charras GT, 2001, ULTRAMICROSCOPY, V86, P85, DOI 10.1016/S0304-3991(00)00076-0
   Cioranescu D, 2002, CR MATH, V335, P99, DOI 10.1016/S1631-073X(02)02429-9
   Cowin S., 2001, BONE MECH HDB
   Dieulesaint E., 1974, ONDES ELASTIQUES SOL
   FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158
   GRISO G, 2005, ADV SMART TECHNOLOGI
   Hornung U., 1997, HOMOGENIZATION POROU
   MARINO AA, 1970, NATURE, V228, P473, DOI 10.1038/228473a0
   MECHKOUR H, 2003, 3 WORLD C STRUCT CON, V3, P329
   MECHKOUR H, 2004, THESIS U MARNE LA VA
   RAHMOUNE M, 1997, THESIS U P M CURIE P
   Rohan E, 2003, MATH COMPUT SIMULAT, V61, P261, DOI 10.1016/S0378-4754(02)00082-4
   ROHAN E, 2005, IN PRESS J THEOR COM
   ROHAN E, 2002, THESIS U W BOHEMIA P
   Sanchez-Palencia E., 1980, LECT NOTES PHYS, V127
   SEARBY ND, 2001, BED BIOENG C ASME NE, V50, P665
   Sikavitsas VI, 2001, BIOMATERIALS, V22, P2581, DOI 10.1016/S0142-9612(01)00002-3
   Telega JJ, 2000, CR ACAD SCI II B, V328, P225, DOI 10.1016/S1287-4620(00)00121-6
   Terada K, 2000, INT J SOLIDS STRUCT, V37, P2285, DOI 10.1016/S0020-7683(98)00341-2
   Terada K, 1998, COMPUT METHOD APPL M, V153, P223, DOI 10.1016/S0045-7825(97)00071-6
   Wiesmann HP, 2001, BBA-MOL CELL RES, V1538, P28, DOI 10.1016/S0167-4889(00)00135-X
NR 27
TC 24
Z9 24
U1 1
U2 16
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-5096
J9 J MECH PHYS SOLIDS
JI J. Mech. Phys. Solids
PD NOV
PY 2005
VL 53
IS 11
BP 2529
EP 2556
DI 10.1016/j.jmps.2005.05.006
PG 28
WC Materials Science, Multidisciplinary; Mechanics; Physics, Condensed
   Matter
SC Materials Science; Mechanics; Physics
GA 976NV
UT WOS:000232741300009
DA 2018-10-20
ER

PT J
AU Oudadesse, H
   Derrien, AC
   Lefloch, M
AF Oudadesse, H
   Derrien, AC
   Lefloch, M
TI Infrared and nuclear magnetic resonance structural studies vs. thermal
   treatment of geopolymers/biphasic calcium phosphates
SO JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY
LA English
DT Article
DE aluminosilicate; biphasic; hydroxyapatite; orthopaedic surgeons;
   porosity; structure; thermal treatment; tricalcic calcium
ID SILICATE-GLASSES; HYDROXYAPATITE; BEHAVIOR; SPECTROSCOPY; SPECTRA
AB In biomaterial field, the introduction of new types of composites presents a great interest for orthopaedic surgeons. In this work, geopolymers which are a family of aluminosilicates were synthesised and mixed with biphasic mixture (hydroxyapatite and of tricalcic phosphate).
   The optimised thermal treatment causes the reduction of pH to 7 units and favours the expansion of composites. Consequently, the increasing of porosity percentage was induced. These properties offer a good opportunity for applied composite as potential osseous biomaterial. To study the consequences of thermal treatment in the initial amorphous structure of composites some physico-chemical techniques like SEM, MAS-NMR and FTIR were employed. These methods permitted to evaluate the porosity, different links in composites and contributions of different groups of Si and Al before and after thermal treatment.
C1 Univ Rennes 1, Inst Chim, CNRS, UMR 6551, F-35042 Rennes, France.
   Univ Rennes 1, CNRS, UMR 6512, F-35042 Rennes, France.
RP Oudadesse, H (reprint author), Univ Rennes 1, Inst Chim, CNRS, UMR 6551, Campus Beaulieu,263 Ave Gen Leclerc, F-35042 Rennes, France.
EM hassane.oudadesse@univ-rennes1.fr
CR Belkebir A, 2000, SPECTROCHIM ACTA A, V56, P435, DOI 10.1016/S1386-1425(99)00117-1
   Chassot E, 2001, J APPL PHYS, V90, P6440, DOI 10.1063/1.1408267
   Ciecinska M, 2003, J THERM ANAL CALORIM, V72, P199, DOI 10.1023/A:1023932122511
   DAVIDOVITS J, 1996, Patent No. 0815064
   Davidovits J., 1994, INT C ALK CEM CONCR, P131
   Derrien AC, 2004, J THERM ANAL CALORIM, V75, P937, DOI 10.1023/B:JTAN.0000027187.14921.86
   Derrien AC, 2004, NUCL INSTRUM METH B, V226, P281, DOI 10.1016/j.nimb.2004.06.014
   DERRIEN AC, 2004, THESIS U RENNES 1
   Efimov AM, 2000, J NON-CRYST SOLIDS, V275, P189, DOI 10.1016/S0022-3093(00)00250-7
   Flanigen E. M., 1971, ADV CHEM SER, V101, P201
   Hwa LG, 1998, J NON-CRYST SOLIDS, V238, P193, DOI 10.1016/S0022-3093(98)00688-7
   Oudadesse H, 2004, INSTRUM SCI TECHNOL, V32, P545, DOI 10.1081/CI-200029803
   Oudadesse H, 2002, NUCL INSTRUM METH B, V190, P458, DOI 10.1016/S0168-583X(01)01252-6
   REGI MV, 2001, J CHEM SOC DA, P97
   Swanepoel JC, 2002, APPL GEOCHEM, V17, P1143, DOI 10.1016/S0883-2927(02)00005-7
   Ternane R, 2002, J ALLOY COMPD, V333, P62, DOI 10.1016/S0925-8388(01)01558-4
   VanJaarsveld JGS, 1997, MINER ENG, V10, P659, DOI 10.1016/S0892-6875(97)00046-0
   Videau JJ, 1997, J EUR CERAM SOC, V17, P1955, DOI 10.1016/S0955-2219(97)00065-4
   Waclawska I, 2001, J THERM ANAL CALORIM, V65, P141, DOI 10.1023/A:1011580702954
   Zoulgami M, 2002, EUR PHYS J-APPL PHYS, V19, P173, DOI 10.1051/epjap:2002063
   ZOULGAMI M, 2001, THESIS U RENNES 1
NR 21
TC 10
Z9 10
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-6150
J9 J THERM ANAL CALORIM
JI J. Therm. Anal. Calorim.
PD NOV
PY 2005
VL 82
IS 2
BP 323
EP 329
DI 10.1007/s10973-005-0898-9
PG 7
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA 980UM
UT WOS:000233043700007
DA 2018-10-20
ER

PT J
AU Altman, D
   Mellgren, A
   Zetterstrom, J
AF Altman, D
   Mellgren, A
   Zetterstrom, J
TI Rectocele repair using biomaterial augmentation: Current documentation
   and clinical experience
SO OBSTETRICAL & GYNECOLOGICAL SURVEY
LA English
DT Review
ID ABDOMINAL SACRAL COLPOPEXY; PELVIC FLOOR DISORDERS; FOREIGN-BODY
   REACTION; POSTERIOR COLPORRHAPHY; CONNECTIVE-TISSUE; WALL DEFECTS; RAT
   MODEL; MECHANICAL-PROPERTIES; URINARY-INCONTINENCE; STRESS-INCONTINENCE
AB Although the etiology of rectocele remains debated, surgical innovations are currently promoted to improve anatomic outcome while avoiding dyspareunia and alleviating rectal emptying difficulties following rectocele surgery. Use of biomaterials in rectocele repair has become widespread in a short time, but the clinical documentation of their effectiveness and complications is limited. Medline and the Cochrane database were searched electronically from 1964 to May 2005 using the Pubmed and Ovid search engines. All English language publications including any of the search terms "rectocele," "implant," "mesh," "biomaterial," "prolapse," "synthetical," "pelvic floor," "biological," and "compatibility" were reviewed. This review outlines the basic principles for use of biomaterials in pelvic reconstructive surgery and provides a condensation of peer-reviewed articles describing clinical use of biomaterials in rectocele surgery. Historical and new concepts in rectocele surgery are discussed. Factors of importance for human in vivo biomaterial compatibility are presented together with current knowledge from clinical studies. Potential risks and problems associated with the use of biomaterials in rectocele and pelvic reconstructive surgery in general are described. Although use of biomaterials in rectocele and other pelvic organ prolapse surgery offers exciting possibilities, it raises treatment costs and may be associated with unknown and potentially severe complications at short and long term. Clinical benefits are currently unknown and need to be proven in clinical studies.
C1 Danderyd Hosp, Dept Obstet & Gynecol, Karolinska Inst, Pelv Floor Ctr,Div Obstet & Gynecol, S-18288 Danderyd, Sweden.
   Univ Minnesota, Div Colon & Rectal Surg, Minneapolis, MN USA.
RP Altman, D (reprint author), Danderyd Hosp, Dept Obstet & Gynecol, Karolinska Inst, Pelv Floor Ctr,Div Obstet & Gynecol, S-18288 Danderyd, Sweden.
EM daniel.altman@ds.se
CR Abramov Y, 2005, OBSTET GYNECOL, V105, P314, DOI 10.1097/01.AOG.0000151990.08019.30
   ADLER R H, 1962, Surg Forum, V13, P29
   ALLEN RE, 1990, BRIT J OBSTET GYNAEC, V97, P770, DOI 10.1111/j.1471-0528.1990.tb02570.x
   Altman D, 2005, DIS COLON RECTUM, V48, P1233, DOI 10.1007/s10350-005-0023-y
   Altman D, 2004, ACTA OBSTET GYN SCAN, V83, P995, DOI 10.1111/j.0001-6349.2004.00646.x
   Altomare DF, 2002, DIS COLON RECTUM, V45, P1549, DOI 10.1097/01.DCR.0000034050.16880.12
   ARNOLD MW, 1990, DIS COLON RECTUM, V33, P684, DOI 10.1007/BF02150745
   Bailey MT, 2003, J BIOMED MATER RES A, V66A, P93, DOI 10.1002/jbm.a.10543
   Beets GL, 1996, EUR J SURG, V162, P823
   Bellon JM, 1997, J BIOMATER APPL, V12, P121, DOI 10.1177/088532829701200203
   Bellon JM, 2002, AM J SURG, V184, P154, DOI 10.1016/S0002-9610(02)00907-8
   Bellon JM, 1998, BIOMATERIALS, V19, P669, DOI 10.1016/S0142-9612(97)00162-2
   BERTOLAMI CN, 1991, PLAST RECONSTR SURG, V87, P1089, DOI 10.1097/00006534-199106000-00011
   BLOCK IR, 1986, DIS COLON RECTUM, V29, P707, DOI 10.1007/BF02555314
   Boccasanta P, 2004, DIS COLON RECTUM, V47, P1285, DOI 10.1007/s10350-004-0582-3
   Brun J. L., 1992, Bio-Medical Materials and Engineering, V2, P203
   Burrows LJ, 2003, INT UROGYNECOL J PEL, V14, P160, DOI 10.1007/s00192-002-1019-y
   Cardozo L, 1998, OBSTET GYNECOL, V92, P722, DOI 10.1016/S0029-7844(98)00175-6
   Cervigni M, 2001, Curr Opin Urol, V11, P429, DOI 10.1097/00042307-200107000-00016
   Clemens JQ, 2000, UROLOGY, V56, P589, DOI 10.1016/S0090-4295(00)00740-8
   Cosson M, 2003, INT UROGYNECOL J PEL, V14, P169, DOI 10.1007/s00192-003-1066-z
   Cundiff GW, 1998, AM J OBSTET GYNECOL, V179, P1451, DOI 10.1016/S0002-9378(98)70009-2
   Debodinance P, 2002, J Gynecol Obstet Biol Reprod (Paris), V31, P527
   Debodinance P, 1999, EUR J OBSTET GYN R B, V87, P23, DOI 10.1016/S0301-2115(99)00068-8
   Deligiannidis N, 2002, Hernia, V6, P51
   Dell JR, 2005, INT UROGYNECOL J, V16, P44, DOI 10.1007/s00192-004-1217-x
   Dietz HP, 2004, AM J OBSTET GYNECOL, V191, P95, DOI 10.1016/j.ajog.2004.01.025
   Dietz HP, 2003, INT UROGYNECOL J, V14, P24, DOI 10.1007/s00192-002-1001-8
   Dietz HP, 2003, INT UROGYNECOL J PEL, V14, P239, DOI 10.1007/s00192-003-1041-8
   EMGE L, 1966, CLIN OBSTET GYNECOL, V4, P997
   Fenner DE, 2000, CLIN OBSTET GYNECOL, V43, P650, DOI 10.1097/00003081-200009000-00024
   FERGUSON W H, 1964, Am Surg, V30, P227
   FitzGerald MP, 2000, AM J OBSTET GYNECOL, V182, P1565, DOI 10.1067/mob.2000.107327
   FRANCIS WJA, 1961, J OBSTET GYN BR COMM, V68, P1
   GUNASEKARAN S, 1988, BIOMATER ARTIF CELL, V16, P771, DOI 10.3109/10731198809117568
   Hayflick L, 1985, Clin Geriatr Med, V1, P15
   Henry MM, 1992, COLOPROCTOLOGY PELVI, P316
   Heriot AG, 2004, BRIT J SURG, V91, P1340, DOI 10.1002/bjs.4543
   Hilger WS, 2003, AM J OBSTET GYNECOL, V189, P1606, DOI 10.1016/j.ajog.2003.10.689
   Jones NHJR, 2003, BRIT J SURG, V90, P466, DOI 10.1002/bjs.4065
   Junge K, 2002, J INVEST SURG, V15, P319, DOI 10.1080/08941930290086137
   Kahn M A, 1998, Int Urogynecol J Pelvic Floor Dysfunct, V9, P37, DOI 10.1007/BF01900540
   Kahn MA, 1997, BRIT J OBSTET GYNAEC, V104, P82, DOI 10.1111/j.1471-0528.1997.tb10654.x
   Kenton K, 1999, AM J OBSTET GYNECOL, V181, P1360, DOI 10.1016/S0002-9378(99)70406-0
   Kenton KS, 2002, AM J OBSTET GYNECOL, V187, P233, DOI 10.1067/mob.2002.121086
   Khouw IMSL, 2000, J BIOMED MATER RES, V52, P439, DOI 10.1002/1097-4636(20001205)52:3<439::AID-JBM1>3.0.CO;2-C
   Klinge U, 1999, EUR J SURG, V165, P665
   Klinge U, 2002, J SURG RES, V103, P208, DOI 10.1006/jsre.2002.6358
   Kobashi KC, 1999, J UROLOGY, V162, P2070, DOI 10.1016/S0022-5347(05)68103-7
   Kohli N, 1998, OBSTET GYNECOL, V92, P999, DOI 10.1016/S0029-7844(98)00330-5
   Kohli N, 2003, INT UROGYNECOL J PEL, V14, P146, DOI 10.1007/s00192-002-1013-4
   Lemer ML, 1999, NEUROUROL URODYNAM, V18, P497, DOI 10.1002/(SICI)1520-6777(1999)18:5<497::AID-NAU12>3.0.CO;2-K
   Leonardo C, 2002, UROL INT, V68, P6, DOI 10.1159/000048410
   Lim YN, 2005, INT UROGYNECOL J, V16, P126, DOI 10.1007/s00192-004-1236-7
   LIPTON S, 1994, J AM COLL SURGEONS, V178, P595
   Lopez A, 2001, INT UROGYNECOL J PEL, V12, P97, DOI 10.1007/PL00004032
   Luber KM, 2001, AM J OBSTET GYNECOL, V184, P1496, DOI 10.1067/mob.2001.114868
   Lyons TL, 1997, J AM ASSOC GYN LAP, V4, P381, DOI 10.1016/S1074-3804(05)80232-4
   MacLennan AH, 2000, BRIT J OBSTET GYNAEC, V107, P1460, DOI 10.1111/j.1471-0528.2000.tb11669.x
   Maher C, 2007, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD004014.PUB3, 10. 1002/ 14651858. CD004014. pub3]
   MAKINEN J, 1986, ARCH GYNECOL OBSTET, V239, P17, DOI 10.1007/BF02134283
   Marinkovic SP, 2003, BJOG-INT J OBSTET GY, V110, P323, DOI 10.1016/S1470-0328(02)01557-4
   MAYS PK, 1990, BIOCHEM SOC T, P18
   MELLGREN A, 1995, DIS COLON RECTUM, V38, P7, DOI 10.1007/BF02053850
   Mercer-Jones MA, 2004, DIS COLON RECTUM, V47, P864, DOI 10.1007/s10350-004-0526-y
   Miklos JR, 1998, AM J OBSTET GYNECOL, V179, P1418, DOI 10.1016/S0002-9378(98)70004-3
   NICHOLS DH, 1970, AM J OBSTET GYNECOL, V108, P215, DOI 10.1016/0002-9378(70)90299-1
   OLIVER RF, 1982, BIOMATERIALS, V3, P38, DOI 10.1016/0142-9612(82)90059-X
   OSTER S, 1981, ACTA OBSTET GYN SCAN, V60, P493, DOI 10.3109/00016348109155466
   PARKER MC, 1993, ANN ROY COLL SURG, V75, P193
   Patsner B, 2000, OBSTET GYNECOL, V95, P1029, DOI 10.1016/S0029-7844(99)00559-1
   Pollack J, 2004, OBSTET GYNECOL, V104, P1397, DOI 10.1097/01.AOG.0000147597.45349.e8
   Porter WE, 1999, AM J OBSTET GYNECOL, V181, P1353, DOI 10.1016/S0002-9378(99)70376-5
   RICHARDSON AC, 1976, AM J OBSTET GYNECOL, V126, P568, DOI 10.1016/0002-9378(76)90751-1
   RICHARDSON AC, 1993, CLIN OBSTET GYNECOL, V36, P976, DOI 10.1097/00003081-199312000-00022
   Rosch R, 2003, EUR SURG RES, V35, P161, DOI 10.1159/000070045
   RUIZTORRES A, 1978, GERONTOLOGY, V24, P337
   Samuelsson EC, 1999, AM J OBSTET GYNECOL, V180, P299, DOI 10.1016/S0002-9378(99)70203-6
   Sand PK, 2001, AM J OBSTET GYNECOL, V184, P1357, DOI 10.1067/mob.2001.115118
   Singh K, 2003, OBSTET GYNECOL, V101, P320, DOI 10.1016/S0029-7844(02)02616-9
   Sloots CEJ, 2003, INT J COLORECTAL DIS, V18, P342, DOI 10.1007/s00384-002-0469-5
   SMITH ARB, 1989, BRIT J OBSTET GYNAEC, V96, P24, DOI 10.1111/j.1471-0528.1989.tb01571.x
   SNOOKS SJ, 1986, INT J COLORECTAL DIS, V1, P20, DOI 10.1007/BF01648831
   Stojkovic S G, 2003, Colorectal Dis, V5, P169, DOI 10.1046/j.1463-1318.2003.00427.x
   Swift SE, 2001, INT UROGYNECOL J, V12, P187, DOI 10.1007/s001920170062
   Tulikangas PK, 2001, OBSTET GYNECOL, V98, P634, DOI 10.1016/S0029-7844(01)01524-1
   Ulmsten U, 1998, Int Urogynecol J Pelvic Floor Dysfunct, V9, P210, DOI 10.1007/BF01901606
   Ulmsten U, 1999, CURR OPIN OBSTET GYN, V11, P509, DOI 10.1097/00001703-199910000-00017
   Versi E, 2001, INT UROGYNECOL J, V12, P107, DOI 10.1007/s001920170074
   WALTER AJ, 2001, AM UROGYNECOLOGIC SO, P20
   Watson SJ, 1996, J AM COLL SURGEONS, V183, P257
   Williams D, 1998, Med Device Technol, V9, P10
   YOSHIOKA K, 1991, DIS COLON RECTUM, V34, P704, DOI 10.1007/BF02050355
   ZHENG F, 2004, AM J OBSTET GYNECOL, P191
NR 94
TC 15
Z9 15
U1 1
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7828
EI 1533-9866
J9 OBSTET GYNECOL SURV
JI Obstet. Gynecol. Surv.
PD NOV
PY 2005
VL 60
IS 11
BP 753
EP 760
DI 10.1097/01.ogx.0000182906.75926.cb
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 980PK
UT WOS:000233030300004
PM 16250924
DA 2018-10-20
ER

PT J
AU Schleicher, I
   Parker, A
   Leavesley, D
   Crawford, R
   Upton, Z
   Xiao, Y
AF Schleicher, I
   Parker, A
   Leavesley, D
   Crawford, R
   Upton, Z
   Xiao, Y
TI Surface modification by complexes of vitronectin and growth factors for
   serum-free culture of human osteoblasts
SO TISSUE ENGINEERING
LA English
DT Article
ID IGF-BINDING-PROTEINS; FACTOR-I; BONE-CELLS; FIBRONECTIN; ADSORPTION;
   ATTACHMENT; MIGRATION; ADHESION; PROLIFERATION; WETTABILITY
AB Cell attachment, expansion, and migration in three-dimensional biomaterials are crucial steps for effective delivery of osteogenic cells into bone defects. Complexes composed of vitronectin (VN), insulin-like growth factors (IGFs), and insulin growth factor-binding proteins (IGFBPs) have been reported to enhance cell attachment, proliferation, and migration in a variety of cell lines in vitro. The aim of this study was to examine whether prebound complexes of VN and IGFs +/- IGFBPs could facilitate human osteoblast serum-free expansion in vitro and enhance cell attachment, proliferation, and migration in three-dimensional biomaterial constructs. Human osteoblasts derived from alveolar bone chips and the established human osteoblast cell line Saos-2 were used. These cells were seeded on tissue culture plates and porous scaffolds of type I collagen sponges and polyglycolic acid (PGA), which had been coated with VN +/- IGFBP-5 +/- IGF-I. Cell attachment, proliferation, and migration were evaluated by cell counting, confocal microscopy, and scanning electron microscopy. The number of attached human osteoblasts was significantly higher in VN-coated polystyrene culture dishes. Furthermore, significant increases in cell proliferation were observed when growth factors were bound to these surfaces in the presence of VN. In the two scaffold materials examined, greater cell attachment was found in type I collagen sponges compared with PGA scaffolds. However, coating the scaffolds with complexes composed of VN + IGF-I or VN + IGFBP-5 + IGF-I enhanced cell attachment on PGA. Moreover, the presence of VN + IGFBP-5 + IGF-I resulted in significantly greater osteoblast migration into deep pore areas as compared with untreated scaffolds or scaffolds treated with fetal calf serum. These results demonstrated that complexes of VN + IGFBP-5 + IGF-I can be used to expand osteoblasts in vitro under serum-free conditions and enhance the attachment and migration of human osteoblasts in three-dimensional culture. This in turn suggests a potential application in surface modification of biomaterials for tissue reconstruction.
C1 Queensland Univ Technol, Brisbane, Qld 4001, Australia.
   Prince Charles Hosp, Brisbane, Qld 4032, Australia.
   Queensland Univ Technol, Inst Hlth & Biomed Innovat, Ctr Sci Res, Brisbane, Qld, Australia.
RP Xiao, Y (reprint author), Queensland Univ Technol, 2 George St,Level 4,Q Block, Brisbane, Qld 4001, Australia.
EM yin.xiao@qut.edu.au
RI Leavesley, David/C-9532-2009; Upton, Zee/I-9777-2012
OI Leavesley, David/0000-0002-1033-5459; Parker, Tony/0000-0002-5118-524X;
   Crawford, Ross/0000-0001-6079-1316; Xiao, Yin/0000-0003-1785-3491
CR Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   Altankov G, 1996, J BIOMAT SCI-POLYM E, V8, P299
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Basle MF, 1998, ORTHOPADE, V27, P136
   BAUTISTA CM, 1991, BIOCHEM BIOPH RES CO, V176, P756, DOI 10.1016/S0006-291X(05)80249-9
   Edens RE, 2001, ARCH BIOCHEM BIOPHYS, V391, P278, DOI 10.1006/abbi.2001.2398
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   HORBETT TA, 1994, J BIOMAT SCI-POLYM E, V6, P15, DOI 10.1163/156856295X00724
   Hyde C, 2004, J INVEST DERMATOL, V122, P1198, DOI 10.1111/j.0022-202X.2004.022527.x
   Jadlowiec JA, 2003, EXPERT OPIN BIOL TH, V3, P409, DOI 10.1517/14712598.3.3.409
   Jia D, 2000, BONE, V27, P785, DOI 10.1016/S8756-3282(00)00400-2
   Jones John I., 1995, Progress in Growth Factor Research, V6, P319, DOI 10.1016/0955-2235(95)00015-1
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Kricker JA, 2003, ENDOCRINOLOGY, V144, P2807, DOI 10.1210/en.2002-221086
   Laffargue P, 2000, J BIOMED MATER RES, V49, P415, DOI 10.1002/(SICI)1097-4636(20000305)49:3<415::AID-JBM15>3.3.CO;2-Q
   Lamba NMK, 1998, FRONTIERS TISSUE ENG, P121
   LEAVESLEY DI, 1992, J CELL BIOL, V117, P1101, DOI 10.1083/jcb.117.5.1101
   Lee YJ, 2003, BIOMATERIALS, V24, P1059, DOI 10.1016/S0142-9612(02)00439-8
   Linkhart TA, 1996, BONE, V19, pS1, DOI 10.1016/S8756-3282(96)00138-X
   Maile LA, 2002, J BIOL CHEM, V277, P1800, DOI 10.1074/jbc.M108380200
   MCFARLAND CD, 1909, J BIOMED MATER RES, V44, P1
   McQueeney K, 2001, GROWTH HORM IGF RES, V11, P346, DOI 10.1054/ghir.2001.0250
   MOHAN S, 1999, IGF SYSTEM MOL BIOL, P457
   Nam T, 2002, ENDOCRINOLOGY, V143, P30, DOI 10.1210/en.143.1.30
   Noble A, 2003, ENDOCRINOLOGY, V144, P2417, DOI 10.1210/en.2002-221138
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Piskin E, 2002, INT J ARTIF ORGANS, V25, P434
   PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cb.07.110191.001423
   Preissner KT, 1998, THROMB RES, V89, P1, DOI 10.1016/S0049-3848(97)00298-3
   Raschke M, 2002, BONE, V30, P144, DOI 10.1016/S8756-3282(01)00640-8
   Rezania A, 1999, J ORTHOPAED RES, V17, P615, DOI 10.1002/jor.1100170423
   Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9
   STEELE JG, 1995, BIOMATERIALS, V16, P1057, DOI 10.1016/0142-9612(95)98901-P
   STEELE JG, 1993, J BIOMED MATER RES, V27, P927, DOI 10.1002/jbm.820270712
   Upton Z, 1999, ENDOCRINOLOGY, V140, P2928, DOI 10.1210/en.140.6.2928
   Vermeer AWP, 2001, BBA-GEN SUBJECTS, V1526, P61, DOI 10.1016/S0304-4165(01)00101-5
   Weller M, 1990, Fortschr Ophthalmol, V87, P221
   WERGEDAL JE, 1990, J BONE MINER RES, V5, P179, DOI 10.1002/jbmr.5650050212
   Xiao Y, 2003, TISSUE ENG, V9, P1167, DOI 10.1089/10763270360728071
   Xu QJ, 2004, CIRC RES, V94, pE46, DOI 10.1161/01.RES.0000124761.62846.DF
   Zoungrana T, 1997, J COLLOID INTERF SCI, V190, P437, DOI 10.1006/jcis.1997.4895
NR 41
TC 20
Z9 22
U1 0
U2 5
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD NOV
PY 2005
VL 11
IS 11-12
BP 1688
EP 1698
DI 10.1089/ten.2005.11.1688
PG 11
WC Cell & Tissue Engineering
SC Cell Biology
GA 005NH
UT WOS:000234829500007
PM 16411814
DA 2018-10-20
ER

PT J
AU Heinonen, M
   Oila, O
   Nordstrom, K
AF Heinonen, M
   Oila, O
   Nordstrom, K
TI Current issues in the regulation of human tissue-engineering products in
   the European Union
SO TISSUE ENGINEERING
LA English
DT Article
AB Tissue engineering (TE) is an emerging technology that combines expertise in life sciences, clinical medicine, and engineering. Current challenges in TE include anticipating and streamlining appropriate regulation with product development. Consequently this study has focused on views of developers, companies, and regulators on biological risks of TE products, aspects of commercial applications, and patentability. Most concerns about TE products focus on risk of cancer formation, infection risk, and rejection risk. Thus, at the present time, product developers should follow guidelines for medicinal products, in order to address product safety at an adequate level. According to the data of the present study, cell and biomaterial products, manipulated cells, and scaffolds appear to be the primary interest for commercial product development. In contrast, producing services were not considered as interesting. Constraints are also imposed by patentability, which stipulates demands for technical performance and highlights ethical issues, which are difficult to address.
C1 Helsinki Univ Technol, Lab Biochem & Microbiol, FIN-02150 Espoo, Finland.
RP Heinonen, M (reprint author), Helsinki Univ Technol, Lab Biochem & Microbiol, FIN-02150 Espoo, Finland.
EM maarit.k.heinonen@helsinki.fi
RI Nordstrom, Katrina/K-6822-2012
OI Nordstrom, Katrina/0000-0003-3508-9810
CR BOCK AK, 2003, IPTS PUBLICATIONS
   Caulfield TA, 2003, TRENDS BIOTECHNOL, V21, P101, DOI 10.1016/S0167-7799(03)00006-4
   FOSTER L, 2002, DRUG PLUS INT, V1
   Lysaght MJ, 2004, TISSUE ENG, V10, P309, DOI 10.1089/107632704322791943
   Mason J., 1996, QUALITATIVE RES
   Nieminen O, 2004, DRUG DISCOV TODAY, V9, P387, DOI 10.1016/S1359-6446(03)02938-6
   NIEMINEN O, 2004, DRUG INF, V3, P253
   *OP EUR GROUP ETH, 2002, ETH ASP PAT INV INV
   Orive G, 2003, TRENDS BIOTECHNOL, V21, P109, DOI 10.1016/S0167-7799(03)00003-9
   PARKER S, 2001, J COMMERC BIOTECHNOL, V8, P66
   SENKER J, 2003, HUMAN TISSUE ENG PRO
   SMITH ME, 2003, REGUL AFFAIRS FO MAY
NR 12
TC 21
Z9 22
U1 0
U2 3
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD NOV
PY 2005
VL 11
IS 11-12
BP 1905
EP 1911
DI 10.1089/ten.2005.11.1905
PG 7
WC Cell & Tissue Engineering
SC Cell Biology
GA 005NH
UT WOS:000234829500030
PM 16411837
DA 2018-10-20
ER

PT J
AU Madhan, B
   Subramanian, V
   Rao, JR
   Nair, BU
   Ramasami, T
AF Madhan, B
   Subramanian, V
   Rao, JR
   Nair, BU
   Ramasami, T
TI Stabilization of collagen using plant polyphenol: Role of catechin
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE collagen; catechin; polyphenol; rat tail tendon (RTT); tannin
ID ATOMIC-FORCE MICROSCOPY; RAT TAIL TENDON; GALLIC ACID; TANNINS;
   STABILITY; ULTRASTRUCTURE; PEPTIDES; BIOLOGY; HEALTH; HELIX
AB Collagen. a unique connective tissue protein finds extensive application as biocompatible biomaterial in wound healing, as drug carriers, cosmetics, etc. A work has been undertaken to study the stabilization of type I collagen using the plant polyphenol catechin. Catechin treated collagen fibres showed a shrinkage temperature around 70 degrees C implying that catechin is able to impart thermal stability to collagen. Catechin treated collagen fibres has been found to be stable even after treatment with high concentration of the secondary structural destabilizer, urea. Circular dichroism studies revealed that there is no major alteration in the structure of collagen on treatment with catechin. The study has demonstrated the involvement of hydrogen bonding and hydrophobic interactions as the major forces involved in the stabilization of collagen by the plant polyphenol, catechin. (c) 2005 Elsevier B.V. All rights reserved.
C1 Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
   Cent Leather Res Inst, Ctr Human & Org Resources Dev, Madras 600020, Tamil Nadu, India.
RP Rao, JR (reprint author), Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
EM clrichem@mailcity.com
RI Nair, Balachandran/D-1508-2010; Madhan, Balaraman/B-3136-2009;
   Thangarasu, Kandasamy/B-8503-2009; Rao, Jonnalagadda/B-8486-2009;
   Venkatesan, Subramanian/A-8478-2013
OI Madhan, Balaraman/0000-0002-4198-8452; 
CR BALENTINE DA, 1992, PHENOLIC COMPOUNDS F
   Baxter NJ, 1997, BIOCHEMISTRY-US, V36, P5566, DOI 10.1021/bi9700328
   Bella J, 1996, J MOL BIOL, V264, P734, DOI 10.1006/jmbi.1996.0673
   Borasky R., 1949, J AM LEATHER CHEM AS, V44, P830
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   Chung KT, 1998, TRENDS FOOD SCI TECH, V9, P168, DOI 10.1016/S0924-2244(98)00028-4
   Chung KT, 1998, CRIT REV FOOD SCI, V38, P421, DOI 10.1080/10408699891274273
   Feng YB, 1996, J AM CHEM SOC, V118, P10351, DOI 10.1021/ja961260c
   Figueiro SD, 2004, CARBOHYD POLYM, V56, P313, DOI 10.1016/j.carbpol.2004.01.011
   FRANZBLAU C, 1976, BIOCHIM BIOPHYS ACTA, V427, P302, DOI 10.1016/0005-2795(76)90306-8
   GALE M, 1995, BIOPHYS J, V68, P2124, DOI 10.1016/S0006-3495(95)80393-0
   Gayatri R, 2001, BIOCHEM BIOPH RES CO, V283, P229, DOI 10.1006/bbrc.2001.4713
   Gross G.G., 1999, PLANT POLYPHENOLS
   Hulmes DJS, 2002, J STRUCT BIOL, V137, P2, DOI 10.1006/jsbi.2002.4450
   Isenburg JC, 2005, BIOMATERIALS, V26, P1237, DOI 10.1016/j.biomaterials.2004.04.034
   KATZ W, 1933, COLLEGIUM, V754, P85
   KUTTAN R, 1981, EXPERIENTIA, V37, P221, DOI 10.1007/BF01991620
   LONG CG, 1993, BIOCHEMISTRY-US, V32, P11688, DOI 10.1021/bi00094a027
   Madhan B, 2004, J AM LEATHER CHEM AS, V99, P157
   Madhan B, 2003, CHEM PHYS LETT, V369, P131, DOI 10.1016/S0009-2614(02)01993-0
   Madhan B, 2002, BIOMATERIALS, V23, P2841, DOI 10.1016/S0142-9612(01)00410-0
   Madhan B, 2001, CHEM PHYS LETT, V346, P334, DOI 10.1016/S0009-2614(01)00910-1
   Naczk M, 1996, J AGR FOOD CHEM, V44, P2144, DOI 10.1021/jf960165k
   Nimni M. E., 1988, COLLAGEN, VI
   Okuda T., 1995, PROG CH ORG NAT PROD, P1
   Paige MF, 1998, BIOPHYS J, V74, P3211, DOI 10.1016/S0006-3495(98)78027-0
   Paige MF, 2001, MICRON, V32, P341, DOI 10.1016/S0968-4328(00)00037-8
   Porter LJ, 1989, METHODS PLANT BIOCH
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   RENUGOPALAKRISHNAN V, 1989, MACROMOLECULES, V22, P4121, DOI 10.1021/ma00200a054
   SINGLETON VL, 1976, PHENOLIC SULFUR NITR
   Sionkowska A, 1999, INT J BIOL MACROMOL, V24, P337, DOI 10.1016/S0141-8130(99)00047-1
   Sionkowska A, 2000, POLYM DEGRAD STABIL, V68, P147, DOI 10.1016/S0141-3910(99)00176-7
   SMITH JW, 1968, NATURE, V219, P157, DOI 10.1038/219157a0
   SUNDARALINGAM M, 1989, SCIENCE, V244, P1333, DOI 10.1126/science.2734612
   Tang HR, 2003, J AGR FOOD CHEM, V51, P6652, DOI 10.1021/jf034380u
   TANG HR, 2004, BIOPOLYMERS, V70, P403
   Timasheff SN, 1998, ADV PROTEIN CHEM, V51, P355
   Usha R, 2000, THERMOCHIM ACTA, V356, P59, DOI 10.1016/S0040-6031(00)00518-9
   VENUGOPAL MG, 1994, BIOCHEMISTRY-US, V33, P7948, DOI 10.1021/bi00191a023
   Wang AJ, 1997, BIOCHEMISTRY-US, V36, P9101, DOI 10.1021/bi970247h
   WAUTERS P, 1986, BIOCHEM PHARMACOL, V35, P2971, DOI 10.1016/0006-2952(86)90495-8
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
NR 43
TC 113
Z9 116
U1 7
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD OCT 30
PY 2005
VL 37
IS 1-2
BP 47
EP 53
DI 10.1016/j.ijbiomac.2005.08.005
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 984DX
UT WOS:000233283800007
PM 16183110
DA 2018-10-20
ER

PT J
AU Cunha, PLR
   Castro, RR
   Rocha, FAC
   de Paula, RCM
   Feitosa, JPA
AF Cunha, PLR
   Castro, RR
   Rocha, FAC
   de Paula, RCM
   Feitosa, JPA
TI Low viscosity hydrogel of guar gum: Preparation and physicochemical
   characterization
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE guar gum; hydrogel; viscosity; thermal stability; glutaraldehyde; Hylan
ID CROSS-LINKED GUAR; MOLECULAR-WEIGHT; DISSOLUTION KINETICS;
   CONTROLLED-RELEASE; AQUEOUS-SOLUTION; IN-VITRO; GALACTOMANNAN;
   GLUTARALDEHYDE; FILMS; OSTEOARTHRITIS
AB Guar gum was cross-linked with glutaraldehyde and characterized by GPC, rheology, WADX, SEM and TGA. This guar gum is a galactomannan polysaccharide, that contains small amount of arabinose, glucose and uronic acid, besides galactose and mannose. The polymer has high molar mass, with M-w, M-n and M-v, values of 2.0 x 10(6), 1.2 x 10(6) and 1.9 x 10(6) g/mol, respectively. The reticulation follows a slow process and lead to a viscosity increase of 40 times compared with the original guru solution. The final viscosity was similar to that of Hylan G-F 20, a hyaluronate derivative, commercially used in viscosupplementation treatment. The gel contains 95.6% of water and the amount of residual glutaraldehyde is much lower than the LD-50. Porous structure was detected by SEM and thermal stability was improved by the cross-linking. The low viscosity, the small amount of remained glutaraldehyde, and the thermal stability indicates that the guar hydrogel has potential to be applied as biomaterial with specific rheological requirements. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Fed Ceara, Dept Quim Organ & Inorgan, BR-60455760 Fortaleza, Ceara, Brazil.
   Univ Fed Ceara, Dept Fisiol & Farmacol, BR-60455760 Fortaleza, Ceara, Brazil.
   Univ Fed Ceara, Dept Clin Med, BR-60455760 Fortaleza, Ceara, Brazil.
RP Feitosa, JPA (reprint author), Univ Fed Ceara, Dept Quim Organ & Inorgan, C Postal 12-200, BR-60455760 Fortaleza, Ceara, Brazil.
EM judith@dqoi.ufc.br
RI rocha, francisco/O-1988-2018
OI rocha, francisco/0000-0003-4370-3294
CR Azero EG, 2002, POLYM TEST, V21, P551, DOI 10.1016/S0142-9418(01)00123-4
   Barbucci R, 2002, BIOMATERIALS, V23, P4503, DOI 10.1016/S0142-9612(02)00194-1
   Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1
   BURDICK J, 2004, Patent No. 6800298
   Burke MD, 2000, MACROMOLECULES, V33, P7500, DOI 10.1021/ma0007861
   Burruano BT, 2002, CONTRACEPTION, V66, P137, DOI 10.1016/S0010-7824(02)00336-0
   Chen LY, 2004, BIOMATERIALS, V25, P3725, DOI 10.1016/j.biomaterials.2003.09.100
   Cheng Y, 2002, INT J BIOL MACROMOL, V31, P29, DOI 10.1016/S0141-8130(02)00046-6
   Cheng Y, 2002, MACROMOLECULES, V35, P10155, DOI 10.1021/ma020887e
   CLOURASIA M, 2004, DRUG DELIV, V11, P129
   Conrozier T, 2003, JOINT BONE SPINE, V70, P128, DOI 10.1016/S1297-319X(03)00005-8
   CUNHA PLR, 2005, Patent No. 05021987
   de Nooy AEJ, 2000, BIOMACROMOLECULES, V1, P259, DOI 10.1021/bm005517h
   Debon SJJ, 2001, FOOD CHEM, V73, P401, DOI 10.1016/S0308-8146(00)00312-5
   DOUBLIER JL, 1981, J TEXTURE STUD, V12, P151, DOI 10.1111/j.1745-4603.1981.tb01229.x
   Gliko-Kabir I, 1998, PHARMACEUT RES, V15, P1019, DOI 10.1023/A:1011921925745
   Gliko-Kabir I, 1999, CARBOHYD RES, V316, P6, DOI 10.1016/S0008-6215(99)00025-7
   Gliko-Kabir I, 2000, J CONTROL RELEASE, V63, P129, DOI 10.1016/S0168-3659(99)00180-7
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   KAWAHARA J, 1992, ANAL BIOCHEM, V201, P94, DOI 10.1016/0003-2697(92)90178-A
   Kim BH, 2003, MACROMOL RES, V11, P291, DOI 10.1007/BF03218366
   Konishi M, 2003, J CONTROL RELEASE, V92, P301, DOI 10.1016/S0168-3659(03)00364-X
   Launay B, 1997, CARBOHYD POLYM, V34, P385, DOI 10.1016/S0144-8617(97)00104-5
   Murthy SN, 2004, INT J PHARM, V272, P11, DOI 10.1016/j.ijpharm.2003.11.019
   OCHOA E, 2004, Patent No. 02140322
   PATEL SP, 1987, INT J BIOL MACROMOL, V9, P314, DOI 10.1016/0141-8130(87)90001-8
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   ROBINSON G, 1982, CARBOHYD RES, V107, P17, DOI 10.1016/S0008-6215(00)80772-7
   Rujiravanit R, 2003, MACROMOL BIOSCI, V3, P604, DOI 10.1002/mabi.200300027
   Soppirnath KS, 2002, EUR J PHARM BIOPHARM, V53, P87, DOI 10.1016/S0939-6411(01)00205-3
   STANLEY W, 1978, STRUCTURE FUNCTION M
   Wang Q, 2003, CARBOHYD POLYM, V53, P75, DOI 10.1016/S0144-8617(03)00009-2
   Wang Q, 2002, CARBOHYD POLYM, V49, P131, DOI 10.1016/S0144-8617(01)00327-7
   WILLIAMS S, 2002, Patent No. 6555123
NR 36
TC 43
Z9 44
U1 0
U2 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD OCT 30
PY 2005
VL 37
IS 1-2
BP 99
EP 104
DI 10.1016/j.ijbiomac.2005.09.001
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 984DX
UT WOS:000233283800014
PM 16221491
DA 2018-10-20
ER

PT J
AU Chiang, HS
   Huang, YY
   Jiang, CC
AF Chiang, Hongsen
   Huang, Yi-You
   Jiang, Ching-Chuan
TI REPAIR OF ARTICULAR CARTILAGE INJURY
SO BIOMEDICAL ENGINEERING-APPLICATIONS BASIS COMMUNICATIONS
LA English
DT Article
AB Articular cartilage defects heal poorly and lead to consequences as osteoarthritis. Clinical experience has indicated that no existing medication would substantially promote the healing process, and the cartilage defect requires surgical replacement. Allograft decays quickly for multiple reasons including the preparation process and immune reaction, and the outcome is disappointing. The extreme shortage of sparing in articular cartilage has much discouraged the use of autograft, which requires modification. The concept that constructs a chondral or osteochondral construct for the replacement of injured native tissue introduces that of tissue engineering. Limited number of cells are expanded either in vitro or in vivo, and resided temporally on a scaffold of biomaterial, which also acts as a vehicle to transfer the cells to the recipient site. Three core elements constitute this technique: the cell, a biodegradable scaffold, and an environment suitable for cells to present their proposed activity. Modern researches have kept updating those elements for a better performance of such cultivation of living tissue.
C1 [Chiang, Hongsen; Huang, Yi-You; Jiang, Ching-Chuan] Natl Taiwan Univ, Inst Biomed Engn, 1,Sect 1,Jen Ai Rd, Taipei 100, Taiwan.
   [Chiang, Hongsen; Jiang, Ching-Chuan] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Taipei, Taiwan.
   [Chiang, Hongsen; Jiang, Ching-Chuan] Natl Taiwan Univ, Coll Med, Taipei, Taiwan.
RP Huang, YY (reprint author), Natl Taiwan Univ, Inst Biomed Engn, 1,Sect 1,Jen Ai Rd, Taipei 100, Taiwan.
EM yyhuang@ha.mc.ntu.edu.tw
OI Jiang, Ching-Chuan/0000-0001-7954-0875; Chiang,
   Hongsen/0000-0001-8781-5146
CR AndersonMackenzie JM, 1997, RES VET SCI, V63, P29, DOI 10.1016/S0034-5288(97)90154-5
   ASAHINA I, 1993, J CELL BIOL, V123, P921, DOI 10.1083/jcb.123.4.921
   Awad HA, 2003, TISSUE ENG, V9, P1301, DOI 10.1089/10763270360728215
   Baragi VM, 1997, OSTEOARTHR CARTILAGE, V5, P275, DOI 10.1016/S1063-4584(97)80023-4
   Biddulph D M, 2000, Methods Cell Sci, V22, P9, DOI 10.1023/A:1009824106368
   Bouwmeester SJM, 1997, INT ORTHOP, V21, P313, DOI 10.1007/s002640050175
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brittberg M, 1999, CLIN ORTHOP RELAT R, pS147
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   Caterson EJ, 2002, ANN NY ACAD SCI, V961, P134, DOI 10.1111/j.1749-6632.2002.tb03066.x
   Chaipinyo K, 2004, J ORTHOPAED RES, V22, P446, DOI 10.1016/j.orthres.2003.07.001
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   CHEN P, 1991, EXP CELL RES, V195, P509, DOI 10.1016/0014-4827(91)90403-H
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Chiang H, 2005, J ORTHOP RE IN PRESS
   ChimalMonroy J, 1997, INT J DEV BIOL, V41, P91
   Chow JCY, 2004, ARTHROSCOPY, V20, P681, DOI 10.1016/j.arthro.2004.06.005
   Farquharson C, 1998, EUR J CELL BIOL, V76, P110, DOI 10.1016/S0171-9335(98)80023-X
   Fortier LA, 2002, AM J VET RES, V63, P301, DOI 10.2460/ajvr.2002.63.301
   French MM, 2004, ANN BIOMED ENG, V32, P50, DOI 10.1023/B:ABME.0000007790.65773.e0
   Frenkel SR, 2004, ANN BIOMED ENG, V32, P26, DOI 10.1023/B:ABME.0000007788.41804.0d
   Fuss M, 2000, ANN ANAT, V182, P303
   Gao RZ, 2002, TISSUE ENG, V8, P827, DOI 10.1089/10763270260424187
   Giannini Sandro, 2002, Foot Ankle Clin, V7, P621, DOI 10.1016/S1083-7515(02)00023-2
   Gole MD, 2004, J ORTHOP RES, V22, P781, DOI 10.1016/j.orthres.2003.11.006
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P274
   Grad S, 2005, TISSUE ENG, V11, P249, DOI 10.1089/ten.2005.11.249
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   Hangody L, 2003, J BONE JOINT SURG AM, V85A, P25, DOI 10.2106/00004623-200300002-00004
   Hangody L, 2001, CLIN ORTHOP RELAT R, pS328, DOI 10.1097/00003086-200110001-00030
   HARMAND MF, 1984, J CELL PHYSIOL, V119, P359, DOI 10.1002/jcp.1041190315
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   HENDRICKSON DA, 1994, J ORTHOPAED RES, V12, P485, DOI 10.1002/jor.1100120405
   Horas U, 2003, J BONE JOINT SURG AM, V85A, P185, DOI 10.2106/00004623-200302000-00001
   IWASAKI M, 1993, ENDOCRINOLOGY, V132, P1603, DOI 10.1210/en.132.4.1603
   JIANG TX, 1993, DEV BIOL, V155, P545, DOI 10.1006/dbio.1993.1051
   JOHNSON L L, 1986, Arthroscopy, V2, P54, DOI 10.1016/S0749-8063(86)80012-3
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   KATO Y, 1987, J CELL BIOL, V104, P311, DOI 10.1083/jcb.104.2.311
   KON M, 1981, EUR SURG RES, V13, P387, DOI 10.1159/000128206
   Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1
   Kulyk WM, 1996, EXP CELL RES, V223, P290, DOI 10.1006/excr.1996.0084
   KULYK WM, 1991, DEV BIOL, V146, P38, DOI 10.1016/0012-1606(91)90444-8
   Kus W M, 1999, Ann Transplant, V4, P101
   Lee David A, 2004, Methods Mol Biol, V238, P159
   Lee HS, 2003, STEM CELLS, V21, P190, DOI 10.1634/stemcells.21-2-190
   LEFEBVRE V, 1990, BIOCHIM BIOPHYS ACTA, V1051, P266, DOI 10.1016/0167-4889(90)90132-W
   Liu YC, 2002, TISSUE ENG, V8, P709, DOI 10.1089/107632702760240616
   Lu LC, 2001, CLIN ORTHOP RELAT R, pS251
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Mainil-Varlet P, 2003, J BONE JOINT SURG AM, V85A, P45, DOI 10.2106/00004623-200300002-00007
   Malda J, 2004, TISSUE ENG, V10, P987, DOI 10.1089/1076327041887637
   Mankani MH, 2001, BIOTECHNOL BIOENG, V72, P96, DOI 10.1002/1097-0290(20010105)72:1<96::AID-BIT13>3.0.CO;2-A
   Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708
   Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745
   Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006
   Mauck RL, 2002, ANN BIOMED ENG, V30, P1046, DOI 10.1114/1.1512676
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   MIKHAILOV AT, 1988, CELL DIFFER DEV, V22, P145, DOI 10.1016/0045-6039(88)90026-7
   Miyamoto M, 2003, OSTEOARTHR CARTILAGE, V11, P644, DOI 10.1016/S1063-4584(03)00118-3
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   Ng KW, 2005, J ORTHOP RES, V23, P134, DOI 10.1016/j.orthres.2004.05.015
   O'Driscoll SW, 1999, CLIN ORTHOP RELAT R, pS186, DOI 10.1097/00003086-199910001-00020
   Ochi M, 2001, ARTIF ORGANS, V25, P172, DOI 10.1046/j.1525-1594.2001.025003172.x
   ODRISCOLL SW, 1986, J BONE JOINT SURG AM, V68A, P1017, DOI 10.2106/00004623-198668070-00008
   ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017
   Ogueta S, 2002, MOL CELL ENDOCRINOL, V190, P51, DOI 10.1016/S0303-7207(02)00013-8
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   Phipatanakul Wesley P, 2004, Am J Orthop (Belle Mead NJ), V33, P345
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Quarto R, 1997, ENDOCRINOLOGY, V138, P4966, DOI 10.1210/en.138.11.4966
   Rahfoth B, 1998, OSTEOARTHR CARTILAGE, V6, P50, DOI 10.1053/joca.1997.0092
   REVILLIONCARETTE F, 1986, DIFFERENTIATION, V33, P121, DOI 10.1111/j.1432-0436.1986.tb00417.x
   Rohde RS, 2004, CLIN ORTHOP
   Ronziere MC, 2003, BIOMATERIALS, V24, P851, DOI 10.1016/S0142-9612(02)00418-0
   Samuel RE, 2002, HUM GENE THER, V13, P791, DOI 10.1089/10430340252898975
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/1076327042500391
   Seidel JO, 2004, BIORHEOLOGY, V41, P445
   Shea CM, 2003, J CELL BIOCHEM, V90, P1112, DOI 10.1002/jcb.10734
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   SHOEMAKER RS, 1992, AM J VET RES, V53, P1446
   Siebler T, 2002, BONE, V31, P457, DOI 10.1016/S8756-3282(02)00855-4
   Solchaga LA, 2002, TISSUE ENG, V8, P333, DOI 10.1089/107632702753725085
   Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033
   Temenoff JS, 2002, J BIOMED MATER RES, V59, P429, DOI 10.1002/jbm.1259
   Tonon R, 2000, J BONE MINER RES, V15, P1669, DOI 10.1359/jbmr.2000.15.9.1669
   Toolan BC, 1996, J BIOMED MATER RES, V31, P273, DOI 10.1002/(SICI)1097-4636(199606)31:2<273::AID-JBM15>3.0.CO;2-M
   TSONIS PA, 1991, DEV BIOL, V143, P130, DOI 10.1016/0012-1606(91)90060-G
   Tsukazaki T, 1994, Osteoarthritis Cartilage, V2, P259, DOI 10.1016/S1063-4584(05)80078-0
   Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200
   Tuli R, 2004, TISSUE ENG, V10, P1169, DOI 10.1089/ten.2004.10.1169
   Tuli R, 2002, ANN NY ACAD SCI, V961, P172, DOI 10.1111/j.1749-6632.2002.tb03077.x
   van der Kraan PM, 2002, OSTEOARTHR CARTILAGE, V10, P631, DOI 10.1053/joca.2002.0806
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   Vunjak-Novakovic G, 2002, BIORHEOLOGY, V39, P259
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Waldman SD, 2003, J BONE JOINT SURG AM, V85A, P101, DOI 10.2106/00004623-200300002-00013
   Williams KA, 2002, BIOTECHNOL PROGR, V18, P951, DOI 10.1021/bp020087n
   Williams RJ, 2004, AM J SPORT MED, V32, P132, DOI 10.1177/0095399703258733
   Wong M, 1997, DEV BIOL, V192, P492, DOI 10.1006/dbio.1997.8766
   Woodfield TBF, 2002, CRIT REV EUKAR GENE, V12, P209, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i3.40
   Zhou SH, 2004, J BONE MINER RES, V19, P463, DOI 10.1359/JBMR.0301239
NR 103
TC 1
Z9 2
U1 0
U2 0
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 1016-2372
EI 1793-7132
J9 BIOMED ENG-APP BAS C
JI Biomed. Eng.-Appl. Basis Commun.
PD OCT 25
PY 2005
VL 17
IS 5
BP 243
EP 251
DI 10.4015/S1016237205000366
PG 9
WC Engineering, Biomedical
SC Engineering
GA V98GA
UT WOS:000213386700004
DA 2018-10-20
ER

PT J
AU Kulkarni, AR
   Hukkeri, VI
   Sung, HW
   Liang, HF
AF Kulkarni, AR
   Hukkeri, VI
   Sung, HW
   Liang, HF
TI A novel method for the synthesis of the PEG-crosslinked chitosan with a
   pH-independent swelling behavior
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE chitosan; crosslinking; poly(ethylene glycol); swelling property
ID DELIVERY; LINKING; MICROSPHERES; HYDROGEL; RELEASE; DRUG
AB In this study, a simple method was developed to crosslink chitosan using poly(ethylene glycol) (PEG) with different molecular weights. Crosslinking of chitosan was confirmed by various spectral analyses. The differential scanning calorimetric (DSC) study indicated that the rigid crystalline structure of chitosan was decreased after cross-linking with PEG. The PEG-crosslinked chitosan (PEG-Ch) showed a pH-independent swelling behavior: swelled in both the simulated stomach (pH 1.1) and intestinal (pH 7.4) solutions. The swelling ratio of PEG-Ch increased significantly with a higher molecular weight of PEG used. In contrast, chitosan dissolved completely in a simulated stomach solution and showed a comparatively less swelling in a simulated intestinal solution. Thus, the prepared PEG-Ch could be a better biomaterial than chitosan in the development of orally sustained drug-delivery devices.
C1 KLES Coll Pharm, Hubli 580031, India.
   Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan.
RP Kulkarni, AR (reprint author), KLES Coll Pharm, Hubli 580031, India.
EM kulkarni73@yahoo.com
CR Al-Helw AA, 1998, J MICROENCAPSUL, V15, P373, DOI 10.3109/02652049809006864
   Benson MT, 2003, IND ENG CHEM RES, V42, P4147, DOI 10.1021/ie020638e
   Bhattarai N, 2004, MACROMOL BIOSCI, V5, P107, DOI 10.1002/mabi.200400140
   Chen SC, 2004, J CONTROL RELEASE, V96, P285, DOI 10.1016/j.jconrel.2004.02.002
   Dashevsky A, 2004, EUR J PHARM BIOPHARM, V58, P45, DOI 10.1016/j.ejpb.2004.03.013
   Dong YM, 2004, J APPL POLYM SCI, V93, P1553, DOI 10.1002/app.20630
   Goycoolea FM, 2003, MACROMOL BIOSCI, V3, P612, DOI 10.1002/mabi.200300011
   Hejazi R, 2003, J CONTROL RELEASE, V89, P151, DOI 10.1016/S0168-3659(03)00126-3
   Kolhe P, 2003, BIOMACROMOLECULES, V4, P173, DOI 10.1021/bm025689+
   Kumbar SG, 2002, J MICROENCAPSUL, V19, P173, DOI 10.1080/02652040110065422
   Lee KY, 1998, J CONTROL RELEASE, V51, P213, DOI 10.1016/S0168-3659(97)00173-9
   Sashiwa H, 2004, PROG POLYM SCI, V29, P887, DOI 10.1016/j.progpolymsci.2004.04.001
   Taboada E, 2004, J APPL POLYM SCI, V91, P807, DOI 10.1002/app.13171
   Zeng MF, 2004, J MEMBRANE SCI, V245, P95, DOI 10.1016/j.memsci.2004.08.004
NR 14
TC 26
Z9 27
U1 0
U2 15
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD OCT 20
PY 2005
VL 5
IS 10
BP 925
EP 928
DI 10.1002/mabi.200500048
PG 4
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 980GP
UT WOS:000233002900001
PM 16208628
DA 2018-10-20
ER

PT J
AU Fang, N
   Zhu, AP
   Chan-Park, MB
   Chan, V
AF Fang, N
   Zhu, AP
   Chan-Park, MB
   Chan, V
TI Adhesion contact dynamics of fibroblasts on biomacromolecular surfaces
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE adhesion dynamics; biophysics; cytoskeleton; polymer
ID ADSORBED PROTEINS; DELIVERY-SYSTEM; GENE DELIVERY; CELL-ADHESION;
   IN-VITRO; CHITOSAN; COMPLEX; BIOCOMPATIBILITY; WETTABILITY; BIOMATERIAL
AB Biomacromolecules like gelatin and chitosan have emerged as highly versatile biomimetic coatings for applications in tissue engineering. The elucidation of the interfacial kinetics of cell adhesion on biomacromolecular surfaces will pave the way for the rational design of chitosan/ gelatin-based systems for cell regeneration. Biomacromolecular ultra-thin films, chemically immobilized on fused silica are ideal experimental models for determining the effect of surface properties on the biophysical cascades following cell seeding. In this study, confocal reflectance interference contrast microscopy (C-RICM), in conjunction with phase contrast microscopy and fluorescence confocal microscopy, was applied to detect the adhesion contact dynamics of 3T3 fibroblasts on chitosan and gelatin ultrathin films. X-ray photoelectron spectroscopy (XPS) confirmed the immobilization of chitosan or gelatin on the silanized glass surface. Both the initial cell deformation rate and the change of two-dimensional spread area of the 3T3 fibroblasts are higher on gelatin-modified surfaces than on chitosan surfaces. The steady-state adhesion energy of 3T3 fibroblasts on gelatin film is three times higher than that on chitosan film. Immuno-staining of actin further demonstrates the different organization of cytoskeleton, likely induced by the change in cell signaling mechanism on the two biomacromolecular surfaces. The better attachment of 3T3 fibroblast to gelatin is postulated to be caused by the presence of adhesive domains on gelatin.
C1 Nanyang Technol Univ, Div Chem & Biomol Engn, Ctr Biotechnol, Singapore 639798, Singapore.
   Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.
   Yangzhou Univ, Coll Chem & Chem Engn, Yangzhou 225009, Peoples R China.
RP Chan, V (reprint author), Nanyang Technol Univ, Div Chem & Biomol Engn, Ctr Biotechnol, 50 Nanyang Ave, Singapore 639798, Singapore.
EM mvchan@ntu.edu.sg
RI Chan-Park, Mary/G-6196-2010; Chan, Vincent/G-6197-2010
OI Chan-Park, Mary/0000-0003-3761-7517; Chan, Vincent/0000-0003-2149-4479
CR Aspden TJ, 1997, J PHARM SCI, V86, P509, DOI 10.1021/js960182o
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Chan V, 2002, LANGMUIR, V18, P3134, DOI 10.1021/la015684i
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Choee JH, 2004, J APPL POLYM SCI, V92, P599, DOI 10.1002/app.20048
   Erbacher P, 1998, PHARMACEUT RES, V15, P1332, DOI 10.1023/A:1011981000671
   Fakhry A, 2004, BIOMATERIALS, V25, P2075, DOI 10.1016/j.biomaterials.2003.08.068
   Fuller G. M., 1998, MOL BASIS MED CELL B
   Giesbers M, 2002, J COLLOID INTERF SCI, V252, P138, DOI 10.1006/jcis.2002.8388
   GRANT RA, 1980, APPL PROTEIN CHEM
   HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9
   He P, 1998, INT J PHARMACEUT, V166, P75, DOI 10.1016/S0378-5173(98)00027-1
   HORBETT TA, 1994, COLLOID SURFACE B, V2, P225, DOI 10.1016/0927-7765(94)80037-5
   Khang G, 2002, J APPL POLYM SCI, V85, P1253, DOI 10.1002/app.10680
   Kim CH, 2004, MACROMOL RES, V12, P367, DOI 10.1007/BF03218413
   Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002
   Lauffenburger DA, 2001, NAT CELL BIOL, V3, pE110, DOI 10.1038/35074631
   Leong KW, 1998, J CONTROL RELEASE, V53, P183, DOI 10.1016/S0168-3659(97)00252-6
   Lin WC, 2004, BIOMATERIALS, V25, P1947, DOI 10.1016/j.biomaterials.2003.08.027
   LINDAHL U, 1978, ANNU REV BIOCHEM, V47, P385, DOI 10.1146/annurev.bi.47.070178.002125
   Mao HQ, 1996, P INT S CONTROL REL, V23, P401
   Mao JS, 2004, BIOMATERIALS, V25, P3973, DOI 10.1016/j.biomaterials.2003.10.080
   OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   RATNER B, 1996, BIOMATERIALS SCI
   Ravi Kumar Majeti N. V., 2000, REACTIVE FUNCTIONAL, V46, P1
   Richardson SCW, 1999, INT J PHARMACEUT, V178, P231, DOI 10.1016/S0378-5173(98)00378-0
   Rotsch C, 1999, P NATL ACAD SCI USA, V96, P921, DOI 10.1073/pnas.96.3.921
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Wan KT, 2001, MED BIOL ENG COMPUT, V39, P605, DOI 10.1007/BF02345154
   Wang HJ, 2004, TISSUE ENG, V10, P1054, DOI 10.1089/1076327041887709
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Xia WY, 2004, J BIOMED MATER RES B, V71B, P373, DOI 10.1002/jbm.b.30087
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
   Yin C, 2003, BIOMATERIALS, V24, P837, DOI 10.1016/S0142-9612(02)00416-7
NR 39
TC 17
Z9 17
U1 0
U2 14
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD OCT 20
PY 2005
VL 5
IS 10
BP 1022
EP 1031
DI 10.1002/mabi.200500123
PG 10
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 980GP
UT WOS:000233002900012
PM 16208681
DA 2018-10-20
ER

PT J
AU Dabagh, M
   Abdekhodaie, MJ
   Khorasani, MT
AF Dabagh, M
   Abdekhodaie, MJ
   Khorasani, MT
TI Effects of polydimethylsiloxane grafting on the calcification, physical
   properties, and biocompatibility of polyurethane in a heart valve
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE polyurethanes; modification; calcification; heart valve; siloxanes
ID IN-VITRO FUNCTION; FATIGUE FAILURE; SURFACE; DURABILITY; PROSTHESIS;
   INVITRO
AB Segmented polyurethane (PU) has proven to be the best biomaterial for artificial heart valves, but the calcification of polyurethane surfaces causes serious problems in long-term implants. This work was undertaken to evaluate the effects of polydimethylsiloxane (PDMS) grafting on the calcification, biocompatibility, and blood compatibility of polyurethane. A grafted polyurethane film was compared with virgin polyurethane surfaces. Physical properties of the samples were examined using different techniques. The hydrophobicity of the polyurethane films increased as a result of silicone modification. The effects of surface modification of polyurethane films on their calcification and fibroblast cell (L 929) and platelet behavior were evaluated in vitro. Fourier transform infrared spectroscopy indicated the direct involvement of the polyether soft segments of the polymer in the calcification process. Scanning electron microscopy of films indicated that grafting of silicone rubber to the surface of polyurethane successfully prevented the calcification process. The morphology of fibroblast cells that adhered to the PU films and modified films was similar to that of controls and showed the same proliferation. On the other hand, grafting PDMS onto PU did not affect the amount of platelets that adhered to the polyurethane surfaces. (c) 2005 Wiley Periodicals, Inc.
C1 Sharif Univ Technol, Dept Chem Engn, Tehran, Iran.
   Iran Polymer Inst, Tehran, Iran.
RP Dabagh, M (reprint author), Sharif Univ Technol, Dept Chem Engn, POB 9465-11385, Tehran, Iran.
EM mahsa_dab@yahoo.com
RI Dabagh, Mahsa/B-7915-2014
OI Dabagh, Mahsa/0000-0002-6833-5443; Abdekhodaie, Mohammad
   J/0000-0002-3998-3142; Dabagh, Mahsa/0000-0003-1540-7420
CR BAMFORD C H, 1992, Clinical Materials, V10, P243, DOI 10.1016/0267-6605(92)90018-O
   Bernacca G M, 1992, J Heart Valve Dis, V1, P115
   BERNACCA GM, 1992, J MATER SCI-MATER M, V3, P293, DOI 10.1007/BF00705296
   Bernacca GM, 1997, J BIOMED MATER RES, V34, P371
   BERNACCA GM, 1995, BIOMATERIALS, V16, P279, DOI 10.1016/0142-9612(95)93255-C
   Bernacca GM, 1998, INT J ARTIF ORGANS, V21, P814
   Bernacca GM, 1996, J HEART VALVE DIS, V5, P538
   Bernacca GM, 1997, INT J ARTIF ORGANS, V20, P327
   BERNACCA GM, 1997, BIOMATERIALS, V14, P756
   BRAUNWALD NS, 1965, J THORAC CARDIOV SUR, V49, P485
   Cherrys B, 1981, POLYM SURFACES, P161
   Chu S. H., 1984, BIOL BIOPROSTHETIC V, P805
   DADESTAN M, 2001, J BIOMED MATER RES, V57, P183
   EBERT CD, 1982, J BIOMED MATER RES, V16, P629, DOI 10.1002/jbm.820160510
   ENGBERS GH, 1991, INT J ARTIF ORGANS, V14, P199
   FERRANS VJ, 1980, AM J CARDIOL, V46, P721, DOI 10.1016/0002-9149(80)90421-X
   FISHER AC, 1992, INT J ARTIF ORGANS, V15, P284
   FREIJLARSSON C, 1993, J APPL POLYM SCI, V50, P345, DOI 10.1002/app.1993.070500215
   FUJIMOTO K, 1993, J POLYM SCI POL CHEM, V31, P1035, DOI 10.1002/pola.1993.080310426
   GARCIABENGOCHEA JB, 1991, J CARDIAC SURG, V6, P613
   GOLOMB G, 1991, BIOMATERIALS, V12, P397, DOI 10.1016/0142-9612(91)90008-X
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P87, DOI 10.1002/jbm.820231309
   HAN DK, 1993, J BIOMED MATER RES, V27, P1063, DOI 10.1002/jbm.820270812
   HEROLD M, 1987, HELMHOLTZ I TRI LEAF, P231
   HILBERT SL, 1987, J THORAC CARDIOV SUR, V94, P419
   JANSEN J, 1986, Life Support Systems, V4, P130
   JANSEN J, 1992, J MED ENG TECHNOL, V16, P27, DOI 10.3109/03091909209021954
   KOLFF WJ, 1989, ANN THORAC SURG, V49, P98
   LO HB, 1988, T AM SOC ART INT ORG, V34, P839
   Mackay TG, 1996, BIOMATERIALS, V17, P1857, DOI 10.1016/0142-9612(95)00242-1
   Mackay TG, 1996, ARTIF ORGANS, V20, P1017, DOI 10.1111/j.1525-1594.1996.tb04589.x
   PEDERSEN CJ, 1967, J AM CHEM SOC, V89, P7017, DOI 10.1021/ja01002a035
   Saito N, 1997, BIOMATERIALS, V18, P1195, DOI 10.1016/S0142-9612(97)00046-X
   SCHOEN FJ, 1991, REPLACEMENT CARDIAC, P357
   Tanzi M. C., 1993, Clinical Materials, V12, P17, DOI 10.1016/0267-6605(93)90023-Z
   TANZI M C, 1991, Clinical Materials, V8, P57, DOI 10.1016/0267-6605(91)90010-D
   Thoma R J, 1987, J Biomater Appl, V1, P449
   WISMAN CB, 1982, T AM SOC ART INT ORG, V28, P164
NR 38
TC 21
Z9 24
U1 2
U2 26
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD OCT 15
PY 2005
VL 98
IS 2
BP 758
EP 766
DI 10.1002/app.22132
PG 9
WC Polymer Science
SC Polymer Science
GA 961RW
UT WOS:000231680500029
DA 2018-10-20
ER

PT J
AU Elvin, CM
   Carr, AG
   Huson, MG
   Maxwell, JM
   Pearson, RD
   Vuocolo, T
   Liyou, NE
   Wong, DCC
   Merritt, DJ
   Dixon, NE
AF Elvin, CM
   Carr, AG
   Huson, MG
   Maxwell, JM
   Pearson, RD
   Vuocolo, T
   Liyou, NE
   Wong, DCC
   Merritt, DJ
   Dixon, NE
TI Synthesis and properties of crosslinked recombinant pro-resilin
SO NATURE
LA English
DT Article
ID ELASTIC PROTEINS; SOUND PRODUCTION; IDENTIFICATION; LINKING; TIMBAL
AB Resilin is a member of a family of elastic proteins that includes elastin, as well as gluten, gliadin, abductin and spider silks. Resilin is found in specialized regions of the cuticle of most insects, providing low stiffness, high strain and efficient energy storage(1,2); it is best known for its roles in insect flight(3,4) and the remarkable jumping ability of fleas(5,6) and spittle bugs(7). Previously, the Drosophila melanogaster CG15920 gene was tentatively identified as one encoding a resilin-like protein(8,9) (pro-resilin). Here we report the cloning and expression of the first exon of the Drosophila CG15920 gene as a soluble protein in Escherichia coli. We show that this recombinant protein can be cast into a rubber-like biomaterial by rapid photochemical crosslinking. This observation validates the role of the putative elastic repeat motif in resilin function. The resilience ( recovery after deformation) of crosslinked recombinant resilin was found to exceed that of unfilled synthetic polybutadiene, a high resilience rubber. We believe that our work will greatly facilitate structural investigations into the functional properties of resilin and shed light on more general aspects of the structure of elastomeric proteins. In addition, the ability to rapidly cast samples of this biomaterial may enable its use in situ for both industrial and biomedical applications.
C1 CSIRO Livestock Ind, St Lucia, Qld 4072, Australia.
   CSIRO Text & Fibre Technol, Geelong, Vic 3216, Australia.
   Univ Queensland, Sch Integrat Biol, St Lucia, Qld 4072, Australia.
   Australian Natl Univ, Res Sch Chem, Canberra, ACT 0200, Australia.
RP Elvin, CM (reprint author), CSIRO Livestock Ind, Queensland Biosci Precinct, St Lucia, Qld 4072, Australia.
EM chris.elvin@csiro.au
RI Vuocolo, Tony/H-7533-2013; Merritt, David/D-2318-2010; elvin,
   chris/H-2333-2013; Dixon, Nicholas/A-1226-2008; Huson,
   Mickey/K-2474-2012
OI Merritt, David/0000-0002-8573-7508; Dixon, Nicholas/0000-0002-5958-6945;
   Huson, Mickey/0000-0003-1859-7805
CR AARON BB, 1981, BIOPOLYMERS, V20, P1247, DOI 10.1002/bip.1981.360200611
   ANDERSEN SO, 1964, BIOCHIM BIOPHYS ACTA, V93, P213, DOI 10.1016/0304-4165(64)90289-2
   Andersen SO, 2002, ELASTOMERIC PROTEINS
   ANDERSEN SVEND OLAV, 1964, ADVANCES INSECT PHYSIOL, V2, P1, DOI 10.1016/S0065-2806(08)60071-5
   Anderson S O, 1966, Acta Physiol Scand Suppl, V263, P1
   Ardell DH, 2001, INSECT BIOCHEM MOLEC, V31, P965, DOI 10.1016/S0965-1748(01)00044-3
   Burrows M, 2003, NATURE, V424, P509, DOI 10.1038/424509a
   Cowie J.M.G., 1973, POLYM CHEM PHYS MODE
   Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020
   Gorb SN, 1999, NATURWISSENSCHAFTEN, V86, P552, DOI 10.1007/s001140050674
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Keeley FW, 2002, PHILOS T R SOC B, V357, P185, DOI 10.1098/rstb.2001.1027
   Lehmann FO, 2001, J EXP BIOL, V204, P627
   Li B, 2002, J MUSCLE RES CELL M, V23, P561, DOI 10.1023/A:1023474909980
   Malencik DA, 1996, BIOCHEMISTRY-US, V35, P4375, DOI 10.1021/bi9526037
   Neff D, 2000, ARTHROPOD STRUCT DEV, V29, P75, DOI 10.1016/S1467-8039(00)00014-1
   NEVILLE AC, 1967, P R ENTOMOL SOC LOND, V32, P9
   Pometun MS, 2004, J BIOL CHEM, V279, P7982, DOI 10.1074/jbc.M310948200
   ROTHSCHILD M, 1975, PHILOS T ROY SOC B, V271, P457, DOI 10.1098/rstb.1975.0062
   Rousseau R, 2004, BIOPHYS J, V86, P1393, DOI 10.1016/S0006-3495(04)74210-1
   SINGARAVELU G, 1991, NATL ACAD SCI LETT, V14, P147
   Skals N, 1999, J EXP BIOL, V202, P2937
   Tatham AS, 2002, PHILOS T ROY SOC B, V357, P229, DOI 10.1098/rstb.2001.1031
   Treloar L. R. G., 1975, PHYS RUBBER ELASTICI
   URRY DW, 2002, ELASTOMERIC PROTEINS, P54
   VARMAN AR, 1980, EXPERIENTIA, V36, P564, DOI 10.1007/BF01965802
   Weis-Fogh T, 1960, J EXP BIOL, V37, P887
   WEISFOGH T, 1961, J MOL BIOL, V3, P520, DOI 10.1016/S0022-2836(61)80018-1
   WEISFOGH T, 1961, CELL ORGANISM, P283
   YOUNG D, 1995, J EXP BIOL, V198, P1001
NR 30
TC 254
Z9 259
U1 5
U2 131
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD OCT 13
PY 2005
VL 437
IS 7061
BP 999
EP 1002
DI 10.1038/nature04085
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 973AU
UT WOS:000232496100040
PM 16222249
DA 2018-10-20
ER

PT J
AU Cabodi, M
   Choi, NW
   Gleghorn, JP
   Lee, CSD
   Bonassar, LJ
   Stroock, AD
AF Cabodi, M
   Choi, NW
   Gleghorn, JP
   Lee, CSD
   Bonassar, LJ
   Stroock, AD
TI A microfluidic biomaterial
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID IMMOBILIZATION; MATRICES; RELEASE; SYSTEMS
C1 Cornell Univ, Sch Chem & Biomol Engn, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.
   Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.
RP Stroock, AD (reprint author), Cornell Univ, Sch Chem & Biomol Engn, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.
EM ads10@cornell.edu
RI Choi, Nakwon/K-8915-2013; Bonassar, Lawrence/C-2103-2016
OI Choi, Nakwon/0000-0003-2993-9233; Bonassar, Lawrence/0000-0003-1094-6433
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Beebe DJ, 2000, P NATL ACAD SCI USA, V97, P13488, DOI 10.1073/pnas.250273097
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   DURING MJ, 1989, ANN NEUROL, V25, P351, DOI 10.1002/ana.410250406
   Fidkowski C, 2005, TISSUE ENG, V11, P302, DOI 10.1089/ten.2005.11.302
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   GUISAN JM, 1991, BIOTECHNOL BIOENG, V38, P1144, DOI 10.1002/bit.260381005
   Gundiah G, 2003, J MATER CHEM, V13, P2118, DOI 10.1039/b304007k
   King KR, 2004, ADV MATER, V16, P2007, DOI 10.1002/adma.200306522
   LABARBERA M, 1982, AM SCI, V70, P54
   Li RH, 1996, BIOTECHNOL BIOENG, V50, P365, DOI 10.1002/(SICI)1097-0290(19960520)50:4<365::AID-BIT3>3.0.CO;2-J
   Masuda K, 2003, J ORTHOPAED RES, V21, P139, DOI 10.1016/S0736-0266(02)00109-2
   McDonald JC, 2002, ANAL CHEM, V74, P1537, DOI 10.1021/ac010938q
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Seifert DB, 1997, BIOTECHNOL PROGR, V13, P562, DOI 10.1021/bp9700723
   Vozzi G, 2003, BIOMATERIALS, V24, P2533, DOI 10.1016/S0142-9612(03)00052-8
NR 19
TC 142
Z9 145
U1 4
U2 69
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD OCT 12
PY 2005
VL 127
IS 40
BP 13788
EP 13789
DI 10.1021/ja054820t
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA 971VQ
UT WOS:000232413300023
PM 16201789
DA 2018-10-20
ER

PT J
AU Hsieh, CY
   Tsai, SP
   Wang, DM
   Chang, YN
   Hsieh, HJ
AF Hsieh, CY
   Tsai, SP
   Wang, DM
   Chang, YN
   Hsieh, HJ
TI Preparation of gamma-PGA/chitosan composite tissue engineering matrices
SO BIOMATERIALS
LA English
DT Article
DE chitosan; gamma-PGA; tissue enginecring; composite matrices
ID POLYION COMPLEX FIBER; SOLUTION INTERFACES; FLUORESCEIN ISOTHIOCYANATE;
   LABORATORY MEDIA; CHITOSAN; GELLAN; GELATIN; ACID); BIODEGRADATION;
   CONJUGATION
AB gamma-poly(glutamic acid) (gamma-PGA), a hydrophilic and biodegradable polymer, was chosen to modify chitosan matrices to produce a gamma-PGA/chitosan composite biomaterial. Three types of both dense and porous composite matrices containing different amounts of PGA were fabricated. Chitosan and gamma-PGA matrices were also prepared as controls. Fluorescence staining indicated that chitosan and gamma-PGA were evenly distributed in the composite matrices. SEM micrographs showed that an interconnected porous structure with a pore size of 30 100 mu m was present in all porous matrices except the gamma-PGA ones. By increasing the percentage of gamma-PGA from 0% to 20%, the swelling ratio of the matrices was enhanced from 1.6 to 3.2. Similarly, the contact angle of the matrices decreased from 113 degrees to 94 degrees. These data suggested that the surface hydrophilicity, water absorption rate, and swelling ratio were improved by adding gamma-PGA to the matrices. Additionally, the mechanical strength of the porous gamma-PGA/chitosan matrices was about 25 50%, higher than that of the unmodified chitosan matrices. The composite matrices were also examined and found to be an appropriate environment for cell attachment and proliferation. The cell density on the 20% gamma-PGA-modified matrices was almost triple that on the unmodified chitosan matrices on day 5. In summary, the gamma-PGA/chitosan composite matrices. due to their better hydrophilic, cytocompatible, and mechanical properties, are very promising biomaterials for tissue engineering applications. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan.
   Da Yeh Univ, Dept Bioind Technol, Changhua, Taiwan.
RP Hsieh, HJ (reprint author), Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan.
EM hjhsieh@ntu.edu.tw
CR Amaike M, 1998, MACROMOL RAPID COMM, V19, P287, DOI 10.1002/(SICI)1521-3927(19980601)19:6<287::AID-MARC287>3.0.CO;2-X
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   CHILVERS GR, 1987, CARBOHYD POLYM, V7, P111, DOI 10.1016/0144-8617(87)90053-1
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Iwata H, 1998, BIOMATERIALS, V19, P1869, DOI 10.1016/S0142-9612(98)00095-7
   Kaplan D.L., 1998, BIOPOLYMERS RENEWABL
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Koyano T, 1998, J BIOMED MATER RES, V39, P486
   Kratz G, 1997, SCAND J PLAST RECONS, V31, P119, DOI 10.3109/02844319709085478
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Li C, 2000, CLIN CANCER RES, V6, P2829
   Lysenko EA, 1998, MACROMOLECULES, V31, P4511, DOI 10.1021/ma980366k
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MIYAMOTO S, 1998, J ARTIF ORGANS, V1, P10
   Multani AS, 1997, ANTICANCER RES, V17, P4269
   MUZZARELLI RAA, 1977, CHITIN
   Ohkawa K, 1998, BIOMATERIALS, V19, P1855, DOI 10.1016/S0142-9612(98)00091-X
   Ohkawa K, 2001, MACROMOL MATER ENG, V286, P168, DOI 10.1002/1439-2054(20010301)286:3<168::AID-MAME168>3.3.CO;2-Z
   Otani Y, 1996, J Biomed Mater Res, V31, P158
   Otani Y, 1999, ANN THORAC SURG, V67, P922, DOI 10.1016/S0003-4975(99)00153-8
   Rhoades J, 2000, APPL ENVIRON MICROB, V66, P80, DOI 10.1128/AEM.66.1.80-86.2000
   Richard A, 2001, CRIT REV BIOTECHNOL, V21, P219, DOI 10.1080/07388550108984171
   Roller S, 1999, INT J FOOD MICROBIOL, V47, P67, DOI 10.1016/S0168-1605(99)00006-9
   SAKIYAMA T, 1993, J APPL POLYM SCI, V50, P2021, DOI 10.1002/app.1993.070501121
   STAIKOS G, 1993, J APPL POLYM SCI, V48, P215, DOI 10.1002/app.1993.070480204
   THE TH, 1970, IMMUNOLOGY, V18, P875
   THE TH, 1970, IMMUNOLOGY, V18, P865
   Yamamoto H, 2001, J APPL POLYM SCI, V79, P437, DOI 10.1002/1097-4628(20010118)79:3<437::AID-APP60>3.3.CO;2-H
   Yamamoto H, 1997, MACROMOLECULES, V30, P3936, DOI 10.1021/ma961766f
   Yamamoto H, 2000, MACROMOL CHEM PHYSIC, V201, P84, DOI 10.1002/(SICI)1521-3935(20000101)201:1<84::AID-MACP84>3.0.CO;2-Y
NR 31
TC 140
Z9 153
U1 4
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2005
VL 26
IS 28
BP 5617
EP 5623
DI 10.1016/j.biomaterials.2005.02.012
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 931NO
UT WOS:000229492200005
PM 15878366
DA 2018-10-20
ER

PT J
AU Chennazhy, KP
   Krishnan, LK
AF Chennazhy, KP
   Krishnan, LK
TI Effect of passage number and matrix characteristics on differentiation
   of endothelial cells cultured for tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE endothelial cell; vascular graft; extracellular matrix; FIBRIN; gelatin;
   phenotypic alteration
ID FOCAL ADHESIONS; VASCULAR GRAFTS; GROWTH-FACTOR; IN-VITRO; APOPTOSIS;
   IDENTIFICATION; PROLIFERATION; FIBRINOGEN; EXTENSION; PROTEINS
AB Cells can sense the physical and chemical properties of artificial materials used as scaffolds for tissue engineering and regulate their behavior. Therefore. biomimetic and biospecific molecules are coated on materials to regulate function of cells on the tissue-engineered product. These bioactive molecules can be attached in a defined spectrum, concentration and spatial distribution in order to control adhesion. growth. viability. differentiation. and function of the cells. When autologous cells are used for tissue engineering, initially limited cells obtained may often need an amplification of cell number by passage in tissue Culture before they are seeded on a biomaterial or scaffold. We have conducted this Study to Understand how the characteristics of bioactive molecule coating might affect proliferation. apoptosis and differentiation when endothelial cell (EC) is serially passaged. Proliferation was assessed by proliferating cell nuclear antigen (PCNA) staining along with counting of cells harvested from confluent monolayer. Apoptosis was assessed by Annexin V staining and differentiation by Semi quantitative reverse transcriptase polymerase chain reaction (RT-PCR) for von Willebrand factor (vWF) expression and quantification of its release using enzyme linked immunosorbant assay (ELISA). and thrombogenicity by comparing platelet adhesion to EC monolayer Dacron grafts (DG) with specific protein coating. The results indicate that ECs easily lose its proliferation potential when they Lire Cultured repeatedly on gelatin, turn apoptotic and over express the prothrombotic protein-vWF. Whereas. when it is grown on a matrix composed of fibrin, fibronectin, gelatin and vascular EC growth factor (VEGF), the cells retained their ability to proliferate, remained viable and were relatively less thrombogenic, even when passage number progressed. It is concluded that if ECs Lire grown on the composite matrix that mimics natural vessel scaffold. the cell number can be amplified without affecting its normal physiological function and may be used to generate effective tissue-engineered cardiovascular constructs. (c) 2005 Published by Elsevier Ltd.
C1 Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Thrombosis Res Unit, Trivandrum 695012, Kerala, India.
RP Krishnan, LK (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Thrombosis Res Unit, Trivandrum 695012, Kerala, India.
EM lissykk@setimst.ker.nic.in
CR ANDERSON JS, 1987, SURGERY, V101, P577
   BACAKOVA L, 2004, TISSUE ENG, V53, P835
   Balcells M, 2002, J CELL PHYSIOL, V191, P155, DOI 10.1002/jcp.10087
   BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366
   BRASH JL, 1987, PROTEINS INTERFACES, P490
   Conte MS, 1998, FASEB J, V12, P43
   Craig SW, 1996, CURR OPIN CELL BIOL, V8, P74, DOI 10.1016/S0955-0674(96)80051-2
   DEJANA E, 1990, BLOOD, V75, P1509
   Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08
   FORD JW, 1981, IN VITRO CELL DEV B, V17, P44, DOI 10.1007/BF02618029
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   GRINNELL F, 1980, CELL, V19, P517, DOI 10.1016/0092-8674(80)90526-7
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Korff T, 1999, J CELL SCI, V112, P3249
   Kumar TRS, 2002, TISSUE ENG, V8, P763
   Kumar TRS, 2001, BIOMATERIALS, V22, P2769
   MACIAG T, 1979, P NATL ACAD SCI USA, V76, P5674, DOI 10.1073/pnas.76.11.5674
   MAIER JAM, 1990, SCIENCE, V249, P1570, DOI 10.1126/science.2218499
   RADOMSKI JS, 1987, J SURG RES, V42, P133, DOI 10.1016/0022-4804(87)90110-7
   Resmi KR, 2004, THROMB RES, V114, P121, DOI 10.1016/j.thromres.2004.05.014
   Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043
   SATO I, 1993, BIOCHEM BIOPH RES CO, V195, P1070, DOI 10.1006/bbrc.1993.2153
   SKARJA GA, 1998, BIOMATERIALS, V23, P219
   Wagner M, 2001, EXP GERONTOL, V36, P1327, DOI 10.1016/S0531-5565(01)00105-X
   Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141
   Zhang JL, 2002, MECH AGEING DEV, V123, P613, DOI 10.1016/S0047-6374(01)00412-2
NR 27
TC 42
Z9 42
U1 1
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2005
VL 26
IS 28
BP 5658
EP 5667
DI 10.1016/j.biomaterials.2005.02.024
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 931NO
UT WOS:000229492200010
DA 2018-10-20
ER

PT J
AU Grigolo, B
   De Franceschi, L
   Roseti, L
   Cattini, L
   Facchini, A
AF Grigolo, B
   De Franceschi, L
   Roseti, L
   Cattini, L
   Facchini, A
TI Down regulation of degenerative cartilage molecules in chondrocytes
   grown on a hyaluronan-based scaffold
SO BIOMATERIALS
LA English
DT Article
DE chondrocytes; hyaluronic acid; arthritis; apoptosis; metalloproteinases
ID HUMAN ARTICULAR CHONDROCYTES; NITRIC-OXIDE; GENE-EXPRESSION;
   RHEUMATOID-ARTHRITIS; CATHEPSIN-B; OSTEOARTHRITIS; TRANSPLANTATION;
   PHENOTYPE; APOPTOSIS; KNEE
AB Hyaluronic-acid-based biomaterials used for cartilage repair allow the expression of specific extracellular matrix molecules by human chondrocytes grown onto them. We investigated whether these biomaterials could also create an environment in which the cells downregulate the expression of some catabolic factors.
   Chondrocytes were isolated from human articular cartilage obtained from the knees of patients with a history of trauma. First, the cells were expanded in monolayers and then they were seeded on a hyaluronic-acid derivative scaffold. Constructs and surnatants were collected and analysed at 1.3, 7, 14 and 21 days after seeding. Immunohistochemical analysis for CD44 and caspase was carried Out on paraffin-em bedded sections. The Tunnel method LIS used to identity chondrocyte apoptosis status. Secretion of MMP-1 and MMP-13 in the surnatants of the cells grown onto the biomaterial was measured by enzyme-linked immunosorbent assay. Nitric oxide (NO) production was evaluated by estimating the stable NO metabolite nitrite by the Griess method. A real-time RT-PCR analysis was performed on the constructs to evaluate the expression of type I and II collagens, aggrecan, Sox-9, MMP-1 and MMP-13 mRNAs at the different experimental times evaluated.
   Decreased levels of metalloproteinases and nitric oxide were observed in the surnatants of chondrocytes grown onto the hyaluronan-based scaffold. This was also confirmed by real-time PCR analysis which showed that the cells expressed the specific differentiated phenotype downregulating the expression of some catabolic molecules. Cells apoptosis decreased during the culture period, which further supported the biochemical data.
   The ability of the hyaluronan scaffold to reduce the expression and production of molecules involved in cartilage degenerative diseases indicates its use to treat early lesions of osteoarthritic patients. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Ist Ortoped Rizzoli, Ist Ric Codivilla Putti, Lab Immunol & Genet, I-40136 Bologna, Italy.
   Univ Bologna, Dipartimento Med Interna & Gastroenterol, I-40138 Bologna, Italy.
RP Grigolo, B (reprint author), Ist Ortoped Rizzoli, Ist Ric Codivilla Putti, Lab Immunol & Genet, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM grigolob@alma.unibo.it
RI Grigolo, Brunella/J-5417-2016
OI Grigolo, Brunella/0000-0002-3990-6745
CR ARCHER CW, 1990, J CELL SCI, V97, P361
   AULTHOUSE AL, 1989, IN VITRO CELL DEV B, V25, P659
   BAICI A, 1988, ANN RHEUM DIS, V47, P684, DOI 10.1136/ard.47.8.684
   BASSLEER C, 1986, IN VITRO CELL DEV B, V22, P113
   BLANCO FJ, 1995, J IMMUNOL, V154, P4018
   BLANCO FJ, 1995, AM J PATHOL, V146, P75
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P109, DOI 10.2106/00004623-200300003-00017
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   Fenton C, 2004, DRUGS, V64, P1231, DOI 10.2165/00003495-200464110-00006
   Grigolo B, 2002, BIOMATERIALS, V23, P1187, DOI 10.1016/S0142-9612(01)00236-8
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   Grigolo B, 2003, BIOMATERIALS, V24, P1751, DOI 10.1016/S0142-9612(02)00569-0
   Hardy MM, 2002, ARTHRITIS RHEUM, V46, P1789, DOI 10.1002/art.10356
   Hashimoto S, 1998, ARTHRITIS RHEUM-US, V41, P1266, DOI 10.1002/1529-0131(199807)41:7<1266::AID-ART18>3.0.CO;2-Y
   Henrotin YE, 2003, OSTEOARTHR CARTILAGE, V11, P747, DOI 10.1016/S1063-4584(03)00150-X
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   KIMURA T, 1984, CLIN ORTHOP RELAT R, P231
   KUHN K, 2004, OSTEOARTHR CARTILAGE, V121, P1
   Lesley J, 2000, J BIOL CHEM, V275, P26967
   LI WQ, 2004, FREE RADIC BIOL MED, V15, P196
   Lisignoli G, 2001, ARTHRITIS RHEUM-US, V44, P1800, DOI 10.1002/1529-0131(200108)44:8<1800::AID-ART317>3.0.CO;2-1
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maleski MP, 1996, EXP CELL RES, V225, P55, DOI 10.1006/excr.1996.0156
   MANEIRO E, 2000, CLIN EXP RHEUMATOL, V223, P307
   Marcacci M, 2002, KNEE SURG SPORT TR A, V10, P154, DOI 10.1007/s00167-001-0275-6
   Martel-Pelletier Johanne, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS31
   Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366
   Mazzetti I, 2001, CLIN SCI, V101, P593, DOI 10.1042/CS20010030
   Moskowitz Roland W, 2004, Am J Orthop (Belle Mead NJ), V33, P10
   PAVESIO A, 2003, TISSUE ENG CARTILAGE, P203
   PELLETIER JP, 1990, ARTHRITIS RHEUM, V33, P1466, DOI 10.1002/art.1780331003
   Peterson L, 2003, J BONE JOINT SURG AM, V85A, P17, DOI 10.2106/00004623-200300002-00003
   Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482
   Wang CT, 2004, J BONE JOINT SURG AM, V86A, P538, DOI 10.2106/00004623-200403000-00012
   Wegman A, 2004, J RHEUMATOL, V31, P344
   ZWICKY, 2000, HISTOCHEM CELL BIOL, V114, P362
NR 37
TC 38
Z9 39
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2005
VL 26
IS 28
BP 5668
EP 5676
DI 10.1016/j.biomaterials.2005.02.030
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 931NO
UT WOS:000229492200011
PM 15878372
DA 2018-10-20
ER

PT J
AU Lisignoli, G
   Cristino, S
   Piacentini, A
   Toneguzzi, S
   Grassi, F
   Cavallo, C
   Zini, N
   Solimando, L
   Maraldi, NM
   Facchini, A
AF Lisignoli, G
   Cristino, S
   Piacentini, A
   Toneguzzi, S
   Grassi, F
   Cavallo, C
   Zini, N
   Solimando, L
   Maraldi, NM
   Facchini, A
TI Cellular and molecular events during chondrogenesis of human mesenchymal
   stromal cells grown in a three-dimensional hyaluronan based scaffold
SO BIOMATERIALS
LA English
DT Article
DE mesenchymal stromal cells; chondrogenesis; biomaterial; tissue
   engineering
ID STEM-CELLS; IN-VITRO; TGF-BETA; CARTILAGE; BONE; REPAIR;
   DIFFERENTIATION; TRANSPLANTATION; CHONDROCYTE; CULTURE
AB Mesenchymal stromal cells (MSCs) seem to be a good alternative to chondrocytes for cartilage regeneration. To obtain new information on the sequence of cellular and molecular events during in vitro chondrogenic differentiation we analysed MSCs on a widely used hyaluronic acid biomaterial (Hyaff(g) -11). Cellular differentiation was induced using two different concentrations of TGF beta 1 (10 and 20 ng/ml) and the process was analysed at different time points (24 h, and 7, 14 21 and 28 days) using techniques of light and electron microscopy, real-time PCR and immunohistochemistry. We found that without TGF beta MSCs did not survive while in the presence of TGF beta the cells significantly proliferated from day 7 until day 28. Light and electron microscopy showed that TGF beta at 20 ng/ml better induced the formation of cartilage-like tissue. Real-time PCR showed an increased expression of collagen type II, IX and aggrecan associated to a down-regulation of collagen type I. Immunohistochemical analysis confirmed that collagen type I was down-modulated while collagen type II increased from day 14 to day 28.
   These data clearly showed that higher concentrations of TGF beta (20 ng/ml) induce chondrogenesis of MSCs on Hyaff(g)-11 scaffold better than 10 ng/ml of TGF beta. This process is characterized by a sequence of cellular and molecular events that deal with the in vitro formation of a cartilage-like tissue. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Ist Ortoped Rizzoli, Lab Immunol & Genet, I-40136 Bologna, Italy.
   Ist Ortoped Rizzoli, Sez Bologna, CNR, ITOI, I-40136 Bologna, Italy.
   Ist Ortoped Rizzoli, Lab Biol Cellulare & Microscopia Elettron, I-40136 Bologna, Italy.
   Univ Bologna, Dipartimento Med Interne & Gastroenterol, I-40138 Bologna, Italy.
RP Lisignoli, G (reprint author), Ist Ortoped Rizzoli, Lab Immunol & Genet, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM labimge@alma.unibo.it
OI Cavallo, Carola/0000-0002-2913-856X; ZINI, NICOLETTA/0000-0002-4442-7079
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   Bosnakovski D, 2004, EXP HEMATOL, V32, P502, DOI 10.1016/j.exphem.2004.02.009
   Brun P, 1999, J BIOMED MATER RES, V46, P337, DOI 10.1002/(SICI)1097-4636(19990905)46:3<337::AID-JBM5>3.3.CO;2-H
   Buckwalter JA, 2004, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000131638.81519.de
   Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J
   CABAUD HE, 1982, AM J SPORT MED, V10, P259, DOI 10.1177/036354658201000501
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Chimal-Monroy J, 2003, DEV BIOL, V257, P292, DOI 10.1016/S0012-1606(03)00066-6
   Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3
   Grigolo B, 2002, BIOMATERIALS, V23, P1187, DOI 10.1016/S0142-9612(01)00236-8
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   Hollander Anthony P, 2003, Novartis Found Symp, V249, P218
   Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbre.2004.06.029
   KAISHO T, 1992, J IMMUNOL, V149, P4088
   Kavalkovich KW, 2002, IN VITRO CELL DEV-AN, V38, P457
   Knudson CB, 2004, CLIN ORTHOP RELAT R, pS152, DOI 10.1097/01.blo.0000143804.26638.82
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Lisignoli G, 2001, BIOMATERIALS, V22, P2095, DOI 10.1016/S0142-9612(00)00398-7
   LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z
   Majumdar MK, 2000, J CELL PHYSIOL, V185, P98
   Marcacci M, 2002, KNEE SURG SPORT TR A, V10, P154, DOI 10.1007/s00167-001-0275-6
   Martin JA, 2002, BIOGERONTOLOGY, V3, P257, DOI 10.1023/A:1020185404126
   Miura Y, 2002, J BONE JOINT SURG AM, V84A, P793, DOI 10.2106/00004623-200205000-00015
   MYAZONO K, 1994, ADV IMMUNOL, V55, P181
   OLLIER L, 1867, TRAITE EXPT CLIN REG, P117
   Pavesio Alessandra, 2003, Novartis Found Symp, V249, P203
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   ROZEN S, 2000, BIOINFORMATICS METHO, P365, DOI DOI 10.1385/1-59259-192-2:365
   Schmitt B, 2003, DIFFERENTIATION, V71, P567, DOI 10.1111/j.1432-0436.2003.07109003.x
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200
   Ushida T, 2002, CELL TRANSPLANT, V11, P489
   Walsh S, 2003, CELL TISSUE RES, V311, P187, DOI 10.1007/s00441-002-0679-8
   Wang XH, 2004, BIOMATERIALS, V25, P3681, DOI 10.1016/j.biomaterials.2003.10.102
   Zhou SH, 2004, J BONE MINER RES, V19, P463, DOI 10.1359/JBMR.0301239
NR 37
TC 88
Z9 93
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2005
VL 26
IS 28
BP 5677
EP 5686
DI 10.1016/j.biomaterials.2005.02.031
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 931NO
UT WOS:000229492200012
PM 15878373
DA 2018-10-20
ER

PT J
AU Renouf-Glauser, AC
   Rose, J
   Farrar, DF
   Cameron, RE
AF Renouf-Glauser, AC
   Rose, J
   Farrar, DF
   Cameron, RE
TI The effect of crystallinity on the deformation mechanism and bulk
   mechanical properties of PLLA
SO BIOMATERIALS
LA English
DT Article
DE polylactic acid; degradation; XRD (X-ray diffraction); mechanical
   properties; crystallinity
ID X-RAY-SCATTERING; PHOSPHATE-BUFFERED SOLUTION; SIMULTANEOUS SMALL-ANGLE;
   POLYETHYLENE DEFORMATION; POLY(L-LACTIDE) FILMS; SYNCHROTRON-RADIATION;
   MOLECULAR-WEIGHT; IN-VITRO; HYDROLYSIS; DEGRADATION
AB Poly (L-lactide) is a widely studied biomaterial, currently approved for use in a range of medical devices, however, most in vitro studies have so far focussed upon either the bulk properties during degradation and/or deformation, or on the microstructure of the unloaded material during degradation. This study aimed to combine these approaches through the technique of simultaneous small-angle X-ray scattering and tensile testing at various stages of degradation up to 8 months, on material with a range of induced microstructures. Results showed that the amorphous material deformed by crazing in the dry, wet and degraded states, however, the mechanism by which the craze developed changed significantly on hydration. Despite this difference, there was little change in the bulk mechanical properties. Crystalline materials deformed through crystal-mediated deformation, with contributions from both cavitation and fibrillated shear, but surprisingly, differences in the length scales within the spherulitic structure caused by annealing at different temperatures had very little effect on the mechanism of deformation, though differences were seen in the bulk properties. Furthermore, hydration had little effect on the crystalline materials, though degradation over 8 months resulted in loss of mechanical properties for samples produced at higher annealing temperatures. In conclusion, the introduction of crystallinity had a huge effect on both bulk and microscopic properties of PLLA, but the spherulitic structure of the crystalline material affected the bulk properties significantly more than it did the micromechanism of deformation. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
   Smith & Nephew Grp Res Ctr, York YO10 5DF, N Yorkshire, England.
RP Cameron, RE (reprint author), Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
EM rec11@cam.ac.uk
OI Cameron, Ruth/0000-0003-1573-4923
CR Baiardo M, 2003, J APPL POLYM SCI, V90, P1731, DOI 10.1002/app.12549
   BROWN HR, 1986, J POLYM SCI POL PHYS, V24, P11, DOI 10.1002/polb.1986.180240102
   BROWN HR, 1981, J MACROMOL SCI PP B, V19, DOI UNSP 487487-522
   Butler MF, 1998, MACROMOLECULES, V31, P6234, DOI 10.1021/ma970681r
   Butler MF, 1997, POLYMER, V38, P5521, DOI 10.1016/S0032-3861(97)00111-0
   Duek EAR, 1999, POLYMER, V40, P6465, DOI 10.1016/S0032-3861(98)00846-5
   FISCHER EW, 1973, KOLLOID Z Z POLYM, V251, P980, DOI 10.1007/BF01498927
   Galeski A, 2003, PROG POLYM SCI, V28, P1643, DOI 10.1016/j.progpolymsci.2003.09.003
   GOODSHIP AE, 1998, SCI BASIC ORTHOPAEDI
   Kohn J, 1996, BIOMATERIALS SCI INT
   LI SM, 1990, J MATER SCI-MATER M, V1, P198, DOI 10.1007/BF00701077
   Li SM, 1999, BIOMATERIALS, V20, P35, DOI 10.1016/S0142-9612(97)00226-3
   Lode U, 1998, MACROMOL RAPID COMM, V19, P35, DOI 10.1002/(SICI)1521-3927(19980101)19:1<35::AID-MARC35>3.0.CO;2-3
   NAKAMURA T, 1989, J BIOMED MATER RES, V23, P1115, DOI 10.1002/jbm.820231003
   Perego G, 1996, J APPL POLYM SCI, V59, P37, DOI 10.1002/(SICI)1097-4628(19960103)59:1<37::AID-APP6>3.3.CO;2-7
   PISTNER H, 1994, BIOMATERIALS, V15, P439, DOI 10.1016/0142-9612(94)90223-2
   Pluta M, 2002, J APPL POLYM SCI, V86, P1386, DOI 10.1002/app.11280
   Pomper T, 1999, J MACROMOL SCI PHYS, VB38, P869, DOI 10.1080/00222349908248145
   Salomons GJ, 1999, J APPL CRYSTALLOGR, V32, P71, DOI 10.1107/S0021889898010486
   Tsuji H, 2000, POLYM DEGRAD STABIL, V67, P179, DOI 10.1016/S0141-3910(99)00111-1
   Tsuji H, 2000, J APPL POLYM SCI, V77, P1452, DOI 10.1002/1097-4628(20000815)77:7<1452::AID-APP7>3.0.CO;2-S
   TSUJI H, 1995, POLYMER, V36, P2709, DOI 10.1016/0032-3861(95)93647-5
   Tsuji H, 2001, MACROMOL MATER ENG, V286, P398, DOI 10.1002/1439-2054(20010701)286:7<398::AID-MAME398>3.0.CO;2-G
   Tsuji H, 1997, J APPL POLYM SCI, V63, P855
   Tsuji H, 2004, POLYM DEGRAD STABIL, V84, P515, DOI 10.1016/j.polymdegradstab.2004.01.010
   Zhang XC, 2000, POLYMER, V41, P3797, DOI 10.1016/S0032-3861(99)00594-7
NR 26
TC 71
Z9 71
U1 5
U2 63
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2005
VL 26
IS 29
BP 5771
EP 5782
DI 10.1016/j.biomaterials.2005.03.002
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 940FI
UT WOS:000230128700003
PM 15949544
DA 2018-10-20
ER

PT J
AU Tsai, AT
   Rice, J
   Scatena, M
   Liaw, L
   Ratner, BD
   Giachelli, CM
AF Tsai, AT
   Rice, J
   Scatena, M
   Liaw, L
   Ratner, BD
   Giachelli, CM
TI The role of osteopontin in foreign body giant cell formation
SO BIOMATERIALS
LA English
DT Article
DE osteopontin; knockout mice; macrophages; foreign body reaction; foreign
   body giant cells
ID INDUCED BONE-RESORPTION; MACROPHAGE FUSION; IN-VITRO; DEFICIENT MICE;
   BACTERIAL-INFECTION; GENETIC-RESISTANCE; MEDIATED-IMMUNITY; HUMAN
   MONOCYTES; EXPRESSION; RECEPTOR
AB Foreign body giant cells (FBGCs) are a hallmark of the foreign body reaction caused by biomaterial implantation and are thought to contribute to biomaterial degradation and the duration of the response. Osteopontin (OPN) is a secreted, acidic matricellular protein with multiple phosphorylation sites that is highly expressed at sites of inflammation. OPN wildtype and knockout mice were implanted with poly(vinyl alcohol) sponges and explanted at 14 days. OPN knockout mice had more foreign body giant cells but fewer macrophages surrounding the implants than their wildtype counterparts. In an in vitro human FBGC assay, addition of soluble OPN was found to reduce macrophage fusion to giant cells. These are the first studies to show a direct inhibitory role of OPN in FBGC formation in response to implantation. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   Univ Washington, Dept Pathol, Seattle, WA 98195 USA.
   Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA.
   Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
RP Giachelli, CM (reprint author), Univ Washington, Dept Bioengn, Box 351720, Seattle, WA 98195 USA.
EM ceci@u.washington.edu
FU NHLBI NIH HHS [HL18645, HL07312]
CR Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860
   Blystone SD, 1999, J CELL BIOL, V145, P889, DOI 10.1083/jcb.145.4.889
   Boissy P, 1998, J CELL SCI, V111, P2563
   CARLOS TM, 1994, BLOOD, V84, P2068
   Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960
   Crawford HC, 1998, CANCER RES, V58, P5206
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   DeFife KM, 1999, FASEB J, V13, P823
   Ellison JA, 1998, STROKE, V29, P1698, DOI 10.1161/01.STR.29.8.1698
   Ellison JA, 1999, ANN NY ACAD SCI, V890, P204, DOI 10.1111/j.1749-6632.1999.tb07996.x
   Ellison JA, 1998, STROKE, V29, P1707
   ENELOW RI, 1992, AM J RESP CELL MOL, V6, P57
   FISHBEIN MC, 1982, J THORAC CARDIOV SUR, V83, P602
   Giachelli CM, 1998, AM J PATHOL, V152, P353
   GREEN SJ, 1988, EXP CELL RES, V178, P224, DOI 10.1016/0014-4827(88)90393-X
   Harris ES, 2000, J BIOL CHEM, V275, P23409, DOI 10.1074/jbc.R000004200
   Hartner A, 2001, AM J KIDNEY DIS, V38, P153, DOI 10.1053/ajkd.2001.25209
   Hernandez-Pando R, 2000, IMMUNOLOGY, V100, P352, DOI 10.1046/j.1365-2567.2000.00025.x
   Hirata A, 2003, AM J PATHOL, V163, P203, DOI 10.1016/S0002-9440(10)63644-9
   HRI R, IN PRESS CALCIF TISS
   Ihara H, 2001, J BIOL CHEM, V276, P13065, DOI 10.1074/jbc.M010938200
   Ishijima M, 2002, J BONE MINER RES, V17, P661, DOI 10.1359/jbmr.2002.17.4.661
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Katagiri YU, 1999, CANCER RES, V59, P219
   Kawashima R, 1999, BIOCHEM BIOPH RES CO, V256, P527, DOI 10.1006/bbrc.1999.0372
   Khan KMF, 1997, J BIOL CHEM, V272, P8270, DOI 10.1074/jbc.272.13.8270
   Kim SY, 2002, MOL CELLS, V13, P429
   Lee MY, 1999, NEUROSCI LETT, V271, P81, DOI 10.1016/S0304-3940(99)00526-1
   LEVY RJ, 1983, AM J PATHOL, V113, P143
   LIAW L, 1995, CIRC RES, V77, P665, DOI 10.1161/01.RES.77.4.665
   LIAW L, 1994, CIRC RES, V74, P214, DOI 10.1161/01.RES.74.2.214
   Liaw L, 1998, J CLIN INVEST, V101, P1468
   LOBB RR, 1994, J CLIN INVEST, V94, P1722, DOI 10.1172/JCI117519
   McNally AK, 1996, AM J PATHOL, V149, P975
   McNally AK, 2003, AM J PATHOL, V163, P1147, DOI 10.1016/S0002-9440(10)63474-8
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MURRY CE, 1994, AM J PATHOL, V145, P1450
   Myerowitz R, 2002, HUM MOL GENET, V11, P1343, DOI 10.1093/hmg/11.11.1343
   Nau GJ, 1999, INFECT IMMUN, V67, P4223
   O'Regan AW, 2000, IMMUNOL TODAY, V21, P475, DOI 10.1016/S0167-5699(00)01715-1
   O'Regan AW, 2001, AM J RESP CRIT CARE, V164, P2243, DOI 10.1164/rccm2104139
   O'Regan AW, 1999, J IMMUNOL, V162, P1024
   Ophascharoensuk V, 1999, KIDNEY INT, V56, P571, DOI 10.1046/j.1523-1755.1999.00580.x
   Panzer U, 2001, KIDNEY INT, V59, P1762, DOI 10.1046/j.1523-1755.2001.0590051762.x
   PATARCA R, 1989, J EXP MED, V170, P145, DOI 10.1084/jem.170.1.145
   PATARCA R, 1993, CRIT REV IMMUNOL, V13, P225
   PICHLER R, 1994, AM J PATHOL, V144, P915
   PICHLER RH, 1995, J AM SOC NEPHROL, V6, P1186
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   REICHART WM, 1999, HDB BIOMATERIALS EVA
   Smith HR, 1996, REV MICROBIOL, V27, P45
   Smith LL, 1999, J CELL BIOCHEM, V73, P20, DOI 10.1002/(SICI)1097-4644(19990401)73:1<20::AID-JCB3>3.0.CO;2-3
   Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101
   SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9
   Steitz SA, 2002, AM J PATHOL, V161, P2035, DOI 10.1016/S0002-9440(10)64482-3
   Sterling H, 1998, J CELL BIOL, V143, P837, DOI 10.1083/jcb.143.3.837
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Vignery A, 2000, INT J EXP PATHOL, V81, P291, DOI 10.1046/j.1365-2613.2000.00164.x
   VISSERS MCM, 1988, J IMMUNOL METHODS, V110, P203, DOI 10.1016/0022-1759(88)90104-4
   Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509
   Weiss JM, 2001, J EXP MED, V194, P1219, DOI 10.1084/jem.194.9.1219
   Yoshitake H, 1999, P NATL ACAD SCI USA, V96, P8156, DOI 10.1073/pnas.96.14.8156
   Yu XQ, 1998, P ASSOC AM PHYSICIAN, V110, P50
   ZHAO XL, 1991, J AUSTR I STEEL CONS, V25, P2
NR 69
TC 41
Z9 42
U1 1
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2005
VL 26
IS 29
BP 5835
EP 5843
DI 10.1016/j.biomaterials.2005.03.003
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 940FI
UT WOS:000230128700010
PM 15949549
DA 2018-10-20
ER

PT J
AU Yan, YN
   Wang, XH
   Pan, YQ
   Liu, HX
   Cheng, J
   Xiong, Z
   Lin, F
   Wu, RD
   Zhang, RJ
   Lu, QP
AF Yan, YN
   Wang, XH
   Pan, YQ
   Liu, HX
   Cheng, J
   Xiong, Z
   Lin, F
   Wu, RD
   Zhang, RJ
   Lu, QP
TI Fabrication of viable tissue-engineered constructs with 3D cell-assembly
   technique
SO BIOMATERIALS
LA English
DT Article
DE cell assembling; rapid prototyping; three-dimensional precursor;
   implantable bioartificial organs; hydrogel
ID DEPOSITION; SCAFFOLDS
AB We have recently developed an organ manufacturing technique that enables us to form cell/biomaterial complex three-dimensional (3D) architectures in designed patterns. This technique employs a highly accurate 3D micropositioning system with a pressue-controlled syringe to deposit cell/biomaterial structures with a lateral resolution of 10 pm. The pressure-activated micro-syringe is equipped with a fine-bore exit needle using which a wide variety of 3D patterns with different arrays of channels (through-holes) were created. The channels can supply living cells with nutrients and allow removing the cell metabolites. The embedded cells remain viable and perform biological functions as long as the 3D structures are retained. The new technology has the potential for eventual high-throughput production of artificial human tissues and organs. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Tsing Hua Univ, Dept Mech Engn, Ctr Organism Mfg, Beijing 100084, Peoples R China.
   Tsing Hua Univ, Inst Life Sci & Med, Beijing 100084, Peoples R China.
RP Wang, XH (reprint author), Tsing Hua Univ, Dept Mech Engn, Ctr Organism Mfg, Beijing 100084, Peoples R China.
EM wangxiaohong@tsinghua.edu.cn
RI Lin, Feng/K-7906-2012
OI Lin, Feng/0000-0003-1855-504X
CR Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Kim SS, 2000, TISSUE ENG, V6, P39, DOI 10.1089/107632700320874
   LISA RB, 2003, TISSUE ENG, V9, P401
   Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7
   Moghe PV, 1997, BIOTECHNOL BIOENG, V56, P706, DOI 10.1002/(SICI)1097-0290(19971220)56:6<706::AID-BIT14>3.0.CO;2-5
   REICHLING JJ, 1988, DIGEST DIS SCI, V33, P1601, DOI 10.1007/BF01535953
   SACHS E, 1992, J ENG IND-T ASME, V114, P481
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Vozzi G, 2002, TISSUE ENG, V8, P1089, DOI 10.1089/107632702320934182
   Xiong Z, 2002, SCRIPTA MATER, V46, P771, DOI 10.1016/S1359-6462(02)00071-4
NR 10
TC 139
Z9 153
U1 2
U2 54
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2005
VL 26
IS 29
BP 5864
EP 5871
DI 10.1016/j.biomaterials.2005.02.027
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 940FI
UT WOS:000230128700013
PM 15949552
DA 2018-10-20
ER

PT J
AU Kasten, P
   Vogel, J
   Luginbuhl, R
   Niemeyer, P
   Tonak, M
   Lorenz, H
   Helbig, L
   Weiss, S
   Fellenberg, J
   Leo, A
   Simank, HG
   Richter, W
AF Kasten, P
   Vogel, J
   Luginbuhl, R
   Niemeyer, P
   Tonak, M
   Lorenz, H
   Helbig, L
   Weiss, S
   Fellenberg, J
   Leo, A
   Simank, HG
   Richter, W
TI Ectopic bone formation associated with mesenchymal stem cells in a
   resorbable calcium deficient hydroxyapatite carrier
SO BIOMATERIALS
LA English
DT Article
DE bone healing; biocompatibility; bone; bone regeneration; bone tissue
   engineering; calcium phosphate; ceramic structure; composite;
   hydroxyapatite; in situ hybridization; in vivo test; mesenchymal stem
   cell; osteoblast; osteoconduction; osteogenesis; platelet; progenitor
   cell; porosity; surface roughness
ID MARROW STROMAL CELLS; TISSUE-ENGINEERED BONE; EX-VIVO EXPANSION;
   IN-VIVO; REPAIR; PROGENITOR; DEFECTS; MOUSE; GROWTH; DIFFERENTIATION
AB Bone substitute materials can induce bone formation in combination with mesenchymal stem cells (MSC). The aim of the current study was to examine ectopic in vivo bone formation with and without MSC on a new resorbable ceramic, called calcium deficient hydroxyapatite (CDHA). Ceramic blocks characterized by a large surface (48 m(2)/g) were compared with beta-tricalcium phosphate (beta-TCP), hydroxyapatite (HA) ceramics (both ca. 0.5 m(2)/g surface) and demineralized bone matrix (DBM). Before implantation in the back of SCID mice carriers were freshly loaded with 2 x 105 expanded human MSC or loaded with cells and kept under osteogenic conditions for two weeks in vitro. Culture conditions were kept free of xenogenic supplements. Deposits of osteoid at the margins of ceramic pores occurred independent of osteogenic pre-induction, contained human cells, and appeared in 4/16 MSC/CDHA composites compared to 2/16 MSC/beta-TCP composites. ALP activity was significantly higher in samples with MSC versus empty controls (p < 0.001). Furthermore, ALP was significantly (p < 0.05) higher for all ceramics when compared to the DBM matrix. Compared to previous studies, overall bone formation appeared to be reduced possibly due to the strict human protocol. Ectopic bone formation in the novel biomaterial CDHA varied considerably with the cell pool and was at least equal to beta-TCP blocks. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Heidelberg Univ, Dept Orthopaed Surg, D-69118 Heidelberg, Germany.
   Dr Hc Robert Mathys Fdn, CH-2544 Bettlach, Switzerland.
   Univ Freiburg, Dept Orthoped & Traumatol, Freiburg, Germany.
   Heidelberg Univ, Inst Immunol, Blood Bank, D-69120 Heidelberg, Germany.
RP Kasten, P (reprint author), Heidelberg Univ, Dept Orthopaed Surg, Schlierbacher Landstr 200A, D-69118 Heidelberg, Germany.
EM Philip.Kasten@gmx.de
RI Richter, Wiltrud/V-3217-2017
OI Richter, Wiltrud/0000-0003-4694-2768
CR Aguzzi A, 1997, B WORLD HEALTH ORGAN, V75, P505
   Angele P, 1999, TISSUE ENG, V5, P545, DOI 10.1089/ten.1999.5.545
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   Bohner M, 2000, INJURY, V31, pS37
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115
   GEBHART M, 1991, Acta Orthopaedica Belgica, V57, P130
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   HAYNESWORTH SE, 1992, BONE, V13, P69, DOI 10.1016/8756-3282(92)90363-2
   Jiang YH, 2003, P NATL ACAD SCI USA, V100, P11854, DOI 10.1073/pnas.1834196100
   Kasten P, 2004, Z ORTHOP GRENZGEB, V142, P467, DOI 10.1055/s-2004-820342
   Kasten P, 2003, BIOMATERIALS, V24, P2593, DOI 10.1016/S0142-9612(03)00062-0
   KIEVITS F, 1988, J IMMUNOL, V140, P4253
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335
   Kuznetsov SA, 2000, TRANSPLANTATION, V70, P1780, DOI 10.1097/00007890-200012270-00018
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   MacDermott R P, 1983, Behring Inst Mitt, P122
   Majors AK, 1997, J ORTHOPAED RES, V15, P546, DOI 10.1002/jor.1100150410
   Mankani MH, 2001, BIOTECHNOL BIOENG, V72, P96, DOI 10.1002/1097-0290(20010105)72:1<96::AID-BIT13>3.0.CO;2-A
   Muraglia A, 2000, J CELL SCI, V113, P1161
   Muraglia A, 1998, BONE, V22, p131S, DOI 10.1016/S8756-3282(98)00009-X
   Murphy JM, 2002, ARTHRITIS RHEUM, V46, P704, DOI 10.1002/art.10118
   NADE S, 1983, CLIN ORTHOP RELAT R, P255
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Oreffo ROC, 1998, SCAND J RHEUMATOL, V27, P415
   Phinney DG, 1999, J CELL BIOCHEM, V75, P424, DOI 10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.3.CO;2-#
   Puelacher WC, 1996, INT J ORAL MAX SURG, V25, P223, DOI 10.1016/S0901-5027(96)80035-X
   QUARTO R, 1995, CALCIFIED TISSUE INT, V56, P123, DOI 10.1007/BF00296343
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615
   Rueger JM, 1998, ORTHOPADE, V27, P72
   Rueger JM, 1998, ORTHOPADE, V27, P89
   Shang QX, 2001, J CRANIOFAC SURG, V12, P586, DOI 10.1097/00001665-200111000-00017
   Vacanti CA, 1999, CLIN ORTHOP RELAT R, pS375
   Walker JA, 2003, ANAL BIOCHEM, V315, P122, DOI 10.1016/S0003-2697(03)00081-2
   Winter A, 2003, ARTHRITIS RHEUM, V48, P418, DOI 10.1002/art.10767
   Wippermann B, 1999, ANN CHIR GYNAECOL FE, V88, P194
   Wozney JM, 2002, SPINE, V27, pS2, DOI 10.1097/01.BRS0000020725.01916.7E
NR 40
TC 126
Z9 131
U1 0
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2005
VL 26
IS 29
BP 5879
EP 5889
DI 10.1016/j.biomaterials.2005.03.001
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 940FI
UT WOS:000230128700015
PM 15913762
DA 2018-10-20
ER

PT J
AU Unsworth, LD
   Sheardown, H
   Brash, JL
AF Unsworth, LD
   Sheardown, H
   Brash, JL
TI Polyethylene oxide surfaces of variable chain density by chemisorption
   of PEO-thiol on gold: Adsorption of proteins from plasma studied by
   radiolabelling and immunoblotting
SO BIOMATERIALS
LA English
DT Article
DE surface modification; fibrinogen; plasma protein; protein adsorption;
   protein resistant surface; Vroman effect; western blots; poly(ethylene
   oxide)
ID SELF-ASSEMBLED MONOLAYERS; POLY(ETHYLENE GLYCOL); BIOMATERIAL SURFACES;
   FIBRINOGEN; IDENTIFICATION; RESISTANCE; CONTACT; LENGTH
AB The mechanisms involved in the inhibition of protein adsorption by polyethylene oxide (PEO) are not completely understood, but it is believed that PEO chain length, chain density and chain conformation all play a role. In this work, surfaces formed by chemisorption of PEO-thiol to gold were investigated: the effects of PEO chain density, chain length (600, 750, 2000 and 5000 MW) and end-group (-OH, -OCH3) on protein adsorption from plasma are reported. Similar to previous single protein adsorption studies (L.D. Unsworth et al., Langmuir 2005-121:1036-41) it was found that, of the different surfaces investigated, PEO layers formed from solutions near the cloud point adsorbed the lowest amount of fibrinogen from plasma. Layers of hydroxyl-terminated PEO of MW 600 formed under these low solubility conditions showed almost complete suppression (versus controls) of the Vroman effect, with 20 +/- 1 ng/cm(2) adsorbed fibrinogen at the Vroman peak and 6.7 +/- 0.6 ng/cm(2) at higher plasma concentration. By comparison, Vroman peak adsorption was 70 +/- 20 and 50 +/- 3 ng/cm(2), respectively, for 750-OCH3 and 2000-OCH3 layers formed under low solubility conditions; adsorption on these surfaces at higher plasma concentration was 16 +/- 9 and 12 +/- 3 ng/cm(2). Thus in addition to the effect of solution conditions noted previously, the results of this study also suggest a chain end group effect which inhibits fibrinogen adsorption to, and/or facilitates displacement from, hydroxyl terminated PEO layers. Fibrinogen adsorption from plasma was not significantly different for surfaces prepared with PEO of molecular weight 750 and 2000 when the chain density was the same (similar to 0.5chains/nm(2)) supporting the conclusion that chain density may be the key property for suppression of protein adsorption. The proteins eluted from the surfaces after contact with plasma were investigated by SDS-PAGE and immunoblotting. A number of proteins were detected on the various surfaces including fibrinogen, albumin, C3 and apolipoprotein A-I. The blot responses were zero or weak for all four proteins of the contact system; some complement activation was observed on all of the surfaces studied. (c) 2005 Elsevier Ltd. All rights reserved.
C1 McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
RP Brash, JL (reprint author), McMaster Univ, Dept Chem Engn, 1280 Main St W, Hamilton, ON L8S 4L7, Canada.
EM brashjl@mcmaster.ca
RI Unsworth, Larry/A-7231-2011
OI Unsworth, Larry/0000-0003-3162-3545
CR ALEXANDER S, 1977, J PHYS-PARIS, V38, P983, DOI 10.1051/jphys:01977003808098300
   Andrade JD, 1985, SURFACE INTERFACIAL, V2, P1
   BRASH JL, 1984, THROMB HAEMOSTASIS, V51, P326
   BRASH JL, 1987, ANN NY ACAD SCI, V516, P206, DOI 10.1111/j.1749-6632.1987.tb33043.x
   Cornelius RM, 2002, J BIOMED MATER RES, V60, P622, DOI 10.1002/jbm.10117
   Cornelius RM, 2002, BIOMATERIALS, V23, P3583, DOI 10.1016/S0142-9612(02)00083-2
   CORNELIUS RM, 1993, J BIOMAT SCI-POLYM E, V4, P291, DOI 10.1163/156856293X00573
   DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001
   Du YJ, 2003, J APPL POLYM SCI, V90, P594, DOI 10.1002/app.12545
   Du YJ, 2000, COLLOID SURFACE B, V17, P59, DOI 10.1016/S0927-7765(99)00053-3
   HARRIS J, 1992, PROCEEDINGS OF THE SIXTH NORTH AMERICAN CRANE WORKSHOP, P1
   Jahns Gerlinde, 1993, Clinical Materials, V14, P303, DOI 10.1016/0267-6605(93)90017-2
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   Malmsten M, 1998, J COLLOID INTERF SCI, V202, P507, DOI 10.1006/jcis.1998.5513
   MCINTYRE N, 1991, LIPIDS LIPOPROTEINS
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Slack SM, 1995, ACS SYM SER, V602, P112
   Szleifer I, 1997, BIOPHYS J, V72, P595, DOI 10.1016/S0006-3495(97)78698-3
   TAN J, 2001, T SOC BIOMATER, V24, P499
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   Unsworth LD, 2005, LANGMUIR, V21, P1036, DOI 10.1021/la047672d
   Unsworth LD, 2005, J COLLOID INTERF SCI, V281, P112, DOI 10.1016/j.jcis.2004.08.022
   Vert M, 2000, J BIOMAT SCI-POLYM E, V11, P1307, DOI 10.1163/156856200744345
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   VROMAN L, 1987, SEMIN THROMB HEMOST, V13, P79, DOI 10.1055/s-2007-1003477
   Wirtz R, 2004, LANGMUIR, V20, P1527, DOI 10.1021/la036027o
   WOJCIECHOWSKI P, 1986, J COLLOID INTERF SCI, V111, P455, DOI 10.1016/0021-9797(86)90048-2
   Zhang F, 2001, J BIOMAT SCI-POLYM E, V12, P515, DOI 10.1163/156856201300194252
   Zhu B, 2001, J BIOMED MATER RES, V56, P406, DOI 10.1002/1097-4636(20010905)56:3<406::AID-JBM1110>3.0.CO;2-R
NR 32
TC 111
Z9 112
U1 6
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2005
VL 26
IS 30
BP 5927
EP 5933
DI 10.1016/j.biomaterials.2005.03.010
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 945YK
UT WOS:000230538700001
PM 15958239
DA 2018-10-20
ER

PT J
AU Cai, SS
   Liu, YC
   Shu, XZ
   Prestwich, GD
AF Cai, SS
   Liu, YC
   Shu, XZ
   Prestwich, GD
TI Injectable glycosaminoglycan hydrogels for controlled release of human
   basic fibroblast growth factor
SO BIOMATERIALS
LA English
DT Article
DE heparin; hyaluronan; chondroitin sulfate; wound healing;
   neovascularization; synthetic extracellular matrix
ID HYALURONIC-ACID; DRUG-DELIVERY; GELATIN HYDROGEL; IN-VITRO; HEPARIN;
   BIOMATERIALS; DERIVATIVES; TISSUE; FILMS; PROTEINS
AB Synthetic hydrogel mimics of the extracellular matrix (ECM) were created by crosslinking a thiol-modified analog of heparin with thiol-modified hyaluronan (HA) or chondroitin sulfate (CS) with poly(ethylene glycol) diacrylate (PEGDA). The covalently bound heparin provided a crosslinkable analog of a heparan sulfate proteoglycan, thus providing a multivalent biomaterial capable of controlled release of basic fibroblast growth factor (bFGF). Hydrogels contained > 97% water and formed rapidly in < 10 min. With as little as 1% (w/w) covalently bound heparin (relative to total glycosaminoglycan content), the rate of release of bFGF in vitro was substantially reduced. Total bFGF released increased with lower percentages of heparin; essentially quantitative release of bFGF was observed from heparin-free hydrogels. Moreover, the hydrogel-released bFGF retained 55% of its biological activity for up to 28 days as determined by a cell proliferation assay. Finally, when these hydrogels were implanted into subcutaneous pockets in Balb/c mice, neovascularization increased dramatically with HA and CS hydrogels that contained both bFGF and crosslinked heparin. In contrast, hydrogels lacking bFGF or crosslinked heparin showed little increase in neovascularization. Thus, covalently linked, heparin-containing glycosaminoglycan hydrogels that can be injected and crosslinked in situ constitute highly promising new materials for controlled release of heparin-binding growth factors in vivo. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Utah, Dept Med Chem, Salt Lake City, UT 84108 USA.
RP Prestwich, GD (reprint author), Univ Utah, Dept Med Chem, 419 Wakara Way,Suite 205, Salt Lake City, UT 84108 USA.
EM gprestwich@pharm.utah.edu
FU NIDCD NIH HHS [R01 DC04663]
CR Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   BENESCH R, 1958, P NATL ACAD SCI USA, V44, P848, DOI 10.1073/pnas.44.9.848
   Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5
   BUTTERWORTH PH, 1967, ARCH BIOCHEM BIOPHYS, V118, P716, DOI 10.1016/0003-9861(67)90409-2
   Cadee JA, 2002, J CONTROL RELEASE, V78, P1, DOI 10.1016/S0168-3659(01)00483-7
   CLELAND J, 2001, J CONTROL RELEASE, V2, P13
   Davies MJ, 1997, J BIOMATER APPL, V12, P31, DOI 10.1177/088532829701200103
   EDELMAN ER, 1991, BIOMATERIALS, V12, P619, DOI 10.1016/0142-9612(91)90107-L
   FOLKMAN J, 1992, ADV EXP MED BIOL, V313, P355
   Gilbert ME, 2004, LARYNGOSCOPE, V114, P1406, DOI 10.1097/00005537-200408000-00017
   HICKEY MJ, 1994, BIOCHEM BIOPH RES CO, V201, P1066, DOI 10.1006/bbrc.1994.1813
   Hong L, 2001, NEUROSURGERY, V49, P954, DOI 10.1097/00006123-200110000-00030
   Kimura Y, 2002, TISSUE ENG, V8, P603, DOI 10.1089/107632702760240526
   Kirker KR, 2004, J BURN CARE REHABIL, V25, P276, DOI 10.1097/01.BCR.0000124790.69026.3D
   Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X
   Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   Li H, 2004, BIOMACROMOLECULES, V5, P895, DOI 10.1021/bm034463j
   Liu LS, 2002, J BIOMED MATER RES, V62, P128, DOI 10.1002/jbm.10238
   LIU Y, 2004, IN PRESS HA 2003
   Liu YC, 2004, J BIOMED MATER RES A, V68A, P142, DOI 10.1002/jbm.a.10142
   Loo BM, 2002, J BIOL CHEM, V277, P32616, DOI 10.1074/jbc.M204961200
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.08.014, 10.1016/j.biomaterials.2003.10.092]
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Luo Y, 2001, EXPERT OPIN THER PAT, V11, P1395
   Luo Y, 1999, BIOCONJUGATE CHEM, V10, P755, DOI 10.1021/bc9900338
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   Maquet V, 2001, BIOMATERIALS, V22, P1137, DOI 10.1016/S0142-9612(00)00357-4
   Ozeki M, 2002, TISSUE ENG, V8, P359, DOI 10.1089/107632702760184637
   PALSSON BO, 2003, TISSUE ENG
   Peattie RA, 2004, BIOMATERIALS, V25, P2789, DOI 10.1016/j.biomaterials.2003.09.054
   POUYANI T, 1994, BIOCONJUGATE CHEM, V5, P339, DOI 10.1021/bc00028a010
   Prestwich G. D., 2002, HYALURONAN BIOMEDICA, V277
   Prestwich GD, 1998, J CONTROL RELEASE, V53, P93, DOI 10.1016/S0168-3659(97)00242-3
   Prestwich GD, 2001, BIOMATERIALS CHEM MO
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Salbach PB, 2000, BRIT J CLIN PHARMACO, V50, P221, DOI 10.1111/j.1365-2125.2000.00246.x
   Shu XZ, 2004, J BIOMED MATER RES A, V68A, P365, DOI 10.1002/jbm.a.20002
   Shu XZ, 2004, CHEMISTRY AND BIOLOGY OF HYALURONAN, P475
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9
   Tabata Y, 2000, TISSUE ENG, V6, P279, DOI 10.1089/10763270050044452
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   Tabata Y, 1999, BIOMATERIALS, V20, P2169, DOI 10.1016/S0142-9612(99)00121-0
   Tanihara M, 2001, J BIOMED MATER RES, V56, P216, DOI 10.1002/1097-4636(200108)56:2<216::AID-JBM1086>3.3.CO;2-E
   THANNHAUSER TW, 1987, METHOD ENZYMOL, V143, P115
   Vercruysse KP, 1998, CRIT REV THER DRUG, V15, P513
   Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461
   Yamauchi K, 2001, BIOMATERIALS, V22, P855, DOI 10.1016/S0142-9612(00)00249-0
   YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W
   ZHANG JD, 1991, P NATL ACAD SCI USA, V88, P3446, DOI 10.1073/pnas.88.8.3446
   Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52
NR 53
TC 285
Z9 294
U1 9
U2 150
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2005
VL 26
IS 30
BP 6054
EP 6067
DI 10.1016/j.biomaterials.2005.03.012
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 945YK
UT WOS:000230538700015
PM 15958243
DA 2018-10-20
ER

PT J
AU Mahabole, MP
   Aiyer, RC
   Ramakrishna, CV
   Sreedhar, B
   Khairnar, RS
AF Mahabole, MP
   Aiyer, RC
   Ramakrishna, CV
   Sreedhar, B
   Khairnar, RS
TI Synthesis, characterization and gas sensing property of hydroxyapatite
   ceramic
SO BULLETIN OF MATERIALS SCIENCE
LA English
DT Article
DE hydroxyapatite; biomaterial; ceramics; gas sensor; X-ray photoelectron
   spectroscopy; infrared spectroscopy
ID HYDROTHERMAL SYNTHESIS; THERMAL-STABILITY; MONOCLINIC HYDROXYAPATITE;
   CALCIUM HYDROXYAPATITE; PHOSPHATE; SPECTROSCOPY; TEMPERATURE; PARTICLES;
   COATINGS; POWDERS
AB Hydroxyapatite (HAp) biomaterial ceramic was synthesized by three different processing routes viz. wet chemical process, microwave irradiation process, and hydrothermal technique. The synthesized ceramic powders were characterized by SEM, XRD, FTIR and XPS techniques. The dielectric measurements were carried out as a function of frequency at room temperature and the preliminary study on CO gas sensing property of hydroxyapatite was investigated. The XRD pattern of the hydroxyapatite biomaterial revealed that hydroxyapatite ceramic has hexagonal structure. The average crystallite size was found to be in the range 31-54 nm. Absorption bands corresponding to phosphate and hydroxyl functional groups, which are characteristic of hydroxyapatite, were confirmed by FTIR. The dielectric constant was found to vary in the range 913 at room temperature. Hydroxyapatite can be used as CO gas sensor at an optimum temperature near 125 degrees C. X-ray photoelectron spectroscopic studies showed the Ca/P ratio of 1.63 for the HAp sample prepared by chemical process. The microwave irradiation technique yielded calcium rich HAp whereas calcium deficient HAp was obtained by hydrothermal method.
C1 Swami Ramanand Teerth Marathwada Univ, Sch Phys Sci, Nanded 431606, India.
   Univ Poona, Dept Phys, Pune 411007, Maharashtra, India.
   Indian Inst Chem Technol, Hyderabad 500007, Andhra Pradesh, India.
RP Khairnar, RS (reprint author), Swami Ramanand Teerth Marathwada Univ, Sch Phys Sci, Nanded 431606, India.
EM rk2kin@yahoo.com
CR Aizawa M, 2000, J CERAM SOC JPN, V108, P249, DOI 10.2109/jcersj.108.1255_249
   Aizawa M, 1999, J MATER SCI, V34, P2865, DOI 10.1023/A:1004635418655
   Bailliez S, 2004, PROCESS SAF ENVIRON, V82, P175, DOI 10.1205/095758204322972816
   Bertoni E, 1998, J INORG BIOCHEM, V72, P29, DOI 10.1016/S0162-0134(98)10058-2
   Furuzono T, 2001, J BIOMED MATER RES, V56, P9, DOI 10.1002/1097-4636(200107)56:1<9::AID-JBM1073>3.0.CO;2-2
   Furuzono T, 2001, J MATER SCI LETT, V20, P111, DOI 10.1023/A:1006725931450
   Gross KA, 1998, J AM CERAM SOC, V81, P106
   Gross KA, 1998, J MATER SCI, V33, P3985, DOI 10.1023/A:1004605014652
   Ikoma T, 1999, J SOLID STATE CHEM, V144, P272, DOI 10.1006/jssc.1998.8120
   Ikoma T, 1999, J MATER SCI LETT, V18, P1225, DOI 10.1023/A:1006610521173
   Ishikawa T, 2000, LANGMUIR, V16, P10221, DOI 10.1021/la0004855
   Jillavenkatesa A, 1999, J MATER SCI, V34, P4821, DOI 10.1023/A:1004607709747
   Jillavenkatesa A, 1998, J MATER SCI, V33, P4111, DOI 10.1023/A:1004436732282
   JULLAVENKATESA A, 1998, CANADIAN J ANAL SCI, V43, P161
   Katsuki H, 1999, J AM CERAM SOC, V82, P2257
   Kim W, 2001, ULTRASON SONOCHEM, V8, P85, DOI 10.1016/S1350-4177(00)00034-1
   Komath M, 2000, B MATER SCI, V23, P135, DOI 10.1007/BF02706555
   MORALES JG, 2000, CRYST RES TECHNOL, V36, P15
   More P.S., 2003, MATER LETT, V58, P205
   More PS, 2003, MATER LETT, V57, P2177, DOI 10.1016/S0167-577X(02)01170-9
   NAGAI M, 1988, SENSOR ACTUATOR, V15, P145, DOI 10.1016/0250-6874(88)87004-5
   Panda RN, 2001, JPN J APPL PHYS 1, V40, P5030, DOI 10.1143/JJAP.40.5030
   Park E, 1998, J MATER SCI-MATER M, V9, P643, DOI 10.1023/A:1008931508465
   Park E, 1998, MATER LETT, V36, P38, DOI 10.1016/S0167-577X(97)00287-5
   Raikar G. N., 1996, Surface Science Spectra, V4, P9, DOI 10.1116/1.1247808
   Rivera EM, 1999, MATER LETT, V41, P128, DOI 10.1016/S0167-577X(99)00118-4
   Roncari E, 2000, J MATER SCI LETT, V19, P33, DOI 10.1023/A:1006743513318
   Shaoxian Z., 1993, MATER RES SOC S P, V292, P271
   Slosarczyk A, 1999, CERAM INT, V25, P561, DOI 10.1016/S0272-8842(98)00019-4
   Slosarczyk A, 1999, J MATER SCI LETT, V18, P1163, DOI 10.1023/A:1006677806537
   Somiya S, 2000, B MATER SCI, V23, P453, DOI 10.1007/BF02903883
   Sugiyama S, 1999, J SOLID STATE CHEM, V143, P296, DOI 10.1006/jssc.1998.8126
   Sugiyama S, 1999, J SOLID STATE CHEM, V142, P319, DOI 10.1006/jssc.1998.8040
   TAGAI H, 1980, MECH PROPERTIES BIOM, P477
   Tampieri A, 1997, J MATER SCI-MATER M, V8, P29, DOI 10.1023/A:1018538212328
   Tampieri A, 2000, MATER CHEM PHYS, V64, P54, DOI 10.1016/S0254-0584(99)00252-7
   Tanaka H, 2000, PHYS CHEM CHEM PHYS, V2, P2647, DOI 10.1039/b001877p
   Vaidhyanathan B, 1996, B MATER SCI, V19, P1163, DOI 10.1007/BF02744651
   Verges M. A., 2000, J MATER RES, V15, P2526
   Yoshida Y, 2000, J DENT RES, V79, P709, DOI 10.1177/00220345000790020301
   YOSHIMURA M, 1994, J MATER SCI, V29, P3399, DOI 10.1007/BF00352039
NR 41
TC 94
Z9 95
U1 2
U2 44
PU INDIAN ACADEMY SCIENCES
PI BANGALORE
PA C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN 0250-4707
J9 B MATER SCI
JI Bull. Mat. Sci.
PD OCT
PY 2005
VL 28
IS 6
BP 535
EP 545
DI 10.1007/BF02706339
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA 980MI
UT WOS:000233022200003
DA 2018-10-20
ER

PT J
AU Cartier, R
   Ranga, A
   Mongrain, R
AF Cartier, R
   Ranga, A
   Mongrain, R
TI Aortic root reconstruction: From principles to numerical modelling
SO CANADIAN JOURNAL OF CARDIOLOGY
LA English
DT Article; Proceedings Paper
CT 58th Annual Meeting of the Canadian-Cardiovascular-Society
CY OCT 23, 2005
CL Montreal, CANADA
SP Canadian Cardiovasc Soc, Pulsus Grp Inc
DE aortic root; marfan; medial disease; reconstruction
ID VALVE-SPARING PROCEDURE; ASCENDING AORTA; FINITE-ELEMENT;
   MARFAN-SYNDROME; REPLACEMENT; ANEURYSM; LEAFLET; REPAIR; INCOMPETENCE;
   PROSTHESIS
AB Reconstructing the aortic root represents a formidable task for modern cardiac surgery. By the time an individual reaches 75 years of age his or her aortic apparatus has been submitted to more than three billion cardiac cycles, leaving no place for engineering flaws or misconception. The rules that have been established through millions of years of evolution are strict and demanding. During the past two decades, the cardiovascular community has manifested a growing interest in this topic, especially in patients with medial degenerative disease. However, the ideal reconstruction is still to be devised. To achieve a physiological root reconstruction that preserves the diastolic and systolic function of the valve as well as prevents premature degeneration, a few principles have to be respected. Neglecting any one of them has consequences on the normal functioning of the aortic valve. Current surgical techniques have limitations due to the limited availability of biomaterial and the lack Of useful tools to assess pathophysiological conditions and assist Surgeons in designing better custom-made reconstructions of the aortic root. The authors present a review of the principles behind the physiology of the reconstruction of the aortic root, and review the literature on computerized models exploring the biomechanics and kinetics of the ascending aorta.
C1 Montreal Heart Inst, Dept Cardiac Surg, Montreal, PQ H1T 1C8, Canada.
   Montreal Heart Inst, Biomech Grp, Montreal, PQ H1T 1C8, Canada.
   Montreal Heart Inst, Dept Res, Montreal, PQ H1T 1C8, Canada.
RP Cartier, R (reprint author), Montreal Heart Inst, Dept Cardiac Surg, 5000 Belanger St E, Montreal, PQ H1T 1C8, Canada.
EM rc2910@aol.com
CR Beck A, 2001, J HEART VALVE DIS, V10, P1
   BELLHOUSE BJ, 1968, NATURE, V219, P1059, DOI 10.1038/2191059a0
   BENTALL H, 1968, THORAX, V23, P338, DOI 10.1136/thx.23.4.338
   Blais C, 2003, CIRCULATION, V108, P983, DOI 10.1161/01.CIR.0000085167.67105.32
   BREWER RJ, 1976, J THORAC CARDIOV SUR, V72, P413
   Capps SB, 2000, J THORAC CARDIOV SUR, V119, P975, DOI 10.1016/S0022-5223(00)70092-4
   Cartier R, 2004, ANN THORAC SURG, V78, P2215, DOI 10.1016/j.athoracsur.2004.02.111
   CHRISTIE GW, 1982, FINITE ELEMENTS BIOM
   COCHRAN RP, 1995, J THORAC CARDIOV SUR, V109, P1049, DOI 10.1016/S0022-5223(95)70187-7
   DAVID TE, 1995, J THORAC CARDIOV SUR, V109, P345, DOI 10.1016/S0022-5223(95)70396-9
   DAVID TE, 1992, J THORAC CARDIOV SUR, V103, P617
   David TE, 1996, OP TECH CARDIAC THOR, V1, P44
   De Paulis R, 2002, ANN THORAC SURG, V74, P53, DOI 10.1016/S0003-4975(02)03583-X
   Demers P, 2003, CIRCULATION, V108, pE116, DOI 10.1161/01.CIR.0000092236.67713.04
   Gelsomino S, 2001, CARDIOVASC SURG, V9, P299, DOI 10.1016/S0967-2109(00)00142-3
   GHISTA DN, 1977, J BIOMECH, V10, P313, DOI 10.1016/0021-9290(77)90004-5
   Gnyaneshwar R, 2002, ANN THORAC SURG, V73, P1122, DOI 10.1016/S0003-4975(01)03588-3
   Grande KJ, 1998, ANN BIOMED ENG, V26, P534, DOI 10.1114/1.122
   Grande-Allen KJ, 2001, IEEE T BIO-MED ENG, V48, P647, DOI 10.1109/10.923783
   Grande-Allen KJ, 2001, J THORAC CARDIOV SUR, V122, P946, DOI 10.1067/mtc.2001.116314
   Grande-Allen KJ, 2000, J THORAC CARDIOV SUR, V119, P753, DOI 10.1016/S0022-5223(00)70011-0
   Hopkins RA, 2003, EUR J CARDIO-THORAC, V24, P886, DOI 10.1016/S1010-7940(03)00619-5
   Ioannou CV, 2003, EUR J VASC ENDOVASC, V26, P195, DOI 10.1053/ejvs.2002.1917
   KOUCHOUKOS NT, 1986, J THORAC CARDIOV SUR, V92, P691
   KUNZELMAN, 1994, J THORAC CARDIOV SUR, V107, P1402
   Leyh RG, 1999, CIRCULATION, V100, P2153, DOI 10.1161/01.CIR.100.21.2153
   MERCER JL, 1973, J THORAC CARDIOV SUR, V65, P511
   Mitchell GF, 2003, CIRCULATION, V108, P1592, DOI 10.1161/01.CIR.0000093435.04334.1F
   Ranga A., 2004, Journal of Medical Engineering & Technology, V28, P95, DOI 10.1080/0309190042000193847
   Roman MJ, 2000, HYPERTENSION, V36, P489, DOI 10.1161/01.HYP.36.4.489
   ROMAN MJ, 1989, AM J CARDIOL, V64, P507, DOI 10.1016/0002-9149(89)90430-X
   ROUSSEAU EPM, 1988, J BIOMECH, V21, P545, DOI 10.1016/0021-9290(88)90218-7
   SARSAM MAI, 1993, J THORAC CARDIOV SUR, V105, P435
   SEELY FB, 1952, ANALYTICAL MECHANICS, P111
   SILVER MA, 1985, AM J CARDIOL, V55, P454, DOI 10.1016/0002-9149(85)90393-5
   STEIN PD, 1971, AM HEART J, V81, P622, DOI 10.1016/0002-8703(71)90005-6
   Svensson LG, 2003, ANN THORAC SURG, V76, P1751, DOI 10.1016/S0003-4975(03)00439-9
   SWANSON WM, 1974, CIRC RES, V35, P871, DOI 10.1161/01.RES.35.6.871
   THUBRIKAR M, 1990, AORTIC VALVE, P1
   YACOUB M, 1983, CIRCULATION, V68, P321
   Yacoub MH, 1998, J THORAC CARDIOV SUR, V115, P1080, DOI 10.1016/S0022-5223(98)70408-8
NR 41
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0828-282X
EI 1916-7075
J9 CAN J CARDIOL
JI Can. J. Cardiol.
PD OCT
PY 2005
VL 21
IS 12
BP 1071
EP 1076
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 978KC
UT WOS:000232871000014
PM 16234892
DA 2018-10-20
ER

PT J
AU Hua, F
   Mon, K
   Pasupathi, P
   Gordon, G
   Shoesmith, D
AF Hua, F
   Mon, K
   Pasupathi, P
   Gordon, G
   Shoesmith, D
TI A review of corrosion of titanium grade 7 and other titanium alloys in
   nuclear waste repository environments
SO CORROSION
LA English
DT Review
DE general corrosion; hydrogen-induced cracking; localized corrosion;
   palladium; passive film; repository environments; stress corrosion
   cracking; titanium alloys
ID ANODIC OXIDE-FILMS; PITTING CORROSION; GAMMA-RADIATION; BIOMATERIAL
   APPLICATIONS; HYDROGEN-PEROXIDE; STAINLESS-STEEL; BENTONITE CLAY;
   SULFURIC-ACID; FLUORIDE-ION; BEHAVIOR
AB Titanium alloy degradation modes are reviewed in relation to their performance in repository environments. General corrosion, localized corrosion, stress corrosion cracking, hydrogen-induced cracking, microbiologically influenced corrosion, and radiation-assisted corrosion of 71 alloys are considered. With respect to the Ti Grade 7 drip shields selected for emplacement in the repository at Yucca Mountain, general corrosion. hydrogen-induced cracking, and radiation-assisted corrosion either do not initiate or propagate sufficiently fast over a 10,000-year time frame in likely repository environments to cause penetration of the drip shield. Stress corrosion cracking (in the absence of disruptive events) is of no consequence to barrier performance; and localized corrosion and microbiologically influenced corrosion are not expected to occur. To facilitate the discussion, Ti Grades 2, 5, 7, 9, 11, 12, 16, 17, 18, and 24 are included in this review.
C1 US DOE, Yucca Mt Project M&O Bechtel SAIC Co LLC, Las Vegas, NV 89144 USA.
   US DOE, Yucca Mt Project M&O Framatome ANP, Las Vegas, NV 89144 USA.
   Univ Western Ontario, Dept Chem, London, ON N6A 5B7, Canada.
RP Hua, F (reprint author), US DOE, Yucca Mt Project M&O Bechtel SAIC Co LLC, 1180 Town Ctr Dr, Las Vegas, NV 89144 USA.
EM fred_hua@ymp.gov
CR Andresen P. L., 2001, CORROSION 2001
   Andresen P.L., 2002, STRESS CORROSION CRA
   ARMSTRONG RD, 1973, CORROS SCI, V13, P409, DOI 10.1016/0010-938X(73)90027-9
   *ASTM INT, 2002, B26502 ASTM INT
   ASTM International, 2004, ANN BOOK ASTM STAND
   ASTM International, 1997, ANN BOOK ASTM STAND, V11.06
   Basame SB, 2000, J ELECTROCHEM SOC, V147, P1376, DOI 10.1149/1.1393364
   *BECHT SAIC CO, 2003, ANLEBSMD000003 BECHT
   *BECHT SAIC CO, 2003, ANLEBSMD000006 BECHT
   BECK TR, 1973, J ELECTROCHEM SOC, V120, P1310, DOI 10.1149/1.2403253
   BECK TR, 1973, J ELECTROCHEM SOC, V120, P1317, DOI 10.1149/1.2403254
   BLACKWOOD DJ, 1988, ELECTROCHIM ACTA, V33, P1143, DOI 10.1016/0013-4686(88)80206-8
   BROSSIA CS, 2001, 2001003 CNWRA
   *BSC, 2003, ANLEBSMD000004 BSC
   CASILLAS N, 1994, J ELECTROCHEM SOC, V141, P636, DOI 10.1149/1.2054783
   CHENG TP, 1993, MATER CHEM PHYS, V36, P156, DOI 10.1016/0254-0584(93)90025-H
   CHOI YK, 1992, J ELECTROCHEM SOC, V139, P1803, DOI 10.1149/1.2069501
   Clarke C. F., 1995, AECL11284
   CLARKE CF, 1994, CORROS SCI, V36, P487, DOI 10.1016/0010-938X(94)90039-6
   Clarke CF, 1997, CORROS SCI, V39, P1545, DOI 10.1016/S0010-938X(97)00055-3
   COTTON JB, 1970, CHEM ENG PROG, V66, P57
   Cotton JB, 1967, PLATIN MET REV, V11, P50
   COVINGTON LC, 1979, CORROSION, V35, P378, DOI 10.5006/0010-9312-35.8.378
   Covington LC, 1981, ASTM STP, P163
   *CRWMS M O, 2000, ANLEBSMD000001 CRWMS
   *CRWMS M O, 2000, TDRWISMD000002 CRWMS
   CURTY C, 1999, ELECTROCHEMICAL SOC, V9927, P445
   de Mele MFL, 2000, J APPL ELECTROCHEM, V30, P95
   DEBRUYN W, 1991, TASK 3 CHARACTERIZAT
   DUNN DS, 2000, CORROSION 2000
   Else TA, 2003, APPL ENVIRON MICROB, V69, P5006, DOI 10.1128/AEM.69.8.5006-5010.2003
   ESTILL JC, 1998, ENG MAT CHARACTERIZA, V3
   FARMER J, 2000, P ASME PVP C HELD JU
   Fontana M. G., 1986, CORROSION ENG
   FUKUZUKA T, 1980, TITANIUM 80 SCI TECH
   Garfias-Mesias LF, 1998, J ELECTROCHEM SOC, V145, P2005, DOI 10.1149/1.1838590
   GDOWSKI GE, 1997, UCRLID121191 LLNL
   GLASS RS, 1986, CORROS SCI, V26, P577, DOI 10.1016/0010-938X(86)90025-9
   GLASS RS, 1983, ELECTROCHIM ACTA, V28, P1507, DOI 10.1016/0013-4686(83)85209-8
   GLASS RS, 1986, CORROSION 86
   Gordon GM, 2002, CORROSION, V58, P811, DOI 10.5006/1.3287662
   GREEF R, 1985, INSTRUMENTAL METHODS, pCH7
   GREENE CA, 2001, MAT RES SOC S P WARR, V663, P515
   HALL JA, 1985, TITANIUM SCI TECHNOL, P2603
   HANAWA T, 1992, APPL SURF SCI, V55, P269, DOI 10.1016/0169-4332(92)90178-Z
   Hanawa T, 1998, J BIOMED MATER RES, V40, P530, DOI 10.1002/(SICI)1097-4636(19980615)40:4<530::AID-JBM3>3.0.CO;2-G
   Hardie D, 1999, CORROS SCI, V41, P155, DOI 10.1016/S0010-938X(98)00109-7
   HORN J, 1999, CORROSION 1999
   HORN J, 2000, CORROSION 2000
   HUA F, 2003, CORROSION 2003
   HUA F, 2002, CORROSION 2002
   HUBLER GK, 1980, CORROS SCI, V20, P103, DOI 10.1016/0010-938X(80)90114-6
   HURLEN T, 1991, ELECTROCHIM ACTA, V36, P189, DOI 10.1016/0013-4686(91)85200-Q
   IKEDA BM, 1998, 06819REP012000078R00
   IKEDA BM, 1998, 06819REP012000039R00
   IKEDA BM, 2000, P INT S ENV IND CRAC, P235
   Kamikubo F., 1981, P 8 INT C MET CORR, P1378
   KELLY EJ, 1979, J ELECTROCHEM SOC, V126, P2064, DOI 10.1149/1.2128862
   KIDOH T, 1989, J IRON STEEL I JPN, V75, P96
   KIM YJ, 1987, CORROSION, V43, P85, DOI 10.5006/1.3583122
   KIM YJ, 1987, CORROSION, V43, P92, DOI 10.5006/1.3583123
   KITAYAMA S, 1992, CORROSION 92
   Kofstad P, 1988, HIGH TEMPERATURE COR
   KOIZUMI T, 1973, P 2 INT C TIT SCI TE, P2383
   KUDELKA S, 1995, BER BUNSEN PHYS CHEM, V99, P1020, DOI 10.1002/bbpc.199500025
   LIAN T, 1999, CORROSION 99
   Little B, 1996, CAN J MICROBIOL, V42, P367, DOI 10.1139/m96-052
   Macdonald DD, 1999, PURE APPL CHEM, V71, P951, DOI 10.1351/pac199971060951
   MANDRY MJ, 1972, J ELECTROCHEM SOC, V119, P29, DOI 10.1149/1.2404124
   MATTSSON H, 1990, WERKST KORROS, V41, P383
   MATTSSON H, 1990, WERKST KORROS, V41, P578
   MATTSSON H, 1985, MATER RES SOC S P, V50, P483
   MCKAY P, 1987, P CORR CHEM PITS CRE, P107
   Michaelis A, 1998, ELECTROCHIM ACTA, V43, P119, DOI 10.1016/S0013-4686(97)00240-5
   MOLECKE MA, 1982, SAND820429 SAND NAT
   MOODY NR, 1991, MICROSTRUCTURE / PROPERTY RELATIONSHIPS IN TITANIUM ALUMINIDES AND ALLOYS, P587
   Mountford Jr J. A., 2002, CORROSION 2002
   Murai T, 1977, CORROS ENG, V26, P177
   Nakagawa M, 2001, Dent Mater J, V20, P305
   Nakagawa M, 1999, J DENT RES, V78, P1568, DOI 10.1177/00220345990780091201
   Noel J.J., 1999, THESIS U MANITOBA
   Noel J. J., 2001, P CORR 2001 RES TOP, P65
   OHTSUKA T, 1987, J ELECTROCHEM SOC, V134, P2406, DOI 10.1149/1.2100212
   Ohtsuka T, 1999, J ELECTROANAL CHEM, V473, P272, DOI 10.1016/S0022-0728(99)00238-7
   OHTSUKA T, 1999, ELECTROCHEMICAL SOC, V9927, P330
   OKADA T, 1983, ELECTROCHIM ACTA, V28, P1113, DOI 10.1016/0013-4686(83)80015-2
   Pan J, 1996, J BIOMED MATER RES, V30, P393
   PAN J, 1994, J BIOMED MATER RES, V28, P113, DOI 10.1002/jbm.820280115
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   Paton NE, 1974, HYDROGEN METALS, P409
   PETIT JA, 1980, CORROSION, V36, P145, DOI 10.5006/0010-9312-36.3.145
   Posey F. A., 1967, DESALINATION, V3, P269
   PYUN SI, 1996, HYDROGEN EFFECTS MAT, P261
   RAETZERSCHEIBE HJ, 1978, CORROSION, V34, P437, DOI 10.5006/0010-9312-34.12.437
   Reclaru L, 1998, BIOMATERIALS, V19, P85, DOI 10.1016/S0142-9612(97)00179-8
   Revie R. Winston, 2000, UHLIGS CORROSION HDB
   ROY A, 1999, CORROSION 99
   ROY A, 1998, CORROSION 98
   SATOH H, 1987, PLATIN MET REV, V31, P115
   SCHMUKI P, 1995, ELECTROCHIM ACTA, V40, P775, DOI 10.1016/0013-4686(94)00341-W
   Schutz R., 1996, PLATIN MET REV, V40, P54
   Schutz R. W., 1986, PROCESS IND CORROSIO, P503
   Schutz R. W., 1993, CORROSION CONTROL A, V3A, P1213
   Schutz RW, 2003, CORROSION, V59, P1043, DOI 10.5006/1.3277524
   SCHUTZ RW, 1985, MAT PERFORMANCE HOUS, P39
   SCHUTZ RW, 1995, CORROSION 95
   SCHUTZ RW, 1988, P 6 WORLD C TIT HELD, V4, P1917
   SCHUTZ RW, 1987, METALS HDB, V13, P669
   SCHUTZ RW, 1985, TITANIUM SCI TECHNOL, V4, P2617
   SEDRIKS AJ, 1975, CORROSION, V31, P60, DOI 10.5006/0010-9312-31.2.60
   SHIBATA T, 1994, CORROS SCI, V36, P1735, DOI 10.1016/0010-938X(94)90128-7
   SHIBATA T, 1995, CORROS SCI, V37, P253, DOI 10.1016/0010-938X(94)00133-Q
   SHIFLER DA, 1997, P 1997 TRIS C CORR H
   SHIH DS, 1988, ACTA METALL MATER, V36, P111, DOI 10.1016/0001-6160(88)90032-6
   SHIMOGORI K, 1985, TITANIUM SCI TECHNOL, V2, P1111
   Shoesmith D.W., 1999, AECL11999
   Shoesmith D. W., 1997, AECL11709
   Shoesmith D.W., 1995, AECL10972
   Shoesmith D. W., 1995, AECL10973
   Shoesmith DW, 1997, CAN J CHEM, V75, P1566, DOI 10.1139/v97-188
   SHOESMITH DW, 1997, AECL11770
   SHOESMITH DW, 2003, COMMUNICATION
   SHUTZ RW, 1988, CORROSION 88
   SIKORA E, 1995, CRITICAL FACTORS LOC, V9515, P341
   SMAILOS E, 1991, EUR13672EN COMM EUR
   SMAILOS E, 1987, MAT RELIABILITY BACK
   SORENSEN NR, 1990, P CORR NUCL FUEL WAS
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V110, P9, DOI 10.1016/0021-9797(86)90348-6
   TAKAMURA A, 1967, TITANIUM ZIRCONIUM, V15, P192
   Tomari H., 1999, ZAIRYO TO KANKYO, V48, P807
   UHLIG HH, 1948, CORROSION HDB, P1144
   *US DOE, 2002, DOERW0539
   *US NUCL WAST TECH, 2001, INT WORKSH LONG TERM
   van der Lingen E., 1994, P C TIT PROD APPL SA, P450
   Wang ZF, 1999, CORROSION, V55, P128, DOI 10.5006/1.3283973
   WATANABE T, 1988, P 6 WORLD C TIT HELD, V4, P1735
   WATANABE T, 1989, NIPPON STEEL TECHNIC, V39, P29
   WILHELMSEN W, 1987, ELECTROCHIM ACTA, V32, P1469, DOI 10.1016/0013-4686(87)85088-0
   WONG LL, 2003, ASME PVP, V467, P63
   WU JBC, 1985, TITANIUM SCI TECHNOL, V4, P2595
NR 140
TC 38
Z9 40
U1 2
U2 23
PU NATL ASSN CORROSION ENG
PI HOUSTON
PA 1440 SOUTH CREEK DRIVE, HOUSTON, TX 77084-4906 USA
SN 0010-9312
J9 CORROSION
JI Corrosion
PD OCT
PY 2005
VL 61
IS 10
BP 987
EP 1003
DI 10.5006/1.3280899
PG 17
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 974VP
UT WOS:000232619800008
DA 2018-10-20
ER

PT J
AU Liu, Y
   Sun, LZ
   Wang, G
AF Liu, Y
   Sun, LZ
   Wang, G
TI Tomography-based 3-D anisotropic elastography using boundary
   measurements
SO IEEE TRANSACTIONS ON MEDICAL IMAGING
LA English
DT Article
DE adjoint method; anisotropic biomaterial; breast imaging; elastography;
   finite-element method; tomography
ID MAGNETIC-RESONANCE-ELASTOGRAPHY; MODULUS RECONSTRUCTION; INVERSE
   PROBLEMS; ELASTIC MEDIUM; STRAIN IMAGES; TISSUE; DISPLACEMENT;
   VISUALIZATION; NONUNIQUENESS; RESOLUTION
AB While ultrasound- and magnetic resonance-based elastography techniques have proved to be powerful biomedical imaging tools, most approaches assume isotropic material properties. In this paper, a general framework is developed for tomography-based anisotropic elastography. An anatomically well-motivated piece-wise homogeneous model is proposed to represent a class of biological objects consisting of different regions. With established tomography modality, static displacements are measured on the entire external and internal boundaries, and the force distribution is recorded on part of the external surface. A principle is proposed to identify the anisotropic elastic moduli of the constituent regions with the obtained boundary measurements. The reconstruction procedure is optimization-based with minimizing an objective function that measures the difference between the predicted and observed displacements. Analytic gradients of the objective function with respect to the elastic moduli are calculated using an adjoint method, and are utilized to significantly improve the numerical efficiency. Simulations are performed to identify the elastic moduli in a breast phantom consisting of soft tissue and a hard tumor. For isotropic phantom, one set of the boundary measurements enables unique reconstruction results for the tissue and tumor. For anisotropic phantom, however, multiple sets of the measurements corresponding to different deformation modes become necessary.
C1 Univ Iowa, Dept Civil & Environm Engn, Seamans Ctr 4114, Iowa City, IA 52242 USA.
   Univ Iowa Hosp & Clin, Dept Radiol, Iowa City, IA 52242 USA.
RP Sun, LZ (reprint author), Univ Iowa, Dept Civil & Environm Engn, Seamans Ctr 4114, Iowa City, IA 52242 USA.
EM lizhi-sun@uiowa.edu
RI Sun, Lizhi/C-5205-2008
FU NIBIB NIH HHS [EB002667-01]
CR Barbone PE, 2004, INVERSE PROBL, V20, P283, DOI 10.1088/0266-5611/20/1/017
   Barbone PE, 2002, PHYS MED BIOL, V47, P2147, DOI 10.1088/0031-9155/47/12/310
   Cox SJ, 1997, MATH MECH SOLIDS, V2, P297, DOI 10.1177/108128659700200304
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   Gao L, 1996, ULTRASOUND MED BIOL, V22, P959, DOI 10.1016/S0301-5629(96)00120-2
   Gennisson JL, 2003, J ACOUST SOC AM, V114, P536, DOI 10.1121/1.1579008
   Hajnal JV, 2001, MED IMAGE REGISTRATI
   Kallel F, 1996, IEEE T MED IMAGING, V15, P299, DOI 10.1109/42.500139
   Kang HB, 2003, INVERSE PROBL, V19, P703, DOI 10.1088/0266-5611/19/3/314
   KARDESTUNCER H, 1987, FINITE ELEMENT HDB
   LIU DC, 1989, MATH PROGRAM, V45, P503, DOI 10.1007/BF01589116
   Liu HT, 2003, MED PHYS, V30, P2340, DOI 10.1118/1.1599953
   LIU Y, 2003, THESIS U PENNSYLVANI
   Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6
   MAZZUCATO AL, 2003, 2003009 MSRI
   McCracken PJ, 2005, MAGNET RESON MED, V53, P628, DOI 10.1002/mrm.20388
   MCKNIGHT AL, 2002, AM J ROENTGENOL, V178
   McLaughlin JR, 2004, INVERSE PROBL, V20, P25, DOI 10.1088/0266-5611/20/1/002
   McPherson CP, 1997, CANCER, V79, P1923, DOI 10.1002/(SICI)1097-0142(19970515)79:10<1923::AID-CNCR13>3.0.CO;2-X
   Meinel JF, 2003, ACAD RADIOL, V10, P607, DOI 10.1016/S1076-6332(03)80078-8
   MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924
   Nakamura G, 1999, SIAM J APPL MATH, V59, P1879, DOI 10.1137/S0036139998337164
   Nakamura G, 1996, SIAM J APPL MATH, V56, P602, DOI 10.1137/S003613999426630X
   NAKAMURA G, 1995, SIAM J MATH ANAL, V26, P263, DOI 10.1137/S0036141093247494
   Oberai AA, 2004, PHYS MED BIOL, V49, P2955, DOI 10.1088/0031-9155/49/13/
   Oberai AA, 2003, INVERSE PROBL, V19, P297, DOI 10.1088/0266-5611/19/2/304
   Ophir J, 1997, INT J IMAG SYST TECH, V8, P89, DOI 10.1002/(SICI)1098-1098(1997)8:1<89::AID-IMA11>3.0.CO;2-G
   OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W
   Ophir J., 1999, J ENG MED, V213, P203
   Plewes DB, 2000, PHYS MED BIOL, V45, P1591, DOI 10.1088/0031-9155/45/6/314
   Rozvany G.I.N., 1995, APPL MECH REV, V48, P41, DOI DOI 10.1115/1.3005097
   Samani A, 2001, IEEE T MED IMAGING, V20, P271, DOI 10.1109/42.921476
   Samani A, 2001, IEEE T MED IMAGING, V20, P877, DOI 10.1109/42.952726
   Sarvazyan AP, 1995, ACOUST IMAGING, V21, P223, DOI DOI 10.1007/978-1-4615-1943-0_23
   Sinkus R, 2000, PHYS MED BIOL, V45, P1649, DOI 10.1088/0031-9155/45/6/317
   Sinkus R, 2005, MAGNET RESON MED, V53, P372, DOI 10.1002/mrm.20355
   SKOVORODA AR, 1995, IEEE T ULTRASON FERR, V42, P747, DOI 10.1109/58.393117
   SKOVORODA AR, 1994, IEEE T ULTRASON FERR, V41, P302, DOI 10.1109/58.285463
   Tanner C, 2002, PROC SPIE, V4684, P1807, DOI 10.1117/12.467155
   Taylor LS, 2000, PHYS MED BIOL, V45, P1477, DOI 10.1088/0031-9155/45/6/306
   WALPOLE LJ, 1984, P ROY SOC LOND A MAT, V391, P149, DOI 10.1098/rspa.1984.0008
   WANG Z, 2005, MRS SPRING M SAN FRA
   Weaver J, 2002, MED PHYS, V29, P1291
   Weaver JB, 2001, MED PHYS, V28, P1620, DOI 10.1118/1.1386776
   Wellman P., 1999, BREAST TISSUE STIFFN
   Zhu YN, 2003, IEEE T MED IMAGING, V22, P890, DOI 10.1109/TMI.2003.815065
NR 46
TC 33
Z9 33
U1 0
U2 2
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0278-0062
J9 IEEE T MED IMAGING
JI IEEE Trans. Med. Imaging
PD OCT
PY 2005
VL 24
IS 10
BP 1323
EP 1333
DI 10.1109/TMI.2005.857232
PG 11
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical; Engineering, Electrical & Electronic; Imaging Science &
   Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging
SC Computer Science; Engineering; Imaging Science & Photographic
   Technology; Radiology, Nuclear Medicine & Medical Imaging
GA 969LX
UT WOS:000232236800008
PM 16229418
DA 2018-10-20
ER

PT J
AU Ajdukovic, Z
   Najman, S
   Dordevic, LJ
   Savic, V
   Mihailovic, D
   Petrovic, D
   Ignjatovic, N
   Uskokovic, D
AF Ajdukovic, Z
   Najman, S
   Dordevic, LJ
   Savic, V
   Mihailovic, D
   Petrovic, D
   Ignjatovic, N
   Uskokovic, D
TI Repair of bone tissue affected by osteoporosis with
   hydroxyapatite-poly-L-lactide (HAp-PLLA) with and without blood plasma
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE reparation; mandible; rat; osteoporosis; hydroxyapatite-poly-L-lactide
ID INTERNAL-FIXATION; COMPOSITE RODS; IN-VIVO; FRACTURES; IMPLANTS;
   BEHAVIOR
AB The aim of this study is to examine the reparatory ability of the synthetic biomaterial hydroxyapatite-poly-L-lactide (HAp-PLIA), the replacement of alveolar ridge, and rehabilitation of bone defects caused by osteoporosis, in an experimental group of animals. The experiments are performed on syngeneic Sprague Dawley rats. Osteoporosis is induced by glucocorticoids in rats during a 12-week period. After this, the experimental group of animals is divided into five subgroups. An artificial defect is made in the alveolar bone on the left side of the mandible. In one group of animals, the defect is left to heal by itself, while in other groups, pure HAp-PLIA or one mixed with plasma is implanted. The best results are achieved by the implantation of the HAp-PLIA composite biomaterial mixed with autologous plasma. Formation of a new mandibular bone is seen, growing intensely, leading to rapid osteogenesis.
C1 Serbian Acad Arts & Sci, Inst Tech Sci, YU-11000 Belgrade, Serbia Monteneg.
   Fac Med, Clin Stomatol, Dept Prosthodont, Nis, Serbia Monteneg.
   Fac Med, Inst Biol, Nis, Serbia Monteneg.
   Fac Med, Inst Biochem Res, Nis, Serbia Monteneg.
   Fac Med, Inst Pathol, Nis, Serbia Monteneg.
   Fac Med, Clin Stomatol, Dept Maxillofacial Surg, Nis, Serbia Monteneg.
RP Uskokovic, D (reprint author), Serbian Acad Arts & Sci, Inst Tech Sci, K Mihailova 35-4, YU-11000 Belgrade, Serbia Monteneg.
EM uskok@itn.sanu.ac.yu
RI Uskokovic, Dragan/B-4129-2008; Ignjatovic, Nenad/C-4489-2008
OI Uskokovic, Dragan/0000-0002-0421-4968; Ignjatovic,
   Nenad/0000-0002-5749-094X; Najman, Stevo/0000-0002-2411-9802
CR Cehreli MC, 2003, J BIOMATER APPL, V17, P265, DOI 10.1177/088532803032109
   De Aza PN, 2003, BIOMATERIALS, V24, P1437, DOI 10.1016/S0142-9612(02)00530-6
   FUJITA T, 1997, OSTEOPOROSIS INT, V7, P19
   Furukawa T, 2000, CLIN ORTHOP RELAT R, P247
   Furukawa T, 2000, BIOMATERIALS, V21, P889, DOI 10.1016/S0142-9612(99)00232-X
   Furukawa T, 2000, J BIOMED MATER RES, V50, P410, DOI 10.1002/(SICI)1097-4636(20000605)50:3<410::AID-JBM16>3.0.CO;2-Y
   Heidemann W, 2001, BIOMATERIALS, V22, P2371, DOI 10.1016/S0142-9612(00)00424-5
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 2004, J BIOMED MATER RES B, V71B, P284, DOI 10.1002/jbm.b.30093
   Ignjatovic N, 2001, BIOMATERIALS, V22, P571, DOI 10.1016/S0142-9612(00)00215-5
   Ignjatovic NL, 1999, J MICROSC-OXFORD, V196, P243
   Ong JL, 1999, INT J ORAL MAX IMPL, V14, P217
   Paschalis EP, 1997, CALCIFIED TISSUE INT, V61, P480, DOI 10.1007/s002239900371
   Stentz WC, 1997, J PERIODONTOL, V68, P933, DOI 10.1902/jop.1997.68.10.933
   Suda T, 1997, OSTEOPOROSIS INT, V7, P43, DOI 10.1007/BF03194341
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Yasunaga T, 1999, J BIOMED MATER RES, V47, P412, DOI 10.1002/(SICI)1097-4636(19991205)47:3<412::AID-JBM17>3.0.CO;2-B
NR 18
TC 13
Z9 15
U1 0
U2 7
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD OCT
PY 2005
VL 20
IS 2
BP 179
EP 190
DI 10.1177/0885328205050519
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 971QH
UT WOS:000232398600005
PM 16183676
DA 2018-10-20
ER

PT J
AU Homaeigohar, SSH
   Shokrgozar, MA
   Sadi, AY
   Khavandi, A
   Javadpour, J
   Hosseinalipour, M
AF Homaeigohar, SSH
   Shokrgozar, MA
   Sadi, AY
   Khavandi, A
   Javadpour, J
   Hosseinalipour, M
TI In vitro evaluation of biocompatibility of beta-tricalcium
   phosphate-reinforced high-density polyethylene; an orthopedic composite
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
ID CALCIUM; HYDROXYAPATITE; CELLS; DIFFERENTIATION; PROLIFERATION;
   BIOCERAMICS; CARBONATE; CERAMICS; IMPLANTS; GROWTH
AB Beta-tricalcium phosphate-reinforced high-density polyethylene (P-TCP/HDPE) is a new biomaterial which was made as a copy of bone composition with the aim of replacement of bony tissues. The composite samples were prepared using medical grade TCP powder and granular polyethylene. The raw materials were first compounded and the resulting composite preforms were compression molded into desired shape. The biocompatibility of composite samples with different volume fractions of TCP (20, 30, and 40 vol %) was assessed by proliferation, alkaline phosphatase (ALP), and cell adhesion assays using G-292 osteoblast cells. Cell-material interaction on the surface of the composites was observed by scanning electron microscopy (SEM). The effect of beta-TCP/HDPE on the behavior of G-292 cells was compared with those of a composite and a negative control samples. Results showed the composite samples had a higher proliferation rate of G-292 cells in the presence of composite samples as compared to the composite control sample after 3, 7, and 14 days of incubation period. ALP production after incubation in the presence of composite samples was seen to peak on the day 7. The number of adhered cells on the composite samples was higher than the numbers adhered on composite and negative control samples after the above incubation periods. Morphology investigation of adhered cells by SEM indicated a normal morphology and also many of the cells were in the process of cell division. The above results indicate that beta-TCP/HDPE samples are biocompatible, nontoxic, and in some cases show an increase in the proliferation rate of the cells, ALP production, and cell adhesion as compared to the control counterparts. (c) 2005 Wiley Periodicals, Inc.
C1 Pasteur Inst Iran, Natl Cell Bank Iran, Tehran, Iran.
   IUST, Dept Mat Sci & Engn, Tehran, Iran.
RP Shokrgozar, MA (reprint author), Pasteur Inst Iran, Natl Cell Bank Iran, Tehran, Iran.
EM mashokrgozar@yahoo.com
RI Homaeigohar, Shahin/E-1796-2015; khavandi, alireza/S-6562-2018;
   Khavandi, Alireza/S-3732-2018; shokrgozar, mohammad ali/L-4149-2017
OI Homaeigohar, Shahin/0000-0003-2426-6690; shokrgozar, mohammad
   ali/0000-0001-5123-4155
CR Barralet J, 1998, J BIOMED MATER RES, V41, P79, DOI 10.1002/(SICI)1097-4636(199807)41:1<79::AID-JBM10>3.0.CO;2-C
   Ehara A, 2003, BIOMATERIALS, V24, P831, DOI 10.1016/S0142-9612(02)00411-8
   Evans SL, 1998, BIOMATERIALS, V19, P1329, DOI 10.1016/S0142-9612(97)00217-2
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P298
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hulshoff JEG, 1998, J BIOMED MATER RES, V40, P464, DOI 10.1002/(SICI)1097-4636(19980605)40:3<464::AID-JBM18>3.0.CO;2-J
   KANATANI M, 1991, BIOCHEM BIOPH RES CO, V181, P1425, DOI 10.1016/0006-291X(91)92098-5
   Layman DL, 1998, J BIOMED MATER RES, V40, P282, DOI 10.1002/(SICI)1097-4636(199805)40:2<282::AID-JBM13>3.0.CO;2-O
   LOZA J, 1995, BONE, V16, P341
   Maxian SH, 1998, J BIOMED MATER RES, V40, P171, DOI 10.1002/(SICI)1097-4636(199805)40:2<171::AID-JBM1>3.0.CO;2-I
   Monchau F, 2002, BIOMOL ENG, V19, P143, DOI 10.1016/S1389-0344(02)00023-0
   Oreffo ROC, 1998, BIOMATERIALS, V19, P1845, DOI 10.1016/S0142-9612(98)00084-2
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   RAMCHANDRA RR, 1997, J MATER SCI-MATER M, V8, P511
   RAVIGAVITAL N, 2000, J BIOMED MATER RES, V51, P660
   Suzuki T, 2000, J BIOSCI BIOENG, V89, P18, DOI 10.1016/S1389-1723(00)88045-7
   Tampieri A, 1997, J MATER SCI-MATER M, V8, P29, DOI 10.1023/A:1018538212328
   Tas A. Cuneyt, 1997, J MATER SCI-MATER M, V8, P91
   VERGERVIK K, 1992, BONE GRAFTS BONE SUB, P112
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
NR 21
TC 14
Z9 16
U1 1
U2 4
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT 1
PY 2005
VL 75A
IS 1
BP 14
EP 22
DI 10.1002/jbm.a.30333
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 963PP
UT WOS:000231816600002
PM 16092112
DA 2018-10-20
ER

PT J
AU Kraft, CN
   Burian, B
   Diedrich, O
   Gessmann, J
   Wimmer, MA
   Pennekamp, PH
AF Kraft, CN
   Burian, B
   Diedrich, O
   Gessmann, J
   Wimmer, MA
   Pennekamp, PH
TI Microvascular response of striated muscle to common arthroplasty-alloys:
   A comparative in vivo study with CoCrMo, Ti-6A1-4V, and Ti-6A1-7Nb
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE CoCrMo; Ti-6Al-4V; Ti-6A1-7Nb; alloplastic alloys; microcirculation;
   biocompatibility
ID MARROW STROMAL CELLS; STAINLESS-STEEL; METAL-IONS; TITANIUM; COBALT;
   MICROCIRCULATION; TOXICITY; PARTICLES; CORROSION; CHROMIUM
AB The impairment of skeletal muscle microcirculation by a biomaterial may have profound consequences. Due to excellent physical and corrosion characteristics, CoCrMo-, Ti-6Al-4V-, and Ti-6Al-7Nb-alloys are commonly used in orthopedic surgery. Yet concern has been raised with regard to the implications of inevitable corrosion product of these metals on the surrounding biologic environment, particularly in the case of CoCrMo. We, therefore, studied in vivo nutritive perfusion and leukocytic response of striated muscle to these alloys, thereby drawing conclusions on their inflammatory potential. In 28 hamsters, utilizing the dorsal skinfold chamber preparation and intravital microscopy, we could demonstrate that the implant material CoCrMo has a marked impact on local microvascular parameters. While the Ti-alloys Ti-6Al-4V and Ti-6Al-7Nb induced only a transient and moderate inflammatory response, the implantation of a CoCrMo sample led to a distinct and persistent activation of leukocytes combined with disruption of the microvascular endothelial integrity and marked leukocyte extravasation. Animals with Ti-alloys showed a clear tendency of recuperation, while in all but one CoCrMo-treated animals, a breakdown of microcirculation prior to the scheduled end of the experiment was observed. Overall, the alloy Ti-6Al-7Nb was tolerated slightly better than Ti-6Al-4V under the chosen test conditions, though this discrepancy was not statistically significant. Conclusively, the commonly used biomaterials Ti-6Al-7Nb and Ti-6Al-4V induce a considerably lower inflammatory response in the skeletal muscle microvascular system, compared to a CoCrMo-alloy. With a minimum of adverse host reaction, our results indicate that for this particular model Ti-alloys are better tolerated than CoCrMo implant materials. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Bonn, Dept Orthoped Surg, D-53105 Bonn, Germany.
   Univ Basel, Dept Surg, CH-4003 Basel, Switzerland.
   Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA.
RP Kraft, CN (reprint author), Univ Bonn, Dept Orthoped Surg, D-53105 Bonn, Germany.
EM umcb01@uni-bonn.de
CR Brunner J, 2000, MICROCIRCULATION, V7, P103, DOI 10.1038/sj.mn.7300094
   Chen FS, 1999, J BIOMED MATER RES, V48, P904, DOI 10.1002/(SICI)1097-4636(1999)48:6<904::AID-JBM21>3.0.CO;2-5
   Chou I N, 1989, Biomed Environ Sci, V2, P358
   COTRAN RS, 1989, PATHOLOGIC BASIS DIS, P39
   DOBBS HS, 1980, BIOMATERIALS, V1, P193, DOI 10.1016/0142-9612(80)90016-2
   DORR LD, 1990, CLIN ORTHOP RELAT R, P82
   ENDRICH B, 1980, RES EXP MED, V177, P125, DOI 10.1007/BF01851841
   Faleiro C, 1996, BIOMETALS, V9, P321, DOI 10.1007/BF00140600
   FANTONE JC, 1982, AM J PATHOL, V107, P397
   Ferreira ME, 2003, J TRACE ELEM MED BIO, V17, P45, DOI 10.1016/S0946-672X(03)80045-7
   GOODMANN SB, 1995, PARTICULATE DEBRIS M, P27
   GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662
   Hallab NJ, 2002, J BIOMED MATER RES, V60, P420, DOI 10.1002/jbm.10106
   Hallab NJ, 2001, J BIOMED MATER RES, V56, P427, DOI 10.1002/1097-4636(20010905)56:3<427::AID-JBM1112>3.3.CO;2-5
   HALLAB NJ, 2005, IN PRESS J TEST EVAL
   Haynes DR, 1998, CLIN ORTHOP RELAT R, P223
   Haynes DR, 2000, J BIOMED MATER RES, V49, P167, DOI 10.1002/(SICI)1097-4636(200002)49:2<167::AID-JBM3>3.0.CO;2-9
   Howie D, 1996, CLIN ORTHOP S, V329, P217
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   JACOBS JJ, 1996, CLIN ORTHOP S, V329, P256
   Kraft CN, 2003, J BONE JOINT SURG BR, V85B, P133, DOI 10.1302/0301-620X.85B1.12749
   Kraft CN, 2001, J BIOMED MATER RES, V57, P404, DOI 10.1002/1097-4636(20011205)57:3<404::AID-JBM1183>3.0.CO;2-W
   Kraft CN, 2000, J BIOMED MATER RES, V49, P192, DOI 10.1002/(SICI)1097-4636(200002)49:2<192::AID-JBM6>3.0.CO;2-C
   Lee SH, 1997, J ORTHOP RES, V15, P40, DOI 10.1002/jor.1100150107
   MAREK M, 1994, P ELECTROCHEM SOC, V15, P73
   McKay GC, 1996, BIOMATERIALS, V17, P1339, DOI 10.1016/0142-9612(96)88681-9
   MENGER MD, 1993, IMMUNOL TODAY, V14, P519, DOI 10.1016/0167-5699(93)90179-O
   Menger MD, 1996, BRIT J SURG, V83, P588, DOI 10.1002/bjs.1800830506
   PRIES AR, 1988, INT J MICROCIRC, V7, P327
   PULEO DA, 1992, J BIOMED MATER RES, V26, P291, DOI 10.1002/jbm.820260303
   PULEO DA, 1995, J APPL BIOMATER, V6, P109, DOI 10.1002/jab.770060205
   RAE T, 1981, J BONE JOINT SURG BR, V63, P435
   Savarino L, 2002, J BIOMED MATER RES, V63, P467, DOI 10.1002/jbm.10299
   Schaser KD, 1999, J ORTHOPAED RES, V17, P678, DOI 10.1002/jor.1100170509
   SEMLITSCHM, 1986, BIOL BIOCH PERFORMAN, P69
   Shettlemore MG, 1999, J BIOMED MATER RES, V45, P395
   SIVASH KM, 1967, ALLOPLASTRY HIP JOIN
   Sun ZL, 1997, J BIOMED MATER RES, V34, P29, DOI 10.1002/(SICI)1097-4636(199701)34:1<29::AID-JBM5>3.0.CO;2-P
   SUNDERMAN FW, 1989, J ORTHOPAED RES, V7, P307, DOI 10.1002/jor.1100070302
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   THOMPSON GJ, 1995, J APPL BIOMATER, V6, P249, DOI 10.1002/jab.770060406
   Willert HG, 2005, J BONE JOINT SURG AM, V87A, P28, DOI 10.2106/JBJS.A.02039pp
NR 43
TC 15
Z9 15
U1 1
U2 7
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT 1
PY 2005
VL 75A
IS 1
BP 31
EP 40
DI 10.1002/jbm.a.30407
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 963PP
UT WOS:000231816600004
PM 16078208
DA 2018-10-20
ER

PT J
AU Maeyama, R
   Kwon, IK
   Mizunoe, Y
   Anderson, JM
   Tanaka, M
   Matsuda, T
AF Maeyama, R
   Kwon, IK
   Mizunoe, Y
   Anderson, JM
   Tanaka, M
   Matsuda, T
TI Novel bactericidal surface: Catechin-loaded surface-erodible polymer
   prevents biofilm formation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biofilm; catechin; Escherichia coli; local delivery; biodegradable
   polymer
ID BILIARY STENT BLOCKAGE; ESCHERICHIA-COLI; ADHERENCE; RESISTANCE;
   ADHESION; INVITRO
AB We developed a novel bactericidal surface based on a catechin-loaded surface-erodible polymer. (-)-Epigallocatechin-3-gallate (EGCg), which is the main constituent of tea catechins, showed a dose-dependent inhibitory effect on Escherichia coli biofilm formation and a dose-dependent enhanced destructive effect on biofilm. EGCg-immobilized surfaces were prepared by photopolymerization. of liquid biodegradable polyesters. The releasing rate was enhanced with an increase in surface-erosion rate of photocured polymers. Polymers with high releasing capacity dose-dependently reduced biofilm formation on the surfaces. The confocal laser scanning microscopic and scanning electron microscopic observations revealed that EGCg induced bio-film-destructing activities, which include bacterial membrane damage, degradation of exopolysaccharides, and detachment of colonized cells. From these results, potential advantages of the clinical use of catechin-loaded polymercoated implants or catheters are discussed in terms of a reduced occurrence of biomaterial-centered infections without substantial toxicity or adverse effects. (c) 2005 Wiley Periodicals, Inc.
C1 Kyushu Univ, Fac Med Sci, Div Biomed Engn, Higashi Ku, Fukuoka 8128582, Japan.
   Kyushu Univ, Fac Med Sci, Div Surg & Oncol, Higashi Ku, Fukuoka 8128582, Japan.
   Kyushu Univ, Fac Med Sci, Div Bacteriol, Higashi Ku, Fukuoka 8128582, Japan.
   Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
RP Matsuda, T (reprint author), Kyushu Univ, Fac Med Sci, Div Biomed Engn, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.
EM matsuda@med.kyushu-u.ac.jp
FU NIBIB NIH HHS [EB-00279]
CR Allison DG, 1998, FEMS MICROBIOL LETT, V167, P179, DOI 10.1016/S0378-1097(98)00386-3
   Amarowicz R, 2000, NAHRUNG, V44, P60, DOI [10.1002/(SICI)1521-3803(20000101)44:1<60::AID-FOOD60>3.0.CO;2-L, 10.1002/(SICI)1521-3803(20000101)44:1<60::AID-FOOD60>3.3.CO;2-C]
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Beveridge TJ, 1997, FEMS MICROBIOL REV, V20, P291, DOI 10.1111/j.1574-6976.1997.tb00315.x
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Higashi JM, 1998, J BIOMED MATER RES, V39, P341, DOI 10.1002/(SICI)1097-4636(19980305)39:3<341::AID-JBM1>3.0.CO;2-J
   HONGO T, 1996, HYOUJUNSEIRIGAKU, P677
   IKIGAI H, 1993, BIOCHIM BIOPHYS ACTA, V1147, P132, DOI 10.1016/0005-2736(93)90323-R
   JANSEN B, 1993, GASTROINTEST ENDOSC, V39, P670, DOI 10.1016/S0016-5107(93)70220-5
   Klueh U, 2000, J BIOMED MATER RES, V53, P621, DOI 10.1002/1097-4636(2000)53:6<621::AID-JBM2>3.0.CO;2-Q
   Kondo K, 1999, ARCH BIOCHEM BIOPHYS, V362, P79, DOI 10.1006/abbi.1998.1015
   Leung JW, 2001, GASTROINTEST ENDOSC, V53, P431, DOI 10.1067/mge.2001.113089
   Leung JW, 2000, GASTROINTEST ENDOSC, V51, P296, DOI 10.1016/S0016-5107(00)70358-0
   LEUNG JWC, 1992, GASTROINTEST ENDOSC, V38, P338, DOI 10.1016/S0016-5107(92)70428-3
   Maeyama R, 2004, J BIOMED MATER RES A, V70A, P274, DOI 10.1002/jbm.a.30077
   Matsuda T, 2004, BIOMACROMOLECULES, V5, P295, DOI 10.1021/bm034231k
   Merritt K, 1998, J BIOMED MATER RES, V39, P415, DOI 10.1002/(SICI)1097-4636(19980305)39:3<415::AID-JBM10>3.0.CO;2-9
   NICKEL JC, 1985, EUR J CLIN MICROBIOL, V4, P213, DOI 10.1007/BF02013600
   Pastrana-Bonilla E, 2003, J AGR FOOD CHEM, V51, P5497, DOI 10.1021/jf030113c
   SPEER AG, 1988, ANN INTERN MED, V108, P546, DOI 10.7326/0003-4819-108-4-546
   SUNG JY, 1993, J GASTROEN HEPATOL, V8, P28, DOI 10.1111/j.1440-1746.1993.tb01171.x
   Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743
   Tsang TK, 1997, J LAB CLIN MED, V130, P643, DOI 10.1016/S0022-2143(97)90114-1
   van de Belt H, 2001, BIOMATERIALS, V22, P1607, DOI 10.1016/S0142-9612(00)00313-6
   WATANABE M, 1989, ANTIMICROB AGENTS CH, V33, P1837, DOI 10.1128/AAC.33.11.1837
   Yoda Yoshiyuki, 2004, Journal of Infection and Chemotherapy, V10, P55, DOI 10.1007/s10156-003-0284-0
   Zhao W H, 2001, J Infect Chemother, V7, P195, DOI 10.1007/s101560100035
NR 28
TC 24
Z9 28
U1 1
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT 1
PY 2005
VL 75A
IS 1
BP 146
EP 155
DI 10.1002/jbm.a.30346
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 963PP
UT WOS:000231816600016
PM 16028232
DA 2018-10-20
ER

PT J
AU Kim, JK
   Scott, EA
   Elbert, DL
AF Kim, JK
   Scott, EA
   Elbert, DL
TI Proteomic analysis of protein adsorption: Serum amyloid P adsorbs to
   materials and promotes leukocyte adhesion
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE protein adsorption; proteomics; serum amyloid P; leukocyte
ID C-REACTIVE PROTEIN; POLY(D,L-LACTIC ACID) NANOPARTICLES; FC-GAMMA
   RECEPTORS; BIOMATERIAL SURFACES; PLASMA-PROTEINS; COMPONENT BINDS;
   PARTICLES; IDENTIFICATION; BLOOD; DEGRADATION
AB Serum and plasma protein adsorption on materials was analyzed using gel electrophoresis and ion trap mass spectrometry. Following incubation of polypropylene, polyethylene terephthalate (PET), or polydimethylsiloxane (PDMS) with 5% serum for longer than 4 h, we found unexpectedly high amounts of the pentraxin serum amyloid P. It was previously shown that serum amyloid P is constitutively expressed in humans, functions as an opsonin, and interacts with the Fc gamma receptors on leukocytes. We demonstrate that serum amyloid P adsorbed to tissue culture polystyrene, PDMS, and PET promotes the adhesion of granulocytes and monocytes in the presence of calcium. The methods developed for these studies may be useful for the large-scale study of protein adsorption and do not rely on radiolabeling or the availability of antibodies. (c) 2005 Wiley Periodicals, Inc.
C1 Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.
   Washington Univ, Ctr Mat Innovat, St Louis, MO 63130 USA.
   Washington Univ, Dept Chem Engn, St Louis, MO 63130 USA.
RP Elbert, DL (reprint author), Washington Univ, Dept Biomed Engn, Campus Box 1097,1 Brookings Dr, St Louis, MO 63130 USA.
EM elbert@biomed.wustl.edu
RI Scott, Evan/K-1963-2014; Elbert, Donald/B-2040-2008
OI Elbert, Donald/0000-0001-6480-9536; Scott, Evan/0000-0002-8945-2892
CR Allemann E, 1997, J BIOMED MATER RES, V37, P229, DOI 10.1002/(SICI)1097-4636(199711)37:2<229::AID-JBM12>3.0.CO;2-9
   Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200
   Bharadwaj D, 2001, J IMMUNOL, V166, P6735, DOI 10.4049/jimmunol.166.11.6735
   Bickerstaff MCM, 1999, NAT MED, V5, P694
   BRASH JL, 1986, J BIOMED MATER RES, V20, P1263, DOI 10.1002/jbm.820200904
   BREEMHAAR W, 1984, BIOMATERIALS, V5, P269, DOI 10.1016/0142-9612(84)90071-1
   Brodbeck WG, 2003, J MATER SCI-MATER M, V14, P671, DOI 10.1023/A:1024951330265
   BUTLER PJG, 1990, J EXP MED, V172, P13, DOI 10.1084/jem.172.1.13
   Cornelius RM, 2002, J BIOMED MATER RES, V60, P622, DOI 10.1002/jbm.10117
   Cornelius RM, 2002, BIOMATERIALS, V23, P3583, DOI 10.1016/S0142-9612(02)00083-2
   DE FRUTOS PG, 1994, J IMMUNOL, V152, P2430
   Derhami K, 2001, J BIOMED MATER RES, V56, P234, DOI 10.1002/1097-4636(200108)56:2<234::AID-JBM1090>3.3.CO;2-R
   EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0
   FENG L, 1994, J COLLOID INTERF SCI, V166, P419, DOI 10.1006/jcis.1994.1313
   Gillmore JD, 2004, IMMUNOLOGY, V112, P255, DOI 10.1111/j.1365-2567.2004.01860.x
   Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690
   HAMAZAKI H, 1988, BIOCHEM BIOPH RES CO, V150, P212, DOI 10.1016/0006-291X(88)90507-4
   HENZEL WJ, 1993, P NATL ACAD SCI USA, V90, P5011, DOI 10.1073/pnas.90.11.5011
   HO CH, 1991, J BIOMED MATER RES, V25, P423, DOI 10.1002/jbm.820250402
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P403, DOI 10.1002/jbm.820150311
   HUNT DF, 1986, P NATL ACAD SCI USA, V83, P6233, DOI 10.1073/pnas.83.17.6233
   JENNEY GR, 1999, J BIOMED MATER RES, V49, P435
   KABAT EA, 1976, STRUCTURAL CONCEPTS
   KIAEI D, 1992, J BIOMAT SCI-POLYM E, V4, P35
   LEROUX JC, 1994, J BIOMED MATER RES, V28, P471, DOI 10.1002/jbm.820280410
   LIMBER GK, 1974, THROMB RES, V5, P735, DOI 10.1016/0049-3848(74)90117-0
   Luck M, 1999, BIOMATERIALS, V20, P2063, DOI 10.1016/S0142-9612(99)00110-6
   LYMAN DJ, 1974, T AM SOC ART INT ORG, VB 20, P474
   Magnani A, 2004, ELECTROPHORESIS, V25, P2413, DOI 10.1002/elps.200305826
   Mold C, 2002, J AUTOIMMUN, V19, P147, DOI 10.1006/jaut.2002.0615
   MULZER SR, 1989, J BIOMED MATER RES, V23, P1483, DOI 10.1002/jbm.820231210
   Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709
   PEPYS MB, 1978, CLIN EXP IMMUNOL, V32, P119
   PEPYS MB, 1994, CLIN EXP IMMUNOL, V97, P152
   PEPYS MB, 1979, NATURE, V278, P259, DOI 10.1038/278259a0
   RAPOZA RJ, 1990, J COLLOID INTERF SCI, V136, P480, DOI 10.1016/0021-9797(90)90395-5
   Rosengren A, 2003, BIOMATERIALS, V24, P147, DOI 10.1016/S0142-9612(02)00272-7
   Rosengren A, 2002, BIOMATERIALS, V23, P1237, DOI 10.1016/S0142-9612(01)00244-7
   Sen JW, 2002, SCAND J IMMUNOL, V56, P85, DOI 10.1046/j.1365-3083.2002.01109.x
   SERBAN D, 1987, SCAND J IMMUNOL, V25, P275, DOI 10.1111/j.1365-3083.1987.tb01073.x
   Soma M, 2001, BIOCHEM BIOPH RES CO, V286, P200, DOI 10.1006/bbrc.2001.5364
   STANISLAWSKI L, 1995, J BIOMED MATER RES, V29, P315, DOI 10.1002/jbm.820290306
   STEELE JG, 1995, BIOMATERIALS, V16, P1057, DOI 10.1016/0142-9612(95)98901-P
   Sun DH, 2003, J BIOMED MATER RES A, V65A, P290, DOI 10.1002/jbm.a.10477
   TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299
   Videm V, 2004, BIOMATERIALS, V25, P43, DOI 10.1016/S0142-9612(03)00470-8
   Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686
   WASINGER VC, 1995, ELECTROPHORESIS, V16, P1090, DOI 10.1002/elps.11501601185
NR 48
TC 27
Z9 27
U1 0
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT 1
PY 2005
VL 75A
IS 1
BP 199
EP 209
DI 10.1002/jbm.a.30424
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 963PP
UT WOS:000231816600022
PM 16082704
DA 2018-10-20
ER

PT J
AU Aggarwal, P
   Phaneuf, MD
   Bide, MJ
   Sousa, KA
   LoGerfo, FW
AF Aggarwal, P
   Phaneuf, MD
   Bide, MJ
   Sousa, KA
   LoGerfo, FW
TI Development of an infection-resistant bifunctionalized Dacron
   biomaterial
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; Ciprofloxacin; infection resistance; Dacron; antimicrobial
ID SURFACE-MODIFYING MACROMOLECULES; VASCULAR PROSTHETIC INFECTION; GRAFTS;
   PREVENTION; EFFICACY; PROTEIN
AB A novel infection-resistant biomaterial was created by applying the antibiotic Ciprofloxacin (Cipro) to a recently developed bifunctionalized polyethylene terephthalate ("polyester," Dacron) material using textile-dyeing technology. Dacron was modified via exposure to ethylenediamine (EDA) to create amine and carboxylic acid sites within the polymer backbone. Cipro was applied to the bifunctionalized Dacron construct under varied experimental conditions, with resulting antimicrobial activity determined via zone of inhibition. Dacron segments treated at a liquor ratio of 20:1, with 5% Cipro on weight of fabric (owf), at PH 8 for 4 h at 70 degrees C followed by autoclaving showed antimicrobial activity for 78 days (length of study). Segments treated similarly but without autoclaving lost activity within I day. Dyeing time and temperature did not significantly affect antibiotic release/ activity, but segments dyed at pHs higher or lower than 8 had less antimicrobial activity. The long-term infection resistance provided by this technique may answer major problems of infection from which implantable Dacron biomedical devices suffer. (c) 2005 Wiley Periodicals, Inc.
C1 Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.
   BioSurfaces, Ashland, MA 01721 USA.
   Univ Rhode Isl, Dept Text, Kingston, RI 02881 USA.
RP Aggarwal, P (reprint author), Beth Israel Deaconess Med Ctr, 4 Blackfan Circle,Room 131, Boston, MA 02115 USA.
EM aggarwal@bu.edu
FU NHLBI NIH HHS [R41 HL078596]
CR AVRAMOVIC JR, 1991, AUST NZ J SURG, V61, P436, DOI 10.1111/j.1445-2197.1991.tb00258.x
   Bergamini TM, 1996, J SURG RES, V60, P3, DOI 10.1006/jsre.1996.0002
   BETHESDA MD, 1995, INF CONTR S INFL MED
   BIDE MJ, 1993, AATTC REV, V25, P15
   BIDE MJ, 1999, AATTC REV
   CHERVU A, 1991, J VASC SURG, V13, P897
   Dickinson RB, 2000, ANTIMICROBIAL/ANTI-INFECTIVE MATERIALS, P67
   GRECO RS, 1985, ARCH SURG-CHICAGO, V120, P71
   HAVERICH A, 1992, J VASC SURG, V15, P187, DOI 10.1016/0741-5214(92)70027-I
   Ho JY, 2000, J BIOMAT SCI-POLYM E, V11, P1085
   Jahangir AR, 2002, J BIOMED MATER RES, V60, P135, DOI 10.1002/jbm.10033
   Johnson A, 1989, THEORY COLORATION TE
   LizanGarcia M, 1997, INFECT CONT HOSP EP, V18, P310
   Manivannan G, 2000, ANTIMICROBIAL/ANTI-INFECTIVE MATERIALS, P1
   Marchant Roger E., 1994, P13
   Muller RJ, 2001, J BIOTECHNOL, V86, P87, DOI 10.1016/S0168-1656(00)00407-7
   Nagel JA, 1996, J BIOMAT SCI-POLYM E, V7, P769, DOI 10.1163/156856296X00110
   Nunn D. M., 1979, DYEING SYNTHETIC POL
   OZAKI CK, 1993, J SURG RES, V55, P543, DOI 10.1006/jsre.1993.1181
   Phaneuf MD, 1997, BIOMATERIALS, V18, P755, DOI 10.1016/S0142-9612(96)00193-7
   Phaneuf MD, 2001, ASAIO J, V47, P634, DOI 10.1097/00002480-200111000-00013
   PHANEUF MD, 1993, J BIOMED MATER RES, V27, P233, DOI 10.1002/jbm.820270213
   Risberg B, 2000, Lakartidningen, V97, P4280
   Shore J., 1990, COLORANTS AUXILIARIE
   SHUE WB, 1988, J VASC SURG, V8, P600, DOI 10.1067/mva.1988.avs0080600
   SUGARMAN B, 1982, INFECTION, V10, P9, DOI 10.1007/BF01640828
   Tang YW, 1997, J BIOMED MATER RES, V35, P371, DOI 10.1002/(SICI)1097-4636(19970605)35:3<371::AID-JBM11>3.0.CO;2-I
   WHITE JV, 1991, J VASC SURG, V13, P753
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Zhang X, 2000, ANTIMICROBIAL/ANTI-INFECTIVE MATERIALS, P149
   ZHONG T, 2003, AATCC REV, V3, P24
NR 31
TC 6
Z9 6
U1 2
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT 1
PY 2005
VL 75A
IS 1
BP 224
EP 231
DI 10.1002/jbm.a.30427
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 963PP
UT WOS:000231816600025
PM 16078211
DA 2018-10-20
ER

PT J
AU Hedia, HS
AF Hedia, HS
TI Design of functionally graded dental implant in the presence of
   cancellous bone
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE hydroxyapatite; collagen; bone; porosity; stress; ceramic
ID NONHOMOGENEOUS MATERIALS; STRAIN DISTRIBUTION; THERMAL-STRESSES; CRACK
   PROBLEM; BIOMATERIALS; MODULUS; FIELDS
AB In a previous work by the author [Hedia HS, Mahmoud NA. Biomed Mater Eng 2004;14(2):133-143], a functionally graded material (FGM) dental implant was designed without cancellous bone in the model. In this investigation, the effect of the presence of cancellous bone as a thin layer around the dental implant was investigated. It is well known that the main inorganic component of natural bone is hydroxyapatite (HAP) and that the main organic component is collagen (Col). HAP implants are not bioabsorbable, and because induction of bone into and around the artificially made HAP is not always satisfactory, loosening or breakage of HAP implants might occur after implantation in the clinical application. The development of a new material that is bioabsorbable and that has osteoconductive activity is needed. Therefore, the aim of the current investigation was to design an implant, in the presence of cancellous bone as a thin layer around it, from FGM. In this study, a novel biomaterial, Col/HAP, as a FGM, was developed using the finite element and optimization techniques that are available in the ANSYS package. These materials have a self-organized character similar to that of natural bone. The investigations have shown that the maximum stress in the cortical bone and cancellous bone for the Col/HAP functionally graded implant has been reduced by about 40% and 19%, respectively, compared with currently used titanium dental implants. (c) 2005 Wiley Periodicals, Inc.
C1 Mansoura Univ, Fac Engn, Prod Engn & MC Design Dept, Mansoura 35516, Egypt.
RP Hedia, HS (reprint author), Mansoura Univ, Fac Engn, Prod Engn & MC Design Dept, Mansoura 35516, Egypt.
EM hedia@mans.edu.eg
RI Hedia, Hassan/I-8289-2012
CR Bonfield W, 1998, ACTA MATER, V46, P2509, DOI 10.1016/S1359-6454(98)80035-9
   BOUGHTON P, CERAMIC POLYM FUNCTI
   Brear K, 1988, Eng Med, V17, P163
   Choi HJ, 1996, J APPL MECH-T ASME, V63, P479, DOI 10.1115/1.2788893
   Clift S E, 1993, Proc Inst Mech Eng H, V207, P133, DOI 10.1243/PIME_PROC_1993_207_285_02
   Clift S E, 1992, Proc Inst Mech Eng H, V206, P233, DOI 10.1243/PIME_PROC_1992_206_295_02
   Erdogan F, 1997, J APPL MECH-T ASME, V64, P449, DOI 10.1115/1.2788914
   ERDOGAN F, 1991, J APPL MECH-T ASME, V58, P410, DOI 10.1115/1.2897201
   FUCHIYAMA T, 1993, CERAMIC T FUNCTIONAL, V34, P425
   FUJIMOTO T, 2001, P 4 INT C THERM STRE, P121
   HAYES WC, 1986, FRONTIERS BIOMECHANI, P196
   Hedia HS, 2004, BIO-MED MATER ENG, V14, P133
   Hedia HS, 2002, BIO-MED MATER ENG, V12, P111
   HUISKES R, 1984, CALCIFIED TISSUE INT, V36, pS110, DOI 10.1007/BF02406143
   HUISKES R, 1986, BIOMECHANCIS BONE IM, P245
   ITOH S, 2000, 46 ANN M ORTH RES SO
   Jallot E, 1998, MED ENG PHYS, V20, P697, DOI 10.1016/S1350-4533(98)00073-3
   JIN ZH, 1994, J APPL MECH-T ASME, V61, P738, DOI 10.1115/1.2901529
   KATTI K, 2002, 15 ENG MECH C ASCE J
   KERNER EH, 1956, P PHYS SOC LOND B, V69, P808, DOI 10.1088/0370-1301/69/8/305
   Kingery W. D., 1976, INTRO CERAMICS
   Miyao R, 2001, J DENT MAT, V20, P344
   Nemat-Alla M, 2003, INT J SOLIDS STRUCT, V40, P7339, DOI 10.1016/j.ijsolstr.2003.08.017
   NODA N, 1993, J THERM STRESSES, V16, P181, DOI 10.1080/01495739308946224
   NODA N, 1995, JSME INT J A-MECH M, V38, P364, DOI 10.1299/jsmea1993.38.3_364
   Reis RL, 2001, MATER RES INNOV, V4, P263, DOI 10.1007/s100190000103
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   SURESH S, 1998, FUDAMENTALS FUCTIONA
   Wang BL, 2000, J APPL MECH-T ASME, V67, P87, DOI 10.1115/1.321153
   ZIENKIEWICZ OC, 1977, FINITE ELEMENT METHO
   1992, ANSYS US MANUAL VERS
NR 31
TC 38
Z9 40
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT
PY 2005
VL 75B
IS 1
BP 74
EP 80
DI 10.1002/jbm.b.30275
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 968NC
UT WOS:000232168200010
PM 16025465
DA 2018-10-20
ER

PT J
AU Lin, PW
   Wu, CC
   Chen, CH
   Ho, HO
   Chen, YC
   Sheu, MT
AF Lin, PW
   Wu, CC
   Chen, CH
   Ho, HO
   Chen, YC
   Sheu, MT
TI Characterization of cortical neuron outgrowth in two- and
   three-dimensional culture systems
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE biomaterial; three-dimensional culture model; collagen; fibrin
ID PERIPHERAL-NERVE REGENERATION; DORSAL-ROOT GANGLIA; EXTRACELLULAR-MATRIX
   MOLECULES; GROWTH CONE GUIDANCE; SCHWANN-CELL GRAFTS; RAT SPINAL-CORD;
   NEURITE GROWTH; FIBRIN GLUE; IN-VITRO; PROMOTE REGENERATION
AB To improve the ability of regeneration by grafting living cells or by adding growth factor to a lesion site, it is important to find good biomaterials for neuron survival and regeneration. This study focused on two- and three-dimensional cultures in a matrix using biomaterials such as agarose, collagen, fibrin, and their mixtures, because these are considered to be suitable biomaterials for neuron outgrowth. Cortical neurons were dissected from E17 rat embryos and cultured in agarose gel, collagen gel, fibrin glue, and mixtures of collagen and fibrin. Results showed that neurons cultured in collagen gel and fibrin glue had longer periods of survival (more than 3 weeks) and better neurite extension than those observed in agarose gels. As to the survival rate according to the MTT and lactate dehydrogenase assays, fibrin glue was the most suitable biomaterial for neuron survival among the biomaterials examined. With two-dimensional fibrin plating, neuron cells exhibited cell aggregation and stress fibers, but the same results were not observed with collagen gel. There were no differences in neurite extension and survival in the mixtures of collagen and fibrin. The results suggest that collagen and fibrin can provide a suitable substrate for a three-dimensional culture matrix for neuronal survival and differentiation. (c) 2005 Wiley Periodicals, Inc.
C1 Taipei Med Univ, Grad Inst Pharmaceut Sci, Taipei, Taiwan.
   Taipei Municipal Wan Fang Hosp, Taipei, Taiwan.
   Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan.
   Taipei Med Univ, Sch Med, Dept Anesthesiol, Taipei, Taiwan.
   Taipei Med Univ, Dept Med Technol, Taipei, Taiwan.
   Taipei Med Univ, Grad Inst Biomed Mat, Taipei 110, Taiwan.
RP Sheu, MT (reprint author), Taipei Med Univ, Grad Inst Pharmaceut Sci, Taipei, Taiwan.
EM mingsheu@tmu.edu.tw
CR AEBISCHER P, 1990, BRAIN RES, V531, P211, DOI 10.1016/0006-8993(90)90776-8
   Bach AD, 2001, TISSUE ENG, V7, P45, DOI 10.1089/107632701300003287
   Baldwin SP, 1996, INT J DEV NEUROSCI, V14, P351, DOI 10.1016/0736-5748(96)00018-4
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409
   Bloch J, 2001, EXP NEUROL, V172, P425, DOI 10.1006/exnr.2001.7778
   Borkenhagen M, 1998, J BIOMED MATER RES, V40, P392, DOI 10.1002/(SICI)1097-4636(19980603)40:3<392::AID-JBM8>3.0.CO;2-C
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Bryan DJ, 2000, TISSUE ENG, V6, P129, DOI 10.1089/107632700320757
   Chen RN, 2004, BIOMATERIALS, V25, P2679, DOI 10.1016/j.biomaterials.2003.09.070
   Chernousov MA, 2000, HISTOL HISTOPATHOL, V15, P593, DOI 10.14670/HH-15.593
   Currie LJ, 2001, PLAST RECONSTR SURG, V108, P1713, DOI 10.1097/00006534-200111000-00045
   Dubey N, 2001, BIOMATERIALS, V22, P1065, DOI 10.1016/S0142-9612(00)00341-0
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   GUENARD V, 1992, J NEUROSCI, V12, P3310
   Guest JD, 1997, EXP NEUROL, V148, P502, DOI 10.1006/exnr.1997.6693
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   Herbert CB, 1996, J COMP NEUROL, V365, P380, DOI 10.1002/(SICI)1096-9861(19960212)365:3<380::AID-CNE4>3.0.CO;2-0
   Herbert CB, 1998, J BIOMED MATER RES, V40, P551, DOI 10.1002/(SICI)1097-4636(19980615)40:4<551::AID-JBM6>3.0.CO;2-E
   Ho HO, 2001, J CONTROL RELEASE, V77, P97, DOI 10.1016/S0168-3659(01)00467-9
   Hunzinker E. B., 2001, OSTEOARTHR CARTILAGE, V10, P432
   Isogai N, 2000, PLAST RECONSTR SURG, V105, P953, DOI 10.1097/00006534-200003000-00019
   Jessen KR, 1999, TRENDS NEUROSCI, V22, P402, DOI 10.1016/S0166-2236(98)01391-5
   Kaps C, 2002, ARTHRITIS RHEUM, V46, P149, DOI 10.1002/1529-0131(200201)46:1<149::AID-ART10058>3.0.CO;2-W
   KREWSON CE, 1994, BIOTECHNOL BIOENG, V43, P555, DOI 10.1002/bit.260430704
   LEE YH, 1994, J NEUROCHEM, V62, P2325
   LEVI ADO, 1994, J NEUROSCI, V14, P1309
   Ma W, 1998, DEV BRAIN RES, V106, P155, DOI 10.1016/S0165-3806(97)00208-3
   Mosahebi A, 2001, TISSUE ENG, V7, P525, DOI 10.1089/107632701753213156
   Newman JP, 1996, ARCH OTOLARYNGOL, V122, P399
   O'Connor SM, 2000, J NEUROSCI METH, V102, P187, DOI 10.1016/S0165-0270(00)00303-4
   O'Connor SM, 2001, NEUROSCI LETT, V304, P189, DOI 10.1016/S0304-3940(01)01769-4
   O'Shaughnessy TJ, 2003, NEUROSCI LETT, V340, P169, DOI 10.1016/S0304-3940(03)00083-1
   Oudega M, 2001, BIOMATERIALS, V22, P1125, DOI 10.1016/S0142-9612(00)00346-X
   Paves H, 1997, CELL TISSUE RES, V290, P285, DOI 10.1007/s004410050933
   Pearson RG, 2003, TISSUE ENG, V9, P201, DOI 10.1089/107632703764664675
   Robinson GA, 2000, J NEUROSURG, V93, P275, DOI 10.3171/jns.2000.93.2.0275
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   SMITH GV, 1988, EXP BRAIN RES, V69, P299
   Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X
   Sterne GD, 1997, EUR J NEUROSCI, V9, P1388, DOI 10.1111/j.1460-9568.1997.tb01493.x
   Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x
   van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3
   Wechselberger G, 1998, J UROLOGY, V160, P583, DOI 10.1016/S0022-5347(01)62962-8
   Weeks BS, 1998, EXP CELL RES, V243, P375, DOI 10.1006/excr.1998.4157
   Whitworth IH, 1996, J HAND SURG-BRIT EUR, V21B, P514, DOI 10.1016/S0266-7681(96)80058-1
   Woerly S, 1996, BIOMATERIALS, V17, P301, DOI 10.1016/0142-9612(96)85568-2
   Woerly S, 2000, NEUROSURG REV, V23, P59
   Yao M, 1999, LARYNGOSCOPE, V109, P1263, DOI 10.1097/00005537-199908000-00015
   ZENG L, 1995, SCAND J PLAST RECONS, V29, P199, DOI 10.3109/02844319509050127
NR 51
TC 31
Z9 32
U1 0
U2 8
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT
PY 2005
VL 75B
IS 1
BP 146
EP 157
DI 10.1002/jbm.b.30276
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 968NC
UT WOS:000232168200019
PM 16001420
DA 2018-10-20
ER

PT J
AU Masuoka, K
   Asazuma, T
   Ishihara, M
   Sato, M
   Hattori, H
   Ishihara, M
   Yoshihara, Y
   Matsui, T
   Takase, B
   Kikuchi, M
   Nemoto, K
AF Masuoka, K
   Asazuma, T
   Ishihara, M
   Sato, M
   Hattori, H
   Ishihara, M
   Yoshihara, Y
   Matsui, T
   Takase, B
   Kikuchi, M
   Nemoto, K
TI Tissue engineering of articular cartilage using an allograft of cultured
   chondrocytes in a membrane-sealed atelocollagen honeycomb-shaped
   scaffold (ACHMS scaffold)
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE regeneration; articular cartilage; chondrocytes; scaffold; tissue
   engineering
ID FULL-THICKNESS DEFECTS; INTERVERTEBRAL DISC; REPAIR; COLLAGEN;
   TRANSPLANTATION; POLYMERS; ALGINATE; REGENERATION; BIOMATERIAL; MATRIX
AB The aim of this study was to investigate with tissue engineering procedures the possibility of using atelocollagen honeycomb-shaped scaffolds sealed with a membrane (ACHMS scaffold) for the culturing of chondrocytes to repair articular cartilage defects. Chondrocytes from the articular cartilage of Japanese white rabbits were cultured in ACHMS scaffolds to allow a high-density, three-dimensional culturing for up to 21 days. Although the DNA content in the scaffold increased at a lower rate than monolayer culturing, scanning electron microscopy data showed that the scaffold was filled with grown chondrocytes and their produced extracellular matrix after 21 days. In addition, glycosaminoglycan (GAG) accumulation in the scaffold culture was at a higher level than the monolayer culture. Cultured cartilage in vitro for 14 days showed enough elasticity and stiffness to be handled in vivo. An articular cartilage defect was initiated in the patellar groove of the femur of rabbits and was subsequently filled with the chondrocyte-cultured ACHMS scaffold, ACHMS scaffold alone, or nonfilled (control). Three months after the operations, histological analysis showed that only defects inserted with chondrocytes being cultured in ACHMS scaffolds were filled with reparative hyaline cartilage, and thereby highly expressing type II collagen. These results indicate that implantation of allogenic chondrocytes cultured in ACHMS scaffolds may be effective in repairing articular cartilage defects. (c) 2005 Wiley Periodicals, Inc.
C1 Natl Def Med Coll, Res Inst, Div Biomed Engn, Tokorozawa, Saitama 3598513, Japan.
   Natl Def Med Coll, Dept Orthopaed Surg, Tokorozawa, Saitama 3598513, Japan.
   Tokai Univ, Sch Med, Dept Orthopaed Surg, Kanagawa 2591193, Japan.
   Natl Def Med Coll, Dept Med Engn, Tokorozawa, Saitama 3598513, Japan.
RP Ishihara, M (reprint author), Natl Def Med Coll, Res Inst, Div Biomed Engn, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.
EM ishihara@ndmc.ac.jp
OI Sato, Masato/0000-0003-4049-7325
CR Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   COLETTI JM, 1972, J BONE JOINT SURG AM, VA 54, P147, DOI 10.2106/00004623-197254010-00014
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808
   Frenkel SR, 1997, J BONE JOINT SURG BR, V79B, P831, DOI 10.1302/0301-620X.79B5.7278
   Fussenegger M, 2003, ANN PLAS SURG, V51, P493, DOI 10.1097/01.sap.0000067726.32731.E1
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   ITOH H, 2001, ARTIF ORGANS, V25, P231
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Liu YC, 2002, TISSUE ENG, V8, P709, DOI 10.1089/107632702760240616
   Loty S, 1998, J BIOMED MATER RES, V42, P213, DOI 10.1002/(SICI)1097-4636(199811)42:2<213::AID-JBM6>3.0.CO;2-S
   Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708
   Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Rahfoth B, 1998, OSTEOARTHR CARTILAGE, V6, P50, DOI 10.1053/joca.1997.0092
   Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C
   Sato M, 2003, SPINE, V28, P548, DOI 10.1097/00007632-200303150-00007
   Sato M, 2003, MED BIOL ENG COMPUT, V41, P365, DOI 10.1007/BF02348444
   Sato Masato, 2003, J Biomed Mater Res A, V64, P248, DOI 10.1002/jbm.a.10287
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   vanSusante JLC, 1995, ACTA ORTHOP SCAND, V66, P549, DOI 10.3109/17453679509002314
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Wyre RM, 2000, BIOMATERIALS, V21, P335, DOI 10.1016/S0142-9612(99)00185-4
NR 29
TC 46
Z9 52
U1 1
U2 5
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT
PY 2005
VL 75B
IS 1
BP 177
EP 184
DI 10.1002/jbm.b.30284
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 968NC
UT WOS:000232168200022
PM 16025467
DA 2018-10-20
ER

PT J
AU Sprague, EA
   Palmaz, JC
AF Sprague, EA
   Palmaz, JC
TI A model system to assess key vascular responses to biomaterials
SO JOURNAL OF ENDOVASCULAR THERAPY
LA English
DT Article
DE fibrinogen; platelets; inflammation; endothelium; stents; monocytes;
   biomaterials; biocompatibility
ID CORONARY-ARTERY-DISEASE; FIBRINOGEN ADSORPTION; PLATELET-ADHESION;
   RANDOMIZED-TRIAL; CELL-MIGRATION; COATED STENTS; STEEL STENTS;
   RESTENOSIS; SURFACE; GOLD
AB Purpose: To establish a reproducible laboratory test to evaluate prospective vascular biomaterials with respect to their thromboinflammatory properties by examining fibrinogen, platelet, and monocyte binding. Endothelial migration onto these surfaces was used as an index of vascular healing.
   Methods: To evaluate biomaterials for potential thrombogenicity and inflammation, binding assays of radiolabeled human fibrinogen, platelets, and monocytes were performed on standard pieces of vascular biomaterials, including metals and polymeric and ceramic-coated materials. Using an established in vitro endothelial cell migration model, the relative migration rate of cultured human aortic endothelial cells onto these vascular biomaterials was measured and compared. The fibrinogen, platelet, and monocyte binding results were combined along with the migration results to create an overall score of biocompatibility.
   Results: A significant direct relation of platelet and monocyte binding to the amount of adsorbed fibrinogen was observed. In contrast, migration rates of cultured human aortic endothelial cells onto the same biomaterial surfaces were found to be inversely related the amount of bound fibrinogen. Among the materials tested, stainless steel received the highest score of biocompatibility, while turbostratic carbon scored the lowest.
   Conclusions: Fibrinogen, platelet, and monocyte binding levels, as well as endothelial migration rates onto vascular material surfaces, provide a basis for evaluating thrombogenicity, inflammatory potential, and endothelialization in the laboratory prior to in vivo testing.
C1 Univ Texas, Hlth Sci Ctr, Dept Radiol, San Antonio, TX 78229 USA.
RP Sprague, EA (reprint author), Univ Texas, Hlth Sci Ctr, Dept Radiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.
EM sprague@uthscsa.edu
CR Ahmed Z, 2000, CELL MOTIL CYTOSKEL, V46, P6
   Airoldi F, 2004, AM J CARDIOL, V93, P474, DOI 10.1016/j.amjcard.2003.10.048
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   Bailly AL, 1996, J BIOMED MATER RES, V30, P101, DOI 10.1002/(SICI)1097-4636(199601)30:1<101::AID-JBM13>3.0.CO;2-R
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   CHINN JA, 1991, THROMB HAEMOSTASIS, V65, P608
   CLOWES AW, 1989, J CARDIOVASC PHAR S6, V14, P12
   De Scheerder I, 2000, J INVASIVE CARDIOL, V12, P389
   Eriksson C, 1997, J BIOMED MATER RES, V37, P130, DOI 10.1002/(SICI)1097-4636(199710)37:1<130::AID-JBM16>3.0.CO;2-K
   FEUERSTEIN IA, 1991, J BIOMED MATER RES, V25, P185, DOI 10.1002/jbm.820250206
   GINSBERG MH, 1988, THROMB HAEMOSTASIS, V59, P1
   Han RO, 2001, AM J CARDIOL, V88, P253, DOI 10.1016/S0002-9149(01)01636-8
   Holmes DR, 2000, AM J CARDIOL, V86, P1073, DOI 10.1016/S0002-9149(00)01162-0
   Kastrati A, 2000, CIRCULATION, V101, P2478, DOI 10.1161/01.CIR.101.21.2478
   Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048
   LIBBY P, 1992, CIRCULATION, V86, P11147
   Linder S, 2002, BIOMATERIALS, V23, P767, DOI 10.1016/S0142-9612(01)00182-X
   MONTALESCOT G, 1995, CIRCULATION, V92, P31, DOI 10.1161/01.CIR.92.1.31
   Otsuka M, 2002, ATHEROSCLEROSIS, V164, P371, DOI 10.1016/S0021-9150(02)00177-6
   Park SJ, 2002, AM J CARDIOL, V89, P872, DOI 10.1016/S0002-9149(02)02206-3
   PEREZLUNA VH, 1994, J BIOMED MATER RES, V28, P1111, DOI 10.1002/jbm.820281002
   PHILLIPS DR, 1988, BLOOD, V71, P831
   Rogers C, 1996, CIRCULATION, V94, P2909, DOI 10.1161/01.CIR.94.11.2909
   Sprague EA, 1997, J VASC INTERV RADIOL, V8, P83, DOI 10.1016/S1051-0443(97)70521-9
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   THAKUR ML, 1976, THROMB RES, V9, P345, DOI 10.1016/0049-3848(76)90135-3
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   UGAROVA TP, 1993, J BIOL CHEM, V268, P21080
   Ugarova TP, 2001, ANN NY ACAD SCI, V936, P368
   WILLIAMS DF, 1985, J BIOMED MATER RES, V19, P313, DOI 10.1002/jbm.820190312
   Yongoli C, 1999, J COLLOID INTERF SCI, V214, P38, DOI DOI 10.1006/JCIS.1999.6159
NR 32
TC 20
Z9 22
U1 0
U2 7
PU ALLIANCE COMMUNICATIONS GROUP DIVISION ALLEN PRESS
PI LAWRENCE
PA 810 EAST 10TH STREET, LAWRENCE, KS 66044 USA
SN 1526-6028
J9 J ENDOVASC THER
JI J. Endovascular Ther.
PD OCT
PY 2005
VL 12
IS 5
BP 594
EP 604
DI 10.1583/05-1555.1
PG 11
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA 974WB
UT WOS:000232621000011
PM 16212461
DA 2018-10-20
ER

PT J
AU Waar, K
   Degener, JE
   van Luyn, MJ
   Harmsen, HJM
AF Waar, K
   Degener, JE
   van Luyn, MJ
   Harmsen, HJM
TI Fluorescent in situ hybridization with specific DNA probes offers
   adequate detection of Enterococcus faecalis and Enterococcus faecium in
   clinical samples
SO JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article
ID TARGETED OLIGONUCLEOTIDE PROBES; RESISTANT ENTEROCOCCI; IDENTIFICATION;
   INFECTIONS; POPULATIONS; LACTOCOCCI
AB Enterococcus faecalis and Enterococcus faecium are among the leading causes of hospital-acquired infections. Reliable and quick identification of E faecalis and E faecium is important for accurate treatment and understanding their role in the pathogenesis of infections. Fluorescent in situ hybridization (FISH) of whole bacterial cells with oligonucleotides targeted at the 16S rRNA molecule leads to a reduced time to identification. In clinical practice, FISH therefore can be used in situations in which quick identification is necessary for optimal treatment of the patient. Furthermore, the abundance, spatial distribution and bacterial cell morphology can be observed in situ. This report describes the design of two fluorescent-labelled oligonucleotides that, respectively, detect the 16S rRNA of E. faecalis and the 16S rRNA of E faecium, Enterococcus hirae, Enterococcus mundtii, Enterococcus villorum and Enterococcus saccharolyticus. Different protocols for the application of these oligonucleotides with FISH in different clinical samples such as faeces or blood cultures are given. Enterococci in a biofilm attached to a biomaterial were also visualized. Embedding of the biomaterial preserved the morphology and therefore the architecture of the biofilm could be observed. The usefulness of other studies describing FISH for detection of enterococci is generally hampered by the fact that they have only focused on one material and one protocol to detect the enterococci. However, the results of this study show that the probes can be used both in the routine laboratory to detect and determine the enterococcal species in different clinical samples and in a research setting to enumerate and detect the enterococci in their physical environment.
C1 Univ Groningen, Dept Med Microbiol, NL-9713 GZ Groningen, Netherlands.
   Univ Groningen, Dept Pathol & Lab Med, Biol Sect, NL-9713 GZ Groningen, Netherlands.
RP Harmsen, HJM (reprint author), Univ Groningen, Dept Med Microbiol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.
EM h.j.m.harmsen@med.umcg.nl
CR AMANN RI, 1995, MICROBIOL REV, V59, P143
   AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919
   Behr T, 2000, SYST APPL MICROBIOL, V23, P563, DOI 10.1016/S0723-2020(00)80031-4
   BEIMFOHR C, 1993, SYST APPL MICROBIOL, V16, P450, DOI 10.1078/072320202320771525
   BETZL D, 1990, APPL ENVIRON MICROB, V56, P2927
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Facklam R. R., 1999, MANUAL CLIN MICROBIO, P297
   FACKLAM RR, 1989, J CLIN MICROBIOL, V27, P731
   Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336
   Gilad J, 1998, EUR J CLIN MICROBIOL, V17, P576, DOI 10.1007/BF01708623
   Harmsen Hermie J.M., 1999, Microbial Ecology in Health and Disease, V11, P3, DOI 10.1080/089106099435862
   HOLDEMAN LV, 1977, ANAEROBE LAB MANUAL
   Huycke MM, 1998, EMERG INFECT DIS, V4, P239, DOI 10.3201/eid0402.980211
   Jansen GJ, 2000, J CLIN MICROBIOL, V38, P814
   KAUFHOLD A, 1991, J CLIN MICROBIOL, V29, P1075
   Low DE, 2001, CLIN INFECT DIS, V32, pS133, DOI 10.1086/320185
   Ludwig W, 1998, ELECTROPHORESIS, V19, P554, DOI 10.1002/elps.1150190416
   Maidak BL, 1997, NUCLEIC ACIDS RES, V25, P109, DOI 10.1093/nar/25.1.109
   Monstein HJ, 1998, MICROBIOL-UK, V144, P1171, DOI 10.1099/00221287-144-5-1171
   Munson EL, 2003, J CLIN MICROBIOL, V41, P495, DOI 10.1128/JCM.41.1.495-497.2003
   Murray BE, 1997, AM J MED, V102, P284, DOI 10.1016/S0002-9343(99)80270-8
   Neut D, 2003, CLIN ORTHOP RELAT R, P261, DOI 10.1097/01.blo.0000073345.50837.84
   Pascual A, 2002, CLIN MICROBIOL INFEC, V8, P256, DOI 10.1046/j.1469-0691.2002.00418.x
   Patel R, 1998, J CLIN MICROBIOL, V36, P3399
   POULSEN LK, 1995, J BACTERIOL, V177, P5840, DOI 10.1128/jb.177.20.5840-5845.1995
   Pryce TM, 1999, J MICROBIOL METH, V36, P147, DOI 10.1016/S0167-7012(99)00026-3
   RUOFF KL, 1990, J CLIN MICROBIOL, V28, P435
   Vancanneyt M, 2001, INT J SYST EVOL MICR, V51, P393, DOI 10.1099/00207713-51-2-393
NR 28
TC 44
Z9 46
U1 0
U2 6
PU SOC GENERAL MICROBIOLOGY
PI READING
PA MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG,
   BERKS, ENGLAND
SN 0022-2615
J9 J MED MICROBIOL
JI J. Med. Microbiol.
PD OCT
PY 2005
VL 54
IS 10
BP 937
EP 944
DI 10.1099/jmm.0.46022-0
PG 8
WC Microbiology
SC Microbiology
GA 971JG
UT WOS:000232379500006
PM 16157547
OA Bronze
DA 2018-10-20
ER

PT J
AU Deriu, D
   Di Venere, A
   Mei, G
   Santucci, R
   Rosato, N
AF Deriu, D
   Di Venere, A
   Mei, G
   Santucci, R
   Rosato, N
TI Structural characterization of new chitosan-containing hybrid bioactive
   gels
SO JOURNAL OF NON-CRYSTALLINE SOLIDS
LA English
DT Article
ID IN-VITRO; SILICA; GLASS; REGENERATION; MATRIX; GROWTH
AB The aim of the present study is the characterization of a new hybrid biomaterial obtained by combining a natural biopolymer, i.e chitosan, with an inorganic phase previously modified by the addition of calcium and phosphate ions. To this issue, we have prepared different chitosan-containing samples and tested both their solvent permeability and ion release capability. Data reveal the occurrence of a severe swelling process, whose kinetics is slowed down by the presence of increasing amounts of chitosan. Structural tests were performed by employing infrared spectroscopy and weight change measurements; further, the changes induced by chitosan on the biogel matrix were determinated by the use of confocal microscopy. Our results demonstrate that chitosan modifies the overall chemical structure of the inorganic phase, and reduces leaching effects without producing relevant interferences to the formation of the apatite layer on the bioactive gel surface. By defining more accurate limits to biopolymer incorporation into the bioactive gels, our data provide new insights on the potential offered by chitosan for incorporation into new biocompatible materials. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy.
   INFM, Natl Inst Phys Matter, Genoa, Italy.
RP Rosato, N (reprint author), Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, Via Montpellier, I-00133 Rome, Italy.
EM mei@med.uniroma2.it
CR Arcos D, 2003, J BIOMED MATER RES A, V65A, P344, DOI 10.1002/jbm.a.10503
   Ayers MR, 2001, J NON-CRYST SOLIDS, V285, P123, DOI 10.1016/S0022-3093(01)00442-2
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   Dong Shaojun, 2002, J Biotechnol, V82, P303, DOI 10.1016/S1389-0352(01)00048-4
   Gill I, 2001, CHEM MATER, V13, P3404, DOI 10.1021/cm0102483
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   Jin W, 2002, ANAL CHIM ACTA, V461, P1, DOI 10.1016/S0003-2670(02)00229-5
   Jones JR, 2003, CURR OPIN SOLID ST M, V7, P301, DOI 10.1016/j.cossms.2003.09.012
   KAI Z, 2003, J BIOMED MATER RES A, V66, P860
   Kontonasaki E, 2002, CRYST RES TECHNOL, V37, P1165, DOI 10.1002/1521-4079(200211)37:11<1165::AID-CRAT1165>3.0.CO;2-R
   Kumar R.M.N.V., 2000, REACT FUNCT POLYM, V46, P1
   Lin J, 1997, TRAC-TREND ANAL CHEM, V16, P200, DOI 10.1016/S0165-9936(97)00021-6
   Martinez Y, 2004, POLYMER, V45, P3257, DOI 10.1016/j.polymer.2004.03.046
   Miao Y, 2001, ANAL CHIM ACTA, V437, P87, DOI 10.1016/S0003-2670(01)00986-2
   Palumbo G, 1997, J MATER SCI-MATER M, V8, P417, DOI 10.1023/A:1018553505001
   Park SB, 2001, BIOMATERIALS, V22, P323, DOI 10.1016/S0142-9612(00)00187-3
   Retuert J, 2003, J MATER RES, V18, P487, DOI 10.1557/JMR.2003.0062
   Roller S, 1999, INT J FOOD MICROBIOL, V47, P67, DOI 10.1016/S0168-1605(99)00006-9
   SHERIEF M, 2002, MATER CHEM PHYS, V77, P846
   Sinha VR, 2004, INT J PHARM, V274, P1, DOI 10.1016/j.ijpharm.2003.12.026
   Udawatte CP, 2000, MATER LETT, V45, P298, DOI 10.1016/S0167-577X(00)00121-X
   Vallet-Regi M, 2000, CHEM MATER, V12, P961, DOI 10.1021/cm991110b
   Venkateswara Rao, 2003, SCI TECHNOL ADV MAT, V4, P509
   Wen JY, 1996, CHEM MATER, V8, P1667, DOI 10.1021/cm9601143
   Yang JM, 2004, J MEMBRANE SCI, V236, P39, DOI 10.1016/j.memsci.2004.02.005
   Yano S, 1998, MAT SCI ENG C-BIO S, V6, P75, DOI 10.1016/S0928-4931(98)00043-5
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
   Zheng LY, 2003, CARBOHYD POLYM, V54, P527, DOI 10.1016/j.carbpol.2003.07.009
NR 28
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-3093
J9 J NON-CRYST SOLIDS
JI J. Non-Cryst. Solids
PD OCT 1
PY 2005
VL 351
IS 37-39
BP 3037
EP 3043
DI 10.1016/j.jnoncrysol.2005.07.013
PG 7
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA 970YB
UT WOS:000232347200010
DA 2018-10-20
ER

PT J
AU Kutasi, K
   Bibinov, N
   von Keudell, A
   Wiesemann, K
AF Kutasi, K
   Bibinov, N
   von Keudell, A
   Wiesemann, K
TI Wettabilities of plasma deposited polymer films
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th European Conference on Atomic and Molecular Physics of Ionized
   Gases
CY SEP 01-05, 2004
CL Constanta, ROMANIA
DE polymer film; wettability; plasma deposition method
ID DIAMOND-LIKE CARBON; DLC COATINGS; AMORPHOUS-CARBON; IN-VITRO; SURFACES;
   BIOCOMPATIBILITY; WATER; BIOMATERIAL
AB We have investigated the wettability of hydrocarbon films deposited in capacitively coupled He, Ar/C(2)H(2) rf discharges. Depending on the discharge pulse lengths we obtained hydrophobic films with contact angles either between 80 degrees and 86 degrees or between 100 degrees and 140 degrees. By treating the latter class of hydrophobic films in Ar or He discharges the film surfaces became hydrophilic with a contact angle not distinguishable from 0 degrees. The investigated films were non-hygroscopic.
C1 Res Inst Solid State Phys & Opt, H-1525 Budapest, Hungary.
   Ruhr Univ Bochum, D-44780 Bochum, Germany.
RP Kutasi, K (reprint author), Res Inst Solid State Phys & Opt, POB 49, H-1525 Budapest, Hungary.
OI von Keudell, Achim/0000-0003-3887-9359
CR Allen M, 2001, J BIOMED MATER RES, V58, P319, DOI 10.1002/1097-4636(2001)58:3<319::AID-JBM1024>3.0.CO;2-F
   ANGUS J, 1986, PLASMA DEPOSITED THI
   BIBINOV N, 2003, P ISPC 16 TAORM IT, P50
   BUTTER R, 1995, DIAM RELAT MATER, V4, P857, DOI 10.1016/0925-9635(94)05280-8
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   KOIDL P, 1991, NATO ADV SCI I B-PHY, V266, P243
   Kwok SCH, 2005, DIAM RELAT MATER, V14, P78, DOI 10.1016/j.diamond.2004.07.019
   MITURA E, 1994, DIAM RELAT MATER, V3, P896, DOI 10.1016/0925-9635(94)90295-X
   MUTSUKURA N, 1992, J APPL PHYS, V72, P43, DOI 10.1063/1.352145
   OLBORSKA A, 1994, DIAM RELAT MATER, V3, P899, DOI 10.1016/0925-9635(94)90296-8
   Onda T, 1996, LANGMUIR, V12, P2125, DOI 10.1021/la950418o
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   vonKeudell A, 1997, J VAC SCI TECHNOL A, V15, P402, DOI 10.1116/1.580498
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
   Zajickova L, 2003, THIN SOLID FILMS, V425, P72, DOI 10.1016/S0040-6090(02)01133-1
NR 19
TC 5
Z9 5
U1 1
U2 3
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD OCT
PY 2005
VL 7
IS 5
BP 2549
EP 2556
PG 8
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA 978SU
UT WOS:000232894100049
DA 2018-10-20
ER

PT J
AU Rosca, JCM
   Santana, EDH
   Castro, JR
   Lopez, AS
   Vasilescu, E
   Drob, P
   Vasilescu, C
AF Rosca, JCM
   Santana, EDH
   Castro, JR
   Lopez, AS
   Vasilescu, E
   Drob, P
   Vasilescu, C
TI Characterisation of anodic films formed on titanium and its alloys
SO MATERIALS AND CORROSION-WERKSTOFFE UND KORROSION
LA English
DT Article
ID DENTAL IMPLANT APPLICATIONS; APATITE-FORMING ABILITY; SIMULATED
   BODY-FLUID; CORROSION BEHAVIOR; OXIDE-FILMS; HYDROXYAPATITE COATINGS;
   OXIDIZED TITANIUM; TI-6AL-4V ALLOY; SURFACE; METAL
AB The properties of the anodic oxide films formed on titanium and its implant alloys Ti-5Al-4V and Ti-6Al-4Fe are investigated in this paper. Anodic oxide films were prepared by electrochemical treatment in 3M sulphuric acid solution at 60 V for I min, followed by a thermal treatment consisting of heating at 500 degrees C for 24 h and then cooling in water. Electrochemical impedance spectroscopy (EIS) measurements were carried out at open circuit potential. Nyquist and Bode spectra exhibit a two-time constant system, attesting an oxide with two layers: a barrier inner oxide and a porous outer one. All spectra change in time, indicating a thickening of the films. Open circuit potentials were monitored (long-term, 25,000 exposure hours) in Ringer 2 solution of different pH values (6.98, 4.35, 2.5) for titanium, Ti5Al-4V and Ti-6Al-4F e alloy but without treatment with the purpose to compare the biomaterial behaviour. It was pointed out some variations of the open circuit potentials around electropositive values, suggesting slow dissolution, re-passivation or adsorption processes.
C1 Inst Phys Chem IG Murgulescu, Bucharest 060021, Romania.
   LasPalmas Gran Canaria Univ, Dept Mech Engn, Tafira 35017, Spain.
RP Vasilescu, E (reprint author), Inst Phys Chem IG Murgulescu, Spl Independentei 202,POB 12-194, Bucharest 060021, Romania.
EM evasiles@chimfiz.icf.ro
RI Vasilescu, Ecaterina/C-5129-2013; Vasilescu, Cora/C-1062-2012; Drob,
   Paula/C-5170-2013
OI Vasilescu, Cora/0000-0002-8991-9544; Vasilescu,
   Ecaterina/0000-0002-0295-1585; Drob, Paula/0000-0001-7556-7018
CR Al-Mayouf AM, 2004, MATER CORROS, V55, P524, DOI 10.1002/maco.200303770
   Al-Mayouf AM, 2004, MATER CORROS, V55, P88, DOI 10.1002/maco.200303697
   Asami K, 2002, SURF INTERFACE ANAL, V34, P144, DOI 10.1002/sia.1271
   Bautista A, 2005, MATER CORROS, V56, P98, DOI 10.1002/maco.200403818
   Birch JR, 2000, CORROSION, V56, P1233, DOI 10.5006/1.3280511
   BOUKAMP BA, 1986, SOLID STATE IONICS, V20, P31, DOI 10.1016/0167-2738(86)90031-7
   Browne M, 2000, BIOMATERIALS, V21, P385, DOI 10.1016/S0142-9612(99)00200-8
   Ciolac S, 1999, REV ROUM CHIM, V44, P431
   Feng B, 2002, J MATER SCI-MATER M, V13, P457, DOI 10.1023/A:1014737831371
   Godley R, 2004, J MATER SCI-MATER M, V15, P1073, DOI 10.1023/B:JMSM.0000046388.07961.81
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   GUAL E, 1993, J CHEM EDUC, V70, P176
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   Liang B, 2003, BIOMATERIALS, V24, P4959, DOI 10.1016/S0142-9612(03)00421-6
   Lu X, 2004, J MATER SCI, V39, P6809, DOI 10.1023/B:JMSC.0000045608.64178.55
   MARSH J, 1998, ELECTROCHIM ACTA, V43, P650
   Pang M, 2001, CORROSION, V57, P523, DOI 10.5006/1.3290378
   Popa MV, 2004, ELECTROCHIM ACTA, V49, P2113, DOI 10.1016/j.electacta.2003.12.036
   Popa MV, 2003, REV CHIM-BUCHAREST, V54, P503
   POPA MV, 2003, MATER CORROS, V541, P215
   Pourbaix M., 1974, ATLAS ELECTROCHEMICA
   Raghavan V, 2002, J PHASE EQUILIB, V23, P182, DOI 10.1361/1054971023604080
   Sampathkumaran U, 2001, ADV ENG MATER, V3, P401, DOI 10.1002/1527-2648(200106)3:6<401::AID-ADEM401>3.0.CO;2-L
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   Teraoka K, 2000, MAT SCI ENG C-BIO S, V13, P105, DOI 10.1016/S0928-4931(00)00183-1
   Thair L, 2004, MATER CORROS, V55, P358, DOI 10.1002/maco.200303724
   Uchida M, 2003, J BIOMED MATER RES A, V64A, P164, DOI 10.1002/jbm.a.10414
   Uchida M, 2002, J BIOMED MATER RES, V63, P522, DOI 10.1002/jbm.10304
   Velten D, 2002, J BIOMED MATER RES, V59, P18, DOI 10.1002/jbm.1212
   Venugopalan R, 2000, BIOMATERIALS, V21, P1669, DOI 10.1016/S0142-9612(00)00049-1
   Wang CX, 2003, BIOMATERIALS, V24, P3069, DOI 10.1016/S0142-9612(03)00154-6
   Wang XX, 2003, BIOMATERIALS, V24, P4631, DOI 10.1016/S0142-9612(03)00357-0
   Wei M, 2002, BIOMATERIALS, V23, P167, DOI 10.1016/S0142-9612(01)00092-8
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Zhang CG, 2001, BIOMATERIALS, V22, P1357, DOI 10.1016/S0142-9612(00)00289-1
NR 37
TC 3
Z9 3
U1 0
U2 6
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0947-5117
J9 MATER CORROS
JI Mater. Corros.
PD OCT
PY 2005
VL 56
IS 10
BP 692
EP 696
DI 10.1002/maco.200503885
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 976RZ
UT WOS:000232752200004
DA 2018-10-20
ER

PT J
AU Gordin, DM
   Gloriant, T
   Nemtoi, G
   Chelariu, R
   Aelenei, N
   Guillou, A
   Ansel, D
AF Gordin, DM
   Gloriant, T
   Nemtoi, G
   Chelariu, R
   Aelenei, N
   Guillou, A
   Ansel, D
TI Synthesis, structure and electrochemical behavior of a beta Ti-12Mo-5Ta
   alloy as new biomaterial
SO MATERIALS LETTERS
LA English
DT Article
DE metals and alloys; X-ray diffraction; microstructure; electrochemical
   properties
ID BIOMEDICAL TITANIUM-ALLOYS; CORROSION BEHAVIOR; CELL VIABILITY;
   TI-13NB-13ZR; MODULUS; DESIGN; TI
AB We have synthesized a new Ti-based alloy that combines Ti with the non-toxic elements Ta and Mo. Ingot of composition Ti-12Mo-5Ta was prepared by melting pure elements in an arc-melting furnace. The alloy was annealed at 950 degrees C for one hour under high vacuum and quenched in water at room temperature. The alloy was characterized by X-ray diffraction, observed by microscopy and found to have a body-centered-cubic structure (beta-type). We have measured. the Young's modulus of Ti-12Mo-5Ta by ultrasonic technique and found a lower value (about 74 GPa) than the classical alpha+beta Ti-6Al-4V alloy (120 GPa). As long-term stability in biological environment is required, we. have evaluated the electrochemical behavior of both alloys Experiments, i.e. measurements of open-circuit potential (OCP) versus time and the observation of linear and cyclic potentiodynamic polarization curves, were carried out in simulated body fluid (Ringer's solution) for two immersion times. Under these conditions both titanium alloys exhibit spontaneous passivity and high corrosion resistance. The excellent electrochemical properties combined with low elastic modulus make the new beta-type Ti-12Mo-5Ta alloy suitable for use as a bone substitute. (C) 2005 Elsevier B.V. All rights reserved.
C1 INSA Rennes, GRCM, EA 2620, F-35043 Rennes, France.
   Al I Cuza Univ, Fac Chem, Phys & Theoret Chem Dept, Iasi 70050, Romania.
   Gh Asachi Tech Univ, Fac Mat Sci & Engn, Dept Mat Sci, Iasi 70050, Romania.
   Gh Asachi Tech Univ, Fac Ind Chem, Dept Phys Chem, Iasi 70050, Romania.
RP Gloriant, T (reprint author), INSA Rennes, GRCM, EA 2620, 20 Ave Buttes Coesmes, F-35043 Rennes, France.
EM Thierry.Gloriant@insa-rennes.fr
RI Cuza, UAIC/D-2604-2009
OI Gordin, Doina Margareta/0000-0003-2200-9930
CR Ankem S, 1999, MAT SCI ENG A-STRUCT, V263, P127, DOI 10.1016/S0921-5093(98)01170-8
   Brunette D. M., 2001, TITANIUM MED, P145
   Cai Z, 2003, BIOMATERIALS, V24, P213, DOI 10.1016/S0142-9612(02)00293-4
   Davidson J. A., 1986, P IMPL MAN MAT TECHN, P122
   DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P231
   DONACHIE MJ, 1989, TITANIUM TECHNICAL G, V31, P218
   Freese H. L., 2001, TITANIUM MED, P25
   Garcia-Alonso MC, 2003, BIOMATERIALS, V24, P19, DOI 10.1016/S0142-9612(02)00237-5
   Gordin DM, 2004, J MATER SCI-MATER M, V15, P885, DOI 10.1023/B:JMSM.0000036276.32211.31
   Guillemot F, 2004, MED BIOL ENG COMPUT, V42, P137, DOI 10.1007/BF02351023
   Hon YH, 2003, MATER TRANS, V44, P2384, DOI 10.2320/matertrans.44.2384
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Kuroda D, 2001, TETSU TO HAGANE, V87, P500, DOI 10.2355/tetsutohagane1955.87.7_500
   Lin DJ, 2002, BIOMATERIALS, V23, P1723, DOI 10.1016/S0142-9612(01)00233-2
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   LUTTEROTTI L, 1992, J APPL CRYSTALLOGR, V25, P459, DOI 10.1107/S0021889892001122
   Maehara K, 2002, MATER TRANS, V43, P2936, DOI 10.2320/matertrans.43.2936
   Mudali UK, 2003, SADHANA-ACAD P ENG S, V28, P601
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   NIIOMI M, 1998, MAT SCI ENG A-STRUCT, V243, P231
   NIIOMI M, 2002, METALL MATER TRANS A, V33, P477
   Niiomi M., 2002, MAT T, V43, P2970
   OKASAKI Y, 2002, MAT T, V43, P3134
   Okazaki Y, 2000, MATER T JIM, V41, P1247, DOI 10.2320/matertrans1989.41.1247
   Okazaki Y, 1998, MATER T JIM, V39, P1053, DOI 10.2320/matertrans1989.39.1053
   SCHUTZ RW, 1993, TITANIUM ALLOYS 1990, P75
   Song Y, 2002, MATER TRANS, V43, P3028, DOI 10.2320/matertrans.43.3028
   STEIMANN SG, 1980, BIOMATERIALS, P1
   Weiss I, 1998, MAT SCI ENG A-STRUCT, V243, P46, DOI 10.1016/S0921-5093(97)00783-1
NR 30
TC 55
Z9 57
U1 1
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD OCT
PY 2005
VL 59
IS 23
BP 2936
EP 2941
DI 10.1016/j.matlet.2004.09.063
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 955FE
UT WOS:000231210000019
DA 2018-10-20
ER

PT J
AU Gordin, DM
   Gloriant, T
   Nemtoi, G
   Chelariu, R
   Aelenei, N
   Guillou, A
   Ansel, D
AF Gordin, DM
   Gloriant, T
   Nemtoi, G
   Chelariu, R
   Aelenei, N
   Guillou, A
   Ansel, D
TI Synthesis, structure and electrochemical behavior of a beta Ti-12Mo-5Ta
   alloy as new biomaterial
SO MATERIALS LETTERS
LA English
DT Article
DE metals and alloys; X-ray diffraction; microstructure; electrochemical
   properties
ID BIOMEDICAL TITANIUM-ALLOYS; CORROSION BEHAVIOR; CELL VIABILITY;
   TI-13NB-13ZR; MODULUS; DESIGN; TI
AB We have synthesized a new Ti-based alloy that combines Ti with the non-toxic elements Ta and Mo. Ingot of composition Ti-12Mo-5Ta was prepared by melting pure elements in an arc-melting furnace. The alloy was annealed at 950 degrees C for 1 h under high vacuum and quenched in water at room temperature. The alloy was characterized by X-ray diffraction, observed by microscopy and found to have a body-centered-cubic structure (beta-type). We have measured the Young's modulus of Ti-12Mo-5Ta by ultrasonic technique and found a lower value (about 74 GPa) than the classical alpha + beta Ti-6Al-4V alloy (120 GPa). As long-term stability in biological environment is required, we have evaluated the electrochemical behavior of both alloys. Experiments, i.e. measurements of open-circuit potential (OCP) versus time and the observation of linear and cyclic potentiodynamic polarization curves, were carried out in simulated body fluid (Ringer's solution) for two immersion times. Under these conditions both titanium alloys exhibit spontaneous passivity and high corrosion resistance. The excellent electrochemical properties combined with low elastic modulus make the new beta-type Ti-12Mo-5Ta alloy suitable for use as a bone substitute. (C) 2005 Elsevier B.V. All rights reserved.
C1 INSA Rennes, GRCM, EA 2620, F-35043 Rennes, France.
   Al I Cuza Univ, Fac Chem, Phys & Theoret Chem Dept, Iasi 70050, Romania.
   Gh Asachi Tech Univ, Fac Mat Sci & Engn, Dept Mat Sci, Iasi 70050, Romania.
   Gh Asachi Tech Univ, Fac Ind Chem, Dept Phys Chem, Iasi 70050, Romania.
RP Gloriant, T (reprint author), INSA Rennes, GRCM, EA 2620, 20 Ave Buttes Coesmes, F-35043 Rennes, France.
EM Thierry.Gloriant@insa-rennes.fr
RI Cuza, UAIC/D-2604-2009
OI Gordin, Doina Margareta/0000-0003-2200-9930
CR Ankem S, 1999, MAT SCI ENG A-STRUCT, V263, P127, DOI 10.1016/S0921-5093(98)01170-8
   Brunette D. M., 2001, TITANIUM MED, P145
   Cai Z, 2003, BIOMATERIALS, V24, P213, DOI 10.1016/S0142-9612(02)00293-4
   Davidson J. A., 1986, P IMPL MAN MAT TECHN, P122
   DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P231
   DONACHIE MJ, 1989, TITANIUM TECHNICAL G, V31, P218
   Freese H. L., 2001, TITANIUM MED, P25
   Garcia-Alonso MC, 2003, BIOMATERIALS, V24, P19, DOI 10.1016/S0142-9612(02)00237-5
   Gordin DM, 2004, J MATER SCI-MATER M, V15, P885, DOI 10.1023/B:JMSM.0000036276.32211.31
   Guillemot F, 2004, MED BIOL ENG COMPUT, V42, P137, DOI 10.1007/BF02351023
   Hon YH, 2003, MATER TRANS, V44, P2384, DOI 10.2320/matertrans.44.2384
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Kuroda D, 2001, TETSU TO HAGANE, V87, P500, DOI 10.2355/tetsutohagane1955.87.7_500
   Lin DJ, 2002, BIOMATERIALS, V23, P1723, DOI 10.1016/S0142-9612(01)00233-2
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   LUTTEROTTI L, 1992, J APPL CRYSTALLOGR, V25, P459, DOI 10.1107/S0021889892001122
   Maehara K, 2002, MATER TRANS, V43, P2936, DOI 10.2320/matertrans.43.2936
   Mudali UK, 2003, SADHANA-ACAD P ENG S, V28, P601
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   NIIOMI M, 1998, MAT SCI ENG A-STRUCT, V243, P231
   NIIOMI M, 2002, METALL MATER TRANS A, V33, P477
   Niiomi M., 2002, MAT T, V43, P2970
   OKASAKI Y, 2002, MAT T, V43, P3134
   Okazaki Y, 2000, MATER T JIM, V41, P1247, DOI 10.2320/matertrans1989.41.1247
   Okazaki Y, 1998, MATER T JIM, V39, P1053, DOI 10.2320/matertrans1989.39.1053
   SCHUTZ RW, 1993, TITANIUM ALLOYS 1990, P75
   Song Y, 2002, MATER TRANS, V43, P3028, DOI 10.2320/matertrans.43.3028
   STEIMANN SG, 1980, BIOMATERIALS, P1
   Weiss I, 1998, MAT SCI ENG A-STRUCT, V243, P46, DOI 10.1016/S0921-5093(97)00783-1
NR 30
TC 16
Z9 19
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD OCT
PY 2005
VL 59
IS 23
BP 2959
EP 2964
DI 10.1016/j.matlet.2004.09.064
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 955FE
UT WOS:000231210000023
DA 2018-10-20
ER

PT J
AU Cui, CX
   Liu, H
   Li, YC
   Sun, JB
   Wang, R
   Liu, SJ
   Greer, AL
AF Cui, CX
   Liu, H
   Li, YC
   Sun, JB
   Wang, R
   Liu, SJ
   Greer, AL
TI Fabrication and biocompatibility of nano-TiO2/titanium alloys
   biomaterials
SO MATERIALS LETTERS
LA English
DT Article
DE nanoparticles; biomaterial; simulated body fluid (SBF); biocompatibility
ID CALCIUM-PHOSPHATE COATINGS; SPRAYED HYDROXYAPATITE COATINGS; BIOMEDICAL
   APPLICATIONS; IMPLANTS
AB Using the process that titanium alloys were embedded by nanometer titanium dioxide powders and sintered in the high temperature furnace, the nano-TiO2/titanium alloys biomedical material was fabricated out. The particle size of TiO2 particles on the surface of Ti alloy was mainly 50-90 nm. The experimental results indicated that the films of nanocrystalline titanium oxide powders on the surface of Ti alloy were with an excellent biocompatibility. By cultivation in the simulated body fluid (SBF) for 7 days, the Ca phosphates were deposited on the specimen surface; and n (Ca)/n (P) atom ratio is about 1.6:1, which is similar to that of HA and human bone. (C) 2005 Elsevier B.V. All rights reserved.
C1 Hebei Univ Technol, Sch Mat Sci & Engn, Tianjin 300130, Peoples R China.
   Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
RP Cui, CX (reprint author), Hebei Univ Technol, Sch Mat Sci & Engn, Dingzigu,Rd 1,Hongqiao Dist, Tianjin 300130, Peoples R China.
EM Hutcui@hebut.edu.cn
RI Greer, Alan Lindsay/G-1977-2011; Greer, Lindsay/E-9433-2017
CR ASK M, 1988, APPL SURF SCI, V35, P283
   Dasarathy H, 1996, J BIOMED MATER RES, V31, P81, DOI 10.1002/(SICI)1097-4636(199605)31:1<81::AID-JBM10>3.0.CO;2-P
   DONACHIE MJ, 1988, TITANIUM TECHNICAL G, P29
   Haddow DB, 1998, J SOL-GEL SCI TECHN, V13, P261, DOI 10.1023/A:1008699421635
   HAMAN JD, 1995, J THERM SPRAY TECHN, V4, P179, DOI 10.1007/BF02646110
   HERO H, 1994, J BIOMED MATER RES, V28, P343, DOI 10.1002/jbm.820280308
   Jillavenkatesa A, 1998, J MATER SCI, V33, P4111, DOI 10.1023/A:1004436732282
   Kamitakahara M, 2003, BIOMATERIALS, V24, P1357, DOI 10.1016/S0142-9612(02)00513-6
   Kilpadi DV, 1998, J BIOMED MATER RES, V40, P646, DOI 10.1002/(SICI)1097-4636(19980615)40:4<646::AID-JBM17>3.3.CO;2-L
   KLEIN CPAT, 1994, J BIOMED MATER RES, V28, P909, DOI 10.1002/jbm.820280810
   Korkusuz F, 1999, Bull Hosp Jt Dis, V58, P86
   Kyeck S., 1999, Materials Science Forum, V308-311, P368
   Montenero A, 2000, J MATER SCI, V35, P2791, DOI 10.1023/A:1004738900778
   ONG JL, 1991, J AM CERAM SOC, V74, P2301, DOI 10.1111/j.1151-2916.1991.tb08301.x
   Pham MT, 1997, THIN SOLID FILMS, V310, P251, DOI 10.1016/S0040-6090(97)00330-1
   Ronold HJ, 2002, BIOMATERIALS, V23, P4211, DOI 10.1016/S0142-9612(02)00167-9
   Singh RK, 1996, MATER MANUF PROCESS, V11, P481, DOI 10.1080/10426919608947498
   Tsui YC, 1998, BIOMATERIALS, V19, P2031, DOI 10.1016/S0142-9612(98)00104-5
   WANG BC, 1993, SURF COAT TECH, V58, P107, DOI 10.1016/0257-8972(93)90181-M
   WOLKE JGC, 1994, J BIOMED MATER RES, V28, P1477, DOI 10.1002/jbm.820281213
   Yamashita K, 1996, J AM CERAM SOC, V79, P3313, DOI 10.1111/j.1151-2916.1996.tb08111.x
NR 21
TC 45
Z9 47
U1 2
U2 72
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD OCT
PY 2005
VL 59
IS 24-25
BP 3144
EP 3148
DI 10.1016/j.matlet.2005.05.037
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 957JJ
UT WOS:000231365800041
DA 2018-10-20
ER

PT J
AU Tognana, E
   Padera, RF
   Chen, F
   Vunjak-Novakovic, G
   Freed, LE
AF Tognana, E
   Padera, RF
   Chen, F
   Vunjak-Novakovic, G
   Freed, LE
TI Development and remodeling of engineered cartilage-explant composites in
   vitro and in vivo
SO OSTEOARTHRITIS AND CARTILAGE
LA English
DT Article
DE tissue engineered cartilage; bone remodeling; biomaterial; bioreactor
ID ARTICULAR-CARTILAGE; HUMAN CHONDROCYTES; ADHESIVE STRENGTH; REPAIR;
   TISSUE; COLLAGEN; SCAFFOLDS; DEFECTS; CELLS; REDIFFERENTIATION
AB Objective: Development and remodeling of engineered cartilage-explant composites were studied in vitro and in vivo.
   Design: Individual and interactive effects of cell chondrogenic potential (primary or fifth passage bovine calf chondrocytes), scaffold degradation rate (hyaluronan benzyl ester or polyglycolic acid), and adjacent tissue cell activity and architecture (vital trabecular bone (VB), articular cartilage (AC), devitalized bone (DB) or digested cartilage (DC)) were evaluated over 8 weeks in vitro (bioreactor cultures) and in vivo (ectopic implants).
   Results: In vitro, significant effects of cell type on construct adhesive strength (P < 0.001) and scaffold type on adhesive strength (P < 0.001), modulus (P = 0.014), glycosaminoglycans (GAG) (P < 0.001), and collagen (P = 0.039) were observed. Chondrogenesis was best when the scaffold degradation rate matched the extracellular matrix deposition rate. In vivo, adjacent tissue type affected adhesive strength (P < 0.001), modulus (P < 0.001), and GAG (P < 0.001) such that 8-week values obtained for bone (VB and DB) were higher than for cartilage (AC). In the AC/construct group, chondrogenesis appeared attenuated in the region of the construct close to the AC. In contrast, in the VB/construct group, a 500 mu m thick zone of mature hyaline-like cartilage formed at the interface, and signs of active remodeling were present in the bone that included osteoclastic and osteoblastic activity and trabecular rebuttressing; these features were not present in the DB group or in vitro.
   Conclusions: Development and remodeling of composites based on engineered cartilage were mediated in vitro by cell chondrogenic potential and scaffold degradation rate, and in vivo by type of adjacent tissue and time. (c) 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
C1 MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   Fidia Adv Biopolymers, Abano Terme, Italy.
   Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA.
RP Freed, LE (reprint author), MIT, Div Hlth Sci & Technol, E25-330,77 Mass Ave, Cambridge, MA 02139 USA.
EM Lfreed@mit.edu
OI Freed, Lisa/0000-0002-0720-8432; Vunjak-Novakovic,
   Gordana/0000-0002-9382-1574
CR BENICEWICZ BC, 1990, J BIOACT COMPAT POL, V5, P453, DOI 10.1177/088391159000500407
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Bos PK, 2002, ARTHRITIS RHEUM, V46, P976, DOI 10.1002/art.10208
   BRAVENBOER JV, 2003, T ORTHOP RES SOC, V28
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Caplan AI, 1997, CLIN ORTHOP RELAT R, P254
   DiMicco MA, 2002, OSTEOARTHR CARTILAGE, V10, P218, DOI 10.1053/joca.2001.0502
   DiMicco MA, 2001, J ORTHOPAED RES, V19, P1105, DOI 10.1016/S0736-0266(01)00037-7
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435
   Giurea A, 2002, J ORTHOPAED RES, V20, P1274, DOI 10.1016/S0736-0266(02)00084-0
   Grigolo B, 2002, BIOMATERIALS, V23, P1187, DOI 10.1016/S0142-9612(01)00236-8
   HOLLANDER AP, 1994, J CLIN INVEST, V93, P1722, DOI 10.1172/JCI117156
   Hunziker EB, 1998, J BONE JOINT SURG BR, V80B, P144, DOI 10.1302/0301-620X.80B1.7531
   HUNZIKER EB, 1999, CLIN ORTHOP S, V367, pS135
   Hunzinker E. B., 2001, OSTEOARTHR CARTILAGE, V10, P432
   Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J
   Kafienah W, 2002, TISSUE ENG, V8, P817, DOI 10.1089/10763270260424178
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   LEE MC, 2000, CLIN ORTHOPAEDICS, V370, P286
   LIPMAN JM, 1983, CALCIFIED TISSUE INT, V35, P767, DOI 10.1007/BF02405121
   LUYTEN FP, 1992, J BIOL CHEM, V267, P3691
   Lynn AK, 2004, J BONE JOINT SURG BR, V86B, P1093, DOI 10.1302/0301-620X.86B8.15609
   Malpeli M, 2004, TISSUE ENG, V10, P145, DOI 10.1089/107632704322791790
   Mandl EW, 2004, TISSUE ENG, V10, P109, DOI 10.1089/107632704322791754
   Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Milella E, 2002, BIOMATERIALS, V23, P1053, DOI 10.1016/S0142-9612(01)00217-4
   MORETTI M, IN PRESS J BIOMECH
   Obradovic B, 2001, J ORTHOPAED RES, V19, P1089, DOI 10.1016/S0736-0266(01)00030-4
   Pei M, 2002, FASEB J, V16, P1691, DOI 10.1096/fj.02-0083fje
   Peretti GM, 1998, J ORTHOPAED RES, V16, P89, DOI 10.1002/jor.1100160115
   Peretti GM, 1999, TISSUE ENG, V5, P317, DOI 10.1089/ten.1999.5.317
   Peretti GM, 2003, J BIOMED MATER RES A, V64A, P517, DOI 10.1002/jbm.a.10367
   RANDOLPH MA, 2004, T ORTHOP RES SOC, V29
   REINDEL ES, 1995, J ORTHOPAED RES, V13, P751, DOI 10.1002/jor.1100130515
   Schulze-Tanzil G, 2004, OSTEOARTHR CARTILAGE, V12, P448, DOI 10.1016/j.joca.2004.02.007
   Sellers RS, 2000, J BONE JOINT SURG AM, V82A, P151, DOI 10.2106/00004623-200002000-00001
   Solchaga LA, 2005, OSTEOARTHR CARTILAGE, V13, P297, DOI 10.1016/j.joca.2004.12.016
   Tognana E, 2005, OSTEOARTHR CARTILAGE, V13, P129, DOI 10.1016/j.joca.2004.10.015
   Tuan RS, 2003, J BONE JOINT SURG AM, V85A, P137, DOI 10.2106/00004623-200300002-00019
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   Vunjak-Novakovic G, 2002, BIORHEOLOGY, V39, P259
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Yoo JU, 1998, CLIN ORTHOP RELAT R, pS73
NR 48
TC 25
Z9 25
U1 0
U2 5
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 1063-4584
J9 OSTEOARTHR CARTILAGE
JI Osteoarthritis Cartilage
PD OCT
PY 2005
VL 13
IS 10
BP 896
EP 905
DI 10.1016/j.joca.2005.05.003
PG 10
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA 977QC
UT WOS:000232817300007
PM 16019238
OA Bronze
DA 2018-10-20
ER

PT J
AU Beltrano, J
   Torrisi, L
   Margarone, D
AF Beltrano, J
   Torrisi, L
   Margarone, D
TI Biocompatible film deposition by using Nd : YAG pulsed laser
SO RADIATION EFFECTS AND DEFECTS IN SOLIDS
LA English
DT Article; Proceedings Paper
CT 2nd International Workshop on Production of Intense Beams of Highly
   Charged Ions and Pulse Plasma Laser Ablation
CY JUN 08-11, 2005
CL Giardini Naxos, ITALY
SP Univ Messina, Inst Nazl Fis Nucl
DE hydroxyapatite; biomaterial; pulsed laser deposition
ID HYDROXYAPATITE
AB A Nd:YAG laser operating at the fundamental wavelength (1064 nm) and at the second harmonic (532 nm), with 9 ns pulse duration, 100-900 mJ pulse energy, and 30 Hz repetition rate mode, was employed to ablate in vacuum (10(-6) mbar) biomaterial targets and to deposit thin films on substrate backings. Titanium target was ablated at the fundamental frequency and deposited on near-Si substrates. The ablation yield increases with the laser fluence and at 40J/cm(2) the ablation yield for titanium is 1.2 x 10(16) atoms/pulse. Thin film of titanium was deposited on silicon substrates placed at different distance and angles with respect to the target and analysed with different surface techniques (optical microscopy, scanning electron spectrosopy (SEM), and surface profile).
   Hydroxyapatite (HA) target was ablated to the second harmonic and thin films were deposited on Ti and Si substrates. The ablation yield at a laser fluence of 10J/cm(2) is about 5x10(14) HA molecules/pulse. Thin film of HA, deposited on silicon substrates placed at different distance and angles with respect to the target, was analysed with different surface techniques (optical microscopy, SEM, and Raman spectroscopy).
   Metallic films show high uniformity and absence of grains, whereas the bio-ceramic film shows a large grain size distribution. Both films found special application in the field of biomaterial coverage.
C1 Ist Nazl Fis Nucl, Lab Nazl Sud, I-95129 Catania, Italy.
   Univ Messina, Dipartimento Fis, I-98100 Messina, Italy.
   Ist Nazl Fis Nucl, Sez Catania, Grp Coll Messina, Messina, Italy.
RP Beltrano, J (reprint author), Ist Nazl Fis Nucl, Lab Nazl Sud, I-95129 Catania, Italy.
EM curie71@hotmail.com
OI Lorenzo, Torrisi/0000-0003-0853-136X
CR deAza PN, 1997, CHEM MATER, V9, P916, DOI 10.1021/cm9604266
   HENCH LL, 1991, MRS BULL, V16, P62
   Nakamoto K., 1986, INFRARED RAMAN SPECT, P138
   PALAZZO U, 1992, RIV ITAL OSTEOINTEGR, V2, P10
   Ravaglioli A., 1992, BIOCERAMICS
   TORRISI L, 1993, THIN SOLID FILMS, V227, P32, DOI 10.1016/0040-6090(93)90183-P
   TORRISI L, 1993, APPL PHYS LETT, V62, P237, DOI 10.1063/1.108976
   TORRISI L, 2000, REV SCI INSTRUM, V71, P11
NR 8
TC 3
Z9 3
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1042-0150
J9 RADIAT EFF DEFECT S
JI Radiat. Eff. Defects Solids
PD OCT-DEC
PY 2005
VL 160
IS 10-12
BP 545
EP 552
DI 10.1080/10420150500492479
PG 8
WC Nuclear Science & Technology; Physics, Fluids & Plasmas; Physics,
   Condensed Matter
SC Nuclear Science & Technology; Physics
GA 019AZ
UT WOS:000235809300015
DA 2018-10-20
ER

PT J
AU Goppert, TM
   Muller, RH
AF Goppert, TM
   Muller, RH
TI Adsorption kinetics of plasma proteins on solid lipid nanoparticles for
   drug targeting
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE plasma protein adsorption kinetics; solid lipid nanoparticles;
   two-dimensional polyacrylamide gel electrophoresis; Vroman-effect;
   poloxamer 407; poloxamine 908
ID 2-DIMENSIONAL ELECTROPHORESIS; BIOMATERIAL SURFACES; COLLOIDAL CARRIERS;
   SAMPLE PREPARATION; SERUM-PROTEINS; BONE-MARROW; PARTICLES; LIPOSOMES;
   DELIVERY; PATTERNS
AB The interactions of intravenously injected carriers with plasma proteins are the determining factor for the in vivo fate of the particles. In this study the adsorption kinetics on solid lipid nanoparticles (SLN) were investigated and compared to the adsorption kinetics on previously analyzed polymeric model particles and O/W-emulsions. The adsorbed proteins were determined using two-dimensional polyacrylamide gel electrophoresis (2-DE). Employing diluted human plasma, a transient adsorption of fibrinogen was observed on the surface of SLN stabilized with the surfactant Tego Care 450, which in plasma of higher concentrations was displaced by apolipoproteins. This was in agreement with the "Vroman-effect" previously determined on solid surfaces. It says that in the early stages of adsorption, more plentiful proteins with low affinity are displaced by less plentiful with higher affinity to the surface. Over a period of time (0.5 min to 4 h) more interesting for the organ distribution of long circulating carriers, no relevant changes in the composition of the adsorption patterns of SLN, surface-modified with poloxamine 908 and poloxamer 407, respectively, were detected. This is in contrast to the chemically similar surface-modified polymeric particles but well in agreement with the surface-modified O/W-emulsions. As there is no competitive displacement of apolipoproteins on these modified SLN, the stable adsorption patterns may be better exploited for drug targeting than particles with an adsorption pattern being very dependent on contact time with plasma. (c) 2005 Elsevier B.V. All rights reserved.
C1 Free Univ Berlin, Inst Pharm, Dept Pharmaceut Technol Biotechnol & Qual Managem, D-12169 Berlin, Germany.
RP Muller, RH (reprint author), Free Univ Berlin, Inst Pharm, Dept Pharmaceut Technol Biotechnol & Qual Managem, Kelchstr 31, D-12169 Berlin, Germany.
EM mpharma@zedat.fu-berlin.de
CR ANDERSON NL, 1991, ELECTROPHORESIS, V12, P883, DOI 10.1002/elps.1150121108
   ARAI T, 1990, COLLOID SURFACE, V51, P186
   Archambault JG, 2004, COLLOID SURFACE B, V39, P9, DOI 10.1016/j.colsurfb.2004.08.009
   Babensee JE, 1998, BIOMATERIALS, V19, P839, DOI 10.1016/S0142-9612(97)00242-1
   BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1357, DOI 10.1002/elps.11501401209
   Blunk T, 1996, EUR J PHARM BIOPHARM, V42, P262
   BLUNK T, 1993, ELECTROPHORESIS, V14, P1382, DOI 10.1002/elps.11501401214
   BOISSONVIDAL C, 1991, J BIOMED MATER RES, V25, P67, DOI 10.1002/jbm.820250106
   BRASH JL, 1993, J BIOMAT SCI-POLYM E, V4, P591, DOI 10.1163/156856293X00816
   BRASH JL, 1987, PROTEINS INTERFACES, P490
   Camner P, 2002, J APPL PHYSIOL, V92, P2608, DOI 10.1152/japplphysiol.01067.2001
   Cattel L, 2003, TUMORI, V89, P237
   COOK BC, 1992, J COLLOID INTERF SCI, V153, P1, DOI 10.1016/0021-9797(92)90292-T
   Cornelius RM, 2002, J BIOMED MATER RES, V60, P622, DOI 10.1002/jbm.10117
   Cornelius RM, 2002, BIOMATERIALS, V23, P3583, DOI 10.1016/S0142-9612(02)00083-2
   Diederichs JE, 1996, ELECTROPHORESIS, V17, P607, DOI 10.1002/elps.1150170332
   Gessner A, 2001, INT J PHARM, V214, P87, DOI 10.1016/S0378-5173(00)00639-6
   Goppert TM, 2004, ELECTROPHORESIS, V25, P134, DOI 10.1002/elps.200305690
   GORG A, 1995, ICES 95 M PAR
   GRAHAM DE, 1979, J COLLOID INTERF SCI, V70, P403, DOI 10.1016/0021-9797(79)90048-1
   Harnisch S, 2000, EUR J PHARM BIOPHARM, V49, P41, DOI 10.1016/S0939-6411(99)00064-8
   Harnisch S, 1998, ELECTROPHORESIS, V19, P349, DOI 10.1002/elps.1150190233
   HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P424, DOI 10.1016/0003-2697(88)90209-6
   Hoogland C, 2000, NUCLEIC ACIDS RES, V28, P286, DOI 10.1093/nar/28.1.286
   ILLUM L, 1987, LIFE SCI, V40, P367, DOI 10.1016/0024-3205(87)90138-X
   ILLUM L, 1987, LIFE SCI, V40, P1553, DOI 10.1016/0024-3205(87)90120-2
   Jahangir R, 2003, BIOMATERIALS, V24, P121, DOI 10.1016/S0142-9612(02)00269-7
   JULIANO R L, 1988, Advanced Drug Delivery Reviews, V2, P31, DOI 10.1016/0169-409X(88)90004-X
   Kreuter J, 2002, J DRUG TARGET, V10, P317, DOI 10.1080/10611860290031877
   LEROUX JC, 1995, LIFE SCI, V57, P695, DOI 10.1016/0024-3205(95)00321-V
   LILIEMARK E, 1995, LEUKEMIA LYMPHOMA, V18, P113, DOI 10.3109/10428199509064930
   Luck M, 1998, J BIOMED MATER RES, V39, P478
   Luck M, 1997, ELECTROPHORESIS, V18, P2961, DOI 10.1002/elps.1150181538
   Luck M, 1998, J CONTROL RELEASE, V55, P107, DOI 10.1016/S0168-3659(98)00030-3
   MOGHIMI SM, 1993, BIOCHIM BIOPHYS ACTA, V1179, P157, DOI 10.1016/0167-4889(93)90137-E
   Moghimi SM, 1999, BBA-GEN SUBJECTS, V1472, P399, DOI 10.1016/S0304-4165(99)00157-9
   Muller R.H., 1996, European Patent, Patent No. [605497, 0605497]
   Muller RH, 1996, J DRUG TARGET, V4, P161, DOI 10.3109/10611869609015973
   Muller RH, 2002, ADV DRUG DELIVER REV, V54, pS131, DOI 10.1016/S0169-409X(02)00118-7
   Muller RH, 2000, EUR J PHARM BIOPHARM, V50, P161, DOI 10.1016/S0939-6411(00)00087-4
   MULLER RH, 1989, BIOADHESION POSSIBIL, P202
   MULLER RH, 2002, NEW DRUGS, V2, P38
   Ogawara K, 2004, J CONTROL RELEASE, V100, P451, DOI 10.1016/j.jconrel.2004.07.028
   Olbrich C, 2004, J PHARM PHARMACOL, V56, P883, DOI 10.1211/0022357023754
   OMULLANE JE, 1987, ANN NY ACAD SCI, V507, P120, DOI 10.1111/j.1749-6632.1987.tb45796.x
   Park YJ, 2003, J BIOMED MATER RES A, V67A, P751, DOI 10.1002/jbm.a.10167
   PHILLIPS MC, 1992, STRUCTURE FUNCTION A, P217
   PORTER CJH, 1992, FEBS LETT, V305, P62, DOI 10.1016/0014-5793(92)80655-Z
   Price ME, 2001, BBA-BIOMEMBRANES, V1512, P191, DOI 10.1016/S0005-2736(01)00330-3
   ROSSENEU M, 1992, STRUCTURE FUNCTION A
   Thiele L, 2003, BIOMATERIALS, V24, P1409, DOI 10.1016/S0142-9612(02)00525-2
   Thode K, 1997, PARTICLE AND SURFACE CHARACTERISATION METHODS, P229
   Thode K, 1997, PHARMACEUT RES, V14, P905, DOI 10.1023/A:1012104017761
   Unsworth LD, 2005, LANGMUIR, V21, P1036, DOI 10.1021/la047672d
   VROMAN L, 1986, J COLLOID INTERF SCI, V111, P391, DOI 10.1016/0021-9797(86)90042-1
   VROMAN L, 1980, BLOOD, V55, P156
   Weyhers H., 1995, P 1 WORLD M APGI APV, P489
   Wissing SA, 2004, ADV DRUG DELIVER REV, V56, P1257, DOI 10.1016/j.addr.2003.12.002
   Yamazaki A, 1999, BBA-BIOMEMBRANES, V1421, P103, DOI 10.1016/S0005-2736(99)00117-0
NR 59
TC 122
Z9 128
U1 5
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
EI 1873-3476
J9 INT J PHARMACEUT
JI Int. J. Pharm.
PD SEP 30
PY 2005
VL 302
IS 1-2
BP 172
EP 186
DI 10.1016/j.ijpharm.2005.06.025
PG 15
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 971WW
UT WOS:000232416600019
PM 16098695
DA 2018-10-20
ER

PT J
AU Kammerer, RA
   Kostrewa, D
   Progias, P
   Honnappa, S
   Avila, D
   Lustig, A
   Winkler, FK
   Pieters, J
   Steinmetz, MO
AF Kammerer, RA
   Kostrewa, D
   Progias, P
   Honnappa, S
   Avila, D
   Lustig, A
   Winkler, FK
   Pieters, J
   Steinmetz, MO
TI A conserved trimerization motif controls the topology of short coiled
   coils
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE protein engineering; sequence-to-structure rules; protein-protein
   interaction; salt bridges; x-ray crystallography
ID DE-NOVO DESIGN; TRANSMEMBRANE PROTEIN GP41; ALPHA-FIBROUS PROTEINS; GCN4
   LEUCINE-ZIPPER; OLIGOMERIZATION DOMAINS; CRYSTAL-STRUCTURE;
   MEMBRANE-FUSION; HEPTAD REPEAT; AMINO-ACID; PEPTIDE
AB In recent years, short coiled coils have been used for applications ranging from biomaterial to medical sciences. For many of these applications knowledge of the factors that control the topology of the engineered protein systems is essential. Here, we demonstrate that trimerization of short coiled coils is determined by a distinct structural motif that encompasses specific networks of surface salt bridges and optimal hydrophobic packing interactions. The motif is conserved among intracellular, extracellular, viral, and synthetic proteins and defines a universal molecular determinant for trimer formation of short coiled coils. In addition to being of particular interest for the biotechnological production of candidate therapeutic proteins, these findings may be of interest for viral drug development strategies.
C1 Paul Scherrer Inst, CH-5232 Villigen, Switzerland.
   Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 PT, Lancs, England.
   Basel Inst Immunol, CH-4005 Basel, Switzerland.
   Univ Basel, Bioctr, CH-4056 Basel, Switzerland.
RP Steinmetz, MO (reprint author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.
EM michel.steinmetz@psi.ch
OI Steinmetz, Michel/0000-0001-6157-3687; Pieters, Jean/0000-0002-5284-9757
FU Wellcome Trust
CR Akey DL, 2001, BIOCHEMISTRY-US, V40, P6352, DOI 10.1021/bi002829w
   Arndt KM, 2001, J MOL BIOL, V312, P221, DOI 10.1006/jmbi.2001.4915
   Beck K, 1997, EMBO J, V16, P3767, DOI 10.1093/emboj/16.13.3767
   BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259
   BLACKLOW SC, 1995, BIOCHEMISTRY-US, V34, P14955, DOI 10.1021/bi00046a001
   Burkhard P, 2002, J MOL BIOL, V318, P901, DOI 10.1016/S0022-2836(02)00114-6
   Burkhard P, 2000, PROTEIN SCI, V9, P2294, DOI 10.1110/ps.9.12.2294
   CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W
   Cho CH, 2004, P NATL ACAD SCI USA, V101, P5547, DOI 10.1073/pnas.0307574101
   Contegno F, 2002, P NATL ACAD SCI USA, V99, P1865, DOI 10.1073/pnas.042460299
   CONWAY JF, 1990, INT J BIOL MACROMOL, V12, P328, DOI 10.1016/0141-8130(90)90023-4
   CONWAY JF, 1991, INT J BIOL MACROMOL, V13, P14, DOI 10.1016/0141-8130(91)90004-E
   Eckert DM, 2001, P NATL ACAD SCI USA, V98, P11187, DOI 10.1073/pnas.201392898
   Frank S, 2002, J BIOL CHEM, V277, P19071, DOI 10.1074/jbc.M202146200
   Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042
   HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0
   HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779
   Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8
   Kammerer RA, 2004, P NATL ACAD SCI USA, V101, P4435, DOI 10.1073/pnas.0306786101
   Kammerer RA, 1998, J BIOL CHEM, V273, P10602, DOI 10.1074/jbc.273.17.10602
   Kohn WD, 1998, TRENDS BIOTECHNOL, V16, P379, DOI 10.1016/S0167-7799(98)01212-8
   Latvanlehto A, 2003, J BIOL CHEM, V278, P37590, DOI 10.1074/jbc.M305974200
   LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075
   LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162
   Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0
   Malashkevich VN, 2001, P NATL ACAD SCI USA, V98, P8502, DOI 10.1073/pnas.151254798
   McAlinden A, 2003, J BIOL CHEM, V278, P42200, DOI 10.1074/jbc.M302429200
   Meier M, 2002, J STRUCT BIOL, V137, P65, DOI 10.1006/jsbi.2002.4467
   Muller KM, 2000, METHOD ENZYMOL, V328, P261
   OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029
   PARRY DAD, 1982, BIOSCIENCE REP, V2, P1017, DOI 10.1007/BF01122170
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Rieker JD, 2000, METHOD ENZYMOL, V328, P282, DOI 10.1016/S0076-6879(00)28403-6
   Ryadnov MG, 2003, J AM CHEM SOC, V125, P9388, DOI 10.1021/ja0352045
   Severin K, 1997, NATURE, V389, P706
   Singh M, 1999, J MOL BIOL, V290, P1031, DOI 10.1006/jmbi.1999.2796
   Singh M, 1998, P NATL ACAD SCI USA, V95, P2738, DOI 10.1073/pnas.95.6.2738
   Supekar VM, 2004, P NATL ACAD SCI USA, V101, P17958, DOI 10.1073/pnas.0406128102
   Tai LJ, 2002, J BIOL CHEM, V277, P735, DOI 10.1074/jbc.M108604200
   Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866
   Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002
   Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Weng YK, 1998, J VIROL, V72, P9676
   Weng YK, 2000, J VIROL, V74, P5368, DOI 10.1128/JVI.74.11.5368-5372.2000
   Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606
   WOOLFSON DN, 1995, PROTEIN SCI, V4, P1596, DOI 10.1002/pro.5560040818
   Yang ZN, 1999, J STRUCT BIOL, V126, P131, DOI 10.1006/jsbi.1999.4116
NR 48
TC 67
Z9 72
U1 0
U2 4
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 27
PY 2005
VL 102
IS 39
BP 13891
EP 13896
DI 10.1073/pnas.0502390102
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 969KB
UT WOS:000232231900034
PM 16172398
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Microfluidic biomaterial
SO CHEMICAL & ENGINEERING NEWS
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 1
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD SEP 26
PY 2005
VL 83
IS 39
BP 37
EP 37
PG 1
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 967YR
UT WOS:000232127900044
DA 2018-10-20
ER

PT J
AU Guilherme, MR
   Reis, AV
   Takahashi, SH
   Rubira, AF
   Feitosa, JPA
   Muniz, EC
AF Guilherme, MR
   Reis, AV
   Takahashi, SH
   Rubira, AF
   Feitosa, JPA
   Muniz, EC
TI Synthesis of a novel superabsorbent hydrogel by copolymerization of
   acrylamide and cashew gum modified with glycidyl methacrylate
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE cashew gum; acrylamide; methacrylated-polysaccharide; aqueous-DMSO;
   superabsorbent hydrogel
ID POLYACRYLAMIDE HYDROGELS; ANACARDIUM-OCCIDENTALE; EXUDATE
   POLYSACCHARIDE; RHEOLOGICAL PROPERTIES; SEMI-IPNS; TREE GUM; BEHAVIOR;
   WATER; RELEASE; POLY(N-ISOPROPYLACRYLAMIDE)
AB Novel superabsorbent hydrogels were manufactured using chemically modified cashew gum (CGMA) and acrylamide (AAm) as reactants. The route for the synthesis was feasible due to the incorporation of glycidyl methacrylate (GMA) into structure of cashew gum (CG) to form the cashew gum-methacrylated (CGMA), in an appropriate mixture water-DMSO, as solvent, and using TEMED as catalyst. Thereafter, the CGMA was copolymerized with AAm yielding (CGMA-co-AAm) hydrogels. The main characteristics of raw and the modified materials are reported in this paper. C-13 NMR, H-1 NMR and FTIR spectroscopies confirmed the incorporation of vinyl groups, from GMA, into CG structure. By the spectrophotometry analyses, it was found that, ca. 82% of GMA was incorporated to the CG after 24 h of reaction. The cross-linking of CGMA or co-polymerization of CGMA with acrylamide leads to a hydrogel formation. Their gelation was characterized by FT-IR analysis. Alkaline hydrolysis at 40 degrees C for 3 and 4.5 h increased the water uptake (WU) capacity. Hydrolyzed CGMA-co-AAm hydrogels present higher values of WU (up to 1500) and may be classified as water superabsorbent material. Applications in agriculture, as soil conditioner, and in biomedical field, as biomaterial (scaffold) are being investigated. (C) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Estadual Maringa, Dept Quim, GMPC, BR-87020 Maringa, Parana, Brazil.
   Univ Fed Ceara, Dept Quim Organ & Inorgan, BR-60455760 Fortaleza, Ceara, Brazil.
RP Muniz, EC (reprint author), Univ Estadual Maringa, Dept Quim, GMPC, Av Colombo,5790 Zona Sete, BR-87020 Maringa, Parana, Brazil.
EM ecmuniz@uem.br
RI Guilherme, Marcos/J-6008-2012
OI Muniz, Edvani/0000-0001-6685-1519; Guilherme, Marcos/0000-0002-4260-5660
CR Bajpai AK, 2003, CARBOHYD POLYM, V53, P271, DOI 10.1016/S0144-8617(03)00071-7
   Bell CL, 1995, ADV POLYM SCI, V122, P125
   BOURANIS DL, 1995, COMMUN SOIL SCI PLAN, V26, P2461, DOI 10.1080/00103629509369460
   Chatzoudis GK, 1999, COMMUN SOIL SCI PLAN, V30, P2465, DOI 10.1080/00103629909370387
   Chatzoudis GK, 1998, J AGR FOOD CHEM, V46, P2830, DOI 10.1021/jf970969f
   Chen J, 2000, CARBOHYD POLYM, V41, P259, DOI 10.1016/S0144-8617(99)00144-7
   DEPAULA RCM, 1995, CARBOHYD POLYM, V26, P177, DOI 10.1016/0144-8617(95)00006-S
   DRUBOVSKII SA, 1994, POLYM GELS NETW, V2, P49
   Ferreira L, 2000, CARBOHYD POLYM, V41, P15, DOI 10.1016/S0144-8617(99)00064-8
   Guilherme MR, 2003, POLYMER, V44, P4213, DOI 10.1016/S0032-3861(03)00370-7
   GUILHERME MR, 2004, Patent No. 0404265
   GUTOWSKA A, 1994, MACROMOLECULES, V27, P4167, DOI 10.1021/ma00093a018
   Kabiri K, 2003, EUR POLYM J, V39, P1341, DOI 10.1016/S0014-3057(02)00391-9
   Karadag E, 2002, EUR POLYM J, V38, P2133, DOI 10.1016/S0014-3057(02)00117-9
   Kwok AY, 2003, POLYMER, V44, P7335, DOI 10.1016/j.polymer.2003.09.026
   Mahdavinia GR, 2004, EUR POLYM J, V40, P1399, DOI 10.1016/j.europolymj.2004.01.039
   Menestrina JM, 1998, PHYTOCHEMISTRY, V47, P715, DOI 10.1016/S0031-9422(97)00666-3
   Mothe CG, 1999, FOOD HYDROCOLLOID, V13, P501, DOI 10.1016/S0268-005X(99)00035-1
   Mothe CG, 2000, THERMOCHIM ACTA, V357, P9, DOI 10.1016/S0040-6031(00)00358-0
   Muniz EC, 2000, J MEMBRANE SCI, V172, P287, DOI 10.1016/S0376-7388(00)00346-X
   Muniz EC, 2001, MACROMOLECULES, V34, P4480, DOI 10.1021/ma001192l
   Okay O, 2000, EUR POLYM J, V36, P393, DOI 10.1016/S0014-3057(99)00058-0
   Reis AV, 2003, INT J PHARM, V267, P13, DOI 10.1016/j.ijpharm.2003.08.001
   Sannino A, 2003, J BIOMED MATER RES A, V67A, P1016, DOI 10.1002/jbm.a.10149
   Sarubbo LA, 2000, J CHROMATOGR B, V743, P79, DOI 10.1016/S0378-4347(99)00516-2
   Silva DA, 2004, CARBOHYD POLYM, V58, P163, DOI 10.1016/j.carbpol.2004.06.034
   VANDIJKWOLTHUIS WNE, 1995, MACROMOLECULES, V28, P6317, DOI 10.1021/ma00122a044
   Yang SY, 2003, BIOMACROMOLECULES, V4, P987, DOI 10.1021/bm034035d
   Zakaria MB, 1996, CARBOHYD POLYM, V29, P25, DOI 10.1016/0144-8617(95)00132-8
NR 29
TC 84
Z9 88
U1 4
U2 73
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD SEP 21
PY 2005
VL 61
IS 4
BP 464
EP 471
DI 10.1016/j.carbpol.2005.06.017
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 969OZ
UT WOS:000232245100011
DA 2018-10-20
ER

PT J
AU Chevallier, P
   Janvier, R
   Mantovani, D
   Laroche, G
AF Chevallier, P
   Janvier, R
   Mantovani, D
   Laroche, G
TI In vitro biological performances of phosphorylcholine-grafted ePTFE
   prostheses through RFGD plasma techniques
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE blood compatibility; phosphorylcholine; plasma treatment;
   polytetrafluoroethylene
ID PHOSPHOLIPID POLAR GROUP; POLYETHYLENE-GLYCOL; PLATELET DEPOSITION;
   MOLECULAR BARRIERS; NEOINTIMAL HYPERPLASIA; BIOMATERIAL THROMBOSIS;
   ATHROMBOGENIC COATINGS; ARTERIAL PROSTHESES; SURFACE-CHEMISTRY;
   GLOW-DISCHARGE
AB Arterial prostheses made of microporous Teflon (R) (ePTFE) are currently used in vascular surgery as bypasses for small and medium vessels. However, several clinical complications, such as thrombosis, frequently occur in these prostheses when implanted in humans. In this work, an original strategy was developed to improve the hemo-compatibility of ePTFE prostheses, based on glow-discharge surface modification followed by chemical grafting of phosphorylcholine, known for its hemocompatible properties. This procedure leads to a covalent attachment of the molecules, therefore preventing their removal by shear stress induced by blood flow at the implant wall. The improvement of the modified ePTFE arterial prostheses have been investigated by in vitro tests such as thromboelastography, neutrophil adsorption, platelet aggregation, and cell cultures. These in vitro tests put in evidence that thrombogenicity index, platelet aggregation, and neutrophil adhesion were decreased by the molecule grafted on the prostheses. Moreover, the cell growth on the surface of the PRC-grafted prostheses was greatly enhanced in its comparison to the virgin prosthesis. Based on these results, it could be concluded that PRC grafting on ePTFE prostheses permit to improve in vitro hemocompatibilty and biocompatability in comparison wit their virgin counterpart.
C1 CHUQ, Hop St Francois Assise, Ctr Rech, Unite Biotechnol & Bioingn, Quebec City, PQ G1L 3L5, Canada.
   Univ Laval, Dept Genie Mines Met & Mat, Quebec City, PQ G1K 7P4, Canada.
RP Laroche, G (reprint author), CHUQ, Hop St Francois Assise, Ctr Rech, Unite Biotechnol & Bioingn, 10 Rue Espinay, Quebec City, PQ G1L 3L5, Canada.
EM gaetan.laroche@gmn.ulaval.ca
OI Mantovani, Diego/0000-0001-9672-895X
CR ANDREWS WE, 1969, SURGERY, V66, P535
   Baumann H, 1997, SEMIN THROMB HEMOST, V23, P215, DOI 10.1055/s-2007-996093
   Baumann H, 1997, SEMIN THROMB HEMOST, V23, P203, DOI 10.1055/s-2007-996092
   BRASH JL, 1977, ANN NY ACAD SCI, V283, P356, DOI 10.1111/j.1749-6632.1977.tb41781.x
   BRIGGS D, 1989, HDB STAT SECONDARY I, P164
   Campbell E J, 1994, ASAIO J, V40, pM853, DOI 10.1097/00002480-199407000-00118
   CHAKFE N, 1993, POLYM POLYM COMPOS, V1, P229
   CHAPIN RE, 1993, FUND APPL TOXICOL, V21, P8, DOI 10.1006/faat.1993.1065
   CHAPMAN D, 1993, LANGMUIR, V9, P39, DOI 10.1021/la00025a012
   Chapman D, 1998, PROG COLL POL SCI S, V108, P17
   Chen CY, 1997, ANN VASC SURG, V11, P74, DOI 10.1007/s100169900013
   Chen CY, 1998, J SURG RES, V77, P119, DOI 10.1006/jsre.1998.5399
   Chevallier P, 2001, J PHYS CHEM B, V105, P12490, DOI 10.1021/jp011607k
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   Deible CR, 1999, BIOMATERIALS, V20, P101, DOI 10.1016/S0142-9612(98)00001-5
   Deible CR, 1998, BIOMATERIALS, V19, P1885, DOI 10.1016/S0142-9612(98)00098-2
   Deible CR, 1998, J BIOMED MATER RES, V41, P251
   Estrela-Lopis I, 2001, BIOPHYS J, V80, P749, DOI 10.1016/S0006-3495(01)76054-7
   *FDN MAL COEUR CAN, 1999, NOUV VIS MAL CARD AC
   Fujii H, 2000, THROMB RES, V100, P519, DOI 10.1016/S0049-3848(00)00364-9
   GUIDOIN R, 1993, BIOMATERIALS, V14, P678, DOI 10.1016/0142-9612(93)90067-C
   Guidoin R, 1996, ASAIO J, V42, P974, DOI 10.1097/00002480-199642060-00010
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ, P785
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   ISHIHARA K, 1995, BIOMATERIALS, V16, P873, DOI 10.1016/0142-9612(95)94150-J
   ISHIHARA K, 1993, J BIOMED MATER RES, V27, P1309, DOI 10.1002/jbm.820271011
   Iwasaki Y, 1999, J BIOMAT SCI-POLYM E, V10, P513, DOI 10.1163/156856299X00450
   Iwasaki Y, 1998, J BIOMAT SCI-POLYM E, V9, P801, DOI 10.1163/156856298X00163
   JOZEFONVICZ J, 1990, Journal of Biomaterials Science Polymer Edition, V1, P147
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   Levesque S, 2002, COLLOID SURFACE B, V25, P205, DOI 10.1016/S0927-7765(01)00323-X
   LOH FC, 1993, POLYMER, V34, P5000, DOI 10.1016/0032-3861(93)90036-A
   Machy D, 2002, J BIOMAT SCI-POLYM E, V13, P963, DOI 10.1163/156856202320401997
   Mantovani D., 1999, Plasmas and Polymers, V4, P207, DOI 10.1023/A:1021805110689
   Mantovani D, 1999, BIOMATERIALS, V20, P1023, DOI 10.1016/S0142-9612(98)00227-0
   MANTSCH HH, 1991, CHEM PHYS LIPIDS, V57, P213, DOI 10.1016/0009-3084(91)90077-O
   Massia SP, 2000, BIOMATERIALS, V21, P2253, DOI 10.1016/S0142-9612(00)00151-4
   *MED DAT INT, 1999, US MARK CARD CARD SU
   NEWMAN JC, 1991, STATIC SIMS HDB POLY
   Ritter EF, 1997, SURGERY, V122, P888, DOI 10.1016/S0039-6060(97)90329-9
   SANTERRE JP, 1992, J BIOMED MATER RES, V26, P1003, DOI 10.1002/jbm.820260804
   Sefton MV, 2001, J BIOMED MATER RES, V55, P447, DOI 10.1002/1097-4636(20010615)55:4<447::AID-JBM1036>3.0.CO;2-5
   SHOENFELD NA, 1987, J VASC SURG, V5, P76, DOI 10.1067/mva.1987.avs0050076
   Stuhlmeier KM, 1999, BBA-GEN SUBJECTS, V1428, P177, DOI 10.1016/S0304-4165(99)00065-3
   Tegoulia VA, 2000, J BIOMED MATER RES, V50, P291, DOI 10.1002/(SICI)1097-4636(20000605)50:3<291::AID-JBM2>3.0.CO;2-1
   URETZKY G, 1990, J THORAC CARDIOV SUR, V100, P769
   YIANNI YP, 1992, PRESS RES MONOGRAPH, P187
   Yung LYL, 1998, BIOMATERIALS, V19, P31, DOI 10.1016/S0142-9612(97)00220-2
   Zhang Q, 2002, J BIOMED MATER RES, V60, P502, DOI 10.1002/jbm.1294
   Zwaal R F, 1983, Subcell Biochem, V9, P299
   ZWAAL RFA, 1977, NATURE, V268, P358, DOI 10.1038/268358a0
   2001, Patent No. 02070032
NR 54
TC 28
Z9 31
U1 0
U2 11
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD SEP 16
PY 2005
VL 5
IS 9
BP 829
EP 839
DI 10.1002/mabi.200500088
PG 11
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 967GI
UT WOS:000232079100003
PM 16134089
DA 2018-10-20
ER

PT J
AU Babensee, JE
   Paranjpe, A
AF Babensee, JE
   Paranjpe, A
TI Differential levels of dendritic cell maturation on different
   biomaterials used in combination products
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; dendritic cells; maturation; adjuvant
ID TOLL-LIKE RECEPTORS; NF-KAPPA-B; IMMUNE-RESPONSE; HYALURONIC-ACID;
   BIOARTIFICIAL PANCREAS; ANTIBODY-RESPONSES; INNATE IMMUNITY; MODEL
   ANTIGEN; DC-SIGN; CARTILAGE
AB Immature dendritic cells (iDCs) were derived from human peripheral blood monocytes, and treated with films of biomaterials commonly used in combination products (e.g., tissue engineered constructs or vaccines) to assess the resultant dendritic cell (DC) maturation compared to positive control of lipopolysaccharide (LPS) treatment for DC maturation or negative control of untreated iDCs. The following biomaterials were tested: alginate, agarose, chitosan, hyaluronic acid, 75:25 poly(lactic-co-glycolic acid) (PLGA). The effect of DC culture on these films was undertaken to identify biomaterials which support DC maturation and those biomaterials that did not. Dendritic cells treated with chitosan or PLGA (agarose to a lesser extent) films increased expression levels of CD86, CD40, and HLA-DQ, compared to control iDCs, similar to LPS-matured DCs whereas DCs treated with alginate or hyaluronic acid films decreased their expression levels of these same molecules. In summary, a differential effect of the biomaterial on which iDCs were cultured was observed as far as the extent of induced DC maturation. The effect of biomaterials on DC maturation, and the associated adjuvant effect, is a novel biocompatibility selection and design criteria for biomaterials to be used in combination products in which immune consequences are potential complications or outcomes. (c) 2005 Wiley Periodicals, Inc.
C1 Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
   Emory Univ, Atlanta, GA 30332 USA.
RP Babensee, JE (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM Julia.babensee@bme.gatech.edu
CR Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   COLTON CK, 1991, T ASME, V113, P152
   de Chalain T, 1999, J BIOMED MATER RES, V44, P280, DOI 10.1002/(SICI)1097-4636(19990305)44:3<280::AID-JBM6>3.0.CO;2-H
   Ding ZM, 1999, J IMMUNOL, V163, P5029
   Engering A, 2002, TRENDS IMMUNOL, V23, P480, DOI 10.1016/S1471-4906(02)02296-2
   Ertl HCJ, 1996, VACCINE, V14, P879, DOI 10.1016/0264-410X(96)00005-9
   ESPEVIK T, 1993, EUR J IMMUNOL, V23, P255, DOI 10.1002/eji.1830230140
   Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723
   Flo TH, 2002, J BIOL CHEM, V277, P35489, DOI 10.1074/jbc.M201366200
   Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200
   Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5
   Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815
   GHOSH S, 1998, ANNU REV IMMUNOL, V16, P224
   Hitchen PG, 1998, BIOCHEM J, V333, P601, DOI 10.1042/bj3330601
   Hwang SM, 2000, BIOCHEM BIOPH RES CO, V271, P229, DOI 10.1006/bbrc.2000.2602
   IWATA H, 1992, J BIOMED MATER RES, V26, P967, DOI 10.1002/jbm.820260711
   Janeway CA, 1998, SEMIN IMMUNOL, V10, P349, DOI 10.1006/smim.1998.0142
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   Jotwani R, 2003, EUR J IMMUNOL, V33, P2980, DOI 10.1002/eji.200324392
   Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3
   Kulseng B, 1999, TRANSPLANTATION, V67, P978, DOI 10.1097/00007890-199904150-00008
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Lemoine D, 1998, INT J PHARMACEUT, V176, P9, DOI 10.1016/S0378-5173(98)00303-2
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8
   Martin I, 2001, J BIOMED MATER RES, V55, P229, DOI 10.1002/1097-4636(200105)55:2<229::AID-JBM1009>3.3.CO;2-H
   Matzelle MM, 2004, BIOMATERIALS, V25, P295, DOI 10.1016/S0142-9612(03)00531-3
   MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015
   May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3
   McCluskie M J, 2001, Curr Opin Investig Drugs, V2, P35
   Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Newman KD, 1998, J CONTROL RELEASE, V54, P49, DOI 10.1016/S0168-3659(97)00142-9
   O'Hagan DT, 2003, NAT REV DRUG DISCOV, V2, P727, DOI 10.1038/nrd1176
   OHAGAN DT, 1993, VACCINE, V11, P965, DOI 10.1016/0264-410X(93)90387-D
   Papas KK, 1999, BIOTECHNOL BIOENG, V66, P219
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   Przetak M, 2003, VACCINE, V21, P961, DOI 10.1016/S0264-410X(02)00737-5
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   Rahfoth B, 1998, OSTEOARTHR CARTILAGE, V6, P50, DOI 10.1053/joca.1997.0092
   Sabroe I, 2003, J IMMUNOL, V171, P1630, DOI 10.4049/jimmunol.171.4.1630
   Seferia P.G., 2001, VACCINE, V19, P661
   Singh M, 2000, P NATL ACAD SCI USA, V97, P811, DOI 10.1073/pnas.97.2.811
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   STARKE JR, 1987, PEDIATR RES, V22, P698, DOI 10.1203/00006450-198712000-00017
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   TACHIYAMA G, 1986, THROMB RES, V37, P309
   Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863
   Tomihata K, 1997, J BIOMED MATER RES, V37, P243
   Tun T, 1996, CELL TRANSPLANT, V5, pS59, DOI 10.1016/0963-6897(96)00042-5
   van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182
   WARR GA, 1980, BIOCHEM BIOPH RES CO, V93, P737, DOI 10.1016/0006-291X(80)91139-0
   WEBER N, 2003, J BIOMED MATER RES A, V68, P496
   Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317
   Yang R, 2002, SCAND J IMMUNOL, V55, P2, DOI 10.1046/j.0300-9475.2001.01033.x
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837
   Zhao Z, 1996, J PHARM SCI-US, V85, P1261, DOI 10.1021/js9602812
   Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588
NR 63
TC 74
Z9 77
U1 0
U2 14
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2005
VL 74A
IS 4
BP 503
EP 510
DI 10.1002/jbm.a.30429
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 959JC
UT WOS:000231513000001
PM 16158496
DA 2018-10-20
ER

PT J
AU Phaneuf, MD
   Bide, MJ
   Hannel, SL
   Platek, MJ
   Monahan, TS
   Contreras, MA
   Phaneuf, TM
   LoGerfo, FW
AF Phaneuf, MD
   Bide, MJ
   Hannel, SL
   Platek, MJ
   Monahan, TS
   Contreras, MA
   Phaneuf, TM
   LoGerfo, FW
TI Development of an infection-resistant, bioactive wound dressing surface
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE wound dressing; antimicrobial; thrombin; surface modification; textile
   dyeing technology; crosslinking
ID ACUTE MYOCARDIAL-INFARCTION; PTFE VASCULAR GRAFT; DYEING TECHNOLOGY;
   DACRON; PROSTHESES; PREVENTION; THROMBIN; INVITRO; CIPROFLOXACIN;
   ANTIBIOTICS
AB Trauma, whether caused by an accident or in an intentional manner, results in significant morbidity and mortality. The goal of this study was to develop a novel biomaterial surface in vitro and ex vivo that provides both localized infection resistance nd hemostatic properties. Our hypothesis is that a combination of specific surface characteristics can be successfully incorporated into a single biomaterial. Functional groups were created with woven Dacron (Cntrl) material via exposure to ethylenediamine (CEDA). The antibiotic ciprofloxacin (Cipro) was then applied to the C-EDA material using pad/autoclave technique (CEDA-AB) followed by surface immobilization of the coagulation cascade enzyme thrombin (C-EDA-AB-Thrombin). Antimicrobial activity by the C-EDA-AB surface persisted for 5 days compared with Cntrl and dipped controls, which lasted < 1 h. C-EDA-AB-Thrombin surfaces had 2.6- and 105-fold greater surface thrombin activity compared with nonspecifically bound thrombin and Cipro-dyed surfaces, respectively. Surface thrombus formation ex vivo was evident after 1 min of exposure, with thrombus organization evident by 2.5 min. In contrast, C-EDA-AB and Cntrl segments showed only blood protein adsorption on the fibers. Thus, this study demonstrated that Cipro and thrombin can be simultaneously incorporated onto a biomaterial surface while maintaining their respective biological activities. (c) 2005 Wiley Periodicals, Inc.
C1 BioSurfaces, Ashland, MA 01721 USA.
   Univ Rhode Isl, Dept Text Fash Merchandising & Design, Kingston, RI 02881 USA.
   Univ Rhode Isl, Dept Elect Engn Surface Sci & Technol, Kingston, RI 02881 USA.
   Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.
RP Phaneuf, MD (reprint author), BioSurfaces, 171 Main St,Suite 302, Ashland, MA 01721 USA.
EM biosurfaces@verizon.net
CR AGGARWAL P, 2003, P AM CHEM SOC OCT
   *AM COLL SURG, 2003, HIGHL AM COLL SURG
   *AM TRAUM SOC, 2002, TRAUM SYST AG FUT EX
   ANDERSON HV, 1993, NEW ENGL J MED, V329, P703
   BARSHAVIT R, 1983, SCIENCE, V220, P728, DOI 10.1126/science.6836310
   Bide M, 2003, AATCC REV, V3, P24
   BIDE M, 1993, TEXT CHEM COLOR, V25, P15
   BIZIOS R, 1986, J CELL PHYSIOL, V128, P485, DOI 10.1002/jcp.1041280318
   CHERVU A, 1991, J VASC SURG, V14, P521, DOI 10.1016/0741-5214(91)90246-Q
   CHVAPIL M, 1991, J SURG RES, V51, P245, DOI 10.1016/0022-4804(91)90102-R
   COLEMAN R, 1987, HEMOSTASIS THROMBOSI
   *E ASS SURG TRAUM, 1998, TRAUM PRACT GUID PRA
   FENTON JW, 1988, SEMIN THROMB HEMOST, V14, P234, DOI 10.1055/s-2007-1002783
   Fitton A, 1992, Clin Pharmacokinet, V22 Suppl 1, P1
   GoeauBrissonniere O, 1996, J MAL VASCUL, V21, P146
   GOLOMB G, 1991, J BIOMED MATER RES, V25, P937, DOI 10.1002/jbm.820250803
   GRECO F, 1991, J BIOMED MATER RES, V25, P39, DOI 10.1002/jbm.820250104
   GRECO RS, 1985, ARCH SURG-CHICAGO, V120, P71
   GROHE K, 1992, CHEM BRIT, V28, P34
   GULBA DC, 1991, CIRCULATION, V83, P937, DOI 10.1161/01.CIR.83.3.937
   HARVEY RA, 1981, ANN SURG, V194, P642, DOI 10.1097/00000658-198111000-00015
   HAVERICH A, 1992, J VASC SURG, V15, P187, DOI 10.1016/0741-5214(92)70027-I
   HOWELL JM, 1992, ANN EMERG MED, V21, P976, DOI 10.1016/S0196-0644(05)82938-5
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   KRAJICEK M, 1969, J CARDIOVASC SURG, V10, P453
   LINDSEY D, 1982, J TRAUMA, V22, P186, DOI 10.1097/00005373-198203000-00002
   LizanGarcia M, 1997, INFECT CONT HOSP EP, V18, P310
   MCDOUGAL EG, 1986, J VASC SURG, V4, P5, DOI 10.1067/mva.1986.avs0040005
   MODAK SM, 1987, SURG GYNECOL OBSTET, V164, P143
   OKAHARA K, 1995, EUR J VASC ENDOVASC, V9, P408, DOI 10.1016/S1078-5884(05)80008-5
   OZAKI CK, 1993, J SURG RES, V55, P543, DOI 10.1006/jsre.1993.1181
   Phaneuf MD, 1997, BIOMATERIALS, V18, P755, DOI 10.1016/S0142-9612(96)00193-7
   Phaneuf MD, 2000, ANTIMICROBIAL/ANTI-INFECTIVE MATERIALS, P239
   PHANEUF MD, 1995, J APPL BIOMATER, V6, P289, DOI 10.1002/jab.770060410
   PHANEUF MD, 1993, J BIOMED MATER RES, V27, P233, DOI 10.1002/jbm.820270213
   PHANEUF MD, 2002, NOVEL BIFUNCTIONALIZ
   SAWAN S, 1999, INFECT RESISTANT MAT
   SAWYER PN, 1979, J BIOMED MATER RES, V13, P937, DOI 10.1002/jbm.820130611
   SCHER KS, 1982, AM SURGEON, V48, P268
   SHENK JS, 1989, J SURG RES, V47, P487, DOI 10.1016/0022-4804(89)90125-X
   SHEPARD AD, 1984, J VASC SURG, V1, P829, DOI 10.1067/mva.1984.avs0010829
   Strachan C J, 1991, Eur J Vasc Surg, V5, P627, DOI 10.1016/S0950-821X(05)80896-5
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   Tweden KS, 1997, ASAIO J, V43, pM475
   Vournakis JN, 2003, J SURG RES, V113, P1, DOI 10.1016/S0022-4804(03)00161-6
   WALZ DA, 1986, ANN NY ACAD SCI, V485, P323, DOI 10.1111/j.1749-6632.1986.tb34594.x
   Whalen RL, 1997, ASAIO J, V43, pM842
   WOOD MJ, 1988, BRIT J CLIN PRACT, V42, P469
NR 48
TC 14
Z9 14
U1 2
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2005
VL 74A
IS 4
BP 666
EP 676
DI 10.1002/jbm.a.30347
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 959JC
UT WOS:000231513000018
PM 16028237
DA 2018-10-20
ER

PT J
AU Hole, BB
   Schwarz, JA
   Gilbert, JL
   Atkinson, BL
AF Hole, BB
   Schwarz, JA
   Gilbert, JL
   Atkinson, BL
TI A study of biologically active peptide sequences (P-15) on the surface
   of an ABM scaffold (PepGen P-15 (TM)) using AFM and FTIR
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE AFM; FTIR; tissue engineering; hydroxyapatite; xenograft
ID FOURIER SELF-DECONVOLUTION; CONTINUOUS PK DISTRIBUTION;
   ELECTRON-SPIN-RESONANCE; GAMMA-ALOOH INTERFACE; PROTON BINDING;
   CELL-BINDING; SPECTROSCOPY; PROTEINS; BONE; HYDROXYAPATITE
AB Cellular response to any biomaterial surface is governed by a number of factors including topography, surface chemistry, surface charge, structural heterogeneity, and physiological conditions. Understanding these factors at the nanoscale level is crucial to develop improved biomaterials. Any changes in these properties due to surface modifications need to be addressed properly, as they could have significant impact on the cellular interaction with biomaterials. In this study, the topography and surface chemistry of commercially available tissue engineered xenograft, PepGen P-15 (TM) [comprised of a synthetic peptide P-15 irreversibly attached to anorganic bovine bone mineral (OsteoGraf/N (R))] was studied using Atomic Force Microscopy (AFM), and Fourier Transform Infrared Spectroscopy (FTIR). FTIR confirmed the presence of the peptide on the surface of PepGen P-15 (TM). Changes in the peptide conformation, which includes a decrease in the P-strand accompanied by an increase in unordered structures/ random coil structures after attachment on OsteoGraf/-N (R) is observed. Specific functional groups, which are involved in the binding mechanism, are identified. The results suggest that the attachment of the peptide on OsteoGraf/-N (R) occurs via a specific surface docking ionic interaction involving the C-terminal carboxylic group on the peptide with positive domains generated by hydroxyl vacancies on the apatite surface. (c) 2005 Wiley Periodicals, Inc.
C1 Syracuse Univ, Dept Chem Engn & Mat Sci, Syracuse, NY 13244 USA.
   Syracuse Univ, Dept Bioengn, Syracuse, NY 13244 USA.
   Dentsply Friadent CeraMed, Lakewood, CO 80228 USA.
RP Hole, BB (reprint author), Syracuse Univ, Dept Chem Engn & Mat Sci, Syracuse, NY 13244 USA.
EM bbhole@syr.edu
CR Bhatnagar RS, 1997, J BIOMOL STRUCT DYN, V14, P547, DOI 10.1080/07391102.1997.10508155
   Bhatnagar RS, 1999, TISSUE ENG, V5, P53, DOI 10.1089/ten.1999.5.53
   BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307
   Contescu A, 1997, CARBON, V35, P83, DOI 10.1016/S0008-6223(96)00125-X
   Contescu A, 1998, CARBON, V36, P247, DOI 10.1016/S0008-6223(97)00168-1
   CONTESCU C, 1994, J PHYS CHEM-US, V98, P4327, DOI 10.1021/j100067a020
   CONTESCU C, 1993, LANGMUIR, V9, P1754, DOI 10.1021/la00031a024
   COSTANTINO HR, 1994, J PHARM SCI-US, V83, P1662, DOI 10.1002/jps.2600831205
   DOI Y, 1982, CALCIFIED TISSUE INT, V34, pS47
   DOI Y, 1979, CALCIFIED TISSUE INT, V28, P107, DOI 10.1007/BF02441228
   DONG AC, 1995, J PHARM SCI-US, V84, P415, DOI 10.1002/jps.2600840407
   Hanks T, 2004, BIOMATERIALS, V25, P4831, DOI 10.1016/j.biomaterials.2003.12.007
   HOLE BB, 2004, THESIS SYRACUSE U
   Huffman EWD, 2003, MICROCHEM J, V74, P249, DOI 10.1016/S0026-265X(03)00031-6
   JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140
   KAUPPINEN JK, 1981, APPL SPECTROSC, V35, P271, DOI 10.1366/0003702814732634
   KAUPPINEN JK, 1981, APPL OPTICS, V20, P1866, DOI 10.1364/AO.20.001866
   Kendrick BS, 1996, J PHARM SCI, V85, P155, DOI 10.1021/js950332f
   Kirkham J, 2002, CURR OPIN COLLOID IN, V7, P124, DOI 10.1016/S1359-0294(02)00017-1
   KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8
   LITTLE LH, 1966, INFRARED SPECTRA ABD
   MANTSCH HH, 1986, SPECTROSCOPY BIOL SY, P1
   Nordin J, 1998, LANGMUIR, V14, P3655, DOI 10.1021/la9712449
   Nordin J, 1997, LANGMUIR, V13, P4085, DOI 10.1021/la970066g
   PATEL N, 1997, LANGMUIR, V13, P4106
   PRESTRELSKI SJ, 1993, BIOPHYS J, V65, P661, DOI 10.1016/S0006-3495(93)81120-2
   Qian JJ, 1996, J BIOMED MATER RES, V31, P545, DOI 10.1002/(SICI)1097-4636(199608)31:4<545::AID-JBM15>3.0.CO;2-F
   SCHWARZ JA, 2002, ENCY SURFACE COLLOID
   SCHWARZ JA, 1994, CATALYSIS, V11, P127
   Tanaka H, 1999, J COLLOID INTERF SCI, V214, P31, DOI 10.1006/jcis.1999.6154
   Terra J, 2002, PHILOS MAG A, V82, P2357, DOI 10.1080/01418610210131010
   VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1243, DOI 10.1002/bip.360301309
   YANG WJ, 1985, APPL SPECTROSC, V39, P282, DOI 10.1366/0003702854248917
NR 33
TC 17
Z9 18
U1 2
U2 8
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2005
VL 74A
IS 4
BP 712
EP 721
DI 10.1002/jbm.a.30331
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 959JC
UT WOS:000231513000023
PM 16021612
DA 2018-10-20
ER

PT J
AU Jackson, LE
   Kariuki, BM
   Smith, ME
   Barralet, JE
   Wright, AJ
AF Jackson, LE
   Kariuki, BM
   Smith, ME
   Barralet, JE
   Wright, AJ
TI Synthesis and structure of a calcium polyphosphate with a unique
   criss-cross arrangement of helical phosphate chains
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID BINARY-SYSTEM P2O5-2CAOP(2)O(5); BONE SUBSTITUTE APPLICATIONS; SCAFFOLDS
AB We report here the facile synthesis and structural characterization of gamma-Ca(PO3)2, a novel polymorph of calcium polyphosphate. The single-step synthesis of this potential biomaterial was achieved using flux methods at 250 degrees C, yielding a single-phase product stable at room temperature. Single-crystal X-ray diffraction determined the structure to be of monoclinic symmetry (a = 9.5669(2) angstrom, b = 9.5023(2) angstrom, c = 10.3717(3) angstrom, and beta = 93.474(2)degrees, space group Cc), with layers of helical polyphosphate chains directed alternately along the [110] and [110] unit cell directions to produce a unique arrangement of criss-cross polyphosphate layers separated by calcium ions. Further structural characterization by MAS-NMR and FT-IR was found to be consistent with this structure. Thermal studies indicated that gamma-Ca(PO3)(2) is stable up to 690 degrees C, whereupon it irreversibly converts to the P-Ca(PO3)(2) polymorph.
C1 Univ Birmingham, Sch Chem, Birmingham B15 2TT, W Midlands, England.
   Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England.
   McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada.
RP Wright, AJ (reprint author), Univ Birmingham, Sch Chem, Birmingham B15 2TT, W Midlands, England.
EM a.j.wright@bham.ac.uk
RI barralet, jake/A-5820-2008; Renold, Ria/K-7051-2018; Kariuki,
   Benson/E-3469-2017
OI barralet, jake/0000-0003-3543-6042; Kariuki, Benson/0000-0002-8658-3897
CR Barlow JW, 1997, U. S. Patent, Patent No. 5639402
   BARLOW JW, 2001, Patent No. 618351
   BROWN WE, 1985, Patent No. 4518430
   *BRUK AXS INC, SAINTPLUS PROGR SUIT
   *BRUK AXS INC, SHELXTL PROGR SUIT S
   Dion A, 2005, BIOMATERIALS, V26, P4486, DOI 10.1016/j.biomaterials.2004.11.010
   DURIF A, 1966, B SOC FR MINERAL CR, V89, P273
   Durif A., 1995, CRYSTAL CHEM CONDENS
   FUKUI H, 1977, J DENT RES, V56, P1260, DOI 10.1177/00220345770560102801
   Greenblatt M, 1996, SOLID STATE IONICS, V86-8, P995, DOI 10.1016/0167-2738(96)00240-8
   GRIFFITH EJ, 1981, P INT S PHOSPHORUS C, P361
   Grynpas MD, 2002, BIOMATERIALS, V23, P2063, DOI 10.1016/S0142-9612(01)00336-2
   Guo LH, 2004, J MATER SCI, V39, P7041, DOI 10.1023/B:JMSC.0000047549.18666.85
   Hill WL, 1944, AM J SCI, V242, P457, DOI 10.2475/ajs.242.9.457
   Hill WL, 1944, AM J SCI, V242, P542, DOI 10.2475/ajs.242.10.542
   HILL WL, 1945, J ASSOC OFF AGR CHEM, V28, P105
   JACKSON LE, 2005, KEY ENG MATER, V284, P75
   JOST KH, 1961, ACTA CRYSTALLOGR, V14, P844, DOI 10.1107/S0365110X6100245X
   Kulaev I, 2000, ANNU REV MICROBIOL, V54, P709, DOI 10.1146/annurev.micro.54.1.709
   Larson A. C., 1994, GEN STRUCTURE ANAL S
   LEHR JR, 1967, CHEM ENG B, V6, P166
   LIN Z, 2002, CHINESE J REPARATIVE, V16, P300
   MCINTOSH AO, 1956, ANAL CHEM, V28, P1424, DOI 10.1021/ac60117a019
   MORIN C, 1961, B SOC CHIM FR, P1726
   Park EK, 2004, BIOMATERIALS, V25, P3403, DOI 10.1016/j.biomaterials.2003.10.031
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   Porter NL, 2001, J BIOMED MATER RES, V56, P504, DOI 10.1002/1097-4636(20010915)56:4<504::AID-JBM1122>3.0.CO;2-J
   RAMSAY SD, 2005, KEY ENG MATER, P787
   RIETVELD HM, 1967, ACTA CRYSTALLOGR, V22, P151, DOI 10.1107/S0365110X67000234
   ROTHAMMEL W, 1989, ACTA CRYSTALLOGR C, V45, P551, DOI 10.1107/S0108270188012922
   SCHNEIDER M, 1985, Z ANORG ALLG CHEM, V527, P99, DOI 10.1002/zaac.19855270810
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Wright AJ, 1998, INORG CHEM, V37, P3858, DOI 10.1021/ic980212l
NR 33
TC 19
Z9 21
U1 4
U2 9
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
EI 1520-5002
J9 CHEM MATER
JI Chem. Mat.
PD SEP 6
PY 2005
VL 17
IS 18
BP 4642
EP 4646
DI 10.1021/cm050984x
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 962OR
UT WOS:000231742600014
DA 2018-10-20
ER

PT J
AU Wagner, DE
   Phillips, CL
   Ali, WM
   Nybakken, GE
   Crawford, ED
   Schwab, AD
   Smith, WF
   Fairman, R
AF Wagner, DE
   Phillips, CL
   Ali, WM
   Nybakken, GE
   Crawford, ED
   Schwab, AD
   Smith, WF
   Fairman, R
TI Toward the development of peptide nanofilaments and nanoropes as smart
   materials
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biomaterial; coiled coil; protein design; circular dichroism; atomic
   force microscopy
ID GCN4 LEUCINE-ZIPPER; COILED-COIL; SYNTHETIC-POLYMERS; DESIGN; HYDROGELS;
   PROTEINS; FIBER; STABILITY; FORCE
AB Protein design studies using coiled coils have illustrated the potential of engineering simple peptides to self-associate into polymers and networks. Although basic aspects of self-assembly in protein systems have been demonstrated, it remains a major challenge to create materials whose large-scale structures are well determined from design of local protein-protein interactions. Here, we show the design and characterization of a helical peptide, which uses phased hydrophobic interactions to drive assembly into nanofilaments and fibrils ("nanoropes"). Using the hydrophobic effect to drive self-assembly circumvents problems of uncontrolled self-assembly seen in previous approaches that used electrostatics as a mode for self-assembly. The nanostructures designed here are characterized by biophysical methods including analytical ultracentrifugation, dynamic light scattering, and circular dichroism to measure their solution properties, and atomic force microscopy to study their behavior on surfaces. Additionally, the assembly of such structures can be predictably regulated by using various environmental factors, such as pH, salt, other molecular crowding reagents, and specifically designed "capping" peptides. This ability to regulate self-assembly is a critical feature in creating smart peptide biomaterials.
C1 Haverford Coll, Dept Physiol, Haverford, PA 19041 USA.
   Haverford Coll, Dept Phys, Haverford, PA 19041 USA.
RP Fairman, R (reprint author), Haverford Coll, Dept Physiol, 370 Lancaster Ave, Haverford, PA 19041 USA.
EM rfairman@haverford.edu
CR Akey DL, 2001, BIOCHEMISTRY-US, V40, P6352, DOI 10.1021/bi002829w
   Boice JA, 1996, BIOCHEMISTRY-US, V35, P14480, DOI 10.1021/bi961831d
   Fairman R, 1996, BIOCHEMISTRY-US, V35, P2824, DOI 10.1021/bi952784c
   HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779
   Ji XL, 1998, ULTRAMICROSCOPY, V72, P165, DOI 10.1016/S0304-3991(97)00169-1
   Laue TM, 1992, ANAL ULTRACENTRIFUGA, P90
   MacPhee CE, 2004, CURR OPIN SOLID ST M, V8, P141, DOI 10.1016/j.cossms.2004.01.010
   North B, 2001, J MOL BIOL, V311, P1081, DOI 10.1006/jmbi.2001.4900
   Oakley MG, 1998, BIOCHEMISTRY-US, V37, P12603, DOI 10.1021/bi981269m
   ODIAN G, 1991, PRINCIPLES POLYMERIZ
   Ogihara NL, 2001, P NATL ACAD SCI USA, V98, P1404, DOI 10.1073/pnas.98.4.1404
   OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757
   OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029
   Pandya MJ, 2000, BIOCHEMISTRY-US, V39, P8728, DOI 10.1021/bi000246g
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Potekhin SA, 2001, CHEM BIOL, V8, P1025, DOI 10.1016/S1074-5521(01)00073-4
   Prive GG, 1999, PROTEIN SCI, V8, P1400, DOI 10.1110/ps.8.7.1400
   ROSEN H, 1957, ARCH BIOCHEM BIOPHYS, V67, P10, DOI 10.1016/0003-9861(57)90241-2
   Ryadnov MG, 2003, ANGEW CHEM INT EDIT, V42, P3021, DOI 10.1002/anie.200351418
   Ryadnov MG, 2003, NAT MATER, V2, P329, DOI 10.1038/nmat885
   SU JY, 1994, BIOCHEMISTRY-US, V33, P15501, DOI 10.1021/bi00255a032
   Umemura K, 1996, SCANNING, V18, P275
   Vandermeulen GWM, 2004, MACROMOL BIOSCI, V4, P383, DOI 10.1002/mabi.200300079
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Wang C, 2001, BIOMACROMOLECULES, V2, P912, DOI 10.1021/bm0155322
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   Yeates TO, 2002, CURR OPIN STRUC BIOL, V12, P464, DOI 10.1016/S0959-440X(02)00350-0
   Zhu H, 2000, J MOL BIOL, V300, P1377, DOI 10.1006/jmbi.2000.3936
   Zimenkov Y, 2004, TETRAHEDRON, V60, P7237, DOI 10.1016/j.tet.2004.06.068
NR 29
TC 86
Z9 88
U1 1
U2 32
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 6
PY 2005
VL 102
IS 36
BP 12656
EP 12661
DI 10.1073/pnas.0505871102
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 962FP
UT WOS:000231716700004
PM 16129839
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Yoneda, M
   Terai, H
   Imai, Y
   Okada, T
   Nozaki, K
   Inoue, H
   Miyamoto, S
   Takaoka, K
AF Yoneda, M
   Terai, H
   Imai, Y
   Okada, T
   Nozaki, K
   Inoue, H
   Miyamoto, S
   Takaoka, K
TI Repair of an intercalated long bone defect with a synthetic
   biodegradable bone-inducing implant
SO BIOMATERIALS
LA English
DT Article
DE BMP (bone morphogenetic protein); bone tissue engineering;
   biodegradation; osteoconduction; drug delivery; calcium phosphate
ID BETA-TRICALCIUM PHOSPHATE; GLYCOL BLOCK-COPOLYMERS; MORPHOGENETIC
   PROTEIN; POROUS HYDROXYAPATITE; DELIVERY SYSTEM; OSTEOCLASTIC
   RESORPTION; POLYMER; GRAFT; COLLAGEN; CARRIERS
AB Recombinant human bone morphogenetic protein (rhBMP)-2 in a block copolymer composed of poly-D,L-lactic acid with randomly inserted p-dioxanone and polyethylene glycol (PLA-DX-PEG) as a carrier and porous beta-tricalcium phosphate (beta-TCP) blocks were used to generate a new fully absorbable osteogenic biomaterial. The bone regenerability of the rhBMP-2/PLA-DX-PEG/ beta-TCP composite was studied in a critical-sized rabbit bone defect model. In an initial study, a composite of PLA-DX-PEG (250mg) and beta-TCP (300 mg) loaded with or without rhBMP2 (50 mu g) was implanted into a 1.5 cm intercalated bone defect created in a rabbit femur. Defects were assessed by biweekly radiography until 8 weeks postoperatively. The bony union of the defect was recognized only in the BNIP-loaded group. To obtain further data on biomechanical and remodeling properties, another BNIP-loaded composites group was made and observed up to 24 weeks. All defects were completely repaired without residual traces of implants. Anatomical and mechanical properties of the repaired bone examined by histology, 3-dimensional CT (3D-CT) and mechanical testing were essentially equivalent to the nonoperated-on femur at 24 weeks. These experimental results indicate that fully absorbable rhBMP-2/PLA-DX-PEG/beta-TCP is a promising composite having osteogenicity efficient enough for repairing large bone defects. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Osaka City Univ, Sch Med, Dept Orthopaed Surg, Abeno Ku, Osaka 5458585, Japan.
   Yamanouchi Pharmaceut Co Ltd, Appl Pharmacol Labs, Inst Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan.
   Olympus Co Ltd, Tokyo 1928512, Japan.
RP Terai, H (reprint author), Osaka City Univ, Sch Med, Dept Orthopaed Surg, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.
EM hterai@med.osaka-cu.ac.jp
CR Baltzer AWA, 2000, GENE THER, V7, P734, DOI 10.1038/sj.gt.3301166
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   CRIGEL MH, 2002, VET COMP ORTHOPAED T, V3, P158
   DEBRUIJN JD, 1994, J BIOMED MATER RES, V28, P105, DOI 10.1002/jbm.820280114
   Dong J, 2001, J BIOMED MATER RES, V57, P208, DOI 10.1002/1097-4636(200111)57:2<208::AID-JBM1160>3.0.CO;2-N
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   HOOGENDOORN HA, 1984, CLIN ORTHOP RELAT R, P281
   Jeppsson C, 1999, ACTA ORTHOP SCAND, V70, P77, DOI 10.3109/17453679909000963
   Jingushi Seiya, 2002, J Orthop Sci, V7, P490, DOI 10.1007/s007760200085
   Kaneko H, 2000, BONE, V27, P479, DOI 10.1016/S8756-3282(00)00358-6
   KIRKERHEAD CA, 1995, CLIN ORTHOP RELAT R, P222
   Laffargue P, 1999, BONE, V25, p55S, DOI 10.1016/S8756-3282(99)00134-9
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Matsushita N, 2004, J BIOMED MATER RES A, V70A, P450, DOI 10.1002/jbm.a.30102
   Murakami N, 2003, BIOMATERIALS, V24, P2153, DOI 10.1016/S0142-9612(03)00041-3
   Murakami N, 2002, J BIOMED MATER RES, V62, P169, DOI 10.1002/jbm.10236
   Ozawa M, 1995, J JPN SOC BIOMATER, V13, P167
   Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715
   Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0
   Saito N, 2001, J BONE JOINT SURG AM, V83A, pS92
   Saito N, 1999, J BIOMED MATER RES, V47, P104, DOI 10.1002/(SICI)1097-4636(199910)47:1<104::AID-JBM15>3.0.CO;2-7
   TAKAOKA K, 1988, CLIN ORTHOP RELAT R, P250
   URIST MR, 1984, CLIN ORTHOP RELAT R, P277
   URIST MR, 1987, CLIN ORTHOP RELAT R, P295
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Zabka AG, 2001, J ORTHOP RES, V19, P318, DOI 10.1016/S0736-0266(00)90003-2
NR 27
TC 68
Z9 78
U1 4
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2005
VL 26
IS 25
BP 5145
EP 5152
DI 10.1016/j.biomaterials.2005.01.054
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 920OK
UT WOS:000228699800007
PM 15792541
DA 2018-10-20
ER

PT J
AU Li, WJ
   Tuli, R
   Huang, XX
   Laquerriere, P
   Tuan, RS
AF Li, WJ
   Tuli, R
   Huang, XX
   Laquerriere, P
   Tuan, RS
TI Multilineage differentiation of human mesenchymal stem cells in a
   three-dimensional nanofibrous scaffold
SO BIOMATERIALS
LA English
DT Article
DE electrospinning; nanofiber; mesenchymal stem cell; adipogenesis;
   chondrogenesis; osteogenesis
ID IN-VITRO; PROGENITOR CELLS; HUMAN MARROW; CHONDROGENIC DIFFERENTIATION;
   BONE; TISSUE; CARTILAGE; THERAPY; CULTURE; MUSCLE
AB Functional engineering of musculoskeletal tissues generally involves the use of differentiated or progenitor cells seeded with specific growth factors in biomaterial scaffolds. Ideally, the scaffold should be a functional and structural biomimetic of the native extracellular matrix and support multiple tissue morphogenesis. We have previously shown that electrospun, three-dimensional nanofibrous scaffolds that morphologically resemble collagen fibrils are capable of promoting favorable biological responses from seeded cells, indicative of their potential application for tissue engineering. In this study, we tested a three-dimensional nanofibrous scaffold fabricated from poly(e.-caprolactone) (PCL) for its ability to support and maintain multilineage differentiation of bone marrow-derived human mesenchymal stem cells (hMSCs) in vitro. hMSCs were seeded onto pre-fabricated nanofibrous scaffolds, and were induced to differentiate along adipogenic, chondrogenic, or osteogenic lineages by culturing in specific differentiation media. Histological and scanning electron microscopy observations, gene expression analysis, and immunohistochemical detection of lineage-specific marker molecules confirmed the formation of three-dimensional constructs containing cells differentiated into the specified cell types. These results suggest that the PCL-based nanofibrous scaffold is a promising candidate scaffold for cell-based, multiphasic tissue engineering. Published by Elsevier Ltd.
C1 NIAMSD, Cartilage Biol & Orthopaed Branch, NIH, Bethesda, MD 20892 USA.
   NIH, Off Res Serv, Dept Hlth & Human Serv, Div Bioengn & Phys Sci, Bethesda, MD 20892 USA.
   Thomas Jefferson Univ, Cell & Tissue Engn Grad Program, Philadelphia, PA 19107 USA.
RP Tuan, RS (reprint author), NIAMSD, Cartilage Biol & Orthopaed Branch, NIH, Bldg 50,Room 1503,MSC 8022, Bethesda, MD 20892 USA.
EM tuanr@mail.nih.gov
RI Li, Wan-Ju/A-7002-2008; Laquerriere, Patrice/P-1025-2016
OI Laquerriere, Patrice/0000-0001-7637-9094; Li, Wan-Ju/0000-0002-6579-8063
FU NIAMS NIH HHS [Z01 AR 41113]
CR Abukawa H, 2003, J ORAL MAXIL SURG, V61, P94, DOI 10.1053/joms.2003.50015
   Adachi N, 2002, J RHEUMATOL, V29, P1920
   AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5
   Andrades J A, 1996, Int J Dev Biol, VSuppl 1, p107S
   Angele P, 1999, TISSUE ENG, V5, P545, DOI 10.1089/ten.1999.5.545
   Anton F., 1934, U.S. Patent, Patent No. [1,975,504, 1975504]
   Boo JS, 2002, J CRANIOFAC SURG, V13, P231, DOI 10.1097/00001665-200203000-00009
   Bosch P, 2000, J ORTHOP RES, V18, P933, DOI 10.1002/jor.1100180613
   Cancedda R, 2003, MATRIX BIOL, V22, P81, DOI 10.1016/S0945-053X(03)00012-X
   Caplan AI, 2000, TISSUE ENG, V6, P1, DOI 10.1089/107632700320838
   Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245
   Denker AE, 1999, DIFFERENTIATION, V64, P67, DOI 10.1046/j.1432-0436.1999.6420067.x
   Gao JZ, 2001, TISSUE ENG, V7, P363, DOI 10.1089/10763270152436427
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   LI WJ, 2004, BIOMATERIALS, V26, P599
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Noth U, 2002, TISSUE ENG, V8, P131, DOI 10.1089/107632702753503126
   Noth U, 2002, J ORTHOPAED RES, V20, P1060, DOI 10.1016/S0736-0266(02)00018-9
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   PUCHTLER H, 1969, J HISTOCHEM CYTOCHEM, V17, P110, DOI 10.1177/17.2.110
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   Schaefer D, 2000, BIOMATERIALS, V21, P2599, DOI 10.1016/S0142-9612(00)00127-7
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   Tuli R, 2004, TISSUE ENG, V10, P1169, DOI 10.1089/ten.2004.10.1169
   Wada MR, 2002, DEVELOPMENT, V129, P2987
   Wang ML, 2002, J ORTHOPAED RES, V20, P1175, DOI 10.1016/S0736-0266(02)00076-1
   Yaylaoglu MB, 1999, BIOMATERIALS, V20, P1513, DOI 10.1016/S0142-9612(99)00062-9
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 38
TC 447
Z9 472
U1 10
U2 163
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2005
VL 26
IS 25
BP 5158
EP 5166
DI 10.1016/j.biomaterials.2005.01.002
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 920OK
UT WOS:000228699800009
PM 15792543
DA 2018-10-20
ER

PT J
AU Bokhari, MA
   Akay, G
   Zhang, SG
   Birch, MA
AF Bokhari, MA
   Akay, G
   Zhang, SG
   Birch, MA
TI Enhancement of osteoblast growth and differentiation in vitro on a
   peptide hydrogel - polyHIPE polymer hybrid material
SO BIOMATERIALS
LA English
DT Article
DE bone tissue engineering; cell adhesion; hydrogel; osteoblast;
   osteogenesis; adhesion mechanism
ID SELF-COMPLEMENTARY OLIGOPEPTIDE; NEURITE EXTENSION; CELL ATTACHMENT;
   BONE-FORMATION; SCAFFOLDS; BIOMATERIALS; MATRICES; PROTEIN; DNA
AB The objective of this study was to investigate the effect of combining two biomaterials on osteoblast proliferation, differentiation and mineralised matrix formation in vitro. The first biomaterial has a well-defined architecture and is known as PolyHIPE polymer (PHP), The second biomaterial is a biologically inspired self-assembling peptide hydrogel (RAD16-I, also called PuraMatrix (TM)) that produces a nanoscale environment similar to native extracellular matrix (ECM). Our work investigates the effect of combining RAD16-I with two types of PHP (HA (Hydroxyapatite)-PHP and H (Hydrophobic)-PHP) and evaluates effects on osteoblast growth and differentiation. Results demonstrated successful incorporation of RAD16-1 into both types of PHP. Osteoblasts were observed to form multicellular layers on the combined biomaterial surface and also within the scaffold. Dynamic cell seeding and culturing techniques were compared to static seeding methods and produced a more even distribution of cells throughout the constructs. Cells were found to penetrate the scaffold to a maximum depth of 3 mm after 35 days in culture. There was a significant increase in cell number in H-PHP constructs coated with RAD16-1 compared to H-PHP alone. Our results show that RAD16-1 enhances osteoblast differentiation and indicates that the incorporation of this peptide provides a more permissive environment for osteoblast growth. We have developed a microcellular polymer containing a nanoscale environment to enhance cell: biomaterial interactions and promote osteoblast growth in vitro. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Newcastle Upon Tyne, Fac Med, Sch Surg & Reprod Sci Orthopaed, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   Univ Newcastle Upon Tyne, Sch Chem Engn & Adv Mat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   Univ Newcastle Upon Tyne, Inst Nanoscale Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA.
RP Birch, MA (reprint author), Univ Newcastle Upon Tyne, Fac Med, Sch Surg & Reprod Sci Orthopaed, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM m.a.birch@ncl.ac.uk
RI Birch, Mark/B-7051-2009
CR Akay G, 2004, BIOMATERIALS, V25, P3991, DOI 10.1016/j.biomaterials.2003.10.086
   AKAY G, 2002, Patent No. 1183328
   BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874
   Blackshaw SE, 1997, P ROY SOC B-BIOL SCI, V264, P657, DOI 10.1098/rspb.1997.0093
   Botchwey EA, 2003, J BIOMED MATER RES A, V67A, P357, DOI 10.1002/jbm.a.10111
   DENHARDT DT, 1993, FASEB J, V7, P1475
   Dillon GP, 1998, J BIOMAT SCI-POLYM E, V9, P1049, DOI 10.1163/156856298X00325
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   HOFFMANN A, 2003, J BIOMED MATER RES A, V67, P191
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   MALAVAL L, 1994, J CELL PHYSIOL, V158, P555, DOI 10.1002/jcp.1041580322
   PARK JB, 1992, BIOMATERIALS INTRO
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   SHIN H, 2003, BIOMATERIALS, V24, P353
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   van den Dolder J, 2003, TISSUE ENG, V9, P315, DOI 10.1089/107632703764664783
   WEST DC, 1985, ANAL BIOCHEM, V147, P289, DOI 10.1016/0003-2697(85)90274-X
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Yu XJ, 1999, TISSUE ENG, V5, P291, DOI 10.1089/ten.1999.5.291
   ZHANG SG, 1992, EMBO J, V11, P3787, DOI 10.1002/j.1460-2075.1992.tb05464.x
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 30
TC 181
Z9 193
U1 3
U2 59
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2005
VL 26
IS 25
BP 5198
EP 5208
DI 10.1016/j.biomaterials.2005.01.040
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 920OK
UT WOS:000228699800013
PM 15792547
DA 2018-10-20
ER

PT J
AU Gauthier, O
   Muller, R
   von Stechow, D
   Lamy, B
   Weiss, P
   Bouler, JM
   Aguado, E
   Daculsi, G
AF Gauthier, O
   Muller, R
   von Stechow, D
   Lamy, B
   Weiss, P
   Bouler, JM
   Aguado, E
   Daculsi, G
TI In vivo bone regeneration with injectable calcium phosphate biomaterial:
   A three-dimensional micro-computed tomographic, biomechanical and SEM
   study
SO BIOMATERIALS
LA English
DT Article
DE calcium phosphate; composite; biomaterial; bone cement; in vivo test;
   bone regeneration; micro-computed tomography (mu CT); compressive
   strength
ID TRABECULAR BONE; MICROCOMPUTED TOMOGRAPHY; MORPHOMETRIC-ANALYSIS;
   CANCELLOUS BONE; CEMENT; SUBSTITUTE; INGROWTH; MODEL; VITRO;
   HYDROXYAPATITE
AB This in vivo study investigated the efficiency of all injectable calcium phosphate bone substitute (IBS) for bone regenerative procedures through non-destructive three-dimensional (3D) micro-tomographic (mu CT) imaging, biomechanical testing with a nondestructive micro-indentation technique and 2D scanning electron microscopy (SEM) analysis. The injectable biomaterial was obtained by mixing a biphasic calcium phosphate (BCP) ceramic mineral phase and a cellulosic polymer. The BCP particles were 200-500 mu m or 80-200 mu m in diameter. The injectable material was implanted for 6 weeks into critical-sized bone defects Lit the distal end of rabbit femurs.
   Extensive new bone apposition was noted with both 2D and 3D techniques. Micro-CT showed that newly formed bone was in perfect continuity with the trabecular host bone structure and demonstrated the high interconnectivity of the restored bone network. For both IBS formulations, SEM and mu CT gave very close measurements. The only detected significant difference concerned the amount of newly formed bone obtained with IBS 80-200 that appeared significantly higher with mu CT analysis than with SEM (p = 0.00007). Student t-tests did not show any significant difference in the amount of newly formed bone and remaining ceramic obtained from mu CT analysis or SEM. Regression analysis showed satisfactory correlation between both the amount of newly formed bone and remaining ceramic obtained from mu CT or SEM. For IBS 200-500, the newly formed bone rate inside the defect was 28.0 +/- 5.2% with SEM and yield strength of the samples was 18.8 +/- 5.4 MPa. For IBS 80-200, the newly formed bone rate inside the defect was 31.7 +/- 5.1 % with SEM and yield strength of the samples was 26.8 +/- 4.5 Wa. Yield strength appeared well correlated with the amount of newly formed bone, specially observed with mu CT.
   This study showed the ability of non-destructive techniques to investigate biological and mechanical aspects of bone replacement with injectable biomaterials. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Ecole Natl Vet, Nantes, France.
   Beth Israel Deaconess Med Ctr, Orthoped Biomech Lab, Boston, MA 02215 USA.
   Harvard Univ, Sch Med, Boston, MA 02215 USA.
   Ecole Cent Nantes, Lab Mecan Mat, Nantes, France.
   Fac Chirurg Dent, INSERM, Equipe Mixte Mat Interet Biol 9903, F-44042 Nantes, France.
   Ecole Natl Vet, Lab Chirurg, F-44307 Nantes, France.
RP Gauthier, O (reprint author), Ecole Natl Vet, Nantes, France.
EM gauthier@vet-nantes.fr
RI Daculsi, Guy/P-1320-2014; Muller, Ralph/A-1198-2008; Weiss,
   Pierre/P-1372-2014; Gauthier, Olivier/A-4639-2015
OI Daculsi, Guy/0000-0003-1030-3446; Muller, Ralph/0000-0002-5811-7725;
   Weiss, Pierre/0000-0002-6159-8590; BOULER,
   Jean-Michel/0000-0001-9784-5584
CR Appleyard RC, 1999, OSTEOARTHR CARTILAGE, V7, P281, DOI 10.1053/joca.1998.0202
   Boix D, 2004, J PERIODONTOL, V75, P663, DOI 10.1902/jop.2004.75.5.663
   Cassidy C, 2003, J BONE JOINT SURG AM, V85A, P2127, DOI 10.2106/00004623-200311000-00010
   Cavagna R, 1999, J LONG-TERM EFF MED, V9, P403
   Charriere E, 2001, BIOMATERIALS, V22, P2937, DOI 10.1016/S0142-9612(01)00041-2
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Daculsi G, 1995, CNRS patent, Patent No. [9521634, WO 95/21634]
   David V, 2003, J BONE MINER RES, V18, P1622, DOI 10.1359/jbmr.2003.18.9.1622
   Delecrin J, 2000, SPINE, V25, P563, DOI 10.1097/00007632-200003010-00006
   Doi Y, 2001, BIOMATERIALS, V22, P847, DOI 10.1016/S0142-9612(00)00248-9
   Fang TD, 2004, BONE, V34, P1004, DOI 10.1016/j.bone.2004.02.011
   Frankenburg EP, 1998, J BONE JOINT SURG AM, V80A, P1112, DOI 10.2106/00004623-199808000-00004
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   Gabet Y, 2004, BONE, V35, P65, DOI 10.1016/j.bone.2004.03.025
   Gauthier O, 1999, J BIOMED MATER RES, V47, P28, DOI 10.1002/(SICI)1097-4636(199910)47:1<28::AID-JBM4>3.0.CO;2-P
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Gauthier O, 2003, J BIOMED MATER RES A, V66A, P47, DOI 10.1002/jbm.a.10506
   GAUTHIER O, 1999, BONE, V25, P71
   Grimandi G, 1998, J BIOMED MATER RES, V39, P660, DOI 10.1002/(SICI)1097-4636(19980315)39:4<660::AID-JBM22>3.0.CO;2-9
   Guicheux J, 1998, J BONE MINER RES, V13, P739, DOI 10.1359/jbmr.1998.13.4.739
   Hara T, 2002, BONE, V31, P107, DOI 10.1016/S8756-3282(02)00782-2
   Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Ikenaga M, 1998, J BIOMED MATER RES, V40, P139, DOI 10.1002/(SICI)1097-4636(199804)40:1<139::AID-JBM16>3.0.CO;2-J
   Khairoun I, 2002, J BIOMED MATER RES, V60, P633, DOI 10.1002/jbm.10132
   Larsson S, 2002, CLIN ORTHOP RELAT R, P23
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Malard O, 2005, BONE, V36, P323, DOI 10.1016/j.bone.2004.07.018
   Muller R, 1997, ST HEAL T, V40, P61
   Muller R, 1998, BONE, V23, P59, DOI 10.1016/S8756-3282(98)00068-4
   Nageie E, 2004, CALCIFIED TISSUE INT, V75, P15, DOI 10.1007/s00223-004-0151-8
   Orr TE, 2001, BIOMATERIALS, V22, P1953, DOI 10.1016/S0142-9612(00)00370-7
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   RAMRAKHIANI M, 1979, ACTA ANAT, V103, P358
   Ransford AO, 1998, J BONE JOINT SURG BR, V80B, P13, DOI 10.1302/0301-620X.80B1.7276
   Rhee Y, 2004, J BONE MINER RES, V19, P931, DOI 10.1359/JBMR.040123
   Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1
   Xu HKHK, 2004, J ORTHOPAED RES, V22, P535, DOI 10.1016/j.orthres.2003.09.010
   Yamamoto H, 1998, BIOMATERIALS, V19, P1587, DOI 10.1016/S0142-9612(97)00121-X
NR 40
TC 131
Z9 132
U1 4
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2005
VL 26
IS 27
BP 5444
EP 5453
DI 10.1016/j.biomaterials.2005.01.072
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 926YB
UT WOS:000229158500003
PM 15860201
DA 2018-10-20
ER

PT J
AU Sundback, CA
   Shyu, JY
   Wang, YD
   Faquin, WC
   Langer, RS
   Vacanti, JP
   Hadlock, TA
AF Sundback, CA
   Shyu, JY
   Wang, YD
   Faquin, WC
   Langer, RS
   Vacanti, JP
   Hadlock, TA
TI Biocompatibility analysis of poly(glycerol sebacate) as a nerve guide
   material
SO BIOMATERIALS
LA English
DT Article
DE biocompatibility; Schwann cells; nerve guide; fibrosis degradation
ID EPSILON-CAPROLACTONE POLYMER; PERIPHERAL-NERVE; SCHWANN-CELLS;
   TRIMETHYLENE CARBONATE; LONG GAPS; L-LACTIDE; REGENERATION; TUBE;
   CONDUITS; PROTEASE
AB No satisfactory method currently exists for bridging neural defects. Autografts lead to linadequate functional recovery. and most available artificial neural conduits possess unfavorable swelling and pro-inflammatory characteristics. This Study examined the biocompatibility of a novel biodegradable elastomer, poly(glycerol sebacate) (PGS), for neural reconstruction applications, as the material possesses favorable mechanical property and degradation characteristics. The effect of PGS on Schwann cell metabolic activity, attachment, proliferation, and apoptosis were examined in vitro in comparison with poly(lactide-co-glycolide) (PLGA), a biomaterial widely utilized for tissue engineering applications. The in vivo tissue response to PGS was compared with PLGA implanted juxtaposed to the sciatic nerve; the physical changes in the implant material were measured during the degradation process. PGS had no deleterious effect on Schwann cell metabolic activity, attachment, or proliferation, and did not induce apoptosis; the in vitro effects of PGS were similar to or superior to that of PLGA. In vivo, PGS demonstrated a favorable tissue response profile compared with PLGA, with significantly less inflammation and fibrosis and Without detectable swelling during degradation. PGS is an excellent candidate material for neural reconstruction applications given its lack of in vitro Schwann cell toxicity and minimal in vivo tissue response. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Surg, Boston, MA 02114 USA.
   Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
   Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol, Boston, MA 02114 USA.
   MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Otolaryngol, Boston, MA 02114 USA.
RP Sundback, CA (reprint author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Surg, Wellman 625,55 Fruit St, Boston, MA 02114 USA.
EM csundback@partners.org
OI Wang, Yadong/0000-0003-2067-382X
CR *ASTM INT, 1996, F81301 ASTM
   BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9
   DenDunnen WFA, 1996, MICROSURG, V17, P348, DOI 10.1002/(SICI)1098-2752(1996)17:7<348::AID-MICR2>3.0.CO;2-C
   DENDUNNEN WFA, 1995, J BIOMED MATER RES, V29, P757, DOI 10.1002/jbm.820290612
   Evans GRD, 1999, BIOMATERIALS, V20, P1109, DOI 10.1016/S0142-9612(99)00010-1
   Fabre T, 2001, BIOMATERIALS, V22, P2951, DOI 10.1016/S0142-9612(01)00012-6
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   Harley BA, 2004, CELLS TISSUES ORGANS, V176, P153, DOI 10.1159/000075035
   HENRY EW, 1985, EXP NEUROL, V90, P652, DOI 10.1016/0014-4886(85)90162-1
   LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0
   LANGONE F, 1995, BIOMATERIALS, V16, P347, DOI 10.1016/0142-9612(95)93851-4
   Lundborg G, 1988, NERVE INJURY REPAIR
   MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015
   NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0
   OZTURK SS, 1990, BIOTECHNOL PROGR, V6, P121, DOI 10.1021/bp00002a005
   Pego AP, 2003, J BIOMED MATER RES A, V67A, P876, DOI 10.1002/jbm.a.10074
   Pego AP, 2001, J BIOMAT SCI-POLYM E, V12, P35
   ROBINSON PH, 1991, MICROSURG, V12, P412, DOI 10.1002/micr.1920120608
   Rodriguez FJ, 1999, BIOMATERIALS, V20, P1489, DOI 10.1016/S0142-9612(99)00055-1
   RYDEVIK BL, 1990, J ORTHOPAED RES, V8, P694, DOI 10.1002/jor.1100080511
   Schappacher M, 2001, BIOMATERIALS, V22, P2849, DOI 10.1016/S0142-9612(01)00029-1
   THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0
   UPHILL PF, 1996, MED DEVICE TECHNOL, V11, P24
   Valero-Cabre A, 2001, J NEUROSCI RES, V63, P214, DOI 10.1002/1097-4547(20010115)63:2<214::AID-JNR1014>3.0.CO;2-D
   Wang Y., 2003, UNPUB
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Weir NA, 2004, BIOMATERIALS, V25, P3939, DOI 10.1016/j.biomaterials.2003.10.076
   Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4
NR 29
TC 236
Z9 247
U1 7
U2 114
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2005
VL 26
IS 27
BP 5454
EP 5464
DI 10.1016/j.biomaterials.2005.02.004
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 926YB
UT WOS:000229158500004
PM 15860202
DA 2018-10-20
ER

PT J
AU Karageorgiou, V
   Kaplan, D
AF Karageorgiou, V
   Kaplan, D
TI Porosity of 3D biomaterial scaffolds and osteogenesis
SO BIOMATERIALS
LA English
DT Review
DE porosity; scaffolds; bone; osteogenesis; tissue engineering; polymeric
   biomaterials
ID BMP-INDUCED OSTEOGENESIS; POLY(PROPYLENE FUMARATE) SCAFFOLDS; IN-VIVO
   PERFORMANCE; BONE-GRAFT SUBSTITUTES; TISSUE-ENGINEERED BONE; MESENCHYMAL
   STEM-CELLS; ACID-BASED SCAFFOLDS; POROUS HYDROXYAPATITE; TITANIUM
   IMPLANTS; TRABECULAR BONE
AB Porosity and pore size of biomaterial scaffolds play a critical role in bone formation in vitro and in vivo. This review explores the state of knowledge regarding the relationship between porosity and pore size of biomaterials used for bone regeneration. The effect of these morphological features on osteogenesis in vitro and in vivo, as well as relationships to mechanical properties of the scaffolds, are addressed. In vitro, lower porosity stimulates osteogenesis by suppressing cell proliferation and forcing cell aggregation. In contrast, in vivo, higher porosity and pore size result in greater bone ingrowth, a conclusion that is supported by the absence of reports that show enhanced osteogenic outcomes for scaffolds with low void volumes. However, this trend results in diminished mechanical properties, thereby setting an upper functional limit for pore size and porosity. Thus, a balance must be reached depending on the repair, rate of remodeling and rate of degradation of the scaffold material. Based on early studies, the minimum requirement for pore size is considered to be similar to 100 mu m due to cell size, migration requirements and transport. However, pore sizes > 300 mu m are recommended. due to enhanced new bone formation and the formation of capillaries. Because of vasculariziation, pore size has been shown to affect the progression of osteogenesis. Small pores favored hypoxic conditions and induced osteochondral formation before osteogenesis, while large pores, that are well-vascularized, lead to direct osteogenesis (without preceding cartilage formation). Gradients in pore sizes are recommended for future studies focused oil the formation of multiple tissues and tissue interfaces. New fabrication techniques, Such as solid-free form fabrication, can potentially be used to generate scaffolds with morphological and mechanical properties more selectively designed to meet the specificity of bone-repair needs. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, D (reprint author), Tufts Univ, Dept Chem & Biol Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
OI Karageorgiou, Vassilis/0000-0002-0892-510X
FU NIDCR NIH HHS [DE13405-04]; NIBIB NIH HHS [EB003110-02]
CR AKAY G, 2004, MICROCELLULAR POLYHI
   Akin FA, 2001, J BIOMED MATER RES, V57, P588, DOI 10.1002/1097-4636(20011215)57:4<588::AID-JBM1206>3.0.CO;2-Y
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   An YH, 2000, BIOMATERIALS, V21, P2635, DOI 10.1016/S0142-9612(00)00132-0
   ANTIN M, 1999, J BIOMED MATER RES, P382
   Ayers RA, 1999, J BIOMED MATER RES, V45, P42
   Barralet JE, 2002, BIOMATERIALS, V23, P3063, DOI 10.1016/S0142-9612(01)00401-X
   Barry JJA, 2004, BIOMATERIALS, V25, P3559, DOI 10.1016/j.biomaterials.2003.10.023
   Berven S, 2001, EUR SPINE J, V10, pS169, DOI 10.1007/s005860100270
   Bilezikian J, 2002, PRINCIPLES BONE BIOL
   Borden M, 2003, BIOMATERIALS, V24, P597, DOI 10.1016/S0142-9612(02)00374-5
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   Burdick JA, 2003, BIOMATERIALS, V24, P1613, DOI 10.1016/S0142-9612(02)00538-0
   Burdick JA, 2002, J BIOMED MATER RES, V63, P484, DOI 10.1002/jbm.10298
   CANCEDDA R, 2003, NOVART FDN SYMP, V249, P239
   CANCEDDA R, 2003, NOVART FDN SYMP, V249, P143
   Cancedda Ranieri, 2003, Novartis Found Symp, V249, P133
   Cartmell S, 2004, J BIOMED MATER RES A, V69A, P97, DOI 10.1002/jbm.a.20118
   Chang YS, 1998, J ARTHROPLASTY, V13, P816, DOI 10.1016/S0883-5403(98)90037-7
   Chen FL, 2002, J ORAL MAXIL SURG, V60, P1155, DOI 10.1053/joms.2002.34991
   Chen GP, 2001, J BIOMED MATER RES, V57, P8, DOI 10.1002/1097-4636(200110)57:1<8::AID-JBM1135>3.0.CO;2-H
   Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5
   Coombes A. G. A., 1994, Clinical Materials, V17, P35, DOI 10.1016/0267-6605(94)90046-9
   COOPER DM, 2004, CALCIF TISSUE INT
   Cullinane D. M., 2002, PRINCIPLES BONE BIOL, P17
   Currey JD, 2004, J BIOMECH, V37, P549, DOI 10.1016/j.jbiomech.2003.08.008
   D'Lima DD, 1998, J ARTHROPLASTY, V13, P928, DOI 10.1016/S0883-5403(98)90201-7
   Damien E, 2003, J BIOMED MATER RES A, V66A, P241, DOI 10.1002/jbm.a.10564
   Dard M, 2000, Clin Oral Investig, V4, P126, DOI 10.1007/s007840050128
   Disegi J A, 2000, Injury, V31 Suppl 4, P2
   Dong J, 2001, J BIOMED MATER RES, V57, P208, DOI 10.1002/1097-4636(200111)57:2<208::AID-JBM1160>3.0.CO;2-N
   El-Ghannam AR, 2004, J BIOMED MATER RES A, V69A, P490, DOI 10.1002/jbm.a.30022
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Fisher JP, 2001, J BIOMAT SCI-POLYM E, V12, P673
   Follet H, 2004, BONE, V34, P783, DOI 10.1016/j.bone.2003.12.012
   Gogolewski S, 2000, Injury, V31 Suppl 4, P28
   Gong WL, 2001, J BIOMED MATER RES, V54, P320, DOI 10.1002/1097-4636(20010305)54:3<320::AID-JBM20>3.0.CO;2-E
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gotz HE, 2004, BIOMATERIALS, V25, P4057, DOI 10.1016/j.biomaterials.2003.11.002
   Groeneveld EHJ, 1999, J BIOMED MATER RES, V48, P393, DOI 10.1002/(SICI)1097-4636(1999)48:4<393::AID-JBM1>3.3.CO;2-3
   Harvey EJ, 1999, J BONE JOINT SURG AM, V81A, P93, DOI 10.2106/00004623-199901000-00013
   HOLLINGER JO, 1994, CLIN PLAST SURG, V21, P415
   Hu YH, 2002, J BIOMED MATER RES, V59, P563, DOI 10.1002/jbm.1269
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Itala AI, 2001, J BIOMED MATER RES, V58, P679, DOI 10.1002/jbm.1069
   Itoh M, 2004, BIOMATERIALS, V25, P2577, DOI 10.1016/j.biomaterials.2003.09.071
   Jin QM, 2000, J BIOMED MATER RES, V51, P491, DOI 10.1002/1097-4636(20000905)51:3<491::AID-JBM25>3.0.CO;2-1
   Kaplan FS, 1994, ORTHOPAEDIC BASIC SC, P128
   Keaveny TM, 2001, ANNU REV BIOMED ENG, V3, P307, DOI 10.1146/annurev.bioeng.3.1.307
   Kim HD, 2002, J BIOMED MATER RES, V59, P573, DOI 10.1002/jbm.10011
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   KIRKERHEAD CA, 1995, VET SURG, V24, P408, DOI 10.1111/j.1532-950X.1995.tb01352.x
   Kruyt MC, 2003, TISSUE ENG, V9, P327, DOI 10.1089/107632703764664792
   Kuboki Y, 2002, CONNECT TISSUE RES, V43, P529, DOI 10.1080/03008200290001104
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4
   Lee SJ, 2000, YONSEI MED J, V41, P704, DOI 10.3349/ymj.2000.41.6.704
   Lee YM, 2001, J BIOMED MATER RES, V54, P216, DOI 10.1002/1097-4636(200102)54:2<216::AID-JBM8>3.0.CO;2-C
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Leon CALY, 1998, ADV COLLOID INTERFAC, V76, P341, DOI 10.1016/S0001-8686(98)00052-9
   Lewandrowski KU, 2003, TISSUE ENG, V9, P85, DOI 10.1089/107632703762687564
   Lewandrowski KU, 2000, J BIOMAT SCI-POLYM E, V11, P879, DOI 10.1163/156856200744075
   Li PJ, 2003, J BIOMED MATER RES A, V66A, P79, DOI 10.1002/jbm.a.10519
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Lickorish D, 2004, J BIOMED MATER RES A, V68A, P19, DOI 10.1002/jbm.a..20031
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Lin J, 2004, CHINESE EDUC SOC, V37, P5
   LINDE F, 1989, J BIOMECH, V22, P485, DOI 10.1016/0021-9290(89)90209-1
   Liu LS, 1999, BIOMATERIALS, V20, P1097, DOI 10.1016/S0142-9612(99)00006-X
   Marks S. C., 2002, PRINCIPLES BONE BIOL, V1, P3
   Maspero FA, 2002, J BIOMED MATER RES, V62, P89, DOI 10.1002/jbm.10212
   Meaney D F, 1995, Clin Podiatr Med Surg, V12, P363
   MEINEL L, 2004, IN PRESS J BIOMED MA
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nishiguchi S, 2001, J BIOMED MATER RES, V54, P198, DOI 10.1002/1097-4636(200102)54:2<198::AID-JBM6>3.0.CO;2-7
   Noel Daniele, 2002, Curr Opin Investig Drugs, V3, P1000
   Oh SH, 2003, BIOMATERIALS, V24, P4011, DOI 10.1016/S0142-9612(03)00284-9
   Ohgushi H., 2003, NOVART FDN SYMP, V249, P127
   Ohgushi H., 2003, NOVART FDN SYMP, V249, P170
   Ohgushi Hajime, 2003, Novartis Found Symp, V249, P118
   Orban JM, 2002, TISSUE ENG, V8, P529, DOI 10.1089/107632702760240454
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Park HK, 2001, NEUROL RES, V23, P267, DOI 10.1179/016164101101198424
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Pilliar R M, 1998, Implant Dent, V7, P305, DOI 10.1097/00008505-199807040-00009
   Pohler O. E., 2000, INJURY S4, V1, P7
   Porter BD, 2000, J BIOMECH ENG-T ASME, V122, P286, DOI 10.1115/1.429659
   Rah DK, 2000, YONSEI MED J, V41, P756, DOI 10.3349/ymj.2000.41.6.756
   Ringe J, 2002, NATURWISSENSCHAFTEN, V89, P338, DOI 10.1007/s00114-002-0344-9
   Rocha LB, 2002, BIOMATERIALS, V23, P449, DOI 10.1016/S0142-9612(01)00126-0
   ROHLMANN A, 1980, ARCH ORTHOP TRAUM SU, V97, P95, DOI 10.1007/BF00450930
   Rokkanen P., 1996, J TRAUMA, V40, P123
   Roy TD, 2003, J BIOMED MATER RES A, V66A, P283, DOI 10.1002/jbm.a.10582
   Rubin JP, 1997, PLAST RECONSTR SURG, V100, P1336, DOI 10.1097/00006534-199710000-00043
   Schaefer D, 2000, BIOMATERIALS, V21, P2599, DOI 10.1016/S0142-9612(00)00127-7
   Schwarz K, 1998, MACROMOL RAPID COMM, V19, P613, DOI 10.1002/(SICI)1521-3927(19981201)19:12<613::AID-MARC613>3.3.CO;2-D
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   Sikavitsas VI, 2003, J BIOMED MATER RES A, V67A, P944, DOI 10.1002/jbm.a.10126
   Simon JL, 2003, J BIOMED MATER RES A, V66A, P275, DOI 10.1002/jbm.a.10569
   Steflik D E, 1999, Adv Dent Res, V13, P27
   Story BJ, 1998, INT J ORAL MAX IMPL, V13, P749
   Sul YT, 2002, CLIN ORAL IMPLAN RES, V13, P252, DOI 10.1034/j.1600-0501.2002.130304.x
   Sul YT, 2002, BIOMATERIALS, V23, P491, DOI 10.1016/S0142-9612(01)00131-4
   Sul YT, 2002, BIOMATERIALS, V23, P1809, DOI 10.1016/S0142-9612(01)00307-6
   Svehla M, 2000, J BIOMED MATER RES, V51, P15, DOI 10.1002/(SICI)1097-4636(200007)51:1<15::AID-JBM3>3.0.CO;2-9
   Tabata Y, 2003, TISSUE ENG, V9, pS5, DOI 10.1089/10763270360696941
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Tache A, 2004, INT J ORAL MAX IMPL, V19, P19
   Takahashi Y, 2004, J BIOMAT SCI-POLYM E, V15, P41, DOI 10.1163/156856204322752228
   TARVAINEN T, 1986, ANN BIOMED ENG, V14, P417, DOI 10.1007/BF02367362
   Trantolo DJ, 2003, INT J ORAL MAX IMPL, V18, P182
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   van den Dolder J, 2003, BIOMATERIALS, V24, P1745, DOI 10.1016/S0142-9612(02)00537-9
   VANLUYN MJA, 1992, J BIOMED MATER RES, V26, P1091, DOI 10.1002/jbm.820260810
   Vehof JWM, 2002, CLIN ORAL IMPLAN RES, V13, P94, DOI 10.1034/j.1600-0501.2002.130112.x
   Vehof JWM, 2002, J BIOMED MATER RES, V60, P241, DOI 10.1002/jbm.10073
   Vehof JWM, 2000, BIOMATERIALS, V21, P2003, DOI 10.1016/S0142-9612(00)00094-6
   Warren SM, 2004, J CRANIOFAC SURG, V15, P34, DOI 10.1097/00001665-200401000-00012
   Wolfe MS, 2002, J BIOMED MATER RES, V61, P159, DOI 10.1002/jbm.10058
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Zellin G, 1996, CONNECT TISSUE RES, V35, P279, DOI 10.3109/03008209609029202
   Zhang C, 2001, J BIOMED MATER RES, V54, P407, DOI 10.1002/1097-4636(20010305)54:3<407::AID-JBM140>3.3.CO;2-3
   Zhang K, 2004, BIOMATERIALS, V25, P2489, DOI 10.1016/j.biomaterials.2003.09.033
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhang X, 2001, Biomed Sci Instrum, V37, P463
   Zhang Y, 2002, J BIOMED MATER RES, V61, P1, DOI 10.1002/jbm.10176
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 131
TC 2732
Z9 2843
U1 127
U2 1830
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2005
VL 26
IS 27
BP 5474
EP 5491
DI 10.1016/j.biomaterials.2005.02.002
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 926YB
UT WOS:000229158500006
PM 15860204
DA 2018-10-20
ER

PT J
AU Piga, R
   Micheletto, R
   Kawakami, Y
AF Piga, R
   Micheletto, R
   Kawakami, Y
TI Nano-probing of the membrane dynamics of rat pheochromocytoma by
   near-field optics
SO BIOPHYSICAL CHEMISTRY
LA English
DT Article
DE PC12; SNOM; cardiac myocites; membrane; cell; dynamics
ID NERVE GROWTH-FACTOR; FIBER PROBE; CLONAL LINE; CELLS; FABRICATION;
   MICROSCOPY; MECHANISMS; EXOCYTOSIS; RELEASE; PC12
AB High-resolution analysis of activities of live cells is limited by the use of non-invasive methods. Apparatuses such as SEM, STM or AFM are not practicable because the necessary treatment or the harsh contact with system probe will disturb or destroy the cell. Optical methods are purely non-invasive, but they are usually diffraction limited and then their resolution is limited to approximately I gm. To overcome these restrictions, we introduce here the study of membrane activity of a live cell sample using a Scanning Near-field Optical Microscope (SNOM). A near field optical microscope is able to detect tiny vertical movement on the cell membrane in the range of only 1 nm or less, about 3 orders of magnitude better than conventional optical microscopes. It is a purely non-invasive, non-contact method, so the natural life activity of the sample is unperturbed. In this report, we demonstrated the nanometer-level resolving ability of our SNOM system analyzing cardiomyocytes samples of which membrane movement is known, and then we present new intriguing data of sharp 40 mn cell membrane sudden events on rat pheochromocytoma. cell line PC12. All the measurements are carried out in culture medium with alive and unperturbed samples. We believe that this methodology will open a new approach to investigate live samples. The extreme sensitivity of SNOM allows measurements that are not possible with any other method on live biomaterial paving the way for a broad range of novel studies and applications. (c) 2005 Elsevier B.V. All rights reserved.
C1 Kyoto Univ, Grad Sch Engn, Dept Elect Sci, Nishikyo Ku, Kyoto 6158510, Japan.
   Adv Ind Sci & Technol, Human Stress Signal Res Ctr, Ikeda, Osaka 5638577, Japan.
RP Piga, R (reprint author), Kyoto Prefectural Univ Med, Kamigyo Ku, Dai 1 Naika,Dai 8 Kenkyushitu, Kyoto 6028566, Japan.
EM ros-pi02@koto.kpu-m.ac.jp
RI Micheletto, Ruggero/F-6942-2011
OI Micheletto, Ruggero/0000-0003-1707-6493
CR BEHL C, 1992, BIOCHEM BIOPH RES CO, V186, P944, DOI 10.1016/0006-291X(92)90837-B
   BETZIG E, 1991, SCIENCE, V251, P1468, DOI 10.1126/science.251.5000.1468
   DEYNER M, 2003, J NANOSCI NANOTECHNO, V3, P496
   GREENE LA, 1977, BRAIN RES, V138, P521, DOI 10.1016/0006-8993(77)90687-4
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   GREENE LA, 1977, BRAIN RES, V129, P247, DOI 10.1016/0006-8993(77)90005-1
   KILTY JE, 1991, SCIENCE, V254, P578, DOI 10.1126/science.1948035
   Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19
   Martin TFJ, 1997, TRENDS CELL BIOL, V7, P271, DOI 10.1016/S0962-8924(97)01060-X
   Micheletto R, 2001, OPT COMMUN, V188, P11, DOI 10.1016/S0030-4018(00)01147-0
   Micheletto R, 1999, APPL OPTICS, V38, P6648, DOI 10.1364/AO.38.006648
   Mononobe S, 1997, APPL OPTICS, V36, P1496, DOI 10.1364/AO.36.001496
   OHTSU M, 1995, OPTOELECTRON-DEVICES, V10, P147
   RUKENSTEIN A, 1991, J NEUROSCI, V11, P2552
   Saiki T, 1996, APPL PHYS LETT, V68, P2612, DOI 10.1063/1.116198
   SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0
   WEEKS BS, 1991, J CELL PHYSIOL, V147, P62, DOI 10.1002/jcp.1041470109
NR 17
TC 5
Z9 5
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0301-4622
J9 BIOPHYS CHEM
JI Biophys. Chem.
PD SEP 1
PY 2005
VL 117
IS 2
BP 141
EP 146
DI 10.1016/j.bpc.2005.04.018
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Chemistry, Physical
SC Biochemistry & Molecular Biology; Biophysics; Chemistry
GA 961LV
UT WOS:000231664800004
PM 15923074
DA 2018-10-20
ER

PT J
AU Prakasham, RS
   Rao, CS
   Rao, RS
   Sarma, PN
AF Prakasham, RS
   Rao, CS
   Rao, RS
   Sarma, PN
TI Alkaline protease production by an isolated Bacillus circulans under
   solid-state fermentation using agroindustrial waste: Process parameters
   optimization
SO BIOTECHNOLOGY PROGRESS
LA English
DT Article
ID ALKALOPHILIC BACILLUS; PENICILLIUM SP; SP JB-99; LICHENIFORMIS;
   PURIFICATION; ENZYME
AB Alkaline protease production using isolated Bacillus circulans under solid-state fermentation environment was optimized by using Taguchi orthogonal array (OA) experimental design (DOE) methodology to understand the interaction of a large number of variables spanned by factors and their settings with a small number of experiments in order to economize the process optimization. The software-designed experiments with an OA worksheet of L-27 was selected to optimize fermentation (temperature, particle size, moisture content and pH), nutrition (yeast extract and maltose), and biomaterial-related (inoculum size and incubation time) factors for the best production yields. Analysis of experimental data using Qualitek-4 methodology showed significant variation in enzyme production levels (32000-73000 units per gram material) and dependence on the selected factors and their assigned levels. Validation of experimental results on alkaline protease production by this bacterial strain based on DOE methodology revealed 51% enhanced protease production compared to average performance of the fermentation, indicating the importance of this methodology in the evaluation of main and interaction effects of the selected factors individually and in combination for bioprocess optimization.
C1 Indian Inst Chem Technol, Bioengn & Environm Ctr, Hyderabad 500007, Andhra Pradesh, India.
RP Prakasham, RS (reprint author), Indian Inst Chem Technol, Bioengn & Environm Ctr, Hyderabad 500007, Andhra Pradesh, India.
EM prakasam@iict.res.in
RI Ravella, Sreenivas/B-2313-2012
OI Chaganti, Subba Rao/0000-0001-9796-3986
CR Agrawal D, 2004, PROCESS BIOCHEM, V39, P977, DOI 10.1016/S0032-9592(03)00212-7
   Banerjee R, 2003, BIOCHEM ENG J, V13, P149, DOI 10.1016/S1369-703X(02)00127-4
   Cheng SW, 1995, BIOSCI BIOTECH BIOCH, V59, P2239, DOI 10.1271/bbb.59.2239
   Ellaiah P, 2002, J SCI IND RES INDIA, V61, P690
   Ferrero MA, 1996, APPL MICROBIOL BIOT, V45, P327, DOI 10.1007/s002530050691
   FRANKENA J, 1986, APPL MICROBIOL BIOT, V24, P106, DOI 10.1007/BF00938779
   FUJIWARA N, 1987, J FERMENT BIOENG, V65, P345, DOI 10.1016/0385-6380(87)90098-7
   Germano S, 2003, ENZYME MICROB TECH, V32, P246, DOI 10.1016/S0141-0229(02)00283-1
   Johnvesly B, 2002, BIORESOURCE TECHNOL, V82, P61, DOI 10.1016/S0960-8524(01)00147-X
   Johnvesly B, 2001, PROCESS BIOCHEM, V37, P139, DOI 10.1016/S0032-9592(01)00191-1
   KEMBHAVI AA, 1993, APPL BIOCHEM BIOTECH, V28, P409
   KOLE MM, 1988, J CHEM TECHNOL BIOT, V41, P197
   Kumar CG, 1999, PROCESS BIOCHEM, V34, P441, DOI 10.1016/S0032-9592(98)00110-1
   Lee EG, 2000, J MICROBIOL BIOTECHN, V10, P677
   Mabrouk SS, 1999, BIORESOURCE TECHNOL, V69, P155, DOI 10.1016/S0960-8524(98)00165-5
   Mehrotra S, 1999, BIORESOURCE TECHNOL, V67, P201, DOI 10.1016/S0960-8524(98)00107-2
   NG TK, 1986, THERMOPHILES GENERAL, P197
   Pandey A, 2003, BIOCHEM ENG J, V13, P81, DOI 10.1016/S1369-703X(02)00121-3
   PHADATARE SU, 1993, ENZYME MICROB TECH, V15, P72, DOI 10.1016/0141-0229(93)90119-M
   Phadke MS, 1988, QUAL RELIAB ENG INT, V4, P159
   Prakasham RS, 2005, APPL BIOCHEM BIOTECH, V120, P133, DOI 10.1385/ABAB:120:2:133
   PRASAD KK, 2005, IN PRESS BIOCH ENG J
   Rao RS, 2004, PROCESS BIOCHEM, V39, P951, DOI 10.1016/S0032-9592(03)00207-3
   SEN S, 1993, INDIAN J MICROBIOL, V33, P43
   STRAUCH MA, 1993, MOL MICROBIOL, V7, P337, DOI 10.1111/j.1365-2958.1993.tb01125.x
   Uyar F, 2004, PROCESS BIOCHEM, V39, P1893, DOI 10.1016/j.procbio.2003.09.016
   ZAMOST BL, 1990, J IND MICROBIOL, V5, P303, DOI 10.1007/BF01578205
NR 27
TC 39
Z9 43
U1 0
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 8756-7938
J9 BIOTECHNOL PROGR
JI Biotechnol. Prog.
PD SEP-OCT
PY 2005
VL 21
IS 5
BP 1380
EP 1388
DI 10.1021/bp050095e
PG 9
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 972NU
UT WOS:000232461300004
PM 16209541
DA 2018-10-20
ER

PT J
AU Jordan, O
   Doelker, E
   Rufenacht, DA
AF Jordan, O
   Doelker, E
   Rufenacht, DA
TI Biomaterials used in injectable implants (liquid embolics) for
   percutaneous filling of vascular spaces
SO CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
LA English
DT Review
DE aneurysms; arteriovenous malformations; embolization; implant;
   injectable biomaterials; interventional procedures; tumors
ID CEREBRAL ARTERIOVENOUS-MALFORMATIONS; CELLULOSE-ACETATE POLYMER; VINYL
   ALCOHOL COPOLYMER; PORTAL-VEIN EMBOLIZATION; CALCIUM ALGINATE GEL; SWINE
   RETE-MIRABILE; SKULL-BASE TUMORS; ENDOVASCULAR TREATMENT; EXPERIMENTAL
   ANEURYSMS; CLINICAL-EXPERIENCE
AB The biomaterials currently used in injectable implants (liquid embolics) for minimally invasive image-guided treatment of vascular lesions undergo, once injected in situ, a phase transition based on a variety of physicochemical principles. The mechanisms leading to the formation of a solid implant include polymerization, precipitation and cross-linking through ionic or thermal process. The biomaterial characteristics have to meet the requirements of a variety of treatment conditions. The viscosity of the liquid is adapted to the access instrument, which can range from 0.2 mm. to 3 mm in diameter and from a few centimeters up to 200 cm in length. Once such liquid embolics reach the vascular space, they are designed to become occlusive by inducing thrombosis or directly blocking the lesion when hardening of the embolics occurs. The safe delivery of such implants critically depends on their visibility and their hardening mechanism. Once delivered, the safety and effectiveness issues are related to implant functions such as biocompatibility, biodegradability or biomechanical properties. We review here the available and the experimental products with respect to the nature of the polymer, the mechanism of gel cast formation and the key characteristics that govern the choice of effective injectable implants.
C1 Univ Geneva, Sch Pharm, CH-1211 Geneva, Switzerland.
   Univ Hosp Geneva, Dept Neuroradiol, CH-1211 Geneva, Switzerland.
RP Jordan, O (reprint author), Univ Geneva, Sch Pharm, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.
EM olivier.jordan@pharm.unige.ch
RI Jordan, Olivier/B-5590-2009
OI Jordan, Olivier/0000-0003-3752-2198
CR Barr JD, 1999, J VASC INTERV RADIOL, V10, P165, DOI 10.1016/S1051-0443(99)70459-8
   Becker TA, 2001, J BIOMED MATER RES, V54, P76, DOI 10.1002/1097-4636(200101)54:1<76::AID-JBM9>3.0.CO;2-V
   Becker TA, 2002, NEUROSURGERY, V51, P453, DOI 10.1227/01.NEU.0000020083.33150.81
   Belkoff SM, 2000, SPINE, V25, P1061, DOI 10.1097/00007632-200005010-00004
   Casasco A, 1999, AM J NEURORADIOL, V20, P179
   CASASCO A, 1994, AM J NEURORADIOL, V15, P1233
   Chaloupka JC, 1999, AM J NEURORADIOL, V20, P401
   Choe YH, 2001, KOREAN J RADIOL, V2, P121, DOI 10.3348/kjr.2001.2.3.121
   Deramond H, 1998, RADIOL CLIN N AM, V36, P533, DOI 10.1016/S0033-8389(05)70042-7
   Deramond H, 1999, BONE, V25, p17S, DOI 10.1016/S8756-3282(99)00127-1
   Duffner F, 2002, CLIN NEUROPATHOL, V21, P13
   EKELUND L, 1981, CARDIOVASC INTER RAD, V4, P1, DOI 10.1007/BF02552398
   ELLMAN BA, 1984, INVEST RADIOL, V19, P416, DOI 10.1097/00004424-198409000-00014
   Erbe EM, 2001, EUR SPINE J, V10, pS147, DOI 10.1007/s005860100288
   Gobin YP, 2001, RADIOLOGY, V221, P309, DOI 10.1148/radiol.2212001140
   Gruber A, 2000, MINIM INVAS NEUROSUR, V43, P62, DOI 10.1055/s-2000-8321
   Gruber A, 1996, AM J NEURORADIOL, V17, P1323
   GUNTHER R, 1978, CARDIOVASC RADIOL, V1, P101, DOI 10.1007/BF02552003
   Hamada J, 2002, J NEUROSURG, V97, P889, DOI 10.3171/jns.2002.97.4.0889
   Hamada J, 2002, J NEUROSURG, V97, P881, DOI 10.3171/jns.2002.97.4.0881
   Hatano T, 2003, NEUROSURGERY, V53, P393, DOI 10.1227/01.NEU.0000073595.92557.36
   Heini PF, 2001, EUR SPINE J, V10, pS205, DOI 10.1007/s005860100308
   Jahan R, 2001, NEUROSURGERY, V48, P984, DOI 10.1097/00006123-200105000-00003
   Jasper LE, 2002, J MATER SCI-MATER M, V13, P1, DOI 10.1023/A:1013673830184
   JORDAN O, 2004, T 7 WORLD BIOM C SYD, P706
   Kawaguchi T, 2000, NEUROL MED-CHIR, V40, P366, DOI 10.2176/nmc.40.366
   Kazekawa K, 1998, J Clin Neurosci, V5 Suppl, P45, DOI 10.1016/S0967-5868(98)90011-X
   Kazekawa K, 1997, J BIOMED MATER RES, V38, P79, DOI 10.1002/(SICI)1097-4636(199722)38:2<79::AID-JBM1>3.0.CO;2-D
   Kerber CW, 2000, NEUROSURG CLIN N AM, V11, P85, DOI 10.1016/S1042-3680(18)30148-7
   Kim IM, 2002, J NEUROSURG, V97, P718, DOI 10.3171/jns.2002.97.3.0718
   KINUGASA K, 1994, NEUROSURGERY, V34, P694, DOI 10.1227/00006123-199404000-00019
   KINUGASA K, 1992, J NEUROSURG, V77, P501, DOI 10.3171/jns.1992.77.4.0501
   Klisch J, 2002, NEURORADIOLOGY, V44, P503, DOI 10.1007/s00234-001-0761-z
   Klisch J, 2002, AM J NEURORADIOL, V23, P422
   Ko GY, 2003, RADIOLOGY, V227, P407, DOI 10.1148/radiol.2272011702
   Komemushi A, 2002, ACTA RADIOL, V43, P186, DOI 10.1034/j.1600-0455.2002.430217.x
   KONDO S, 1996, ADV INTERVENTIONAL N, P31
   Laurent A, 1998, BIOMED PHARMACOTHER, V52, P76, DOI 10.1016/S0753-3322(98)80007-3
   LAURENT A, 1997, J NEURORADIOLOGY, V24, P314
   Levrier O, 2003, J NEURORADIOLOGY, V30, P95
   MANDAI S, 1992, J NEUROSURG, V77, P497, DOI 10.3171/jns.1992.77.4.0497
   Martin JB, 2003, RADIOLOGY, V229, P593, DOI 10.1148/radiol.2292020976
   Matsumaru Y, 1997, J BIOMAT SCI-POLYM E, V8, P555, DOI 10.1163/156856297X00452
   Matsumaru Y, 1996, J BIOMAT SCI-POLYM E, V7, P795, DOI 10.1163/156856296X00138
   Maurer CA, 2000, J HEPATOL, V32, P261, DOI 10.1016/S0168-8278(00)80071-9
   Mawad ME, 2002, J NEUROSURG, V96, P474, DOI 10.3171/jns.2002.96.3.0474
   Molyneux AJ, 2000, J NEUROSURG, V93, P304, DOI 10.3171/spi.2000.93.2.0304
   Molyneux AJ, 2004, AM J NEURORADIOL, V25, P39
   Mottu F, 2000, BIOMATERIALS, V21, P803, DOI 10.1016/S0142-9612(99)00243-4
   Mottu F, 2002, BIOMATERIALS, V23, P121, DOI 10.1016/S0142-9612(01)00087-4
   Murayama Y, 2000, AM J NEURORADIOL, V21, P1726
   Murayama Y, 1998, NEUROSURGERY, V43, P1164, DOI 10.1097/00006123-199811000-00081
   *N BCA TRAIL INV, 2002, AM J NEURORADIOL, V23, P748
   Ohnishi K, 1998, HEPATO-GASTROENTEROL, V45, P1254
   Ohyama T, 2004, BIOMATERIALS, V25, P3845, DOI 10.1016/j.biomaterials.2003.10.021
   Oowaki H, 2000, BIOMATERIALS, V21, P1039, DOI 10.1016/S0142-9612(99)00278-1
   Park S, 1999, J VASC INTERV RADIOL, V10, P339, DOI 10.1016/S1051-0443(99)70040-0
   Paulsen RD, 1999, NEUROSURGERY, V44, P991, DOI 10.1097/00006123-199905000-00031
   Pollak JS, 2001, J VASC INTERV RADIOL, V12, P907, DOI 10.1016/S1051-0443(07)61568-1
   Probst EN, 1999, AM J NEURORADIOL, V20, P1695
   RAO VRK, 1989, AM J NEURORADIOL, V10, P135
   Raymond J, 2004, BIOMATERIALS, V25, P3983, DOI 10.1016/j.biomaterials.2003.10.085
   Raymond J, 2003, AM J NEURORADIOL, V24, P1214
   RICHTER G, 1984, INVEST RADIOL, V19, P36, DOI 10.1097/00004424-198401000-00009
   SADATO A, 1994, NEURORADIOLOGY, V36, P634, DOI 10.1007/BF00600429
   Sampei K, 1996, NEURORADIOLOGY, V38, P291
   SAMPEI K, 1996, ADV INTERVENTIONAL N, P293
   SATOH K, 1996, ADV INTERVENTIONAL N, P329
   Seo TS, 2000, CARDIOVASC INTER RAD, V23, P177, DOI 10.1007/s002700010039
   Shi ZS, 2002, CHINESE MED J-PEKING, V115, P555
   STOESSLEIN F, 1982, CARDIOVASC INTER RAD, V5, P264, DOI 10.1007/BF02565409
   SU CC, 1991, SURG NEUROL, V36, P4, DOI 10.1016/0090-3019(91)90125-S
   Sugawara Takayuki, 1993, Neurologia Medico-Chirurgica, V33, P71, DOI 10.2176/nmc.33.71
   SUGIU K, 1995, J NEUROSURG, V83, P531, DOI 10.3171/jns.1995.83.3.0531
   Sugiu K, 2001, NEUROSURGERY, V49, P1257, DOI 10.1097/00006123-200111000-00046
   SZMIGIELSKI W, 1981, INVEST RADIOL, V16, P65, DOI 10.1097/00004424-198101000-00012
   TAKI W, 1990, AM J NEURORADIOL, V11, P163
   TERADA T, 1991, J NEUROSURG, V75, P655, DOI 10.3171/jns.1991.75.4.0655
   Tikkakoski T, 2001, ACTA RADIOL, V42, P80, DOI 10.1034/j.1600-0455.2001.042001080.x
   Tokunaga K, 1999, NEUROSURGERY, V44, P981, DOI 10.1097/00006123-199905000-00026
   Tokunaga K, 1998, INTERV NEURORADIOL, V4, P117, DOI 10.1177/15910199980040S125
   VINTERS HV, 1985, NEURORADIOLOGY, V27, P279, DOI 10.1007/BF00339559
   Wright KC, 1999, J VASC INTERV RADIOL, V10, P1207, DOI 10.1016/S1051-0443(99)70221-6
   Yakes W F, 1990, J Vasc Interv Radiol, V1, P89, DOI 10.1016/S1051-0443(90)72510-9
   Yakes WF, 1997, NEUROSURGERY, V40, P1145, DOI 10.1097/00006123-199706000-00005
   Yamada Y, 1996, J COORD CHEM, V38, P1, DOI 10.1080/00958979608022685
NR 86
TC 23
Z9 23
U1 1
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0174-1551
EI 1432-086X
J9 CARDIOVASC INTER RAD
JI Cardiovasc. Interv. Radiol.
PD SEP-OCT
PY 2005
VL 28
IS 5
BP 561
EP 569
DI 10.1007/s00270-004-0238-7
PG 9
WC Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical
   Imaging
SC Cardiovascular System & Cardiology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 966PU
UT WOS:000232033900002
PM 15959697
DA 2018-10-20
ER

PT J
AU Declercq, H
   De Ridder, LI
   Cornelissen, MJ
AF Declercq, H
   De Ridder, LI
   Cornelissen, MJ
TI Isolation and osteogenic differentiation of rat periosteum-derived cells
SO CYTOTECHNOLOGY
LA English
DT Article
DE alkaline phosphatase; differentiation; FTIR; isolation; mineralization;
   periosteum; tissue engineering; transmission electron microscopy
ID FIBROBLAST-GROWTH-FACTOR; OSTEOCHONDROGENIC DIFFERENTIATION;
   OSTEOBLASTIC CELLS; BONE-MARROW; IN-VITRO; CULTURE; PROLIFERATION;
   EXPRESSION; CHONDROGENESIS; CALCIFICATION
AB Selection of appropriate cultures having an osteogenic potential is a necessity if cell/biomaterial interactions are studied in long-term cultures. Osteoblastic cells derived from rat long bones or calvaria have the disadvantage of being in an advanced differentiation stage which results in terminal differentiation within 21 days. In this regard, less differentiated periosteum-derived osteoprogenitors could be more suitable.
   Periosteum-derived cells were isolated from the tibiae of adult Wistar rats (n = 12). The osteogenic potential with regard to alkaline phosphatase activity, morphology, nodule formation and mineralization was studied by culturing them in an osteogenic medium for up to 4 months.
   Seventy-five percent of the cultures (n = 9) did not show any increase in alkaline phosphatase activity nor nodule formation during long-term culture for up to 4 months. Nevertheless, in 25% of the cultures, alkaline phosphatase activity started from negligible (< 5 mM pNP/mg protein) and increased towards approximately 50 mM pNP/mg protein. Three-dimensional nodule formation was observed at passages 3-5. In further passages (P5-P7), nodule formation capacity decreased and a diffuse mineralization pattern was observed.
   Suitable cultures with osteogenic capacity, can be selected at early passages based on the presence of cuboidal cells. These cells have the advantage of retaining their osteogenic potential even after prolonged cultivation (6-7 passages) before final differentiation occurs. Although periosteal cells are suitable for long term in vitro evaluation of biomaterials, the isolation and selection is time consuming. Hence, a more appropriate source to study cell/biomaterial interactions should be more convenient.
C1 Univ Ghent, Dept Anat Embryol Histol & Med Phys, B-9000 Ghent, Belgium.
RP Cornelissen, MJ (reprint author), Univ Ghent, Dept Anat Embryol Histol & Med Phys, Louis Pasteurlaan 2, B-9000 Ghent, Belgium.
EM Ria.Cornelissen@Ugent.be
CR Arnold U, 2002, BIOMATERIALS, V23, P2303, DOI 10.1016/S0142-9612(01)00364-7
   ATTAWIA MA, 1995, J BIOMED MATER RES, V29, P843, DOI 10.1002/jbm.820290709
   Bahrami S, 2000, ANAT REC, V259, P124
   BOCK P, 1984, SEMIDUNNSCHNITT, P98
   Breitbart AS, 1998, PLAST RECONSTR SURG, V101, P567, DOI 10.1097/00006534-199803000-00001
   Burdick JA, 2002, J BIOMED MATER RES, V63, P484, DOI 10.1002/jbm.10298
   Calandrelli L, 2002, J BIOMED MATER RES, V59, P611, DOI 10.1002/jbm.10014
   Dalby MJ, 2002, BIOMATERIALS, V23, P569, DOI 10.1016/S0142-9612(01)00139-9
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P85, DOI 10.1002/1529-0131(200101)44:1<85::AID-ANR12>3.0.CO;2-6
   Declercq H, 2004, BIOMATERIALS, V25, P757, DOI 10.1016/S0142-9612(03)00580-5
   Declerq HA, 2005, BIOMATERIALS, V26, P4964, DOI 10.1016/j.biomaterials.2005.01.025
   Driessens FCM, 1990, BIOMINERALS
   Furuya K, 1999, J CELL BIOCHEM, V72, P177, DOI 10.1002/(SICI)1097-4644(19990201)72:2<177::AID-JCB2>3.0.CO;2-#
   Gruber R, 2001, ENDOCRINOLOGY, V142, P2087, DOI 10.1210/en.142.5.2087
   Hanada K, 2001, J CELL BIOCHEM, V81, P284, DOI 10.1002/1097-4644(20010501)81:2<284::AID-JCB1043>3.0.CO;2-D
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   IWASAKI M, 1995, J BONE JOINT SURG AM, V77A, P543, DOI 10.2106/00004623-199504000-00007
   IWASAKI M, 1994, J BONE MINER RES, V9, P1195
   IZUMI T, 1992, J BONE MINER RES, V7, P115
   KOSHIHARA Y, 1989, IN VITRO CELL DEV B, V25, P37
   KOSHIHARA Y, 1987, BIOCHEM BIOPH RES CO, V145, P651, DOI 10.1016/0006-291X(87)91014-X
   Lisignoli G, 2001, BIOMATERIALS, V22, P2095, DOI 10.1016/S0142-9612(00)00398-7
   Moursi AM, 2002, BIOMATERIALS, V23, P133, DOI 10.1016/S0142-9612(01)00088-6
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   Pieters IY, 1998, INORG CHEM, V37, P6392, DOI 10.1021/ic9802810
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   SCHWARTZ E, 1997, CULTURE ANIMAL CELLS, P332
   Scotchford CA, 1998, BIOMATERIALS, V19, P1, DOI 10.1016/S0142-9612(97)00236-6
   Solchaga LA, 1998, ACTA ORTHOP SCAND, V69, P426, DOI 10.3109/17453679808999061
   Spitzer RS, 2002, J BIOMED MATER RES, V59, P690, DOI 10.1002/jbm.1277
NR 30
TC 6
Z9 6
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-9069
J9 CYTOTECHNOLOGY
JI Cytotechnology
PD SEP
PY 2005
VL 49
IS 1
BP 39
EP 50
DI 10.1007/s10616-005-5167-z
PG 12
WC Biotechnology & Applied Microbiology; Cell Biology
SC Biotechnology & Applied Microbiology; Cell Biology
GA 013YF
UT WOS:000235445200004
PM 19003061
OA Green Published
DA 2018-10-20
ER

PT J
AU Hirata, I
   Nomura, Y
   Tabata, H
   Miake, Y
   Yanagisawa, T
   Okazaki, M
AF Hirata, I
   Nomura, Y
   Tabata, H
   Miake, Y
   Yanagisawa, T
   Okazaki, M
TI SEM observation of collagen fibrils secreted from the body surface of
   osteoblasts on a CO(3)apatite-collagen sponge
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE osteoblast; collagen fibril; secretion; CO(3)apatite-collagen sponge
ID BONE-FORMATION; COMPOSITES
AB The secretion of collagen by osteoblasts was observed by scanning electron microscopy (SEM). Osteoblast-like cells were cultured on a CO(3)apatite-collagen sponge reinforced with a porous HAp frame. After three days' incubation, a number of newly created matrix fibrils, forming a network structure, were observed at the cell surface. SEM also showed that osteoblasts secreted collagen fibrils from their membrane, and that the collagen fibrils were twisted together. When collagen in an aqueous sol solution was sprayed onto the extremely smooth surface of a mica plate to support the secretion of osteoblasts, a collagen network structure could be clearly observed with atomic force microscopy (AFM). With this in vitro phenomenon, we could confirm the formation of collagen network structure without biological function. Therefore, it was suggested that the CO(3)apatite-collagen sponge used in this study is a favorable scaffold biomaterial, on which osteoblasts could produce the unmistakable, characteristic extracellular matrix for mineralization. For therapeutic use of hard tissue biomaterials, collagen formation as an extracellular matrix (ECM) is very important because mineralization is subsequent to ECM.
C1 Hiroshima Univ, Grad Sch Biomed Sci, Dept Biomat Sci, Minami Ku, Hiroshima 7348553, Japan.
   Osaka Univ, Inst Sci & Ind Res, Ctr Nanotechnol, Osaka 5670047, Japan.
   Tokyo Dent Coll, Dept Ultrastruct Sci, Mihama Ku, Chiba 2618502, Japan.
RP Okazaki, M (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Biomat Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.
EM okazakix@hiroshima-u.ac.jp
CR Bokhari M, 2003, ADV EXP MED BIOL, V534, P247
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   Itoh M, 2004, BIOMATERIALS, V25, P2577, DOI 10.1016/j.biomaterials.2003.09.071
   LEBRASSEUR N, 2004, J CELL BIOL, V166, P443
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   OKAZAKI M, 1989, BIOMATERIALS, V10, P564, DOI 10.1016/0142-9612(89)90064-1
   OKAZAKI M, 1990, BIOMATERIALS, V11, P568, DOI 10.1016/0142-9612(90)90080-A
   Service RF, 2000, SCIENCE, V289, P1498, DOI 10.1126/science.289.5484.1498
   Tanahashi M, 1996, BIOMATERIALS, V17, P47, DOI 10.1016/0142-9612(96)80754-X
   Tanaka S, 2001, JPN J APPL PHYS 1, V40, P4217, DOI 10.1143/JJAP.40.4217
   TENHUISEN KS, 1994, J BIOMED MATER RES, V28, P27, DOI 10.1002/jbm.820280105
   Tieliewuhan Y, 2004, DENT MATER J, V23, P258, DOI 10.4012/dmj.23.258
   Watson J. D., 1994, MOL BIOL CELL
   Yamasaki Y, 2003, BIOMATERIALS, V24, P4913, DOI 10.1016/S0142-9612(03)00414-9
   Yamasaki Y, 2002, J BIOMED MATER RES, V62, P99, DOI 10.1002/jbm.10220
NR 16
TC 1
Z9 1
U1 2
U2 7
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KAMAGOME TS BDG, KOMAGONE, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD SEP
PY 2005
VL 24
IS 3
BP 460
EP 464
DI 10.4012/dmj.24.460
PG 5
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 981LT
UT WOS:000233090800026
PM 16279740
OA Bronze
DA 2018-10-20
ER

PT J
AU Oudadesse, H
   Derrien, AC
   Lucas-Girot, A
AF Oudadesse, H
   Derrien, AC
   Lucas-Girot, A
TI Statistical experimental design for studies of porosity and compressive
   strength in composite materials applied as biomaterials
SO EUROPEAN PHYSICAL JOURNAL-APPLIED PHYSICS
LA English
DT Article
ID CALCIUM-PHOSPHATE CERAMICS; BONE INGROWTH; PARAMETERS; RESORPTION
AB Composites studied in this work are the associations of aluminosilicates and 13% of calcium phosphates. These composites present great interest. They are destined to be applied in biomedical field, particularly in orthopedic or jawbone surgery. Calcium phosphates are composed of HA ( hydroxyapatite) and TCP (tricalcic phosphate). The success of synthesised bony biomaterials depends on two determinant factors: the porosity ( which facilitate the cells deposition and the vascularisation) and the compressive strength ( which permits the support of body charge). In this way, a statistical experimental design was employed to quantify the influence of these two synthesis parameters. It concerns the effect of the K2O/SiO2 molecular ratio (X-1) and the effect of the calcium phosphate (HA/TCP) weight % (X-2). The K2O/SiO2 molecular ratio characterises the synthesis of the aluminosilicate. It varies between two limit levels: the stoichiometric ratio K2O/SiO2 = 0.54 corresponding to: X-1 = - 1 and the ratio K2O/ SiO2 = 0.80 corresponding to X-1 = 1. In bony biomaterials field, various calcium phosphates are commonly used as biomaterials. In our previous works, the influence of the commercial hydroxyapatite HA and tri-calcium phosphate TCP ( 13 wt%) addition was investigated. To study the effect of calcium phosphate composition, the weight percentage of mixing HA and TCP varied between two levels: the composite aluminosilicate with 13 wt% of HA ( X2 = - 1) and the composite aluminosilicate with 13 wt% of TCP (X-2 = 1). Eight samples were studied. The statistical experimental design predicted answer surfaces for compressive strength and percentage of porosity. After the validation of models, it was possible to determine composite which presents best compromise between percentage of porosity and compressive strength. This composite will be evaluated by "in-vitro" and "in-vivo" studies to investigate its potential for forthcoming applied as biomaterial.
C1 Univ Rennes 1, Inst Chim, CNRS, UMR 6511, F-35042 Rennes, France.
RP Oudadesse, H (reprint author), Univ Rennes 1, Inst Chim, CNRS, UMR 6511, Campus Beaulieu,263 Ave Gen Leclerc, F-35042 Rennes, France.
EM hassane.oudadesse@univ-rennes1.fr
CR Bouler JM, 1996, J BIOMED MATER RES, V32, P603, DOI 10.1002/(SICI)1097-4636(199612)32:4<603::AID-JBM13>3.0.CO;2-E
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Davidovits 6 J., 1988, GEOPOLYMER 88, V88, P25
   DEGROOT K, 1991, CENTENNIAL MEMORIAL, V99, P943
   DERRIEN AC, 2003, J THERM ANAL, V75, P937
   DOEHLERT DH, 1970, APPL STATISTICS, V19, P231
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   GOUPY J, 1988, PLANS EXPERIENCES SU
   Jallot E, 1999, EUR PHYS J-APPL PHYS, V6, P205, DOI 10.1051/epjap:1999172
   KOKUBO T, 1991, J CERAM SOC JPN, V99, P665
   LEHUEC JC, 1995, BIOMATERIALS, V16, P113, DOI 10.1016/0142-9612(95)98272-G
   Liu DM, 1997, CERAM INT, V23, P135, DOI 10.1016/S0272-8842(96)00009-0
   Lucas-Girot A, 2002, BIOMATERIALS, V23, P503, DOI 10.1016/S0142-9612(01)00132-6
   REGI MV, 2001, J CHEM SOC DA, P97
   Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Zoulgami M, 2002, EUR PHYS J-APPL PHYS, V19, P173, DOI 10.1051/epjap:2002063
NR 18
TC 9
Z9 9
U1 0
U2 5
PU EDP SCIENCES S A
PI LES ULIS CEDEX A
PA 17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A,
   FRANCE
SN 1286-0042
J9 EUR PHYS J-APPL PHYS
JI Eur. Phys. J.-Appl. Phys
PD SEP
PY 2005
VL 31
IS 3
BP 217
EP 223
DI 10.1051/epjap:2005062
PG 7
WC Physics, Applied
SC Physics
GA 964IY
UT WOS:000231875500010
DA 2018-10-20
ER

PT J
AU Angres, B
AF Angres, B
TI Cell microarrays
SO EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
LA English
DT Review
DE 3D; antibody; biomaterial; cell chip; cell microarray; cell printing;
   dielectrophoresis; extracellular; matrix; glycan; membrane; peptide-MHC;
   nonpositional array; peptide; positional array; reverse transfection;
   small molecule
ID HIGH-THROUGHPUT; MAMMALIAN-CELLS; ANTIBODY MICROARRAY; TRANSFECTION
   MICROARRAY; NONADHERENT CELLS; FUNCTIONAL ASSAYS; GENE-EXPRESSION;
   QUANTUM DOTS; STEM-CELLS; ARRAYS
AB In the postgenomic era, DNA and protein arrays are increasing the speed at which knowledge is gathered on gene expression in cells and tissues. At the same time, researchers realize that a miniaturized and parallelized analysis of whole cells may equally expedite the acquisition of data describing cellular properties and function. Researchers are starting to explore means of generating and using cell microarrays to investigate cells at higher throughput. In this initial phase of exploration, cell microarrays are being developed for various cellular analyses including the effects of gene expression, cellular reactions to the biomolecular environment, and profiling of cell surface molecules. This article will provide an overview of different types of eukaryotic cell microarrays described to date, how they are generated, and their fields of application.
C1 Univ Tubingen, NMI Nat & Med Sci Inst, Dept Cellular Assay Syst, D-72770 Reutlingen, Germany.
RP Angres, B (reprint author), Univ Tubingen, NMI Nat & Med Sci Inst, Dept Cellular Assay Syst, Markwiesenstr 55, D-72770 Reutlingen, Germany.
EM angres@nmi.de
CR Albrecht DR, 2005, LAB CHIP, V5, P111, DOI 10.1039/b406953f
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Angres B, 2004, EUR CELLS MATER, V7, P40
   Baghdoyan S, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh074
   Bailey SN, 2004, P NATL ACAD SCI USA, V101, P16144, DOI 10.1073/pnas.0404425101
   Belov L, 2003, PROTEOMICS, V3, P2147, DOI 10.1002/pmic.200300599
   Belov L, 2001, CANCER RES, V61, P4483
   Beske O, 2004, J BIOMOL SCREEN, V9, P173, DOI 10.1177/1087057103260088
   Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101
   Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248
   Chang FH, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh029
   CHANG TW, 1983, J IMMUNOL METHODS, V65, P217
   Cheung VG, 2002, NAT GENET, V32, P522, DOI 10.1038/ng1036
   Chittur SV, 2004, COMB CHEM HIGH T SCR, V7, P531
   Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038
   Conrad C, 2004, GENOME RES, V14, P1130, DOI 10.1101/gr.2383804
   Delehanty JB, 2004, ANAL CHEM, V76, P7323, DOI 10.1021/ac049259g
   Delehanty JB, 2004, BIOSENS BIOELECTRON, V20, P773, DOI 10.1016/j.bios.2004.04.016
   Edwards BS, 2004, CURR OPIN CHEM BIOL, V8, P392, DOI 10.1016/j.cbpa.2004.06.007
   Erfle H, 2004, BIOTECHNIQUES, V37, P454, DOI 10.2144/04373RT01
   ERFLE H, 2004, BIOTECHNIQUES, V37, P460
   ERFLE H, 2004, BIOTECHNIQUES, V37, P462
   Falsey JR, 2001, BIOCONJUGATE CHEM, V12, P346, DOI 10.1021/bc000141q
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735
   Furuya Tomoko, 2002, Methods in Cell Science, V24, P41, DOI 10.1023/A:1024181512088
   Gerhold DL, 2002, NAT GENET, V32, P547, DOI 10.1038/ng1042
   Gray DS, 2004, BIOSENS BIOELECTRON, V19, P771, DOI 10.1016/j.bios.2003.08.013
   Groves JT, 2001, LANGMUIR, V17, P5129, DOI 10.1021/la010481f
   Haab B B, 2001, Curr Opin Drug Discov Devel, V4, P116
   Hodder P, 2004, J BIOMOL SCREEN, V9, P417, DOI 10.1177/1087057104264038
   Hoff A, 2002, CHEMBIOCHEM, V3, P1183, DOI 10.1002/1439-7633(20021202)3:12<1183::AID-CBIC1183>3.0.CO;2-Q
   Hoff A, 2004, MOL DIVERS, V8, P311, DOI 10.1023/B:MODI.0000036241.85469.85
   Hovis JS, 2001, LANGMUIR, V17, P3400, DOI 10.1021/la0017577
   How SE, 2004, COMB CHEM HIGH T SCR, V7, P423, DOI 10.2174/1386207043328616
   Huang Y, 2002, ANAL CHEM, V74, P3362, DOI 10.1021/ac011273v
   Kapur R, 1999, BIOMED MICRODEVICES, V2, P99, DOI 10.1023/A:1009993519771
   Kato K, 2004, BIOTECHNIQUES, V37, P444, DOI 10.2144/04373RR02
   Kato K, 2003, BIOTECHNIQUES, V35, P1014, DOI 10.2144/03355rr01
   KATO K, 2004, BIOTECHNIQUES, V37, P452
   Kato K, 2003, BIOTECHNIQUES, V35, P1020
   KATO K, 2004, BIOTECHNIQUES, V37, P450
   Ko IK, 2005, BIOMATERIALS, V26, P687, DOI 10.1016/j.biomaterials.2004.03.014
   Kumar R, 2003, GENOME RES, V13, P2333, DOI 10.1101/gr.1575003
   Lal SP, 2002, DRUG DISCOV TODAY, V7, pS143, DOI 10.1016/S1359-6446(02)02413-3
   Liu AY, 2000, CANCER RES, V60, P3429
   MacBeath G, 2000, SCIENCE, V289, P1760
   Mattheakis LC, 2004, ANAL BIOCHEM, V327, P200, DOI 10.1016/j.ab.2004.01.031
   Mishina YM, 2004, J BIOMOL SCREEN, V9, P196, DOI 10.1177/1087057103261880
   Mousses S, 2003, GENOME RES, V13, P2341, DOI 10.1101/gr.1478703
   Nimrichter L, 2004, GLYCOBIOLOGY, V14, P197, DOI 10.1093/glycob/cwh022
   Oode K, 2000, AM J PATHOL, V157, P723, DOI 10.1016/S0002-9440(10)64585-3
   Pennington ME, 1996, MOL DIVERS, V2, P19, DOI 10.1007/BF01718696
   Pethig R, 1996, CRIT REV BIOTECHNOL, V16, P331, DOI 10.3109/07388559609147425
   Redmond TM, 2004, MOL CELL PROTEOMICS, V3, P770, DOI 10.1074/mcp.M400018-MCP200
   Ruckstuhl T, 2005, BIOSENS BIOELECTRON, V20, P1872, DOI 10.1016/j.bios.2004.06.050
   Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43
   Schwenk JM, 2002, BIOTECHNIQUES, P54
   Silva JM, 2004, P NATL ACAD SCI USA, V101, P6548, DOI 10.1073/pnas.0400165101
   Smith AM, 2004, PHOTOCHEM PHOTOBIOL, V80, P377, DOI 10.1562/2004-06-21-IR-209.1
   Soen Y, 2003, PLOS BIOL, V1, P429, DOI 10.1371/journal.pbio.0000065
   Song AM, 2004, BIOORG MED CHEM LETT, V14, P161, DOI 10.1016/j.bmcl.2003.09.067
   Stephan JP, 2002, AM J PATHOL, V161, P787, DOI 10.1016/S0002-9440(10)64238-1
   Stoll D, 2005, CURR OPIN DRUG DISC, V8, P239
   Szili E, 2004, BIOSENS BIOELECTRON, V19, P1395, DOI 10.1016/j.bios.2003.12.019
   Takita M, 2003, CYTOM PART A, V55A, P24, DOI 10.1002/cyto.a.10066
   VANHECKE D, 2004, ONCOGENE, V23, P8358
   Watson A, 2003, BIOTECHNIQUES, V34, P296, DOI 10.2144/03342bi01
   Webb BL, 2003, J BIOMOL SCREEN, V8, P620, DOI 10.1177/1087057103259324
   Wheeler DB, 2005, NAT GENET, V37, pS25, DOI 10.1038/ng1560
   Wheeler DB, 2004, NAT METHODS, V1, P127, DOI 10.1038/NMETH711
   Wilson WC, 2003, ANAT REC PART A, V272A, P491, DOI 10.1002/ar.a.10057
   Xu QC, 2004, MOL DIVERS, V8, P301, DOI 10.1023/B:MODI.0000036238.42200.3d
   Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011
   Yamauchi F, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh176
   Yoshikawa T, 2004, J CONTROL RELEASE, V96, P227, DOI 10.1016/j.jconrel.2004.01.024
   Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114
NR 77
TC 37
Z9 38
U1 3
U2 26
PU FUTURE DRUGS LTD
PI LONDON
PA UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEYY CENTRAL, LONDON N3 1QB,
   ENGLAND
SN 1473-7159
J9 EXPERT REV MOL DIAGN
JI Expert Rev. Mol. Diagn.
PD SEP
PY 2005
VL 5
IS 5
BP 769
EP 779
DI 10.1586/14737159.5-5.769
PG 11
WC Pathology
SC Pathology
GA 966LJ
UT WOS:000232021100015
PM 16149879
DA 2018-10-20
ER

PT J
AU Vrijhof, EJ
   de Bruine, A
   Zwinderman, A
   Nijeholt, AABLA
   Koole, L
AF Vrijhof, EJ
   de Bruine, A
   Zwinderman, A
   Nijeholt, AABLA
   Koole, L
TI New nonabsorbable stent versus a microsurgical procedure for vasectomy
   reversal: evaluating tissue reactions at the anastomosis in rabbits
SO FERTILITY AND STERILITY
LA English
DT Article
DE vasovasostomy; vasectomy reversal; vasectomy; stent; polymeric;
   biomaterial
ID VASOVASOSTOMY; OBSTRUCTION; PREDICTORS; SUCCESS; HOLLOW
AB Objective: To investigate whether a newly designed, nonabsorbable polymeric stent for the reconstruction of the vas deferens provided less structuring at the site of the anastomosis in comparison- with the conventional microsurgical reconstruction of the vas deferens.
   Design: Prospective randomized study in 26 rabbits, comparing the one-layer microscopic sutured procedure with a biocompatible stent.
   Setting: University animal laboratory center.
   Intervention(s): Pre- and postoperative average total sperm count, motility, and progressive motile sperm density (PMSD) levels were measured. Histologic sections were taken from the area of the anastomosis, testes, and epididymi after final semen analysis.
   Main Outcome Measure(s): Rates of stricture and semen parameters.
   Result(s): The vas deferens of the rabbits that received a stent showed an inflammatory reaction within the vas wall adjacent to the stent. Transmural histiocytic or eosinophilic reactions were seen in 2/13 (15%) of the stented. animals, with atrophy of the epithelium. Histologic cross-sections of the stented vas deferens demonstrated patency. Microscopically sutured rabbits showed more partial obstructions at the site of the anastomosis (5/13 [38%]) with transmural infiltration of lymphocytes and histiocytes. Despite these partial obstructions the vasa were patent. There was a statistically significant difference in favor of the stent with respect to the total sperm count (P=.05). No differences were seen in motility (P=.057) or PMSD (P=.13).
   Conclusion(s): The newly developed stent provided patency rates comparable with the conventional,, one-layer microscopic procedure but showed significantly less structuring of the anastomoses.
C1 Catharina Hosp, Dept Urol, NL-5602 ZA Eindhoven, Netherlands.
   Univ Hosp Maastricht, Dept Pathol, Maastricht, Netherlands.
   Leiden Univ, Dept Med Stat, NL-2300 RA Leiden, Netherlands.
   Leiden Univ, Med Ctr, Dept Urol, Leiden, Netherlands.
   Univ Maastricht, Ctr Biomat Res, Maastricht, Netherlands.
RP Vrijhof, EJ (reprint author), Catharina Hosp, Dept Urol, POB 1350, NL-5602 ZA Eindhoven, Netherlands.
EM eric.vrijhof@planet.nl
CR BELKER AM, 1991, J UROLOGY, V145, P505, DOI 10.1016/S0022-5347(17)38381-7
   Belker AM, 1998, J UROLOGY, V159, P835, DOI 10.1016/S0022-5347(01)63746-7
   BERGER RE, 1989, FERTIL STERIL, V51, P504
   Carbone DJ, 1998, J UROLOGY, V159, P827, DOI 10.1016/S0022-5347(01)63744-3
   Fischer MA, 2000, BJU INT, V85, P1085, DOI 10.1046/j.1464-410x.2000.00668.x
   FLAM TA, 1989, UROLOGY, V33, P490, DOI 10.1016/0090-4295(89)90140-4
   Fox M, 2000, BJU INT, V86, P474, DOI 10.1046/j.1464-410X.2000.00766.x
   FREUND M, 1969, FERTIL STERIL, V20, P163
   Fuse H., 1995, International Urology and Nephrology, V27, P451, DOI 10.1007/BF02550083
   Hernandez J, 1999, J UROLOGY, V161, P1153, DOI 10.1016/S0022-5347(01)61616-1
   Matthews GJ, 1997, J UROLOGY, V157, P844, DOI 10.1016/S0022-5347(01)65060-2
   MONTIE JE, 1973, FERTIL STERIL, V24, P877
   NUWAYSER ES, 1975, T AM SOC ART INT ORG, V21, P523
   Paick JS, 2003, J UROLOGY, V169, P1052, DOI 10.1097/01.ju.0000052666.97595.f6
   ROYLE MG, 1985, BRIT J UROL, V57, P780, DOI 10.1111/j.1464-410X.1985.tb07053.x
   SILBER SJ, 1977, FERTIL STERIL, V28, P1191
   VRIJHOF HJEJ, 1994, UROL INT, V53, P143, DOI 10.1159/000282656
NR 17
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2005
VL 84
IS 3
BP 743
EP 748
DI 10.1016/j.fertnstert.2005.03.063
PG 6
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 965ZE
UT WOS:000231988600031
PM 16169412
DA 2018-10-20
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI HET-CAM testing combined with histology: Arapid and simple method for
   biomaterial selection
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD SEP
PY 2005
VL 28
IS 9
BP 889
EP 889
PG 1
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 972VH
UT WOS:000232480800085
DA 2018-10-20
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Biomaterial surface modification by the thin tin layer deposition
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD SEP
PY 2005
VL 28
IS 9
BP 896
EP 896
PG 1
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 972VH
UT WOS:000232480800111
DA 2018-10-20
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI HET-CAM biomaterial evaluation gives comparable results to in vivo
   models regarding biocompatibility patterns
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD SEP
PY 2005
VL 28
IS 9
BP 934
EP 934
PG 1
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 972VH
UT WOS:000232480800251
DA 2018-10-20
ER

PT J
AU MacEwan, MR
   Brodbeck, WG
   Matsuda, T
   Anderson, JM
AF MacEwan, MR
   Brodbeck, WG
   Matsuda, T
   Anderson, JM
TI Monocyte/lymphocyte interactions and the foreign body response: in vitro
   effects of biomaterial surface chemistry
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article; Proceedings Paper
CT 30th Annual Meeting of the Society-for-Biomaterials
CY APR 27-30, 2005
CL Memphis, TN
SP Soc Biomat
DE coculture; biocompatibility; foreign body response; macrophage;
   lymphocyte
ID GIANT-CELL FORMATION; MONOCYTE/MACROPHAGE ADHESION; MACROPHAGE;
   BIOCOMPATIBILITY; MONOCYTES; APOPTOSIS; MIGRATION
AB To determine the effect of biomaterial surface chemistry on leukocyte interaction and activity at the material/tissue interface, human peripheral blood monocytes and lymphocytes were cultured on a series of poly(ethylene terephthalate) (PET)-based biomaterials. Both monocytes and lymphocytes were isolated from whole human blood and separated by a nonadherent density centrifugation method before being plated on PET disks, surface modified by photograft copolymerization to yield hydrophobic, hydrophilic, anionic, and cationic surface properties. Monocytes and lymphocytes were cultured separately, to elicit baseline levels of activity, in direct coculture, to promote direct cell surface interactions, or in an indirect coculture system with both cell types separated by a 0.02-mu m Transwell apparatus, to promote indirect paracrine interactions. Monocyte adhesion, macrophage fusion, and lymphocyte proliferation were measured on days 3, 7, 10, and, 14 of culture. Results demonstrated that the presence of monocytes increased the activity of cocultured lymphocytes at the biomaterial/tissue interface, while the corresponding presence of lymphocytes increased the activation and fusion of indirectly cocultured monocytes. Biomaterial surface chemistry was also found to have a significant effect on monocyte adhesion and activation, and lymphocyte activity. Hydrophilic surfaces significantly inhibited both initial and longterm monocyte adhesion, and inhibited lymphocyte proliferation at longer time points. Anionic and cationic surfaces both exhibited mild inhibition of monocyte adhesion at prolonged time,points, yet evoked different responses in lymphocyte populations. Anionic surfaces increased lymphocyte proliferation at longer time points and increased levels of macrophage fusion, while cationic surfaces decreased levels of lymphocyte proliferation and inhibited monocyte activity. These results elucidate the complex role of juxtacrine and paracrine interactions between monocytes and lymphocytes in the foreign body response, as well as promote the consideration of hydrophilic surfaces in future designs of implantable biomedical devices and prostheses. (c) 2005 Wiley Periodicals, Inc.
C1 Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA.
   Kyushu Univ, Dept Biomed Engn, Fukuoka 812, Japan.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
EM jma6@case.edu
FU NIBIB NIH HHS [EB 00282]
CR ABRAMSON SL, 1990, J IMMUNOL, V144, P625
   ADAMS DO, 1992, INFLAMMATION BASIC P, P637
   Anderson J.M., 1994, PROB GEN SURG, V11, P147
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P123
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375
   CIMA LG, 1994, J CELL BIOCHEM, V56, P155, DOI 10.1002/jcb.240560206
   COLDITZ IG, 1992, IMMUNOLOGY, V76, P272
   Collier T O, 1997, Biomed Sci Instrum, V33, P178
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   DEFIFE KM, 1997, J IMMUNOL, V158, P3395
   HENSON PM, 1980, AM J PATHOL, V101, P494
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   IMHOF BA, 1995, ADV IMMUNOL, V58, P345, DOI 10.1016/S0065-2776(08)60623-9
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   JOHNSTON RB, 1988, NEW ENGL J MED, V318, P747, DOI 10.1056/NEJM198803243181205
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MCNALLY AK, 1995, AM J PATHOL, V147, P1497
   Nakayama Y, 1996, MACROMOLECULES, V29, P8622, DOI 10.1021/ma9606014
   NAKAYAMA Y, UNPUB MICROPROCESS F
   Shankar Ravi, 1994, P67
   SUTTON JS, 1966, J CELL BIOL, V28, P303, DOI 10.1083/jcb.28.2.303
   Szleifer I, 1997, BIOPHYS J, V72, P595, DOI 10.1016/S0006-3495(97)78698-3
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
NR 30
TC 45
Z9 46
U1 1
U2 18
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2005
VL 74A
IS 3
BP 285
EP 293
DI 10.1002/jbm.a.30316
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 954UG
UT WOS:000231179900001
PM 16124082
DA 2018-10-20
ER

PT J
AU Lynn, AK
   Nakamura, T
   Patel, N
   Porter, AE
   Renouf, AC
   Laity, PR
   Best, SM
   Cameron, RE
   Shimizu, Y
   Bonfield, W
AF Lynn, AK
   Nakamura, T
   Patel, N
   Porter, AE
   Renouf, AC
   Laity, PR
   Best, SM
   Cameron, RE
   Shimizu, Y
   Bonfield, W
TI Composition-controlled nanocomposites of apatite and collagen
   incorporating silicon as an osseopromotive agent
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE collagen; apatite; silicon; composite; bone
ID SELF-ORGANIZATION MECHANISM; MATRIX IN-VITRO; OCTACALCIUM PHOSPHATE;
   SUBSTITUTED HYDROXYAPATITE; FUSION MODEL; BONE; GROWTH; BIOMATERIAL;
   TEMPERATURE; CERAMICS
AB The development of a novel biocomposite of apatite (Ap) and collagen incorporating low-level additions of silicon (Si) as an osseopromotive agent is detailed. Designed to mimic the structural and compositional characteristics of developing bone, this composite is produced via a coprecipitation method, through which the weight percentage of Ap (i.e., the Ap/collagen ratio) can be varied. Coprecipitates produced at Ap contents of 80 wt % (Ap/collagen = 4:1), 60 wt % (Ap/collagen = 3:2), and 40 wt % (Ap/collagen = 2:3) Ap showed markedly different morphologies, ranging from ceramic-like particulates to rope-like macro-fibrils; at all three Ap contents, however, the nanostructural features of the composites remained qualitatively indistinguishable, with equiaxed Ap nanocrystals distributed randomly throughout a matrix of amorphous collagen. Si incorporation was observed to occur preferentially in the collagenous phase-a result with potential impact on local controlled release of Si. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Cambridge St Johns Coll, Cambridge Ctr Med Mat, Dept Mat Sci & Met, Cambridge CB2 1TP, England.
   Kyoto Univ, Inst Frontier Med Sci, Dept Bioartificial Organs, Sakyo Ku, Kyoto 6068507, Japan.
   Lawrence Berkeley Lab, Natl Ctr Electron Microscopy, Berkeley, CA 94720 USA.
RP Lynn, AK (reprint author), Univ Cambridge St Johns Coll, Cambridge Ctr Med Mat, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 1TP, England.
EM andrew.k.lynn@cantab.net
OI Cameron, Ruth/0000-0003-1573-4923; Laity, Peter/0000-0001-8608-875X
CR BIANCHI E, 1967, J BIOL CHEM, V242, P1361
   CAPLAN AI, 1988, CIBA F SYMP, V136, P3
   CARLISLE EM, 1980, J NUTR, V110, P352
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   CARTER DR, 1978, CLIN ORTHOP RELAT R, V135, P192
   CHRISTIANSEN DL, 1993, CELL MATER, V3, P177
   Cornell C N, 1991, J Orthop Trauma, V5, P1
   de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004
   FROST HM, 1989, CLIN ORTHOP RELAT R, P283
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Hata K, 2002, J CERAM SOC JPN, V110, P990, DOI 10.2109/jcersj.110.990
   Hata K, 2001, J CERAM SOC JPN, V109, P461, DOI 10.2109/jcersj.109.1269_461
   HEMMERLE J, 1995, J MATER SCI-MATER M, V6, P360, DOI 10.1007/BF00120305
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Iijima M, 1995, CONNECT TISSUE RES, V32, P519
   IIJIMA M, 1994, J CRYST GROWTH, V137, P553, DOI 10.1016/0022-0248(94)90998-9
   Iijima M, 1997, CONNECT TISSUE RES, V36, P51, DOI 10.3109/03008209709160213
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.0.CO;2-9
   John A, 2001, J BIOMAT SCI-POLYM E, V12, P689, DOI 10.1163/156856201316883485
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kikuchi M, 2004, COMPOS SCI TECHNOL, V64, P819, DOI 10.1016/j.compscitech.2003.09.002
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   LANDIS WJ, 1986, CALCIFIED TISSUE INT, V38, P52, DOI 10.1007/BF02556595
   Lawson AC, 1998, P I MECH ENG H, V212, P413, DOI 10.1243/0954411981534187
   Lickorish D, 2004, J BIOMED MATER RES A, V68A, P19, DOI 10.1002/jbm.a..20031
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Muschler GF, 1996, CLIN ORTHOP RELAT R, P250
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Rhee SH, 2001, BIOMATERIALS, V22, P2843, DOI 10.1016/S0142-9612(01)00028-X
   SIMMONS DJ, 1974, CHRONOBIOLOGIA, V1, P97
   TENHUISEN KS, 1995, J BIOMED MATER RES, V29, P803, DOI 10.1002/jbm.820290704
   WALSH WR, 2000, CLIN ORTHOP RELAT R, V375, P258
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Wozney JM, 2002, SPINE, V27, pS2, DOI 10.1097/01.BRS0000020725.01916.7E
   YOSHII S, 1988, J BIOMED MATER RES-A, V22, P327, DOI 10.1002/jbm.820221410
NR 37
TC 31
Z9 33
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2005
VL 74A
IS 3
BP 447
EP 453
DI 10.1002/jbm.a.30373
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 954UG
UT WOS:000231179900018
PM 15983990
DA 2018-10-20
ER

PT J
AU Knowles, NG
   Miyashita, Y
   Usui, ML
   Marshall, AJ
   Pirrone, A
   Hauch, KD
   Ratner, BD
   Underwood, RA
   Fleckman, P
   Olerud, JE
AF Knowles, NG
   Miyashita, Y
   Usui, ML
   Marshall, AJ
   Pirrone, A
   Hauch, KD
   Ratner, BD
   Underwood, RA
   Fleckman, P
   Olerud, JE
TI A model for studying epithelial attachment and morphology at the
   interface between skin and percutaneous devices
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterials; organ culture; epidermis; poly(HEMA); bacteria
ID BLOOD-STREAM INFECTION; CATHETER-RELATED INFECTIONS; PREVENTION;
   TISSUES; PATHOGENESIS; IMPLANTS; ACCESS
AB Percutaneous devices are indispensable in modern medicine, yet complications from their use result in significant morbidity, mortality, and cost. Bacterial biofilm at the device exit site accounts for most infections in short-term devices. We hypothesize that advanced biomaterials can be developed that facilitate attachment of skin cells to percutaneous devices, forming a seal to preclude bacterial invasion. To study the skin/biomaterial interface systematically, we first identified biomaterials with physical properties compatible with histological processing of skin. Second, we developed an organ culture system to study skin response to implants. Organ cultures implanted with porous poly(2-hydroxyethyl methacrylate) [poly(HEMA)] or poly-tetrafluoroethylene (PTFE) could easily be evaluated histologically with preservation of the skin/biomaterial interface. Epithelial cells migrated down the cut edges of the biomaterial in a pattern seen in marsupialization of percutaneous devices in vivo. This in vitro model maintains skin viability and allows histologic evaluation of the skin/biomaterial interface, making this a useful, inexpensive test-bed for studies of epidermal attachment to modified biomaterials. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Washington, Dept Med, Div Dermatol, Seattle, WA 98195 USA.
   Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
   Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RP Olerud, JE (reprint author), Univ Washington, Dept Med, Div Dermatol, Box 356524,1959 NE Pacific St, Seattle, WA 98195 USA.
EM olerudje@u.washington.edu
FU NIDDK NIH HHS [DK59221]
CR AOKI H, 1987, MED PROG TECHNOL, V12, P213
   Chatzinikolaou I, 2000, Semin Respir Infect, V15, P264
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Crnich CJ, 2002, CLIN INFECT DIS, V34, P1232, DOI 10.1086/339863
   Heaney TG, 1996, J BIOMED MATER RES, V32, P593, DOI 10.1002/(SICI)1097-4636(199612)32:4<593::AID-JBM12>3.0.CO;2-F
   HOLBROOK KA, 1991, ANN NY ACAD SCI, V642, P167
   JANSEN JA, 1991, J BIOMED MATER RES, V25, P1535, DOI 10.1002/jbm.820251210
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, P137
   Knabe C, 1999, BIOMATERIALS, V20, P503, DOI 10.1016/S0142-9612(98)00195-1
   LUFT JH, 1961, J BIOPHYS BIOCHEM CY, V9, P409, DOI 10.1083/jcb.9.2.409
   Maki DG, 1997, ANN INTERN MED, V127, P257, DOI 10.7326/0003-4819-127-4-199708150-00001
   MARSHALL AJ, 2001, T SOC BIOMATER   APR
   Mermel LA, 2000, ANN INTERN MED, V133, P395
   MERMEL LA, 1991, AM J MED, V91, pS197, DOI 10.1016/0002-9343(91)90369-9
   Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009
   Miyashita Y., 2003, Journal of Investigative Dermatology, V121, P0260
   MIYASHITA Y, 2002, TIMB S EMBR GROWTH D
   O'Grady NP, 2002, MMWR RECOMM REP, V51, P1
   PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598
   Raad II, 2002, ARCH INTERN MED, V162, P871, DOI 10.1001/archinte.162.8.871
   Raad Issam, 1993, Journal of Infectious Diseases, V168, P400
   RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754
   Safdar N, 2002, MEDICINE, V81, P466, DOI 10.1097/00005792-200211000-00007
   Schroeder HE, 1997, PERIODONTOL 2000, V13, P91, DOI 10.1111/j.1600-0757.1997.tb00097.x
   Shin Y, 1997, ARTIF ORGANS, V21, P995
   TSAO MC, 1982, J CELL PHYSIOL, V110, P219, DOI 10.1002/jcp.1041100217
   VONRECUM AF, 1984, J BIOMED MATER RES, V18, P323, DOI 10.1002/jbm.820180403
   VONRECUM AF, 1981, CRC CR REV BIOM ENG, V5, P37
   WINTER GD, 1974, J BIOMED MATER RES, V8, P99, DOI 10.1002/jbm.820080311
   Yu C, 1999, ASAIO J, V45, P531, DOI 10.1097/00002480-199911000-00005
   Zeltinger J, 1997, CELL TISSUE RES, V290, P51, DOI 10.1007/s004410050907
NR 31
TC 22
Z9 22
U1 0
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2005
VL 74A
IS 3
BP 482
EP 488
DI 10.1002/jbm.a.30384
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 954UG
UT WOS:000231179900023
PM 15983994
DA 2018-10-20
ER

PT J
AU Pryor, ME
   Polimeni, G
   Koo, KT
   Hartman, MJ
   Gross, H
   April, M
   Safadi, FF
   Wikesjo, UME
AF Pryor, ME
   Polimeni, G
   Koo, KT
   Hartman, MJ
   Gross, H
   April, M
   Safadi, FF
   Wikesjo, UME
TI Analysis of rat calvaria defects implanted with a platelet-rich plasma
   preparation: histologic and histometric observations
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE bone; growth factors; osteogenesis; platelet-rich plasma; tissue
   engineering
ID BONE MORPHOGENETIC PROTEIN-2; GROWTH-FACTOR; TRANSFORMING
   GROWTH-FACTOR-BETA-1; MANDIBULAR RECONSTRUCTION; AUTOGENOUS SCAFFOLDS;
   CRANIOTOMY DEFECTS; DENTAL IMPLANTS; REGENERATION; REPAIR;
   OSSEOINTEGRATION
AB Objectives: It has been suggested that degranulating platelet alpha-granules release growth factors having a potential to modulate bone formation. The objective of this study was to evaluate the osteoconductive potential of a platelet-rich plasma (PRP) preparation.
   Methods: Thirty adult male Sprague-Dawley rats were used. The PRP preparation was obtained from 10 ml of whole blood drawn from one age-matched donor rat. The preparation was processed by gradient density centrifugation and stored at -80 degrees C until use. Using aseptic techniques, the PRP preparation soak loaded onto an absorbable collagen sponge (ACS) or ACS alone was surgically implanted into contralateral critical size 6-mm calvaria osteotomies in 18 animals. Twelve animals received ACS versus sham surgery in contralateral defects. Animals were sacrificed at 4 and 8 weeks when biopsies were collected for histologic and histometric analysis.
   Results: The animals were maintained without adverse events. Bone formation was highly variable in sites receiving PRP and control treatments. Defect bone fill at 4 weeks averaged (+/- SD) 28.8 +/- 27.4% (PRP/ACS) versus 39.1 +/- 24.4% (ACS; p=0.2626) and 62.0 +/- 20.0% (ACS) versus 71.6 +/- 32.2% (sham surgery; p=0.1088), and at 8 weeks 81.0 +/- 12.9% (PRP/ACS) versus 64.5 +/- 28.1% (ACS; p=0.2626) and 75.6 +/- 34.1% (ACS) versus 74.1 +/- 24.2% (sham surgery; p=0.7353). Remnants of the ACS biomaterial were observed at both 4 and 8 weeks in sites implanted with PRP/ACS or ACS.
   Conclusions: The results suggest that the PRP preparation has a limited potential to promote local bone formation.
C1 Temple Univ, Sch Dent, Dept Periodontol, Lab Appl Periodontal & Craniofacial Regenerat, Philadelphia, PA 19140 USA.
   Univ Detroit, Mercy Sch Dent, Dept Periodontol & Dent Hyg, Detroit, MI 48221 USA.
   Temple Univ, Sch Med, Cent Anim Facil, Philadelphia, PA 19122 USA.
   Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19122 USA.
RP Wikesjo, UME (reprint author), Temple Univ, Sch Dent, Dept Periodontol, Lab Appl Periodontal & Craniofacial Regenerat, 3223 N Broad St, Philadelphia, PA 19140 USA.
EM wikesjo@comcast.net
RI Wikesjo, Ulf/A-4159-2009
OI Wikesjo, Ulf/0000-0003-1607-0583
CR Aghaloo TL, 2004, INT J ORAL MAX IMPL, V19, P59
   Aghaloo TL, 2002, J ORAL MAXIL SURG, V60, P1176, DOI 10.1053/joms.2002.34994
   Ahn SH, 2003, J PERIODONTOL, V74, P787, DOI 10.1902/jop.2003.74.6.787
   Anitua E, 1999, INT J ORAL MAX IMPL, V14, P529
   ANSELME K, 1990, J BIOMED MATER RES, V24, P689, DOI 10.1002/jbm.820240605
   Blom EJ, 2001, CLIN ORAL IMPLAN RES, V12, P609, DOI 10.1034/j.1600-0501.2001.120609.x
   BOSCH C, 1995, CLEFT PALATE-CRAN J, V32, P311, DOI 10.1597/1545-1569(1995)032<0311:GBRICB>2.3.CO;2
   Bosch C, 1998, J CRANIOFAC SURG, V9, P310, DOI 10.1097/00001665-199807000-00004
   Bosch C, 1996, J CRANIOFAC SURG, V7, P300, DOI 10.1097/00001665-199607000-00011
   Camargo PM, 2002, J PERIODONTAL RES, V37, P300, DOI 10.1034/j.1600-0765.2002.01001.x
   CANALIS E, 1989, ENDOCRIN METAB CLIN, V18, P903, DOI 10.1016/S0889-8529(18)30348-7
   Choi BH, 2004, INT J ORAL MAX SURG, V33, P56, DOI 10.1045/ijom.2003.0466
   DAHLIN C, 1991, J NEUROSURG, V74, P487, DOI 10.3171/jns.1991.74.3.0487
   Danesh-Meyer M J, 2001, J Int Acad Periodontol, V3, P48
   Fennis JPM, 2004, INT J ORAL MAX SURG, V33, P48, DOI 10.1054/ijom.2003.0452
   Fennis JPM, 2002, INT J ORAL MAX SURG, V31, P281, DOI 10.1054/ijom.2002.0151
   Furst G, 2003, CLIN ORAL IMPLAN RES, V14, P500, DOI 10.1034/j.1600-0501.2003.00859.x
   FURST G, 2003, INT J ORAL MAXILLOF, V18, P685
   FURST G, 2004, CLIN ORAL IMPLAN RES, V15, P301
   Goodkin David A., 1993, Wound Repair and Regeneration, V1, P203, DOI 10.1046/j.1524-475X.1993.10405.x
   Heldin CH, 1999, PHYSIOL REV, V79, P1283
   Jakse N, 2003, CLIN ORAL IMPLAN RES, V14, P578, DOI 10.1034/j.1600-0501.2003.00928.x
   Kim ES, 2001, J PROSTHET DENT, V86, P428, DOI 10.1067/mpr.2001.115874
   Kim SG, 2002, J ORAL MAXIL SURG, V60, P1018, DOI 10.1053/joms.2002.34413
   Koch RM, 2000, WOUND REPAIR REGEN, V8, P179, DOI 10.1046/j.1524-475x.2000.00179.x
   Lind M, 1996, ACTA ORTHOP SCAND, V67, P407, DOI 10.3109/17453679609002342
   MARDEN LJ, 1994, J BIOMED MATER RES, V28, P1127, DOI 10.1002/jbm.820281003
   MARDEN LJ, 1993, J CLIN INVEST, V92, P2897, DOI 10.1172/JCI116912
   Marx R E, 2001, Implant Dent, V10, P225
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   MCPHERSON J M, 1992, Clinical Materials, V9, P225, DOI 10.1016/0267-6605(92)90103-Z
   MULLIKEN JB, 1980, PLAST RECONSTR SURG, V65, P553, DOI 10.1097/00006534-198005000-00001
   Naaman NBA, 1998, INT J ORAL MAX IMPL, V13, P115
   Robiony M, 2002, J ORAL MAXIL SURG, V60, P630, DOI 10.1053/joms.2002.33107
   ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6
   Rudkin GH, 1996, PLAST RECONSTR SURG, V97, P469, DOI 10.1097/00006534-199602000-00032
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P505
   Schliephake H, 2002, INT J ORAL MAX SURG, V31, P469, DOI 10.1054/ijom.2002.0244
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Selvig KA, 2002, J PERIODONTOL, V73, P1020, DOI 10.1902/jop.2002.73.9.1020
   Shanaman R, 2001, INT J PERIODONT REST, V21, P345
   SLATER M, 1995, J ORTHOP RES, V13, P655, DOI 10.1002/jor.1100130504
   SPORN MB, 1989, JAMA-J AM MED ASSOC, V262, P938, DOI 10.1001/jama.262.7.938
   Sykaras N, 2001, CLIN ORAL IMPLAN RES, V12, P339, DOI 10.1034/j.1600-0501.2001.012004339.x
   TAKAGI K, 1982, ANN SURG, V196, P100, DOI 10.1097/00000658-198207000-00020
   Thaller SR, 1998, J CRANIOFAC SURG, V9, P138, DOI 10.1097/00001665-199803000-00010
   THALLER SR, 1993, ANN PLAS SURG, V31, P429, DOI 10.1097/00000637-199311000-00007
   TURNBULL RS, 1974, J PERIODONTAL RES, V9, P39, DOI 10.1111/j.1600-0765.1974.tb00651.x
   Whitman DH, 1997, J ORAL MAXIL SURG, V55, P1294, DOI 10.1016/S0278-2391(97)90187-7
   Winn SR, 1999, J BIOMED MATER RES, V45, P414, DOI 10.1002/(SICI)1097-4636(19990615)45:4<414::AID-JBM17>3.0.CO;2-Z
   Zechner W, 2003, INT J ORAL MAX IMPL, V18, P15
NR 51
TC 40
Z9 44
U1 0
U2 1
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0303-6979
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD SEP
PY 2005
VL 32
IS 9
BP 966
EP 972
DI 10.1111/j.1600-051X.2005.00772.x
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 952GQ
UT WOS:000230992400008
PM 16104961
DA 2018-10-20
ER

PT J
AU Park, C
   Choi, JC
   Choi, YH
   Nakamura, H
   Shimanouchi, K
   Horiuchi, T
   Misono, H
   Sewaki, T
   Soda, K
   Ashiuchi, M
   Sung, MH
AF Park, C
   Choi, JC
   Choi, YH
   Nakamura, H
   Shimanouchi, K
   Horiuchi, T
   Misono, H
   Sewaki, T
   Soda, K
   Ashiuchi, M
   Sung, MH
TI Synthesis of super-high-molecular-weight poly-gamma-glutamic acid by
   Bacillus subtilis subsp chungkookjang
SO JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC
LA English
DT Article
DE poly-gamma-glutamic acid; Bacillus subtilis subsp chungkookjang;
   purification; molecular weight; chemical determination; stereochemistry
ID POLY(GAMMA-GLUTAMIC ACID); LICHENIFORMIS; BIOSYNTHESIS; RACEMASE
AB Poly-gamma-glutamic acid (PGA) with high molecular weight is a most promising biomaterial in industrial uses; however, it generally diverse in molecular structure and co-produced with polysaccharides and various other biopolymers. In this study, it was ascertained that Bacillus subtilis subsp. chungkookjang cells are superior to B. subtilis (natto) cells as the biocatalyst for the synthesis of super-high-molecular-weight PGA (over 2000 k). We effectively purified PGA and fractionated according to its molecular weight by anion-exchange chromatography, and further developed a simple method for determination of the molecular weight of PGA on the basis of numbers of glutamate monomers generated by hydrolysis and a free amino group quantified with 1-fluoro-2,4-dinitrobenzene (FDNB). The molecular weight determination with FDNB was available even for a super-high-molecular-weight PGA, e.g. the 2000-k polymer. Super-high-molecular-weight PGAs (average 2000 k and 7000 k), which were synthesized by the use of B. subtilis subsp. chungkookjang cells in the presence of a high concentration of ammonium sulfate, were rich in L-glutamate rather than in the D-enantiomer. (c) 2005 Elsevier B.V. All rights reserved.
C1 BioLeaders Corp, Taejon, South Korea.
   Kochi Univ, Dept Bioresources Sci, Nankoku, Kochi 783, Japan.
   BioLeaders Japan Corp, Ibaraki, Osaka, Japan.
   Kookmin Univ, Dept Bio & Nanochem, Seoul 136702, South Korea.
RP Sung, MH (reprint author), BioLeaders Corp, Taejon, South Korea.
EM smoonhee@kookmin.ac.kr
CR Ashiuchi M, 1999, BIOCHEM BIOPH RES CO, V263, P6, DOI 10.1006/bbrc.1999.1298
   Ashiuchi M, 2004, APPL ENVIRON MICROB, V70, P4249, DOI 10.1128/AEM.70.7.4249-4255.2004
   Ashiuchi M, 2003, J MOL CATAL B-ENZYM, V23, P249, DOI 10.1016/S1381-1177(03)00087-0
   Ashiuchi M, 2003, J MOL CATAL B-ENZYM, V23, P101, DOI 10.1016/S1381-1177(03)00076-6
   Ashiuchi M, 2001, APPL MICROBIOL BIOT, V57, P764, DOI 10.1007/s00253-001-0848-9
   Ashiuchi M, 2002, APPL MICROBIOL BIOT, V59, P9, DOI 10.1007/s00253-002-0984-x
   Ashiuchi M, 1998, J BIOCHEM-TOKYO, V123, P1156
   ASHIUCHI M, 2002, BIOPOLYMERS, V7, P123
   CROMWICK AM, 1995, INT J BIOL MACROMOL, V17, P259, DOI 10.1016/0141-8130(95)98153-P
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   GOTO A, 1992, BIOSCI BIOTECH BIOCH, V56, P1031, DOI 10.1271/bbb.56.1031
   ITOH Y, 1996, BIOSCI BIOTECH BIOCH, V60, P1239
   Kambourova M, 2001, APPL ENVIRON MICROB, V67, P1004, DOI 10.1128/AEM.67.2.1004-1007.2001
   Kimura K, 2004, MICROBIOL-SGM, V150, P2911, DOI 10.1099/mic.0.27045-0
   Kimura K, 2003, APPL ENVIRON MICROB, V69, P2491, DOI 10.1128/AEM.69.5.2491-2497.2003
   Ko YH, 1998, BIOTECHNOL BIOENG, V57, P430, DOI 10.1002/(SICI)1097-0290(19980220)57:4<430::AID-BIT6>3.0.CO;2-N
   KUBOTA H, 1993, BIOSCI BIOTECH BIOCH, V57, P1212, DOI 10.1271/bbb.57.1212
   MAKINO S, 1989, J BACTERIOL, V171, P722, DOI 10.1128/jb.171.2.722-730.1989
   Meister A., 1965, BIOCH AMINO ACIDS
   Nagai T, 1997, J GEN APPL MICROBIOL, V43, P139, DOI 10.2323/jgam.43.139
   Paraskevas G, 2002, J PHARMACEUT BIOMED, V29, P865, DOI 10.1016/S0731-7085(02)00207-8
   Perez-Camero G, 1999, BIOTECHNOL BIOENG, V63, P110, DOI 10.1002/(SICI)1097-0290(19990405)63:1<110::AID-BIT11>3.0.CO;2-T
   Shih IL, 2001, BIORESOURCE TECHNOL, V79, P207, DOI 10.1016/S0960-8524(01)00074-8
   SUNG MH, 2003, Patent No. 2003433754
   SUNG MH, 2003, Patent No. 1020030090873
   YOSHIDA T, 2002, BIOPOLYMERS, V7, P107
NR 26
TC 38
Z9 40
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1381-1177
J9 J MOL CATAL B-ENZYM
JI J. Mol. Catal. B-Enzym.
PD SEP 1
PY 2005
VL 35
IS 4-6
BP 128
EP 133
DI 10.1016/j.molcatb.2005.06.007
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Physical
SC Biochemistry & Molecular Biology; Chemistry
GA 963CL
UT WOS:000231780400009
DA 2018-10-20
ER

PT J
AU Craig, MR
   Poelstra, KA
   Sherrell, JC
   Kwon, MS
   Belzile, EL
   Brown, TE
AF Craig, MR
   Poelstra, KA
   Sherrell, JC
   Kwon, MS
   Belzile, EL
   Brown, TE
TI A novel total knee arthroplasty infection model in rabbits
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE MRSA; infection; animal model; biomaterial infection; rabbit
ID RESISTANT STAPHYLOCOCCUS-AUREUS; REPLACEMENT; PREVENTION; REVISION;
   IMPLANTS
AB Infection of biomaterial implants is an expensive and devastating complication of orthopaedic surgery historically ranging from less than 1% in primary total knee arthroplasty (TKA) to 10% in revision TKA. An in vivo animal model was developed to test the efficacy of innovative therapies for the prevention of biomaterial centered infections caused by methicillin-resistant Staphylococcus cells aureus bacteria (MRSA). Twenty-two New Zealand White rabbits were used in this study. After proper anesthesia, a stainless-steel screw with a high molecular weight polyethylene (UHMWPE) washer was cemented in a defect created in the intra-articular, nonarticulating portion of the lateral femoral condyle of each knee. After closure of the joint capsule, each knee was inoculated with 0, 10(2), 10(3), or 10(4) colony forming units (CFU) of MRSA. Animals were sacrificed after 7 days at which time joint aspirate, tissues and biomaterial samples were examined for evidence of infection.
   A total of 42 knees were used for analysis. When saline was injected into the knee, 0/10 of the knees demonstrated evidence of biomaterial centered infection (with the contralateral knee receiving 10(4) CFU MRSA). Four of 10 knees developed a biomaterial centered infection when 10(2) CFU MRSA was introduced. Seven out of 10 knees developed a biomaterial centered infection when either 10(3) or 10(4) CFU MRSA was injected. No evidence of septicemia (positive blood cultures) was found in any animal. This rabbit knee model utilizes commonly employed inexpensive orthopaedic implant materials in an in vivo milieu and provides an effective method for the evaluation of treatments for biomaterial centered infections. (c) 2005 Orthopaedic Research Society. Published by Elsevier Ltd. All rights reserved.
C1 Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA 22908 USA.
   CHUQ, Hotel Dieu, Div Orthopaed Surg, Quebec City, PQ G1R 2J6, Canada.
RP Brown, TE (reprint author), Univ Virginia, Dept Orthopaed Surg, Box 800159 HSC, Charlottesville, VA 22908 USA.
EM tb4g@virginia.edu
CR An YH, 1997, J BONE JOINT SURG BR, V79B, P816, DOI 10.1302/0301-620X.79B5.7228
   Arens S, 1996, J BONE JOINT SURG BR, V78B, P647
   Belmatoug N, 1996, J INFECT DIS, V174, P414, DOI 10.1093/infdis/174.2.414
   CAMERON HU, 1982, CLIN ORTHOP RELAT R, P141
   Cremieux AC, 1997, CLIN INFECT DIS, V25, P1295, DOI 10.1086/516135
   Farr BM, 2004, CURR OPIN INFECT DIS, V17, P317, DOI 10.1097/01.qco.0000136926.52673.cd
   FEHRING TK, 2001, CLIN ORTHOP RELAT R, V392, pG315
   Kilgus DJ, 2002, CLIN ORTHOP RELAT R, P116, DOI 10.1097/01.blo.0000030492.43495.63
   Na'was T, 1998, J CLIN MICROBIOL, V36, P414
   Peersman G, 2001, CLIN ORTHOP RELAT R, P15
   PETTY W, 1985, J BONE JOINT SURG AM, V67A, P1236, DOI 10.2106/00004623-198567080-00015
   Poelstra KA, 2000, SPINE, V25, P406, DOI 10.1097/00007632-200002150-00003
   RAND JA, 1982, ORTHOP CLIN N AM, V13, P201
   Saleh KJ, 2002, J ARTHROPLASTY, V17, P967, DOI 10.1054/arth.2002.35823
   SCULCO TP, 2002, AAOS PUBLICATION
   Sharkey PF, 2002, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000036002.13841.32
   Sheehan E, 2004, J ORTHOPAED RES, V22, P39, DOI 10.1016/S0736-0266(03)00152-9
   SOUTHWOOD RT, 1987, CLIN ORTHOP RELAT R, P33
   WILSON MG, 1990, J BONE JOINT SURG AM, V72A, P878, DOI 10.2106/00004623-199072060-00013
   WINDSOR RE, 1994, J AM ACAD ORTHOP SUR, V2, P44
   1999, AAOS B, V47, P14
NR 21
TC 22
Z9 26
U1 0
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0736-0266
EI 1554-527X
J9 J ORTHOP RES
JI J. Orthop. Res.
PD SEP
PY 2005
VL 23
IS 5
BP 1100
EP 1104
DI 10.1016/j.orthres.2005.03.007
PG 5
WC Orthopedics
SC Orthopedics
GA 968PD
UT WOS:000232173600016
PM 15927441
OA Bronze
DA 2018-10-20
ER

PT J
AU Jang, JH
   Rives, CB
   Shea, LD
AF Jang, JH
   Rives, CB
   Shea, LD
TI Plasmid delivery in vivo from porous tissue-engineering scaffolds:
   Transgene expression and cellular Transfection
SO MOLECULAR THERAPY
LA English
DT Article
DE biomaterial; gene therapy; synthetic; scaffolds; plasmid; angiogenesis
ID GROWTH-FACTOR DELIVERY; GENE-EXPRESSION; BONE-FORMATION; POLYMER
   MATRICES; DNA DELIVERY; THERAPY; SYSTEM; ANGIOGENESIS; INJECTION; CELLS
AB Tissue engineering scaffolds capable of sustained plasmid release can promote gene transfer locally and stimulate new tissue formation. We have investigated the scaffold design parameters that influence the extent and duration of transgene expression and have characterized the distribution of transfected cells. Porous scaffolds with encapsulated plasmid were fabricated from poly(lactide-co-glycolide) with a gas foaming procedure, with wet granulation employed to mix the components homogeneously prior to foaming. Wet granulation enhanced plasmid incorporation relative to standard procedures and also enhanced in vivo transgene expression, possibly through the increased loading and maintenance of the scaffold pore structure. The plasmid loading regulated the quantity and duration of transgene expression, with expression for 105 days achieved at the highest dosage. Expression was localized to the implantation site, though the distribution of transfected cells varied with time. Transfected cells were initially observed at the scaffold periphery (day 3), then within the pores and adjacent to the polymer (day 17), and finally throughout the scaffold interior (day 126). Delivery of a plasmid encoding VEGF increased the blood vessel density relative to control. Correlating scaffold design with gene transfer efficiency and tissue formation will facilitate application of plasmid-releasing scaffolds to multiple tissues.
C1 Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd E156, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Jang, Jae-Hyung/G-8030-2012; Shea, Lonnie/B-7615-2009
FU NIBIB NIH HHS [R01 EB003806-01, R01 EB003806]
CR Berry M, 2001, MOL CELL NEUROSCI, V17, P706, DOI 10.1006/mcne.2001.0975
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939
   Eliaz RE, 2002, GENE THER, V9, P1230, DOI 10.1038/sj.gt.3301786
   Eming SA, 1999, J INVEST DERMATOL, V112, P297, DOI 10.1046/j.1523-1747.1999.00522.x
   Fang JM, 1996, P NATL ACAD SCI USA, V93, P5753, DOI 10.1073/pnas.93.12.5753
   Hu YY, 2003, J BIOMED MATER RES A, V67A, P591, DOI 10.1002/jbm.a.10070
   Huang YC, 2003, J BIOMED MATER RES A, V67A, P1384, DOI 10.1002/jbm.a.20036
   Ingber DE, 1995, J BIOMECH, V28, P1471, DOI 10.1016/0021-9290(95)00095-X
   Jang JH, 2004, EXPERT REV MED DEVIC, V1, P127, DOI 10.1586/17434440.1.1.127
   Jang JH, 2003, J CONTROL RELEASE, V86, P157, DOI 10.1016/S0168-3659(02)00369-3
   KAWABATA K, 1995, PHARMACEUT RES, V12, P825, DOI 10.1023/A:1016248701505
   Khavari PA, 1997, DERMATOL CLIN, V15, P27, DOI 10.1016/S0733-8635(05)70412-5
   Langer R, 1998, NATURE, V392, P5
   Levy MY, 1996, GENE THER, V3, P201
   Li S., 1999, AM J PHYSIOL, V276, P796
   Ma T, 1999, BIOTECHNOL PROGR, V15, P715, DOI 10.1021/bp990072y
   MANTHORPE M, 1993, HUM GENE THER, V4, P419, DOI 10.1089/hum.1993.4.4-419
   Meuli M, 2001, J INVEST DERMATOL, V116, P131, DOI 10.1046/j.1523-1747.2001.00139.x
   Murphy WL, 1999, J PERIODONTAL RES, V34, P413, DOI 10.1111/j.1600-0765.1999.tb02275.x
   Murphy WL, 2002, TISSUE ENG, V8, P43, DOI 10.1089/107632702753503045
   Nishikawa M, 2002, BIOL PHARM BULL, V25, P275, DOI 10.1248/bpb.25.275
   Nof M, 2002, J BIOMED MATER RES, V59, P349, DOI 10.1002/jbm.1251
   Ochiya T, 1999, NAT MED, V5, P707
   Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   Pascher A, 2004, GENE THER, V11, P133, DOI 10.1038/sj.gt.3302155
   Peters MC, 2002, J BIOMED MATER RES, V60, P668, DOI 10.1002/jbm.10134
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Sarkar N, 2002, J CARDIOVASC PHARM, V39, P215, DOI 10.1097/00005344-200202000-00008
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Smith MK, 2004, TISSUE ENG, V10, P63, DOI 10.1089/107632704322791709
   Takakura Y, 1998, ADV DRUG DELIVER REV, V34, P93, DOI 10.1016/S0169-409X(98)00006-4
   Thornton FJ, 1998, BIOCHEM BIOPH RES CO, V246, P654, DOI 10.1006/bbrc.1998.8681
   Tseng WC, 1999, BBA-GENE STRUCT EXPR, V1445, P53, DOI 10.1016/S0167-4781(99)00039-1
   Tyrone JW, 2000, J SURG RES, V93, P230, DOI 10.1006/jsre.2000.5912
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   Whang K, 1998, J BIOMED MATER RES, V42, P491, DOI 10.1002/(SICI)1097-4636(19981215)42:4<491::AID-JBM3>3.0.CO;2-F
   Zaharoff DA, 2002, GENE THER, V9, P1286, DOI 10.1038/sj.gt.3301799
NR 41
TC 111
Z9 116
U1 0
U2 23
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1525-0016
J9 MOL THER
JI Mol. Ther.
PD SEP
PY 2005
VL 12
IS 3
BP 475
EP 483
DI 10.1016/j.ymrhe.2005.03.036
PG 9
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA 960LP
UT WOS:000231592400015
PM 15950542
DA 2018-10-20
ER

PT J
AU Bengali, Z
   Shea, LD
AF Bengali, Z
   Shea, LD
TI Gene delivery by immobilization to cell-adhesive substrates
SO MRS BULLETIN
LA English
DT Article
DE biomaterials; gene therapy; plasmid delivery; reverse transfection;
   solid-phase delivery; tissue engineering; transfected cell arrays
ID ANTIBODY-TETHERED ADENOVIRUS; DNA COMPLEXES; TRANSFECTION; MICROARRAYS;
   EXPRESSION; SURFACE
AB Biomaterials can potentially enhance the delivery of viral and nonviral vectors for both basic science and clinical applications. Vectors typically consist of nucleic acids (DNA, RNA) packaged with proteins, lipids, or cationic polymers, which facilitate cellular internalization and trafficking. These vectors can associate with biomaterials that support cell adhesion, a process we term substrate-mediated delivery. Substrate immobilization localizes the DNA and the delivery vector to the cellular microenvironment. The interaction between the vector and substrate must be appropriately balanced to mediate immobilization, yet allow for cellular internalization. Balancing the binding between the biomaterial and the vector is dependent upon the surface chemistries of the material and the vector, which can be designed to provide both specific (e.g., biotin-avidin, the strongest known noncovalent interaction between a protein and its ligand) and nonspecific (e.g., van der Waals) interactions. In this review, we describe the biomaterial and vector properties that mediate binding and gene transfer, identify potential applications, and present opportunities for further development.
RI Sanguansri, Luz/B-6630-2011; Shea, Lonnie/B-7615-2009
OI Sanguansri, Luz/0000-0003-1908-7604; 
FU NIGMS NIH HHS [R01 GM066830-01A1, R01 GM066830]
CR Abrahams JM, 2002, STROKE, V33, P1376, DOI 10.1161/01.STR.0000014327.03964.C0
   Bajaj B, 2001, BIOTECHNOL PROGR, V17, P587, DOI 10.1021/bp010039n
   Barry MA, 2003, EXPERT OPIN BIOL TH, V3, P925, DOI 10.1517/eobt.3.6.925.21256
   Bengali Z, 2005, BIOTECHNOL BIOENG, V90, P290, DOI 10.1002/bit.20393
   Bielinska AU, 2000, BIOMATERIALS, V21, P877, DOI 10.1016/S0142-9612(99)00229-X
   CHANG FH, 2004, NUCLEIC ACIDS RES, V32, P33
   Delehanty JB, 2004, ANAL CHEM, V76, P7323, DOI 10.1021/ac049259g
   Honma K, 2001, BIOCHEM BIOPH RES CO, V289, P1075, DOI 10.1006/bbrc.2001.6133
   Klugherz BD, 2002, HUM GENE THER, V13, P443, DOI 10.1089/10430340252792576
   Levy RJ, 2001, GENE THER, V8, P659, DOI 10.1038/sj.gt.3301452
   Luo D, 2000, NAT BIOTECHNOL, V18, P893, DOI 10.1038/78523
   Michiels F, 2002, NAT BIOTECHNOL, V20, P1154, DOI 10.1038/nbt746
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   Pandori MW, 2002, VIROLOGY, V299, P204, DOI 10.1006/viro.2002.1510
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   Segura T, 2003, J CONTROL RELEASE, V93, P69, DOI 10.1016/j.jconrel.2003.08.003
   Segura T, 2002, BIOCONJUGATE CHEM, V13, P621, DOI 10.1021/bc015575f
   SENGURA T, 2005, BIOMATERIALS, V26, P1575
   Shen H, 2004, NAT MATER, V3, P569, DOI 10.1038/nmat1179
   Stachelek SJ, 2004, GENE THER, V11, P15, DOI 10.1038/sj.gt.3302129
   Tseng WC, 1997, J BIOL CHEM, V272, P25641, DOI 10.1074/jbc.272.41.25641
   Varga CM, 2001, MOL THER, V4, P438, DOI 10.1006/mthe.2001.0475
   WALTER DH, 2003, CIRCULATI0N, V110, P36
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yamauchi F, 2004, BBA-GEN SUBJECTS, V1672, P138, DOI 10.1016/j.bbagen.2004.03.008
   Yoshikawa T, 2004, J CONTROL RELEASE, V96, P227, DOI 10.1016/j.jconrel.2004.01.024
   Zhang JT, 2004, LANGMUIR, V20, P8015, DOI 10.1021/la048888i
   Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114
NR 28
TC 20
Z9 21
U1 1
U2 8
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD SEP
PY 2005
VL 30
IS 9
BP 659
EP 662
DI 10.1557/mrs2005.193
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 966CF
UT WOS:000231996500018
PM 19319206
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Pingsmann, A
   Blatt, R
   Breusch, S
   Jurgens, C
   Thietje, R
   Krodel, A
   Zinser, W
   Michiels, I
   Niethard, FU
   Niedhart, C
   Renzing-Kohler, K
   Pfefferle, HJ
AF Pingsmann, A
   Blatt, R
   Breusch, S
   Jurgens, C
   Thietje, R
   Krodel, A
   Zinser, W
   Michiels, I
   Niethard, FU
   Niedhart, C
   Renzing-Kohler, K
   Pfefferle, HJ
TI Efficacy and safety of a novel moldable, resorbable, and degradable
   sealant of bone surfaces for hemostasis after bone graft harvesting from
   the iliac crest
SO SPINE
LA English
DT Article
DE hemostasis; bone graft; biomaterial; clinical safety; topical hemostat
ID BOVINE THROMBIN; MICROFIBRILLAR COLLAGEN; CARDIAC-SURGERY; FIBRIN
   SEALANT; CLINICAL-TRIAL; WAX; COMPLICATIONS; OPERATIONS; FLEECE; AGENTS
AB Study Design. A prospective, controlled, open, randomized multicenter study.
   Objective. The study's objective was to demonstrate equivalence of a novel, moldable, resorbable, and degradable synthetic polymer ( Bone Seal) compared with a collagen fleece ( Lyostypt) in efficacy and safety for topical hemostasis after iliac crest bone graft harvesting.
   Summary of Background Data. Harvesting corticocancellous bone from the iliac crest is a well established procedure in orthopedic and particularly in spine surgery. It is associated with significant morbidity at the donor site where hematoma formation may cause impaired wound healing and infections in up to 10% of cases.
   Methods. A total of 112 patients were included in the safety analysis. Safety was determined by a compound wound healing score and the incidence of adverse clinical effects. One hundred and eight patients were studied for equivalence in efficacy using a compound bleeding score. The handling properties and the application to the bone surface of either device were measured with two additional compound scores.
   Results. The mean bleeding scores in the final analysis was 4.5 +/- 1.3 for the Bone Seal group and 4.2 +/- 1.3 for the collagen fleece group. Bone Seal was better applicable to the bleeding bone surfaces than the collagen fleece, even though its handling was more complicated. Wound healing and the incidences of adverse clinical events were comparable in either study group.
   Conclusions. Bone Seal is an effective and safe hemostatic material for sealing bleeding bone surfaces after iliac crest bone graft harvesting. By virtue of its hemostatic efficacy, Bone Seal is preventive for wound healing disorders.
C1 Essen Univ Med Sch, Dept Orthopaed, Essen, Germany.
   Essen Univ Med Sch, Inst Med Informat Biometry & Epidemiol, Essen, Germany.
   Merck Biomat GmbH, Darmstadt, Germany.
   Univ Heidelberg, Univ Dept Orthopaed, Heidelberg, Germany.
   Berufsgenossenschaftliches Trauma Ctr Hamburg, Hamburg, Germany.
   Alfried Krupp Hosp, Dept Orthopaed, Essen, Germany.
   Rhein Westfal TH Aachen, Univ Dept Orthopaed, D-5100 Aachen, Germany.
RP Pingsmann, A (reprint author), Biberburg Orthopaed Associates, Gatower Str 241, D-14089 Berlin, Germany.
EM a.pingsmann@biberburg.de
CR ABBOTT WM, 1975, SURGERY, V78, P723
   ALLISON RT, 1994, BRIT J BIOMED SCI, V51, P14
   Anfinsen O G, 1993, J Foot Ankle Surg, V32, P505
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Bauer KA, 2001, NEW ENGL J MED, V345, P1305, DOI 10.1056/NEJMoa011099
   BAUER P, 1994, BIOMETRICS, V50, P1029, DOI 10.2307/2533441
   BERRUYER M, 1993, J THORAC CARDIOV SUR, V105, P892
   BLANCHE C, 1988, INT SURG, V7, P342
   CHVAPIL M, 1983, J TRAUMA, V23, P1042, DOI 10.1097/00005373-198312000-00004
   COBDEN RH, 1976, J BONE JOINT SURG AM, V58, P70, DOI 10.2106/00004623-197658010-00012
   CRAIG C C, 1977, Spine, V2, P313, DOI 10.1097/00007632-197712000-00013
   DEPALMA AF, 1972, SURG GYNECOL OBSTETR, V134, P755
   ENGELHARDT GH, 1989, ARZNEIMITTEL-FORSCH, V39-1, P259
   FINN MD, 1992, J ORAL MAXIL SURG, V50, P608, DOI 10.1016/0278-2391(92)90443-4
   GEARY JR, 1950, ANN SURG, V132, P1128, DOI 10.1097/00000658-195012000-00012
   HARJULA A, 1983, SCAND J THORAC CARD, V17, P277, DOI 10.3109/14017438309099365
   HARRIS WH, 1978, J BONE JOINT SURG AM, V60, P454, DOI 10.2106/00004623-197860040-00004
   JACKSON MR, 1996, BLOOD COAGUL FIBRIN, V7, P37
   Katz SE, 1996, OPHTHALMIC PLAST REC, V12, P121, DOI 10.1097/00002341-199606000-00006
   Kjaergard HK, 1996, EUR J CARDIO-THORAC, V10, P727, DOI 10.1016/S1010-7940(96)80332-0
   Kruger J, 1992, Zentralbl Neurochir, V53, P33
   KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009
   *MERCK BIOM GMBH, 1999, EMD85980 MERCK BIOM
   Ono K, 2001, SURGERY, V130, P844, DOI 10.1067/msy.2001.117197
   Orgill DP, 1998, J BIOMED MATER RES, V39, P358, DOI 10.1002/(SICI)1097-4636(19980305)39:3<358::AID-JBM3>3.0.CO;2-I
   Oz MC, 2000, ANN THORAC SURG, V69, P1376, DOI 10.1016/S0003-4975(00)01194-2
   Robertson PA, 2001, SPINE, V26, P1473, DOI 10.1097/00007632-200107010-00018
   ROBICSEK F, 1981, ANN THORAC SURG, V31, P357, DOI 10.1016/S0003-4975(10)60967-8
   ROUSOU J, 1989, J THORAC CARDIOV SUR, V97, P194
   Russell JL, 2000, MED HYPOTHESES, V55, P474, DOI 10.1054/mehy.2000.1095
   SARR MG, 1984, ANN THORAC SURG, V38, P415, DOI 10.1016/S0003-4975(10)62300-4
   Schmitt JM, 1998, J BIOMED MATER RES, V41, P584, DOI 10.1002/(SICI)1097-4636(19980915)41:4<584::AID-JBM10>3.3.CO;2-N
   Schoenecker JG, 2001, AM J PATHOL, V159, P1957, DOI 10.1016/S0002-9440(10)63043-X
   Sherman R, 2001, ORTHOPEDICS, V24, P137
   SILVERSTEIN ME, 1981, J TRAUMA, V21, P388, DOI 10.1097/00005373-198105000-00011
   SILVERSTEIN ME, 1980, J TRAUMA, V20, P688, DOI 10.1097/00005373-198008000-00010
   SUDMANN B, 1993, ACTA ORTHOP SCAND, V64, P336, DOI 10.3109/17453679308993639
   Sugamori T, 2000, J BIOMED MATER RES, V49, P225, DOI 10.1002/(SICI)1097-4636(200002)49:2<225::AID-JBM10>3.0.CO;2-V
   Turpie AGG, 2001, NEW ENGL J MED, V344, P619, DOI 10.1056/NEJM200103013440901
   Wippermann BW, 1997, CHIRURG, V68, P1286, DOI 10.1007/s001040050361
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Zwischenberger JB, 1999, J INVEST SURG, V12, P101
NR 43
TC 2
Z9 2
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0362-2436
J9 SPINE
JI SPINE
PD SEP 1
PY 2005
VL 30
IS 17
BP 1911
EP 1917
DI 10.1097/01.brs.0000176324.00314.ef
PG 7
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 960BI
UT WOS:000231564800001
PM 16135979
DA 2018-10-20
ER

PT J
AU Hosseinkhani, H
   Inatsugu, Y
   Hiraoka, Y
   Inoue, S
   Tabata, Y
AF Hosseinkhani, H
   Inatsugu, Y
   Hiraoka, Y
   Inoue, S
   Tabata, Y
TI Perfusion culture enhances osteogenic differentiation of rat mesenchymal
   stem cells in collagen sponge reinforced with poly( glycolic acid) fiber
SO TISSUE ENGINEERING
LA English
DT Article
ID MARROW STROMAL CELLS; MINERALIZED MATRIX DEPOSITION; IN-VITRO;
   3-DIMENSIONAL SCAFFOLDS; ARTIFICIAL TISSUES; GENE-EXPRESSION; FLOW
   PERFUSION; BONE; INCREASES; BIOMATERIAL
AB The objective of this study was to obtain fundamental knowledge about in vitro culture systems to enhance the proliferation and differentiation of mesenchymal stem cells ( MSCs) in collagen sponge reinforced by the incorporation of poly( glycolic acid) ( PGA) fiber. A collagen solution with PGA fiber homogeneously localized at PGA: collagen weight ratios of 0.67, 1.25, 2.5, and 5 was freeze-dried, followed by cross-linking of combined dehydrothermal, glutaraldehyde, and ultraviolet treatment. Scanning electron microscopy revealed that collagen sponges exhibited homogeneous and interconnected pore structures with an average size of 180 mu m, irrespective of PGA fiber incorporation. When rat MSCs were seeded into collagen sponge with or without PGA fiber incorporation, more attached cells were observed in collagen sponge incorporating PGA fiber than in collagen sponge without PGA fiber incorporation, irrespective of the PGA:collagen ratio. The proliferation and osteogenic differentiation of MSCs in PGA-reinforced sponge at a weight ratio of 5 were greatly influenced by the culture method and growth conditions. Alkaline phosphatase ( ALP) activity and osteocalcin content of MSCs cultured in PGA-reinforced sponge by the perfusion method became maximum at a flow rate of 0.2 mL/min, although they increased with culture time period. It may be concluded that appropriate perfusion conditions enable MSCs to positively improve the extent of proliferation and differentiation.
C1 Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Field Tissue Engn, Kyoto, Japan.
RP Tabata, Y (reprint author), Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Field Tissue Engn, Kyoto, Japan.
EM yasuhiko@frontier.kyoto-u.ac.jp
CR Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Cartmell SH, 2003, TISSUE ENG, V9, P1197, DOI 10.1089/10763270360728107
   Castilho Leda R, 2002, Adv Biochem Eng Biotechnol, V74, P129
   Chen GP, 1999, CHEM LETT, P561, DOI 10.1246/cl.1999.561
   Chesler NC, 2004, J BIOMECH ENG-T ASME, V126, P309, DOI 10.1115/1.1695578
   Davisson T, 2002, TISSUE ENG, V8, P807, DOI 10.1089/10763270260424169
   DOHI Y, 1992, J BONE MINER RES, V7, P1173
   Freed LE, 1998, ADV DRUG DELIVER REV, V33, P15, DOI 10.1016/S0169-409X(98)00017-9
   FREED LE, 1993, J CELL BIOCHEM, V51, P257, DOI 10.1002/jcb.240510304
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Glowacki J, 1998, CELL TRANSPLANT, V7, P319, DOI 10.1016/S0963-6897(98)00003-7
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169
   Hiraoka Y, 2003, TISSUE ENG, V9, P1101, DOI 10.1089/10763270360728017
   Ingber DE, 1995, J BIOMECH, V28, P1471, DOI 10.1016/0021-9290(95)00095-X
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Kawai K, 2001, J BIOMED MATER RES, V57, P346, DOI 10.1002/1097-4636(20011205)57:3<346::AID-JBM1177>3.0.CO;2-8
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Kloth S, 1998, IN VITRO CELL DEV-AN, V34, P515
   KLOTH S, 1995, FASEB J, V9, P963
   KOLLER MR, 1992, ANN NY ACAD SCI, V665, P105, DOI 10.1111/j.1749-6632.1992.tb42578.x
   Koppelstaetter C, 2004, ALTEX-ALTERN TIEREXP, V21, P51
   Lee YM, 2001, J BIOMED MATER RES, V54, P216, DOI 10.1002/1097-4636(200102)54:2<216::AID-JBM8>3.0.CO;2-C
   LENNON DP, 1995, EXP CELL RES, V219, P211, DOI 10.1006/excr.1995.1221
   Ma PX, 1999, J BIOMED MATER RES, V44, P217
   Ma T, 2000, BIOTECHNOL BIOENG, V70, P606, DOI 10.1002/1097-0290(20001220)70:6<606::AID-BIT2>3.0.CO;2-H
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   MINUTH WW, 1992, KIDNEY INT, V41, P215, DOI 10.1038/ki.1992.30
   Minuth WW, 1998, CELL TISSUE RES, V291, P1
   Minuth WW, 2000, J BIOMAT SCI-POLYM E, V11, P495, DOI 10.1163/156856200743832
   Mueller SM, 1999, J BONE MINER RES, V14, P2118, DOI 10.1359/jbmr.1999.14.12.2118
   MuellerKlieser W, 1997, AM J PHYSIOL-CELL PH, V273, pC1109
   Mundy G.R., 1999, BONE REMODELING ITS
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Noshi T, 2000, J BIOMED MATER RES, V52, P621
   Papas KK, 1999, BIOTECHNOL BIOENG, V66, P219
   Peretti GM, 2000, TISSUE ENG, V6, P567, DOI 10.1089/107632700750022206
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Radisic M, 2004, AM J PHYSIOL-HEART C, V286, pH507, DOI 10.1152/ajpheart.00171.2003
   RAO J, 1992, ANAL BIOCHEM, V207, P186, DOI 10.1016/0003-2697(92)90521-8
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   Schneider AI, 1999, IN VITRO CELL DEV-AN, V35, P515
   SCHWARTZ RM, 1991, P NATL ACAD SCI USA, V88, P6760, DOI 10.1073/pnas.88.15.6760
   Shin H, 2004, J BIOMED MATER RES A, V69A, P535, DOI 10.1002/jbm.a.30027
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Sittinger M, 1997, INT J ARTIF ORGANS, V20, P57
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Takahashi Y, 2003, TISSUE ENG, V9, P931, DOI 10.1089/107632703322495574
   van den Dolder J, 2003, J BIOMED MATER RES A, V64A, P235, DOI 10.1002/jbm.a.10365
   Vandenburgh H, 1996, HUM GENE THER, V7, P2195, DOI 10.1089/hum.1996.7.17-2195
   Wang YC, 2003, TISSUE ENG, V9, P1205, DOI 10.1089/10763270360728116
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   Wendt D, 2003, BIOTECHNOL BIOENG, V84, P205, DOI 10.1002/bit.10759
   Woerly S, 1996, BIOMATERIALS, V17, P301, DOI 10.1016/0142-9612(96)85568-2
   Xie YB, 2001, TISSUE ENG, V7, P585, DOI 10.1089/107632701753213200
   Yoshikawa T, 1998, J BIOMED MATER RES, V41, P568, DOI 10.1002/(SICI)1097-4636(19980915)41:4<568::AID-JBM8>3.3.CO;2-6
   Yoshikawa T, 1996, J BIOMED MATER RES, V32, P481
NR 58
TC 68
Z9 70
U1 3
U2 15
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD SEP
PY 2005
VL 11
IS 9-10
BP 1476
EP 1488
DI 10.1089/ten.2005.11.1476
PG 13
WC Cell & Tissue Engineering
SC Cell Biology
GA 985AA
UT WOS:000233347300018
PM 16259602
DA 2018-10-20
ER

PT J
AU Eder, C
   Falkner, E
   Chiari-Grisar, C
   Schoeffl, H
   Losert, UM
   Nehrer, S
AF Eder, C.
   Falkner, E.
   Chiari-Grisar, C.
   Schoeffl, H.
   Losert, U. M.
   Nehrer, S.
TI 3 R complient biomaterial testing: HET-CAM evaluation of biomaterials
   gives comparable results to in vivo models regarding biocompatibility
   patterns
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
C1 [Eder, C.; Chiari-Grisar, C.; Nehrer, S.] Med Univ Vienna, Dept Orthopaed Surg, Vienna, Austria.
   [Falkner, E.; Losert, U. M.] Med Univ Vienna, Core Unit Biomed Res, Vienna, Austria.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP
PY 2005
VL 158
SU 1
BP S214
EP S214
PG 1
WC Toxicology
SC Toxicology
GA V44GT
UT WOS:000202991900479
DA 2018-10-20
ER

PT J
AU Du, D
   Cai, J
   Ju, HX
   Yan, F
   Chen, J
   Jiang, XQ
   Chen, HY
AF Du, D
   Cai, J
   Ju, HX
   Yan, F
   Chen, J
   Jiang, XQ
   Chen, HY
TI Construction of a biomimetic zwitterionic interface for monitoring cell
   proliferation and apoptosis
SO LANGMUIR
LA English
DT Article
ID STEM-CELLS; ADHESION; BIOMATERIALS; SURFACES; FIBROBLASTS; GROWTH
AB A new zwitterionic monolayer film of sulfobetaine was constructed by grafting novelly designed N,N'-dimethyl (beta-hydroxyethyloxyethyl) ammonium propanesulfonate (DHAPS) to hydroxyl groups of glass in the presence of hexamethylene diisocyanate (HDI) as a coupling agent and dibutyltin dilaurate (DBTDL) as a catalyst. Experiments of blood adhesion proved that the zwitterionic film possessed excellent hydrophilicity and very good biocompatibility and provided an appropriate biomimetic interface for adhesion and proliferation of cells. Thus, the monitoring of the cell proliferation and apoptotic processes on the zwitterionic surface during an incubation process was achieved, using different techniques, such as electrochemical impedance spectroscopy, scanning electron microscopy, flow cytometric assay, and Trypan blue staining. K562 leukemia cells, as a model, cultured in vitro on the zwitterionic surface kept their viability for 5 days and remained healthy and undifferentiated, indicating that the zwitterionic surface did not have a deleterious effect on cell growth in normal conditions. Thus, this man-made interface would be applicable to the growth of cells and the study of biomaterial-cell interaction and has potential applications in medicine and cytobiology.
C1 Nanjing Univ, Coll Chem & Chem Engn, Dept Chem, Educ Minist China,Key Lab Analyt Chem Life Sci, Nanjing 210093, Peoples R China.
   Nanjing Univ, Coll Chem & Chem Engn, Dept Polymer Sci & Engn, Nanjing 210093, Peoples R China.
   Jiangsu Inst Canc Prevent & Cure, Nanjing 210009, Peoples R China.
RP Ju, HX (reprint author), Nanjing Univ, Coll Chem & Chem Engn, Dept Chem, Educ Minist China,Key Lab Analyt Chem Life Sci, Nanjing 210093, Peoples R China.
EM hxju@nju.edu.cn
RI Du, Dan (Annie)/G-3821-2012; Ju, Huangxian/B-2265-2010; Jiang,
   Xiqun/I-8128-2014
CR Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Andreescu S, 2004, ANAL CHEM, V76, P2321, DOI 10.1021/ac035436m
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Claase MB, 2003, BIOMACROMOLECULES, V4, P57, DOI 10.1021/bm0256045
   Curtis A., 1995, Journal of Cellular Engineering Incorporating Molecular Engineering, V1, P35
   Dai Z, 2003, ANAL CHEM, V75, P5429, DOI 10.1021/ac034213t
   Feng WJ, 2003, ANAL CHEM, V75, P4148, DOI 10.1021/ac0343127
   Gao JM, 1998, J BIOMED MATER RES, V42, P417, DOI 10.1002/(SICI)1097-4636(19981205)42:3<417::AID-JBM11>3.3.CO;2-N
   Huang H., 2004, BIOCH BIOPHYSICAL RE, V214, P787
   JACKSON M, 1995, BBA-MOL BASIS DIS, V1270, P1, DOI 10.1016/0925-4439(94)00056-V
   Kaji H, 2004, LANGMUIR, V20, P16, DOI 10.1021/la035537f
   Kramer S, 2004, J AM CHEM SOC, V126, P5388, DOI 10.1021/ja031674n
   Lakard S, 2004, BIOELECTROCHEMISTRY, V62, P19, DOI 10.1016/j.bioelechem.2003.03.009
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Luong JHT, 2001, ANAL CHEM, V73, P1844, DOI 10.1021/ac0011585
   RAMSEY WS, 1984, IN VITRO CELL DEV B, V20, P802
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   SHELTON RM, 1988, BIOMATERIALS, V9, P24, DOI 10.1016/0142-9612(88)90065-8
   Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160
   STEELE JG, 1992, J BIOMED MATER RES, V26, P861, DOI 10.1002/jbm.820260704
   Streuli C, 1999, CURR OPIN CELL BIOL, V11, P634, DOI 10.1016/S0955-0674(99)00026-5
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919
   Yuan J, 2004, POLYM INT, V53, P1722, DOI 10.1002/pi.1545
   Yuan J., 2004, COLLOID SURFACE B, V36, P19
   Zhao K, 2002, J MATER SCI-MATER M, V13, P849, DOI 10.1023/A:1016596228316
NR 26
TC 21
Z9 23
U1 1
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD AUG 30
PY 2005
VL 21
IS 18
BP 8394
EP 8399
DI 10.1021/la051071k
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 959WM
UT WOS:000231550000046
PM 16114948
DA 2018-10-20
ER

PT J
AU Feiler, AA
   Sandberg, T
   Caldwell, KD
AF Feiler, AA
   Sandberg, T
   Caldwell, KD
TI Mucin interactions with biomaterial surfaces
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 230th National Meeting of the American-Chemical-Society
CY AUG 28-SEP 01, 2005
CL Washington, DC
C1 Uppsala Univ, Dept Surface Biotechnol, SE-75123 Uppsala, Sweden.
EM adam.feiler@ytbioteknik.uu.se; Karin.Caldwell@ytbioteknik.uu.se
NR 0
TC 1
Z9 1
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 28
PY 2005
VL 230
MA 700-POLY
BP U4318
EP U4318
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 032TJ
UT WOS:000236797308685
DA 2018-10-20
ER

PT J
AU Su, J
   Meredith, JC
AF Su, J
   Meredith, JC
TI Knowledge discovery applications in combinatorial biomaterial surface
   design
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 230th National Meeting of the American-Chemical-Society
CY AUG 28-SEP 01, 2005
CL Washington, DC
C1 Georgia Inst Technol, Coulter Sch Biomed Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.
EM gtg602c@prism.gatech.edu
RI Su, Jing/B-3171-2013; Meredith, Carson/B-3323-2009
OI Meredith, Carson/0000-0003-2519-5003
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 28
PY 2005
VL 230
MA 600-PMSE
BP U3786
EP U3787
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA 032TJ
UT WOS:000236797307591
DA 2018-10-20
ER

PT J
AU Wu, LQ
   Ghodssi, R
   Elabd, YA
   Payne, GF
AF Wu, LQ
   Ghodssi, R
   Elabd, YA
   Payne, GF
TI Biomimetic pattern transfer from a hard material to a soft biomaterial
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 230th National Meeting of the American-Chemical-Society
CY AUG 28-SEP 01, 2005
CL Washington, DC
C1 Univ Maryland, Inst Biotechnol, Ctr Biosyst Res, College Pk, MD 20742 USA.
   Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA.
   Drexel Univ, Dept Chem & Biol Engn, Philadelphia, PA 19104 USA.
EM wuq@umbi.umd.edu
RI Elabd, Yossef/G-9866-2014
OI Elabd, Yossef/0000-0002-7790-9445
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 28
PY 2005
VL 230
MA 157-PMSE
BP U3576
EP U3577
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA 032TJ
UT WOS:000236797307154
DA 2018-10-20
ER

PT J
AU Ruhe, PQ
   Boerman, OC
   Russel, FGM
   Spauwen, PHM
   Mikos, AG
   Jansen, JA
AF Ruhe, PQ
   Boerman, OC
   Russel, FGM
   Spauwen, PHM
   Mikos, AG
   Jansen, JA
TI Controlled release of rhBMP-2 loaded poly(DL-lactic-co-glycolic
   acid)/calcium phosphate cement composites in vivo
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE bone engineering; calcium phosphate; PLGA microparticles; rhBMP-2;
   release
ID BONE MORPHOGENETIC PROTEIN-2; BIODEGRADABLE POLYMER MICROPARTICLES;
   GROWTH-FACTOR BETA-1; RAT ECTOPIC MODEL; CALCIUM-PHOSPHATE; BIOMATERIAL
   CARRIERS; DELIVERY; PHARMACOKINETICS; MICROSPHERES; VITRO
AB The release kinetics of recombinant human bone morphogenetic protein-2 (rhBMP-2) loaded poly(DL-lactic-co-glycolic acid)/calcium phosphate cement (PLGA/Ca-P cement) composites were studied in vivo. RhBMP-2 was radiolabeled with 131, and entrapped within PLGA microparticles or adsorbed onto the microparticle surface. PLGA microparticles were prepared of high molecular weight (HMW) PLGA (weight average molecular weight [M-W] 49,100 1700) or low molecular weight (LMW) PLGA (M-w 5,900 +/- 300) and used for preparation of 30:70 wt.% PLGA/Ca-P cement composite discs. Release of I-131- rhBMP-2 loaded composites was assessed by scintigraphic imaging according to a 2 2 two-level full factorial design in the rat ectopic model during four weeks. In vivo release kinetics varied among formulations. All formulations showed slow release without initial burst, and displayed a linear release from 3 to 28 days. Release of LMW entrapped rhBMP-2 composites (1.7 +/- 0.3%/day) was significantly faster than release from other formulations (p < 0.01). After 28 days, retention within the composites was 65 +/- 5%, 75 +/- 4%, 50 +/- 4% and 70 +/- 6% of the initial rhBNW-2 for HMW entrapped, HMW adsorbed, LMW entrapped and LMW adsorbed rhBMP-2 composites, respectively. Release from the composite was probably slowed down by an interaction of rhBMP-2 and Ca-P cement after rhBMP-2 release from PLGA microparticles. We conclude that PLGA/Ca-P cement composites can be considered as sustained slow release vehicles and that the release and retention of rhBMP-2 can be modified according to the desired profile to a limited extent. (c) 2005 Elsevier B.V. All rights reserved.
C1 Radboud Univ Nijmegen Med Ctr, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   Radboud Univ Nijmegen Med Ctr, Dept Nucl Med, NL-6500 HB Nijmegen, Netherlands.
   Radboud Univ Nijmegen Med Ctr, Dept Pharmacol & Toxicol, NL-6500 HB Nijmegen, Netherlands.
   Radboud Univ Nijmegen Med Ctr, Dept Plast & Reconstruct Surg, NL-6500 HB Nijmegen, Netherlands.
   Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
RP Jansen, JA (reprint author), Radboud Univ Nijmegen Med Ctr, Dept Biomat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM j.jansen@dent.umcn.nl
RI Jansen, John/H-8055-2014; Russel, Frans/B-3184-2014; Boerman,
   Otto/A-8112-2014
OI Russel, Frans/0000-0002-7959-2314; Boerman, Otto/0000-0001-6832-101X
CR Alpaslan C, 1996, BRIT J ORAL MAX SURG, V34, P414, DOI 10.1016/S0266-4356(96)90098-4
   BROWN WE, 1985, Patent No. 4518430
   Chow L C, 2001, Monogr Oral Sci, V18, P148
   Cleek RL, 1997, J BIOMED MATER RES, V35, P525, DOI 10.1002/(SICI)1097-4636(19970615)35:4<525::AID-JBM12>3.0.CO;2-A
   CUNNINGHAM NS, 1992, P NATL ACAD SCI USA, V89, P11740, DOI 10.1073/pnas.89.24.11740
   del Real RP, 2002, BIOMATERIALS, V23, P3673, DOI 10.1016/S0142-9612(02)00101-1
   FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   GLOKIE CM, 2002, J CRANIOFAC SURG, V13, P111
   Ladd A L, 1999, J Am Acad Orthop Surg, V7, P279
   Larsson S, 2002, CLIN ORTHOP RELAT R, P23
   LeGeros R Z, 1991, Monogr Oral Sci, V15, P1
   Louis-Ugbo J, 2002, J ORTHOPAED RES, V20, P1050, DOI 10.1016/S0736-0266(02)00011-6
   Lu L, 2000, J BIOMED MATER RES, V50, P440, DOI 10.1002/(SICI)1097-4636(20000605)50:3<440::AID-JBM19>3.0.CO;2-G
   Oldham JB, 2000, J BIOMECH ENG-T ASME, V122, P289, DOI 10.1115/1.429662
   Ooms EM, 2002, J BIOMED MATER RES, V61, P9, DOI 10.1002/jbm.10029
   Pean JM, 1998, J CONTROL RELEASE, V56, P175, DOI 10.1016/S0168-3659(98)00086-8
   Peter SJ, 2000, J BIOMED MATER RES, V50, P452, DOI 10.1002/(SICI)1097-4636(20000605)50:3<452::AID-JBM20>3.3.CO;2-S
   Puleo DA, 1998, J BIOMED MATER RES, V41, P104, DOI 10.1002/(SICI)1097-4636(199807)41:1<104::AID-JBM13>3.0.CO;2-N
   REDDI AH, 1993, J BONE MINER RES, V8, P499
   Ruhe PQ, 2003, J BONE JOINT SURG AM, V85A, P75
   RUHE PQ, COMMUNICATION
   RUHE PQ, IN PRESS J BIOMED MA
   Schrier JA, 1999, PHARM DEV TECHNOL, V4, P611, DOI 10.1081/PDT-100101400
   Shive M. S., 1997, ADV DRUG DELIV REV, V28, P5
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Uludag H, 2001, J BONE JOINT SURG AM, V83, P128
   Woo BH, 2001, PHARMACEUT RES, V18, P1747, DOI 10.1023/A:1013382832091
NR 29
TC 117
Z9 121
U1 2
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD AUG 18
PY 2005
VL 106
IS 1-2
BP 162
EP 171
DI 10.1016/j.jconrel.2005.04.018
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 962NG
UT WOS:000231738900016
PM 15972241
DA 2018-10-20
ER

PT J
AU Lee, JW
   Na, DS
   Chae, SK
   Kim, C
   Kang, JY
   Ju, BK
   Lee, H
   Kim, SU
   Hwang, CN
   Lee, SH
AF Lee, JW
   Na, DS
   Chae, SK
   Kim, C
   Kang, JY
   Ju, BK
   Lee, H
   Kim, SU
   Hwang, CN
   Lee, SH
TI Using the chorions of fertilized zebrafish eggs as a biomaterial for the
   attachment and differentiation of mouse stem cells
SO LANGMUIR
LA English
DT Article
ID EMBRYONAL CARCINOMA-CELLS; EXTRACELLULAR-MATRIX; NEURONAL
   DIFFERENTIATION; CARDIAC TRANSCRIPTION; IN-VITRO; EXPRESSION; PROTEIN;
   ACID; BLASTOCYSTS; COMPONENTS
AB The development of proper biomaterials is critical for the success of cell therapy and modern tissue engineering. Here, we extruded the yolk and remaining inner mass from fertilized zebrafish eggs and used the resulting chorions as a biomaterial for the differentiation and attachment of mouse P19 embryonic carcinoma (EC) cells. Cells inserted into the chorion showed the spontaneous formation of embryoid body due to the repulsive cell adhesion of the chorion and differentiated specifically into neural cells and cardiomyocytes. In contrast, dissolved chorion extracellular matrix (ECM) conferred enhanced cell attachment on it, suggesting that a unique property of the zebrafish chorion with nanoporous structure appears to be responsible for the simple and controllable embryoid formation for stem cell differentiation. These results indicate that chorions from fertilized zebrafish eggs may be used as an extracellular matrix alternative and applied for stem cell differentiation to specific cell lineages.
C1 Korea Univ, Dept Elect Engn, Seoul 136701, South Korea.
   Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea.
   Korea Inst Sci & Technol, Microsyst Res Ctr, Seoul 136791, South Korea.
RP Ju, BK (reprint author), Korea Univ, Dept Elect Engn, Seoul 136701, South Korea.
EM bkju@korea.ac.kr
CR Aharoni D, 1997, CURR BIOL, V7, P43, DOI 10.1016/S0960-9822(06)00026-1
   AMSTRONG MT, 2003, EXP CELL RES, V288, P235
   Bonsignorio D, 1996, ZYGOTE, V4, P101, DOI 10.1017/S0967199400002975
   Chan AWS, 2000, SCIENCE, V287, P317, DOI 10.1126/science.287.5451.317
   Devgan V, 2004, BIOCHEM BIOPH RES CO, V313, P1030, DOI 10.1016/j.bbrc.2003.11.184
   DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E
   Geiger H, 1998, CELL, V93, P1055, DOI 10.1016/S0092-8674(00)81210-6
   Giri RK, 2003, EXP CELL RES, V291, P451, DOI 10.1016/S0014-4827(03)00405-1
   Haapasalo A, 1999, ONCOGENE, V18, P1285, DOI 10.1038/sj.onc.1202401
   Hamada-Kanazawa M, 2004, FEBS LETT, V560, P192, DOI 10.1016/S0014-5793(04)00086-9
   Jesuthasan S, 2002, SCIENCE, V297, P1484, DOI 10.1126/science.1076115
   Khademhosseini A, 2004, BIOMATERIALS, V25, P3583, DOI 10.1016/j.biomaterials.2003.10.033
   LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X
   Marchini D, 1997, BIOCHEM BIOPH RES CO, V240, P657, DOI 10.1006/bbrc.1997.7694
   McBride K, 2001, CAN J PHYSIOL PHARM, V79, P673, DOI 10.1139/cjpp-79-8-673
   McDonough JL, 2004, PROG CARDIOVASC DIS, V47, P207, DOI 10.1016/j.pcad.2004.07.001
   Mengerink KJ, 2001, GLYCOBIOLOGY, V11, p37R, DOI 10.1093/glycob/11.4.37R
   Montag M, 2000, BIOL REPROD, V62, P1738, DOI 10.1095/biolreprod62.6.1738
   Monzen K, 1999, MOL CELL BIOL, V19, P7096
   Natale DR, 2004, DEV BIOL, V268, P76, DOI 10.1016/j.ydbio.2003.12.011
   PRZYBORSKI SA, 1995, DEV BRAIN RES, V89, P187, DOI 10.1016/0165-3806(95)00117-V
   Rawson DM, 2000, AQUAC RES, V31, P325, DOI 10.1046/j.1365-2109.2000.00401.x
   Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593
   RODRIGUEZ ER, 1994, BIOCHEM BIOPH RES CO, V205, P1899, DOI 10.1006/bbrc.1994.2892
   Rombouts K, 2002, J HEPATOL, V37, P788, DOI 10.1016/S0168-8278(02)00275-1
   Skerjanc IS, 1999, TRENDS CARDIOVAS MED, V9, P139, DOI 10.1016/S1050-1738(99)00017-1
   van der Heyden MAG, 2003, CARDIOVASC RES, V58, P410, DOI 10.1016/S0008-6363(03)00247-5
   Wang H, 1999, BBA-GENE STRUCT EXPR, V1446, P156, DOI 10.1016/S0167-4781(99)00066-4
   Whetton AD, 1998, CURR OPIN CELL BIOL, V10, P721, DOI 10.1016/S0955-0674(98)80113-0
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
NR 30
TC 5
Z9 5
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD AUG 16
PY 2005
VL 21
IS 17
BP 7615
EP 7620
DI 10.1021/la0504255
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 957QU
UT WOS:000231389200001
PM 16089359
DA 2018-10-20
ER

PT J
AU Cheng, XH
   Canavan, HE
   Stein, MJ
   Hull, JR
   Kweskin, SJ
   Wagner, MS
   Somorjai, GA
   Castner, DG
   Ratner, BD
AF Cheng, XH
   Canavan, HE
   Stein, MJ
   Hull, JR
   Kweskin, SJ
   Wagner, MS
   Somorjai, GA
   Castner, DG
   Ratner, BD
TI Surface chemical and mechanical properties of plasma-polymerized
   N-isopropylacrylamide
SO LANGMUIR
LA English
DT Article
ID SCANNING FORCE MICROSCOPY; GENERATION VIBRATIONAL SPECTROSCOPY;
   VOLUME-PHASE-TRANSITION; RESPONSIVE POLYMER; MICROMECHANICAL PROPERTIES;
   THERMORESPONSIVE POLYMER; FILM CHEMISTRY; POLY(N-ISOPROPYLACRYLAMIDE)
   GELS; STRUCTURAL-CHARACTERIZATION; ELECTRON-MICROSCOPY
AB Surface-immobilized poly(N-isopropyl acrylamide) (pNIPAM) is currently used for a wide variety of biosensor and biomaterial applications. A thorough characterization of the surface properties of pNIPAM thin films will benefit those applications. In this work, we present analysis of a plasma-polymerized NIPAM (ppNIPAM) coating by multiple surface analytical techniques, including time-of-flight secondary-ion mass spectrometry (ToF-SIMS), contact angle measurement, atomic force microscopy (AFM), and sum frequency generation (SFG) vibrational spectroscopy. ToF-SIMS data show that the plasma-deposited NIPAM polymer on the substrate is cross-linked with a good retention of the monomer integrity. Contact angle results confirm the thermoresponsive nature of the film as observed by a change of surface wettability as a function of temperature. Topographic and force-distance curve measurements by AFM further demonstrate that the grafted film shrinks or swells depending on the temperature of the aqueous environment. A clear transition of the elastic modulus is observed at 31-32 degrees C. The change of the surface wettability and mechanical properties vs temperature are attributed to different conformations taken by the polymer, which is reflected on the outmost surface as distinct side chain groups orienting outward at different temperatures as measured by SFG. The results suggest that a ppNIPAM thin film on a substrate experiences similar mechanical and chemical changes to pNIPAM bulk polymers in solution. The SFG result provides evidence supporting the current theory of the lower critical solution temperature (LCST) behavior of pNIPAM.
C1 Univ Washington Engn Biomat, Dept Bioengn, Natl ESCA, Seattle, WA 98195 USA.
   Univ Washington, Surface Anal Ctr Biomed Problems, Dept Bioengn, Seattle, WA USA.
   Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
   Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.
   Lawrence Berkeley Natl Lab, Div Sci Mat, Berkeley, CA 94720 USA.
RP Ratner, BD (reprint author), Univ Washington Engn Biomat, Dept Bioengn, Natl ESCA, Box 351720, Seattle, WA 98195 USA.
EM ratner@uweb.engr.washington.edu
FU NIGMS NIH HHS [GM-065098]; NIBIB NIH HHS [P41 EB002027-23S1, P41
   EB002027]
CR Akiyama Y, 2004, LANGMUIR, V20, P5506, DOI 10.1021/la036139f
   Baker SP, 1997, THIN SOLID FILMS, V308, P289, DOI 10.1016/S0040-6090(97)00556-7
   Bergbreiter DE, 2001, MACROMOLECULES, V34, P3018, DOI 10.1021/ma000873d
   Bohanon T, 1996, J BIOMAT SCI-POLYM E, V8, P19, DOI 10.1163/156856297X00551
   Boutris C, 1997, POLYMER, V38, P2567, DOI 10.1016/S0032-3861(97)01024-0
   Bruscolini P, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051805
   Cai WS, 2001, COLLOID POLYM SCI, V279, P793, DOI 10.1007/s003960100506
   Canavan HE, 2005, LANGMUIR, V21, P1949, DOI 10.1021/la048546c
   Chen Q, 1999, J AM CHEM SOC, V121, P446, DOI 10.1021/ja9831453
   Chen YJ, 2003, ENZYME MICROB TECH, V32, P120, DOI 10.1016/S0141-0229(02)00272-7
   Chen Z, 2002, ANNU REV PHYS CHEM, V53, P437, DOI 10.1146/annurev.physchem.53.091801.115126
   Chen Z, 1999, J PHYS CHEM B, V103, P2935, DOI 10.1021/jp984502z
   Cheng XH, 2004, J BIOMED MATER RES A, V70A, P159, DOI 10.1002/jbm.a.30053
   Chern JM, 2004, J APPL POLYM SCI, V92, P3651, DOI 10.1002/app.20301
   Chizhik SA, 1998, LANGMUIR, V14, P2606, DOI 10.1021/la980042p
   Coughlan DC, 2004, J CONTROL RELEASE, V98, P97, DOI 10.1016/j.jconrel.2004.04.014
   d'Agostino R., 1990, PLASMA DEPOSITION TR
   Domke J, 1998, LANGMUIR, V14, P3320, DOI 10.1021/la9713006
   Fong RB, 2002, BIOTECHNOL BIOENG, V79, P271, DOI 10.1002/bit.10315
   Grabstain V, 2003, BIOTECHNOL PROGR, V19, P1728, DOI 10.1021/bp034161t
   Harmon ME, 2003, LANGMUIR, V19, P10947, DOI 10.1021/la030217h
   Harmon ME, 2003, POLYMER, V44, P4547, DOI 10.1016/S0032-3861(03)00463-4
   Hartley P. G., 2000, Plasmas and Polymers, V5, P47, DOI 10.1023/A:1009508426115
   HIROTSU S, 1991, J CHEM PHYS, V94, P3949, DOI 10.1063/1.460672
   Huber DL, 2003, SCIENCE, V301, P352, DOI 10.1126/science.1080759
   Ista LK, 2001, LANGMUIR, V17, P2552, DOI 10.1021/la001257d
   JACKSON JE, 1980, J QUAL TECHNOL, V12, P201
   Jandt KD, 1998, MAT SCI ENG R, V21, P221, DOI 10.1016/S0927-796X(97)00012-0
   Janicijevic A, 2003, J MICROSC-OXFORD, V212, P264, DOI 10.1111/j.1365-2818.2003.01254.x
   Katsumoto Y, 2002, J PHYS CHEM A, V106, P3429, DOI 10.1021/jp0124903
   Kikuchi A, 2004, MACROMOL SYMP, V207, P217, DOI 10.1002/masy.200450319
   Kim J, 2004, LANGMUIR, V20, P4640, DOI 10.1021/la0498511
   Kim SH, 2002, BIOMATERIALS, V23, P1657, DOI 10.1016/S0142-9612(01)00292-7
   Kobayashi J, 2003, ANAL CHEM, V75, P3244, DOI 10.1021/ac026364m
   Kobayashi J, 2001, ANAL CHEM, V73, P2027, DOI 10.1021/ac0013507
   Kost J, 2001, ADV DRUG DELIVER REV, V46, P125, DOI 10.1016/S0169-409X(00)00136-8
   Kurisawa M, 2000, J CONTROL RELEASE, V68, P1, DOI 10.1016/S0168-3659(00)00246-7
   Lin SY, 1999, POLYMER, V40, P2619, DOI 10.1016/S0032-3861(98)00512-6
   Liu HC, 2003, J BIOMED MATER RES A, V67A, P1424, DOI 10.1002/jbm.a.20004
   LOPEZ GP, 1992, J POLYM SCI POL CHEM, V30, P2415, DOI 10.1002/pola.1992.080301116
   LOPEZ GP, 1992, J POLYM SCI POL CHEM, V30, P2427, DOI 10.1002/pola.1992.080301117
   LOPEZ GP, 1991, LANGMUIR, V7, P766, DOI 10.1021/la00052a027
   Luo QZ, 2003, ELECTROPHORESIS, V24, P3694, DOI 10.1002/elps.200305577
   Maeda Y, 2001, LANGMUIR, V17, P7535, DOI 10.1021/la010007+
   Malmstadt N, 2003, ANAL CHEM, V75, P2943, DOI 10.1021/ac034274r
   Matzelle TR, 2002, J PHYS CHEM B, V106, P2861, DOI 10.1021/jp0128426
   Miranda PB, 1999, J PHYS CHEM B, V103, P3292, DOI 10.1021/jp9843757
   Munz M, 2003, ADV POLYM SCI, V164, P87, DOI 10.1007/b11055
   NAGAYAMA H, 1995, MACROMOL CHEM PHYSIC, V196, P611, DOI 10.1002/macp.1995.021960216
   Opdahl A, 2001, CHEM REC, V1, P101
   Pan YV, 2001, BIOMACROMOLECULES, V2, P32, DOI 10.1021/bm0000642
   Ratner BD, 2003, ABSTR PAP AM CHEM S, V225, pU582
   Reese CE, 2004, J AM CHEM SOC, V126, P1493, DOI 10.1021/ja037118a
   Reich Z, 2001, BIOTECHNOL ADV, V19, P451, DOI 10.1016/S0734-9750(01)00077-5
   Reichelt R, 2004, MACROMOL SYMP, V210, P501, DOI 10.1002/masy.200450656
   Roy I, 2003, CHEM BIOL, V10, P1161, DOI 10.1016/j.chembiol.2003.12.004
   SCHILD HG, 1991, LANGMUIR, V7, P665, DOI 10.1021/la00052a013
   Senff H, 2000, COLLOID POLYM SCI, V278, P830, DOI 10.1007/s003960000329
   Sheiko SS, 2000, ADV POLYM SCI, V151, P61
   SHIBAYAMA M, 1994, MACROMOLECULES, V27, P5060, DOI 10.1021/ma00096a031
   SHIMIZU T, 2002, CIRC RES, V90, P40
   STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0
   SUZUKI Y, 1992, J CHEM PHYS, V97, P3808, DOI 10.1063/1.462962
   Takahashi K, 2004, J CHEM PHYS, V120, P2972, DOI 10.1063/1.1636695
   TAKEI YG, 1994, MACROMOLECULES, V27, P6163, DOI 10.1021/ma00099a035
   Takeoka Y, 2003, ADV MATER, V15, P199, DOI 10.1002/adma.200390044
   TAM KC, 1992, POLYMER, V33, P436, DOI 10.1016/0032-3861(92)91008-P
   Tsuda Y, 2004, J BIOMED MATER RES A, V69A, P70, DOI 10.1002/jbm.a.20114
   Tsukruk VV, 2001, LANGMUIR, V17, P6715, DOI 10.1021/la010761v
   Tsukruk VV, 1998, J MATER SCI, V33, P4905, DOI 10.1023/A:1004457532183
   Twaites BR, 2004, J CONTROL RELEASE, V97, P551, DOI 10.1016/j.jconrel.2004.03.032
   WANG Y, 2003, 12 INT C SOL STAT SE
   WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9
   Zhu QZ, 2000, ANALYST, V125, P2260, DOI 10.1039/b005748g
NR 74
TC 138
Z9 138
U1 2
U2 102
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD AUG 16
PY 2005
VL 21
IS 17
BP 7833
EP 7841
DI 10.1021/la050417o
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 957QU
UT WOS:000231389200031
PM 16089389
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Allen, R
   Nielson, R
   Wise, DD
   Shear, JB
AF Allen, R
   Nielson, R
   Wise, DD
   Shear, JB
TI Catalytic three-dimensional protein architectures
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID INTERMOLECULAR CROSS-LINKING; SINGLE-CELL ELECTROPORATION; EMBRYONIC
   STEM-CELLS; CAPILLARY-ELECTROPHORESIS; SOFT LITHOGRAPHY;
   DIFFERENTIATION; GLUTAMATE; MICROMACHINES; GUIDANCE; CULTURES
AB We demonstrate a strategy for microfabricating catalytically active, three-dimensional matrixes composed of cross-linked protein in cellular and microfluidic environments. In this approach, a pulsed femtosecond laser is used to excite photosensitizers via multiphoton absorption within three-dimensionally defined volumes, a process that promotes cross-linking of protein residue side chains in the vicinity of the laser focal point. In this manner, it is possible to fabricate protein microparticles with dimensions on the order of the multiphoton focal volume (less than 1 mu m(3)) or, by scanning the position of a laser focal point relative to a specimen, to generate surface-adherent matrixes or cables that extend through solution for hundreds of micrometers. We show that protein matrixes can be functionalized either through direct cross-linking of enzymes, by decoration of avidin matrixes with biotinylated enzymes, or by cross-linking biotinylated proteins that then are linked to biotinylated enzymes via an avidin couple. Several formats are explored, including microparticles that can be translocated to desired sites of action (including cytosolic positions), protein pads that generate product gradients within cell cultures, and on-column nanoreactors for microfluidic systems. These biomaterial fabrication technologies offer opportunities for studying a variety of cell functions, ranging from single-cell biochemistry and development to perturbation and analysis of small populations of cultured cells.
C1 Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA.
   Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA.
RP Shear, JB (reprint author), Univ Texas, Dept Chem & Biochem, 1 Univ Stn A5300, Austin, TX 78712 USA.
EM jshear@mail.utexas.edu
FU NIBIB NIH HHS [8R21 EB 000423-02]
CR Baldacchini T, 2004, J APPL PHYS, V95, P6072, DOI 10.1063/1.1728296
   Basu S, 2004, BIOMACROMOLECULES, V5, P2347, DOI 10.1021/bm049707u
   Basu S, 2004, BIOMACROMOLECULES, V5, P572, DOI 10.1021/bm0344194
   Cazillis M, 2004, EUR J NEUROSCI, V19, P798, DOI 10.1111/j.1460-9568.2004.03138.x
   Chiem N, 1997, ANAL CHEM, V69, P373, DOI 10.1021/ac9606620
   CHIEM NH, 1998, J CLIN CHEM, V44, P591
   COLMAN R, 1991, GLUTAMATE DEHYDROGEN
   DEROSA G, 1979, BIOCHIM BIOPHYS ACTA, V567, P116, DOI 10.1016/0005-2744(79)90178-5
   Folch A, 2000, J BIOMED MATER RES, V52, P346, DOI 10.1002/1097-4636(200011)52:2<346::AID-JBM14>3.0.CO;2-H
   Galajda P, 2001, APPL PHYS LETT, V78, P249, DOI 10.1063/1.1339258
   Gostkowski ML, 1998, J AM CHEM SOC, V120, P18, DOI 10.1021/ja9727427
   Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5
   HARTWELL LH, 1999, NATURE, V402, P47
   Holden MA, 2004, ANAL CHEM, V76, P1838, DOI 10.1021/ac035234q
   Kaehr B, 2004, P NATL ACAD SCI USA, V101, P16104, DOI 10.1073/pnas.0407204101
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kato M, 2004, ANAL CHEM, V76, P1896, DOI 10.1021/ac035107u
   Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130
   Kawata S, 2003, MATER RES SOC SYMP P, V758, P163
   Kochevar IE, 2000, PHOTOCHEM PHOTOBIOL, V72, P548, DOI 10.1562/0031-8655(2000)072<0548:SOBNOR>2.0.CO;2
   Korzh V, 2002, DIFFERENTIATION, V70, P221, DOI 10.1046/j.1432-0436.2002.700601.x
   Liu H, 2005, TISSUE ENG, V11, P319, DOI 10.1089/ten.2005.11.319
   LOHOF AM, 1992, J NEUROSCI, V12, P1253
   Lucius R, 1999, CELL MOL LIFE SCI, V56, P1008, DOI 10.1007/s000180050490
   Moan J, 2003, ANTICANCER RES, V23, P3591
   Olofsson J, 2003, CURR OPIN BIOTECH, V14, P29, DOI 10.1016/S0958-1669(02)00003-4
   PANTANO P, 1993, ANAL CHEM, V65, P623, DOI 10.1021/ac00053a023
   Paulino TP, 2005, BIOCHEM MOL BIOL EDU, V33, P46, DOI 10.1002/bmb.2005.494033010424
   Pettit DL, 1997, NEURON, V19, P465, DOI 10.1016/S0896-6273(00)80361-X
   PINES J, 1999, NATL CELL BIOL, V1, P73
   Pitts JD, 2002, PHOTOCHEM PHOTOBIOL, V76, P135, DOI 10.1562/0031-8655(2002)076<0135:NPFMET>2.0.CO;2
   RAJAS F, 1993, BIOCHEM J, V295, P447, DOI 10.1042/bj2950447
   Rosoff WJ, 2004, NAT NEUROSCI, V7, P678, DOI 10.1038/nn1259
   Seong GH, 2003, ANAL CHEM, V75, P3161, DOI 10.1021/ac034155b
   SERVIN J, 2003, OPT LETT, V28, P301
   Shen HR, 2000, J PHOTOCH PHOTOBIO A, V133, P115, DOI 10.1016/S1010-6030(00)00228-8
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X
   Spikes JD, 1999, PHOTOCHEM PHOTOBIOL, V70, P130, DOI 10.1111/j.1751-1097.1999.tb07980.x
   Takayama S, 2003, CHEM BIOL, V10, P123, DOI 10.1016/S1074-5521(03)00019-X
   Takayama S, 2001, NATURE, V411, P1016, DOI 10.1038/35082637
   TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123
   Wang ZQ, 1997, J CHROMATOGR B, V695, P59, DOI 10.1016/S0378-4347(97)00101-1
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527
   Zhang XH, 2002, NEURON, V36, P675, DOI 10.1016/S0896-6273(02)01023-1
NR 46
TC 38
Z9 38
U1 2
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
J9 ANAL CHEM
JI Anal. Chem.
PD AUG 15
PY 2005
VL 77
IS 16
BP 5089
EP 5095
DI 10.1021/ac0507892
PG 7
WC Chemistry, Analytical
SC Chemistry
GA 955OT
UT WOS:000231236300002
PM 16097743
DA 2018-10-20
ER

PT J
AU Foster, LJR
   Sanguanchaipaiwong, V
   Gabelish, CL
   Hook, J
   Stenzel, M
AF Foster, LJR
   Sanguanchaipaiwong, V
   Gabelish, CL
   Hook, J
   Stenzel, M
TI A natural-synthetic hybrid copolymer of polyhydroxyoctanoate-diethylene
   glycol: biosynthesis and properties
SO POLYMER
LA English
DT Article; Proceedings Paper
CT IUPAC World Polymer Congress
CY JUL 04-09, 2004
CL Paris, FRANCE
SP IUPAC
DE polyhydroxyalkanoate; diethylene glycol; microporous films
ID END GROUP-STRUCTURE; PSEUDOMONAS-OLEOVORANS; POLY(ETHYLENE GLYCOL);
   MOLECULAR-WEIGHT; POLYESTERS; POLYMERS
AB The bacterium Pseudomonas oleovorans was utilized to produce a novel natural-synthetic hybrid block copolymer. This hybrid biomaterial consists of the natural hydrophobic polymer polyhydroxyoctanoate (PHO) end-capped with hydrophilic synthetic diethylene glycol (DEG). The addition of the synthetic component, in the form of PEG106, to the bioprocessing stage significantly affected polymer yield and properties compared to its non-hybridized counterpart. Compared to PHO polymer, the PHO-DEG hybrid possessed a significantly higher C8 component and reduced molecular mass. In contrast, thermal and crystalline properties were similar in both polymer types. While the molecular weight ratio of the natural and synthetic blocks is approximately 1000: 1, the small hydrophilic component exerted a powerful influence during polymer processing. Under conditions of high humidity, solvent cast films of the PHO-DEG hybrid self-assembled into ordered microporous arrays. Thus, a novel natural-synthetic hybrid comprized of biocompatible components has been produced. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Adv Macromol Design, Bio Polymers Res Grp, Sydney, NSW 2052, Australia.
   Univ New S Wales, Sch Chem Engn & Ind Chem, Ctr Adv Macromol Design, Sydney, NSW 2052, Australia.
   Univ New S Wales, Nucl Magnet Resonance Facil, Sydney, NSW 2052, Australia.
RP Foster, LJR (reprint author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Adv Macromol Design, Bio Polymers Res Grp, Sydney, NSW 2052, Australia.
EM j.foster@unsw.edu.au
RI Hook, James/D-6805-2011; Stenzel, Martina/B-8586-2008
OI Hook, James/0000-0002-1185-7320; Stenzel, Martina/0000-0002-6433-4419
CR ALBERTSSON PA, 1986, PARTITION CELL PARTI, pCH3
   ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   Ashby RD, 2002, APPL MICROBIOL BIOT, V60, P154, DOI 10.1007/s00253-002-1110-9
   Ashby RD, 1997, TETRAHEDRON, V53, P15209, DOI 10.1016/S0040-4020(97)00958-7
   Ashby RD, 1999, BIOTECHNOL BIOENG, V62, P106, DOI 10.1002/(SICI)1097-0290(19990105)62:1<106::AID-BIT12>3.0.CO;2-X
   AZUMA Y, 1992, POLYMER, V33, P4763, DOI 10.1016/0032-3861(92)90690-X
   Brandl H, 1990, Adv Biochem Eng Biotechnol, V41, P77
   Dawes E A, 1973, Adv Microb Physiol, V10, P135, DOI 10.1016/S0065-2911(08)60088-0
   Doi Y., 1990, MICROBIAL POLYESTERS
   Foster LJR, 1996, INT J BIOL MACROMOL, V19, P177, DOI 10.1016/0141-8130(96)01125-7
   FOSTER LJR, 1995, BIOMATERIALS, V16, P341, DOI 10.1016/0142-9612(95)93263-D
   FOSTER LJR, 2000, POLYM RENEWABLE RESO, pCH6
   GROSS RA, 1989, MACROMOLECULES, V22, P1106, DOI 10.1021/ma00193a018
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   HOLMES PA, 1985, PHYS TECHNOL, V16, P32, DOI 10.1088/0305-4624/16/1/305
   HOWELLS ER, 1982, CHEM IND-LONDON, P508
   Inada Y, 1990, J BIOACT COMPAT POL, V5, P343, DOI 10.1177/088391159000500309
   Kai Z, 2003, BIOCH ENG J, V16, P115
   Kim O, 2000, J POLYM RES, V7, P91, DOI 10.1007/s10965-006-0108-x
   Labarre D, 2001, TRENDS BIOMATER ARTI, V15, P1
   Lee MY, 2000, POLYMER, V41, P1703, DOI 10.1016/S0032-3861(99)00347-X
   Lemogne M., 1925, ANN I PASTEUR PARIS, V39, P144
   Nishikawa T, 1999, MAT SCI ENG C-BIO S, V8-9, P495, DOI 10.1016/S0928-4931(99)00075-2
   Saad B, 1999, INT J BIOL MACROMOL, V25, P293, DOI 10.1016/S0141-8130(99)00044-6
   Shi FY, 1996, MACROMOLECULES, V29, P10, DOI 10.1021/ma950707j
   Shi FY, 1996, MACROMOLECULES, V29, P7753, DOI 10.1021/ma960805k
   STEINBUCHEL A, 1996, BIOTECHNOLOGY, P405
   Stenzel-Rosenbaum MH, 2001, MACROMOLECULES, V34, P5433, DOI 10.1021/ma0021803
   YASIN M, 1993, PLAST RUB COMPOS PRO, V19, P15
NR 29
TC 24
Z9 25
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD AUG 8
PY 2005
VL 46
IS 17
BP 6587
EP 6594
DI 10.1016/j.polymer.2005.05.012
PG 8
WC Polymer Science
SC Polymer Science
GA 953TZ
UT WOS:000231104700034
DA 2018-10-20
ER

PT J
AU Mizutani, Y
   Hattori, M
   Okuyama, M
   Kasuga, T
   Nogami, M
AF Mizutani, Y
   Hattori, M
   Okuyama, M
   Kasuga, T
   Nogami, M
TI Preparation of porous poly(L-lactic acid) composite containing
   hydroxyapatite whiskers
SO CHEMISTRY LETTERS
LA English
DT Article
ID POLYMERS; PHOSPHATE; MEMBRANE; MATRICES; SCAFFOLD; INVITRO
AB A new type of porous biomaterial for bone repair was successfully prepared using poly(L-lactic acid) short fibers of approximate to 700 mu m and hydroxyapatite whiskers (W-HAs) of 60 mu m (in average length). When W-HAs of <= 70 wt% were introduced, the composites could have about 80% porosity including numerous, interconnecting pores of > 10 mu m in diameter. W-HAs play an important role in formation of the pores, which allow penetration of nutriments and ingrowth of bone cells.
C1 NGK Spark Plug Co Ltd, R&D Ctr, Komaki 4858510, Japan.
   Nagoya Inst Technol, Showa Ku, Nagoya, Aichi 4668555, Japan.
RP Mizutani, Y (reprint author), NGK Spark Plug Co Ltd, R&D Ctr, 2808 Iwasaki, Komaki 4858510, Japan.
CR ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082
   Bhattarai SR, 2004, BIOMATERIALS, V25, P2595, DOI 10.1016/j.biomaterials.2003.09.043
   Ciapetti G, 2003, BIOMATERIALS, V24, P3815, DOI 10.1016/S0142-9612(03)00263-1
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   GREGOIRE M, 1990, J BIOMED MATER RES, V24, P165, DOI 10.1002/jbm.820240204
   Kikuchi M, 2004, BIOMATERIALS, V25, P5979, DOI 10.1016/j.biomaterials.2004.02.001
   Kose GT, 2003, BIOMATERIALS, V24, P1949, DOI 10.1016/S0142-9612(02)00613-0
   Ma PX, 2001, J BIOMED MATER RES, V54, P284, DOI 10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W
   Maeda H, 2004, MATER TRANS, V45, P989, DOI 10.2320/matertrans.45.989
   Maeda H, 2002, J MATER RES, V17, P727, DOI 10.1557/JMR.2002.0104
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   Mizutani Y, 2005, POLYMER, V46, P3789, DOI 10.1016/j.polymer.2005.03.037
   MIZUTANI Y, 2004, PHOSPHORUS RES B, V17, P180
   MIZUTANI Y, 2003, P 3 AS BIOC, V3, P1
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   TAMAI N, 2004, JOINT SURG, V23, P100
   van Tienen TG, 2002, BIOMATERIALS, V23, P1731, DOI 10.1016/S0142-9612(01)00280-0
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
NR 19
TC 2
Z9 2
U1 1
U2 4
PU CHEMICAL SOC JAPAN
PI TOKYO
PA 1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN
SN 0366-7022
EI 1348-0715
J9 CHEM LETT
JI Chem. Lett.
PD AUG 5
PY 2005
VL 34
IS 8
BP 1110
EP 1111
DI 10.1246/cl.2005.1110
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA 956LT
UT WOS:000231302000020
DA 2018-10-20
ER

PT J
AU Wollensak, G
   Iomdina, E
   Dittert, DD
   Salamatina, O
   Stoltenburg, G
AF Wollensak, G
   Iomdina, E
   Dittert, DD
   Salamatina, O
   Stoltenburg, G
TI Cross-linking of scleral collagen in the rabbit using riboflavin and UVA
SO ACTA OPHTHALMOLOGICA SCANDINAVICA
LA English
DT Article
DE progressive myopia; sclera; UVA; riboflavin; collagen cross-linking;
   Young's modulus
ID FORM-DEPRIVATION MYOPIA; PROGRESSIVE MYOPIA; DAMAGE
AB Purpose: Scleral biomechanical weakness and thinning is known to be one of the main factors in the pathogenesis of progressive myopia. We tried to strengthen rabbit sclera by cross-linking scleral collagen using ultraviolet A (UVA) and the photosensitizer riboflavin.
   Methods: Circumscribed 10 x 10 mm sectors of the posterior - equatorial sclera of six chinchilla rabbit eyes were treated in vivo using a UVA double diode with 4.2 mW/cm(2) UVA at 370 nm and applying 0.1% riboflavin-5-phosphate drops as photosensitizer for 30 min. 1 day postoperatively biomechanical stress-strain measurements of three treated scleral strips were performed using a microcomputer-controlled biomaterial testing device and compared to non-treated contralateral control sclera. In addition, three treated eyes were examined histologically by light microscopy, TUNEL staining and electron microscopy to evaluate side-effects.
   Results: Following the cross-linking treatment, the ultimate stress was 11.87 +/- 1.8 MPa versus 3.63 +/- 0.40 in the controls (increase of 227.9%, p = 0.014), Young's modulus 27.67 +/- 4.16 MPa versus 4.9 +/- 2.15 MPa in the controls (increase of 464.7%, p=0.021) and ultimate strain 92.2 +/- 7.43% versus 165.63 +/- 19.09% in the controls (decrease of 54.52%, p=0.012). Histologically, serious side-effects were found in the entire posterior globe with almost complete loss of the photoreceptors, the outer nuclear layer and the retinal pigment epithelium (RPE).
   Conclusions: Our new method of scleral collagen cross-linking proved very effective in increasing the scleral mechanical strength; the new treatment may represent an option for strengthening scleral tissue in progressive myopia. However, serious side-effects were observed in the outer retina. In future studies these side-effects could be avoided by reducing the irradiation dose below the cytotoxic level of the retina. Before its clinical application, the new method should be tested in a myopia animal model.
C1 Moscow Helmholtz Res Inst Eye Dis, Moscow, Russia.
   Univ Clin Carl Gustav Carus, Inst Pathol, Dresden, Germany.
   Russian Acad Sci, NN Semenov Chem Phys Inst, Moscow, Russia.
   Charite Berlin, Inst Neuropathol, Berlin, Germany.
RP Wollensak, G (reprint author), Wildentensteig 4, DE-14195 Berlin, Germany.
EM gwollens@hotmail.com
CR Ambati J, 2000, INVEST OPHTH VIS SCI, V41, P1181
   Avetisov ES, 1997, ACTA OPHTHALMOL SCAN, V75, P618
   AWETISSOW ES, 1980, KLIN MONATSBL AUGENH, V176, P777, DOI 10.1055/s-2008-1057552
   BAILEY AJ, 1987, EYE-T OPHTH SOC UK, V1, P175, DOI 10.1038/eye.1987.34
   Bell G R, 1993, J Am Optom Assoc, V64, P332
   BELL GR, 1978, J AM OPTOM ASSOC, V49, P1399
   Bullimore MA, 2002, INVEST OPHTH VIS SCI, V43, P2110
   CURTIN BJ, 1979, ARCH OPHTHALMOL-CHIC, V97, P912, DOI 10.1001/archopht.1979.01020010470017
   FUNATA M, 1990, GRAEF ARCH CLIN EXP, V228, P174, DOI 10.1007/BF02764314
   Gorgels GMF, 1995, INVEST OPHTH VIS SCI, V36, P851
   Iomdina E.N., 1993, P 14 C BIOM PAR INT, P616
   KATO Y, 1994, PHOTOCHEM PHOTOBIOL, V59, P343, DOI 10.1111/j.1751-1097.1994.tb05045.x
   Liu K.R., 1986, J FORMOS MED ASSOC, V85, P1032
   MCBRIEN NA, 1994, EXP EYE RES, V59, P475, DOI 10.1006/exer.1994.1133
   McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0
   MECHANIC G, 1972, BIOCHEM BIOPH RES CO, V47, P267, DOI 10.1016/S0006-291X(72)80038-X
   NOELL WK, 1980, VISION RES, V20, P1163, DOI 10.1016/0042-6989(80)90055-3
   Pierro L, 1999, RETINA-J RET VIT DIS, V19, P401, DOI 10.1097/00006982-199909000-00005
   Saw SM, 2002, OPHTHALMOLOGY, V109, P415, DOI 10.1016/S0161-6420(01)00972-1
   Troilo D, 2000, INVEST OPHTH VIS SCI, V41, P2043
   Weiss AH, 2003, BRIT J OPHTHALMOL, V87, P1025, DOI 10.1136/bjo.87.8.1025
   Wollensak G, 2004, J CATARACT REFR SURG, V30, P689, DOI 10.1016/j.jcrs.2003.11.032
   Wollensak G, 2004, CORNEA, V23, P43, DOI 10.1097/00003226-200401000-00008
   Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1
   ZUCLICH JA, 1989, HEALTH PHYS, V56, P671, DOI 10.1097/00004032-198905000-00012
NR 25
TC 62
Z9 72
U1 1
U2 7
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1395-3907
J9 ACTA OPHTHALMOL SCAN
JI Acta Ophthalmol. Scand.
PD AUG
PY 2005
VL 83
IS 4
BP 477
EP 482
DI 10.1111/j.1600-0420.2005.00447.x
PG 6
WC Ophthalmology
SC Ophthalmology
GA 953FY
UT WOS:000231063200014
PM 16029274
OA Bronze
DA 2018-10-20
ER

PT J
AU Jin, HJ
   Park, J
   Karageorgiou, V
   Kim, UJ
   Valluzzi, R
   Kaplan, DL
AF Jin, HJ
   Park, J
   Karageorgiou, V
   Kim, UJ
   Valluzzi, R
   Kaplan, DL
TI Water-stable silk films with reduced beta-sheet content
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID BOMBYX-MORI SILK; MARROW STROMAL CELL; POLY(ETHYLENE OXIDE); FIBROIN
   MEMBRANE; SOLID-STATE; IN-VITRO; BIOMATERIALS; SPECTROSCOPY; FIBERS; NMR
AB Silk fibers have outstanding mechanical properties. These fibers are insoluble in organic solvents and water, are biocompatible, and exhibit slow biodegradation in vitro and in vivo due to the hydrophobic nature of the protein and the presence of a high content of beta-sheet structure. Regenerated silk fibroin can be processed into a variety of materials normally stabilized by the induction of beta-sheet formation through the use of solvents or by physical stretching. To extend the biomaterial utility of silk proteins, options to form water-stable silk-based materials with reduced beta-sheet formation would be desirable. To address this need for more rapidly degradable silk biomaterials, we report the preparation of water-stable films from regenerated silk fibroin solutions, with reduced beta-sheet content. The keys to this process are the preparation of concentrated (8 % by weight) aqueous solutions of fibroin and a subsequent water-based annealing procedure. These new materials degrade more rapidly due to the reduced P-sheet content, as determined in vitro via enzymatic hydrolysis, yet support human adult stem-cell expansion in vitro in a similar or improved fashion to the crystallized proteins in film form. These new silk-based materials extend the range of biomaterial properties that can be generated from this unique family of proteins.
C1 Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   Tufts Univ, Dept Phys & Astron, Medford, MA 02155 USA.
   Inha Univ, Dept Polymner Sci & Engn, Inchon 402751, South Korea.
RP Jin, HJ (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
OI Karageorgiou, Vassilis/0000-0002-0892-510X
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   ASAKURA T, 1992, J POLYM SCI POL PHYS, V30, P693, DOI 10.1002/polb.1992.090300706
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Chou L, 1999, BIOMATERIALS, V20, P977, DOI 10.1016/S0142-9612(98)00254-3
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   Forlani G, 2000, INT BIODETER BIODEGR, V46, P271, DOI 10.1016/S0964-8305(00)00099-8
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Knight DP, 2002, PHILOS T R SOC B, V357, P155, DOI 10.1098/rstb.2001.1030
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   MAGOSHI J, 1979, J POLYM SCI POL PHYS, V17, P515, DOI 10.1002/pol.1979.180170315
   MERCER EH, 1954, TEXT RES J, V24, P135, DOI 10.1177/004051755402400208
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Monti P, 1998, J RAMAN SPECTROSC, V29, P297, DOI 10.1002/(SICI)1097-4555(199804)29:4<297::AID-JRS240>3.0.CO;2-G
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Park A, 1996, J BIOMED MATER RES, V31, P117
   Pins GD, 1997, J APPL POLYM SCI, V63, P1429, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1429::AID-APP5>3.3.CO;2-O
   Pulapura S, 1992, J Biomater Appl, V6, P216, DOI 10.1177/088532829200600303
   Putthanarat S, 2002, POLYMER, V43, P3405, DOI 10.1016/S0032-3861(02)00161-1
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Shen Y, 1998, MACROMOLECULES, V31, P8857, DOI 10.1021/ma980281j
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   TSUKADA M, 1986, J POLYM SCI POL PHYS, V24, P457, DOI 10.1002/polb.1986.090240219
   Yang Y, 2003, J DENT RES, V82, P449, DOI 10.1177/154405910308200609
   Yao JM, 2002, MACROMOLECULES, V35, P6, DOI 10.1021/ma011335j
NR 33
TC 324
Z9 330
U1 3
U2 177
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD AUG
PY 2005
VL 15
IS 8
BP 1241
EP 1247
DI 10.1002/adfm.200400405
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 956SG
UT WOS:000231319500002
DA 2018-10-20
ER

PT J
AU Marx, KA
   Zhou, T
   Montrone, A
   McIntosh, D
   Braunhut, SJ
AF Marx, KA
   Zhou, T
   Montrone, A
   McIntosh, D
   Braunhut, SJ
TI Quartz crystal microbalance biosensor study of endothelial cells and
   their extracellular matrix following cell removal: Evidence for
   transient cellular stress and viscoelastic changes during detachment and
   the elastic behavior of the pure matrix
SO ANALYTICAL BIOCHEMISTRY
LA English
DT Article
DE quartz crystal microbalance; endothelial cells; MCF-7 cells;
   extracellular matrix; viscoelastic behavior; elastic behavior; actin;
   stress; fluorescence microscopy
ID LIVING CELLS; CANCER CELLS; DECYL ESTER; ADHESION; ATTACHMENT; GROWTH;
   SENSOR; RESONATORS; INTERFACE; SCAFFOLD
AB A quartz crystal microbalance (QCM) cell biosensor utilizing living endothelial cells (ECs) or human breast cancer cells (MCF-7) adhering to the gold QCM surface was used to study the relative contributions of the cells and their underlying extracellular matrix (ECM) to the measured QCM Delta f and Delta R shifts. The ECM represents a natural biomaterial that is synthesized by the cells to enable their attachment to surfaces. We followed the detachment of the ECs or MCF-7 cells from their ECM using a nonproteolytic method and were able to apportion the total frequency, Delta f, decrease of the biosensor into contributions from cell attachment and from the intact underlying ECM. We also demonstrated that the Delta f shift remaining after EC removal corresponds to ECM as determined by light microscopic visualization of the stained protein. During the process of cell detachment, we observed a novel transient increase in viscoelastic behavior expressed as a transient increase in the motional resistance, Delta R, parameter. Then we showed via a simulation experiment using ECs stained with fluorescent rhodamine-labeled phalloidin, an actin stain, that the transient viscoelastic increase correlated with cellular stress exhibited by the cells during removal with ethylene glycol bis(2-aminoethyl ether)-N,N,N',N'-tetraacetic acid. Prior to cells lifting from their ECM, the attached ECs rearrange their actin microfilaments first into peripheral stress fibers and second into internal aggregates, to maintain cell-cell connectivity, retain their spread morphology, and attempt to adhere more tightly to their underlying ECM. The decrease in Delta R following its transient rise corresponds to cells finally losing their attachment focal points and lifting from the ECM. We also characterized the normalized f shifts, -Delta(Delta f)(ECM)/attached cell and -Delta(Delta f)(cells)/attached cell, as a function of varying the number of adherent cells. Finally, we demonstrate that the underlying native ECM biomaterial, from which all cells have been removed, does not exhibit any significant level of energy dissipation, in contrast to the cells when they are attached to the ECM. (c) 2005 Elsevier Inc. All rights reserved.
C1 Univ Massachusetts, Ctr Intelligent Biomat, Lowell, MA 01854 USA.
   Univ Massachusetts, Dept Chem, Lowell, MA 01854 USA.
   Univ Massachusetts, Dept Biol Sci, Lowell, MA 01854 USA.
RP Marx, KA (reprint author), Univ Massachusetts, Ctr Intelligent Biomat, Lowell, MA 01854 USA.
EM Kenneth_Marx@uml.edu
FU NIGMS NIH HHS [R21 GM 58583]
CR AYALON O, 1994, J CELL BIOL, V126, P247, DOI 10.1083/jcb.126.1.247
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   Braunhut SJ, 2005, ASSAY DRUG DEV TECHN, V3, P77, DOI 10.1089/adt.2005.3.77
   Braunhut SJ, 2004, MATER RES SOC SYMP P, V1, P403
   Cavic BA, 1999, ANALYST, V124, P1405, DOI 10.1039/a903236c
   Christopher RA, 1997, J CELL SCI, V110, P569
   ENGERMAN RL, 1967, LAB INVEST, V17, P738
   Fredriksson C, 1998, LANGMUIR, V14, P248, DOI 10.1021/la971005l
   GRYTE DM, 1993, BIOTECHNOL PROGR, V9, P105, DOI 10.1021/bp00019a016
   Li J, 2005, BIOSENS BIOELECTRON, V20, P1333, DOI 10.1016/j.bios.2004.05.004
   Marx KA, 2003, BIOMACROMOLECULES, V4, P1099, DOI 10.1021/bm020116i
   Marx KA, 1999, BIOTECHNOL PROGR, V15, P522, DOI 10.1021/bp990038j
   Marx KA, 2003, BIOTECHNOL PROGR, V19, P987, DOI 10.1021/bp0201096
   Marx KA, 2002, MATER RES SOC SYMP P, V711, P125
   Marx KA, 2002, J ELECTROANAL CHEM, V521, P53, DOI 10.1016/S0022-0728(02)00644-7
   Marx KA, 2001, BIOSENS BIOELECTRON, V16, P773, DOI 10.1016/S0956-5663(01)00219-6
   Muratsugu M, 1997, ANAL CHIM ACTA, V342, P23, DOI 10.1016/S0003-2670(96)00576-4
   PAIGE K, 1991, IN VITRO CELL DEV B, V27, P151
   REDEPENNING J, 1993, ANAL CHEM, V65, P3378, DOI 10.1021/ac00071a008
   Rickert J, 1996, BIOSENS BIOELECTRON, V11, P591, DOI 10.1016/0956-5663(96)83294-5
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   SU HB, 1994, ANAL CHEM, V66, P769, DOI 10.1021/ac00078a002
   Walles T, 2003, BIOMATERIALS, V24, P1233, DOI 10.1016/S0142-9612(02)00490-8
   Ward M, 1995, PHYSICAL ELECTROCHEM, P293
   Wegener J, 2000, BIOPHYS J, V78, P2821, DOI 10.1016/S0006-3495(00)76825-1
   Wegener J, 1998, EUR BIOPHYS J BIOPHY, V28, P26, DOI 10.1007/s002490050180
   WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101
   ZAHIR N, 2002, CURR OPIN GENE DEV, V14, P71
   Zhou T, 2000, BIOTECHNOL PROGR, V16, P268, DOI 10.1021/bp000003f
   ZHOU T, 1999, DRUG DELIVERY IMPLAN, V550, P177
NR 31
TC 50
Z9 52
U1 0
U2 16
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0003-2697
J9 ANAL BIOCHEM
JI Anal. Biochem.
PD AUG 1
PY 2005
VL 343
IS 1
BP 23
EP 34
DI 10.1016/j.ab.2005.05.013
PG 12
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 950LM
UT WOS:000230858600002
PM 15979557
DA 2018-10-20
ER

PT J
AU Rydholm, AE
   Bowman, CN
   Anseth, KS
AF Rydholm, AE
   Bowman, CN
   Anseth, KS
TI Degradable thiol-acrylate photopolymers: polymerization and degradation
   behavior of an in situ forming biomaterial
SO BIOMATERIALS
LA English
DT Article
DE thiol-acrylate polymerization; in situ cross-linking;
   photopolymerization; hydrolytic degradation; poly(ethylene glycol)
ID B-PLA HYDROGEL; TISSUE ENGINEERING APPLICATIONS; GLYCOL) FUMARATE)
   HYDROGELS; STATISTICAL KINETIC-MODEL; POLY(ETHYLENE GLYCOL); BULK
   DEGRADATION; CROSS-LINKING; NETWORKS; ENE; DELIVERY
AB Degradable thiol-acrylate photopolymers are a new class of biomaterials capable of rapidly polymerizing under physiological conditions upon exposure to UV light, with or without added photoinitiators, and to depths exceeding 10 cm. These materials are formed in situ, and the versatility of their chemistry affords a high degree of control over the final material properties. For example, variations in monomer mole fractions directly affect the final network molecular structure, varying the time required to achieve complete mass loss from 25 to 100 days, the molecular weight distributions of the degradation products, and the swelling ratios and compressive moduli throughout degradation. Additionally, varying the mole fraction of multifunctional thiol monomer in the initial reaction mixture controls the concentration of reactive sites in the network available for post-polymerization modification of the polymer. (c) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Colorado, Dept Chem & Biol Engn, Ctr Engn, Boulder, CO 80309 USA.
   Univ Colorado, Hlth Sci Ctr, Dept Restorat Dent, Denver, CO 80045 USA.
   Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
RP Anseth, KS (reprint author), Univ Colorado, Dept Chem & Biol Engn, Ctr Engn, Room ECCH 111,Campus Box 424, Boulder, CO 80309 USA.
EM kristi.anseth@colorado.edu
RI Bowman, Christopher/B-1490-2008
OI Bowman, Christopher/0000-0001-8458-7723
FU NIDCR NIH HHS [R01 DE12998]
CR Anseth KS, 2001, MACROMOL RAPID COMM, V22, P564, DOI 10.1002/1521-3927(20010501)22:8<564::AID-MARC564>3.0.CO;2-S
   Behravesh E, 2002, BIOMACROMOLECULES, V3, P374, DOI 10.1021/bm010158r
   Berchtold KA, 2004, MACROMOLECULES, V37, P3165, DOI 10.1021/ma035862
   BERCHTOLD KA, 1999, RADT EUR 99 C P BERL, P767
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Burkoth AK, 2000, BIOMATERIALS, V21, P2395, DOI 10.1016/S0142-9612(00)00107-1
   CAO YL, 1999, TISSUE ENG METHODS P
   Chen TH, 2003, BIOMATERIALS, V24, P2831, DOI 10.1016/S0142-9612(03)00096-6
   Cramer NB, 2003, MACROMOLECULES, V36, P7964, DOI 10.1021/ma034667s
   Cramer NB, 2002, MACROMOLECULES, V35, P5361, DOI 10.1021/ma0200672
   Cramer NB, 2001, J POLYM SCI POL CHEM, V39, P3311, DOI 10.1002/pola.1314
   CRAMER NB, 2004, IN PRESS J POLYM S A
   Davis KA, 2003, BIOMATERIALS, V24, P2485, DOI 10.1016/S0142-9612(02)00582-3
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Elbert DL, 2001, J CONTROL RELEASE, V76, P11, DOI 10.1016/S0168-3659(01)00398-4
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   HELLER J, 1985, J CONTROL RELEASE, V1, P233
   HOYLE CE, 1984, J POLYM SCI POL CHEM, V22, P1865, DOI 10.1002/pol.1984.170220808
   HOYLE CE, 2001, RADTECH JAP 2000 TEC, P211
   Jacobine A. F., 1993, RAD CURING POLYM SCI, V3, P219
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   KURISAWA M, 1995, MACROMOL RAPID COMM, V16, P663, DOI 10.1002/marc.1995.030160905
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Martens PJ, 2003, BIOMACROMOLECULES, V4, P283, DOI 10.1021/bm025666v
   Mason MN, 2001, MACROMOLECULES, V34, P4630, DOI 10.1021/ma010025y
   Metters AT, 2000, J PHYS CHEM B, V104, P7043, DOI 10.1021/jp000523t
   Metters AT, 2000, POLYMER, V41, P3993, DOI 10.1016/S0032-3861(99)00629-1
   Metters AT, 2001, J PHYS CHEM B, V105, P8069, DOI 10.1021/jp004083h
   METTERS AT, 2000, THESIS BOULDER CO U
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Porter BD, 2000, J BIOMECH ENG-T ASME, V122, P286, DOI 10.1115/1.429659
   Posner T, 1905, BER DTSCH CHEM GES, V38, P646, DOI 10.1002/cber.190503801106
   Quick DJ, 2003, PHARM RES, V20, P1730, DOI 10.1023/B:PHAM.0000003368.66471.6a
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Shung AK, 2003, TISSUE ENG, V9, P243, DOI 10.1089/107632703764664710
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Temenoff JS, 2004, BIOMACROMOLECULES, V5, P5, DOI 10.1021/bm030067p
   Temenoff JS, 2002, J BIOMED MATER RES, V59, P429, DOI 10.1002/jbm.1259
   VANDIJKWOLTHUIS WNE, 1995, MACROMOLECULES, V28, P6317, DOI 10.1021/ma00122a044
   Vernon B, 2003, J BIOMED MATER RES A, V64A, P447, DOI 10.1002/jbm.a.10369
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Woods J. G., 1992, RAD CURABLE ADHESIVE, P333
NR 48
TC 168
Z9 171
U1 7
U2 103
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2005
VL 26
IS 22
BP 4495
EP 4506
DI 10.1016/j.biomaterials.2004.11.046
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 907UK
UT WOS:000227743300001
PM 15722118
DA 2018-10-20
ER

PT J
AU Lan, MA
   Gersbach, CA
   Michael, KE
   Keselowsky, BG
   Garcia, AJ
AF Lan, MA
   Gersbach, CA
   Michael, KE
   Keselowsky, BG
   Garcia, AJ
TI Myoblast proliferation and differentiation on fibronectin-coated self
   assembled monolayers presenting different surface chemistries
SO BIOMATERIALS
LA English
DT Article
DE cell adhesion; integrin; self-assembled monolayers; fibronectin;
   differentiation; myoblast
ID FOCAL ADHESION KINASE; CELL-ADHESION; PROTEIN ADSORPTION; INTEGRIN
   BINDING; IN-VITRO; TYROSINE PHOSPHORYLATION; SKELETAL MYOBLASTS;
   ACTIVATION; MYOGENESIS; GROWTH
AB Biomaterial surface properties modulate protein adsorption and cell adhesion to elicit diverse cellular responses in biomedical and biotechnological applications. We used alkanethiol self-assembled monolayers presenting well-defined chemistries (OH, CH3, NH2, and COOH) to analyze the effects of surface chemistry on myoblast proliferation and differentiation. Surfaces were pre-coated with equivalent densities of fibronectin. C2C12 skeletal myoblasts exhibited surface-dependent differences in cell proliferation (COOH = NH2 > CH3 = OH). Myogenin and troponin T gene expression levels were up-regulated on CH3 and OH surfaces compared to other chemistries. Furthermore, immunostaining for sarcomeric myosin revealed surface chemistry-dependent differences in myogenic differentiation following the pattern OH > CH3 > NH2 = COOH. Immunostaining analyses of integrin subunits demonstrated surface chemistry-dependent differences in integrin binding to adsorbed fibronectin. OH and CH3 surfaces supported selective binding Of alpha(5)beta(1) integrin while the COOH and NH2, functionalities displayed binding of both alpha(5)beta(1), and alpha(v)beta(3). Myogenic differentiation correlated with differences in integrin binding; surface chemistries that supported selective binding Of alpha(5)beta(1) displayed enhanced differentiation. Finally, blocking beta(1), but not beta(3), integrins inhibited differentiation, implicating specific integrins in the differentiation process. These results demonstrate that Surface chemistry modulates myoblast proliferation and differentiation via differences in integrin binding to adsorbed fibronectin. (c) 2004 Elsevier Ltd. All rights reserved.
C1 Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, GTEC Undergrad Res Scholars Program, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Emory Dept Biomed Engn, Georgia Tech, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Petit Inst Bioengn & Biosci, 315 Ferst Dr,Room 2314, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
RI Keselowsky, Benjamin/A-8000-2009
FU NIGMS NIH HHS [T32 GM008433]; NIBIB NIH HHS [R01-EB003364]
CR Allen LT, 2003, P NATL ACAD SCI USA, V100, P6331, DOI 10.1073/pnas.1031426100
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Byers BA, 2002, J BONE MINER RES, V17, P1931, DOI 10.1359/jbmr.2002.17.11.1931
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Garcia AJ, 2002, CRIT REV EUKAR GENE, V12, P151, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.50
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Gersbach CA, 2004, BIOTECHNOL BIOENG, V88, P369, DOI 10.1002/bit.20251
   Goel HL, 2002, J CELL PHYSIOL, V193, P187, DOI 10.1002/jcp.10161
   Goel HL, 2002, DIFFERENTIATION, V70, P257, DOI 10.1046/j.1432-0436.2002.700604.x
   Goel HL, 2002, CELL PROLIFERAT, V35, P131, DOI 10.1046/j.1365-2184.2002.00232.x
   Gorbet MB, 2001, J LAB CLIN MED, V137, P345, DOI 10.1067/mlc.2001.114677
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Keselowsky BG, 2005, BIOMATERIALS, V26, P413, DOI 10.1016/j.biomaterials.2004.02.050
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Pompe T, 2003, J BIOMED MATER RES A, V67A, P647, DOI 10.1002/jbm.a.10130
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x
   Sastry SK, 1996, J CELL BIOL, V133, P169, DOI 10.1083/jcb.133.1.169
   SCHOEN RC, 1982, HYBRIDOMA, V1, P99, DOI 10.1089/hyb.1.1982.1.99
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   Vreeland WN, 2002, CURR OPIN BIOTECH, V13, P87, DOI 10.1016/S0958-1669(02)00292-6
   Yao CC, 1996, J CELL SCI, V109, P3139
NR 35
TC 143
Z9 148
U1 3
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2005
VL 26
IS 22
BP 4523
EP 4531
DI 10.1016/j.biomaterials.2004.11.028
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 907UK
UT WOS:000227743300004
PM 15722121
DA 2018-10-20
ER

PT J
AU Strehl, R
   Tallheden, T
   Sjogren-Jansson, E
   Minuth, WW
   Lindahl, A
AF Strehl, R
   Tallheden, T
   Sjogren-Jansson, E
   Minuth, WW
   Lindahl, A
TI Long-term maintenance of human articular cartilage in culture for
   biomaterial testing
SO BIOMATERIALS
LA English
DT Article
DE biocompatability; bioreactor; in vitro test; cell culture; human
   articular cartilage; tissue culture; perfusion; differentiation
ID AUTOLOGOUS CHONDROCYTE TRANSPLANTATION; INTERMITTENT
   HYDROSTATIC-PRESSURE; IN-VITRO; MATRIX METALLOPROTEINASES;
   EXTRACELLULAR-MATRIX; ARTIFICIAL TISSUES; KNEE; OSTEOARTHRITIS;
   PROTEOGLYCAN; DEFECTS
AB Cartilage is a tissue that derives its unique mechanical and biological properties from the combination of relatively few cells and a large amount of a complex extracellular matrix. Furthermore, cartilage tissue is comparatively slow to respond to changes or harmful influences. To date, the optimal generation and long-term maintenance of cultured human articular cartilage for in vitro testing of biomaterials, poses an experimental difficulty. Experiments using cultured isolated chondrocytes in combination with scaffolds often fail to yield results comparable to the in-vivo situation. Consequently, our aim was to develop a culture method that allows in vitro maintenance of human hyaline cartilage explants in an optimal quality over an extended period of time. Such a culture could, for example, be used to determine the long-term effect of a new scaffold on intact cartilage, as an in vitro model for repair processes and to investigate biomaterial integration.
   In this study we compared conventional static cultures with and without serum supplementation to a serum-free perfusion culture for the ability to maintain human articular cartilage explants in a morphologically intact and differentiated state over an extended period of time of up to 56 days. Results were evaluated and compared by morphological, histochemical and immunohistochemical methods.
   The experiments showed that short-term maintenance of cartilage in a differentiated state for up to 14 days is possible under all culture conditions tested. However, best long-term culture results for up to 56 days were obtained with perfusion culture under serum-free conditions. Such a perfusion culture system can be used to perform biocompatabilty tests in vitro by long-term coculture of biomaterial and intact human articular cartilage. (c) 2004 Elsevier Ltd. All rights reserved.
C1 Sahlgrens Univ Hosp, Inst Lab Med, Dept Clin Chem & Transfus Med, RCEM1, SE-41345 Gothenburg, Sweden.
   Univ Regensburg, Dept Mol & Cellular Anat, D-93053 Regensburg, Germany.
RP Sjogren-Jansson, E (reprint author), Sahlgrens Univ Hosp, Inst Lab Med, Dept Clin Chem & Transfus Med, RCEM1, Bruna Straket 16, SE-41345 Gothenburg, Sweden.
EM raimund.strehl@cellartis.com; esj@medic.gu.se
RI Lindahl, Anders/H-9550-2014
OI Lindahl, Anders/0000-0003-2871-5166
CR Blevins FT, 1998, ORTHOPEDICS, V21, P761
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P109, DOI 10.2106/00004623-200300003-00017
   BRITTBERG M, 1996, CLIN ORTHOP RELAT R, V326, P270
   BUCHWALTER JA, 1990, ARTICULAR CARTILAGE, P19
   Chambers MG, 2001, ARTHRITIS RHEUM, V44, P1455, DOI 10.1002/1529-0131(200106)44:6<1455::AID-ART241>3.0.CO;2-J
   DAVIDSON MK, 1987, ISRAEL J MED SCI, V23, P551
   DAVIS MA, 1989, AM J EPIDEMIOL, V130, P278, DOI 10.1093/oxfordjournals.aje.a115334
   Dieppe P, 2000, KNEE, V7, P135, DOI 10.1016/S0968-0160(00)00043-0
   Domm C, 2000, ORTHOPADE, V29, P91
   Fuentes MA, 2002, ARCH ORAL BIOL, V47, P643, DOI 10.1016/S0003-9969(02)00052-3
   Grigolo B, 2002, BIOMATERIALS, V23, P1187, DOI 10.1016/S0142-9612(01)00236-8
   Grigolo B, 2002, Reumatismo, V54, P364
   Hangody L, 2001, FOOT ANKLE INT, V22, P552, DOI 10.1177/107110070102200704
   Hansen U, 2001, J BIOMECH, V34, P941, DOI 10.1016/S0021-9290(01)00050-1
   HOMMINGA GN, 1990, J BONE JOINT SURG BR, V72, P1003
   Hunter CJ, 2004, TISSUE ENG, V10, P736, DOI 10.1089/1076327041348310
   HUNTER W, 1743, PHILOS T R SOC LOND, V42, P514, DOI DOI 10.1098/RSTL.1742.0079)
   Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721, DOI 10.2106/00004623-199605000-00012
   INSALL J, 1974, CLIN ORTHOP RELAT R, P61
   Ishiguro N, 2001, ARTHRITIS RHEUM, V44, P2503, DOI 10.1002/1529-0131(200111)44:11<2503::AID-ART430>3.0.CO;2-P
   Kaps C, 2002, MED BIOL ENG COMPUT, V40, P485, DOI 10.1007/BF02345083
   Marcacci M, 2002, KNEE SURG SPORT TR A, V10, P154, DOI 10.1007/s00167-001-0275-6
   Martensson O., 2002, Advances in Food Sciences, V24, P4
   Mattioli-Belmonte M, 2003, INT J ARTIF ORGANS, V26, P1077
   Minuth WW, 1998, CELL TISSUE RES, V291, P1
   MINUTH WW, 1992, EUR J CELL BIOL, V57, P132
   Mort JS, 2001, ARTHRITIS RES, V3, P337, DOI 10.1186/ar325
   Moskowitz Roland W, 2004, Am J Orthop (Belle Mead NJ), V33, P5
   Obradovic B, 2001, J ORTHOPAED RES, V19, P1089, DOI 10.1016/S0736-0266(01)00030-4
   Perka C, 2000, CLIN EXP RHEUMATOL, V18, P13
   Peterson L, 2000, Clin Orthop Relat Res, P212, DOI 10.1097/00003086-200005000-00020
   Risbud M, 2001, CELL TRANSPLANT, V10, P755, DOI 10.3727/000000001783986224
   Sittinger M, 1997, INT J ARTIF ORGANS, V20, P57
   Strehl R, 2002, TISSUE ENG, V8, P37, DOI 10.1089/107632702753503036
   Suh JK, 1996, BIORHEOLOGY, V33, P289, DOI 10.1016/0006-355X(96)00023-6
   TALLHEDEN T, UNPUB CELL TRANSPLAN
   Torzilli PA, 1998, OSTEOARTHR CARTILAGE, V6, P260, DOI 10.1053/joca.1998.0119
   URBAN JPG, 1989, BIOCHIM BIOPHYS ACTA, V992, P59, DOI 10.1016/0304-4165(89)90050-0
   van der Kraan PM, 2002, OSTEOARTHR CARTILAGE, V10, P631, DOI 10.1053/joca.2002.0806
   Wang J, 2003, OSTEOARTHR CARTILAGE, V11, P801, DOI 10.1016/S1063-4584(03)00168-7
   Wang XH, 2004, BIOMATERIALS, V25, P3681, DOI 10.1016/j.biomaterials.2003.10.102
NR 42
TC 24
Z9 25
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2005
VL 26
IS 22
BP 4540
EP 4549
DI 10.1016/j.biomaterials.2004.11.037
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 907UK
UT WOS:000227743300006
PM 15722123
DA 2018-10-20
ER

PT J
AU Boura, C
   Muller, S
   Vautier, D
   Dumas, D
   Schaaf, P
   Voegel, JC
   Stoltz, JF
   Menu, P
AF Boura, C
   Muller, S
   Vautier, D
   Dumas, D
   Schaaf, P
   Voegel, JC
   Stoltz, JF
   Menu, P
TI Endothelial cell - interactions with polyelectrolyte multilayer films
SO BIOMATERIALS
LA English
DT Article
DE polyelectrolyte multilayers; endothelial cells; cell adhesion; beta 1
   integrins; focal adhesion kinase
ID FOCAL ADHESIONS; SHEAR-STRESS; CHONDROSARCOMA CELLS; PROTEIN
   INTERACTIONS; BYPASS GRAFTS; SURFACE; COATINGS; FLOW; CYTOSKELETAL;
   FIBRONECTIN
AB The seeding of endothelial cells (ECs) on biomaterial surfaces became a major challenge, allowing to improve the non-thrombogenic properties of these surfaces. Recently, the use of polyelectrolyte films has been suggested as a new versatile technique of surface modification aimed at tissue engineering. In this study, we evaluate the adhesion properties of ECs on two types of polyelectrolyte films ending either by poly(D-lysine) (PDL), or poly(allylamine hydrochloride) (PAH), and compared them to data obtained on PDL or PAH monolayers, glass and fibronectin (Fn)-coated glass. ECs seeded on polyelectrolyte films showed a good morphology, allowing ECs to resist physiological shear stress better compared to ECs seeded on glass or Fn. The expression of beta 1 integrins was slightly lower on polyelectrolyte films than on control surfaces. However, the phosphorylation of focal adhesion kinase, involved in the transduction of adhesion signal, was not modified on PAH ending films compared to control surfaces; whereas it became lower on PDL ending films. Finally, PAH ending films improve strongly ECs adhesion without disturbing the adhesion mechanism, necessary for the development of a new endothelium. These types of films or similar build-ups could thus be used in the future as a way to modify surfaces for vascular tissue engineering. (c) 2004 Elsevier Ltd. All rights reserved.
C1 CNRS, Lab Mecan & Ingn Cellulaire & Tissulaire, LEMTA, UMR 7563,Fac Sci, F-54505 Vandoeuvre Les Nancy, France.
   INSERM, U595, Fac Chirurg Dent, F-67085 Strasbourg, France.
   ULP, CNRS, Inst Charles Sadron, UPR 22, F-67083 Strasbourg, France.
RP Menu, P (reprint author), CNRS, Lab Mecan & Ingn Cellulaire & Tissulaire, LEMTA, UMR 7563,Fac Sci, F-54505 Vandoeuvre Les Nancy, France.
EM cedric.boura@medecinc.uhp-nancy.fr; menu@pharma.uhp-nancy.fr
RI Dumas, Dominique/A-5633-2012; Boura, Cedric/E-4070-2012; SCHAAF,
   Pierre/J-2751-2016
OI SCHAAF, Pierre/0000-0001-7423-5492
CR ALBELDA SM, 1993, LAB INVEST, V68, P4
   Balcells M, 2002, J CELL PHYSIOL, V191, P155, DOI 10.1002/jcp.10087
   Barbee KA, 1995, BIOCHEM CELL BIOL, V73, P501, DOI 10.1139/o95-055
   Benkirane-Jessel N, 2004, ADV FUNCT MATER, V14, P174, DOI 10.1002/adfm.200304413
   Bos GW, 1998, ARCH PHYSIOL BIOCHEM, V106, P100, DOI 10.1076/apab.106.2.100.4384
   Bouaziz A, 1997, BIOMATERIALS, V18, P107, DOI 10.1016/S0142-9612(96)00114-7
   Boura C, 2003, BIOMATERIALS, V24, P3521, DOI 10.1016/S0142-9612(03)00214-X
   Brown E, 1996, IMMUNOL LETT, V54, P189, DOI 10.1016/S0165-2478(96)02671-5
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Gilmore AP, 1996, STRUCTURE, V4, P647, DOI 10.1016/S0969-2126(96)00069-X
   IVARSSON BL, 1989, J SURG RES, V47, P203, DOI 10.1016/0022-4804(89)90108-X
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   KAEHLER J, 1989, J VASC SURG, V9, P535, DOI 10.1067/mva.1989.vs0090535
   Ladam G, 2000, BIOMACROMOLECULES, V1, P674, DOI 10.1021/bm005572q
   Ladam G, 2001, LANGMUIR, V17, P878, DOI 10.1021/la0013087
   Ladam G, 2000, LANGMUIR, V16, P1249, DOI 10.1021/la990650k
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   Mathur AB, 2003, J BIOMED MATER RES A, V64A, P155, DOI 10.1002/jbm.a.10403
   MCLEAN GW, 2000, J BIOL CHEM, V28, P2333
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   Muller M, 2001, MACROMOL RAPID COMM, V22, P390, DOI 10.1002/1521-3927(20010301)22:6<390::AID-MARC390>3.0.CO;2-B
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Richert L, 2002, BIOMACROMOLECULES, V3, P1170, DOI 10.1021/bm.0255490
   Salacinski HJ, 2001, MED BIOL ENG COMPUT, V39, P609, DOI 10.1007/BF02345431
   Sanborn SL, 2002, BIOMATERIALS, V23, P1, DOI 10.1016/S0142-9612(01)00066-7
   SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192
   SCHNEIDER A, 1992, J VASC SURG, V15, P649, DOI 10.1016/0741-5214(92)90010-6
   Seifalian AM, 2002, ARTIF ORGANS, V26, P307, DOI 10.1046/j.1525-1594.2002.06841.x
   Shiratori SS, 2000, MACROMOLECULES, V33, P4213, DOI 10.1021/ma991645q
   Short SM, 1998, MOL BIOL CELL, V9, P1969, DOI 10.1091/mbc.9.8.1969
   Sirois E, 1998, BIOMATERIALS, V19, P1925, DOI 10.1016/S0142-9612(98)00094-5
   STEELE JG, 1994, J BIOMAT SCI-POLYM E, V6, P511, DOI 10.1163/156856294X00473
   Tryoen-Toth P, 2002, J BIOMED MATER RES, V60, P657, DOI 10.1002/jbm.10110
   Vautier D, 2003, CELL MOTIL CYTOSKEL, V56, P147, DOI 10.1002/cm.10140
   Vautier D, 2002, J BIOMAT SCI-POLYM E, V13, P713, DOI 10.1163/156856202320269175
   Vuori K, 1998, J MEMBRANE BIOL, V165, P191, DOI 10.1007/s002329900433
   Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997
NR 41
TC 77
Z9 78
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2005
VL 26
IS 22
BP 4568
EP 4575
DI 10.1016/j.biomaterials.2004.11.036
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 907UK
UT WOS:000227743300009
PM 15722126
DA 2018-10-20
ER

PT J
AU Simpson, NE
   Khokhlova, N
   Oca-Cossio, JA
   McFarlane, SS
   Simpson, CP
   Constantinidis, I
AF Simpson, NE
   Khokhlova, N
   Oca-Cossio, JA
   McFarlane, SS
   Simpson, CP
   Constantinidis, I
TI Effects of growth regulation on conditionally-transformed
   alginate-entrapped insulin secreting cell lines in vitro
SO BIOMATERIALS
LA English
DT Article
DE alginate; insulinoma cells; bioartificial pancreas; tetracycline;
   doxycycline
ID BIOARTIFICIAL ENDOCRINE PANCREAS; ENCAPSULATED BETA-TC3 CELLS; ISLETS;
   MATRIX
AB The ability to control cell growth is an issue of critical importance for the use of transformed beta-cell lines within a bioartificial pancreas. Such control can be achieved either by entrapping the cells in a biomaterial that can inhibit cell proliferation or by genetically modifying the cells to regulate growth. Integrating tetracycline-off or -on operon systems into murine insulinoma cell lines (beta TC-tet and R7T1, respectively) allows cell growth regulation upon exposure to tetracycline (TC) or its derivative doxycycline (Dox), respectively. However, the effects of this regulatory approach on the long-term phenotypic metabolic and secretory stability of alginate-entrapped cells have yet to be thoroughly investigated. In this study, Cultures of beta TC-tet and RM cells entrapped in alginate beads were allowed to grow freely, or were growth-regulated, either at the onset, or after 20 days of growth. The data show that growth regulation of alginate-entrapped cells is achievable with chronic administration of the regulatory compound in a concentration-dependent manner. However, as these cultures age, the amount of insulin released does not always reflect the metabolic and histological characteristics of the Cultures. This change, coupled with a loss of glucose stimulated insulin secretion in the Dox treated R7T1 cell line, indicate a phenotypic shift of cells with an activated tet-operon. These observations have implications on the selection and long-term function of three-dimensional bioartificial pancreatic constructs that include conditionally transformed beta-cell lines. (c) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Florida, Dept Med, Div Endocrinol, Lab Tissue Engn, Gainesville, FL 32610 USA.
   Georgia Tech, Emory Ctr Engn Living Tissues, Atlanta, GA 30332 USA.
RP Constantinidis, I (reprint author), Univ Florida, Dept Med, Div Endocrinol, Lab Tissue Engn, 1600 SW Archer Rd,POB 100226, Gainesville, FL 32610 USA.
EM consti@medicine.ufl.edu
FU NIDDK NIH HHS [DK47858, DK56980]
CR Benson JP, 1997, CELL TRANSPLANT, V6, P395, DOI 10.1016/S0963-6897(97)00044-4
   CHENG SY, 2004, UNPUB CELL TRANSPLAN
   Coger R, 1997, TISSUE ENG, V3, P375, DOI 10.1089/ten.1997.3.375
   Constantinidis I, 1999, BIOMATERIALS, V20, P2019, DOI 10.1016/S0142-9612(99)00104-0
   de Vos P, 2002, DIABETOLOGIA, V45, P159, DOI 10.1007/s00125-001-0729-x
   EFRAT S, 1993, DIABETES, V42, P901, DOI 10.2337/diabetes.42.6.901
   Fleischer N, 1998, DIABETES, V47, P1419, DOI 10.2337/diabetes.47.9.1419
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Milo-Landesman D, 2001, CELL TRANSPLANT, V10, P645
   NEWGARD CB, 1994, DIABETES, V43, P341, DOI 10.2337/diabetes.43.3.341
   Papas KK, 1999, BIOTECHNOL BIOENG, V66, P219
   Papas KK, 1997, BIOCHEM J, V326, P807, DOI 10.1042/bj3260807
   REACH G, 1993, DIABETIC MED, V10, P105, DOI 10.1111/j.1464-5491.1993.tb00025.x
   Simpson NE, 2004, BIOMATERIALS, V25, P2603, DOI 10.1016/j.biomaterials.2003.09.046
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   SOONSHIONG P, 1993, P NATL ACAD SCI USA, V90, P5843, DOI 10.1073/pnas.90.12.5843
   Stabler C, 2001, BIOMATERIALS, V22, P1301, DOI 10.1016/S0142-9612(00)00282-9
   SUN A, 1980, ARTIF ORGANS, V4, P275
   SUN AM, 1988, METHOD ENZYMOL, V137, P575
   TRIVEDI N, 2001, TRANSPLANTATION, V71, P211
   van Schilfgaarde R, 1999, J MOL MED-JMM, V77, P199, DOI 10.1007/s001090050336
   WEBER CJ, 1999, CELL ENCAPSULATION T, P117
   Zimmer Y, 1999, FEBS LETT, V457, P65, DOI 10.1016/S0014-5793(99)01008-X
NR 23
TC 22
Z9 22
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2005
VL 26
IS 22
BP 4633
EP 4641
DI 10.1016/j.biomaterials.2004.11.054
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 907UK
UT WOS:000227743300016
PM 15722133
DA 2018-10-20
ER

PT J
AU Boomker, JM
   Luttikhuizen, DT
   Veninga, H
   de Leij, LFMH
   The, TH
   de Haan, A
   van Luyn, MJA
   Harmsen, MC
AF Boomker, JM
   Luttikhuizen, DT
   Veninga, H
   de Leij, LFMH
   The, TH
   de Haan, A
   van Luyn, MJA
   Harmsen, MC
TI The modulation of angiogenesis in the foreign body response by the
   poxviral protein M-T7
SO BIOMATERIALS
LA English
DT Article
DE gene therapy; glycosaminoglycan; immunomodulation; macrophage;
   chemotaxis
ID DERMAL SHEEP COLLAGEN; BIODEGRADABLE BIOMATERIAL; TISSUE REACTION;
   BINDING; RATS; GLYCOSAMINOGLYCANS; CHEMOKINES; GAMMA
AB The foreign body response is characterized by enhanced recruitment of inflammatory cells. As the directional movement of cells is controlled by chemokines, disruption of the chemokine network would be an attractive approach to improve biocompatibility of an implanted material. The sequestration of chemokines by cell surface-expressed glycosaminoglycans (GAGS) is vital for in vivo chemokine activity. The myxoma virus encodes a soluble protein, M-T7, that interacts with conserved GAG-binding domains of chemokines to block chemokine-mediated leukocyte recruitment. We hypothesized that M-T7 might also affect the function of other inflammation-associated proteins in addition to chemokines that bind to GAG. In our studies, we focussed on the modulation of the GAG-binding molecules macrophage chemoattractant protein-1 (MCP-1) and vascular endothelial growth factor-164 (VEGF(164)) in the inflammatory reaction against subcutaneously implanted degradable cross-linked dermal sheep collagen discs in AO rats. Genetic delivery of M-T7 delays the influx of macrophages into the collagen discs. In addition, angiogenesis around the implanted material was reduced. The discs revealed reduced levels of rat MCP-1 and rat VEGF(164). This was not due to down regulation of transcription of the genes that encode MCP-1 and VEGF(164). Our in vivo observations suggest that, in addition to chemokines such as MCP-1, M-T7 neutralizes VEGF(164). (C) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Groningen, Med Ctr, Med Biol Sect, Dept Pathol & Lab Med, NL-9713 GZ Groningen, Netherlands.
   Univ Groningen, Med Ctr, Dept Clin Immunol, NL-9713 GZ Groningen, Netherlands.
   Univ Groningen, Inst Drug Explorat, GUIDE, NL-9700 AV Groningen, Netherlands.
RP Boomker, JM (reprint author), Univ Groningen, Med Ctr, Med Biol Sect, Dept Pathol & Lab Med, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.
EM j.m.boomker@med.rug.nl
OI Veninga, Henrike/0000-0001-8731-0615
CR Bedard ELR, 2003, TRANSPLANTATION, V76, P249, DOI 10.1097/01.TP.0000061604.57432.E3
   DAVIS HL, 1993, HUM GENE THER, V4, P733, DOI 10.1089/hum.1993.4.6-733
   DIJKSTRA CD, 1993, PROG HISTOCHEM CYTOC, V27, P1
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047
   Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738
   Khouw IMSL, 2000, J BIOMED MATER RES, V52, P439, DOI 10.1002/1097-4636(20001205)52:3<439::AID-JBM1>3.0.CO;2-C
   Khouw IMSL, 1998, J BIOMED MATER RES, V41, P202, DOI 10.1002/(SICI)1097-4636(199808)41:2<202::AID-JBM4>3.0.CO;2-M
   Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d
   Lalani AS, 1997, J VIROL, V71, P4356
   Liu LY, 2000, J CLIN INVEST, V105, P1613, DOI 10.1172/JCI8934
   MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113
   Nakagawa Y, 2003, J BIOMED MATER RES B, V66B, P347, DOI 10.1002/jbm.b.10020
   Pieper JS, 2000, BIOMATERIALS, V21, P1689, DOI 10.1016/S0142-9612(00)00052-1
   van Amerongen Machteld J., 2002, Angiogenesis, V5, P173, DOI 10.1023/A:1023822504224
   van Luyn MJA, 1998, J BIOMED MATER RES, V39, P398
   VANWACHEM PB, 1991, BIOMATERIALS, V12, P215, DOI 10.1016/0142-9612(91)90203-M
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
NR 18
TC 12
Z9 14
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2005
VL 26
IS 23
BP 4874
EP 4881
DI 10.1016/j.biomaterials.2004.11.059
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 915PI
UT WOS:000228315900019
PM 15763267
DA 2018-10-20
ER

PT J
AU Anderson, DG
   Putnam, D
   Lavik, EB
   Mahmood, TA
   Langer, R
AF Anderson, DG
   Putnam, D
   Lavik, EB
   Mahmood, TA
   Langer, R
TI Biomaterial microarrays: rapid, microscale screening of polymer-cell
   interaction
SO BIOMATERIALS
LA English
DT Article
DE microarray; biomaterials; PLGA
ID STEM-CELLS; DIFFERENTIATION; CHONDROCYTES; DELIVERY; BIOLOGY; DESIGN;
   SHAPE
AB The identification of biomaterials that induce optimal gene expression patterns and allow for appropriate levels of cellular attachment is of central importance in tissue engineering and cell therapy. Herein, we describe the creation of cell-compatible, biomaterial microarrays, that allow rapid, microscale testing of biomaterial interactions with cells. As proof of principle, we simultaneously characterized over 3456 human mesenchymal stem cell (hMSC)-biomaterial composite interactions, and describe preliminary studies on the utility of these arrays with a neural stem cell line (NSC), and primary articular chondrocytes. (C) 2004 Elsevier Ltd. All rights reserved.
C1 MIT, Dept Chem Engn, Div Biol Engn, Cambridge, MA 02139 USA.
   Cornell Univ, Sch Chem & Biomol Engn, Dept Biomed Engn, Ithaca, NY USA.
   Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.
RP Langer, R (reprint author), MIT, Dept Chem Engn, Div Biol Engn, 45 Carleton St,E25-342, Cambridge, MA 02139 USA.
EM rlanger@mit.edu
OI Putnam, David/0000-0002-0794-4915
FU NHLBI NIH HHS [HL60435]
CR Abraham VC, 2004, TRENDS BIOTECHNOL, V22, P15, DOI 10.1016/j.tibtech.2003.10.012
   Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987
   Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   Brocchini S, 2001, ADV DRUG DELIVER REV, V53, P123, DOI 10.1016/S0169-409X(01)00224-1
   Chen RR, 2003, PHARMACEUT RES, V20, P1103, DOI 10.1023/A:1025034925152
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lanza R, 2000, PRINCIPLES TISSUE EN
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Papadaki M, 2001, J BIOMED MATER RES, V54, P47, DOI 10.1002/1097-4636(200101)54:1<47::AID-JBM6>3.0.CO;2-3
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Saltzman W. M., 2000, PRINCIPLES TISSUE EN, P221
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160
   Streuli C, 1999, CURR OPIN CELL BIOL, V11, P634, DOI 10.1016/S0955-0674(99)00026-5
   Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799
   Yandava BD, 1999, P NATL ACAD SCI USA, V96, P7029, DOI 10.1073/pnas.96.12.7029
NR 23
TC 194
Z9 198
U1 2
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2005
VL 26
IS 23
BP 4892
EP 4897
DI 10.1016/j.biomaterials.2004.11.052
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 915PI
UT WOS:000228315900021
PM 15763269
DA 2018-10-20
ER

PT J
AU Declerq, HA
   Verbeeck, RMH
   De Ridder, LIFJM
   Schacht, EH
   Cornelissen, MJ
AF Declerq, HA
   Verbeeck, RMH
   De Ridder, LIFJM
   Schacht, EH
   Cornelissen, MJ
TI Calcification as an indicator of osteoinductive capacity of biomaterials
   in osteoblastic cell cultures
SO BIOMATERIALS
LA English
DT Article
DE osteoblast differentiation; extracellular matrix; calcification; bone
   apatite; biomaterial
ID IN-VITRO MINERALIZATION; BIODEGRADABLE POLYMERS; BONE; DIFFERENTIATION;
   BIOMINERALIZATION; PROLIFERATION; ESTABLISHMENT; DEPOSITION; PERIOSTEUM;
   PHENOTYPE
AB Mineralized extracellular matrix formation is representative for the osteoinductive capacity of biomaterials and is often tested in vitro. Characteristics of in vitro mineralization of primary rat osteoblastic cells (bone marrow, calvaria, periosteum, fetal and adult long bone) and UMR-106 cells were compared by von Kossa staining, FTIR, X-ray diffractometry, TEM and related to parameters of early (ALP and collagen I formation) and late (osteocalcin secretion) osteoblast expression. All Cultures expressed high alkaline phosphatase activity and were able to form bone apatite. However, a nodular versus diffuse mineralization pattern was observed. Bone marrow, calvaria and periosteum (early passage) derived cells mineralized restrictively on the three-dimensional area of a nodule. The extracellular matrix consisted of collagen I fibers, among matrix vesicles loaded with needle-like crystals. Long bone, late passage periosteum derived and UMR-106 cells exhibited a diffuse mineralization pattern. Needle-like crystals were observed between the cells but collagen fibers and matrix Vesicles Could not be detected. Secretion of osteocalcin was detected in cultures derived from bone marrow and absent in UMR-106 and long bone derived cell cultures. The present study demonstrates that dystrophic calcification can not be distinguished from cell-mediated calcification with von Kossa, FTIR and X-ray diffractometry. Primary osteoblastic cells capable of forming nodules are recommended to evaluate the osteoinductive properties of biomaterials. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Ghent Univ, Dept Anat Embryol Histol & Med Phys, B-9000 Ghent, Belgium.
   Ghent Univ, Dept Dent Mat Sci, B-9000 Ghent, Belgium.
   Ghent Univ, Polymer Mat Res Grp, B-9000 Ghent, Belgium.
RP Cornelissen, MJ (reprint author), Ghent Univ, Dept Anat Embryol Histol & Med Phys, Louis Pasteurlaan 2, B-9000 Ghent, Belgium.
EM Ria.Cornelissen@Ugent.be
RI Liu, Yifei/L-7828-2014
OI Liu, Yifei/0000-0002-1087-9827
CR Ahmad M, 1999, BIOMATERIALS, V20, P211, DOI 10.1016/S0142-9612(98)00152-5
   Allen MJ, 2003, VET CLIN PATH, V32, P101, DOI 10.1111/j.1939-165X.2003.tb00323.x
   Andre-Frei V, 2000, CALCIFIED TISSUE INT, V66, P204, DOI 10.1007/s002230010041
   Arnold U, 2002, BIOMATERIALS, V23, P2303, DOI 10.1016/S0142-9612(01)00364-7
   ARONOW MA, 1990, J CELL PHYSIOL, V143, P213, DOI 10.1002/jcp.1041430203
   AUBIN JE, 1998, HDB PRACTICAL ANIMAL, P88
   Bonewald LF, 2003, CALCIFIED TISSUE INT, V72, P537, DOI 10.1007/s00223-002-1057-y
   Boskey AL, 1996, CONNECT TISSUE RES, V35, P357, DOI 10.3109/03008209609029212
   Boskey AL, 2003, CALCIFIED TISSUE INT, V72, P533, DOI 10.1007/s00223-003-1002-8
   Boskey AL, 2003, CONNECT TISSUE RES, V44, P5, DOI 10.1080/03008200390152007
   Boskey AL, 1996, CALCIFIED TISSUE INT, V58, P177, DOI 10.1007/BF02526884
   Boyan BD, 2002, CALCIFIED TISSUE INT, V71, P519, DOI 10.1002/s00223-001-1114-y
   Chak CW, 1995, CELL BIOL INT, V19, P979, DOI 10.1006/cbir.1995.1039
   DAVIES JE, 2002, METHODS TISSUE ENG, V26, P333
   Declercq H, 2004, BIOMATERIALS, V25, P757, DOI 10.1016/S0142-9612(03)00580-5
   Driessens FCM, 1990, BIOMINERALS
   Ehara A, 2003, BIOMATERIALS, V24, P831, DOI 10.1016/S0142-9612(02)00411-8
   El-Amin SF, 2003, BIOMATERIALS, V24, P1213, DOI 10.1016/S0142-9612(02)00451-9
   Goto T, 2003, BIOMATERIALS, V24, P3885, DOI 10.1016/S0142-9612(03)00258-8
   GRONOWICZ G, 1989, J BONE MINER RES, V4, P313
   Hale LV, 2000, CALCIFIED TISSUE INT, V67, P80, DOI 10.1007/s00223001101
   HALSTEAD LR, 1992, CALCIFIED TISSUE INT, V50, P93, DOI 10.1007/BF00297304
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Jonsson KB, 1999, ACTA ORTHOP SCAND, V70, P365, DOI 10.3109/17453679908997826
   Kato Y, 2001, J BONE MINER RES, V16, P1622, DOI 10.1359/jbmr.2001.16.9.1622
   KHOUJA HI, 1990, BONE, V11, P385, DOI 10.1016/8756-3282(90)90131-H
   KOSHIHARA Y, 1989, IN VITRO CELL DEV B, V25, P37
   Kuhn LT, 2000, J BONE MINER RES, V15, P1301, DOI 10.1359/jbmr.2000.15.7.1301
   Laczka-Osyczka A, 1998, J BIOMED MATER RES, V42, P433, DOI 10.1002/(SICI)1097-4636(19981205)42:3<433::AID-JBM13>3.0.CO;2-H
   Lisignoli G, 2001, BIOMATERIALS, V22, P2095, DOI 10.1016/S0142-9612(00)00398-7
   Lynch MP, 1998, J CELL BIOCHEM, V68, P31
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   Siggelkow H, 1999, J CELL BIOCHEM, V75, P22, DOI 10.1002/(SICI)1097-4644(19991001)75:1<22::AID-JCB3>3.3.CO;2-Y
   STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420
   YOON KG, 1988, BIOCHEMISTRY-US, V15, P8521
NR 35
TC 98
Z9 101
U1 2
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2005
VL 26
IS 24
BP 4964
EP 4974
DI 10.1016/j.biomaterials.2005.01.025
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 919KQ
UT WOS:000228617300009
PM 15769532
DA 2018-10-20
ER

PT J
AU Marcon, P
   Marsich, E
   Vetere, A
   Mozetic, P
   Campa, C
   Donati, I
   Vittur, F
   Gamini, A
   Paoletti, S
AF Marcon, P
   Marsich, E
   Vetere, A
   Mozetic, P
   Campa, C
   Donati, I
   Vittur, F
   Gamini, A
   Paoletti, S
TI The role of Galectin-1 in the interaction between chondrocytes and a
   lactose-modified chitosan
SO BIOMATERIALS
LA English
DT Article
DE Galectin-1; glycopolymer; biomaterial; chondrocyte; cartilage
ID GALACTOSIDE-BINDING LECTIN; S-TYPE LECTIN; EXTRACELLULAR-MATRIX;
   ARTICULAR-CARTILAGE; CELL-ADHESION; GASTROINTESTINAL-TRACT;
   MOLECULAR-CLONING; EXPRESSION; SEQUENCE; LAMININ
AB Evidences for the involvement of the Galectin-1 in the interaction of pig chondrocytes with a lactose-modified chitosan, namely Chitlac, are reported. The Chitlac glycopolymer has been shown to promote pig chondrocyte aggregation and to induce extracellular matrix production. Highly pure Galectin-1 was obtained from pig spleen by affinity chromatography and its identity was determined by ion spray mass spectrometry analysis of tryptic peptide fragments obtained after in-gel digestion. The complete sequence of pig Galectin-1 CDS was obtained by screening a pig EST database using human Galectin-1 sequence as template. The Galectin-1 cDNA was cloned into a pGEX-4T-1 expression vector and the recombinant protein was purified, characterized and used to produce a rabbit anti-serum. Recombinant Galectin-1 interacts in a dose-dependent manner with Chitlac as determined with ELISA assay. Expression level of galeclin-1 gene, quantified by real-time PCR, was significantly higher in chondrocytes cultivated on Chitlac. In the same way, the presence of Chitlac stimulates secretion of Galectin-1 in culture medium that, by immunohistochemical analysis, revealed to be clustered on the surface of Chitlac-induced aggregates. These data indicate the role of Galectin-1 as a bridging agent between Chitlac and chondrocyte aggregates. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Trieste, Dept Biochem Biophys & Macromol Chem, I-34127 Trieste, Italy.
   Bracco Imaging SpA CRM Trieste, I-34012 Trieste, Italy.
RP Vetere, A (reprint author), Univ Trieste, Dept Biochem Biophys & Macromol Chem, Via L Giorgieri 1, I-34127 Trieste, Italy.
EM vetere@bbcm.univ.trieste.it
RI Donati, Ivan/C-3725-2017
OI Paoletti, Sergio/0000-0001-5944-8182; Vetere,
   Amedeo/0000-0001-5608-0773; MARSICH, ELEONORA/0000-0002-0700-4464;
   Mozetic, Pamela/0000-0001-8641-0526
CR Ahmed H, 1996, J BIOCHEM, V120, P1007
   Andre S, 1999, J CANCER RES CLIN, V125, P461, DOI 10.1007/s004320050303
   BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7
   Brun P, 1999, J MATER SCI-MATER M, V10, P683, DOI 10.1023/A:1008960413362
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022
   Colnot C, 1999, CELL MOL BIOL, V45, P1191
   COOPER DNW, 1999, GLYCOBIOLOGY, V9, P31
   COURAUD PO, 1989, J BIOL CHEM, V264, P1310
   Donati I, 2005, BIOMATERIALS, V26, P987, DOI 10.1016/j.biomaterials.2004.04.015
   Dunphy JL, 2000, J BIOL CHEM, V275, P32106, DOI 10.1074/jbc.M003739200
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   GITT MA, 1992, J BIOL CHEM, V267, P10601
   GITT MA, 1995, J BIOL CHEM, V270, P5032, DOI 10.1074/jbc.270.10.5032
   Gitt MA, 1998, J BIOL CHEM, V273, P2954, DOI 10.1074/jbc.273.5.2954
   GRANDOLFO M, 1993, CALCIFIED TISSUE INT, V52, P42, DOI 10.1007/BF00675625
   GU MJ, 1994, J CELL SCI, V107, P175
   HIRABAYASHI J, 1988, J BIOCHEM-TOKYO, V104, P1
   Hughes RC, 2001, BIOCHIMIE, V83, P667
   Inohara H, 1998, EXP CELL RES, V245, P294, DOI 10.1006/excr.1998.4253
   Jensen ON, 1999, METH MOL B, V112, P513
   JIA SH, 1988, J BIOL CHEM, V263, P6009
   Kasai K, 1996, J BIOCHEM-TOKYO, V119, P1
   Kopitz J, 1998, J BIOL CHEM, V273, P11205, DOI 10.1074/jbc.273.18.11205
   Kopitz J, 2001, J BIOL CHEM, V276, P35917, DOI 10.1074/jbc.M105135200
   Levy Y, 2001, J BIOL CHEM, V276, P31285, DOI 10.1074/jbc.M100340200
   LU JX, 1999, BIOMATERIALS, V20, P1133
   MADSEN P, 1995, J BIOL CHEM, V270, P5823, DOI 10.1074/jbc.270.11.5823
   Maeda N, 2003, J BIOL CHEM, V278, P18938, DOI 10.1074/jbc.M209673200
   Matarrese P, 2000, INT J CANCER, V85, P545, DOI 10.1002/(SICI)1097-0215(20000215)85:4<545::AID-IJC17>3.0.CO;2-N
   Mattioli-Belmonte M, 1999, MED BIOL ENG COMPUT, V37, P130, DOI 10.1007/BF02513279
   MERKLE RK, 1989, ARCH BIOCHEM BIOPHYS, V274, P404, DOI 10.1016/0003-9861(89)90453-0
   Moiseeva EP, 1999, J VASC RES, V36, P47, DOI 10.1159/000025625
   Nurminskaya M, 1996, DEV DYNAM, V206, P260, DOI 10.1002/(SICI)1097-0177(199607)206:3<260::AID-AJA4>3.0.CO;2-G
   Ochieng J, 1998, BIOCHEM BIOPH RES CO, V246, P788, DOI 10.1006/bbrc.1998.8708
   ODA Y, 1991, GENE, V99, P279
   OZEKI Y, 1995, GLYCOBIOLOGY, V5, P255, DOI 10.1093/glycob/5.2.255
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Ramkumar R, 2000, J MOL RECOGNIT, V13, P299, DOI 10.1002/1099-1352(200009/10)13:5<299::AID-JMR504>3.0.CO;2-O
   RAZ A, 1991, CANCER RES, V51, P2173
   Rechreche H, 1997, EUR J BIOCHEM, V248, P225, DOI 10.1111/j.1432-1033.1997.00225.x
   Sambrook J, 2001, MOL CLONING LAB MANU
   Su ZZ, 1996, P NATL ACAD SCI USA, V93, P7252, DOI 10.1073/pnas.93.14.7252
   Symons A, 2000, GLYCOBIOLOGY, V10, P559, DOI 10.1093/glycob/10.6.559
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Tureci O, 1997, J BIOL CHEM, V272, P6416, DOI 10.1074/jbc.272.10.6416
   VANDENBRULE FA, 1995, BIOCHEM BIOPH RES CO, V209, P760, DOI 10.1006/bbrc.1995.1564
   Wada J, 1997, J BIOL CHEM, V272, P6078, DOI 10.1074/jbc.272.9.6078
   Wasano K, 1997, J HISTOCHEM CYTOCHEM, V45, P275, DOI 10.1177/002215549704500212
   Yang RY, 2001, J BIOL CHEM, V276, P20252, DOI 10.1074/jbc.M010914200
   ZHOU Q, 1990, ARCH BIOCHEM BIOPHYS, V281, P27, DOI 10.1016/0003-9861(90)90408-Q
NR 50
TC 32
Z9 33
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2005
VL 26
IS 24
BP 4975
EP 4984
DI 10.1016/j.biomaterials.2005.01.044
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 919KQ
UT WOS:000228617300010
PM 15769533
DA 2018-10-20
ER

PT J
AU Niu, XF
   Wang, YL
   Luo, YF
   Pan, J
   Shang, JF
   Guo, LX
AF Niu, XF
   Wang, YL
   Luo, YF
   Pan, J
   Shang, JF
   Guo, LX
TI Synthesis of the biomimetic polymer: Aliphatic diamine and RGDS modified
   poly(d,l-lactic acid)
SO CHINESE CHEMICAL LETTERS
LA English
DT Article
DE poly(d,l-lactic acid); maleic anhydride; butanediamine; arg-gly-asp-ser;
   modification
ID BIOMATERIAL
AB A novel poly(d, l-lactic acid) (PDLLA) based biomimetic polymer was synthesized by grafting maleic anhydride, butanediamine and arg-gly-asp-ser (RGDS) peptides onto the backbone of PDLLA, aiming to overcome the acidity and auto-accelerating degradation of PDLLA during degradation and to improve its biospecificity and biocompatibility. The synthetic copolymer was characterized by FTIR, C-13 NMR and amino acid analyzer (AAA).
C1 Chongqing Univ, Minist Educ, Ctr Bioengn, Key Lab Biomech & Tissue Engn, Chongqing 400044, Peoples R China.
RP Wang, YL (reprint author), Chongqing Univ, Minist Educ, Ctr Bioengn, Key Lab Biomech & Tissue Engn, Chongqing 400044, Peoples R China.
EM wyl@cqu.edu.cn
CR Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Han DK, 1996, MACROMOLECULES, V29, P5233, DOI 10.1021/ma9601070
   Luo YF, 2004, CHINESE CHEM LETT, V15, P521
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Wang XM, 1997, T NONFERR METAL SOC, V7, P5
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Yu Yen, 2000, SHENGWU YIYONG CAILI, P54
NR 8
TC 7
Z9 11
U1 0
U2 3
PU CHINESE CHEMICAL SOCIETY
PI BEIJING
PA C/O DEPT INT AFFAIRS, SECRETARY OF CHEM SOC, PO BOX 2709, BEIJING
   100080, PEOPLES R CHINA
SN 1001-8417
J9 CHINESE CHEM LETT
JI Chin. Chem. Lett.
PD AUG
PY 2005
VL 16
IS 8
BP 1035
EP 1038
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA 952WM
UT WOS:000231036500013
DA 2018-10-20
ER

PT J
AU Poll, B
   Buttler, P
   Graber, HG
   Lampert, F
   Becker, C
AF Poll, B
   Buttler, P
   Graber, HG
   Lampert, F
   Becker, C
TI Engrafting periodontal fibroblasts with new 3-dimensional polylactide
   foams
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE polylactide scaffolds; periodontal fibroblasts; cell carrier matrix
ID GUIDED TISSUE REGENERATION; MONOCLONAL-ANTIBODIES; GINGIVAL FIBROBLASTS;
   IN-VITRO; CELLS; DEGRADATION; CULTURE
AB In clinical periodontics, "tissue engineering" techniques have been developed to guide the regenerative process following periodontal disease. We explored a new shaped biomaterial in order to promote cellular adhesion, proliferation and migration of periodontal cells. Granules of poly-D,L-lactide were foamed In specially designed moulds by a controlled gas-loading process. Explant cultures of periodontal tissue were seeded at different densities on the 3-dimensional scaffolds following analysis of cytotoxicity, cell proliferation and differentiation. The moulding procedure led to porous structures with predetermined tubes for cellular locomotion. Cells adhered to and populated the material's surface and inner cavities while retaining fibroblastic phenotype. An optimal ratio between cellular proliferation and mortality rate was achieved at a seeding density of > 10(6) cells/cm(3) scaffold. We designed modified polylactide scaffolds capable of acting as a stent and a cell carrier matrix. The foaming process is easy, cheap and suitable for commercial production.
C1 Rhein Westfal TH Aachen, Fac Med, Dept Urol, D-52074 Aachen, Germany.
   Rhein Westfal TH Aachen, Univ Hosp, Dept Urol, D-52074 Aachen, Germany.
   Rhein Westfal TH Aachen, Fac Med, Dept Operat Dent Periodontol & Prevent Dent, D-5100 Aachen, Germany.
   Rhein Westfal TH Aachen, Univ Hosp, Dept Operat Dent Periodontol & Prevent Dent, D-5100 Aachen, Germany.
RP Becker, C (reprint author), Rhein Westfal TH Aachen, Fac Med, Dept Urol, Pauwelsstr 30, D-52074 Aachen, Germany.
EM cbecker@ukaachen.de
CR Bartold PM, 2000, PERIODONTOL 2000, V24, P253, DOI 10.1034/j.1600-0757.2000.2240113.x
   Becker C, 2002, EUR J ORAL SCI, V110, P137, DOI 10.1034/j.1600-0722.2002.11202.x
   BUCHHOLZ B, 1993, J MATER SCI-MATER M, V4, P381, DOI 10.1007/BF00122196
   FARJANEL J, 1984, BIOCHEM BIOPH RES CO, V123, P1002, DOI 10.1016/S0006-291X(84)80233-8
   Graber HG, 1999, J PERIODONTOL, V70, P388, DOI 10.1902/jop.1999.70.4.388
   Hillmann G, 2002, BIOMATERIALS, V23, P1461, DOI 10.1016/S0142-9612(01)00270-8
   Ignatius AA, 2001, J BIOMAT SCI-POLYM E, V12, P185, DOI 10.1163/156856201750180915
   Maquet V, 2001, BIOMATERIALS, V22, P1137, DOI 10.1016/S0142-9612(00)00357-4
   Murphy WL, 1999, J PERIODONTAL RES, V34, P413, DOI 10.1111/j.1600-0765.1999.tb02275.x
   Page Roy C, 2002, Compend Contin Educ Dent, V23, P11
   RATNER BD, 1996, BIOMATERIALS SCI INT, P64
   SCANTLEBURY TV, 1993, J PERIODONTOL, V64, P1129, DOI 10.1902/jop.1993.64.11s.1129
   Takata T, 2001, J PERIODONTAL RES, V36, P322, DOI 10.1034/j.1600-0765.2001.360508.x
   Unsal B, 1999, J Oral Sci, V41, P57
   Voges Jurgen, 2002, J Exp Ther Oncol, V2, P70, DOI 10.1046/j.1359-4117.2002.01012.x
   Ziccardi V B, 1996, N Y State Dent J, V62, P48
NR 16
TC 1
Z9 1
U1 0
U2 1
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD AUG
PY 2005
VL 28
IS 8
BP 827
EP 833
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 972VG
UT WOS:000232480700009
PM 16211533
DA 2018-10-20
ER

PT J
AU Christenson, EM
   Dadsetan, M
   Anderson, JM
   Hiltner, A
AF Christenson, EM
   Dadsetan, M
   Anderson, JM
   Hiltner, A
TI Biostability and macrophage-mediated foreign body reaction of
   silicone-modified polyurethanes
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article; Proceedings Paper
CT 30th Annual Meeting of the Society-for-Biomaterials
CY APR 27-30, 2005
CL Memphis, TN
SP Soc Biomat
DE poly(ether urethane); poly(carbonate urethane); silicone; foreign body
   response; apoptosis
ID POLY(ETHERURETHANE UREA) ELASTOMERS; GIANT-CELL FORMATION; IN-VIVO;
   POLY(CARBONATE URETHANE); MONOCYTES MACROPHAGES; BIODEGRADATION;
   INTERLEUKIN-4; BIOCOMPATIBILITY; MECHANISMS; APOPTOSIS
AB In this study, the effect of soft segment chemistry on the phase morphology and in vivo response of commercial-grade poly(ether urethane) (PEU), silicone-modified PEU (PEU-S), poly(carbonate urethane) (PCU), and silicone-modified.PCU (PCU-S) elastomers were examined. Silicone-modified polyurethanes were developed to combine the biostability of silicone with the mechanical properties of PEUs. Results from the infrared spectroscopy confirmed the presence of silicone at the surface of the PEU-S and PCU-S films. Atomic force microscopy phase imaging indicated that the overall two-phase morphology of PEUs, necessary for its thermoplastic elastomeric properties, was not disrupted by the silicone modification. After material characterization, the in vivo foreign body response and biostability of the polyurethanes were studied using a subcutaneous cage implant protocol. The results from the cage implant study indicated that monocytes adhere, differentiate to macrophages which fuse to form foreign body giant cells on all of the polyurethanes. However, the silicone-modified surfaces promoted apoptosis of adherent macrophages at 4 days and high levels of macrophage fusion after 21 days. These results confirm that the surface of a biomaterial may influence the induction of apoptosis of adherent macrophages in vivo and are consistent with previous cell culture studies of these materials. This study validates the use of our standard cell culture protocol to predict in vivo behavior and further supports the hypothesis that interleukin-4 is the primary mediator of macrophage fusion and foreign body giant cell formation in vivo. The impact of these findings on the biostability of polyurethanes is the subject of current investigations. Attenuated total reflectance-Fourier transform infrared analysis of explanted specimens provided evidence of chain scission and crosslinking at the surface of all of the polyurethanes. The silicone modification did not fully inhibit the oxidative biodegradation of the polyether or polycarbonate soft segments; however, the rate of chain scission of PEU-S and PCU-S seemed to be slower than the control polyurethanes. To verify this finding and to quantify the rate of chain scission in order to predict long-term biostability, an in vitro environment that simulated the microenvironment at the adherent cell-material interface was used to accelerate the biodegradation of the polyurethanes. Polyurethane films were treated in vitro for up to 36 days in 20% hydrogen peroxide/0.1M cobalt chloride solution at 37 C. Characterization with attenuated total reflectance-Fourier transform infrared and scanning electron microscopy showed soft segment and hard segment degradation consistent with the chemical changes observed after long-term in vivo treatment. The biostability ranking of these four materials based on rate of chain scission and surface pitting was as follows: PEU < PEU-S : PCU < PCU-S. The silicone modification increased the biostability of the PEU and PCU elastomers while maintaining the thermoplastic elastomeric properties. (c) 2005 Wiley Periodicals, Inc.
C1 Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Ctr Appl Polymer Res, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA.
RP Hiltner, A (reprint author), Case Western Reserve Univ, Dept Macromol Sci, 10900 Euclid Ave, Cleveland, OH 44106 USA.
EM pah6@cwru.edu
RI Cosgriff-Hernandez, Elizabeth/E-6391-2016
OI Cosgriff-Hernandez, Elizabeth/0000-0002-4701-5600
FU NIBIB NIH HHS [EB-00272]
CR Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Christenson EM, 2004, J BIOMED MATER RES A, V70A, P245, DOI 10.1002/jbm.a.30067
   Christenson EM, 2004, J BIOMED MATER RES A, V69A, P407, DOI 10.1002/jbm.a.30002
   Dillon J., 1989, INFRARED SPECTROSCOP
   Fare S, 1999, J BIOMED MATER RES, V45, P62, DOI 10.1002/(SICI)1097-4636(199904)45:1<62::AID-JBM9>3.0.CO;2-F
   Garrett JT, 2001, MACROMOLECULES, V34, P7066, DOI 10.1021/ma0102114
   Gogolewski S., 1991, TRENDS POLYM SCI, V1, P47
   HERGENROTHER RW, 1994, BIOMATERIALS, V15, P635, DOI 10.1016/0142-9612(94)90215-1
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   KALMAN PG, 1991, J BIOMED MATER RES, V25, P199, DOI 10.1002/jbm.820250207
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P819, DOI 10.1002/jbm.820280709
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Lambda N., 1998, POLYURETHANES BIOMED
   Lelah M. D., 1986, POLYURETHANES MED
   LIM F, 1994, BIOMATERIALS, V15, P408, DOI 10.1016/0142-9612(94)90218-6
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   Martin DJ, 2000, BIOMATERIALS, V21, P1021, DOI 10.1016/S0142-9612(99)00271-9
   MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   Schubert MA, 1997, J BIOMED MATER RES, V34, P519, DOI 10.1002/(SICI)1097-4636(19970315)34:4<519::AID-JBM12>3.0.CO;2-7
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   Shive MS, 2002, J BIOMED MATER RES, V60, P148, DOI 10.1002/jbm.10035
   Stokes K, 1987, J Biomater Appl, V1, P411
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   Szycher M, 1992, Med Device Technol, V3, P42
   Ward RS, 1996, ASAIO J, V42, P17
   Wiggins MJ, 2001, J BIOMED MATER RES, V58, P302
   WIGGINS MJ, 2003, J BIOMED MATER RES A, V68, P668
   WU Y, 1992, J APPL POLYM SCI, V46, P201, DOI 10.1002/app.1992.070460202
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 31
TC 36
Z9 36
U1 0
U2 15
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG 1
PY 2005
VL 74A
IS 2
BP 141
EP 155
DI 10.1002/jbm.a.30317
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 945KB
UT WOS:000230500300001
PM 16201029
DA 2018-10-20
ER

PT J
AU Fu, Q
   Zhou, N
   Huang, WH
   Wang, DP
   Zhang, LY
   Li, HF
AF Fu, Q
   Zhou, N
   Huang, WH
   Wang, DP
   Zhang, LY
   Li, HF
TI Effects of nano HAP on biological and structural properties of glass
   bone cement
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE nanoscale hydroxyapatite; bone cement; cell proliferation
ID CALCIUM-PHOSPHATE CEMENT; ANTIBIOTIC DELIVERY SYSTEM; GIANT-CELL TUMOR;
   RELEASE
AB A novel type of glass-based nanoscale hydroxyapatite (HAP) bioactive bone cement (designed as GBN-HAPC) was synthesized by adding nanoscale hydroxyapatite crystalline (20-40 nm), into the self-setting glass-based bone cement (GBC). The inhibition rate of nanoscale HAP and micron HAP on osteosarcoma U2-OS cells was examined. The effects of nanoscale HAP on the crystal phase, microstructure and compressive strength of GBNHAPC were studied, respectively. It was concluded that nanoscale HAP could inhibit the cell proliferation, whereas micron HAP could not, and that nanoscale HAP could be dispersed in the cement evenly and the morphology did not change significantly after a longer immersion time. XRD and FTIR results show nanoscale HAP did not affect the setting reaction of the cement. Furthermore, GBNHAPC had a higher compressive strength (92.6 +/- 3.8 MPa) than GBC (80.1 +/- 3.0 MPa). It was believed that GBNHAPC might be a desirable biomaterial that could not only fill bone defects but also inhibit cancer cell growth. (c) 2005 Wiley Periodicals, Inc.
C1 Tongji Univ, Sch Mat Sci & Engn, Shanghai 200092, Peoples R China.
   Tongji Univ, Tongji Hosp, Shanghai 200065, Peoples R China.
RP Fu, Q (reprint author), Tongji Univ, Sch Mat Sci & Engn, Shanghai 200092, Peoples R China.
EM fuharry@hotmail.com
RI Fu, Qiang/B-1972-2013
CR Aoki H., 1993, REP I MED DENT ENG, V27, P39
   BINI SA, 1995, CLIN ORTHOP RELAT R, P245
   Bohner M, 1997, J PHARM SCI, V86, P565, DOI 10.1021/js960405a
   CAMPANACCI M, 1987, J BONE JOINT SURG AM, V69A, P106, DOI 10.2106/00004623-198769010-00018
   Filho OP, 1996, J BIOMED MATER RES, V30, P509
   Hamanishi C, 1996, J BIOMED MATER RES, V33, P139, DOI 10.1002/(SICI)1097-4636(199623)33:3<139::AID-JBM3>3.0.CO;2-R
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Liu CS, 1997, J MATER SCI-MATER M, V8, P803, DOI 10.1023/A:1018529116330
   MALONEY WJ, 1990, J BONE JOINT SURG BR, V72, P966
   OTSUKA M, 1994, J PHARM SCI, V83, P259, DOI 10.1002/jps.2600830230
   Otsuka M, 1997, BIOMATERIALS, V18, P1559, DOI 10.1016/S0142-9612(97)00097-5
   Shinzato S, 2001, J BIOMED MATER RES, V56, P571, DOI 10.1002/1097-4636(20010915)56:4<571::AID-JBM1129>3.0.CO;2-H
   Tamura J, 1996, J BIOMED MATER RES, V30, P85, DOI 10.1002/(SICI)1097-4636(199601)30:1<85::AID-JBM11>3.0.CO;2-P
   Yang QZ, 2002, BIOMATERIALS, V23, P2751, DOI 10.1016/S0142-9612(02)00010-8
   ZHANG SC, 1996, J WUHAN UNIV TECHNOL, V18, P5
NR 15
TC 34
Z9 36
U1 0
U2 15
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG 1
PY 2005
VL 74A
IS 2
BP 156
EP 163
DI 10.1002/jbm.a.30322
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 945KB
UT WOS:000230500300002
PM 15962272
DA 2018-10-20
ER

PT J
AU Brodbeck, WG
   MacEwan, M
   Colton, E
   Meyerson, H
   Anderson, JM
AF Brodbeck, WG
   MacEwan, M
   Colton, E
   Meyerson, H
   Anderson, JM
TI Lymphocytes and the foreign body response: Lymphocyte enhancement of
   macrophage adhesion and fusion
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE foreign body response; macrophages; lymphocytes; foreign body giant cell
ID IN-VIVO; MONOCYTES MACROPHAGES; SURFACE-CHEMISTRY; GIANT-CELLS; T-CELLS;
   INTERLEUKIN-4; EXPRESSION; DIFFERENTIATION; BIOMATERIALS; MIGRATION
AB The host foreign body response ensues immediately following implantation of medical devices and prostheses. We have previously identified the role of macrophages in adhering to biomaterial surfaces and guiding the foreign body response while fusing into foreign body giant cells (FBGCs) and concentrating degradative and phagocytic activities. Despite their early and transient presence around implanted biomaterials, few studies have focused on the role of lymphocytes in the foreign body response and biocompatibility. To address this, an in vitro human lymphocyte/macrophage coculture system has been developed. Using this system, it has been shown that when lymphocytes are present during the initial adhesion of monocytes, the rate of monocyte adhesion and fusion is significantly increased (1,500 cells/mm(2) and 60%, respectively) when compared to either no lymphocytes present (500 cells/mm(2) adhesion and 0% fusion). Although lymphocytes adhered to the tissue culture polystyrene surface, 90% of the lymphocytes were associated with adherent macrophages. However, these cell-cell direct interactions were not necessary to influence macrophage adhesion or fusion as separating the two cell types by a Transwell insert still resulted in significantly increased levels of macrophage adhesion (p < 0.05 when compared to macrophage only cultures). Conversely, the presence of macrophages in Transwell experiments increased lymphocyte proliferation rates at all time points tested. These studies begin to detail the interactions between lymphocytes and macrophages in the absence of known antigen that appropriately relates to the scenarios experienced upon implantation of biomedical devices and the initiation of the foreign body response. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Hosp Cleveland, Dept Pathol, Cleveland, OH 44106 USA.
   Univ Hosp Cleveland, Dept Hematopathol & Flow Cytometry, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Univ Hosp Cleveland, Dept Pathol, Cleveland, OH 44106 USA.
EM jma6@case.edu
FU NIBIB NIH HHS [EB-00282]
CR Anderson J.M., 1994, PROB GEN SURG, V11, P147
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   BELLER DI, 1978, FED PROC, V37, P91
   Bergman AJ, 1999, BIOMATERIALS, V20, P2235, DOI 10.1016/S0142-9612(99)00154-4
   BODEKER BGD, 1980, EUR J IMMUNOL, V10, P702, DOI 10.1002/eji.1830100909
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375
   CEUSOT RJ, 2002, MOL IMMUNOL, V39, P997
   CIMA LG, 1994, J CELL BIOCHEM, V56, P155, DOI 10.1002/jcb.240560206
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   HELLE M, 1988, EUR J IMMUNOL, V18, P957, DOI 10.1002/eji.1830180619
   HOUSSIAU FA, 1988, EUR J IMMUNOL, V18, P653, DOI 10.1002/eji.1830180427
   IMHOF BA, 1995, ADV IMMUNOL, V58, P345, DOI 10.1016/S0065-2776(08)60623-9
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   LOTZ M, 1988, J EXP MED, V167, P1253, DOI 10.1084/jem.167.3.1253
   MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   PETILLO O, 1994, J BIOMED MATER RES, V28, P635, DOI 10.1002/jbm.820280514
   Shankar Ravi, 1994, P67
   UYTTENHOVE C, 1988, J EXP MED, V167, P1417, DOI 10.1084/jem.167.4.1417
   YOKOYAMA M, 1986, J BIOMED MATER RES, V20, P867, DOI 10.1002/jbm.820200702
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 26
TC 51
Z9 52
U1 1
U2 16
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG 1
PY 2005
VL 74A
IS 2
BP 222
EP 229
DI 10.1002/jbm.a.30313
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 945KB
UT WOS:000230500300010
PM 15948198
DA 2018-10-20
ER

PT J
AU Whang, KM
   McDonald, J
   Khan, A
   Satsangi, N
AF Whang, KM
   McDonald, J
   Khan, A
   Satsangi, N
TI A novel osteotropic biomaterial OG-PLG: Synthesis and in vitro release
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE statin; controlled delivery; synthesis and characterization;
   poly[lactide-co-glycolide]; bone regeneration
ID BONE MORPHOGENETIC PROTEIN-2; COA REDUCTASE INHIBITORS; MASSIVE
   POLY(ALPHA-HYDROXY ACIDS); STRUCTURE PROPERTY RELATIONSHIPS;
   BIOABSORBABLE SCAFFOLDS; AQUEOUS-MEDIA; DEGRADATION; SIMVASTATIN;
   DELIVERY; POLYMER
AB Statins (e.g., simvastatin) have shown to induce expression of the bone morphogenic protein-2 gene in bone cells, but they are not used clinically because of a lack of a suitable delivery device. The overall objective is to develop optimized statin delivery devices for bone regeneration. The specific objective was to determine the effect of grafting statins to biodegradable poly[lactide-co-glycolide] (PLG) on release kinetics. Simvastatin was grafted to PLG (OG-PLG) and characterized using contact-angle measurements, attenuated total reflectance-Fourier transform infrared, and ultraviolet-visible spectroscopy to determine success of the synthesis. An ultraviolet-visible assay for measuring release of statins and degraded OG-PLG in media was also developed. In vitro release studies using films and scaffolds made with PLG, PLG blended with simvastatin (PLG + Sim), and OG-PLG (simvastatin grafted to PLG) blended into PLG at different concentrations showed that release rate of OG-PLG from films was significantly greater than that of PLG + Sim. However, release rate from scaffolds showed PLG + Sim to be significantly higher than that of OG-PLG. The diffusion-controlled release kinetics of simvastatin from PLG + Sim seems to be more heavily affected by device morphology, whereas the degradation-controlled release kinetics seem to be less affected. In short, release kinetics can be modulated by grafting statins to PLG. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Texas, Hlth Sci Ctr, Dept Restorat Dent, Div Biomat, San Antonio, TX 78229 USA.
   Univ Texas, Hlth Sci Ctr, Dept Prosthodont, San Antonio, TX 78229 USA.
RP Whang, KM (reprint author), Univ Texas, Hlth Sci Ctr, Dept Restorat Dent, Div Biomat, 7703 Floyd Curl Dr,MSC 7890, San Antonio, TX 78229 USA.
EM whang@uthscsa.edu
FU NIDCR NIH HHS [DE14318, 1R03DE14653]
CR Akamaru T, 2003, SPINE, V28, P429, DOI 10.1097/00007632-200303010-00004
   Bessho K, 2002, J BIOMED MATER RES, V61, P61, DOI 10.1002/jbm.10169
   BEUMER GJ, 1994, J BIOMED MATER RES, V28, P545, DOI 10.1002/jbm.820280504
   Bostrom M, 1996, CLIN ORTHOP RELAT R, P272
   Cummings SR, 2000, JAMA-J AM MED ASSOC, V283, P3255, DOI 10.1001/jama.283.24.3255
   Ebara S, 2002, SPINE, V27, pS10, DOI 10.1097/01.BRS.0000020727.98493.20
   ENGEL CR, 1955, CAN J CHEM, V33, P1515, DOI 10.1139/v55-185
   Farnier M, 1998, AM J CARDIOL, V82, p3J, DOI 10.1016/S0002-9149(98)00423-8
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   HABERSTADT C, 1992, MATER RES SOC S P, V252, P3223
   HECKMAN JD, 1991, J BONE JOINT SURG AM, V73A, P750, DOI 10.2106/00004623-199173050-00015
   Heckman JD, 1999, J BONE JOINT SURG AM, V81A, P1717, DOI 10.2106/00004623-199912000-00009
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Issack Paul S, 2003, Am J Orthop (Belle Mead NJ), V32, P429
   LEWIS DH, 1990, DRUGS PHARM SCI BIOD, P1
   LI SM, 1990, J MATER SCI-MATER M, V1, P131, DOI 10.1007/BF00700872
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   Maeda T, 2001, BIOCHEM BIOPH RES CO, V280, P874, DOI 10.1006/bbrc.2000.4232
   Meier CR, 2000, JAMA-J AM MED ASSOC, V283, P3205, DOI 10.1001/jama.283.24.3205
   MIYANO M, 1965, J AM CHEM SOC, V87, P3958, DOI 10.1021/ja01095a030
   Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946
   Ruhe PQ, 2003, J BONE JOINT SURG AM, V85A, P75
   Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0
   Sandhu HS, 2003, SPINE, V28, pS64, DOI 10.1097/00007632-200308011-00012
   Sandhu HS, 1995, SPINE, V20, P2669, DOI 10.1097/00007632-199512150-00008
   Schrier J A, 2001, AAPS PharmSciTech, V2, pE18
   Schrier J A, 2001, AAPS PharmSciTech, V2, pE17
   Seeherman H, 2002, SPINE, V27, pS16, DOI 10.1097/01.BRS.0000020728.34131.03
   SERAJUDDIN ATM, 1991, J PHARM SCI, V80, P830, DOI 10.1002/jps.2600800905
   Sugiyama M, 2000, BIOCHEM BIOPH RES CO, V271, P688, DOI 10.1006/bbrc.2000.2697
   Sykaras Nikitas, 2003, J Oral Sci, V45, P57
   THERIN M, 1992, BIOMATERIALS, V13, P594, DOI 10.1016/0142-9612(92)90027-L
   VYAS KP, 1990, DRUG METAB DISPOS, V18, P203
   Wang L, 2000, J PHARMACEUT BIOMED, V21, P1243, DOI 10.1016/S0731-7085(99)00231-9
   Wang PS, 2000, JAMA-J AM MED ASSOC, V283, P3211, DOI 10.1001/jama.283.24.3211
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   Whang K, 2000, BIOMATERIALS, V21, P2545, DOI 10.1016/S0142-9612(00)00122-8
   Whang K, 1998, J BIOMED MATER RES, V42, P491, DOI 10.1002/(SICI)1097-4636(19981215)42:4<491::AID-JBM3>3.0.CO;2-F
   WHANG K, 2000, AM SOC BON MIN RES 2, pS225
   Wozney JM, 2002, SPINE, V27, pS2, DOI 10.1097/01.BRS0000020725.01916.7E
   YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681
NR 42
TC 19
Z9 20
U1 1
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG 1
PY 2005
VL 74A
IS 2
BP 237
EP 246
DI 10.1002/jbm.a.30309
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 945KB
UT WOS:000230500300012
PM 15981201
DA 2018-10-20
ER

PT J
AU Whang, KM
   Grageda, E
   Khan, A
   McDonald, J
   Lawton, M
   Satsangi, N
AF Whang, KM
   Grageda, E
   Khan, A
   McDonald, J
   Lawton, M
   Satsangi, N
TI A novel osteotropic biomaterial OG-PLG: In vitro efficacy
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE statin; simvastatin grafted to poly(lactide-co-glycolicle) (OG-PLG); rat
   bone marrow cells; bone regeneration
ID COA REDUCTASE INHIBITORS; MARROW STROMAL CELLS; OSTEOBLAST
   DIFFERENTIATION; BONE; SIMVASTATIN; EXPRESSION; PROTEIN; STATINS;
   FRACTURES; COMPACTIN
AB Previously, a novel osteotropic biomaterial, OG-PLG [simvastatin grafted to poly(lactide-co-glycolide), PLG], was synthesized and shown to have degradation-controlled release kinetics. The objective here was to determine the effect of grafting statins to PLG on bone regeneration in vitro. Rat bone marrow cells were stimulated in vitro with simvastatin dissolved in media, saponified simvastatin dissolved in media, simvastatin released through diffusion from emulsion freeze-dried scaffolds, and OG-PLG. Unstimulated cultures and cultures stimulated with dexamethasone were used as negative and positive controls, respectively. In vitro bone formation was assessed using the alkaline phosphatase (ALP) and von Kossa assays at different times up to 16 days. ALP analysis revealed that saponified simvastatin at 10(-7) M and OG-PLG significantly increased ALP expression at various time points. von Kossa assay showed that simvastatin, saponified simvastatin, and OG-PLG significantly enhanced mineralization, with the effect from OG-PLG being the most significant. In short, OG-PLG significantly enhanced in vitro bone cell mineralization beyond the effect of simvastatin or saponified simvastatin dissolved in media and simvastatin released via diffusion from scaffolds. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Texas, Hlth Sci Ctr, Dept Restorat Dent, Div Biomat, San Antonio, TX 78229 USA.
   Univ Texas, Hlth Sci Ctr, Dept Prosthodont, San Antonio, TX 78229 USA.
RP Whang, KM (reprint author), Univ Texas, Hlth Sci Ctr, Dept Restorat Dent, Div Biomat, 7703 Floyd Curl Dr,MSC 7890, San Antonio, TX 78229 USA.
EM whang@uthscsa.edu
FU NIDCR NIH HHS [1 R03DE 14653, DE14318]
CR Aubin JE, 1999, J CELL BIOCHEM, V72, P396, DOI 10.1002/(SICI)1097-4644(19990301)72:3<396::AID-JCB9>3.3.CO;2-Y
   Bi LX, 1999, CALCIFIED TISSUE INT, V64, P63, DOI 10.1007/s002239900580
   Cummings SR, 2000, JAMA-J AM MED ASSOC, V283, P3255, DOI 10.1001/jama.283.24.3255
   HABERSTADT C, 1992, MATER RES SOC S P, V252, P323
   HARRIS SE, 1994, J BONE MINER RES, V9, P389
   KENLEY RA, 1993, PHARMACEUT RES, V10, P1393, DOI 10.1023/A:1018902720816
   KEYOMARSI K, 1991, CANCER RES, V51, P3602
   Maeda T, 2003, ENDOCRINOLOGY, V144, P681, DOI 10.1210/en.2002.220682
   Maeda T, 2001, BIOCHEM BIOPH RES CO, V280, P874, DOI 10.1006/bbrc.2000.4232
   Meier CR, 2000, JAMA-J AM MED ASSOC, V283, P3205, DOI 10.1001/jama.283.24.3205
   Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946
   Ohnaka K, 2001, BIOCHEM BIOPH RES CO, V287, P337, DOI 10.1006/bbrc.2001.5597
   Ohno T, 2003, TRANSPLANTATION, V76, P869, DOI 10.1097/01.TP.0000074992.49236.58
   Phillips BW, 2001, BIOCHEM BIOPH RES CO, V284, P478, DOI 10.1006/bbrc.2001.4987
   Song CL, 2003, BIOCHEM BIOPH RES CO, V308, P458, DOI 10.1016/S0006-291X(03)01408-6
   Sugiyama M, 2000, BIOCHEM BIOPH RES CO, V271, P688, DOI 10.1006/bbrc.2000.2697
   TODD PA, 1990, DRUGS, V40, P583, DOI 10.2165/00003495-199040040-00007
   Wang PS, 2000, JAMA-J AM MED ASSOC, V283, P3211, DOI 10.1001/jama.283.24.3211
   Wang XD, 2003, ARCH BIOCHEM BIOPHYS, V415, P6, DOI 10.1016/S0003-9861(03)00213-3
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   WHANG K, 2005, IN PRESS J BIOMED MA
   Wong RWK, 2003, BRIT J ORAL MAX SURG, V41, P244, DOI 10.1016/S0266-4356(03)00081-0
NR 22
TC 14
Z9 14
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG 1
PY 2005
VL 74A
IS 2
BP 247
EP 253
DI 10.1002/jbm.a.30370
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 945KB
UT WOS:000230500300013
PM 15962265
DA 2018-10-20
ER

PT J
AU Lee, VA
   Craig, RG
   Filisko, FE
   Zand, R
AF Lee, VA
   Craig, RG
   Filisko, FE
   Zand, R
TI Microcalorimetry of the adsorption of lysozyme onto polymeric substrates
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE lysozyme; protein adsorption; protein conformation; microcalorimetry;
   biocompatibility; interfacial energy
ID BOVINE PANCREAS RIBONUCLEASE; FOREIGN SURFACE INTERACTIONS; HUMAN-PLASMA
   ALBUMIN; PROTEIN ADSORPTION; 3-DIMENSIONAL STRUCTURE; POLYSTYRENE
   SURFACES; SERUM-ALBUMIN; THERMODYNAMICS; CALORIMETRY; MECHANISMS
AB The conformation of blood proteins adsorbed on biomaterial surfaces probably plays a significant role in the biocompatibility of bloodcontacting implants. This paper reports heats of adsorption of a globular protein, lysozyme, onto three uncharged polymeric substrates. Variations in heats among substrates reflect differences in the lysozyme/substrate interaction as well as the possibility of substrate-dependent conformations. In each case, a series of plateaus appeared in the adsorption isotherm with increasing concentration. In the cases of two substrates, polystyrene and poly(styrene-co-butyl methacrylate), endothermic discontinuities appeared at rises between plateaus. It is proposed that the step pattern in each isotherm reflects distinct conformational states of lysozyme on the substrate surfaces. Endothermic discontinuities may be latent heats associated with change to a more stable conformation after initial adsorption. The absence of discontinuities in the case of poly(styrene-co-allyl alcohol) suggests structural transitions occur to a smaller extent on this material and results in conformations different from those which occur when lysozyme is adsorbed by polystyrene or by poly(styrene-co-butyl methacrylate). (c) 2005 Elsevier Inc. All rights reserved.
C1 Univ Texas, Hlth Sci Ctr, San Antonio, TX 78285 USA.
   Univ Michigan, Ann Arbor, MI 48109 USA.
RP Lee, VA (reprint author), Univ Texas, Hlth Sci Ctr, 7703 Floyd Curl Dr, San Antonio, TX 78285 USA.
EM leev@uthscsa.edu
CR BIRDI KS, 1973, J COLLOID INTERFACE, V43
   Cantor C. R., 1980, BIOPHYSICAL CHEM
   CHATTORAJ DK, 1959, J AM CHEM SOC, V81, P5128, DOI 10.1021/ja01528a027
   CHIU TH, 1976, T AM SOC ART INT ORG, V22, P498
   COOPER A, 1976, P NATL ACAD SCI USA, V73, P2740, DOI 10.1073/pnas.73.8.2740
   FAIR BD, 1980, J COLLOID INTERF SCI, V77, P525, DOI 10.1016/0021-9797(80)90325-2
   FILISKO FE, 1986, BIOMATERIALS, V7, P348, DOI 10.1016/0142-9612(86)90005-0
   FLEER GJ, 1988, MAKROMOL CHEM-M SYMP, V17, P39, DOI 10.1002/masy.19880170106
   GIVOL D, 1965, P NATL ACAD SCI USA, V53, P676, DOI 10.1073/pnas.53.3.676
   HLADY V, 1979, J COLLOID INTERF SCI, V69, P460, DOI 10.1016/0021-9797(79)90135-8
   JOLLES P, 1960, ENZYMES
   KANG IK, 1988, BIOMATERIALS, V9, P138, DOI 10.1016/0142-9612(88)90112-3
   KOGOWSKI G, 1980, J PHYS CHEM-US, V84, P2262, DOI 10.1021/j100455a009
   KOUTSOUKOS PG, 1983, J COLLOID INTERF SCI, V95, P385, DOI 10.1016/0021-9797(83)90198-4
   KRESHECK GC, 1969, BIOCHEMISTRY-US, V8, P8, DOI 10.1021/bi00829a002
   Lee VA, 1996, J BIOMED MATER RES, V31, P51, DOI 10.1002/(SICI)1097-4636(199605)31:1<51::AID-JBM7>3.0.CO;2-P
   Levine S N, 1969, J Biomed Mater Res, V3, P83, DOI 10.1002/jbm.820030108
   LEWANDOWSKA K, 1992, J BIOMED MATER RES, V26, P1343, DOI 10.1002/jbm.820261007
   Lu JR, 1998, J COLLOID INTERF SCI, V206, P212, DOI 10.1006/jcis.1998.5680
   LUNDSTROM I, 1987, POLYM SURFACES INTER
   Macritchie F, 1978, Adv Protein Chem, V32, P283, DOI 10.1016/S0065-3233(08)60577-X
   MARON SH, 1972, J MACROMOL SCI PHYS, VB  6, P57, DOI 10.1080/00222347208224789
   NORDE W, 1979, J COLLOID INTERF SCI, V71, P350, DOI 10.1016/0021-9797(79)90245-5
   NORDE W, 1978, J COLLOID INTERF SCI, V66, P295, DOI 10.1016/0021-9797(78)90307-7
   NYILAS E, 1974, T AM SOC ART INT ORG, VB 20, P480
   OLESEN H, 1968, ACTA CHEM SCAND, V22, P1386, DOI 10.3891/acta.chem.scand.22-1386
   PACE C N, 1975, Critical Reviews in Biochemistry, V3, P1, DOI 10.3109/10409237509102551
   Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X
   SAXENA VP, 1970, BIOCHEMISTRY-US, V9, P5015
   STEVENS O, 1967, P SOC EXP BIOL MED, V124, P187
   WAHLGREN M, 1991, TRENDS BIOTECHNOL, V9, P201, DOI 10.1016/0167-7799(91)90064-O
   YAN G, 1995, PROTEINS INTERFACES, V2
   1975, HDB BIOCH MOL BIOL, V2
NR 33
TC 12
Z9 12
U1 1
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD AUG 1
PY 2005
VL 288
IS 1
BP 6
EP 13
DI 10.1016/j.jcis.2005.02.057
PG 8
WC Chemistry, Physical
SC Chemistry
GA 936NB
UT WOS:000229861600002
PM 15927555
DA 2018-10-20
ER

PT J
AU Yang, JM
   Lin, HT
   Yang, SJ
AF Yang, JM
   Lin, HT
   Yang, SJ
TI Evaluation of poly(N-isopropylacrylamide) modified hydroxyl-terminated
   polybutadiene based polyurethane membrane
SO JOURNAL OF MEMBRANE SCIENCE
LA English
DT Article
DE hydroxyl-terminated polybutadiene; polyurethane;
   poly(N-isopropylacrylamide); wettability; permeability
ID SBS-G-VP; DMAEMA COPOLYMER MEMBRANE; WATER-VAPOR TRANSMISSION; OXYGEN
   PERMEATION; SURFACE-PROPERTIES; BIOMATERIAL USAGE; WOUND DRESSINGS;
   CULTURED-CELLS; UV-RADIATION; TEMPERATURE
AB Hydroxyl-terminated polybutadiene (HTPB) based polyurethane was synthesized by reacting equal equivalent of 4,4-methylene dipheny) diisocyanate (MDI) and hydroxyl-terminated polybutadiene with 1,4-butane diol (BDO) as chain extender. The HTPB based polyurethane was modified by UV radiation with N-isopropylacrylamide monomer to get poly (N-isopropylacrylamide) modified polyurethane (PUNIPAAm). The cohesive properties were calculated by group contribution methods. The characterization of the PUNIPAAm membrane was studied by the Fourier transform infrared spectroscopy, Nikon Microphot-Fx, and Universal Testing Machine for the chemical composition, morphology, and stress-strain curve. Water content and contact angles of distilled water on the PUNIPAAm membrane were evaluated and the surface tension of PUNIPAAm was calculated. The diffusion coefficient of distilled water in the membrane was determined. The measurement of water vapor transmission rate on PUNIPAAm membranes was also evaluated. It was found that the values of surface tension, water vapor transmission rate, and diffusion coefficient of water on PUNIPAAm membranes were higher than those on pure polyurethane. The property changes reduced the permeability of oxygen through PUNIPAAm membrane. The preexponential terms (P-O) and activation energies (E-act) for oxygen through various PUNIPAAm membranes were obtained by the Arrhenius law. The preexponential term P-O for PUNIPAAm membranes is lower than that of pure PU; whereas there is no significant difference for the activation energy of oxygen through PUNIPAAm and pure PU. (c) 2005 Elsevier B.V. All rights reserved.
C1 Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
RP Yang, JM (reprint author), Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
EM jmyang@mail.cgu.edu.tw
CR CARDONA LR, 1996, BIOMATERIALS, V17, P1639
   CHEN CC, 2000, Patent No. 6022330
   COLEMAN MM, 1988, MACROMOLECULES, V21, P59, DOI 10.1021/ma00179a014
   HSIUE GH, 1988, J BIOMED MATER RES, V22, P405, DOI 10.1002/jbm.820220504
   Kikuchi A, 1998, J BIOMAT SCI-POLYM E, V9, P1331, DOI 10.1163/156856298X00424
   Lim YH, 1997, J APPL POLYM SCI, V64, P2647
   Lin FH, 2000, MATER CHEM PHYS, V64, P189, DOI 10.1016/S0254-0584(99)00262-X
   LYMAN DJ, 1974, T AM SOC ART INT ORG, VB 20, P474
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   OKANO T, 1995, J CONTROL RELEASE, V36, P125, DOI 10.1016/0168-3659(95)00054-C
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   Takahashi H, 2003, BLOOD COAGUL FIBRIN, V14, P87, DOI 10.1097/01.mbc.0000046174.72384.29
   TAKEI YG, 1995, BIOMATERIALS, V16, P667, DOI 10.1016/0142-9612(95)99692-F
   Uchida K, 2000, BIOMATERIALS, V21, P923, DOI 10.1016/S0142-9612(99)00260-4
   VANKREVELEN DW, 1976, PROPERTIES POLYM, pCH7
   Wu P, 1996, BIOMATERIALS, V17, P1373, DOI 10.1016/0142-9612(96)87277-2
   WU P, 1995, BIOMATERIALS, V16, P171, DOI 10.1016/0142-9612(95)92114-L
   Yakushiji T, 1999, ANAL CHEM, V71, P1125, DOI 10.1021/ac980677t
   YAMADA N, 1990, MAKROMOL CHEM-RAPID, V11, P571
   Yamato M, 2001, TISSUE ENG, V7, P473, DOI 10.1089/10763270152436517
   Yang JM, 2003, J APPL POLYM SCI, V90, P1331, DOI 10.1002/app.12787
   Yang JM, 1997, J APPL POLYM SCI, V65, P365, DOI 10.1002/(SICI)1097-4628(19970711)65:2<365::AID-APP17>3.0.CO;2-Z
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 2002, J MEMBRANE SCI, V208, P105, DOI 10.1016/S0376-7388(02)00180-1
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1997, J BIOMED MATER RES, V35, P175, DOI 10.1002/(SICI)1097-4636(199705)35:2<175::AID-JBM5>3.0.CO;2-K
   Yang JM, 1997, J APPL POLYM SCI, V65, P109
   YANG JM, 1995, ANGEW MAKROMOL CHEM, V231, P1, DOI 10.1002/apmc.1995.052310101
   YANG JM, 1990, J APPL POLYM SCI, V39, P1475, DOI 10.1002/app.1990.070390706
   Yang JM, 1997, J MEMBRANE SCI, V128, P133, DOI 10.1016/S0376-7388(96)00312-2
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   Yang JM, 1999, J MEMBRANE SCI, V153, P175, DOI 10.1016/S0376-7388(98)00261-0
   Yang JM, 2001, J MEMBRANE SCI, V187, P159, DOI 10.1016/S0376-7388(01)00340-4
   Yang JM, 1999, J BIOMED MATER RES, V45, P133, DOI 10.1002/(SICI)1097-4636(199905)45:2<133::AID-JBM8>3.3.CO;2-4
   Yang JM, 2001, J MEMBRANE SCI, V183, P37, DOI 10.1016/S0376-7388(00)00550-0
   YANG JM, 1990, J APPL POLYM SCI, V41, P1141, DOI 10.1002/app.1990.070410523
   Yang JM, 2004, J MEMBRANE SCI, V243, P1, DOI 10.1016/j.memsci.2004.03.019
NR 37
TC 17
Z9 18
U1 1
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0376-7388
J9 J MEMBRANE SCI
JI J. Membr. Sci.
PD AUG 1
PY 2005
VL 258
IS 1-2
BP 97
EP 105
DI 10.1016/j.memsci.2005.02.033
PG 9
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 942QD
UT WOS:000230296000013
DA 2018-10-20
ER

PT J
AU El Fray, M
   Boccaccini, AR
AF El Fray, M
   Boccaccini, AR
TI Novel hybrid PET/DFA-TiO2 nanocomposites by in situ polycondensation
SO MATERIALS LETTERS
LA English
DT Article
DE polymers; nanomaterials; TiO2 nanoparticles
ID TISSUE ENGINEERING APPLICATIONS; COMPOSITE-MATERIALS; NANOPHASE
   CERAMICS; POLYESTER; TIO2; SOL; BIOCOMPATIBILITY; OSTEOBLAST;
   COPOLYMERS; ADHESION
AB Multiblock poly(aliphatic/aromatic-ester)s containing phthalic acid sequences (as in poly(ethylene terephthalate) (PET) or poly(butylene terephthalate) (PBT)) and a dimmer fatty acid (DFA) represent novel biocompatible materials offering the processability of thermoplastics combined with the good elasticity of rubber (thermoplastic elastomers, TPE). In the present investigation TiO2 nanoparticles were incorporated into PET/DFA copolymer with the aim of increasing mechanical properties and bioactivity, for use of the composites in tissue engineering and other biomedical applications. It was found that a relatively low concentration of TiO2 nanoparticles (0.13 vol.%) led to an impressive improvement of fracture strength (100%) and elongation at fracture (300%). As expected, the surface roughness increased with the addition of TiO2 nanoparticles. However upon immersion in simulated body fluid for up to 21 days, the composites did not exhibit formation of hydroxyapatite crystals on their surfaces, confirming the "bioinert" character of the composite constituents. This indicates that the possible bioactive behavior of the composites in in vitro or in vivo conditions may be related to the improved nanotopography imparted by TiO2 nanoparticle additions rather than due to chemistry related effects at the cell/biomaterial interface. (c) 2005 Elsevier B.V. All rights reserved.
C1 Szcsecin Univ Technol, Inst Polymer, PL-70322 Szczecin, Poland.
   Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England.
RP El Fray, M (reprint author), Szcsecin Univ Technol, Inst Polymer, Pulaskiego 10, PL-70322 Szczecin, Poland.
EM mirfray@ps.pl
RI El Fray, Miroslawa/J-4128-2016; Boccaccini, Aldo/C-7905-2013
OI El Fray, Miroslawa/0000-0002-2474-3517
CR Areva S, 2004, J BIOMED MATER RES A, V70A, P169, DOI 10.1002/jbm.a.20120
   BAKKER D, 1990, J BIOMED MATER RES, V24, P489, DOI 10.1002/jbm.820240407
   Boccaccini AR, 2003, COMPOS SCI TECHNOL, V63, P2417, DOI 10.1016/S0266-3538(03)00275-6
   Chen XC, 2002, J MATER SCI LETT, V21, P1637, DOI 10.1023/A:1020871830587
   El Fray M, 2000, J MATER SCI-MATER M, V11, P757
   El Fray M, 1996, ANGEW MAKROMOL CHEM, V234, P103
   El Fray M, 2003, NANOSTRUCTURED ELAST, P1
   ELFRAY M, 2003, SCI PAPERS I ORGANIC, V52, P481
   ETTLINGER M, TECHNICAL B PIGMENTS, V80, P5
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   Holden G., 1996, THERMOPLASTIC ELASTO
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jokinen M, 1998, J BIOMED MATER RES, V42, P295, DOI 10.1002/(SICI)1097-4636(199811)42:2<295::AID-JBM15>3.0.CO;2-I
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Moritz N, 2003, J BIOMED MATER RES A, V65A, P9, DOI 10.1002/jbm.a.10434
   Prowans P, 2002, BIOMATERIALS, V23, P2973, DOI 10.1016/S0142-9612(02)00026-1
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Renke-Gluszko M, 2004, BIOMATERIALS, V25, P5191, DOI 10.1016/j.biomaterials.2003.12.021
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Savaiano JK, 2004, BIOMATERIALS, V25, P1205, DOI 10.1016/j.biomaterials.2003.08.012
   SZYCHER M, 1990, POLYURETHANE ELASTOM
   Wang SX, 1999, J MATER SCI LETT, V18, P2009, DOI 10.1023/A:1006646219253
   Webster TJ, 2003, AM CERAM SOC BULL, V82, P23
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wise DL, 2000, BIOMATERIALS BIOENGI
   Zheng MP, 2000, J MATER SCI LETT, V19, P433, DOI 10.1023/A:1006703224379
NR 27
TC 37
Z9 37
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD AUG
PY 2005
VL 59
IS 18
BP 2300
EP 2304
DI 10.1016/j.matlet.2005.03.008
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 935XQ
UT WOS:000229817100014
DA 2018-10-20
ER

PT J
AU Lee, SH
   Takahashi, E
   Nomura, N
   Chiba, A
AF Lee, SH
   Takahashi, E
   Nomura, N
   Chiba, A
TI Effect of heat treatment on microstructure and mechanical properties of
   Ni- and C-free Co-Cr-Mo alloys for medical applications
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE cobalt chromium molybdenum alloy; microstructure; mechanical properties;
   heat treatment; biomaterial; nickel carbon free
ID IMPLANT ALLOY
AB The effect of pre-heat treatments, followed by a hot forging process, on the microstructure and strength of Co-Cr-Mo alloys was investigated. Four pre-heat treatments were conducted at 1170, 1200, 1230 and 1260 degrees C for three different time condition: 2, 6 and 15 h and then water cooled to room temperature. Tensile tests and XRD analyses were carried out on both as-east alloy and heat-treated alloys. The volume fraction of retained gamma phase increases with increasing the heat treatment temperature, suggesting that the gamma -> epsilon martensitic transformation is suppressed by a higher temperature heat treatment. Tensile strength slightly decreases with increasing the heat treatment temperature and the heat treatment time, whereas the ductility slightly increases. The a phase completely dissolves into matrix when the alloy is heat-treated at 1260 degrees C for longer than 6 h.
C1 Iwate Univ, Ctr Reg Collaborat Res & Educ, Morioka, Iwate 0208551, Japan.
   Iwate Univ, Fac Engn, Dept Welf Engn, Morioka, Iwate 0208551, Japan.
RP Lee, SH (reprint author), Iwate Univ, Ctr Reg Collaborat Res & Educ, Morioka, Iwate 0208551, Japan.
RI NOMURA, Naoyuki/L-7149-2017; Chiba, Akihiko/D-1326-2011
CR Chiba A, 2005, MATER SCI FORUM, V475-479, P2317, DOI 10.4028/www.scientific.net/MSF.475-479.2317
   Huang P, 1999, MATER LETT, V39, P249, DOI 10.1016/S0167-577X(99)00022-1
   Montero-Ocampo C, 1999, METALL MATER TRANS A, V30, P611, DOI 10.1007/s11661-999-0052-6
   Pickering F. B., 1978, PHYS METALLURGY DESI, P10
   Sage M., 1950, REV METALL, V49, P139
   SHI LQ, 1994, J MATER SCI, V29, P1233, DOI 10.1007/BF00975070
   SHI LQ, 1993, J MATER SCI, V28, P1312, DOI 10.1007/BF01191970
   TAYLOR RNJ, 1983, J MATER SCI, V18, P3265, DOI 10.1007/BF00544151
   ZHUANG LZ, 1989, J MATER SCI, V24, P381, DOI 10.1007/BF01107415
NR 9
TC 30
Z9 30
U1 0
U2 7
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD AUG
PY 2005
VL 46
IS 8
BP 1790
EP 1793
DI 10.2320/matertrans.46.1790
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 958VP
UT WOS:000231476600013
DA 2018-10-20
ER

PT J
AU Matsuura, H
   Inoue, T
   Ogasawara, K
   Sasaki, M
   Konno, H
   Kuzu, Y
   Nishimoto, H
   Ogawa, A
AF Matsuura, H
   Inoue, T
   Ogasawara, K
   Sasaki, M
   Konno, H
   Kuzu, Y
   Nishimoto, H
   Ogawa, A
TI Quantitative analysis of magnetic resonance imaging susceptibility
   artifacts caused by neurosurgical biomaterials: Comparison of 0.5, 1.5.
   and 3.0 Tesla magnetic fields
SO NEUROLOGIA MEDICO-CHIRURGICA
LA English
DT Article
DE ceramic; magnetic field strength; magnetic resonance imaging;
   neurosurgical implants
ID RECONSTRUCTION; QUANTIFICATION; COMPATIBILITY; VISUALIZATION; IMAGES
AB Magnetic resonance (MR) imaging is an important diagnostic tool for neurosurgical diseases but susceptibility artifacts caused by biomaterial instrumentation frequently causes difficulty in visualizing postoperative changes. The susceptibility artifacts caused by neurosurgical biomaterials were compared quantitatively by 0.5, 1.5, and 3.0 Tesla MR imaging. MR imaging of uniform size and shape of pieces ceramic (zirconia), pure titanium, titanium alloy, and cobalt-based alloy was performed at 0.5, 1.5, and 3.0 Tesla. A linear region of interest was defined across the center of the biomaterial in the transverse direction, and the susceptibility artifact diameter was calculated. Susceptibility artifacts developed around all biomaterials at all magnetic field strengths. The artifact diameters caused by pure titanium, titanium alloy, and cobalt-based alloy increased in the order of 0.5, 1.5, to 3.0 Tesla magnetic fields. The artifact diameter of ceramic was not influenced by magnetic field strength, and was the smallest of all biomaterials at all magnetic field strengths. The artifacts caused by biomaterials except ceramic increase with the magnetic field strength. Ceramic instrumentation will minimize artifacts in all magnetic fields.
C1 Iwate Med Univ, Sch Med, Dept Neurosurg, Morioka, Iwate 0208505, Japan.
   Iwate Med Univ, Sch Med, Dept Radiol, Morioka, Iwate 0208505, Japan.
RP Inoue, T (reprint author), Iwate Med Univ, Sch Med, Dept Neurosurg, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.
EM tainoue@iwate-med.ac.jp
CR BATZDORF U, 1991, SPINE, V16, P123, DOI 10.1097/00007632-199102000-00004
   BYDDER GM, 1982, AM J ROENTGENOL, V139, P215, DOI 10.2214/ajr.139.2.215
   CHRISTOFFERSSON JO, 1991, ACTA RADIOL, V32, P426, DOI 10.1177/028418519103200519
   CROOKS LE, 1982, RADIOLOGY, V144, P843, DOI 10.1148/radiology.144.4.7111736
   CROOKS LE, 1983, RADIOLOGY, V146, P123, DOI 10.1148/radiology.146.1.6849032
   FARAHANI K, 1990, COMPUT MED IMAG GRAP, V14, P409, DOI 10.1016/0895-6111(90)90040-I
   Frahm C, 1996, CARDIOVASC INTER RAD, V19, P335
   Grieve JP, 1999, NEURORADIOLOGY, V41, P680, DOI 10.1007/s002340050824
   KOBAYASHI S, 1981, SURG NEUROL, V15, P196, DOI 10.1016/0090-3019(81)90142-7
   KOYAMA T, 1986, SURG NEUROL, V25, P71, DOI 10.1016/0090-3019(86)90118-7
   Matsuura H, 2002, J NEUROSURG, V97, P1472, DOI 10.3171/jns.2002.97.6.1472
   Nitatori T, 1999, Radiat Med, V17, P329
   Port JD, 2000, J COMPUT ASSIST TOMO, V24, P958, DOI 10.1097/00004728-200011000-00024
   Shellock FG, 1998, RADIOLOGY, V206, P838, DOI 10.1148/radiology.206.3.9494511
   Shellock FG, 1996, JMRI-J MAGN RESON IM, V6, P954, DOI 10.1002/jmri.1880060620
   TOMINAGA T, 1995, NEUROSURGERY, V36, P951, DOI 10.1227/00006123-199505000-00010
   YAMASHIMA T, 1988, ACTA NEUROCHIR, V90, P157, DOI 10.1007/BF01560572
NR 17
TC 31
Z9 34
U1 0
U2 3
PU JAPAN NEUROSURGICAL SOC
PI TOKYO
PA C/O AKAMON-MAE IWATA BLDG, 5-27-8 HONGO, BUNKYO-KU, TOKYO, 113-0033,
   JAPAN
SN 0470-8105
J9 NEUROL MED-CHIR
JI Neurol. Med.-Chir.
PD AUG
PY 2005
VL 45
IS 8
BP 395
EP 398
DI 10.2176/nmc.45.395
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 957BG
UT WOS:000231343700003
PM 16127256
OA Bronze
DA 2018-10-20
ER

PT J
AU Krischek, B
   Morgenstern, E
   Mestres, P
   Klinkhardt, U
   Brannath, W
   Wieding, U
   Nemeh, A
   Heinrich, W
   Schenk, J
   Wenzel, T
   Wenzel, E
AF Krischek, B
   Morgenstern, E
   Mestres, P
   Klinkhardt, U
   Brannath, W
   Wieding, U
   Nemeh, A
   Heinrich, W
   Schenk, J
   Wenzel, T
   Wenzel, E
TI Adhesion, spreading, and aggregation of platelets in flowing blood and
   the reliability of the retention test Homburg
SO SEMINARS IN THROMBOSIS AND HEMOSTASIS
LA English
DT Article; Proceedings Paper
CT Symposium on Significance of Drug Monitoring and the Reliability of
   Platelet Function Tests
CY FEB, 2003
CL Innsbruck, AUSTRIA
SP Soc Thrombos & Haemostas Res
DE platelet function measurement; platelet adhesion; platelet aggregation;
   shear stress; platelet-biomaterial interaction
ID SUBENDOTHELIUM; DISEASE
AB Adhesion and aggregation are important parameters characterizing the function of intact platelets in flowing blood and in contact with a more or less thrombogenic surface. In the retention test Homburg (RTH), platelets are exposed to a standardized textured surface (Sysmex retention tubes) under defined conditions of flow. Platelet counts are performed before and after the Sysmex retention tube passage. The difference between these values indicates the percentage of retained platelets (retention index). Decreased retention in the RTH indicates a loss of function or defective platelet function; increase is associated with an increased activation of platelets, for example, in patients with vascular diseases. For further evaluation of the retention phenomenon the filters were fixed after cell passage and examined by scanning electron microscopy (SEM) and transmission electron microscopy (TEM). SEM and TEM micrographs show activated platelets adhering and spreading on the filter surface, comparable with platelets on a disturbed endothelium.
   Also, we examined the influence of different G forces and centrifugation times on the retention behavior of the platelets in citrated platelet-rich plasma (PRP) and whole blood (WB). G forces influenced the retention index in PRP and WB significantly and in a different way. Finally, we used a platelet standard, as customary in the quality check, to determine the serial as well as the day-to-day precision.
C1 Univ Hosp Marburg, Dept Neurosurg, D-35033 Marburg, Germany.
   Univ Hosp Saarland, Inst Anat, Saarbrucken, Germany.
   Univ Hosp Frankfurt, Inst Clin Pharmacol, Frankfurt, Germany.
   Med Univ Vienna, Dept Med Stat, Vienna, Austria.
   Univ Hosp Saarland, Dept Clin Hemostaseol & Transfus Med, Saarbrucken, Germany.
   Univ Hosp Saarland, Working Party Hemostasis, Saarbrucken, Germany.
   Univ Marburg, Dept Neurosurg, Marburg, Germany.
RP Krischek, B (reprint author), Univ Hosp Marburg, Dept Neurosurg, Baldingerstr, D-35033 Marburg, Germany.
EM krischek@med.uni-marburg.de
CR Ahnadi CE, 2003, THROMB HAEMOSTASIS, V90, P940, DOI 10.1160/TH03-02-0097
   BAUMGARTNER HR, 1980, J LAB CLIN MED, V95, P208
   BAUMGARTNER HR, 1978, THROMB HAEMOSTASIS, V39, P782
   CONOVER WJ, 1981, TECHNOMETRICS, V23, P351, DOI 10.2307/1268225
   Harrison P, 2000, BRIT J HAEMATOL, V111, P733
   Hayward CPM, 2003, THROMB HAEMOSTASIS, V90, P770
   HELLEM AJ, 1960, SCAND J CLIN LAB I S, V51, P1
   MESTRES P, 1999, EUR J CELL BIOL S50, V78, P32
   Michelson A D, 1999, Curr Opin Hematol, V6, P342, DOI 10.1097/00062752-199909000-00012
   Rand ML, 2003, TRANSFUS APHER SCI, V28, P307, DOI 10.1016/S1473-0502(03)00050-8
   SALZMAN E, 1963, J LAB CLIN MED, V62, P724
   SCHENK JF, 2001, J THROMB HAEMOST S, DOI UNSP P384
   SCHENK JF, 2002, ANN HEMATOL, V81, pA1
   TSCHOPP TB, 1979, HAEMOSTASIS, V8, P19
NR 14
TC 5
Z9 6
U1 0
U2 3
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0094-6176
J9 SEMIN THROMB HEMOST
JI Semin. Thromb. Hemost.
PD AUG
PY 2005
VL 31
IS 4
BP 449
EP 457
DI 10.1055/s-2005-916680
PG 9
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 965YL
UT WOS:000231986700013
PM 16149023
DA 2018-10-20
ER

PT J
AU LeBlanc, KA
AF LeBlanc, KA
TI Incisional hernia repair: Laparoscopic techniques
SO WORLD JOURNAL OF SURGERY
LA English
DT Article
ID VENTRAL HERNIA; EXPANDED POLYTETRAFLUOROETHYLENE; PATCH REPAIR;
   COMPLICATIONS; EXPERIENCE; RECURRENCE; LESSONS; PTFE; MESH
AB Repair of incisional hernias using the laparoscopic technique has continued to evolve since its inception in 1991. An analysis of the current literature has revealed that hernias as large as 1600 cm(2) have been successfully repaired with this method. The average size appears to be about 105 cm(2). Several choices of a biomaterial are available today, differing in the type of synthetic product or products that are used to manufacture them. Others incorporate an absorbable component. The goal of all of them is to prevent adhesion formation. The fixation devices that can be used are also varied. The results of laparoseopic incisional hernia repair are described. The conversion rate of these procedures is an impressive 2.4% with an enterotomy rate of 1.8%. These results affirm the low risk of this operation. The recurrence rate of 4.2% confirms the permanence of the repair. This procedure may become the standard of care in the near future.
C1 Minimally Invas Surg Inst, Baton Rouge, LA 70808 USA.
   Louisiana State Univ, Sch Med, Dept Surg, New Orleans, LA 70112 USA.
RP LeBlanc, KA (reprint author), Minimally Invas Surg Inst, 7777 Hennessy Blvd,Suite 612, Baton Rouge, LA 70808 USA.
EM DOCMBA2@aol.com
CR Aura T, 2002, J LAPAROENDOSC ADV A, V12, P263, DOI 10.1089/109264202760268041
   Bageacu S, 2002, SURG ENDOSC, V16, P345, DOI 10.1007/s00464-001-0018-2
   Ben-Haim M, 2002, SURG ENDOSC, V16, P785, DOI 10.1007/s00464-001-9126-2
   Berger D, 2002, SURG ENDOSC, V16, P1720, DOI 10.1007/s00464-002-9036-y
   Birgisson G, 2001, SURG ENDOSC-ULTRAS, V15, P1419, DOI 10.1007/s004640080077
   Bower CE, 2004, SURG ENDOSC, V18, P672, DOI 10.1007/s00464-003-8506-1
   Carbajo MA, 2003, SURG ENDOSC, V17, P118, DOI 10.1007/s00464-002-9079-0
   Cassar K, 2002, BRIT J SURG, V89, P534, DOI 10.1046/j.1365-2168.2002.02083.x
   Chelala E, 2003, Hernia, V7, P191
   Chowbey PK, 2000, J LAPAROENDOSC ADV A, V10, P79, DOI 10.1089/lap.2000.10.79
   Clark JL, 2001, J SURG RES, V99, P33, DOI 10.1006/jsre.2001.6093
   DeMaria EJ, 2000, SURG ENDOSC-ULTRAS, V14, P326, DOI 10.1007/s004640020013
   Eid GM, 2003, SURGERY, V134, P599, DOI 10.1016/S0039-6060(03)00273-6
   Franklin M E Jr, 2004, Hernia, V8, P23, DOI 10.1007/s10029-003-0163-8
   Franklin M E Jr, 2004, Hernia, V8, P186
   Frantzides CT, 2004, SURG ENDOSC, V18, P1488, DOI 10.1007/s00464-004-8105-9
   Gillian G Kevin, 2002, JSLS, V6, P315
   Heniford BT, 2003, ANN SURG, V238, P391, DOI 10.1097/01.sla.0000086662.49499.ab
   HESSELINK VJ, 1993, SURG GYNECOL OBSTET, V176, P228
   Kyzer S, 1999, SURG ENDOSC-ULTRAS, V13, P928, DOI 10.1007/s004649901137
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   LeBlanc K A, 2001, Hernia, V5, P41, DOI 10.1007/BF01576164
   LeBlanc K A, 2003, Hernia, V7, P118, DOI 10.1007/s10029-003-0117-1
   LEBLANC KA, 1993, SURG LAPAROSC ENDOSC, V3, P39
   LeBlanc KA, 2002, SURG ENDOSC, V16, P1542, DOI 10.1007/s00464-001-8271-y
   LeBlanc Karl A, 2003, JSLS, V7, P383
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P393
   ROTH JS, 1999, HERNIA, V4, P209
   Sanchez L J, 2004, Hernia, V8, P138, DOI 10.1007/s10029-003-0195-0
   Toy FK, 1998, SURG ENDOSC, V12, P955, DOI 10.1007/s004649900755
   VANDERLINDEN FTPM, 1988, NETH J SURG, V40, P127
NR 31
TC 51
Z9 57
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0364-2313
J9 WORLD J SURG
JI World J.Surg.
PD AUG
PY 2005
VL 29
IS 8
BP 1073
EP 1079
DI 10.1007/s00268-005-7971-1
PG 7
WC Surgery
SC Surgery
GA 949KD
UT WOS:000230783700025
PM 15983711
DA 2018-10-20
ER

PT J
AU Lee, HF
   Sheu, HS
   Jeng, US
   Huang, CF
   Chang, FC
AF Lee, HF
   Sheu, HS
   Jeng, US
   Huang, CF
   Chang, FC
TI Preparation and supramolecular self-assembly of a
   polypeptide-block-polypseudorotaxane
SO MACROMOLECULES
LA English
DT Article
ID ALPHA-CYCLODEXTRIN; POLY(ETHYLENE GLYCOL); INCLUSION COMPLEXES; DIBLOCK
   OLIGOMERS; COPOLYMERS; POLYMER; POLY(EPSILON-CAPROLACTONE); POLYVINYL;
   HYDROGELS; PEPTIDES
AB We have successfully prepared a new class of self-assembled biomaterial: a polypeptide-block-polypseudorotaxane diblock copolymer. This diblock copolymer is comprised of an a-helical polypeptide rod, based on gamma-benzyl-L-glutamate, and an originally coiled segment P(EO19-r-PO3); it forms inclusion complexes with a-cyclodextrins (alpha-CDs) to give crystalline polypseudorotaxanes. Formation of the polypseudorotaxane converts the conformation of P(EO19-r-PO3) from a flexible chain into a rodlike structure, which results in a novel block copolymer exhibiting a rod-rod conformation. Intrinsic interactions (e.g., the polypseudorotaxane's channel-type crystallization, the polypeptide's secondary structure, and microphase separation) within and between these rod-rod diblock copolymers contribute to their hierarchical self-assembly behavior, which we characterized using DSC, H-1 NMR spectroscopy, C-13 CP/MAS NMR spectroscopy, WAXS, and SAXS. The data obtained from the WAXS and SAXS studies clearly indicate the formation of juxtaposed bilayer-like nanostructure featuring hexagonally packed PBLG stacks and channel-type polypseudorotaxane moieties.
C1 Natl Chiao Tung Univ, Inst Appl Chem, Hsinchu 30050, Taiwan.
   Natl Synchrotron Radiat Res Ctr, Hsinchu Sci Pk, Taiwan.
RP Chang, FC (reprint author), Natl Chiao Tung Univ, Inst Appl Chem, Hsinchu 30050, Taiwan.
EM changfc@mail.nctu.edu.tw
RI Chang, Feng-Chih/G-5195-2010; Huang, Chih-Feng/C-2297-2012
OI Huang, Chih-Feng/0000-0002-8062-8708
CR BILLOT JP, 1976, MAKROMOL CHEM, V177, P1889
   BILLOT JP, 1977, MAKROMOL CHEM, V178, P641
   BLOCK H, 1983, POLYYBENZYL L GLUTAM
   Caillol S, 2003, MACROMOLECULES, V36, P1118, DOI 10.1021/ma021187c
   Chen JT, 1996, SCIENCE, V273, P343, DOI 10.1126/science.273.5273.343
   Cornelissen JJLM, 1998, SCIENCE, V280, P1427, DOI 10.1126/science.280.5368.1427
   DALY WH, 1988, TETRAHEDRON LETT, V29, P5859, DOI 10.1016/S0040-4039(00)82209-1
   Deming TJ, 1997, ADV MATER, V9, P299, DOI 10.1002/adma.19970090404
   DEMING TJ, 2000, J POLYM SCI A, V38, P2011
   DOUY A, 1982, POLYMER, V23, P1039, DOI 10.1016/0032-3861(82)90405-0
   Gallot B, 1996, PROG POLYM SCI, V21, P1035, DOI 10.1016/S0079-6700(96)00010-X
   GEHRKE SH, 1993, ADV POLYM SCI, V110, P81
   GLATTER O, 1980, SMALL ANGLE XRAY SCA
   Halstenberg S, 2002, BIOMACROMOLECULES, V3, P710, DOI 10.1021/bm015629o
   HARADA A, 1993, MACROMOLECULES, V26, P5698, DOI 10.1021/ma00073a026
   HARADA A, 1990, MACROMOLECULES, V23, P2821, DOI 10.1021/ma00212a039
   Harada A, 1997, MACROMOLECULES, V30, P7115, DOI 10.1021/ma970680z
   HARADA A, 1993, NATURE, V364, P516, DOI 10.1038/364516a0
   HARADA A, 1992, NATURE, V356, P325, DOI 10.1038/356325a0
   HARADA A, 1994, NATURE, V370, P126, DOI 10.1038/370126a0
   Huang L, 1998, POLYMER, V39, P4857, DOI 10.1016/S0032-3861(97)00568-5
   Hwang MJ, 2004, MACROMOLECULES, V37, P8820, DOI 10.1021/ma0487397
   Kaplan DL, 1998, POLYM DEGRAD STABIL, V59, P25, DOI 10.1016/S0141-3910(97)00000-1
   Kawaguchi Y, 2000, MACROMOLECULES, V33, P4472, DOI 10.1021/ma992103b
   Klok HA, 2001, ADV MATER, V13, P1217, DOI 10.1002/1521-4095(200108)13:16<1217::AID-ADMA1217>3.0.CO;2-D
   Klok HA, 2000, MACROMOLECULES, V33, P7819, DOI 10.1021/ma0009606
   Kong XX, 2004, MACROMOLECULES, V37, P8180, DOI 10.1021/ma048888p
   LAI YH, IN PRESS NUCL INST B
   Lecommandoux S, 2001, MACROMOLECULES, V34, P9100, DOI 10.1021/ma010940j
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee M, 2001, CHEM REV, V101, P3869, DOI 10.1021/cr0001131
   Li J, 2003, J AM CHEM SOC, V125, P1788, DOI 10.1021/ja026623p
   LI J, 2003, MACROMOLECULES, V37, P8820
   McMillan RA, 1999, MACROMOLECULES, V32, P3643, DOI 10.1021/ma981660f
   Muthukumar M, 1997, SCIENCE, V277, P1225, DOI 10.1126/science.277.5330.1225
   Papadopoulos P, 2004, BIOMACROMOLECULES, V5, P81, DOI 10.1021/bm034291q
   PERLY B, 1976, MAKROMOL CHEM, V177, P2569
   Rusa CC, 2001, MACROMOLECULES, V34, P1318, DOI 10.1021/ma001868c
   Schlaad H, 2002, POLYMER, V43, P5321, DOI 10.1016/S0032-3861(02)00360-9
   Shimomura T, 2000, POLYM ADVAN TECHNOL, V11, P837, DOI 10.1002/1099-1581(200008/12)11:8/12<837::AID-PAT61>3.0.CO;2-B
   Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242
   WATANABE J, 1984, POLYMER, V25, P1711, DOI 10.1016/0032-3861(84)90242-8
NR 42
TC 32
Z9 34
U1 0
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD JUL 26
PY 2005
VL 38
IS 15
BP 6551
EP 6558
DI 10.1021/ma050254a
PG 8
WC Polymer Science
SC Polymer Science
GA 947EU
UT WOS:000230627000043
DA 2018-10-20
ER

PT J
AU Aoyagi, S
   Kudo, M
AF Aoyagi, S
   Kudo, M
TI Observation of fluorescence-labeled protein A on a biosensor surface by
   means of TOF-SIMS
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article; Proceedings Paper
CT 10th International Meeting on Chemical Sensors
CY JUL 11-14, 2004
CL Tsukuba, JAPAN
DE TOF-SIMS; mutual information; protein; biosensor; quantum dot
ID ION MASS-SPECTROMETRY; IMMUNOSENSOR; FILMS
AB The ability to carry out evaluations of proteins on biomaterial surfaces such as the distribution of each protein and the orientation of immobilized proteins are required for the development of high performance materials. Since proteins all have the same basic chemical structure it is difficult to distinguish one from the others by means of spectroscopy, even though such techniques do provide useful chemical information. Time-of-flight secondary ion mass spectrometry (TOF-SIMS) provides an avenue into the submicron-scale distribution of specific chemicals and enables investigation of chemical conditions on materials surfaces. Though TOF-SIMS also has problems with the characterization of the mass spectra of protein samples, the mass spectra can be interpreted using data analysis techniques such as are provided by information theory.
   In this study, the distribution of fluorescence-labeled protein A immobilized on glass plates was chemically visualized by means of TOF-SIMS and a spectra analysis technique making use of mutual information. With this analysis technique, TOF-SIMS spectra can be interpreted such that it allows one to select specific peaks for chemical imaging of proteins. In addition, fragment ions from protein A labeled with different fluorescence substances, FITC and quantum dots, are characterizable by means of the mutual information, and their chemical conditions are investigated. (c) 2004 Elsevier B.V. All rights reserved.
C1 Seikei Univ, Fac Engn, Dept Appl Phys, Musashino, Tokyo 1808633, Japan.
RP Aoyagi, S (reprint author), Seikei Univ, Fac Engn, Dept Appl Phys, 3-3-1 Kichijoji Kitamachi, Musashino, Tokyo 1808633, Japan.
EM asatoka@nifty.com
CR Aoyagi S, 2005, BIOSENS BIOELECTRON, V20, P1680, DOI 10.1016/j.bios.2004.06.041
   Aoyagi S, 2004, APPL SURF SCI, V231, P470, DOI 10.1016/j.apsusc.2004.03.181
   Aoyagi S, 2004, APPL SURF SCI, V231, P432, DOI 10.1016/j.apsusc.2004.03.162
   Aoyagi S, 2004, J MEMBRANE SCI, V236, P91, DOI 10.1016/j.memsci.2004.02.010
   Aoyagi S, 2003, BIOSENS BIOELECTRON, V18, P791, DOI 10.1016/S0956-5663(03)00046-0
   AOYAGI S, 2003, J SURF SCI NANOTECHN, V1, P67
   Eckschlager K, 1990, J CHEMOMETR, V4, P195, DOI 10.1002/cem.1180040303
   Lhoest JB, 2001, J BIOMED MATER RES, V57, P432, DOI 10.1002/1097-4636(20011205)57:3<432::AID-JBM1186>3.0.CO;2-G
   Lin CI, 2004, J CHROMATOGR A, V1027, P259, DOI 10.1016/j.chroma.2003.10.037
   Lloyd KG, 2004, APPL SURF SCI, V231, P207, DOI 10.1016/j.apsusc.2004.03.016
   Medintz IL, 2003, NAT MATER, V2, P630, DOI 10.1038/nmat961
   SHANNON CE, 1947, MATH THEORY INFORMAT
   Wagner MS, 2004, APPL SURF SCI, V231, P366, DOI 10.1016/j.apsusc.2004.03.100
   Wagner MS, 2002, ANAL CHEM, V74, P1824, DOI 10.1021/ac0111311
NR 14
TC 9
Z9 9
U1 0
U2 2
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD JUL 22
PY 2005
VL 108
IS 1-2
BP 708
EP 712
DI 10.1016/j.snb.2004.12.012
PG 5
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA 943CS
UT WOS:000230330300117
DA 2018-10-20
ER

PT J
AU Hussain, MA
   Agnihotri, A
   Siedlecki, CA
AF Hussain, MA
   Agnihotri, A
   Siedlecki, CA
TI AFM imaging of ligand binding to platelet integrin alpha(IIb)beta(3)
   receptors reconstituted into planar lipid bilayers
SO LANGMUIR
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; IIB-IIIA COMPLEX; OPTICAL TWEEZERS;
   CONFORMATIONAL REGULATION; ELECTRON-MICROSCOPY; FIBRINOGEN; RGD;
   THROMBASTHENIA; GLYCOPROTEINS; AGGREGATION
AB The platelet integrin alpha(IIb)beta(3) plays a key role in platelet adhesion, activation, and aggregation at the subendothelium and at protein-coated synthetic biomaterials. In this study, interactions between alpha(IIb)beta(3) and both protein and peptide ligands for the receptor were imaged under physiological conditions by high-resolution atomic force microscopy (AFM). To directly image the ligand-receptor interactions, alpha(IIb)beta(3) receptors were reconstituted into a supported lipid bilayer formed on a mica surface in the AFM fluid cell assembly and subsequently activated with Mn2+. Fibrinogen, the natural protein ligand for the integrin, as well as a nanogold-labeled peptide ligand (an RGD-containing heptamer) were infused into the AFM fluid cell, incubated with the reconstituted and activated receptors, and imaged under buffer. Height images illustrating topographical features showed the integrin reconstituted in the bilayer. Fibrinogen molecules binding to the receptors were easily observed in the height images, with fibrinogen showing its characteristic trinodular structure and occasionally bridging integrin receptors. Fibrinogen was observed to bind to integrins at the D-domain consistent with the location of the gamma-chain dodecapeptide, while fibrinogen bridging integrins bound to receptors on opposite sides of the protein consistent with a 2-fold axis of symmetry. Peptide ligands were not visible in height images; however, phase images that map the mechanical properties detected the nanogold labels and demonstrated the presence of peptide ligands bound to the receptors. The results demonstrate the ability of this high-resolution microscopy technique to directly visualize single ligand/receptor interactions in a dynamic and physiologically relevant environment, and establish a framework for future fundamental studies of single protein/receptor interactions during normal pathological processes as well as biomaterial surface-induced thrombosis.
C1 Penn State Univ, Milton S Hershey Med Ctr, Dept Surg, Biomed Engn Inst, Hershey, PA 17033 USA.
   Penn State Univ, Milton S Hershey Med Ctr, Dept Bioengn, Biomed Engn Inst, Hershey, PA 17033 USA.
RP Siedlecki, CA (reprint author), Penn State Univ, Milton S Hershey Med Ctr, Dept Surg, Biomed Engn Inst, Hershey, PA 17033 USA.
EM csiedlecki@psu.edu
RI Hussain, Mohammad/K-3524-2012
CR Agnihotri A, 2004, LANGMUIR, V20, P8846, DOI 10.1021/la049239
   ALBRECHT RM, 1989, AM J ANAT, V185, P149, DOI 10.1002/aja.1001850208
   ALBRECHT RM, 1992, METHOD ENZYMOL, V215, P456
   Arya M, 2002, LASER SURG MED, V30, P306, DOI 10.1002/lsm.10044
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Bockelmann U, 2002, BIOPHYS J, V82, P1537, DOI 10.1016/S0006-3495(02)75506-9
   Boudreaux MK, 2001, VET PATHOL, V38, P249, DOI 10.1354/vp.38-3-249
   BRIAN AA, 1984, P NATL ACAD SCI-BIOL, V81, P6159, DOI 10.1073/pnas.81.19.6159
   Brouhard GJ, 2003, IEEE T BIO-MED ENG, V50, P121, DOI 10.1109/TBME.2002.805463
   CALVETE JJ, 1994, THROMB HAEMOSTASIS, V72, P1
   Dietrich Anja, 2002, J Biotechnol, V82, P211
   DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E
   EPPELL SJ, 1995, BIOPHYS J, V68, P671, DOI 10.1016/S0006-3495(95)80228-6
   FARRELL DH, 1992, P NATL ACAD SCI USA, V89, P10729, DOI 10.1073/pnas.89.22.10729
   FARRELL DH, 1994, J BIOL CHEM, V269, P226
   Garrett JT, 2001, MACROMOLECULES, V34, P7066, DOI 10.1021/ma0102114
   GINSBERG MH, 1995, THROMB HAEMOSTASIS, V74, P352
   HAINFELD JF, 1997, CELL VISION, V4, P408
   Holland NB, 2000, J BIOMED MATER RES, V51, P307, DOI 10.1002/1097-4636(20000905)51:3<307::AID-JBM3>3.0.CO;2-H
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   Hussain MA, 2004, MICRON, V35, P565, DOI 10.1016/j.micron.2004.02.010
   KIEFFER N, 1990, ANNU REV CELL BIOL, V6, P329
   Kokkoli E, 2004, LANGMUIR, V20, P2397, DOI 10.1021/la035597l
   Lee I, 2003, ULTRAMICROSCOPY, V97, P341, DOI 10.1016/S0304-3991(03)00059-7
   Lee I, 2001, SURF SCI, V491, P433, DOI 10.1016/S0039-6028(01)01309-7
   Lin H, 2000, BIOCHEMISTRY-US, V39, P3192, DOI 10.1021/bi991624o
   Marchant RE, 1997, THROMB HAEMOSTASIS, V77, P1048
   MARGUERIE GA, 1980, J BIOL CHEM, V255, P154
   MULLER B, 1993, J BIOL CHEM, V268, P6800
   Nagao E, 1999, BIOPHYS J, V76, P3289, DOI 10.1016/S0006-3495(99)77481-3
   Pang GKH, 2000, ULTRAMICROSCOPY, V81, P35, DOI 10.1016/S0304-3991(99)00164-3
   PARISE LV, 1985, J BIOL CHEM, V260, P698
   Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174
   Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922
   Simmons SR, 1996, J LAB CLIN MED, V128, P39, DOI 10.1016/S0022-2143(96)90112-2
   STEINER B, 1989, J BIOL CHEM, V264, P13102
   Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2
   Thompson NL, 1997, CURR OPIN BIOTECH, V8, P58, DOI 10.1016/S0958-1669(97)80158-9
   Tomiyama Y, 2000, INT J HEMATOL, V72, P448
   Tullu Milind S., 2001, Indian Journal of Pediatrics, V68, P563, DOI 10.1007/BF02723255
   WEISEL JW, 1992, J BIOL CHEM, V267, P16637
NR 41
TC 28
Z9 30
U1 1
U2 22
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUL 19
PY 2005
VL 21
IS 15
BP 6979
EP 6986
DI 10.1021/la046943h
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 945MU
UT WOS:000230507400045
PM 16008412
DA 2018-10-20
ER

PT J
AU Hao, L
   Lawrence, J
   Li, L
AF Hao, L
   Lawrence, J
   Li, L
TI The wettability modification of bio-grade stainless steel in contact
   with simulated physiological liquids by the means of laser irradiation
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT Spring Meeting of the European-Materials-Research-Society
CY MAY 24-28, 2004
CL Strasbourg, FRANCE
SP European Mat Res Soc
DE laser; wertability; 316LS stainless steel; surface energy
ID PARTIALLY-STABILIZED ZIRCONIA; CO2-LASER TREATMENT; SOLID-SURFACES;
   CELL-ADHESION; EXCIMER; MECHANISMS; METALS
AB Early surface events that occur rapidly upon implantation of a biomaterial into biological fluids determine the subsequent response. These involve wetting by physiological liquids followed by adsorption of proteins and cells to the biomaterials surface. A CO, laser and high power diode laser (HPDL) were used to modify the surface properties of the material and thus manipulate the wettability of the material and its interaction with physiological liquids. The contact angles, theta, of selected test liquids including simulated physiological liquids shows that the wettability of the stainless steel improved after CO2 and HPDL treatment. The determined adhesion work of stainless steel towards stimulated physiological fluid enhanced after laser treatment, implying better interaction with the biological liquids. It is demonstrated that the laser could be a novel and controllable technique for enhancing the biocompatibility of bio-grade stainless steel. (c) 2005 Elsevier B.V. All rights reserved.
C1 Loughborough Univ Technol, Wolfson Sch Mech Engn, Rapid Mfg Grp, Loughborough LE11 3TU, Leics, England.
   Univ Manchester, Inst Sci & Technol, Dept Mech Aerosp & Mfg Engn, Laser Proc Res Ctr, Manchester M60 1QD, Lancs, England.
RP Hao, L (reprint author), Loughborough Univ Technol, Wolfson Sch Mech Engn, Rapid Mfg Grp, Loughborough LE11 3TU, Leics, England.
EM l.hao@lboro.ac.uk
OI Hao, Liang/0000-0003-2071-7044; Lawrence, Jonathan/0000-0002-1649-9948
CR Amaral M, 2002, BIOMATERIALS, V23, P4123, DOI 10.1016/S0142-9612(02)00155-2
   Annarelli CC, 1999, J COLLOID INTERF SCI, V213, P386, DOI 10.1006/jcis.1999.6153
   Critchlow GW, 1997, INT J ADHES ADHES, V17, P143, DOI 10.1016/S0143-7496(96)00037-1
   FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008
   Hao L, 2004, J LASER APPL, V16, P252, DOI 10.2351/1.1809636
   Hao L, 2004, COLLOID SURFACE B, V34, P87, DOI 10.1016/j.colsurfb.2003.12.008
   Hao L, 2003, MAT SCI ENG C-BIO S, V23, P627, DOI 10.1016/S0928-4931(03)00056-0
   Hao L, 2003, J PHYS D APPL PHYS, V36, P1292, DOI 10.1088/0022-3727/36/11/309
   HEITZ J, 1992, APPL PHYS A-MATER, V55, P391, DOI 10.1007/BF00324090
   HENARI F, 1995, APPL OPTICS, V34, P581, DOI 10.1364/AO.34.000581
   KINLOCH AJ, 1987, ADHESION ADHESIVES S, P30
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lawrence J, 2002, J LASER APPL, V14, P107, DOI 10.2351/1.1471560
   Lawrence J, 2000, APPL SURF SCI, V154, P664, DOI 10.1016/S0169-4332(99)00416-X
   NEUMANN AW, 1972, J COLLOID INTERF SCI, V38, P341, DOI 10.1016/0021-9797(72)90251-2
   Olfert M, 1996, J LASER APPL, V8, P79, DOI 10.2351/1.4745407
   RATNER BD, 1998, PROGR BIOMEDICAL ENG, V6, P219
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   Schmidt C, 2001, J BIOMED MATER RES, V54, P209, DOI 10.1002/1097-4636(200102)54:2<209::AID-JBM7>3.0.CO;2-7
   TAMADA Y, 1993, POLYMER, V34, P2208, DOI 10.1016/0032-3861(93)90752-V
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   VOGLER EA, 1993, SURFACTANT SCI SERIE, V49, P184
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
   李建国, 1993, Rare Metals, V12, P84
NR 24
TC 41
Z9 42
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JUL 15
PY 2005
VL 247
IS 1-4
BP 453
EP 457
DI 10.1016/j.apsusc.2005.01.163
PG 5
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 939UQ
UT WOS:000230098300071
DA 2018-10-20
ER

PT J
AU Andersson, M
   Andersson, J
   Sellborn, A
   Berglin, M
   Nilsson, B
   Elwing, H
AF Andersson, M
   Andersson, J
   Sellborn, A
   Berglin, M
   Nilsson, B
   Elwing, H
TI Quartz crystal microbalance-with dissipation monitoring (QCM-D) for real
   time measurements of blood coagulation density and immune complement
   activation on artificial surfaces
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE quartz crystal microbalance; blood coagulation; complement activation;
   enzyme immuno assay
ID PLASMON RESONANCE; WHOLE-BLOOD; POLYMER-FILMS; CROSS-LINKING; IN-VITRO;
   PROTEIN; ADSORPTION; CONTACT; ELLIPSOMETRY; BIOMATERIAL
AB A recently developed variant of quartz crystal microbalance (QCM) called QCM-with dissipation monitoring (QCM-D) allows simultaneous and simple measurements of changes in adsorbed mass as well as the viscoelastic property (D-factor) of deposited protein layers on the sensor surface. We have taken the QCM-D technology a step further and demonstrated its advantages in the study of protein assembly as a consequence of surface induced immune complement activation, or contact activated blood coagulation. In the present study we have continued our QCM-D investigations of surface assembly of fibrin clot formation and complement activation and incubated differently modified quartz sensor surfaces in blood plasma and sera. Polymer surfaces used were spin-coated polyethylene, poly(ethylene terephtalate), poly(methylmetacrylate) and poly(dimethylsiloxane). Also used were sputtered titanium and heparin grafted surfaces. In this investigation we found that we could describe the surface induced coagulation with four independent parameters: (1) Time of onset of coagulation, (2) fibrin deposition rate, (3) total frequency shift at stable plateau, and (4) fibrin clot density. The most important finding was that the blood plasma clot density can be assessed with the use of D determinations and that the clot density varied significantly with the chemical composition of the surface. However, the D-factor did not give any new analytical information about the possible complement activation mechanisms. Nevertheless, the QCM-D was found to be a reliable tool for the analysis of surface induced complement activation.
   We also compared the QCM-D technique with traditional enzyme immuno assay (EIA) measurements of soluble products from the surface activation of the complement and coagulation systems. We found that the results from EIA and QCM-D measurements corresponded well for the complement activation but not for the coagulation, probably due to the biological complexity of the coagulation system. (c) 2004 Elsevier B.V. All rights reserved.
C1 Univ Gothenburg, Interface Biophys Lundberg Lab, Dept Cell & Mol Biol, SE-40530 Gothenburg, Sweden.
   Univ Uppsala Hosp, Rudbeck Lab C5, Clin Immunol Sect, Dept Oncol Radiol & Clin Immunol, SE-75185 Uppsala, Sweden.
RP Andersson, M (reprint author), Univ Gothenburg, Interface Biophys Lundberg Lab, Dept Cell & Mol Biol, Box 462, SE-40530 Gothenburg, Sweden.
EM marcus.andersson@gmm.gu.se
RI Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730
CR Andersson M, 2002, J BIOMAT SCI-POLYM E, V13, P907, DOI 10.1163/156856202320401951
   Bengtsson A, 1998, XENOTRANSPLANTATION, V5, P176, DOI 10.1111/j.1399-3089.1998.tb00025.x
   Berglin M, 2004, BIOMATERIALS, V25, P4581, DOI 10.1016/j.biomaterials.2003.11.050
   Bergseth G, 2000, THROMB RES, V99, P41, DOI 10.1016/S0049-3848(00)00226-7
   Christensen K, 2001, BIOMATERIALS, V22, P349, DOI 10.1016/S0142-9612(00)00190-3
   Collen A, 2001, BLOOD, V97, P973, DOI 10.1182/blood.V97.4.973
   DAHLGREN C, 1981, J IMMUNOL METHODS, V40, P171, DOI 10.1016/0022-1759(81)90064-8
   DeHeer DH, 2001, J BIOMED MATER RES, V54, P12, DOI 10.1002/1097-4636(200101)54:1<12::AID-JBM2>3.0.CO;2-X
   ELWING H, 1986, EUR J BIOCHEM, V156, P359, DOI 10.1111/j.1432-1033.1986.tb09591.x
   Garbassi F., 1994, POLYM SURFACES PHYS
   Glasmastar K, 2002, J COLLOID INTERF SCI, V246, P40, DOI 10.1006/jcis.2001.8060
   Hansson KM, 2002, BIOSENS BIOELECTRON, V17, P747, DOI 10.1016/S0956-5663(02)00048-9
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Hong J, 2001, J LAB CLIN MED, V138, P139, DOI 10.1067/mlc.2001.116486
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Jorneskog G, 1996, DIABETOLOGIA, V39, P1519, DOI 10.1007/s001250050607
   Kalltorp M, 1999, J BIOMED MATER RES, V47, P251, DOI 10.1002/(SICI)1097-4636(199911)47:2<251::AID-JBM16>3.0.CO;2-O
   Marx KA, 2003, BIOMACROMOLECULES, V4, P1099, DOI 10.1021/bm020116i
   MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P197, DOI 10.1111/j.1365-3083.1985.tb01871.x
   NILSSON B, 1988, J IMMUNOL METHODS, V107, P281, DOI 10.1016/0022-1759(88)90229-3
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   Sanchez J, 2002, THROMB RES, V105, P407, DOI 10.1016/S0049-3848(02)00051-8
   SAURBREY G, 1959, Z PHYS, V155, P206
   Sellborn A, 2003, COLLOID SURFACE B, V27, P295, DOI 10.1016/S0927-7765(02)00066-8
   Tang LP, 1998, J BIOMED MATER RES, V41, P333, DOI 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L
   Vikinge TP, 2000, J BIOMED OPT, V5, P51, DOI 10.1117/1.429968
   Vikinge TP, 2000, BIOSENS BIOELECTRON, V15, P605, DOI 10.1016/S0956-5663(00)00125-1
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Walivaara B, 1996, J BIOMAT SCI-POLYM E, V8, P41, DOI 10.1163/156856297X00560
NR 31
TC 66
Z9 70
U1 2
U2 51
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD JUL 15
PY 2005
VL 21
IS 1
BP 79
EP 86
DI 10.1016/j.bios.2004.09.026
PG 8
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA 969XJ
UT WOS:000232268900009
PM 15967354
DA 2018-10-20
ER

PT J
AU Shchipunov, YA
   Karpenko, TY
   Krekoten, AV
   Postnova, IV
AF Shchipunov, YA
   Karpenko, TY
   Krekoten, AV
   Postnova, IV
TI Gelling of otherwise nongelable polysaccharides
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE sol-gel; chitosan; hyaluronate; cyclodextrin; mineralization; silica
   nanocomposite; organic-inorganic nanocomposite; hydrogel; biomaterial
ID POROUS SILICA MATERIALS; LINEAR VISCOELASTICITY; GEL POINT; HYDROGELS;
   PSEUDOPOLYROTAXANES; CYCLODEXTRIN; BIOLOGICALS; POLYMERS; DESIGN; CHITIN
AB It was shown first that solutions of nongelable polysaccharides, including such practically important ones as chitosan, hyaluronate, and cyclodextrin, can be gelled by generating silica in situ via sol-gel processing. This could be done owing to a novel silica precursor that is completely water-soluble and compatible with biopolymers. The gelation was caused by mineralization of carbohydrate macromolecules, which strengthened them and provided their cross-linking. (c) 2005 Elsevier Inc. All rights reserved.
C1 Russian Acad Sci, Inst Chem, Far E Dept, Vladivostok 690022, Russia.
RP Shchipunov, YA (reprint author), Russian Acad Sci, Inst Chem, Far E Dept, Vladivostok 690022, Russia.
EM yas@ich.dvo.ru
OI Postnova, Irina/0000-0002-5623-6763
CR Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   CHAMBON F, 1987, J RHEOL, V31, P683, DOI 10.1122/1.549955
   Coradin T, 2003, J SOL-GEL SCI TECHN, V26, P1165, DOI 10.1023/A:1020787514512
   Coradin T, 2001, CHEM COMMUN, P2496, DOI 10.1039/b108324b
   FERRY JD, 1980, VISCOELASTIC PROPERT
   Frausto da Silva JJR, 2001, BIOL CHEM ELEMENTS I
   Gill I, 2000, TRENDS BIOTECHNOL, V18, P282, DOI 10.1016/S0167-7799(00)01457-8
   Gill I, 1998, J AM CHEM SOC, V120, P8587, DOI 10.1021/ja9814568
   Goodwin J. W., 2000, RHEOLOGY CHEM INTRO
   Gruber JV, 1999, PRINCIPLES POLYM SCI, P325
   Han BH, 2003, MICROPOR MESOPOR MAT, V66, P127, DOI 10.1016/j.micromeso.2003.09.003
   Han BH, 2002, CHEM MATER, V14, P3477, DOI 10.1021/cm0113088
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hirano S, 1996, Biotechnol Annu Rev, V2, P237, DOI 10.1016/S1387-2656(08)70012-7
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Kaplan DL, 1998, BIOPOLYMERS RENEWABL, P1, DOI DOI 10.1007/978-3-662-03680-8_
   Larson R. G., 1999, STRUCTURE RHEOLOGY C
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lu ZL, 2002, CHEM REV, V102, P3543, DOI 10.1021/cr010358t
   MEHROTRA RC, 1967, INDIAN J CHEM, V5, P444
   Meyer M, 2002, J PHYS CHEM B, V106, P1528, DOI 10.1021/jp013371q
   Pedroni V, 2000, COLLOID POLYM SCI, V278, P964, DOI 10.1007/s003960000348
   Perry CC, 2000, J BIOL INORG CHEM, V5, P537, DOI 10.1007/s007750000130
   Pierre A. C., 1998, INTRO SOL GEL PROCES
   Roberts G, 1992, CHITIN CHEM
   SANDFORD P. A., 1983, POLYSACCHARIDES, V2
   Sattler K, 1998, BER BUNSEN PHYS CHEM, V102, P1544, DOI 10.1002/bbpc.19981021106
   Shchipunov YA, 2003, J COLLOID INTERF SCI, V268, P68, DOI 10.1016/S0021-9797(03)00457-0
   Shchipunov YA, 2004, LANGMUIR, V20, P3882, DOI 10.1021/la0356912
   SHCHIPUNOV YA, IN PRESS J COLLOID I
   SHCHIPUNOV YA, 2005, IN PRESS HYDROBIOLOG
   Shumilina EV, 2002, COLLOID J+, V64, P372, DOI 10.1023/A:1015985229667
   SIMPSON TL, 1981, SILOCON SILICEOUS ST
   Syrbe A, 1998, INT DAIRY J, V8, P179, DOI 10.1016/S0958-6946(98)00041-7
   Tharanathan RN, 2003, CRIT REV FOOD SCI, V43, P61, DOI 10.1080/10408690390826455
   VOLKANI BE, 1981, SILICON SILICEOUS ST, P157
   Wallington SA, 1997, J SOL-GEL SCI TECHN, V8, P1127, DOI 10.1023/A:1018396005125
   WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853
   YANAKI T, 2001, GELS HDB, V2, P30
   Zaremba CM, 1996, CURR OPIN SOLID ST M, V1, P425, DOI 10.1016/S1359-0286(96)80035-0
NR 40
TC 36
Z9 37
U1 2
U2 15
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD JUL 15
PY 2005
VL 287
IS 2
BP 373
EP 378
DI 10.1016/j.jcis.2005.02.004
PG 6
WC Chemistry, Physical
SC Chemistry
GA 935AO
UT WOS:000229751300001
PM 15925600
DA 2018-10-20
ER

PT J
AU Makamba, H
   Hsieh, YY
   Sung, WC
   Chen, SH
AF Makamba, H
   Hsieh, YY
   Sung, WC
   Chen, SH
TI Stable permanently hydrophilic protein-resistant thin-film coatings on
   poly(dimethylsiloxane) substrates by electrostatic self-assembly and
   chemical cross-linking
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; SURFACE MODIFICATION; POLYELECTROLYTE
   MULTILAYERS; MICROFLUIDIC DEVICES; POLY(ETHYLENE GLYCOL); ELECTROOSMOTIC
   FLOW; PLASMA TREATMENT; ELECTROPHORESIS; POLYMERS; POLYDIMETHYLSILOXANE
AB Poly(dimethylsiloxane) (PDMS) is a biomaterial that presents serious surface instability characterized by hydrophobicity recovery. Permanently hydrophilic PDMS surfaces were created using electrostatic self-assembly of polyethyleneimine and poly(acrylic acid) on top of a hydrolyzed poly(styrene-alt-maleic anhydride) base layer adsorbed on PDMS. Cross-linking of the polyelectrolyte multilayers (PEMS) by carbodiimide coupling and covalent attachment of poly(ethylene glycol) (PEG) chains to the PEMS produced stable, hydrophilic, protein-resistant coatings, which resisted hydrophobicity recovery in air. Attenuated total reflection Fourier transform infrared spectroscopy and X-ray photoelectron spectroscopy revealed that the thin films had excellent chemical stability and resisted hydrophobicity recovery in air over 77 days of measurement. The spectra also showed a dense coverage for PEG dialdehyde and excellent resistance to protein adsorption from undiluted rat serum. Atomic force microscopy revealed dense coverage with PEG dialdehyde and PEG diamine. Contact angle measurements showed that all films were hydrophilic and that the PEG dialdehyde-topped thin film had a virtually constant contact angle (similar to 20 degrees) over the five months of the study. Electrokinetic analysis of the coatings in microchannels always exposed to air also gave good protein separation and constant electroosmotic flow during the five months that the measurements were done. We expect that the stable, hydrophilic, protein-resistant thin-film coatings will be useful for many applications that require long-term surface stability.
C1 Natl Cheng Kung Univ, Dept Chem, Tainan 701, Taiwan.
RP Chen, SH (reprint author), Natl Cheng Kung Univ, Dept Chem, Tainan 701, Taiwan.
EM shchen@mail.ncku.edu.tw
RI Sung, Wang-Chou/G-3710-2011
CR ADAMSON AW, 1997, PHYS CHEM SURFACES, P357
   Bearinger JP, 2003, NAT MATER, V2, P259, DOI 10.1038/nmat851
   BERGSTROM K, 1993, COLLOID SURF A, V77, P159
   BRACH DW, 2001, BIOMATERIALS, V22, P1035
   Caruso F, 1998, LANGMUIR, V14, P4559, DOI 10.1021/la971288h
   Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DENICOLA RR, 1950, J UROLOGY, V63, P168, DOI 10.1016/S0022-5347(17)68748-2
   Dou YH, 2004, ELECTROPHORESIS, V25, P3024, DOI 10.1002/elps.200405986
   *DOW CORN CORP, 1998, IMPL INF BOOKL
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Efimenko K, 2002, J COLLOID INTERF SCI, V254, P306, DOI 10.1006/jcis.202.8594
   Farhat TR, 2002, ELECTROCHEM SOLID ST, V5, pB13, DOI 10.1149/1.1452484
   Fritz JL, 1995, J ADHESION, V54, P33, DOI 10.1080/00218469508014379
   Genzer J, 2000, SCIENCE, V290, P2130, DOI 10.1126/science.290.5499.2130
   Groll J, 2004, J AM CHEM SOC, V126, P4234, DOI 10.1021/ja0318028
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   HERNWERTH S, 2003, J AM CHEM SOC, V125, P9359
   Hillborg H, 1998, POLYMER, V39, P1991, DOI 10.1016/S0032-3861(97)00484-9
   Hiller J, 2002, NAT MATER, V1, P59, DOI 10.1038/nmat719
   Holland NB, 1998, NATURE, V392, P799
   HU S, 2004, ANAL CHEM, V74, P1865
   Hu SW, 2002, ANAL CHEM, V74, P4117, DOI 10.1021/ac025700w
   HUANG XH, 1988, ANAL CHEM, V60, P1837, DOI 10.1021/ac00168a040
   JACOBSON SC, 1994, ANAL CHEM, V66, P1107, DOI 10.1021/ac00079a028
   JESSEL N, 2003, J ADV MAT, V15, P692
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Lahann J, 2003, ANAL CHEM, V75, P2117, DOI 10.1021/ac020557s
   Lahey F., 1946, ANN SURG, V124, P1027
   Lai JY, 1996, J ADHES SCI TECHNOL, V10, P231, DOI 10.1163/156856196X00364
   LEGER L, 1992, REP PROG PHYS, V55, P431, DOI 10.1088/0034-4885/55/4/001
   Lin CC, 2002, ELECTROPHORESIS, V23, P3550, DOI 10.1002/1522-2683(200210)23:20<3550::AID-ELPS3550>3.0.CO;2-A
   Liu Y, 2000, ANAL CHEM, V72, P5939, DOI 10.1021/ac000932l
   Lobo RFM, 2003, NANOTECHNOLOGY, V14, P101, DOI 10.1088/0957-4484/14/1/322
   Lowman GM, 2002, THIN SOLID FILMS, V405, P135, DOI 10.1016/S0040-6090(01)01669-8
   Mamedov AA, 2002, NAT MATER, V1, P190, DOI 10.1038/nmat747
   Mao HB, 2002, ANAL CHEM, V74, P379, DOI 10.1021/ac010822u
   MARGEL S, 1980, MACROMOLECULES, V13, P19, DOI 10.1021/ma60073a004
   MASUDA S, 1989, IEEE T IND APPL, V25, P762
   Metzke M, 2003, J AM CHEM SOC, V125, P7760, DOI 10.1021/ja0349507
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   OWEN MJ, 1994, J ADHES SCI TECHNOL, V8, P1063, DOI 10.1163/156856194X00942
   Papra A, 2001, LANGMUIR, V17, P4090, DOI 10.1021/la0016930
   Park MK, 2004, J AM CHEM SOC, V126, P13723, DOI 10.1021/ja0484707
   Piehler J, 1996, BIOSENS BIOELECTRON, V11, P579, DOI 10.1016/0956-5663(96)83293-3
   Qin D, 1996, ADV MATER, V8, P917, DOI 10.1002/adma.19960081110
   ROMAN GT, IN PRESS ANAL CHEM
   Ruiz-Taylor LA, 2001, P NATL ACAD SCI USA, V98, P852, DOI 10.1073/pnas.98.3.852
   Sharma S, 2004, LANGMUIR, V20, P348, DOI 10.1021/la0347531
   Slentz BE, 2002, J CHROMATOGR A, V948, P225, DOI 10.1016/S0021-9673(01)01319-X
   Stroock AD, 2003, LANGMUIR, V19, P2466, DOI 10.1021/la026379f
   Sung WC, 2003, ELECTROPHORESIS, V24, P3648, DOI 10.1002/elps.200305623
   THERRY B, 2003, BIOMACROMOLECULES, V4, P1564
   THIERRY B, 2004, J AM CHEM SOC, V126, P7494
   Uyama Y, 1998, ADV POLYM SCI, V137, P1
   Wu A, 1999, J AM CHEM SOC, V121, P4883, DOI 10.1021/ja9833624
   Xiao DQ, 2002, LANGMUIR, V18, P9971, DOI 10.1021/la0205553
   Xiao DQ, 2004, ANAL CHEM, V76, P2055, DOI 10.1021/ac035254s
   Yang TL, 2003, J AM CHEM SOC, V125, P4779, DOI 10.1021/ja029469f
   Yang TL, 2001, ANAL CHEM, V73, P165, DOI 10.1021/ac000997o
NR 60
TC 86
Z9 90
U1 3
U2 57
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
J9 ANAL CHEM
JI Anal. Chem.
PD JUL 1
PY 2005
VL 77
IS 13
BP 3971
EP 3978
DI 10.1021/ac0502706
PG 8
WC Chemistry, Analytical
SC Chemistry
GA 942GL
UT WOS:000230270800030
PM 15987099
DA 2018-10-20
ER

PT J
AU Miller, L
   Guerra, AB
   Bidros, RS
   Trahan, C
   Baratta, R
   Metzinger, SE
AF Miller, L
   Guerra, AB
   Bidros, RS
   Trahan, C
   Baratta, R
   Metzinger, SE
TI A comparison of resistance to fracture among four commercially available
   forms of hydroxyapatite cement
SO ANNALS OF PLASTIC SURGERY
LA English
DT Article
DE hydroxyapatite cement; resistance fracture
ID CALCIUM-PHOSPHATE CEMENTS; CRANIAL BONE; BIOMECHANICAL ANALYSIS;
   CRANIOPLASTY; RECONSTRUCTION; COMPLICATIONS; TEMPERATURE; EXPERIENCE;
   FIXATION; GRAFTS
AB Hydroxyapatite cement is a relatively new biomaterial that has found widespread use in craniomaxillofacial surgery. Despite its common usage, complication rates as high as 32% have been reported. When failed implants are removed, implant fracture has been cited as a potential cause of failure. The purpose of this study was to evaluate resistance to fracture among 4 commercially available hydroxyapatite cement formulations. The materials tested included Norian Cramofacial Repair System (carbonated apatite cement) (AO North America, Devon, PA), Norian CRS Fast Set Putty (carbonated apatite cement) (AO North America), BoneSource (hydroxyapatite cement) (Stryker Leibinger, Portage, MI), and Mimix (hydroxyapatite cement) (Walter Lorenz Surgical, Inc, Jacksonville, FL). To ensure consistency, all materials were embedded in acrylic wells. Each material was placed into a well 2.54 cm in diameter and 0.953 cm in thickness. The materials were prepared per manufacturer specifications. All materials were incubated at 37.0 degrees C, in 6% CO2, 100% humidity for 36 hours. Using the Bionix NITS Test System, a 12-mm-diameter probe applied incremental force to the center of the disk at a rate of 0.1 mm per second. The transmitted force was measured using a Bionix NITS Axial-Torsional Load Transducer for each disk. The force which resulted in fracture was recorded for each material. Ten disks of each material were processed by this method, for a total of 40 disks. The significance of resistance to fracture for the 4 compounds was analyzed using 1-way analysis of variance with post hoc Scheffe method. Mean fracture force with related P values was plotted for direct comparison of group outcomes. Material type contributed significantly to variance in fracture force for the biomaterials studied. Norian CRS required the greatest mean fracture force (13 85 N, SD +/- 292 N), followed by Norian CRS Fast Set Putty (1143 N, SD +/- 193 N). Mimix required a mean fracture force of 740 N, SD +/- 79 N. BoneSource required a mean fracture force of 558 N, SD +/- 150 N. Mimix and BoneSource required significantly less force for fracture when compared with Norian CRS and Fast Set Putty (P < 0.01). Comparisons of fracture load resistance between 4 commonly used bone substitute materials have not been previously reported. Increasing biomaterial strength may reduce complications resulting from reinjury to cranioplasty sites. In this model, Norian CRS. and Norian, CRS Fast Set Putty demonstrated a significantly greater resistance to fracture when compared with BoneSource and Mimix.
C1 Aesthet Surg Associates, Metairie, LA 70006 USA.
   McCollough Inst Appearance & Hlth, Gulf Shores, AL USA.
   Louisiana State Univ, Hlth Sci Ctr, Dept Orthoped Surg, New Orleans, LA USA.
RP Guerra, AB (reprint author), Aesthet Surg Associates, 3601 Houma Blvd,Suite 300, Metairie, LA 70006 USA.
EM drguerra@gmail.com
CR Baker SB, 2002, PLAST RECONSTR SURG, V109, P1789, DOI 10.1097/00006534-200205000-00003
   Barone CM, 2000, J CRANIOFAC SURG, V11, P495, DOI 10.1097/00001665-200011050-00010
   Brody HJ, 2001, DERMATOL SURG, V27, P792, DOI 10.1046/j.1524-4725.2001.01014.x
   Brown PW, 1986, CEMENTS RES PROGR, P352
   Charriere E, 2001, BIOMATERIALS, V22, P2937, DOI 10.1016/S0142-9612(01)00041-2
   CHEN NT, 1994, PLAST RECONSTR SURG, V93, P714, DOI 10.1097/00006534-199404000-00009
   CHOW LC, 1991, NIPPON SERAM KYO GAK, V99, P954
   COE JD, 1989, SPINE, V14, P1122, DOI 10.1097/00007632-198910000-00016
   Constantino PD, 1991, ARCH OTOLARYNGOL, V117, P379
   Eppley BL, 2004, J CRANIOFAC SURG, V15, P422, DOI 10.1097/00001665-200405000-00013
   Eppley BL, 2003, J CRANIOFAC SURG, V14, P209, DOI 10.1097/00001665-200303000-00014
   Fernandez E, 1996, J BIOMED MATER RES, V32, P367, DOI 10.1002/(SICI)1097-4636(199611)32:3<367::AID-JBM9>3.0.CO;2-Q
   FRIEDMAN CD, 1991, ARCH OTOLARYNGOL, V117, P385
   Fujishiro Y, 2001, J BIOMED MATER RES, V54, P525, DOI 10.1002/1097-4636(20010315)54:4<525::AID-JBM80>3.0.CO;2-#
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   GLASSMAN RD, 1990, PLAST RECONSTR SURG, V86, P1103, DOI 10.1097/00006534-199012000-00009
   Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163
   KLINE RM, 1995, PLAST RECONSTR SURG, V95, P5, DOI 10.1097/00006534-199501000-00002
   LEWIS VL, 1990, ANN PLAS SURG, V24, P276, DOI 10.1097/00000637-199003000-00014
   MARTIN RI, 1995, J MATER SCI-MATER M, V6, P138, DOI 10.1007/BF00120289
   MATIC D, 2002, P 81 ANN M AM ASS PL
   Matic DB, 2004, J CRANIOFAC SURG, V15, P415, DOI 10.1097/00001665-200405000-00012
   Mihara H, 2001, SPINE, V26, P1662, DOI 10.1097/00007632-200108010-00007
   Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003
   Nahum A M, 1975, Clin Plast Surg, V2, P59
   ODOM GL, 1952, J NEUROSURG, V9, P606, DOI 10.3171/jns.1952.9.6.0606
   Ousterhout DK, 1996, CLIN PLAST SURG, V23, P183
   Pietrzak WS, 2003, J CRANIOFAC SURG, V14, P176, DOI 10.1097/00001665-200303000-00008
   RAY BS, 1947, J NEUROSURG, V4, P299, DOI 10.3171/jns.1947.4.4.0299
   Sanan A, 1997, NEUROSURGERY, V40, P588, DOI 10.1097/00006123-199703000-00033
   SARGENT LA, 1991, PLAST RECONSTR SURG, V89, P1176
   SCOTT M, 1962, SURG GYNECOL OBSTET, V115, P453
   SHINDO ML, 1993, ARCH OTOLARYNGOL, V119, P185
   SPENCE WT, 1954, J NEUROSURG, V11, P219, DOI 10.3171/jns.1954.11.3.0219
   WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8
NR 35
TC 24
Z9 26
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0148-7043
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD JUL
PY 2005
VL 55
IS 1
BP 87
EP 92
DI 10.1097/01.sap.0000162510.05196.c6
PG 6
WC Surgery
SC Surgery
GA 942ZT
UT WOS:000230322100030
PM 15985797
DA 2018-10-20
ER

PT J
AU Di Palma, F
   Guignandon, A
   Chamson, A
   Lafage-Proust, MH
   Laroche, N
   Peyroche, S
   Vico, L
   Rattner, A
AF Di Palma, F
   Guignandon, A
   Chamson, A
   Lafage-Proust, MH
   Laroche, N
   Peyroche, S
   Vico, L
   Rattner, A
TI Modulation of the responses of human osteoblast-like cells to
   physiologic mechanical strains by biomaterial surfaces
SO BIOMATERIALS
LA English
DT Article
DE osteoblast; biomaterial; roughness; mechanical strain; cell number;
   alkaline phosphatase; fibronectin; cadherin; titanium; MG-63
ID IN-VITRO; FIBRONECTIN FIBRILLOGENESIS; TITANIUM-ALLOY;
   ALKALINE-PHOSPHATASE; EXTRACELLULAR-MATRIX; N-CADHERIN; ROUGHNESS;
   ADHESION; MG-63; PROLIFERATION
AB In a previous study we demonstrated that MG-63 cells cultured on Ti-6Al-4V discs covered by alumina ceramic and submitted to intermittent mechanical strain (IMS) presented morphological alteration associated with enhanced differentiation. Here we examine how the mechanical response of osteoblasts can be modulated by the nature of the substrate. MG-63 cells were cultured on four materials: polystyrene and Ti-6Al-4V (average roughness = 0.48 mum) as smooth substrates; Ti-6Al-4V (average roughness = 5.76 pm) and Ti-6Al-4V covered with alumina (average roughness = 5.21 mum) as rough substrates. Mechanical strains were applied for 15 min, three times a day for 1-5 days with a 600 mustrains magnitude and a 0.25 Hz frequency. IMS stimulated alkaline phosphatase activity by 25-35% on all substrates and had no effect on cell growth on either substrate. Fibronectin (FN) was chosen as representative of cell-matrix interaction. FN production was increased by 60% after 1 day of stretching only on alumina-coated discs. FN organization examined on smooth substrates was affected by 5 days of IMS, showing a thickening of the fibres. The same modifications induced by IMS were previously observed on alumina-covered discs. Vinculin expression was not affected by IMS whatever the substrate. Cell-cell interactions were determined by N-cadherin immunoblotting. N-cadherin expression was increased by IMS specifically on rough substrates. Our results suggest that the nature of the surface did not influence the upregulation of alkaline phosphatase activity induced by IMS, but modulates specifically cell-substrate as well as cell-cell interactions in response to IMS. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ St Etienne, Fac Med, Lab Biol Tissu Osseux, INSERM,Equipe E366, F-42023 St Etienne 02, France.
RP Rattner, A (reprint author), Univ St Etienne, Fac Med, Lab Biol Tissu Osseux, INSERM,Equipe E366, 15 Rue Ambroise Pare, F-42023 St Etienne 02, France.
EM Aline.Rattner@univ-st-etienne.fr
RI Vico, Laurence/O-1927-2018
OI Vico, Laurence/0000-0002-2110-287X
CR Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799
   Baneyx G, 2001, P NATL ACAD SCI USA, V98, P14464, DOI 10.1073/pnas.251422998
   Bannister SR, 2002, J BIOMED MATER RES, V60, P167, DOI 10.1002/jbm.10037
   BOYAN BD, 1989, J BIOL CHEM, V264, P11879
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Carvalho RS, 2002, J CELL BIOCHEM, V84, P497
   Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5
   CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   Di Palma F, 2004, BIOMATERIALS, V25, P2565, DOI 10.1016/j.biomaterials.2003.09-026
   Di Palma F, 2003, BIOMATERIALS, V24, P3139, DOI 10.1016/S0142-9612(03)00152-2
   Ferrari SL, 2000, J BONE MINER RES, V15, P198, DOI 10.1359/jbmr.2000.15.2.198
   Grizon F, 2002, J DENT, V30, P195, DOI 10.1016/S0300-5712(02)00018-0
   Guignandon A, 2003, CELL COMMUN ADHES, V10, P69, DOI 10.1080/15419060390260987
   Kaspar D, 2000, J BIOMECH, V33, P45, DOI 10.1016/S0021-9290(99)00171-2
   Labat B, 2000, BIOMATERIALS, V21, P1275, DOI 10.1016/S0142-9612(00)00013-2
   LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0
   Lin W, 2002, CONNECT TISSUE RES, V43, P22
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Lohmann CH, 2000, J BONE MINER RES, V15, P1169, DOI 10.1359/jbmr.2000.15.6.1169
   Marie PJ, 2002, J CELL PHYSIOL, V190, P297, DOI 10.1002/jcp.10073
   Matsunaga T, 1999, CALCIFIED TISSUE INT, V65, P454, DOI 10.1007/s002239900732
   Montanaro L, 2002, BIOMATERIALS, V23, P3651, DOI 10.1016/S0142-9612(02)00098-4
   Moroni A, 1999, J ORTHOP TRAUMA, V13, P477, DOI 10.1097/00005131-199909000-00003
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Ralphs JR, 2002, MATRIX BIOL, V21, P67, DOI 10.1016/S0945-053X(01)00179-2
   Rosa Adalberto Luiz, 2003, Braz. Dent. J., V14, P16, DOI 10.1590/S0103-64402003000100003
   Rosa AL, 2003, CLIN ORAL IMPLAN RES, V14, P43, DOI 10.1034/j.1600-0501.2003.140106.x
   Sanders JE, 2001, J BIOMECH, V34, P1581, DOI 10.1016/S0021-9290(01)00145-2
   Santini MT, 2003, BIOELECTROMAGNETICS, V24, P327, DOI 10.1002/bem.10113
   Schwartz Z, 2001, J BIOMED MATER RES, V56, P417, DOI 10.1002/1097-4636(20010905)56:3<417::AID-JBM1111>3.0.CO;2-K
   Schwarzbauer JE, 1999, CURR OPIN CELL BIOL, V11, P622, DOI 10.1016/S0955-0674(99)00017-4
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Suzuki K, 1997, BONE, V21, P507, DOI 10.1016/S8756-3282(97)00204-4
   Winter LC, 2003, J BIOMED MATER RES A, V67A, P1269, DOI 10.1002/jbm.a.20028
   Yang RS, 2002, MOL PHARMACOL, V61, P1163, DOI 10.1124/mol.61.5.1163
   Zhuang JP, 2000, CIRC RES, V87, P316, DOI 10.1161/01.RES.87.4.316
NR 40
TC 18
Z9 19
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2005
VL 26
IS 20
BP 4249
EP 4257
DI 10.1016/j.biomaterials.2004.10.041
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 902PM
UT WOS:000227369000006
PM 15683648
DA 2018-10-20
ER

PT J
AU Jansen, EJP
   Sladek, REJ
   Bahar, H
   Yaffe, A
   Gijbels, MJ
   Kuijer, R
   Bulstra, SK
   Guldemond, NA
   Binderman, I
   Koole, LH
AF Jansen, EJP
   Sladek, REJ
   Bahar, H
   Yaffe, A
   Gijbels, MJ
   Kuijer, R
   Bulstra, SK
   Guldemond, NA
   Binderman, I
   Koole, LH
TI Hydrophobicity as a design criterion for polymer scaffolds in bone
   tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE tissue engineering; scaffolds; biocompatibility in vivo; demineralised
   bone matrix
ID CARTILAGE; DELIVERY; BIOMATERIALS; DEGRADATION; CULTURE; REPAIR; COILS;
   RATS
AB Porous polymeric scaffolds play a key role in most tissue-engineering strategies. A series of non-degrading porous scaffolds was prepared, based on bulk-copolymerisation of 1-vinyl-2-pyrrolidinone (NVP) and n-butyl methacrylate (BMA), followed by a particulate-leaching step to generate porosity. Biocompatibility of these scaffolds was evaluated in vitro and in vivo. Furthermore, the scaffold materials were studied using the so-called demineralised bone matrix (DBM) as an evaluation system in vivo. The DBM, which is essentially a part of a rat femoral bone after processing with mineral acid, provides a suitable environment for ectopic bone formation, provided that the cavity of the DBM is filled with bone marrow prior to subcutaneous implantation in the thoracic region of rats. Various scaffold materials, differing with respect to composition and, hence, hydrophilicity, were introduced into the centre of DBMs. The ends were closed with rat bone marrow, and ectopic bone formation was monitored after 4, 6, and 8 weeks, both through X-ray microradiography and histology. The 50:50 scaffold particles were found to readily accommodate formation of bone tissue within their pores, whereas this was much less the case for the more hydrophilic 70:30 counterpart scaffolds. New healthy bone tissue was encountered inside the pores of the 50:50 scaffold material, not only at the periphery of the constructs but also in the center. Active osteoblast cells were found at the bone-biomaterial interfaces. These data indicate that the hydrophobicity of the biomaterial is, most likely, an important design criterion for polymeric scaffolds which should promote the healing of bone defects. Furthermore, it is argued that stable, non-degrading porous biomaterials, like those used in this study, provide an important tool to expand our comprehension of the role of biomaterials in scaffold-based tissue engineering approaches. (c) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Maastricht, Ctr Biomat Res, NL-6200 MD Maastricht, Netherlands.
   Univ Hosp Maastricht, Dept Orthopaed Surg, NL-6202 AZ Maastricht, Netherlands.
   Tel Aviv Univ, Dept Oral Biol, Maurice & Gabriela Goldschleger Sch Dent Med, IL-69978 Tel Aviv, Israel.
   Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Dept Prosthodont, Jerusalem, Israel.
   Univ Maastricht, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands.
   Univ Maastricht, Dept Human Pathol, Cardiovasc Res Inst, NL-6200 MD Maastricht, Netherlands.
RP Koole, LH (reprint author), Univ Maastricht, Ctr Biomat Res, POB 616, NL-6200 MD Maastricht, Netherlands.
EM l.koole@bioch.unimaas.nl
RI Kuijer, Roel/A-6690-2015
OI Kuijer, Roel/0000-0002-7637-4944
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Aldenhoff YBJ, 2004, BIOMATERIALS, V25, P3125, DOI 10.1016/j.biomaterials.2003.10.012
   Bahar H, 2003, J PERIODONTOL, V74, P366, DOI 10.1902/jop.2003.74.3.366
   Benzina A, 1996, J BIOMED MATER RES, V32, P459, DOI 10.1002/(SICI)1097-4636(199611)32:3<459::AID-JBM20>3.0.CO;2-A
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Bruining MJ, 2000, BIOMACROMOLECULES, V1, P418, DOI 10.1021/bm000009t
   Capito RM, 2003, IEEE ENG MED BIOL, V22, P42, DOI 10.1109/MEMB.2003.1256271
   Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372
   Hanssen HHL, 1999, J BIOMED MATER RES, V48, P820, DOI 10.1002/(SICI)1097-4636(1999)48:6<820::AID-JBM9>3.0.CO;2-K
   Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G
   Homicz MR, 2003, LARYNGOSCOPE, V113, P25, DOI 10.1097/00005537-200301000-00005
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   NIMNI ME, 1988, CLIN ORTHOP RELAT R, P255
   ODIAN W, 1991, PRINCIPLES POLYMERIZ
   Pijls RT, 2004, BIO-MED MATER ENG, V14, P383
   Sharma B, 2004, ANN BIOMED ENG, V32, P148, DOI 10.1023/B:ABME.0000007799.60142.78
   Thomson RC, 1999, BIOMATERIALS, V20, P2007, DOI 10.1016/S0142-9612(99)00103-9
   Thomson RC, 1995, ADV POLYM SCI, V122, P245
   WIEDEMANN AAM, 2003, BIOMATERIALS, V23, P3319
   Yaffe A, 1997, J PERIODONTOL, V68, P884, DOI 10.1902/jop.1997.68.9.884
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P587, DOI 10.1016/S1010-7940(00)00373-0
NR 22
TC 90
Z9 99
U1 3
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2005
VL 26
IS 21
BP 4423
EP 4431
DI 10.1016/j.biomaterials.2004.11.001
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 905OW
UT WOS:000227579500009
PM 15701371
DA 2018-10-20
ER

PT J
AU Devouge, S
   Salvagnini, C
   Marchand-Brynaert, J
AF Devouge, S
   Salvagnini, C
   Marchand-Brynaert, J
TI A practical molecular clip for immobilization of receptors and
   biomolecules on devices' surface: Synthesis, grafting protocol and
   analytical assay
SO BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
LA English
DT Article
DE surface chemistry; photografting; biochip; biomaterial
ID SELF-ASSEMBLED MONOLAYERS; BIOLOGICAL EVALUATION; RGD PEPTIDOMIMETICS;
   CELLULAR ADHESION; ENDOTHELIAL-CELLS; PLASMON RESONANCE; WET CHEMISTRY;
   MEMBRANES; ADSORPTION; PROTEIN
AB Deposition of O-succinimidyl 4-(p-azido-phenyl)butanoate (4) onto inorganic device (FTIR-ATR crystal) or polymer material (filtration membrane) followed by irradiation at 254 nm led to surface functionalisation with NHS esters. Further reaction with biomolecules allowed their covalent grafting. The reactivity of the photoactivated surfaces was assayed by two methods: (i) the coupling with 3,5-bis(trifluoromethyl)benzylamine (7) and subsequent XPS analysis; (ii) the coupling with 4,5-bis-tritiated lysine (10) and subsequent LSC measurement of the radioactivity. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Catholique Louvain, Unite Chim Organ & Med, B-1348 Louvain, Belgium.
RP Marchand-Brynaert, J (reprint author), Univ Catholique Louvain, Unite Chim Organ & Med, Batiment Lavoisier Pl L Pasteur 1, B-1348 Louvain, Belgium.
EM marchand@chim.ucl.ac.be
CR Bayley H, 1977, Methods Enzymol, V46, P69
   Biltresse S, 2000, J POLYM SCI POL CHEM, V38, P3510, DOI 10.1002/1099-0518(20001001)38:19<3510::AID-POLA70>3.0.CO;2-L
   Biltresse S, 2005, BIOMATERIALS, V26, P4576, DOI 10.1016/j.biomaterials.2004.11.042
   Biltresse S, 2002, J POLYM SCI POL CHEM, V40, P770, DOI 10.1002/pola.10156
   Biltresse S, 2004, BIOORGAN MED CHEM, V12, P5379, DOI 10.1016/j.bmc.2004.07.055
   Boxus T, 1996, POLYM ADVAN TECHNOL, V7, P589, DOI 10.1002/(SICI)1099-1581(199607)7:7<589::AID-PAT551>3.3.CO;2-2
   Brynda E, 1998, BIOSENS BIOELECTRON, V13, P165, DOI 10.1016/S0956-5663(97)00107-3
   CARNAZZI E, 1994, J MED CHEM, V37, P1841, DOI 10.1021/jm00038a013
   Chung TW, 2003, ARTIF ORGANS, V27, P155, DOI 10.1046/j.1525-1594.2003.07045.x
   Deng L, 1996, J AM CHEM SOC, V118, P5136, DOI 10.1021/ja960461d
   Duchet J, 1997, LANGMUIR, V13, P2271, DOI 10.1021/la960598h
   Duchet J, 2001, COMPOS INTERFACE, V8, P177, DOI 10.1163/15685540152594659
   Green RJ, 1997, BIOMATERIALS, V18, P405, DOI 10.1016/S0142-9612(96)00141-X
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Kumar P, 2004, BIOORG MED CHEM LETT, V14, P1097, DOI 10.1016/jj.bmcl.2003.12.077
   Lahiri J, 1999, ANAL CHEM, V71, P777, DOI 10.1021/ac980959t
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   Liley M, 1997, LANGMUIR, V13, P4190, DOI 10.1021/la970258b
   Lin YS, 2001, ARTIF ORGANS, V25, P617, DOI 10.1046/j.1525-1594.2001.025008617.x
   Marchand-Brynaert J, 1999, BIOMATERIALS, V20, P1773, DOI 10.1016/S0142-9612(99)00072-1
   Marchand-Brynaert J, 1998, RRD POLYM SCI, V2, P335
   MARCHANDBRYNAER. J, 1999, SURFACE CHEM ELECTRO, P91
   Marchant-Brynaert J., 2000, POLYM SURFACE MODIFI, V2, P281
   MAZAO R, 1984, J COLLOID INTERF SCI, V100, P465
   SAGIV J, 1980, J AM CHEM SOC, V102, P92, DOI 10.1021/ja00521a016
   SHIN H, 2003, BIOMATERIALS, V24, P4553
   Stefan IC, 2000, LANGMUIR, V16, P5945, DOI 10.1021/la0000466
   WEIGEL C, 1990, CHEM MOD S, V3, P39
   Zammatteo Nathalie, 2002, Biotechnol Annu Rev, V8, P85, DOI 10.1016/S1387-2656(02)08005-5
NR 29
TC 22
Z9 22
U1 0
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-894X
J9 BIOORG MED CHEM LETT
JI Bioorg. Med. Chem. Lett.
PD JUL 1
PY 2005
VL 15
IS 13
BP 3252
EP 3256
DI 10.1016/j.bmcl.2005.04.071
PG 5
WC Chemistry, Medicinal; Chemistry, Organic
SC Pharmacology & Pharmacy; Chemistry
GA 939HD
UT WOS:000230062300016
PM 15935661
DA 2018-10-20
ER

PT J
AU Moskovitz, Y
   Srebnik, S
AF Moskovitz, Y
   Srebnik, S
TI Mean-field model of immobilized enzymes embedded in a grafted polymer
   layer
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID PROTEIN ADSORPTION; HETEROPOLYMER ADSORPTION; CONFORMATIONAL-CHANGES;
   ALPHA-CHYMOTRYPSIN; SURFACES; BRUSHES; STABILITY; STABILIZATION;
   BIOMATERIALS; CONFINEMENT
AB Two-dimensional mean-field lattice theory is used to model immobilization and stabilization of an enzyme on a hydrophobic surface using grafted polymers. Although the enzyme affords biofunctionality, the grafted polymers stabilize the enzyme and impart biocompatibility. The protein is modeled as a compact hydrophobic-polar polymer, designed to have a specific bulk conformation reproducing the catalytic cleft of natural enzymes. Three scenarios are modeled that have medical or industrial importance: 1), It is shown that short hydrophilic grafted polymers, such as polyethylene glycol, which are often used to provide biocompatibility, can also serve to protect a surface-immobilized enzyme from adsorption and denaturation on a hydrophobic surface. 2), Screening of the enzyme from the surface and nonspecific interactions with biomaterial in bulk solution requires a grafted layer composed of short hydrophilic polymers and long triblock copolymers. 3), Hydrophilic polymers grafted on a hydrophobic surface in contact with an organic solvent form a dense hydrophilic nanoenvironment near the surface that effectively shields and stabilizes the enzyme against both surface and solvent.
C1 Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel.
RP Srebnik, S (reprint author), Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel.
EM simchas@tx.technion.ac.il
OI Srebnik, Simcha/0000-0001-9843-1869; Moskovitz,
   Yevgeny/0000-0001-9133-1961
CR AMBRUS CM, 1978, SCIENCE, V201, P837, DOI 10.1126/science.567372
   Biswas R, 2004, CHEM PHYS LETT, V387, P221, DOI 10.1016/j.cplett.2004.02.018
   Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7
   Celej MS, 2004, BIOCHEM J, V378, P1059, DOI 10.1042/BJ20031536
   Currie EPK, 2003, ADV COLLOID INTERFAC, V100, P205, DOI 10.1016/S0001-8686(02)00061-1
   Currie EPK, 1999, PURE APPL CHEM, V71, P1227, DOI 10.1351/pac199971071227
   DILL KA, 1995, PROTEIN SCI, V4, P561
   Efremova NV, 2001, LANGMUIR, V17, P7628, DOI 10.1021/la010405c
   Eggers DK, 2001, PROTEIN SCI, V10, P250, DOI 10.1110/ps.36201
   El-Sherif H, 2001, J MOL CATAL B-ENZYM, V14, P15, DOI 10.1016/S1381-1177(00)00237-X
   Engel MFM, 2004, P NATL ACAD SCI USA, V101, P11316, DOI 10.1073/pnas.0401603101
   Fang F, 2002, LANGMUIR, V18, P5497, DOI 10.1021/la020027r
   Fang F, 2001, BIOPHYS J, V80, P2568, DOI 10.1016/S0006-3495(01)76228-5
   Fernandez-Lafuente R, 1999, J MOL CATAL B-ENZYM, V7, P173, DOI 10.1016/S1381-1177(99)00040-5
   FERNANDEZLAFUENTE, 1999, ENZYME MICROB TECH, V24, P96
   FERNANDEZLAFUENTE, 1999, J MOL CATAL B-ENZYM, V7, P181
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Hadicke E, 1999, PHYS CHEM CHEM PHYS, V1, P3891, DOI 10.1039/a903949j
   Halperin A, 1999, LANGMUIR, V15, P2525, DOI 10.1021/la981356f
   Henry M, 2003, LANGMUIR, V19, P6271, DOI 10.1021/la034081z
   HOFFMAN AS, 1972, T AM SOC ART INT ORG, V18, P10
   HOLM C, 2004, POLYELECTROLYTES DEF, V2, P67
   Huang YB, 2000, J CONTROL RELEASE, V65, P63, DOI 10.1016/S0168-3659(99)00233-3
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jonsson M, 2004, COLLOID SURFACE B, V37, P71, DOI 10.1016/j.colsurfb.2004.06.010
   Karlstrom G, 2001, COLLOID SURFACE B, V20, P245, DOI 10.1016/S0927-7765(00)00199-5
   KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7
   KIAEI D, 1992, RADIAT PHYS CHEM, V39, P463
   Kidoaki S, 2001, LANGMUIR, V17, P1080, DOI 10.1021/la000003p
   Kinjo AR, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.031911
   KLIBANOV AM, 1989, TRENDS BIOCHEM SCI, V14, P141, DOI 10.1016/0968-0004(89)90146-1
   LAVIN A, 1985, SCIENCE, V230, P543, DOI 10.1126/science.4048947
   LEININGER RI, 1966, SCIENCE, V152, P1625, DOI 10.1126/science.152.3729.1625
   Lensun L, 2002, LANGMUIR, V18, P9924, DOI 10.1021/la020473e
   Mateo C, 2000, ENZYME MICROB TECH, V26, P509, DOI 10.1016/S0141-0229(99)00188-X
   MCPHERSON TB, 1995, PROTEINS INTERFACES, V2, P395
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7
   Moskovitz Y, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.032902
   Pal SK, 2004, CHEM REV, V104, P2099, DOI 10.1021/cr020689l
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   Ping G, 2003, J CHEM PHYS, V118, P8042, DOI 10.1063/1.1564053
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   RUHE J, 2004, POLYELECTROLYTES DEF, P79
   Ryu G, 1992, ASAIO J, V38, pM644
   Satulovsky J, 2000, P NATL ACAD SCI USA, V97, P9037, DOI 10.1073/pnas.150236197
   SCHEUTJENS JMHM, 1979, J PHYS CHEM-US, V83, P1619, DOI 10.1021/j100475a012
   SCOPES RK, 1994, PROTEIN PURIFICATION, P95
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Srebnik S, 2001, J CHEM PHYS, V114, P9179, DOI 10.1063/1.1368400
   Srebnik S, 1998, J CHEM PHYS, V109, P6415, DOI 10.1063/1.477285
   Steels BM, 2000, J CHROMATOGR B, V743, P41, DOI 10.1016/S0378-4347(00)00206-1
   Szleifer I, 1997, PHYSICA A, V244, P370, DOI 10.1016/S0378-4371(97)00293-8
   TANG H, 1994, EUROPHYS LETT, V28, P19, DOI 10.1209/0295-5075/28/1/004
   TIBERG F, 1992, COLLOID POLYM SCI, V270, P1188, DOI 10.1007/BF01095059
   Trachtenberg M C, 1999, Life Support Biosph Sci, V6, P293
   Turkova J, 1999, J CHROMATOGR B, V722, P11, DOI 10.1016/S0378-4347(98)00434-4
   Ulbrich-Hofmann R, 1999, J MOL CATAL B-ENZYM, V7, P125, DOI 10.1016/S1381-1177(99)00026-0
   WANG CC, 1993, J BIOMAT SCI-POLYM E, V4, P357, DOI 10.1163/156856293X00041
   WATANABE S, 1988, METHOD ENZYMOL, V137, P545
   Wei Y, 2001, J NANOSCI NANOTECHNO, V1, P83, DOI 10.1166/jnn.2001.014
   WIJMANS CM, 1992, MACROMOLECULES, V25, P2657, DOI 10.1021/ma00036a016
   WIJMANS CM, 1994, J CHEM PHYS, V101, P8214, DOI 10.1063/1.468206
   Woodle MC, 1998, ADV DRUG DELIVER REV, V32, P139, DOI 10.1016/S0169-409X(97)00136-1
   YEUNG C, 1993, MACROMOLECULES, V26, P1914, DOI 10.1021/ma00060a018
   Zheng L, 1998, ANALYST, V123, P1735, DOI 10.1039/a800710a
   Zhou HX, 2001, BIOCHEMISTRY-US, V40, P11289, DOI 10.1021/bi0155504
NR 68
TC 19
Z9 19
U1 0
U2 11
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JUL
PY 2005
VL 89
IS 1
BP 22
EP 31
DI 10.1529/biophysj.104.053686
PG 10
WC Biophysics
SC Biophysics
GA 939ZX
UT WOS:000230114500007
PM 15805165
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Fukuhara, S
   Tomita, S
   Nakatani, T
   Fujisato, T
   Ohtsu, Y
   Ishida, M
   Yutani, C
   Kitamura, O
AF Fukuhara, S
   Tomita, S
   Nakatani, T
   Fujisato, T
   Ohtsu, Y
   Ishida, M
   Yutani, C
   Kitamura, O
TI Bone marrow cell-seeded biodegradable polymeric scaffold enhances
   angiogenesis and improves function of the infarcted heart
SO CIRCULATION JOURNAL
LA English
DT Article
DE angiogenesis; biomaterial; bone marrow cells; ischemic heart disease
ID FIBROBLAST-GROWTH-FACTOR; THERAPEUTIC ANGIOGENESIS; CARDIAC GRAFT;
   TRANSPLANTATION; IMPLANTATION; MYOCARDIUM; MYOGENESIS; FAILURE; MODEL;
   RAT
AB Background The present study examined whether a bioengineered polyglycolic acid cloth (PGAC) impregnated with bone marrow cells (BMC) improved the function and angiogenesis of the infarcted heart.
   Methods and Results The coronary artery was ligated in Lewis rats and the infarcted area was covered with a PGAC in group 1 (n=8), with a PGAC containing basic-fibroblast growth factor (b-FGF) in group 2 (n=11) and a PGAC containing b-FGF and freshly isolated BMC in group 3 (n=10). In addition, BMC derived from transgenic mice expressing green fluorescent protein (GFP)-BMC were seeded into a PGAC, which was sutured over the infarcted area of C57BL/6 mice (n=5). In the rat study, developed and systolic pressures, dp/dt max and dp/dt min) were the highest in group 3, as were the capillary density in the PGAC and infarcted area. In the mouse study, there were few GFP-BMC in the PGAC, but none in the infarcted area.
   Conclusions A PGAC with BMC improved cardiac function by inducing angiogenesis without migration of BMC. Freshly isolated BMC work as angiogenic inducers and a PGAC is useful as a "drug delivery system".
C1 Natl Cardiovasc Ctr, Dept Regenerat Med & Tissue Engn, Suita, Osaka 5658565, Japan.
   Natl Cardiovasc Ctr, Dept Pathol, Suita, Osaka 5658565, Japan.
   Natl Cardiovasc Ctr, Dept Cardiovasc Surg, Suita, Osaka 5658565, Japan.
   Natl Cardiovasc Ctr, Dept Organ Transplantat, Suita, Osaka 5658565, Japan.
RP Tomita, S (reprint author), Natl Cardiovasc Ctr, Dept Regenerat Med & Tissue Engn, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.
EM shinjitomita@hotmail.com
OI FUJISATO, Toshia/0000-0002-7206-093X
CR BEATTY PG, 1993, BLOOD, V81, P249
   Fujisato T, 1996, BIOMATERIALS, V17, P155, DOI 10.1016/0142-9612(96)85760-7
   FUJISATO T, 2000, 6 WORLD BIOM C T, P1496
   FUKUHARA S, 2005, CELL TRANSPLANT, V13, P741
   Hamano K, 2000, CELL TRANSPLANT, V9, P439, DOI 10.1177/096368970000900315
   ISHIDA M, 2005, IN PRESS J HEART LUN
   Iwakura A, 2001, CIRCULATION, V104, P325
   KACHINSKY AM, 1995, J HISTOCHEM CYTOCHEM, V43, P843, DOI 10.1177/43.8.7542682
   Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817
   Kobayashi T, 2000, J SURG RES, V89, P189, DOI 10.1006/jsre.2000.5828
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li RK, 2000, J THORAC CARDIOV SUR, V119, P368, DOI 10.1016/S0022-5223(00)70193-0
   Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999
   MARTIN PJ, 1987, ADV IMMUNOL, V40, P379, DOI 10.1016/S0065-2776(08)60243-6
   Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5
   Nishida S, 2003, CIRC J, V67, P334
   Noishiki Y, 1996, NAT MED, V2, P90, DOI 10.1038/nm0196-90
   Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X
   Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Pouzet B, 2000, CIRCULATION, V102, P210
   Sakai T, 2001, J THORAC CARDIOV SUR, V121, P932, DOI 10.1067/mtc.2001.113600
   Sata M, 2003, CIRC J, V67, P983, DOI 10.1253/circj.67.983
   Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9
   TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018
   Tomita S, 2002, J THORAC CARDIOV SUR, V123, P1132, DOI 10.1067/mtc.2002.120716
   Tomita S, 1999, CIRCULATION, V100, P247
   Whalen G F, 1989, Growth Factors, V1, P157, DOI 10.3109/08977198909029125
NR 28
TC 24
Z9 26
U1 0
U2 3
PU JAPANESE CIRCULATION SOCIETY
PI KYOTO
PA KINKI INVENTION CENTER, 14 YOSHIDA KAWAHARACHO, SAKYO-KU, KYOTO,
   606-8305, JAPAN
SN 1346-9843
J9 CIRC J
JI Circ. J.
PD JUL
PY 2005
VL 69
IS 7
BP 850
EP 857
DI 10.1253/circj.69.850
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 939WB
UT WOS:000230102200013
PM 15988112
OA Bronze
DA 2018-10-20
ER

PT J
AU Ito, A
   Otsuka, M
   Kawamura, H
   Ikeuchi, M
   Ohgushi, H
   Sogo, Y
   Ichinose, N
AF Ito, A
   Otsuka, M
   Kawamura, H
   Ikeuchi, M
   Ohgushi, H
   Sogo, Y
   Ichinose, N
TI Zinc-containing tricalcium phosphate and related materials for promoting
   bone formation
SO CURRENT APPLIED PHYSICS
LA English
DT Article; Proceedings Paper
CT 2nd Korea-China Symposium on Biomaterials and Nano-Bio Technology
CY OCT 17-21, 2004
CL Yonsei Univ, Seoul, SOUTH KOREA
SP Nat Sci Fdn China, Korea Sci Engn Fdn, Korea Acad Sc Tech
HO Yonsei Univ
DE biomaterials and biological interface
ID OSTEOBLASTIC MC3T3-E1 CELLS; L-HISTIDINATO ZINC; CALCIUM-PHOSPHATE;
   PROTEIN-SYNTHESIS; RABBIT FEMORA; CERAMICS; RATS; BETA;
   CYTOCOMPATIBILITY; SOLUBILITY
AB Calcium phosphate is a suitable carrier of zinc, an essential element that has stimulatory effects on bone formation in vitro and in vivo as well as an inhibitory effect on osteoclastic bone resorption in vitro. The highest zinc content is attained in beta-tricalcium phosphate, where the zinc content reaches 6 wt%. Both rat and human bone marrow cells (BMCs) cultured on zinc-containing beta-tricalcium phosphate and hydroxyapatite composite ceramics differentiated more than BMCs cultured on zinc-free composite ceramics in the presence of beta-glycerophosphate and dexamethasone. The acceptable dose of zinc,was higher for human BMCs than for rat BMCs. The solubility of ZnTCP, which contains a nontoxic level of zinc, decreased to 52-92% that of pure TCP in the pH range of 5.0-7.4. However, the resorbed volume of ZnTCP was much lower than that expected from the in vitro solubility of ZnTCP, becoming as low as 26-20% that of TCP, which indicates that the reduction in the resorbability of ZnTCP would be attributable principally to its lowered cellular activation property relative to that associated with pure TCP. Probably due to the lowered cellular activation property associated with ZnTCP, bone loss at the bone-implant interface was significantly arrested in the long-term implantation of ZnTCP/HAP. The intramuscular injection of ZnTCP powder is effective in increasing bone mineral density in the vicinity of the injected site in osteopenic animals. All these findings suggest that zinc-containing calcium phosphate is a biomaterial that promotes bone formation. (c) 2005 Elsevier B.V. All rights reserved.
C1 Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan.
   Kobe Pharmaceut Univ, Dept Pharmaceut Technol, Kobe, Hyogo 6588558, Japan.
   Ryugasaki Saisekai Hosp, Dept Orthoped Surg, Ryugasaki, Ibaraki, Japan.
   Waseda Univ, Sch Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan.
RP Ito, A (reprint author), Natl Inst Adv Ind Sci & Technol, Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.
EM atsuo-ito@aist.go.jp
RI Sogo, Yu/L-8045-2018; Ito, Atsuo/M-6785-2018
OI Sogo, Yu/0000-0003-1228-4648; Ito, Atsuo/0000-0003-3318-040X
CR BETTGER WJ, 1993, J NUTR BIOCHEM, V4, P194, DOI 10.1016/0955-2863(93)90052-X
   Hamilton EI, 1973, SCIENCE TOTAL ENVIRO, V1, P341, DOI DOI 10.1016/0048-9697(73)90024-7
   HASHIZUME M, 1993, MOL CELL BIOCHEM, V122, P59, DOI 10.1007/BF00925737
   Ikeuchi M, 2003, J BIOMED MATER RES A, V67A, P1115, DOI 10.1002/jbm.a.10041
   Ito A, 2000, J BIOMED MATER RES, V50, P178, DOI 10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.0.CO;2-5
   Ito A, 2002, J BIOMED MATER RES, V60, P224, DOI 10.1002/jbm.10068
   Ito A, 2002, MAT SCI ENG C-BIO S, V22, P21, DOI 10.1016/S0928-4931(02)00108-X
   Kawamura H, 2003, J BIOMED MATER RES A, V65A, P468, DOI 10.1002/jbm.a.10524
   Kawamura H, 2000, J BIOMED MATER RES, V50, P184, DOI 10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3
   Lowe NM, 2002, P NUTR SOC, V61, P181, DOI 10.1079/PNS2002154
   Lutz W, 2000, BIOCHEM BIOPH RES CO, V271, P1, DOI 10.1006/bbrc.2000.2570
   McCusker RH, 1998, J DAIRY SCI, V81, P1790, DOI 10.3168/jds.S0022-0302(98)75748-0
   MOONGA BS, 1995, J BONE MINER RES, V10, P453
   Otsuka M, 2004, J BIOMED MATER RES A, V69A, P552, DOI 10.1002/jbm.a.30040
   Sogo Y, 2004, MAT SCI ENG C-BIO S, V24, P709, DOI 10.1016/j.msec.2004.08.016
   Sogo Y, 2004, MATER SCI TECH-LOND, V20, P1079, DOI 10.1179/026708304225019704
   Sogo Y, 2002, J BIOMED MATER RES, V62, P457, DOI 10.1002/jbm.10200
   UNDERWOOD EJ, 1977, TRACE ELEMENTS HUMAN, P197
   World Health Organization, 1973, WHO TECH REP SER, V532, P9
   YAMAGUCHI M, 1990, RES EXP MED, V190, P295, DOI 10.1007/BF00000035
   YAMAGUCHI M, 1986, BIOCHEM PHARMACOL, V35, P773, DOI 10.1016/0006-2952(86)90245-5
   YAMAGUCHI M, 1994, MOL CELL BIOCHEM, V136, P163, DOI 10.1007/BF00926077
   YAMAGUCHI M, 1994, PEPTIDES, V15, P1367, DOI 10.1016/0196-9781(94)90110-4
NR 23
TC 88
Z9 92
U1 0
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD JUL
PY 2005
VL 5
IS 5
BP 402
EP 406
DI 10.1016/j.cap.2004.10.006
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 944HX
UT WOS:000230419000002
DA 2018-10-20
ER

PT J
AU Zhai, Y
   Cui, FZ
   Wang, Y
AF Zhai, Y
   Cui, FZ
   Wang, Y
TI Formation of nano-hydroxyapatite on recombinant human-like collagen
   fibrils
SO CURRENT APPLIED PHYSICS
LA English
DT Article; Proceedings Paper
CT 2nd Korea-China Symposium on Biomaterials and Nano-Bio Technology
CY OCT 17-21, 2004
CL Yonsei Univ, Seoul, SOUTH KOREA
SP Nat Sci Fdn China, Korea Sci Engn Fdn, Korea Acad Sc Tech
HO Yonsei Univ
DE recombinant human collagen; biomineralization; hydroxyapatite; tissue
   engineering; fibril
AB Mineralization of recombinant human-like collagen is an important biomaterial for bone tissue engineering. Features of the formation of nano-hydroxyapatite on recombinant human-like collagen surface were investigated by SEM, XRD, FTIR and TEM. Formation mechanism of the nano-crystals is also discussed. The nano-HA is about 6-25 nm in size and with their c-axis parallel to the fibrils orientation. (c) 2005 Elsevier B.V. All rights reserved.
C1 Tsing Hua Univ, Dept Mat Sci & Engn, Biomat Lab, Beijing 100084, Peoples R China.
RP Cui, FZ (reprint author), Tsing Hua Univ, Dept Mat Sci & Engn, Biomat Lab, Beijing 100084, Peoples R China.
EM cuifz@mail.tsinghua.edu.cn
RI Liu, Yifei/L-7828-2014
OI Liu, Yifei/0000-0002-1087-9827
CR Asher D M, 1999, Dev Biol Stand, V100, P103
   Cui FZ, 1996, J STRUCT BIOL, V117, P204, DOI 10.1006/jsbi.1996.0084
   Furuzono T, 2001, J MATER SCI LETT, V20, P111, DOI 10.1023/A:1006725931450
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hellman KB, 1996, DEV BIOL STAND, V88, P231
   LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003
   Miekka SI, 2003, VOX SANG, V84, P36, DOI 10.1046/j.1423-0410.2003.00256.x
   Patino MG, 2003, J PERIODONTAL RES, V38, P458, DOI 10.1034/j.1600-0765.2003.00017.x
   SCHRIEBER R, 1993, DEV BIOL STAND, V80, P195
   SIGEL H, 1982, CHEM REV, V82, P385, DOI 10.1021/cr00050a003
   SLAVICA L, 2001, THERMOCHIM ACTA, V374, P13
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   WEINER S, 1986, FEBS LETT, V206, P262, DOI 10.1016/0014-5793(86)80993-0
   Zhang S, 1997, J MATER SCI-MATER M, V8, P25, DOI 10.1023/A:1018586128257
   Zhang W, 2003, CHEM MATER, V15, P3221, DOI 10.1021/cm030080g
   1371919A
NR 16
TC 58
Z9 66
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD JUL
PY 2005
VL 5
IS 5
BP 429
EP 432
DI 10.1016/j.cap.2005.01.004
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 944HX
UT WOS:000230419000008
DA 2018-10-20
ER

PT J
AU Chung, HJ
   Go, DH
   Bae, JW
   Jung, IK
   Lee, JW
   Park, KD
AF Chung, HJ
   Go, DH
   Bae, JW
   Jung, IK
   Lee, JW
   Park, KD
TI Synthesis and characterization of Pluronic((R)) grafted chitosan
   copolymer as a novel injectable biomaterial
SO CURRENT APPLIED PHYSICS
LA English
DT Article; Proceedings Paper
CT 2nd Korea-China Symposium on Biomaterials and Nano-Bio Technology
CY OCT 17-21, 2004
CL Yonsei Univ, Seoul, SOUTH KOREA
SP Nat Sci Fdn China, Korea Sci Engn Fdn, Korea Acad Sc Tech
HO Yonsei Univ
DE thermosensitivity; chitosan; Pluronic((R)); hydrogels; water soluble
ID RELEASE
AB Water-soluble thermosensitive chitosan copolymers were prepared by coupling Pluronic (R) onto chitosan using 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) and N-hydroxysuccinimide (NHS) as coupling agents. The physicochemical properties of the resulting copolymers were characterized and they formed thermally reversible hydrogels, which exhibit a lower critical solution temperature (LCST) at 34 degrees C in aqueous solutions. As a result, chitosan copolymers attest to the usefulness as an injectable material for cell and drug delivery because of their thermally reversible property. (c) 2005 Elsevier B.V. All rights reserved.
C1 Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea.
   Korea Inst Sci & Technol Informat, Dept Mat & Component Informat Anal, Seoul 130742, South Korea.
RP Park, KD (reprint author), Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea.
EM kdp@ajou.ac.kr
CR ALMGREN M, 1992, J COLLOID INTERF SCI, V151, P157, DOI 10.1016/0021-9797(92)90247-J
   BAE YH, 1990, J POLYM SCI POL PHYS, V28, P923, DOI 10.1002/polb.1990.090280609
   Cho KY, 2003, INT J PHARM, V260, P83, DOI 10.1016/S0378-5173(03)00259-X
   Haipeng G, 2000, J Biomed Mater Res, V52, P285, DOI 10.1002/1097-4636(200011)52:2<285::AID-JBM7>3.3.CO;2-7
   HOLLINGER JO, 1986, CLIN ORTHOP RELAT R, P290
   Kikuchi A, 2002, PROG POLYM SCI, V27, P1165, DOI 10.1016/S0079-6700(02)00013-8
   LUNDSTED LG, 1976, BLOCK GRAFT COPOLYME, V2, P1
   Usami Y, 1997, CARBOHYD POLYM, V32, P115, DOI 10.1016/S0144-8617(96)00153-1
   YOSHIDA R, 1992, IND ENG CHEM RES, V31, P2339, DOI 10.1021/ie00010a013
   ZALIPSKY S, 1983, EUR POLYM J, V19, P1177, DOI 10.1016/0014-3057(83)90016-2
NR 10
TC 71
Z9 75
U1 4
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD JUL
PY 2005
VL 5
IS 5
BP 485
EP 488
DI 10.1016/j.cap.2005.01.015
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 944HX
UT WOS:000230419000020
DA 2018-10-20
ER

PT J
AU Zhang, SM
   Liu, J
   Zhou, W
   Cheng, L
   Guo, XD
AF Zhang, SM
   Liu, J
   Zhou, W
   Cheng, L
   Guo, XD
TI Interfacial fabrication and property of hydroxyapatite/polylactide
   resorbable bone fixation composites
SO CURRENT APPLIED PHYSICS
LA English
DT Article; Proceedings Paper
CT 2nd Korea-China Symposium on Biomaterials and Nano-Bio Technology
CY OCT 17-21, 2004
CL Yonsei Univ, Seoul, SOUTH KOREA
SP Nat Sci Fdn China, Korea Sci Engn Fdn, Korea Acad Sc Tech
HO Yonsei Univ
DE biomaterial; interface; composite; hydroxyapatite; resorbability
AB Based on surface modification of hydroxyapatite with silane derivatives, interfacial fabrications of hydroxyapatite (HAP)/polylactide (PLA) resorbable bone fixation composites are realized. The results indicate that interfacial adhesion, swelling property, and ultimate mechanical properties of the HAP/PLA composites are significantly improved. As a result, the maximum bending strength enhances 27.8%. Scanning electron microscopy (SEM) observation suggests that the modified HA particles are homogeneously dispersed in the composites, their size ranges are about 2-15 mu m. The modified HA/PLA composites are of toughened rupture. This conclusion is consistent with bending property of the composites. Finally, a possible mechanism for the interfacial adhesion is also discussed. (c) 2005 Elsevier B.V. All rights reserved.
C1 Huazhong Univ Sci & Technol, Adv Biomat & Tissue Engn Ctr, Wuhan 430074, Peoples R China.
   Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan 430051, Peoples R China.
RP Zhang, SM (reprint author), Huazhong Univ Sci & Technol, Adv Biomat & Tissue Engn Ctr, Life Sci Bldg, Wuhan 430074, Peoples R China.
EM smzhang@mail.hust.edu.cn
RI guo, xiaodong/K-2600-2013
CR Deng XM, 2001, J MATER SCI LETT, V20, P281, DOI 10.1023/A:1006714010765
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   ZHANG SM, 2003, NEW ADV MAT SCI ENG, P230
NR 4
TC 35
Z9 39
U1 0
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD JUL
PY 2005
VL 5
IS 5
BP 516
EP 518
DI 10.1016/j.cap.2005.01.023
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 944HX
UT WOS:000230419000027
DA 2018-10-20
ER

PT J
AU Kim, YH
   Song, H
   Riu, DH
   Kim, SR
   Kim, HJ
   Moon, JH
AF Kim, YH
   Song, H
   Riu, DH
   Kim, SR
   Kim, HJ
   Moon, JH
TI Preparation of porous Si-incorporated hydroxyapatite
SO CURRENT APPLIED PHYSICS
LA English
DT Article; Proceedings Paper
CT 2nd Korea-China Symposium on Biomaterials and Nano-Bio Technology
CY OCT 17-21, 2004
CL Yonsei Univ, Seoul, SOUTH KOREA
SP Nat Sci Fdn China, Korea Sci Engn Fdn, Korea Acad Sc Tech
HO Yonsei Univ
DE hydroxyapatite; silicon; incorporation; porous block; biomaterial
ID SILICON-SUBSTITUTED HYDROXYAPATITE
AB A porous silicon-incorporated hydroxyapatite has been prepared using natural coral as a calcium source to obtain a biomaterial having a good biocompatibility. Si-incorporated hydroxyapatite has been prepared by hydrothermal treatment in 2 M (NH4)(2)HPO4 and solvothermal treatment in silicon acetate saturated acetone solution at 180 degrees C of the natural coral repeatedly. From the XRD analysis, it was confirmed that the single-phase hydroxyapatite containing silicon has formed without revealing the presence of extra phases related to silicon dioxide or other calcium phosphate species. Compressive strength of the porous silicon-incorporated hydroxyapatite was 5.5 MPa and silicon content was ranged from 0.12% to 0.19% by weight. SEM and EDS investigation confirmed the presence of silicon in the framework of hydroxyapatite structure. (c) 2005 Published by Elsevier B.V.
C1 Korea Inst Ceram Engn & Technol, Seoul 153801, South Korea.
   Meta Biomed Co Ltd, Choongbuk 363880, South Korea.
   Yonsei Univ, Dept Ceram Engn, Seoul 120749, South Korea.
RP Kim, YH (reprint author), Korea Inst Ceram Engn & Technol, Seoul 153801, South Korea.
EM yhkokim@kicet.re.kr
CR Ben-Nissan B, 2003, CURR OPIN SOLID ST M, V7, P283, DOI 10.1016/j.cossms.2003.10.001
   Bertoni E, 1998, J INORG BIOCHEM, V72, P29, DOI 10.1016/S0162-0134(98)10058-2
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Hayakawa S, 1999, J AM CERAM SOC, V82, P2155
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Kim SR, 2002, KEY ENG MATER, V218-2, P85, DOI 10.4028/www.scientific.net/KEM.218-220.85
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   KOKUBO T., 1994, BIOCERAMICS, V7, P49
   POTER AE, 2003, BIOMATERIALS, V24, P4609
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   Shi DL, 1998, MAT SCI ENG C-BIO S, V6, P175, DOI 10.1016/S0928-4931(98)00048-4
NR 12
TC 20
Z9 20
U1 1
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
EI 1878-1675
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD JUL
PY 2005
VL 5
IS 5
BP 538
EP 541
DI 10.1016/j.cap.2005.01.031
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 944HX
UT WOS:000230419000033
DA 2018-10-20
ER

PT J
AU Tanzi, MC
AF Tanzi, MC
TI Bioactive technologies for hemocompatibility
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Review
DE bioactive; biomembrane mimicry; biomimetic; biopassive; glycomimesis;
   hemocompatibility materials; heparin immobilization; polyethylene oxide;
   surface immobilizing agents; surface modification
ID EXTRACORPOREAL-CIRCULATION CIRCUITS; TRILLIUM(TM) BIOPASSIVE SURFACE;
   BLOOD-COMPATIBLE MATERIALS; HEPARIN-COATED CIRCUITS; IN-VITRO;
   CARDIOPULMONARY BYPASS; ANTICOAGULANT ACTIVITY; RECOMBINANT HIRUDIN;
   PROTEIN ADSORPTION; POLYMER SURFACES
AB The contact of any biomaterial with blood gives rise to multiple pathophysiologic defensive mechanisms such as activation of the coagulation cascade, platelet adhesion and activation of the complement system and leukocytes. The reduction of these events is of crucial importance for the successful clinical performance of a cardiovascular device. This can be achieved by improving the hemocompatibility of the device materials or by pharmacologic inhibition of the key enzymes responsible for the activation of the cascade reactions, or a combination of both. Different strategies have been developed during the last 20 years, and this article attempts to review the most significant, by dividing them into three main categories: bioinert or biopassive, biomimetic and bioactive strategies. With regard to bioactive strategies, particular attention is given to heparin immobilization and recent related technologies. References from both scientific literature and commercial sites are provided. Future development and studies are suggested.
C1 Politecn Milan, Dept Bioengn, I-20123 Milan, Italy.
RP Tanzi, MC (reprint author), Politecn Milan, Dept Bioengn, Pzza L Da Vinci 32, I-20123 Milan, Italy.
EM tanzi@biomed.polimi.it
RI Tanzi, Maria Cristina/I-4620-2013
OI Tanzi, Maria Cristina/0000-0002-4913-6633
CR ALBANESE A, 1994, BIOMATERIALS, V15, P129, DOI 10.1016/0142-9612(94)90262-3
   Alcantar NA, 2000, J BIOMED MATER RES, V51, P343, DOI 10.1002/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D
   Aldenhoff YBJ, 1997, BIOMATERIALS, V18, P167, DOI 10.1016/S0142-9612(96)00095-6
   Aldenhoff Yvette B. J., 2003, European Cells & Materials, V5, P61
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   Amos R.A., 1995, ENCY HDB BIOMATERI A, V1, P895
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Bentolila A, 2000, J MED CHEM, V43, P2591, DOI 10.1021/jm000089j
   Cazzaniga A, 2000, INT J ARTIF ORGANS, V23, P319
   CHAPMAN D, 1993, LANGMUIR, V9, P39, DOI 10.1021/la00025a012
   Chung YC, 2005, BIOMATERIALS, V26, P2313, DOI 10.1016/j.biomaterials.2004.06.043
   Cornelius RM, 2003, J BIOMED MATER RES A, V67A, P475, DOI 10.1002/jbm.a.10118
   Dal Park H, 2002, J BIOMED MATER RES, V60, P186
   DURRANI AA, 1986, BIOMATERIALS, V7, P121, DOI 10.1016/0142-9612(86)90068-2
   Ferruti P., 1996, POLYM MAT ENCY, V5, P3334
   FEYRER R, 2003, CARDIOVASC ENG, V8, P1
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   Frost MC, 2005, BIOMATERIALS, V26, P1685, DOI 10.1016/j.biomaterials.2004.06.006
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GOTT VL, 1963, SCIENCE, V142, P1297, DOI 10.1126/science.142.3597.1297
   GRAINGER DW, 1990, J BIOMED MATER RES, V24, P403, DOI 10.1002/jbm.820240402
   Gu YJ, 1998, ANN THORAC SURG, V65, P1342, DOI 10.1016/S0003-4975(98)00223-9
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   HOFMA SH, 2001, CURR INTERV CARDIOL, V3, P28
   Inui K, 1999, ARTIF ORGANS, V23, P1107, DOI 10.1111/j.1525-1594.1999.06335.x
   Ishihara K, 2000, J BIOMAT SCI-POLYM E, V11, P1183, DOI 10.1163/156856200744264
   Iwasaki Y, 2003, J BIOMED MATER RES A, V65A, P164, DOI 10.1002/jbm.a.10459
   Janvier G, 1996, ANN THORAC SURG, V62, P1926, DOI 10.1016/S0003-4975(96)00942-3
   Jee KS, 2004, BIOMACROMOLECULES, V5, P1877, DOI 10.1021/bm049795i
   Johnell M, 2005, BIOMATERIALS, V26, P1731, DOI 10.1016/j.biomaterials.2004.05.029
   Johnell M, 2002, J THORAC CARDIOV SUR, V124, P321, DOI 10.1067/mtc.2002.122551
   JOHNELL M, 2003, ACTA U UPSAL, V1299, P65
   Jun Z., 2003, COLLOID SURFACE B, V28, P1
   KAPPELMAYER J, 1993, CIRC RES, V72, P1075, DOI 10.1161/01.RES.72.5.1075
   KASHIWAGI T, 1993, BIOMATERIALS, V14, P1145, DOI 10.1016/0142-9612(93)90159-Y
   Kidane AG, 2004, BIOMACROMOLECULES, V5, P798, DOI 10.1021/bm0344553
   Kim YH, 1997, MACROMOL SYMP, V118, P565, DOI 10.1002/masy.19971180174
   Kolusheva S, 2001, J AM CHEM SOC, V123, P417, DOI 10.1021/ja0034139
   KRISTENSEN EM, 2003, BIOMATERIALS, V23, P4153
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   LENINGER RI, 1966, SCIENCE, V152, P1625
   Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724
   Lewis AL, 2000, BIOMATERIALS, V21, P1847, DOI 10.1016/S0142-9612(00)00055-7
   Lian FR, 2001, BIOCHEMISTRY-US, V40, P8508, DOI 10.1021/bi0101906
   LIN HB, 1992, J BIOMAT SCI-POLYM E, V3, P217, DOI 10.1163/156856292X00132
   LIN HB, 1992, BIOMATERIALS, V13, P905, DOI 10.1016/0142-9612(92)90113-3
   Lin YS, 2001, ARTIF ORGANS, V25, P617, DOI 10.1046/j.1525-1594.2001.025008617.x
   Liu H, 2002, LANGMUIR, V18, P1332, DOI 10.1021/la011254g
   Liu JH, 1999, J APPL POLYM SCI, V74, P2947, DOI 10.1002/1097-4628(19991213)74:12<2947::AID-APP21>3.0.CO;2-1
   Lu JR, 2001, LANGMUIR, V17, P3382, DOI 10.1021/la0017429
   Mao C, 2004, ADV COLLOID INTERFAC, V110, P5, DOI 10.1016/j.cis.2004.02.001
   MATSUDA T, 1990, T AM SOC ART INT ORG, V36, P161
   Matsusaki M, 2002, BIOCONJUGATE CHEM, V13, P23, DOI 10.1021/bc010008d
   McClung WG, 2001, BIOMATERIALS, V22, P1919, DOI 10.1016/S0142-9612(00)00378-1
   McClung WG, 2000, J BIOMED MATER RES, V49, P409, DOI 10.1002/(SICI)1097-4636(20000305)49:3<409::AID-JBM14>3.0.CO;2-0
   Morrissey JH, 2001, THROMB HAEMOSTASIS, V86, P66
   MUNRO MS, 1981, T AM SOC ART INT ORG, V27, P499
   Murphy EF, 1999, LANGMUIR, V15, P1313, DOI 10.1021/la9813580
   Olander B, 2003, BIOMACROMOLECULES, V4, P145, DOI 10.1021/bm025654+
   Oliveira GB, 2003, BIOMATERIALS, V24, P4777, DOI 10.1016/S0142-9612(03)00376-4
   Orban JM, 2000, MACROMOLECULES, V33, P4205, DOI 10.1021/ma9915780
   Ovrum E, 2003, J CARDIAC SURG, V18, P140, DOI 10.1046/j.1540-8191.2003.02007.x
   Palanzo DA, 2001, PERFUSION-UK, V16, P279, DOI 10.1177/026765910101600403
   Petrini P, 2000, J BIOMAT SCI-POLYM E, V11, P353, DOI 10.1163/156856200743751
   Phaneuf MD, 1997, BIOMATERIALS, V18, P755, DOI 10.1016/S0142-9612(96)00193-7
   Phaneuf MD, 1998, ARTIF ORGANS, V22, P657, DOI 10.1046/j.1525-1594.1998.05091.x
   PHANEUF MD, 1997, BIOMATERIALS, V18, P1495
   Ranucci M, 1999, ANN THORAC SURG, V67, P994, DOI 10.1016/S0003-4975(99)00062-4
   REGEN SL, 1983, MACROMOLECULES, V16, P335, DOI 10.1021/ma00236a034
   Ross EE, 2001, LANGMUIR, V17, P2305, DOI 10.1021/la010752
   SANDHU S, 2004, DEV BIOINTERACTING M, P1
   SEFTON MV, 2004, BIOMATERIALS SCI INT, P456
   Sharma CP, 2001, J BIOMATER APPL, V15, P359, DOI 10.1106/YY8L-M4DD-AGW1-QAGU
   Shen MC, 2001, J BIOMAT SCI-POLYM E, V12, P961, DOI 10.1163/156856201753252507
   Sheth SR, 1997, P NATL ACAD SCI USA, V94, P8399, DOI 10.1073/pnas.94.16.8399
   Silver JH, 1999, BIOMATERIALS, V20, P1533, DOI 10.1016/S0142-9612(98)00173-2
   Sinay P, 1999, NATURE, V398, P377, DOI 10.1038/18783
   Sofia SJ, 1998, J BIOMED MATER RES, V40, P153, DOI 10.1002/(SICI)1097-4636(199804)40:1<153::AID-JBM18>3.0.CO;2-P
   Spijker HT, 2003, BIOMATERIALS, V24, P4717, DOI 10.1016/S0142-9612(03)00380-6
   Sun XL, 2002, BIOMACROMOLECULES, V3, P1065, DOI 10.1021/bm025561s
   Svedhem S, 2003, LANGMUIR, V19, P6730, DOI 10.1021/la034172w
   Tang YW, 1996, J APPL POLYM SCI, V62, P1133, DOI 10.1002/(SICI)1097-4628(19961121)62:8<1133::AID-APP1>3.0.CO;2-J
   Tanzi MC, 2004, NATO SCI SER II MATH, V180, P51
   TANZI MC, 1992, BIOMATERIALS, V13, P425, DOI 10.1016/0142-9612(92)90162-H
   Taton KS, 2002, COLLOID SURFACE B, V24, P123, DOI 10.1016/S0927-7765(01)00225-9
   Tayama E, 2000, ARTIF ORGANS, V24, P618, DOI 10.1046/j.1525-1594.2000.06615.x
   TEGOULIA VA, 2001, LANGMUIR, V17, P1533
   Tsai C C, 1994, ASAIO J, V40, pM619, DOI 10.1097/00002480-199407000-00073
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
   Videm V, 1999, J THORAC CARDIOV SUR, V117, P803, DOI 10.1016/S0022-5223(99)70302-8
   Wang DA, 2003, J BIOMED MATER RES A, V65A, P498, DOI 10.1002/jbm.a.10533
   Wang DA, 2002, BIOMACROMOLECULES, V3, P1286, DOI 10.1021/bm0255950
   WARD RS, 1995, MED PLASTICS BIOMATE
   WARD RS, 2004, T 7 WORLD BIOM C SYD, P433
   WARD RS, 1984, POLYURETHANES BIOMED, P180
   Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   Wildevuur CRH, 1997, EUR J CARDIO-THORAC, V11, P616, DOI 10.1016/S1010-7940(96)01122-0
   Wissink MJB, 2001, BIOMATERIALS, V22, P151, DOI 10.1016/S0142-9612(00)00164-2
   Wyers MC, 1999, CARDIOVASC PATHOL, V8, P153, DOI 10.1016/S1054-8807(99)00005-8
   Yianni YP, 1992, STRUCTURAL DYNAMIC P, P187
   Yoneyama T, 2002, BIOMATERIALS, V23, P1455, DOI 10.1016/S0142-9612(01)00268-X
   Zehnder JL, 1999, NATURE, V400, P714, DOI 10.1038/23360
NR 104
TC 59
Z9 60
U1 4
U2 33
PU EXPERT REVIEWS
PI LONDON
PA UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB,
   ENGLAND
SN 1743-4440
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD JUL
PY 2005
VL 2
IS 4
BP 473
EP 492
DI 10.1586/17434440.2.4.473
PG 20
WC Engineering, Biomedical
SC Engineering
GA 019KS
UT WOS:000235834600015
PM 16293086
DA 2018-10-20
ER

PT J
AU Tang, LP
   Hu, WJ
AF Tang, LP
   Hu, WJ
TI Molecular determinants of biocompatibility
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Review
DE biocompatibility; biomaterials; fibrinogen; fibrosis; foreign body
   reactions; inflammation; macrophages; neutrophils; phagocytes
ID TUMOR-NECROSIS-FACTOR; ACUTE INFLAMMATORY RESPONSES; ADSORBED
   FIBRINOGEN; PROTEIN ADSORPTION; TISSUE REACTION; CONFORMATIONAL-CHANGES;
   ARTERIAL PROSTHESES; GAMMA-GLOBULIN; CELL-ADHESION; BIOMATERIALS
AB The biocompatibility of medical implants dictates the fate of almost all medical devices. It is well established that medical devices trigger a variety of adverse tissue responses, such as inflammation, fibrosis, infection and thrombosis. However, the mechanisms involved in biomaterial-mediated tissue responses remain largely unknown. The lack of such knowledge hinders the development of biomaterials with better biocompatibility and safety. The aim of this review is to summarize our current understanding of the processes governing foreign body reactions to tissue-contact devices. Obviously, this information is urgently needed for assisting the rational design of materials or medical devices to minimize undesirable tissue reactions upon implantation and, in addition, to promote the wound healing process.
C1 Univ Texas, Biomed Engn Program, Arlington, TX 76019 USA.
RP Tang, LP (reprint author), Univ Texas, Biomed Engn Program, POB 19138, Arlington, TX 76019 USA.
EM ltang@uta.edu; wenjinghu@comcast.net
CR ALTIERI DC, 1993, J BIOL CHEM, V268, P1847
   ALTMAN JJ, 1986, DIABETES, V35, P625, DOI 10.2337/diabetes.35.6.625
   ALTMAN JJ, 1986, T AM SOC ART INT ORG, V32, P145
   AMON M, 1994, INT OPHTHALMOL, V18, P9, DOI 10.1007/BF00919407
   AMON M, 1993, J CATARACT REFR SURG, V19, P258, DOI 10.1016/S0886-3350(13)80953-4
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   ANDRADE JD, 1984, PURE APPL CHEM, V56, P1345, DOI 10.1351/pac198456101345
   ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   ARCHER J, 1980, J SURG RES, V28, P77, DOI 10.1016/0022-4804(80)90086-4
   ATHANASOU NA, 1992, J BONE JOINT SURG BR, V74, P57
   BERGER K, 1972, ANN SURG, V175, P118, DOI 10.1097/00000658-197201000-00018
   BOHNERT JL, 1986, J COLLOID INTERF SCI, V111, P363, DOI 10.1016/0021-9797(86)90040-8
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BRANDSTEDT S, 1980, ACTA CHIR SCAND, V146, P483
   BRAQUET P, 1987, IMMUNOL TODAY, V8, P345, DOI 10.1016/0167-5699(87)90010-7
   Butler K, 1997, Biomed Sci Instrum, V34, P18
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   Carro LP, 1999, ARTHROSCOPY, V15, P103, DOI 10.1053/ar.1999.v15.015010
   CHANDRAKASAN G, 1991, CELL MOL BIOL, V37, P751
   CHINN JA, 1992, J BIOMED MATER RES, V26, P757, DOI 10.1002/jbm.820260606
   CHRISTENSON L, 1989, J BIOMED MATER RES, V23, P705, DOI 10.1002/jbm.820230704
   CHRISTENSON L, 1991, J BIOMED MATER RES, V25, P1119, DOI 10.1002/jbm.820250906
   CHUANG HYK, 1980, THROMB RES, V19, P1, DOI 10.1016/0049-3848(80)90398-9
   Clark HR, 1999, BIOTECHNOL PROGR, V15, P259, DOI 10.1021/bp990003j
   COLEMAN SE, 1986, J BIOMED MATER RES, V20, P301, DOI 10.1002/jbm.820200304
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   DiPietro LA, 1998, J CLIN INVEST, V101, P1693, DOI 10.1172/JCI1020
   DOMANSKIS EJ, 1976, PLAST RECONSTR SURG, V58, P689, DOI 10.1097/00006534-197612000-00006
   Fahey T J 3rd, 1990, Cytokine, V2, P92, DOI 10.1016/1043-4666(90)90002-B
   FAN ST, 1993, J IMMUNOL, V150, P2972
   FREYRIA AM, 1991, BIOMATERIALS, V12, P111, DOI 10.1016/0142-9612(91)90187-F
   GORDON M, 1982, J BONE JOINT SURG AM, V64, P574, DOI 10.2106/00004623-198264040-00013
   HANLON WA, 1991, J LEUKOCYTE BIOL, V50, P43
   HENRY CH, 1993, J ORAL MAXIL SURG, V51, P352, DOI 10.1016/S0278-2391(10)80343-X
   HENSON PM, 1975, J CLIN INVEST, V56, P1053, DOI 10.1172/JCI108152
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   HUMPHRIES MJ, 1987, J BIOL CHEM, V262, P6886
   JASTY M, 1993, J APPL BIOMATER, V4, P273, DOI 10.1002/jab.770040310
   Khouw IMSL, 1998, J BIOMED MATER RES, V41, P202, DOI 10.1002/(SICI)1097-4636(199808)41:2<202::AID-JBM4>3.0.CO;2-M
   KOSSOVSKY N, 1991, J BIOMED MATER RES, V25, P1287, DOI 10.1002/jbm.820251009
   Kryshtalskyj B, 1996, Ont Dent, V73, P40
   LEE RG, 1974, J BIOMED MATER RES, V8, P251, DOI 10.1002/jbm.820080507
   LEIBOVICH SJ, 1976, AM J PATHOL, V84, P501
   LINDSAY RM, 1980, T AM SOC ART INT ORG, V26, P603
   LU DR, 1991, J COLLOID INTERF SCI, V144, P271, DOI 10.1016/0021-9797(91)90258-A
   Lu HF, 1997, J CLIN INVEST, V99, P1340, DOI 10.1172/JCI119293
   MACRITCHIE F, 1972, J COLLOID INTERF SCI, V38, P484, DOI 10.1016/0021-9797(72)90264-0
   MCCARTHY JB, 1990, J CELL BIOL, V110, P777, DOI 10.1083/jcb.110.3.777
   MCRITCHIE DI, 1991, J LAB CLIN MED, V118, P48
   MORRISSEY BW, 1976, T AM SOC ART INT ORG, V22, P278
   MORRISSEY BW, 1978, J COLLOID INTERF SCI, V65, P423, DOI 10.1016/0021-9797(78)90093-0
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   NUSBACHER J, 1978, BLOOD, V51, P359
   OLD LJ, 1985, SCIENCE, V230, P630, DOI 10.1126/science.2413547
   PEREZ RL, 1995, J IMMUNOL, V154, P1879
   POLLAK VE, 1982, AM J NEPHROL, V2, P195, DOI 10.1159/000166646
   PRESCOTT RJ, 1994, J CLIN PATHOL, V47, P375, DOI 10.1136/jcp.47.4.375
   RAPOZA R J, 1989, Journal of Biomaterials Science Polymer Edition, V1, P99, DOI 10.1163/156856289X00091
   SCHAAF P, 1988, COLLOID SURFACE, V31, P89, DOI 10.1016/0166-6622(88)80184-7
   SCHIAVONE PA, 1993, KNEE SURG SPORT TR A, V1, P9
   Schroven I T, 1994, Knee Surg Sports Traumatol Arthrosc, V2, P214, DOI 10.1007/BF01845590
   SEVASTIANOV VI, 1988, CRIT REV BIOCOMPAT, V4, P109
   SLACK SM, 1989, J COLLOID INTERF SCI, V133, P148, DOI 10.1016/0021-9797(89)90288-9
   STARK GB, 1990, ANN PLAS SURG, V24, P156, DOI 10.1097/00000637-199002000-00009
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   TANG L, 2000, BIOMATERIAL ENG DEVI, V1, P3
   TANG L, 1999, TISSUE ENG PROSTHETI, P207
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   THORNHILL TS, 1990, BIOMATERIALS, V11, P69
   TRUMPY IG, 1993, J ORAL MAXIL SURG, V51, P624, DOI 10.1016/S0278-2391(10)80259-9
   TURNER RFB, 1991, BIOMATERIALS, V12, P361, DOI 10.1016/0142-9612(91)90003-S
   Ugarova TP, 1998, J BIOL CHEM, V273, P22519, DOI 10.1074/jbc.273.35.22519
   UGAROVA TP, 1993, J BIOL CHEM, V268, P21080
   van Diest PJ, 1998, J CLIN PATHOL, V51, P493, DOI 10.1136/jcp.51.7.493
   VILCEK J, 1986, J EXP MED, V163, P632, DOI 10.1084/jem.163.3.632
   WIGREN R, 1991, FEBS LETT, V280, P225, DOI 10.1016/0014-5793(91)80298-H
   YATES SG, 1973, SURG GYNECOL OBSTET, V136, P12
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 80
TC 58
Z9 60
U1 2
U2 23
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1743-4440
EI 1745-2422
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD JUL
PY 2005
VL 2
IS 4
BP 493
EP 500
DI 10.1586/17434440.2.4.493
PG 8
WC Engineering, Biomedical
SC Engineering
GA 019KS
UT WOS:000235834600016
PM 16293087
DA 2018-10-20
ER

PT J
AU Park, H
   Radisic, M
   Lim, JO
   Chang, BH
   Vunjak-Novakovic, G
AF Park, H
   Radisic, M
   Lim, JO
   Chang, BH
   Vunjak-Novakovic, G
TI A novel composite scaffold for cardiac tissue engineering
SO IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
LA English
DT Article
DE cardiac myoeyte; collagen; caprolactone; PLGA; biocompatibility;
   perfusion
ID INFARCTED MYOCARDIUM; HEART-VALVES; COLLAGEN; MUSCLE; CELLS; MODEL
AB One approach to the engineering of functional cardiac tissue for basic studies and potential clinical use involves bioreactor cultivation of dissociated cells on a biomaterial scaffold. Our objective was to develop a scaffold that is (1) highly porous with large interconnected pores (to facilitate mass transport), (2) hydrophilic (to enhance cell attachment), (3) structurally stable (to withstand the shearing forces during bioreactor cultivation), (4) degradable (to provide ultimate biocompatibility of the tissue graft), and (5) elastic (to enable transmission of contractile forces). The scaffold of choice was made as a composite of poly(DL-lactide-co-caprolaetone), poly(DL-lactide-co-glyeolide) (PLGA), and type I collagen, with open interconnected pores and the average void volume of 80 +/- 5%. Neonatal rat heart cells suspended in Matrigel were seeded into the scaffold at a physiologically high density (1.35 X 10(8) cells/cm(3)) and cultivated for 8 d in cartridges perfused with culture medium or in orbitally mixed dishes (25 rpm); collagen sponge (Ultrafoam (TM)) and PLGA sponge served as controls. Construct cellularity, presence of cardiac markers, and contractile properties were markedly improved in composite scaffolds as compared with both controls.
C1 MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   Kyungpook Natl Univ, Inst Med Res, Taegu 700721, South Korea.
   Wake Forest Univ, Bowman Gray Sch Med, Inst Regenerat Med, Winston Salem, NC 27157 USA.
   Kyungpook Natl Univ, Dept Thorac & Cardiovasc Surg, Taegu 700721, South Korea.
RP Vunjak-Novakovic, G (reprint author), MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
EM gordana@mit.edu
OI Vunjak-Novakovic, Gordana/0000-0002-9382-1574; Radisic,
   Milica/0000-0003-1249-4135
CR Agrawal C M, 1995, Tissue Eng, V1, P241, DOI 10.1089/ten.1995.1.241
   Akins RE, 2002, CIRC RES, V90, P120, DOI 10.1161/res.90.2.120
   Bader A, 1998, EUR J CARDIO-THORAC, V14, P279, DOI 10.1016/S1010-7940(98)00171-7
   Bursac N, 1999, AM J PHYSIOL-HEART C, V277, pH433, DOI 10.1152/ajpheart.1999.277.2.H433
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Dai NT, 2004, BIOMATERIALS, V25, P4263, DOI 10.1016/j.biomaterials.2003.11.022
   Dohmen PM, 2002, ANN THORAC SURG, V74, P1438, DOI 10.1016/S0003-4975(02)03881-X
   Freed L. E., 2000, PRINCIPLES TISSUE EN, P143
   Freed LE, 1998, ADV DRUG DELIVER REV, V33, P15, DOI 10.1016/S0169-409X(98)00017-9
   Hua FJ, 2002, J BIOMED MATER RES, V63, P161, DOI 10.1002/jbm.10121.abs
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   Krupnick AS, 2002, J HEART LUNG TRANSPL, V21, P233, DOI 10.1016/S1053-2498(01)00349-7
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Leor J, 2000, CIRCULATION, V102, P56
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Ozawa T, 2002, CIRCULATION, V106, P1176
   Papadaki M, 2001, AM J PHYSIOL-HEART C, V280, pH168
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Radisic M, 2004, AM J PHYSIOL-HEART C, V286, pH507, DOI 10.1152/ajpheart.00171.2003
   Radisic M, 2003, BIOTECHNOL BIOENG, V82, P403, DOI 10.1002/bit.10594
   Radisic M, 2005, SCAFFOLDING TISSUE E, P491
   SHINOKA T, 1995, ANN THORAC SURG, V60, P513
   Shirota T, 2003, BIOMATERIALS, V24, P2295, DOI 10.1016/S0142-9612(03)00042-5
   Sodian R, 2000, ANN THORAC SURG, V70, P140, DOI 10.1016/S0003-4975(00)01255-8
   WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408
   Zimmermann WH, 2003, HEART FAIL REV, V8, P259, DOI 10.1023/A:1024725818835
NR 27
TC 78
Z9 80
U1 1
U2 17
PU SOC IN VITRO BIOLOGY
PI LARGO
PA 9315 LARGO DR WEST, STE 25, LARGO, MD 20774 USA
SN 1071-2690
J9 IN VITRO CELL DEV-AN
JI In Vitro Cell. Dev. Biol.-Anim.
PD JUL-AUG
PY 2005
VL 41
IS 7
BP 188
EP 196
PG 9
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 975CZ
UT WOS:000232639900002
PM 16223333
DA 2018-10-20
ER

PT J
AU Mattioli-Belmonte, M
   Lucarini, G
   Virgili, L
   Biagini, G
   Detomaso, L
   Favia, P
   D'Agostino, R
   Gristina, R
   Gigante, A
   Bevilacqua, C
AF Mattioli-Belmonte, M
   Lucarini, G
   Virgili, L
   Biagini, G
   Detomaso, L
   Favia, P
   D'Agostino, R
   Gristina, R
   Gigante, A
   Bevilacqua, C
TI Mesenchymal stem cells on plasma-deposited acrylic acid coatings: An in
   vitro investigation to improve biomaterial performance in bone
   reconstruction
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE plasma-deposited coatings; acrylic acid; polymer surface modification;
   mesenchymal stem cells; cell behavior; bone scaffolds
ID BIOMEDICAL POLYMERS
AB In this in vitro investigation of a heterogeneous range of biofunctional and modulatory performances of mesenchymal stem cells (MSCs) grown on two plasma-deposited acrylic acid (pdAA) coatings, which differed in chemical characteristics, a view of their potential utility as hybrid scaffolds for bone tissue engineering was obtained. The in vitro behavior of MKS was compared to that of MG-63 cells, an osteoblast-like cell line that is commonly used to test biocompatibility of materials intended for bone-tissue interface. The coatings exerted a greater stimulus on MSCs and on MG-63 cells in comparison with control cultures. Both studied coatings exhibited satisfactory compatibility and modulatory effects on MSCs, thus they may be suitable for use in 2D or 3D scaffolds for bone tissue reconstruction.
C1 Univ Politecn delle Marche, Ist Morfol Umana Normale, I-60020 Ancona, Italy.
   Univ Bari, Dipartimento Chim, I-70126 Bari, Italy.
   Univ Bari, CNR, IMIP, I-70126 Bari, Italy.
   Univ Politecn Marche, Dipartimento Patol Mol & Terapie Innovat, I-60020 Ancona, Italy.
RP Mattioli-Belmonte, M (reprint author), Univ Politecn delle Marche, Ist Morfol Umana Normale, Via Tronto 10-A, I-60020 Ancona, Italy.
EM belmonte@med.univpm.it
RI Mattioli-Belmonte, Monica/J-5861-2012
OI GIGANTE, ANTONIO/0000-0003-0772-563X
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BeauvaisJouneau A, 1997, EXP CELL RES, V233, P1, DOI 10.1006/excr.1997.3554
   DAGOSTINO R, 1990, PLASMA MAT INTERACTI, V496
   DAGOSTINO R, 1997, NATO ASI SERIES E, V346
   Detomaso L, 2005, BIOMATERIALS, V26, P3831, DOI 10.1016/j.biomaterials.2004.10.011
   ETIENNEMANNEVIL.S, 2002, NATURE, V429, P629
   Favia P, 2003, SURF COAT TECH, V169, P707, DOI 10.1016/S0257-8972(03)00174-9
   Favia P, 2002, J PHOTOPOLYM SCI TEC, V15, P341
   FAVIA P, 2002, VIDE, P1
   Fazzi R, 2002, LEUKEMIA RES, V26, P839, DOI 10.1016/S0145-2126(02)00008-5
   Hardikar AA, 2003, P NATL ACAD SCI USA, V100, P7117, DOI 10.1073/pnas.1232230100
   Harris CT, 2004, J BIOMED MATER RES A, V68A, P747, DOI 10.1002/jbm.a.20107
   HERZOG EL, 2003, BLOOD, V102, P2483
   Hoffman A.S., 1996, BIOMATERIALS SCI INT, P124
   Huss R, 2002, BRIT J HAEMATOL, V118, P305, DOI 10.1046/j.1365-2141.2002.03587.x
   JAVAZON EH, 2004, EXPT HEMATOLOGY, V32, P4141
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   Montanaro L, 2002, BIOMATERIALS, V23, P3651, DOI 10.1016/S0142-9612(02)00098-4
   PALUMBO F, 1999, PLASMAS POLYM, V4, P133
   Pender SLF, 2000, AM J PATHOL, V157, P1955, DOI 10.1016/S0002-9440(10)64834-1
   RATNER BD, 1990, PLASMA DEPOSITION TR, P496
   Shen H, 2004, NAT MATER, V3, P569, DOI 10.1038/nmat1179
   SHIMAZUI T, 2004, ONCOL REP, V118, P357
   Shin H, 2004, J BIOMED MATER RES A, V69A, P535, DOI 10.1002/jbm.a.30027
   Suh H, 2001, ARTIF ORGANS, V25, P459, DOI 10.1046/j.1525-1594.2001.025006459.x
   Torricelli P, 2003, BIOMED PHARMACOTHER, V57, P57, DOI 10.1016/S0753-3322(02)00329-3
   Zhang Y, 2002, J BIOMED MATER RES, V61, P1, DOI 10.1002/jbm.10176
NR 27
TC 18
Z9 20
U1 0
U2 7
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JUL
PY 2005
VL 20
IS 4
BP 343
EP 360
DI 10.1177/0883911505055159
PG 18
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 939RK
UT WOS:000230089900002
DA 2018-10-20
ER

PT J
AU Orsini, G
   Traini, T
   Scarano, A
   Degidi, M
   Perrotti, V
   Piccirilli, M
   Piattelli, A
AF Orsini, G
   Traini, T
   Scarano, A
   Degidi, M
   Perrotti, V
   Piccirilli, M
   Piattelli, A
TI Maxillary sinus augmentation with Bio-Oss((R)) particles: A light,
   scanning, and transmission electron microscopy study in man
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE Bio-Oss((R)) particles; electron microscopy; humans
ID BONE-TITANIUM INTERFACE; ANORGANIC BOVINE BONE; PLATELET-RICH PLASMA;
   NONCOLLAGENOUS MATRIX PROTEINS; HUMAN OSTEOGENIC PROTEIN-1; HUMAN
   CORTICAL BONE; MINERAL BIO-OSS; DENTAL IMPLANTS; FLOOR ELEVATION;
   HISTOLOGICAL-EVALUATION
AB Biological interactions occurring at the bone-biomaterial interface are critical for long-term clinical success. Bio-Oss (R) is a deproteinized, sterilized bovine bone that has been extensively used in bone regeneration procedures. The aim of the present study was a comparative light, scanning, and electron microscopy evaluation of the interface between Bio-Oss (R) and bone in specimens retrieved after sinus augmentation procedures. Under light microscopy, most of the particles were surrounded by newly formed bone, while in a few cases, at the interface of some particles it was possible to observe marrow spaces and biological fluids. Under scanning electron microscopy, in most cases, the particle perimeter appeared lined by bone that was tightly adherent to the biomaterial surface. Transmission electron microscopy showed that the bone tissue around the biomaterial showed all the phases of the bone healing process. In some areas, randomly organized collagen fibers were present, while in other areas, newly formed compact bone was present. In the first bone lamella collagen fibers contacting the Bio-Oss (R) surface were oriented at 243.73 +/- 7.12 degrees (mean +/- SD), while in the rest of the lamella they were oriented at 288.05 +/- 4.86 degrees (mean +/- SD) with a statistically significant difference of 44.32 degrees (p < 0.001). In the same areas the intensity of gray value was 172.56 +/- 18.15 (mean +/- SD) near the biomaterial surface and 158.71 +/- 21.95 (mean +/- SD) in the other part of the lamella with an unstatistically significant difference of 13.79 (P = 0.071). At the bone-biomaterial interface there was also an electron-dense layer similar to cement lines. This layer had a variable morphology being, in some areas, a thin line, and in other areas, a thick irregular band. The analyses showed that Bio-Oss (R) particles do not interfere with the normal osseous healing process after sinus lift procedures and promote new bone formation. In conclusion, this study serves as a better understanding of the morphollogic characteristics of Bio-Oss (R) and its interaction with the surrounding tissues. (c) 2005 Wiley Periodicals, Inc.
C1 Univ G dAnnunzio, Dept Stomatol & Oral Sci, I-66100 Chieti, Italy.
   Univ G dAnnunzio, Sch Dent, I-66100 Chieti, Italy.
RP Piattelli, A (reprint author), Univ G dAnnunzio, Dept Stomatol & Oral Sci, Via Dei Vestini 31, I-66100 Chieti, Italy.
EM apiattelli@unich.it
RI Orsini, Giovanna/B-5470-2016; Scarano, Antonio/F-6961-2017
OI Orsini, Giovanna/0000-0002-2641-0695; Scarano,
   Antonio/0000-0003-1374-6146; Traini, Tonino/0000-0002-0265-8709
CR Artzi Z, 2004, INT J ORAL MAX IMPL, V19, P357
   Artzi Z, 2002, CLIN ORAL IMPLAN RES, V13, P420, DOI 10.1034/j.1600-0501.2002.130411.x
   Artzi Z, 2000, J PERIODONTOL, V71, P1015, DOI 10.1902/jop.2000.71.6.1015
   Ayukawa Y, 1998, J BIOMED MATER RES, V41, P111
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Bosshardt DD, 2003, EUR J ORAL SCI, V111, P51, DOI 10.1034/j.1600-0722.2003.00015.x
   Brunski J B, 1999, Adv Dent Res, V13, P99
   Brunski JB, 2000, INT J ORAL MAX IMPL, V15, P15
   BURR DB, 1988, J BIOMECH, V21, P939, DOI 10.1016/0021-9290(88)90132-7
   CARTER DR, 1977, CLIN ORTHOP RELAT R, P265
   Davies JE, 1997, J BIOMED MATER RES, V36, P429, DOI 10.1002/(SICI)1097-4636(19970915)36:4<429::AID-JBM1>3.0.CO;2-G
   Davies JE, 1996, ANAT REC, V245, P426
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1289, DOI 10.1002/jbm.820241003
   De Lange G, 1993, J Oral Implantol, V19, P123
   DELANGE GL, 1990, J BIOMED MATER RES, V24, P829, DOI 10.1002/jbm.820240704
   DELANGE GL, 1989, BIOMATERIALS, V10, P121, DOI 10.1016/0142-9612(89)90044-6
   DEMPSTER WT, J APPL PHYSL 1961, V16, P355
   Ewers R, 2004, CLIN ORAL IMPLAN RES, V15, P96, DOI 10.1111/j.1600-0501.2004.00987.x
   FAWNS HT, 1953, ANN RHEUM DIS, V12, P105, DOI 10.1136/ard.12.2.105
   FRASCA P, 1981, ACTA ANAT, V109, P115
   Furst G, 2003, CLIN ORAL IMPLAN RES, V14, P500, DOI 10.1034/j.1600-0501.2003.00859.x
   GANELES J, 1986, J PERIODONTOL, V57, P133, DOI 10.1902/jop.1986.57.3.133
   GOTTESMAN T, 1980, J BIOMECH, V13, P89, DOI 10.1016/0021-9290(80)90182-7
   Haas R, 1998, CLIN ORAL IMPLAN RES, V9, P107, DOI 10.1034/j.1600-0501.1998.090206.x
   Haas R, 1998, CLIN ORAL IMPLAN RES, V9, P117, DOI 10.1034/j.1600-0501.1998.090207.x
   Haas R, 2002, INT J ORAL MAX IMPL, V17, P337
   Hofman S, 1999, BIOMATERIALS, V20, P1155, DOI 10.1016/S0142-9612(97)00082-3
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P476, DOI 10.1034/j.1600-0501.1997.080606.x
   Kaufman Eliaz, 2003, J Esthet Restor Dent, V15, P272, DOI 10.1111/j.1708-8240.2003.tb00298.x
   Kawaguchi H, 2001, J PERIODONTAL RES, V36, P205, DOI 10.1034/j.1600-0765.2001.036004205.x
   KAWAGUCHI H, 1993, CELL MATER, V3, P337
   Landi L, 2000, INT J PERIODONT REST, V20, P575
   LINDER L, 1985, ACTA ORTHOP SCAND, V56, P269, DOI 10.3109/17453678508993011
   LINDER L, 1983, ACTA ORTHOP SCAND, V54, P45, DOI 10.3109/17453678308992868
   LINDER L, 1989, ACTA ORTHOP SCAND, V60, P135, DOI 10.3109/17453678909149240
   LINDER L, CLIN ORTHOP 1992, V276, P147
   Maiorana C, 2003, INT J PERIODONT REST, V23, P227
   Margolin MD, 1998, J PERIODONTOL, V69, P911, DOI 10.1902/jop.1998.69.8.911
   Mayfield LJA, 2001, CLIN ORAL IMPLAN RES, V12, P508
   McAllister BS, 1998, INT J PERIODONT REST, V18, P227
   McKee MD, 1996, CONNECT TISSUE RES, V35, P197, DOI 10.3109/03008209609029192
   MCKEE MD, 1995, ANN NY ACAD SCI, V760, P177, DOI 10.1111/j.1749-6632.1995.tb44629.x
   McKee MD, 1996, MICROSC RES TECHNIQ, V33, P141, DOI 10.1002/(SICI)1097-0029(19960201)33:2<141::AID-JEMT5>3.0.CO;2-W
   McKee MD, 1996, ANAT RECORD, V245, P394, DOI 10.1002/(SICI)1097-0185(199606)245:2<394::AID-AR19>3.0.CO;2-K
   MCKEE MD, CELL MAT 1993, V3, P219
   MELLORS RC, 1964, LAB INVEST, V13, P183
   Nanci A, 1996, MICROSC RES TECHNIQ, V33, P214
   Nanci A, 1999, J STRUCT BIOL, V126, P256, DOI 10.1006/jsbi.1999.4137
   Nanci A, 1998, BIOL MECH TOOTH ERUP, P487
   PARFITT AM, 1987, BONE, V8, pS1
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Proussaefs P, 2003, INT J PERIODONT REST, V23, P185
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Rodriguez A, 2003, J ORAL MAXIL SURG, V61, P157, DOI 10.1053/joms.2003.50041
   Rosen VB, 2002, BIOMATERIALS, V23, P921
   Sennerby L, 1991, CLIN ORAL IMPLAN RES, V2, P103, DOI 10.1034/j.1600-0501.1991.020302.x
   SOKOLOFF L, AM J PATHOL 1973, V73, P261
   Steflik D E, 1992, Int J Oral Maxillofac Implants, V7, P497
   STEFLIK DE, 1993, J BIOMED MATER RES, V27, P791, DOI 10.1002/jbm.820270612
   STEFLIK DE, 1993, ORAL SURG ORAL MED O, V76, P467, DOI 10.1016/0030-4220(93)90014-U
   STEFLIK DE, 1989, J BIOMED MATER RES, V23, P895, DOI 10.1002/jbm.820230807
   STEFLIK DE, 1992, J ORAL IMPLANTOL, V18, P110
   Tapety FI, 2004, CLIN ORAL IMPLAN RES, V15, P315, DOI 10.1111/j.1600-0501.2004.01012.x
   Tawil G, 2001, INT J ORAL MAX IMPL, V16, P713
   Valentini P, 1998, CLIN ORAL IMPLAN RES, V9, P59, DOI 10.1034/j.1600-0501.1998.090108.x
   Valentini P, 1997, INT J PERIODONT REST, V17, P233
   VANBLITTERSWIJK CA, 1990, J BIOMED MATER RES, V24, P433, DOI 10.1002/jbm.820240403
   VANBLITTERSWIJK CA, 1985, BIOMATERIALS, V6, P243, DOI 10.1016/0142-9612(85)90020-1
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
NR 69
TC 60
Z9 63
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2005
VL 74B
IS 1
BP 448
EP 457
DI 10.1002/jbm.b.30196
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 940PA
UT WOS:000230155200005
PM 15889429
DA 2018-10-20
ER

PT J
AU Schopper, C
   Ziya-Ghazvini, F
   Goriwoda, W
   Moser, D
   Wanschitz, F
   Spassova, E
   Lagogiannis, G
   Auterith, A
   Ewers, R
AF Schopper, C
   Ziya-Ghazvini, F
   Goriwoda, W
   Moser, D
   Wanschitz, F
   Spassova, E
   Lagogiannis, G
   Auterith, A
   Ewers, R
TI HA/TCP compounding of a porous CaP biomaterial improves bone formation
   and scaffold degradation - A long-term histological study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bioresorbable; calcium phosphate(s); degradation; histology; bone
   remodeling
ID CALCIUM-PHOSPHATE CERAMICS; BETA-TRICALCIUM PHOSPHATE; DIFFERENT
   CHEMICAL-COMPOSITION; SOFT-TISSUES; HYDROXYAPATITE; IMPLANTS; DEFECTS;
   OSSEOINTEGRATION; RECONSTRUCTION; REGENERATION
AB In the present study, two biphasic calcium phosphate biomaterials (BCP) with HA/TCP ratios of 50150 and 30/70 were obtained from a pure HA biomaterial. The biomaterials which showed the same three-dimensional geometry were implanted into corticocancellous costal defects of sheep. In the specimens of all three biomaterials, abundant bone formation, mineral dissolution from the biomaterial scaffolds, and active cellular resorption of the scaffolds was present after 6 and 12 months. Backscattered electron microscopy showed bone invasion into the pores of the scaffolds and micromechanical interlocking at the bone/biomaterial interface without intervening soft tissue. The pattern of bone formation and scaffold resorption was different for cortical and cancellous bone. No time-based effect, however, was observed. Overall, the BCP biornaterials had formed significantly more bone than the HA biomaterial. Also, scaffold resorption, which was followed by a replacement with newly formed bone, was significantly higher in the BCP biornaterials. Although no significant differences were observed between both BCP biornaterials, the present study had confirmed the assumption that HA/TCP compounding was suitable to improve bone formation and scaffold resorption in the investigated biornaterials and at the same time maintain the osteoconductive properties of the scaffolds. (c) 2005 Wiley Periodicals. Inc.
C1 Med Univ Vienna, Dept Craniomaxillofacial & Oral Surg, Vienna, Austria.
   Ctr Telecommun & Navigat Surg, Inst Cranio Maxillo Facial & Oral Rehabil, Vienna, Austria.
   Med Univ Vienna, Dept Med Stat, Vienna, Austria.
RP Schopper, C (reprint author), Med Univ Vienna, Dept Craniomaxillofacial & Oral Surg, Vienna, Austria.
EM christian.schopper@meduniwien.ac.at
CR ASSAEL LA, 1991, J ORAL MAXIL SURG, V49, P1059, DOI 10.1016/0278-2391(91)90138-C
   Blokhuis TJ, 2000, J BIOMED MATER RES, V51, P369, DOI 10.1002/1097-4636(20000905)51:3<369::AID-JBM10>3.0.CO;2-J
   BOWERS GM, 1986, J PERIODONTOL, V57, P286, DOI 10.1902/jop.1986.57.5.286
   Boyde A, 1999, BONE, V24, P579, DOI 10.1016/S8756-3282(99)00083-6
   BRIGHTON CT, 1992, CLIN ORTHOP RELAT R, P287
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   DACULSI G, 1990, J BIOMED MATER RES, V24, P391
   DECKER B, 1995, ANAT REC, V242, P310, DOI 10.1002/ar.1092420304
   DIAZFLORES L, 1991, HISTOL HISTOPATHOL, V6, P269
   Donath K, 1988, TRENN DUENNSCHLIFF T
   Dorozhkin SV, 2002, ANGEW CHEM, V114, P3260
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   Ewers R, 2004, CLIN ORAL IMPLAN RES, V15, P96, DOI 10.1111/j.1600-0501.2004.00987.x
   EWERS R, 1989, Patent No. 2532
   FRAYSSINET P, 1993, BIOMATERIALS, V14, P423, DOI 10.1016/0142-9612(93)90144-Q
   Fujita R, 2003, J ORAL MAXIL SURG, V61, P1045, DOI 10.1016/S0278-2391(03)00317-3
   GAO TJ, 1995, BIOMATERIALS, V16, P1175, DOI 10.1016/0142-9612(95)93583-Y
   Gatti AM, 1998, BIOCERAMICS, V11, P399
   HASHIMOTOUOSHIMA M, 1995, INT J PERIODONT REST, V15, P205
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hoexter Daid L, 2002, J Oral Implantol, V28, P290, DOI 10.1563/1548-1336(2002)028<0290:BRGM>2.3.CO;2
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JARCHO M, 1986, DENT CLIN N AM, V30, P25
   KLAWITTER JJ, 1979, THESIS CLEMSON U CLE
   KLEIN C, 1994, BIOMATERIALS, V15, P31, DOI 10.1016/0142-9612(94)90193-7
   Koerten HK, 1999, J BIOMED MATER RES, V44, P78, DOI 10.1002/(SICI)1097-4636(199901)44:1<78::AID-JBM9>3.0.CO;2-6
   Manjubala I, 2002, J BIOMED MATER RES, V63, P200, DOI 10.1002/jbm.10128
   Mankani MH, 2001, BIOTECHNOL BIOENG, V72, P96, DOI 10.1002/1097-0290(20010105)72:1<96::AID-BIT13>3.0.CO;2-A
   Merry JC, 1998, J MATER SCI-MATER M, V9, P779, DOI 10.1023/A:1008975507498
   Monchau F, 2002, BIOMOL ENG, V19, P143, DOI 10.1016/S1389-0344(02)00023-0
   MULLERMAI CM, 1990, SCANNING MICROSCOPY, V4, P613
   Mundy G.R., 1999, BONE REMODELING ITS
   NERY EB, J PERIODONTOL 1992, V68, P729
   Oonishi H, 1999, J BIOMED MATER RES, V44, P31, DOI 10.1002/(SICI)1097-4636(199901)44:1<31::AID-JBM4>3.0.CO;2-9
   PARFITT AM, 1983, J CLIN INVEST, V72, P1396, DOI 10.1172/JCI111096
   Piattelli A, 1996, BIOMATERIALS, V17, P1767, DOI 10.1016/0142-9612(95)00342-8
   PIATTELLI A, 1994, BIOCERAMICS, V7, P177
   RAWLINGS CE, 1993, NEUROSURGERY, V33, P935
   ROZEMA FR, 1991, THESIS U GRONINGEN G, P61
   SAFFAR JL, 1990, J PERIODONTOL, V61, P209, DOI 10.1902/jop.1990.61.4.209
   SAMMARCO VJ, FOOT ANKLE CLIN 2002, V7, P19
   SCHLIEPHAKE H, 1993, INT J ORAL MAX SURG, V22, P20, DOI 10.1016/S0901-5027(05)80350-9
   Schmitz JP, 1999, J ORAL MAXIL SURG, V57, P1122, DOI 10.1016/S0278-2391(99)90338-5
   Schopper Christian, 2003, Clin Oral Implants Res, V14, P743
   SHEEN R, BR J PLAST SURG 1988, V41, P138
   SPECTOR M, 1994, CLIN PLAST SURG, V21, P437
   Trombelli L, 2002, J CLIN PERIODONTOL, V29, P117, DOI 10.1034/j.1600-051X.29.s3.7.x
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   Watzinger F, 2000, BRIT J ORAL MAX SURG, V38, P312, DOI 10.1054/bjom.1999.0228
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
NR 51
TC 96
Z9 99
U1 2
U2 20
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2005
VL 74B
IS 1
BP 458
EP 467
DI 10.1002/jbm.b.30199
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 940PA
UT WOS:000230155200006
PM 15912537
DA 2018-10-20
ER

PT J
AU Pan, J
   Wang, YL
   Qin, SH
   Zhang, BB
   Luo, YF
AF Pan, J
   Wang, YL
   Qin, SH
   Zhang, BB
   Luo, YF
TI Grafting reaction of poly(D,L)lactic acid with maleic anhydride and
   hexanediamine to introduce more reactive groups in its bulk
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE poly (D,L-lactic acid); grafting reaction; maleic anhydride;
   hexanediamine
ID POLYMER; POLYLACTIDE; COPOLYMERS; ADHESION
AB Bioactivity of biomaterials was a new requirement, especially in tissue engineering and drug delivery. As a traditional used biomaterial, polylactide (PLA) had no bioactivity, of course, and it still had few reactive groups to introduce some bioactive molecules in its bulk. Here, we want to introduce carboxyl groups and amino groups in the side chain of PLA to get more reactive groups for incorporating bioactive molecular later and to maintain the structure of main chain to keep its biodegradability, and to settle the acidity of PLA during hydrolysis at the same time. It was performed as follows: first, maleic anhydride was covalently grafted onto the side chain of PLA by a free radical reaction at 100 degrees C for 20 h with BPO as the initiator. Then, by amidation with a maleic anhydride group on PLA at room temperature, hexanediamine was incorporated. The resulting polymers have been characterized via GPC, C-13 NMR, DSC, and TGA. The graft ratio was tested by titration. The pH changes during hydrolysis in 0.1 M PBS with pH 7.4 of PLA, MPLA, and HPLA were investigated. All the results showed that this research has grafted maleic anhydride and then hexanediamine in the bulk of PLA. The molecular weight degradation during reaction was less than 20%. The graft ratios of were 2.68, 2.36, and 1.86%, respectively in 5, 10, and 20% raw MA in MPLA; and the anhydride groups grafted in MPLA can completely react with hexanediamine at room temperature. The pH value of HPLA remained neutral within 12 weeks' hydrolysis compared with the resulted acidity of PLA and NIPLA. (c) 2005 Wiley Periodicals, Inc.
C1 Chongqing Univ, Dept Bioengn, Chongqing 400044, Peoples R China.
RP Pan, J (reprint author), Chongqing Univ, Dept Bioengn, Chongqing 400044, Peoples R China.
EM panj@cqu.edu.cn
CR ARVANITOYANNIS I, 1995, POLYMER, V36, P2947, DOI 10.1016/0032-3861(95)94344-S
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.3.CO;2-U
   Carlisle ES, 2000, TISSUE ENG, V6, P45, DOI 10.1089/107632700320883
   DRUMHELLER PD, 1994, ANAL BIOCHEM, V222, P380, DOI 10.1006/abio.1994.1506
   Elisseeff J, 1997, MACROMOLECULES, V30, P2182, DOI 10.1021/ma961411w
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   Griffith G.L., 2000, ACTA MAT, V48, P263
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   GUTWALD R, 1994, J MATER SCI-MATER M, V5, P485, DOI 10.1007/BF00058988
   Heinen W, 1996, MACROMOLECULES, V29, P1151, DOI 10.1021/ma951015y
   LEE KY, 2001, CELL INTERACTIVE POL, V2, P51
   LEWIS CDH, 1990, BIODEGRADABLE POLYM
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   MCINTIRE LV, 2002, WTEC PANEL REPORT TI, P71
   Mooney D J, 1995, Tissue Eng, V1, P107, DOI 10.1089/ten.1995.1.107
   MOONEY DJ, 1994, CELL TRANSPLANT, V3, P203, DOI 10.1177/096368979400300209
   OTSUKA H, 2000, P 22 ANN EMBS INT C
   RUSSELL KE, 1988, J POLYM SCI POL CHEM, V26, P2273, DOI 10.1002/pola.1988.080260821
   Sodergard A, 1998, RRD POLYM SCI, V2, P263
   Taguchi K, 1988, MACROMOLECULES, V21, P3338
   Trivedi BC, 1982, MALEIC ANHYDRIDE
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
NR 23
TC 35
Z9 39
U1 2
U2 32
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2005
VL 74B
IS 1
BP 476
EP 480
DI 10.1002/jbm.b.30208
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 940PA
UT WOS:000230155200008
PM 15889445
DA 2018-10-20
ER

PT J
AU Wang, DW
   Fermor, B
   Gimble, JM
   Awad, HA
   Guilak, F
AF Wang, DW
   Fermor, B
   Gimble, JM
   Awad, HA
   Guilak, F
TI Influence of oxygen on the proliferation and metabolism of adipose
   derived adult stem cells
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Article
ID MESENCHYMAL PROGENITOR CELLS; TISSUE-ENGINEERED CARTILAGE;
   ARTICULAR-CARTILAGE; STROMAL CELLS; IN-VITRO; GENE-EXPRESSION; LOWERED
   OXYGEN; DIFFERENTIATION; TENSION; BONE
AB Articular cartilage is an avascular connective tissue that exhibits little intrinsic capacity for repair. Articular cartilage exists in a reduced oxygen (similar to 5%) environment in vivo; therefore, oxygen tension may be an important factor that regulates the metabolism of chondrocyte progenitors. A number of recent studies have developed tissue engineering approaches for promoting cartilage repair using undifferentiated progenitor cells seeded on biomaterial scaffolds, but little is known about how oxygen might influence these engineered tissues. Human adipose-derived adult stem (hADAS) cells isolated from the stroma of subcutaneous fat were suspended in alginate beads and cultured in control or chondrogenic media in either low oxygen (5%) or atmospheric oxygen tension (20%)for up to 14 days. Under chondrogenic conditions, low oxygen tension significantly inhibited the proliferation of hADAS cells, but induced a two-fold increase in the rate of protein synthesis and a three-fold increase in total collagen synthesis. Low oxygen tension also increased glycosaminoglycan synthesis at certain timepoints. Immunohistochemical analysis showed significant production of cartilage-associated matrix molecules, including collagen type II and chondroitin-4-sulfate. These findings suggest oxygen tension may play an important role in regulating the proliferation and metabolism of hADAS cells as they undergo chondrogenesis, and the exogenous control of oxygen tension may provide a means of increasing the overall accumulation of matrix macromolecules in tissue-engineered cartilage.
C1 Duke Univ, Med Ctr, Dept Surg, Div Orthopaed Surg,Orthopaed Res Labs, Durham, NC 27710 USA.
   Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA.
RP Guilak, F (reprint author), Duke Univ, Med Ctr, Dept Surg, Div Orthopaed Surg,Orthopaed Res Labs, 375 MSRB,Box 3093, Durham, NC 27710 USA.
EM guilak@duke.edu
RI Awad, Hani/G-6976-2014
OI Awad, Hani/0000-0003-2197-2610; Guilak, Farshid/0000-0001-7380-0330
FU NIA NIH HHS [AG15768]; NIGMS NIH HHS [GM08679]; NIAMS NIH HHS [AR49294,
   AR50245, AR49790, AR48182]
CR Akizuki S, 1997, ARTHROSCOPY, V13, P9, DOI 10.1016/S0749-8063(97)90204-8
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   BERESFORD JN, 1984, BIOCHIM BIOPHYS ACTA, V801, P58, DOI 10.1016/0304-4165(84)90212-5
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Blevins FT, 1998, ORTHOPEDICS, V21, P761
   BRADLEY TR, 1978, J CELL PHYSIOL, V97, P517, DOI 10.1002/jcp.1040970327
   Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247
   Buckwalter JA, 1998, J ORTHOP SPORT PHYS, V28, P192, DOI 10.2519/jospt.1998.28.4.192
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Csete M, 2001, J CELL PHYSIOL, V189, P189, DOI 10.1002/jcp.10016
   Enobakhare BO, 1996, ANAL BIOCHEM, V243, P189, DOI 10.1006/abio.1996.0502
   Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270
   Fermor B, 1998, CELL BIOL INT, V22, P635, DOI 10.1006/cbir.1998.0302
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Frisbie DD, 1999, VET SURG, V28, P242, DOI 10.1053/jvet.1999.0242
   Ghivizzani S C, 2000, Phys Med Rehabil Clin N Am, V11, P289
   Gimble JM, 1996, BONE, V19, P421, DOI 10.1016/S8756-3282(96)00258-X
   Grimshaw MJ, 2000, OSTEOARTHR CARTILAGE, V8, P386, DOI 10.1053/joca.1999.0314
   Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138
   Grounds MD, 2002, J HISTOCHEM CYTOCHEM, V50, P589, DOI 10.1177/002215540205000501
   Guilak F, 2004, BIORHEOLOGY, V41, P389
   Halvorsen YDC, 2001, TISSUE ENG, V7, P729, DOI 10.1089/107632701753337681
   Halvorsen YDC, 2001, METABOLISM, V50, P407, DOI 10.1053/meta.2001.21690
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   IWASAKI M, 1994, J BONE MINER RES, V9, P1195
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   KOLLER MR, 1992, BLOOD, V80, P403
   Leddy HA, 2004, J BIOMED MATER RES B, V70B, P397, DOI 10.1002/jbm.b.30053
   Lee CR, 2000, J ORTHOPAED RES, V18, P790, DOI 10.1002/jor.1100180517
   Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081
   LEONARD CM, 1989, P NATL ACAD SCI USA, V86, P10113, DOI 10.1073/pnas.86.24.10113
   MAEDA H, 1986, EXP HEMATOL, V14, P930
   Martinez-Serrano Alberto, 2001, Current Gene Therapy, V1, P279, DOI 10.2174/1566523013348562
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   Mizuno H, 2002, PLAST RECONSTR SURG, V109, P199, DOI 10.1097/00006534-200201000-00030
   Morrison SJ, 2000, J NEUROSCI, V20, P7370
   Muir H, 1970, J Bone Joint Surg Br, V52, P554
   Murphy CL, 2001, TISSUE ENG, V7, P791, DOI 10.1089/107632701753337735
   Nehrer S, 2000, INVEST RADIOL, V35, P639, DOI 10.1097/00004424-200010000-00009
   NEVO Z, 1988, MECH AGEING DEV, V45, P157, DOI 10.1016/0047-6374(88)90105-4
   Nicoll SB, 2001, CONNECT TISSUE RES, V42, P59, DOI 10.3109/03008200109014249
   Nishimura K, 1999, ARTHRITIS RHEUM, V42, P2631, DOI 10.1002/1529-0131(199912)42:12<2631::AID-ANR18>3.0.CO;2-H
   OTTE P, 1991, Z RHEUMATOL, V50, P304
   PETERKOFSKY B, 1982, IMMUNOCHEMISTRY EXTR, P19
   Peterson L, 2000, Clin Orthop Relat Res, P212, DOI 10.1097/00003086-200005000-00020
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rempel D, 2001, J ORTHOPAED RES, V19, P143, DOI 10.1016/S0736-0266(00)00005-X
   Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C
   Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2
   Safford KM, 2004, EXP NEUROL, V187, P319, DOI 10.1016/j.expneurol.2004.01.027
   Sen A, 2001, J CELL BIOCHEM, V81, P312, DOI 10.1002/1097-4644(20010501)81:2<312::AID-JCB1046>3.0.CO;2-Q
   SHAPIRO IM, 1991, CARTILAGE MOL ASPECT, P97
   SILVER IA, 1975, PHILOS T ROY SOC B, V271, P261, DOI 10.1098/rstb.1975.0050
   SPENCER CA, 1990, BIOCHEM J, V265, P911, DOI 10.1042/bj2650911
   Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033
   Strehl R, 2002, TISSUE ENG, V8, P37, DOI 10.1089/107632702753503036
   Studer L, 2000, J NEUROSCI, V20, P7377
   TAYLOR WG, 1974, EXP CELL RES, V86, P152, DOI 10.1016/0014-4827(74)90660-0
   Wickham M Quinn, 2003, Clin Orthop Relat Res, P196, DOI 10.1097/01.blo.0000072467.53786.ca
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 61
TC 153
Z9 172
U1 1
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9541
EI 1097-4652
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD JUL
PY 2005
VL 204
IS 1
BP 184
EP 191
DI 10.1002/jcp.20324
PG 8
WC Cell Biology; Physiology
SC Cell Biology; Physiology
GA 931ZU
UT WOS:000229524800021
PM 15754341
DA 2018-10-20
ER

PT J
AU Smits, KM
   Schouten, JS
   Smits, LJ
   Stelma, FE
   Nelemans, P
   Prins, MH
AF Smits, KM
   Schouten, JS
   Smits, LJ
   Stelma, FE
   Nelemans, P
   Prins, MH
TI A review on the design and reporting of studies on drug-gene interaction
SO JOURNAL OF CLINICAL EPIDEMIOLOGY
LA English
DT Review
DE pharmacogenetics; methodology; study design and reporting; study
   quality; effect modification; drug-gene interactions
ID RANDOMIZED CONTROLLED-TRIALS; BETA(2)-ADRENERGIC RECEPTOR; BETA-AGONIST;
   POLYMORPHISMS; QUALITY; ALBUTEROL; ASSOCIATION; ASTHMATICS
AB Objective: Methodological standards for clinical pharmacogenetic studies should be developed to improve reporting of studies and facilitate their inclusion in systematic reviews. The essence of these studies lies within the concept of effect modification.
   Study Design and Setting: A narrative review discussing methodological issues in the design and reporting of pharmacogenetic studies.
   Results: Studying effect modification within a trial leads to the comparison of subgroups based on genotype. Differences in effect based on genotype should preferably be expressed in absolute terms (risk differences) to facilitate clinical decisions on treatment. Information on the distribution of potential effect modifiers or prognostic factors should be available to prevent a biased comparison of differences in effect between genotypes. The distribution of genotypes should also be presented and compared to Hardy-Weinberg equilibrium to check for selection bias. Additional points of interest include the possibility of selective nonavailability of biomaterial and the choice of a statistical model to study effect modification.
   Conclusion: Additional methodological issues should be taken into account when designing and reporting pharmacogenetic studies, to ensure high study quality. We present several important issues for future studies investigating drug-gene interactions that can serve as a basis for further discussion on methodology in pharmacogenetics. (c) 2005 Elsevier Inc. All rights reserved.
C1 Univ Maastricht, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands.
RP Smits, KM (reprint author), Univ Maastricht, Dept Epidemiol, POB 616, NL-6200 MD Maastricht, Netherlands.
EM kim.smits@epid.unimaas.nl
RI Smits, Luc/C-5331-2008; Schouten, Johannes S.A.G./M-9376-2016
OI Schouten, Johannes S.A.G./0000-0001-6495-7758
CR Bogardus ST, 1999, JAMA-J AM MED ASSOC, V281, P1919, DOI 10.1001/jama.281.20.1919
   COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452
   Fletcher R, 1996, CLIN EPIDEMIOLOGY ES
   Greenland S, 1983, Stat Med, V2, P243, DOI 10.1002/sim.4780020219
   Israel E, 2000, AM J RESP CRIT CARE, V162, P75, DOI 10.1164/ajrccm.162.1.9907092
   Kim DK, 2000, NEUROREPORT, V11, P215, DOI 10.1097/00001756-200001170-00042
   KOOPMAN JS, 1981, AM J EPIDEMIOL, V113, P716, DOI 10.1093/oxfordjournals.aje.a113153
   Kotani Y, 1999, J ASTHMA, V36, P583, DOI 10.3109/02770909909087295
   Lima JJ, 1999, CLIN PHARMACOL THER, V65, P519, DOI 10.1016/S0009-9236(99)70071-8
   MAITLANDVANDERZEE, 2000, EUR J PHARMACOL, V410, P121
   Martinez FD, 1997, J CLIN INVEST, V100, P3184, DOI 10.1172/JCI119874
   Moher D, 1998, JAMA-J AM MED ASSOC, V279, P1489, DOI 10.1001/jama.279.18.1489
   MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W
   Rothman K., 1998, MODERN EPIDEMIOLOGY
   SACKETT DL, 2000, EVIDENCE BASED MED H
   Steimer W, 2002, CLIN CHIM ACTA, V315, P137, DOI 10.1016/S0009-8981(01)00713-6
   Tan S, 1997, LANCET, V350, P995, DOI 10.1016/S0140-6736(97)03211-X
   Taylor DR, 2000, THORAX, V55, P762, DOI 10.1136/thorax.55.9.762
   Taylor DR, 2000, J ASTHMA, V37, P691, DOI 10.3109/02770900009087308
   Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0
NR 20
TC 15
Z9 19
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0895-4356
J9 J CLIN EPIDEMIOL
JI J. Clin. Epidemiol.
PD JUL
PY 2005
VL 58
IS 7
BP 651
EP 654
DI 10.1016/j.jclinepi.2005.01.001
PG 4
WC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA 938YB
UT WOS:000230038200002
PM 15939214
DA 2018-10-20
ER

PT J
AU Das, P
   Akkus, O
   Azad, AM
AF Das, P
   Akkus, O
   Azad, AM
TI Optimization of the mineral content in polymeric gels: The effect of
   calcium to phosphate molar ratio
SO JOURNAL OF CRYSTAL GROWTH
LA English
DT Article
DE biomimetics; mineralization; molar-ratio; Raman spectroscopy; SEM;
   hydroxyapatite
ID DIAPHYSEAL BONE DEFECTS; IN-VIVO; HYDROXYAPATITE; REGENERATION;
   BIOMATERIAL; TEMPERATURE; COMPOSITES; MEMBRANES; CRYSTAL; CARRIER
AB The influence of calcium to phosphate (Ca/P) molar ratio on the extent of mineralization in a model (poly)acrylamide gel was investigated under simulated physiological conditions. We hypothesized that the optimal growth of hydroxyapatite crystals will take place at the stoichiometric Ca/P molar ratio of 1.67. Phosphate ions were incorporated during the polymerization of the gel and mineralization was initiated by submersion of the gel in calcium acetate solution. Ca/P molar ratios were varied in the range of 0.5-5.0. The mineralized gel was characterized by Raman spectroscopy, scanning electron microscopy (SEM) and mineral weight fraction analysis via ashing. Raman spectra captured across the bulk of the gels indicated the presence of mineral at the core section. The phosphate symmetric stretching peak was observed in the range of 955-960cm(-1) which is characteristic of hydroxyapatite. SEM images showed that crystals formed at Ca/P = 2.0 were denser and larger in size than at other molar ratios. In agreement with SEM images, the dry weight fraction of mineral reached the maximum at the molar ratio of 2.0 and the extent of mineralization rapidly declined as the molar ratio diverged from 2.0. Also, the crystallinity of the mineral was optimum at the molar ratio of 2.0. Thus it appears that for effective mineralization, the molar ratio of the two ions needs to be in excess of the stoichiometric requirement, suggesting that ions are expended in processes other than the formation and growth of hydroxyapatite crystals. Therefore, the optimal level of mineralization in biontimetic-based growth of calcium phosphate crystals in sol-gel environment requires consideration of a range of molar ratios as opposed to using the molar ratios corresponding to that of the crystal species intended to grow. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Toledo, Dept Bioengn, Toledo, OH 43606 USA.
   Univ Toledo, Dept Chem Engn, Toledo, OH 43606 USA.
RP Akkus, O (reprint author), Univ Toledo, Dept Bioengn, 2801 W Bancroft St, Toledo, OH 43606 USA.
EM ozan.akkus@utoledo.edu
RI Akkus, Ozan/C-2320-2008
OI Akkus, Ozan/0000-0003-3523-3421
CR Anee TK, 2003, MATER CHEM PHYS, V80, P725, DOI 10.1016/S0254-0584(03)00116-0
   Ashok M, 2003, MATER LETT, V57, P2066, DOI 10.1016/S0167-577X(02)01140-0
   BRIGHT RW, 1984, OSTEOCHONDRAL ALLOGR, P241
   BRIGHT RW, 1984, OSTEOCHONDRAL ALLOGR, P223
   Campbell DG, 1999, AUST NZ J SURG, V69, P517, DOI 10.1046/j.1440-1622.1999.01615.x
   De Yoreo JJ, 2003, REV MINERAL GEOCHEM, V54, P57, DOI 10.2113/0540057
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   GUGALA Z, 1999, J ORTHOP TRAUMA, V13, P18
   HOLLINGER JO, 1986, CLIN ORTHOP RELAT R, P290
   Iijima M, 1998, J CRYST GROWTH, V194, P125, DOI 10.1016/S0022-0248(98)00605-8
   IJIMA M, 1992, CALCIFIED TISSUE INT, V50, P357
   IMAI H, 2003, CHEM COMMUN, V15, P1952
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.0.CO;2-9
   Itoh S, 2002, J BIOMED MATER RES, V63, P507, DOI 10.1002/jbm.10305
   JORGENSON SS, 1994, SPINE, V19, P2048, DOI 10.1097/00007632-199409150-00005
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Li JG, 1997, BIOMATERIALS, V18, P743, DOI 10.1016/S0142-9612(96)00206-2
   Marques PAAP, 2004, J MATER CHEM, V14, P1861, DOI 10.1039/b403495c
   Meinig RP, 1997, J ORTHOP TRAUMA, V11, P551, DOI 10.1097/00005131-199711000-00002
   Meinig RP, 1996, J ORTHOP TRAUMA, V10, P178, DOI 10.1097/00005131-199604000-00006
   Russell JL, 1999, ORTHOPEDICS, V22, P532
   Sotome S, 2004, MAT SCI ENG C-BIO S, V24, P341, DOI 10.1016/j.msec.2003.12.003
   Takagi S, 2001, J BIOMED MATER RES, V58, P36, DOI 10.1002/1097-4636(2001)58:1<36::AID-JBM50>3.3.CO;2-R
   Tarnowski CP, 2002, J BONE MINER RES, V17, P1118, DOI 10.1359/jbmr.2002.17.6.1118
   URIST MR, 1981, CLIN ORTHOP RELAT R, P97
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
NR 28
TC 4
Z9 5
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-0248
J9 J CRYST GROWTH
JI J. Cryst. Growth
PD JUL 1
PY 2005
VL 280
IS 3-4
BP 587
EP 593
DI 10.1016/j.jcrysgro.2005.04.029
PG 7
WC Crystallography; Materials Science, Multidisciplinary; Physics, Applied
SC Crystallography; Materials Science; Physics
GA 941SR
UT WOS:000230235000038
DA 2018-10-20
ER

PT J
AU Ignjatovic, N
   Ajdukovic, Z
   Uskokovic, D
AF Ignjatovic, N
   Ajdukovic, Z
   Uskokovic, D
TI New biocomposite [biphasic calcium
   phosphate/poly-DL-lactide-co-glycolide/biostimulative agent] filler for
   reconstruction of bone tissue changed by osteoporosis
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID COMPOSITE BIOMATERIALS; BIODEGRADABLE POLYMERS; HAP/PLLA COMPOSITE;
   HYDROXYAPATITE; BIOCERAMICS; CELLS
AB Biphasic calcium phosphate-poly-DL-lactide-co-glycolide composite biomaterial with and without biostimulative agents (protein-rich plasma or fibrin) was synthesised in the form suitable for reconstruction of bone defects. The composite used as filler was obtained by precipitation in solvent-non-solvent systems. The material, calcium phosphate granules covered by polymer, was characterised by wide-angle X-ray structural analysis, scanning electron microscopy, infrared spectroscopy and differential scanning calorimetry. Reparation of bone tissue damaged by osteoporosis was investigated in vivo on rats. The method applied enabled production of granules of calcium phosphate-poly-DL-lactide-co-glycolide composite biomaterial of average diameter 150-200 mu m. Histological analysis confirmed recuperation of the alveolar bone, which osteoporosis-induced defects were repaired using composite biomaterial. By addition of biostimulative agents, intensity of PP osteogenesis increases accompanied by the formation of regular, new bone structure. (C) 2005 Springer Science + Business Media, Inc.
C1 Serbian Acad Arts & Sci, Inst Tech Sci, Belgrade, Serbia Monteneg.
   Univ Nis, Fac Stomatol, Nis, Serbia Monteneg.
RP Uskokovic, D (reprint author), Serbian Acad Arts & Sci, Inst Tech Sci, Belgrade, Serbia Monteneg.
EM uskok@itn.sanu.ac.yu
RI Ignjatovic, Nenad/C-4489-2008; Uskokovic, Dragan/B-4129-2008
OI Ignjatovic, Nenad/0000-0002-5749-094X; Uskokovic,
   Dragan/0000-0002-0421-4968
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   AJDUKOVIC Z, 2004, THESIS U NISH
   Albertsson AC, 2003, BIOMACROMOLECULES, V4, P1466, DOI 10.1021/bm034247a
   Becker W, 2000, J PERIODONTOL, V71, P625, DOI 10.1902/jop.2000.71.4.625
   BLACH N, 2002, BIOMATERIALS, V23, P1579
   BROWN P, 1998, BONE, V22, P45
   Calandrelli L, 2000, POLYMER, V41, P8027, DOI 10.1016/S0032-3861(00)00165-8
   Chappard D, 1996, J BONE MINER RES, V11, P676
   Choi BH, 2004, INT J ORAL MAX SURG, V33, P56, DOI 10.1045/ijom.2003.0466
   Durucan C, 2000, J BIOMED MATER RES, V51, P726, DOI 10.1002/1097-4636(20000915)51:4<726::AID-JBM22>3.3.CO;2-C
   El-Amin SF, 2003, BIOMATERIALS, V24, P1213, DOI 10.1016/S0142-9612(02)00451-9
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   FUJITA T, 1997, OSTEOPOROSIS INT, V7, P19
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HUMMEL D, 1984, ATLAS POLYM PLASTICS, P273
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 2001, Z METALLKD, V92, P145
   Ignjatovic N, 2001, BIOMATERIALS, V22, P571, DOI 10.1016/S0142-9612(00)00215-5
   Ignjatovic NL, 1999, J MICROSC-OXFORD, V196, P243
   Kenny SM, 2003, J MATER SCI-MATER M, V14, P923, DOI 10.1023/A:1026394530192
   KLEMETTI E, 1993, J PROSTHET DENT, V70, P21, DOI 10.1016/0022-3913(93)90032-J
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Najman S, 2004, BIO-MED MATER ENG, V14, P61
   Nazhat SN, 2001, J BIOMED MATER RES, V58, P335, DOI 10.1002/jbm.1026
   Raynaud S, 2001, J AM CERAM SOC, V84, P359
   RIGGS BL, 1991, WESTERN J MED, V154, P63
   Schliephake H, 2001, INT J ORAL MAX SURG, V30, P531, DOI 10.1054/ijom.2001.0164
   STAFFORD HJ, 1994, J ORTHOP RES, V12, P29, DOI 10.1002/jor.1100120105
   Thorn JJ, 2004, INT J ORAL MAX SURG, V33, P95, DOI 10.1054/ijom.2003.0461
   Trapani G, 2003, INT J PHARM, V268, P47, DOI 10.1016/j.ijpharm.2003.08.016
NR 30
TC 25
Z9 26
U1 3
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2005
VL 16
IS 7
BP 621
EP 626
DI 10.1007/s10856-005-2532-6
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 936LF
UT WOS:000229856800004
PM 15965593
DA 2018-10-20
ER

PT J
AU Xu, WH
   Xiao, ZY
   Zhang, TY
AF Xu, WH
   Xiao, ZY
   Zhang, TY
TI Mechanical properties of silicone elastomer on temperature in
   biomaterial application
SO MATERIALS LETTERS
LA English
DT Article
DE mechanical properties; silicone elastomer; biomaterial application
ID SURFACES; HARDNESS
AB The present work uses nanoindentation method to measure the hardness of silicone elastomer annealed at 80 degrees C, 120 degrees C, 200 degrees C, 300 degrees C, and 350 degrees C for 60 min, respectively. Based on the apparent surface analysis, a linear relationship is found between the hardness and the reciprocal of the penetration depth. It is found that hardness of the polymer sample obviously decreases after annealing at 80 degrees C, which is due to the removal of any potential surface residual stresses under the initial annealing process. If the annealing temperature is larger than 300 degrees C, the hardness increased a lot. Therefore, from the characterization of surface hardness, what kind of (delete) temperature ever reached in the device made of silicone elastomer in the biology field can be deduced. (c) 2005 Elsevier B.V. All rights reserved.
C1 Chinese Acad Sci, Inst Chem, Beijing 100080, Peoples R China.
   Chinese Acad Sci, Grad Sch, Beijing 100080, Peoples R China.
   Hong Kong Univ Sci & Technol, Dept Mech Engn, Kowloon, Hong Kong, Peoples R China.
RP Xu, WH (reprint author), Chinese Acad Sci, Inst Chem, Beijing 100080, Peoples R China.
EM whxu@cashq.ac.cn
RI Zhang, Tong-Yi/A-8828-2016
OI xiao, zeyu/0000-0002-3457-5772
CR GORMAN SP, 2002, MED DEVICE TECHNOLOG
   Hamadani BH, 2004, APPL PHYS LETT, V84, P443, DOI 10.1063/1.1639945
   Kim SO, 2003, NATURE, V424, P411, DOI 10.1038/nature01775
   Maeda N, 2002, SCIENCE, V297, P379, DOI 10.1126/science.1072378
   Milnes MR, 2002, ENVIRON HEALTH PERSP, V110, P393, DOI 10.1289/ehp.02110s3393
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Xu WH, 2001, APPL PHYS LETT, V79, P4112, DOI 10.1063/1.1426271
   Zhang TY, 2004, ACTA MATER, V52, P57, DOI 10.1016/j.actamat.2003.08.026
   Zhang TY, 2002, J MATER RES, V17, P1715, DOI 10.1557/JMR.2002.0254
   Zhang YP, 2004, J THERM BIOL, V29, P45, DOI 10.1016/j.jtherbio.2003.10.007
NR 10
TC 11
Z9 11
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD JUL
PY 2005
VL 59
IS 17
BP 2153
EP 2155
DI 10.1016/j.matlet.2005.02.052
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 929XD
UT WOS:000229379000012
DA 2018-10-20
ER

PT J
AU Akahori, T
   Niinomi, M
   Koyanagi, Y
   Kasuga, T
   Toda, H
   Fukui, H
   Ogawa, M
AF Akahori, T
   Niinomi, M
   Koyanagi, Y
   Kasuga, T
   Toda, H
   Fukui, H
   Ogawa, M
TI Mechanical properties of biocompatible beta-type titanium alloy coated
   with calcium phosphate invert glass-ceramic layer
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE titanium-29 mass%niobium-13mass%tantalum-4.6mass%zirconium; bioactive
   glass; microstructure; tensile properties; Young's modulus; fatigue
   properties
ID BIOMEDICAL APPLICATIONS; HYDROXYAPATITE COATINGS; HEAT-TREATMENT;
   FATIGUE; TI-29NB-13TA-4.6ZR; MICROSTRUCTURE; BIOCERAMICS; BEHAVIOR;
   ALKALI
AB The presence of calcium phosphate invert glass-ceramic (designated as CPIG) layer on the surface of artificial implant products can improve the bonding between these products and bones.
   In this study, the morphology of the CPIG layer on the surface of a beta-type titanium alloy, Ti-29Nb-13Ta-4.6Zr (TNTZ), was investigated for biomaterial applications by a dip-coating treatment. Furthermore, the mechanical properties of TNTZ coated with the CPIG layer were also investigated.
   In the CPIG layer, a compositionally gradient zone with a thickness of approximately 2.0 mu m exists on the surface of the TNTZ. The titanium concentration in the zone increases with the decreasing distance from the CPIG surface toward the base materials. On the other hand, calcium and phosphorus concentrations in the zone increase with the distance from the TNTZ surface. The tensile bonding strength between TNTZ and the CPIG layer is 25 MPa and that between aged TNTZ and the CPIG layer is 18.6 MPa.
   For easily understanding the change in mechanical properties by a dip-coating treatment, the values of those on TNTZ and TNTZ coated with CPIG layer were shown as follows. The tensile strength increases remarkably by a dip-coating treatment as compared with that of assolutionized TNTZ while the elongation is a reverse trend. Young's modulus of TNTZ and aged TNTZ coated with the CPIG increases by 15 to 27 GPa after the dip-coating treatment as compared with that of as-solutionized TNTZ (approximately 60 GPa). The fatigue limit of TNTZ coated with the CPIG layer is nearly equal to that (approximately 300 MPa) of as-solutionized TNTZ. On the other hand, the fatigue limit of aged TNTZ coated with the CPIG layer is a 100 MPa higher than that of as-solutionized TNTZ.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   Nagoya Inst Technol, Dept Mat Sci & Engn, Nagoya, Aichi 4668555, Japan.
   Aichi Gakuin Univ, Sch Dent, Nagoya, Aichi 4648650, Japan.
   Daido Steel Co Ltd, R&D, Nagoya, Aichi 4578584, Japan.
RP Akahori, T (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
RI Niinomi, Mitsuo/B-5965-2011
CR Akahori T, 2000, METALL MATER TRANS A, V31, P1949, DOI 10.1007/s11661-000-0222-z
   Akahori T, 2004, MATER TRANS, V45, P1540, DOI 10.2320/matertrans.45.1540
   Akahori T, 2003, J JPN I MET, V67, P652, DOI 10.2320/jinstmet1952.67.11_652
   Ding SJ, 2003, SURF COAT TECH, V165, P248, DOI 10.1016/S0257-8972(02)00745-4
   DOREMUS RH, 1992, J MATER SCI, V27, P285, DOI 10.1007/BF00543915
   Fan YW, 2005, BIOMATERIALS, V26, P1623, DOI 10.1016/j.biomaterials.2004.06.019
   Hanawa T, 1997, J BIOMED MATER RES, V34, P273
   HAYASHI K, 1999, J JPN SCI MECH ENG A, V65, P2080
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Ikeda M, 2002, METALL MATER TRANS A, V33, P487, DOI 10.1007/s11661-002-0110-9
   KASAUGA T, 2001, BIOMATERIALS, V22, P577
   KASAUGA T, 2000, MAT JPN, V39, P250
   Kim HM, 1997, J CERAM SOC JPN, V105, P111, DOI 10.2109/jcersj.105.111
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Kuroda D, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P99
   LANCEFIELD WR, 1993, INTRO BIOCERAMICS, P223
   Liang FH, 2003, SURF COAT TECH, V165, P133, DOI 10.1016/S0257-8972(02)00735-1
   MINAKAWA K, 1989, TETSU TO HAGANE, V75, P1104, DOI 10.2355/tetsutohagane1955.75.7_1104
   Nelea V, 2003, SURF COAT TECH, V173, P315, DOI 10.1016/S0257-8972(03)00729-1
   Niinomi M, 2003, J JPN I MET, V67, P604, DOI 10.2320/jinstmet1952.67.10_604
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Niinomi M., 2004, BIOMATERIALS ORTHOPE, P41
   Nonami T., 1998, MAT JPN, V37, P856
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   Zheng XB, 2000, BIOMATERIALS, V21, P841, DOI 10.1016/S0142-9612(99)00255-0
NR 26
TC 10
Z9 10
U1 1
U2 9
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2005
VL 46
IS 7
BP 1564
EP 1569
DI 10.2320/matertrans.46.1564
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 950RI
UT WOS:000230874500023
OA Bronze
DA 2018-10-20
ER

PT J
AU Maruyama, N
   Kawasaki, H
   Yamamoto, A
   Hiromoto, S
   Imai, H
   Hanawa, T
AF Maruyama, N
   Kawasaki, H
   Yamamoto, A
   Hiromoto, S
   Imai, H
   Hanawa, T
TI Friction-wear properties of nickel-free Co-Cr-Mo alloy in a simulated
   body fluid
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE cobalt-chromium-molybdenum alloy; friction-wear test; meta-on-metal
   friction; biomaterial
ID AUSTENITIC STEELS; HIGH-NITROGEN
AB Friction-wear properties of a Co-29 mass%Cr-6 mass%Mo alloy (ASTM F799-95) but reducing the amount of nickel were evaluated with friction-wear test using a pin-on-flat type reciprocating friction tester in air and phosphate buffered saline, PBS(-), as a quasi-biological environment under applied stress of 1.0, 3.5 and 5.0 MPa to understand the performance of this alloy for metal-on-metal type artificial hip joints. In addition, metal ions dissolved in PBS(-) after the test was quantified. As a result, wear loss in PBS(-) is much smaller than that in air and increases with the increase of applied stress in both air and PBS(-), while the coefficient of friction in steady state during the test is larger in PBS(-) than in air, according to lubrication behavior of wear debris and PBS(-). Wear damage in PBS(-) is smaller than that in air, however more small scale of irregularity is observed in PBS(-) than that in air. Nickel and molybdenum are preferentially dissolved during the test.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
   Shibaura Inst Technol, Dept Mat Sci & Technol, Tokyo 1088548, Japan.
   Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 3050044, Japan.
RP Hanawa, T (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
EM hanawa.met@tmd.ac.jp
RI HIROMOTO, Sachiko/H-2686-2011
CR Ahlroos T, 1997, WEAR, V211, P113, DOI 10.1016/S0043-1648(97)00074-4
   [Anonymous], 1999, IARC MON EV CARC RIS, V74, P65
   Hanawa T, 2004, MAT SCI ENG C-BIO S, V24, P745, DOI 10.1016/j.msec.2004.08.018
   Huang P, 1999, MATER LETT, V39, P244, DOI 10.1016/S0167-577X(99)00021-X
   Ikeda D, 2002, SURF COAT TECH, V156, P301, DOI 10.1016/S0257-8972(02)00094-4
   KILNER T, 1982, J BIOMED MATER RES, V16, P63, DOI 10.1002/jbm.820160109
   KILNER T, 1986, J MATER SCI, V21, P1346
   Menzel J, 1996, ISIJ INT, V36, P893, DOI 10.2355/isijinternational.36.893
   Uggowitzer PJ, 1996, ISIJ INT, V36, P901, DOI 10.2355/isijinternational.36.901
   Wang A, 1999, WEAR, V225, P708, DOI 10.1016/S0043-1648(98)00384-6
   WILLIAMS DF, 1998, ENCY MAT SCI TECHNOL, P41
   YAMAMOTO A, 1995, J JPN I MET, V59, P463, DOI 10.2320/jinstmet1952.59.4_463
   Zhou J, 2004, J TRIBOL-T ASME, V126, P386, DOI 10.1115/1.1611511
NR 13
TC 16
Z9 16
U1 0
U2 6
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2005
VL 46
IS 7
BP 1588
EP 1592
DI 10.2320/matertrans.46.1588
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 950RI
UT WOS:000230874500026
OA Bronze
DA 2018-10-20
ER

PT J
AU Hiromoto, S
   Kano, K
   Suzuki, Y
   Asami, K
   Chiba, A
   Hanawa, T
AF Hiromoto, S
   Kano, K
   Suzuki, Y
   Asami, K
   Chiba, A
   Hanawa, T
TI Surface characterization and anodic polarization of
   nitrogen-ion-implanted nickel-free Co-Cr-Mo alloy
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE cobalt-chromium-molybdenum alloy; nitrogen ion implantation; surface
   analysis; anodic polarization; biomaterial
ID PHYSIOLOGICAL SOLUTION; TITANIUM; XPS; ADSORPTION; TI-6AL-4V; CHROMIUM;
   OXIDES; IRON
AB Nitrogen ions were implanted in a nickel-free Co-Cr-Mo alloy in amounts of 10(19), 10(20), and 10(21) ions m(-2) with an acceleration energy of 150 keV and ion-beam current-density of 10(-15) MA m(-2) to improve the friction-wear properties. Changes in the composition of the surface layer of the alloy with ion implantation, autoclaving, and immersion in Hanks' solution as a simulated body fluid were characterized using X-ray photoelectron spectroscopy to evaluate the stability of the material and predict the safety and tissue compatibility of the material. The surface oxide layer on the mechanically polished Co-Cr-Mo alloy consisted of oxidic species of cobalt, chromium, and molybdenum, and its thickness was about 2.5 nm. The surface film contained a large amount of OH-, that is, the oxide was hydrated or oxyhydroxidized. After N2+ implantation, nitrogen atoms existed as cobalt nitride in the substrate just under the surface oxide and NH3 or NH4 in the surface oxide, and these amounts increased with the increase of the dose. Chromium was concentrated in the surface oxide but depleted in the substrate with ion implantation. Cobalt was preferentially oxidized by autoclaving and depleted in the substrate after autoclaving. Calcium phosphate was formed, and cobalt was preferentially dissolved during immersion in Hanks' solution. N2+-implanted Co-Cr-Mo alloy with an amount of 10(20) ions m(-2) showed the highest corrosion resistance.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
   Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 3050044, Japan.
   Iwate Univ, Fac Engn, Morioka, Iwate 0208551, Japan.
   RIKEN, Adv Dev & Supporting Ctr, Beam Applicat Team, Wako, Saitama 3510198, Japan.
   Tohoku Univ, Mat Res Inst, Sendai, Miyagi 9808577, Japan.
RP Hanawa, T (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
EM hanawa.met@tmd.ac.jp
RI HIROMOTO, Sachiko/H-2686-2011; Chiba, Akihiko/D-1326-2011
CR [Anonymous], 1999, IARC MONOGRAPHS EVAL, V74, P65
   ASAMI K, 1984, CORROS SCI, V24, P83, DOI 10.1016/0010-938X(84)90039-8
   ASAMI K, 1976, J ELECTRON SPECTROSC, V9, P469, DOI 10.1016/0368-2048(76)80065-5
   ASAMI K, 1977, CORROS SCI, V17, P559, DOI 10.1016/S0010-938X(77)80002-4
   ASAMI K, 1977, CORROS SCI, V17, P713, DOI 10.1016/0010-938X(77)90067-1
   Asami K., 1985, P 6 EUR S CORR BEH A, P769
   BUCHANAN RA, 1987, J BIOMED MATER RES, V21, P355, DOI 10.1002/jbm.820210308
   Frauchiger L, 1999, APPL SURF SCI, V143, P67, DOI 10.1016/S0169-4332(98)00932-5
   HANAWA T, 1992, APPL SURF SCI, V55, P269, DOI 10.1016/0169-4332(92)90178-Z
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   HASHIMOTO K, 1977, BOSHOKU GIJUTSU, V26, P445
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   Li PJ, 1998, J BIOMED MATER RES, V41, P341, DOI 10.1002/(SICI)1097-4636(19980905)41:3<341::AID-JBM1>3.0.CO;2-C
   MCKELLOP HA, 1990, J BIOMED MATER RES, V24, P1413, DOI 10.1002/jbm.820241102
   ONG JL, 1995, J MATER SCI-MATER M, V6, P113, DOI 10.1007/BF00120418
   ROSTLUND T, 1990, J BIOMED MATER RES, V24, P847, DOI 10.1002/jbm.820240705
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
   SHIRLEY DA, 1972, PHYS REV B, V5, P4709, DOI 10.1103/PhysRevB.5.4709
   SORP S, 1977, SURF SCI, V68, P10
   TERAMOTO K, 1978, BOSHOKU GIJUTSU, V27, P57
   Uggowitzer PJ, 1996, ISIJ INT, V36, P901, DOI 10.2355/isijinternational.36.901
   Wagner C.D., 1979, HDB XRAY PHOTOELECTR, P80
   Wagner C.D., 1990, PRACTICAL SURFACE AN, V1, P595
   Wagner CD, 1979, HDB XRAY PHOTOELECTR, P74
NR 25
TC 3
Z9 3
U1 1
U2 8
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2005
VL 46
IS 7
BP 1627
EP 1632
DI 10.2320/matertrans.46.1627
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 950RI
UT WOS:000230874500032
OA Bronze
DA 2018-10-20
ER

PT J
AU Waar, K
   van der Mei, HC
   Harmsen, HJM
   de Vries, J
   Atema-Smit, J
   Degener, JE
   Busscher, HJ
AF Waar, K
   van der Mei, HC
   Harmsen, HJM
   de Vries, J
   Atema-Smit, J
   Degener, JE
   Busscher, HJ
TI Atomic force microscopy study on specificity and non-specificity of
   interaction forces between Enterococcus faecalis cells with and without
   aggregation substance
SO MICROBIOLOGY-SGM
LA English
DT Article
ID PLATE FLOW CHAMBER; SEX-PHEROMONE; STREPTOCOCCUS-FAECALIS; MICROBIAL
   ADHESION; INFECTIONS; DEPOSITION; VIRULENCE; BACTERIA; DEVICES
AB Enterococcus faecalis is one of the leading causes of hospital-acquired infections, and indwelling medical devices are especially prone to infection. E faecalis expressing aggregation substance (Agg) adheres to biomaterial surfaces by means of positive cooperativity, i.e. the ability of one adhering organism to stimulate adhesion of other organisms in its immediate vicinity. In this study, atomic force microscopy (AFM) was used to measure the specificity and non-specificity of interaction forces between E faecalis cells with and without Agg. Bacteria were attached to a substratum surface and a tip-less cantilever. Two E faecalis strains expressing different forms of Agg showed nearly twofold higher interaction forces between bacterial cells than a strain lacking Agg [adhesive force (F-adh), -1(.)3 nN]. The strong interaction forces between the strains with Agg were reduced after adsorption of antibodies against Agg from -2(.)6 and -2(.)3 nN to -1(.)2 and -1.3 nN, respectively. This suggests that the non-specific interaction force between the enterococci amounts to approximately 1(.)2 nN, while the specific force component is only twofold stronger. Comparison of the results of the AFM interaction forces with the positive cooperativity after adhesion to a biomaterial in a parallel-plate flow chamber showed that in the absence of strong interaction forces between the cells, positive cooperativity was also absent. In conclusion, this is believed to be the first time that the influence of specific antibodies on interaction forces between E faecalis cells has been demonstrated by AFM, thereby experimentally distinguishing between specific and non-specific force components.
C1 Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 GZ Groningen, Netherlands.
   Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, NL-9713 GZ Groningen, Netherlands.
RP van der Mei, HC (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, Hanzeplein 1, NL-9713 GZ Groningen, Netherlands.
EM h.c.van.der.mei@med.umcg.nl
CR BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Bolshakova AV, 2001, ULTRAMICROSCOPY, V86, P121, DOI 10.1016/S0304-3991(00)00075-9
   Bowen WR, 2002, BIOTECHNOL BIOENG, V79, P170, DOI 10.1002/bit.10321
   Busscher H J, 1992, FEMS Microbiol Rev, V8, P199
   BUSSCHER HJ, 1995, METHOD ENZYMOL, V253, P455
   CLEWELL DB, 1985, J BACTERIOL, V162, P1212
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   De Boever EH, 2000, MOL MICROBIOL, V37, P1327, DOI 10.1046/j.1365-2958.2000.02072.x
   DICKINSON GM, 1989, ANTIMICROB AGENTS CH, V33, P602, DOI 10.1128/AAC.33.5.602
   Dufrene YF, 2000, BIOPHYS J, V78, P3286, DOI 10.1016/S0006-3495(00)76864-0
   Dufrene YF, 2003, CURR OPIN MICROBIOL, V6, P317, DOI 10.1016/S1369-5274(03)00058-4
   DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479
   IKE Y, 1983, P NATL ACAD SCI-BIOL, V80, P5369, DOI 10.1073/pnas.80.17.5369
   JACOB AE, 1974, J BACTERIOL, V117, P360
   JETT BD, 1994, CLIN MICROBIOL REV, V7, P462
   Lower SK, 2001, SCIENCE, V292, P1360, DOI 10.1126/science.1059567
   MUSCHOLL A, 1993, EUR J BIOCHEM, V214, P333, DOI 10.1111/j.1432-1033.1993.tb17928.x
   Muscholl-Silberhorn A, 1999, MOL MICROBIOL, V34, P620, DOI 10.1046/j.1365-2958.1999.01631.x
   Poelstra KA, 2000, J BIOMED MATER RES, V51, P224, DOI 10.1002/(SICI)1097-4636(200008)51:2<224::AID-JBM11>3.0.CO;2-G
   Razatos A, 1998, P NATL ACAD SCI USA, V95, P11059, DOI 10.1073/pnas.95.19.11059
   Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795
   SJOLLEMA J, 1990, COLLOID SURFACE, V47, P337, DOI 10.1016/0166-6622(90)80082-F
   Vadillo-Rodrigues V, 2004, APPL ENVIRON MICROB, V70, P5441, DOI 10.1128/AEM.70.9.5441-5446.2004
   van der Mei HC, 2000, BIOPHYS J, V78, P2668, DOI 10.1016/S0006-3495(00)76810-X
   VANOSS CJ, 1991, J DISPER SCI TECHNOL, V12, P201, DOI 10.1080/01932699108913120
   VANRAAMSDONK M, 1995, COLLOID SURFACE B, V4, P401, DOI 10.1016/0927-7765(95)01195-O
   Waar K, 2002, MICROBIOL-SGM, V148, P1863, DOI 10.1099/00221287-148-6-1863
   Waar K, 2002, J INFECT DIS, V185, P1121, DOI 10.1086/339682
   Yu JL, 1996, SCAND J GASTROENTERO, V31, P625, DOI 10.3109/00365529609009140
NR 29
TC 25
Z9 26
U1 1
U2 5
PU SOC GENERAL MICROBIOLOGY
PI READING
PA MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG,
   BERKS, ENGLAND
SN 1350-0872
J9 MICROBIOL-SGM
JI Microbiology-(UK)
PD JUL
PY 2005
VL 151
BP 2459
EP 2464
DI 10.1099/mic.0.27877-0
PN 7
PG 6
WC Microbiology
SC Microbiology
GA 949OT
UT WOS:000230798700036
PM 16000736
OA Bronze
DA 2018-10-20
ER

PT J
AU Stiehl, JB
AF Stiehl, JB
TI Trabecular metal in hip reconstructive surgery
SO ORTHOPEDICS
LA English
DT Review
ID TANTALUM; BONE; IMPLANTS; INGROWTH
AB Biological ingrowth surfaces have become a standard prosthetic element in reconstructive hip surgery. A material's properties, three-dimensional architecture, and surface texture all play integral parts in its biological performance. Trabecular metal is an important new biomaterial that has been introduced to enhance the potential of biological ingrowth as well as provide a structural scaffold in cases of severe bone deficit. Initial clinical applications have focused on,bone restoration in tumor and salvage cases and in primary and revision reconstructive cases where the increased biological fixation would be of clinical benefit. The bone ingrowth potential and mechanical integrity of this material offer exciting options for orthopedic reconstructive surgeons.
C1 Columbia Hosp, Milwaukee, WI USA.
RP Stiehl, JB (reprint author), 575 W River Woods Pkwy, Milwaukee, WI 53212 USA.
CR Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   BOBYN JD, 1999, ANN M AM AC ORTH SUR
   CLAASSEN B, 1997, 23 ANN M SOC BIOM AP
   Friedman R J, 1994, Instr Course Lect, V43, P233
   GALANTE J, 1971, J BONE JOINT SURG AM, VA 53, P101, DOI 10.2106/00004623-197153010-00009
   Gruen TA, 2005, J ARTHROPLASTY, V20, P369, DOI 10.1016/j.arth.2004.12.049
   GUNSON A, 2001, ANN M AM SOC BIOM AP
   Heiner A. D., 1998, Journal of Musculoskeletal Research, V2, P267, DOI 10.1142/S0218957798000263
   LEWALLEN D, 2002, HARVARD HIP COURSE 2
   LEWIS RJ, 2003, ANN M AM AC ORTH SUR
   LITSKY AS, 1999, 25 ANN M SOC BIOM AP
   PILLIAR RM, 1975, BIOMED ENG, V10, P126
   POGGIE RA, 2001, 44 ANN M ORTH RES SO
   POGGIE RA, 2002, 44 ANN M ORTH RES SO
   POGGIE RA, 2002, 7 ANN INT BIOL S 200
   POGGIE RA, 1999, 45 ANN M ORTH RES SO
   Stiehl JB, 2000, J ARTHROPLASTY, V15, P849, DOI 10.1054/arth.2000.9320
   STIEHL JB, 1991, J ARTHROPLASTY S, V6, P85
   TOH KK, 2001, 44 ANN ORTH RES SOC
   TURNER TM, 1995, T SOC BIOMATERIALS, V21, P125
   UNGER AS, 2002, ANN M AM AC ORTH SUR
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   ZHANG Y, 1998, J MUSCULOSKELETAL RE, V3, P245
NR 26
TC 23
Z9 24
U1 1
U2 4
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 0147-7447
J9 ORTHOPEDICS
JI Orthopedics
PD JUL
PY 2005
VL 28
IS 7
BP 662
EP 670
PG 9
WC Orthopedics
SC Orthopedics
GA 973SW
UT WOS:000232543900009
PM 16119281
DA 2018-10-20
ER

PT J
AU Li, XM
   Feng, QL
   Jiao, YF
   Cui, FH
AF Li, XM
   Feng, QL
   Jiao, YF
   Cui, FH
TI Collagen-based scaffolds reinforced by chitosan fibres for bone tissue
   engineering
SO POLYMER INTERNATIONAL
LA English
DT Article
DE chitosan fibre; compressive strength; porosity; scaffold; modifying
   factor
ID COLORIMETRIC ASSAY; BIOCOMPATIBILITY; CYTOTOXICITY; BIOMATERIAL; SYSTEMS
AB In this paper, porous bone scaffolds reinforced with chitosan fibres were prepared. The porosity and pore size of the reinforced scaffolds were both satisfactory. The reinforced scaffolds resembled natural bone in both components and crystal size. Only if the length of the fibres was no shorter than the critical length, could the fibres reinforce the material. We have proposed an empirical formula to calculate the critical length of the fibres for the porous materials and determined the modifying factor (F-1) for the porous bone scaffold investigated in this work. Along with the increase of the fibres' volume content, the compressive strength of the scaffold also increased. We have proposed a further empirical formula for calculating the compressive strength of the porous reinforced materials and determined the modifying factor (F-sigma) for the porous reinforced bone scaffold examined in these studies. Along with the degradation in vitro, the decrease in strength of the reinforced scaffold was less than that of the unreinforced scaffold. The growth rate of osteoblast cells on the reinforced scaffold was higher than that on the unreinforced scaffold. These results suggest that the reinforced scaffold may be a promising candidate matrix for repairing large bone defects. (c) 2005 Society of Chemical Industry.
C1 Tsing Hua Univ, Dept Mat Sci & Engn, Biomat Lab, Beijing 100084, Peoples R China.
RP Feng, QL (reprint author), Tsing Hua Univ, Dept Mat Sci & Engn, Biomat Lab, Beijing 100084, Peoples R China.
EM biomater@mail.tsinghua.edu.cn
OI Feng, Qingling/0000-0003-1288-300X
CR AGARWAL BD, 1980, ANAL PERFORMANCE FIB, P1012
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Aiedeh K, 1997, J MICROENCAPSUL, V14, P567, DOI 10.3109/02652049709006810
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P117
   Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   HANCOX NJ, 1981, FIBRE COMPOSITE HYBR, P775
   Hu YH, 2002, J BIOMED MATER RES, V59, P563, DOI 10.1002/jbm.1269
   Kratz G, 1997, SCAND J PLAST RECONS, V31, P119, DOI 10.3109/02844319709085478
   LIAO S, 2003, THESIS TSINGHUA U BE
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   SGOURAS D, 1990, J MATER SCI-MATER M, V1, P61, DOI 10.1007/BF00839070
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   SMITH MD, 1992, INT J ARTIF ORGANS, V15, P191
   TORUN KG, 2003, BIMATERIALS, V24, P1949
   VACANTI JP, 1997, PRINCIPLES TISSUE EN, P1
   WANG RZ, 1995, J MATER SCI LETT, V14, P490, DOI 10.1007/BF00665911
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
   Yan YN, 2003, MATER LETT, V57, P2623, DOI 10.1016/S0167-577X(02)01339-3
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
NR 20
TC 40
Z9 44
U1 1
U2 20
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD JUL
PY 2005
VL 54
IS 7
BP 1034
EP 1040
DI 10.1002/pi.1804
PG 7
WC Polymer Science
SC Polymer Science
GA 938BA
UT WOS:000229973700007
DA 2018-10-20
ER

PT J
AU Shih, IL
   Wu, PJ
   Shieh, CJ
AF Shih, IL
   Wu, PJ
   Shieh, CJ
TI Microbial production of a poly (gamma-glutamic acid) derivative by
   Bacillus subtilis
SO PROCESS BIOCHEMISTRY
LA English
DT Article
DE bioconjugate; Bacillus subtilis; poly (gamma-glutamic acid);
   biomaterial; gamma-PGA; glycerol
ID POLY(GAMMA-GLUTAMIC ACID); LICHENIFORMIS; BIOSYNTHESIS; MICROORGANISMS;
   POLYPEPTIDE
AB Bacillus subtilis Cl, a bacterium capable of producing a glycerol and gamma-PGA bioconjugate, was studied. C1 is a glutamate independent bacterium, which produces the gamma-PGA derivative in the absence of L-glutamate. A large amount of the bioconjugate, 21.4 g/l, was produced when the bacteria were cultured in medium T at 37 C, 150 rpm for 6 days. The number-average molecular weight (M) of the bioconjugate was over 1 x 107 as determined by gel permeation chromatography, amino acid analysis showed only glutamic acid peak and the H-1 NMR spectrum showed chemical shifts of both gamma-PGA and glycerol. The D-glutamate content was over 97% in every bioconjugate produced under the conditions used and the D-glutamate content was indifferent to the Mn2+ concentrations under study. During bioconjugate production, an intracellular glutamate racemase activity was detected, suggesting the enzyme is involved in the D-glutamate supply. The molecular weight of the bioconjugate varied with salt concentration in the medium; the molecular weight decreased by a factor of approximately 10 from 7.94 x 10(6) to 0.73 x 10(6) Da at 4-day cultivation time for cultures, which contained 0.05 and 5% NaCl, respectively. The viscosity of the bioconjugate produced by C1 is significantly higher than that of gamma-PGA itself. This bioconjugate is the first example of gamma-PGA derivative directly produced by microbes; thus, it is a unique biomaterial. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Da Yeh Univ, Dept Environm Engn, Changhua, Taiwan.
   Da Yeh Univ, Dept Bioind Technol, Changhua, Taiwan.
RP Shih, IL (reprint author), Da Yeh Univ, Dept Environm Engn, Changhua, Taiwan.
EM ils@mail.dyu.edu.tw
CR ABE K, 1997, BIOSCI BIOTECH BIOCH, V61, P1043
   Ashiuchi M, 2001, APPL MICROBIOL BIOT, V57, P764, DOI 10.1007/s00253-001-0848-9
   Ashiuchi M, 2002, APPL MICROBIOL BIOT, V59, P9, DOI 10.1007/s00253-002-0984-x
   Ashiuchi M, 1998, J BIOCHEM-TOKYO, V123, P1156
   BIRRER GA, 1994, INT J BIOL MACROMOL, V16, P265, DOI 10.1016/0141-8130(94)90032-9
   BORBELY M, 1994, POLYM BULL, V32, P127, DOI 10.1007/BF00306378
   Bovarnick M, 1942, J BIOL CHEM, V145, P415
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   FUJII H, 1963, J AGR CHEM SOC JPN, V37, P407
   GOTO A, 1992, BIOSCI BIOTECH BIOCH, V56, P1031, DOI 10.1271/bbb.56.1031
   HANBY WE, 1946, BIOCHEM J, V40, P297, DOI 10.1042/bj0400297
   Inatsu Y, 2002, JARQ-JPN AGR RES Q, V36, P169, DOI 10.6090/jarq.36.169
   IVANOVICS G., 1937, Zeitschrift fur Immunitatsforschung, V90, P5
   KUBOTA H, 1993, J POLYM SCI POL CHEM, V31, P2877, DOI 10.1002/pola.1993.080311127
   Kunioka M, 1997, APPL MICROBIOL BIOT, V47, P469, DOI 10.1007/s002530050958
   KUNIOKA M, 1993, KOBUNSHI RONBUNSHU, V50, P755, DOI 10.1295/koron.50.755
   LEONARD CG, 1958, J BACTERIOL, V76, P499
   Markland P, 1999, INT J PHARM, V178, P183, DOI 10.1016/S0378-5173(98)00373-1
   Perez-Camero G, 1999, BIOTECHNOL BIOENG, V63, P110, DOI 10.1002/(SICI)1097-0290(19990405)63:1<110::AID-BIT11>3.0.CO;2-T
   Richard A, 2001, CRIT REV BIOTECHNOL, V21, P219, DOI 10.1080/07388550108984171
   SEKINE T, 2000, J BIOMED MATER RES, V35, P305
   Shih IL, 2003, BIOTECHNOL LETT, V25, P1709, DOI 10.1023/A:1026042302102
   Shih IL, 2002, ENZYME MICROB TECH, V31, P213, DOI 10.1016/S0141-0229(02)00103-5
   Shih IL, 2001, BIORESOURCE TECHNOL, V79, P207, DOI 10.1016/S0960-8524(01)00074-8
   Shih IL, 2001, BIORESOURCE TECHNOL, V78, P267, DOI 10.1016/S0960-8524(01)00027-X
   WU PJ, 2004, THESIS DA YEH U TAIW
NR 26
TC 35
Z9 41
U1 1
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-5113
J9 PROCESS BIOCHEM
JI Process Biochem.
PD JUL
PY 2005
VL 40
IS 8
BP 2827
EP 2832
DI 10.1016/j.procbio.2004.12.009
PG 6
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering, Chemical
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering
GA 925IU
UT WOS:000229047600035
DA 2018-10-20
ER

PT J
AU Yao, L
   Swartz, DD
   Gugino, SF
   Russell, JA
   Andreadis, ST
AF Yao, L
   Swartz, DD
   Gugino, SF
   Russell, JA
   Andreadis, ST
TI Fibrin-based tissue-engineered blood vessels: Differential effects of
   biomaterial and culture parameters on mechanical strength and vascular
   reactivity
SO TISSUE ENGINEERING
LA English
DT Article
ID SMOOTH-MUSCLE-CELLS; REMODELING IN-VITRO; GROWTH-FACTOR-BETA; MEDIA
   EQUIVALENT; COLLAGEN; CONSTRUCTS; ARTERIES; MATRIX; REGENERATION;
   EXPRESSION
AB We have shown that fibrin- based small- diameter tissue- engineered blood vessels ( TEVs) exhibited considerable mechanical strength and could withstand implantation in the jugular veins of lambs, where they remained patent for 15 weeks. The microtopology of fibrin matrix is influenced by the concentration of fibrinogen and calcium, whereas fibrinolysis and matrix remodeling are affected by the presence of the fibrinolytic inhibitor aprotinin. Here we report the effects of these components on two key properties of TEVs, namely mechanical strength and vasoreactivity. We found that high concentrations of fibrinogen or calcium decreased significantly both strength and reactivity. Surprisingly, aprotinin increased mechanical strength but decreased vascular reactivity in a dose- dependent manner. Transforming growth factor beta(1) ( TGF- beta(1)) and insulin had a moderate effect on mechanical strength but significantly enhanced reactivity, through receptor- and non- receptor mediated pathways. In addition, the combination of TGF- beta(1), insulin, and aprotinin resulted in significant improvement of both properties. Our data suggest that the microtopology of fibrin matrix and the rates of fibrinolysis and extracellular matrix synthesis may affect the properties of TEVs significantly. They also indicate that biomaterial and culture parameters may have differential effects on mechanical properties versus vascular reactivity and, therefore, engineering blood vessels under conditions that maximize tissue strength may not always result in optimal function. Instead, strength and reactivity must be used in concert for more accurate evaluation of tissue- engineered vascular constructs.
C1 SUNY Buffalo, Bioengn Lab, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
   SUNY Buffalo, Women & Childrens Hosp Buffalo, Buffalo, NY 14260 USA.
   SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA.
RP Andreadis, ST (reprint author), SUNY Buffalo, Bioengn Lab, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
EM sandread@eng.buffalo.edu
OI Swartz, Daniel/0000-0003-1674-1527
CR Bader A, 2000, TRANSPLANTATION, V70, P7
   Cummings CL, 2004, BIOMATERIALS, V25, P3699, DOI 10.1016/j.biomaterials.2003.10.073
   Geer DJ, 2004, TISSUE ENG, V10, P1006, DOI 10.1089/ten.2004.10.1006
   Geer DJ, 2002, TISSUE ENG, V8, P787, DOI 10.1089/10763270260424141
   Gonzalez W, 2001, J CARDIOVASC PHARM, V37, P219, DOI 10.1097/00005344-200102000-00009
   Grassl ED, 2003, J BIOMED MATER RES A, V66A, P550, DOI 10.1002/jbm.a.10589
   Grassl ED, 2002, J BIOMED MATER RES, V60, P607, DOI 10.1002/jbm.10107
   Herbert CB, 1998, J BIOMED MATER RES, V40, P551, DOI 10.1002/(SICI)1097-4636(19980615)40:4<551::AID-JBM6>3.0.CO;2-E
   Higgins SP, 2003, J BIOMED MATER RES A, V67A, P295, DOI 10.1002/jbm.a.10599
   Hirai J, 1996, CELL TRANSPLANT, V5, P93, DOI 10.1016/0963-6897(95)02002-0
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0
   Markewitz BA, 2001, CARDIOVASC RES, V49, P200, DOI 10.1016/S0008-6363(00)00221-2
   Neidert MR, 2002, BIOMATERIALS, V23, P3717, DOI 10.1016/S0142-9612(02)00106-0
   Nerem RM, 2000, YONSEI MED J, V41, P735, DOI 10.3349/ymj.2000.41.6.735
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Niklason LE, 2001, J VASC SURG, V33, P628, DOI 10.1067/mva.2001.111747
   Niklason LE, 1999, SCIENCE, V286, P1493, DOI 10.1126/science.286.5444.1493
   Ross JJ, 2003, MATRIX BIOL, V22, P477, DOI 10.1016/S0945-053X(03)00078-7
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Seliktar D, 2003, TISSUE ENG, V9, P657, DOI 10.1089/107632703768247359
   Seliktar D, 2001, ANN BIOMED ENG, V29, P923, DOI 10.1114/1.1415522
   Stegemann JP, 2003, ANN BIOMED ENG, V31, P391, DOI 10.1114/1.1558031
   Sugo S, 2001, J CARDIOVASC PHARM, V37, P25, DOI 10.1097/00005344-200101000-00004
   Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, pH1451, DOI 10.1152/ajpheart.00479.2004
   Tranquillo RT, 2002, ANN NY ACAD SCI, V961, P251, DOI 10.1111/j.1749-6632.2002.tb03094.x
   Tuan TL, 1996, EXP CELL RES, V223, P127, DOI 10.1006/excr.1996.0065
   Wang MC, 1995, MAT SCI ENG C-BIOMIM, V3, P131, DOI 10.1016/0928-4931(95)00116-6
   Wozniak G, 2003, CARDIOVASC SURG, V11, P17, DOI 10.1016/S0967-2109(03)00067-X
NR 30
TC 58
Z9 61
U1 0
U2 21
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUL
PY 2005
VL 11
IS 7-8
BP 991
EP 1003
DI 10.1089/ten.2005.11.991
PG 13
WC Cell & Tissue Engineering
SC Cell Biology
GA 965OK
UT WOS:000231959800002
PM 16144435
OA Green Published
DA 2018-10-20
ER

PT J
AU Walsh, JF
   Manwaring, ME
   Tresco, PA
AF Walsh, JF
   Manwaring, ME
   Tresco, PA
TI Directional neurite outgrowth is enhanced by engineered meningeal
   cell-coated substrates
SO TISSUE ENGINEERING
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; RAT SPINAL-CORD; OLFACTORY ENSHEATHING CELLS;
   ADULT-RAT; EXTRACELLULAR-MATRIX; AXONAL REGENERATION; CONTACT GUIDANCE;
   WHITE-MATTER; IN-VITRO; INHIBITORY MOLECULES
AB After injury to the CNS, the anatomical organization of the tissue is disrupted, posing a barrier to the regeneration of axons. Meningeal cells, a central participant in the CNS tissue response to injury, migrate into the core of the wound site in an unorganized fashion and deposit a disorganized extracellular matrix ( ECM) that produces a nonpermissive environment. Previous work in our laboratory has shown that the presentation of nanometer- scale topographic cues to these cells influences their morphological, cytoskeletal, and secreted ECM alignment. In the present study, we provided similar environmental cues to meningeal cells and examined the ability of the composite construct to influence dorsal root ganglion regeneration in vitro. When grown on control surfaces of meningeal cells lacking underlying topographic cues, there was no bias in neurite outgrowth. In contrast, when grown on monolayers of meningeal cells with underlying nanometer- scale topography, neurite outgrowth length was greater and was directed parallel to the underlying surface topography even though there exists an intervening meningeal cell layer. The observed outgrowth was significantly longer than on laminin- coated surfaces, which are considered to be the optimal substrata for promoting outgrowth of dorsal root ganglion neurons in culture. These results suggest that the nanometer- level surface finish of an implanted biomaterial may be used to organize the encapsulation tissue that accompanies the implantation of materials into the CNS. It furthermore suggests a simple approach for improving bridging materials for repair of nerve tracts or for affecting cellular organization at a device - tissue interface.
C1 Univ Utah, Dept Bioengn, Keck Ctr Tussue Engn, Salt Lake City, UT 84112 USA.
RP Tresco, PA (reprint author), Univ Utah, Dept Bioengn, Keck Ctr Tussue Engn, Salt Lake City, UT 84112 USA.
EM tresco@utah.ed
CR ABNET K, 1991, DEV BRAIN RES, V59, P187, DOI 10.1016/0165-3806(91)90099-5
   Ahmed Z, 2003, TISSUE ENG, V9, P219, DOI 10.1089/107632703764664693
   Berry M, 1983, Acta Neurochir Suppl (Wien), V32, P31
   Biran R, 2003, EXP NEUROL, V184, P141, DOI 10.1016/S0014-4886(03)00253-X
   Biran R, 2001, J BIOMED MATER RES, V55, P1
   BROOK GA, 1994, EXP NEUROL, V126, P31, DOI 10.1006/exnr.1994.1040
   Brook GA, 1998, J NEUROSCI RES, V53, P51, DOI 10.1002/(SICI)1097-4547(19980701)53:1<51::AID-JNR6>3.0.CO;2-I
   Brook GA, 2001, GLIA, V33, P118, DOI 10.1002/1098-1136(200102)33:2<118::AID-GLIA1011>3.0.CO;2-Y
   CARBONELL AL, 1988, BRAIN RES, V439, P337, DOI 10.1016/0006-8993(88)91491-6
   Chauhan NB, 1999, INT J DEV NEUROSCI, V17, P255, DOI 10.1016/S0736-5748(99)00003-9
   Davies SJA, 1997, NATURE, V390, P680
   Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999
   Detrait E, 1998, J NEUROSCI METH, V84, P193, DOI 10.1016/S0165-0270(98)00114-9
   DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291
   EBENDAL T, 1977, CELL TISSUE RES, V175, P439
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Hermanns S, 2001, J NEUROSCI METH, V110, P141, DOI 10.1016/S0165-0270(01)00427-7
   KAO CC, 1977, EXP NEUROL, V54, P591, DOI 10.1016/0014-4886(77)90259-X
   KLIOT M, 1990, EXP NEUROL, V109, P57, DOI 10.1016/S0014-4886(05)80008-1
   KRIKORIAN JG, 1981, EXP NEUROL, V72, P698, DOI 10.1016/0014-4886(81)90018-2
   Li MS, 1996, GLIA, V18, P306, DOI 10.1002/(SICI)1098-1136(199612)18:4<306::AID-GLIA5>3.0.CO;2-V
   Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000
   Li Y, 2003, J NEUROSCI, V23, P7783
   LIESI P, 1988, DEV BIOL, V130, P774, DOI 10.1016/0012-1606(88)90366-1
   Manwaring ME, 2004, BIOMATERIALS, V25, P3631, DOI 10.1016/j.biomaterials.2003.10.043
   Manwaring ME, 2001, BIOMATERIALS, V22, P3155, DOI 10.1016/S0142-9612(01)00068-0
   MATHEWSON AJ, 1985, BRAIN RES, V327, P61, DOI 10.1016/0006-8993(85)91499-4
   MCKEON RJ, 1991, J NEUROSCI, V11, P3398
   Miller C, 2001, TISSUE ENG, V7, P705, DOI 10.1089/107632701753337663
   Ness R, 1997, GLIA, V19, P47, DOI 10.1002/(SICI)1098-1136(199701)19:1<47::AID-GLIA5>3.0.CO;2-7
   Niclou SP, 2003, MOL CELL NEUROSCI, V24, P902, DOI 10.1016/S1044-7431(03)00243-4
   Pasterkamp RJ, 1998, PROG BRAIN RES, V117, P151
   Pettigrew DB, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-9
   Pettigrew DB, 1999, J NEUROSCI, V19, P8358
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Rajnicek AM, 1997, J CELL SCI, V110, P2915
   Reier P J, 1988, Adv Neurol, V47, P87
   REIER PJ, 1986, J COMP NEUROL, V247, P275, DOI 10.1002/cne.902470302
   RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0
   RISLING M, 1983, BRAIN RES, V280, P15, DOI 10.1016/0006-8993(83)91169-1
   RUDGE JS, 1990, J NEUROSCI, V10, P3594
   Sajanti J, 1999, BBA-MOL BASIS DIS, V1454, P209, DOI 10.1016/S0925-4439(99)00016-2
   Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315
   SCHACHNER M, 1981, DEV BIOL, V83, P328, DOI 10.1016/0012-1606(81)90478-4
   SCHOLES JH, 1979, NATURE, V278, P620, DOI 10.1038/278620a0
   Scholl M, 2000, J NEUROSCI METH, V104, P65, DOI 10.1016/S0165-0270(00)00325-3
   Schreyer D J, 1987, Brain Res, V432, P291
   Schwab ME, 1996, PHYSIOL REV, V76, P319
   Shearer MC, 2003, MOL CELL NEUROSCI, V24, P913, DOI 10.1016/j.mcn.2003.09.004
   SIEVERS J, 1994, J NEUROCYTOL, V23, P135, DOI 10.1007/BF01183867
   SILVER J, 1980, J COMP NEUROL, V189, P101, DOI 10.1002/cne.901890106
   Sims TJ, 1999, EXP BRAIN RES, V125, P495, DOI 10.1007/s002210050707
   Stepien E, 1999, CELL BIOL INT, V23, P105, DOI 10.1006/cbir.1998.0256
   SUNG JH, 1981, J NEUROPATH EXP NEUR, V40, P645, DOI 10.1097/00005072-198111000-00006
   VIDALSANZ M, 1987, J NEUROSCI, V7, P2894
   Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6
   Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x
   Yeung CK, 2001, NEUROSCI LETT, V301, P147, DOI 10.1016/S0304-3940(01)01628-7
   Yoshii S, 2003, SPINE, V28, P2346, DOI 10.1097/01.BRS.0000085302.95413.16
   Yoshinari M, 2003, J BIOMED MATER RES A, V65A, P359, DOI 10.1002/jbm.a.10521
NR 60
TC 27
Z9 28
U1 1
U2 8
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUL
PY 2005
VL 11
IS 7-8
BP 1085
EP 1094
DI 10.1089/ten.2005.11.1085
PG 10
WC Cell & Tissue Engineering
SC Cell Biology
GA 965OK
UT WOS:000231959800011
PM 16144444
DA 2018-10-20
ER

PT J
AU Pangborn, CA
   Athanasiou, KA
AF Pangborn, CA
   Athanasiou, KA
TI Effects of growth factors on meniscal fibrochondrocytes
SO TISSUE ENGINEERING
LA English
DT Article
ID KNEE-JOINT MENISCUS; PRESSURE DISTRIBUTION; LOAD-BEARING;
   ULTRASTRUCTURE; CELLS
AB To tissue engineer the knee meniscus, our laboratory follows a paradigm that includes biomaterial scaffolding, mechanical stimulation, and growth factor addition. The aim of this study was to study extracellular matrix ( ECM) component uptake by meniscal fibrochondrocytes when stimulated with platelet- derived growth factor AB, transforming growth factor beta(1) ( TGF- beta(1)), insulin- like growth factor type 1, and basic fibroblast growth factor at various concentrations ( low, medium, and high levels for each). Growth factors were applied to monolayer cultures for 3 weeks in a soluble form as part of the culture medium. Radiolabeling with [H-3] proline and [S-35] sulfate was performed to indicate collagen and glycosaminoglycan production, respectively. TGF- beta(1) is the only growth factor that increased the uptake of both components. It showed the most consistent behavior and the highest response. There is no conclusive evidence whether the high concentration of TGF- beta(1) ( 100 ng/ mL) is better than the medium concentration ( 10 ng/ mL). Therefore the results of this study demonstrate that TGF- beta(1) at either 10 or 100 ng/ mL can be used to upregulate ECM production in monolayer cultures of meniscal fibrochondrocytes.
C1 Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
RP Athanasiou, KA (reprint author), Rice Univ, Dept Bioengn, MS-142,POB 1892, Houston, TX 77251 USA.
EM athanasiou@rice.edu
FU NIAMS NIH HHS [R01 AR47839-2]
CR AHMED AM, 1983, J BIOMECH ENG-T ASME, V105, P216, DOI 10.1115/1.3138409
   AHMED AM, 1992, KNEE MENISCUS BASIC, P59
   Anderson D R, 1993, Knee Surg Sports Traumatol Arthrosc, V1, P44, DOI 10.1007/BF01552158
   Bhargava MM, 1999, AM J SPORT MED, V27, P636, DOI 10.1177/03635465990270051601
   Bullough P G, 1970, J Bone Joint Surg Br, V52, P564
   COLLIER S, 1995, OSTEOARTHR CARTILAGE, V3, P127, DOI 10.1016/S1063-4584(05)80045-7
   Detamore MS, 2004, ARCH ORAL BIOL, V49, P577, DOI 10.1016/j.archoralbio.2004.01.015
   FUKUBAYASHI T, 1980, ACTA ORTHOP SCAND, V51, P871, DOI 10.3109/17453678008990887
   GHADIALLY FN, 1983, J ANAT, V136, P773
   GHOSH P, 1987, CLIN ORTHOP RELAT R, V224, P52
   HOSHINO A, 1987, J BONE JOINT SURG BR, V69, P807
   IMLER SM, 2003, 2003 SUMM BIOENG C J, P535
   KRAUSE WR, 1976, J BONE JOINT SURG AM, V58, P599, DOI 10.2106/00004623-197658050-00003
   KUROSAWA H, 1980, CLIN ORTHOP RELAT R, V149, P283
   MCDEVITT CA, 1990, CLIN ORTHOP RELAT R, P8
   Nakano T, 1997, J ORTHOPAED RES, V15, P213, DOI 10.1002/jor.1100150209
   NEWMAN AP, 1989, AM J SPORT MED, V17, P164, DOI 10.1177/036354658901700205
   Shrive N G, 1978, Clin Orthop Relat Res, P279
   Sweigart MA, 2001, TISSUE ENG, V7, P111, DOI 10.1089/107632701300062697
   Walker P S, 1975, Clin Orthop Relat Res, P184, DOI 10.1097/00003086-197506000-00027
   WHIPPLE RR, 1985, T 31 ANN M ORTH RES, P367
NR 21
TC 44
Z9 57
U1 2
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4947
J9 TISSUE ENG
JI Tissue Eng.
PD JUL
PY 2005
VL 11
IS 7-8
BP 1141
EP 1148
DI 10.1089/ten.2005.11.1141
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA 965OK
UT WOS:000231959800017
PM 16144450
DA 2018-10-20
ER

PT J
AU Kumarasuriyar, A
   Jackson, RA
   Grondahl, L
   Trau, M
   Nurcombe, V
   Cool, SM
AF Kumarasuriyar, A
   Jackson, RA
   Grondahl, L
   Trau, M
   Nurcombe, V
   Cool, SM
TI Poly(beta-hydroxybutyrate-co-beta-hydroxyvalerate) supports in vitro
   osteogenesis
SO TISSUE ENGINEERING
LA English
DT Article
ID HYDROXYBUTYRATE-HYDROXYVALERATE COPOLYMERS; BIODEGRADABLE MEDICAL
   DEVICES; OSTEOBLAST-LIKE CELLS; MARROW STROMAL CELLS; BONE-MARROW;
   SURFACE-ROUGHNESS; HISTOLOGICAL-EVALUATION; GENE-EXPRESSION;
   DIFFERENTIATION; POLYMERS
AB Studies have demonstrated that polymeric biomaterials have the potential to support osteoblast growth and development for bone tissue repair. Poly( beta- hydroxybutyrate- co- beta- hydroxyvalerate) ( PHBV), a bioabsorbable, biocompatible polyhydroxy acid polymer, is an excellent candidate that, as yet, has not been extensively investigated for this purpose. As such, we examined the attachment characteristics, self- renewal capacity, and osteogenic potential of osteoblast- like cells ( MC3T3- E1 S14) when cultured on PHBV films compared with tissue culture polystyrene ( TCP). Cells were assayed over 2 weeks and examined for changes in morphology, attachment, number and proliferation status, alkaline phosphatase ( ALP) activity, calcium accumulation, nodule formation, and the expression of osteogenic genes. We found that these spindle- shaped MC3T3- E1 S14 cells made cell - cell and cell - substrate contact. Time- dependent cell attachment was shown to be accelerated on PHBV compared with collagen and laminin, but delayed compared with TCP and fibronectin. Cell number and the expression of ALP, osteopontin, and pro- collagen alpha 1( I) mRNA were comparable for cells grown on PHBV and TCP, with all these markers increasing over time. This demonstrates the ability of PHBV to support osteoblast cell function. However, a lag was observed for cells on PHBV in comparison with those on TCP for proliferation, ALP activity, and cbfa- 1 mRNA expression. In addition, we observed a reduction in total calcium accumulation, nodule formation, and osteocalcin mRNA expression. It is possible that this cellular response is a consequence of the contrasting surface properties of PHBV and TCP. The PHBV substrate used was rougher and more hydrophobic than TCP. Although further substrate analysis is required, we conclude that this polymer is a suitable candidate for the continued development as a biomaterial for bone tissue engineering.
C1 Inst Mol & Cell Biol, Stem Cell & Tissue Repair Lab, Singapore 138673, Singapore.
   Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.
   Univ Queensland, Sch Mol & Microbial Sci, St Lucia, Qld, Australia.
   Univ Queensland, Ctr Nanotechnol & Biomat, St Lucia, Qld, Australia.
RP Cool, SM (reprint author), Inst Mol & Cell Biol, Stem Cell & Tissue Repair Lab, 61 Biopolis Dr Proteos, Singapore 138673, Singapore.
EM scool@imcb.a-star.edu.sg
RI Trau, Matt/E-3944-2015; ASTAR, IMCB/E-2320-2012
OI Trau, Matt/0000-0001-5516-1280; Grondahl, Lisbeth/0000-0001-6012-9808
CR An YH, 2000, BIOMATERIALS, V21, P2635, DOI 10.1016/S0142-9612(00)00132-0
   Boyan BD, 1995, CELL MATER, V5, P323
   Bruinink A, 2001, BIOMATERIALS, V22, P2465, DOI 10.1016/S0142-9612(00)00434-8
   Di Toro R, 2004, EUR J PHARM SCI, V21, P161, DOI 10.1016/j.ejps.2003.10.001
   Diefenderfer DL, 2003, J BONE JOINT SURG AM, V85A, P19, DOI 10.2106/00004623-200300003-00005
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174
   Freshney RI, 2000, CULTURE ANIMAL CELLS
   GALGUT P, 1991, J CLIN PERIODONTOL, V18, P581, DOI 10.1111/j.1600-051X.1991.tb00093.x
   GILDING DK, 1981, BIOCOMPATIBILITY CLI, P209
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   GOGOLEWSKI S, 1992, Clinical Materials, V10, P13, DOI 10.1016/0267-6605(92)90079-9
   HAMMOND T, 1995, DEGRADABLE POLYM, P87
   Hankermeyer C R, 1999, Rev Environ Contam Toxicol, V159, P1
   Hatton P. V., 1994, Clinical Materials, V17, P71, DOI 10.1016/0267-6605(94)90014-0
   HAYMAN EG, 1983, P NATL ACAD SCI-BIOL, V80, P4003, DOI 10.1073/pnas.80.13.4003
   HOLLAND SJ, 1987, BIOMATERIALS, V8, P289, DOI 10.1016/0142-9612(87)90117-7
   Howard D, 2002, BIOCHEM BIOPH RES CO, V299, P208, DOI 10.1016/S0006-291X(02)02561-5
   Hu YH, 2003, J BIOMED MATER RES A, V64A, P583, DOI 10.1002/jbm.a.10438
   IBARAKI K, 1992, J BONE MINER RES, V7, P743
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   KNOWLES JC, 1992, BIOMATERIALS, V13, P491, DOI 10.1016/0142-9612(92)90099-A
   Kose GT, 2003, BIOMATERIALS, V24, P4999, DOI 10.1016/S0142-9612(03)00417-4
   Kose GT, 2003, BIOMATERIALS, V24, P1949, DOI 10.1016/S0142-9612(02)00613-0
   KOSTOPOULOS L, 1994, CLIN ORAL IMPLAN RES, V5, P66, DOI 10.1034/j.1600-0501.1994.050202.x
   KOSTOPOULOS L, 1994, CLIN ORAL IMPLAN RES, V5, P75, DOI 10.1034/j.1600-0501.1994.050203.x
   Liao SS, 2003, SPINE, V28, P1954, DOI 10.1097/01.BRS.0000083240.13332.F6
   Liao Su-san, 2003, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V25, P36
   LIN TC, 1985, 11 ANN M SOC BIOM SA
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   Lohmann CH, 2000, J BONE MINER RES, V15, P1169, DOI 10.1359/jbmr.2000.15.6.1169
   Lutton C, 2001, AUST J CHEM, V54, P621, DOI 10.1071/CH01118
   LUZIER WD, 1992, P NATL ACAD SCI USA, V89, P839, DOI 10.1073/pnas.89.3.839
   Malekzadeh R, 1998, J PERIODONTOL, V69, P1256, DOI 10.1902/jop.1998.69.11.1256
   Martin P, 1995, CELEST MECH DYN ASTR, V63, P29, DOI 10.1007/BF00691913
   Mas A, 1997, EUR POLYM J, V33, P331, DOI 10.1016/S0014-3057(96)00154-1
   Matsuzaka K, 2000, CLIN ORAL IMPLAN RES, V11, P325, DOI 10.1034/j.1600-0501.2000.011004325.x
   Payne RG, 2002, BIOMATERIALS, V23, P4359, DOI 10.1016/S0142-9612(02)00184-9
   Pratap J, 2003, CANCER RES, V63, P5357
   QUARLES LD, 1992, J BONE MINER RES, V7, P683
   Rouxhet L, 1998, MACROMOL SYMP, V130, P347, DOI 10.1002/masy.19981300130
   Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550
   SHIBATA Y, 1993, INT J BIOCHEM, V25, P239, DOI 10.1016/0020-711X(93)90012-4
   STEIN GS, 1990, FASEB J, V4, P3111
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893
   Wang M, 2001, J MATER SCI-MATER M, V12, P855, DOI 10.1023/A:1012899318688
   Wang YW, 2004, BIOMATERIALS, V25, P669, DOI 10.1016/S0142-9612(03)00561-1
   Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200
   YASIN M, 1989, BIOMATERIALS, V10, P400, DOI 10.1016/0142-9612(89)90132-4
NR 53
TC 40
Z9 41
U1 1
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4947
J9 TISSUE ENG
JI Tissue Eng.
PD JUL
PY 2005
VL 11
IS 7-8
BP 1281
EP 1295
DI 10.1089/ten.2005.11.1281
PG 15
WC Cell & Tissue Engineering
SC Cell Biology
GA 965OK
UT WOS:000231959800031
PM 16144464
DA 2018-10-20
ER

PT J
AU Busuttil, SJ
   Drumm, C
   Plow, EF
AF Busuttil, SJ
   Drumm, C
   Plow, EF
TI In vivo comparison of the inflammatory response induced by different
   vascular biomaterials
SO VASCULAR
LA English
DT Article; Proceedings Paper
CT 26th World Congress of the
   International-Society-of-Cardiovascular-Surgery
CY MAR 21-25, 2004
CL Maui, HI
SP Int Soc Cardiovasc Surg
DE biomaterials; inflammation; macrophages; neutrophils
ID COMPLEMENT ACTIVATION; BACTERIAL BIOFILMS; PROSTHESES; BIOCOMPATIBILITY;
   POLYETHYLENE; INVIVO
AB Biomaterial implants induce a local inflammatory response. A comparison of the inflammatory cell response was made between several biomaterials commonly used as vascular prostheses.
   Disks of polyethylene terephthalate (PET), polytetrafluoroethylene (PTFE), aluminum, titanium, copper, and stainless steel were surgically placed into the peritoneum of mice. Recruited macrophage and neutrophil populations were measured after recovery from the disk surface and peritoneal lavage.
   Following peritoneal biomaterial implants, there was no difference in total neutrophil or macrophage recruitment between mice implanted with PET, PTFE, aluminum, or titanium disks. However, there was significant attenuation of total neutrophil and macrophage recruitment to stainless steel compared with the other implants. Similarly, there was no significant difference in the percentage of leukocytes adherent to the PET, aluminum, or titanium disks. Macrophage adherence to the stainless steel disks was attenuated by 19.1%, and the number of neutrophils was attenuated by 69.1% when compared with PET implant mice. Mice implanted with copper disks universally expired.
   Leukocyte recruitment did not differ between PET, PTFE, aluminum, or titanium disks, suggesting that these materials stimulate similar inflammatory responses. Stainless steel disks recruited both fewer neutrophils and fewer macrophages and support lower adherence of these cells than the other biomaterials. Copper incited an overwhelming and fatal response.
C1 Case Western Reserve Univ, Dept Surg, Cleveland, OH 44106 USA.
   Cleveland Vet Affairs Med Ctr, Cleveland, OH USA.
   Cleveland Clin Fdn, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Cleveland, OH 44195 USA.
   Cleveland Clin Fdn, Dept Mol Cardiol, Cleveland, OH 44195 USA.
RP Busuttil, SJ (reprint author), Case Western Reserve Univ, Dept Surg, Cleveland, OH 44106 USA.
EM sbusuttil@smail.umaryland.edu
FU NHLBI NIH HHS [HL 17964]
CR BANDYK DF, 1991, J VASC SURG, V13, P575
   Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043
   BERGAMINI TM, 1988, J VASC SURG, V7, P21, DOI 10.1067/mva.1988.avs0070021
   Busuttil SJ, 2004, J THROMB HAEMOST, V2, P1798, DOI 10.1111/j.1538-7836.2004.00916.x
   HIMMELHOCH SR, 1969, BIOCHEMISTRY-US, V8, P914, DOI 10.1021/bi00831a022
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P37, DOI 10.1002/jbm.820200105
   MAROIS Y, 1993, BIOMATERIALS, V14, P255, DOI 10.1016/0142-9612(93)90115-I
   RUTHERFORD RB, 2000, VASCULAR SURG
   SHAH PM, 1983, J TRAUMA, V23, P1030, DOI 10.1097/00005373-198312000-00002
   SHEPARD AD, 1984, J VASC SURG, V1, P829, DOI 10.1067/mva.1984.avs0010829
   Syrovets T, 1997, BLOOD, V89, P4574
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tang LP, 1998, J BIOMED MATER RES, V41, P333, DOI 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L
   TORRES JL, 1988, ARCH BIOCHEM BIOPHYS, V267, P271, DOI 10.1016/0003-9861(88)90032-X
NR 16
TC 12
Z9 12
U1 0
U2 5
PU B C DECKER INC
PI HAMILTON
PA 20 HUGHSON ST SOUTH, PO BOX 620, L C D 1, HAMILTON, ONTARIO L8N 3K7,
   CANADA
SN 1708-5381
J9 VASCULAR
JI Vascular
PD JUL-AUG
PY 2005
VL 13
IS 4
BP 230
EP 235
DI 10.1258/rsmvasc.13.4.230
PG 6
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 960ZX
UT WOS:000231632800006
PM 16229796
DA 2018-10-20
ER

PT J
AU Ng, LT
   Swami, S
AF Ng, LT
   Swami, S
TI IPNs based on chitosan with NVP and NVP/HEMA synthesised through
   photoinitiator-free photopolymerisation technique for biomedical
   applications
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE chitosan; IPN hydrogel; photopolymerisation; keratinocytes; biomaterial
ID COLORIMETRIC ASSAY; CONTROLLED-RELEASE; HYDROGELS; MALEIMIDE; DELIVERY
AB Biocompatible interpenetration polymeric network (IPN) hydrogels based on chitosan with N-vinylpyrrolidinone (NVP) as well as its copolymer with 2-hydroxymethyl methacrylate (HEMA) were synthesised using the photopolymerisation technique without the inclusion of any photoinitiator or crosslinking agent. These hydrogels were characterised using the Fourier-transform infrared spectroscopy (FTIR) technique. Equilibrium swelling of these hydrogels was performed in Milli-Q water and drug release studies were carried out using theophylline as the model drug. These tests showed that the IPN comprised of chitosan and NVP with a very small amount of N-hydroxymethyl maleimide (HMMI) included exhibited higher swelling abilities and fast drug release rates than the IPN which contained chitosan, NVP and HEMA. Kinetic studies of water diffusion into these hydrogels and drug release revealed that with the exception of the IPN with HEMA incorporated, the other hydrogels did not adhere to the Fickian diffusion model. These hydrogels were tested for their biocompatibility with human epidermal keratinocyte cells (HaCaT). A positive cell growth as evidenced by the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) cell proliferation assay indicated that these hydrogels are non-toxic to human keratinocytes and can be potentially used as biomaterials for biomedical applications. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Western Sydney, Coll Sci Technol & Environm, Sydney, NSW 1797, Australia.
RP Ng, LT (reprint author), Univ Western Sydney, Coll Sci Technol & Environm, Locked Bag 1797, Sydney, NSW 1797, Australia.
EM l.ng@uws.edu.au
CR GERLIER D, 1986, J IMMUNOL METHODS, V94, P57, DOI 10.1016/0022-1759(86)90215-2
   Hejazi R., 2002, POLYM BIOMATERIALS, P213
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Ng LT, 2004, RADIAT PHYS CHEM, V69, P321, DOI 10.1016/S0969-806X(03)00476-6
   Ng LT, 2002, POLYM INT, V51, P1398, DOI 10.1002/pi.1062
   Ng LT, 2001, J APPL POLYM SCI, V79, P466
   Pessina A, 2001, CELL PROLIFERAT, V34, P243, DOI 10.1046/j.0960-7722.2001.00214.x
   Risbud MV, 2000, J CONTROL RELEASE, V68, P23, DOI 10.1016/S0168-3659(00)00208-X
   Shu XZ, 2001, INT J PHARM, V212, P19, DOI 10.1016/S0378-5173(00)00582-2
   Singer T. O., 1994, J INT MARKETING, V2, P53
   TAWNEY PO, 1961, J ORG CHEM, V26, P15, DOI 10.1021/jo01060a004
NR 11
TC 31
Z9 32
U1 1
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JUN 20
PY 2005
VL 60
IS 4
BP 523
EP 528
DI 10.1016/j.carbpol.2005.03.009
PG 6
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 939LW
UT WOS:000230075300013
DA 2018-10-20
ER

PT J
AU Laurence, S
   Bareille, R
   Baquey, C
   Fricain, JC
AF Laurence, S
   Bareille, R
   Baquey, C
   Fricain, JC
TI Development of a resorbable macroporous cellulosic material used as
   hemostatic in an osseous environment
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cellulose; hemostatic; macroporous biomaterial; bone; biocompatibility
ID OXIDIZED CELLULOSE; COLORIMETRIC ASSAY; CYTO-TOXICITY; BIOCOMPATIBILITY;
   BIODEGRADATION; AGENTS; SPONGE; MODEL; RAT
AB The control of bleeding is a frequently encountered therapeutic problem, particularly during dental surgery. The most efficient substances used to resolve this problem are not risk-free because of their animal or human origins, so cellulosic materials are potentially of interest. The aim of this study was to develop a resorbable macroporous cellulosic material for use as a resorbable hemostatic agent in bone sites. The degradation and the cytocompatibility of the cellulosic material versus controls were evaluated and its behaviour in vivo was studied. An original process using calcium carbonate powder as inverse matrix was used to develop a macroporous material. In order to predegrade the cellulosic material for hemostatic use, oxidation was performed with periodate. A dialdehyde component unstable at physiological pH was thus obtained. The material was found to have cytotoxicity, biocompatibility, and resorption properties similar to control but its hemostatic power was higher. &COPY; 2005 Wiley Periodicals, Inc.
C1 Univ Bordeaux 2, INSERM U577, F-33076 Bordeaux, France.
RP Laurence, S (reprint author), Univ Bordeaux 2, INSERM U577, 146,Rue Leo Saignat, F-33076 Bordeaux, France.
EM seblaurel@wanadoo.fr
CR *AFNOR, 1999, EV BIOL DISP MED 13
   *AFNOR, 1999, EV BIOL DISP MED 14
   BALA K, 1982, BIOMATERIALS, V3, P97, DOI 10.1016/0142-9612(82)90041-2
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   BOYNE PJ, 1966, ORAL SURG ORAL MED O, V21, P805, DOI 10.1016/0030-4220(66)90104-6
   DEGENSHEIN GA, 1963, NEW YORK STATE J MED, V63, P2639
   DIMITRIJEVICH SD, 1990, CARBOHYD RES, V195, P247
   Fricain JC, 2002, BIOMATERIALS, V23, P971, DOI 10.1016/S0142-9612(01)00152-1
   LEWIS KF, 1966, METHOD ENZYMOL, P269
   Martson M, 1999, BIOMATERIALS, V20, P1989, DOI 10.1016/S0142-9612(99)00094-0
   Martson M, 1998, EUR SURG RES, V30, P426, DOI 10.1159/000008609
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nevell TP, 1963, METHODS CARBOHYDRATE, V3, P164
   Nevell TP, 1985, CELLULOSE CHEM ITS A, P243
   Okamoto T, 1994, Braz Dent J, V5, P85
   PARISH CR, 1983, J IMMUNOL METHODS, V58, P225, DOI 10.1016/0022-1759(83)90277-6
   RACCUIA JS, 1992, AM J SURG, V163, P234, DOI 10.1016/0002-9610(92)90108-4
   SCHER KS, 1982, SURGERY, V91, P301
   SINGH M, 1982, BIOMATERIALS, V3, P16, DOI 10.1016/0142-9612(82)90055-2
   SINGH M, 1979, BIOMATER ARTIF CELL, V7, P495, DOI 10.3109/10731197909118964
   Sinha T. J., 1986, BIOMATERIALS, V7, P193
   SWIFT DM, 1986, J EXP ZOOL, V240, P65, DOI 10.1002/jez.1402400109
   Wagner WR, 1996, J SURG RES, V66, P100, DOI 10.1006/jsre.1996.0379
NR 23
TC 15
Z9 16
U1 2
U2 12
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 15
PY 2005
VL 73A
IS 4
BP 422
EP 429
DI 10.1002/jbm.a.30280
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 933AG
UT WOS:000229595600005
PM 15880722
DA 2018-10-20
ER

PT J
AU Forch, R
   Zhang, ZH
   Knoll, W
AF Forch, R
   Zhang, ZH
   Knoll, W
TI Soft plasma treated surfaces: Tailoring of structure and properties for
   biomaterial applications
SO PLASMA PROCESSES AND POLYMERS
LA English
DT Review
DE crosslinking; elasticity; plasma polymerisation; solvent effects;
   tailoring surface properties; three-dimensional interface
ID GUIDE MODE SPECTROSCOPY; ENHANCED FLUORESCENCE SPECTROSCOPY; SCANNING
   FORCE MICROSCOPY; VINYL ACETIC-ACID; ACRYLIC-ACID; MALEIC-ANHYDRIDE;
   POLYMER SURFACES; THIN-FILMS; MONOMOLECULAR FUNCTIONALIZATION; HUMAN
   KERATINOCYTES
AB This paper aims to discuss and review developments in plasma surface modification techniques which have been seen over the past few years, with particular emphasis on low energy or soft plasma assisted surface polymerisation processes. While early work focussed mainly on protective coatings and surface activation, the advancements in micro-technology in the 1980s followed by those in nanotechnology in the 1990s and 2000s have resulted in new challenges for surface processing and surface modification processes. The latest advancements in plasma polymer chemistry have shown tremendous potential for the synthesis of reasonably well defined molecular structures with a high retention of functional groups. Some of the latest achievements and newest insights into the behaviour of such deposits in a liquid environment will be discussed, with a particular focus on bio-nanotechnological applications. Utilising novel approaches in surface and interface analysis, it will be shown that plasma polymers can be tailored to have considerable elasticity with reversible swelling characteristics, offering a three-dimensional interface for biomolecular immobilisation procedures in a liquid environment.
C1 Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
RP Forch, R (reprint author), Natl Univ Singapore, 10 Kent Ridge Crescent, Singapore 119260, Singapore.
EM foerch@mpip-mainz.mpg.de
RI Foerch, Renate/B-8198-2011
CR Aizawa H, 2000, MAT SCI ENG C-BIO S, V12, P49, DOI 10.1016/S0928-4931(00)00157-0
   Akimoto T, 2003, BIOSENS BIOELECTRON, V18, P1447, DOI 10.1016/S0956-5663(03)00064-2
   Alexander MR, 1998, J MATER CHEM, V8, P937
   Alexander MR, 1999, POLYMER, V40, P5479, DOI 10.1016/S0032-3861(98)00784-8
   Alexander MR, 1998, SURF INTERFACE ANAL, V26, P961, DOI 10.1002/(SICI)1096-9918(199812)26:13<961::AID-SIA432>3.0.CO;2-7
   AMEEN AP, 1994, POLYMER, V35, P4382, DOI 10.1016/0032-3861(94)90096-5
   AMEEN AP, 1993, POLYMER, V34, P1795, DOI 10.1016/0032-3861(93)90418-A
   AUST EF, 1994, TRENDS POLYM SCI, V2, P313
   Barton D, 2003, CHEM COMMUN, P348, DOI 10.1039/b210781c
   Beck AJ, 1998, CHEM COMMUN, P1221, DOI 10.1039/a801778f
   BECK AJ, 1995, J CHEM SOC CHEM COMM, P1053, DOI 10.1039/c39950001053
   Beck AJ, 2003, TISSUE ENG, V9, P1123, DOI 10.1089/10763270360728035
   Beck AJ, 1996, POLYMER, V37, P5537, DOI 10.1016/S0032-3861(96)00479-X
   Berger R, 1997, MICROELECTRON ENG, V35, P373, DOI 10.1016/S0167-9317(96)00201-8
   Berger R, 1997, SCIENCE, V276, P2021, DOI 10.1126/science.276.5321.2021
   Beyer D, 1997, J BIOMED MATER RES, V36, P181, DOI 10.1002/(SICI)1097-4636(199708)36:2<181::AID-JBM6>3.0.CO;2-G
   BIEDERMANN H, 2004, PLASMA POLYM FILMS, V1
   Bumbu GG, 2004, MACROMOL CHEM PHYSIC, V205, P1713, DOI 10.1002/macp.200400195
   BURNSTEIN E, 1972, J VAC SCI TECHNOL, V11, P1004
   Calderon JG, 1998, MACROMOLECULES, V31, P3216, DOI 10.1021/ma970924f
   Calderon JG, 1997, ABSTR PAP AM CHEM S, V213, P534
   Candan S, 1998, J VAC SCI TECHNOL A, V16, P1702, DOI 10.1116/1.581288
   Chen XL, 1996, CHEM MATER, V8, P1067, DOI 10.1021/cm9504854
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Cicala G, 2003, DIAM RELAT MATER, V12, P2020, DOI 10.1016/S0925-9635(03)00293-0
   Cicala G, 2002, MACROMOLECULES, V35, P8920, DOI 10.1021/ma025536e
   Daw R, 1998, BIOMATERIALS, V19, P1717, DOI 10.1016/S0142-9612(98)00080-5
   Dogue ILJ, 1995, NUCL INSTRUM METH B, V105, P164
   Evenson SA, 2000, CHEM MATER, V12, P3038, DOI 10.1021/cm000223o
   Favia P, 2003, SURF COAT TECH, V169, P609, DOI 10.1016/S0257-8972(03)00123-3
   Favia P, 2002, VIDE, V57, P40
   Favia P, 2002, J PHOTOPOLYM SCI TEC, V15, P341
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   Feng XF, 2003, SURF COAT TECH, V171, P96, DOI 10.1016/S0257-8972(03)00246-9
   FOERCH R, 1992, J POLYM SCI POL CHEM, V30, P279, DOI 10.1002/pola.1992.080300212
   FOERCH R, 1991, KUNSTST-GER PLAST+, V81, P260
   FOERCH R, 1993, J ADHES SCI TECHNOL, V7, P1077, DOI 10.1163/156856193X00592
   FOERCH R, 1990, J POLYM SCI POL CHEM, V28, P193, DOI 10.1002/pola.1990.080280114
   France RM, 1998, J MATER CHEM, V8, P37, DOI 10.1039/a705098d
   Friedrich J, 2003, J ADHES SCI TECHNOL, V17, P1591, DOI 10.1163/156856103322396695
   Friedrich J, 2003, COMPOS INTERFACE, V10, P139, DOI 10.1163/156855403765826865
   Gong X, 2000, J POLYM SCI POL PHYS, V38, P2323, DOI 10.1002/1099-0488(20000901)38:17<2323::AID-POLB120>3.0.CO;2-6
   Haddow DB, 2003, J BIOMED MATER RES A, V64A, P80, DOI 10.1002/jbm.a.10356
   Han LCM, 1998, J POLYM SCI POL CHEM, V36, P3121, DOI 10.1002/(SICI)1099-0518(199812)36:17<3121::AID-POLA14>3.0.CO;2-Q
   Han LCM, 1997, LANGMUIR, V13, P5941, DOI 10.1021/la9706779
   Han LCM, 2000, J VAC SCI TECHNOL B, V18, P799, DOI 10.1116/1.591279
   Han LM, 1998, CHEM MATER, V10, P1422, DOI 10.1021/cm970779k
   Hendricks SK, 2000, J BIOMED MATER RES, V50, P160, DOI 10.1002/(SICI)1097-4636(200005)50:2<160::AID-JBM10>3.0.CO;2-M
   Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P3, DOI 10.1016/S0925-4005(98)00321-9
   Hu JJ, 2003, ADV FUNCT MATER, V13, P692, DOI 10.1002/adfm.200304384
   IGARASHI S, UNPUB
   Jacobsen V, 2002, THIN SOLID FILMS, V409, P185, DOI 10.1016/S0040-6090(02)00128-1
   Jacobsen V, 2001, SURF COAT TECH, V142, P1105, DOI 10.1016/S0257-8972(01)01261-0
   Jenkins ATA, 2000, LANGMUIR, V16, P6381, DOI 10.1021/la991649o
   Kambhampati D, 2001, BIOSENS BIOELECTRON, V16, P1109, DOI 10.1016/S0956-5663(01)00239-1
   Kim J, 2003, ANAL BIOCHEM, V313, P41, DOI 10.1016/S0003-2697(02)00563-8
   Kitching KJ, 2003, ABSTR PAP AM CHEM S, V225, pU578
   Knoll W, 1998, ANNU REV PHYS CHEM, V49, P569, DOI 10.1146/annurev.physchem.49.1.569
   KNOLL W, 1997, HDB OPTICAL PROPERTI
   Kojima K, 2003, ANAL CHEM, V75, P1116, DOI 10.1021/ac0257391
   KRETSCHM.E, 1971, Z PHYS, V241, P313, DOI 10.1007/BF01395428
   Kuhn G, 2001, SURF COAT TECH, V142, P494, DOI 10.1016/S0257-8972(01)01056-8
   Lamendola R, 1998, EUR PHYS J-APPL PHYS, V4, P65, DOI 10.1051/epjap:1998244
   Leich MA, 1998, MACROMOLECULES, V31, P7618, DOI 10.1021/ma980332c
   LEICH MA, 1998, ABSTR PAP AM CHEM S, V215, P337
   Liebermann T, 2000, COLLOID SURFACE A, V171, P115, DOI 10.1016/S0927-7757(99)00550-6
   Liebermann T, 2000, COLLOID SURFACE A, V169, P337, DOI 10.1016/S0927-7757(00)00449-0
   Mackie NM, 1997, ABSTR PAP AM CHEM S, V213, P527
   Mackie NM, 1998, LANGMUIR, V14, P1227, DOI 10.1021/la970953j
   Mar MN, 1999, SENSOR ACTUAT B-CHEM, V54, P125, DOI 10.1016/S0925-4005(98)00330-X
   Miyachi H, 2000, BIOTECHNOL BIOENG, V69, P323, DOI 10.1002/1097-0290(20000805)69:3<323::AID-BIT10>3.0.CO;2-T
   MULLER M, 1999, SURF COAT TECH, V119, P802
   Muller R., 1991, INTEGRIERTE OPTIK
   Nakamura R, 1997, ANAL CHEM, V69, P4649, DOI 10.1021/ac970571i
   Neumann MS, 2000, AIDS EDUC PREV, V12, P1
   Neumann T, 2002, ADV FUNCT MATER, V12, P575, DOI 10.1002/1616-3028(20020916)12:9<575::AID-ADFM575>3.0.CO;2-4
   Neumann T, 2001, ISRAEL J CHEM, V41, P69, DOI 10.1560/F0Q3-WHXD-T7VH-JJ78
   OEHR C, 1999, SURF COAT TECH, V119, P25
   Pan YV, 2002, PLASMAS POLYM, V7, P171, DOI 10.1023/A:1016295419941
   PANCHALINGAM V, 1993, ABSTR PAP AM CHEM S, V205, P228
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   RAETHER H, SURFACE PLASMONS
   Roy S, 2002, LANGMUIR, V18, P6319, DOI 10.1021/la025578w
   Ryan ME, 1996, CHEM MATER, V8, P37, DOI 10.1021/cm9503691
   Salz D, 2000, PHYS CHEM CHEM PHYS, V2, P3105, DOI 10.1039/b002327m
   SAVAGE CR, 1991, ABSTR PAP AM CHEM S, V201, P53
   SAVAGE CR, 1991, CHEM MATER, V3, P575, DOI 10.1021/cm00016a005
   Schiller S, 2002, CHEM MATER, V14, P235, DOI 10.1021/cm011139r
   Schlindwein WS, 2000, POLYM INT, V49, P953, DOI 10.1002/1097-0126(200009)49:9<953::AID-PI406>3.0.CO;2-L
   Schonherr H, 2000, CHEM COMMUN, P1303, DOI 10.1039/b003756g
   Schonherr H, 2000, CHEM MATER, V12, P3689, DOI 10.1021/cm0010351
   Sciarratta V, 2003, SURF COAT TECH, V174, P805, DOI 10.1016/S0257-8972(03)00564-4
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   Swalen J. D., 1986, Journal of Molecular Electronics, V2, P155
   Tarducci C, 2002, CHEM MATER, V14, P2541, DOI 10.1021/cm010939z
   TAWA K, 2002, ABSTR PAP AM CHEM S, V223, P475
   TIEFENTHALER K, 1989, J OPT SOC AM B, V6, P209, DOI 10.1364/JOSAB.6.000209
   Truica-Marasescu F, 2004, PLASMA PROCESS POLYM, V1, P153, DOI 10.1002/ppap.200400020
   van Os MT, 1999, CHEM MATER, V11, P3252, DOI 10.1021/cm991068k
   van Os MT, 1999, MATER RES SOC SYMP P, V544, P45
   Vohrer U, 2003, ANAL BIOANAL CHEM, V375, P929, DOI 10.1007/s00216-003-1750-3
   Walker AK, 1999, ANAL BIOCHEM, V271, P123, DOI 10.1006/abio.1999.4141
   Whittle JD, 2002, J MATER CHEM, V12, P2726, DOI 10.1039/b201471h
   WIGREN R, 1991, FEBS LETT, V280, P225, DOI 10.1016/0014-5793(91)80298-H
   Wu YLJ, 2000, COLLOID SURFACE B, V18, P235, DOI 10.1016/S0927-7765(99)00150-2
   Yang GH, 2002, J VAC SCI TECHNOL A, V20, P1955, DOI 10.1116/1.1513640
   Yasuda H, 2003, NUCL INSTRUM METH A, V515, P15, DOI 10.1016/j.nima.2003.08.125
   Yasuda H, 2000, J POLYM SCI POL CHEM, V38, P943, DOI 10.1002/(SICI)1099-0518(20000315)38:6<943::AID-POLA3>3.0.CO;2-3
   Yu F, 2003, ANAL CHEM, V75, P2610, DOI 10.1021/ac026161y
   Zhang J, 2003, THIN SOLID FILMS, V435, P108, DOI 10.1016/S0040-6090(03)00413-9
   Zhang J, 2003, ACTA PHYS SIN-CH ED, V52, P1707
   Zhang Y, 2002, POLYMER, V43, P7279, DOI 10.1016/S0032-3861(02)00711-5
   Zhang Z, 2003, SURF COAT TECH, V174, P588, DOI 10.1016/S0257-8972(03)00806-5
   Zhang Z, 2003, LANGMUIR, V19, P4765, DOI 10.1021/la026980d
   ZHANG Z, 2004, THESIS U MAINZ MAINZ
   Zhang ZH, 2003, MACROMOLECULES, V36, P7689, DOI 10.1021/ma034673o
   Zou XP, 2002, SURF COAT TECH, V149, P119, DOI 10.1016/S0257-8972(01)01490-6
NR 117
TC 137
Z9 139
U1 1
U2 41
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1612-8850
J9 PLASMA PROCESS POLYM
JI Plasma Process. Polym.
PD JUN 14
PY 2005
VL 2
IS 5
BP 351
EP 372
DI 10.1002/ppap.200400083
PG 22
WC Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter;
   Polymer Science
SC Physics; Polymer Science
GA 943WK
UT WOS:000230385400001
DA 2018-10-20
ER

PT J
AU Roach, P
   Farrar, D
   Perry, CC
AF Roach, P
   Farrar, D
   Perry, CC
TI Interpretation of protein adsorption: Surface-induced conformational
   changes
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID HUMAN-SERUM-ALBUMIN; QUARTZ-CRYSTAL MICROBALANCE; INDUCED
   STRUCTURAL-CHANGES; SCANNING FORCE MICROSCOPY; BIOMATERIAL SURFACES;
   BINDING; FIBRINOGEN; ADHESION; POLYURETHANES; SPECTROSCOPY
AB Protein adhesion plays a major role in determining the biocompatibility of materials. The first stage of implant integration is the adhesion of protein followed by cell attachment. Surface modification of implants (surface chemistry and topography) to induce and control protein and cell adhesion is currently of great interest. This communication presents data on protein adsorption (bovine serum albumin and fibrinogen) onto model hydrophobic (CH3) and hydrophilic (OH) surfaces, investigated using a quartz crystal microbalance (QCM) and grazing angle infrared spectroscopy. Our data suggest that albumin undergoes adsorption via a single step whereas fibrinogen adsorption is a more complex, multistage process. Albumin has a stronger affinity toward the CH3 compared to OH terminated surface. In contrast, fibrinogen adheres more rapidly to both surfaces, having a slightly higher affinity toward the hydrophobic surface. Conformational assessment of the adsorbed proteins by grazing angle infrared spectroscopy (GA-FTIR) shows that after an initial 1 h incubation few further time-dependent changes are observed. Both proteins exhibited a less organized secondary structure upon adsorption onto a hydrophobic surface than onto a hydrophilic surface, with the effect observed greatest for albumin. This study demonstrates the ability of simple tailor-made monochemical surfaces to influence binding rates and conformation of bound proteins through protein-surface interactions. Current interest in biocompatible materials has focused on surface modifications to induce rapid healing, both of implants and for wound care products. This effect may also be of significance at the next stage of implant integration, as cell adhesion occurs through the surface protein layer.
C1 Nottingham Trent Univ, Div Chem, Interdisciplinary Biomed Res Ctr, Sch Biomed & Nat Sci, Nottingham NG11 8NS, England.
   Smith & Nephew Grp Res Ctr, York YO10 5DF, N Yorkshire, England.
RP Perry, CC (reprint author), Nottingham Trent Univ, Div Chem, Interdisciplinary Biomed Res Ctr, Sch Biomed & Nat Sci, Nottingham NG11 8NS, England.
EM Carole.Perry@ntu.ac.uk
RI Zhou, Feng/E-9510-2011; Roach, Paul/G-2330-2012
OI Perry, Professor Carole/0000-0003-1517-468X
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BOS OJM, 1989, J BIOL CHEM, V264, P953
   CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
   CARTER DC, 1989, SCIENCE, V244, P1195, DOI 10.1126/science.2727704
   Caruso F, 1997, J COLLOID INTERF SCI, V186, P129, DOI 10.1006/jcis.1996.4625
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Ferretti S, 2000, TRAC-TREND ANAL CHEM, V19, P530, DOI 10.1016/S0165-9936(00)00032-7
   FOSTER JF, 1977, ALBUMIN STRUCTURE FU, P53, DOI DOI 10.1016/B978-0-08-019603-9.50010-7
   Fredriksson C, 1998, J MATER SCI-MATER M, V9, P785, DOI 10.1023/A:1008927624337
   FU FN, 1994, APPL SPECTROSC, V48, P1432, DOI 10.1366/0003702944028065
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   JOHANSSON S, 1997, FRONT BIOSCI, V2, P126
   Kasemo B., 1999, ADV DENT RES, V13, P1
   KIAEI D, 1995, J BIOMED MATER RES, V29, P729, DOI 10.1002/jbm.820290609
   Kidoaki S, 1999, LANGMUIR, V15, P7639, DOI 10.1021/la990357k
   Kim HS, 1998, J AM CHEM SOC, V120, P4417, DOI 10.1021/ja9735315
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   LENK TJ, 1991, LANGMUIR, V7, P1755, DOI 10.1021/la00056a030
   MIYAZAWA T, 1961, J AM CHEM SOC, V83, P712, DOI 10.1021/ja01464a042
   PITT WG, 1988, J BIOMED MATER RES, V22, P359, DOI 10.1002/jbm.820220502
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   REED RG, 1975, BIOCHEMISTRY-US, V14, P4578, DOI 10.1021/bi00692a004
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Shirtcliffe NJ, 2004, J MICROMECH MICROENG, V14, P1384, DOI 10.1088/0960-1317/14/10/013
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   SJOHOLM I, 1973, J BIOL CHEM, V248, P8434
   Ta TC, 2000, ANAL CHEM, V72, P2627, DOI 10.1021/ac991137e
   TABORELLI M, 1995, J BIOMED MATER RES, V29, P707, DOI 10.1002/jbm.820290606
   Voinova MV, 2002, BIOSENS BIOELECTRON, V17, P835, DOI 10.1016/S0956-5663(02)00050-7
   Wu YQ, 2002, APPL SPECTROSC, V56, P1186, DOI 10.1366/000370202760295449
   Yang Z, 2000, P NATL ACAD SCI USA, V97, P3907, DOI 10.1073/pnas.080065697
NR 33
TC 793
Z9 805
U1 25
U2 543
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD JUN 8
PY 2005
VL 127
IS 22
BP 8168
EP 8173
DI 10.1021/ja042898o
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 933HM
UT WOS:000229619500055
PM 15926845
DA 2018-10-20
ER

PT J
AU Irwin, EF
   Ho, JE
   Kane, SR
   Healy, KE
AF Irwin, EF
   Ho, JE
   Kane, SR
   Healy, KE
TI Analysis of interpenetrating polymer networks via quartz crystal
   microbalance with dissipation monitoring
SO LANGMUIR
LA English
DT Article
ID SURFACE-PLASMON RESONANCE; SELF-ASSEMBLED MONOLAYERS; PROTEIN
   ADSORPTION; MULTILAYER FILMS; BIOMATERIAL SURFACES; PLATELET-ADHESION;
   OXIDE SURFACES; COUPLED WATER; IN-VITRO; POLYSTYRENE
AB A quartz crystal microbalance with dissipation monitoring (QCM-D) was used to assess the physical properties of interpenetrating polymer networks (IPNs) through swelling experiments in ambient humidity and in phosphate-buffered saline (PBS), pH 7.4. The IPNs, based on acrylamide (AAm) and poly(ethylene glycol) (pEG), swell from thin, rigid films when dry (16.7 +/- 5.2 nm on Si/SiO2) to expanded, viscoelastic films when hydrated (107 +/- 24.2 nm on Si/SiO2). The dry IPNs could be analyzed using the Sauerbrey relationship, but for the hydrated films it was necessary to interpret QCM-D data with a Kelvin-Voigt viscoelastic model. A complex modulus vertical bar G*vertical bar of 116 +/- 38.1 kPa for the swollen IPN surface on Si/SiO2 was defined by the model. The QCM-D was also employed to quantify the adsorption of human fibrinogen, a protein important in thrombus formation, onto the IPNs. Fibrinogen adsorption studies demonstrated the sensitivity of the QCM-D, as well as confirmed the nonfouling nature of the IPN surface, where less than 5 ng/cm(2) of fibrinogen was adsorbed.
C1 Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.
RP Healy, KE (reprint author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
EM kehealy@socrates.berkeley.edu
FU NIAMS NIH HHS [AR43187-07]
CR BAKER JP, 1992, MACROMOLECULES, V25, P1955, DOI 10.1021/ma00033a019
   Barber TA, 2003, J BIOMED MATER RES A, V64A, P38, DOI 10.1002/jbm.a.10321
   Bearinger JP, 1997, LANGMUIR, V13, P5175, DOI 10.1021/la970101j
   Belu AM, 2003, BIOMATERIALS, V24, P3635, DOI 10.1016/S0142-9612(03)00159-5
   Bottom V. E., 1982, INTRO QUARTZ CRYSTAL
   Brant P, 1996, MACROMOLECULES, V29, P5628, DOI 10.1021/ma951349n
   Briggs D., 1998, SURFACE ANAL POLYM X
   Caruso F, 1997, LANGMUIR, V13, P3427, DOI 10.1021/la9608223
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   DIMILLA PA, 1992, J COLLOID INTERF SCI, V153, P212, DOI 10.1016/0021-9797(92)90313-B
   Domke J, 1998, LANGMUIR, V14, P3320, DOI 10.1021/la9713006
   EXTRAND CW, 1994, POLYM ENG SCI, V34, P390, DOI 10.1002/pen.760340503
   Fredriksson C, 1998, LANGMUIR, V14, P248, DOI 10.1021/la971005l
   Fredriksson C, 1998, J MATER SCI-MATER M, V9, P785, DOI 10.1023/A:1008927624337
   GARVEY MJ, 1974, J COLLOID INTERF SCI, V49, P57, DOI 10.1016/0021-9797(74)90298-7
   HARBERS GM, UNPUB LANGMUIR
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Hook F, 1998, P NATL ACAD SCI USA, V95, P12271, DOI 10.1073/pnas.95.21.12271
   HOOK F, 2004, BIOFUNCTIONAL SURFAC, P774
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   Knobler CM, 1999, CURR OPIN COLLOID IN, V4, P46, DOI 10.1016/S1359-0294(99)00002-3
   KUMAR A, 1994, LANGMUIR, V10, P1498, DOI 10.1021/la00017a030
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   Marx KA, 2003, BIOMACROMOLECULES, V4, P1099, DOI 10.1021/bm020116i
   Model MA, 2000, J BIOMED MATER RES, V50, P90, DOI 10.1002/(SICI)1097-4636(200004)50:1<90::AID-JBM13>3.0.CO;2-3
   Munro JC, 2004, MACROMOLECULES, V37, P925, DOI 10.1021/ma030297w
   Otzen DE, 2003, COLLOID SURFACE B, V29, P67, DOI 10.1016/S0927-7765(02)00186-8
   Park S, 2000, J BIOMED MATER RES, V53, P568, DOI 10.1002/1097-4636(200009)53:5<568::AID-JBM17>3.0.CO;2-8
   Petty M. C., 1996, LANGMUIR BLODGETT FI
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Plunkett MA, 2003, LANGMUIR, V19, P6837, DOI 10.1021/la034281a
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Reimhult E, 2004, ANAL CHEM, V76, P7211, DOI 10.1021/ac0492970
   Reimhult E., 2002, PHYS REV E, V66
   Richert L, 2004, BIOMACROMOLECULES, V5, P1908, DOI 10.1021/bm0498023
   Rodahl M, 1996, REV SCI INSTRUM, V67, P3238, DOI 10.1063/1.1147494
   Sabbatini L, 1996, J ELECTRON SPECTROSC, V81, P285, DOI 10.1016/0368-2048(95)02528-6
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Tsai WB, 1999, J BIOMAT SCI-POLYM E, V10, P163, DOI 10.1163/156856299X00117
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
NR 46
TC 61
Z9 61
U1 6
U2 66
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUN 7
PY 2005
VL 21
IS 12
BP 5529
EP 5536
DI 10.1021/la0470737
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 934OK
UT WOS:000229717900045
PM 15924485
DA 2018-10-20
ER

PT J
AU Jastrzebska, M
   Zalewska-Rejdak, J
   Wrzalik, R
   Kocot, A
   Barwinski, B
   Mroz, I
   Cwalina, B
AF Jastrzebska, M
   Zalewska-Rejdak, J
   Wrzalik, R
   Kocot, A
   Barwinski, B
   Mroz, I
   Cwalina, B
TI Dimethyl suberimidate cross-linked pericardium tissue: Raman
   spectroscopic and atomic force microscopy investigations
SO JOURNAL OF MOLECULAR STRUCTURE
LA English
DT Article; Proceedings Paper
CT 27th European Congress on Molecular Spectroscopy
CY SEP 05-10, 2004
CL AGH Univ Sci & Technol, Cracow, POLAND
SP AGH Univ Sci & Technol, Fac Mat Sci Ceram
HO AGH Univ Sci & Technol
DE cross-linking; collagen; Raman spectroscopy; atomic force microscopy
ID FT-RAMAN; ELECTRON-MICROSCOPY; RESONANCE RAMAN; TRIPLE HELICES; LASER
   RAMAN; COLLAGEN; PROTEINS; BINDING; SKIN; SCATTERING
AB Chemically stabilized pericardium tissue is widely used as a tissue-derived biomaterial for the preparation of bioprostheses such as heart valves or vascular grafts. The bifunctional imidoester dimethyl suberimidate (DMS) belongs to the wide class of the cross-linking reagents and is often used to cross-link a variety of proteins, including collagen matrices and collagen-based tissues. Raman spectroscopy in the wide frequency range 200-4000 cm(-1) and contact mode atomic force microscopy (AFM) have been employed to investigate the structural changes and chemical bonds in DMS cross-linked porcine pericardium tissue. It has been found, that in addition to the commonly accepted reaction with the F-amine groups of lysine or hydroxylysine residues, DMS may interact also with the carbonyl CO and amide NH groups of the peptide bond in collagen. Our paper presents for the first time spectral evidence for the peptide contribution to the formation of DMS-collagen cross-links. The results confirm also possible competition between the hydrolysis of the free imidoester group and cross-linking reaction. Products of the partial alkaline hydrolysis of DMS have been found in the spectra. The observed changes in the surface topography of the fibrils as well as in their spatial organization in the tissue support the formation of both intra- and interfibrillar cross-links in DMS-stabilized tissue. (c) 2005 Elsevier B.V. All rights reserved.
C1 Med Univ Silesia, Fac Pharm, Dept Biophys, PL-41200 Sosnowiec, Poland.
   Univ Silesia, Inst Phys, Dept Biophys & Mol Phys, PL-40007 Katowice, Poland.
   Univ Wroclaw, Inst Expt Phys, PL-50204 Wroclaw, Poland.
RP Jastrzebska, M (reprint author), Med Univ Silesia, Fac Pharm, Dept Biophys, Ostrogorska 30, PL-41200 Sosnowiec, Poland.
EM maja@slam.katowice.pl
CR Chalmers J.M., 2002, HDB VIBRATIONAL SPEC
   Charulatha V, 2003, BIOMATERIALS, V24, P759, DOI 10.1016/S0142-9612(02)00412-X
   Charulatha V, 1997, J BIOMED MATER RES, V36, P478
   Chen DM, 2002, SPECTROCHIM ACTA A, V58, P2291, DOI 10.1016/S1386-1425(01)00725-9
   DAVIES GE, 1970, P NATL ACAD SCI USA, V66, P651, DOI 10.1073/pnas.66.3.651
   Deng WG, 2001, FASEB J, V15, P2463, DOI 10.1096/fj.01-0259com
   Dick LA, 1999, BIOCHEMISTRY-US, V38, P6406, DOI 10.1021/bi981760d
   Du XZ, 2004, SPECTROCHIM ACTA A, V60, P401, DOI 10.1016/S1386-1425(03)00238-5
   Edwards HGM, 2002, VIB SPECTROSC, V28, P3, DOI 10.1016/S0924-2031(01)00141-2
   Edwards HGM, 1997, J MOL STRUCT, V435, P49, DOI 10.1016/S0022-2860(97)00122-1
   FRUSHOUR BG, 1975, BIOPOLYMERS, V14, P379, DOI 10.1002/bip.1975.360140211
   GATHERCOLE LJ, 1993, J CHEM SOC FARADAY T, V89, P2589, DOI 10.1039/ft9938902589
   Gniadecka M, 1998, J INVEST DERMATOL, V110, P393, DOI 10.1046/j.1523-1747.1998.00146.x
   Jahn A, 2002, SPECTROCHIM ACTA A, V58, P2271, DOI 10.1016/S1386-1425(01)00697-7
   Jastrzebska M, 2003, J RAMAN SPECTROSC, V34, P424, DOI 10.1002/jrs.1016
   Jastrzebska M, 2003, J BIOMAT SCI-POLYM E, V14, P185, DOI 10.1163/156856203321142605
   JENA BP, 2002, ATOMIC FORCE MICROSC, V68
   Kato K, 2001, EUR PHYS J E, V6, P7, DOI 10.1007/s101890170022
   Leikin S, 1997, P NATL ACAD SCI USA, V94, P11312, DOI 10.1073/pnas.94.21.11312
   Lemor R, 2000, J RAMAN SPECTROSC, V31, P171, DOI 10.1002/(SICI)1097-4555(200003)31:3<171::AID-JRS470>3.0.CO;2-O
   Lin-Vien D., 1991, HDB INFRARED RAMAN C
   Liquier J, 1999, J RAMAN SPECTROSC, V30, P657
   Nagatomo S, 2002, BIOPHYS CHEM, V98, P217, DOI 10.1016/S0301-4622(02)00103-5
   NAIMARK WA, 1992, AM J PHYSIOL-HEART C, V262, pH1095
   Paez JMG, 2001, BIOMATERIALS, V22, P2759
   PRESCOTT B, 1984, BIOPOLYMERS, V23, P235, DOI 10.1002/bip.360230206
   Rajkumar BJM, 2002, SPECTROCHIM ACTA A, V58, P1923, DOI 10.1016/S1386-1425(01)00641-2
   Raspanti M, 2001, MATRIX BIOL, V20, P601, DOI 10.1016/S0945-053X(01)00174-3
   Rintoul L, 2000, BIOPOLYMERS, V57, P19, DOI 10.1002/(SICI)1097-0282(2000)57:1<19::AID-BIP4>3.0.CO;2-Z
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   SEBAG J, 1994, INVEST OPHTH VIS SCI, V35, P2976
   Tait JK, 1995, SPECTROCHIM ACTA A, V51, P2101, DOI 10.1016/0584-8539(95)01456-5
   TWARDOWSKI J, 1994, RAMAN IR SPECTROSCOP
   Venturoni M, 2003, BIOCHEM BIOPH RES CO, V303, P508, DOI 10.1016/S0006-291X(03)00390-5
   Wang Y, 2002, J BIOMED MATER RES, V60, P300, DOI 10.1002/jbm.10108
   WILLIAMS AC, 1995, BBA-PROTEIN STRUCT M, V1246, P98, DOI 10.1016/0167-4838(94)00189-N
   Wu DY, 2004, SPECTROCHIM ACTA A, V60, P137, DOI 10.1016/S1386-1425(03)00190-2
   YUTHAVONG Y, 1975, BIOCHIM BIOPHYS ACTA, V382, P116, DOI 10.1016/0005-2736(75)90378-8
NR 38
TC 16
Z9 16
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-2860
EI 1872-8014
J9 J MOL STRUCT
JI J. Mol. Struct.
PD JUN 3
PY 2005
VL 744
SI SI
BP 789
EP 795
DI 10.1016/j.molstruc.2004.11.040
PG 7
WC Chemistry, Physical
SC Chemistry
GA 933UF
UT WOS:000229657700111
DA 2018-10-20
ER

PT J
AU Qiao, Q
   Wang, XC
   Sun, JM
   Zhao, R
   Liu, ZF
   Wang, Y
   Sun, BD
   Yan, YJ
   Qi, KM
AF Qiao, Q
   Wang, XC
   Sun, JM
   Zhao, R
   Liu, ZF
   Wang, Y
   Sun, BD
   Yan, YJ
   Qi, KM
TI Management for postoperative complications of breast augmentation by
   injected polyacrylamide hydrogel
SO AESTHETIC PLASTIC SURGERY
LA English
DT Article
DE biomaterial; breast augmentation; polyacrylamide hydrogel
ID IMPLANT
AB Polyacrylamide hydrogel, a new biomaterial, has been used for injected breast augmentation in China since 1997. A series of 30 patients with various complications after injected polyacrylamide hydrogel visited the author's department. Most of these patients had undergone injection of both breasts. The average age of the patients was 27.6 years, and the time of consultation for the complications was from 3 to 36 months postopertively. Nearly all the patients had breast lumps and other common complications including breast pain, disfigurement, and infection. Ultrasound examination showed diffuse, irregular, anechoic zones of mammary tissue. Pathologic results indicated inflammatory cell infiltration and fibrous capsular formation. An open suction technique and partial mastectomies via periareolar incisions were performed for the all patients. Most of their symptoms were relieved after removal of the polyacrylamide hydrogel. Only one patient had undergone immediate breast reconstruction with implants, whereas five patients had received breast implants secondarily via an axillary incision. The authors conclude that polyacrylamide hydrogel should be prohibited for injected breast augmentation before more scientific data are available about the long effect of the gel in breast tissue.
C1 Beijing Union Med Coll Hosp, Dept Plast & Cosmet Surg, Beijing 100730, Peoples R China.
RP Wang, XC (reprint author), Beijing Union Med Coll Hosp, Dept Plast & Cosmet Surg, Beijing 100730, Peoples R China.
EM wangxiancheng64@hotmail.com
CR AKIYAMA T, 1958, JAPAN J PLASTIC RECO, V1, P244
   Boo-Chai K, 1969, Br J Plast Surg, V22, P281, DOI 10.1016/S0007-1226(69)80120-7
   Chao MJ, 2000, J PRACT AESTH PLAST, V11, P16
   CHEN TH, 1995, BRIT J PLAST SURG, V48, P71, DOI 10.1016/0007-1226(95)90099-3
   Cheng NX, 2002, AESTHET PLAST SURG, V26, P375, DOI 10.1007/s00266-002-2052
   Christensen LH, 2003, PLAST RECONSTR SURG, V111, P1883, DOI 10.1097/01.PRS.0000056873.87165.5A
   CONWAY H, 1963, Plast Reconstr Surg, V32, P294, DOI 10.1097/00006534-196309000-00002
   DUNN KW, 1992, BRIT J PLAST SURG, V45, P315, DOI 10.1016/0007-1226(92)90060-B
   Filatov A V, 1998, Stomatologiia (Mosk), V77, P45
   GERSUNY R, 1911, UEBER SUBCUTANE PROT
   KING D J, 1989, Reviews on Environmental Health, V8, P3
   Kopf E., 1976, ROCKY MOUNTAIN M J, V75, P77
   Niechajev I, 2000, PLAST RECONSTR SURG, V105, P1173, DOI 10.1097/00006534-200003000-00055
   OHTAKE N, 1989, AESTHET PLAST SURG, V13, P67, DOI 10.1007/BF01571471
   ROBERT WC, 1977, BR J PLAST SURG, V60, P534
NR 15
TC 33
Z9 38
U1 2
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0364-216X
J9 AESTHET PLAST SURG
JI Aesthet. Plast. Surg.
PD JUN
PY 2005
VL 29
IS 3
BP 156
EP 161
DI 10.1007/s00266-004-0099-0
PG 6
WC Surgery
SC Surgery
GA 944WO
UT WOS:000230461800009
PM 15948018
DA 2018-10-20
ER

PT J
AU Goodman, PD
   Barlow, ET
   Crapo, PM
   Mohammad, SF
   Solen, KA
AF Goodman, PD
   Barlow, ET
   Crapo, PM
   Mohammad, SF
   Solen, KA
TI Computational model of device-induced thrombosis and thromboembolism
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE thrombosis; thrombogenecity; hemocompatibility
ID IIB-IIIA RECEPTOR; SHEAR-STRESS; HOLLOW-FIBER; CONCENTRATION PROFILES;
   PLATELET-AGGREGATION; ANTITHROMBIN-III; BLOOD-PLATELETS; FLOW-CYTOMETRY;
   ACTIVATION; ADHESION
AB A numerical model of thrombosis/thromboembolism (T/TE) is presented that predicts the progression of thrombus growth and thromboembolization in low-shear devices (hemodialyzers, oxygenators, etc.). Coupled convection-diffusion-reaction equations were solved to predict velocities, platelet agonist (ADP, thromboxane A2, and thrombin) concentrations, agonist-induced and shear-induced platelet activation, and platelet transport and adhesion to biomaterial surfaces and adherent platelets (hence, thrombus growth). Single-platelet and thrombus embolization were predicted from shear forces and surface adhesion strengths. Values for the platelet-biomaterial reaction constant and the platelet adhesion strength were measured in specific experiments, but all other parameter values were obtained from published sources. The model generated solutions for sequential time steps, while adjusting velocity patterns to accommodate growing surface thrombi.
   Heparinized human blood was perfused (0.75 ml/min) through 580 mu m-ID polyethylene flow cells with flow contractions (280 mu m-ID). Thrombus initiation, growth, and embolization were observed with videomicroscopy, while embolization was confirmed by light scattering, and platelet adhesion was determined by scanning electron microscopy.
   Numerical predictions and experimental observations were similar in indicating: 1) the same three thrombotic locations in the flow cell and the relative order of thrombus development in those locations, 2) equal thrombus growth rates on polyethylene and silicon rubber (in spite of differing overall T/TE), and 3) similar effects of flow rate (1.5 ml/min versus 0.75 ml/min) on platelet adhesion and thrombosis patterns.
C1 Brigham Young Univ, Dept Chem Engn, Provo, UT 84602 USA.
   Univ Utah, Dept Pathol, Salt Lake City, UT USA.
RP Solen, KA (reprint author), Brigham Young Univ, Dept Chem Engn, 350 CB,BYU Campus, Provo, UT 84602 USA.
EM ken_solen@byu.edu
CR AARTS PAMM, 1986, J BIOMECH, V19, P799, DOI 10.1016/0021-9290(86)90130-2
   ADAMS GA, 1983, AM J PHYSIOL, V244, pH109
   ADAMS GA, 1981, AM J PHYSIOL, V240, pH99
   Baldwin J T, 1990, ASAIO Trans, V36, pM274
   BASMADJIAN D, 1989, J BIOMED MATER RES, V23, P1315, DOI 10.1002/jbm.820231108
   BASMADJIAN D, 1990, ANN BIOMED ENG, V18, P685, DOI 10.1007/BF02368455
   BORN GVR, 1972, PLATELETS THROMBOSIS, P113
   DeSomer F, 1996, J CARDIOTHOR VASC AN, V10, P884, DOI 10.1016/S1053-0770(96)80050-4
   Eloot S, 2002, ARTIF ORGANS, V26, P590, DOI 10.1046/j.1525-1594.2002.07081.x
   FEUERSTEIN IA, 1991, J BIOMED MATER RES, V25, P185, DOI 10.1002/jbm.820250206
   FEUERSTEIN IA, 1975, T AM SOC ART INT ORG, V21, P427
   FOGELSON AL, 1992, SIAM J APPL MATH, V52, P1089, DOI 10.1137/0152064
   FOLIE BJ, 1989, BIOPHYS J, V56, P1121, DOI 10.1016/S0006-3495(89)82760-2
   FROJMOVIC M, 1991, BIOPHYS J, V59, P815, DOI 10.1016/S0006-3495(91)82294-9
   FROJMOVIC MM, 1994, BIOPHYS J, V67, P2060, DOI 10.1016/S0006-3495(94)80689-7
   FUNG YC, 1984, BIODYNAMICS CIRCULAT
   GIACOMINI A, 2001, LAB HEMATOL, V7, P180
   GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415
   Goodman PD, 2000, ASAIO J, V46, P576, DOI 10.1097/00002480-200009000-00013
   GRABOWSKI EF, 1978, MICROVASC RES, V16, P183, DOI 10.1016/0026-2862(78)90054-7
   GRABOWSKI EF, 1972, IND ENG CHEM FUND, V11, P224, DOI 10.1021/i160042a013
   GRIFFITH MJ, 1982, J BIOL CHEM, V257, P7360
   GRIFFITH MJ, 1982, J BIOL CHEM, V257, P3899
   Gu YJ, 2000, ARTIF ORGANS, V24, P43, DOI 10.1046/j.1525-1594.2000.06351.x
   HELLUMS JD, 1994, ANN BIOMED ENG, V22, P445, DOI 10.1007/BF02367081
   HUBBELL JA, 1986, BIOPHYS J, V50, P937, DOI 10.1016/S0006-3495(86)83535-4
   JEN CJ, 1996, HEART CIRC PHYSL, V39, pH160
   JONES RL, 1979, CHEM BIOCH PHARM ACT, P210
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, P137
   Kennedy SD, 1997, AM J CLIN PATHOL, V107, P99
   Langford EJ, 1996, ARTERIOSCL THROM VAS, V16, P51, DOI 10.1161/01.ATV.16.1.51
   Lemire PP, 2002, ARTIF ORGANS, V26, P971, DOI 10.1046/j.1525-1594.2002.07114.x
   Mandrusov E, 1998, AICHE J, V44, P233, DOI 10.1002/aic.690440202
   MCPHERSON LB, 1972, BLOOD, V44, P411
   MERRILL EW, 1967, J APPL PHYSIOL, V23, P178
   REYNOLDS LO, 1993, J BIOMAT SCI-POLYM E, V4, P451
   Ronco C, 2002, J AM SOC NEPHROL, V13, pS53
   ROSING J, 1985, BLOOD, V65, P319
   Solen K, 2003, J BIOMED OPT, V8, P70, DOI 10.1117/1.1527934
   Sorensen EN, 1999, ANN BIOMED ENG, V27, P436, DOI 10.1114/1.200
   Sorensen EN, 1999, ANN BIOMED ENG, V27, P449, DOI 10.1114/1.201
   STRONG AB, 1987, J BIOMED MATER RES, V21, P1039, DOI 10.1002/jbm.820210810
   STUBLEY GD, 1987, PHYSICOCHEM HYDRODYN, V8, P221
   TREICHLER J, 1993, ARTIF ORGANS, V17, P797
   TSCHOPP TB, 1976, THROMB HAEMOSTASIS, V35, P334
   TURRITO VT, 1975, T AM SOC ART INT ORG, V21, P593
   WEISS HJ, 1982, PLATELETS PATHOPHYSI
   Wootton DM, 2001, ANN BIOMED ENG, V29, P321, DOI 10.1114/1.1359449
   Wu YP, 1997, ARTERIOSCL THROM VAS, V17, P3202, DOI 10.1161/01.ATV.17.11.3202
NR 49
TC 47
Z9 49
U1 1
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUN
PY 2005
VL 33
IS 6
BP 780
EP 797
DI 10.1007/s10439-005-2951-z
PG 18
WC Engineering, Biomedical
SC Engineering
GA 939LU
UT WOS:000230075100007
PM 16078618
DA 2018-10-20
ER

PT J
AU Garrigues, GE
   Cho, DR
   Rubash, HE
   Goldring, SR
   Herndon, JH
   Shanbhag, AS
AF Garrigues, GE
   Cho, DR
   Rubash, HE
   Goldring, SR
   Herndon, JH
   Shanbhag, AS
TI Gene expression clustering using self-organizing maps: analysis of the
   macrophage response to particulate biomaterials
SO BIOMATERIALS
LA English
DT Article
DE osteolysis; aseptic loosening; gene expression; self-organizing maps;
   macrophage; total joint replacement; microarrays; Ti-alloy; UHMWPE; wear
   debris
ID NECROSIS-FACTOR-ALPHA; TOTAL HIP-ARTHROPLASTY; WEAR DEBRIS; IN-VITRO;
   BONE-RESORPTION; TGF-BETA; OSTEOLYSIS; PARTICLES; MEMBRANE; REPLACEMENTS
AB The most common cause of total joint replacement failure is peri-implant bone loss causing pain and prosthesis loosening. This process, known as osteolysis or aseptic loosening, is characterized by macrophage phagocytosis of particulate implant wear debris. In an incompletely defined step, particulate biomaterial debris induces macrophages to release a variety of inflammatory mediators and signaling proteins that lead to bone loss. In an in vitro model of this process, we used microarray technology and data analysis techniques, including the use of self-organizing maps (SOMs), to understand the mRNA gene expression changes occurring in macrophages exposed to clinically relevant particles of ultra-high molecular weight polyethylene and TiAlV alloy. Earlier studies have been limited by technology that only allowed analysis of a few genes at a time, but the microarray techniques used in this paper generate the quantitative analysis of over a thousand genes simultaneously.
   Our microarray analysis utilized an SOM clustering to elucidate general patterns in the data, lists of top up- and down-regulated genes for each time point and genes with differential expression under different biomaterial exposures. The expression levels of the majority of genes (>95%) did not vary over time or with exposure to different biomaterials, but a few important genes, such as TNF-alpha, IL-1beta, IL-6, and MIP1alpha, proved to be highly regulated in response to biomaterial exposure. We also uncovered a novel set of genes, which not only validates and logically extends the current model of the pathogenesis of osteolysis and aseptic loosening, but also provides new targets for further research and therapeutics. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Harvard Univ, Sch Med, Biomat Lab, Massachusetts Gen Hosp, Boston, MA 02114 USA.
   Beth Israel Deaconess Med Ctr, Bone & Joint Inst, Boston, MA 02215 USA.
RP Shanbhag, AS (reprint author), Harvard Univ, Sch Med, Biomat Lab, Massachusetts Gen Hosp, GRJ 1115,55 Fruit St, Boston, MA 02114 USA.
EM shanbhag@helix.mgh.harvard.edu
FU NIAMS NIH HHS [AR47465 A03]
CR Absolom D R, 1986, Methods Enzymol, V132, P95
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Bassett DE, 1999, NAT GENET, V21, P51, DOI 10.1038/4478
   CAMPBELL P, 1994, J BIOMED MATER RES, V28, P523, DOI 10.1002/jbm.820280415
   CHIBA J, 1994, CLIN ORTHOP RELAT R, V300, P304
   FRIEDMAN RJ, 1993, J BONE JOINT SURG AM, V75A, P1086, DOI 10.2106/00004623-199307000-00017
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GOLDRING SR, 1993, J BONE JOINT SURG AM, V75A, P799, DOI 10.2106/00004623-199306000-00001
   GOODMAN SB, 1989, CLIN ORTHOP RELAT R, V244, P182
   GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685
   Haden ST, 2000, CALCIFIED TISSUE INT, V66, P414, DOI 10.1007/s002230010084
   Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200
   HARRIS WH, 1995, CLIN ORTHOP RELAT R, P46
   HAYNES DR, 1993, J BONE JOINT SURG AM, V75A, P825, DOI 10.2106/00004623-199306000-00004
   Held TK, 1999, INFECT IMMUN, V67, P206
   Herberts P, 2000, ACTA ORTHOP SCAND, V71, P111, DOI 10.1080/000164700317413067
   HOROWITZ SM, 1993, J BONE JOINT SURG AM, V75A, P802, DOI 10.2106/00004623-199306000-00002
   Jacobs JJ, 1994, J AM ACAD ORTHOP SUR, V2, P212
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   Jones DH, 2002, ANN RHEUM DIS, V61, P32
   KLAMPFER L, 1994, MOL CELL BIOL, V14, P6561, DOI 10.1128/MCB.14.10.6561
   Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549
   LEE JM, 1992, J BONE JOINT SURG BR, V74, P380
   Letterio JJ, 1997, CLIN IMMUNOL IMMUNOP, V84, P244, DOI 10.1006/clin.1997.4409
   Makhluf HA, 2000, BIOCHEM BIOPH RES CO, V268, P669, DOI 10.1006/bbrc.2000.2182
   Maloney WJ, 1996, AAOS INSTR COURS LEC, V45, P171
   MALONEY WJ, 1993, J BONE JOINT SURG AM, V75A, P835, DOI 10.2106/00004623-199306000-00005
   Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051
   Mattei MG, 1996, GENOMICS, V32, P168, DOI 10.1006/geno.1996.0098
   Morrissette Naomi, 1999, Trends in Cell Biology, V9, P199, DOI 10.1016/S0962-8924(99)01540-8
   Papadopoulos NG, 1997, CLIN RHEUMATOL, V16, P162, DOI 10.1007/BF02247845
   Peng CY, 1998, CELL GROWTH DIFFER, V9, P197
   ROODMAN GD, 1992, J CLIN INVEST, V89, P46, DOI 10.1172/JCI115584
   Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4
   SARMA V, 1992, J IMMUNOL, V148, P3302
   Schwarz EM, 2000, J ORTHOPAED RES, V18, P849, DOI 10.1002/jor.1100180602
   Sethi RK, 2003, BIOMATERIALS, V24, P2561, DOI 10.1016/S0142-9612(03)00056-5
   SHANBHAG AS, 1995, J ARTHROPLASTY, V10, P498, DOI 10.1016/S0883-5403(05)80152-4
   Shanbhag AS, 1996, J ORTHOPAED RES, V14, P1000, DOI 10.1002/jor.1100140622
   SHANBHAG AS, 1994, J BONE JOINT SURG BR, V76B, P60
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Shanbhag AS, 2000, J BIOMED MATER RES, V53, P100, DOI 10.1002/(SICI)1097-4636(2000)53:1<100::AID-JBM14>3.0.CO;2-4
   Shanbhag AS, 1998, J BIOMED MATER RES, V41, P497, DOI 10.1002/(SICI)1097-4636(19980905)41:3<497::AID-JBM21>3.3.CO;2-G
   Shanbhag AS, 1997, CLIN ORTHOP RELAT R, P205
   Sinha RK, 1998, AAOS INSTR COURS LEC, V47, P307
   SOLBACH W, 1991, IMMUNOL TODAY, V12, P4, DOI 10.1016/0167-5699(91)90103-Z
   Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771
   Takai Y, 2001, PHYSIOL REV, V81, P153
   Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907
   Vermes C, 2001, J ARTHROPLASTY, V16, P95, DOI 10.1054/arth.2001.28719
   Vincenz C, 1997, J BIOL CHEM, V272, P6578, DOI 10.1074/jbc.272.10.6578
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359
   WRIGHT TM, 1996, IMPLANT WEAR FUTURE
   Yang IH, 1999, J BIOMED MATER RES, V48, P220, DOI 10.1002/(SICI)1097-4636(1999)48:3<220::AID-JBM4>3.0.CO;2-P
   Yasuda H, 1999, BONE, V25, P109, DOI 10.1016/S8756-3282(99)00121-0
   Youssef P, 1999, J RHEUMATOL, V26, P2523
NR 59
TC 39
Z9 39
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 16
BP 2933
EP 2945
DI 10.1016/j.biomaterials.2004.06.034
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892UM
UT WOS:000226675500015
PM 15603788
DA 2018-10-20
ER

PT J
AU Thian, ES
   Huang, J
   Best, SM
   Barber, ZH
   Bonfield, W
AF Thian, ES
   Huang, J
   Best, SM
   Barber, ZH
   Bonfield, W
TI Magnetron co-sputtered silicon-containing hydroxyapatite thin films - an
   in vitro study
SO BIOMATERIALS
LA English
DT Article
DE maimetron co-sputtering; silicon-substituted hydroxyapatite (Si-HA);
   thin films/coatings; human osteoblast-like (HOB) cells; heat treatment
ID OSTEOBLAST-LIKE CELLS; CA-P COATINGS; VIVO DISSOLUTION BEHAVIOR;
   CALCIUM-PHOSPHATE; TITANIUM IMPLANTS; CERAMIC COATINGS; BONE;
   DIFFERENTIATION; PROLIFERATION; BIOMATERIALS
AB The use of silicon-substituted hydroxyapatite (Si-HA) as a biomaterial has been reported recently. In vivo testing has shown that Si-HA promotes early bonding of the bone/implant interface. In order to extend its usage to major load-bearing applications such as artificial hip replacement implants, it has been proposed that the material could be used in the form of a coating on implant surfaces. This paper reports a preliminary study of the biocompatibility of magnetron co-sputtered silicon-containing hydroxyapatite (Si-HA) coatings on a metallic substrate. Magnetron co-sputtered Si-HA films of thickness 600 nm with a Si content of approximately 0.8 wt% were produced on titanium substrates. X-ray diffraction analysis showed that the as-deposited Si-HA films were either amorphous or made up of very small crystals. The crystallinity of Si-HA films was increased after post-deposition heat treatment at 700 degreesC for 3 h, and the principal peaks were attributable to HA. The formation of nano-scale silicon-calcium phosphate precipitates was noted on the heat-treated films. In vitro cell culture has demonstrated that human osteoblast-like cells attached and grew well on all films, with the highest cell growth and signs of mineralisation observed on the heat-treated Si-HA films. In addition, many focal contacts were produced on the films and the cells had well-defined actin cytoskeletal organisation. This work shows that as-deposited and heat-treated Si-HA films have excellent bioactivity and are good candidates when rapid bone apposition is required. Furthermore, heat-treated Si-HA films have improved biostability compared to as-deposited films under physiological conditions. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Cambridge, Dept Mat Sci & Met, Cambridge Ctr Med Mat, Cambridge CB2 3QZ, England.
   Univ Cambridge, Dept Mat Sci & Met, Dev Mat Grp, Cambridge CB2 3QZ, England.
RP Thian, ES (reprint author), Univ Cambridge, Dept Mat Sci & Met, Cambridge Ctr Med Mat, Pembroke St, Cambridge CB2 3QZ, England.
EM est23@cam.ac.uk
OI Thian, Eng San/0000-0001-6925-6811
CR Aparicio C, 2002, J MATER SCI-MATER M, V13, P1105, DOI 10.1023/A:1021173500990
   Barrere F, 2003, J MATER SCI-MATER M, V14, P419, DOI 10.1023/A:1023210817683
   CARLISLE EM, 1972, SCIENCE, V178, P619, DOI 10.1126/science.178.4061.619
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   DALTON JE, 1995, J BIOMED MATER RES, V29, P239, DOI 10.1002/jbm.820290215
   DEBRUIJN JD, 1994, BIOMATERIALS, V15, P543, DOI 10.1016/0142-9612(94)90021-3
   Dubois JC, 1999, BIOMATERIALS, V20, P1841, DOI 10.1016/S0142-9612(99)00082-4
   DUCHEYNE P, 1993, J BIOMED MATER RES, V27, P25, DOI 10.1002/jbm.820270105
   FURLONG RJ, 1991, J BONE JOINT SURG BR, V73, P741
   GIBSON IR, 1999, 12 INT S CER MED NAR, P191
   Huang J, 1997, J MATER SCI-MATER M, V8, P775, DOI 10.1023/A:1018516813604
   HULSHOFF JEG, 1995, J BIOMED MATER RES, V29, P967, DOI 10.1002/jbm.820290808
   Ito A, 2002, MAT SCI ENG C-BIO S, V22, P21, DOI 10.1016/S0928-4931(02)00108-X
   Jansen J A, 1993, Clin Oral Implants Res, V4, P28, DOI 10.1034/j.1600-0501.1993.040104.x
   KANGASNIEMI IMO, 1994, J BIOMED MATER RES, V28, P563, DOI 10.1002/jbm.820280506
   KEETING PE, 1992, J BONE MINER RES, V7, P1281, DOI 10.1002/jbmr.5650071107
   Kitsugi T, 1996, J BIOMED MATER RES, V32, P149
   KLEIN CPAT, 1994, J BIOMED MATER RES, V28, P961, DOI 10.1002/jbm.820280815
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   LeGeros R. Z., 1993, INTRO BIOCERAMICS, P139
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   MORONI A, 1994, J MATER SCI-MATER M, V5, P411, DOI 10.1007/BF00058975
   Moroni A, 1998, J BONE JOINT SURG AM, V80A, P547, DOI 10.2106/00004623-199804000-00011
   Ong JL, 2002, J BIOMED MATER RES, V59, P184, DOI 10.1002/jbm.1232
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   Patel N, 2002, KEY ENG MATER, V218-2, P383, DOI 10.4028/www.scientific.net/KEM.218-220.383
   Porter AE, 2004, J MATER SCI, V39, P1895, DOI 10.1023/B:JMSC.0000016213.77001.71
   Porter AE, 2003, BIOMATERIALS, V24, P4609, DOI 10.1016/S0142-9612(03)00355-7
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   SCHWARZ K, 1972, NATURE, V239, P333, DOI 10.1038/239333a0
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Thian ES, 2004, KEY ENG MAT, V254-2, P111, DOI 10.4028/www.scientific.net/KEM.254-256.111
   Webster TJ, 2002, J BIOMED MATER RES, V59, P312, DOI 10.1002/jbm.1247
   Wolke JGC, 2003, BIOMATERIALS, V24, P2623, DOI 10.1016/S0142-9612(03)00067-X
   Wolke JGC, 1998, J BIOMED MATER RES, V39, P524
   Wolke JGC, 1998, J BIOMED MATER RES, V43, P270, DOI 10.1002/(SICI)1097-4636(199823)43:3<270::AID-JBM7>3.0.CO;2-K
   WOLKE JGC, 1994, J BIOMED MATER RES, V28, P1477, DOI 10.1002/jbm.820281213
NR 38
TC 100
Z9 104
U1 1
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 16
BP 2947
EP 2956
DI 10.1016/j.biomaterials.2004.07.058
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892UM
UT WOS:000226675500016
PM 15603789
DA 2018-10-20
ER

PT J
AU Bennewitz, NL
   Babensee, JE
AF Bennewitz, NL
   Babensee, JE
TI The effect of the physical form of poly(lactic-co-glycolic acid)
   carriers on the humoral immune response to co-delivered antigen
SO BIOMATERIALS
LA English
DT Article
DE poly (lactic-co-glycolic acid) microparticles and scaffolds; adjuvant;
   immune response; controlled release; tissue engineering
ID TOLL-LIKE RECEPTOR-4; DENDRITIC CELLS; POLY(L-LACTIC ACID); HOST
   RESPONSE; MODEL; MICROSPHERES; DEGRADATION; SCAFFOLDS; RELEASE; SIGNALS
AB A model shed antigen, ovalbumin (OVA), was incorporated into polymeric biomaterial carriers made of poly(lactic-co-glycolic acid) (PLGA) in the form of microparticles (MP) or scaffolds (SC). These polymeric biomaterial carrier vehicles with incorporated antigen were then injected or implanted into mice and the resulting time-dependent systemic humoral immune response towards the controlled released OVA was assessed by following the OVA-specific IgG concentration and isotypes using ELISA. To assess the differential level of enhancement of the immune response depending on the form of carrier vehicle (MP vs. SC), the total amount of polymer and OVA delivered was kept constant as well as the release rate of OVA for both carrier vehicles. The level of the humoral immune response was higher and sustained for OVA released from PLGA SC which were implanted with associated tissue damage, and lower and transient when the same amount of polymer and OVA were delivered from PLGA MP, which were minimally invasively delivered by injection. This immune response was primarily Th2 helper T cell-dependent, although for the strong adjuvant, CFA, and PLGA SC carriers there was both a Th2 and Th1 response contribution. These results implicate 'danger signals' associated with the implantation of the scaffolds due to tissue injury which primed the system for an enhanced immune response. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Georgia Tech, Emory Ctr Engn Living Tissues, Atlanta, GA 30332 USA.
   Emory Univ, Atlanta, GA 30332 USA.
RP Babensee, JE (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Georgia Tech, Emory Ctr Engn Living Tissues, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM julia.babensee@bme.gatech.edu
CR ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Babensee JE, 2000, TISSUE ENG, V6, P165, DOI 10.1089/107632700320784
   Beg AA, 2002, TRENDS IMMUNOL, V23, P509, DOI 10.1016/S1471-4906(02)02317-7
   Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030
   Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200
   Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6
   GHOSH S, 1998, ANNU REV IMMUNOL, V16, P224
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Loudovaris T, 1996, TRANSPLANTATION, V61, P1678, DOI 10.1097/00007890-199606270-00003
   Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F
   Matzelle MM, 2004, BIOMATERIALS, V25, P295, DOI 10.1016/S0142-9612(03)00531-3
   MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015
   May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3
   Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131
   Meese TM, 2002, J BIOMAT SCI-POLYM E, V13, P141, DOI 10.1163/156856202317414339
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Murillo M, 2002, J CONTROL RELEASE, V85, P237, DOI 10.1016/S0168-3659(02)00276-6
   Newman KD, 1998, J CONTROL RELEASE, V54, P49, DOI 10.1016/S0168-3659(97)00142-9
   Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200
   RUHE PQ, 2002, J BONE J SURG, V85, P75
   SAYEGH MH, 1994, TRANSPLANTATION, V57, P1295, DOI 10.1097/00007890-199405150-00001
   Scholl I, 2004, CLIN EXP ALLERGY, V34, P315, DOI 10.1111/j.1365-2222.2004.01884.x
   Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887
   VONRECUM HA, 1995, BIOMATERIALS, V16, P441, DOI 10.1016/0142-9612(95)98816-W
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
NR 26
TC 60
Z9 60
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 16
BP 2991
EP 2999
DI 10.1016/j.biomaterials.2004.08.023
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892UM
UT WOS:000226675500021
PM 15603794
DA 2018-10-20
ER

PT J
AU Park, GE
   Pattison, MA
   Park, K
   Webster, TJ
AF Park, GE
   Pattison, MA
   Park, K
   Webster, TJ
TI Accelerated chondrocyte functions on NaOH-treated PLGA scaffolds
SO BIOMATERIALS
LA English
DT Article
DE PLGA; articular cartilage; chondrocyte; NaOH treatment; scaffold
ID MUSCLE-CELL FUNCTION; SURFACE-FEATURES; ACID) FOAMS; IN-VITRO;
   CARTILAGE; POLYMER; COMPOSITES; ADHESION
AB Compared to conventional poly(lactic-co-glycolic acid) (PLGA), previous studies have shown that NaOH-treated PLGA two-dimensional substrates enhanced functions of osteoblasts (bone-forming cells), vascular and bladder smooth muscle cells, and chondrocytes (cartilage-synthesizing cells). In this same spirit, the purpose of this in vitro study was to fabricate three-dimensional NaOH-treated PLGA scaffolds and determine their efficacy toward articular cartilage applications. To improve functions of chondrocytes including their adhesion, growth, differentiation, and extracellular matrix synthesis, PLGA scaffolds were modified via chemical etching techniques using 1 N NaOH for 10min. Results demonstrated that NaOH-treated PLGA three-dimensional scaffolds enhanced chondrocyte functions compared to non-treated scaffolds. Specifically, chondrocyte numbers, total intracellular protein content, and the amount of extracellular matrix components (such as glycosaminoglycans and collagens) were significantly greater on NaOH-treated than on non-treated PLGA scaffolds. Underlying material properties that may have enhanced chondrocyte functions include a more hydrophilic surface (due to hydrolytic degradation of PLGA by NaOH), increased surface area, altered porosity (both percent and diameter of individual pores), and a greater degree of nanometer roughness. For these reasons, this study adds a novel tissue-engineering scaffold to the cartilage biomaterial community: NaOH-treated PLGA. Clearly, such modifications to PLGA may ultimately enhance the efficacy of tissue-engineering scaffolds for articular cartilage repair. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Pharmaceut, W Lafayette, IN 47907 USA.
RP Webster, TJ (reprint author), Purdue Univ, Dept Biomed Engn, 1296 Potter Bldg, W Lafayette, IN 47907 USA.
EM twebster@ecn.purdue.edu
CR BOSTMAN O, 1990, J BONE JOINT SURG BR, V72, P592
   Gao JM, 1998, J BIOMED MATER RES, V42, P417, DOI 10.1002/(SICI)1097-4636(19981205)42:3<417::AID-JBM11>3.3.CO;2-N
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   MA PX, 1995, J BIOMED MATER RES, V29, P1587, DOI 10.1002/jbm.820291215
   MA PX, 1998, TISSUE ENG METHODS P, P47
   MATLAGA BF, 1983, J BIOMED MATER RES, V17, P185, DOI 10.1002/jbm.820170115
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Parsons JR, 1998, HDB BIOMATERIAL PROP, P40
   ROSEN JJ, 1980, POLYM SCI TECHNOL B, V12, P667
   Savaiano JK, 2004, BIOMATERIALS, V25, P1205, DOI 10.1016/j.biomaterials.2003.08.012
   Sims CD, 1996, PLAST RECONSTR SURG, V98, P843, DOI 10.1097/00006534-199610000-00015
   Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Thapa A, 2003, J BIOMED MATER RES A, V67A, P1374, DOI 10.1002/jbm.a.20037
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   WALSH BJ, 1992, ANAL BIOCHEM, V203, P187, DOI 10.1016/0003-2697(92)90301-M
   WROBLE RR, 2000, PHYSICIAN SPORTSMED, V28, P11
NR 22
TC 158
Z9 170
U1 2
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 16
BP 3075
EP 3082
DI 10.1016/j.biomaterials.2004.08.005
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892UM
UT WOS:000226675500029
PM 15603802
DA 2018-10-20
ER

PT J
AU Vacatello, M
   D'Auria, G
   Falcigno, L
   Dettin, M
   Gambaretto, R
   Di Bello, C
   Paolillo, L
AF Vacatello, M
   D'Auria, G
   Falcigno, L
   Dettin, M
   Gambaretto, R
   Di Bello, C
   Paolillo, L
TI Conformational analysis of heparin binding peptides
SO BIOMATERIALS
LA English
DT Article
ID MOLECULAR-DYNAMICS; FORCE-FIELD; NMR; SPECTROSCOPY; ADHESION; PROGRAM;
   BIOMATERIALS; MINIMIZATION; FIBRONECTIN; CELLS
AB A properly engineered biomaterial for dental/orthopaedic applications must induce specific responses from the osteoblasts at the implant site. A most desirable response is an efficient adhesion, as it represents the first phase in the cell/material interaction and the quality of this phase will influence the cell's capacity to organize into a new functional tissue. The four osteoblast-adhesive peptides discussed in this paper are mapped on the 339-364 sequence ((339)MAPRPSLAKKQRFRHRNRKGYRSQRG(364)) located in the primary heparin-binding site of human vitronectin (HVP). Adsorbed on a polystyrene scaffold, these peptides display different adhesive activities towards osteoblasts. In this paper we report on the structural analysis in solution of the peptides through NMR and computational techniques. We find that the peptides with the highest adhesive activities display a hydrophobic patch opposite to the charged surface candidate to interact with heparin. These findings suggest that the peptides might adsorb on the polystyrene support in a favourable orientation for their activity. Furthermore, molecular models obtained for the four peptides in solution were used in rigid docking simulations with a heparin model. Assuming that the peptide solution conformations are not very different from the polystyrene-adsorbed structures, the simulations reveal that peptide adhesive activity is also affected by the number of ionic interactions and spacing between charged residues. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Naples Federico II, Dept Chem, I-80126 Naples, Italy.
   CNR, Inst Biostruct & Bioimaging, I-80134 Naples, Italy.
   Univ Padua, Dept Chem Proc Engn, I-35131 Padua, Italy.
RP Vacatello, M (reprint author), Univ Naples Federico II, Dept Chem, Complesso Univ Monte S Angelo,Via Cintia, I-80126 Naples, Italy.
EM manuela@chemistry.unina.it
RI Falcigno, Lucia/A-6720-2012; D'Auria, Gabriella/E-2076-2011
OI D'Auria, Gabriella/0000-0002-1340-8545
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6
   BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4
   Brooks III C. L., 1988, ADV CHEM PHYS, VLXXI, P33
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21
   CASE DA, 1996, AMBER 6
   Chon JH, 2001, AM J PHYSIOL-CELL PH, V280, pC1394
   DALTON BA, 1995, J CELL SCI, V108, P2083
   Dettin M, 2002, J BIOMED MATER RES, V60, P466, DOI 10.1002/jbm.10066
   DETTIN M, UNPUB BIOMATERIALS
   FLETCHER R, 1964, COMPUT J, V7, P149, DOI 10.1093/comjnl/7.2.149
   Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284
   GUNTERT P, 1991, Journal of Biomolecular NMR, V1, P447, DOI 10.1007/BF02192866
   GUNTERT P, 1997, DYANA J MOL BIOL, V273, P283
   JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   KUMAR A, 1981, J AM CHEM SOC, V103, P3654, DOI 10.1021/ja00403a008
   LIFSON S, 1979, J AM CHEM SOC, V101, P5111, DOI 10.1021/ja00512a001
   LIN HB, 1994, J BIOMED MATER RES, V28, P329, DOI 10.1002/jbm.820280307
   MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849
   PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D
   PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062
   PULEO DA, 1991, BONE, V12, P271, DOI 10.1016/8756-3282(91)90075-T
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   VANGUNSTEREN WF, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI 10.1002/anie.199009921
   VANGUNSTEREN WF, 1980, J COMPUT CHEM, V1, P266, DOI 10.1002/jcc.540010308
   WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216
   WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q
   WUETHRICH K, 1983, J MOL BIOL, V169, P949
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
NR 31
TC 10
Z9 10
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 16
BP 3207
EP 3214
DI 10.1016/j.biomaterials.2004.09.009
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892UM
UT WOS:000226675500042
PM 15603815
DA 2018-10-20
ER

PT J
AU Zhang, J
   Senger, B
   Vautier, D
   Picart, C
   Schaaf, P
   Voegel, JC
   Lavalle, P
AF Zhang, J
   Senger, B
   Vautier, D
   Picart, C
   Schaaf, P
   Voegel, JC
   Lavalle, P
TI Natural polyelectrolyte films based on layer-by layer deposition of
   collagen and hyaluronic acid
SO BIOMATERIALS
LA English
DT Article
DE surface treatment; extracellular matrix (ECM); collagen; multilayered
   films; layer-by-layer assembly; biomimetic material
ID ATOMIC-FORCE MICROSCOPY; MULTILAYER FILMS; EXPONENTIAL-GROWTH; BIOACTIVE
   COATINGS; CELLULAR ADHESION; POLYMER-FILMS; CROSS-LINKING; IN-VITRO;
   ADSORPTION; SURFACES
AB The aim of the present work was to assemble extracellular matrix components into polyelectrolyte multilayers using the layer-by-layer deposition method. The films are constructed with type-I collagen and hyaluronic acid. The construction exhibits the general features observed during polyelectrolyte multilayer buildup: alternate positive and negative values of the zeta potential of the film during its construction and regular increase of the film thickness with the number, n, of deposition step. This increase is shown to be linear with n. As expected for a linearly growing film, the confocal microscopy shows that when the film is brought in contact with a collagen solution, collagen does not diffuse into the film but interacts only with its outer layer. However, the films are not constituted of homogeneously distributed polyanion/polycation complexes as it is usually observed, but they are formed of fibers as imaged by AFM. The typical width of these fibers increases with the number of deposition steps. Finally, it is found that chondrosarcoma cells spread well and synthesize extracellular matrix components only on the collagen ending films, whereas no cellular matrix was found for HA ending ones. Such architectures may be further functionalized by inclusion of active drugs, peptides, proteins..., and could be used as tunable biomaterial interfaces. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Strasbourg 1, Fac Chirurg Dentaire, Unit 595, INSERM, F-67085 Strasbourg, France.
   Ecole Europeenne Chim Polymers & Mat Strasbourg, F-67085 Strasbourg 2, France.
   Univ Strasbourg 1, CNRS, Inst Charles Sadron, F-67083 Strasbourg, France.
RP Lavalle, P (reprint author), Univ Strasbourg 1, Fac Chirurg Dentaire, Unit 595, INSERM, 11 Rue Humann, F-67085 Strasbourg, France.
EM philippe.lavalle@odonto-ulp.u-strasbg.fr
RI Lavalle, Philippe/E-6328-2016; SCHAAF, Pierre/J-2751-2016
OI Lavalle, Philippe/0000-0001-8798-912X; SCHAAF,
   Pierre/0000-0001-7423-5492; PICART, Catherine/0000-0002-4854-6366;
   PICART, Catherine/0000-0003-0130-1000
CR Balasubramani M, 2001, BURNS, V27, P534, DOI 10.1016/S0305-4179(01)00018-3
   Barbani N, 1999, J APPL POLYM SCI, V72, P971, DOI 10.1002/(SICI)1097-4628(19990516)72:7<971::AID-APP13>3.0.CO;2-N
   Bertrand P, 2000, MACROMOL RAPID COMM, V21, P319, DOI 10.1002/(SICI)1521-3927(20000401)21:7<319::AID-MARC319>3.0.CO;2-7
   Boura C, 2003, BIOMATERIALS, V24, P3521, DOI 10.1016/S0142-9612(03)00214-X
   Burke SE, 2003, BIOMACROMOLECULES, V4, P1773, DOI 10.1021/bm034184w
   Caruso F, 1997, LANGMUIR, V13, P3427, DOI 10.1021/la9608223
   Caruso F, 1999, J AM CHEM SOC, V121, P6039, DOI 10.1021/ja990441m
   Caruso F, 1998, J PHYS CHEM B, V102, P2011, DOI 10.1021/jp980198y
   Charulatha V, 2003, BIOMATERIALS, V24, P759, DOI 10.1016/S0142-9612(02)00412-X
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   DECHER G, 1994, BIOSENS BIOELECTRON, V9, P677, DOI 10.1016/0956-5663(94)80065-0
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Gingras M, 2003, BIOMATERIALS, V24, P1653, DOI 10.1016/S0142-9612(02)00572-0
   Grant GGS, 2001, BIOMED MICRODEVICES, V3, P301, DOI 10.1023/A:1012456714628
   Hoogeveen NG, 1996, LANGMUIR, V12, P3675, DOI 10.1021/la951574y
   Ishida O, 1997, J BONE MINER RES, V12, P1657, DOI 10.1359/jbmr.1997.12.10.1657
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   JESSEL N, 2004, IN PRESS ADV MAT
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Khademhosseini A, 2004, BIOMATERIALS, V25, P3583, DOI 10.1016/j.biomaterials.2003.10.033
   Ladam G, 2000, LANGMUIR, V16, P1249, DOI 10.1021/la990650k
   Lapcik L, 1998, CHEM REV, V98, P2663, DOI 10.1021/cr941199z
   Laurent TC, 1998, CHEM BIOL MED APPL H
   Lavalle P, 2002, MACROMOLECULES, V35, P4458, DOI 10.1021/ma0119833
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Liu LS, 1999, BIOMATERIALS, V20, P1097, DOI 10.1016/S0142-9612(99)00006-X
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026
   LVOV Y, 1994, PHYSICA B, V198, P89, DOI 10.1016/0921-4526(94)90134-1
   Lvov Y, 1997, LANGMUIR, V13, P6195, DOI 10.1021/la970517x
   McAloney RA, 2001, LANGMUIR, V17, P6655, DOI 10.1021/la010136q
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Morra M, 2003, BIOMATERIALS, V24, P4639, DOI 10.1016/S0142-9612(03)00360-0
   Park SN, 2003, BIOMATERIALS, V24, P1631, DOI 10.1016/S0142-9612(02)00550-1
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Salloum DS, 2004, BIOMACROMOLECULES, V5, P1089, DOI 10.1021/bm034522t
   Schoeler B, 2003, MACROMOLECULES, V36, P5258, DOI 10.1021/ma034018g
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9
   Sinani VA, 2003, NANO LETT, V3, P1177, DOI 10.1021/nl0255045
   Sukhorukov GB, 1996, THIN SOLID FILMS, V284, P220, DOI 10.1016/S0040-6090(95)08309-X
   TAGIKAWA M, 1989, CANCER RES, V49, P3996
   Thierry B, 2003, BIOMACROMOLECULES, V4, P1564, DOI 10.1021/bm0341834
   Thierry B, 2003, J AM CHEM SOC, V125, P7494, DOI 10.1021/ja034321x
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   ZEMBALA M, 1994, COLLOID SURFACE B, V3, P119
   Zimmerman E, 2002, BIOPHYS J, V82, P1848, DOI 10.1016/S0006-3495(02)75535-5
NR 50
TC 156
Z9 159
U1 1
U2 83
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 16
BP 3353
EP 3361
DI 10.1016/j.biomaterials.2004.08.019
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892UM
UT WOS:000226675500058
PM 15603831
DA 2018-10-20
ER

PT J
AU Horan, RL
   Antle, K
   Collette, AL
   Huang, YZ
   Huang, J
   Moreau, JE
   Volloch, V
   Kaplan, DL
   Altman, GH
AF Horan, RL
   Antle, K
   Collette, AL
   Huang, YZ
   Huang, J
   Moreau, JE
   Volloch, V
   Kaplan, DL
   Altman, GH
TI In vitro degradation of silk fibroin
SO BIOMATERIALS
LA English
DT Article
DE degradation; silk; scaffold; ligament; mechanical properties
ID LIGAMENT AUGMENTATION; BOMBYX-MORI; FIBERS
AB A significant need exists for long-term degradable biomaterials which can slowly and predictably transfer a load-bearing burden to developing biological tissue. In this study Bombyx mori silk fibroin yarns were incubated in 1 mg/ml Protease XIV at 37 degreesC to create an in vitro model system of proteolytic degradation. Samples were harvested at designated time points up to 12 weeks and (1) prepared for scanning electron microscopy (SEM), (2) lyophilized and weighed, (3) mechanical properties determined using a servohydraulic Instron 8511, (4) dissolved and run on a SDS-PAGE gel, and (5) characterized with Fourier transform infrared spectroscopy. Control samples were incubated in phosphate-buffered saline. Fibroin was shown to proteolytically degrade with predictable rates of change in fibroin diameter, failure strength, cycles to failure, and mass. SEM indicated increasing fragmentation of individual fibroin filaments from protease-digested samples with time of exposure to the enzyme; particulate debris was present within 7 days of incubation. Gel electrophoresis indicated a decreasing amount of the silk 25 kDa light chain and a shift in the molecular weight of the heavy chain with increasing incubation time in protease. Results support that silk is a mechanically robust biomaterial with predictable long-term degradation characteristics. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Altman, GH (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St,Room 153, Medford, MA 02155 USA.
EM gregory.altman@tufts.edu
FU NIAMS NIH HHS [R44 AR049139-03, R01 AR46563-01]
CR Agrawal CM, 2000, BIOMATERIALS, V21, P2443, DOI 10.1016/S0142-9612(00)00112-5
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Bonnarens F, 1987, ANTERIOR CRUCIATE DE, V239-253
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   DUNN MG, 1993, J BIOMED MATER RES, V27, P1545, DOI 10.1002/jbm.820271211
   Durselen L, 2001, J BIOMED MATER RES, V58, P666, DOI 10.1002/jbm.1067
   FRANK BC, 1997, J BONE JOINT SURG AM, V79, P1556
   Freddi G, 1999, INT J BIOL MACROMOL, V24, P251, DOI 10.1016/S0141-8130(98)00087-7
   ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017
   Kumar K, 1999, ARTHROSCOPY, V15, P422, DOI 10.1016/S0749-8063(99)70061-7
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   MARKOLF KL, 1989, J BONE JOINT SURG AM, V71A, P887, DOI 10.2106/00004623-198971060-00013
   McCarthy Donal M., 1993, P343
   MUNETA T, 1994, J ORTHOPAED RES, V12, P138, DOI 10.1002/jor.1100120117
   Richert K. J., 2000, Dairy, Food and Environmental Sanitation, V20, P24
   TSUBOUCHI K, 2002, Patent No. 1241178
   Tsukada M, 1986, J SERIC SCI JPN, V55, P120
   Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s
   WEITZEL PP, 2002, ORTHOP CLIN N AM, P653
NR 22
TC 421
Z9 449
U1 15
U2 186
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 17
BP 3385
EP 3393
DI 10.1016/j.biomaterials.2004.09.020
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 896XQ
UT WOS:000226968200002
PM 15621227
DA 2018-10-20
ER

PT J
AU Aizawa, M
   Porter, AE
   Best, SM
   Bonfield, W
AF Aizawa, M
   Porter, AE
   Best, SM
   Bonfield, W
TI Ultrastructural observation of single-crystal apatite fibres
SO BIOMATERIALS
LA English
DT Article
DE hydroxyapatite; microstructure; transmission electron microscopy;
   apatite fibre; single crystal
ID POROUS CERAMICS; HYDROXYAPATITE; BIOCERAMICS; PARTICLES
AB Hydroxyapatite (HAp) has been widely used as a biomaterial for substituting human hard tissues such as bone. By altering the morphology of HAp crystals, novel properties may be produced by controlling the orientation of the crystal planes. Apatite fibres were successfully synthesized by precipitation from aqueous solutions containing Ca(NO3)(2), (NH4)(2)HPO4, urea and HNO3. The products were composed of carbonate-containing apatite fibres with preferred orientation along the {h00} planes. Examination of individual fibres using transmission electron microscopy showed that the as-synthesized apatite fibres were highly strained single crystals with the c-axis orientation parallel to the long axis of the fibre. The crushed fibres consisted of domains that were preferentially oriented with the c-axis parallel to the long axis of the fibres. When the apatite fibres were heated to 800, 1000 and 1200 degreesC for 1 h, the domains were removed and grain boundaries, dislocations and voids were formed. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Meiji Univ, Dept Ind Chem, Sch Sci & Technol, Tama Ku, Kawasaki, Kanagawa 2148571, Japan.
   Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
RP Aizawa, M (reprint author), Meiji Univ, Dept Ind Chem, Sch Sci & Technol, Tama Ku, 1-1-1 Higashimita, Kawasaki, Kanagawa 2148571, Japan.
EM mamorua@isc.meiji.ac.jp
CR Aizawa M, 2003, KEY ENG MAT, V240-2, P647, DOI 10.4028/www.scientific.net/KEM.240-242.647
   Aizawa M, 2000, J CERAM SOC JPN, V108, P249, DOI 10.2109/jcersj.108.1255_249
   Aizawa M, 1999, J MATER SCI, V34, P2865, DOI 10.1023/A:1004635418655
   Aizawa M, 1999, MATER RES BULL, V34, P1215, DOI 10.1016/S0025-5408(99)00118-X
   Aizawa M., 1998, INORG MATER, V5, P387
   AIZAWA M, 2001, KEY ENG MATER, V218, P465
   AIZAWA M, 1999, MAT INTEGRATION, V12, P75
   AIZAWA M, 1999, BIOCERAMICS, V12, P453
   AIZAWA M, 2003, T MAT RES SOC JPN, V28, P849
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HOBBS JW, 1979, ANAL ELECT MICROSCOP, P437
   IOKU K, 1988, NIPPON KAGAKU KAISHI, P1565, DOI 10.1246/nikkashi.1988.1565
   *JOINT COMM POWD D, 90432 JOINT COMM POW
   KAWASAKI T, 1991, J CHROMATOGR, V544, P147, DOI 10.1016/S0021-9673(01)83984-4
   Kawata M, 2004, J MATER SCI-MATER M, V15, P817, DOI 10.1023/B:JMSM.0000032823.66093.aa
   NAGATA F, 1995, J CERAM SOC JPN, V103, P70
NR 17
TC 85
Z9 88
U1 0
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 17
BP 3427
EP 3433
DI 10.1016/j.biomaterials.2004.09.044
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 896XQ
UT WOS:000226968200006
PM 15621231
DA 2018-10-20
ER

PT J
AU Unger, RE
   Peters, K
   Huang, Q
   Funk, A
   Paul, D
   Kirkpatrick, CJ
AF Unger, RE
   Peters, K
   Huang, Q
   Funk, A
   Paul, D
   Kirkpatrick, CJ
TI Vascularization and gene regulation of human endothelial cells growing
   on porous polyethersulfone (PES) hollow fiber membranes
SO BIOMATERIALS
LA English
DT Article
DE polyethersulfone; PES; vascularization; endothelial cell; cell
   compatibility; gene regulation
ID SILK FIBROIN NET; IN-VITRO; INVITRO ENDOTHELIALIZATION; BONE; GRAFTS;
   BIOMATERIALS; SUBSTRATE; CARTILAGE; SURFACES; CULTURE
AB Open-cell hollow fibers made of polyethersulfone (PES) manufactured in the absence of solvents with pore diameters smaller than 100mum were examined for vascularization by human endothelial cells. The goal of this study was to determine whether the 3-D porous character of the PES surface affected human endothelial cell morphology and functions. Freshly isolated human endothelial cells from the skin (HDMEC), from the lung (HPMEC) and from umbilical cords (HUVEC) and two human endothelial cell lines, HPMEC-ST1.6R and ISO-HAS.cl were added to PES fibers and cell adherence and growth was followed by confocal laser scanning microscopy. Prior coating of PES with gelatin or fibronectin was necessary for adhesion and spreading of cells over the uneven porous surface with time. Confluent cells exhibited typical strong PECAM-I expression at cell-cell borders. Little expression of the activation markers E-selectin, ICAM-1, and VCAM-1 was observed by RT-PCR of endothelial cells growing on PES. However, after stimulation for 4h by LPS, activation of these markers was observed and it was shown by immunofluorescent staining that induction occurred in most of the cells, thus confirming an intact functionality. Finally, cells growing as a monolayer on PES migrated to form microvessel-like structures when placed under conditions that stimulated angiogenesis. Thus, human endothelial cells grown on fibronectin-coated PES fibers retain important endothelial-cell specific morphological and functional properties and PES may serve as a useful biomaterial in tissue engineering and biotechnology applications. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Johannes Gutenberg Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
   GKSS Forschungszentrum Geesthacht GmbH, Inst Chem, Geesthacht, Germany.
RP Unger, RE (reprint author), Johannes Gutenberg Univ Mainz, Inst Pathol, Langenbeckstr 1, D-55101 Mainz, Germany.
EM unger@pathologie.klinik.uni-mainz.de
RI Peters, Kirsten/S-3484-2016
CR ANDERSON JS, 1987, SURGERY, V101, P577
   BONOMINI D, 2003, CONTRIB NEPHROL, P117
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   David S, 2003, CONTRIB NEPHROL, V138, P43
   Doll B, 2001, CRIT REV EUKAR GENE, V11, P173
   Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227
   Hermanns MI, 2004, LAB INVEST, V84, P736, DOI 10.1038/labinvest.3700081
   Huang Q, 1999, J MEMBRANE SCI, V161, P287, DOI 10.1016/S0376-7388(99)00122-2
   HUANG Q, 2001, MEMBRANE TECHNOL, V140, P6
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   Hunter SK, 1999, ASAIO J, V45, P37, DOI 10.1097/00002480-199901000-00009
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   KAEHLER J, 1989, J VASC SURG, V9, P535, DOI 10.1067/mva.1989.vs0090535
   Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385
   Locatelli F, 2003, Contrib Nephrol, P55
   Lonnemann G, 2001, ARTIF ORGANS, V25, P951, DOI 10.1046/j.1525-1594.2001.06832.x
   Moce-Llivina L, 2003, J VIROL METHODS, V109, P99, DOI 10.1016/S0166-0934(03)00046-6
   PAUL D, 2002, RECENT RES DEV, P179
   Peters K, 2002, BIOMATERIALS, V23, P3413, DOI 10.1016/S0142-9612(02)00042-X
   Pignataro B, 1997, BIOMATERIALS, V18, P1461, DOI 10.1016/S0142-9612(97)00090-2
   Ripamonti U., 2000, Current Pharmaceutical Biotechnology, V1, P47, DOI 10.2174/1389201003379031
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   Sipe JD, 2002, ANN NY ACAD SCI, V961, P1, DOI 10.1111/j.1749-6632.2002.tb03040.x
   Stefoni Sergio, 2003, Contrib Nephrol, P68
   Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434
   Unger RE, 2005, BIOMATERIALS, V26, P1877, DOI 10.1016/j.biomaterials.2004.05.032
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Zhao CS, 2001, ARTIF ORGANS, V25, P60
   ZILLA P, 1989, SURGERY, V105, P515
NR 32
TC 64
Z9 68
U1 3
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 17
BP 3461
EP 3469
DI 10.1016/j.biomaterials.2004.09.047
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 896XQ
UT WOS:000226968200010
PM 15621235
DA 2018-10-20
ER

PT J
AU Witte, RP
   Kao, WYJ
AF Witte, RP
   Kao, WYJ
TI Keratinocyte-fibroblast paracrine interaction: the effects of substrate
   and culture condition
SO BIOMATERIALS
LA English
DT Article
DE hydrogels; PEG; cell adhesion; fibroblast co-culture; huKGF
ID POLY(ETHYLENE GLYCOL) DIACRYLATE; GELATIN-BASED HYDROGELS;
   GROWTH-FACTOR; INTERPENETRATING NETWORKS; PHYSICOCHEMICAL ANALYSIS;
   POLYMER NETWORKS; IN-VITRO; REGENERATION; EXPRESSION; MIGRATION
AB Interactions between epidermal-dermal cells via soluble factors provide important signals in regulating the reepithelialization of wounded skin. For example, keratinocytes regulate the expression of keratinocyte growth factor (KGF) in fibroblasts through the release of interleukin-1 beta (IL-1beta). In this study, a previously developed polyethyleneglycol-based interpenetrating network (IPN) system was utilized as a platform for the delivery of keratinocyte-active factors. The effect of substrate chemistry, culture condition, and the delivery of exogenous keratinocyte-active factors on the keratinocyte behavior and the keratinocyte-fibroblast paracrine relationship was delineated. Adherent keratinocyte density on TCPS and glutaraldehyde-fixed gelatin hydrogels but not on IPN was significantly increased with culture time in the presence of growth supplements independent of the released KGF from the gelatin hydrogel and IPN. In the presence of fibroblasts, adherent keratinocyte density on gelatin hydrogels was higher than that without fibroblasts. This phenomenon was not observed on IPN and polycarbonate membrane. In summary, the delivered exogenous huKGF (i.e., released from a biomaterial matrix) operates in tandem with fibroblasts in regulating keratinocyte activation (i.e., IL-1beta release and adhesion) in a surface-dependent manner. Immunoassay analysis of cell culture keratinocyte-fibroblast paracrine relationship as characterized by IL-1beta and KGF could not be established in the presence of IPNs, 0.1% glutaraldehyde-fixed gelatin hydrogels, and polycarbonate membranes. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA.
   Univ Wisconsin, Coll Engn, Dept Biomed Engn, Madison, WI USA.
RP Kao, WYJ (reprint author), Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53705 USA.
EM wjkao@pharmacy.wisc.edu
FU NHLBI NIH HHS [HL-77825]; NIBIB NIH HHS [EB-00290]
CR Andreadis ST, 2001, FASEB J, V15, P898, DOI 10.1096/fj.00-0324com
   Bannasch H, 2003, CLIN PLAST SURG, V30, P573, DOI 10.1016/S0094-1298(03)00075-0
   Beer HD, 2000, J INVEST DERM SYMP P, V5, P34, DOI 10.1046/j.1087-0024.2000.00009.x
   Burmania JA, 2003, J BIOMED MATER RES A, V67A, P224, DOI 10.1002/jbm.a.10106
   Cho CS, 1999, INT J PHARM, V181, P235, DOI 10.1016/S0378-5173(99)00031-9
   Desai NP, 2000, J MICROENCAPSUL, V17, P677
   Einerson NJ, 2003, BIOMATERIALS, V24, P509, DOI 10.1016/S0142-9612(02)00369-1
   El-Ghalbzouri A, 2002, BRIT J DERMATOL, V147, P230, DOI 10.1046/j.1365-2133.2002.04871.x
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Freshny RI, 2000, CULTURE ANIMAL CELLS, P89
   Gillis P, 1999, J CELL SCI, V112, P2049
   Harris JM, 1997, ACS S SERIES, V680
   Hwang DC, 1996, J AGR FOOD CHEM, V44, P751, DOI 10.1021/jf9503826
   Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200
   Maas-Szabowski N, 1999, J CELL SCI, V112, P1843
   Maas-Szabowski N, 2000, J INVEST DERMATOL, V114, P1075, DOI 10.1046/j.1523-1747.2000.00987.x
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   Michelson PH, 1999, AM J PHYSIOL-LUNG C, V277, pL737, DOI 10.1152/ajplung.1999.277.4.L737
   Nakayama Y, 1999, J BIOMED MATER RES, V48, P511, DOI 10.1002/(SICI)1097-4636(1999)48:4<511::AID-JBM17>3.3.CO;2-M
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Putnins EE, 1999, CELL ADHES COMMUN, V7, P211, DOI 10.3109/15419069909010803
   Slonina D, 2001, RADIAT RES, V156, P761, DOI 10.1667/0033-7587(2001)156[0761:EOKGFO]2.0.CO;2
   Stevens KR, 2002, J BIOMAT SCI-POLYM E, V13, P1353, DOI 10.1163/15685620260449741
   Werner S, 1998, CYTOKINE GROWTH F R, V9, P153, DOI 10.1016/S1359-6101(98)00010-0
   Zilinski JL, 2004, J BIOMED MATER RES A, V68A, P392, DOI 10.1002/jbm.a.20079
NR 25
TC 31
Z9 36
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 17
BP 3673
EP 3682
DI 10.1016/j.biomaterials.2004.09.054
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 896XQ
UT WOS:000226968200033
PM 15621258
DA 2018-10-20
ER

PT J
AU Moore, T
   Adhikari, R
   Gunatillake, P
AF Moore, T
   Adhikari, R
   Gunatillake, P
TI Chemosynthesis of bioresorbable poly(gamma-butyrolactone) by
   ring-opening polymerisation: a review
SO BIOMATERIALS
LA English
DT Review
DE polyhydroxybutyric acid; polymerisation; scaffold; degradation
ID GAMMA-HYDROXYBUTYRIC ACID; UMBILICAL-CORD CELLS; BETA-BUTYROLACTONE;
   EPSILON-CAPROLACTONE; CYCLIC ESTERS; CAPILLARY-ELECTROPHORESIS;
   CATALYZED POLYMERIZATION; DIRECT COPOLYMERIZATION; DELTA-VALEROLACTONE;
   GHB LEVELS
AB Recent advances in the synthesis of poly(gamma-butyrolactone) have yielded homopolymers of up to 50,000Mw from the low-cost monomer gamma-butyrolactone. This monomer has for the better part of a century been thought impossible to polymerise. Poly(gamma-butyrolactone) displays properties that are ideal for tissue-engineering applications and the bacterially derived equivalent, poly(4-hydroxybutyrate) (P4HB), has been evaluated for such uses. The glass transition temperature (-48 to -51 degreesC), melting point (53-60degreesC), tensile strength (50 MPa), Young's modulus (70 MPa) and elongation at break (1000%) of P4HB make it a very useful biomaterial. Poly(gamma-butyrolactone) degrades to give gamma-hydroxybutyric acid which is a naturally occurring metabolite in the body and it has been shown to be bioresorbable.
   Investigation into the synthesis of poly(gamma-butyrolactone) has recently produced homo-oligomeric diols 400-1000Mw that are suitable for reacting with diisocyanates to form polyurethanes. Biodegradable polyurethanes made from diols of polyglycolide (PGA) and poly(epsilon-caprolactone) (PCL) have the disadvantage of high glass transition and slow degradation, respectively. Poly(gamma-butyrolactone) can be thought of as being the missing link in the biodegradable polyester family immediately between PGA and PCL and displaying intermediate properties. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Swinburne Univ Technol, Sch Sci & Engn, Hawthorn, Vic 3122, Australia.
   CSIRO, Clayton, Vic 3169, Australia.
   PolyNovo Biomat Pty Ltd, Clayton, Vic 3169, Australia.
RP Moore, T (reprint author), Swinburne Univ Technol, Sch Sci & Engn, John St, Hawthorn, Vic 3122, Australia.
EM tim.moore@csiro.au
RI Gunatillake, Pathiraja/A-1375-2008
OI Gunatillake, Pathiraja/0000-0002-7035-8214
CR ABATE R, 1994, MACROMOLECULES, V27, P332, DOI 10.1021/ma00080a004
   Adams TB, 1998, FOOD CHEM TOXICOL, V36, P249, DOI 10.1016/S0278-6915(97)00163-4
   Addolorato G, 2000, ALCOHOL, V20, P217, DOI 10.1016/S0741-8329(99)00084-1
   Addolorato G, 1999, LIFE SCI, V65, pPL191, DOI 10.1016/S0024-3205(99)00395-1
   Addolorato G, 1998, DRUG ALCOHOL DEPEN, V53, P7, DOI 10.1016/S0376-8716(98)00094-5
   Agarwal S, 2003, MACROMOLECULES, V36, P3545, DOI 10.1021/ma0258713
   Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   AUBIN M, 1981, POLYMER, V22, P1223, DOI 10.1016/0032-3861(81)90137-3
   Avella M, 1997, POLYMER, V38, P6135, DOI 10.1016/S0032-3861(97)00166-3
   BAILEY WJ, 1976, J POLYM SCI       PS, V56, P117
   Baldacci A, 2003, J CHROMATOGR A, V990, P99, DOI 10.1016/S0021-9673(02)01704-1
   Bortolotti F, 2004, J CHROMATOGR B, V800, P239, DOI 10.1016/j.jchromb.2003.09.062
   Bosman IJ, 2003, FORENSIC SCI INT, V133, P17, DOI 10.1016/S0379-0738(03)00044-6
   Burlakov VV, 2003, J MOL CATAL A-CHEM, V200, P63, DOI 10.1016/S1381-1169(03)00023-2
   Cai Q, 2002, POLYM ADVAN TECHNOL, V13, P105, DOI 10.1002/pat.161
   Carai MAM, 2001, EUR J PHARMACOL, V428, P315, DOI 10.1016/S0014-2999(01)01334-6
   Carothers W. H., 1932, J AM CHEM SOC, V54, P761, DOI [10.1021/ja01341a046, DOI 10.1021/JA01341A046]
   Cheeseman MA, 1999, FOOD CHEM TOXICOL, V37, P387, DOI 10.1016/S0278-6915(99)00024-1
   Craig K, 2000, J EMERG MED, V18, P65, DOI 10.1016/S0736-4679(99)00163-8
   Deng XM, 2000, EUR POLYM J, V36, P2739, DOI 10.1016/S0014-3057(00)00032-X
   Doi Y, 1996, POLYM DEGRAD STABIL, V51, P281, DOI 10.1016/0141-3910(95)00178-6
   Dong H, 1998, BIOTECHNOL LETT, V20, P905, DOI 10.1023/A:1005482232687
   Duda A, 1998, POLYM DEGRAD STABIL, V59, P215, DOI 10.1016/S0141-3910(97)00167-5
   Duda A, 1996, MACROMOL CHEM PHYSIC, V197, P1273, DOI 10.1002/macp.1996.021970408
   Elian AA, 2002, FORENSIC SCI INT, V128, P120, DOI 10.1016/S0379-0738(02)00183-4
   Elliott SP, 2003, FORENSIC SCI INT, V133, P9, DOI 10.1016/S0379-0738(03)00043-4
   Engelmayr GC, 2003, BIOMATERIALS, V24, P2523, DOI 10.1016/S0142-9612(03)00051-6
   Epple M, 1998, J BIOMED MATER RES, V43, P83
   Fattore L, 2000, ALCOHOL, V20, P247, DOI 10.1016/S0741-8329(99)00088-9
   Freier T, 2002, BIOMATERIALS, V23, P2649, DOI 10.1016/S0142-9612(01)00405-7
   FUKUZAKI H, 1990, EUR POLYM J, V26, P457, DOI 10.1016/0014-3057(90)90052-6
   FUKUZAKI H, 1989, MAKROMOL CHEM, V190, P1553
   Gallimberti L, 2000, ALCOHOL, V20, P257, DOI 10.1016/S0741-8329(99)00089-0
   Galloway GP, 2000, ALCOHOL, V20, P263, DOI 10.1016/S0741-8329(99)00090-7
   Gao JM, 1998, J BIOMED MATER RES, V42, P417, DOI 10.1002/(SICI)1097-4636(19981205)42:3<417::AID-JBM11>3.3.CO;2-N
   Gessa GL, 2000, ALCOHOL, V20, P271, DOI 10.1016/S0741-8329(99)00091-9
   Gibson KM, 2003, BIOL PSYCHIAT, V54, P763, DOI 10.1016/S0006-3223(03)00113-6
   HALL HK, 1958, J AM CHEM SOC, V80, P6409, DOI 10.1021/ja01556a060
   HAMITOU A, 1977, J POLYM SCI POL CHEM, V15, P865, DOI 10.1002/pol.1977.170150409
   Hayakawa M, 1997, MACROMOL CHEM PHYS, V198, P1305, DOI 10.1002/macp.1997.021980502
   Higgins Thomas F. Jr., 1996, Journal of Emergency Medicine, V14, P435, DOI 10.1016/0736-4679(96)00080-7
   Hoerstrup SP, 2002, ANN THORAC SURG, V74, P46, DOI 10.1016/S0003-4975(02)03649-4
   Hoerstrup SP, 2001, EUR J CARDIO-THORAC, V20, P164, DOI 10.1016/S1010-7940(01)00706-0
   HORI Y, 1995, POLYMER, V36, P4703, DOI 10.1016/0032-3861(95)96838-Y
   Hou QP, 2002, MACROMOL RAPID COMM, V23, P247
   Ingels M, 2000, J EMERG MED, V19, P47, DOI 10.1016/S0736-4679(00)00188-8
   INOUE S, 1961, MAKROMOLEKUL CHEM, V48, P229
   ITO K, 1970, MAKROMOLEKUL CHEM, V139, P153
   JEDLINSKI Z, 1991, MACROMOLECULES, V24, P349, DOI 10.1021/ma00002a002
   Kadner A, 2004, EUR J CARDIO-THORAC, V25, P635, DOI 10.1016/j.ejcts.2003.12.038
   Kadner A, 2002, ANN THORAC SURG, V74, pS1422
   Kadokawa J, 2002, GREEN CHEM, V4, P14, DOI 10.1039/b107609b
   Kageyama K, 1999, POLYM J, V31, P1005, DOI 10.1295/polymj.31.1005
   Kasuya K, 1996, INT J BIOL MACROMOL, V19, P35, DOI 10.1016/0141-8130(96)01097-5
   Kasuya K, 1999, INT J BIOL MACROMOL, V24, P329, DOI 10.1016/S0141-8130(99)00046-X
   KAUFMANN H, 1951, ANGEW CHEM, V63, P480
   Kiparisova EG, 1997, ZH FIZ KHIM+, V71, P974
   KORTE F, 1966, J POLYM SCI POL LETT, V4, P685, DOI 10.1002/pol.1966.110041004
   KRICHELDORF HR, 1985, MAKROMOL CHEM, V186, P955
   LeBeau MA, 2001, FORENSIC SCI INT, V119, P161, DOI 10.1016/S0379-0738(00)00426-6
   LEBEDEV B, 1984, MAKROMOL CHEM, V185, P1235
   Lee CW, 1998, EUR POLYM J, V34, P117, DOI 10.1016/S0014-3057(98)80001-3
   Lee CW, 1997, MACROMOL CHEM PHYSIC, V198, P1109, DOI 10.1002/macp.1997.021980414
   Lepoittevin B, 2002, POLYMER, V43, P4017, DOI 10.1016/S0032-3861(02)00229-X
   Mao JX, 2003, APPL CATAL A-GEN, V255, P337, DOI 10.1016/S0926-860X(03)00640-9
   Martin DP, 2003, BIOCHEM ENG J, V16, P97, DOI 10.1016/S1369-703X(03)00040-8
   MATHISEN T, 1991, J APPL POLYM SCI, V42, P2365, DOI 10.1002/app.1991.070420829
   Meredith JC, 2000, MACROMOL CHEM PHYSIC, V201, P733, DOI 10.1002/(SICI)1521-3935(20000301)201:6<733::AID-MACP733>3.3.CO;2-X
   Miglani JS, 2000, GEN HOSP PSYCHIAT, V22, P213, DOI 10.1016/S0163-8343(00)00071-2
   Miura H, 1999, KOBUNSHI RONBUNSHU, V56, P291, DOI 10.1295/koron.56.291
   Moncini M, 2000, ALCOHOL, V20, P285, DOI 10.1016/S0741-8329(99)00093-2
   Moriya Fumio, 2004, Leg Med (Tokyo), V6, P47, DOI 10.1016/j.legalmed.2003.09.004
   Na YH, 2002, MACROMOLECULES, V35, P727, DOI 10.1021/ma011530y
   NAKAMURA S, 1992, MACROMOLECULES, V25, P4237, DOI 10.1021/ma00043a001
   Nakayama A, 1998, POLYMER, V39, P1213, DOI 10.1016/S0032-3861(97)00401-1
   Nakayama A, 1996, J ENVIRON POLYM DEGR, V4, P205, DOI 10.1007/BF02067454
   Nicholson KL, 2001, DRUG ALCOHOL DEPEN, V63, P1, DOI 10.1016/S0376-8716(00)00191-5
   Nishiura M, 1999, MACROMOLECULES, V32, P8245, DOI 10.1021/ma990101l
   Nobes GAR, 1996, MACROMOLECULES, V29, P4829, DOI 10.1021/ma951774g
   Oishi A., 2000, Jpn. Pat., Patent No. [JP2000281767, 2000281767]
   Oishi A., 2003, Jpn. Pat., Patent No. [JP2003252968, 2003252968]
   PAJERSKI AD, 1993, MAKROMOL CHEM-M SYMP, V73, P7, DOI 10.1002/masy.19930730104
   Perry TE, 2003, ANN THORAC SURG, V75, P761, DOI 10.1016/S0003-4975(02)03776-1
   REEVE MS, 1994, MACROMOLECULES, V27, P825, DOI 10.1021/ma00081a030
   Rigamonti AE, 2000, ALCOHOL, V20, P293, DOI 10.1016/S0741-8329(99)00094-4
   ROTH RH, 1970, BIOCHEM PHARMACOL, V19, P1087, DOI 10.1016/0006-2952(70)90370-9
   ROTH RH, 1965, BIOCHEM PHARMACOL, V14, P177, DOI 10.1016/0006-2952(65)90073-0
   Saiyasombat W, 1998, POLYMER, V39, P5581, DOI 10.1016/S0032-3861(97)10370-6
   Sakurada K, 2002, TOXICOL LETT, V129, P207, DOI 10.1016/S0378-4274(02)00019-X
   Schneider I, 2001, GENET ENG NEWS, V21, P1
   SHELTON JR, 1971, J POLYM SCI A1, V9, P2789, DOI 10.1002/pol.1971.150091004
   TADA K, 1964, MAKROMOLEKUL CHEM, V77, P220
   Tang ZH, 2003, J POLYM SCI POL CHEM, V41, P1934, DOI 10.1002/pola.10740
   Tedeschi L, 2003, LIFE SCI, V72, P2481, DOI 10.1016/S0024-3205(03)00143-7
   TSUDA T, 1964, KOGYO KAGAKU ZASSHI, V67, P2150
   UYAMA H, 1993, CHEM LETT, P1149, DOI 10.1246/cl.1993.1149
   Weir NA, 2004, BIOMATERIALS, V25, P3939, DOI 10.1016/j.biomaterials.2003.10.076
   Wong CGT, 2004, TRENDS PHARMACOL SCI, V25, P29, DOI 10.1016/j.tips.2003.11.001
   Yamashita M, 1996, MACROMOLECULES, V29, P1798, DOI 10.1021/ma951400n
   YAMASHITA Y, 1969, MACROMOLECULES, V2, P613, DOI 10.1021/ma60012a009
   YAMASHITA Y, 1966, J POLYM SCI A1, V4, P2121, DOI 10.1002/pol.1966.150040908
   YEVSTROPOV AA, 1980, VYSOKOMOL SOEDIN A+, V22, P2450
   Yoon JS, 1999, EUR POLYM J, V35, P781, DOI 10.1016/S0014-3057(98)00068-8
   ZHANG Y, 1990, MACROMOLECULES, V23, P3206, DOI 10.1021/ma00215a002
   ZHULIN VM, 1988, DOKL AKAD NAUK SSSR+, V298, P1411
NR 105
TC 59
Z9 61
U1 2
U2 61
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 18
BP 3771
EP 3782
DI 10.1016/j.biomaterials.2004.10.002
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 899KR
UT WOS:000227143800001
PM 15626425
DA 2018-10-20
ER

PT J
AU Keskin, DS
   Tezcaner, A
   Korkusuz, P
   Korkusuz, F
   Hasirci, V
AF Keskin, DS
   Tezcaner, A
   Korkusuz, P
   Korkusuz, F
   Hasirci, V
TI Collagen-chondroitin sulfate-based PLLA-SAIB-coated rhBMP-2 delivery
   system for bone repair
SO BIOMATERIALS
LA English
DT Article
DE collagen; chondroitin sulfate; PLLA; SAIB; rhBMP-2; controlled drug
   delivery
ID RAT ECTOPIC MODEL; MORPHOGENETIC PROTEIN-2; CONTROLLED-RELEASE;
   BIOMATERIAL CARRIERS; INDUCED OSTEOGENESIS; DEFECTS; POLYMER;
   PHARMACOKINETICS; AUGMENTATION; SABER(TM)
AB Bone morphogenetic proteins (BMPs) are osteoinductive proteins used intensively in clinical investigations involving various bone-related treatments. Owing to their high potential in new bone formation they require local application at the treatment site. For this purpose various controlled delivery systems with BMPs as the excipients have been prepared in recent years. Focusing on this clinical need a disc-shaped BMP carrier was designed as a local delivery system using soluble collagen and chondroitin sulfate. In situ release studies carried out with a model protein (FITC-labeled Protein A) presented a very high rate of release; with most of the protein content being released within 24h. This rate could be decreased by providing a poly(L-lactide) (PLLA) and sucrose acetate isobutyrate-based (SAIB-based) coat around the release system, applied after BMP loading. In this way, it was possible to extend the release period from 24 h to about 12 days. In situ release of BMP from the same carriers, as quantitated using an ELISA kit, was even slower, with 50% of the protein being released in 15 days.
   In order to be able to secure the BMP delivery system at the bone defect site and to provide support a mesh knitted using Vicryl sutures and bonded with poly(L-lactide-co-glycolide) (PLGA) was tested in in vivo. Two time periods, I and 3 weeks, were used to evaluate the healing process. Osteoinduction by the BMP carrier system was assessed by histology-based bone scoring and X-ray examinations. PLLA-SAIB-coated collagen discs containing BMP presented good biocompatibility and optimum osteogenic stimulation. Structural changes in histological micrographs at week I indicated dose-dependent periosteal ossification. At the end of week 3 histological findings with both BMP (1 and 2 mug) doses were almost the same. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Middle E Tech Univ, Dept Sci Biol, Biotechnol Res Unit, TR-06531 Ankara, Turkey.
   Middle E Tech Univ, Dept Engn Sci, TR-06531 Ankara, Turkey.
   Hacettepe Univ, Fac Med, Dept Histol & Embryol, TR-06100 Ankara, Turkey.
   Middle E Tech Univ, Med Ctr, TR-06531 Ankara, Turkey.
   Middle E Tech Univ, Dept Phys Educ & Sport, TR-06531 Ankara, Turkey.
RP Hasirci, V (reprint author), Middle E Tech Univ, Dept Sci Biol, Biotechnol Res Unit, TR-06531 Ankara, Turkey.
EM vhasirci@metu.edu.tr
RI KORKUSUZ, PETEK/I-8321-2013; KORKUSUZ, FEZA/I-9501-2013; Xu,
   Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
CR AN YH, 1999, ANIMAL MODELS ORTHOP, P251
   Bennett BT, 1994, ESSENTIALS ANIMAL RE, P1
   Bessho K, 2002, J BIOMED MATER RES, V61, P61, DOI 10.1002/jbm.10169
   Boyne P J, 1997, Int J Periodontics Restorative Dent, V17, P11
   Burns PJ, 1998, THERIOGENOLOGY, V49, P256, DOI 10.1016/S0093-691X(98)90609-4
   COOK SD, 1995, J BONE JOINT SURG AM, V77A, P734, DOI 10.2106/00004623-199505000-00010
   Franke H, 2000, BRAIN RES PROTOC, V5, P248, DOI 10.1016/S1385-299X(00)00020-9
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   Heckman JD, 1999, J BONE JOINT SURG AM, V81A, P1717, DOI 10.2106/00004623-199912000-00009
   Howell TH, 1997, INT J PERIODONT REST, V17, P125
   JOHNSON EE, 1988, CLIN ORTHOP RELAT R, P257
   Knoll A, 1999, MICROVASC RES, V58, P1, DOI 10.1006/mvre.1999.2149
   Kokubo S, 2004, BIOMATERIALS, V25, P1795, DOI 10.1016/j.biomaterials.2003.08.030
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Laffargue P, 1999, BONE, V25, p55S, DOI 10.1016/S8756-3282(99)00134-9
   LU HH, 2003, BIOCHEM BIOPH RES CO, V13, P882
   Maeda H, 2004, INT J PHARM, V275, P109, DOI 10.1016/j.ijpharm.2004.01.040
   Nagao H, 2002, INT J ORAL MAX SURG, V31, P66, DOI 10.1054/ijom.2001.0133
   Niedhart C, 2003, J BIOMED MATER RES A, V65A, P17, DOI 10.1002/jbm.a.10362
   Okamoto T, 2004, J THORAC CARDIOV SUR, V127, P329, DOI 10.1016/j.jtcvs.2003.08.017
   Okumu FW, 2002, BIOMATERIALS, V23, P4353, DOI 10.1016/S0142-9612(02)00174-6
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Royals MA, 1999, J BIOMED MATER RES, V45, P231, DOI 10.1002/(SICI)1097-4636(19990605)45:3<231::AID-JBM11>3.0.CO;2-H
   Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715
   Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0
   Saito N, 2003, BIOMATERIALS, V24, P2287, DOI 10.1016/S0142-9612(03)00040-1
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Vehof JWM, 2002, J BIOMED MATER RES, V61, P440, DOI 10.1002/jbm.10216
NR 29
TC 49
Z9 52
U1 2
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 18
BP 4023
EP 4034
DI 10.1016/j.biomaterials.2004.09.063
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 899KR
UT WOS:000227143800025
PM 15626448
DA 2018-10-20
ER

PT J
AU Macleod, TM
   Williams, G
   Sanders, R
   Green, CJ
AF Macleod, TM
   Williams, G
   Sanders, R
   Green, CJ
TI Histological evaluation of Permacol (TM) as a subcutaneous implant over
   a 20-week period in the rat model
SO BRITISH JOURNAL OF PLASTIC SURGERY
LA English
DT Article
DE biomaterials; subcutaneous implant; porcine; histological response;
   biocompatibitity
ID DERMAL COLLAGEN ALLOGRAFTS; SOFT-TISSUE AUGMENTATION; TEMPLATE; PIG
AB This study assessed the suitability of Permacol (TM) (a porcine derived, isocyanate cross linked collagen based biomaterial.) as an alternative to autologous tissue in soft tissue reconstruction. The Sprague-Dawley rat was used as a model for subcutaneous implantation over a 20 week period and comparison made with two other porcine biomaterials (small intestinal submucosa and glycerol treated-ethylene oxide sterilised porcine dermis). Implants were scored histometrically on the degree of acute inflammation, chronic inflammation, fibrosis and stromal response. The vascularity and percentage composition of collagen within Permacol (TM) were assessed by stereology and seescan image analysis, respectively. In general. terms, Permacol (TM) was well tolerated as a subcutaneous implant, with only a minor chronic inflammatory response remaining after a 20 week period of implantation. There was evidence of collagen degradation during this period and vascular ingrowth into Permacol (TM) was limited. Permacol (TM) has the potential for a broad range of applications in plastic surgery, but may benefit from modification to promote a more rapid degree of vascularisation. (c) 2005 The British Association of Plastic Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 Mt Vernon Hosp, Restorat Appearance & Funct Trust, Northwood HA6 2RN, Middx, England.
   Northwick Pk Hosp & Clin Res Ctr, Northwick Pk Inst Med Res, Harrow HA1 3UJ, Middx, England.
RP Macleod, TM (reprint author), City Hosp Nottingham, Dept Plast Surg, Hucknall Rd, Nottingham NG5 1PB, England.
EM tmhighlander@yahoo.co.uk
CR DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   Eppley BL, 2001, PLAST RECONSTR SURG, V107, P757, DOI 10.1097/00006534-200103000-00016
   Ghosh MM, 1997, ANN PLAS SURG, V39, P390, DOI 10.1097/00000637-199710000-00010
   GRIFFITHS RW, 1982, BRIT J PLAST SURG, V35, P519, DOI 10.1016/0007-1226(82)90056-X
   Holl-Allen R T, 1984, J R Coll Surg Edinb, V29, P151
   Krauss MC, 1999, SEMIN CUTAN MED SURG, V18, P119, DOI 10.1016/S1085-5629(99)80036-4
   LIVESEY SA, 1995, TRANSPLANTATION, V60, P1, DOI 10.1097/00007890-199507150-00001
   LOEWE O, 1913, MUNCHEN MED WCHNSCHR, V24, P1320
   Matouskova E, 1997, BRIT J DERMATOL, V136, P901
   OLIVER RF, 1982, BIOMATERIALS, V3, P38, DOI 10.1016/0142-9612(82)90059-X
   OLIVER RF, 1975, NATURE, V258, P537, DOI 10.1038/258537a0
   OLIVER RF, 1976, CLIN ORTHOP RELAT R, P291
   OLIVER RF, 1972, BRIT J EXP PATHOL, V53, P540
   SHAKESPEARE PG, 1980, LANCET, V1, P795
   *TISS SCI LAB, 1998, IMPL BIOM
   Wang HJ, 1997, J TRAUMA, V42, P177, DOI 10.1097/00005373-199702000-00002
NR 16
TC 68
Z9 74
U1 0
U2 11
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0007-1226
J9 BRIT J PLAST SURG
JI Br. J. Plast. Surg.
PD JUN
PY 2005
VL 58
IS 4
BP 518
EP 532
DI 10.1016/j.bjps.2004.12.012
PG 15
WC Surgery
SC Surgery
GA 933YB
UT WOS:000229667700017
PM 15897038
DA 2018-10-20
ER

PT J
AU Duan, SF
   Zhu, W
   Yu, L
   Ding, JD
AF Duan, SF
   Zhu, W
   Yu, L
   Ding, JD
TI Negative cooperative effect of cytotoxicity of a di-component initiating
   system for a novel injectable tissue engineering hydrogel
SO CHINESE SCIENCE BULLETIN
LA English
DT Article
DE tissue engineering; injectable biomaterial; hydrogel; initiator;
   cytotoxicity
ID HYALURONIC-ACID; IN-VITRO; SCAFFOLDS; CELLS; CYTOCOMPATIBILITY;
   CARTILAGE
AB Chemically cross-linked hydrogels constitute a novel injectable tissue engineering material. At present, one of the key problems is to find an appropriate initiator. This study evaluated the cytotoxicity in vitro of a water-soluble redox initiating system consisting of ammonium persulfate (APS) and N, N, N', N'-tetramethylethylenediamine (TEMED). Gelation time of PEG diacrylate macromer in phosphate buffer saline solution was first adjusted to guarantee that the examined initiator concentrations are sufficiently high to trigger polymerization of macromers. NIH/3T3 fibroblasts were employed to examine cytotoxicity via MTT measurements and optical microscopic observations. It has been found that the combined APS/TEMED system exhibits negative cooperative effect, for the underlying cytotoxicity is even lower than that of APS or TEMED at certain concentrations.
C1 Fudan Univ, Dept Macromol Sci, Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
RP Ding, JD (reprint author), Fudan Univ, Dept Macromol Sci, Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
EM jdding1@fudan.edu.cn
CR Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Cai Q, 2002, BIOMATERIALS, V23, P4483, DOI 10.1016/S0142-9612(02)00168-0
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   FENG XD, 1988, MAKROMOL CHEM, V189, P77
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Liu J, 1997, CRYOBIOLOGY, V35, P1, DOI 10.1006/cryo.1997.2018
   Ma ZW, 2003, J BIOMED MATER RES B, V67B, P610, DOI 10.1002/jbm.b.10049
   Mao JS, 2003, CHINESE SCI BULL, V48, P1807, DOI 10.1360/03wb0243
   Mao JS, 2003, BIOMATERIALS, V24, P1621, DOI 10.1016/S0142-9612(02)00549-5
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
   [吴林波 Wu Linbo], 2003, [功能高分子学报, Journal of Functional Polymer], V16, P91
   Zhang XZ, 2000, CHEM J CHINESE U, V21, P1309
NR 15
TC 18
Z9 18
U1 1
U2 24
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1001-6538
J9 CHINESE SCI BULL
JI Chin. Sci. Bull.
PD JUN
PY 2005
VL 50
IS 11
BP 1093
EP 1096
DI 10.1360/982004-459
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 962DY
UT WOS:000231712400007
DA 2018-10-20
ER

PT J
AU Simunek, A
   Cierny, M
   Kopecka, D
   Kohout, A
   Bukac, J
   Vahalova, D
AF Simunek, A
   Cierny, M
   Kopecka, D
   Kohout, A
   Bukac, J
   Vahalova, D
TI The sinus lift with phycogenic bone substitute - A histomorphometric
   study
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE Algipore; apatite; dental implants; histomorphometry; osseointegration;
   sinus lift
ID NARROW SIZE RANGE; MAXILLARY SINUS; AUTOGENOUS BONE; FLOOR ELEVATION;
   POROUS HYDROXYAPATITE; TRICALCIUM PHOSPHATE; IMPLANT PLACEMENT; DENTAL
   IMPLANTS; AUGMENTATION; COMBINATION
AB Objectives: The aim of this histomorphometric prospective study was to ascertain the efficacy of phycogenic bone substitute in an augmented sinus. The process of graft healing, bone remodeling, and biomaterial replacement was examined.
   Material and methods: The phycogenic material (fluorohydroxyapatite) made from calcium-encrusted sea algae was used for the sinus lifts. Twenty-four procedures were carried out (one-stage and two-stage equally) and 45 titanium stepped-screw implants were placed. The patients were followed for 12-23 months. In intervals of 6, 9, 12, or 15 months after the sinus lift, 24 graft specimens were taken with a trephine bur. These specimens were examined histomorphometrically.
   Results: The grafting material was gradually resorbed and replaced by newly formed bone. Between the sixth and 15th month after the sinus lift, the percentage of newly formed bone grew linearly (from 15.5&PLUSMN; 9.6% to 40.8&PLUSMN; 15.3%) and the percentage of bone substitute decreased linearly (from 34.5&PLUSMN; 8.6% to 13&PLUSMN; 9.6%). After 15 months, the density of trabeculae in grafted bone corresponded to cancellous bone of good quality; however, the bone substitute was not completely resorbed during this period. No significant difference between the quality of the newly formed bone in the cases of the one- and two-stage sinus lifts was found.
   Conclusion: Sinus lift carried out with phycogenic bone substitute was shown to be an effective method with limited invasiveness and a high survival rate of implants (97.8%).
C1 Charles Univ, Fac Med Hradec Kralove, Dept Stomatol, Hradec Kralove, Czech Republic.
   Fac Hosp, Fingerland Dept Pathol, Hradec Kralove, Czech Republic.
   Charles Univ, Fac Med Hradec Kralove, Dept Med Biophys, Hradec Kralove, Czech Republic.
RP Simunek, A (reprint author), Teaching Hosp, Dept Stomatol, Hradec Kralove 50005, Czech Republic.
EM simunek_antonin@email.cz
RI Kopecka, Dana/I-7589-2017; Simunek, Antonin/I-8232-2017
OI Kopecka, Dana/0000-0001-8375-2635; Simunek, Antonin/0000-0003-0219-3208
CR ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347
   Artzi Z, 2001, J PERIODONTOL, V72, P911, DOI 10.1902/jop.2001.72.7.911
   BIENIEK KW, 1990, DTSCH ZAHNARZTEBLATT, V1, P24
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Cordioli G, 2001, CLIN ORAL IMPLAN RES, V12, P270, DOI 10.1034/j.1600-0501.2001.012003270.x
   DRAPER NR, 1996, APPL REGRESSION ANAL, P26
   Ewers R, 2004, CLIN ORAL IMPLAN RES, V15, P96, DOI 10.1111/j.1600-0501.2004.00987.x
   Fanuscu MI, 2003, INT J ORAL MAX IMPL, V18, P667
   FEIFEL H, 1995, DTSCH Z MUND KIEFER, V19, P1
   HAESSLER D, 1999, DENT IMPLANTOLOGIE, V3, P216
   Hallman M, 2001, CLIN ORAL IMPLAN RES, V12, P135, DOI 10.1034/j.1600-0501.2001.012002135.x
   Jakse N, 2003, CLIN ORAL IMPLAN RES, V14, P578, DOI 10.1034/j.1600-0501.2003.00928.x
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P11
   JENSEN OT, 1999, SINUS BONE GRAFT
   KASPERK C, 1988, DEUT ZAHNAERZTL Z, V43, P116
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   Landi L, 2000, INT J PERIODONT REST, V20, P575
   Lorenzoni M, 2000, INT J PERIODONT REST, V20, P255
   Mangano C, 2003, INT J ORAL MAX IMPL, V18, P23
   McCarthy C, 2003, INT J ORAL MAX IMPL, V18, P377
   Raghoebar GM, 2001, CLIN ORAL IMPLAN RES, V12, P279, DOI 10.1034/j.1600-0501.2001.012003279.x
   Schepers E, 1998, INT J ORAL MAX IMPL, V13, P655
   Schopper C, 1999, J LONG-TERM EFF MED, V9, P203
   Schopper Christian, 2003, Clin Oral Implants Res, V14, P743
   SCHUMANN B, 1997, DENT IMPLANTOLOGIE, V1, P68
   Szabo G, 2001, INT J ORAL MAX IMPL, V16, P681
   Tadjoedin ES, 2000, CLIN ORAL IMPLAN RES, V11, P334, DOI 10.1034/j.1600-0501.2000.011004334.x
   Tong DC, 1998, INT J ORAL MAX IMPL, V13, P175
   Trisi P, 1999, CLIN ORAL IMPLAN RES, V10, P1
   Valentini P, 2003, INT J ORAL MAX IMPL, V18, P556
   Valentini P, 1998, CLIN ORAL IMPLAN RES, V9, P59, DOI 10.1034/j.1600-0501.1998.090108.x
   Wheeler S L, 1996, Int J Oral Maxillofac Implants, V11, P26
   Wheeler SL, 1997, J ORAL MAXIL SURG, V55, P1287, DOI 10.1016/S0278-2391(97)90186-5
   Xu H, 2003, CLIN ORAL IMPLAN RES, V14, P548, DOI 10.1034/j.1600-0501.2003.00933.x
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
   Zerbo IR, 2001, CLIN ORAL IMPLAN RES, V12, P379, DOI 10.1034/j.1600-0501.2001.012004379.x
NR 36
TC 15
Z9 15
U1 0
U2 3
PU BLACKWELL MUNKSGAARD
PI FREDERIKSBERG C
PA 1 ROSENORNS ALLE, DK-1970 FREDERIKSBERG C, DENMARK
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUN
PY 2005
VL 16
IS 3
BP 342
EP 348
DI 10.1111/j.1600-0501.2005.01097.x
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 924FR
UT WOS:000228964900011
PM 15877755
DA 2018-10-20
ER

PT J
AU Worth, A
   Mucalo, M
   Horne, G
   Bruce, W
   Burbidge, H
AF Worth, A
   Mucalo, M
   Horne, G
   Bruce, W
   Burbidge, H
TI The evaluation of processed cancellous bovine bone as a bone graft
   substitute
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterials; bovine hydroxyapatite; composite bone grafting;
   histomorphometry; ovine condylar defect; xenografting; xenoimplant
ID ANIMAL-DERIVED BONE; BIOMEDICAL APPLICATIONS; YIELD MATERIALS;
   BIO-OSS(R); IMPLANTS; DEFECTS; AUGMENTATION; HUMANS
AB Objective: To determine the ability of a novel bovine cancellous bone xenoimplant to act as an osteoconductive graft in an ovine femoral defect model. An autograft harvested from the xenoimplant site was placed in a contralateral limb defect for comparison.
   Material and methods: The xenoimplant used had been rendered immunologically inert by a novel defatting and deproteinating process. Following surgical implantation of cores into condylar cancellous bone defects, fluorochrome labels were administered to 12 sheep at 2 1/2, 4 1/2 and 8 weeks. Incorporation of the xenoimplants and autografts into the host bone was compared radiographically and histomorphometrically at 10 weeks.
   Results: Radiographically, the degree of osteointegration was comparable. Histomorphometric data, consisting of labelled surface (LS) estimates, confirmed osteoconductive properties of both the xenoimplants and autografts. Remodelling activity was greatest in the xenoimplants at 2 1/2, weeks. At 4 1/2 weeks, there was more activity in the autograft, but by 8 weeks they were performing similarly. Xenoimplant-LS estimates were comparable or greater than those of the autograft at all times.
   Conclusions: Processed bovine cancellous bone xenoimplants were osteoconductive in this model and show promise for development as a biomaterial in human and veterinary orthopaedic surgery.
C1 Massey Univ, Vet Teaching Hosp, Ctr Compan Anim Hlth, Palmerston North, New Zealand.
   Univ Waikato, Dept Chem, Hamilton, New Zealand.
   Univ Otago, Wellington Sch Med, Wellington, New Zealand.
   Adelaide Vet Specialist & Referral Ctr, Vet Specialist Orthopaed Serv, Adelaide, SA, Australia.
RP Worth, A (reprint author), Massey Univ, Vet Teaching Hosp, Ctr Compan Anim Hlth, Private Bag 11-222, Palmerston North, New Zealand.
EM A.J.Worth@massey.ac.nz
RI Mucalo, Michael/E-5263-2013
OI Mucalo, Michael/0000-0002-7655-9885
CR Anderson JC, 2001, AM J ARCHAEOL, V105, P371, DOI 10.2307/507312
   Anderson LA, 2000, J MATER SCI-MATER M, V11, P743
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Eriksen E, 1994, BONE HISTOMORPHOMETR, P33
   Hallman M, 2001, CLIN ORAL IMPLAN RES, V12, P135, DOI 10.1034/j.1600-0501.2001.012002135.x
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   Johnson GS, 2000, J MATER SCI-MATER M, V11, P427, DOI 10.1023/A:1008987908917
   KERWIN SC, 1991, COMP CONT EDUC PRACT, V13, P1558
   KLINGE B, 1992, J ORAL MAXIL SURG, V50, P241, DOI 10.1016/0278-2391(92)90320-Y
   Ladd A L, 1999, J Am Acad Orthop Surg, V7, P279
   Merkx MAW, 1999, BIOMATERIALS, V20, P639, DOI 10.1016/S0142-9612(98)00219-1
   OHASHI H, 1994, J MATER SCI-MATER M, V5, P225, DOI 10.1007/BF00121093
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Richardson CR, 1999, J CLIN PERIODONTOL, V26, P421, DOI 10.1034/j.1600-051X.1999.260702.x
   Salama R, 1973, J Bone Joint Surg Br, V55, P402
   Schlegel AK, 1998, J LONG-TERM EFF MED, V8, P201
   Wolff J., 1986, LAW BONE REMODELLING
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 18
TC 19
Z9 23
U1 0
U2 4
PU BLACKWELL MUNKSGAARD
PI FREDERIKSBERG C
PA 1 ROSENORNS ALLE, DK-1970 FREDERIKSBERG C, DENMARK
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUN
PY 2005
VL 16
IS 3
BP 379
EP 386
DI 10.1111/j.1600-0501.2005.01113.x
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 924FR
UT WOS:000228964900015
PM 15877759
DA 2018-10-20
ER

PT J
AU Altman, D
   Zetterstrom, J
   Lopez, A
   Anzen, B
   Falconer, C
   Hjern, F
   Mellgren, A
AF Altman, D
   Zetterstrom, J
   Lopez, A
   Anzen, B
   Falconer, C
   Hjern, F
   Mellgren, A
TI Functional and anatomic outcome after transvaginal rectocele repair
   using collagen mesh: A prospective study
SO DISEASES OF THE COLON & RECTUM
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the American-Society-of-Colon-and-Rectal-Surgeons
CY JUN 21-26, 2003
CL NEW ORLEANS, LA
SP Amer Soc Colon & Rectal Surg
ID PELVIC ORGAN PROLAPSE; RECTAL INTUSSUSCEPTION; CYSTOCELE REPAIR; SEXUAL
   FUNCTION; DERMAL GRAFT; FASCIA LATA; DEFECOGRAPHY; EVACUATION;
   PERITONEOGRAPHY; INCONTINENCE
AB PURPOSE: This study was designed to evaluate rectocele repair using collagen mesh. METHODS: 32 female patients underwent surgical repair using collagen mesh. Outcome was assessed in 29 patients and preoperative assessment included standardized questionnaire, clinical examination, and defecography. At the six-month follow-up, patients answered a standardized questionnaire and underwent clinical examination. At the 12-month follow-up, patients answered a standardized questionnaire, underwent clinical examination, and defecography. RESULTS: Preoperatively, 26 patients had a Stage 11 and 3 patients had a Stage III rectocele. At the 6-month follow-up, five patients had rectocele ! Stage II (P < 0.001) and at the 12-month follow-up, seven patients had rectocele ! Stage 11 (P < 0.001) at clinical examination. At the preoperative defecography, all patients presented a rectocele. At the 12-month defecography, 14 patients had no rectocele (P < 0.001) and 15 had a rectocele. At the six-month follow-up, there was a significant decrease in rectal emptying difficulties, need of digital support of the posterior vaginal wall at defecation, and defecation frequency. At the 12-month follow-up, symptom improvement remained, but was less pronounced. CONCLUSIONS: Rectocele repair using collagen mesh improved anatomic support, but there is a substantial risk for recurrence with unsatisfactory anatomic and functional outcome one year after surgery. Rectocele repair using mesh was not associated with an increased risk of dyspareunia. Rectocele repair using biomaterial mesh reinforcement needs further evaluation before adopted into clinical practice.
C1 Danderyd Hosp, Karolinska Inst, Pelvic Floor Ctr, Div Obstet & Gynecol, Stockholm, Sweden.
   Danderyd Hosp, Karolinska Inst, Pelvic Floor Ctr, Div Surg, Stockholm, Sweden.
   Univ Minnesota, Div Colon & Rectal Surg, Minneapolis, MN USA.
RP Altman, D (reprint author), Danderyd Hosp, Dept Obstet & Gynecol, S-18288 Stockholm, Sweden.
EM damel.altman@ds.se
CR Altomare DF, 2002, DIS COLON RECTUM, V45, P1549, DOI 10.1097/01.DCR.0000034050.16880.12
   ARNOLD MW, 1990, DIS COLON RECTUM, V33, P684, DOI 10.1007/BF02150745
   Ayabaca SM, 2002, DIS COLON RECTUM, V45, P63, DOI 10.1007/s10350-004-6115-2
   Bremmer S, 1997, RADIOLOGY, V202, P373, DOI 10.1148/radiology.202.2.9015060
   Bremmer S, 1997, ACTA RADIOL, V38, P578
   Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0
   Cruikshank SH, 1999, AM J OBSTET GYNECOL, V180, P859, DOI 10.1016/S0002-9378(99)70656-3
   Cundiff GW, 1998, AM J OBSTET GYNECOL, V179, P1451, DOI 10.1016/S0002-9378(98)70009-2
   FitzGerald MP, 1999, AM J OBSTET GYNECOL, V181, P1339, DOI 10.1016/S0002-9378(99)70374-1
   Fitzgerald MP, 1999, BJU INT, V84, P785
   FRANCIS WJA, 1961, J OBSTET GYN BR COMM, V68, P1
   GOEI R, 1990, RADIOLOGY, V174, P124, DOI 10.1148/radiology.174.1.2294538
   Groutz A, 2001, UROLOGY, V58, P179, DOI 10.1016/S0090-4295(01)01177-3
   Ho YH, 1998, DIS COLON RECTUM, V41, P354, DOI 10.1007/BF02237491
   Iglesia C B, 1997, Int Urogynecol J Pelvic Floor Dysfunct, V8, P105, DOI 10.1007/BF02764826
   Kahn M A, 1998, Int Urogynecol J Pelvic Floor Dysfunct, V9, P37, DOI 10.1007/BF01900540
   Kahn MA, 1997, BRIT J OBSTET GYNAEC, V104, P82, DOI 10.1111/j.1471-0528.1997.tb10654.x
   KELVIN FM, 1992, RADIOLOGY, V184, P547, DOI 10.1148/radiology.184.2.1620863
   Kenton K, 1999, AM J OBSTET GYNECOL, V181, P1360, DOI 10.1016/S0002-9378(99)70406-0
   Kobashi KC, 2000, UROLOGY, V56, P9, DOI 10.1016/S0090-4295(00)00706-8
   Kohli N, 2001, Curr Womens Health Rep, V1, P53
   Kohli N, 2003, INT UROGYNECOL J PEL, V14, P146, DOI 10.1007/s00192-002-1013-4
   Lopez A, 2002, INT UROGYNECOL J PEL, V13, P22, DOI 10.1007/s001920200005
   Lopez A, 2001, INT UROGYNECOL J PEL, V12, P97, DOI 10.1007/PL00004032
   MELLGREN A, 1995, DIS COLON RECTUM, V38, P7, DOI 10.1007/BF02053850
   Miklos JR, 2002, INT UROGYNECOL J PEL, V13, P44, DOI 10.1007/s001920200009
   OLIVER RF, 1982, BIOMATERIALS, V3, P38, DOI 10.1016/0142-9612(82)90059-X
   Osterberg A, 1996, SCAND J GASTROENTERO, V31, P575, DOI 10.3109/00365529609009130
   PACKER MC, 1993, ANN R COLL SURG ENGL, V75, P193
   Patsner B, 2000, OBSTET GYNECOL, V95, P1029, DOI 10.1016/S0029-7844(99)00559-1
   RICHARDSON AC, 1993, CLIN OBSTET GYNECOL, V36, P976, DOI 10.1097/00003081-199312000-00022
   Rogers GR, 2001, INT UROGYNECOL J PEL, V12, P361, DOI 10.1007/s001920170012
   SHORVON PJ, 1989, GUT, V30, P1737, DOI 10.1136/gut.30.12.1737
   SIPROUDHIS L, 1993, DIS COLON RECTUM, V36, P1030, DOI 10.1007/BF02047295
   Sloots CEJ, 2003, INT J COLORECTAL DIS, V18, P342, DOI 10.1007/s00384-002-0469-5
   Stojkovic S G, 2003, Colorectal Dis, V5, P169, DOI 10.1046/j.1463-1318.2003.00427.x
   van Dam JH, 2000, INT J COLORECTAL DIS, V15, P54, DOI 10.1007/s003840050008
   Watson SJ, 1996, J AM COLL SURGEONS, V183, P257
NR 38
TC 32
Z9 37
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0012-3706
J9 DIS COLON RECTUM
JI Dis. Colon Rectum
PD JUN
PY 2005
VL 48
IS 6
BP 1233
EP 1241
DI 10.1007/s10350-005-0023-y
PG 9
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 930KY
UT WOS:000229415900019
PM 15868220
DA 2018-10-20
ER

PT J
AU Wunsch, L
   Ehlers, EM
   Russlies, M
AF Wunsch, L
   Ehlers, EM
   Russlies, M
TI Matrix testing for urothelial tissue engineering
SO EUROPEAN JOURNAL OF PEDIATRIC SURGERY
LA English
DT Article
DE urothelium; urothelial tissue engineering; mechanical matrix testing
ID ACELLULAR MATRIX; RECONSTRUCTION; REGENERATION
AB Introduction: Surgical reconstruction of the bladder is associated with many well-known complications. Tissue engineering is under discussion as a potential therapeutic strategy and many of the proposed benefits are of special interest for children. Biomaterials play a key role in tissue engineering. Many materials have been proposed for the experimental reconstruction of the bladder and urethra. They determine the biological and mechanical characteristics of the reconstructed tissues. Most publications focus on a single material. in order to identify the most suitable biomaterial it was the aim of this study to compare biological and mechanical features of different biomaterials seeded with urothelial cells in vitro. Materials and Methods: Commercially available biomaterials (Biogide((R)), Ethisorb((R)), Lyoplant((R)), SIS(R), Vicryl((R)), Xenoderm((R))) of biologic or synthetic origin were seeded with urothelial cells. Cell-matrix constructs were cultured and investigated by scanning electron microscopy for surface structure and cell morphology. They were also subjected to extension until failure and the force required was reported as f(max). Values obtained and curve shape were compared to specimens of bladder mucosa and submucosa. Results: Cell adhesion and morphology showed marked differences between materials. Cell shape varied from single spherical cells to confluent layers of flat urothelium. f(max) ranged from 0.02 N to 48.86 N for tested materials and 1.19 N for native bladder mucosa/submucosa. Discussion: The materials showed marked differences in biological and mechanical features in vitro. Cells cultured on biogenic matrices were more similar to native urothelium. Most of the tested materials showed different curve shapes and higher f(max) values than native bladder mucosa.
C1 Univ Lubeck, Dept Pediat Surg, D-23538 Lubeck, Germany.
   Univ Lubeck, Dept Anat, D-23538 Lubeck, Germany.
   Univ Lubeck, Dept Orthoped, D-23538 Lubeck, Germany.
RP Wunsch, L (reprint author), Univ Lubeck, Dept Pediat Surg, Ratzeburger Allee 160, D-23538 Lubeck, Germany.
EM wuensch@medinf.mu-luebeck.de
CR ATALA A, 2002, CAMPBELLS UROLOGY, P2595
   Chen F, 2000, WORLD J UROL, V18, P67, DOI 10.1007/s003450050012
   Cross WR, 2003, BJU INT, V92, P165, DOI 10.1046/j.1464-410X.2003.04280.x
   Dahms SE, 1998, BRIT J UROL, V82, P411
   EWALT DH, 1992, J UROLOGY, V148, P544, DOI 10.1016/S0022-5347(17)36650-8
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Kim T., 2000, ADV STUD CONT MATH, V2, P9
   OBERPENNING FO, 1999, NAT BIOTECHNOL, V17, P2
   Pariente JL, 2001, J BIOMED MATER RES, V55, P33, DOI 10.1002/1097-4636(200104)55:1<33::AID-JBM50>3.3.CO;2-Z
   Sievert KD, 2000, WORLD J UROL, V18, P19, DOI 10.1007/s003450050004
NR 10
TC 14
Z9 16
U1 0
U2 1
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0939-7248
J9 EUR J PEDIATR SURG
JI Eur. J. Pediatr. Surg.
PD JUN
PY 2005
VL 15
IS 3
BP 164
EP 169
DI 10.1055/s-2004-830356
PG 6
WC Pediatrics; Surgery
SC Pediatrics; Surgery
GA 945XC
UT WOS:000230535100004
PM 15999308
DA 2018-10-20
ER

PT J
AU Tonello, C
   Vindigni, V
   Zavan, B
   Abatangelo, S
   Abatangelo, G
   Brun, P
   Cortivo, R
AF Tonello, C
   Vindigni, V
   Zavan, B
   Abatangelo, S
   Abatangelo, G
   Brun, P
   Cortivo, R
TI In vitro reconstruction of an endothelialized skin substitute provided
   with a microcapillary network using biopolymer scaffolds
SO FASEB JOURNAL
LA English
DT Article
DE endothelial cells; skin substitute; angiogenesis; hyaluronic acid;
   tissue engineering
ID CAPILLARY-LIKE NETWORK; HYALURONIC-ACID; HUMAN WOUNDS; CELLS; TISSUE;
   EQUIVALENT; KERATINOCYTES; REPLACEMENT; GRAFTS; DERMIS
AB SSuccessful in vitro reconstruction of skin requires the inclusion of several cell types that give rise in coculture to the specific elements present in native skin, and the appropriate scaffolding structure to house and support these cells. In addition to the two main structural components, epidermis and dermis, one critical apparatus of the skin is a capillary network that guarantees adequate perfusion of nutrients and oxygen. The aim of the present study was to develop an in vitro coculture system that assumed the human dermal-epidermal architecture and included a microcapillary network in a three-dimensional biomaterial that guaranteed ease of handling in a clinical setting. Endothelialized skin (ES) was prepared by coculturing three human cell types: keratinocytes, fibroblasts, and endothelial cells, obtained from human full-thickness skin samples, in scaffolds produced from modified hyaluronic acid. Results were evaluated by histological and immunohistochemical analyses at different time points. In vitro, engineered skin obtained with this composite culture developed into a well-differentiated upper layer of stratified keratinocytes lining a dermal-like structure, in which fibroblasts, extracellular matrix and a microvascular network were present. Furthermore, the biodegradable fabric produced from hyaluronic acid and used as the scaffolding support for this in vitro constructed skin graft greatly facilitated handling in the perioperative period.
C1 Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35100 Padua, Italy.
RP Abatangelo, G (reprint author), Univ Padua, Dept Histol Microbiol & Med Biotechnol, Via G Colombo 3, I-35100 Padua, Italy.
EM g.abatangelo@unipd.it
OI Vindigni, Vincenzo/0000-0001-6638-9010
CR Balasubramani M, 2001, BURNS, V27, P534, DOI 10.1016/S0305-4179(01)00018-3
   Black AF, 1999, CELL BIOL TOXICOL, V15, P81, DOI 10.1023/A:1007541713398
   Black AF, 1998, FASEB J, V12, P1331
   BRIGGAMAN RA, 1968, J INVEST DERMATOL, V514, P54
   Brun P, 2000, Ostomy Wound Manage, V46, P44
   Caravaggi C, 2003, DIABETES CARE, V26, P2853, DOI 10.2337/diacare.26.10.2853
   CUONO CB, 1987, PLAST RECONSTR SURG, V80, P626, DOI 10.1097/00006534-198710000-00029
   EADY RA, 1994, J INVEST DERMATOL, V103, P13
   Galassi G, 2000, BIOMATERIALS, V21, P2183, DOI 10.1016/S0142-9612(00)00147-2
   GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706
   GALLICO GG, 1989, PLAST RECONSTR SURG, V84, P1
   Giuggioli D, 2003, RHEUMATOLOGY, V42, P694, DOI 10.1093/rheumatology/keg106
   GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665
   Griffiths M, 2004, TISSUE ENG, V10, P1180, DOI 10.1089/ten.2004.10.1180
   Grigolo B, 2003, Chir Organi Mov, V88, P351
   Guerret S, 2003, WOUND REPAIR REGEN, V11, P35, DOI 10.1046/j.1524-475X.2003.11107.x
   Halbleib M, 2003, BIOMATERIALS, V24, P3125, DOI 10.1016/S0142-9612(03)00156-X
   HANSBROUGH JF, 1994, SURGERY, V115, P633
   Hudon V, 2003, BRIT J DERMATOL, V148, P1094, DOI 10.1046/j.1365-2133.2003.05298.x
   Jones I, 2002, BRIT J PLAST SURG, V55, P185, DOI 10.1054/bjps.2002.3800
   Lam PK, 1999, J TRAUMA, V47, P918, DOI 10.1097/00005373-199911000-00017
   Lisignoli G, 2003, Chir Organi Mov, V88, P363
   Lobmann R, 2003, J DIABETES COMPLICAT, V17, P199, DOI 10.1016/S1056-8727(02)00218-0
   MURPHY JF, 2005, FASEB J ONLINE  0107
   Pavesio Alessandra, 2003, Novartis Found Symp, V249, P203
   Remuzzi A, 2004, TISSUE ENG, V10, P699, DOI 10.1089/1076327041348347
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   ROUSSELLE P, 1994, J CELL BIOL, V125, P205, DOI 10.1083/jcb.125.1.205
   SCALA C, 1992, J HISTOCHEM CYTOCHEM, V40, P1799, DOI 10.1177/40.11.1431065
   Sehchner J. S., 2003, FASEB J, V17, P2250
   Supp DM, 2002, FASEB J, V16, DOI 10.1096/fj.01-0868com
   Tonello C, 2003, BIOMATERIALS, V24, P1205, DOI 10.1016/S0142-9612(02)00450-7
   TRAMPEZINSKI S, 2004, EXP DERMATOL, V13, P98
   Turner NJ, 2004, BIOMATERIALS, V25, P5955, DOI 10.1016/j.biomaterials.2004.02.002
   Weber E, 2004, LYMPHOLOGY, V37, P15
   Zacchi V, 1998, J BIOMED MATER RES, V40, P187, DOI 10.1002/(SICI)1097-4636(199805)40:2<187::AID-JBM3>3.0.CO;2-H
NR 36
TC 44
Z9 45
U1 1
U2 6
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD JUN
PY 2005
VL 19
IS 8
BP 1546
EP +
DI 10.1096/fj.05-3804fje
PG 14
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 941IF
UT WOS:000230207800010
PM 15972294
DA 2018-10-20
ER

PT J
AU Kilian, O
   Alt, V
   Heiss, C
   Jonuleit, T
   Dingeldein, E
   Flesch, I
   Fidorra, U
   Wenisch, S
   Schnettler, R
AF Kilian, O
   Alt, V
   Heiss, C
   Jonuleit, T
   Dingeldein, E
   Flesch, I
   Fidorra, U
   Wenisch, S
   Schnettler, R
TI New blood vessel formation and expression of VEGF receptors after
   implantation of platelet growth factor-enriched biodegradable
   nanocrystalline hydroxyapatite
SO GROWTH FACTORS
LA English
DT Article
DE angiogenesis; platelet factors; VEGF; VEGF receptors; growth factor;
   biomaterial
ID VASCULAR-PERMEABILITY FACTOR; ENDOTHELIAL-CELLS; FLT-1; BONE;
   DIFFERENTIATION; ANGIOGENESIS; ACTIVATION; MECHANISMS; VASCULOTROPIN;
   LOCALIZATION
AB Vascular endothelial growth factor (VEGF) plays a key role for the interaction of osteoblasts and endothelial cells and, therefore, is an important factor for the osteointegration of bone substitutes. The aim of the current work was to study the effects of platelet growth factors (PLF) on new blood vessel formation and VEGF-receptors expression pattern in bone defects filled with nanocrystalline hydroxyapatite (HA) paste in miniature-pigs. Conventional histology, RT-PCR for VEGF and receptors mRNA, Western blot analysis, immunohistochemical staining and quantitative assessment of newly formed vessels was performed. HA enriched with platelet growth factor (HA/PLF+) led to an up-regulation of VEGF-R1 synthesis, a slightly enhanced number of newly formed vessels with higher sprouting activity compared with HA without PLF (HA/PLF-) filling defects. These observation are most likely attributable to a stimulating effect of TGF-beta from the platelet factor on VEGF expression in osteoblasts.
C1 Univ Giessen, Dept Trauma Surg, D-35392 Giessen, Germany.
   CellMed AG, Alzenau, Germany.
   Coripharm GmbH, Obernburg, Germany.
   Univ Tubingen, Dept Trauma Surg, Tubingen, Germany.
RP Kilian, O (reprint author), Univ Giessen, Dept Trauma Surg, Rudolf Buchheim St 7, D-35392 Giessen, Germany.
EM olaf.kilian@chiru.med.uni-giessen.de
CR ANTHONY FW, 1994, PLACENTA, V15, P567
   Augustin HG, 2001, CIRC RES, V89, P645, DOI 10.1161/res.89.8.645
   Boonyaprakob U, 2003, REPRODUCTION, V126, P393, DOI 10.1530/rep.0.1260393
   Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629
   CLAUSS M, 1990, J EXP MED, V172, P1535, DOI 10.1084/jem.172.6.1535
   Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667
   Deindl E, 2003, PHYSIOL RES, V52, P147
   Djonov V, 2003, CELL TISSUE RES, V314, P107, DOI 10.1007/s00441-003-0784-3
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   DVORAK HF, 1986, NEW ENGL J MED, V315, P1650
   Fang JM, 1997, ANAT EMBRYOL, V196, P349, DOI 10.1007/s004290050104
   Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4
   Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019
   Fiallo P, 2002, AM J TROP MED HYG, V66, P180, DOI 10.4269/ajtmh.2002.66.180
   Gabler C, 1999, MOL REPROD DEV, V53, P376, DOI 10.1002/(SICI)1098-2795(199908)53:4<376::AID-MRD2>3.0.CO;2-Z
   Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313
   Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659
   KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987
   KLEINHEINZ J, 2002, MUND KIEFER GESICHTS, V3, P175
   Koolwijk Pieter, 2001, Angiogenesis, V4, P53, DOI 10.1023/A:1016637700638
   LEI J, 1998, PLACENTA, V15, P557
   LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986
   MAYRWOHLFART U, 2002, BONE, V32, P472
   MIDY V, 1994, BIOCHEM BIOPH RES CO, V199, P380, DOI 10.1006/bbrc.1994.1240
   Mitola S, 1997, BLOOD, V90, P1365
   Nakagawa M, 2000, FEBS LETT, V473, P161, DOI 10.1016/S0014-5793(00)01520-9
   Patan S, 2000, J NEURO-ONCOL, V50, P1, DOI 10.1023/A:1006493130855
   Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013
   PLOUET J, 1990, J BIOL CHEM, V265, P22071
   Poulaki V, 2003, J CLIN ENDOCR METAB, V88, P5392, DOI 10.1210/jc.2003-030389
   Pufe T, 2002, CELL TISSUE RES, V309, P387, DOI 10.1007/s00441-002-0605-0
   Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0
   RUBANYI GM, 1994, PHARMACOL REV, V46, P325
   Saadeh PB, 2000, ENDOCRINOLOGY, V141, P2075, DOI 10.1210/en.141.6.2075
   Saadeh PB, 1999, AM J PHYSIOL, V277, P628
   Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785
   SHEN H, 1993, BLOOD, V81, P2767
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Tadic D, 2002, BIOMATERIALS, V23, P2553, DOI 10.1016/S0142-9612(01)00390-8
   Tisher E, 1991, J BIOL CHEM, V266, P11947
   Tolnay E, 1998, VIRCHOWS ARCH, V432, P61, DOI 10.1007/s004280050135
   TOMBRANTINK J, 2004, BIOCHEM BIOPH RES CO, V16, P573
   Uchida S, 2003, BONE, V32, P491, DOI 10.1016/S8756-3282(03)00053-X
   VAILLETTE CJ, 2004, BONE, V34, P288
   VAISMAN N, 1990, J BIOL CHEM, V265, P19461
   Vincenti V, 1996, CIRCULATION, V93, P1493, DOI 10.1161/01.CIR.93.8.1493
   WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988
   Wang DG, 1999, CANCER RES, V59, P1464
   Wang DS, 1997, ENDOCRINOLOGY, V138, P2953, DOI 10.1210/en.138.7.2953
   Welter H, 2003, EXP CLIN ENDOCR DIAB, V111, P33, DOI 10.1055/s-2003-37498
   Wilting J, 1996, DEV BIOL, V176, P76, DOI 10.1006/dbio.1996.9993
NR 51
TC 19
Z9 19
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0897-7194
J9 GROWTH FACTORS
JI Growth Factors
PD JUN
PY 2005
VL 23
IS 2
BP 125
EP 133
DI 10.1080/08977190500126306
PG 9
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA 954CR
UT WOS:000231132200006
PM 16019434
DA 2018-10-20
ER

PT J
AU Kaplan, M
   Baysal, K
AF Kaplan, M
   Baysal, K
TI In vitro toxicity test of ethyl 2-cyanoacrylate, a tissue adhesive used
   in cardiovascular surgery, by fibroblast cell culture method
SO HEART SURGERY FORUM
LA English
DT Article
ID CYANOACRYLATE; CYTOTOXICITY; BONE
AB Background: The aim of this study was to evaluate the cytotoxicity of cyanoacrylate polymers ( ethyl 2-cyanoacrylate) by an elution test system. In such systems, the material is extracted with a cell culture medium, which is subsequently added onto cultured cells, resulting in an indirect contact between the biomaterial and cells.
   Methods: A cell line commonly utilized for cytotoxicity experiments; L929 mouse fibroblasts were used in this study. The effects of extract dilutions on cells were evaluated by two experiments: ( a) The cells were suspended and seeded in a medium containing the extract, followed by a short incubation to observe the effects on cell attachment; (b) cells were seeded in a normal medium. Following cell attachment, this was replaced with a medium containing the extract and long-term effects on cell proliferation were measured. The cytotoxicity was quantified using a cell viability assay, well established for use in the evaluation of cell - biomaterial interactions.
   Results: These results indicate that, in the test system utilized, a tenfold dilution of the extract results in an similar to 10% decrease in cells; this increases to between 30% and 45% in a 1: 1 dilution. When a large number of cells (3000/well) were used, proliferation of cells overcame the cytotoxic effect and consistent results could not be observed.
   Conclusions: In this study, the observed outcomes follow a similar trend on cell attachment and proliferation with acute effects ( 4 hours incubation) of the extracts on the cells, producing slightly higher toxicity. Our findings are parallel with the literature findings.
C1 Siyami Ersek Thorac & Cardiovasc Surg Training &, Dept Cardiovasc Surg, Istanbul, Turkey.
   Sci & Tech Res Council Turkey, Marmara Res Ctr, Res Inst Genet Engn & Biotechnol, Istanbul, Turkey.
RP Kaplan, M (reprint author), 67 Ada,Kardelen 4-4,D-11, TR-34758 Istanbul, Turkey.
EM mehmetkaplan@superonline.com
CR APPLEBAUM JS, 1993, ANN EMERG MED, V22, P1190, DOI 10.1016/S0196-0644(05)80988-6
   BRAUER GM, 1979, J BIOMED MATER RES, V13, P593, DOI 10.1002/jbm.820130406
   Cenni E, 1999, TOXICOL IN VITRO, V13, P801, DOI 10.1016/S0887-2333(99)00058-2
   CIAPETTI G, 1994, BIOMATERIALS, V15, P92, DOI 10.1016/0142-9612(94)90256-9
   DEBLANCO LP, 1994, ENDOD DENT TRAUMATOL, V10, P15
   Demirtas MA, 1998, ANN THORAC SURG, V66, P304
   Demirtas MM, 1999, ASIAN CARDIOVASC THO, V7, P195
   EASTMAN DP, 1998, J HEART VALVE DIS, V7, P888
   Evans CE, 1999, J HAND SURG-BRIT EUR, V24B, P658, DOI 10.1054/jhsb.1999.0279
   Guo YL, 1998, J BIOL CHEM, V273, P4027, DOI 10.1074/jbc.273.7.4027
   Horsley WS, 1997, ANN THORAC SURG, V63, P1492, DOI 10.1016/S0003-4975(97)00115-X
   Kaplan M, 2004, EUR J DRUG METAB PH, V29, P77, DOI 10.1007/BF03190579
   Kaplan M, 2004, EUR J CARDIO-THORAC, V25, P167, DOI 10.1016/j.ejcts.2003.11.016
   LEAHEY AB, 1993, OPHTHALMOLOGY, V100, P173
   LEONARD F., 1967, J BIOMED MAT RES, V1, P3, DOI 10.1002/jbm.820010103
   Montanaro L, 2001, BIOMATERIALS, V22, P59, DOI 10.1016/S0142-9612(00)00163-0
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   Thumwanit V, 1999, AUST DENT J, V44, P248, DOI 10.1111/j.1834-7819.1999.tb00228.x
   WEBER SC, 1984, CLIN ORTHOP RELAT R, P249
   WERKER AM, 1997, ANN THORAC SURG, V63, P122
   YAVUZ SS, 2003, TURKISH THORAC CARDI, V11, P141
NR 21
TC 18
Z9 19
U1 0
U2 6
PU FORUM MULTIMEDIA PUBLISHING, LLC
PI CHARLOTTESVILLE
PA 375 GREENBRIER DR, CHARLOTTESVILLE, VA 22901 USA
SN 1098-3511
J9 HEART SURG FORUM
JI Heart Surg. Forum
PD JUN
PY 2005
VL 8
IS 3
BP E169
EP E172
DI 10.1532/HSF98.20041126
PG 4
WC Cardiac & Cardiovascular Systems; Surgery
SC Cardiovascular System & Cardiology; Surgery
GA 984WD
UT WOS:000233336400011
PM 15936999
DA 2018-10-20
ER

PT J
AU Crawford, A
   Frazer, A
   Fraser, S
   Dickinson, S
   Sims, T
   Hollander, AP
   Hatton, PV
AF Crawford, A
   Frazer, A
   Fraser, S
   Dickinson, S
   Sims, T
   Hollander, AP
   Hatton, PV
TI Deposition of collagen I, II and VI in tissue-engineered cartilage
   constructs: Effect of biomaterial morphology
SO INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
LA English
DT Meeting Abstract
CT Autumn Meeting of the British-Society-for-Matrix-Biology
CY SEP 13-14, 2004
CL Univ Bristol, Bristol, ENGLAND
SP Kendro, Fisher Sci, Thermo, SciQuip, Genzyme, Invitrogen, Leica, Geistlich, R&D Syst, Cellon SA, Verigen, Promega, SLS, Sigma Aldrich, Blackwell Med & Amaxa Biosyst
HO Univ Bristol
C1 Univ Sheffield, Sheffield, S Yorkshire, England.
   Univ Bristol, Bristol, Avon, England.
CR CRAWFORD A, 2004, BIOPOLYMER METHODS T
NR 1
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0959-9673
J9 INT J EXP PATHOL
JI Int. J. Exp. Pathol.
PD JUN
PY 2005
VL 86
IS 3
BP A44
EP A45
PG 2
WC Pathology
SC Pathology
GA 929UM
UT WOS:000229372100069
DA 2018-10-20
ER

PT J
AU Yun, AG
   Padgett, D
   Pellicci, P
   Dorr, LD
AF Yun, AG
   Padgett, D
   Pellicci, P
   Dorr, LD
TI Constrained acetabular liners - Mechanisms of failure
SO JOURNAL OF ARTHROPLASTY
LA English
DT Article
DE instability; constrained liner; acetabulum; impingement; failure
ID TOTAL HIP-ARTHROPLASTY; DISLOCATION; PROSTHESIS; COMPONENT; RECURRENT;
   SALVAGE
AB Although constrained acetabular liners have been successfully used for the treatment of recurrent hip instability, their usage has led to a growing number of associated complications. Twenty-seven patients (29 hips) who experienced failure of the constrained acetabular construct were retrospectively reviewed to define mechanisms of failure. Of these patients, 8 had a recurrent failure of another constrained liner. The 4 modes of failure were failure of fixation to the pelvis, liner dissociation, biomaterial failure, and femoral head dislocation. As constrained liners are highly subject to mechanical overload, the risk of failure can be minimized by reducing prosthetic impingement and avoiding technical errors. (c) 2005 Elsevier Inc. All rights reserved.
C1 Arthritis Inst, Inglewood, CA 90301 USA.
   Hosp Special Surg, New York, NY 10021 USA.
RP Yun, AG (reprint author), Arthritis Inst, 501 E Hardy St,3rd Floor, Inglewood, CA 90301 USA.
CR Anderson M J, 1994, J Arthroplasty, V9, P17, DOI 10.1016/0883-5403(94)90133-3
   Berry D J, 2001, Instr Course Lect, V50, P265
   BONNER KF, 2002, J BONE JOINT SURG AM, V9, P1587
   Callaghan JJ, 2001, CLIN ORTHOP RELAT R, P157
   Cobb TK, 1996, J BONE JOINT SURG AM, V78A, P80, DOI 10.2106/00004623-199601000-00011
   FRASER GA, 1981, J BONE JOINT SURG BR, V63, P552
   Goetz DD, 1998, J BONE JOINT SURG AM, V80A, P502, DOI 10.2106/00004623-199804000-00006
   Goetz DD, 1998, CLIN ORTHOP RELAT R, P171
   Kaper BP, 1998, J BONE JOINT SURG AM, V80A, P561, DOI 10.2106/00004623-199804000-00013
   Kaplan S J, 1987, J Arthroplasty, V2, P119, DOI 10.1016/S0883-5403(87)80018-9
   Lavigne MJF, 2001, J ARTHROPLASTY, V16, P13, DOI 10.1054/arth.2001.28362
   MELDRUM RD, 2001, J ARTHROPLASTY, V6, P748
   Shapiro G S, 2001, Instr Course Lect, V50, P281
NR 13
TC 29
Z9 31
U1 1
U2 3
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 0883-5403
J9 J ARTHROPLASTY
JI J. Arthroplast.
PD JUN
PY 2005
VL 20
IS 4
BP 536
EP 541
DI 10.1016/j.arth.2004.12.054
PG 6
WC Orthopedics
SC Orthopedics
GA 938YM
UT WOS:000230039300020
PM 16124973
DA 2018-10-20
ER

PT J
AU Hylton, DM
   Shalaby, SW
   Latour, RA
AF Hylton, DM
   Shalaby, SW
   Latour, RA
TI Direct correlation between adsorption-induced changes in protein
   structure and platelet adhesion
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE platelet adhesion; circular dichroism; protein adsorption; blood
   compatibility
ID CIRCULAR-DICHROISM SPECTROSCOPY; SECONDARY STRUCTURE; CONFORMATIONAL
   STATES; ELLIPSOMETRY; SURFACES; PLASMA; FIBRINOGEN; SPECTRA; ENZYMES;
   LAYERS
AB It is widely recognized that adsorbed proteins on biomaterial surfaces tend to initiate thrombus formation, although the specific mechanisms involved are still not well understood. In attempts to decrease the conformational change of adsorbed proteins, surface treatments that reduce surface hydrophobicity have been considered, such as the sulfonation of low-density polyethylene and isotactic polypropylene. The objectives of this present research were to study how changes in surface chemistry influence the degree of conformational change of adsorbing proteins and to investigate the correlation between the change in adsorbed protein structure and platelet response. Adsorbed porcine serum albumin and porcine fibrinogen were used as the model proteins for determining the effects of sulfonation on protein conformational change. Circular dichroism spectroscopy studies showed that the proteins were less altered structurally on the sulfonated surfaces. Platelet adhesion studies were used to correlate the number of adhered platelets with the amount of conformational change in adsorbed proteins on the polymer surface. The results of these studies show a linear correlation between platelet adhesion and the degree of adsorption-induced protein conformational change. These findings suggest that the degree of protein conformational change after adsorption is a dominant mechanism governing platelet interactions with biomaterial surfaces. &COPY; 2005 Wiley Periodicals, Inc.
C1 Clemson Univ, Dept Bioengn, Rhodes Engn Res Ctr 501, Clemson, SC 29634 USA.
   Poly Med Inc, Anderson, SC 29625 USA.
RP Latour, RA (reprint author), Clemson Univ, Dept Bioengn, Rhodes Engn Res Ctr 501, Clemson, SC 29634 USA.
EM LatourR@clemson.edu
CR ABBOTT WM, 1998, VASCULAR GRAFTS CHAR, P903
   Arwin H, 2000, THIN SOLID FILMS, V377, P48, DOI 10.1016/S0040-6090(00)01385-7
   Arwin H, 1998, THIN SOLID FILMS, V313, P764, DOI 10.1016/S0040-6090(97)00993-0
   BLONDELLE SE, 1995, BIOPHYS J, V68, P351, DOI 10.1016/S0006-3495(95)80194-3
   Conklin BS, 2002, MED ENG PHYS, V24, P173, DOI 10.1016/S1350-4533(02)00010-3
   ERNST CB, 2001, CURRENT THERAPY VASC, P944
   Herrick S, 1999, INT J BIOCHEM CELL B, V31, P741, DOI 10.1016/S1357-2725(99)00032-1
   Kosa T, 1998, PHARMACEUT RES, V15, P449, DOI 10.1023/A:1011932516717
   Lodish H, 2000, MOL CELL BIOL, P1084
   MALMSTEN M, 1994, J COLLOID INTERF SCI, V168, P247, DOI 10.1006/jcis.1994.1416
   MALMSTEN M, 1994, J COLLOID INTERF SCI, V166, P333, DOI 10.1006/jcis.1994.1303
   Malmsten M, 1997, J COLLOID INTERF SCI, V193, P88, DOI 10.1006/jcis.1997.5039
   MALMSTEN M, 1995, COLLOID SURFACE B, V3, P297
   MCMILLIN CR, 1974, J COLLOID INTERF SCI, V48, P345, DOI 10.1016/0021-9797(74)90170-2
   MINAR E, 1989, RADIOLOGY, V170, P767, DOI 10.1148/radiology.170.3.2521736
   PANKOWSKY DA, 1990, J VASC SURG, V11, P599, DOI 10.1067/mva.1990.18272
   PAOLETTI R, 1995, ARCH GERONTOL GERIAT, V20, P43, DOI 10.1016/0167-4943(94)00604-6
   SANDWICK RK, 1988, J COLLOID INTERF SCI, V121, P1, DOI 10.1016/0021-9797(88)90402-X
   SANDWICK RK, 1987, J COLLOID INTERF SCI, V115, P130, DOI 10.1016/0021-9797(87)90017-8
   Sonoda H, 2001, J BIOMED MATER RES, V55, P266, DOI 10.1002/1097-4636(20010605)55:3<266::AID-JBM1014>3.0.CO;2-C
   Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879
   Sreerama N, 1999, PROTEIN SCI, V8, P370
   Sreerama N, 2001, ANAL BIOCHEM, V299, P271, DOI 10.1006/abio.2001.5420
   SREERAMA N, 1994, J MOL BIOL, V242, P497
   SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Turbill P, 1996, BIOMATERIALS, V17, P1279, DOI 10.1016/0142-9612(96)88673-X
   WILLIAMS DF, 1971, BIOMED ENG, V6, P205
NR 28
TC 77
Z9 79
U1 1
U2 17
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 1
PY 2005
VL 73A
IS 3
BP 349
EP 358
DI 10.1002/jbm.a.30295
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 925ZY
UT WOS:000229093600011
PM 15834930
DA 2018-10-20
ER

PT J
AU Patel, JD
   Iwasaki, Y
   Ishihara, K
   Anderson, JM
AF Patel, JD
   Iwasaki, Y
   Ishihara, K
   Anderson, JM
TI Phospholipid polymer surfaces reduce bacteria and leukocyte adhesion
   under dynamic flow conditions
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE infection; shear stress; phospholipid polymers; Staphylococcus
   epidermidis; leukocytes
ID PROTEIN ADSORPTION; STAPHYLOCOCCUS-EPIDERMIDIS; SHEAR-STRESS;
   BIOMATERIAL INTERACTIONS; POLAR GROUP; BLOOD; HEMOCOMPATIBILITY;
   INFECTIONS; ACTIVATION; CHEMISTRY
AB Persistence of infection can occur when the host immune response is compromised because of the presence of a foreign implant. Surface modification of biomaterials with phospholipid polymers may enhance biocompatibility and reduce incidence of infection by impeding bacterial and leukocyte adhesion. A rotating disk model, which generates shear stress from 0 to 18 dynes/cm(2), was used to characterize adhesion of neutrophils, monocytes, and bacteria in phosphate-buffered saline (PBS) or 25%, human serum on polyethylene terephthalate surfaces coated with a phospholipid polymer, poly[&omega;-methacryloyloxyalkyl phosphorylcholine (MAPC)-co-n-butyl methacrylate (BMA)]. The material designated PMB30 contains a methylene chain length, (CH2)(n), of n = 2, whereas PMHB30 contains a chain length of n = 6. In PBS, bacterial adhesion was shear stress dependent with the lowest bacterial density observed on PMB30. However, the presence of serum proteins eliminated shear stress and surface chemistry effects in addition to bacterial adhesion reduced to &LT; 10% of adhesion in PBS. Trends for leukocyte adhesion in serum demonstrated shear dependence with PMB30 exhibiting the lowest cell density throughout the range of shear stresses. In conclusion, modification of the polyethylene terephthalate surfaces with phospholipid polymers resulted in reduced bacterial and leukocyte adhesion. Furthermore, shortening the methylene chain length of the MAPC copolymer most effectively reduced adhesion. &COPY; 2005 Wiley Periodicals, Inc.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
   Univ Tokyo, Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan.
   Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP Iwasaki, Y (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Urugadai, Tokyo 1010062, Japan.
EM yasu.org@tmd.ac.jp
RI Iwasaki, Yasuhiko/D-6870-2011
OI Iwasaki, Yasuhiko/0000-0003-1603-6174
CR Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   DICKINSON GM, 1989, ANTIMICROB AGENTS CH, V33, P597, DOI 10.1128/AAC.33.5.597
   Dickinson RB, 1997, J BIOMED MATER RES, V36, P152, DOI 10.1002/(SICI)1097-4636(199708)36:2<152::AID-JBM3>3.0.CO;2-J
   Gong YK, 2005, J BIOMED MATER RES A, V72A, P1, DOI 10.1002/jba.a.30135
   GRAY ED, 1984, LANCET, V1, P365
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   Higashi JM, 1999, HDB BIOMATERIALS EVA, P493
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   ISHIHARA K, 1994, J BIOMED MATER RES, V28, P225, DOI 10.1002/jbm.820280213
   ISHIHARA K, 1993, J BIOMED MATER RES, V27, P1309, DOI 10.1002/jbm.820271011
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Iwasaki Y, 1999, BIOMATERIALS, V20, P2185, DOI 10.1016/S0142-9612(99)00123-4
   Iwasaki Y, 1997, J COLLOID INTERF SCI, V192, P432, DOI 10.1006/jcis.1997.5047
   Iwasaki Y, 1997, J BIOMED MATER RES, V36, P508, DOI 10.1002/(SICI)1097-4636(19970915)36:4<508::AID-JBM8>3.0.CO;2-I
   Iwasaki Y, 2001, J BIOMED MATER RES, V57, P72, DOI 10.1002/1097-4636(200110)57:1<72::AID-JBM1143>3.0.CO;2-G
   Iwasaki Y, 1999, J BIOMAT SCI-POLYM E, V10, P513, DOI 10.1163/156856299X00450
   Iwasaki Y, 1996, J BIOMAT SCI-POLYM E, V8, P151, DOI 10.1163/156856296X00228
   IWASAKI Y, 1994, J BIOMAT SCI-POLYM E, V6, P447, DOI 10.1163/156856294X00437
   KLEINSTREUER C, 1997, ENG FLUID DYNAMICS
   LEVICH VG, 1962, PHYSICOCHEMICAL HYDR
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233
   Sapatnekar S, 1997, J BIOMED MATER RES, V35, P409, DOI 10.1002/(SICI)1097-4636(19970615)35:4<409::AID-JBM1>3.0.CO;2-L
   SAPATNEKAR S, 1995, J BIOMED MATER RES, V29, P247, DOI 10.1002/jbm.820290216
   Sawada S, 2003, J BIOMED MATER RES A, V64A, P411, DOI 10.1002/jbm.a.10433
   Shive MS, 2002, J BIOMED MATER RES, V60, P148, DOI 10.1002/jbm.10035
   Shive MS, 1999, J BIOMED MATER RES, V46, P511, DOI 10.1002/(SICI)1097-4636(19990915)46:4<511::AID-JBM9>3.0.CO;2-M
   Shive MS, 2000, P NATL ACAD SCI USA, V97, P6710, DOI 10.1073/pnas.110463197
   STOSSEL TP, 1971, J CLIN INVEST, V50, P1745, DOI 10.1172/JCI106664
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   TANAKA S, 1994, MACROMOL RAPID COMM, V15, P319, DOI 10.1002/marc.1994.030150404
   Tegoulia VA, 2000, J BIOMED MATER RES, V50, P291, DOI 10.1002/(SICI)1097-4636(20000605)50:3<291::AID-JBM2>3.0.CO;2-1
   UEDA T, 1991, J BIOMAT SCI-POLYM E, V3, P185
   VONEIFF C, 2002, LANCET INFECT DIS, V3, P677
   WANG IW, 1993, J INFECT DIS, V167, P329, DOI 10.1093/infdis/167.2.329
   Wootton DM, 1999, ANNU REV BIOMED ENG, V1, P299, DOI 10.1146/annurev.bioeng.1.1.299
   Yung LYL, 1998, BIOMATERIALS, V19, P31, DOI 10.1016/S0142-9612(97)00220-2
NR 40
TC 39
Z9 43
U1 0
U2 17
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 1
PY 2005
VL 73A
IS 3
BP 359
EP 366
DI 10.1002/jbm.a.30302
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 925ZY
UT WOS:000229093600012
PM 15800952
DA 2018-10-20
ER

PT J
AU Zhang, HP
   Ruan, JM
   Zhou, ZC
   Li, YJ
AF Zhang, HP
   Ruan, JM
   Zhou, ZC
   Li, YJ
TI Preparation of monomer of degradable biomaterial poly (L-lactide)
SO JOURNAL OF CENTRAL SOUTH UNIVERSITY OF TECHNOLOGY
LA English
DT Article
DE lactide; polylactide; purification; polymerization
ID POLYMERIZATION; POLYLACTONES; IMPLANTS
AB L-lactide was prepared from L-lactic acid with stannous octoate as the catalyst. The effects of reaction temperature and pressure on the ingredient of crude lactide were investigated. The results show that the mass fraction of meso-lactide increases with the increasing reaction temperature. Crude lactide containing 85.4% L-lactide is obtained when the reaction temperature is 200 degrees C. High purity of L-lactide with a yield of 40.6% is obtained by synthetic purifying method. The properties of L-lactide are characterized by optical purity, infrared spectrum and gas chromatogram/mass spectrum. The L-lactide samples purified by recrystallization and synthetic purifying methods are polymerized with the catalyst of stannous octoate, and the corresponding viscosity average relative molecular masses of poly(L-lactide) are 2.85 x 10(5) and 5.05 x 10(5), respectively. This indicates that the optical purity of L-lactide has great influence on the relative molecular mass of poly( L-lactide).
C1 Cent S Univ, State Key Lab Powder Met, Changsha 410083, Peoples R China.
RP Zhang, HP (reprint author), Cent S Univ, State Key Lab Powder Met, Changsha 410083, Peoples R China.
EM zhpxg@tom.com
CR BERGSMA JE, 1994, CELL MATER, V4, P31
   Chen LX, 2001, J WUHAN UNIV TECHNOL, V16, P10
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   ILLI OE, 1994, J MATER SCI-MATER M, V5, P417, DOI 10.1007/BF00058976
   KRICHELDORF HR, 1995, POLYMER, V36, P1253, DOI 10.1016/0032-3861(95)93928-F
   KRICHELDORF HR, 1985, POLYM BULL, V14, P497
   LEENSLAG JW, 1986, 5 INT C POL MED SURG, P101
   [娄玲 Lou Ling], 2003, [高分子材料科学与工程, Polymer Materials Science & Engineering], V19, P72
   Nicholson JW, 2002, J MATER SCI-MATER M, V13, P417, DOI 10.1023/A:1014305105445
   QUAN DP, 2000, APPL CHEM, V17, P268
   SCHINDLER A, 1979, J POLYM SCI POL CHEM, V17, P2593, DOI 10.1002/pol.1979.170170831
   SUONGHYU H, 1997, BIOMATERIALS, V18, P1503
   TAIZO F, 2000, J BIOMEDICAL MAT RES, V50, P410
   XIN J, 2002, J WUHAN UNIV TECHNOL, V24, P42
   YAMAGUCHI Y, PURIFYING METHOD LAC
   葛海雄, 2001, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V37, P251
NR 16
TC 6
Z9 9
U1 0
U2 10
PU JOURNAL OF CENTRAL SOUTH UNIV TECHNOLOGY
PI HUNAN
PA EDITORIAL OFFICE, CHANGSHA, HUNAN 410083, PEOPLES R CHINA
SN 1005-9784
J9 J CENT SOUTH UNIV T
JI J. Cent. South Univ. Technol.
PD JUN
PY 2005
VL 12
IS 3
BP 246
EP 250
DI 10.1007/s11771-005-0136-4
PG 5
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 941NV
UT WOS:000230222400002
DA 2018-10-20
ER

PT J
AU Kim, CS
   Choi, SH
   Cho, KS
   Chai, JK
   Wikesjo, UME
   Kim, CK
AF Kim, CS
   Choi, SH
   Cho, KS
   Chai, JK
   Wikesjo, UME
   Kim, CK
TI Periodontal healing in one-wall intra-bony defects in dogs following
   implantation of autogenous bone or a coral-derived biomaterial
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE ankylosis; autogenous bone; bone grafting; calcium carbonate; dogs;
   histology; intra-bony defect; root resorption
ID CALCIUM-CARBONATE; HISTOLOGICAL-EVALUATION; CANCELLOUS BONE; BEAGLE
   DOGS; REPAIR; REGENERATION; GRAFTS; MARROW; RESORPTION; LESIONS
AB Aim: Autogenous bone grafts and bone biomaterials are being used as part of protocols aiming at reconstruction of periodontal defects. There is a limited biologic information on the effect of such materials on periodontal healing, in particular aberrant healing events that may prevent their general use. The objective of this study was, using histological techniques, to evaluate periodontal healing with focus on root resorption and ankylosis following implantation of autogenous bone and a coral-derived biomaterial into intra-bony defects in dogs.
   Methods: One-wall intra-bony periodontal defects were surgically created at the distal aspect of the second and the mesial aspect of the fourth mandibular premolars in either right or left jaw quadrants in four Beagle dogs. Each animal received particulated autogenous bone and the resorbable calcium carbonate biomaterial into discrete one-wall intra-bony defects. The mucoperiosteal flaps were positioned and sutured to their pre-surgery position. The animals were euthanized 8 weeks post-surgery when block sections of the defect sites were collected and prepared for qualitative histological analysis.
   Results: There were no significant differences in periodontal healing between sites receiving autograft bone and the coral-derived biomaterial. A well-organized periodontal ligament bridging new bone and cementum regeneration was observed extending coronal to a notch prepared to delineate the apical extent of the defect. Osteoid and bone with enclosed osteocytes were formed onto the surface of both autograft and coral particles. Although small resorption pits were evident in most teeth, importantly none of the biomaterials provoked marked root resorption. Ankylosis was not observed.
   Conclusion: Particulated autogenous bone and the coral-derived biomaterial may be implanted into periodontal defects without significant healing aberrations such as root resorption and ankylosis. The histopathological evaluation suggests that the autogenous bone graft has a limited osteogenic potential as demonstrated in this study model.
C1 Yonsei Univ, Coll Dent, Brain Korea Project Med Sci 21, Dept Periodontol,Res Inst Periodontal Regenerat, Seoul 120749, South Korea.
   Temple Univ, Sch Dent, Dept Periodontol, Lab Appl Periodontal & Craniofacial Regenerat, Philadelphia, PA USA.
RP Kim, CS (reprint author), Yonsei Univ, Coll Dent, Brain Korea Project Med Sci 21, Dept Periodontol,Res Inst Periodontal Regenerat, 134 Shinchon Dong, Seoul 120749, South Korea.
EM ckkim@yumc.yonsei.ac.kr
RI Wikesjo, Ulf/A-4159-2009
OI Wikesjo, Ulf/0000-0003-1607-0583; Kim, Chang-Sung/0000-0003-3902-1071
CR AXHAUSEN W, 1956, J BONE JOINT SURG AM, V38, P593, DOI 10.2106/00004623-195638030-00009
   Becker W, 1998, J PERIODONTOL, V69, P414, DOI 10.1902/jop.1998.69.4.414
   Choi SH, 2002, J PERIODONTOL, V73, P63, DOI 10.1902/jop.2002.73.1.63
   DRAGOO MR, 1973, J PERIODONTOL, V44, P614, DOI 10.1902/jop.1973.44.10.614
   ELLEGAARD B, 1975, J PERIODONTAL RES, V10, P88, DOI 10.1111/j.1600-0765.1975.tb00012.x
   FRANK R, 1974, J PERIODONTOL, V45, P626, DOI 10.1902/jop.1974.45.8.2.626
   Gao TJ, 1997, BIOMATERIALS, V18, P219, DOI 10.1016/S0142-9612(96)00133-0
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   HIATT WH, 1973, J PERIODONTOL, V44, P194, DOI 10.1902/jop.1973.44.4.194
   Kim CK, 1996, J PERIODONTOL, V67, P1301, DOI 10.1902/jop.1996.67.12.1301
   Kim CS, 2004, J PERIODONTOL, V75, P229, DOI 10.1902/jop.2004.75.2.229
   Kim HY, 2002, J PERIODONTOL, V73, P1457, DOI 10.1902/jop.2002.73.12.1457
   LEVIN MP, 1975, J BIOMED MATER RES, V9, P183, DOI 10.1002/jbm.820090207
   MARX RE, 1994, CLIN PLAST SURG, V21, P377
   Moon IS, 1996, J CLIN PERIODONTOL, V23, P945, DOI 10.1111/j.1600-051X.1996.tb00516.x
   OUHAYOUN JP, 1992, J MATER SCI-MATER M, V3, P222, DOI 10.1007/BF00713454
   Pallesen L, 2002, INT J ORAL MAX IMPL, V17, P498
   Park JS, 2003, J CLIN PERIODONTOL, V30, P443, DOI 10.1034/j.1600-051X.2003.10283.x
   Piattelli A, 1997, BIOMATERIALS, V18, P623, DOI 10.1016/S0142-9612(96)00158-5
   RENVERT S, 1985, J CLIN PERIODONTOL, V12, P441, DOI 10.1111/j.1600-051X.1985.tb01380.x
   Reynolds Mark A, 2003, Ann Periodontol, V8, P227, DOI 10.1902/annals.2003.8.1.227
   RIVAULT AF, 1971, J PERIODONTOL, V42, P787, DOI 10.1902/jop.1971.42.12.787
   SCHALLHORN RG, 1972, J PERIODONTOL, V43, P67, DOI 10.1902/jop.1972.43.2.67
   SCHROEDER HE, 1992, INT REV CYTOL, V142, P1, DOI 10.1016/S0074-7696(08)62074-4
   SIGURDSSON TJ, 1994, J PERIODONTOL, V65, P350, DOI 10.1902/jop.1994.65.4.350
   Wikesjo UME, 2003, J PERIODONTOL, V74, P635, DOI 10.1902/jop.2003.74.5.635
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P655, DOI 10.1034/j.1600-051X.2003.00362.x
   WIKESJO UME, 1991, J CLIN PERIODONTOL, V18, P49, DOI 10.1111/j.1600-051X.1991.tb01119.x
   Wikesjo UME, 1999, PERIODONTOL 2000, V19, P21, DOI 10.1111/j.1600-0757.1999.tb00145.x
   WIKESJO UME, 2003, J PERIODONTOL, V74, P955
   Yukna RA, 1998, J CLIN PERIODONTOL, V25, P1036, DOI 10.1111/j.1600-051X.1998.tb02410.x
NR 32
TC 41
Z9 43
U1 0
U2 2
PU BLACKWELL MUNKSGAARD
PI FREDERIKSBERG C
PA 1 ROSENORNS ALLE, DK-1970 FREDERIKSBERG C, DENMARK
SN 0303-6979
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD JUN
PY 2005
VL 32
IS 6
BP 583
EP 589
DI 10.1111/j.1600-051X.2005.00729.x
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 924KE
UT WOS:000228976900008
PM 15882215
DA 2018-10-20
ER

PT J
AU Gerard, C
   Catuogno, C
   Amargier-Huin, C
   Grossin, L
   Hubert, P
   Gillet, P
   Netter, P
   Dellacherie, E
   Payan, E
AF Gerard, C
   Catuogno, C
   Amargier-Huin, C
   Grossin, L
   Hubert, P
   Gillet, P
   Netter, P
   Dellacherie, E
   Payan, E
TI The effect of alginate, hyaluronate and hyaluronate derivatives
   biomaterials on synthesis of non-articular chondrocyte extracellular
   matrix
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 7th World Biomaterials Congress
CY MAY 17-21, 2004
CL Sydney, AUSTRALIA
ID TISSUE-ENGINEERED CARTILAGE; IN-VITRO; SODIUM ALGINATE; COLLAGEN GELS;
   BEADS; ACID; PROLIFERATION; METABOLISM; EXPRESSION; PHENOTYPE
AB Cartilage engineering consists of re-constructing functional cartilage by seeding chondrocytes in suitable biomaterials in vitro. The characteristics of neocartilage differ upon the type of biomaterial chosen. This study aims at determining the appropriate scaffold material for articular cartilage reconstruction using non articular chondrocytes harvested from rat sternum. For this purpose, the use of polysaccharide hydrogels such as alginate (AA) and hyaluronic acid (HA) was investigated. Several ratios of AA/HA were used as well as three derivatives obtained by chemical modification of HA (HA-C18, HA-C12(2.3), HA-C12(2.5)-TEG(0.5)). Sternal chondrocytes were successfully cultured in 3D alginate and alginate/HA scaffolds. HA retention in alginate beads was found to be higher in beads seeded with cells than in beads without cells. HA-C18 improved HA retention in beads but inhibited the chondrocyte synthesis process. Cell proliferation and metabolism were enhanced in all biomaterials when beads were mechanically agitated. Preliminary results have shown that the chondrocyte neo-synthesised matrix had acquired articular characteristics after 21 days culture. (C) 2005 Springer Science + Business Media, Inc.
C1 Fac Med Vandoeuvre Nancy, UHP, CNRS, UMR 7561,Lab Pharmacol, F-54505 Vandoeuvre Les Nancy, France.
   Grp ENSIC, CNRS, UMR 7568, Lab Chim Phys Macromol, F-54000 Nancy, France.
RP Netter, P (reprint author), Fac Med Vandoeuvre Nancy, UHP, CNRS, UMR 7561,Lab Pharmacol, F-54505 Vandoeuvre Les Nancy, France.
CR BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BRODKIN KR, 2005, BIOMATERIALS, V25, P5929
   Chaipinyo K, 2004, J ORTHOPAED RES, V22, P446, DOI 10.1016/j.orthres.2003.07.001
   Chiba K, 1997, SPINE, V22, P2885, DOI 10.1097/00007632-199712150-00011
   CHOW G, 1995, J BIOL CHEM, V270, P27734, DOI 10.1074/jbc.270.46.27734
   Chowdhury TT, 2003, ARCH BIOCHEM BIOPHYS, V417, P105, DOI 10.1016/S0003-9861(03)00340-0
   Cui YL, 2003, J BIOMED MATER RES A, V66A, P770, DOI 10.1002/jbm.a.10071
   D'Souza AL, 2000, ARCH BIOCHEM BIOPHYS, V374, P59, DOI 10.1006/abbi.1999.1626
   Darling EM, 2004, J ORTHOP RES, V22, P1182, DOI 10.1016/j.orthres.2004.03.001
   Frenkel SR, 2004, ANN BIOMED ENG, V32, P26, DOI 10.1023/B:ABME.0000007788.41804.0d
   Gigante A, 2003, J MATER SCI-MATER M, V14, P713, DOI 10.1023/A:1024915817061
   GIGANTHUSELSTEI.C, 2003, J MECH MED BIOL, V1, P59
   Goodstone NJ, 2004, TISSUE ENG, V10, P621, DOI 10.1089/107632704323061979
   GOSH P, 1994, CLIN EXP RHEUMATOL, V12, P75
   Grunder T, 2004, OSTEOARTHR CARTILAGE, V12, P559, DOI 10.1016/j.joca.2004.04.001
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   HAUSELMANN HJ, 1992, MATRIX, V12, P116
   Homandberg GA, 1997, OSTEOARTHR CARTILAGE, V5, P309, DOI 10.1016/S1063-4584(97)80035-0
   Kawasaki K, 1999, J CELL PHYSIOL, V179, P142, DOI 10.1002/(SICI)1097-4652(199905)179:2<142::AID-JCP4>3.0.CO;2-Q
   Lee D A, 1993, Osteoarthritis Cartilage, V1, P137, DOI 10.1016/S1063-4584(05)80029-9
   Lee DA, 2003, ACTA ORTHOP SCAND, V74, P6, DOI 10.1080/00016470310013581
   Lindenhayn K, 1999, J BIOMED MATER RES, V44, P149, DOI 10.1002/(SICI)1097-4636(199902)44:2<149::AID-JBM4>3.0.CO;2-C
   Luyten FP, 2001, BEST PRACT RES CL RH, V15, P759, DOI 10.1053/berh.2001.0192
   Malda J, 2005, BIOMATERIALS, V26, P63, DOI 10.1016/j.biomaterials.2004.02.046
   Masuda K, 2003, J ORTHOPAED RES, V21, P139, DOI 10.1016/S0736-0266(02)00109-2
   MCCOURT PAG, 1994, J BIOL CHEM, V269, P30081
   Mierisch CM, 2003, J BONE JOINT SURG AM, V85A, P1757, DOI 10.2106/00004623-200309000-00015
   Miralles G, 2001, J BIOMED MATER RES, V57, P268, DOI 10.1002/1097-4636(200111)57:2<268::AID-JBM1167>3.0.CO;2-L
   Patti AM, 2001, TISSUE CELL, V33, P294, DOI 10.1054/tice.2001.0178
   Payan E, 1998, ANAL CHEM, V70, P4780, DOI 10.1021/ac9800558
   Pelletier S, 2000, CARBOHYD POLYM, V43, P343, DOI 10.1016/S0144-8617(00)00188-0
   PELLETIER S, 2000, J BIOMED MATER RES, V54, P102
   Shen Yan, 2004, Chin J Traumatol, V7, P42
   Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002
   Stove J, 2002, J ORTHOPAED RES, V20, P551, DOI 10.1016/S0736-0266(01)00141-3
   Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200
NR 36
TC 33
Z9 36
U1 1
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2005
VL 16
IS 6
BP 541
EP 551
DI 10.1007/s10856-005-0530-3
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 931SI
UT WOS:000229505100009
PM 15928870
DA 2018-10-20
ER

PT J
AU Cellesi, F
   Tirelli, N
AF Cellesi, F
   Tirelli, N
TI A new process for cell microencapsulation and other biomaterial
   applications: Thermal gelation and chemical cross-linking in 'tandem'
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 7th World Biomaterials Congress
CY MAY 17-21, 2004
CL Sydney, AUSTRALIA
ID COPOLYMER; ALGINATE; SYSTEM
AB The very rapid gelation of a cell- or biomolecule-containing solution is at the basis of most processes employed in microencapsulation. Adequately quick ('instantaneous') gelation kinetics are provided by a number of phenomena based on physical association.
   On the other hand, physical gels are inherently reversible structures, which can be solubilized or disrupted in response to often poorly controllable phenomena in the environment of application, such as dilution, changes in temperature, ion strength and composition, pH, or other physical or chemical parameters.
   Chemically cross-linked hydrogels would have therefore significant advantages in terms of stability and end-properties; however, the time required for chemical reactions to produce a chemically cross-linked material is in a more general case hardly compatible with microencapsulation processes.
   In a recent study of our laboratory we have proposed a new approach for providing both quick gelation kinetics and good stability, by simply combining the rapid kinetics of a physical hardening phenomenon with a slower chemical curing; the former process is thus responsible of the morphogenesis of the material, while the latter develops its end-properties. (C) 2005 Springer Science + Business Media, Inc.
C1 Univ Manchester, Sch Pharm, Manchester M13 9PL, Lancs, England.
   Univ Manchester, Mol Mat Ctr, Manchester M13 9PL, Lancs, England.
   ETH, Inst Biomed Engn, Zurich, Switzerland.
   ETH, Dept Mat, Zurich, Switzerland.
RP Tirelli, N (reprint author), Univ Manchester, Sch Pharm, Manchester M13 9PL, Lancs, England.
EM nicola.tirelli@man.ac.uk
RI Tirelli, Nicola/P-7210-2014; Tirelli, Nicola/P-3604-2018
OI Tirelli, Nicola/0000-0002-4879-3949; Tirelli,
   Nicola/0000-0002-4879-3949; CELLESI, FRANCESCO/0000-0001-6106-9317
CR ALEXANDRIDIS P, 1995, COLLOID SURFACE A, V96, P1, DOI 10.1016/0927-7757(94)03028-X
   Brandenberger HR, 1999, BIOTECHNOL PROGR, V15, P366, DOI 10.1021/bp990033m
   BUGARSKI B, 1994, AICHE J, V40, P1026, DOI 10.1002/aic.690400613
   Cellesi F, 2004, BIOMATERIALS, V25, P5115, DOI 10.1016/j.biomaterials.2003.12.015
   Cellesi F, 2002, MACROMOL CHEM PHYSIC, V203, P1466, DOI 10.1002/1521-3935(200207)203:10/11<1466::AID-MACP1466>3.0.CO;2-P
   CELLESI F, 2004, IN PRESS BIOTECHNOL
   Cruise GM, 1998, BIOTECHNOL BIOENG, V57, P655, DOI 10.1002/(SICI)1097-0290(19980320)57:6<655::AID-BIT3>3.0.CO;2-K
   Dalton PD, 2002, BIOMATERIALS, V23, P3843, DOI 10.1016/S0142-9612(02)00120-5
   Fundueanu G, 1999, BIOMATERIALS, V20, P1427, DOI 10.1016/S0142-9612(99)00050-2
   Hill RS, 1997, ANN NY ACAD SCI, V831, P332
   Lau BK, 2004, J POLYM SCI POL PHYS, V42, P2014, DOI 10.1002/polb.20105
   LEVEE MG, 1994, BIOTECHNOL BIOENG, V43, P734, DOI 10.1002/bit.260430807
   Li RH, 1998, ADV DRUG DELIVER REV, V33, P87, DOI 10.1016/S0169-409X(98)00022-2
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   Midha R, 2003, J NEUROSURG, V99, P555, DOI 10.3171/jns.2003.99.3.0555
   MORTENSEN K, 1992, PHYS REV LETT, V68, P2340, DOI 10.1103/PhysRevLett.68.2340
   MORTENSEN K, 1993, MACROMOLECULES, V26, P4128, DOI 10.1021/ma00068a010
   Orive G, 2004, TRENDS BIOTECHNOL, V22, P87, DOI 10.1016/j.tibtech.2003.11.004
   Prusse U, 1998, CHEM ENG TECHNOL, V21, P29, DOI 10.1002/(SICI)1521-4125(199801)21:1<29::AID-CEAT29>3.0.CO;2-Y
   ZIMMERMANN U, 2001, BIOTECHNOLOGY, P548
NR 21
TC 14
Z9 14
U1 0
U2 13
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2005
VL 16
IS 6
BP 559
EP 565
DI 10.1007/s10856-005-0532-1
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 931SI
UT WOS:000229505100011
PM 15928872
DA 2018-10-20
ER

PT J
AU Turhani, D
   Cvikl, B
   Watzinger, E
   Weissenbock, M
   Yerit, K
   Thurnher, D
   Lauer, G
   Ewers, R
AF Turhani, D
   Cvikl, B
   Watzinger, E
   Weissenbock, M
   Yerit, K
   Thurnher, D
   Lauer, G
   Ewers, R
TI In vitro growth and differentiation of osteoblast-like cells on
   hydroxyapatite ceramic granule calcified from red algae
SO JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
ID CALCIUM-PHOSPHATE CERAMICS; BONE; BEHAVIOR; DEFECTS; INVITRO; SINUS
AB Purpose: The purpose of this study was to analyze the interaction between osteoblast-like cells isolated from mandibular bone and hydroxyapatite ceramic bone substitute obtained from calcified red algae to assess the growth and differentiation of adherent cells on this biomaterial.
   Materials and Methods: The macroporous ceramic material C GRAFT/Algipore (The Clinician's Preference LLC, Golden, CO) is composed of 100% hydroxyapatite and possesses specific mechanical and physiochemical properties. Osteoblast-like cells were seeded on 200 mg of biomaterial and cultured for 6 and 21 days under osteogenic differentiation conditions. Specific alkaline phosphatase activity, DNA, and protein content of the proliferating cells were analyzed. The morphology of the cells in contact with the biomaterial was examined by scanning electron microscopy. The osteoblastic phenotype of the cells was confirmed by analysis of the expression of bone-specific genes (osteocalcin, osteopontin and collagen type I) by semi-quantitative reverse transcriptase polymerase chain reaction.
   Results: The DNA and protein content increased over the culture period. Scanning electron microscopy showed cells spreading on the surface of the biomaterials, covering the macropores, and colonizing the depth of the particles. The analysis of the expression patterns of bone-related genes confirmed the osteoblastic phenotype of the cultured cells.
   Conclusion: The results of this study showed that hydroxyapatite ceramic bone substitute obtained from calcified red algae support the proliferation and differentiation of human osteoblast-like cells on its surface in vitro and might be suitable for use as scaffolds in tissue engineering strategies in vivo. &COPY; 2005 American Association of Oral and Maxillofacial Surgeons.
C1 Med Univ Vienna, Hosp Craniomaxillofacial & Oral Surg, A-1090 Vienna, Austria.
   Med Univ Vienna, Dept Otorhinolaryngol, A-1090 Vienna, Austria.
   Univ Dresden, Dept Oral & Maxillofacial Surg, Dresden, Germany.
RP Turhani, D (reprint author), Med Univ Vienna, Hosp Craniomaxillofacial & Oral Surg, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
EM dritan.turhani@meduniwien.ac.at
OI Stein, Elisabeth/0000-0002-1240-506X
CR BAGAMBISA F B, 1990, International Journal of Oral and Maxillofacial Implants, V5, P217
   BAGAMBISA FB, 1990, BIOMATERIALS, V11, P50, DOI 10.1016/0142-9612(90)90052-R
   BAGAMBISA FB, 1994, CRANIOMAXILLOFAC SUR, V1, P12
   Baumann A, 1999, MUND KIEFER GESIC S1, V3, P70
   Chang YL, 2000, J BIOMED MATER RES, V52, P270, DOI 10.1002/1097-4636(200011)52:2<270::AID-JBM5>3.0.CO;2-1
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   DODEN E, 1993, CALCIFIED TISSUE INT, V52, P30
   DUCHEYNE P, 1993, J BIOMED MATER RES, V27, P25, DOI 10.1002/jbm.820270105
   Ewers R, 2004, CLIN ORAL IMPLAN RES, V15, P96, DOI 10.1111/j.1600-0501.2004.00987.x
   Ewers R, 1987, Zahnarztl Prax, V38, P318
   EWERS R, 1994, J CRANIO MAXILLOF S1, V22, P92
   FRANK RM, 1991, J CLIN PERIODONTOL, V18, P669, DOI 10.1111/j.1600-051X.1991.tb00108.x
   GOMI K, 1993, BIOMATERIALS, V14, P91, DOI 10.1016/0142-9612(93)90216-O
   GRUNDEL RE, 1991, CLIN ORTHOP RELAT R, P244
   Herr G, 1993, Ann Chir Gynaecol Suppl, V207, P99
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ignatius A, 2005, BIOMATERIALS, V26, P311, DOI 10.1016/j.biomaterials.2004.02.045
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KASPERK C, 1988, INT J ORAL MAX SURG, V17, P319
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   MOORE DC, 1987, J ORTHOP RES, V5, P356, DOI 10.1002/jor.1100050307
   MULLERMAI CM, 1990, SCANNING MICROSCOPY, V4, P613
   OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   SCHOBER C, 1991, Z STOMATOL, V88, P259
   Schopper C, 1999, J LONG-TERM EFF MED, V9, P203
   SCHOPPER C, 2001, ORAL MAXILLOFAC SURG, V13, P3
   Terheyden H, 1997, Mund Kiefer Gesichtschir, V1, P272
   TERHEYDEN H, 1996, J CRANIOMAXILLOFA S1, V24, P114
   WOLFE SA, 1982, CLIN PLAST SURG, V9, P539
   Young GM, 1997, J NEUROSCI METH, V77, P163, DOI 10.1016/S0165-0270(97)00123-4
NR 31
TC 37
Z9 40
U1 0
U2 6
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0278-2391
J9 J ORAL MAXIL SURG
JI J. Oral Maxillofac. Surg.
PD JUN
PY 2005
VL 63
IS 6
BP 793
EP 799
DI 10.1016/j.jams.2005.02.015
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 932PR
UT WOS:000229566300013
PM 15944976
DA 2018-10-20
ER

PT J
AU Drachev, VP
   Thoreson, MD
   Nashine, V
   Khaliullin, EN
   Ben-Amotz, D
   Davisson, VJ
   Shalaev, VM
AF Drachev, VP
   Thoreson, MD
   Nashine, V
   Khaliullin, EN
   Ben-Amotz, D
   Davisson, VJ
   Shalaev, VM
TI Adaptive silver films for surface-enhanced Raman spectroscopy of
   biomolecules
SO JOURNAL OF RAMAN SPECTROSCOPY
LA English
DT Article
DE protein sensing; metal nanostructures; surface-enhanced Raman
   scattering; insulin; protein binding reaction
ID RHODAMINE 6G MOLECULES; ISLAND FILMS; OPTICAL-PROPERTIES; SCATTERING
   SERS; LIGAND-BINDING; ELECTRODE; PYRIDINE; SPECTRA; NANOSTRUCTURES;
   NANOPARTICLES
AB The interaction of biological molecules with a typical substrate for surface-enhanced Raman scattering (SERS) often leads to their structural and functional changes. In this paper we describe SERS substrates, called adaptive silver films (ASFs), in which the biomaterial and the substrate act in concert to produce excellent Raman enhancement through local restructuring of the metal surface while at the same time preserving the properties (such as conformational state and binding activity) of the analyte. These adaptive substrates show great promise for SERS spectroscopy of many different types of biomolecules, and we provide several current examples of their use. Copyright (c) 2005 John Wiley & Sons, Ltd.
C1 Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.
RP Thoreson, MD (reprint author), Purdue Univ, Sch Elect & Comp Engn, 465 NW Ave, W Lafayette, IN 47907 USA.
EM mthoreso@purdue.edu
RI Drachev, Vladimir/J-5778-2013
CR ADRIAN FJ, 1982, J CHEM PHYS, V77, P5302, DOI 10.1063/1.443800
   ALBRECHT MG, 1977, J AM CHEM SOC, V99, P5215, DOI 10.1021/ja00457a071
   BAUER G, 2002, METHODS TOOLS BIOSCI, P253
   BERGMAN JG, 1981, OPT LETT, V6, P33, DOI 10.1364/OL.6.000033
   BROWN CR, 1985, CLIN CHEM, V31, P1500
   Brown KR, 1996, J AM CHEM SOC, V118, P1154, DOI 10.1021/ja952951w
   Butler JE, 2000, J IMMUNOASSAY, V21, P165, DOI 10.1080/01971520009349533
   Callender R, 1998, J RAMAN SPECTROSC, V29, P15, DOI 10.1002/(SICI)1097-4555(199801)29:1<15::AID-JRS211>3.0.CO;2-L
   Campion A, 1998, CHEM SOC REV, V27, P241, DOI 10.1039/a827241z
   Cao YC, 2003, J AM CHEM SOC, V125, P14676, DOI 10.1021/ja0366235
   Cao YWC, 2002, SCIENCE, V297, P1536, DOI 10.1126/science.297.5586.1536
   CHEN CY, 1980, PHYS REV LETT, V45, P1287, DOI 10.1103/PhysRevLett.45.1287
   CHEN CY, 1979, SOLID STATE COMMUN, V32, P63, DOI 10.1016/0038-1098(79)90998-0
   DAVIES JP, 1986, ANAL CHEM, V58, P1290, DOI 10.1021/ac00298a005
   Drachev VP, 2003, PROC SPIE, V5221, P76, DOI 10.1117/12.510572
   Drachev VP, 2004, J PHYS CHEM B, V108, P18046, DOI 10.1021/jp047254h
   DRACHEV VP, 2001, OPTICAL PROPERTIES N, P113
   ECKERTOVA L, 1977, PHYS THIN FILMS
   Ferrari D, 2001, BIOPOLYMERS, V62, P249, DOI 10.1002/bip.1020
   FLEISCHMANN M, 1974, CHEM PHYS LETT, V26, P163, DOI 10.1016/0009-2614(74)85388-1
   Gadenne P, 1997, PHYSICA A, V241, P161, DOI 10.1016/S0378-4371(97)00076-9
   Grubisha DS, 2003, ANAL CHEM, V75, P5936, DOI 10.1021/ac034356f
   GUTCHO S, 1977, CLIN CHEM, V23, P1609
   HAYES FJ, 1994, ANAL CHEM, V66, P1860, DOI 10.1021/ac00083a014
   Haynes CL, 2003, J PHYS CHEM B, V107, P7426, DOI 10.1021/jp027749b
   HOLLAND WR, 1984, PHYS REV LETT, V52, P1041, DOI 10.1103/PhysRevLett.52.1041
   HOLT RE, 1989, J AM CHEM SOC, V111, P2815, DOI 10.1021/ja00190a012
   JEANMAIRE DL, 1977, J ELECTROANAL CHEM, V84, P1, DOI 10.1016/S0022-0728(77)80224-6
   Kneipp K, 1997, PHYS REV LETT, V78, P1667, DOI 10.1103/PhysRevLett.78.1667
   LEITNER A, 1993, APPL OPTICS, V32, P102, DOI 10.1364/AO.32.000102
   LOMBARDI JR, 1986, J CHEM PHYS, V84, P4174, DOI 10.1063/1.450037
   MCCALL SL, 1980, PHYS LETT A, V77, P381, DOI 10.1016/0375-9601(80)90726-4
   Michaels AM, 1999, J AM CHEM SOC, V121, P9932, DOI 10.1021/ja992128q
   Michaels AM, 2000, J PHYS CHEM B, V104, P11965, DOI 10.1021/jp0025476
   MOSKOVITS M, 1978, J CHEM PHYS, V69, P4159, DOI 10.1063/1.437095
   MOSKOVITS M, 1985, REV MOD PHYS, V57, P783, DOI 10.1103/RevModPhys.57.783
   Musick MD, 1997, CHEM MATER, V9, P1499, DOI 10.1021/cm970087w
   Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102
   OTTO A, 1978, SURF SCI, V75, pL392, DOI 10.1016/0039-6028(78)90263-7
   PANDEY PKK, 1984, J CHEM PHYS, V80, P2959, DOI 10.1063/1.447045
   PERSSON BNJ, 1981, CHEM PHYS LETT, V82, P561, DOI 10.1016/0009-2614(81)85441-3
   POCKRAND I, 1980, SOLID STATE COMMUN, V35, P861, DOI 10.1016/0038-1098(80)91040-6
   Prodan E, 2003, SCIENCE, V302, P419, DOI 10.1126/science.1089171
   RITCHIE G, 1982, SURFACE ENHANCED RAM, P361
   Sarychev AK, 2000, PHYS REP, V335, P276
   Schatz G. S., 2002, HDB VIBRATIONAL SPEC, P759
   SCHLEGEL VL, 1991, ANAL CHEM, V63, P241, DOI 10.1021/ac00003a010
   Shafer-Peltier KE, 2003, J AM CHEM SOC, V125, P588, DOI 10.1021/ja028255v
   Shalaev V., 2000, NONLINEAR OPTICS RAN
   Sibbald MS, 1997, J ELECTROANAL CHEM, V438, P179, DOI 10.1016/S0022-0728(97)00035-1
   STOCKMAN MI, 1992, PHYS REV B, V46, P2821, DOI 10.1103/PhysRevB.46.2821
   Stuart HR, 1998, PHYS REV LETT, V80, P5663, DOI 10.1103/PhysRevLett.80.5663
   VANDUYNE RP, 1993, J CHEM PHYS, V99, P2101, DOI 10.1063/1.465276
   Vo-Dinh T, 1998, TRAC-TREND ANAL CHEM, V17, P557, DOI 10.1016/S0165-9936(98)00069-7
   Vo-Dinh T, 1999, J RAMAN SPECTROSC, V30, P785, DOI 10.1002/(SICI)1097-4555(199909)30:9<785::AID-JRS450>3.0.CO;2-6
   Vogel E, 1998, J RAMAN SPECTROSC, V29, P693, DOI 10.1002/(SICI)1097-4555(199808)29:8<693::AID-JRS283>3.0.CO;2-O
   VUORI J, 1991, CLIN CHEM, V37, P2087
   WEITZ DA, 1982, OPT LETT, V7, P168, DOI 10.1364/OL.7.000168
   XU YY, 1992, CLIN CHEM, V38, P2038
   YANG MS, 1993, ANAL CHEM, V65, P3713, DOI 10.1021/ac00072a027
   YANG WH, 1995, J CHEM PHYS, V103, P869, DOI 10.1063/1.469787
   YU NT, 1974, ARCH BIOCHEM BIOPHYS, V160, P614, DOI 10.1016/0003-9861(74)90438-X
   YU NT, 1972, J MOL BIOL, V70, P117, DOI 10.1016/0022-2836(72)90167-2
   YUNT, 1972, J AM CHEM SOC, V94, P3250
NR 64
TC 47
Z9 47
U1 1
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0377-0486
EI 1097-4555
J9 J RAMAN SPECTROSC
JI J. Raman Spectrosc.
PD JUN-JUL
PY 2005
VL 36
IS 6-7
BP 648
EP 656
DI 10.1002/jrs.1356
PG 11
WC Spectroscopy
SC Spectroscopy
GA 950AE
UT WOS:000230829200023
DA 2018-10-20
ER

PT J
AU Qing, XL
   Zheng, CL
   Cui, FZ
AF Qing, XL
   Zheng, CL
   Cui, FZ
TI In vitro endothelialization on CNx films deposited on PTFE
SO JOURNAL OF THE KOREAN PHYSICAL SOCIETY
LA English
DT Article; Proceedings Paper
CT 11th China-Korea Symposium on Thin Film Materials
CY JUN 28-JUL 05, 2004
CL Chengdu, PEOPLES R CHINA
SP Nat Sci Fdn China, Inst Nucl Sci & Technol, Sichuan Univ, SW Inst Phys, Korea Sci & Engn Fdn, Hanyang Univ, Quantum Photon Sci Res Ctr, Inha Univ, Opt Technol Educ Ctr, Korean Vacuum Soc
DE carbon nitride films; endothelial cells; PTFE; biomaterial; IBAD
ID DIAMOND-LIKE CARBON; NITRIDE THIN-FILMS; IMMERSION ION-IMPLANTATION;
   SURFACE MODIFICATION; PLASMA TREATMENT; BIOCOMPATIBILITY; AMMONIA; RAMAN
AB Endothelial cells were successfully seeded onto carbon nitride (CNx) films deposited on polytetrafluoroethylene (PTFE) by using the ion beam-assisted deposition (IBAD) technique. X-ray photoelectron spectroscopy and, Raman characterization of the resulting films showed that MAD was efficient in fabricating CNx films with controllable nitrogen content and sp(2)/sp(3) fraction. The 48 hr cell culture indicated the endothelial cells grew best on CNx film with greatest nitrogen content. The CNx-coated PTFE may be a promising vascular prosthesis in vascular reconstruction.
C1 Tsing Hua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
RP Cui, FZ (reprint author), Tsing Hua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
EM cuifz@tsinghua.edu.cn
CR Alonso F, 2002, DIAM RELAT MATER, V11, P1161, DOI 10.1016/S0925-9635(01)00582-9
   APOSTOLOS KT, 2000, BIOMATER SCI, V11, P1275
   Badey JP, 1996, POLYMER, V37, P1377, DOI 10.1016/0032-3861(96)81135-9
   Baquey C, 1999, NUCL INSTRUM METH B, V151, P255, DOI 10.1016/S0168-583X(99)00106-8
   Bhattacharyya S, 1998, J APPL PHYS, V83, P3917, DOI 10.1063/1.367312
   Chandy T, 2000, BIOMATERIALS, V21, P699, DOI 10.1016/S0142-9612(99)00231-8
   Chen JY, 2002, SURF COAT TECH, V156, P289, DOI 10.1016/S0257-8972(02)00089-0
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Du C, 1998, BIOMATERIALS, V19, P651, DOI 10.1016/S0142-9612(97)00159-2
   Ferrari AC, 2003, DIAM RELAT MATER, V12, P905, DOI 10.1016/S0925-9635(02)00370-9
   He JL, 1998, NUCL INSTRUM METH B, V135, P512, DOI 10.1016/S0168-583X(97)00630-7
   Husein IF, 1996, MAT SCI ENG A-STRUCT, V209, P10, DOI 10.1016/0921-5093(95)10096-2
   Kim J, 2003, J KOREAN PHYS SOC, V42, pS956
   Kim JI, 2004, J KOREAN PHYS SOC, V44, P1071
   Kolitsch A, 2000, SURF COAT TECH, V128, P126, DOI 10.1016/S0257-8972(00)00590-9
   Li DJ, 2001, APPL SURF SCI, V180, P270, DOI 10.1016/S0169-4332(01)00356-7
   LIU AY, 1989, SCIENCE, V245, P841, DOI 10.1126/science.245.4920.841
   Lu A, 2001, BIOMATERIALS, V22, P1439, DOI 10.1016/S0142-9612(00)00302-1
   Mandl S, 2002, SURF COAT TECH, V156, P276, DOI 10.1016/S0257-8972(02)00085-3
   Riedo E, 2000, J APPL PHYS, V88, P4365, DOI 10.1063/1.1309041
   STEFAN L, 2002, BIOMATERIALS, V23, P767
NR 21
TC 1
Z9 1
U1 0
U2 0
PU KOREAN PHYSICAL SOC
PI SEOUL
PA 635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA
SN 0374-4884
J9 J KOREAN PHYS SOC
JI J. Korean Phys. Soc.
PD JUN
PY 2005
VL 46
SU S
BP S24
EP S29
PG 6
WC Physics, Multidisciplinary
SC Physics
GA 932YE
UT WOS:000229589900007
DA 2018-10-20
ER

PT J
AU Sanghvi, AB
   Miller, KPH
   Belcher, AM
   Schmidt, CE
AF Sanghvi, AB
   Miller, KPH
   Belcher, AM
   Schmidt, CE
TI Biomaterials functionalization using a novel peptide that selectively
   binds to a conducting polymer
SO NATURE MATERIALS
LA English
DT Article
ID DYNAMIC FORCE SPECTROSCOPY; ENERGY LANDSCAPES; POLYPYRROLE; SURFACE;
   ADHESION; FILMS; SPECIFICITY; MICROSCOPE; ATTACHMENT; TITANIUM
AB The goal in biomaterial surface modification is to retain a material's bulk properties while modifying only its surface to possess desired recognition and specificity. Here we develop a unique strategy for surface functionalization of an electrically conductive polymer, chlorine-doped polypyrrole (PPyCl), which has been widely researched for various electronic and biomedical applications. An M13 bacteriophage library was used to screen 109 different 12-mer peptide inserts against PPyCl. A binding phage (phi T59) was isolated, and its binding stability and specificity to PPyCl was assessed using fluorescence microscopy and titer count analysis. The relative binding strength and mechanism of the corresponding 12-mer peptide and its variants was studied using atomic force microscopy and fluorescamine assays. Further, the T59 peptide was joined to a cell adhesive sequence and used to promote cell attachment on PPyCl. This strategy can be extended to immobilize a variety of molecules to PPyCl for numerous applications. In addition, phage display can be applied to other polymers to develop bioactive materials without altering their bulk properties.
C1 Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
   Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
   MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
   MIT, Dept Bioengn, Cambridge, MA 02139 USA.
RP Sanghvi, AB (reprint author), Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
EM schmidt@che.utexas.edu
RI Schmidt, Christine/P-1613-2016
CR ADEY NB, 1995, GENE, V156, P27, DOI 10.1016/0378-1119(95)00058-E
   Allison DP, 2002, CURR OPIN BIOTECH, V13, P47, DOI 10.1016/S0958-1669(02)00283-5
   BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8
   Barrett GC, 1998, AMINO ACIDS PEPTIDES
   Berglund J, 1998, ANAL COMMUN, V35, P3, DOI 10.1039/a708046h
   Blackburn S., 1978, AMINO ACID DETERMINA, P121
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Cook AD, 1997, BIOMATERIALS, V18, P1417, DOI 10.1016/S0142-9612(97)00075-6
   Cui XY, 2001, SENSOR ACTUAT A-PHYS, V93, P8, DOI 10.1016/S0924-4247(01)00637-9
   Dammer U, 1996, BIOPHYS J, V70, P2437, DOI 10.1016/S0006-3495(96)79814-4
   DIAZ AF, 1981, J ELECTROANAL CHEM, V129, P115, DOI 10.1016/0368-1874(81)87387-X
   Evans E, 1998, FARADAY DISCUSS, V111, P1
   Flynn CE, 2003, J MATER CHEM, V13, P2414, DOI 10.1039/b307593a
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   HRKACH J, 1999, J MAT SCI RES, V78, P92
   JOZEFONVICZ J, 1990, Journal of Biomaterials Science Polymer Edition, V1, P147
   Kontturi K, 1998, J ELECTROANAL CHEM, V453, P231, DOI 10.1016/S0022-0728(98)00246-0
   Kubies D, 2000, BIOMATERIALS, V21, P529, DOI 10.1016/S0142-9612(99)00219-7
   Labrou NE, 2003, J CHROMATOGR B, V790, P67, DOI 10.1016/S1570-0232(03)00098-9
   LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003
   Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054
   Levy R, 2002, NANOTECHNOLOGY, V13, P33, DOI 10.1088/0957-4484/13/1/307
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219
   MORI T, 2004, CURR PHARM DESIGN, V19, P2335
   MOY VT, 1994, COLLOID SURFACE A, V93, P343, DOI 10.1016/0927-7757(94)02933-4
   Nakamura C, 2004, BIOPOLYMERS, V76, P48, DOI 10.1002/bip.10572
   *NEW ENGL BIOL, 2004, TECHN B NEW ENGL B E, V8120, P1
   *NEW ENGL BIOL, 2004, TECHN B NEW ENGL B E, V8100
   *NEW ENGL BIOL, 2004, TECHN B NEW ENGL B E, V8110, P1
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Rowley Merrill J, 2004, Biotechnol Annu Rev, V10, P151, DOI 10.1016/S1387-2656(04)10006-9
   Sano KI, 2003, J AM CHEM SOC, V125, P14234, DOI 10.1021/ja038414q
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   Sarikaya M, 2004, ANNU REV MATER RES, V34, P373, DOI 10.1146/annurev.matsci.34.040203.121025
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   Silk T, 1998, SYNTHETIC MET, V93, P59, DOI 10.1016/S0379-6779(98)80131-8
   Sutar D, 2002, THIN SOLID FILMS, V417, P40, DOI 10.1016/S0040-6090(02)00649-1
   Tamm J, 1997, ELECTROCHIM ACTA, V42, P2929, DOI 10.1016/S0013-4686(97)00114-X
   Tong YW, 1998, J BIOMED MATER RES, V42, P85, DOI 10.1002/(SICI)1097-4636(199810)42:1<85::AID-JBM11>3.3.CO;2-R
   Undenfriend S, 1972, SCIENCE, V178, P871
   VALENTINI RF, 1992, BIOMATERIALS, V13, P183, DOI 10.1016/0142-9612(92)90069-Z
   Valuev IL, 1998, BIOMATERIALS, V19, P41, DOI 10.1016/S0142-9612(97)00147-6
   Vidal JC, 1999, ANAL CHIM ACTA, V385, P213, DOI 10.1016/S0003-2670(98)00838-1
   Wang LX, 2001, REACT FUNCT POLYM, V47, P125, DOI 10.1016/S1381-5148(00)00079-1
   Whaley SR, 2000, NATURE, V405, P665
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
   Zhang SG, 1999, REACT FUNCT POLYM, V41, P91, DOI 10.1016/S1381-5148(99)00031-0
NR 49
TC 263
Z9 269
U1 7
U2 148
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
J9 NAT MATER
JI Nat. Mater.
PD JUN
PY 2005
VL 4
IS 6
BP 496
EP 502
DI 10.1038/nmat1397
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 931RL
UT WOS:000229502700019
PM 15895095
DA 2018-10-20
ER

PT J
AU Conze, J
   Junge, K
   Klinge, U
   Weiss, C
   Polivoda, M
   Oettinger, AP
   Schumpelick, V
AF Conze, J
   Junge, K
   Klinge, U
   Weiss, C
   Polivoda, M
   Oettinger, AP
   Schumpelick, V
TI Intraabdominal adhesion formation of polypropylene mesh - Influence of
   coverage of omentum and polyglactin
SO SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
LA English
DT Article
DE adhesion; mesh; intraperitoneal onlay mesh technique; polypropylene;
   polyglactin; granuloma
ID ABDOMINAL-WALL DEFECTS; INCISIONAL HERNIA; ENTEROCUTANEOUS FISTULA;
   GREATER OMENTUM; REPAIR; INTRAPERITONEAL; IMPLANTATION; HERNIORRHAPHY;
   MODEL
AB Background: Adhesions after intraabdominal surgical procedures are related to high morbidity and mortality. Biomaterials, particularly those made of polypropylene, in the intraabdominal position have to be considered as pathophysiological cofactor in a multifactorial process of adhesion formation. To investigate the adhesive potential induced by the biomaterial, an animal model was performed. In addition, the influence of coverage by omentum or a polyglactin barrier was investigated.
   Methods: In, 18 Chinchilla rabbits the blomaterial was placed laparoscopically using the intraperitoneal onlay mesh technique. Using this model, a polypropylene-polyglactin mesh compound (PPMC) was used with three different implantation techniques: group 1, PPMC implantation without coverage (PPMC): group 2, PPMC implantation with additional omentum coverage (PPMC-O): and group 3, PPMC implantation with coverage of an absorbable polyglactin mesh (PPMC-V). The degree of adhesion formation was measured 90 days after implantation by computer-assisted planimetry. Morphometric examination followed the explantation analyzing the amount of foreign body response.
   Results: We found a significant reduction of adhesion formation for the PPMC and PPMC-O groups compared to the PPMC-V group, in which dense adhesions were found. Morphometric investigations of the perifilamental granulomas of the pure (PPMC) group revealed a typical foreign body reaction with a mild to moderate fibrosis around all mesh fibers. However, tissue specimens of the PPMC-O and PPMC-V groups indicated a similar inflammatory reaction but significantly increased connective tissue formation around the polymer fibers compared to the pure PPMC group.
   Conclusion: The intraabdominal placement of a pure PPMC shows a neoperitonealization and perifilamental collagenous ingrowth with almost no adhesions. Coverage with omentum (PPMC-O) or polyglactin mesh (PPMC-V) resulted in a significant increase in inflammation and perifilamentary connective tissue formation.
C1 Rhenish Westphalian Tech Univ, Dept Surg, D-52074 Aachen, Germany.
   Rhenish Westphalian Tech Univ, Inst Med Stat, D-52074 Aachen, Germany.
   Russian State Med Univ, Joint Inst Surg Res, Moscow 117437, Russia.
RP Conze, J (reprint author), Rhenish Westphalian Tech Univ, Dept Surg, Pauwelsstr 30, D-52074 Aachen, Germany.
RI Oettinger, Alexander/G-8594-2014
OI Oettinger, Alexander/0000-0001-9894-0671
CR Baptista ML, 2000, SURGERY, V128, P86, DOI 10.1067/msy.2000.106810
   Barlehner E, 1996, ZBL CHIR, V121, P307
   BEELEN RHJ, 1991, NETH J SURG, V43, P145
   BELLOM JM, 1997, J BIOMATER APPL, V12, P112
   Bellon JM, 1998, BIOMATERIALS, V19, P669, DOI 10.1016/S0142-9612(97)00162-2
   Bendavid R, 1997, HERNIA, V1, P5
   BLEICHRODT RP, 1993, SURG GYNECOL OBSTET, V176, P18
   Bujan J, 1997, HISTOL HISTOPATHOL, V12, P683
   CARBAHO MA, 2003, SURG ENDOSC, V17, P18
   Chowbey PK, 2003, SURG LAPARO ENDO PER, V13, P101, DOI 10.1097/00129689-200304000-00008
   CHRISTOFORONI PM, 1996, AM SURGEON, V62, P935
   DURSTEINDECKER C, 1994, AM SURGEON, V60, P157
   ECKMANN B, 1985, LANGENBECK ARCH CHIR, V365, P91, DOI 10.1007/BF01261136
   Eller R, 1997, SURG ENDOSC-ULTRAS, V11, P24, DOI 10.1007/s004649900288
   Farmer L, 1998, AM SURGEON, V64, P144
   Franklin ME, 1998, SURG LAPAROSC ENDOSC, V8, P294, DOI 10.1097/00019509-199808000-00012
   Halverson AL, 1999, SURG ENDOSC-ULTRAS, V13, P14, DOI 10.1007/s004649900888
   JENKINS SD, 1983, SURGERY, V94, P392
   Klinge U, 2002, J SURG RES, V103, P208, DOI 10.1006/jsre.2002.6358
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   MARCH CM, 1992, FERTIL STERIL, V57, P921
   MATLOUB HS, 1992, ANN PLAS SURG, V29, P508, DOI 10.1097/00000637-199212000-00005
   Mori N, 1998, PEDIATR SURG INT, V13, P487, DOI 10.1007/s003830050379
   Morris-Stiff GJ, 1998, J AM COLL SURGEONS, V186, P352, DOI 10.1016/S1072-7515(98)00002-7
   Schumpelick V, 2002, CHIRURG, V73, P888, DOI 10.1007/s00104-002-0535-0
   SEELIG MH, 1995, CHIRURG, V66, P739
   SIMMERMACHER RK, 1994, J AM SURG, V1758, P613
   Vrijland WW, 2000, BRIT J SURG, V87, P348, DOI 10.1046/j.1365-2168.2000.01364.x
NR 28
TC 30
Z9 33
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0930-2794
J9 SURG ENDOSC
JI Surg. Endosc.
PD JUN
PY 2005
VL 19
IS 6
BP 798
EP 803
DI 10.1007/s00464-004-2192-5
PG 6
WC Surgery
SC Surgery
GA 957OF
UT WOS:000231378500010
PM 15868269
DA 2018-10-20
ER

PT J
AU Saiano, F
   Ciofalo, M
   Cacciola, SO
   Ramirez, S
AF Saiano, F
   Ciofalo, M
   Cacciola, SO
   Ramirez, S
TI Metal ion adsorption by Phomopsis sp biomaterial in laboratory
   experiments and real wastewater treatments
SO WATER RESEARCH
LA English
DT Article
DE fungal biomaterial; chitin; chitosan; adsorption isotherm; heavy metal;
   wastewater
ID STREPTOMYCES-RIMOSUS BIOMASS; HEAVY-METALS; AQUEOUS-SOLUTION;
   ASPERGILLUS-NIGER; BIOSORPTION; REMOVAL; CHITIN; MODELS; NI2+
AB An insoluble material of polysaccharidic nature has been obtained by thermal alkali treatment of the filamentous fungus Phomopsis sp. FT-IR spectrum of the resulting material as well as its nitrogen content suggest that chitosan and glucans are the main components of the biomaterial. Information on Lewis base sites has also been obtained and used as a guideline in the evaluation of the complexing ability against a number of metal ions in aqueous media at pH in the range 4-6. Results indicate that after 24 h contact time, up to 870 mu mol/g of lead, 390 mu mol/g of copper, 230 mu mol/g of cadmium, 150 mu mol/g of zinc and 110 mu mol/g of nickel ions are adsorbed into the material. After approximately 10 min, about 70% of the overall adsorption process has already been completed. Adsorbed metal ions can be recovered by washing with dilute acid. Experiments have been extended to a real wastewater effluent confirming the potential of this biomaterial as a depolluting agent. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Palermo, Dipartimento ITAF, Sez Chim, I-90128 Palermo, Italy.
   Univ Palermo, Dipartimento SENFIMIZO, Sez Patol Vegetale & Microbiol Agraria, I-90128 Palermo, Italy.
RP Saiano, F (reprint author), Univ Palermo, Dipartimento ITAF, Sez Chim, Viale Sci,Edificio 4, I-90128 Palermo, Italy.
EM fsaiano@unipa.it
OI Cacciola, Santa Olga/0000-0001-7926-3601
CR ALONZO G, 2001, P 1 EUR BIOR C CHAN
   Babel S, 2003, J HAZARD MATER, V97, P219, DOI 10.1016/S0304-3894(02)00263-7
   Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8
   Bhanoori M, 2000, BBA-GEN SUBJECTS, V1523, P21, DOI 10.1016/S0304-4165(00)00090-8
   *CEM CORP, 1994, APPL MAN
   Coulibaly Lacina, 2003, African Journal of Biotechnology, V2, P620
   Galli E, 2003, LETT APPL MICROBIOL, V37, P133, DOI 10.1046/j.1472-765X.2003.01354.x
   Gavrilescu M, 2004, ENG LIFE SCI, V4, P219, DOI 10.1002/elsc.200420026
   Griffin DH, 1994, FUNGAL PHYSL
   Harvey D., 2000, MODERN ANAL CHEM
   Kapoor A, 1999, BIORESOURCE TECHNOL, V70, P95, DOI 10.1016/S0960-8524(98)00192-8
   Kapoor A, 1997, BIORESOURCE TECHNOL, V61, P221, DOI 10.1016/S0960-8524(97)00055-2
   Kim CY, 1997, J APPL POLYM SCI, V63, P725, DOI 10.1002/(SICI)1097-4628(19970207)63:6<725::AID-APP5>3.0.CO;2-P
   Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7
   MATIS KA, 1994, BIOTECHNOL BIOENG, V44, P354, DOI 10.1002/bit.260440313
   Merce ALR, 2001, BIORESOURCE TECHNOL, V76, P29, DOI 10.1016/S0960-8524(00)00078-X
   Muzzarelli R. A. A., 1980, J APPL BIOCHEM, V2, P54
   Ozer A, 1999, PROCESS BIOCHEM, V34, P919, DOI 10.1016/S0032-9592(99)00011-4
   Pinghe Y., 1999, WATER RES, V33, P1960
   ROY D, 1993, J ENVIRON SCI HEAL A, VA28, P37, DOI 10.1080/10934529309375861
   Sag Y, 1998, PROCESS BIOCHEM, V33, P273, DOI 10.1016/S0032-9592(97)00060-5
   Say R, 2001, BIORESOURCE TECHNOL, V76, P67, DOI 10.1016/S0960-8524(00)00071-7
   Sebe G, 2004, SEP PURIF TECHNOL, V38, P121, DOI 10.1016/j.seppur.2003.10.009
   Sekhar KC, 1998, INT J MINER PROCESS, V53, P107, DOI 10.1016/S0301-7516(97)00061-6
   Selatnia A, 2004, MINER ENG, V17, P903, DOI 10.1016/j.mineng.2004.04.002
   Selatnia A, 2004, BIOCHEM ENG J, V19, P127, DOI 10.1016/j.bej.2003.12.007
   Vianna LNL, 2000, WORLD J MICROB BIOT, V16, P437, DOI 10.1023/A:1008953922144
   White C, 1997, FEMS MICROBIOL REV, V20, P503, DOI 10.1016/S0168-6445(97)00029-6
   Zhang L, 1998, WATER RES, V32, P1437, DOI 10.1016/S0043-1354(97)00348-5
NR 29
TC 38
Z9 44
U1 5
U2 28
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0043-1354
J9 WATER RES
JI Water Res.
PD JUN
PY 2005
VL 39
IS 11
BP 2273
EP 2280
DI 10.1016/j.watres.2005.04.022
PG 8
WC Engineering, Environmental; Environmental Sciences; Water Resources
SC Engineering; Environmental Sciences & Ecology; Water Resources
GA 946RV
UT WOS:000230590800009
PM 15941575
DA 2018-10-20
ER

PT J
AU Sours, RE
   Zellelow, AZ
   Swift, JA
AF Sours, RE
   Zellelow, AZ
   Swift, JA
TI An in situ atomic force microscopy study of uric acid crystal growth
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID STONE FORMATION; URINARY-TRACT; UNITED-STATES; RENAL STONES;
   MONOHYDRATE; CRYSTALLIZATION; DISSOLUTION; KINETICS; FREQUENCY
AB Kidney stones are heterogeneous polycrystalline aggregates that can consist of several different building blocks. A significant number of human stones contain uric acid crystals as a crystalline component, though the molecular-level growth of this important biomaterial has not been previously well-characterized. In the present study, in situ atomic force microscopy (AFM) is used to investigate the real-time growth on the (100) surface of uric acid (UA) single crystals as a function of fundamental solution parameters. Layer-by-layer growth on UA (100) was found to be initiated at screw dislocation sites and to proceed via highly anisotropic rates which depend on the crystallographic direction. The smallest b-steps exhibited minimum heights corresponding to two molecular layers, while fast-moving c-steps more commonly showed monolayer heights. Growth kinetics measured under a range of flow rates, supersaturation levels, and pH values reveal linear trends in the growth kinetics, with faster growth attained in solutions with higher supersaturation and/or pH. The calculated kinetic parameters for UA growth derived from these experiments are in good agreement with the values reported for other crystal systems.
C1 Georgetown Univ, Dept Chem, Washington, DC 20057 USA.
RP Sours, RE (reprint author), Georgetown Univ, Dept Chem, 37th & O St NW, Washington, DC 20057 USA.
EM jas2@georgetown.edu
CR Astier JP, 2001, J CRYST GROWTH, V226, P294, DOI 10.1016/S0022-0248(01)01373-2
   Atsmon A, 1963, URIC ACID LITHIASIS
   BOISTELLE R, 1981, J CRYST GROWTH, V53, P1, DOI 10.1016/0022-0248(81)90050-6
   Cabrera N., 1958, GROWTH PERFECTION CR, P393
   Chernov A. A., 1995, SCI TECHNOLOGY CRYST, P67
   Chernov A.A., 1980, MODERN CRYSTALLOGRAP
   COE FL, 1983, KIDNEY INT, V24, P392, DOI 10.1038/ki.1983.172
   COTTET J, 1959, Pathol Biol, V7, P1975
   De Yoreo JJ, 2003, REV MINERAL GEOCHEM, V54, P57, DOI 10.2113/0540057
   Fink DA, 2003, CHEM MATER, V15, P2718, DOI 10.1021/cm021751y
   Frincu MC, 2004, LANGMUIR, V20, P6524, DOI 10.1021/la049091u
   FUSS M, 1978, EUR UROL, V4, P90
   GRENABO L, 1985, SCAND J UROL NEPHROL, V19, P285, DOI 10.3109/00365598509180271
   Guo SW, 2002, LANGMUIR, V18, P4284, DOI 10.1021/la011754+
   Gvozdev NV, 2004, J CRYST GROWTH, V261, P539, DOI 10.1016/j.jcrysgro.2003.09.026
   HERRING LC, 1962, J UROLOGY, V88, P545, DOI 10.1016/S0022-5347(17)64842-0
   HESSE A, 1975, INVEST UROL, V12, P405
   HILLNER PE, 1992, ULTRAMICROSCOPY, V42, P1387, DOI 10.1016/0304-3991(92)90454-R
   JOHNSON CM, 1979, KIDNEY INT, V16, P624, DOI 10.1038/ki.1979.173
   Konigsberger E, 2001, PURE APPL CHEM, V73, P785, DOI 10.1351/pac200173050785
   Land TA, 1997, SURF SCI, V384, P136, DOI 10.1016/S0039-6028(97)00187-8
   Luo TJM, 2000, J PHYS ORG CHEM, V13, P870, DOI 10.1002/1099-1395(200012)13:12<870::AID-POC324>3.0.CO;2-O
   MANDEL NS, 1989, J UROLOGY, V142, P1516, DOI 10.1016/S0022-5347(17)39145-0
   MANDEL NS, 1976, J AM CHEM SOC, V98, P2319, DOI 10.1021/ja00424a054
   ONUMA K, 1995, J CRYST GROWTH, V154, P118, DOI 10.1016/0022-0248(95)00201-4
   OSER BL, 1965, HAWKS PHYSL CHEM
   Qiu SR, 2004, P NATL ACAD SCI USA, V101, P1811, DOI 10.1073/pnas.0307900100
   RINGERTZ H, 1966, ACTA CRYSTALLOGR, V20, P397, DOI 10.1107/S0365110X66000914
   SCHOLZ D, 1979, UROL RES, V7, P161
   Sheng XX, 2003, J AM CHEM SOC, V125, P2854, DOI 10.1021/ja029575h
   Shirane Y, 1999, UROL RES, V27, P426, DOI 10.1007/s002400050131
   SIERAKOWSKI R, 1978, INVEST UROL, V15, P438
   Sours RE, 2002, J AM CHEM SOC, V124, P8630, DOI 10.1021/ja026083w
   SOURS RE, IN PRESS MOL CRYST L
   SUTOR DJ, 1974, BRIT J UROL, V46, P275, DOI 10.1111/j.1464-410X.1974.tb03828.x
   SWIFT JA, 1997, THESIS YALE U
   WARDLAW H S H, 1952, Med J Aust, V1, P180
NR 37
TC 26
Z9 26
U1 1
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD MAY 26
PY 2005
VL 109
IS 20
BP 9989
EP 9995
DI 10.1021/jp0455733
PG 7
WC Chemistry, Physical
SC Chemistry
GA 928UG
UT WOS:000229296600018
PM 16852207
DA 2018-10-20
ER

PT J
AU Parrish, B
   Breitenkamp, RB
   Emrick, T
AF Parrish, B
   Breitenkamp, RB
   Emrick, T
TI PEG- and peptide-grafted aliphatic polyesters by click chemistry
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID RING-OPENING POLYMERIZATION; EPSILON-CAPROLACTONE; DELTA-VALEROLACTONE;
   DRUG-DELIVERY; COPOLYMERS; BIOMATERIALS; BLOCK; LIGATION; MICELLES;
   POLYMERS
AB Novel aliphatic polyesters with pendent acetylene groups were prepared by controlled ring-opening polymerization and subsequently used for grafting poly(ethylene glycol) and oligopeptide moieties by the Cu(I)-catalyzed addition of azides and alkynes, a type of "click" chemistry. These aliphatic polyesters possess an acetylene graft density that can be tailored by ring-opening copolymerization of alpha-propargyl-delta-valerolactone (1) with is an element of-caprolactone. Since the mild conditions associated with the click reaction are shown to be compatible with the polyester backbone, this method is a generally useful means for grafting numerous types of functionality onto aliphatic polyesters. The amphiphilic graft polyesters prepared in this study are shown to be biocompatible by in vitro cytotoxicity evaluation, suggesting their suitability for a range of biomaterial applications.
C1 Univ Massachusetts, Conte Ctr Polymer Res, Polymer Sci & Engn Dept, Amherst, MA 01003 USA.
RP Emrick, T (reprint author), Univ Massachusetts, Conte Ctr Polymer Res, Polymer Sci & Engn Dept, Amherst, MA 01003 USA.
EM tsemrick@mail.pse.umass.edu
FU NIGMS NIH HHS [T32 GM008515]
CR Albertsson AC, 2003, BIOMACROMOLECULES, V4, P1466, DOI 10.1021/bm034247a
   Armarego W. L. F., 1996, PURIFICATION LAB CHE
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   Carnahan MA, 2002, J AM CHEM SOC, V124, P5291, DOI 10.1021/ja025576y
   Chan W. C., 2000, FMOC SOLID PHASE PEP
   Cordova A, 1999, POLYMER, V40, P6709, DOI 10.1016/S0032-3861(99)00017-8
   De Jesus OLP, 2002, BIOCONJUGATE CHEM, V13, P453, DOI 10.1021/bc010103m
   Duda A, 1998, POLYM DEGRAD STABIL, V59, P215, DOI 10.1016/S0141-3910(97)00167-5
   Gonzalez R, 2003, AM SURGEON, V69, P471
   GREENWALD D, 1994, J SURG RES, V56, P372, DOI 10.1006/jsre.1994.1058
   Helms B, 2004, J AM CHEM SOC, V126, P15020, DOI 10.1021/ja044744e
   HERRMANN JL, 1973, CHEM COMMUN, P711
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   Lee CC, 2004, J POLYM SCI POL CHEM, V42, P3563, DOI 10.1002/pola.20216
   Lee SC, 2003, J CONTROL RELEASE, V89, P437, DOI 10.1016/S0168-3659(03)00162-7
   Link AJ, 2004, J AM CHEM SOC, V126, P10598, DOI 10.1021/ja047629c
   Mecerreyes D, 2000, J POLYM SCI POL CHEM, V38, P870, DOI 10.1002/(SICI)1099-0518(20000301)38:5<870::AID-POLA11>3.0.CO;2-7
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Mizutani M, 2002, BIOMACROMOLECULES, V3, P668, DOI 10.1021/bm0101670
   Moller M, 2000, J POLYM SCI POL CHEM, V38, P2067, DOI 10.1002/(SICI)1099-0518(20000601)38:11<2067::AID-POLA150>3.0.CO;2-1
   Nasongkla N, 2004, ANGEW CHEM INT EDIT, V43, P6323, DOI 10.1002/anie.200460800
   Nederberg F, 2004, MACROMOLECULES, V37, P954, DOI 10.1021/ma035433b
   Parrish B, 2004, MACROMOLECULES, V37, P5863, DOI 10.1021/ma048981d
   Parrish B, 2002, J POLYM SCI POL CHEM, V40, P1983, DOI 10.1002/pola.10277
   Rieger J, 2004, MACROMOLECULES, V37, P9738, DOI 10.1021/ma048768h
   Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4
   STOREY RF, 1991, MAKROMOL CHEM-M SYMP, V42-3, P185, DOI 10.1002/masy.19910420115
   Trollsas M, 2000, MACROMOLECULES, V33, P4619, DOI 10.1021/ma992161x
   Trollsas M, 1999, MACROMOLECULES, V32, P9062, DOI 10.1021/ma991039v
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Wu P, 2004, ANGEW CHEM INT EDIT, V43, P3928, DOI 10.1002/anie.200454078
   Yu D, 1999, MACROMOLECULES, V32, P5186, DOI 10.1021/ma981734n
   Zalipsky S., 1997, POLYETHYLENE GLYCOL
NR 35
TC 473
Z9 485
U1 15
U2 266
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD MAY 25
PY 2005
VL 127
IS 20
BP 7404
EP 7410
DI 10.1021/ja050310n
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 928AX
UT WOS:000229244600044
PM 15898789
DA 2018-10-20
ER

PT J
AU Zhou, YL
   Niinomi, M
   Akahori, T
   Fukui, H
   Toda, H
AF Zhou, YL
   Niinomi, M
   Akahori, T
   Fukui, H
   Toda, H
TI Corrosion resistance and biocompatibility of Ti-Ta alloys for biomedical
   applications
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE biocompatibility; cyto-toxicity; corrosion resistance; wear resistance;
   Ti-Ta alloy; metallic biomaterial
ID ANODIC POLARIZATION PROPERTIES; AQUEOUS CHLORIDE SOLUTIONS;
   TITANIUM-ALLOYS; PHYSIOLOGICAL SOLUTION; PITTING CORROSION; OXIDE-FILMS;
   ELECTROCHEMICAL-BEHAVIOR; METALLIC BIOMATERIALS; MECHANICAL-PROPERTIES;
   MEDICAL IMPLANTS
AB Corrosion resistance, wear resistance and biocompatibility of the studied Ti-Ta alloys with Ta contents of 10, 30 and 70 mass% together with the currently used metallic biomaterials pure titanium (Ti) and Ti-6Al-4V extra low interstitial (ELI) alloy were investigated for biomedical applications. Corrosion resistance was measured by an anodic polarization test using an automatic potentiostat in 5% HCl solution at 310 K. Wear resistance was evaluated using a pin-on-disk type friction wear test system with a load of 4.9 N at 310 K in a simulated body fluid (Ringer's solution), and biocompatibility was judged by evaluating the cyto-toxicity through MTT assay. The passive behaviors are observed for all the studied Ti-Ta alloys, and the TiO2 passive films strengthened by the more stable Ta2O5 passive films result in improved corrosion resistance of the studied Ti-Ta alloys with increasing Ta content. All the studied Ti-Ta alloys are non-cytotoxic like pure Ti. The crystal structure shows little influence on the corrosion resistance and cyto-toxicity of the studied Ti-Ta alloys. The experimental results conform the expected excellent corrosion resistance and biocompatibility of the studied Ti-Ta alloys, which are better than or similar to those of pure Ti or Ti-6Al-4V ELI alloy used as standard biomaterials, suggesting their promising potential for biomedical applications. (c) 2005 Elsevier B.V. All rights reserved.
C1 Toyohashi Univ Technol, Dept Pord Syst Engn, Toyohashi, Aichi 4418580, Japan.
   Aichi Gakuin Univ, Sch Dent, Nagoya, Aichi 4648650, Japan.
RP Zhou, YL (reprint author), Toyohashi Univ Technol, Dept Pord Syst Engn, Toyohashi, Aichi 4418580, Japan.
EM ylzhou_2@yahoo.com
RI Niinomi, Mitsuo/B-5965-2011
CR *ASM INT HDB COMM, 1987, ASM HDB, V13
   Basame SB, 2000, J ELECTROCHEM SOC, V147, P1376, DOI 10.1149/1.1393364
   Boyer R., 1994, MAT PROPERTIES HDB
   BUDINSKI KG, 1991, WEAR, V151, P203, DOI 10.1016/0043-1648(91)90249-T
   Burke GL, 1940, CAN MED ASSOC J, V43, P125
   CASILLAS N, 1994, J ELECTROCHEM SOC, V141, P636, DOI 10.1149/1.2054783
   CASILLAS N, 1993, J ELECTROCHEM SOC, V140, pL142, DOI 10.1149/1.2220897
   Davis JR, 2000, CORROSION UNDERSTAND
   DESOUZA KA, 2003, MATER LETT, V4280, P1
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Gonzalez J, 1998, J MATER SCI, V33, P4173, DOI 10.1023/A:1004469622713
   Guleryuz H, 2004, BIOMATERIALS, V25, P3325, DOI 10.1016/j.biomaterials.2003.10.009
   HABZAKI H, 1997, T I MET FINISH, V75, P18
   Helsen J.A., 1998, METALS BIOMATERIALS
   HORNKJOL S, 1991, ELECTROCHIM ACTA, V36, P1443, DOI 10.1016/0013-4686(91)85332-2
   Imam M., 1996, ASTM STP, P3
   Kasuga T, 2003, BIOMATERIALS, V24, P283, DOI 10.1016/S0142-9612(02)00316-2
   Khan MA, 1999, BIOMATERIALS, V20, P765, DOI 10.1016/S0142-9612(98)00229-4
   KOLMAN DG, 1994, J ELECTROCHEM SOC, V141, P2633, DOI 10.1149/1.2059146
   Kolman DG, 1996, J ELECTROCHEM SOC, V143, P1847, DOI 10.1149/1.1836914
   LAQUE FL, 1963, CORROSION RESISTANCE
   LEACH JSL, 1988, CORROS SCI, V28, P43, DOI 10.1016/0010-938X(88)90005-4
   LEVY M, 1969, J ELECTROCHEM SOC, V116, P323, DOI 10.1149/1.2411838
   Li SJ, 2004, WEAR, V257, P869, DOI 10.1016/j.wear.2004.04.001
   Liang FH, 2003, SURF COAT TECH, V165, P133, DOI 10.1016/S0257-8972(02)00735-1
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Marino CE, 2001, CORROS SCI, V43, P1465, DOI 10.1016/S0010-938X(00)00162-1
   Mato S, 2003, SURF INTERFACE ANAL, V35, P477, DOI 10.1002/sia.1549
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Metikos-Hukovic M, 2003, BIOMATERIALS, V24, P3765, DOI 10.1016/S0142-9612(03)00252-7
   Milosev I, 2000, BIOMATERIALS, V21, P2103, DOI 10.1016/S0142-9612(00)00145-9
   MISHRA AK, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P61
   Murry J. L., 1987, PHASE DIAGRAM BINARY
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Okazaki Y, 1997, MATER T JIM, V38, P78, DOI 10.2320/matertrans1989.38.78
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   Okazaki Y, 1997, MATER T JIM, V38, P344, DOI 10.2320/matertrans1989.38.344
   Okazaki Y, 2002, BIOMATERIALS, V23, P2071, DOI 10.1016/S0142-9612(01)00337-4
   OKAZAKI Y, 1994, MATER T JIM, V35, P58, DOI 10.2320/matertrans1989.35.58
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   PLENK H, 1990, CONCISE ENCY MED DEN, P355
   Poggie RA, 1996, MATER MANUF PROCESS, V11, P185, DOI 10.1080/10426919608947472
   Prigent H, 1998, J BIOMED MATER RES, V39, P200, DOI 10.1002/(SICI)1097-4636(199802)39:2<200::AID-JBM5>3.0.CO;2-T
   ROSSLER S, 2001, J MATER SCI-MATER M, V12, P871
   SEMLITSCH M, 1987, CLIN MATER, V2, P1, DOI DOI 10.1016/0267-6605(87)90015-1
   Shreir L., 1963, CORROSION, V1
   SINGH DDN, 1985, J ELECTROCHEM SOC, V132, P378, DOI 10.1149/1.2113843
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   STEINEMANN SG, 1999, MAT MED ENG, V2, P199
   STERN M, 1959, J ELECTROCHEM SOC, V106, P759, DOI 10.1149/1.2427493
   STERN M, 1959, J ELECTROCHEM SOC, V106, P755, DOI 10.1149/1.2427492
   Sul YT, 2002, BIOMATERIALS, V23, P491, DOI 10.1016/S0142-9612(01)00131-4
   TAYLOR DF, 1969, ENCY CHEM TECHNOLOGY, V19, P630
   Thair L, 2004, MATER CORROS, V55, P358, DOI 10.1002/maco.200303724
   Trillo EA, 2001, J MATER SCI-MATER M, V12, P283, DOI 10.1023/A:1011210101895
   VERMILYEA DA, 1955, J ELECTROCHEM SOC, V102, P207, DOI 10.1149/1.2430031
   VERMILYEA DA, 1957, J ELECTROCHEM SOC, V104, P542, DOI 10.1149/1.2428649
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V384, P92, DOI 10.1016/j.msea.2004.05.084
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
   ZITTER H, 1987, J BIOMED MATER RES, V21, P881, DOI 10.1002/jbm.820210705
NR 62
TC 138
Z9 145
U1 1
U2 48
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD MAY 25
PY 2005
VL 398
IS 1-2
BP 28
EP 36
DI 10.1016/j.msea.2005.03.032
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 938KH
UT WOS:000229998100004
DA 2018-10-20
ER

PT J
AU Li, HY
   Chang, J
   Cao, AM
   Wang, JY
AF Li, HY
   Chang, J
   Cao, AM
   Wang, JY
TI In vitro evaluation of biodegradable poly(butylene succinate) as a novel
   biomaterial
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE alkaline phosphatase activity; biocompatibility; degradation;
   osteoblasts; poly(butylene succinate)
ID COMPOSITE SCAFFOLDS; BUILDING-BLOCKS; DEGRADATION; ACID); CELLS;
   POLYMERS; POLY(EPSILON-CAPROLACTONE); DIFFERENTIATION; ATTACHMENT;
   COPOLYMER
AB Poly(butylene succinate) (PBSU) can be easily synthesized by condensation polymerization of the starting materials of succinic acid and butan-1,4-diol. It has good degradability and possesses excellent processability. Due to these advantages, PBSU was first evaluated in the present study for its potential application as a novel biomaterial. The in vitro biocompatibility of the PBSU was evaluated by monitoring proliferation and differentiation of osteoblasts cultured on the PBSU film substrates for different periods. The results showed that the PBSU was biocompatible as the osteoblasts could proliferate and differentiate on the PBSU plates. In addition, the hydrolytic degradation behavior of the PBSU films in the phosphate-buffered saline (PBS) was also investigated and the results suggested that the PBSU degraded in the PBS solution with the same behavior as that of the degradable poly(alpha-hydroxyesters). In addition to the biocompatibility and hydrolytic degradation, some physical properties, including hydrophilicity, and mechanical and thermal properties of the PBSU substrates, were also determined and the results revealed that the PBSU was hydrophilic and ductile with excellent processability. The biocom-patibility of the PBSU, together with the advantages of hydrolytic degradability, hydrophilicity, and excellent processability, indicated that. PBSU has the potential to be used as a biomaterial for tissue repair.
C1 Chinese Acad Sci, Shanghai Inst Ceram, Biomat & Tissue Engn Res Ctr, Shanghai 200050, Peoples R China.
   Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China.
   Chinese Acad Sci, Shanghai Inst Organ Chem, Polymer Mat Lab, Shanghai 200032, Peoples R China.
   E China Normal Univ, Sch Biol Sci, Shanghai 200062, Peoples R China.
RP Chang, J (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, Biomat & Tissue Engn Res Ctr, 1295 Dingxi Rd, Shanghai 200050, Peoples R China.
EM jchang@mail.sic.ac.cn
CR Abbondanzo SL, 1999, MODERN PATHOL, V12, P706
   Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Ara M, 2002, BIOMATERIALS, V23, P2479, DOI 10.1016/S0142-9612(01)00382-9
   Ba CY, 2003, BIOMACROMOLECULES, V4, P1827, DOI 10.1021/bm034235p
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Bahari L, 1998, POLYM DEGRAD STABIL, V62, P551
   BESSEY OA, 1946, J BIOL CHEM, V164, P321
   Chen LJ, 2002, BIOMATERIALS, V23, P2631, DOI 10.1016/S0142-9612(01)00394-5
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Hashitani T, 2002, FUJITSU SCI TECH J, V38, P112
   IMAIZUMI M, 1967, Patent No. 5658627
   IMAIZUMI M, 1994, Patent No. 5314969
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   KANG IK, 1993, BIOMATERIALS, V14, P787, DOI 10.1016/0142-9612(93)90045-4
   Li HY, 2004, J MATER SCI-MATER M, V15, P1089, DOI 10.1023/B:JMSM.0000046390.09540.c2
   Li HY, 2004, BIOMATERIALS, V25, P5473, DOI 10.1016/j.biomaterials.2003.12.052
   Lo H, 1996, J BIOMED MATER RES, V30, P475, DOI 10.1002/(SICI)1097-4636(199604)30:4<475::AID-JBM5>3.0.CO;2-M
   LOWRY OH, 1954, J BIOL CHEM, V207, P19
   Lu HH, 2003, J BIOMED MATER RES A, V64A, P465, DOI 10.1002/jbm.a.10399
   LU L, 1996, BIOMATERIALS, V7, P359
   Martin C, 1996, BIOMATERIALS, V17, P2373, DOI 10.1016/S0142-9612(96)00075-0
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MOTEKI Y, 1994, Patent No. 5360663
   Moursi AM, 1997, J CELL SCI, V110, P2187
   NAKAMURA A, 1994, Patent No. 5348700
   NICKLIN J, 1999, INSTANT NOTES MICROB
   PITT CG, 1979, J BIOMED MATER RES, V13, P497, DOI 10.1002/jbm.820130313
   REED AM, 1981, POLYMER, V22, P494, DOI 10.1016/0032-3861(81)90168-3
   Serrano MC, 2004, BIOMATERIALS, V25, P5603, DOI 10.1016/j.biomaterials.2004.01.037
   Shirahama H, 2001, J APPL POLYM SCI, V80, P340, DOI 10.1002/1097-4628(20010418)80:3<340::AID-APP1105>3.0.CO;2-F
   Sodergard A, 2002, PROG POLYM SCI, V27, P1123, DOI 10.1016/S0079-6700(02)00012-6
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   TAKA T, 1994, Patent No. 5324794
   TAKAHASHI T, Patent No. 5525409
   TAKAHASHI T, 1994, Patent No. 5349028
   TAKAHASHI T, 1994, Patent No. 5310872
   TYAN YC, 2000, CHIN J MED BIOL ENG, V20, P25
   VanderMeer SAT, 1996, J MATER SCI-MATER M, V7, P359, DOI 10.1007/BF00154549
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   WILLIAMS DF, 1999, WILLIAMS DICT BIOMAT, P40
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
   Yang J, 2004, BIOMACROMOLECULES, V5, P209, DOI 10.1021/bm0343242
   Yang M, 2004, BIOMATERIALS, V25, P1365, DOI 10.1016/j.biomaterials.2003.08.018
   YASUDA Y, 1995, Patent No. 5391644
NR 45
TC 88
Z9 98
U1 0
U2 43
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD MAY 23
PY 2005
VL 5
IS 5
BP 433
EP 440
DI 10.1002/mabi.200400183
PG 8
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 930NO
UT WOS:000229423100009
PM 15889389
DA 2018-10-20
ER

PT J
AU Nash, SMB
   Quayle, PA
   Schreiber, U
   Muller, JF
AF Nash, SMB
   Quayle, PA
   Schreiber, U
   Muller, JF
TI The selection of a model microalgal species as biomaterial for a novel
   aquatic phytotoxicity assay
SO AQUATIC TOXICOLOGY
LA English
DT Article
DE priority pollutants; unicellular algae; toxicity; chlorophyll
   fluorescence; bioassay
ID CHLOROPHYLL FLUORESCENCE; PHOTOSYSTEM-II; SELENASTRUM-CAPRICORNUTUM;
   CHLORELLA-VULGARIS; QUANTUM YIELD; NITZSCHIA-CLOSTERIUM;
   COPPER-COMPLEXES; PAM-FLUOROMETRY; MARINE DIATOM; IN-VIVO
AB A phytotoxicity assay based on the ToxY-PAM dual-channel yield analyser has been developed and successfully incorporated into field assessments for the detection of phytotoxicants in water. As a means of further exploring the scope of the assay application and of selecting a model biomaterial to complement the instrument design, nine algal species were exposed to four chemical substances deemed of priority for water quality monitoring purposes (chlorpyrifos, copper, diuron and nonylphenol ethoxylate). Inter-species differences in sensitivity to the four toxicants varied by a factor of 1.9-100. Measurements of photosystem-II quantum yield using these nine single-celled microalgae as biomaterial corroborated previous studies which have shown that the ToxY-PAM dual-channel yield analyser is a highly sensitive method for the detection of PS-II impacting herbicides. Besides Phaeodactylum tricornutum, the previously applied biomaterial, three other species consistently performed well (Nitzschia closterium, Chlorella vulgaris and Dunaliella tertiolecta) and will be used in further test optimisation experiments. In addition to sensitivity, response time was evaluated and revealed a high degree of variation between species and toxicants. While most species displayed relatively weak and slow responses to copper, C. vulgaris demonstrated an IC10 of 51 &mu; g L-1, with maximum response measured within 25 minutes and inhibition being accompanied by a large decrease in fluorescence yield. The potential for this C vulgaris-based bioassay to be used for the detection of copper is discussed. There was no evidence that the standard ToxY-PAM protocol, using these unicellular algae species, could be used for the detection of chlorpyrifos or nonylphenol ethoxylate at environmentally relevant levels. &COPY; 2005 Elsevier B.V. All rights reserved.
C1 Univ Queensland, Natl Res Ctr Environm Toxicol, Brisbane, Qld 4108, Australia.
   Univ Wurzburg, Lehrstuhl Bot 1, Julius Sachs Inst Biowissensch, D-97082 Wurzburg, Germany.
RP Nash, SMB (reprint author), Univ Queensland, Natl Res Ctr Environm Toxicol, Brisbane, Qld 4108, Australia.
EM s.nash@uq.edu.au
RI Bengtson Nash, Susan/I-3942-2015; Mueller, Jochen/C-6241-2008
OI Bengtson Nash, Susan/0000-0001-5928-0850; Mueller,
   Jochen/0000-0002-0000-1973
CR ARELLANO JB, 1995, PHOTOSYNTH RES, V45, P127, DOI 10.1007/BF00032584
   BLANCK H, 1984, ECOTOX ENVIRON SAFE, V8, P339, DOI 10.1016/0147-6513(84)90003-4
   Butler G. L., 1977, Residue Reviews, V66, P19
   ElJay A, 1997, ARCH HYDROBIOL, V140, P273
   ElJay A, 1996, ARCH ENVIRON CON TOX, V31, P84, DOI 10.1007/BF00203911
   Eullaffroy P, 2003, WATER RES, V37, P1983, DOI 10.1016/S0043-1354(02)00621-8
   Ferraz DGD, 2004, CHEMOSPHERE, V56, P315, DOI 10.1016/j.chemosphere.2004.01.038
   FLORENCE TM, 1986, AQUAT TOXICOL, V8, P11, DOI 10.1016/0166-445X(86)90069-X
   FRANKLIN N, 1998, NEW TROPICAL ALGAL T
   Franklin NM, 2000, AQUAT TOXICOL, V48, P275, DOI 10.1016/S0166-445X(99)00042-9
   GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9
   GOVINDJEE, 1995, AUST J PLANT PHYSIOL, V22, P131, DOI 10.1071/PP9950131
   GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x
   GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029
   HALL JA, 1998, MFE80205 NIWA
   JEGERSCHOLD C, 1995, BIOCHEMISTRY-US, V34, P12747, DOI 10.1021/bi00039a034
   Jones RJ, 2003, MAR ECOL PROG SER, V251, P153, DOI 10.3354/meps251153
   Juneau P, 2002, ARCH ENVIRON CON TOX, V42, P155, DOI 10.1007/s00244-001-0027-0
   Juneau P, 2001, CHEMOSPHERE, V45, P589, DOI 10.1016/S0045-6535(01)00034-0
   KARUBE I, 1986, BIOSENSORS FUNDAMENT, P13
   KENAGA EE, 1980, AQUAT TOXICOL, P707
   Klem K, 2002, WEED RES, V42, P335, DOI 10.1046/j.1365-3180.2002.00293.x
   KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525
   Kupper H, 2002, J PHYCOL, V38, P429, DOI 10.1046/j.1529-8817.2002.t01-1-01148.x
   Lazar D, 1999, BBA-BIOENERGETICS, V1412, P1, DOI 10.1016/S0005-2728(99)00047-X
   MAGUE TH, 1980, LIMNOL OCEANOGR, V25, P262, DOI 10.4319/lo.1980.25.2.0262
   Merz D, 1996, FRESEN J ANAL CHEM, V354, P299
   Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558
   NASH SMB, IN PRESS MARINE POLL
   Nasha SMB, 2005, BIOSENS BIOELECTRON, V20, P1443, DOI 10.1016/j.bios.2004.09.019
   ORR P, 1990, EPS1RM12
   OVERNELL J, 1975, MAR BIOL, V29, P99
   Patsikka E, 1998, PLANT PHYSIOL, V117, P619, DOI 10.1104/pp.117.2.619
   Powner E. T., 1997, Sensor Review, V17, P107, DOI 10.1108/02602289710170276
   Pringsheim E. G., 1946, PURE CULTURES ALGAE
   RAWSON DM, 1989, BIOSENSORS, V4, P299, DOI 10.1016/0265-928X(89)80011-2
   Schreiber U, 2002, PHOTOSYNTH RES, V74, P317, DOI 10.1023/A:1021276003145
   SCHREIBER U, 1995, AUST J PLANT PHYSIOL, V22, P209, DOI 10.1071/PP9950209
   Schreiber U., 2004, CHLOROPHYLL FLUORESC
   SCHREIBER U, 2001, HDB OPERATION
   STAUBER JL, 1985, AQUAT TOXICOL, V6, P297, DOI 10.1016/0166-445X(85)90025-6
   STAUBER JL, 1987, MAR BIOL, V94, P511, DOI 10.1007/BF00431397
   Stein JR, 1973, HDB PHYCOLOGICAL MET
   THOMPSON AS, 1988, CULTURE COLLECTION A
   Vedrine C, 2003, BIOSENS BIOELECTRON, V18, P457, DOI 10.1016/S0956-5663(02)00157-4
   Velasco-Garcia MN, 2003, BIOSYST ENG, V84, P1, DOI 10.1016/S1537-5110(02)00236-2
   Verschueren K, 2001, HDB ENV DATA ORGANIC
   Vulkan R, 2000, ENVIRON SCI TECHNOL, V34, P5115, DOI 10.1021/es/0000910
   WARE GW, 1999, REV ENV CONTAMINATIO
NR 49
TC 31
Z9 34
U1 1
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-445X
J9 AQUAT TOXICOL
JI Aquat. Toxicol.
PD MAY 15
PY 2005
VL 72
IS 4
BP 315
EP 326
DI 10.1016/j.aquatox.2005.02.004
PG 12
WC Marine & Freshwater Biology; Toxicology
SC Marine & Freshwater Biology; Toxicology
GA 926BI
UT WOS:000229097300003
DA 2018-10-20
ER

PT J
AU Shchipunov, YA
   Kojima, A
   Imae, T
AF Shchipunov, YA
   Kojima, A
   Imae, T
TI Polysaccharides as a template for silicate generated by sol-gel
   processes
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE sol-gel; polysaccharide mineralization; hybrid silica nanocomposite;
   biomaterial
ID NANOCOMPOSITES; BIOLOGICALS; POLYMERS
AB The polysaccharides, as established previously (Yu.A. Shchipunov, J. Colloid Interface Sci. 268 (2003) W Yu.A. ShchipUnOV, T.YU. Karpenko, Langmuir 20 (2004) 3882), can manipulate the formation of hybrid silica nanocomposites by sol-gel processes. Here atomic force microscopy was applied to show whether carbohydrate macromolecules serve as a template for silicate. Mica was used as a substrate to adsorb polysaccharide. It was found that its surface is not neutral to the sol-gel processes, providing the silica precipitation. To hinder it, the mica was protected by a monomolecular film of arachidic acid with the help of a Langmuir-Blodgett technique. Hydrophobically modified cationic hydrohyethylcellulose was adsorbed from a diluted aqueous Solution. It was demonstrated that the carbohydrate macromolecules located on the hydrophobic Surface did promote silica precipitation, serving as a template. (c) 2004 Elsevier Inc. All rights reserved.
C1 Russian Acad Sci, Far E Dept, Inst Chem, Vladivostok 690022, Russia.
   Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648602, Japan.
   Nagoya Univ, Res Ctr Mat Sci, Nagoya, Aichi 4648602, Japan.
RP Shchipunov, YA (reprint author), Russian Acad Sci, Far E Dept, Inst Chem, Vladivostok 690022, Russia.
EM yas@ich.dvo.ru
CR Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038
   Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361
   DAVE BC, 1994, ANAL CHEM, V66, pA1120, DOI 10.1021/ac00094a001
   Dujardin E, 2002, ADV MATER, V14, P775, DOI 10.1002/1521-4095(20020605)14:11<775::AID-ADMA775>3.0.CO;2-0
   Frausto da Silva JJR, 2001, BIOL CHEM ELEMENTS I
   Gill I, 2000, TRENDS BIOTECHNOL, V18, P282, DOI 10.1016/S0167-7799(00)01457-8
   Gill I, 1998, J AM CHEM SOC, V120, P8587, DOI 10.1021/ja9814568
   Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129
   MEHROTRA RC, 1967, INDIAN J CHEM, V5, P444
   Pierre A. C., 1998, INTRO SOL GEL PROCES
   SHCHIPANOV YA, 2001, RUSS J PHYS CHEM, V75, P1795
   Shchipunov YA, 2003, J COLLOID INTERF SCI, V268, P68, DOI 10.1016/S0021-9797(03)00457-0
   Shchipunov YA, 2004, LANGMUIR, V20, P3882, DOI 10.1021/la0356912
   Shchipunov YA, 2004, J BIOCHEM BIOPH METH, V58, P25, DOI 10.1016/S0165-022X(03)00108-8
   VOLKANI BE, 1981, SILICON SILICEOUS ST, P157
   Zaremba CM, 1996, CURR OPIN SOLID ST M, V1, P425, DOI 10.1016/S1359-0286(96)80035-0
NR 17
TC 28
Z9 29
U1 0
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD MAY 15
PY 2005
VL 285
IS 2
BP 574
EP 580
DI 10.1016/j.jcis.2004.11.026
PG 7
WC Chemistry, Physical
SC Chemistry
GA 920ZB
UT WOS:000228732900018
PM 15837474
DA 2018-10-20
ER

PT J
AU Kajzer, W
   Kaczmarek, M
   Marciniak, J
AF Kajzer, W
   Kaczmarek, M
   Marciniak, J
TI Biomechanical analysis of stent-oesophagus system
SO JOURNAL OF MATERIALS PROCESSING TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 8th International Conference on Advances in Materials and Processing
   Technologies/13th International Conference on Achievements in Mechanical
   and Materials Engineering
CY MAY 16-19, 2005
CL Gliwice Wisla, POLAND
DE biomaterials; oesophageal stent; finite element method
ID MALIGNANT GASTRIC OUTLET; EXPANDING METAL STENTS; ESOPHAGORESPIRATORY
   FISTULAS; PALLIATION; OBSTRUCTION; STENOSES
AB The paper presents the biomechanical analysis of a stent-oesophagus system. In particular, stresses and strains for the oesophageal stent (Z-type) reflecting its implantation technique were calculated. The obtained results are the basis for the optimization of the geometrical features of the stent and mechanical properties of the metallic biomaterial. (c) 2005 Elsevier B.V. All rights reserved.
C1 Silesian Tech Univ, Inst Engn Mat & Biomat, PL-44100 Gliwice, Poland.
RP Kajzer, W (reprint author), Silesian Tech Univ, Inst Engn Mat & Biomat, Ul Konarskiego 18A, PL-44100 Gliwice, Poland.
EM wojciech.kajzer@polsl.pl
OI Kajzer, Wojciech/0000-0001-9285-1272; Kaczmarek,
   Marcin/0000-0002-0049-1554
CR Adler DG, 2002, AM J GASTROENTEROL, V97, P72
   Binkert CA, 1996, RADIOLOGY, V199, P335, DOI 10.1148/radiology.199.2.8668774
   Feretis C, 1996, ENDOSCOPY, V28, P225, DOI 10.1055/s-2007-1005432
   Kim JH, 2001, ENDOSCOPY, V33, P838, DOI 10.1055/s-2001-17340
   Maetani I, 1996, GASTROINTEST ENDOSC, V44, P468, DOI 10.1016/S0016-5107(96)70102-5
   MARCINIAK J, 2002, BIOMATERIALS WYDAWNI
   MARCINIAK J, 2004, IZNYNIERIA BIOMATERI, V38, P84
   May A, 1998, AM J GASTROENTEROL, V93, P532
   Pinto Pabon I T, 2001, Cardiovasc Intervent Radiol, V24, P147, DOI 10.1007/s002700001742
   PRUSZYNSKI B, 1999, RADIOLOGY IMAGE DIAG
   RALAHON A, 1998, GASTROENTEROL CLIN B, V22, P19
   Saida Y, 1996, DIS COLON RECTUM, V39, P552, DOI 10.1007/BF02058710
   WALKE W, P 11 INT SCI C AMME, P595
   WEIGERT N, 1995, GASTROINTEST ENDOSC, V41, P490, DOI 10.1016/S0016-5107(05)80009-4
   *WILS COOK MED INC, DIAGN THER END ACC
   Yates MR, 1998, ENDOSCOPY, V30, P266, DOI 10.1055/s-2007-1001253
NR 16
TC 13
Z9 15
U1 1
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-0136
J9 J MATER PROCESS TECH
JI J. Mater. Process. Technol.
PD MAY 15
PY 2005
VL 162
SI SI
BP 196
EP 202
DI 10.1016/j.jmatprotec.2005.02.209
PG 7
WC Engineering, Industrial; Engineering, Manufacturing; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA 929VU
UT WOS:000229375500032
DA 2018-10-20
ER

PT J
AU Bengali, Z
   Pannier, AK
   Segura, T
   Anderson, BC
   Jang, JH
   Mustoe, TA
   Shea, LD
AF Bengali, Z
   Pannier, AK
   Segura, T
   Anderson, BC
   Jang, JH
   Mustoe, TA
   Shea, LD
TI Gene delivery through cell culture substrate adsorbed DNA complexes
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE gene delivery; reverse transfection; solid-phase delivery; lipofectamine
   2000; polyethylenimine; biomaterial; substrate-mediated
ID ANTIBODY-TETHERED ADENOVIRUS; IN-VITRO; TRANSFECTION; VECTOR;
   EXPRESSION; MICROARRAYS; VIVO; TRANSDUCTION; FIBRONECTIN; ENHANCEMENT
AB Efficient gene delivery is a fundamental goal of biotechnology and has numerous applications in both basic and applied science. Substrate-mediated delivery and reverse transfection enhance gene transfer by increasing the concentration of DNA in the cellular microenvironment through immobilizing a plasmid to a cell culture substrate prior to cell seeding. In this report, we examine gene delivery of plasmids that were complexed with cationic polymers (polyplexes) or lipids (lipoplexes) and subsequently immobilized to cell culture or biomaterial substrates by adsorption. Polyplexes and lipoplexes were adsorbed to either tissue culture polystyrene or serum-adsorbed tissue culture polystyrene, The quantity of DNA immobilized increased with time of exposure, and the deposition rate and final amount deposited depended upon the properties of the substrate and complex. For polyplexes, serum modification enhanced reporter gene expression up to 1 500-fold relative to unmodified substrates and yielded equivalent or greater expression compared to bolus delivery. For lipoplexes, serum modification significantly increased the number of transfected cells relative to unmodified substrates yet provided similar levels of expression. Immobilized complexes transfect primary cells with improved cellular viability relative to bolus delivery. Finally, this substrate-mediated delivery approach was extended to a widely used biomaterial, poly(lactide-co-glycolide). Immobilization of DNA complexes to tissue culture polystyrene substrates can be a useful tool for enhancing gene delivery for in vitro studies. Additionally, adapting this system to biornaterials may facilitate application to fields such as tissue engineering. (c) 2005 Wiley Periodicals, Inc.
C1 Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA.
   Northwestern Univ, Dept Interdept Biol Sci, Evanston, IL 60208 USA.
   Northwestern Univ, Div Plast & Reconstruct Surg, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60611 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Biol & Chem Engn, 2145 Sheridan Rd E156, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Jang, Jae-Hyung/G-8030-2012; Shea, Lonnie/B-7615-2009
FU NCI NIH HHS [P50 CA089018, P50-CA89018]; NIGMS NIH HHS [R01 GM066830,
   R01 GM41303, R01 GM066830-03, R01 GM041303]
CR Abrahams JM, 2002, STROKE, V33, P1376, DOI 10.1161/01.STR.0000014327.03964.C0
   Bailey SN, 2002, DRUG DISCOV TODAY, V7, pS113, DOI 10.1016/S1359-6446(02)02386-3
   BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8
   Bielinska AU, 2000, BIOMATERIALS, V21, P877, DOI 10.1016/S0142-9612(99)00229-X
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Choosakoonkriang S, 2003, J PHARM SCI, V92, P1710, DOI 10.1002/jps.10437
   Cohen-Sacks H, 2004, J CONTROL RELEASE, V95, P309, DOI 10.1016/j.jconrel.2003.11.001
   Godbey WT, 1999, GENE THER, V6, P1380, DOI 10.1038/sj.gt.3300976
   Hanenberg H, 1996, NAT MED, V2, P876, DOI 10.1038/nm0896-876
   Huang YC, 2003, J BIOMED MATER RES A, V67A, P1384, DOI 10.1002/jbm.a.20036
   Jang JH, 2003, J CONTROL RELEASE, V86, P157, DOI 10.1016/S0168-3659(02)00369-3
   Klugherz BD, 2002, HUM GENE THER, V13, P443, DOI 10.1089/10430340252792576
   Kofron MD, 2004, BIOMATERIALS, V25, P2637, DOI 10.1016/j.biomaterials.2003.09.042
   Lei P, 2002, J VIROL, V76, P8722, DOI 10.1128/JVI.76.17.8722-8728.2002
   Levy RJ, 2001, GENE THER, V8, P659, DOI 10.1038/sj.gt.3301452
   Luo D, 2000, NAT BIOTECHNOL, V18, P893, DOI 10.1038/78523
   Mogford JE, 2002, J CELL PHYSIOL, V190, P259, DOI 10.1002/JCP.10060
   Moret I, 2001, J CONTROL RELEASE, V76, P169, DOI 10.1016/S0168-3659(01)00415-1
   Nof M, 2002, J BIOMED MATER RES, V59, P349, DOI 10.1002/jbm.1251
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   NORDE W, 1986, ADV COLLOID INTERFAC, V25, P267, DOI 10.1016/0001-8686(86)80012-4
   Ogris M, 2001, AAPS PHARMSCI, V3, part. no.
   Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900
   Scherer F, 2002, J GENE MED, V4, P634, DOI 10.1002/jgm.298
   Segura T, 2003, J CONTROL RELEASE, V93, P69, DOI 10.1016/j.jconrel.2003.08.003
   Segura T, 2002, BIOCONJUGATE CHEM, V13, P621, DOI 10.1021/bc015575f
   SEGURA T, IN PRESS BIOMATERIAL
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   SON KK, 2000, BIOCHIM BIOPHYS ACTA, V1466, P1
   Stachelek SJ, 2004, GENE THER, V11, P15, DOI 10.1038/sj.gt.3302129
   STUART MAC, 1991, ADV COLLOID INTERFAC, V34, P477, DOI 10.1016/0001-8686(91)80056-P
   Tseng WC, 1997, J BIOL CHEM, V272, P25641, DOI 10.1074/jbc.272.41.25641
   Uchida E, 2002, BIOL PHARM BULL, V25, P891, DOI 10.1248/bpb.25.891
   Varga CM, 2001, MOL THER, V4, P438, DOI 10.1006/mthe.2001.0475
   Wu RZ, 2002, TRENDS CELL BIOL, V12, P485, DOI 10.1016/S0962-8924(02)02354-1
   Yoshikawa T, 2004, J CONTROL RELEASE, V96, P227, DOI 10.1016/j.jconrel.2004.01.024
   Zelphati O, 1998, BBA-LIPID LIPID MET, V1390, P119, DOI 10.1016/S0005-2760(97)00169-0
   Zhang XH, 2001, J GENE MED, V3, P560, DOI 10.1002/jgm.224
   Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114
NR 39
TC 96
Z9 99
U1 0
U2 21
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD MAY 5
PY 2005
VL 90
IS 3
BP 290
EP 302
DI 10.1002/bit.20393
PG 13
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 920YW
UT WOS:000228732400003
PM 15800863
OA Green Accepted, Green Published
DA 2018-10-20
ER

PT J
AU Bruinink, A
   Kaiser, JP
   Meyer, DC
AF Bruinink, A
   Kaiser, JP
   Meyer, DC
TI Effect of biomaterial surface morphologies on bone marrow cell
   performance
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID OSTEOBLAST-LIKE CELLS; IN-VITRO; DIFFERENTIATION; ROUGHNESS; TITANIUM;
   ADHESION; TISSUE; PROLIFERATION; ORIENTATION; EXPRESSION
C1 Empa Mat Sci & Technol, Lab Biocompatible Mat, CH-9014 St Gallen, Switzerland.
   Univ Zurich Uniklin, CH-8008 Zurich, Switzerland.
RP Bruinink, A (reprint author), Empa Mat Sci & Technol, Lab Biocompatible Mat, Lerchenfeldstr 5, CH-9014 St Gallen, Switzerland.
EM arie.bruinink@empa.ch; dmeyer@balgrist.unizh.ch
CR Acemoglu M, 2004, INT J PHARM, V277, P133, DOI 10.1016/j.ijpharm.2003.06.002
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Boyan BD, 2003, J ORTHOPAED RES, V21, P638, DOI 10.1016/S0736-0266(02)00261-9
   Bruinink A, 2001, BIOMATERIALS, V22, P2465, DOI 10.1016/S0142-9612(00)00434-8
   Bruinink A, 1992, BRAIN BITS PIECES, P23
   Brunette D.M., 1988, SURFACE CHARACTERIZA, P203
   Chehroudi B, 1997, J BIOMED MATER RES, V34, P279
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dalton BA, 2001, J BIOMED MATER RES, V56, P195, DOI 10.1002/1097-4636(200108)56:2<195::AID-JBM1084>3.0.CO;2-7
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   Hatano K, 1999, BONE, V25, P439, DOI 10.1016/S8756-3282(99)00192-1
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jungbauer S, 2004, CHEMPHYSCHEM, V5, P85, DOI 10.1002/cphc.200300868
   Kaiser JP, 2004, J MATER SCI-MATER M, V15, P429, DOI 10.1023/B:JMSM.0000021115.55254.a8
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kotobuki N, 2004, CELL TRANSPLANT, V13, P377, DOI 10.3727/000000004783983756
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   Liao HH, 2003, BIOMATERIALS, V24, P649, DOI 10.1016/S0142-9612(02)00379-4
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   Lossdorfer S, 2004, BIOMATERIALS, V25, P2547, DOI 10.1016/j.biomaterials.2003.09.094
   Madore C, 1997, J MICROMECH MICROENG, V7, P270, DOI 10.1088/0960-1317/7/4/002
   Marks SC, 1996, MICROSC RES TECHNIQ, V33, P121, DOI 10.1002/(SICI)1097-0029(19960201)33:2<121::AID-JEMT3>3.0.CO;2-W
   MAROM R, 2002, J CELL PHYSL, V202, P41
   Monkawa T, 2002, J AM SOC NEPHROL, V13, P1172, DOI 10.1097/01.ASN.0000013162.29833.45
   Mulari MTK, 2004, CALCIFIED TISSUE INT, V75, P253, DOI 10.1007/s00223-004-0172-3
   Navarro JM, 1997, EUR J CLIN INVEST, V27, P620, DOI 10.1046/j.1365-2362.1997.1510698.x
   Qu J, 1996, Oral Dis, V2, P102
   Schneider GB, 2004, J BIOMED MATER RES A, V69A, P462, DOI 10.1002/jbm.a.30016
   Sells-Galvin R., 1994, J BONE MINER RES, V9, P1167
   Shah AK, 1999, BONE, V24, P499, DOI 10.1016/S8756-3282(99)00077-0
   Shi ZQ, 2004, GENE, V343, P117, DOI 10.1016/j.gene.2004.08.009
   Simmons CA, 2001, J ORTHOPAED RES, V19, P187, DOI 10.1016/S0736-0266(00)90006-8
   SUZUKI K, 1993, MATSUMOTO SHIGAKU, V19, P223
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
   Zohar R, 1997, BLOOD, V90, P3471
NR 40
TC 8
Z9 8
U1 1
U2 6
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD MAY
PY 2005
VL 7
IS 5
BP 411
EP 418
DI 10.1002/adem.200500065
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 937KL
UT WOS:000229922900027
DA 2018-10-20
ER

PT J
AU Daniel, J
   Abe, K
   McFetridge, PS
AF Daniel, J
   Abe, K
   McFetridge, PS
TI Development of the human umbilical vein scaffold for cardiovascular
   tissue engineering applications
SO ASAIO JOURNAL
LA English
DT Article
ID SMALL-INTESTINAL SUBMUCOSA; DIAMETER VASCULAR GRAFTS; ABOVE-KNEE
   REVASCULARIZATION; ACELLULAR MATRIX; CORD VEIN; IN-VITRO; BYPASS GRAFTS;
   BLOOD-VESSELS; CROSS-LINKING; COLLAGEN
AB Biologic function and the mechanical performance of vascular grafting materials are important predictors of graft patency. As such, "functional" materials that improve biologic integration and function have become increasingly sought after. An important alternative to synthetic materials is the use of biomaterials derived from ex vivo tissues that retain significant biologic and mechanical function. Unfortunately, inconsistent mechanical properties that result from tedious, time consuming, manual dissection methods have reduced the potential usefulness of many of these materials. We describe the preparation of the human umbilical vein (HUV) for use as an acellular, three-dimensional, vascular scaffold using a novel, automated dissection methodology. The goal of this investigation was to determine the effectiveness of the autodissection methodology to yield an ex vivo biomaterial with improved uniformity and reduced variance. Mechanical properties, including burst pressure, compliance, uniaxial tension testing, and suture holding capacity, were assessed to determine the suitability of the HUV scaffold for vascular tissue engineering applications. The automated methodology results in a tubular scaffold with significantly reduced sample to sample variation, requiring significantly less time to excise the vein from the umbilical cord than manual dissection methods. Short-term analysis of the interactions between primary human vascular smooth muscle cells and fibroblasts HUV scaffold have shown an excellent potential for cellular integration by native cellular remodeling processes. Our work has shown that the HUV scaffold is mechanically sound, uniform, and maintains its biphasic stress-strain relationship throughout tissue processing. By maintaining the mechanical properties of the native blood vessels, in concert with promising cellular interactions, the HUV scaffold may lead to improved grafts for vascular reconstructive surgeries.
C1 Univ Oklahoma, Sch Chem Biol & Mat Engn, Norman, OK USA.
   Univ Oklahoma, Ctr Bioengn, Norman, OK USA.
RP McFetridge, PS (reprint author), Univ Oklahoma, Sch Chem Biol & Mat Engn, 100 E Boyd St, Norman, OK USA.
RI Mcfetridge, Peter/A-2802-2010
CR ARNDT JO, 1968, PFLUG ARCH EUR J PHY, V301, P230, DOI 10.1007/BF00363770
   Bader A, 1998, EUR J CARDIO-THORAC, V14, P279, DOI 10.1016/S1010-7940(98)00171-7
   Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   Billiar K, 2001, J BIOMED MATER RES, V56, P101, DOI 10.1002/1097-4636(200107)56:1<101::AID-JBM1074>3.0.CO;2-6
   BODNAR E, 1986, THORAC CARDIOV SURG, V34, P82, DOI 10.1055/s-2007-1020381
   Budd J S, 1991, Eur J Vasc Surg, V5, P397, DOI 10.1016/S0950-821X(05)80171-9
   Bujan J, 2000, EUR J VASC ENDOVASC, V20, P13, DOI 10.1053/ejvs.2000.1090
   Bychkov S M, 1969, Biokhimiia, V34, P204
   Campbell JH, 1999, CIRC RES, V85, P1173
   Chen MK, 2001, J SURG RES, V99, P352, DOI 10.1006/jsre.2001.6199
   COURTMAN DW, 1995, J BIOMED MATER RES, V29, P1507, DOI 10.1002/jbm.820291207
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Courtman DW, 2001, J BIOMED MATER RES, V55, P576, DOI 10.1002/1097-4636(20010615)55:4<576::AID-JBM1051>3.0.CO;2-9
   DARDIK H, 1988, J VASC SURG, V7, P336, DOI 10.1067/mva.1988.avs0070336
   DARDIK H, 1976, JAMA-J AM MED ASSOC, V236, P2859
   DARDIK H, 1976, SURGERY, V79, P618
   DARDIK H, 1979, AM J SURG, V138, P234, DOI 10.1016/0002-9610(79)90376-3
   Dardik H, 1995, Cardiovasc Surg, V3, P265, DOI 10.1016/0967-2109(95)93874-O
   Dardik H, 2001, J VASC SURG, V33, P658, DOI 10.1067/mva.2001.112315
   DARDIK I, 1973, J MED PRIMATOL, V2, P296
   DARDIK II, 1977, J CARDIOVASC SURG, V18, P555
   DARDIK II, 1975, SURG GYNECOL OBSTET, V140, P567
   Deutsch M, 1999, SURGERY, V126, P847, DOI 10.1067/msy.2099.99852
   Dohmen Pascal M, 2002, Asian Cardiovasc Thorac Ann, V10, P25
   Francis K, 1997, P NATL ACAD SCI USA, V94, P12258, DOI 10.1073/pnas.94.23.12258
   Gamba PG, 2002, PEDIATR SURG INT, V18, P327, DOI 10.1007/s00383-002-0849-5
   Goissis G, 2000, ARTIF ORGANS, V24, P217, DOI 10.1046/j.1525-1594.2000.06537.x
   HASSON JE, 1986, J VASC SURG, V4, P243, DOI 10.1067/mva.1986.avs0040243
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Hoerstrup SP, 2001, EUR J CARDIO-THORAC, V20, P164, DOI 10.1016/S1010-7940(01)00706-0
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Johnson WC, 2000, J VASC SURG, V32, P268, DOI 10.1067/mva.2000.106944
   Kadner A, 2004, EUR J CARDIO-THORAC, V25, P635, DOI 10.1016/j.ejcts.2003.12.038
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   KLEIN J, 1983, BIOCHIM BIOPHYS ACTA, V755, P400, DOI 10.1016/0304-4165(83)90243-X
   Kwon TG, 2002, J UROLOGY, V168, P1754, DOI 10.1097/01.ju.0000030103.53181.7d
   L'Heureux N, 1998, FASEB J, V12, P47
   Langer R, 2000, MOL THER, V1, P12, DOI 10.1006/mthe.1999.0003
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   MALONE JM, 1984, J VASC SURG, V1, P181, DOI 10.1067/mva.1984.avs0010181
   McFetridge PS, 2004, J BIOMED MATER RES A, V70A, P224, DOI 10.1002/jbm.a.30060
   MCFETRIDGE PS, 2002, THESIS U BATH
   MECHANIC GL, 1992, CROSS LINKING COLLAG
   MEYER FA, 1983, BIOCHIM BIOPHYS ACTA, V755, P376, DOI 10.1016/0304-4165(83)90241-6
   MIYATA T, 1989, J VASC SURG, V10, P605, DOI 10.1067/mva.1989.14860
   Nerem RM, 2001, ANNU REV BIOMED ENG, V3, P225, DOI 10.1146/annurev.bioeng.3.1.225
   Nerem RM, 2000, YONSEI MED J, V41, P735, DOI 10.3349/ymj.2000.41.6.735
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Niklason LE, 1997, TRANSPL IMMUNOL, V5, P303
   Oegema TR, 2000, CRYOBIOLOGY, V40, P370, DOI 10.1006/cryo.2000.2253
   OLIVER RF, 1985, IMPLANT TISSUE, P1
   Pegg DE, 1997, CRYOBIOLOGY, V34, P183, DOI 10.1006/cryo.1996.1997
   Probst M, 1997, BRIT J UROL, V79, P505, DOI 10.1046/j.1464-410X.1997.00103.x
   Probst M, 2000, BJU INT, V85, P362, DOI 10.1046/j.1464-410x.2000.00442.x
   REID LC, 1987, METHOD ISOLATION CON
   Roeder R, 1999, J BIOMED MATER RES, V47, P65, DOI 10.1002/(SICI)1097-4636(199910)47:1<65::AID-JBM9>3.0.CO;2-F
   Saito M, 2001, EUR J BIOCHEM, V268, P2817, DOI 10.1046/j.1432-1327.2001.02160.x
   Sawyer P, 1987, MODERN VASCULAR GRAF
   Schaner PJ, 2004, J VASC SURG, V40, P146, DOI 10.1016/j.jvs.2004.03.033
   SCHMIDT CE, 2000, BIOMATERIALS, V21, P2214
   SCHMIDT SP, 1999, TISSUE ENG VASCULAR, P61
   SEIFALIAN AM, 1999, TISSUE ENG VASCULAR, P621
   Tai NR, 2000, BRIT J SURG, V87, P1516, DOI 10.1046/j.1365-2168.2000.01566.x
   TAMURA N, 1999, INT J ARTIF ORGANS, V22, P419
   Teebken OE, 2000, EUR J VASC ENDOVASC, V19, P381, DOI 10.1053/ejvs.1999.1004
   Teebken OE, 2004, EUR J VASC ENDOVASC, V27, P597, DOI 10.1016/j.ejvs.2004.01.027
   Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1006/ejvs.2002.1654
   Vyavahare N, 1997, CIRCULATION, V95, P479
NR 70
TC 55
Z9 55
U1 1
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1058-2916
J9 ASAIO J
JI Asaio J.
PD MAY-JUN
PY 2005
VL 51
IS 3
BP 252
EP 261
DI 10.1097/01.MAT.0000160872.41871.7E
PG 10
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 926MH
UT WOS:000229126800013
PM 15968956
OA Bronze
DA 2018-10-20
ER

PT J
AU Watanabe, J
   Ishihara, K
AF Watanabe, J
   Ishihara, K
TI Cell engineering biointerface focusing on cytocompatibility using
   phospholipid polymer with an isomeric oligo(lactic acid) segment
SO BIOMACROMOLECULES
LA English
DT Article
ID PHOSPHORYLCHOLINE; WATER; STEREOCOMPLEX; COPOLYMERS; SUBSTRATE;
   ADHESION; ASSAY
AB Initial contact between a biological environment and a biomaterial ultimately decides the in vivo performance. Therefore, the fabrication of a delicate biointerface is important because it can be utilized as a platform for novel biomaterials. For the preparation of advanced biomedical devices such as biochips, nanoparticles, and cell engineering devices, the surface properties may be modified by the design of polymeric biomaterials. Anomalous phospholipid polymers with an isomeric oligo(lactic acid) segment were designed and evaluated as a biointerface. The phospholipid polymer containing 2-methacryloyloxyethyl phosphorylcholine was easily copolymerized with isomeric oligo(lactic acid) macromonomers, and the obtained polymer could easily form thin coating membranes as biointerfaces. The oligo(lactic acid) involves three kinds of isomers: DL-, D-, and L-forms. The favorable characteristic on the surface provides regulation of cell-material interactions on the biointerface. The oligo(lactic acid) segment could form hydrophobic domains, which were considered to be located on the interface, to enhance protein adsorption and cell adhesion. The most favorable characteristics on the biointerface were dual functions of cytocompatibility by the phospholipid polymer and cell adhesion property by the oligo(lactic acid) segment. In this study, we focused on the biological responses such as protein adsorption and cell adhesion by change in the oligo(lactic acid) component. The cell viability on the confluent stage was evaluated in terms of metabolic activity.
C1 Univ Tokyo, Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan.
RP Ishihara, K (reprint author), Univ Tokyo, Sch Engn, Dept Mat Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM ishihara@bmw.t.u-tokyo.ac.jp
CR Baskin A, 1980, J BIOMED MATER RES, V14, P393
   Biran I, 2002, ANAL CHEM, V74, P3046, DOI 10.1021/ac020009e
   Cheng XH, 2004, J BIOMED MATER RES A, V70A, P159, DOI 10.1002/jbm.a.30053
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Ishihara K, 1999, J BIOMAT SCI-POLYM E, V10, P1047, DOI 10.1163/156856299X00676
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Kitano H, 2003, LANGMUIR, V19, P10260, DOI 10.1021/la0349673
   Kitano H, 2000, J PHYS CHEM B, V104, P11425, DOI 10.1021/jp000429c
   Konno T, 2004, BIOMACROMOLECULES, V5, P342, DOI 10.1021/bm034356p
   MATSUDA T, 1994, J JAPANESE SOC BIOMA, V12, P187
   Miyamoto D, 2004, BIOMATERIALS, V25, P71, DOI 10.1016/S0142-9612(03)00474-5
   Miyazawa K, 2002, MACROMOLECULES, V35, P2440, DOI 10.1021/ma011898v
   Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4
   Oki A, 2001, ELECTROPHORESIS, V22, P341, DOI 10.1002/1522-2683(200101)22:2<341::AID-ELPS341>3.0.CO;2-W
   Park J, 2004, ANAL CHEM, V76, P2649, DOI 10.1021/ac035321i
   Sawada S, 2003, J BIOMED MATER RES A, V64A, P411, DOI 10.1002/jbm.a.10433
   Takei K, 2004, BIOMACROMOLECULES, V5, P858, DOI 10.1021/bm0344250
   Watanabe J, 2003, ARTIF ORGANS, V27, P242, DOI 10.1046/j.1525-1594.2003.07015.x
   Watanabe J, 2003, CHEM LETT, V32, P192, DOI 10.1246/cl.2003.192
   Watanabe J, 2002, BIOMACROMOLECULES, V3, P1109, DOI 10.1021/bm025586r
   Whelan DM, 2000, HEART, V83, P338, DOI 10.1136/heart.83.3.338
   YONEYAMA T, 2002, BIOMATERIALS, V23, P1445
NR 22
TC 21
Z9 23
U1 1
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY-JUN
PY 2005
VL 6
IS 3
BP 1797
EP 1802
DI 10.1021/bm050138f
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 926QY
UT WOS:000229138900080
PM 15877407
DA 2018-10-20
ER

PT J
AU Andersson, J
   Ekdahl, KN
   Lambris, JD
   Nilsson, B
AF Andersson, J
   Ekdahl, KN
   Lambris, JD
   Nilsson, B
TI Binding of C3 fragments on top of adsorbed plasma proteins during
   complement activation on a model biomaterial surface
SO BIOMATERIALS
LA English
DT Article
DE complement; complement activation; biomaterials; proteins adsorption;
   C3b binding
ID ELLIPSOMETRIC IN-VITRO; SOLID-SURFACES; FACTOR-B; ADSORPTION; BLOOD;
   IMMUNOGLOBULINS; PURIFICATION; COMPSTATIN; GENERATION; CONVERTASE
AB In the present study we investigate whether complement activation in blood in contact with a model biomaterial surface (polystyrene) occurs directly on the material surface or on top of an adsorbed plasma protein layer. Quartz crystal microbalance-dissipation analysis (QCM-D) complemented with enzyme immunoassays and Western blotting were used. QCM-D showed that the surface was immediately covered with a plasma protein film of approximately 8 nm. Complement activation that started concomitantly with the adsorption of the protein film was triggered by a self-limiting classical pathway activation. After adsorption of the protein film, alternative pathway activation provided the bulk of the C3b deposition that added 25% more mass to the surface. The build up of alternative pathway convertase complexes using purified C3 and factors B and D on different protein films as monitored by QCM-D showed that only adsorbed albumin, IgG, but not fibrinogen, allowed Ob binding, convertase assembly and amplification. Western blotting of eluted proteins from the material surface demonstrated that the C3 fragments were covalently bound to other proteins. This is consistent with a model in which the activation is triggered by initiating convertases formed by means of the initially adsorbed proteins and the main O3b binding is mediated by the alternative pathway on top of the adsorbed protein film. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, Clin Immunol Sect, Rudbeck Lab C5, SE-75185 Uppsala, Sweden.
   Univ Kalmar, Dept Chem & Biomed Sci, SE-39182 Kalmar, Sweden.
   Univ Penn, Dept Pathol & Lab Med, Prot Chem Lab, Philadelphia, PA 19104 USA.
RP Nilsson, B (reprint author), Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, Clin Immunol Sect, Rudbeck Lab C5, SE-75185 Uppsala, Sweden.
EM Bo.Nilsson@klinimm.uu.se
RI Nilsson Ekdahl, Kristina/B-5301-2012; Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730; Lambris, John/0000-0002-9370-5776
CR Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   CATANA E, 1991, J IMMUNOL METHODS, V138, P265, DOI 10.1016/0022-1759(91)90175-F
   CHENOWETH DE, 1987, ANN NY ACAD SCI, V516, P306, DOI 10.1111/j.1749-6632.1987.tb33051.x
   CORNELIUS RM, 1993, J BIOMAT SCI-POLYM E, V4, P291, DOI 10.1163/156856293X00573
   EKDAHL KN, 1993, J COLLOID INTERF SCI, V158, P121, DOI 10.1006/jcis.1993.1236
   ELWING H, 1984, J IMMUNOL METHODS, V71, P185, DOI 10.1016/0022-1759(84)90064-4
   FISHELSON Z, 1982, J IMMUNOL, V129, P2603
   HAMMER CH, 1981, J BIOL CHEM, V256, P3995
   HED J, 1984, IMMUNOL LETT, V8, P295, DOI 10.1016/0165-2478(84)90013-0
   Hook F, 1998, P NATL ACAD SCI USA, V95, P12271, DOI 10.1073/pnas.95.21.12271
   JANATOVA J, 1991, COMPLEMENT INFLAMMAT, V8, P61, DOI 10.1159/000463181
   LAMBRIS JD, 1984, J BIOL CHEM, V259, P2685
   Lhotta K, 1998, KIDNEY INT, V53, P1044
   Nilsson B, 1998, BLOOD, V92, P1661
   NILSSON UR, 1972, IMMUNOCHEMISTRY, V9, P709, DOI 10.1016/0019-2791(72)90015-8
   Nilsson UR, 2001, MOL IMMUNOL, V38, P151, DOI 10.1016/S0161-5890(01)00039-6
   PEKNA M, 1993, CLIN EXP IMMUNOL, V91, P404
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   ROSS GD, 1983, J EXP MED, V158, P334, DOI 10.1084/jem.158.2.334
   Sahu A, 1996, J IMMUNOL, V157, P884
   Sahu A, 2003, MOL IMMUNOL, V39, P557, DOI 10.1016/S0161-5890(02)00212-2
   Sahu A, 2000, IMMUNOPHARMACOLOGY, V49, P133, DOI 10.1016/S0162-3109(00)80299-4
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Song WC, 2000, IMMUNOPHARMACOLOGY, V49, P187, DOI 10.1016/S0162-3109(00)80303-3
   Tengvall P, 1998, BIOMATERIALS, V19, P935, DOI 10.1016/S0142-9612(98)00005-2
   Tengvall P, 2001, COLLOID SURFACE B, V20, P51, DOI 10.1016/S0927-7765(00)00174-0
   Tengvall P, 1996, BIOMATERIALS, V17, P1001, DOI 10.1016/0142-9612(96)84675-8
   Tengvall P, 2001, J BIOMED MATER RES, V57, P285, DOI 10.1002/1097-4636(200111)57:2<285::AID-JBM1169>3.0.CO;2-C
   VENKATESH YP, 1988, MOL IMMUNOL, V25, P821, DOI 10.1016/0161-5890(88)90118-6
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   Wettero J, 2002, BIOMATERIALS, V23, P981, DOI 10.1016/S0142-9612(01)00203-4
NR 31
TC 106
Z9 108
U1 2
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 13
BP 1477
EP 1485
DI 10.1016/j.biomaterials.2004.05.011
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 889CX
UT WOS:000226422200004
PM 15522749
DA 2018-10-20
ER

PT J
AU Segura, T
   Chung, PH
   Shea, LD
AF Segura, T
   Chung, PH
   Shea, LD
TI DNA delivery from hyaluronic acid-collagen hydrogels via a
   substrate-mediated approach
SO BIOMATERIALS
LA English
DT Article
DE gene delivery; polyethyleneimine; neutravidin; biotin; reverse
   transfection; solid plase
ID DNA/TRANSFERRIN-PEI COMPLEXES; TARGETED GENE DELIVERY; IN-VIVO; CELLS;
   TRANSFECTION; SIZE; SURFACE; FIBRONECTIN; POLYPLEXES; EXPRESSION
AB Efficient and controlled gene delivery from biodegradable materials can be employed to stimulate cellular processes that lead to tissue regeneration. In this report, a substrate-mediated approach was developed to deliver DNA from hyaluronic acid-collagen hydrogels. The hydrogels were formed by crosslinking HA with poly(ethylene glycol) diglycidyl ether. Poly(ethylene imine)(PEI)/ DNA complexes were immobilized to the substrate using either biotin/neutravidin or non-specific adsorption. Complexes were formed in the presence or absence of salt to regulate complex size, and resulted in complexes with z-average diameters of 1221.7 +/- 152.3 and 139.4 +/- 1.3 nm, respectively. During 48-h incubation in PBS or hyaluronidase, DNA was released slowly from the hydrogel substrate (<30% of immobilized DNA), which was enhanced by incubation with conditioned media (approximate to50% of immobilized DNA). Transgene expression mediated by immobilized, large diameter complexes was 3 to 7-fold greater than for small diameter complexes. However, the percentage of cells expressing the transgene was greater for small diameter complexes (48.7%) than for large diameter complexes (22.3%). Spatially controlled gene transfer was achieved by topographically patterning the hydrogel to pattern cell adhesion. Biomaterial-based gene delivery can be applicable to numerous tissue engineering applications, or as a tool to examine tissue formation. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem Engn, 2145 Sheridad Rd,E156, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009
FU NIGMS NIH HHS [R01 GM066830-01A1, R01GM066830, R01 GM066830]
CR Adami RC, 1999, J PHARM SCI, V88, P739, DOI 10.1021/js990042p
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Braddock M, 2001, ANN MED, V33, P313, DOI 10.3109/07853890109002083
   Choe MM, 2003, AM J PHYSIOL-LUNG C, V285, pL427, DOI 10.1152/ajplung.00005.2003
   Goula D, 1998, GENE THER, V5, P712, DOI 10.1038/sj.gt.3300635
   Hagstrom JE, 2000, CURR OPIN MOL THER, V2, P143
   Harbottle RP, 1998, HUM GENE THER, V9, P1037, DOI 10.1089/hum.1998.9.7-1037
   Honma K, 2001, BIOCHEM BIOPH RES CO, V289, P1075, DOI 10.1006/bbrc.2001.6133
   JULKUNEN I, 1984, BIOCHEM J, V219, P425, DOI 10.1042/bj2190425
   KABANOV AV, 1995, BIOCONJUGATE CHEM, V6, P7, DOI 10.1021/bc00031a002
   Kircheis R, 1997, GENE THER, V4, P409, DOI 10.1038/sj.gt.3300418
   Kunath K, 2003, J CONTROL RELEASE, V88, P159, DOI 10.1016/S0168-3659(02)00458-3
   Kunath K, 2003, J GENE MED, V5, P588, DOI 10.1002/jgm.382
   Levy RJ, 2001, GENE THER, V8, P659, DOI 10.1038/sj.gt.3301452
   Lucas P, 1999, J DRUG TARGET, V7, P143, DOI 10.3109/10611869909085498
   Luo D, 2000, NAT BIOTECHNOL, V18, P893, DOI 10.1038/78523
   Murphy WL, 1999, J PERIODONTAL RES, V34, P413, DOI 10.1111/j.1600-0765.1999.tb02275.x
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   Ogris M, 1998, GENE THER, V5, P1425, DOI 10.1038/sj.gt.3300745
   Ogris M, 2001, AAPS PHARMSCI, V3, part. no.
   Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900
   Oupicky D, 2000, BIOCONJUGATE CHEM, V11, P492, DOI 10.1021/bc990143e
   Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420
   PANNIER AK, IN PRESS MOL THER
   Plank C, 1999, HUM GENE THER, V10, P319, DOI 10.1089/10430349950019101
   PLANK C, 1992, BIOCONJUGATE CHEM, V3, P533, DOI 10.1021/bc00018a012
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   Scholl SM, 2003, J BIOMED BIOTECHNOL, P35
   Segura T, 2003, J CONTROL RELEASE, V93, P69, DOI 10.1016/j.jconrel.2003.08.003
   Segura T, 2002, BIOCONJUGATE CHEM, V13, P621, DOI 10.1021/bc015575f
   SEGURA T, 2004, IN PRESS BIOMATERIAL
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Toncheva V, 1998, BBA-GEN SUBJECTS, V1380, P354, DOI 10.1016/S0304-4165(98)00004-X
   Trubetskoy VS, 1999, NUCLEIC ACIDS RES, V27, P3090, DOI 10.1093/nar/27.15.3090
   Trubetskoy VS, 1998, NUCLEIC ACIDS RES, V26, P4178, DOI 10.1093/nar/26.18.4178
   Trubetskoy VS, 1999, BIOCONJUGATE CHEM, V10, P624, DOI 10.1021/bc9801530
   Williams DA, 1999, ANN NY ACAD SCI, V872, P109, DOI 10.1111/j.1749-6632.1999.tb08457.x
   Wolf E, 1999, OPT PHOTONICS NEWS, V10, P6
   Xu B, 1998, GENE THER, V5, P1235, DOI 10.1038/sj.gt.3300719
NR 39
TC 105
Z9 109
U1 7
U2 48
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 13
BP 1575
EP 1584
DI 10.1016/j.biomaterials.2004.05.007
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 889CX
UT WOS:000226422200014
PM 15522759
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Johnell, M
   Larsson, R
   Siegbahn, A
AF Johnell, M
   Larsson, R
   Siegbahn, A
TI The influence of different heparin surface concentrations and
   antithrombin-binding capacity on inflammation and coagulation
SO BIOMATERIALS
LA English
DT Article
DE heparin; biomaterial; biocompatibility; cell activation
ID FLOW-CYTOMETRIC ASSAY; TISSUE FACTOR; EXTRACORPOREAL-CIRCULATION;
   CARDIOPULMONARY BYPASS; CELL-ADHESION; P-SELECTIN; IN-VITRO; ACTIVATION;
   BLOOD; EXPRESSION
AB The corline heparin surface (CHS) used in the extracorporeal circuit during coronary artery bypass grafting is shown to decrease the activation of inflammation and coagulation. Synchrotron radiation studies have shown that a single layer of the CHS may not completely cover the substrate surface. However, a double layer of CHS results in a uniform surface. We investigated the effect of surfaces with different surface concentrations of heparin on cell activation and coagulation compared to an uncoated surface.
   The CHS is prepared by a conditioning layer of polymeric amine onto which a macromolecular heparin conjugate is attached. We used PVC tubing, uncoated or modified with a single or double layer of the CHS, and circulated fresh whole blood from healthy volunteers in a loop model system at 37degreesC up to 4h. Blood was drawn from the loops at different times and activation of inflammation and coagulation was studied by real-time PCR, flow cytometry and ELISA. The activation of leukocytes and platelets and formation of leukocyte-platelet aggregates were reduced by use of the single-layered CHS compared to the uncoated surface. Use of double-layered CHS resulted in significantly reduced cell activation and thrombin generation. Development of the CHS obtained by the double layer of the coating has improved the biocompatibility of the surface. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Uppsala Univ, Akad Hosp, Lab Coagulat Res, Dept Med Sci, SE-75185 Uppsala, Sweden.
   Akad Hosp, Dept Oncol Radiol & Clin Immunol, Clin Immunol Sect, Rudbeck Lab C5, SE-75185 Uppsala, Sweden.
RP Siegbahn, A (reprint author), Uppsala Univ, Akad Hosp, Lab Coagulat Res, Dept Med Sci, SE-75185 Uppsala, Sweden.
EM agneta.siegbahn@akademiska.se
CR Amirkhosravi A, 1996, THROMB HAEMOSTASIS, V75, P87
   Andersson J, 2003, J BIOMED MATER RES A, V67A, P458, DOI 10.1002/jbm.a.10104
   Arefieva TL, 2001, J CELL PHYSIOL, V188, P403, DOI 10.1002/jcp.1127
   BARBUCCI R, 1994, BIOMATERIALS, V15, P955, DOI 10.1016/0142-9612(94)90075-2
   Ben-Abraham R, 2003, PAEDIATR ANAESTH, V13, P655, DOI 10.1046/j.1460-9592.2003.01069.x
   CAZENAVE JP, 1991, MODERN ASPECTS OF PROTEIN ADSORPTION ON BIOMATERIALS, P49
   CELI A, 1994, P NATL ACAD SCI USA, V91, P8767, DOI 10.1073/pnas.91.19.8767
   FAN ST, 1991, J CLIN INVEST, V87, P50, DOI 10.1172/JCI115000
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   Hunt BJ, 1998, ANN THORAC SURG, V65, P712, DOI 10.1016/S0003-4975(97)01345-3
   Johnell M, 2002, SCAND CARDIOVASC J, V36, P351, DOI 10.1080/140174302762659076
   Johnell M, 2002, J THORAC CARDIOV SUR, V124, P321, DOI 10.1067/mtc.2002.122551
   Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042
   KAPPELMAYER J, 1993, CIRC RES, V72, P1075, DOI 10.1161/01.RES.72.5.1075
   Kjalke M, 1998, THROMB HAEMOSTASIS, V80, P578
   Kristensen EME, 2003, BIOMATERIALS, V24, P4153, DOI 10.1016/S0142-9612(03)00297-7
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   LARSSON R, 2004, IN PRESS ENCY BIOMAT
   Li NL, 1999, CYTOMETRY, V35, P154, DOI 10.1002/(SICI)1097-0320(19990201)35:2<154::AID-CYTO7>3.0.CO;2-Y
   Lindmark E, 2000, ARTERIOSCL THROM VAS, V20, P2322, DOI 10.1161/01.ATV.20.10.2322
   Malarstig A, 2003, THROMB RES, V112, P175, DOI 10.1016/j.thromres.2003.11.001
   Morrissey JH, 2001, THROMB HAEMOSTASIS, V86, P66
   Neumann FJ, 1997, CIRCULATION, V95, P2387, DOI 10.1161/01.CIR.95.10.2387
   Petersen LC, 2001, SEMIN HEMATOL, V38, P39, DOI 10.1053/shem.2001.29510
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tenno T, 2000, LEUKEMIA, V14, P1105, DOI 10.1038/sj.leu.2401785
   Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9
NR 27
TC 40
Z9 41
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 14
BP 1731
EP 1739
DI 10.1016/j.biomaterials.2004.05.029
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892PZ
UT WOS:000226663800014
PM 15576147
DA 2018-10-20
ER

PT J
AU De Jong, WH
   Bergsma, JE
   Robinson, JE
   Bos, RRM
AF De Jong, WH
   Bergsma, JE
   Robinson, JE
   Bos, RRM
TI Tissue response to partially in vitro predegraded poly-L-lactide
   implants
SO BIOMATERIALS
LA English
DT Article
DE PLA implant; histology; immunohistochemistry; predegradation;
   biocompatibility
ID FOREIGN-BODY REACTION; POLY(L-LACTIDE) BONE PLATES; DERMAL SHEEP
   COLLAGEN; INTERNAL-FIXATION; BIODEGRADABLE BIOMATERIAL;
   QUANTITATIVE-ANALYSIS; FRACTURE FIXATION; BLOCK-COPOLYMERS;
   DRUG-DELIVERY; IFN-GAMMA
AB The in vivo local reaction of as-polymerized poly-L-lactide composed of 96% L-lactide and 4% D-lactide (PLA96) was investigated by histology at 2, 13 and 26 weeks after subcutaneous implantation in rats. In order to simulate possible end stage reactions the PLA96 was also predegraded in vitro until approximately 50% weight loss. The local reaction of predegraded PLA (PLA96(168)) was compared to the local reaction of polyethylene (PE) and non-predegraded PLA (PLA96).
   For PE and PLA96 a mild local reaction was observed at all time points consisting of a minimal layer of macrophage like cells with incidentally multinucleated giant cells at the implant interface, surrounded by a mild connective tissue capsule. For PLA96 at weeks 13 and 26 some minimal alterations in terms of degradation and ingrowth of cells was noted. The in vitro incubation (90degreesC for 168 h) of PLA96(168) resulted for the thin 0.2 mm samples in complete degradation. Predegraded 0.5, 1.0 and 2.0 turn PLA96(168) samples were implanted and evaluated. The 1.0 and 2.0 mm samples could be evaluated for all time points investigated. but some 0.5 mm PLA96168 samples were already completely resorbed at week 2 after implantation. In general, responses found for the predegraded PLA96(168) at weeks 2, 13 and 26 were similar with a pronounced macrophage infiltrate containing birefringent material. encapsulation of polymer fragments, and the presence of a debris area consisting Of Polymer and cellular remnants. in lymph nodes foamy macrophages with birefringent material were only observed in lymph nodes draining sites with predegraded PLA96(168).
   Immunohistochemistry was performed for further characterization of the cellular infiltrate. At the implant interface of the nondegrading PE and PLA96, ED1 and OX6 (MHC class 11) positive cells were identified. In the capsule macrophage Eke cells expressed all three macrophage markers ED1, ED2, and ED3. CD4 and CD8 positive cells. indicating T helper and T supressor/cytotoxic cells, respectively. could be observed in low numbers, CD4 more than CD8. Both CD4 and CD8 were occasionally observed within the degrading PLA96(168) implant. Polymorphonuclear neutrophilic granulocytes were mainly observed at 2 weeks after implantation.
   We showed that predegradation Could be used as a means to study late tissue reactions to polymers. Complete degradation may be studied with relatively thin implants, but this may lead to rather optimistic interpretation of resorption periods. When materials are intended to be used for screws and/or plates for bone fixation, implants of at least 1.0-2.0 mm thickness should be used as these May show a more realistic representation of the resorption characteristics of the material under investigation. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Natl Inst Publ Hlth & Environm, Lab Toxicol Pathol & Genet, NL-3720 BA Bilthoven, Netherlands.
   Univ Groningen Hosp, Dept Oral & Maxillofacial Surg, Groningen, Netherlands.
RP De Jong, WH (reprint author), Natl Inst Publ Hlth & Environm, Lab Toxicol Pathol & Genet, POB 1, NL-3720 BA Bilthoven, Netherlands.
EM w.de.jong@rivm.nl
CR An YH, 2000, BIOMATERIALS, V21, P2635, DOI 10.1016/S0142-9612(00)00132-0
   Ashammakhi N, 2003, J CRANIOFAC SURG, V14, P247, DOI 10.1097/00001665-200303000-00021
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   BERGSMA EJ, 1993, J ORAL MAXIL SURG, V51, P666, DOI 10.1016/S0278-2391(10)80267-8
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Bergsma JE, 1995, J MATER SCI-MATER M, V6, P715, DOI 10.1007/BF00134307
   BOS RRM, 1991, BIOMATERIALS, V12, P32, DOI 10.1016/0142-9612(91)90128-W
   Bostman O, 2000, BIOMATERIALS, V21, P2553, DOI 10.1016/S0142-9612(00)00123-X
   Bostman O, 2000, BIOMATERIALS, V21, P2615, DOI 10.1016/S0142-9612(00)00129-0
   Cordewener FW, 2000, BIOMATERIALS, V21, P2433, DOI 10.1016/S0142-9612(00)00111-3
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   Deschamps AA, 2004, BIOMATERIALS, V25, P247, DOI 10.1016/S0142-9612(03)00495-2
   DEVOR DE, 1993, TOXICOL PATHOL, V21, P261, DOI 10.1177/019262339302100301
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hunt JA, 1997, J BIOMED MATER RES, V36, P542
   *ISO, 1994, BIOL EV MED DEV 6
   Jain R, 1998, DRUG DEV IND PHARM, V24, P703, DOI 10.3109/03639049809082719
   Khouw IMSL, 2000, J BIOMED MATER RES, V52, P439, DOI 10.1002/1097-4636(20001205)52:3<439::AID-JBM1>3.0.CO;2-C
   Khouw IMSL, 2000, J BIOMED MATER RES, V50, P259, DOI 10.1002/(SICI)1097-4636(200005)50:2<259::AID-JBM21>3.0.CO;2-B
   Khouw IMSL, 1998, J BIOMED MATER RES, V41, P202, DOI 10.1002/(SICI)1097-4636(199808)41:2<202::AID-JBM4>3.0.CO;2-M
   Khouw IMSL, 2000, J BIOMED MATER RES, V49, P297, DOI 10.1002/(SICI)1097-4636(20000305)49:3<297::AID-JBM1>3.0.CO;2-0
   Kobayashi D, 1998, DRUG DEV IND PHARM, V24, P819, DOI 10.3109/03639049809088526
   LEENSLAG JW, 1987, MACROMOL CHEM, V45, P751
   Margevicius KJ, 1996, J BIOMED MATER RES, V31, P319, DOI 10.1002/(SICI)1097-4636(199607)31:3<319::AID-JBM5>3.0.CO;2-P
   MATSUSUE Y, 1995, CLIN ORTHOP RELAT R, P246
   MATSUSUE Y, 1992, J BIOMED MATER RES, V26, P1553, DOI 10.1002/jbm.820261203
   Matsuzaka K, 2000, CLIN ORAL IMPLAN RES, V11, P325, DOI 10.1034/j.1600-0501.2000.011004325.x
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Pietrzak WS, 2003, J CRANIOFAC SURG, V14, P176, DOI 10.1097/00001665-200303000-00008
   Pietrzak WS, 2000, TISSUE ENG, V6, P425, DOI 10.1089/107632700418128
   Prokop A, 2004, BIOMATERIALS, V25, P259, DOI 10.1016/S0142-9612(03)00496-4
   ROZEMA FR, 1994, J MATER SCI-MATER M, V5, P575, DOI 10.1007/BF00120333
   Saito N, 2001, J BONE JOINT SURG AM, V83A, pS92
   Suuronen R, 1998, J ORAL MAXIL SURG, V56, P604, DOI 10.1016/S0278-2391(98)90461-X
   Suuronen R, 2000, J Craniomaxillofac Trauma, V6, P19
   van den Berg TK, 2001, IMMUNOL REV, V184, P45, DOI 10.1034/j.1600-065x.2001.1840105.x
   van der Elst M, 1999, BIOMATERIALS, V20, P121, DOI 10.1016/S0142-9612(98)00117-3
   van Luyn MJA, 2001, BIOMATERIALS, V22, P1385, DOI 10.1016/S0142-9612(00)00295-7
   van Luyn MJA, 1998, J BIOMED MATER RES, V39, P398
   VANDERELST M, 1995, BIOMATERIALS, V16, P103, DOI 10.1016/0142-9612(95)98270-O
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P1115, DOI 10.1002/jbm.820270817
   Walboomers XF, 2000, BIOMATERIALS, V21, P629, DOI 10.1016/S0142-9612(99)00230-6
NR 43
TC 50
Z9 50
U1 2
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 14
BP 1781
EP 1791
DI 10.1016/j.biomaterials.2004.06.026
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892PZ
UT WOS:000226663800019
PM 15576152
DA 2018-10-20
ER

PT J
AU Kilian, O
   Fuhrmann, R
   Alt, V
   Noll, T
   Coskun, S
   Dingeldein, E
   Schnettler, R
   Franke, RP
AF Kilian, O
   Fuhrmann, R
   Alt, V
   Noll, T
   Coskun, S
   Dingeldein, E
   Schnettler, R
   Franke, RP
TI Plasma transglutaminase factor XIII induces microvessel ingrowth into
   biodegradable hydroxyapatite implants in rats
SO BIOMATERIALS
LA English
DT Article
DE plasma factor XIII; hydroxyapatite; confocal laser scanning microscopy;
   alpha smooth muscle actin antigen; CD34 antigen; angiogenesis
ID BONE-GRAFTS; CELL-ADHESION; ANGIOGENESIS; EXPRESSION; VASCULARIZATION;
   FIBRONECTIN; DEFECTS
AB Coagulation factor XIII is a member of the transglutaminase-family. Transgluaminases cross-link either fibrin monomers in blood coagulation or extracellular proteins in extracellular matrix formation. In early stages of bone healing migration and proliferation of endothelial cells lead to formation of new vessels. The aim of this study was to investigate the angiogenetic activity of plasma factor XIII in bone defects filled with nanoparticulate hydroxyapatite paste. A critical size defect was created in the tibial head of rats which was not filled in group I. In group 11 the defect was filled with hydroxyapatite group III with hydroxyapatite paste enriched with factor XIII. Ten days after surgery angiogenesis in the defects was assessed using immunohistochemistry and confocal laser scanning microscopy. Ac16 antibody was used to detect activation of factor XIII into factor XIIIA. In defects without biomaterial (group 1) vessel-rich connective tissue and diffuse distribution of capillaries was observed. In defects without pure hydroxyapatite (group 11) formation of capillaries was limited to the host bone-hydroxyapatite interface. In contrast. addition of plasma factor XIII to hydroxyapatite (group 111) stimulated formation of vessels within the biomaterial. The cur-rent study reveals that factor XIII can improve angiogenesis in hydroxyapatite. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Giessen, Dept Trauma Surg, D-35392 Giessen, Germany.
   Univ Ulm, Dept Biomat, D-89069 Ulm, Germany.
   Univ Giessen, Inst Physiol, Giessen, Germany.
   Osartis GmbH, Obernburg, Germany.
RP Kilian, O (reprint author), Univ Giessen, Dept Trauma Surg, Rudolf Buchheim Str 7, D-35392 Giessen, Germany.
EM olaf.kilian@chiru.med.uni-giessen.de
CR Adany Roza, 1996, Seminars in Thrombosis and Hemostasis, V22, P399, DOI 10.1055/s-2007-999038
   Bailon-Plaza A, 2001, J THEOR BIOL, V212, P191, DOI 10.1006/jtbi.2001.2372
   Barou O, 2002, BONE, V30, P604, DOI 10.1016/S8756-3282(02)00677-4
   BARRY ELR, 1988, J BIOL CHEM, V263, P10464
   BRIGHTON CT, 1991, J BONE JOINT SURG AM, V73A, P832, DOI 10.2106/00004623-199173060-00006
   Chakkalakal DA, 1999, BONE, V25, P321, DOI 10.1016/S8756-3282(99)00167-2
   CLAES L, 1985, ACTA ORTHOP SCAND, V56, P57
   Dardik R, 2003, ARTERIOSCL THROM VAS, V23, P1472, DOI 10.1161/01.ATV.0000081636.25235.C6
   El-Hakim IE, 1999, INT J ORAL MAX SURG, V28, P304, DOI 10.1016/S0901-5027(99)80164-7
   FINA L, 1990, BLOOD, V75, P2417
   FONSECA RJ, 1983, J ORAL MAXIL SURG, V41, P153, DOI 10.1016/0278-2391(83)90073-3
   GERNGROSS H, 1986, ARCH ORTHOP TRAUM SU, V106, P23, DOI 10.1007/BF00435648
   Glowacki J, 1998, CLIN ORTHOP S, V355, pS82
   Heath DJ, 2002, BIOMATERIALS, V23, P1519, DOI 10.1016/S0142-9612(01)00282-4
   KELLY PJ, 1990, CLIN ORTHOP RELAT R, P275
   KIENAPFEL H, 1995, Z ORTHOP GRENZGEB, V133, P394, DOI 10.1055/s-2008-1039944
   KIRKEBY OJ, 1992, SCAND J PLAST RECONS, V26, P141, DOI 10.3109/02844319209016004
   KNOX P, 1986, J CELL BIOL, V102, P2318, DOI 10.1083/jcb.102.6.2318
   MCDONAGH J, 1994, HEMOSTASIS THROMBOSI, P301
   MUZBEK I, 1993, THROMB HAEMOSTASIS, V69, P282
   MUZBEK L, 1995, THROMB HAEMOSTASIS, V73, P702
   Nurminskaya MV, 2002, J ORTHOPAED RES, V20, P575, DOI 10.1016/S0736-0266(01)00146-2
   Nurminskaya MV, 2002, DEV DYNAM, V223, P24, DOI 10.1002/dvdy.1230
   Ohtsubo S, 2003, HISTOL HISTOPATHOL, V18, P153, DOI 10.14670/HH-18.153
   Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445
   Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0
   Stromblad S, 1996, TRENDS CELL BIOL, V6, P462, DOI 10.1016/0962-8924(96)84942-7
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Tadic D, 2002, BIOMATERIALS, V23, P2553, DOI 10.1016/S0142-9612(01)00390-8
   Ueki S, 1996, J CELL SCI, V109, P2727
   Wozniak Gernold, 1996, Seminars in Thrombosis and Hemostasis, V22, P445, DOI 10.1055/s-2007-999044
NR 31
TC 19
Z9 19
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 14
BP 1819
EP 1827
DI 10.1016/j.biomaterials.2004.06.015
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892PZ
UT WOS:000226663800023
PM 15576156
DA 2018-10-20
ER

PT J
AU Zinger, O
   Zhao, G
   Schwartz, Z
   Simpson, J
   Wieland, M
   Landolt, D
   Boyan, B
AF Zinger, O
   Zhao, G
   Schwartz, Z
   Simpson, J
   Wieland, M
   Landolt, D
   Boyan, B
TI Differential regulation of osteoblasts by substrate microstructural
   features
SO BIOMATERIALS
LA English
DT Article
DE titanium; microarchitecture; microstructure; roughness;
   photolithography; Osteoblasts; MG63 cells; PGE(2); surface;
   electrochemical micromachining
ID TITANIUM SURFACE-ROUGHNESS; SCREW-SHAPED IMPLANTS; GROWTH-FACTOR-BETA;
   CELLS IN-VITRO; BONE-BIOMATERIAL; ACID; OSTEOPONTIN; TOPOGRAPHY;
   EXPRESSION; COLLAGEN
AB Microtextured titanium implant surfaces enhance bone formation in vivo and osteoblast phenotypic expression in vitro, but the mechanisms are not understood. To determine the roles of specific microarchitectural features in modulating osteoblast behavior, we used Ti surfaces prepared by electrochemical micromachining as substrates for MG63 osteoblast-like cell culture. Cell response was compared to tissue culture plastic, a sand-blasted with large grit and acid-etched surface with defined mixed microtopography (SLA), polished Ti surfaces. and polished surfaces electrochemically machined through a photoresist pattern to produce cavities with 100, 30 and 10 mum diameters arranged so that the ratio of the microscopic-scale area of the cavities versus the microscopic-scale area of the flat region between the cavities was equal to I or 6. Microstructured disks were acid-etched. producing overall sub-micron-scale roughness (Ra = 0.7 mum). Cell number, differentiation (alkaline phosphatase: osteocalcin) and local factor levels (TGF-beta1; PGE(2)) varied with micro architecture. 100 mum cavities favored osteoblast attachment and growth. the sub-micron-scale etch 4 enhanced differentiation and TGF-beta1 production, whereas PGE(2) depended on cavity dimensions but not the sub-micron-scale roughness. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
   Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Jerusalem, Israel.
   Univ Texas, Hlth Sci Ctr, San Antonio, TX USA.
   Inst Straumann AG, Waldenburg, Switzerland.
RP Boyan, B (reprint author), Georgia Inst Technol, Dept Biomed Engn, 315 Ferst Dr NW, Atlanta, GA 30332 USA.
EM Barbara.Boyan@bme.gatech.edu
RI Landolt, Dieter/G-9940-2011
CR Ahmad M, 1999, BIOMATERIALS, V20, P211, DOI 10.1016/S0142-9612(98)00152-5
   Bank I, 2003, CELL IMMUNOL, V223, P35, DOI 10.1016/S0008-8749(03)00147-3
   Bannister SR, 2002, J BIOMED MATER RES, V60, P167, DOI 10.1002/jbm.10037
   Basle MF, 1998, J BIOMED MATER RES, V40, P350, DOI 10.1002/(SICI)1097-4636(19980605)40:3<350::AID-JBM2>3.0.CO;2-E
   BONEWALD LF, 1992, J BIOL CHEM, V267, P8943
   BONEWALD LF, 1990, J CELL PHYSIOL, V145, P200, DOI 10.1002/jcp.1041450203
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   BOYAN BD, 1989, J BIOL CHEM, V264, P11879
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Boyan BD, 2001, J BIOMED MATER RES, V55, P350, DOI 10.1002/1097-4636(20010605)55:3<350::AID-JBM1023>3.0.CO;2-M
   BOYAN BD, 2003, J ORTHOP RES, V4, P638
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   BRUNETTE DM, 1991, BONE-BIOMATERIAL INTERFACE, P170
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Carvalho RS, 2003, MATRIX BIOL, V22, P241, DOI 10.1016/S0945-053X(03)00038-6
   Cheroudi B, 1990, J BIOMED MATER RES, V24, P1203
   Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q
   Davies John E, 2003, J Dent Educ, V67, P932
   DODDS RA, 1995, J BONE MINER RES, V10, P1666
   EVERTS V, 1992, J CELL PHYSIOL, V150, P221, DOI 10.1002/jcp.1041500202
   FRANCESCHI RT, 1985, J CELL PHYSIOL, V123, P401, DOI 10.1002/jcp.1041230316
   Hallgren C, 2001, J BIOMED MATER RES, V57, P485, DOI 10.1002/1097-4636(20011215)57:4<485::AID-JBM1194>3.0.CO;2-1
   Kanagaraja S, 2001, BIOMATERIALS, V22, P1809, DOI 10.1016/S0142-9612(00)00362-8
   Keller John C, 2003, Implant Dent, V12, P175
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   KORATKAR R, 1993, PROSTAG LEUKOTR ESS, V48, P175, DOI 10.1016/0952-3278(93)90107-8
   Landolt D, 2003, ELECTROCHIM ACTA, V48, P3185, DOI 10.1016/S0013-4686(03)00368-2
   Li DH, 2002, J BIOMED MATER RES, V60, P325, DOI 10.1002/jbm.10063
   Lohmann CH, 2002, J BIOMED MATER RES, V62, P204, DOI 10.1002/jbm.10290
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Matsuzaka K, 2004, J BIOMED MATER RES A, V68A, P227, DOI 10.1002/jbm.a.10158
   Matsuzaka K, 2003, BIOMATERIALS, V24, P2711, DOI 10.1016/S0142-9612(03)00085-1
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   MILLER SC, 1993, BONE, V14, P143, DOI 10.1016/8756-3282(93)90241-2
   OKIJI T, 1993, ARCH ORAL BIOL, V38, P31, DOI 10.1016/0003-9969(93)90151-B
   Ong J L, 1997, Implant Dent, V6, P19, DOI 10.1097/00008505-199700610-00004
   Ong J L, 1999, J Oral Implantol, V25, P95, DOI 10.1563/1548-1336(1999)025<0095:OPCRTC>2.3.CO;2
   Ong JL, 1998, J BIOMED MATER RES, V39, P176, DOI 10.1002/(SICI)1097-4636(199802)39:2<176::AID-JBM2>3.0.CO;2-M
   Perrin D, 2002, CLIN ORAL IMPLAN RES, V13, P465, DOI 10.1034/j.1600-0501.2002.130504.x
   ROESLER WJ, 1988, J BIOL CHEM, V263, P9063
   Rosengren A, 2003, BIOMATERIALS, V24, P147, DOI 10.1016/S0142-9612(02)00272-7
   Schwartz Z, 2000, J PERIODONTOL, V71, P586, DOI 10.1902/jop.2000.71.4.586
   Schwartz Z, 1999, Adv Dent Res, V13, P38
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   SHEU TJ, 2002, J BONE MINER RES, V5, P915
   Shibata Y, 2002, INT J ORAL MAX IMPL, V17, P771
   Sisk MA, 2001, CLIN ORAL IMPLAN RES, V12, P52, DOI 10.1034/j.1600-0501.2001.012001052.x
   STANFORD CM, 1994, J DENT RES, V73, P1061, DOI 10.1177/00220345940730050801
   Wennerberg A, 1996, BIOMATERIALS, V17, P15, DOI 10.1016/0142-9612(96)80750-2
NR 51
TC 240
Z9 251
U1 4
U2 65
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 14
BP 1837
EP 1847
DI 10.1016/j.biomaterials.2004.06.035
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892PZ
UT WOS:000226663800025
PM 15576158
DA 2018-10-20
ER

PT J
AU Wei, HJ
   Liang, HC
   Lee, MH
   Huan, YC
   Chang, Y
   Sung, HW
AF Wei, HJ
   Liang, HC
   Lee, MH
   Huan, YC
   Chang, Y
   Sung, HW
TI Construction of varying porous structures in acellular bovine pericardia
   as a tissue-engineering extracellular matrix
SO BIOMATERIALS
LA English
DT Article
DE acellular tissue; porosity; biochemical property; mechanical property;
   angiogenesis
ID CROSS-LINKING AGENT; FIXATIVE CONCENTRATION; MECHANICAL-PROPERTIES;
   IN-VITRO; COLLAGEN; GLYCOSAMINOGLYCANS; BIOMATERIAL; TEMPERATURE;
   ELASTIN; GENIPIN
AB In the study, a cell extraction process was used to remove the cellular components from bovine pericardia. Varying pore sizes and porosities of the acellular tissues were then created using acetic acid and collagenase and subsequently fixed with genipin. Biochemical analyses found that these acellular tissues with distinct porous structures consisted primarily of insoluble Collagen, elastin, and tightly bound glycosaminoglycans. The thermal stability. mechanical properties, and capability against enzymatic degradation of the bovine pericardial tissue remained unaltered after cell extraction. However, following further treatment with acetic acid and collagenase, the thermal stability and capability against enzymatic degradation of the acellular tissues declined. The porous structures of the implanted samples seem to determine whether successful microvessel-ingrowth takes place. The acetic-acid- and collagenase-treated tissues, due to their high pore size and porosity, showed a large number of microvessels infiltrating into the interstices of the implanted samples. In contrast, a low density of microvessels was observed infiltrating into the acellular tissue and penetration of microvessels into the cellular tissue was never encountered. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan.
   Natl Yang Ming Univ, Taichung Vet Gen Hosp, Div Cardiovasc Surg, Taichung, Taiwan.
   Natl Yang Ming Univ, Coll Med, Taipei 112, Taiwan.
RP Sung, HW (reprint author), Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan.
EM hwsung@che.nthu.edu.tw
CR Chang Y, 2002, BIOMATERIALS, V23, P2447, DOI 10.1016/S0142-9612(01)00379-9
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Courtman DW, 2001, J BIOMED MATER RES, V55, P576, DOI 10.1002/1097-4636(20010615)55:4<576::AID-JBM1051>3.0.CO;2-9
   EYRE DR, 1980, SCIENCE, V207, P1315, DOI 10.1126/science.7355290
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Faury G, 2001, PATHOL BIOL, V49, P310, DOI 10.1016/S0369-8114(01)00147-X
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   LEE JM, 1989, J BIOMED MATER RES, V23, P457, DOI 10.1002/jbm.820230502
   Lee K., 2000, PRINCIPLES TISSUE EN, P409
   Liang HC, 2003, J BIOMED MATER RES A, V65A, P271, DOI 10.1002/jbm.a.10476
   Martin I, 2001, J BIOMED MATER RES, V55, P229, DOI 10.1002/1097-4636(200105)55:2<229::AID-JBM1009>3.3.CO;2-H
   Matsuda T, 1996, J BIOMED MATER RES, V31, P235, DOI 10.1002/(SICI)1097-4636(199606)31:2<235::AID-JBM10>3.0.CO;2-K
   MCCLAIN PE, 1972, J BIOL CHEM, V247, P692
   MENGER MD, 1990, THORAC CARDIOV SURG, V38, P139, DOI 10.1055/s-2007-1014008
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   Nimni ME, 1988, COLLAGEN, VIII, P1
   NOISHIKI Y, 1986, J BIOMED MATER RES, V20, P337, DOI 10.1002/jbm.820200306
   Noishiki Y, 1986, ASAIO Trans, V32, P114
   Ramshaw JAM, 1999, J BIOMED MATER RES, V47, P309, DOI 10.1002/(SICI)1097-4636(19991205)47:3<309::AID-JBM4>3.0.CO;2-R
   SANDBERG LB, 1981, NEW ENGL J MED, V304, P566, DOI 10.1056/NEJM198103053041004
   SIMIONESCU D, 1993, J BIOMED MATER RES, V27, P697, DOI 10.1002/jbm.820270602
   Sung HW, 1996, J BIOMED MATER RES, V31, P511, DOI 10.1002/(SICI)1097-4636(199608)31:4<511::AID-JBM11>3.0.CO;2-J
   Sung HW, 2000, J BIOMED MATER RES, V52, P77, DOI 10.1002/1097-4636(200010)52:1<77::AID-JBM10>3.0.CO;2-6
   Sung HW, 1998, J BIOMED MATER RES, V42, P560, DOI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
   Sung HW, 1999, BIOMATERIALS, V20, P1759, DOI 10.1016/S0142-9612(99)00069-1
   Sung HW, 1999, J BIOMED MATER RES, V47, P116, DOI 10.1002/(SICI)1097-4636(199911)47:2<116::AID-JBM2>3.0.CO;2-J
   Thomson RC, 1995, ADV POLYM SCI, V122, P245
   Wayne JS, 2001, J REHABIL RES DEV, V38, P191
   WILSON GJ, 1990, T AM SOC ART INT ORG, V36, P340
   Young B, 2000, WHEATERS FUNCTIONAL
NR 31
TC 34
Z9 37
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 14
BP 1905
EP 1913
DI 10.1016/j.biomaterials.2004.06.014
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892PZ
UT WOS:000226663800031
PM 15576164
DA 2018-10-20
ER

PT J
AU Jones, DS
   Djokic, J
   Gorman, SP
AF Jones, DS
   Djokic, J
   Gorman, SP
TI The resistance of polyvinylpyrrolidone-Iodine-poly(epsilon-caprolactone)
   blends to adherence of Escherichia coli
SO BIOMATERIALS
LA English
DT Article
DE poly(epsilon-caprolactone); povidone-iodine; microbial adherence; drug
   release
ID TUBE POLY(VINYL CHLORIDE); IN-VITRO; CANDIDA-ALBICANS; ENCRUSTATION;
   BIOFILM; PREVENTION; POLY(EPSILON-CAPROLACTONE); POLYURETHANE;
   BIOMATERIALS; INFECTIONS
AB In this study, the resistance of biodegradable biomaterials, composed of blends of poly(E-caprolactone) (PCL) and the Polymeric antimicrobial complex, polyvinylpyrrolidone-iodine (PVP-I) to the adherence of a clinical isolate of Escherichia coli is. described. Blends of PCL composed of a range of high (50 000 g mol(-1)) to low (5000 g mol(-1)) molecular weight ratios of polymer and either devoid of or containing PVP-I (1% w/w) were prepared by solvent evaporation. Following incubation (4h). there was no relationship between m. wt. ratio of PCL in films devoid of PVP-I and adherence of E. coli. Conversely, microbial adherence to PCL containing PVP-I decreased as the ratio of high:low m. wt. polymer was decreased and was approximately 1000 fold lower (ban that to comparator films devoid of PVP-I. Following periods of immersion of PVP-I containing PCL films under sink conditions in phosphate buffered saline, subsequent adherence of E coli was substantially reduced for 2 days (40:60m. ratio) and 6 days (100:0m. wt. ratio). Concurrent exposure of PCL and E coli to sub-minimum inhibitory concentrations (sub-MIC) of PVP-I significantly reduced microbial adherence to the biomaterial; however, the molecular weight ratio of PCL did not affect this outcome. Pretreatment of PCL with similar sub-MIC of PVP-I prior to inclusion within the microbial adherence assay significantly decreased the subsequent adherence of E. coli. Greatest reduction in adherence was observed following treatment of PCL wt. ratio) with 0.0156% w/w PVP-I. In conclusion,. this study has illustrated the utility of PVP-I as a suitable therapeutic agent for incorporation within PCL as a novel biomaterial. Due to the combined antimicrobial and biodegradable properties, these biomaterials offer a promising strategy for the reduction in medical device related infection. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Med Devices Grp, Belfast BT9 7BL, Antrim, North Ireland.
RP Jones, DS (reprint author), Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Med Devices Grp, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
EM d.jones@qab.ac.uk
CR Adair CG, 1999, INTENS CARE MED, V25, P1072, DOI 10.1007/s001340051014
   Bonner MC, 1997, INT J PHARM, V151, P201, DOI 10.1016/S0378-5173(97)04903-X
   BUSSCHER HJ, 1990, MICROBIAL CELL SURFA, P335
   DENYER SP, 1990, J CLIN MICROBIOL, V28, P1813
   ELSHERIF A, 1995, BRIT J UROL, V76, P108, DOI 10.1111/j.1464-410X.1995.tb07842.x
   GORMAN SP, 1987, J CLIN PHARM THER, V12, P393, DOI 10.1111/j.1365-2710.1987.tb00552.x
   Gorman SP, 2001, BIOMATERIALS, V22, P2741, DOI 10.1016/S0142-9612(01)00017-5
   Gorman SP, 1997, BIOMATERIALS, V18, P1379, DOI 10.1016/S0142-9612(97)00070-7
   GORMAN SP, 1993, J MED MICROBIOL, V38, P411, DOI 10.1099/00222615-38-6-411
   Gorman SP, 2003, MED IMPLICATIONS BIO, P136
   GOTTARDI W, 1985, J HOSP INFECT, V6, P1, DOI 10.1016/S0195-6701(85)80040-2
   JANSEN B, 1990, ZBL BAKT-INT J MED M, V272, P401, DOI 10.1016/S0934-8840(11)80040-X
   Jones D. S., 2002, PHARM STAT
   Jones D.S., 1995, PHARM SCI, V1, P513
   Jones DS, 2000, PLAST RUBBER COMPOS, V29, P371, DOI 10.1179/146580100101541175
   Jones DS, 1995, PHARMACEUT RES, V12, P1896, DOI 10.1023/A:1016231620470
   Jones DS, 1997, BIOMATERIALS, V18, P503, DOI 10.1016/S0142-9612(96)00170-6
   Jones DS, 2002, BIOMATERIALS, V23, P4449, DOI 10.1016/S0142-9612(02)00158-8
   Jones DS, 2002, PHARMACEUT RES, V19, P818, DOI 10.1023/A:1016104516034
   Jones DS, 2001, J MATER SCI-MATER M, V12, P399, DOI 10.1023/A:1011240818338
   KEANE PF, 1994, BRIT J UROL, V73, P687, DOI 10.1111/j.1464-410X.1994.tb07557.x
   Maki DG, 1997, ANN INTERN MED, V127, P257, DOI 10.7326/0003-4819-127-4-199708150-00001
   Medlicott NJ, 1996, INT J PHARM, V143, P25, DOI 10.1016/S0378-5173(96)04675-3
   MIYAKE Y, 1990, FEMS MICROBIOL LETT, V69, P211
   Raad I, 1997, ANN INTERN MED, V127, P267, DOI 10.7326/0003-4819-127-4-199708150-00002
   STICKLER D, 1993, UROL RES, V21, P407, DOI 10.1007/BF00300077
   Tunney MM, 1997, INT J PHARMACEUT, V151, P121, DOI 10.1016/S0378-5173(97)04902-8
   Tunney MM, 1996, BIOMATERIALS, V17, P1541, DOI 10.1016/0142-9612(96)89780-8
   Tunney MM, 1999, METHOD ENZYMOL, V310, P558
   TUNNEY MM, 1996, REV MED MICROBIOL, V7, P195
   VANDENBROEK PJ, 1985, LANCET, V1, P563
   WEERKAMP AH, 1988, J DENT RES, V67, P1483, DOI 10.1177/00220345880670120801
   ZISMAN A, 1995, J UROLOGY, V153, P718, DOI 10.1016/S0022-5347(01)67697-3
NR 33
TC 45
Z9 48
U1 1
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 14
BP 2013
EP 2020
DI 10.1016/j.biomaterials.2004.06.001
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892PZ
UT WOS:000226663800042
PM 15576175
DA 2018-10-20
ER

PT J
AU Matsuda, A
   Kobayashi, H
   Itoh, S
   Kataoka, K
   Tanaka, J
AF Matsuda, A
   Kobayashi, H
   Itoh, S
   Kataoka, K
   Tanaka, J
TI Immobilization of laminin peptide in molecularly aligned chitosan by
   covalent bonding
SO BIOMATERIALS
LA English
DT Article
DE crab tendon; chitosan; 4-thiobutyrolactone; YIGSR; IKVAV; immobilization
ID SULFHYDRYL GROUPS; DELIVERY; SURFACES; RELEASE; SYSTEM; BEADS; FILMS;
   DRUG
AB We developed a new biomaterial effective for nerve regeneration consisting of molecularly aligned chitosan with laminin peptides bonded covalently. Molecularly aligned chitosan was prepared from crab (Macrocheira kaempferi) tendons by ethanol treatment and 4wt%-NaOH aqueous solutions to remove proteins and calcium phosphate, followed by deacetyl treatment using a 50wt%-NaOH aqueous solution at 100degreesC. Molecularly aligned tendon chitosan was chemically thiolated by reacting 4-thiobutyrolactone with the chitosan amino group. The introduction of thiol groups and their distribution to tendon chitosan and chitosan cast film were confirmed using ATR FT-IR, H-1-NMR, and EDS. The 1.24mumol/g of thiol groups introduced on the surface of tendon chitosan and the chitosan cast film was confirmed using ultraviolet (UV) spectra. Thiol groups of cysteine located at the end of synthetic laminin peptides were then reacted chemically with thiolated chitosan to form chitosan-S-S-laminin peptide. YIGSR estimated at 0.92 mumol/g and IKVAV estimated at 0.28 mumol/g on thiolated tendon chitosan were confirmed using UV spectra. YIGSR was estimated at 0.85 mumol/g and IKVAV was estimated at 0.34 mumol/g on the thiolated chitosan cast film. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Natl Inst Mat Sci, Biomat Res Ctr, Tsukuba, Ibaraki 3050044, Japan.
   Japan Soc Promot Sci, Daito Ku, Tokyo 1100008, Japan.
   Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo 1138510, Japan.
   Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Bunkyo Ku, Tokyo 1138656, Japan.
   Hokkaido Univ, Sapporo, Hokkaido 0010021, Japan.
RP Matsuda, A (reprint author), Natl Inst Mat Sci, Biomat Res Ctr, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.
EM matsuda.atsushi@nims.go.jp; kobayashi.hisatoshi@nims.go.jp
RI kobayashi, hisatoshi/H-2720-2011; Kataoka, Kazunori/K-7108-2012
OI kobayashi, hisatoshi/0000-0001-9487-0725; Kataoka,
   Kazunori/0000-0002-8591-413X
CR BENESCH R, 1962, BIOCHIM BIOPHYS ACTA, V63, P166, DOI 10.1016/0006-3002(62)90349-9
   Bernkop-Schnurch A, 2000, J CONTROL RELEASE, V66, P39, DOI 10.1016/S0168-3659(99)00256-4
   BRUICE TC, 1964, J AM CHEM SOC, V86, P4886, DOI 10.1021/ja01076a032
   BUTTERWORTH PH, 1967, ARCH BIOCHEM BIOPHYS, V118, P716, DOI 10.1016/0003-9861(67)90409-2
   CHEN SC, 2000, KLUW INT S ADV DATA, V21, P1
   Feeney R. E., 1982, Advances in Chemistry Series, V198, P3
   GIRAUDGUILLE MM, 1984, TISSUE CELL, V16, P75, DOI 10.1016/0040-8166(84)90020-X
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ
   Huang RH, 2003, CARBOHYD RES, V338, P483, DOI 10.1016/S0008-6215(02)00505-0
   Itoh S, 2003, BRAIN RES, V993, P111, DOI 10.1016/j.brainres.2003.09.003
   Kam L, 2002, BIOMATERIALS, V23, P511, DOI 10.1016/S0142-9612(01)00133-8
   Kofuji K, 2000, CHEM PHARM BULL, V48, P579
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   Lee KY, 1998, J CONTROL RELEASE, V51, P213, DOI 10.1016/S0168-3659(97)00173-9
   LOWRY TH, 1976, MECH THEORY ORGANIC, P177
   Mao JS, 2003, BIOMATERIALS, V24, P1621, DOI 10.1016/S0142-9612(02)00549-5
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mi FL, 2002, POLYMER, V43, P757, DOI 10.1016/S0032-3861(01)00580-8
   Nishimura S, 1998, CARBOHYD RES, V306, P427, DOI 10.1016/S0008-6215(97)10081-7
   Ouattara B, 2000, INT J FOOD MICROBIOL, V62, P139, DOI 10.1016/S0168-1605(00)00407-4
   Sato M, 2000, J Orthop Sci, V5, P256, DOI 10.1007/s007760050161
   STRYER L, 1988, BIOCHEMISTR
   TANFPASUTHADOL V, 2003, CARBOHYD RES, V338, P937
   Thanou M, 2002, BIOMATERIALS, V23, P153, DOI 10.1016/S0142-9612(01)00090-4
   Tong YW, 2001, BIOMATERIALS, V22, P1029, DOI 10.1016/S0142-9612(00)00338-0
   Yamaguchi I, 2003, BIOMATERIALS, V24, P2031, DOI 10.1016/S0142-9612(02)00633-6
   Yamauchi K, 2001, BIOMATERIALS, V22, P855, DOI 10.1016/S0142-9612(00)00249-0
   Zhu AP, 2002, BIOMATERIALS, V23, P4657, DOI 10.1016/S0142-9612(02)00215-6
NR 28
TC 51
Z9 52
U1 1
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 15
BP 2273
EP 2279
DI 10.1016/j.biomaterials.2004.07.032
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 893DB
UT WOS:000226698400009
PM 15585229
DA 2018-10-20
ER

PT J
AU Lieb, E
   Hacker, M
   Tessmar, J
   Kunz-Schughart, LA
   Fiedler, J
   Dahmen, C
   Hersel, U
   Kessler, H
   Schulz, MB
   Gopferich, A
AF Lieb, E
   Hacker, M
   Tessmar, J
   Kunz-Schughart, LA
   Fiedler, J
   Dahmen, C
   Hersel, U
   Kessler, H
   Schulz, MB
   Gopferich, A
TI Mediating specific cell adhesion to low-adhesive diblock copolymers by
   instant modification with cyclic RGD peptides
SO BIOMATERIALS
LA English
DT Article
DE cell adhesion; RGD peptide; integrin; osteoblast; surface modification;
   biomimetic material; poly(lactic acid); poly(ethylene oxide); diblock
   copolymer
ID OSTEOBLAST-LIKE CELLS; IN-VITRO; POLYMER SCAFFOLDS; BONE-FORMATION;
   HYDROGELS; DIFFERENTIATION; BIOMATERIALS; SURFACES; PENTAPEPTIDES;
   MODULATION
AB One promising strategy to control the interactions between biomaterial surfaces and attaching cells involves the covalent grafting of adhesion peptides to polymers on which protein adsorption, which mediates unspecific cell adhesion, is essentially suppressed. This study demonstrates a surface modification concept for the covalent anchoring of RGD peptides to reactive diblock copolymers based on monoamine poly(ethylene glycol)-block-POIY(D,L-lactic acid) (H2N-PEG-PLA). Films of both the amine-reactive (ST-NHPEG(2)PLA(20)) and the thiol-reactive derivative (MP-NH-PEG(2)PLA(40)) were modified with cyclic alphavbeta3/alphavbeta5 integrin subtype specific RGD peptides simply by incubation of the films with buffered solutions of the peptides. Human osteoblasts known to express these integrins were used to determine cell-polymer interactions. The adhesion experiments revealed significantly increased cell numbers and cell spreading on the RGD-modified surfaces mediated by RGD-integrin-interactions. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Regensburg, Dept Pharmaceut Technol, D-93040 Regensburg, Germany.
   Rice Univ, Dept Bioengn, Houston, TX 77005 USA.
   Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany.
   Univ Ulm, Dept Orthoped, Div Biochem Joint & Connect Tissue Dis, D-89081 Ulm, Germany.
   Tech Univ Munich, Dept Organ Chem Biochem, D-85747 Garching, Germany.
   Graz Univ, Inst Pharmaceut Sci Pharmaceut Technol, A-8010 Graz, Austria.
RP Gopferich, A (reprint author), Univ Regensburg, Dept Pharmaceut Technol, Universitaetsstr 31, D-93040 Regensburg, Germany.
EM achim.goepferich@chemie.uni-regensburg.de
RI Zhou, Feng/E-9510-2011; Tessmar, Joerg/H-3606-2012; Hacker,
   Michael/D-3935-2011; Kessler, Horst/C-1178-2010
OI Tessmar, Joerg/0000-0001-7057-5369; Hacker, Michael/0000-0002-4776-2294;
   Schulz-Siegmund, Michaela/0000-0003-1340-1850
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   AUMAILLEY M, 1991, FEBS LETT, V291, P50, DOI 10.1016/0014-5793(91)81101-D
   BESSELINK GAJ, 1993, APPL BIOCHEM BIOTECH, V43, P227, DOI 10.1007/BF02916455
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.3.CO;2-U
   Gopferich A, 1999, J BIOMED MATER RES, V46, P390
   Gref R, 2000, COLLOID SURFACE B, V18, P301, DOI 10.1016/S0927-7765(99)00156-3
   Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189
   Hacker M, 2003, BIOMATERIALS, V24, P4459, DOI 10.1016/S0142-9612(03)00346-6
   Haubner R, 1996, J AM CHEM SOC, V118, P7461, DOI 10.1021/ja9603721
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   HERSEL UU, 2003, THESIS TU MUNICH
   Hu YH, 2003, J BIOMED MATER RES A, V64A, P583, DOI 10.1002/jbm.a.10438
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Kantlehner M, 1999, ANGEW CHEM INT EDIT, V38, P560, DOI 10.1002/(SICI)1521-3773(19990215)38:4<560::AID-ANIE560>3.0.CO;2-F
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Lieb E, 2003, TISSUE ENG, V9, P71, DOI 10.1089/107632703762687555
   Lucke A, 2000, BIOMATERIALS, V21, P2361, DOI 10.1016/S0142-9612(00)00103-4
   Massia SP, 2001, J BIOMED MATER RES, V56, P390, DOI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
   Mayr-Wohlfart U, 2001, J BONE JOINT SURG BR, V83B, P144, DOI 10.1302/0301-620X.83B1.10219
   MORIKE M, 1995, J MOL MED-JMM, V73, P571, DOI 10.1007/BF00195142
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Schaefer D, 2000, BIOMATERIALS, V21, P2599, DOI 10.1016/S0142-9612(00)00127-7
   Schaffner P, 1999, J MATER SCI-MATER M, V10, P837, DOI 10.1023/A:1008904513304
   Schaffner P, 2003, CELL MOL LIFE SCI, V60, P119, DOI 10.1007/s000180300008
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   Tessmar J, 2003, BIOMATERIALS, V24, P4475, DOI 10.1016/S0142-9612(03)00345-4
   Tessmar JK, 2002, BIOMACROMOLECULES, V3, P194, DOI 10.1021/bn015608u
NR 34
TC 52
Z9 56
U1 1
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 15
BP 2333
EP 2341
DI 10.1016/j.biomaterials.2004.07.010
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 893DB
UT WOS:000226698400016
PM 15585236
DA 2018-10-20
ER

PT J
AU Chen, H
   Zhang, Z
   Chen, Y
   Brook, MA
   Sheardown, H
AF Chen, H
   Zhang, Z
   Chen, Y
   Brook, MA
   Sheardown, H
TI Protein repellant silicone surfaces by covalent immobilization of
   poly(ethylene oxide)
SO BIOMATERIALS
LA English
DT Article
DE PEO; PDMS; hydrosilylation; protein adsorption
ID PLATELET-ADHESION; IN-VITRO; ADSORPTION; POLYDIMETHYLSILOXANE;
   POLYETHYLENE; RUBBER; POLY(DIMETHYLSILOXANE); BIOMATERIAL; HYDROGELS;
   VIVO
AB Polydimethylsiloxane elastomers were surface modified with passivating polyethylene oxide (PEO) polymers of different molecular weights, both monoftinctional and bifunctional. Following the introduction of Si-H groups on the surfaces by acid catalysed equilibration in the presence of polymethylhydrosiloxane, the PEO was linked by platinum-catalyzed hydrosilylation. ATR-FTIR, X-ray photoetectron spectroscopy (XPS) and water contact angle results confirmed that the PEO was successfully grafted to the silicone rubber. Atomic force microscopy and XPS suggested that surface coverage with PEO was very high on the modified surfaces but not complete. The protein-resistant properties of the PEO-modified surfaces were demonstrated by measuring he adsorption of fibrinogen from both buffer and plasma. Fibrinogen adsorption from buffer to the PEO-modified surfaces was reduced by more than 90% compared with controls. (C) 2004 Elsevier Ltd. All rights reserved.
C1 McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
   McMaster Univ, Dept Chem, Hamilton, ON L8S 4L7, Canada.
RP Sheardown, H (reprint author), McMaster Univ, Dept Chem Engn, 1280 Main St, Hamilton, ON L8S 4L7, Canada.
EM mabrook@mcmaster.ca; sheardow@mcmaster.ca
RI chen, Hong/L-6932-2013
CR ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   Bartzoka V, 2000, LANGMUIR, V16, P4589, DOI 10.1021/la991136h
   Bartzoka V, 1999, ADV MATER, V11, P257, DOI 10.1002/(SICI)1521-4095(199903)11:3<257::AID-ADMA257>3.0.CO;2-S
   Beamson G., 1992, HIGH RESOLUTION XPS
   Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043
   Brash JL, 2000, J BIOMAT SCI-POLYM E, V11, P1135, DOI 10.1163/156856200744237
   Brook M, 1996, US patent, Patent No. 5571531
   Brook M. A, 2000, SILICON ORGANIC ORGA
   Brook MA, 2004, J MATER CHEM, V14, P1469, DOI 10.1039/b401278j
   Cha TW, 2002, ANAL BIOCHEM, V311, P27, DOI 10.1016/S0003-2697(02)00399-8
   Chang PCT, 1998, J BIOMED MATER RES, V39, P380
   Chen H, 2004, BIOMATERIALS, V25, P2273, DOI 10.1016/j.biomaterials.2003.09.023
   Chen KY, 1999, J BIOMAT SCI-POLYM E, V10, P1183, DOI 10.1163/156856299X00018
   Childs MA, 2001, BIOMACROMOLECULES, V2, P526, DOI 10.1021/bm0100054
   Clarson S. J., 1993, SILOXANE POLYM
   Compan V, 2004, BIOMATERIALS, V25, P359, DOI 10.1016/S0142-9612(03)00527-1
   Cornelius RM, 1997, J BIOMED MATER RES, V37, P314
   DeFife KM, 1999, J BIOMED MATER RES, V44, P298, DOI 10.1002/(SICI)1097-4636(19990305)44:3<298::AID-JBM8>3.0.CO;2-N
   Frederix F, 2004, J BIOCHEM BIOPH METH, V58, P67, DOI 10.1016/S0165-022X(03)00150-7
   Gettings R. L., 1998, SILICONES PHARM BIOM
   Gong X, 2000, J POLYM SCI POL PHYS, V38, P2323, DOI 10.1002/1099-0488(20000901)38:17<2323::AID-POLB120>3.0.CO;2-6
   Hsiue GH, 1998, J BIOMED MATER RES, V42, P134, DOI 10.1002/(SICI)1097-4636(199810)42:1<134::AID-JBM17>3.0.CO;2-L
   Hu SW, 2002, ANAL CHEM, V74, P4117, DOI 10.1021/ac025700w
   HUANG J, 2002, Patent No. 081183
   Jon SY, 2003, LANGMUIR, V19, P9989, DOI 10.1021/la034839e
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   Kossmehl G., 1980, US Patent, Patent No. [4,332,922, 4332922]
   Kunzler JF, 1996, TRENDS POLYM SCI, V4, P52
   LASSEN B, 1994, COLLOID POLYM SCI, V272, P1143, DOI 10.1007/BF00652384
   Lee JH, 1997, J BIOMED MATER RES, V34, P105, DOI 10.1002/(SICI)1097-4636(199701)34:1<105::AID-JBM14>3.0.CO;2-J
   Merrett K, 2003, J BIOMED MATER RES A, V67A, P981, DOI 10.1002/jbm.a.10165
   Olander B, 2004, J APPL POLYM SCI, V91, P4098, DOI 10.1002/app.13659
   Papra A, 2001, LANGMUIR, V17, P4090, DOI 10.1021/la0016930
   Park JH, 2002, BIOMATERIALS, V23, P1797, DOI 10.1016/S0142-9612(01)00306-4
   SALAMONE JC, 1999, ABSTR PAP AM CHEM S, V217, P163
   SHEU MS, 1993, J ADHES SCI TECHNOL, V7, P1065, DOI 10.1163/156856193X00583
   Wagner MS, 2003, BIOMATERIALS, V24, P1897, DOI 10.1016/S0142-9612(02)00612-9
   Zelisko PM, 2002, LANGMUIR, V18, P8982, DOI 10.1021/la025867k
   Zhao J, 2003, LANGMUIR, V19, P1838, DOI 10.1021/la026228c
NR 39
TC 153
Z9 158
U1 6
U2 67
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 15
BP 2391
EP 2399
DI 10.1016/j.biomaterials.2004.07.068
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 893DB
UT WOS:000226698400022
PM 15585242
DA 2018-10-20
ER

PT J
AU Kim, UJ
   Park, J
   Kim, HJ
   Wada, M
   Kaplan, DL
AF Kim, UJ
   Park, J
   Kim, HJ
   Wada, M
   Kaplan, DL
TI Three-dimensional aqueous-derived biomaterial scaffolds from silk
   fibroin
SO BIOMATERIALS
LA English
DT Article
DE silk; fibroin; scaffold; salt leaching; biodegradation; biomaterial
ID BIODEGRADABLE POLYMER SCAFFOLDS; IN-VITRO; IMPEDANCE SPECTROSCOPY;
   IMAGE-ANALYSIS; SOLID-STATE; BONE; MORI; FABRICATION; HYDROGELS; FOAMS
AB A new all-aqueous process is described to form three-dimensional porous silk fibroin matrices with control of structural and morphological features. The result of this process are scaffolds with controllable porosity and pore sizes that fully degrade in the presence of proteases, unlike prior methods to generate silk-based biomaterials that required the use of organic solvent treatments to impart control of structure and stability in aqueous environments, with low rates of proteolytic hydrolysis. A mechanism is proposed for this novel process that imparts physical stability via hydrophobic interactions. Adjusting the concentration of silk fibroin in water, and the particle size of granular NaCl used in the process, leads to the control of morphological and functional properties of the scaffolds. The aqueous-derived scaffolds had highly homogeneous and interconnected pores with pore sizes ranging from 470 to 940 mum, depending on the mode of preparation. The scaffolds had porosities > 90% and compressive strength and modulus up to 320 +/- 10 and 3330 +/- 500 KPa, respectively, when formed from 10% aqueous solutions of fibroin. The scaffolds fully degraded upon exposure to protease during 21 days, unlike the scaffolds prepared from organic solvent processing. These new silk-based three-dimensional matrices provide useful properties as biomaterial matrices due to the all-aqueous mode of preparation, control of pore size, connectivity of pores, degradability and useful mechanical features. Importantly, this process offers an entirely new window of materials properties when compared with traditional silk fibroin-based materials. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Tufts Univ, Dept Biomed Engn, Ctr Bioengn, Medford, MA 02155 USA.
   Tufts Univ, Dept Chem, Ctr Bioengn, Medford, MA 02155 USA.
   Univ Tokyo, Dept Biomat Sci, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Ctr Bioengn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIBIB NIH HHS [EB003210]
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Asakura T, 2002, J AM CHEM SOC, V124, P8794, DOI 10.1021/ja020244e
   Asakura T., 1994, ENCY AGR SCI, P1
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Blacher S, 2001, COLLOID SURFACE A, V187, P375, DOI 10.1016/S0927-7757(01)00652-5
   Braun FN, 2003, INT J BIOL MACROMOL, V32, P59, DOI 10.1016/S0141-8130(03)00038-2
   Cai Q, 2003, BIOMATERIALS, V24, P3555, DOI 10.1016/S0142-9612(03)00199-6
   Cappello J, 1998, J CONTROL RELEASE, V53, P105, DOI 10.1016/S0168-3659(97)00243-5
   CULLINANE DM, 2001, PRINCIPLES BONE BIOL, V1, P17
   Curtis RA, 2002, BIOPHYS CHEM, V98, P249, DOI 10.1016/S0301-4622(02)00071-6
   Dinerman AA, 2002, J CONTROL RELEASE, V82, P277, DOI 10.1016/S0168-3659(02)00134-7
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1335, DOI 10.1021/bm0300296
   Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131
   Grigsby JJ, 2001, BIOPHYS CHEM, V91, P231, DOI 10.1016/S0301-4622(01)00173-9
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   He SJ, 1999, INT J BIOL MACROMOL, V24, P187, DOI 10.1016/S0141-8130(99)00004-5
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   Hu YH, 2002, J BIOMED MATER RES, V59, P563, DOI 10.1002/jbm.1269
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Kim E.S., 2001, FIBER POLYM, V2, P64, DOI DOI 10.1007/BF02875260
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee SB, 2004, BIOMATERIALS, V25, P2309, DOI 10.1016/j.biomaterials.2003.09.016
   Li GY, 2001, EUR J BIOCHEM, V268, P6600, DOI 10.1046/j.0014-2956.2001.02614.x
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Ma PX, 1999, J BIOMED MATER RES, V46, P60, DOI 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
   Magoshi J., 1996, POLYM MAT ENCY, V1, P667
   Maquet V, 2004, BIOMATERIALS, V25, P4185, DOI 10.1016/j.biomaterials.2003.10.082
   Maquet V, 2000, LANGMUIR, V16, P10463, DOI 10.1021/la000654l
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   MITA K, 1994, J MOL EVOL, V38, P583
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Pego AP, 2003, TISSUE ENG, V9, P981, DOI 10.1089/107632703322495628
   Petrini P, 2001, J MATER SCI-MATER M, V12, P849, DOI 10.1023/A:1012847301850
   ROBINSON DR, 1965, J AM CHEM SOC, V87, P2470, DOI 10.1021/ja01089a029
   Tanaka K, 1999, BBA-PROTEIN STRUCT M, V1432, P92, DOI 10.1016/S0167-4838(99)00088-6
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yoon JJ, 2001, J BIOMED MATER RES, V55, P401, DOI 10.1002/1097-4636(20010605)55:3<401::AID-JBM1029>3.0.CO;2-H
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 51
TC 594
Z9 622
U1 13
U2 262
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 15
BP 2775
EP 2785
DI 10.1016/j.biomaterials.2004.07.044
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 893DB
UT WOS:000226698400062
PM 15585282
DA 2018-10-20
ER

PT J
AU Jager, M
   Sager, M
   Lensing-Hohn, S
   Krauspe, R
AF Jager, M
   Sager, M
   Lensing-Hohn, S
   Krauspe, R
TI The critical size bony defect in a small animal for bone healing studies
   (II): Implant evolution and surgical technique on a rat's femur
SO BIOMEDIZINISCHE TECHNIK
LA English
DT Article
DE bony defect; femur; implant; small animal
ID MESENCHYMAL STEM-CELLS; SEGMENTAL DEFECT; GENE-THERAPY; FRACTURE; MODEL;
   RHBMP-2; REPAIR
AB In the preclinical field of orthopaedic and trauma surgery critical size bony defects (CDS) were used to evaluate the biocompatibility and allow to investigate the osteoinductivity and -conductivity of bone substitutes. Concerning the anatomical size the laboratory rat indicates a lower limit in small animals which are appropriate for experiments on bone. The aim of this study was to define a CSD, to develop a suitable fixation system to stabilize bony fragments in CSD and to point out the specialities of the surgical technique. These informations should help for to design and practice studies concering bone healing on rat's femur. Based on previously acquired anatomical data of rat's femur, the technical challenges and anatomical specialities of different osteosynthesis techniques in rat's femur surgery are demonstrated. Our experiences with different fixation systems and techniques lead to the development of an external fixator, which guarantees for a stable bone fragment fixation, prevents severe soft tissue damage, allows of a roentgenologic evaluation of the defect zone and prevents from undesired direct biomaterial-implant interactions. Neither the proximal nor the distal femoral nailing technique is appropriate for a stable fixation in CSD of rat's femur. To evaluate the reliability of an own developed external fixator 42 nude rats with a 4.0 mm CSD were investigated clinically and roentgenologically over 10 weeks. The external fixator showed only a small implant failure rate. A solid fusion of the bone fragments was not observed within the 10 weeks follow-up period.
C1 Univ Hosp Duesseldorf, Dept Orthopaed, D-40225 Dusseldorf, Germany.
RP Jager, M (reprint author), Univ Dusseldorf, Dept Orthopaed, Orthopaed Res Lab, Moorenstr 5, D-40225 Dusseldorf, Germany.
EM Jaeger@med.uni-duesseldorf.de
CR Baldik Y, 2002, CLIN ORTHOP RELAT R, P343, DOI 10.1097/01.blo.0000022182.66847.8b
   Bruder SP, 1998, CLIN ORTHOP RELAT R, V355, P247
   Chen XQ, 2002, J ORTHOPAED RES, V20, P142, DOI 10.1016/S0736-0266(01)00060-2
   Chen YJ, 2004, J ORTHOPAED RES, V22, P526, DOI 10.1016/j.orthres.2003.10.005
   EINHORN TA, 1984, J BONE JOINT SURG AM, V66A, P274, DOI 10.2106/00004623-198466020-00015
   Gebauer GP, 2002, J ORTHOPAED RES, V20, P587, DOI 10.1016/S0736-0266(01)00136-X
   Harrison LJ, 2003, J ORTHOP TRAUMA, V17, P11, DOI 10.1097/00005131-200301000-00003
   Jager M, 2005, BIOMED TECH, V50, P107, DOI 10.1515/BMT.2005.015
   Kokubu T, 2003, J ORTHOP RES, V21, P503, DOI 10.1016/S0736-0266(02)00209-7
   Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002
   Mark H, 2003, ACTA ORTHOP SCAND, V74, P476, DOI 10.1080/00016470310017820
   Moore DC, 2004, J BIOMED MATER RES A, V69A, P259, DOI 10.1002/jbm.a.20123
   Ohura K, 1999, J BIOMED MATER RES, V44, P168, DOI 10.1002/(SICI)1097-4636(199902)44:2<168::AID-JBM7>3.0.CO;2-4
   Rose T, 2003, LANGENBECK ARCH SURG, V388, P347, DOI 10.1007/s00423-003-0401-7
   SCHALLER O, 1992, ILLUSTRATED VET ANAT
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Shen HC, 2004, J GENE MED, V6, P984, DOI 10.1002/jgm.588
   Tielinen L, 2001, ARCH ORTHOP TRAUM SU, V121, P191, DOI 10.1007/s004020000206
   Tsuchida H, 2003, J ORTHOPAED RES, V21, P44, DOI 10.1016/S0736-0266(02)00108-0
   Vogelin E, 2000, Mund Kiefer Gesichtschir, V4 Suppl 2, pS454, DOI 10.1007/PL00014572
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
NR 21
TC 19
Z9 22
U1 0
U2 3
PU FACHVERLAG SCHIELE SCHON
PI BERLIN
PA MARKGRAFENSTRASSE 11, D-10969 BERLIN, GERMANY
SN 0013-5585
J9 BIOMED TECH
JI Biomed. Tech.
PD MAY
PY 2005
VL 50
IS 5
BP 137
EP 142
DI 10.1515/BMT.2005.020
PG 6
WC Engineering, Biomedical; Medical Informatics
SC Engineering; Medical Informatics
GA 010LA
UT WOS:000235195000003
PM 15966618
DA 2018-10-20
ER

PT J
AU Kurihara, H
   Morita, T
   Shinkai, M
   Nagamune, T
AF Kurihara, H
   Morita, T
   Shinkai, M
   Nagamune, T
TI Recombinant extracellular matrix-like proteins with repetitive elastin
   or collagen-like functional motifs
SO BIOTECHNOLOGY LETTERS
LA English
DT Article
DE artificial extracellular matrix protein; biomaterial; cell adhesion;
   protein polymer; thermally responsive recombinant protein
ID DRUG-DELIVERY; POLYMERS; FIBRONECTIN; ELONGATION; EXPRESSION; SEQUENCES;
   DESIGN; PCR
AB Using overlap elongation PCR, we created repetitive DNA libraries encoding the elastin VPGVG and collagen-like GERGDRGDP sequences. From these libraries we isolated two repetitive DNA sequences, Col-5 encoding [(GERGDRGDP)(5)GER], and Ela-16 encoding [(VPGVG)(16)VPG]. Both proteins were expressed as thioredoxin fusion proteins. The resulting recombinant extracellular matrix-like proteins had the expected properties (cell adhesive ability and thermally responsive structural change) of the functional motif sequence unit used.
C1 Univ Tokyo, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan.
RP Nagamune, T (reprint author), Univ Tokyo, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan.
EM nagamune@bio.t.u-tokyo.ac.jp
RI Nagamune, Teruyuki/R-7708-2017
OI Nagamune, Teruyuki/0000-0002-2435-0270
CR CAPPELLO J, 1990, BIOTECHNOL PROGR, V6, P198, DOI 10.1021/bp00003a006
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P1093, DOI 10.1016/S0169-409X(02)00060-1
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Heslot H, 1998, BIOCHIMIE, V80, P19, DOI 10.1016/S0300-9084(98)80053-9
   Katti MV, 2000, PROTEIN SCI, V9, P1203, DOI 10.1110/ps.9.6.1203
   Kurihara H, 2004, BIOTECHNOL PROGR, V20, P1855, DOI 10.1021/bp049925z
   Kurihara H, 2004, BIOCHEM BIOPH RES CO, V321, P988, DOI 10.1016/j.bbrc.2004.07.061
   MARCOTTE E, 1998, J MOL BIOL, V293, P151
   MCGRATH KP, 1992, J AM CHEM SOC, V114, P727, DOI 10.1021/ja00028a048
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Padgett KA, 1996, GENE, V168, P31, DOI 10.1016/0378-1119(95)00731-8
   Panitch A, 1999, MACROMOLECULES, V32, P1701, DOI 10.1021/ma980875m
   Reiersen H, 1998, J MOL BIOL, V283, P255, DOI 10.1006/jmbi.1998.2067
   SANDBERG LB, 1985, PATHOL BIOL, V33, P266
   YAMADA KM, 1984, J CELL BIOL, V99, P29, DOI 10.1083/jcb.99.1.29
NR 15
TC 12
Z9 12
U1 1
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-5492
J9 BIOTECHNOL LETT
JI Biotechnol. Lett.
PD MAY
PY 2005
VL 27
IS 9
BP 665
EP 670
DI 10.1007/s10529-005-4477-8
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 938WH
UT WOS:000230033600011
PM 15977075
DA 2018-10-20
ER

PT J
AU Penel, G
   Delfosse, C
   Descamps, M
   Leroy, G
AF Penel, G
   Delfosse, C
   Descamps, M
   Leroy, G
TI Composition of bone and apatitic biomaterials as revealed by intravital
   Raman microspectroscopy
SO BONE
LA English
DT Article
DE bone; intravital; Raman; biominerals; protein
ID IN-VIVO; HYDROGEN-PEROXIDE; HYDROXYAPATITE; SPECTROSCOPY; MICROSCOPY;
   BIOAPATITE; POWDERS; ENAMEL
AB Microcharacterization of biominerals allows a better understanding of the pathophysiological events that occur in calcified tissues and synthetic biomaterials. Different methods have been extensively used to conduct such investigations. A new model for the intravital study of the composition and structure of membranous bone by Raman microspectroscopy is described. Titanium bone chambers equipped with a fused-silica optical window were implanted transcutaneously in the calvaria of New Zealand rabbits. The implanted optical windows were well tolerated, and spectral acquisitions were performed without any additional invasive procedure. Bone and implanted apatitic biomaterials were analyzed at different times after surgery. All Raman bands were unambiguously identified in the bone and biomaterial spectra. The main PO4 and CO3 Raman bands in bone spectra were consistent with those found in the carbonated apatite spectrum. The major collagen bands were always observed around 1200-1300 (amide III) and 1600-1700 (amide I) &UDelta; cm(-1) and, 1400-1470 and 2800-3100 &UDelta; cm(-1) (bending and stretching modes of CH groups, respectively). The phenylalanine (Phe) band was identified in all spectra at 1003 &UDelta; cm(-1) and overlapped that of the weak HPO42- ion. The CH bands frequently overlapped the lipid bands. However a distinct protein and lipid bands were detected at 2950 and 2852 &UDelta; cm(-1), respectively. In bone areas close to blood vessels, the Raman signature of hemoglobin was detected with a characteristic band at 754 &UDelta; cm(-1). The changes observed in bone varied as a function of time and location. The composition and structure of all of the biomaterials studied-including those that were resorbable-seemed to remain stable over time and location. We report for the first time the complete intravital study of Raman spectra of bone and calcium phosphate biomaterials over a period of 8 months. This new approach does not require specimen preparation and allows simultaneous observation of mineral and organic bone constituents over time, which therefore should provide insightful information about their relationship. &COPY; 2005 Elsevier Inc. All rights reserved.
C1 Univ Lille 2, Fac Odontol, LBM Raman, Lille, France.
   Univ Valenciennes & Hainaut Cambresis, LMP, Maubeuge, Fr Polynesia.
RP Penel, G (reprint author), LBM Raman, Fac Chirurg Dent, Pl Verdun, F-59000 Lille, France.
EM gpenel@univ-lille2.fr
CR Albrektsson T, 1989, Int J Oral Maxillofac Implants, V4, P45
   Bohic S, 2000, BONE, V26, P341, DOI 10.1016/S8756-3282(99)00276-8
   BRANEMARK P I, 1968, Scandinavian Journal of Plastic and Reconstructive Surgery, V2, P71
   BRANEMARK PI, 1968, ADV MICROCIRCULAT, V1, P1
   BRANEMARK PI, 1968, BLUT, V5, P274
   Camacho NP, 1999, BONE, V25, P287, DOI 10.1016/S8756-3282(99)00165-9
   Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994
   Edwards HGM, 1997, J MOL STRUCT, V435, P49, DOI 10.1016/S0022-2860(97)00122-1
   FERRARO JR, 1994, INTRO RAMAN SPECTROS, V195, P250
   Freeman JJ, 2002, APPL SPECTROSC, V56, P770, DOI 10.1366/000370202760077513
   Freeman JJ, 2001, CALCIFIED TISSUE INT, V68, P156, DOI 10.1007/s002230001206
   Haston JL, 2003, J BIOL CHEM, V278, P41189, DOI 10.1074/jbc.M212854200
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   Kivrak N, 1998, J AM CERAM SOC, V81, P2245
   Lakshmi RJ, 2003, APPL SPECTROSC, V57, P1100, DOI 10.1366/00037020360695964
   Leroy G, 2002, APPL SPECTROSC, V56, P1030, DOI 10.1366/000370202760249765
   Mendelsohn R, 2000, APPL SPECTROSC, V54, P1183, DOI 10.1366/0003702001950751
   Mordon S, 1998, MICROVASC RES, V55, P146, DOI 10.1006/mvre.1998.2068
   Omberg KM, 2002, APPL SPECTROSC, V56, P813, DOI 10.1366/000370202760171464
   Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561
   Penel G, 1999, BONE, V25, p81S, DOI 10.1016/S8756-3282(99)00139-8
   Penel G, 1998, APPL SPECTROSC, V52, P312, DOI 10.1366/0003702981943428
   Penel G, 1997, J MATER SCI-MATER M, V8, P271, DOI 10.1023/A:1018504126866
   SAUER GR, 1994, CALCIFIED TISSUE INT, V54, P414, DOI 10.1007/BF00305529
   Schallreuter KU, 1999, J INVEST DERM SYMP P, V4, P91, DOI 10.1038/sj.jidsp.5640189
   Tarnowski CP, 2002, J BONE MINER RES, V17, P1118, DOI 10.1359/jbmr.2002.17.6.1118
   Tarnowski CP, 2004, J BONE MINER RES, V19, P64, DOI 10.1359/JBMR.0301201
   TERMINE JD, 1973, CALC TISS RES, V13, P73, DOI 10.1007/BF02013723
   Timlin JA, 1999, APPL SPECTROSC, V53, P1429, DOI 10.1366/0003702991945786
   Timlin JA, 2000, ANAL CHEM, V72, P2229, DOI 10.1021/ac9913560
   TSUDA H, 1994, J DENT RES, V73, P1703, DOI 10.1177/00220345940730110501
   WALTERS MA, 1990, J INORG BIOCHEM, V39, P193, DOI 10.1016/0162-0134(90)84002-7
   Weng W, 1997, J EUR CERAM SOC, V17, P1151, DOI 10.1016/S0955-2219(96)00215-4
   Winet H, 1996, BONE, V19, pS39, DOI 10.1016/S8756-3282(96)00133-0
   WINET H, 1995, J ORTHOPAED RES, V13, P679, DOI 10.1002/jor.1100130507
   Wood BR, 2003, FEBS LETT, V554, P247, DOI 10.1016/S0014-5793(03)00975-X
   Zhang HQ, 2003, CERAM INT, V29, P413, DOI 10.1016/S0272-8842(02)00153-0
NR 37
TC 134
Z9 137
U1 1
U2 40
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD MAY
PY 2005
VL 36
IS 5
BP 893
EP 901
DI 10.1016/j.bone.2005.02.012
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 926QA
UT WOS:000229136500016
PM 15814305
DA 2018-10-20
ER

PT J
AU Chen, L
   Chen, XS
   Deng, MX
   Jing, XB
AF Chen, L
   Chen, XS
   Deng, MX
   Jing, XB
TI Synthesis and characterization of ABBA block copolymer of glycolide and
   epsilon-caprolactone
SO CHEMICAL RESEARCH IN CHINESE UNIVERSITIES
LA English
DT Article
DE biomaterial; polyglycolide; poly (epsilon-caprolactone); ring-opening
   polymerization; block copolymer
ID BIODEGRADABLE POLYMERS; COLLOIDAL DISPERSIONS; DRUG-DELIVERY; L-LACTIDE;
   POLYMERIZATION; POLYLACTONES
AB A biodegradable ABBA block copolymer was synthesized via the ring-opening co-polymerization of E-caprolactone (CL, B) and glycolide (A) by means of step polymerization in the presence of ethylene glycol as an initiator and stannous octanoate as a catalyst at 110 degrees C for 48 h. The molecular length of the PCL prepolymer (BB) could be adjusted by controlling the molar ratio of the ethylene glycol initiator to c-caprolactone monomer. The structure and the composition of the block copolymer were determined by the weight ratio of the monomer glycolide (A) to PCL pre-polymer (BB). The block copolymers were characterized by H-1 NMR. GPC, DSC and X-ray. The results confirm the successful synthesis of an ABBA block copolymer.
C1 Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Peoples R China.
   NE Normal Univ, Fac Chem, Changchun 130022, Peoples R China.
RP Chen, XS (reprint author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Peoples R China.
EM xschen@ciac.jl.cn
CR BARAKAT I, 1994, MACROMOL SYMP, V88, P227, DOI 10.1002/masy.19940880118
   Barakat I, 2001, J POLYM SCI POL CHEM, V39, P294, DOI 10.1002/1099-0518(20010115)39:2<294::AID-POLA50>3.0.CO;2-A
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Domb A.J., 1997, HDB BIODEGRADABLE PO, P3
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   GRIJPMA DW, 1990, POLYMER, V31, P2201, DOI 10.1016/0032-3861(90)90096-H
   GRIJPMA DW, 1991, POLYM BULL, V25, P327, DOI 10.1007/BF00316902
   KRICHELDORF HR, 1992, POLYMER, V33, P2817, DOI 10.1016/0032-3861(92)90459-A
   KRICHELDORF HR, 1984, MACROMOLECULES, V17, P2173, DOI 10.1021/ma00140a051
   KRICHELDORF HR, 1985, MAKROMOL CHEM S, V12, P25
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   LANGER R, 1995, ANN BIOMED ENG, V23, P101, DOI 10.1007/BF02368317
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Ling F, 2003, CHEM RES CHINESE U, V19, P516
   Ran XH, 2003, CHEM RES CHINESE U, V19, P107
   SAWHNEY AS, 1990, J BIOMED MATER RES, V24, P1397, DOI 10.1002/jbm.820241011
   VERT M, 1989, ANGEW MAKROMOL CHEM, V166, P155, DOI 10.1002/apmc.1989.051660111
   VERT M, 1986, MAKROMOL CHEM-M SYMP, V6, P109, DOI 10.1002/masy.19860060113
   VERT M, 1995, PURE APPL CHEM A, V32, P786
   Wang SG, 2004, CHEM RES CHINESE U, V20, P191
NR 20
TC 3
Z9 3
U1 0
U2 3
PU HIGHER EDUCATION PRESS
PI BEIJING
PA SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA
SN 1005-9040
EI 2210-3171
J9 CHEM RES CHINESE U
JI Chem. Res. Chin. Univ.
PD MAY
PY 2005
VL 21
IS 3
BP 340
EP 344
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 933JN
UT WOS:000229624800020
DA 2018-10-20
ER

PT J
AU Arciola, CR
   Campoccia, D
   Gamberini, S
   Baldassarri, L
   Montanaro, L
AF Arciola, CR
   Campoccia, D
   Gamberini, S
   Baldassarri, L
   Montanaro, L
TI Prevalence of cna, fnbA and fnbB adhesin genes among Staphylococcus
   aureus isolates from orthopedic infections associated to different types
   of implant
SO FEMS MICROBIOLOGY LETTERS
LA English
DT Article
DE collagen adhesion gene (cna); fibronectin-binding protein; bacterial
   adhesion; biomaterial-associated infections; Staphylococcus aureus
ID FIBRONECTIN-BINDING PROTEIN; COLLAGEN ADHESIN; PROSTHESIS INFECTIONS;
   VIRULENCE DETERMINANT; SEPTIC ARTHRITIS; OSTEOMYELITIS; EXPRESSION;
   STRAINS; IDENTIFICATION; PATHOGENESIS
AB Here are reported data on virulence determinants of Staphylococcus aureus from orthopedic surgical infections, emphasizing on the genes encoding fibronectin (fnbA, fnbB) and collagen (cna) adhesins. 191 S. aureus strains from orthopedic infections (53 from internal fixation devices, 29 external fixation devices, 15 knee arthroprostheses, 30 hip arthroprostheses, 45 surgical reconstruction and 19 non-associated to medical devices) were investigated for the presence of the genes of the collagen-binding protein Cna and of the two fibronectin-binding proteins, FnbA and FnbB. 87 (46%) strains were found to be cna+ without significant variations across the different surgical categories considered. Conversely, the fnbA and the fnbB genes were almost always present in all surgical categories. The finding that, among the investigated adhesins, fibronectin-adhesins are present in the majority of the implant associated S. aureus clinical isolates encourages the development of strategies to specifically block the interaction of bacteria with matrix fibronectin by antagonist ligands. (c) 2005 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
C1 Rizzoli Orthoped Inst, Res Unit Implant Infect, I-40136 Bologna, Italy.
   Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.
   Ist Super Sanita, I-00161 Rome, Italy.
RP Arciola, CR (reprint author), Rizzoli Orthoped Inst, Res Unit Implant Infect, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM carlarenata.arciola@ior.it; montanaro@alma.unibo.it
RI Baldassarri, Lucilla/B-1042-2013; Campoccia, Davide/K-5348-2018
OI Campoccia, Davide/0000-0002-3336-0219
CR Arciola CR, 2003, BIOMATERIALS, V24, P3013, DOI 10.1016/S0142-9612(03)00133-9
   Arciola CR, 2002, J BIOMED MATER RES, V59, P557, DOI 10.1002/jbm.10006
   Blevins JS, 2002, INFECT IMMUN, V70, P470, DOI 10.1128/IAI.70.2.470-480.2002
   Bustanji Y, 2003, P NATL ACAD SCI USA, V100, P13292, DOI 10.1073/pnas.1735343100
   CACARELLA C, 2002, INFECT IMMUN, V70, P3180
   Chakrabarti SK, 2000, J BACTERIOL, V182, P5893, DOI 10.1128/JB.182.20.5893-5897.2000
   CHEUNG AL, 1991, J SURG RES, V50, P150, DOI 10.1016/0022-4804(91)90239-I
   Elasri MO, 2002, BONE, V30, P275, DOI 10.1016/S8756-3282(01)00632-9
   Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0
   GATERMANN S, 1994, INFECT IMMUN, V62, P4556
   Gillaspy AF, 1998, INFECT IMMUN, V66, P3170
   HOLDERBAUM D, 1987, J CLIN MICROBIOL, V25, P2258
   Jett BD, 2002, DNA CELL BIOL, V21, P397, DOI 10.1089/10445490260099683
   Jett BD, 2002, INFECT IMMUN, V70, P4697, DOI 10.1128/IAI.70.8.4697-4700.2002
   Montanaro L, 1999, BIOMATERIALS, V20, P1945, DOI 10.1016/S0142-9612(99)00099-X
   Montanaro L, 1998, MICROBIOLOGICA, V21, P359
   Montanaro L, 1999, MICROBIOLOGICA, V22, P331
   Nashev D, 2004, FEMS MICROBIOL LETT, V233, P45, DOI 10.1016/j.femsle.2004.01.032
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   PATTI JM, 1994, INFECT IMMUN, V62, P152
   Peacock SJ, 2000, J INFECTION, V41, P23, DOI 10.1053/jinf.2000.0657
   Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002
   Rhem MN, 2000, INFECT IMMUN, V68, P3776, DOI 10.1128/IAI.68.6.3776-3779.2000
   Rice K, 2001, INFECT IMMUN, V69, P3791, DOI 10.1128/IAI.69.6.3791-3799.2001
   Ryding U, 1997, J INFECT DIS, V176, P1096, DOI 10.1086/516520
   Smeltzer MS, 2000, POULTRY SCI, V79, P1042, DOI 10.1093/ps/79.7.1042
   Thomas MG, 1999, J INFECT DIS, V179, P291, DOI 10.1086/314576
   Tung HS, 2000, BIOCHEM J, V345, P611, DOI 10.1042/0264-6021:3450611
NR 28
TC 60
Z9 62
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1097
J9 FEMS MICROBIOL LETT
JI FEMS Microbiol. Lett.
PD MAY 1
PY 2005
VL 246
IS 1
BP 81
EP 86
DI 10.1016/j.femsle.2005.03.035
PG 6
WC Microbiology
SC Microbiology
GA 927WO
UT WOS:000229231400011
PM 15869965
OA Bronze
DA 2018-10-20
ER

PT J
AU Zakharov, NA
   Ezhova, ZA
   Koval', EM
   Kalinnikov, VT
   Chalykh, AE
AF Zakharov, NA
   Ezhova, ZA
   Koval', EM
   Kalinnikov, VT
   Chalykh, AE
TI Hydroxyapatite-carboxymethyl cellulose nanocomposite biomaterial
SO INORGANIC MATERIALS
LA English
DT Article
ID CORALLINE HYDROXYAPATITE; COMPOSITE; IMPLANTATION; CERAMICS; CHITOSAN
AB An organic-mineral composite of hydroxyapatite (Ca-10(PO4)(6)(OH)(2)) nanoparticles and carboxymethyl cellulose (CMC) is synthesized via coprecipitation from a solution containing CaCl2, aqueous ammonia, (NH4)(2)HPO4, and CMC. The composition and microstructure of the composite and the lattice parameters and particle size of the hydroxyapatite are determined using x-ray diffraction, chemical analysis, IR spectroscopy, scanning and transmission electron microscopy techniques, electron diffraction, and x-ray microanalysis. The hydroxyapatite nanoparticles are shown to form agglomerates about 200 nm in size. The interaction between the nanoparticles and CMC macromolecules leads to the formation of a pore structure potentially attractive for biomedical applications.
C1 Russian Acad Sci, NS Kurnakov Gen & Inorgan Chem Inst, Moscow 119991, Russia.
   Russian Acad Sci, Inst Chem Phys, Moscow 119991, Russia.
RP Zakharov, NA (reprint author), Russian Acad Sci, NS Kurnakov Gen & Inorgan Chem Inst, Leninskii Pr 31, Moscow 119991, Russia.
EM zakharov@igic.ras.ru
RI Zakhorov, Nikolay/N-5164-2015; Chalykh, Anatoly/E-6236-2014; Koval,
   Elena/N-5148-2015
OI Chalykh, Anatoly/0000-0003-3272-2086; 
CR AOKI H, 1994, MED APPL HYDROXYAPAT, P13
   BIKLES N, 1971, CELLULOSE CELLULOSE
   Botha J, 2004, CALCIFIED TISSUE INT, V74, P162, DOI 10.1007/s00223-003-0124-3
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Chang MC, 2003, BIOMATERIALS, V24, P3087, DOI 10.1016/S0142-9612(03)00150-9
   Doi Y, 1996, J BIOMED MATER RES, V31, P43, DOI 10.1002/(SICI)1097-4636(199605)31:1<43::AID-JBM6>3.0.CO;2-Q
   Elliott J. C., 1994, STRUCTURE CHEM APATI, P111
   Felicio-Fernandes G, 2000, QUIM NOVA, V23, P441, DOI 10.1590/S0100-40422000000400002
   Gorelik S.S., 2002, RENTGENOGRAFICHESKII
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   Itoh S, 2002, J BIOMED MATER RES, V63, P507, DOI 10.1002/jbm.10305
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   *JOINT COMM POWD D, 9432 JOINT COMM POWD
   KASAVINA BS, 1979, ZHIZNKOSTNOI TKANI
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Miyamoto Y, 1998, BIOMATERIALS, V19, P707, DOI 10.1016/S0142-9612(97)00186-5
   Morales JG, 2001, CRYST RES TECHNOL, V36, P15
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   Murugan R, 2003, MACROMOL RES, V11, P14, DOI 10.1007/BF03218272
   Murugan R, 2003, J BIOMAT SCI-POLYM E, V14, P457, DOI 10.1163/156856203766652066
   Murugan R, 2002, MATER LETT, V57, P429, DOI 10.1016/S0167-577X(02)00805-4
   Murugan R, 2002, TRENDS BIOMATER ARTI, V16, P43
   Murugan R., 2003, MATER LETT, V58, P230
   Murugan R, 2002, BIOCERAMICS, V240, P407
   Ogiso M, 1998, J BIOMED MATER RES, V43, P318, DOI 10.1002/(SICI)1097-4636(199823)43:3<318::AID-JBM13>3.0.CO;2-B
   Orlovskii VP, 1997, ZH NEORG KHIM+, V42, P1422
   PLESHKO N, 1991, BIOPHYS J, V60, P786, DOI 10.1016/S0006-3495(91)82113-0
   Purna S K, 2000, Burns, V26, P54
   Schwarzenbach G., 1970, KOMPLEKSONOMETRICHES
   Stoemenos J, 1999, APPL PHYS LETT, V74, P2602, DOI 10.1063/1.123910
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 35
TC 25
Z9 29
U1 3
U2 24
PU MAIK NAUKA/INTERPERIODICA
PI NEW YORK
PA C/O KLUWER ACADEMIC-PLENUM PUBLISHERS, 233 SPRING ST, NEW YORK, NY
   10013-1578 USA
SN 0020-1685
J9 INORG MATER+
JI Inorg. Mater.
PD MAY
PY 2005
VL 41
IS 5
BP 509
EP 515
DI 10.1007/s10789-005-0159-0
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 932KD
UT WOS:000229551700011
DA 2018-10-20
ER

PT J
AU Li, JP
   Li, SH
   Van Blitterswijk, CA
   de Groot, K
AF Li, JP
   Li, SH
   Van Blitterswijk, CA
   de Groot, K
TI A novel porous Ti6Al4V: Characterization and cell attachment
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE Ti6Al4V; porous; sintering; mechanical properties; cell attachment
ID POSTSINTERING HEAT-TREATMENTS; COATED TI-6AL-4V ALLOY;
   MECHANICAL-PROPERTIES; SURGICAL IMPLANTS; BONE INGROWTH; TITANIUM;
   FIXATION; METAL; PROSTHESIS; SURFACE
AB For the first time, a highly porous strong Ti6Al4V was produced by using a "polymeric sponge replication" method. A polymeric sponge, impregnated with a Ti6Al4V slurry prepared from Ti6A14V powders and binders, was subjected to drying and pyrolyzing to remove the polymeric sponge and binders. After sintering at a high temperature and under high vacuum, a porous Ti6A14V was produced. Optical microscopical observation, environmental scanning electron microscopy observation (with energy-dispersive micro X-ray analysis), mechanical tests, and metallurgical analyses were performed on the obtained porous Ti6A14V with regard to the porous structure (both macropores and micropores), mechanical properties, chemical composition, phase compositions, and cell attachment behavior. The porous Ti6A14V made by this method had a three-dimensional trabecular porous structure with interconnected pores mainly ranging from 400 to 700 mu m and a total porosity of about 90%. The compressive strength was 10.3 +/- 3.3 MPa and the elastic constant 0.8 +/- 0.3 GPa. MC3T3-E1 cells attached and spread well in the inner surface of pores. Being similar to cancellous, bone with regard to both interconnected porous structure and mechanical properties, the resulting porous Ti6A14V is expected to be a promising biomaterial for biomedical applications. (c) 2005 Wiley Periodicals, Inc. J Biomed Mater Res 73A: 223-233, 2005.
C1 Univ Twente, NL-3723 MB Bilthoven, Netherlands.
   Beihang Univ, Sch Mech Engn & Automat, Beijing, Peoples R China.
RP Li, JP (reprint author), Univ Twente, Prof Bronkhorstlaan 10-D, NL-3723 MB Bilthoven, Netherlands.
EM j.li@tnw.utwente.nl
OI van Blitterswijk, Clemens/0000-0003-2371-4615
CR Akiyama S, 1987, US Patent, Patent No. 4713277
   ASAOKA K, 1985, J BIOMED MATER RES, V19, P699, DOI 10.1002/jbm.820190609
   BOBYN JD, 1982, CLIN ORTHOP RELAT R, P301
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P291
   CAMERON HU, 1976, J BIOMED MATER RES, V10, P295
   CHEN PQ, 1983, CLIN ORTHOP RELAT R, P24
   CLEMOW AJT, 1981, J BIOMED MATER RES, V15, P73, DOI 10.1002/jbm.820150111
   COOK SD, 1985, BIOMATER ARTIF CELL, V13, P37, DOI 10.3109/10731198509118841
   COOK SD, 1986, BIOMATER ARTIF CELL, V14, P167, DOI 10.3109/10731198609117541
   COOK SD, 1988, J BIOMED MATER RES, V22, P287, DOI 10.1002/jbm.820220404
   DUCHEYNE P, 1984, J BIOMED MATER RES, V18, P293, DOI 10.1002/jbm.820180306
   ENGH CA, 1983, CLIN ORTHOP RELAT R, P52
   Galanete J., 1973, J BIOMED MATER RES, V4, P43, DOI DOI 10.1002/JBM.820070305
   GALANTE J, 1971, J BONE JOINT SURG AM, VA 53, P101, DOI 10.2106/00004623-197153010-00009
   Gergely V, 2003, COMPOS SCI TECHNOL, V63, P2301, DOI 10.1016/S0266-3538(03)00263-X
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
   GU HQ, 1993, BIOMEDICAL MAT SCI
   HAHN H, 1970, Journal of Biomedical Materials Research, V4, P571, DOI 10.1002/jbm.820040407
   Katz J L, 1988, Ann N Y Acad Sci, V523, P283, DOI 10.1111/j.1749-6632.1988.tb38522.x
   Kohn D.H., 1992, MAT SCI TECHNOLOGY C, P31
   KOHN DH, 1990, J BIOMED MATER RES, V24, P1483, DOI 10.1002/jbm.820241106
   KUO KN, 1983, CLIN ORTHOP RELAT R, P108
   Kwon SH, 2002, J AM CERAM SOC, V85, P3129
   LANDON GC, 1986, CLIN ORTHOP RELAT R, P49
   LIN JY, 2000, POWDER METALL TECHNO, V18, P12
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MANIATOPOULOS C, 1988, J PROSTHET DENT, V59, P438, DOI 10.1016/0022-3913(88)90039-X
   MANIATOPOULOS C, 1988, J PROSTHET DENT, V59, P662, DOI 10.1016/0022-3913(88)90378-2
   MANIATOPOULOS C, 1986, J BIOMED MATER RES, V20, P1309, DOI 10.1002/jbm.820200907
   MATIN B, 2000, ADV ENG MATER, V2, P196
   MU W, 1998, TITANIUM METALLURGY
   MURRAY GAW, 1981, J BONE JOINT SURG BR, V63, P138
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   Oliveira M.V., 2002, Mat. Res., V5, P269, DOI 10.1590/S1516-14392002000300009
   Pilliar R M, 1998, Implant Dent, V7, P305, DOI 10.1097/00008505-199807040-00009
   Pilliar R M, 1998, Oral Health, V88, P61
   PILLIAR RM, 1983, CLIN ORTHOP RELAT R, P42
   Pilliar RM, 1998, INT J POWDER METALL, V34, P33
   PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1
   PILLIAR RM, 1975, BIOMED ENG, V10, P126
   PILLIAR RM, 1981, CLIN ORTHOP RELAT R, P249
   Simmons CA, 1999, J BIOMED MATER RES, V47, P127, DOI 10.1002/(SICI)1097-4636(199911)47:2<127::AID-JBM3>3.0.CO;2-C
   WEGMANN G, 2001, P EUR ADV MAT WEEK C
   WEINSTEIN AM, 1977, P 3 ANN M SOC BIOM N
   WELSH RP, 1971, J BONE JOINT SURG AM, VA 53, P963, DOI 10.2106/00004623-197153050-00011
   Wilke A, 1999, ATLA-ALTERN LAB ANIM, V27, P137
   Wilson CE, 2004, J BIOMED MATER RES A, V68A, P123, DOI 10.1002/jbm.a.20015
   WU B, 1990, TECHNOLOGY POWDER ME, V8, P145
   Wu BD, 1988, RARE METAL MAT ENG, V4, P55
   Zhang C, 2000, J BIOMED MATER RES, V52, P354
NR 50
TC 92
Z9 94
U1 3
U2 29
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY 1
PY 2005
VL 73A
IS 2
BP 223
EP 233
DI 10.1002/jbm.a.30278
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 915FV
UT WOS:000228284400011
PM 15761810
DA 2018-10-20
ER

EF